Citrus Sinensis ID: 017936

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360---
Protein Sequence
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIVYAM
Secondary Structure (PSIPRED)
cccccccccccccccccccccccEEEEEEccccEEEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHcccccccEEEEEEEcccEEEEEEEEcccccHHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEccccccccccccccccccccccccccHHcccccccccccccHHHHHHHHHHHHcccccccccccHHHHHHHcHHccEEEEccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccccHHHHHHHHHHHcccccccccHHHcccccccccccccccccccccccccccccEEEEc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccHHHHEHHHHEccccccEEEEEEEEcccccEEEEEEcHccccccHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccccEEEEcccEEEEccccccccccccHHEHcHHHHHHHHccccccEEEHHHHEEEEEEccccccccccccHHHHHHHHccEEEEccccccccccHHHHHHHHHHHcccccHcccHHHHHccccHcccccccccccHHHHHHHHHccHHHHHHHHHHHHHHHccccccccccHHHHcccccccHHHHHHHHHHHHHcccccccEEEEEc
Coil and Loop (DISEMBL)
mdrsamtvgpgmdmpimhdsdrYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINhrslrhpnivrfkeviltpTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKlentlldgspaprlkicdfgyskssvlhsqpkstvgtpayiapevllkkeydgkiadvWSCGVTLYVMLVgaypfedpeepknfRKTIHRILSVqysipdyvhispECRHLISRifvadpakrisipeirnhewflknlpadlvvdnttnnqfeepdqpmqsIDEIMQIIAEAtipaagtqslnqclngsldiddemdedidtdpdldidssgeivyam
Flexible Loop (DISEMBL)
mdrsamtvgpgmdmpiMHDSDRYELVRDIGSGNfgvarlmrdkktEELVAVKyiergdkidenVQREIinhrslrhpnivrfKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSvlhsqpkstvgtpayiAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDedidtdpdldidssgeivyam
Low Complexity Region (SEG)
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLdiddemdedidtdpdldidSSGEIVYAM
Disordered region (IsUnstruct)
*********************RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH****STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNT****************EIMQIIAEATIPAAGTQSLNQCLN*******************************
Disordered Region (DISOPRED)
**********************YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVV*****************************************LNGSLDIDDEM***********IDSSGEIVYAM
Disordered Region (DISEMBL)
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIVYAM
Disordered Region (DISPRO)
**********GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIVYAM
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIVYAM
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	363	2.2.26 [Sep-21-2011]
Q940H6	362	Serine/threonine-protein	yes	no	0.994	0.997	0.887	0.0
Q75H77	362	Serine/threonine-protein	yes	no	0.997	1.0	0.862	0.0
Q75V57	361	Serine/threonine-protein	no	no	0.991	0.997	0.824	1e-174
Q39193	361	Serine/threonine-protein	no	no	0.986	0.991	0.808	1e-173
Q7Y0B9	371	Serine/threonine-protein	no	no	0.892	0.873	0.867	1e-170
Q39192	362	Serine/threonine-protein	no	no	0.958	0.961	0.780	1e-165
A2YNT8	339	Serine/threonine-protein	N/A	no	0.931	0.997	0.725	1e-146
Q0D4J7	339	Serine/threonine-protein	no	no	0.851	0.911	0.776	1e-146
Q75LR7	342	Serine/threonine-protein	no	no	0.829	0.880	0.784	1e-144
P0C5D6	334	Serine/threonine-protein	no	no	0.900	0.979	0.706	1e-142

>sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1

 Score =  647 bits (1670), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 323/364 (88%), Positives = 343/364 (94%), Gaps = 3/364 (0%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1   MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           +IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL+ DNT   QF+E 
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298

Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEM-DEDIDTDPDLDIDSSGEI 359
           DQP QSI+EIMQIIAEAT+P AGTQ+LN  L GSLDIDD+M ++      DLDIDSSGEI
Sbjct: 299 DQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSGEI 358

Query: 360 VYAM 363
           VYAM
Sbjct: 359 VYAM 362

Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1

 Score =  640 bits (1652), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 313/363 (86%), Positives = 336/363 (92%), Gaps = 1/363 (0%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDR+A+TVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMR +   +LVAVKYIERGDKI
Sbjct: 1   MDRAALTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRSRADGQLVAVKYIERGDKI 60

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EPKNFRKTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQRILGVQY 240

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           SIPDYVHISPECR LI+RIFVA+PA RISIPEIRNH WFLKNLPADL+ D+  ++Q+EEP
Sbjct: 241 SIPDYVHISPECRDLIARIFVANPATRISIPEIRNHPWFLKNLPADLMDDSKMSSQYEEP 300

Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 360
           +QPMQS+DEIMQI+AEATIPAAG+  +NQ         D+  ED+D+DPDLD++SSGEIV
Sbjct: 301 EQPMQSMDEIMQILAEATIPAAGSGGINQ-FLNDGLDLDDDMEDLDSDPDLDVESSGEIV 359

Query: 361 YAM 363
           YAM
Sbjct: 360 YAM 362

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1

 Score =  610 bits (1572), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 300/364 (82%), Positives = 335/364 (92%), Gaps = 4/364 (1%)

Query: 1   MDRSAMTVGP-GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK 59
           M+R+A   GP GM+MPIMHD DRYELV++IGSGNFGVARLMR++ + +LVAVKYI+RG+K
Sbjct: 1   MERAA--AGPLGMEMPIMHDGDRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEK 58

Query: 60  IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
           IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERIC+AGRFSEDEA
Sbjct: 59  IDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEA 118

Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
           RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTV
Sbjct: 119 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTV 178

Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
           GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI +IL VQ
Sbjct: 179 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQKILGVQ 238

Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 299
           YSIPDYVHISPECR LI+RIFV +PA RI++PEI+NH WF+KN+PADL+ D   +NQ+EE
Sbjct: 239 YSIPDYVHISPECRDLITRIFVGNPASRITMPEIKNHPWFMKNIPADLMDDGMVSNQYEE 298

Query: 300 PDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEI 359
           PDQPMQ+++EIMQI+AEATIPAAGT  +NQ L  SLD+DD+M++      DLDI+SSGEI
Sbjct: 299 PDQPMQNMNEIMQILAEATIPAAGTSGINQFLTDSLDLDDDMEDMDSDL-DLDIESSGEI 357

Query: 360 VYAM 363
           VYAM
Sbjct: 358 VYAM 361

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1

 Score =  608 bits (1567), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 296/366 (80%), Positives = 332/366 (90%), Gaps = 8/366 (2%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1   MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           SIPD + ISPEC HLISRIFVADPA RISIPEI+ H WFLKNLPADL+ ++ T +QF+EP
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299

Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLD---IDDEMDEDIDTDPDLDIDSSG 357
           +QPMQS+D IMQII+EATIPA      N+CL+  +      D+  +D D++ ++DIDSSG
Sbjct: 300 EQPMQSLDTIMQIISEATIPAVR----NRCLDDFMTDNLDLDDDMDDFDSESEIDIDSSG 355

Query: 358 EIVYAM 363
           EIVYA+
Sbjct: 356 EIVYAL 361

Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1

 Score =  598 bits (1542), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 281/324 (86%), Positives = 308/324 (95%)

Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           DR+A+TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRD++T ELVAVKYIERG+KID
Sbjct: 12  DRAALTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDRRTMELVAVKYIERGEKID 71

Query: 62  ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
           +NVQREIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELFERIC   RFSEDEAR+
Sbjct: 72  DNVQREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFERICKNVRFSEDEARY 131

Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
           FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 132 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 191

Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
           PAYIAPEVLLKKEYDGK ADVWSCGVTLYVM+VGAYPFEDPEEPKNFRKTI RIL+VQYS
Sbjct: 192 PAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVGAYPFEDPEEPKNFRKTIQRILNVQYS 251

Query: 242 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPD 301
           IP+ V ISPECRHLISRIFV DP+ RI+IPEIR+H WFLKNLPADL+ D++ ++Q+EEPD
Sbjct: 252 IPENVDISPECRHLISRIFVGDPSLRITIPEIRSHGWFLKNLPADLMDDDSMSSQYEEPD 311

Query: 302 QPMQSIDEIMQIIAEATIPAAGTQ 325
           QPMQ++D+IMQI+ EATIP A ++
Sbjct: 312 QPMQTMDQIMQILTEATIPPACSR 335

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1

 Score =  580 bits (1496), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 277/355 (78%), Positives = 320/355 (90%), Gaps = 7/355 (1%)

Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
           +D+PIMHDSDRY+ V+DIGSGNFGVARLM D+ T+ELVAVKYIERG+KIDENVQREIINH
Sbjct: 12  IDLPIMHDSDRYDFVKDIGSGNFGVARLMTDRVTKELVAVKYIERGEKIDENVQREIINH 71

Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           RSLRHPNIVRFKEVILTP+HLAIVMEYA+GGEL+ERICNAGRFSEDEARFFFQQLISGVS
Sbjct: 72  RSLRHPNIVRFKEVILTPSHLAIVMEYAAGGELYERICNAGRFSEDEARFFFQQLISGVS 131

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           YCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE+LL
Sbjct: 132 YCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEILL 191

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
           ++EYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+++RKTI RILSV YSIP+ +H+SPE
Sbjct: 192 RQEYDGKLADVWSCGVTLYVMLVGAYPFEDPQEPRDYRKTIQRILSVTYSIPEDLHLSPE 251

Query: 252 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIM 311
           CRHLISRIFVADPA RI+IPEI + +WFLKNLP DL+ +N   +QF+EP+QPMQS+D IM
Sbjct: 252 CRHLISRIFVADPATRITIPEITSDKWFLKNLPGDLMDENRMGSQFQEPEQPMQSLDTIM 311

Query: 312 QIIAEATIPAAGTQSLNQCLN---GSLDIDDEMDEDIDTDPDLDIDSSGEIVYAM 363
           QII+EATIP       N+CL+         D+  +D D++ ++D+DSSGEIVYA+
Sbjct: 312 QIISEATIPTVR----NRCLDDFMADNLDLDDDMDDFDSESEIDVDSSGEIVYAL 362

Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2

 Score =  520 bits (1338), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 249/343 (72%), Positives = 292/343 (85%), Gaps = 5/343 (1%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
           +RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2   ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
           RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           RDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181

Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
           DVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI RILSVQY +PDYV +S ECRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241

Query: 261 VADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 320
           VA+P +RI+IPEI+NH WFLKNLP ++  +   + Q  + + P Q ++EIM II EA  P
Sbjct: 242 VANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARKP 301

Query: 321 AAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIVYAM 363
             G++      +G +     M+ D     D+D++ SG+ V A+
Sbjct: 302 GDGSK-----FSGQIPGLGSMELDDIDTDDIDVEDSGDFVCAL 339

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1

 Score =  518 bits (1334), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 240/309 (77%), Positives = 276/309 (89%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
           +RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2   ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
           RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           RDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181

Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
           DVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI RILSVQY +PDYV +S ECRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241

Query: 261 VADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 320
           VA+P +RI+IPEI+NH WFLKNLP ++  +   + Q  + + P Q ++EIM II EA  P
Sbjct: 242 VANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARKP 301

Query: 321 AAGTQSLNQ 329
             G++   Q
Sbjct: 302 GDGSKFSGQ 310

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1

 Score =  509 bits (1312), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 236/301 (78%), Positives = 269/301 (89%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
           +RYE++RDIGSGNFGVA+L+RD  T  L AVK+IERG KIDE+VQREI+NHRSL+HPNI+
Sbjct: 2   ERYEVMRDIGSGNFGVAKLVRDVATNHLFAVKFIERGLKIDEHVQREIMNHRSLKHPNII 61

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH
Sbjct: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 121

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           RDLKLENTLLDGS  PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSVTPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKVA 181

Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
           DVWSCGVTLYVMLVGAYPFEDP++P+NFRKTI RILSVQYSIPDYV +S +CRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTITRILSVQYSIPDYVRVSADCRHLLSRIF 241

Query: 261 VADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 320
           V +P +RI+IPEI+NH WFLKNLP ++  +   + Q  + + P QS++E+M II EA  P
Sbjct: 242 VGNPEQRITIPEIKNHPWFLKNLPIEMTDEYQRSMQLADMNTPSQSLEEVMAIIQEARKP 301

Query: 321 A 321
            
Sbjct: 302 G 302

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0C5D6|SAPK3_ORYSJ Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. japonica GN=SAPK3 PE=1 SV=1

 Score =  503 bits (1296), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 234/331 (70%), Positives = 282/331 (85%), Gaps = 4/331 (1%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
           +RYE ++++G+GNFGVARL+RDK+++ELVAVKYIERG KIDENVQREIINHRSLRHPNI+
Sbjct: 3   ERYEALKELGAGNFGVARLVRDKRSKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
           RFKEV LTPTHLAIVMEYA+GGELFE+IC AGRFSEDEAR+FFQQLISGVSYCHS+++CH
Sbjct: 63  RFKEVCLTPTHLAIVMEYAAGGELFEQICTAGRFSEDEARYFFQQLISGVSYCHSLEICH 122

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           RDLKLENTLLDGSP PR+KICDFGYSKS++LHS+PKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 123 RDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGKVA 182

Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
           DVWSCGVTLYVMLVG+YPFEDP +P+NFRKTI RIL VQYSIPDYV +S +CR L+S+IF
Sbjct: 183 DVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQIF 242

Query: 261 VADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 320
           VADP+KRI+IPEI+ H WFLKNLP ++      + +  +   P Q+++EIM+II EA +P
Sbjct: 243 VADPSKRITIPEIKKHTWFLKNLPKEISEREKADYKDTDAAPPTQAVEEIMRIIQEAKVP 302

Query: 321 ----AAGTQSLNQCLNGSLDIDDEMDEDIDT 347
               AA    L +      D ++E  ++ DT
Sbjct: 303 GDMAAADPALLAELAELKSDDEEEAADEYDT 333

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	363
255561655	363	Serine/threonine-protein kinase SAPK10,	1.0	1.0	0.911	0.0
224123434	363	predicted protein [Populus trichocarpa]	1.0	1.0	0.911	0.0
388491244	363	unknown [Medicago truncatula]	1.0	1.0	0.925	0.0
225428695	363	PREDICTED: serine/threonine-protein kina	1.0	1.0	0.914	0.0
356575154	364	PREDICTED: serine/threonine-protein kina	1.0	0.997	0.945	0.0
147788088	363	hypothetical protein VITISV_025025 [Viti	1.0	1.0	0.909	0.0
224105505	362	predicted protein [Populus trichocarpa]	0.997	1.0	0.909	0.0
359475222	371	PREDICTED: serine/threonine-protein kina	1.0	0.978	0.894	0.0
356575156	373	PREDICTED: serine/threonine-protein kina	1.0	0.973	0.922	0.0
356521207	364	PREDICTED: serine/threonine-protein kina	1.0	0.997	0.934	0.0

>gi|255561655|ref|XP_002521837.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538875|gb|EEF40473.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis]

 Score =  701 bits (1810), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/363 (91%), Positives = 356/363 (98%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDRSA+T+GPGMD+PIMHDSDRYELV+DIG+GNFGVARLMRDK+T+ELVAVKYIERG+KI
Sbjct: 1   MDRSALTIGPGMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQTDELVAVKYIERGEKI 60

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 240

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           SIPDYVHISPEC+HLISRIFVADPAKRISIPEI+NHEWFLKNLPADL+ D T NNQF+EP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAKRISIPEIKNHEWFLKNLPADLMDDKTINNQFDEP 300

Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 360
           +QP+QSIDEIMQII+EATIPAAGT + NQ L GSLDIDD+M+ED+++DP+LD+DSSGEIV
Sbjct: 301 EQPVQSIDEIMQIISEATIPAAGTGNPNQYLTGSLDIDDDMEEDLESDPELDMDSSGEIV 360

Query: 361 YAM 363
           YAM
Sbjct: 361 YAM 363

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224123434|ref|XP_002330314.1| predicted protein [Populus trichocarpa] gi|222871349|gb|EEF08480.1| predicted protein [Populus trichocarpa]

 Score =  701 bits (1808), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/363 (91%), Positives = 350/363 (96%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDRS MTVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMRDK+ +ELVAVKYIERG+KI
Sbjct: 1   MDRSVMTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRDKQADELVAVKYIERGEKI 60

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN+GRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNSGRFSEDEAR 120

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP STVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPTSTVG 180

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EP+NFR TIHRIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPRNFRSTIHRILNVQY 240

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           SIPDYVHISPEC+HLISRIFVADPAKRI+IPEIRNH+WFLKN PADL+V+N  NNQFEEP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAKRITIPEIRNHDWFLKNFPADLMVENNMNNQFEEP 300

Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 360
           DQPMQSIDEIMQII EATIPAAGT SLN  L GSLDIDDEM+ED+++DP+LD+DSSGEIV
Sbjct: 301 DQPMQSIDEIMQIITEATIPAAGTPSLNHYLTGSLDIDDEMEEDLESDPELDLDSSGEIV 360

Query: 361 YAM 363
           YAM
Sbjct: 361 YAM 363

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388491244|gb|AFK33688.1| unknown [Medicago truncatula]

 Score =  700 bits (1807), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/363 (92%), Positives = 350/363 (96%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDR A  VGPGMDM IMHDSDRYELVRDIGSGNFGVARLMRDK+TEELVAVKYIERG+KI
Sbjct: 1   MDRPANVVGPGMDMLIMHDSDRYELVRDIGSGNFGVARLMRDKQTEELVAVKYIERGEKI 60

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENVQREIINHRSLR PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRRPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQLISGVSYCH+M+VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMEVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI+RIL+V Y
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTINRILNVHY 240

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           SIPDYVHISPEC+HLISRIFVADPAKRISIPEIRNHEWFLKNLP DL+ DN TNNQFEEP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAKRISIPEIRNHEWFLKNLPTDLMDDNGTNNQFEEP 300

Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 360
           DQP QS++EIMQIIAEAT+PAAGTQSLN  L GSLDIDD+M+ED+DTDPDLDIDSSGEIV
Sbjct: 301 DQPTQSVEEIMQIIAEATVPAAGTQSLNPYLTGSLDIDDDMEEDLDTDPDLDIDSSGEIV 360

Query: 361 YAM 363
           YAM
Sbjct: 361 YAM 363

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera]

 Score =  697 bits (1798), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 332/363 (91%), Positives = 348/363 (95%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDRSA+TVGP MD+PIMHDSDRYELVRDIGSGNFGVARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1   MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 240

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           SIPDYVHISPECRHLISRIFVADPA RI+I EIRNHEWFLKNLPADL+ +   +NQ+EEP
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPATRITIAEIRNHEWFLKNLPADLMDETKMDNQYEEP 300

Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 360
           +QPMQSIDEIM+II EA IPAAGTQSLNQ L GSLDIDDEM+ED++TDPDLDIDSSGEIV
Sbjct: 301 EQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSGEIV 360

Query: 361 YAM 363
           YAM
Sbjct: 361 YAM 363

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575154|ref|XP_003555707.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max]

 Score =  694 bits (1790), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/364 (94%), Positives = 355/364 (97%), Gaps = 1/364 (0%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61  DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           SIPDYVHISPECRHLISRIFVADPA+RISIPEIRNHEWFL+NLPADL+V+NT NNQFEEP
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPAQRISIPEIRNHEWFLRNLPADLMVENTMNNQFEEP 300

Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS-LDIDDEMDEDIDTDPDLDIDSSGEI 359
           DQPMQSI+EIMQII+EATIPAAGTQSLNQ L GS    DD+MDED++TDPDLDIDSSGEI
Sbjct: 301 DQPMQSIEEIMQIISEATIPAAGTQSLNQYLTGSLDIDDDDMDEDLETDPDLDIDSSGEI 360

Query: 360 VYAM 363
           VYAM
Sbjct: 361 VYAM 364

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147788088|emb|CAN62745.1| hypothetical protein VITISV_025025 [Vitis vinifera]

 Score =  692 bits (1786), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/363 (90%), Positives = 347/363 (95%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDRSA+TVGP MD+PIMHDSDRYELVRDIGSGNFGVARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1   MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSSAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 240

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           SIPDYVHISPECRHLISRIFVADPA RI+I EIRNH+WFLKNLPADL+ +   +NQ+EEP
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPATRITIAEIRNHDWFLKNLPADLMDETKMDNQYEEP 300

Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 360
           +QPMQSIDEIM+II EA IPAAGTQSLNQ L GSLDIDDEM+ED++TDPDLDIDSSGEIV
Sbjct: 301 EQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSGEIV 360

Query: 361 YAM 363
           YAM
Sbjct: 361 YAM 363

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224105505|ref|XP_002313835.1| predicted protein [Populus trichocarpa] gi|222850243|gb|EEE87790.1| predicted protein [Populus trichocarpa]

 Score =  692 bits (1786), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/363 (90%), Positives = 353/363 (97%), Gaps = 1/363 (0%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDRSAMTVGPGMD+PIMHD DRYELV+DIGSGNFGVARLMRDK+T++LVAVKYIERG+KI
Sbjct: 1   MDRSAMTVGPGMDLPIMHDGDRYELVKDIGSGNFGVARLMRDKQTDDLVAVKYIERGEKI 60

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC AGRFSEDEAR
Sbjct: 61  DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICIAGRFSEDEAR 120

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EP NFR TIHRIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPMNFRNTIHRILNVQY 240

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           SIPDYVHISPEC+HLISRIFVADPA RI+IPEIRNHEWFLKNLPADL+V+NT NN+FEEP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAMRITIPEIRNHEWFLKNLPADLMVENTMNNEFEEP 300

Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 360
           DQPMQSI+EIMQII+EATIPAAGT SLNQ L GSLDIDD+M ED+++DP+LD+DSSGEIV
Sbjct: 301 DQPMQSIEEIMQIISEATIPAAGTPSLNQYLTGSLDIDDDM-EDLESDPELDLDSSGEIV 359

Query: 361 YAM 363
           YAM
Sbjct: 360 YAM 362

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475222|ref|XP_003631617.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 3 [Vitis vinifera]

 Score =  690 bits (1780), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 332/371 (89%), Positives = 348/371 (93%), Gaps = 8/371 (2%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDRSA+TVGP MD+PIMHDSDRYELVRDIGSGNFGVARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1   MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE-- 118
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE  
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEVL 120

Query: 119 ------ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172
                 ARFFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH
Sbjct: 121 MQLAHLARFFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 180

Query: 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
           SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI
Sbjct: 181 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTI 240

Query: 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNT 292
            RIL VQYSIPDYVHISPECRHLISRIFVADPA RI+I EIRNHEWFLKNLPADL+ +  
Sbjct: 241 QRILKVQYSIPDYVHISPECRHLISRIFVADPATRITIAEIRNHEWFLKNLPADLMDETK 300

Query: 293 TNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLD 352
            +NQ+EEP+QPMQSIDEIM+II EA IPAAGTQSLNQ L GSLDIDDEM+ED++TDPDLD
Sbjct: 301 MDNQYEEPEQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLD 360

Query: 353 IDSSGEIVYAM 363
           IDSSGEIVYAM
Sbjct: 361 IDSSGEIVYAM 371

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575156|ref|XP_003555708.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 2 [Glycine max]

 Score =  687 bits (1773), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/373 (92%), Positives = 355/373 (95%), Gaps = 10/373 (2%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61  DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVL 171
           FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK         SSVL
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVHFLRTVISSSVL 180

Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231
           HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT
Sbjct: 181 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 240

Query: 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDN 291
           IHRIL VQYSIPDYVHISPECRHLISRIFVADPA+RISIPEIRNHEWFL+NLPADL+V+N
Sbjct: 241 IHRILKVQYSIPDYVHISPECRHLISRIFVADPAQRISIPEIRNHEWFLRNLPADLMVEN 300

Query: 292 TTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS-LDIDDEMDEDIDTDPD 350
           T NNQFEEPDQPMQSI+EIMQII+EATIPAAGTQSLNQ L GS    DD+MDED++TDPD
Sbjct: 301 TMNNQFEEPDQPMQSIEEIMQIISEATIPAAGTQSLNQYLTGSLDIDDDDMDEDLETDPD 360

Query: 351 LDIDSSGEIVYAM 363
           LDIDSSGEIVYAM
Sbjct: 361 LDIDSSGEIVYAM 373

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356521207|ref|XP_003529248.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max]

 Score =  687 bits (1772), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/364 (93%), Positives = 353/364 (96%), Gaps = 1/364 (0%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDRSAMTVGPGMDMPIMHDSD+YELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1   MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61  DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           SIPDYVHIS ECRHLISRIFVADPA+RISIPEIRNHEWFLKNLPADL+V+NT N QFEEP
Sbjct: 241 SIPDYVHISSECRHLISRIFVADPAQRISIPEIRNHEWFLKNLPADLMVENTMNRQFEEP 300

Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS-LDIDDEMDEDIDTDPDLDIDSSGEI 359
           DQPMQSI+EIMQII+EATIPAAGTQSLNQ L GS    DD+MDED++TDPDLDIDSSGEI
Sbjct: 301 DQPMQSIEEIMQIISEATIPAAGTQSLNQYLTGSLDIDDDDMDEDLETDPDLDIDSSGEI 360

Query: 360 VYAM 363
           VYA+
Sbjct: 361 VYAI 364

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	363
TAIR|locus:2118929	362	OST1 "OPEN STOMATA 1" [Arabido	0.994	0.997	0.859	1.1e-165
TAIR|locus:2174999	361	SNRK2.3 "sucrose nonfermenting	0.994	1.0	0.796	2.7e-155
TAIR|locus:2206046	361	SNRK2.10 "SNF1-related protein	0.845	0.850	0.75	6.8e-127
TAIR|locus:2160559	360	SNRK2.5 "SNF1-related protein	0.845	0.852	0.746	1.4e-126
TAIR|locus:2159597	353	SNRK2.1 "SNF1-related protein	0.865	0.889	0.726	3.7e-126
TAIR|locus:2140104	350	SNRK2.7 "SNF1-related protein	0.842	0.874	0.725	1.5e-122
TAIR|locus:2032075	343	SNRK2-8 "SNF1-RELATED PROTEIN	0.812	0.860	0.756	3.1e-122
TAIR|locus:2045319	339	SNRK2.9 "SNF1-related protein	0.826	0.884	0.697	2.8e-114
TAIR|locus:2102132	535	KIN10 "AT3G01090" [Arabidopsis	0.713	0.484	0.468	3.7e-55
DICTYBASE|DDB_G0277905	727	snfA "AMP-activated protein ki	0.721	0.360	0.461	7.8e-55

TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1612 (572.5 bits), Expect = 1.1e-165, P = 1.1e-165
 Identities = 313/364 (85%), Positives = 330/364 (90%)

Query:     1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
             MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct:     1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58

Query:    61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
             DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct:    59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118

Query:   121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
             FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct:   119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178

Query:   181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
             TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct:   179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238

Query:   241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
             +IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL+ DNT   QF+E 
Sbjct:   239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298

Query:   301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLXXXXXXXXXXXXXXXXXXX-SSGEI 359
             DQP QSI+EIMQIIAEAT+P AGTQ+LN  L GSL                    SSGEI
Sbjct:   299 DQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSGEI 358

Query:   360 VYAM 363
             VYAM
Sbjct:   359 VYAM 362

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009414 "response to water deprivation" evidence=IGI;IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IDA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0009931 "calcium-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:2000377 "regulation of reactive oxygen species metabolic process" evidence=IMP

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010118 "stomatal movement" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005985 "sucrose metabolic process" evidence=IMP

GO:0006636 "unsaturated fatty acid biosynthetic process" evidence=IMP

GO:0019432 "triglyceride biosynthetic process" evidence=IMP

GO:0040007 "growth" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0042744 "hydrogen peroxide catabolic process" evidence=RCA

TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1514 (538.0 bits), Expect = 2.7e-155, P = 2.7e-155
 Identities = 289/363 (79%), Positives = 320/363 (88%)

Query:     1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
             MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct:     1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59

Query:    61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
             DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct:    60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119

Query:   121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
             FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct:   120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179

Query:   181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
             TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+Y
Sbjct:   180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239

Query:   241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
             SIPD + ISPEC HLISRIFVADPA RISIPEI+ H WFLKNLPADL+ ++ T +QF+EP
Sbjct:   240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299

Query:   301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLXXXXXXXXXXXXXXXXXXXSSGEIV 360
             +QPMQS+D IMQII+EATIPA   + L+  +  +L                   SSGEIV
Sbjct:   300 EQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDID-SSGEIV 358

Query:   361 YAM 363
             YA+
Sbjct:   359 YAL 361

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009789 "positive regulation of abscisic acid mediated signaling pathway" evidence=IGI

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0009739 "response to gibberellin stimulus" evidence=IGI

GO:0010029 "regulation of seed germination" evidence=IGI;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0009414 "response to water deprivation" evidence=IGI

TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1246 (443.7 bits), Expect = 6.8e-127, P = 6.8e-127
 Identities = 231/308 (75%), Positives = 271/308 (87%)

Query:    21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
             D+YELV+DIG+GNFGVARLMR K ++ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct:     2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61

Query:    81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
             RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct:    62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121

Query:   141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
             RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL + EYDGK+A
Sbjct:   122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181

Query:   201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
             DVWSCGVTLYVMLVGAYPFED E+PKNF+KTI RI++V+Y IPDYVHIS +C+HL+SRIF
Sbjct:   182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRIF 241

Query:   261 VADPAKRISIPEIRNHEWFLKNLPADLV-VDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 319
             V +  KRI+I +I+ H WFLKNLP +L  +      + E P   +QS++EIM+I+ EA  
Sbjct:   242 VTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFRKENPTFSLQSVEEIMKIVEEAKT 301

Query:   320 PAAGTQSL 327
             PA  ++S+
Sbjct:   302 PARVSRSI 309

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA;RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0048527 "lateral root development" evidence=IMP

GO:0070300 "phosphatidic acid binding" evidence=IDA

TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1243 (442.6 bits), Expect = 1.4e-126, P = 1.4e-126
 Identities = 230/308 (74%), Positives = 269/308 (87%)

Query:    21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
             D+YE+V+D+G+GNFGVARL+R K+T+ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct:     2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61

Query:    81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
             RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct:    62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121

Query:   141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
             RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct:   122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181

Query:   201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
             DVWSCGVTLYVMLVG YPFEDP++P+NFRKTI RI++VQY IPDYVHIS ECRHL+SRIF
Sbjct:   182 DVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRIF 241

Query:   261 VADPAKRISIPEIRNHEWFLKNLPADLVVD-NTTNNQFEEPDQPMQSIDEIMQIIAEATI 319
             V + AKRI++ EI+ H W+LKNLP +L         + E P   +QS+++IM+I+ EA  
Sbjct:   242 VTNSAKRITLKEIKKHPWYLKNLPKELTEPAQAAYYKRETPSFSLQSVEDIMKIVGEARN 301

Query:   320 PAAGTQSL 327
             PA  + ++
Sbjct:   302 PAPSSNAV 309

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1239 (441.2 bits), Expect = 3.7e-126, P = 3.7e-126
 Identities = 228/314 (72%), Positives = 270/314 (85%)

Query:    21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
             D+Y++V+D+G+GNFGVARL+R K T+ELVA+KYIERG KIDENV REIINHRSL+HPNI+
Sbjct:     2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61

Query:    81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
             RFKEVILTPTHLAIVMEYASGGELF+RIC AGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct:    62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121

Query:   141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
             RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct:   122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181

Query:   201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
             DVWSCGVTLYVMLVGAYPFEDP +PKNFRKTI RI++VQY IPDYVHIS EC+HL+SRIF
Sbjct:   182 DVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRIF 241

Query:   261 VADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 320
             V + AKRI++ EI+NH W+LKNLP +L+          +    +QS+++IM+I+ EA  P
Sbjct:   242 VTNSAKRITLKEIKNHPWYLKNLPKELLESAQAAYYKRDTSFSLQSVEDIMKIVGEARNP 301

Query:   321 AAGTQSLNQCLNGS 334
             A  T ++    +G+
Sbjct:   302 APSTSAVKSSGSGA 315

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1205 (429.2 bits), Expect = 1.5e-122, P = 1.5e-122
 Identities = 225/310 (72%), Positives = 263/310 (84%)

Query:    21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
             +RY+++RD+GSGNFGVA+L+R+K   E  AVKYIERG KIDE+VQREIINHR L+HPNI+
Sbjct:     2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61

Query:    81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
             RFKEV +TPTHLAIVMEYA+GGELFERICNAGRFSEDE R++F+QLISGVSYCH+MQ+CH
Sbjct:    62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121

Query:   141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
             RDLKLENTLLDGSP+  LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL +KEY+GKIA
Sbjct:   122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIA 181

Query:   201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
             DVWSCGVTLYVMLVGAYPFEDPE+P+N R TI RILSV Y+IPDYV IS EC+HL+SRIF
Sbjct:   182 DVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLSRIF 241

Query:   261 VADPAKRISIPEIRNHEWFLKNL----PADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 316
             VADP KRI++PEI  H WFLK      P +   DN    + EE ++  QS++EI++II E
Sbjct:   242 VADPDKRITVPEIEKHPWFLKGPLVVPPEEEKCDNGVEEEEEEEEKCRQSVEEIVKIIEE 301

Query:   317 ATIPAAGTQS 326
             A     GT +
Sbjct:   302 ARKGVNGTDN 311

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1202 (428.2 bits), Expect = 3.1e-122, P = 3.1e-122
 Identities = 227/300 (75%), Positives = 262/300 (87%)

Query:    21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
             +RYE+V+DIGSGNFGVA+L+RDK ++EL AVK+IERG KIDE+VQREI+NHRSL HPNI+
Sbjct:     2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61

Query:    81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
             RFKEV+LT THLA+VMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCHS+Q+CH
Sbjct:    62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121

Query:   141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
             RDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL  KEYDGKIA
Sbjct:   122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181

Query:   201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
             DVWSCGVTLYVMLVGAYPFEDP +PK+FRKTI RIL  QY+IPDYV +S ECRHL+SRIF
Sbjct:   182 DVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRIF 241

Query:   261 VADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 320
             VA+P KRI+I EI+NH WFLKNLP ++   +   N    P    Q+++EI+ II EA  P
Sbjct:   242 VANPEKRITIEEIKNHSWFLKNLPVEMYEGSLMMNG---PST--QTVEEIVWIIEEARKP 296

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0080167 "response to karrikin" evidence=IEP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IGI

TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)]

 Score = 1127 (401.8 bits), Expect = 2.8e-114, P = 2.8e-114
 Identities = 212/304 (69%), Positives = 251/304 (82%)

Query:    21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
             ++YE+V+D+G GNFG+ARLMR+K+T ELVAVK+I+RG KIDENV REIINHR+L HPNIV
Sbjct:     2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61

Query:    81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
             RFKEV+LTPTHL IVMEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y H++Q+CH
Sbjct:    62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121

Query:   141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
             RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV  + EYDGK  
Sbjct:   122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSV 181

Query:   201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
             DVWSCGV LYVMLVGAYPFEDP++P+NFRKT+ +I++V Y IP YVHIS +CR L+SRIF
Sbjct:   182 DVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRIF 241

Query:   261 VADPAKRISIPEIRNHEWFLKNLPADLVVDNTT---NNQFEEPDQPMQSIDEIMQIIAEA 317
             VA+P  R ++ EI++H WFLKNLP +L                +   Q ++EIM+I+ EA
Sbjct:   242 VANPLHRSTLKEIKSHAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRVEEIMKIVGEA 301

Query:   318 -TIP 320
              TIP
Sbjct:   302 RTIP 305

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=IGI

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2102132 KIN10 "AT3G01090" [Arabidopsis thaliana (taxid:3702)]

 Score = 569 (205.4 bits), Expect = 3.7e-55, P = 3.7e-55
 Identities = 127/271 (46%), Positives = 160/271 (59%)

Query:    23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
             Y+L R +G G+FG  ++     T   VA+K + R      +++E V+REI   R   HP+
Sbjct:    42 YKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 101

Query:    79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
             I+R  EVI TPT + +VMEY + GELF+ I   GR  EDEAR FFQQ+ISGV YCH   V
Sbjct:   102 IIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 161

Query:   139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
              HRDLK EN LLD      +KI DFG S         K++ G+P Y APEV+  K Y G 
Sbjct:   162 VHRDLKPENLLLDSKC--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 219

Query:   199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
               DVWSCGV LY +L G  PF+D   P  F+K    I    Y++P   H+SP  R LI R
Sbjct:   220 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIPR 273

Query:   259 IFVADPAKRISIPEIRNHEWFLKNLPADLVV 289
             + V DP KR++IPEIR H WF  +LP  L V
Sbjct:   274 MLVVDPMKRVTIPEIRQHPWFQAHLPRYLAV 304

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0000152 "nuclear ubiquitin ligase complex" evidence=IPI

GO:0003006 "developmental process involved in reproduction" evidence=IMP

GO:0010050 "vegetative phase change" evidence=IMP

GO:0010260 "organ senescence" evidence=IMP

GO:0080022 "primary root development" evidence=IMP

GO:0009594 "detection of nutrient" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0010182 "sugar mediated signaling pathway" evidence=IMP

GO:0006007 "glucose catabolic process" evidence=RCA

GO:0006486 "protein glycosylation" evidence=RCA

DICTYBASE|DDB_G0277905 snfA "AMP-activated protein kinase alpha subunit" [Dictyostelium discoideum (taxid:44689)]

 Score = 566 (204.3 bits), Expect = 7.8e-55, P = 7.8e-55
 Identities = 127/275 (46%), Positives = 162/275 (58%)

Query:    23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
             Y L + +G G+FG  +L    +T   VA+K + R      K+DE ++REI N +  RHP+
Sbjct:    31 YRLDKTLGIGSFGKVKLAEHIRTGVKVAIKILNRTKIKNLKMDEKIRREIQNMKLFRHPH 90

Query:    79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
             I++  EVI T T + +VMEY +GGELFE I   G+  EDE+R  FQQ+ISGV YCH   V
Sbjct:    91 IIKLYEVIETTTDIFMVMEYVTGGELFEYIVKNGKLLEDESRRLFQQMISGVDYCHHHMV 150

Query:   139 CHRDLKLENTLLDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
              HRDLK EN LLD  P  + +KI DFG S         K++ G+P Y APEV+  K Y G
Sbjct:   151 VHRDLKPENLLLD--PINKCIKIADFGLSNMMQDGDFLKTSCGSPNYAAPEVISGKLYAG 208

Query:   198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
                DVWSCGV LY  L    PF+D   P  F+K    +    +SIPD+V  SP C  LI 
Sbjct:   209 PEVDVWSCGVILYAFLCAKLPFDDESIPMLFKKIREGV----FSIPDFV--SPSCADLIK 262

Query:   258 RIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNT 292
             ++ V DP KRI+I EIRNH WF   LP  L   +T
Sbjct:   263 KMLVVDPVKRITIHEIRNHPWFQVKLPKYLSSPHT 297

GO:0046956 "positive phototaxis" evidence=IMP

GO:0008283 "cell proliferation" evidence=IMP

GO:0007005 "mitochondrion organization" evidence=IMP

GO:0006754 "ATP biosynthetic process" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0007165 "signal transduction" evidence=ISS

GO:0004679 "AMP-activated protein kinase activity" evidence=ISS

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9C958	SRK2B_ARATH	2, ., 7, ., 1, 1, ., 1	0.7475	0.8484	0.8531	no	no
Q9FFP9	SRK2H_ARATH	2, ., 7, ., 1, 1, ., 1	0.7443	0.8484	0.8555	no	no
A2ZAB5	SAPK3_ORYSI	2, ., 7, ., 1, 1, ., 1	0.7069	0.9008	0.9790	N/A	no
P0C5D6	SAPK3_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7069	0.9008	0.9790	no	no
Q0D4J7	SAPK2_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7766	0.8512	0.9115	no	no
Q5N942	SAPK4_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7313	0.8292	0.8361	no	no
Q02066	AAIP_WHEAT	2, ., 7, ., 1, 1, ., 1	0.7540	0.8402	0.9186	N/A	no
Q9M9E9	SRK2C_ARATH	2, ., 7, ., 1, 1, ., 1	0.7533	0.8126	0.8600	no	no
Q7XQP4	SAPK7_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7689	0.8264	0.8356	no	no
Q9SMQ4	SRK2F_ARATH	2, ., 7, ., 1, 1, ., 1	0.7102	0.8595	0.8914	no	no
Q75LR7	SAPK1_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7840	0.8292	0.8801	no	no
P43292	SRK2G_ARATH	2, ., 7, ., 1, 1, ., 1	0.7284	0.8622	0.8866	no	no
P43291	SRK2A_ARATH	2, ., 7, ., 1, 1, ., 1	0.75	0.8457	0.8457	no	no
Q39193	SRK2I_ARATH	2, ., 7, ., 1, 1, ., 1	0.8087	0.9862	0.9916	no	no
Q39192	SRK2D_ARATH	2, ., 7, ., 1, 1, ., 1	0.7802	0.9586	0.9613	no	no
A2YNT8	SAPK2_ORYSI	2, ., 7, ., 1, 1, ., 1	0.7259	0.9311	0.9970	N/A	no
Q940H6	SRK2E_ARATH	2, ., 7, ., 1, 1, ., 1	0.8873	0.9944	0.9972	yes	no
Q75H77	SAPKA_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.8622	0.9972	1.0	yes	no
Q7XKA8	SAPK5_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7120	0.8264	0.8108	no	no
Q6ZI44	SAPK6_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7573	0.8209	0.8164	no	no
Q7Y0B9	SAPK8_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.8672	0.8925	0.8733	no	no
Q75V57	SAPK9_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.8241	0.9917	0.9972	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	estExt_fgenesh4_pg.C_1300020	hypothetical protein (363 aa)
		(Populus trichocarpa)
Predicted Functional Partners:
	gw1.X.4271.1	hypothetical protein (254 aa)			•						0.451
	gw1.57.100.1	hypothetical protein (187 aa)			•						0.403
	gw1.66.235.1	hypothetical protein (250 aa)			•						0.400

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	363
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-102
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-90
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-67
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-66
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-66
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-63
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-60
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-55
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-54
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-54
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-48
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-48
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-47
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-47
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-46
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-45
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-45
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-45
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-44
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-44
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-44
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-44
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-43
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-43
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-42
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-42
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-42
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-41
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-41
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-41
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-40
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-40
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-40
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-39
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-39
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-39
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-38
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-38
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-38
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-38
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-38
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-37
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-37
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-37
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-37
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-36
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-36
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-36
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-36
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-36
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-36
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-36
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-36
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-36
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-35
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-35
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-35
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-35
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-35
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-35
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-35
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-35
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-35
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-35
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-35
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-35
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-34
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-34
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-34
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-34
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-33
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-33
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-33
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-33
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-33
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-33
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-33
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-33
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-32
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-32
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-32
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-32
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-31
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-31
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-31
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-31
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-30
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-30
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-30
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-30
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-29
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-29
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-29
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-28
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-28
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-28
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-28
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-28
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-28
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-27
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-27
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-27
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-26
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-26
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-26
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-26
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-26
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-26
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-26
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-26
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-26
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-26
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-26
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-26
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-25
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-25
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-25
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-25
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-25
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-25
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-25
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-25
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-24
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-24
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-24
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-24
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-24
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-24
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-24
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-24
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-23
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-23
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-23
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-23
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-23
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-23
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-23
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-23
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-22
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-22
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-22
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-22
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-22
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-22
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-22
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-22
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-22
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-22
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-21
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-21
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-21
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-21
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-21
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-20
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-20
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-20
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-20
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-20
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-20
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-20
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-19
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-19
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-19
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-19
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-19
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-19
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-19
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-18
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-18
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-18
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-16
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-15
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-15
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-14
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-12
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-12
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-09
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.003
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  301 bits (774), Expect = e-102
 Identities = 107/260 (41%), Positives = 150/260 (57%), Gaps = 9/260 (3%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
           YE++  +G G+FG   L RDKKT +LVA+K I  ++  K  E + REI   + L+HPNIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
           R  +V      L +VMEY  GG+LF+ +   GR SEDEARF+ +Q++S + Y HS  + H
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           RDLK EN LLD      +K+ DFG ++      +  + VGTP Y+APEVLL K Y   + 
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV- 177

Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-DYVHISPECRHLISRI 259
           D+WS GV LY +L G  PF   ++     +   +I   +   P     ISPE + LI ++
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 260 FVADPAKRISIPEIRNHEWF 279
            V DP KR++  E   H +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  270 bits (693), Expect = 6e-90
 Identities = 110/263 (41%), Positives = 146/263 (55%), Gaps = 9/263 (3%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPNI 79
           YEL+R +GSG+FG     + K T ++VAVK +       K D+  +REI   R L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           VR  +      HL +VMEY  GG+LF+ +   G  SEDEA+    Q++ G+ Y HS  + 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGK 198
           HRDLK EN LLD +    +KI DFG +K  +  S   +T VGTP Y+APEVLL     G 
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECRHLI 256
             DVWS GV LY +L G  PF   E   +  + I RIL   +++  P +   S E + LI
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 257 SRIFVADPAKRISIPEIRNHEWF 279
            +    DP+KR +  EI  H WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  212 bits (541), Expect = 1e-67
 Identities = 98/252 (38%), Positives = 127/252 (50%), Gaps = 42/252 (16%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVI 86
           +G G FG   L RDKKT + VA+K I++ D     E + REI   + L HPNIV+   V 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 87  LTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
               HL +VMEY  GG L + +  N G+ SEDE      Q++ G+ Y HS  + HRDLK 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 146 ENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
           EN LLD S   ++K+ DFG SK  +   S  K+ VGTPAY+APEVLL K Y  + +D+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            GV LY +                                     PE + LI ++   DP
Sbjct: 180 LGVILYEL-------------------------------------PELKDLIRKMLQKDP 202

Query: 265 AKRISIPEIRNH 276
            KR S  EI  H
Sbjct: 203 EKRPSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  210 bits (537), Expect = 1e-66
 Identities = 93/263 (35%), Positives = 141/263 (53%), Gaps = 22/263 (8%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
           +YE+++ IG G+FG   L+R K   +L  +K I      +K  E+   E+   + L HPN
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
           I+++ E       L IVMEYA GG+L ++I    +    F E++   +F QL   + Y H
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
           S ++ HRD+K +N  L       +K+ DFG SK   S+V  +  K+ VGTP Y++PE+  
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISP 250
            K Y+ K +D+WS G  LY +    +PFE     +N  +   +IL  QY  IP     S 
Sbjct: 177 NKPYNYK-SDIWSLGCVLYELCTLKHPFEG----ENLLELALKILKGQYPPIPS--QYSS 229

Query: 251 ECRHLISRIFVADPAKRISIPEI 273
           E R+L+S +   DP +R SI +I
Sbjct: 230 ELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  210 bits (536), Expect = 2e-66
 Identities = 99/261 (37%), Positives = 139/261 (53%), Gaps = 21/261 (8%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
           +G G+FG   L+R K T +L A+K +++   I        +  R+    + HP IV+   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              T   L +V+EYA GGELF  +   GRFSE+ ARF+  +++  + Y HS+ + +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 145 LENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
            EN LLD  G     +K+ DFG +K      S+  +  GTP Y+APEVLL K Y GK  D
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVD 175

Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261
            WS GV LY ML G  PF   +      +   +IL      P+++  SPE R LIS +  
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDPLRFPEFL--SPEARDLISGLLQ 229

Query: 262 ADPAKRI---SIPEIRNHEWF 279
            DP KR+      EI+ H +F
Sbjct: 230 KDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  201 bits (513), Expect = 7e-63
 Identities = 88/268 (32%), Positives = 132/268 (49%), Gaps = 18/268 (6%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
            +     +G G+FG   L  DK T EL+AVK +E     +E +   +REI    SL+HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 79  IVRFK--EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           IVR+   E       L I +EY SGG L   +   G+  E   R + +Q++ G++Y HS 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
            + HRD+K  N L+D      +K+ DFG +K            S  GTP ++APEV+  +
Sbjct: 121 GIVHRDIKGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPE 251
           EY    AD+WS G T+  M  G  P+ +   P      +++I S      IP+  H+S E
Sbjct: 179 EYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAA---LYKIGSSGEPPEIPE--HLSEE 232

Query: 252 CRHLISRIFVADPAKRISIPEIRNHEWF 279
            +  + +    DP KR +  E+  H + 
Sbjct: 233 AKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  194 bits (495), Expect = 8e-60
 Identities = 97/275 (35%), Positives = 152/275 (55%), Gaps = 34/275 (12%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR----SLR 75
           D +E ++ +G+G+FG   L+R K + +  A+K + +  KI +  Q E ++N +    S+R
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIR 59

Query: 76  HPNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           HP +V     F++     ++L +VMEY  GGELF  +  +GRF E  ARF+  Q++  + 
Sbjct: 60  HPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115

Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           Y HS+ + +RDLK EN LLD  G     +KI DFG++K   +  +  +  GTP Y+APE+
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEI 169

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           +L K Y GK  D W+ G+ +Y ML G  PF D + P    +   +IL  +   P     S
Sbjct: 170 ILSKGY-GKAVDWWALGILIYEMLAGYPPFFD-DNP---IQIYEKILEGKVRFP--SFFS 222

Query: 250 PECRHLISRIFVADPAKRI-----SIPEIRNHEWF 279
           P+ + LI  +   D  KR+      + +I+NH WF
Sbjct: 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  180 bits (460), Expect = 6e-55
 Identities = 94/267 (35%), Positives = 137/267 (51%), Gaps = 23/267 (8%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKE 84
           I  G +G   L + K T ++ A+K I++ D I +N   +++  R      + P +V+   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
                 +L +VMEY  GG+L   + N G   ED AR +  +++  + Y HS  + HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 145 LENTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            +N L+D +    LK+ DFG SK          +    + K  VGTP YIAPEV+L + +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
             K  D WS G  LY  LVG  PF   E P    +    IL+ +   P+ V +S E   L
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHG-ETP---EEIFQNILNGKIEWPEDVEVSDEAIDL 233

Query: 256 ISRIFVADPAKRI---SIPEIRNHEWF 279
           IS++ V DP KR+   SI EI+NH +F
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  179 bits (456), Expect = 2e-54
 Identities = 79/261 (30%), Positives = 129/261 (49%), Gaps = 14/261 (5%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
           +E++  IG G FG     R K+T + VA+K I     +  E +  EI   +  +HPNIV+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCH 140
           +    L    L IVME+ SGG L + + +  +  +E +  +  ++L+ G+ Y HS  + H
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121

Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
           RD+K  N LL  DG     +K+ DFG S          + VGTP ++APEV+  K YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-SVQYSIPDYVHISPECRHLIS 257
            AD+WS G+T   +  G  P+ +        K + +I  +    + +    S E +  + 
Sbjct: 178 -ADIWSLGITAIELAEGKPPYSEL----PPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232

Query: 258 RIFVADPAKRISIPEIRNHEW 278
           +    +P KR +  ++  H +
Sbjct: 233 KCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  178 bits (455), Expect = 4e-54
 Identities = 85/292 (29%), Positives = 139/292 (47%), Gaps = 49/292 (16%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
           ++  + IG G+F    L ++K+T +  A+K      + +  K+    +++E++  R   H
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61

Query: 77  PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           P I++    F++      +L  V+EYA  GEL + I   G   E   RF+  +++  + Y
Sbjct: 62  PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
            HS  + HRDLK EN LLD      +KI DFG +K                         
Sbjct: 118 LHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231
             +  S VGT  Y++PE+L +K   GK +D+W+ G  +Y ML G  PF    E      T
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEY----LT 230

Query: 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI----PEIRNHEWF 279
             +IL ++YS P   +  P+ + LI ++ V DP  R+ +     E++ H +F
Sbjct: 231 FQKILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  167 bits (422), Expect = 3e-48
 Identities = 93/281 (33%), Positives = 135/281 (48%), Gaps = 28/281 (9%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHP- 77
           Y ++R +G G+FG   L RD+K    VA+K + +  +          REI    SL HP 
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCH 134
           NIV+  +       L +VMEY  GG L + +      G  SE EA F   Q++S + Y H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAP 187
           S  + HRD+K EN LLD      +K+ DFG +K       +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 188 EVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHRILSV 238
           EVLL     Y    +D+WS G+TLY +L G  PFE  +         K   +     L+ 
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
             S  +   IS     L+ ++   DP  R+S     +H+  
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  163 bits (415), Expect = 5e-48
 Identities = 91/290 (31%), Positives = 130/290 (44%), Gaps = 41/290 (14%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
           YE +  +G G +GV    RDKKT E+VA+K I R D  +E +     REI   + L+HPN
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
           IV+  +VI T   L +V EY    +L + +    G  S +  +    QL+ G++YCHS +
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK- 192
           + HRDLK +N L++      LK+ DFG +++      P  T    V T  Y APE+LL  
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE------------------DPEEPKNFRK--TI 232
           K Y   + D+WS G     M+ G   F                     E      K    
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232

Query: 233 HRILSVQYSIPDYVHIS---PECRHLISRIFVADPAKRISIPEIRNHEWF 279
                          +    PE   L+S++   +PAKRIS  E   H +F
Sbjct: 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  160 bits (408), Expect = 3e-47
 Identities = 88/269 (32%), Positives = 134/269 (49%), Gaps = 18/269 (6%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGD-KIDENVQREIINHRSLRHPN 78
           R++    IG G FG      +  T EL+AVK I  +  D K  + +  E+     L+HPN
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHSM 136
           +V++  V +    + I MEY SGG L E +   GR   DE   R +  QL+ G++Y HS 
Sbjct: 61  LVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH 118

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLL 191
            + HRD+K  N  LD +    +K+ DFG +      ++ +  + +S  GTPAY+APEV+ 
Sbjct: 119 GIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 192 KKEYDGKI--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
             +  G    AD+WS G  +  M  G  P+   E    F+   H     +  IPD + +S
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMFHVGAGHKPPIPDSLQLS 234

Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
           PE +  + R   +DP KR +  E+  H +
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  162 bits (411), Expect = 4e-47
 Identities = 89/299 (29%), Positives = 137/299 (45%), Gaps = 47/299 (15%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
             ++ ++ +G G+ G   L+R K T +L A+K +++ + I  N       ++EI+   +L
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATL 58

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 132
            HP +        T T+L +VM+Y  GGELF   +       SE+ ARF+  +++  + Y
Sbjct: 59  DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118

Query: 133 CHSMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQP 175
            H + + +RDLK EN LL  S                 P P  K    G  +SSV     
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 176 -----------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
                       S VGT  YIAPEV+    +   + D W+ G+ LY ML G  PF+    
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG--- 234

Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI----SIPEIRNHEWF 279
             N  +T   IL  + + P    +S   R LI ++ V DP+KR+       EI+ H +F
Sbjct: 235 -SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  158 bits (403), Expect = 2e-46
 Identities = 82/263 (31%), Positives = 133/263 (50%), Gaps = 20/263 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
           +G G FG   L++ K      A+K +++   ++   Q  I + +       HP IV+   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
                 ++ ++MEY  GGEL+  + + G F E  ARF+   ++    Y H+  + +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            EN LLD +    +K+ DFG++K      +  +  GTP Y+APE++L K YD    D WS
Sbjct: 121 PENLLLDSN--GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177

Query: 205 CGVTLYVMLVGAYPF-EDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFV 261
            G+ LY +L G  PF ED E+P    +  + IL     +  P+Y  I    + LI ++  
Sbjct: 178 LGILLYELLTGRPPFGEDDEDP---MEIYNDILKGNGKLEFPNY--IDKAAKDLIKQLLR 232

Query: 262 ADPAKRI-----SIPEIRNHEWF 279
            +P +R+      I +I+ H+WF
Sbjct: 233 RNPEERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  156 bits (396), Expect = 1e-45
 Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 16/265 (6%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPN 78
           +EL+R IG G FG   +++ + T+++ A+KY+ +   +++   R ++N R     L HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           +V          ++ +V++   GG+L   +    +FSE++ +F+  +++  + Y HS  +
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K +N LLD      + I DF  +      +   ST GTP Y+APEVL ++ Y   
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SV 178

Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDY-VHISPECRHLI 256
             D WS GVT Y  L G  P+       + R    +I + Q  +   Y    S E    I
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYR-----GHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233

Query: 257 SRIFVADPAKRISIP--EIRNHEWF 279
           +++   DP KR+     +++NH +F
Sbjct: 234 NKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  155 bits (395), Expect = 2e-45
 Identities = 85/265 (32%), Positives = 131/265 (49%), Gaps = 18/265 (6%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPN 78
            Y+L   IG G FGV     + +T + VA+K I      +E    + +EI   ++L+HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           IV++   I T   L I++EYA  G L + I   G F E     +  Q++ G++Y H   V
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120

Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            HRD+K  N L   DG     +K+ DFG + K + +     S VGTP ++APEV+     
Sbjct: 121 IHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRH 254
               +D+WS G T+  +L G  P+ D     N    + RI+   +  +P+   ISPE + 
Sbjct: 177 STA-SDIWSLGCTVIELLTGNPPYYD----LNPMAALFRIVQDDHPPLPE--GISPELKD 229

Query: 255 LISRIFVADPAKRISIPEIRNHEWF 279
            + + F  DP  R +  ++  H W 
Sbjct: 230 FLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  155 bits (393), Expect = 7e-45
 Identities = 87/268 (32%), Positives = 138/268 (51%), Gaps = 20/268 (7%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
           D  E ++ +G+G FG   L+RD+ +E   A+K +   + I     ++V  E    + + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P I+R          L ++MEY  GGELF  + N+GRFS     F+  +++  + Y HS 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
           ++ +RDLK EN LLD      +K+ DFG++K   L  +  +  GTP Y+APEV+  K + 
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ G+ +Y MLVG  PF D     N      +IL+ +   P   H+    + LI
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKILAGKLEFPR--HLDLYAKDLI 229

Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
            ++ V D  +R+        +++NH WF
Sbjct: 230 KKLLVVDRTRRLGNMKNGADDVKNHRWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  155 bits (394), Expect = 1e-44
 Identities = 88/262 (33%), Positives = 132/262 (50%), Gaps = 19/262 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-----LRHPNIVRFK 83
           IG G+FG   L + K   +  AVK +++   + +  Q+ I+  R+     ++HP +V   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T   L  V++Y +GGELF  +     F E  ARF+  ++ S + Y HS+ + +RDL
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
           K EN LLD      L   DFG  K  + HS+  ST  GTP Y+APEVL K+ YD +  D 
Sbjct: 123 KPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDW 179

Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           W  G  LY ML G  PF   +  + +   +++ L ++ +      IS   RHL+  +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN------ISVSARHLLEGLLQK 233

Query: 263 DPAKRI----SIPEIRNHEWFL 280
           D  KR+       EI+NH +F 
Sbjct: 234 DRTKRLGAKDDFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  153 bits (389), Expect = 3e-44
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 37/290 (12%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
           RY+++  IG G  G+    +D++T E VA+K +        I     REI   ++ +HP 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
           +V+  +V    +   +VMEY    +L E + +  R   E + + + + L+ GV+Y H+  
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-KKE 194
           + HRDLK  N L+  S    LKI DFG ++  S          V T  Y APE+L   ++
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------YSIPDYV 246
           YD  + D+W+ G     +L G+ P    E        + R L            S+PDY 
Sbjct: 178 YDPGV-DLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235

Query: 247 HIS-------------PECR----HLISRIFVADPAKRISIPEIRNHEWF 279
            I+             P+       L+  + V DP+KR+S  E   H +F
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  154 bits (391), Expect = 7e-44
 Identities = 96/300 (32%), Positives = 140/300 (46%), Gaps = 53/300 (17%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RH 76
           D +E+++ IG G FG   L+RDK T ++ A+K + + D I  N    +   R +      
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 77  PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           P IV+    F++      HL +VMEY  GG+L   +     F E+ ARF+  +L+  +  
Sbjct: 61  PWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------------------------- 167
            H +   HRD+K +N L+D      +K+ DFG  K                         
Sbjct: 117 VHKLGFIHRDIKPDNILIDADG--HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 168 -SSVLHSQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
                H Q +    STVGTP YIAPEVL    Y  +  D WS GV LY ML G  PF   
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSD 233

Query: 223 EEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRI-SIPEIRNHEWF 279
                 ++T ++I++ + S   P    +SPE   LI R  + DP  R+ S  EI++H +F
Sbjct: 234 ----TLQETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  153 bits (388), Expect = 9e-44
 Identities = 91/262 (34%), Positives = 134/262 (51%), Gaps = 20/262 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
           +G G+FG   L   K T+EL AVK +++   + D++V+  +   R L    +HP + +  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T   L  VMEY +GG+L   I  +GRF E  ARF+  +++ G+ + H   + +RDL
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
           KL+N LLD      +KI DFG  K  +L     ST  GTP YIAPE+L  + Y G   D 
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179

Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           W+ GV LY ML G  PFE  +E + F      IL  +   P    +S E + ++      
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELF----QSILEDEVRYP--RWLSKEAKSILKSFLTK 233

Query: 263 DPAKRISIP-----EIRNHEWF 279
           +P KR+        +I+ H +F
Sbjct: 234 NPEKRLGCLPTGEQDIKGHPFF 255

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  152 bits (385), Expect = 3e-43
 Identities = 97/289 (33%), Positives = 142/289 (49%), Gaps = 32/289 (11%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSLRHPNIV 80
           +G G FG   L+R+K T +  A+K I + + I   + ++ + H        ++ RHP + 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMK-ILKKEVI---IAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
             K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y HS  V +
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKI 199
           RDLKLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL   +Y G+ 
Sbjct: 119 RDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRA 175

Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            D W  GV +Y M+ G  PF + +  K F      IL  +   P    +SPE + L++ +
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPR--TLSPEAKSLLAGL 229

Query: 260 FVADPAKRI-----SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 303
              DP +R+        EI  H +F     A +   +    + E P +P
Sbjct: 230 LKKDPKQRLGGGPEDAKEIMEHRFF-----ASINWQDVVQKKLEPPFKP 273

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  149 bits (378), Expect = 7e-43
 Identities = 84/271 (30%), Positives = 128/271 (47%), Gaps = 27/271 (9%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
           YE++  IG G+FG  R +R K   +++  K I+ G  + E  ++++++     R L+HPN
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60

Query: 79  IVRF--KEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSY 132
           IVR+  + +  +   L IVMEY  GG+L + I           E+       QL+  +  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 133 CH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIA 186
           CH        V HRDLK  N  LD +    +K+ DFG +K     S    T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDY 245
           PE L    YD K +D+WS G  +Y +   + PF      +N  +   +I   ++  IP  
Sbjct: 179 PEQLNHMSYDEK-SDIWSLGCLIYELCALSPPF----TARNQLQLASKIKEGKFRRIPY- 232

Query: 246 VHISPECRHLISRIFVADPAKRISIPEIRNH 276
              S E   +I  +   DP KR S  E+   
Sbjct: 233 -RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  147 bits (373), Expect = 5e-42
 Identities = 81/261 (31%), Positives = 119/261 (45%), Gaps = 12/261 (4%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
           E V+ +G G+ GV   +R K T ++ A+K I      +   Q  RE+   RS   P +V+
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCH 140
                     ++IV+EY  GG L + +   G+  E    +  +Q++ G+ Y H+   + H
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123

Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
           RD+K  N L+   G      KI DFG SK         +T VGT  Y++PE  ++ E   
Sbjct: 124 RDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYS 178

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
             AD+WS G+TL    +G +PF  P +P  F      I             SPE R  IS
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-ICDGPPPSLPAEEFSPEFRDFIS 237

Query: 258 RIFVADPAKRISIPEIRNHEW 278
                DP KR S  E+  H +
Sbjct: 238 ACLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  147 bits (374), Expect = 5e-42
 Identities = 88/262 (33%), Positives = 133/262 (50%), Gaps = 21/262 (8%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
           IG G  G      D+ T + VA+K +    +  E +  EI+  +  +HPNIV + +  L 
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86

Query: 89  PTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
              L +VMEY  GG L + I  N  R +E +  +  ++++ G+ Y HS  V HRD+K +N
Sbjct: 87  GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN 146

Query: 148 TLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            LL  DGS    +K+ DFG++ + +   S+  S VGTP ++APEV+ +K+Y  K+ D+WS
Sbjct: 147 ILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV-DIWS 201

Query: 205 CGVTLYVMLVGAYP-FEDPEEPKNFRKTIHRILSVQYSIPDYVHI---SPECRHLISRIF 260
            G+    M  G  P   +P  P      I         IP   +    SPE +  +++  
Sbjct: 202 LGIMCIEMAEGEPPYLREP--PLRALFLI-----TTKGIPPLKNPEKWSPEFKDFLNKCL 254

Query: 261 VADPAKRISIPEIRNHEWFLKN 282
           V DP KR S  E+  H  FLK 
Sbjct: 255 VKDPEKRPSAEELLQHP-FLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  146 bits (370), Expect = 9e-42
 Identities = 92/260 (35%), Positives = 131/260 (50%), Gaps = 12/260 (4%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN-VQREIINHRSLRHPN 78
           +YE +R +G G FG+  L R K  ++LV +K I  E+  K +    Q E    + L HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
           I+ + E  L    L IVMEYA GG L E I         ED    FF Q++  + + H+ 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + HRDLK +N LLD      +KI DFG SK     S+  + VGTP YI+PE+   K Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K +D+W+ G  LY +      F    E  N    + +I+S  ++ P     SP+ R LI
Sbjct: 180 QK-SDIWALGCVLYELASLKRAF----EAANLPALVLKIMSGTFA-PISDRYSPDLRQLI 233

Query: 257 SRIFVADPAKRISIPEIRNH 276
             +   DP+KR  + +I   
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  148 bits (374), Expect = 1e-41
 Identities = 94/260 (36%), Positives = 140/260 (53%), Gaps = 20/260 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
           +G G+FG   L   K T E  A+K +++ D +  D++V+  ++  R L     HP +   
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 83  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
                T  HL  VMEY +GG+L   I ++GRF E  ARF+  ++I G+ + H   + +RD
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121

Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
           LKL+N LLD      +KI DFG  K ++      ST  GTP YIAPE+L  ++Y+  + D
Sbjct: 122 LKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-D 178

Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-VHISPECRHLISRIF 260
            WS GV LY ML+G  PF   +E + F        S+    P +   IS E +  +S++F
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELFD-------SILNDRPHFPRWISKEAKDCLSKLF 231

Query: 261 VADPAKRISIP-EIRNHEWF 279
             DP KR+ +  +IR H +F
Sbjct: 232 ERDPTKRLGVDGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  147 bits (374), Expect = 2e-41
 Identities = 90/283 (31%), Positives = 143/283 (50%), Gaps = 30/283 (10%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
           ++++  +G G +G   L + K T E+VA+K +++      N  R ++  R +    +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           +V+         +L + MEY  GG+    + N G  SED ARF+  ++   V   H +  
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRDLK EN L+D S    +K+ DFG SK  V  +   S VG+P Y+APEVL  K YD  
Sbjct: 123 IHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178

Query: 199 IADVWSCGVTLYVMLVGAYPF--EDPEEP----KNFRKTIHRILSVQYSIPDYV----HI 248
           + D WS G  LY  L G  PF    P E     K +++T+ R        P Y     ++
Sbjct: 179 V-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR--------PVYDDPRFNL 229

Query: 249 SPECRHLISRIFVADPAKRI-SIPEIRNHEWFLKNLPADLVVD 290
           S E   LI+++ + DP++R  S+ +I+NH +F K +  + + +
Sbjct: 230 SDEAWDLITKL-INDPSRRFGSLEDIKNHPFF-KEVDWNELRE 270

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  144 bits (366), Expect = 6e-41
 Identities = 83/275 (30%), Positives = 130/275 (47%), Gaps = 32/275 (11%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
           + + L+  IG G+FG      DK+T ++VA+K I   E  D+I++ +Q+EI      R P
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSP 59

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
            I ++    L  + L I+MEY  GG   + +   G+  E    F  ++++ G+ Y H   
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118

Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
             HRD+K  N LL  +G     +K+ DFG S   +   S+  + VGTP ++APEV+ +  
Sbjct: 119 KIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIPDYVH 247
           YD K AD+WS G+T   +  G  P  D          PKN   ++               
Sbjct: 175 YDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG-----------NK 222

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
            S   +  +S     DP +R S  E+  H+ F+K 
Sbjct: 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHK-FIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  145 bits (368), Expect = 1e-40
 Identities = 83/266 (31%), Positives = 136/266 (51%), Gaps = 20/266 (7%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPN 78
           +E+   +G+G+FG  R+ + K T E  A+K +++ + +     + +   +S    L HP 
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           IV           +  ++E+  GGELF  +  AGRF  D A+F+  +L+    Y HS  +
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            +RDLK EN LLD      +K+ DFG++K   +  +  +  GTP Y+APEV+  K + GK
Sbjct: 140 IYRDLKPENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGH-GK 194

Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
             D W+ GV LY  + G  PF D + P  FR    +IL+ +   P++       R L+  
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFPNWF--DGRARDLVKG 248

Query: 259 IFVADPAKRI-----SIPEIRNHEWF 279
           +   D  KR+      + +++NH +F
Sbjct: 249 LLQTDHTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  144 bits (365), Expect = 6e-40
 Identities = 101/348 (29%), Positives = 161/348 (46%), Gaps = 77/348 (22%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLR---- 75
           D +E ++ IG G FG  RL++ K T  + A+K + + + +    ++E + H R+ R    
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML----EKEQVAHVRAERDILA 56

Query: 76  ---HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
              +P +V+         +L ++MEY  GG++   +     F+E+E RF+  + I  +  
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
            H +   HRD+K +N LLD      +K+ DFG                            
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 172 HSQPK------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
            S+P                   STVGTP YIAPEV L+  Y  K  D WS GV +Y ML
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEML 233

Query: 214 VGAYPF--EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI--- 268
           VG  PF  ++P+E   +RK I+   ++Q   PD V +SPE + LI R    +  +R+   
Sbjct: 234 VGYPPFCSDNPQE--TYRKIINWKETLQ--FPDEVPLSPEAKDLIKR-LCCEAERRLGNN 288

Query: 269 SIPEIRNHEWF-------LKNLPADLVV-----DNTTN-NQFEEPDQP 303
            + EI++H +F       ++  PA ++       +T+N + FEE D  
Sbjct: 289 GVNEIKSHPFFKGVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLD 336

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  141 bits (356), Expect = 9e-40
 Identities = 84/263 (31%), Positives = 146/263 (55%), Gaps = 24/263 (9%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
           +Y  V+ IG G+FG A L++ K+  +   +K I   +   K  E  ++E+    +++HPN
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
           IV+++E      +L IVM+Y  GG+L+++I NA R   F ED+   +F Q+   + + H 
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 136 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 190
            ++ HRD+K +N  L  DG+    +K+ DFG ++  VL+S     ++ +GTP Y++PE+ 
Sbjct: 120 RKILHRDIKSQNIFLTKDGT----IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEIC 173

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
             + Y+ K +D+W+ G  LY M    + F    E  N +  + +I+   Y  P   H S 
Sbjct: 174 ENRPYNNK-SDIWALGCVLYEMCTLKHAF----EAGNMKNLVLKIIRGSYP-PVSSHYSY 227

Query: 251 ECRHLISRIFVADPAKRISIPEI 273
           + R+L+S++F  +P  R S+  I
Sbjct: 228 DLRNLVSQLFKRNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  140 bits (355), Expect = 3e-39
 Identities = 85/289 (29%), Positives = 131/289 (45%), Gaps = 38/289 (13%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 79
           Y+ +  IG G +GV    RDK T E+VA+K I+     + I +   REI   + L HPNI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
           ++  +V      L +V E+    +L++ I +  R   E   + +  QL+ G+++CHS  +
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLKKEY 195
            HRDLK EN L++      LK+ DFG ++S    S  +     V T  Y APE+LL  + 
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL----------------SVQ 239
                D+WS G     +L     F    E     K I R L                + +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK-IFRTLGTPDPEVWPKFTSLARNYK 234

Query: 240 YSIPDYVHI---------SPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           +S P    +         SP+   L+S++   DP KRI+  +   H +F
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  140 bits (355), Expect = 4e-39
 Identities = 88/283 (31%), Positives = 132/283 (46%), Gaps = 22/283 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVRFKE 84
           IG G+FG    +R + T+ + A+K I +   +  +     +  R++      P IV  K 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              +P  L +V+ + +GGELF  +   GRF    ARF+  +L+  +   H   V +RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVW 203
            EN LLD      + +CDFG  K ++      +T  GTP Y+APE+LL   Y  K  D W
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177

Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
           + GV LY ML G  PF D    + +RK    IL      PD      + + L+  +   D
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPD--GFDRDAKDLLIGLLSRD 231

Query: 264 PAKRISI---PEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 303
           P +R+      EI+NH +F     + L          + P +P
Sbjct: 232 PTRRLGYNGAQEIKNHPFF-----SQLSWKKLLMKGIQPPFKP 269

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  140 bits (354), Expect = 7e-39
 Identities = 88/259 (33%), Positives = 134/259 (51%), Gaps = 18/259 (6%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL----RHPNIVRFK 83
           +G G+FG   L   K   E  AVK +++    ID++V+  ++  R L     +P +    
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T  HL  VME+ +GG+L   I + GRF    A F+  +++ G+ + HS  + +RDL
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
           KL+N +LD      +KI DFG  K +V      ST  GTP YIAPE+L   +Y   + D 
Sbjct: 123 KLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DW 179

Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFV 261
           WS GV LY ML+G  PF   +E + F        S++   P Y   I+ E + ++ ++F 
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFE-------SIRVDTPHYPRWITKESKDILEKLFE 232

Query: 262 ADPAKRISIP-EIRNHEWF 279
            DP +R+ +   IR H +F
Sbjct: 233 RDPTRRLGVVGNIRGHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  139 bits (351), Expect = 2e-38
 Identities = 90/262 (34%), Positives = 133/262 (50%), Gaps = 19/262 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
           +G G FG   L+R+K T    A+K + +   I  + V   +   R L   RHP +   K 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y HS  V +RD+K
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122

Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
           LEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +Y G+  D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179

Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
             GV +Y M+ G  PF + +  + F      IL  +   P    +SPE + L++ +   D
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPR--TLSPEAKSLLAGLLKKD 233

Query: 264 PAKRI-----SIPEIRNHEWFL 280
           P +R+        E+  H +FL
Sbjct: 234 PKQRLGGGPSDAKEVMEHRFFL 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  138 bits (349), Expect = 4e-38
 Identities = 86/259 (33%), Positives = 140/259 (54%), Gaps = 18/259 (6%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
           +G G+FG   L   K T +  A+K +++   + D++V+  ++  R L     HP +    
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T  +L  VMEY +GG+L   I +  +F    A F+  ++I G+ + HS  + +RDL
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
           KL+N LLD      +KI DFG  K ++L      T  GTP YIAPE+LL ++Y+  + D 
Sbjct: 123 KLDNILLDTD--GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV-DW 179

Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFV 261
           WS GV LY ML+G  PF   +E + F+       S++   P Y   ++ E + ++ ++FV
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQ-------SIRMDNPCYPRWLTREAKDILVKLFV 232

Query: 262 ADPAKRISIP-EIRNHEWF 279
            +P +R+ +  +IR H +F
Sbjct: 233 REPERRLGVKGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 5e-38
 Identities = 88/296 (29%), Positives = 133/296 (44%), Gaps = 48/296 (16%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPN 78
           YE +  IG G +G     R+KKT ELVA+K I R +   E       REI   + LRHPN
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPN 59

Query: 79  IVRFKEVILTPTHLAI--VMEYA----SGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           IVR KE++ +    +I  V EY     +G  L +      +F+E + + + +QL+ G+ Y
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQY 115

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRD+K  N L++      LK+ DFG ++     +    T  V T  Y  PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173

Query: 191 L-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-------------- 235
           L    Y  ++ D+WS G  L  + +G   F+   E +   K I  +              
Sbjct: 174 LGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEK-IFELCGSPTDENWPGVSK 231

Query: 236 ------LSVQYSIP----DYVH--ISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
                 L  +        ++    I P    L+ ++   DP KRIS  +   HE+F
Sbjct: 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  136 bits (344), Expect = 6e-38
 Identities = 84/264 (31%), Positives = 131/264 (49%), Gaps = 20/264 (7%)

Query: 26  VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-----PNIV 80
           ++ I  G FG   L + + T +  A+K +++ D I +N    +   R++       P + 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
           +      +  +L +VMEY +GG+    I   G   ED A+ +  +++ GV   H   + H
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           RD+K EN L+D      LK+ DFG S++ +     K  VGTP Y+APE +L    D K++
Sbjct: 121 RDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMS 174

Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH--ISPECRHLISR 258
           D WS G  ++  L G  PF   E P         ILS + + P+ V    SPE   LI+R
Sbjct: 175 DWWSLGCVIFEFLFGYPPFH-AETPD---AVFDNILSRRINWPEEVKEFCSPEAVDLINR 230

Query: 259 IFVADPAKRIS---IPEIRNHEWF 279
           +   DPAKR+      EI++H +F
Sbjct: 231 LLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  136 bits (344), Expect = 6e-38
 Identities = 87/266 (32%), Positives = 130/266 (48%), Gaps = 27/266 (10%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE----------RGDKIDENVQREIINHRSLRHPN 78
           IGSG+FG   L  +  + EL+AVK +E          R   + + + REI   + L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           IV++    L   HL I +EY  GG +   + N G F E   R F +Q++ G++Y H+  +
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLL 191
            HRD+K  N L+D      +KI DFG SK       S+  +    S  G+  ++APEV+ 
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-VQYSIPDYVHISP 250
           +  Y  K AD+WS G  +  ML G +PF D  +     + I +I       IP   +IS 
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQ----LQAIFKIGENASPEIPS--NISS 238

Query: 251 ECRHLISRIFVADPAKRISIPEIRNH 276
           E    + + F  D  KR +  E+  H
Sbjct: 239 EAIDFLEKTFEIDHNKRPTAAELLKH 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 5e-37
 Identities = 88/302 (29%), Positives = 135/302 (44%), Gaps = 64/302 (21%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQ-REIINHRSLR----H 76
           Y++++ +G G FG   L R+K+T ELVA+K +++     +E +  RE+   +SLR    H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 134
           PNIV+ KEV      L  V EY   G L++ +       FSE   R    Q++ G+++ H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
                HRDLK EN L+  S    +KI DFG ++   + S+P  T  V T  Y APE+LL+
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172

Query: 193 -KEYDGKIADVWSCG------VTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------- 238
              Y   + D+W+ G       TL  +  G+   +           +++I SV       
Sbjct: 173 STSYSSPV-DIWALGCIMAELYTLRPLFPGSSEID----------QLYKICSVLGTPTKQ 221

Query: 239 ------------QYSIPDYVHI---------SPECRHLISRIFVADPAKRISIPEIRNHE 277
                        +  P +            SPE   LI  +   DP KR +  +   H 
Sbjct: 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281

Query: 278 WF 279
           +F
Sbjct: 282 YF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 6e-37
 Identities = 83/263 (31%), Positives = 129/263 (49%), Gaps = 21/263 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDEN----VQREIINHRSLRHPNIVRF 82
           +G G FG   L  D  T   +AVK +         +     ++ EI   ++L+H  IV++
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 83  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
              +     L+I MEY  GG + +++   G  +E   R + +Q++ GV Y HS  + HRD
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129

Query: 143 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGK 198
           +K  N L D   A  +K+ DFG SK    + S     KS  GTP +++PEV+  + Y G+
Sbjct: 130 IKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GR 186

Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECRHLI 256
            ADVWS G T+  ML    P+ + E        I +I +      +P   H+SP+ R+ +
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQPTNPQLPS--HVSPDARNFL 240

Query: 257 SRIFVADPAKRISIPEIRNHEWF 279
            R FV +  KR S  E+  H + 
Sbjct: 241 RRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  135 bits (341), Expect = 6e-37
 Identities = 93/262 (35%), Positives = 135/262 (51%), Gaps = 20/262 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
           +G G FG   L+++K T    A+K +++   +  + V   +  +R L   RHP +   K 
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDL 143
              T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y HS   V +RDL
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
           KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +Y G+  D 
Sbjct: 123 KLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179

Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           W  GV +Y M+ G  PF + +  K F      IL  +   P    +SPE + L+S +   
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LSPEAKSLLSGLLKK 233

Query: 263 DPAKRI-----SIPEIRNHEWF 279
           DP +R+        EI  H++F
Sbjct: 234 DPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  135 bits (341), Expect = 9e-37
 Identities = 87/248 (35%), Positives = 128/248 (51%), Gaps = 18/248 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHR------SLRHPNIVR 81
           +G G+FG   L   KKT EL A+K +++GD I  + V+  +   R      S RHP +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
                 T  H+  VMEYA+GG+L   I +   FSE  A F+   ++ G+ Y H  ++ +R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
           DLKL+N LLD      +KI DFG  K  +      ST  GTP ++APEVL +  Y  +  
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182

Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
           D W  GV +Y MLVG  PF   +E + F   ++    V+Y       +S E   ++ R+ 
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPR----FLSREAISIMRRLL 236

Query: 261 VADPAKRI 268
             +P +R+
Sbjct: 237 RRNPERRL 244

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  134 bits (339), Expect = 1e-36
 Identities = 90/261 (34%), Positives = 132/261 (50%), Gaps = 19/261 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
           +G G FG   L+R+K + +  A+K +++   I  + V   +   R L   RHP +   K 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              T   L  VMEY +GGELF  +     FSED  RF+  +++S + Y HS ++ +RDLK
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122

Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVW 203
           LEN +LD      +KI DFG  K  +  +   K+  GTP Y+APEVL   +Y G+  D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179

Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
             GV +Y M+ G  PF + +  K F      IL      P    +S + + L+S + + D
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEDIKFPRT--LSADAKSLLSGLLIKD 233

Query: 264 PAKRI-----SIPEIRNHEWF 279
           P KR+        EI  H +F
Sbjct: 234 PNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  134 bits (339), Expect = 2e-36
 Identities = 88/263 (33%), Positives = 133/263 (50%), Gaps = 22/263 (8%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
           +G G+FG   L   K T+EL A+K I + D I  D++V+  ++  R L    + P + + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 83  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
                T   L  VMEY +GG+L   I   G+F E  A F+  ++  G+ + HS  + +RD
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126

Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
           LKL+N +LD      +KI DFG  K ++   +   T  GTP YIAPE++  + Y GK  D
Sbjct: 127 LKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183

Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261
            W+ GV LY ML G  PF+  +E + F+  +   +S   S      +S E   +   +  
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS------LSKEAVSICKGLLT 237

Query: 262 ADPAKRISI-----PEIRNHEWF 279
             PAKR+        +IR H +F
Sbjct: 238 KHPAKRLGCGPTGERDIREHAFF 260

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  133 bits (336), Expect = 2e-36
 Identities = 84/274 (30%), Positives = 136/274 (49%), Gaps = 23/274 (8%)

Query: 23  YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGD-----KIDENV--QREIINHR 72
           +EL+R +G+G +G   L+R        +L A+K +++       K  E+   +R+++   
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
             R P +V       T T L ++++Y +GGELF  +     F+E E R +  +++  + +
Sbjct: 62  R-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
            H + + +RD+KLEN LLD      + + DFG SK  +   + +  S  GT  Y+APEV+
Sbjct: 121 LHQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 191 LKKEYD-GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-HRILSVQYSIPDYVHI 248
                   K  D WS GV  + +L GA PF    E +N +  I  RIL  +   P    +
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKSKPPFPK--TM 235

Query: 249 SPECRHLISRIFVADPAKRI---SIPEIRNHEWF 279
           S E R  I ++   DP KR+      EI+NH +F
Sbjct: 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  134 bits (338), Expect = 2e-36
 Identities = 84/274 (30%), Positives = 138/274 (50%), Gaps = 22/274 (8%)

Query: 23  YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERG-----DKIDENV--QREIINHR 72
           +EL++ +G+G +G   L+R      T +L A+K +++       K  E+   +R ++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
             + P +V       T   L ++++Y SGGE+F  +     FSEDE RF+  ++I  + +
Sbjct: 62  R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
            H + + +RD+KLEN LLD      + + DFG SK  +   + +  S  GT  Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
             K   GK  D WS G+ ++ +L GA PF    E     +   RIL      P +  I P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF--IGP 236

Query: 251 ECRHLISRIFVADPAKRI-----SIPEIRNHEWF 279
           E + L+ ++   DP KR+        EI+ H +F
Sbjct: 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 2e-36
 Identities = 90/278 (32%), Positives = 130/278 (46%), Gaps = 40/278 (14%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
           + YEL++ IGSG +G     RD  T ELVA+K I  E GD  +  +Q+EI   +  RHPN
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPN 61

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           IV +    L    L IVMEY  GG L +      G  SE +  +  ++ + G++Y H   
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121

Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 190
             HRD+K  N LL  DG     +K+ DFG S    +++  ++ KS +GTP ++APEV   
Sbjct: 122 KIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAV 175

Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP------ 243
             K  YDGK  D+W+ G+T   +     P  D          +H  +   + I       
Sbjct: 176 ERKGGYDGK-CDIWALGITAIELAELQPPMFD----------LH-PMRALFLISKSNFPP 223

Query: 244 ----DYVHISPECRHLISRIFVADPAKRISIPEIRNHE 277
               D    SP     I +    DP KR +  ++  H 
Sbjct: 224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  133 bits (336), Expect = 3e-36
 Identities = 82/265 (30%), Positives = 146/265 (55%), Gaps = 25/265 (9%)

Query: 29  IGSGNFGVARLMRDKKTEE---LVAVKYIERG-----DKIDENVQREIINHRSLRHPNIV 80
           +G G+FG   L+R     +   L A+K +++      D++   ++R+I+    + HP IV
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPFIV 61

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
           +      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + HS+ + +
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           RDLK EN LLD      +K+ DFG SK S+ H  +  S  GT  Y+APEV+ ++ +  + 
Sbjct: 122 RDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QS 178

Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
           AD WS GV ++ ML G+ PF+     K+ ++T+  IL  +  +P +  +SPE + L+  +
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLLRAL 232

Query: 260 FVADPAKRI-----SIPEIRNHEWF 279
           F  +PA R+      + EI+ H +F
Sbjct: 233 FKRNPANRLGAGPDGVEEIKRHPFF 257

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  133 bits (336), Expect = 4e-36
 Identities = 87/261 (33%), Positives = 135/261 (51%), Gaps = 19/261 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
           IG G+FG   L R K  E+  AVK +++   + +  ++ I++ R++     +HP +V   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T   L  V++Y +GGELF  +     F E  ARF+  ++ S + Y HS+ + +RDL
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
           K EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEVL K+ YD +  D 
Sbjct: 123 KPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179

Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           W  G  LY ML G  PF      + +   +++ L ++   P+   I+   RHL+  +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK---PN---ITNSARHLLEGLLQK 233

Query: 263 DPAKRISIP----EIRNHEWF 279
           D  KR+       EI+NH +F
Sbjct: 234 DRTKRLGAKDDFMEIKNHIFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  131 bits (332), Expect = 4e-36
 Identities = 74/266 (27%), Positives = 109/266 (40%), Gaps = 25/266 (9%)

Query: 24  ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
            L + +G G FG         +    E  VAVK + + D  ++ ++   RE    R L H
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNIV+   V      L IVMEY  GG+L  + R       S  +   F  Q+  G+ Y  
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEV 189
           S    HRDL   N L+  +    +KI DFG     Y          K  +    ++APE 
Sbjct: 121 SKNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPES 175

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           L + ++  K +DVWS GV L+ +       E      N    +   L   Y +P   +  
Sbjct: 176 LKEGKFTSK-SDVWSFGVLLWEIF--TLGEEPYPGMSNAE--VLEYLKKGYRLPKPPNCP 230

Query: 250 PECRHLISRIFVADPAKRISIPEIRN 275
           PE   L+ + +  DP  R +  E+  
Sbjct: 231 PELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  131 bits (331), Expect = 4e-36
 Identities = 81/254 (31%), Positives = 122/254 (48%), Gaps = 12/254 (4%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVK---YIERGDKIDENVQ---REIINHRSLRHPNIVRF 82
           +GSG+FG      +    +  AVK     + G    E V+   +EI     L+HPNIV++
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 83  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
                   +L I +E   GG L + +   G F E   R + +Q++ G+ Y H     HRD
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127

Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
           +K  N L+D +    +K+ DFG +K  V  S  KS  G+P ++APEV+ ++   G  AD+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185

Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           WS G T+  M  G  P+   E      K I R   +   IPD  H+S E +  I +    
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELP-PIPD--HLSDEAKDFILKCLQR 241

Query: 263 DPAKRISIPEIRNH 276
           DP+ R +  E+  H
Sbjct: 242 DPSLRPTAAELLEH 255

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  131 bits (331), Expect = 6e-36
 Identities = 75/267 (28%), Positives = 113/267 (42%), Gaps = 30/267 (11%)

Query: 24  ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
            L + +G G FG         +  K +  VAVK + + D  ++ ++   RE    R L H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
           PN+V+   V      L IVMEY  GG+L   +  N  + S  +   F  Q+  G+ Y  S
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL 190
               HRDL   N L+  +    +KI DFG     Y          K  +    ++APE L
Sbjct: 121 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESL 175

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGA---YPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
            + ++  K +DVWS GV L+ +       YP    EE   + K  +R+       P    
Sbjct: 176 KEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL-----PQPPNCP 229

Query: 248 ISPECRHLISRIFVADPAKRISIPEIR 274
             PE   L+ + +  DP  R +  E+ 
Sbjct: 230 --PELYDLMLQCWAEDPEDRPTFSELV 254

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  130 bits (328), Expect = 1e-35
 Identities = 80/261 (30%), Positives = 129/261 (49%), Gaps = 20/261 (7%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHP 77
            Y  +R +G G FG A L R  + + LV  K +     + E  +R+ +N       L+HP
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHP 59

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHS 135
           NI+ +    +    L I MEYA+GG L+++I       F E+   ++  Q++S VSY H 
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLK 192
             + HRD+K  N  L  + A  +K+ DFG SK   S    ++  + VGTP Y++PE+   
Sbjct: 120 AGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQG 175

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
            +Y+ K +D+W+ G  LY +L     F    +  N    + +I+   Y+    V+ S E 
Sbjct: 176 VKYNFK-SDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQGNYTPVVSVY-SSEL 229

Query: 253 RHLISRIFVADPAKRISIPEI 273
             L+  +   DP KR +  E+
Sbjct: 230 ISLVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 1e-35
 Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 15/204 (7%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKY---IERGDKIDENVQREIINHRSLRHP 77
           ++YE++  +G G +GV    R+K T E+VA+K     E  + + +   RE+   R LRH 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 78  NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           NIV  KE       L +V EY      EL E   + G    D  R +  QL+  ++YCHS
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 191
             + HRD+K EN L+  S +  LK+CDFG++++  L ++P S     V T  Y APE+L+
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174

Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
                GK  DVW+ G  +  +L G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 1e-35
 Identities = 92/293 (31%), Positives = 144/293 (49%), Gaps = 24/293 (8%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSLRH-PNIVR 81
           IG G FG    +R K T  + A+K + + + + +        +R I+    L   P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            K    T + L +V +Y SGGELF  +   GRFSED A+F+  +L+  + + H   + +R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
           DLK EN LLD +    + +CDFG SK+++  ++  +T  GT  Y+APEVLL ++   K  
Sbjct: 121 DLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178

Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
           D WS GV ++ M  G  PF   +  + +R     I   +   P  V +S E R  +  + 
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYRN----IAFGKVRFPKNV-LSDEGRQFVKGLL 233

Query: 261 VADPAKRI----SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDE 309
             +P  R+       E++ H +F     AD+  D  +  Q   P +P+   DE
Sbjct: 234 NRNPQHRLGAHRDAVELKEHPFF-----ADIDWDLLSKKQITPPFKPIVDSDE 281

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  129 bits (326), Expect = 2e-35
 Identities = 86/260 (33%), Positives = 137/260 (52%), Gaps = 19/260 (7%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           +Y ++R +G G+FG A L++   +++  A+K I   +     E+ ++E +    ++HPNI
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
           V FKE      HL IVMEY  GG+L ++I    G+ F ED    +F Q+  GV + H  +
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLKK 193
           V HRD+K +N  L  +   ++K+ DFG   S+ L + P +     VGTP Y+ PE+    
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
            Y+ K +D+WS G  LY +    +PF    +  +++  I ++    Y  P   H S E R
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYK-PLPSHYSYELR 229

Query: 254 HLISRIFVADPAKRISIPEI 273
            LI ++F  +P  R S   I
Sbjct: 230 SLIKQMFKRNPRSRPSATTI 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  131 bits (331), Expect = 2e-35
 Identities = 85/310 (27%), Positives = 149/310 (48%), Gaps = 39/310 (12%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSL 74
             +++   +G G+FG  +++R+K T ++ A+K +++   + +        +R+I++  + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
             P I + +       +L +VMEY  GG+L   +     +F ED A+F+  +L+  +   
Sbjct: 60  -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL 191
           H M   HRD+K EN L+D +    +K+ DFG +   ++      K  VGTP YIAPEVL 
Sbjct: 119 HQMGYVHRDIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 192 KKEYDGKIA-----DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PD 244
               DGK       D WS GV  Y M+ G  PF +        KT + I++ Q  +  P+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE----GTSAKTYNNIMNFQRFLKFPE 232

Query: 245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF-------LKNLPADLV-----VDNT 292
              +S +   LI  + +    +R+    +  H +F       ++N     V      D+T
Sbjct: 233 DPKVSSDFLDLIQSL-LCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDT 291

Query: 293 TNNQFEEPDQ 302
           +N  F+EP++
Sbjct: 292 SN--FDEPEK 299

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  130 bits (329), Expect = 3e-35
 Identities = 84/261 (32%), Positives = 124/261 (47%), Gaps = 19/261 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-----SLRHPNIVRFK 83
           IG G+FG   L + K      AVK +++   + +  Q  I+  R     +L+HP +V   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T   L  V++Y +GGELF  +     F E  ARF+  ++ S + Y HS+ + +RDL
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
           K EN LLD      + + DFG  K  V   +  ST  GTP Y+APEVL K+ YD +  D 
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDW 179

Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           W  G  LY ML G  PF   +  + +   +H+ L +             C  L+  +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAA-----CDLLVG-LLHK 233

Query: 263 DPAKRI----SIPEIRNHEWF 279
           D  +R+       EI+NH +F
Sbjct: 234 DQRRRLGAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  129 bits (325), Expect = 3e-35
 Identities = 89/263 (33%), Positives = 135/263 (51%), Gaps = 23/263 (8%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
           RYE+++ IG G+FG   L + K   E   +K I   +   K  E  ++E+I    ++HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
           IV F         L IVMEY  GG+L +RI N  R   FSED+   +F Q+  G+ + H 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 136 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 190
            ++ HRD+K +N  L  +G  A   K+ DFG ++   L+       + VGTP Y++PE+ 
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
             + Y+ K  D+WS G  LY +    +PFE      N  + + +I    ++ P   + S 
Sbjct: 175 QNRPYNNK-TDIWSLGCVLYELCTLKHPFEG----NNLHQLVLKICQGYFA-PISPNFSR 228

Query: 251 ECRHLISRIFVADPAKRISIPEI 273
           + R LIS++F   P  R SI  I
Sbjct: 229 DLRSLISQLFKVSPRDRPSITSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  129 bits (326), Expect = 3e-35
 Identities = 84/264 (31%), Positives = 119/264 (45%), Gaps = 20/264 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRSLRHPNIVRF 82
           +G G FG     + K T ++ A K ++      R  +     +++I+   S R   IV  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58

Query: 83  KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCH 140
                T   L +VM   +GG+L   I N G   F E  A F+  Q+I G+ + H  ++ +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           RDLK EN LLD     R  I D G +       + K   GTP Y+APEVL  + YD    
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-V 175

Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
           D ++ G TLY M+ G  PF   +E     +   R L +    PD    SPE + L   + 
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALL 233

Query: 261 VADPAKRI-----SIPEIRNHEWF 279
             DP KR+     S  E+R H  F
Sbjct: 234 QKDPEKRLGCRGGSADEVREHPLF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  130 bits (328), Expect = 5e-35
 Identities = 85/267 (31%), Positives = 130/267 (48%), Gaps = 24/267 (8%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
           +G G+FG   L   K T+E+ A+K +++ D I  D++V   +   R L    +HP +   
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 83  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
                T   L  VMEY +GG+L  +I  + +F E  +RF+  ++   + + H   V +RD
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121

Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
           LKL+N LLD       K+ DFG  K  +L+    +T  GTP YIAPE+L + EY   + D
Sbjct: 122 LKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV-D 178

Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261
            W+ GV +Y M+ G  PFE   E   F   +H    V Y     V +S E   ++     
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYP----VWLSKEAVSILKAFMT 232

Query: 262 ADPAKRISI-------PEIRNHEWFLK 281
            +P KR+           I+ H +F +
Sbjct: 233 KNPNKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  130 bits (329), Expect = 6e-35
 Identities = 91/309 (29%), Positives = 130/309 (42%), Gaps = 68/309 (22%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRHPN 78
           RYEL++ IGSG +GV     DK+T   VA+K I     D ID + + REI   R LRH N
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 79  IVRFKEVILTPT-----HLAIVMEYA---------SGGELFERICNAGRFSEDEARFFFQ 124
           I+   +++  P+      + IV E           S   L          ++D  ++F  
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQYFLY 110

Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 180
           Q++ G+ Y HS  V HRDLK  N L++ +    LKICDFG ++        K      V 
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVV 168

Query: 181 TPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVML---------------------VGAYP 218
           T  Y APE+LL    Y   I D+WS G     +L                     +G   
Sbjct: 169 TRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227

Query: 219 FEDPEEPKNFRKTIHRILSVQYS--------IPDYVHISPECRHLISRIFVADPAKRISI 270
            ED +   +  K  + + S+            P     SPE   L+ ++ V DP KRI+ 
Sbjct: 228 EEDLKFITS-EKARNYLKSLPKKPKKPLSKLFPG---ASPEAIDLLEKMLVFDPKKRITA 283

Query: 271 PEIRNHEWF 279
            E   H + 
Sbjct: 284 DEALAHPYL 292

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  131 bits (330), Expect = 8e-35
 Identities = 84/275 (30%), Positives = 138/275 (50%), Gaps = 24/275 (8%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRS 73
           ++ +++++ IG G FG  +L+R K ++++ A+K + + + I  +       +R+I+ H +
Sbjct: 42  AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
                IV+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   
Sbjct: 102 --SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAI 158

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEV 189
           HSM   HRD+K +N LLD S    LK+ DFG       + ++     + VGTP YI+PEV
Sbjct: 159 HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEV 214

Query: 190 LLKKEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
           L  +  D   G+  D WS GV LY MLVG  PF        + K +    S+ +  PD +
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--PDDI 272

Query: 247 HISPECRHLISRIFVADPAK--RISIPEIRNHEWF 279
            IS + + LI         +  R  + EI++H +F
Sbjct: 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  129 bits (325), Expect = 9e-35
 Identities = 89/288 (30%), Positives = 140/288 (48%), Gaps = 39/288 (13%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
           + +E ++ I +G +G   L+R K+T +  A+K I + + I  N      V+R+I+     
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
            +P +V       T  HL +VMEY  GG+    + N G    D AR +F + +  + Y H
Sbjct: 60  -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKST 178
           +  + HRDLK +N L+  +    +K+ DFG SK  ++                    K  
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRIL 236
            GTP YIAPEV+L++ Y GK  D W+ G+ LY  LVG  PF  + PEE   F + I    
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVI---- 229

Query: 237 SVQYSIPDYVH-ISPECRHLISRIFVADPAKRI---SIPEIRNHEWFL 280
           S     P+    +  + + LISR+   +P +R+      E++ H +FL
Sbjct: 230 SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  127 bits (322), Expect = 1e-34
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 23/270 (8%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLRHPN 78
           E + ++G+GN GV   +  + T +++AVK I     I+E +Q++I     I H+    P 
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
           IV F         ++I MEY  GG L    +    GR  E         ++ G++Y H  
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ HRD+K  N L++     ++K+CDFG S   V +S  K+ VGT +Y+APE +   +Y
Sbjct: 120 HKIIHRDVKPSNILVNSR--GQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDY 176

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDY-VHI-SPE 251
             K +D+WS G++L  +  G +P+    +P +    I  +L   V    P       SP+
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIVNEPPPRLPSGKFSPD 232

Query: 252 CRHLISRIFVADPAKRISIPEIRNHEWFLK 281
            +  ++   + DP +R S  E+  H +  K
Sbjct: 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  128 bits (323), Expect = 1e-34
 Identities = 87/266 (32%), Positives = 138/266 (51%), Gaps = 13/266 (4%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           IG G+ G+  +  DK T   VAVK ++ R  +  E +  E++  R  +HPNIV      L
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
               L +VME+  GG L + I    R +E++       ++  +S+ H+  V HRD+K ++
Sbjct: 87  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145

Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            LL  DG    R+K+ DFG+ ++ S    + KS VGTP ++APEV+ +  Y G   D+WS
Sbjct: 146 ILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 200

Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            G+ +  M+ G  P+ + E P    K I   L  +  + +   +SP  R  + R+ V DP
Sbjct: 201 LGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPK--LKNLHKVSPRLRSFLDRMLVRDP 257

Query: 265 AKRISIPEIRNHEWFLKNLPADLVVD 290
           A+R +  E+ NH +  K  P   +V 
Sbjct: 258 AQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  127 bits (321), Expect = 5e-34
 Identities = 87/262 (33%), Positives = 134/262 (51%), Gaps = 20/262 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
           +G G+FG   L   K T+EL A+K +++   I D++V+  ++  R L    + P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T   L  VMEY +GG+L  +I   GRF E  A F+  ++  G+ + HS  + +RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
           KL+N +LD      +KI DFG  K ++      K+  GTP YIAPE++  + Y GK  D 
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           W+ GV LY ML G  PFE  +E + F+  +   ++   S      +S E   +   +   
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS------MSKEAVAICKGLMTK 238

Query: 263 DPAKRISI-PE----IRNHEWF 279
            P KR+   PE    I+ H +F
Sbjct: 239 HPGKRLGCGPEGERDIKEHAFF 260

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  127 bits (319), Expect = 8e-34
 Identities = 90/286 (31%), Positives = 142/286 (49%), Gaps = 25/286 (8%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
           +G G+FG   L   K T+EL A+K +++   I D++V+  ++  R L    + P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T   L  VMEY +GG+L   I   G+F E +A F+  ++  G+ + H   + +RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
           KL+N +LD      +KI DFG  K  ++      T  GTP YIAPE++  + Y GK  D 
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           W+ GV LY ML G  PF+  +E + F+  +   +S   S      +S E   +   +   
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS------LSKEAVSICKGLMTK 238

Query: 263 DPAKRISI-PE----IRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 303
            P+KR+   PE    IR H +F +     +  D   N + + P +P
Sbjct: 239 HPSKRLGCGPEGERDIREHAFFRR-----IDWDKLENREIQPPFKP 279

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  126 bits (319), Expect = 1e-33
 Identities = 91/301 (30%), Positives = 155/301 (51%), Gaps = 33/301 (10%)

Query: 29  IGSGNFG---VARLMRDKKTEELVAVKYIERG-------DKIDENVQREIINHRSLRHPN 78
           +G G +G     R +    T ++ A+K +++        D      +R I+   +++HP 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNIL--EAVKHPF 61

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           IV       T   L +++EY SGGELF  +   G F ED A F+  ++   + + H   +
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
            +RDLK EN LLD      +K+ DFG  K S+       T  GT  Y+APE+L++  + G
Sbjct: 122 IYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           K  D WS G  +Y ML GA PF      +N +KTI +IL  + ++P Y  ++PE R L+ 
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPF----TAENRKKTIDKILKGKLNLPPY--LTPEARDLLK 232

Query: 258 RIFVADPAKRI-SIPE----IRNHEWFLKNLPADLVVDNTTNNQFEEPDQP-MQSIDEIM 311
           ++   +P+ R+ + P     +++H +F +++  D ++      + E P +P +QS +++ 
Sbjct: 233 KLLKRNPSSRLGAGPGDAAEVQSHPFF-RHVNWDDLL----ARKVEPPFKPLLQSEEDVS 287

Query: 312 Q 312
           Q
Sbjct: 288 Q 288

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  126 bits (318), Expect = 1e-33
 Identities = 84/249 (33%), Positives = 125/249 (50%), Gaps = 17/249 (6%)

Query: 27  RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIV 80
           R +G G+FG   L R K++  L AVK +++ D I  D++V+  +   R L     HP + 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
           +      TP  L  VME+ +GG+L   I  + RF E  ARF+  ++ S + + H   + +
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKI 199
           RDLKL+N LLD       K+ DFG  K  + + +  ST  GTP YIAPE+L +  Y G  
Sbjct: 120 RDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPS 176

Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            D W+ GV LY ML G  PFE   E   F      IL+ +   P ++    +   ++   
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPTWLS--QDAVDILKAF 230

Query: 260 FVADPAKRI 268
              +P  R+
Sbjct: 231 MTKNPTMRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 1e-33
 Identities = 82/271 (30%), Positives = 125/271 (46%), Gaps = 32/271 (11%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRH--- 76
           R EL   IG G +G     +   T  +VA+K I      D+  ++QRE+     LR    
Sbjct: 5   RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI ++    L    L I+MEYA GG +   +  AG  +E       ++++  + Y H +
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK-KE 194
            V HRD+K  N L+  +    +K+CDFG +     +S  +ST VGTP ++APEV+ + K 
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-------H 247
           YD K AD+WS G+T+Y M  G  P+ D                    IP           
Sbjct: 179 YDTK-ADIWSLGITIYEMATGNPPYSD-----------VDAFRAMMLIPKSKPPRLEDNG 226

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEW 278
            S   R  ++     +P +R+S  E+   +W
Sbjct: 227 YSKLLREFVAACLDEEPKERLSAEELLKSKW 257

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  125 bits (317), Expect = 1e-33
 Identities = 95/307 (30%), Positives = 134/307 (43%), Gaps = 66/307 (21%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
           D YE +  I  G +GV    RDKKT E+VA+K +    K+++  +       REI     
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60

Query: 74  LRHPNIVRFKEVIL--TPTHLAIVMEYASGGE-----LFERICNAGRFSEDEARFFFQQL 126
           L+HPNIV  KEV++      + +VMEY    E     L E +     F + E +    QL
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115

Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAY 184
           +SGV++ H   + HRDLK  N LL  +    LKICDFG ++   S L    +  V T  Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172

Query: 185 IAPEVLL-KKEYDGKIADVWSCG------VTLYVMLVGA--------------YPFED-- 221
            APE+LL  KEY   I D+WS G      +T   +  G                P E   
Sbjct: 173 RAPELLLGAKEYSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 222 PEEPKNFRKTIHRILSVQYSIPDYVHISPECRH---------LISRIFVADPAKRISIPE 272
           P     F +         ++   Y  +  +            L++R+   DPAKRIS  +
Sbjct: 232 PG----FSELPG-AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286

Query: 273 IRNHEWF 279
              H +F
Sbjct: 287 ALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  126 bits (319), Expect = 3e-33
 Identities = 89/316 (28%), Positives = 129/316 (40%), Gaps = 73/316 (23%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
           +  ++ IG G FG   L+R   T  L A+K + + D +  N       +R+I+      +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--N 60

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             +V+         +L  VM+Y  GG++   +   G F ED ARF+  +L   +   H M
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------S 168
              HRD+K +N L+D      +K+ DFG             Y K               S
Sbjct: 121 GFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 169 SVLHSQPK----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212
            +   + K                S VGTP YIAPEVLL+  Y  ++ D WS GV LY M
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 237

Query: 213 LVGAYPFEDPE------EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
           LVG  PF          +  N+  T+H        IP    +S E   LI R+       
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLH--------IPSQAKLSREASDLILRL-CCGAED 288

Query: 267 RI---SIPEIRNHEWF 279
           R+      EI+ H +F
Sbjct: 289 RLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  123 bits (312), Expect = 3e-33
 Identities = 75/271 (27%), Positives = 129/271 (47%), Gaps = 27/271 (9%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
            + ++++  +G G++G       K+T ++VA+K +   + + + + +EI   +    P I
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           V++       T L IVMEY   G + +  +I N    +E+E      Q + G+ Y HS +
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
             HRD+K  N LL+       K+ DFG S + +   ++  + +GTP ++APEV+ +  Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--------DYVHI 248
            K AD+WS G+T   M  G  P+ D          IH +    + IP        D    
Sbjct: 178 NK-ADIWSLGITAIEMAEGKPPYSD----------IHPM-RAIFMIPNKPPPTLSDPEKW 225

Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           SPE    + +  V DP +R S  ++  H + 
Sbjct: 226 SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  123 bits (310), Expect = 7e-33
 Identities = 85/271 (31%), Positives = 126/271 (46%), Gaps = 29/271 (10%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-----------VQREIINHRSLRHP 77
           IG G +G   L  +  T E++AVK +E    I              ++ EI   + L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           NIV++     T  +L+I +EY  GG +   +   GRF E   RFF +Q++ G++Y HS  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LLK 192
           + HRDLK +N L+D       KI DFG SK S     + Q  S  G+  ++APEV     
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS---IPDYV--H 247
           + Y  K+ D+WS G  +  M  G  P+ D E      K     L  + S   IP  V  +
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-----LGNKRSAPPIPPDVSMN 240

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEW 278
           +SP     ++  F  +P  R +  E+  H +
Sbjct: 241 LSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  122 bits (309), Expect = 7e-33
 Identities = 83/261 (31%), Positives = 125/261 (47%), Gaps = 20/261 (7%)

Query: 22  RYELVRDIGSGNFG-VARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
            +++++ +G G++G V ++ R  D +   L  V       K  E+   EI    S+ HPN
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
           I+ +KE  L    L IVMEYA  G+L + I    +      E E    F QL+ G+   H
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKK 193
             ++ HRDLK  N LL       +KI D G SK  VL     K+ +GTP Y+APEV   +
Sbjct: 121 EQKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGR 176

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPEC 252
            Y  K +D+WS G  LY M   A PF    E ++ +   +++   +Y  IP     S + 
Sbjct: 177 PYSYK-SDIWSLGCLLYEMATFAPPF----EARSMQDLRYKVQRGKYPPIPP--IYSQDL 229

Query: 253 RHLISRIFVADPAKRISIPEI 273
           ++ I  +    P  R +  +I
Sbjct: 230 QNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  123 bits (310), Expect = 1e-32
 Identities = 98/293 (33%), Positives = 137/293 (46%), Gaps = 46/293 (15%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
           Y+ V  IG G +GV    RDK T E+VA+K I R +  DE V     REI   + L HPN
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
           IVR  +V+ +   L +V E+    +L + + ++     D      +  QL+ G++YCHS 
Sbjct: 60  IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK 192
           +V HRDLK +N L+D   A  LK+ DFG +++      P  T    V T  Y APE+LL 
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLG 173

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILS---------VQYSI 242
                   D+WS G     M+     F  D E  + FR  I R L          V  S+
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVT-SL 230

Query: 243 PDYV----------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           PDY                 ++  +   L+S++ V DPAKRIS      H +F
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  122 bits (307), Expect = 2e-32
 Identities = 92/291 (31%), Positives = 132/291 (45%), Gaps = 42/291 (14%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
           ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L HPN
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           IV+  +VI T   L +V E+     + F              + +  QL+ G+++CHS +
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKK 193
           V HRDLK +N L++   A  +K+ DFG +++  +   P  T    V T  Y APE+LL  
Sbjct: 121 VLHRDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILLGC 175

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIPD 244
           +Y     D+WS G     M+     F  D E  + FR  I R L            S+PD
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSLPD 233

Query: 245 YV----------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           Y                  +  + R L+S++   DP KRIS      H +F
Sbjct: 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  122 bits (308), Expect = 2e-32
 Identities = 80/299 (26%), Positives = 127/299 (42%), Gaps = 44/299 (14%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLR 75
           RYE  + +G G + V    RDK+T  +VA+K I+ G++      I+    REI   + L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           HPNI+   +V    +++ +V E+       E++        +  + + +    + G+ Y 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEV 189
           HS  + HRDLK  N L+       LK+ DFG ++S      P       V T  Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           L    + G   D+WS G     +L+   PF   +   +    I   L            S
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232

Query: 242 IPDYVHISP---------------ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 285
           +PDYV   P               +   L+ R+   +P KRI+  +   H +F  N PA
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF-SNDPA 290

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  122 bits (307), Expect = 6e-32
 Identities = 82/269 (30%), Positives = 134/269 (49%), Gaps = 25/269 (9%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDEN------VQREIINHRSLR 75
           +  +R +G+G+FG   L   K  +   VA+K  E+   I +        +R+I+N+  + 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY--IN 89

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           HP  V         ++L +V+E+  GGE F  +    RF  D   F+  Q++    Y  S
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           + + +RDLK EN LLD      +K+ DFG++K  V+ ++  +  GTP YIAPE+LL   +
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVGH 205

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
            GK AD W+ G+ +Y +LVG  PF   E    ++K +  I+      P +  +   C+HL
Sbjct: 206 -GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII----YFPKF--LDNNCKHL 258

Query: 256 ISRIFVADPAKRI-----SIPEIRNHEWF 279
           + ++   D  KR          ++ H WF
Sbjct: 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  120 bits (302), Expect = 7e-32
 Identities = 83/267 (31%), Positives = 129/267 (48%), Gaps = 23/267 (8%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
           +G+G F      RD KT  L+AVK +          +++ E +++EI     L HP+I+R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
                   +H  + +E+ +GG +   +   G F E     + +QL+ G+SY H  Q+ HR
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLKKE 194
           D+K  N L+D S   RL+I DFG   ++ L ++           +GT A++APEVL  ++
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPEC 252
           Y G+  DVWS G  +  M     P+ + E+  N    I +I S     SIP+  H+SP  
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPE--HLSPGL 240

Query: 253 RHLISRIFVADPAKRISIPEIRNHEWF 279
           R +  R     P  R    E+  H  F
Sbjct: 241 RDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 1e-31
 Identities = 72/268 (26%), Positives = 108/268 (40%), Gaps = 30/268 (11%)

Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           +G G FG     +L         VAVK ++     +E     +E    + L HPN+VR  
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCH 134
            V      L +V+EY  GG+L  + R       S +++    + L+S       G+ Y  
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLL 191
           S +  HRDL   N L+       +KI DFG S+        +   G    I   APE L 
Sbjct: 123 SKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180

Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFE--DPEEPKNFRKTIHRILSVQYSIPDYVHI 248
              +  K +DVWS GV L+ +  +GA P+     EE       +   L   Y +P   + 
Sbjct: 181 DGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRLPKPEYC 232

Query: 249 SPECRHLISRIFVADPAKRISIPEIRNH 276
             E   L+   +  DP  R +  E+   
Sbjct: 233 PDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  119 bits (300), Expect = 5e-31
 Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 19/261 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
           IG G+FG   L + K   +  AVK +++   ++   Q+ I+  R++     +HP +V   
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T   L  V+++ +GGELF  +     F E  ARF+  ++ S + Y HS+ + +RDL
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
           K EN LLD      + + DFG  K  +  S   +T  GTP Y+APEV+ K+ YD  + D 
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV-DW 179

Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           W  G  LY ML G  PF   +  + +   +H+ L ++         S     ++  +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPG------ASLTAWSILEELLEK 233

Query: 263 DPAKRI----SIPEIRNHEWF 279
           D  +R+       EI+ H +F
Sbjct: 234 DRQRRLGAKEDFLEIQEHPFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  118 bits (298), Expect = 6e-31
 Identities = 93/295 (31%), Positives = 146/295 (49%), Gaps = 45/295 (15%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           D+YE V  IG G +GV    RD+ T E +A+K I R ++ DE V     REI   + ++H
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQQLISGVSYCH 134
            NIVR ++V+ +   L +V EY    +L + + ++  F+++    + +  Q++ G++YCH
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVL 190
           S +V HRDLK +N L+D      LK+ DFG +++  +   P  T    V T  Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEIL 175

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQY-------- 240
           L   +     D+WS G  ++  +V   P    D E  + F+  I RIL            
Sbjct: 176 LGSRHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFK--IFRILGTPNEETWPGVT 232

Query: 241 SIPDYVH----------------ISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           S+PDY                  + P    L+S++   DP+KRI+      HE+F
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287

Length = 294

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  117 bits (295), Expect = 7e-31
 Identities = 81/254 (31%), Positives = 129/254 (50%), Gaps = 16/254 (6%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           +G G +G+    RD  T+  +A+K I ER  +  + +  EI  H  L+H NIV++     
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 88  TPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
                 I ME   GG L           + +E    F+ +Q++ G+ Y H  Q+ HRD+K
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135

Query: 145 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIAD 201
            +N L++ + +  +KI DFG SK  + ++   ++  GT  Y+APEV+ K  + Y G  AD
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPAD 193

Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKN--FRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
           +WS G T+  M  G  PF +  EP+   F+  + +I      IP+   +S E ++ I R 
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI---HPEIPE--SLSAEAKNFILRC 248

Query: 260 FVADPAKRISIPEI 273
           F  DP KR S  ++
Sbjct: 249 FEPDPDKRASAHDL 262

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  117 bits (294), Expect = 1e-30
 Identities = 87/273 (31%), Positives = 123/273 (45%), Gaps = 20/273 (7%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
           D YEL+  IG G   V          E VA+K I+  +K   +V    +E+       HP
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHP 59

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCH 134
           N+V++    +    L +VM Y SGG L +        G   E       ++++ G+ Y H
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAP 187
           S    HRD+K  N LL  DGS    +KI DFG S S            K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Query: 188 EVL-LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
           EV+     YD K AD+WS G+T   +  GA P+      K    T+        +  DY 
Sbjct: 176 EVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234

Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
             S   R +IS     DP+KR +  E+  H++F
Sbjct: 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  115 bits (290), Expect = 4e-30
 Identities = 78/254 (30%), Positives = 123/254 (48%), Gaps = 20/254 (7%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
           +E++  IG G+FGV   +  K  + + A+K I+   K++   + E I+       L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSM 136
           I+R+ E  L    L IVMEYA  G+L + +         ED+   FF Q++ G+++ HS 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 193
           ++ HRD+K  N  LD      +KI D G +K  +L        + VGTP Y++PE+   K
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
            Y+ K +DVW+ GV LY    G +PF    +  N    I +I+   +  P     S +  
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPF----DANNQGALILKIIRGVFP-PVSQMYSQQLA 230

Query: 254 HLISRIFVADPAKR 267
            LI +    D  +R
Sbjct: 231 QLIDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  115 bits (291), Expect = 5e-30
 Identities = 79/290 (27%), Positives = 124/290 (42%), Gaps = 41/290 (14%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKY-IERGDKIDE-NVQREIINHRSLR-HPNI 79
           Y+++  IG G F      + +KT +  A+K   +    +++ N  REI   R L  HPNI
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 80  VRFKEVILTPTH--LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
           +R  EV+       LA+V E      L+E I    R   E   + +  QL+  + + H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
            + HRD+K EN L+       LK+ DFG  +   ++S+P  T  + T  Y APE LL   
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 195 YDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPKNFRKTIHRILSV----------QYSIP 243
           Y G   D+W+ G   + +L   +P F    E     K IH +L            +    
Sbjct: 175 YYGPKMDIWAVGCVFFEIL-SLFPLFPGTNELDQIAK-IHDVLGTPDAEVLKKFRKSRHM 232

Query: 244 DY--------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           +Y               + S E   L+ ++   DP +RI+  +   H +F
Sbjct: 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  115 bits (288), Expect = 6e-30
 Identities = 88/264 (33%), Positives = 128/264 (48%), Gaps = 22/264 (8%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD-KIDENVQREIINH--RSLR 75
           RY L + +G G+FG   L++DKK    E L  +K I  G+   +E VQ          L 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 131
           HP IV+F    L      I+ EY  G +L  ++          SE++   +F QL+ GV 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
           Y H  ++ HRDLK +N  L  +    LKI DFG S+  +      +T  GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHIS 249
             + YD K +D+WS G  LY M   A+ FE     +NF   + RI+     S+P+    S
Sbjct: 178 KHQGYDSK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPTPSLPE--TYS 230

Query: 250 PECRHLISRIFVADPAKRISIPEI 273
            +   ++  +   DP+ R S  EI
Sbjct: 231 RQLNSIMQSMLNKDPSLRPSAAEI 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  114 bits (287), Expect = 2e-29
 Identities = 78/278 (28%), Positives = 139/278 (50%), Gaps = 25/278 (8%)

Query: 23  YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGDKIDE-------NVQREIINHR 72
           +EL++ +G+G +G   L+R      + +L A+K +++   + +         +R+++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
             + P +V       T T L ++++Y +GGELF  +    RF E E + +  +++  + +
Sbjct: 62  R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
            H + + +RD+KLEN LLD +    + + DFG SK        +  S  GT  Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 191 LKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
              +  +D K  D WS GV +Y +L GA PF    E  +  +   RIL  +   P    +
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM 235

Query: 249 SPECRHLISRIFVADPAKRI-----SIPEIRNHEWFLK 281
           S   + +I R+ + DP KR+        EI+ H +F K
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  115 bits (290), Expect = 3e-29
 Identities = 85/287 (29%), Positives = 125/287 (43%), Gaps = 51/287 (17%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVK--YIERGDKIDENVQREIINHRSLRHPNIVR 81
           E V  IGSG  G    +  + T  L A+K  Y    D +   + REI   R + HPN+V+
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
             ++      + +++E+  GG L        +F  D AR    Q++SG++Y H   + HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LLKKEYD 196
           D+K  N L++   A  +KI DFG S+       P  S+VGT AY++PE     L    YD
Sbjct: 193 DIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250

Query: 197 GKIADVWSCGVTLYVMLVGAYPF------------------EDPEEPKNFRKTIHRILSV 238
           G   D+WS GV++    +G +PF                  + PE P             
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT----------- 299

Query: 239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 285
                     S E RH IS     +PAKR S  ++  H + L+  P 
Sbjct: 300 ---------ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337

Length = 353

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  112 bits (283), Expect = 8e-29
 Identities = 82/290 (28%), Positives = 133/290 (45%), Gaps = 38/290 (13%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHP 77
           +YE +  IG G +G     ++++T E+VA+K + R D  DE V     REI   + L+H 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS 135
           NIVR  +V+ +   L +V EY    +  ++  ++  G    +  + F  QL+ G+++CHS
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KK 193
             V HRDLK +N L++ +    LK+ DFG +++  +      + V T  Y  P+VL   K
Sbjct: 118 HNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------YSIPDY 245
            Y   I D+WS G     +     P     +  +  K I R+L             +PDY
Sbjct: 176 LYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234

Query: 246 V----------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
                             ++   R L+  + V +P +RIS  E   H +F
Sbjct: 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  112 bits (283), Expect = 1e-28
 Identities = 92/312 (29%), Positives = 138/312 (44%), Gaps = 67/312 (21%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
           +E +  IG G +G+    RD  + E+VA+K +    ER D I  +  REI    +LRHPN
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPN 67

Query: 79  IVRFKEVILTPTHLA---IVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           IV  KEV+    HL    +VMEY       L + +     FSE + +    QL+ G+ Y 
Sbjct: 68  IVELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYL 124

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLL- 191
           H   + HRDLK+ N LL       LKI DFG +++  L ++P +  V T  Y APE+LL 
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182

Query: 192 KKEYDGKIADVWSCG---------------------VTLYVMLVGA-----YP------- 218
              Y   I D+W+ G                     + L + L+G      +P       
Sbjct: 183 CTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241

Query: 219 ---FEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 275
              F  P++P N  K  H+          +  +S     L++ + + DP KR +  E   
Sbjct: 242 VGKFTLPKQPYNNLK--HK----------FPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289

Query: 276 HEWFLKN-LPAD 286
             +F +  LP +
Sbjct: 290 SSYFKEKPLPCE 301

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  111 bits (280), Expect = 1e-28
 Identities = 74/269 (27%), Positives = 112/269 (41%), Gaps = 29/269 (10%)

Query: 24  ELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
           EL + +G G FG      L    + TE  VAVK ++ G  ++  E    E    + L HP
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           NIVR   V      L IV EY  GG+L  F R  +  + +  +      Q+  G+ Y  S
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 190
               HRDL   N L+  +    +KI DFG S+   ++            +     APE L
Sbjct: 121 KNFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED--PEEPKNFRKTIHRILSVQYSIPDYVH 247
              ++  K +DVWS GV L+ +  +G  P+     EE     +  +R+       P+   
Sbjct: 177 KDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLP-----RPENCP 230

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNH 276
              E   L+ + +  DP  R +  E+   
Sbjct: 231 --DELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 3e-28
 Identities = 79/275 (28%), Positives = 127/275 (46%), Gaps = 30/275 (10%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           D +E++ ++G G FG     + K+T    A K I+   +    D  V+ +I++    +HP
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
           NIV   E       L I++E+  GG L   +    R  +E + R+  +Q++  +++ HS 
Sbjct: 63  NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122

Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-- 191
           +V HRDLK  N LL  DG     +K+ DFG S  +    Q + T +GTP ++APEV+   
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 192 ---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-- 246
                 YD K AD+WS G+TL  +          E P +    +  +L +  S P  +  
Sbjct: 179 TFKDNPYDYK-ADIWSLGITLIELAQM-------EPPHHELNPMRVLLKILKSEPPTLDQ 230

Query: 247 --HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
               S      +    V DP  R +  E+  H + 
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  110 bits (277), Expect = 3e-28
 Identities = 75/268 (27%), Positives = 121/268 (45%), Gaps = 22/268 (8%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
             +++ + IG G F V           +VA+K ++  + +D    ++  +EI   + L H
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
           PN++++    +    L IV+E A  G+L   I +  +      E     +F QL S + +
Sbjct: 62  PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 187
            HS ++ HRD+K  N  +  +    +K+ D G      SK++  HS     VGTP Y++P
Sbjct: 122 MHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSP 175

Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
           E + +  Y+ K +D+WS G  LY M     PF    +  N      +I    Y      H
Sbjct: 176 ERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADH 232

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRN 275
            S E R L+SR    DP KR  I  +  
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 3e-28
 Identities = 83/299 (27%), Positives = 123/299 (41%), Gaps = 54/299 (18%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSLR-- 75
           YE + +IG G +G     RD  T   VA+K +     E G  I  +  REI   + L   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58

Query: 76  -HPNIVRFKEVILTP-----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLIS 128
            HPNIVR  +V   P       L +V E+       +   C       +  +   +QL+ 
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 129 GVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
           GV + HS ++ HRDLK +N L+  DG    ++KI DFG ++         S V T  Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRA 174

Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVM---------------------LVGAYPFED-PEE 224
           PEVLL+  Y   + D+WS G     +                     ++G    E+ P  
Sbjct: 175 PEVLLQSSYATPV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233

Query: 225 ----PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
                 +F        S +  +P+   I  E   L+ ++   +P KRIS  E   H +F
Sbjct: 234 VSLPRSSFPSY--TPRSFKSFVPE---ICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  112 bits (281), Expect = 4e-28
 Identities = 96/350 (27%), Positives = 161/350 (46%), Gaps = 68/350 (19%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-- 78
           D +E ++ IG G FG  RL++ K T  + A+K + + D +++     I   R +      
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 79  --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             +V+         +L ++ME+  GG++   +      SE+  +F+  + +  +   H +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK--------- 176
              HRD+K +N LLD      +K+ DFG               ++ H+ P          
Sbjct: 121 GFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 177 ----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF- 219
                           STVGTP YIAPEV ++  Y+ K+ D WS GV +Y ML+G  PF 
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237

Query: 220 -EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRN 275
            E P+E   +RK ++   ++ +  P  V IS + + LI R F  D   RI    + EI++
Sbjct: 238 SETPQE--TYRKVMNWKETLVF--PPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKS 292

Query: 276 HEWF-------LKNLPADL-----VVDNTTN-NQFEEPD--QPMQSIDEI 310
           H +F       ++  PA +      +D+T+N ++F E D  QP ++  E 
Sbjct: 293 HPFFEGVDWGHIRERPAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEP 342

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  111 bits (279), Expect = 7e-28
 Identities = 85/302 (28%), Positives = 129/302 (42%), Gaps = 52/302 (17%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHP 77
            RY+ + +IGSG +GV     D ++ + VA+K I     +    +R   E+   R  +H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 78  NIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           NI+  ++++  P      + +VM+     +L   I +    +E+  R+F  QL+ G+ Y 
Sbjct: 65  NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PKSTVGTPAYIAPE 188
           HS  V HRDLK  N L++      L+I DFG     S S   H       V T  Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPD-- 244
           +LL   EY   I D+WS G     ML     F     P KN+   +  ILSV  S  +  
Sbjct: 182 LLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLF-----PGKNYVHQLKLILSVLGSPSEEV 235

Query: 245 ---------------------------YVHISPECRHLISRIFVADPAKRISIPEIRNHE 277
                                      +   SPE   L+S++   DP +RI++ +   H 
Sbjct: 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295

Query: 278 WF 279
           + 
Sbjct: 296 FL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 7e-28
 Identities = 72/230 (31%), Positives = 110/230 (47%), Gaps = 42/230 (18%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---- 75
           +  +ELV  IG G +G     R KKT +LVA+K ++  +  +E ++ E      LR    
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSN 61

Query: 76  HPNIVRFKEVILTPTH------LAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQ 125
           HPNI  F    +          L +VME   GG   +L + +   G R  E+   +  ++
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 126 LISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST----- 178
            + G++Y H  +V HRD+K +N LL  +      +K+ DFG S      +Q  ST     
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDSTLGRRN 171

Query: 179 --VGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
             +GTP ++APEV+   E     YD + +DVWS G+T   +  G  P  D
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCD 220

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  110 bits (276), Expect = 2e-27
 Identities = 90/274 (32%), Positives = 137/274 (50%), Gaps = 22/274 (8%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
           ++ YE+V+ IG G FG  +L+R K T ++ A+K + + + I  +        R +     
Sbjct: 42  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            P +V+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   HS
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 160

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           M   HRD+K +N LLD S    LK+ DFG     +K  ++     + VGTP YI+PEVL 
Sbjct: 161 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 216

Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
            +    Y G+  D WS GV LY MLVG  PF        + K ++   S+ +  PD   I
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDI 274

Query: 249 SPECRHLISRIFVADPAKRI---SIPEIRNHEWF 279
           S E ++LI   F+ D   R+    + EI+ H +F
Sbjct: 275 SKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  108 bits (272), Expect = 3e-27
 Identities = 81/275 (29%), Positives = 139/275 (50%), Gaps = 34/275 (12%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           IG G+ G+  + R+K +   VAVK ++ R  +  E +  E++  R  +H N+V   +  L
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
               L ++ME+  GG L + I +  R +E++     + ++  + Y HS  V HRD+K ++
Sbjct: 89  VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147

Query: 148 TL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            L  LDG    R+K+ DFG+ ++ S    + KS VGTP ++APEV+ +  Y  ++ D+WS
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DIWS 202

Query: 205 CGVTLYVMLVGAYPF--EDP--------EEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
            G+ +  M+ G  P+  + P        + P    K  H+             ISP  R 
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHK-------------ISPVLRD 249

Query: 255 LISRIFVADPAKRISIPEIRNHEWFLK-NLPADLV 288
            + R+   +P +R +  E+ +H + L+  LP  LV
Sbjct: 250 FLERMLTREPQERATAQELLDHPFLLQTGLPECLV 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  109 bits (273), Expect = 7e-27
 Identities = 83/274 (30%), Positives = 137/274 (50%), Gaps = 22/274 (8%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
           ++ Y++V+ IG G FG  +L+R K ++++ A+K + + + I  +        R +     
Sbjct: 42  AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            P +V+         +L +VMEY  GG+L   + N     E  A+F+  +++  +   HS
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           M + HRD+K +N LLD      LK+ DFG      ++ ++     + VGTP YI+PEVL 
Sbjct: 161 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLK 216

Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
            +    Y G+  D WS GV L+ MLVG  PF        + K +    S+ +  P+ V I
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF--PEDVEI 274

Query: 249 SPECRHLISRIFVADPAKRI---SIPEIRNHEWF 279
           S   ++LI   F+ D   R+    + EI+ H +F
Sbjct: 275 SKHAKNLIC-AFLTDREVRLGRNGVEEIKQHPFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  107 bits (269), Expect = 8e-27
 Identities = 69/196 (35%), Positives = 101/196 (51%), Gaps = 17/196 (8%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHP 77
            +  +R+IG G+FG     RD +T E+VA+K +    K      ++II      + LRHP
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75

Query: 78  NIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           N + +K   L      +VMEY   S  ++ E   +     E E        + G++Y HS
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
            +  HRD+K  N LL  +    +K+ DFG   S+ L S   S VGTP ++APEV+L   +
Sbjct: 134 HERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMDE 188

Query: 193 KEYDGKIADVWSCGVT 208
            +YDGK  DVWS G+T
Sbjct: 189 GQYDGK-VDVWSLGIT 203

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  106 bits (267), Expect = 1e-26
 Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 49/295 (16%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
           Y  +  IG G +GV    R+KKT ++VA+K I R +  +E V     REI   + L+HPN
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           IV  ++V++  + L ++ E+ S    +  + +        +  + +  Q++ G+ +CHS 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVL 190
           +V HRDLK +N L+D      +K+ DFG +++         H      V T  Y APEVL
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHE-----VVTLWYRAPEVL 173

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQ--------Y 240
           L         D+WS G T++  +    P    D E  + FR  I RIL            
Sbjct: 174 LGSPRYSTPVDIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRILGTPTEDVWPGVT 230

Query: 241 SIPDYVHISPECR----------------HLISRIFVADPAKRISIPEIRNHEWF 279
           S+PDY +  P+ +                 L+ ++ + DPAKRIS  +  NH +F
Sbjct: 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  106 bits (267), Expect = 1e-26
 Identities = 82/293 (27%), Positives = 126/293 (43%), Gaps = 46/293 (15%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
           ++ +  +G G +      R++ T E+VA+K I    E G        REI   + L+H N
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHEN 59

Query: 79  IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           IVR  +VI T   L +V EY      +  +     G    +  + F  QL+ G+++CH  
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KKE 194
           +V HRDLK +N L++      LK+ DFG +++  +  +   + V T  Y AP+VLL  + 
Sbjct: 120 RVLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF-----ED-----------------------PEEPK 226
           Y   I D+WS G  +  M+ G   F     ED                       PE   
Sbjct: 178 YSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236

Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            F +   +   +Q   P   H  P    L+ R+   +P  RIS  +   H WF
Sbjct: 237 TFPRYPPQ--DLQQLFP---HADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  107 bits (269), Expect = 1e-26
 Identities = 88/328 (26%), Positives = 135/328 (41%), Gaps = 76/328 (23%)

Query: 10  PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---- 65
              + P   +  +YE +  IG G FG     R KKT+++VA+K +     + EN +    
Sbjct: 1   DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFP 55

Query: 66  ----REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAG- 112
               REI   + L+H N+V   E+  T             +V E+    +L   + N   
Sbjct: 56  ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNV 114

Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSV 170
           +F+  E +   + L++G+ Y H  ++ HRD+K  N L+  DG     LK+ DFG +++  
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFS 170

Query: 171 LHSQPKST-----VGTPAYIAPEVLLKKEYDGKIADVWSCG------------------- 206
           L    K       V T  Y  PE+LL +   G   D+W  G                   
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230

Query: 207 --VTLYVMLVGA-----YP-------FEDPEEPKN-FRKTIHRILSVQYSIPDYVHISPE 251
             +TL   L G+     +P       F+  E P+   RK   R+         YV   P 
Sbjct: 231 HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP-------YVK-DPH 282

Query: 252 CRHLISRIFVADPAKRISIPEIRNHEWF 279
              LI ++ V DPAKRI      NH++F
Sbjct: 283 ALDLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  106 bits (267), Expect = 2e-26
 Identities = 89/324 (27%), Positives = 147/324 (45%), Gaps = 39/324 (12%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRH 76
           ++RY  ++ +G G FG+    RD+ T + VA+K I +      + +   RE+   + LRH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 77  PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            NI+   ++ ++P   +  V E    G    R+  +    +   ++F  Q++ G+ Y HS
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KE 194
             V HRDLK  N L++ +    LKICDFG ++  +   Q    V T  Y APE++L  ++
Sbjct: 127 AGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182

Query: 195 YDGKIADVWSCGVTLYVMLVGA--YPFEDP------------EEPKNFRKTI--HRILSV 238
           YD ++ D+WS G     ML G   +P +D               P +   TI     L  
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241

Query: 239 QYSIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF-LKNLPADL- 287
             S+P          + +  P    L+ ++ V DP KRIS  E   H +    + P D  
Sbjct: 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP 301

Query: 288 VVDNTTNNQFEEPDQPMQSIDEIM 311
           V +   +  F + D P+ +   +M
Sbjct: 302 VAEEKFDWSFNDADLPVDTWKVMM 325

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  105 bits (264), Expect = 4e-26
 Identities = 82/267 (30%), Positives = 129/267 (48%), Gaps = 20/267 (7%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIV 80
           +Y     IG G  G      D  T + VA+K +    +   E +  EI+  R  +HPNIV
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + HS QV H
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138

Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
           RD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ +K Y  
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH---ISPECRH 254
           K+ D+WS G+    M+ G  P+ +    +N  + ++ I +     P+  +   +S   R 
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIAT--NGTPELQNPEKLSAIFRD 247

Query: 255 LISRIFVADPAKRISIPEIRNHEWFLK 281
            ++R    D  KR S  E+  H  FLK
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHP-FLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  105 bits (262), Expect = 4e-26
 Identities = 81/261 (31%), Positives = 130/261 (49%), Gaps = 20/261 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
           IG G+FG      D +T+++VA+K I+  +  DE  ++Q+EI        P + ++    
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 87  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
           L  T L I+MEY  GG   + +  AG F E +     ++++ G+ Y HS +  HRD+K  
Sbjct: 72  LKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130

Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWS 204
           N LL  S    +K+ DFG +   +  +Q K  + VGTP ++APEV+ +  YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWS 186

Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYV-HISPECRHLISRIFV 261
            G+T   +  G        EP N      R+L +  + + P      S   +  I     
Sbjct: 187 LGITAIELAKG--------EPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238

Query: 262 ADPAKRISIPEIRNHEWFLKN 282
            DP+ R +  E+  H++ +KN
Sbjct: 239 KDPSFRPTAKELLKHKFIVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  105 bits (263), Expect = 4e-26
 Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 12/196 (6%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
           +++E++  +G G +GV    R K+T+E+VA+K     E  +++ E   RE+   R+L+  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 78  NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           NIV  KE       L +V EY      EL E + N      ++ R +  QLI  + +CH 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHK 118

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
             + HRD+K EN L+  S    LK+CDFG++++    S    T  V T  Y +PE+LL  
Sbjct: 119 NDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176

Query: 194 EYDGKIADVWSCGVTL 209
            Y GK  D+WS G  L
Sbjct: 177 PY-GKAVDMWSVGCIL 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  106 bits (266), Expect = 4e-26
 Identities = 98/329 (29%), Positives = 150/329 (45%), Gaps = 45/329 (13%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKID-ENVQREIINHRSLRHPN 78
           +Y  ++ IG G +G+    ++ +T E VA+K I     ++ID +   REI   R L H N
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 79  IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           ++  K+ I+ P H      + IV E     +L + I ++   S+D  ++F  QL+ G+ Y
Sbjct: 66  VIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLL 191
            HS  V HRDLK  N LL+ +    LKICDFG ++ +S         V T  Y APE+LL
Sbjct: 124 IHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181

Query: 192 K-KEYDGKIADVWSCG---------------------VTLYVMLVGAYPFEDPE--EPKN 227
              EY   I DVWS G                     + L   L+G+   ED      + 
Sbjct: 182 NCSEYTTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 228 FRKTIHRILSVQYSIP---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKN 282
            R+ I R L           + H +P    L+ ++ V DP+KRI++ E   H +   L +
Sbjct: 241 ARRYI-RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299

Query: 283 LPADLVVDNTTNNQFEEPDQPMQSIDEIM 311
              + V     +  FEE     + I E++
Sbjct: 300 PSDEPVCQTPFSFDFEEDALTEEDIKELI 328

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  105 bits (264), Expect = 6e-26
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)

Query: 27  RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREI-INHRSLRHPNIVR 81
           R IG G++    L+  KKT  + A+K I++    D+     VQ E  +   +  HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
                 T + L  V+E+ SGG+L   +    +  E+ ARF+  ++   +++ H   + +R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
           DLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L  ++Y   + 
Sbjct: 121 DLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177

Query: 201 DVWSCGVTLYVMLVGAYPFE-----DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
           D W+ GV ++ M+ G  PF+     D  +          IL  Q  IP    +S +   +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKASSV 235

Query: 256 ISRIFVADPAKRI------SIPEIRNHEWF 279
           +      DP +R+         +I++H +F
Sbjct: 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  104 bits (262), Expect = 6e-26
 Identities = 78/278 (28%), Positives = 121/278 (43%), Gaps = 26/278 (9%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
           ++   +  +G G  G     R K T  + A+K I       + + + RE+  ++S + P 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 79  IVRFKEVILTP--THLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVS 131
           IV++    L    + + I MEY  GG L + I        GR  E       + ++ G+S
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           Y HS ++ HRD+K  N LL       +K+CDFG S   V  S   +  GT  Y+APE + 
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQ 176

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIP------ 243
            K Y    +DVWS G+TL  +    +PF  PE           +LS  V    P      
Sbjct: 177 GKPYSIT-SDVWSLGLTLLEVAQNRFPFP-PEGEPPLGPI--ELLSYIVNMPNPELKDEP 232

Query: 244 -DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 280
            + +  S E +  I +    DP +R +  ++  H W  
Sbjct: 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  105 bits (262), Expect = 6e-26
 Identities = 81/265 (30%), Positives = 136/265 (51%), Gaps = 13/265 (4%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           IG G+ G+  +   K + +LVAVK ++ R  +  E +  E++  R  +H N+V      L
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
               L +VME+  GG L + I    R +E++       ++  +S  H+  V HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146

Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            LL  DG    R+K+ DFG+ ++ S    + KS VGTP ++APE++ +  Y G   D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201

Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            G+ +  M+ G  P+ + E P    K I   L  +  + +   +SP  +  + R+ V DP
Sbjct: 202 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPK--LKNLHKVSPSLKGFLDRLLVRDP 258

Query: 265 AKRISIPEIRNHEWFLKNLPADLVV 289
           A+R +  E+  H +  K  P   +V
Sbjct: 259 AQRATAAELLKHPFLAKAGPPSCIV 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  104 bits (262), Expect = 8e-26
 Identities = 91/307 (29%), Positives = 128/307 (41%), Gaps = 61/307 (19%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           D+++++  IG G +G     RDK T ELVA+K + R D   E       REI   R L H
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNH 65

Query: 77  PNIVRFKEVILTPTHLA-----------IVMEYASG---GELFERICNAGRFSEDEARFF 122
            NIV  KE I+T    A           +V EY      G L   + +   FSED  + F
Sbjct: 66  RNIVNLKE-IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121

Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 180
            +QL+ G++YCH     HRD+K  N LL+     ++K+ DFG ++          T  V 
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---------------P 225
           T  Y  PE+LL +E  G   DVWSCG  L  +      F+  +E               P
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239

Query: 226 KNF--------------RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 271
             +              +K   R L  ++S      I      L+  +   DP+KR +  
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFS-----FIPTPALDLLDHMLTLDPSKRCTAE 294

Query: 272 EIRNHEW 278
           E  N  W
Sbjct: 295 EALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  103 bits (259), Expect = 9e-26
 Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 8/201 (3%)

Query: 13  DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIIN 70
           D+   +  + +EL++ IGSG +G     R+  T EL A+K I  E G+     VQ+EII 
Sbjct: 1   DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIM 59

Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
            +  +H NIV +    L    L I ME+  GG L +     G  SE +  +  ++ + G+
Sbjct: 60  MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEV 189
            Y HS    HRD+K  N LL  +    +K+ DFG S   +   ++ KS +GTP ++APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177

Query: 190 LLKKEYDG--KIADVWSCGVT 208
              +   G  ++ D+W+ G+T
Sbjct: 178 AAVERKGGYNQLCDIWAVGIT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  108 bits (271), Expect = 1e-25
 Identities = 85/260 (32%), Positives = 125/260 (48%), Gaps = 42/260 (16%)

Query: 14  MPIMHDS-----DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQR- 66
           MP  +D      + YE+++ IG+G FG   L++ K+T+E    K I  RG K  E  Q  
Sbjct: 1   MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60

Query: 67  -EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNA----GRFSEDEA 119
            E+   R L+H NIVR+ +  L   +  L I+ME+   G+L   I       G+  E   
Sbjct: 61  IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120

Query: 120 RFFFQQLISGVSYCHSMQ-------VCHRDLKLENTLLDG---------------SPAPR 157
               +QL+  ++YCH+++       V HRDLK +N  L                 +  P 
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180

Query: 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVG 215
            KI DFG SK+  + S   S VGTP Y +PE+LL   K YD K +D+W+ G  +Y +  G
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSG 239

Query: 216 AYPFEDPEEPKNFRKTIHRI 235
             PF    +  NF + I  +
Sbjct: 240 KTPF---HKANNFSQLISEL 256

Length = 1021

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  103 bits (259), Expect = 1e-25
 Identities = 80/265 (30%), Positives = 123/265 (46%), Gaps = 19/265 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN---IVRFKE 84
           +G G FG     + + T +L A K + +   K  +  +  ++  R L   +   IV    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 85  VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCH 140
              T T L +VM   +GG+L   I N       F E  A F+  Q+ISG+ + H  ++ +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           RDLK EN LLD      ++I D G + +     S+ K   GTP ++APE+L  +EYD  +
Sbjct: 121 RDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178

Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            D ++ GVTLY M+    PF    E    ++   RIL+   + PD    SP  +     +
Sbjct: 179 -DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEAL 235

Query: 260 FVADPAKRI-----SIPEIRNHEWF 279
              DP KR+     +   +R H  F
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHPLF 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  103 bits (258), Expect = 1e-25
 Identities = 83/267 (31%), Positives = 132/267 (49%), Gaps = 22/267 (8%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRH 76
           + L + +G G FG   L  D  T   +AVK ++   +  E  +       EI   ++L H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 77  PNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
             IV++   +  P    L+I ME+  GG + +++ + G  +E+  R + +Q++ GVSY H
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVL 190
           S  + HRD+K  N L D      +K+ DFG SK      +  +  KS  GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-VHIS 249
             + Y G+ AD+WS G T+  ML    P+ + E      K     ++ Q + P    H+S
Sbjct: 182 SGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-----IATQPTNPVLPPHVS 235

Query: 250 PECRHLISRIFVADPAKRISIPEIRNH 276
             CR  + RIFV +   R S  E+  H
Sbjct: 236 DHCRDFLKRIFV-EAKLRPSADELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  103 bits (259), Expect = 3e-25
 Identities = 75/268 (27%), Positives = 132/268 (49%), Gaps = 20/268 (7%)

Query: 27  RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
           R IG G++    L+R KK +++ A+K +++      + ID     + +  ++  +P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
                 T + L +V+EY +GG+L   +    +  E+ ARF+  ++   +++ H   + +R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
           DLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L  +EY G   
Sbjct: 121 DLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177

Query: 201 DVWSCGVTLYVMLVGAYPFE---DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           D W+ GV ++ M+ G  PF+   D  +          IL     IP +  +S +  H++ 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLK 235

Query: 258 RIFVADPAKRI------SIPEIRNHEWF 279
                DP +R+         +I++H +F
Sbjct: 236 GFLNKDPKERLGCQPQTGFSDIKSHTFF 263

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  103 bits (258), Expect = 4e-25
 Identities = 89/325 (27%), Positives = 146/325 (44%), Gaps = 39/325 (12%)

Query: 27  RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
           R IG G++    L+R KKTE + A+K +++      + ID     + +  ++  HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
                 T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++Y H   + +R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
           DLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L  ++Y G   
Sbjct: 121 DLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177

Query: 201 DVWSCGVTLYVMLVGAYPFE-----DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
           D W+ GV ++ M+ G  PF+     D  +          IL  Q  IP    +S +   +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASV 235

Query: 256 ISRIFVADPAKRISI------------PEIRNHEW-----------FLKNLPADLVVDNT 292
           +      DP +R+              P  RN +W           F  N+  +  +DN 
Sbjct: 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNF 295

Query: 293 TNNQFEEPDQPMQSIDEIMQIIAEA 317
                 EP Q     D+I++ I ++
Sbjct: 296 DAQFTNEPVQLTPDDDDIVRKIDQS 320

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  103 bits (258), Expect = 7e-25
 Identities = 90/337 (26%), Positives = 155/337 (45%), Gaps = 66/337 (19%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN---- 78
           +E ++ IG G FG  RL++ K T  + A+K + + D +++     I   R +        
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           +V+         +L ++ME+  GG++   +      +E+E +F+  + +  +   H +  
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK----------- 176
            HRD+K +N LLD      +K+ DFG               ++ HS P            
Sbjct: 123 IHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 177 --------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--E 220
                         STVGTP YIAPEV ++  Y+ K+ D WS GV +Y ML+G  PF  E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239

Query: 221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP---EIRNHE 277
            P+E   ++K ++   ++ +  P  V IS + + LI R F  +   RI  P   EI+ + 
Sbjct: 240 TPQE--TYKKVMNWKETLIF--PPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEIKTNP 294

Query: 278 WF-------LKNLPADL-----VVDNTTN-NQFEEPD 301
           +F       ++  PA +      +D+T+N ++F + D
Sbjct: 295 FFEGVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSD 331

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 8e-25
 Identities = 97/373 (26%), Positives = 160/373 (42%), Gaps = 86/373 (23%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDE----NVQREIINHRSL 74
           + +  V+ IG G FG  RL++ K T ++ A+K + + +  K D+      +R+++     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
             P +V          +L ++ME+  GG+L   +     FSED  RF+  + +  +   H
Sbjct: 60  -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK-------------- 167
            +   HRD+K +N L+D      +K+ DFG             Y K              
Sbjct: 119 KLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 168 --------SSVLHSQPK-------------STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
                   +  + S+ +             STVGTP YIAPE+ L++ Y G+  D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLG 235

Query: 207 VTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
             ++  L+G  PF  E+  E   +RK I+   ++ +  PD +H+S E   LI R+ + + 
Sbjct: 236 AIMFECLIGWPPFCSENSHE--TYRKIINWRETLYF--PDDIHLSVEAEDLIRRL-ITNA 290

Query: 265 AKRI---SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP-MQSI--------DEIMQ 312
             R+      EI++H +F         VD  T  Q   P  P ++SI        DE+ Q
Sbjct: 291 ENRLGRGGAHEIKSHPFFRG-------VDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQ 343

Query: 313 IIAEATIPAAGTQ 325
           +  EA        
Sbjct: 344 VP-EAPALKQAAP 355

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  101 bits (253), Expect = 9e-25
 Identities = 86/273 (31%), Positives = 127/273 (46%), Gaps = 31/273 (11%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
           IG G+FG      D +T+E+VA+K I+  +  DE  ++Q+EI        P I R+    
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 87  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
           L  T L I+MEY  GG   + +   G   E       ++++ G+ Y HS +  HRD+K  
Sbjct: 72  LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130

Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSC 205
           N LL  S    +K+ DFG +         ++T VGTP ++APEV+ +  YD K AD+WS 
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSL 187

Query: 206 GVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIP--DYVH--------I 248
           G+T   +  G  P  D          PKN   T    L  QYS P  ++V          
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT----LEGQYSKPFKEFVEACLNKDPRF 243

Query: 249 SPECRHLISRIFVADPAKRIS-IPEI--RNHEW 278
            P  + L+   F+    K+ S + E+  R   W
Sbjct: 244 RPTAKELLKHKFITRYTKKTSFLTELIDRYKRW 276

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  101 bits (253), Expect = 1e-24
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 35/290 (12%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDK--IDENVQREIINHRSLRHP 77
           ++YE +  IG G++GV    R+++T ++VA+K ++E  D   I +   REI   + L+HP
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           N+V   EV      L +V EY     L E   N     E   +    Q +  V++CH   
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKKE 194
             HRD+K EN L+  +   ++K+CDFG+++  +L          V T  Y APE+L+   
Sbjct: 121 CIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 195 YDGKIADVWSCGVTLYVMLVGA--YPFE-DPEEPKNFRKTI------HR-ILSVQ----- 239
             G   DVW+ G     +L G   +P + D ++    RKT+      H+ I S       
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236

Query: 240 YSIPD----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            SIP+          + +IS      +      DP +R+S  E+  H +F
Sbjct: 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  100 bits (251), Expect = 1e-24
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 26/267 (9%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
           IG G FG     R   T ++ A+K +++     +  +   +N R +         P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
                 TP  L  +++  +GG+L   +   G FSE E RF+  ++I G+ + H+  V +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
           DLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL K     
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
             AD +S G  L+ +L G  PF    + K+  +     L+V   +PD    SPE + L+ 
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTVNVELPD--SFSPELKSLLE 231

Query: 258 RIFVADPAKRISI-----PEIRNHEWF 279
            +   D +KR+        E++ H +F
Sbjct: 232 GLLQRDVSKRLGCLGRGAQEVKEHVFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  100 bits (250), Expect = 2e-24
 Identities = 80/262 (30%), Positives = 125/262 (47%), Gaps = 20/262 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 82
           +G G FG   L  D  T   +A K ++   +  E  +       EI   ++L+H  IV++
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 83  KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
              +       L I MEY  GG + +++   G  +E   R + +Q++ G+SY HS  + H
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
           RD+K  N L D   A  +K+ DFG SK   ++  S    +S  GTP +++PEV+  + Y 
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY- 186

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           G+ ADVWS G T+  ML    P+ + E        I +I +   +     HIS   R  +
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPTNPQLPSHISEHARDFL 242

Query: 257 SRIFVADPAKRISIPEIRNHEW 278
             IFV +   R S  E+  H +
Sbjct: 243 GCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  100 bits (250), Expect = 2e-24
 Identities = 67/191 (35%), Positives = 104/191 (54%), Gaps = 8/191 (4%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
           YEL++ +GSG +G     R+  T EL AVK I  E GD     +Q+EI   +  +H NIV
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIV 69

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
            +    L+   L I MEY  GG L +     G  SE +  +  ++ + G++Y HS    H
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129

Query: 141 RDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG-- 197
           RD+K  N LL  +    +K+ DFG  +K +   ++ KS +GTP ++APEV   ++  G  
Sbjct: 130 RDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187

Query: 198 KIADVWSCGVT 208
           ++ D+W+ G+T
Sbjct: 188 QLCDIWAVGIT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  100 bits (250), Expect = 2e-24
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 28/265 (10%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
           IG G+FG      D +T+++VA+K I+  +  DE  ++Q+EI        P + ++    
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 87  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
           L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS +  HRD+K  
Sbjct: 72  LKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130

Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKIADVWS 204
           N LL  S    +K+ DFG +   +  +Q K    VGTP ++APEV+ +  YD K AD+WS
Sbjct: 131 NVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWS 186

Query: 205 CGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
            G+T   +  G  P  +          PKN   T    L   YS P         +  + 
Sbjct: 187 LGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKP--------LKEFVE 234

Query: 258 RIFVADPAKRISIPEIRNHEWFLKN 282
                +P+ R +  E+  H++ ++ 
Sbjct: 235 ACLNKEPSFRPTAKELLKHKFIVRF 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  100 bits (250), Expect = 2e-24
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 27/270 (10%)

Query: 23  YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI------------ERGDKIDENVQREII 69
           Y ++  +GSG FG V ++ +    + L+A+K I            ER   I + V    I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQ 125
               LRHPNIVR+ +  L    L IVM+   G  L E   +      RF+E+     F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 126 LISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
           ++  + Y H   ++ HRDL   N +L      ++ I DFG +K     S+  S VGT  Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IP 243
             PE++  + Y G+ ADVW+ G  LY M     PF       N      +I+   Y  +P
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYS----TNMLSLATKIVEAVYEPLP 234

Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEI 273
           + ++ S +   +I+     D   R  I ++
Sbjct: 235 EGMY-SEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 99.3 bits (247), Expect = 4e-24
 Identities = 79/245 (32%), Positives = 122/245 (49%), Gaps = 19/245 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQREIINHRSLRHPNIVRF 82
           +G G FG   L  D  T   +AVK +      +   K    ++ EI   ++LRH  IV++
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 83  KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
              +  P    L+I +EY  GG + +++   G  +E+  R + +Q++ GVSY HS  + H
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
           RD+K  N L D   A  +K+ DFG SK   ++  S    KS  GTP +++PEV+  + Y 
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY- 186

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           G+ ADVWS   T+  ML    P+ + E      K   +       +PD   +S  CR  +
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM--LPD--GVSDACRDFL 242

Query: 257 SRIFV 261
            +IFV
Sbjct: 243 KQIFV 247

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  100 bits (249), Expect = 5e-24
 Identities = 86/266 (32%), Positives = 130/266 (48%), Gaps = 18/266 (6%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
           +Y     IG G  G      D  T + VA+K I  +     E +  EI+  + L++PNIV
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
            F +  L    L +VMEY +GG L + +        DEA+     ++ +  + + H+ QV
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV 136

Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
            HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ +K Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
             K+ D+WS G+    M+ G  P+ + E P      I    + +   P+   +SP  R  
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSPIFRDF 248

Query: 256 ISRIFVADPAKRISIPEIRNHEWFLK 281
           ++R    D  KR S  E+  H  FLK
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHP-FLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  102 bits (255), Expect = 5e-24
 Identities = 63/186 (33%), Positives = 106/186 (56%), Gaps = 17/186 (9%)

Query: 92  LAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
           +A+V++YA+ G+L + I +  +    F E EA   F Q++  V + HS  + HRD+K  N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173

Query: 148 TLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            LL  +    +K+ DFG+SK   ++V     ++  GTP Y+APE+  +K Y  K AD++S
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230

Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHLISRIFVAD 263
            GV LY +L    PF+     +N  + +H+ L+ +Y  +P    ISPE + +++ +  +D
Sbjct: 231 LGVLLYELLTLKRPFDG----ENMEEVMHKTLAGRYDPLPP--SISPEMQEIVTALLSSD 284

Query: 264 PAKRIS 269
           P +R S
Sbjct: 285 PKRRPS 290

Length = 496

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 99.0 bits (247), Expect = 9e-24
 Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 18/221 (8%)

Query: 25  LVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
            ++ +G G+FG   L R       T E VAVK +     ++   + +REI   R+L H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 79  IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
           IV++K V   P    L ++MEY   G L + +  +  + +      F  Q+  G+ Y  S
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA-YIAPEVLL 191
            +  HRDL   N L++      +KI DFG +K           K    +P  + APE L 
Sbjct: 128 QRYIHRDLAARNILVESE--DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             ++    +DVWS GVTLY +     P + P  P  F + I
Sbjct: 186 TSKFSSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMI 223

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 99.4 bits (247), Expect = 1e-23
 Identities = 81/274 (29%), Positives = 129/274 (47%), Gaps = 21/274 (7%)

Query: 26  VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
           +R+IG G+FG     RD +T E+VA+K +    K      ++II      + ++HPN + 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 82  FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           +K   L      +VMEY   S  +L E   +     E E        + G++Y HS  + 
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147

Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
           HRD+K  N LL  +   ++K+ DFG   S+ + S   S VGTP ++APEV+L   + +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           GK+ DVWS G+T  + L    P   P    N    ++ I   +         S   R+ +
Sbjct: 203 GKV-DVWSLGITC-IELAERKP---PLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257

Query: 257 SRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
                  P  R +  E+  H + L+  P  +++D
Sbjct: 258 DSCLQKIPQDRPTSEELLKHMFVLRERPETVLID 291

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  100 bits (250), Expect = 1e-23
 Identities = 87/312 (27%), Positives = 132/312 (42%), Gaps = 67/312 (21%)

Query: 26  VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 79
           ++ +G G FG   L     T  L A+K + + D ++ N       +R+I+      +  +
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           V+         +L  VM+Y  GG++   +     F E  ARF+  +L   +   H M   
Sbjct: 64  VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123

Query: 140 HRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSSVLHS---QPK----- 176
           HRD+K +N L  LDG     +K+ DFG             Y K S +     +P      
Sbjct: 124 HRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179

Query: 177 ---------------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL 209
                                      S VGTP YIAPEVLL+K Y  ++ D WS GV L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVIL 238

Query: 210 YVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA--DPAKR 267
           + MLVG  PF  P   +   K I+   ++   IP  V +SPE   LI+++  +  +   R
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH--IPPQVKLSPEAVDLITKLCCSAEERLGR 296

Query: 268 ISIPEIRNHEWF 279
               +I+ H +F
Sbjct: 297 NGADDIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 99.0 bits (246), Expect = 1e-23
 Identities = 80/274 (29%), Positives = 127/274 (46%), Gaps = 21/274 (7%)

Query: 26  VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
           +R+IG G+FG     RD +  E+VA+K +    K      ++II      + LRHPN ++
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 82  FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           ++   L      +VMEY   S  +L E   +     E E        + G++Y HS  + 
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137

Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
           HRD+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV+L   + +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           GK+ DVWS G+T  + L    P   P    N    ++ I   +       H S   R+ +
Sbjct: 193 GKV-DVWSLGITC-IELAERKP---PLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247

Query: 257 SRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
                  P  R +   +  H + L+  P  +++D
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  100 bits (251), Expect = 2e-23
 Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 18/291 (6%)

Query: 40  MRDKKTEELVAVKYIERGDKIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
            R    +E V  K++   D+      R E+    +  H  IV+  +   +   L ++MEY
Sbjct: 87  TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146

Query: 99  ASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154
            SGG+L ++I    +    F E E    F Q++  +   HS ++ HRDLK  N  L   P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204

Query: 155 APRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYV 211
              +K+ DFG+SK    SV      S  GTP Y+APE+  +K Y  K AD+WS GV LY 
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYE 263

Query: 212 MLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 271
           +L    PF+ P +    R+ + ++L  +Y  P    +S   + L+  +   +PA R +  
Sbjct: 264 LLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQ 318

Query: 272 EIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAA 322
           ++ + E FLK + A+L  D   +++   P    + + ++ +    A  P++
Sbjct: 319 QLLHTE-FLKYV-ANLFQDIVRHSETISPHDREEILRQLQESGERAPPPSS 367

Length = 478

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 77/320 (24%), Positives = 120/320 (37%), Gaps = 66/320 (20%)

Query: 22  RYELVRDIGSGNFGVARLMRDK--KTEELVAVKYIE----RGDKIDENVQREIINHRSLR 75
           +YE+   IG G +G     + K  K  +  A+K  +    +   I ++  REI   R L+
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 76  HPNIVRFKEVILTPTHLAIVM--EYASGGEL----FERICNAGRFSEDEARFFFQQLISG 129
           H N+V   EV L     ++ +  +YA         F R            +    Q+++G
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 130 VSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS------TVGT 181
           V Y HS  V HRDLK  N L+  +G     +KI D G ++  + ++  K        V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178

Query: 182 PAYIAPEVLL-KKEYDGKIADVWSCG------VTLYVMLVGA------------------ 216
             Y APE+LL  + Y   I D+W+ G      +TL  +  G                   
Sbjct: 179 IWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237

Query: 217 -----YPFED--------PEEPKNFRKTIHRILSVQYSIPDYVHI----SPECRHLISRI 259
                 P E         PE      K          S+  ++        +   L+ ++
Sbjct: 238 FEVLGTPTEKDWPDIKKMPEYDT-LMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296

Query: 260 FVADPAKRISIPEIRNHEWF 279
              DP KRI+  E   H +F
Sbjct: 297 LEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 97.3 bits (242), Expect = 3e-23
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 18/205 (8%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
           +G G +G           +L+AVK +E         +K  E +Q E+   +SL+H NIV+
Sbjct: 8   LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
           +    L    ++I ME+  GG +   +   G   E     + +Q++ GV+Y H+  V HR
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLLKKE 194
           D+K  N +L   P   +K+ DFG ++          HS   KS  GTP ++APEV+ +  
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
           Y G+ +D+WS G T++ M  G  P 
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 97.5 bits (243), Expect = 3e-23
 Identities = 81/293 (27%), Positives = 135/293 (46%), Gaps = 41/293 (13%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDKIDENVQ----REIINHRSLR 75
           ++YE +  +G G++G+    + K+T ++VA+K ++E  D  D+ V+    REI   + LR
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
           H N+V   EV      L +V E+     L   E+  N     E   R +  Q++ G+ +C
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFC 116

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
           HS  + HRD+K EN L+  S +  +K+CDFG+++ ++       T  V T  Y APE+L+
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFED------------------PEEPKNFRKT-- 231
                G+  D+W+ G  +  ML G   F                    P   + F+K   
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233

Query: 232 --IHRILSVQYSIP---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
               R+  V+   P    +  +S     L  +    DP  R S  ++ +HE+F
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 97.4 bits (242), Expect = 4e-23
 Identities = 80/257 (31%), Positives = 132/257 (51%), Gaps = 14/257 (5%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           IG G+ G+  +  +K T + VAVK ++ R  +  E +  E++  R   H N+V      L
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
               L +VME+  GG L + I    R +E++       ++  +SY H+  V HRD+K ++
Sbjct: 90  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148

Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            LL  DG    R+K+ DFG+ ++ S    + KS VGTP ++APEV+ +  Y G   D+WS
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203

Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            G+ +  M+ G  P+ + E P    + I   L  +  + D   +S   R  +  + V +P
Sbjct: 204 LGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPR--VKDSHKVSSVLRGFLDLMLVREP 260

Query: 265 AKRISIPEIRNHEWFLK 281
           ++R +  E+  H  FLK
Sbjct: 261 SQRATAQELLQHP-FLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 96.5 bits (240), Expect = 5e-23
 Identities = 81/269 (30%), Positives = 124/269 (46%), Gaps = 30/269 (11%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
           IG G FG     R   T ++ A+K +++     +  +   +N R +         P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
                 TP  L+ +++  +GG+L   +   G FSE E RF+  ++I G+ + H+  V +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYD 196
           DLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL K   YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ILSVQYSIPDYVHISPECRHL 255
              AD +S G  L+ +L G  PF   +     +  I R  L++   +PD    SPE R L
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPD--SFSPELRSL 229

Query: 256 ISRIFVADPAKRI-----SIPEIRNHEWF 279
           +  +   D  +R+        E++ H +F
Sbjct: 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 96.2 bits (239), Expect = 5e-23
 Identities = 77/261 (29%), Positives = 120/261 (45%), Gaps = 22/261 (8%)

Query: 23  YELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
           +++ + IG G F     A  + D+K   L  V+  E  D K  ++  +EI   + L HPN
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
           ++++ +  +    L IV+E A  G+L + I    +      E     +F QL S V + H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
           S +V HRD+K  N  +  +    +K+ D G      SK++  H    S VGTP Y++PE 
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           + +  Y+ K +D+WS G  LY M     PF    +  N      +I    Y      H S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIEQCDYPPLPTEHYS 234

Query: 250 PECRHLISRIFVADPAKRISI 270
            + R L+S     DP +R  I
Sbjct: 235 EKLRELVSMCIYPDPDQRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 96.3 bits (239), Expect = 1e-22
 Identities = 80/264 (30%), Positives = 130/264 (49%), Gaps = 14/264 (5%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
           +Y     IG G  G      D  T + VA++ +  +     E +  EI+  R  ++PNIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + HS QV H
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139

Query: 141 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+  + VGTP ++APEV+ +K Y  
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           K+ D+WS G+    M+ G  P+ + E P      I    + +   P+   +S   R  ++
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 251

Query: 258 RIFVADPAKRISIPEIRNHEWFLK 281
           R    D  KR S  E+  H+ FLK
Sbjct: 252 RCLDMDVEKRGSAKELLQHQ-FLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 65/276 (23%), Positives = 126/276 (45%), Gaps = 22/276 (7%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-- 76
            ++  E + D+G+GN G    ++   T  ++A K +  G K   +V+++I+    + H  
Sbjct: 3   RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHEC 60

Query: 77  --PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
             P IV F    L   ++ + ME+   G L       G    +        ++ G++Y +
Sbjct: 61  RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120

Query: 135 SM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
           ++ ++ HRD+K  N L++     ++K+CDFG S   +++S   + VGT  Y++PE +   
Sbjct: 121 NVHRIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGG 177

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIPDY- 245
           +Y  K +DVWS G+++  + +G +PF            P      + +I  VQ   P   
Sbjct: 178 KYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI--VQEPPPRLP 234

Query: 246 -VHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 280
                 + R  +    + DP +R +  ++     F+
Sbjct: 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 95.8 bits (238), Expect = 1e-22
 Identities = 82/280 (29%), Positives = 131/280 (46%), Gaps = 27/280 (9%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
           +D +E++  IG G +G    + +KK   L AVK ++    +DE ++ E    +SL  HPN
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80

Query: 79  IVRFKEVILTPTHLA-----IVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
           +V+F  +      L      +V+E  +GG   EL + +   G R  E    +     + G
Sbjct: 81  VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPE 188
           + + H+ ++ HRD+K  N LL       +K+ DFG S   +    +  ++VGTP ++APE
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198

Query: 189 VL-LKKEYDGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
           V+  +++YD       DVWS G+T   +  G  P  D    K   K I R        P 
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRNPP-----PT 252

Query: 245 YVHISPECR---HLISRIFVADPAKRISIPEIRNHEWFLK 281
            +H    CR   H IS+  + D   R S+  +  H  F+K
Sbjct: 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP-FIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 95.9 bits (238), Expect = 1e-22
 Identities = 81/264 (30%), Positives = 126/264 (47%), Gaps = 14/264 (5%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
           +Y     IG G  G      D  T + VA+K +  +     E +  EI+  R  ++PNIV
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + HS QV H
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIH 138

Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
           RD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ +K Y  
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           K+ D+WS G+    M+ G  P+ + E P      I    + +   P+   +S   R  ++
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--RLSAVFRDFLN 250

Query: 258 RIFVADPAKRISIPEIRNHEWFLK 281
           R    D  +R S  E+  H  FLK
Sbjct: 251 RCLEMDVDRRGSAKELLQHP-FLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 95.7 bits (239), Expect = 3e-22
 Identities = 83/298 (27%), Positives = 128/298 (42%), Gaps = 45/298 (15%)

Query: 18  HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSL 74
           H   +YE+++ +G G +G+     D++T+E+VA+K I    +   + QR   EI+  + L
Sbjct: 4   HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQEL 63

Query: 75  R-HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISG 129
             HPNIV+   VI       I + +    E  E     +  A    +   R+   QL+  
Sbjct: 64  GDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIMYQLLKA 119

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPA 183
           + Y HS  V HRDLK  N LL+     R+K+ DFG ++S     +          V T  
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF---------------------EDP 222
           Y APE+LL      K  D+WS G  L  ML+G   F                     ED 
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237

Query: 223 EEPK-NFRKTIHRILSV--QYSIPDYV-HISPECRHLISRIFVADPAKRISIPEIRNH 276
           E  K  F  T+   L    +  + + +   S +   L+ ++ V +P KR++  E   H
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 82/300 (27%), Positives = 122/300 (40%), Gaps = 50/300 (16%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP 77
             RY+ +  IG G +G+      K T   VA+K I   +     +   REI   R  +H 
Sbjct: 4   GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 133
           NI+   + I+ P       +     EL E    ++      S D  ++F  Q++ G+ Y 
Sbjct: 64  NIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 189
           HS  V HRDLK  N LL+      LKICDFG ++ +             V T  Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180

Query: 190 LLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV--------- 238
           +L  K Y   I D+WS G  L  ML     F     P K++   ++ IL V         
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSNRPLF-----PGKDYLHQLNLILGVLGTPSQEDL 234

Query: 239 ---------QY--SIPDY--VHISPECRH-------LISRIFVADPAKRISIPEIRNHEW 278
                     Y  S+P    V  +    +       L+ ++   +P KRI++ E   H +
Sbjct: 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 94.9 bits (236), Expect = 3e-22
 Identities = 86/301 (28%), Positives = 123/301 (40%), Gaps = 49/301 (16%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           D YE +  IG G +G     RDK T +LVA+K   R +  +E +     REI   + L  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59

Query: 77  -PNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGR-----FSEDEARFFFQQ 125
              IVR  +V           L +V EY    +L + + + GR           + F  Q
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 184
           L+ GV++CH   V HRDLK +N L+D      LKI D G  ++ S+        + T  Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177

Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-------- 236
            APEVLL   +     D+WS G     M      F    E +     I ++L        
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFKLLGTPTEQVW 236

Query: 237 ------------------SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
                              +  ++PD   +SPE   L+ ++   DPAKRIS      H +
Sbjct: 237 PGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Query: 279 F 279
           F
Sbjct: 294 F 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 94.5 bits (235), Expect = 3e-22
 Identities = 70/280 (25%), Positives = 129/280 (46%), Gaps = 22/280 (7%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D  E++ ++G GN+G    +  + T   +A+K I    ++DE+   +II    + H    
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVS 58

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           P IV F         + + MEY   G   +L+          ED  R     ++ G+ + 
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 134 -HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
                + HRD+K  N L++G+   ++K+CDFG S  +++ S  K+ +G  +Y+APE +  
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKS 175

Query: 193 KEYDGKI-----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-SVQYSIPDYV 246
              +        +DVWS G+++  M +G YP+  PE   N    +  I+     ++P   
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP-PETYANIFAQLSAIVDGDPPTLPS-- 232

Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 286
             S + +  +++     P +R +  ++  H W +K   AD
Sbjct: 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 95.8 bits (238), Expect = 4e-22
 Identities = 88/318 (27%), Positives = 131/318 (41%), Gaps = 73/318 (22%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
           +  ++ +G G FG   L R   T+ L A+K + + D +  N       +R+I+      +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--N 60

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             +VR         +L  VM+Y  GG++   +   G F ED ARF+  +L   V   H M
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120

Query: 137 QVCHRDLKLENTLLD--------------------------GSPAPRLKICDFGYS---- 166
              HRD+K +N L+D                               R    DF       
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 167 --------------KSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
                         +++  H +    S VGTP YIAPEVLL+  Y  ++ D WS GV LY
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239

Query: 211 VMLVGAYPF--EDPEEPK----NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            MLVG  PF  + P E +    N++ ++H        IP    +SPE   LI ++    P
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLH--------IPPQAKLSPEASDLIIKL-CRGP 290

Query: 265 AKRI---SIPEIRNHEWF 279
             R+      EI+ H +F
Sbjct: 291 EDRLGKNGADEIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 93.8 bits (234), Expect = 5e-22
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 11/209 (5%)

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           +PN ++    + T     ++M+Y   G+LF+ +   G+ SE E +   +QL+  ++  H 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + H D+KLEN L D +   R+ +CD+G  K       P    GT  Y +PE +    Y
Sbjct: 128 HNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNY 183

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           D    D W+ GV  Y +L G +PF+ D +E  +    + R    Q  +P   ++S     
Sbjct: 184 DVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNAND 239

Query: 255 LISRIFVADPAKR-ISIPEIRNHEWFLKN 282
            +  +   +   R  +  EI  H  FLK 
Sbjct: 240 FVQSMLKYNINYRLTNYNEIIKHP-FLKI 267

Length = 267

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 94.3 bits (234), Expect = 6e-22
 Identities = 67/192 (34%), Positives = 101/192 (52%), Gaps = 17/192 (8%)

Query: 26  VRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQ---REIINHRSLRHPNIVR 81
           + +IG G+FG      +  T E+VAVK +   G + +E  Q   +E+   + L+HPN + 
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 82  FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           +K   L      +VMEY   S  +L E   +     E E        + G++Y HS  + 
Sbjct: 86  YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143

Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
           HRD+K  N LL  +   ++K+ DFG   S+   S   S VGTP ++APEV+L   + +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198

Query: 197 GKIADVWSCGVT 208
           GK+ DVWS G+T
Sbjct: 199 GKV-DVWSLGIT 209

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 81/279 (29%), Positives = 131/279 (46%), Gaps = 30/279 (10%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVK------YIERGDKIDENVQREIINHRSL 74
           D +E+++ IG G FG   +++ K T ++ A+K       ++R +      +R+++ +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 133
           R   I           +L +VM+Y  GG+L   +     R  ED ARF+  +++  +   
Sbjct: 61  RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 187
           H +   HRD+K +N LLD +   RL   DFG    S L      T      VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172

Query: 188 EVLLKKEYDGK-----IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242
           E+L   E DGK       D WS GV +Y ML G  PF      + + K ++     Q+  
Sbjct: 173 EILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP- 230

Query: 243 PDYVHISPECRHLISRIFVADPAK--RISIPEIRNHEWF 279
           PD   +S E + LI R+  +   +  R  + + ++H +F
Sbjct: 231 PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 80/299 (26%), Positives = 137/299 (45%), Gaps = 41/299 (13%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSL 74
           D +E+++ IG G FG   +++ K TE + A+K + + + +          +R ++ +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
           +   I           +L +VM+Y  GG+L   +     R  ED ARF+  +++  +   
Sbjct: 61  QW--ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 134 HSMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
           H +   HRD+K +N LLD +   R       LK+   G  +SSV        VGTP YI+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYIS 171

Query: 187 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242
           PE+L   E      G   D WS GV +Y ML G  PF      + + K ++     ++  
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQF 229

Query: 243 PDYV-HISPECRHLISRIFVADPAKRI---SIPEIRNHEWF-------LKNLPADLVVD 290
           P ++  +S E + LI R+ +    +R+    I + + H +F       ++NL A  + D
Sbjct: 230 PSHITDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPD 287

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 15/202 (7%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNI 79
           + +E++ ++G G FG     ++K+T  L A K I+ + ++  E+   EI    S  HPNI
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
           V+  +      +L I++E+ +GG +   +    R  +E + R   +Q +  ++Y H  ++
Sbjct: 65  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124

Query: 139 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL---- 191
            HRDLK  N L  LDG     +K+ DFG S  +    Q + S +GTP ++APEV++    
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 192 -KKEYDGKIADVWSCGVTLYVM 212
             + YD K ADVWS G+TL  M
Sbjct: 181 KDRPYDYK-ADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 92.4 bits (229), Expect = 2e-21
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 15/203 (7%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
           ++ +E++ ++G G FG     ++K+T  L A K IE   + + E+   EI    +  HP 
Sbjct: 11  NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
           IV+          L I++E+  GG +   +    R  +E + +   +Q++  + Y HSM+
Sbjct: 71  IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130

Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL--- 191
           + HRDLK  N LL  DG     +K+ DFG S  +V   Q + S +GTP ++APEV++   
Sbjct: 131 IIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186

Query: 192 --KKEYDGKIADVWSCGVTLYVM 212
                YD K AD+WS G+TL  M
Sbjct: 187 MKDTPYDYK-ADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 91.6 bits (227), Expect = 2e-21
 Identities = 75/266 (28%), Positives = 131/266 (49%), Gaps = 31/266 (11%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSLRHP 77
           Y  VR +G G++G   L+R +   +   +K +      R ++     + ++++   L+HP
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQ--LKHP 59

Query: 78  NIVRFKEVIL-TPTHLAIVMEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCH 134
           NIV ++E        L IVM +  GG+L+ ++    G+   E++   +F Q+   + Y H
Sbjct: 60  NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLL 191
              + HRDLK +N  L  +    +K+ D G ++  VL +Q     + +GTP Y++PE+  
Sbjct: 120 EKHILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFS 175

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP----DYVH 247
            K Y+ K +DVW+ G  +Y M    + F      K+    ++RI  ++  +P    DY  
Sbjct: 176 NKPYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRI--IEGKLPPMPKDY-- 226

Query: 248 ISPECRHLISRIFVADPAKRISIPEI 273
            SPE   LI+ +    P KR S+  I
Sbjct: 227 -SPELGELIATMLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 91.2 bits (226), Expect = 5e-21
 Identities = 71/264 (26%), Positives = 121/264 (45%), Gaps = 20/264 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNIVR 81
           +G G FG    ++ K T ++ A K +++       G+K+   +++EI+    +  P IV 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHSMQVC 139
                 + THL +VM   +GG+L   I N G    +  R   +  Q+  G+ + HSM + 
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117

Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           +RD+K EN LLD     RL   D G +             GT  Y+APE+L ++ Y   +
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            D ++ G ++Y M+ G  PF+D +E     +   R L  +    ++ + + E + +    
Sbjct: 176 -DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233

Query: 260 FVADPAKRISIPEI----RNHEWF 279
               P  R+   E     R HE+F
Sbjct: 234 LAKKPEDRLGSREKNDDPRKHEFF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 91.2 bits (226), Expect = 8e-21
 Identities = 83/287 (28%), Positives = 128/287 (44%), Gaps = 45/287 (15%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
           +G G +      R K T+ LVA+K I  E  +       RE+   + L+H NIV   ++I
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 87  LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
            T   L +V EY    +L + + + G   +    + F  QL+ G++YCH  +V HRDLK 
Sbjct: 74  HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132

Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVW 203
           +N L++      LK+ DFG +++  + ++  S  V T  Y  P++LL   +Y  +I D+W
Sbjct: 133 QNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI-DMW 189

Query: 204 SCGVTLYVMLVGA--YPFEDPEEPKNFRKTIHRILS----------------VQYSIPDY 245
             G   Y M  G   +P    EE  +F   I RIL                   Y+ P Y
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEEFKSYNYPKY 246

Query: 246 VHISPECRH------------LISRIFVADPAKRISIPEIRNHEWFL 280
                +C H            L+S++   +  KRIS  E   H +F 
Sbjct: 247 ---RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 90.9 bits (225), Expect = 8e-21
 Identities = 67/192 (34%), Positives = 98/192 (51%), Gaps = 9/192 (4%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
           +G G +      R K TE LVA+K I  E  +       RE+   ++L+H NIV   ++I
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 87  LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
            T   L +V EY    +L + + N G   S    + F  QL+ G+SYCH  ++ HRDLK 
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP 131

Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVW 203
           +N L++      LK+ DFG +++  + ++  S  V T  Y  P+VLL   EY   I D+W
Sbjct: 132 QNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI-DMW 188

Query: 204 SCGVTLYVMLVG 215
             G  LY M  G
Sbjct: 189 GVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 69/215 (32%), Positives = 93/215 (43%), Gaps = 22/215 (10%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
             RY  +R +G G+ G+     D   ++ VAVK I   D    ++  REI   R L H N
Sbjct: 4   GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63

Query: 79  IVRFKEVILT-----------PTHLA---IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
           IV+  EV+              T L    IV EY         +   G  SE+ AR F  
Sbjct: 64  IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMY 121

Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVG 180
           QL+ G+ Y HS  V HRDLK  N  ++ +    LKI DFG ++    H   K      + 
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
           T  Y +P +LL      K  D+W+ G     ML G
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 87/293 (29%), Positives = 126/293 (43%), Gaps = 40/293 (13%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
           + Y+ +  +G G++      R K T +LVA+K I    E G        RE    + L+H
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHS 135
            NIV   ++I T   L +V EY    +L + + + G   S    R F  QL+ G++YCH 
Sbjct: 63  ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KK 193
            +V HRDLK +N L+  S    LK+ DFG +++  + S+  S  V T  Y  P+VLL   
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------- 237
           EY   + D+W  G   Y M  G   F    + ++    I R+L                 
Sbjct: 180 EYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238

Query: 238 VQYSIPDY------VHIS-----PECRHLISRIFVADPAKRISIPEIRNHEWF 279
             YS P Y       H       P    L  +    +P KRIS  E   H +F
Sbjct: 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 73/225 (32%), Positives = 109/225 (48%), Gaps = 21/225 (9%)

Query: 22  RY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSL 74
           RY + +R +G G+FG   L      +  T E+VAVK ++R  G +     ++EI   ++L
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63

Query: 75  RHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
            H NIV++K          L ++MEY   G L + +    + +  +   F QQ+  G++Y
Sbjct: 64  YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAY 122

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPE 188
            HS    HRDL   N LLD      +KI DFG +K+      + + +    +P +  A E
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 189 VLLKKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
            L  KE     A DVWS GVTLY +L      + P  PK F + I
Sbjct: 181 CL--KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMI 221

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 88.5 bits (219), Expect = 4e-20
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 22/261 (8%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
           + + + IG G F              VA+K ++  D +D   + + I      + L HPN
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
           ++++    +    L IV+E A  G+L   I +  +      E     +F QL S + + H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
           S +V HRD+K  N  +  +    +K+ D G      SK++  H    S VGTP Y++PE 
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           + +  Y+ K +D+WS G  LY M     PF    +  N      +I    Y      H S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYS 234

Query: 250 PECRHLISRIFVADPAKRISI 270
            E R L++     DP KR  I
Sbjct: 235 EELRQLVNMCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 88.9 bits (220), Expect = 4e-20
 Identities = 79/283 (27%), Positives = 130/283 (45%), Gaps = 38/283 (13%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
           SD +E++  IG G +G    + +KK     AVK ++    IDE ++ E    ++L  HPN
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76

Query: 79  IVRF-----KEVILTPTHLAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
           +V+F     K+ +     L +V+E  +GG   +L +     G R  E    +   + + G
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 187
           + + H  +  HRD+K  N LL  +    +K+ DFG S   +S    +  ++VGTP ++AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAP 193

Query: 188 EVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRI 235
           EV+     L   YD +  DVWS G+T   +  G  P  D          P+N   T+H+ 
Sbjct: 194 EVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ- 251

Query: 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
                  P+    S E    I +    D  KR ++ ++  H +
Sbjct: 252 -------PEL--WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 89.4 bits (222), Expect = 4e-20
 Identities = 100/355 (28%), Positives = 151/355 (42%), Gaps = 85/355 (23%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGDKIDENVQREIINHRSLR---- 75
           RYEL++++G G +G+    R+ +T  EE VA+K      KI     ++I+  R+LR    
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54

Query: 76  ------HPNIVRFKEV-ILTPTHLAIVMEYASGGELFE----RICNAG-RFSEDEARFFF 123
                 H NI    ++ I+ P +   +  Y    EL E    +I  +G   ++   + F 
Sbjct: 55  LRHFRGHKNITCLYDMDIVFPGNFNELYLYE---ELMEADLHQIIRSGQPLTDAHFQSFI 111

Query: 124 QQLISGVSYCHSMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQPKST 178
            Q++ G+ Y HS  V HRDLK  N L   D      LKICDFG ++  S     +    T
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMT 167

Query: 179 --VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE---------------- 220
             V T  Y APE++L  +   K  DVWS G  L  +L     F+                
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227

Query: 221 DPEEPKNFRKTIHRILSVQ-----YSIPDYVHI---------SPECRHLISRIFVADPAK 266
            P+E     +T+ RI S +      S+P+             +P    L+ ++   DP K
Sbjct: 228 TPDE-----ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTK 282

Query: 267 RISIPEIRNH----EWFLKNLPAD-LVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 316
           RIS+ E   H     W   + P D  V     +  FE  D    S++E+  +I E
Sbjct: 283 RISVEEALEHPYLAIW---HDPDDEPVCQKPFDFSFESED----SMEELRDMIIE 330

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 89.1 bits (221), Expect = 6e-20
 Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 24/211 (11%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
           RY++   IG G++GV     D  T E VA+K I   + + E+V       REI   R LR
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57

Query: 76  HPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
           HP+IV  K ++L P+      + +V E     +L + I      + +  +FF  QL+  +
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIA 186
            Y H+  V HRDLK +N L +     +LKICDFG ++ +   +         V T  Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 187 PEVL--LKKEYDGKIADVWSCGVTLYVMLVG 215
           PE+      +Y   I D+WS G     +L G
Sbjct: 175 PELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 88.1 bits (218), Expect = 7e-20
 Identities = 66/227 (29%), Positives = 116/227 (51%), Gaps = 19/227 (8%)

Query: 11  GMDMPIMHD-SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
            +D+  + D +  +ELV  +G+G +G     R  KT +L A+K ++  +  +E ++ EI 
Sbjct: 5   DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEIN 64

Query: 69  INHRSLRHPNIVRFKEVILT---PTH---LAIVMEYASGGELFERICN--AGRFSEDEAR 120
           +  +   H NI  +    +    P H   L +VME+   G + + + N       ED   
Sbjct: 65  MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 179
           +  ++++ G+++ H+ +V HRD+K +N LL  +    +K+ DFG S         ++T +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFI 182

Query: 180 GTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
           GTP ++APEV+   E     YD + +D+WS G+T   M  GA P  D
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 86/344 (25%), Positives = 137/344 (39%), Gaps = 72/344 (20%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----- 75
           DRY+ +  +GSG +G      D KT   VA+K      K+    Q  I   R+ R     
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68

Query: 76  ----HPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
               H N++   +V    + L       +V     G +L   I    + S+D  +F   Q
Sbjct: 69  KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126

Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
           ++ G+ Y HS  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRW 180

Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDP------------------- 222
           Y APE++L   +  +  D+WS G  +  +L G   +P  D                    
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240

Query: 223 -----EEPKNFRKTIHRILSVQYSIPDYVHI----SPECRHLISRIFVADPAKRISIPEI 273
                E  +N+ +++      Q    D+  +    +P    L+ ++ V DP KRI+  E 
Sbjct: 241 QKISSESARNYIQSLP-----QMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295

Query: 274 RNHEWFLK-NLPADLVVDNTTNNQFEEPDQPMQ-----SIDEIM 311
             H +  + + P D  V    +  FE  D  +         EIM
Sbjct: 296 LAHPYLAEYHDPEDEPVAPPYDQSFESRDLTVDEWKELVYKEIM 339

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 85/284 (29%), Positives = 135/284 (47%), Gaps = 23/284 (8%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRH 76
           D +  E + +IGSG  G    MR KKT  ++AVK + R    +EN +R +++       H
Sbjct: 13  DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSH 71

Query: 77  --PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSY 132
             P IV+     +T + + I ME  S    +L +RI   G   ED        ++  + Y
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHY 129

Query: 133 C-HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL 190
                 V HRD+K  N LLD S    +K+CDFG S   V  S+ K+ + G  AY+APE +
Sbjct: 130 LKEKHGVIHRDVKPSNILLDAS--GNVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERI 186

Query: 191 ----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDY 245
                  +YD + ADVWS G++L  +  G +P+++ +    F + + +IL  +  S+P  
Sbjct: 187 DPPDPNPKYDIR-ADVWSLGISLVELATGQFPYKNCK--TEF-EVLTKILQEEPPSLPPN 242

Query: 246 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVV 289
              SP+    +      D  KR    E+  H +  +   A++ V
Sbjct: 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 123 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
             + +D+WS G++L  M +G YP   P+
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 80/303 (26%), Positives = 123/303 (40%), Gaps = 43/303 (14%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLR 75
           +D YE +  +G G++      + K   +LVA+K I    E G        RE    + L+
Sbjct: 4   ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLK 61

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           H NIV   ++I T   L +V EY           + G    +  + F  QL+ G+SY H 
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 194
             + HRDLK +N L+  S    LK+ DFG +++  + S   S  V T  Y  P+VLL   
Sbjct: 122 RYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------YSIPDYV 246
                 D+W  G     M+ G   F   ++ ++  + I  +L           +S+P   
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP--- 236

Query: 247 HISPE----------------------CRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
           H  PE                         L S++    P  R+S     +HE+F  +LP
Sbjct: 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF-SDLP 295

Query: 285 ADL 287
             L
Sbjct: 296 PRL 298

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 11/208 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   ++ K +  ++A K I    +I   ++ +II    + H    
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV F     +   ++I ME+  GG L + +  A R  E+        ++ G++Y    
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            Q+ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 123 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
             + +D+WS G++L  + +G YP   P+
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYPIPPPD 206

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 86.5 bits (214), Expect = 2e-19
 Identities = 75/267 (28%), Positives = 126/267 (47%), Gaps = 26/267 (9%)

Query: 26  VRDIGSGNFGVARLMR----DKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNI 79
           +RD+G G+FG   L R       T E VAVK +  E G     ++++EI   R+L H NI
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 80  VRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 136
           V++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G+ Y  S 
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLLK 192
           Q  HRDL   N L++     ++KI DFG +K+     +    K  + +P +  APE L++
Sbjct: 129 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSV---QYSI 242
            ++    +DVWS GVTLY +L        P         P + + T+ R++ V      +
Sbjct: 187 SKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245

Query: 243 PDYVHISPECRHLISRIFVADPAKRIS 269
           P   +   E   L+ + +   P+KR +
Sbjct: 246 PRPPNCPEEVYQLMRKCWEFQPSKRTT 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 22/216 (10%)

Query: 24  ELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
           EL+  IG       +  L + K T  LVAVK I       E++   Q+EII  R L+HPN
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60

Query: 79  IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           I+ +    +  + L +V   M Y S  +L +     G   E    F  + +++ + Y HS
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAP 187
               HR +K  + LL G    ++ +    YS        +  V+H  PKS+V    +++P
Sbjct: 120 KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 188 EVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
           EVL +  + Y+ K  D++S G+T   +  G  PF+D
Sbjct: 178 EVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 86.5 bits (214), Expect = 6e-19
 Identities = 79/321 (24%), Positives = 138/321 (42%), Gaps = 43/321 (13%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
           DRY  ++ +GSG +G      D++T   VA+K + R    +   +   RE+   + ++H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 78  NIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           N++   +V      L       +VM +   G    ++    + SED  +F   Q++ G+ 
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           Y H+  + HRDLK  N  L  +    LKI DFG ++ +   S+    V T  Y APEV+L
Sbjct: 133 YIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFE--------------------------DPEEP 225
              +  +  D+WS G  +  ML G   F+                            E+ 
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248

Query: 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLP 284
           KN+ K + R     +      + +P   +++ ++ V D   RI+  E   H +F + + P
Sbjct: 249 KNYVKKLPRFRKKDFRSL-LPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307

Query: 285 ADLVVDNTTNNQFEEPDQPMQ 305
            D       ++ F+E DQ ++
Sbjct: 308 EDETEAPPYDDSFDEVDQSLE 328

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 85.8 bits (212), Expect = 6e-19
 Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 39/291 (13%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
           + Y  +  +G G +      R K TE LVA+K I  E  +       RE+   + L+H N
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
           IV   +++ T   L +V EY    +L + + + G   S    + F  Q++ G++YCH  +
Sbjct: 66  IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEY 195
           V HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P+VLL   EY
Sbjct: 125 VLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 196 DGKIADVWSCGVTLYVMLVGA--YPFEDPEEPKNFRKTIHRILSV--------------- 238
             +I D+W  G   + M  G   +P    E+  +    I R+L                 
Sbjct: 183 STQI-DMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSNDEF 238

Query: 239 -QYSIPDY-----VHISP----ECRHLISRIFVADPAKRISIPEIRNHEWF 279
             Y+ P Y     ++ +P    E   L+++    +  KRIS  E   H +F
Sbjct: 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.5 bits (209), Expect = 7e-19
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 22/207 (10%)

Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
            ++++G+G FGV +  + +   + VA+K I+ G   ++    E      L H  +V+   
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
           V      + IV EY S G      C      E   RF   QL+        G++Y  S Q
Sbjct: 67  VCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
             HRDL   N L+D      +K+ DFG S+  VL  +  S+VG+     +  PEVLL  +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177

Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
           +  K +DVW+ GV ++ V  +G  P+E
Sbjct: 178 FSSK-SDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 85.3 bits (211), Expect = 7e-19
 Identities = 73/287 (25%), Positives = 123/287 (42%), Gaps = 32/287 (11%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQR--EIINHRS 73
           +   R +G G FG     + + T ++ A K +E+       G+ +  N ++  E +N R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 131
                +V       T   L +V+   +GG+L   I N G   F E+ A F+  ++  G+ 
Sbjct: 62  -----VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVL 190
             H  ++ +RDLK EN LLD      ++I D G +   +   +  +  VGT  Y+APEV+
Sbjct: 117 DLHRERIVYRDLKPENILLDDY--GHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVV 173

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
             + Y     D W  G  +Y M+ G  PF   +E     +   R+   Q    +    S 
Sbjct: 174 KNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSE 230

Query: 251 ECRHLISRIFVADPAKRI-----SIPEIRNHEWF----LKNLPADLV 288
             R +  ++   DP  R+        E++ H +F     K L A ++
Sbjct: 231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGML 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 71/273 (26%), Positives = 128/273 (46%), Gaps = 22/273 (8%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSLRH 76
           +E+++ IG G FG   +++ K  +++ A+K + + + +          +R+++ +   + 
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
             I           +L +VM+Y  GG+L   +     R  ED ARF+  +++  +   H 
Sbjct: 63  --ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
           +   HRD+K +N L+D +   RL   DFG     +     +S+  VGTP YI+PE+L   
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 194 EYDGK-----IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
           E DGK       D WS GV +Y ML G  PF      + + K ++     Q+       +
Sbjct: 179 E-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP-AQVTDV 236

Query: 249 SPECRHLISRIFVADPAK--RISIPEIRNHEWF 279
           S + + LI R+  +   +  +  I + + H +F
Sbjct: 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 83.6 bits (206), Expect = 3e-18
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 18/214 (8%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 81
           +ELV  +G+G +G     R  KT +L A+K ++     +E +++EI +  +   H NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 82  FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 133
           +    +          L +VME+   G + + I N       E+   +  ++++ G+S+ 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 192
           H  +V HRD+K +N LL  +    +K+ DFG S         ++T +GTP ++APEV+  
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 193 KE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
            E     YD K +D+WS G+T   M  GA P  D
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 218

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 74/298 (24%), Positives = 132/298 (44%), Gaps = 43/298 (14%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   +  + +  ++A K I    +I   ++ +II    + H    
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNS 58

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
           P IV F     +   ++I ME+  GG L + +  AGR  E+        ++ G++Y    
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 175

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDP-----------EEPKNFRKTIHRILSVQ----- 239
             + +D+WS G++L  M +G YP   P              +   K  HR +S       
Sbjct: 176 TVQ-SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234

Query: 240 -----YSIPDYV-----------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
                + + DY+             S E +  + +    +P +R  + E+  H +  +
Sbjct: 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 79/322 (24%), Positives = 125/322 (38%), Gaps = 81/322 (25%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
             YE++  +G G FG     R  KT  +VA+K I    E+ D       REI   + L+H
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKH 66

Query: 77  PNIVRFKEVIL--------TPTHLAIVMEYA----SGGELFE--RICNAGRFSEDEARFF 122
           PN+V   ++ +            + +V  Y     SG  L E   +    + +E + + +
Sbjct: 67  PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCY 120

Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------ 176
             QL+ G++Y H   + HRD+K  N L+D      LKI DFG ++       P       
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPPNPKGGG 176

Query: 177 --------STVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVM--------------- 212
                   + V T  Y  PE+LL ++ Y   + D+W  G     M               
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTRRPILQGKSDIDQ 235

Query: 213 ------LVGAYPFED--PE-------EPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
                 L G  P E+  P        E  +      R L  ++       + PE   L+S
Sbjct: 236 LHLIFKLCGT-PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG-----KLGPEGLDLLS 289

Query: 258 RIFVADPAKRISIPEIRNHEWF 279
           ++   DP KR++  +   H +F
Sbjct: 290 KLLSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 83.1 bits (205), Expect = 4e-18
 Identities = 74/270 (27%), Positives = 122/270 (45%), Gaps = 28/270 (10%)

Query: 27  RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
           R +G G FG     + + T ++ A K +E+       G+ +  N +++I+   + R   +
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRF--V 62

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
           V       T   L +V+   +GG+L   I + G   F E  A F+  ++  G+   H  +
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
           + +RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+  + Y  
Sbjct: 123 IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---VQYSIPDYVHISPECRH 254
              D W+ G  LY M+ G  PF+   + K  R+ + R++     +YS       SP+ R 
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVQEEYS----EKFSPDARS 234

Query: 255 LISRIFVADPAKRI-----SIPEIRNHEWF 279
           L   +   DP +R+        E++ H  F
Sbjct: 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 85.2 bits (211), Expect = 5e-18
 Identities = 89/330 (26%), Positives = 129/330 (39%), Gaps = 67/330 (20%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR------ 75
           RY+++R IG G  G   L  D      VA+K I R D  +      ++  R LR      
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN----PLLKKRFLREAKIAA 57

Query: 76  ---HPNIVRFKEVILTPTHLAIVMEYASG---GELFERICNAGRFSEDEAR------FF- 122
              HP IV    +      +   M Y  G     L + +      S++ A       F  
Sbjct: 58  DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117

Query: 123 -FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------Y 165
            F ++ + + Y HS  V HRDLK +N LL       + I D+G                 
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
            + ++ +S    P   VGTP Y+APE LL         D+++ GV LY ML  ++P+   
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR- 233

Query: 223 EEPKNFRKTI--HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPEIRN 275
              K  RK      ILS     P Y  I P    +  +    DPA+R S       ++  
Sbjct: 234 ---KKGRKISYRDVILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289

Query: 276 H-----EWFLKNLPADLVVDNTTNNQFEEP 300
           H     EW +K   A L+    +  +F EP
Sbjct: 290 HLQGSPEWTVK---ATLMTKKKSCWKFYEP 316

Length = 932

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 81/293 (27%), Positives = 121/293 (41%), Gaps = 47/293 (16%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHP 77
           E  R IG G FGV   + D +  + VA+K +     + +N      V RE+      +H 
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMP---NVFQNLVSCKRVFRELKMLCFFKHD 59

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSEDEARFFFQQLISGVSY 132
           N++   + IL P H+    E     EL +      I +    S D  + F  Q++ G+ Y
Sbjct: 60  NVLSALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRD+K  N L++ +    LKICDFG ++          T  V T  Y APE+L
Sbjct: 119 LHSAGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176

Query: 191 L-KKEYDGKIADVWSCGVTLYVMLVGAYPFE----------------DP--EEPKNFRK- 230
           +  + Y   + D+WS G     +L     F+                 P  E  ++  + 
Sbjct: 177 MGSRHYTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235

Query: 231 TIHRILSVQYSIPD----YVHISP---ECRHLISRIFVADPAKRISIPEIRNH 276
               IL   +  P     Y   S    E  HL+ R+ V DP KRIS  +   H
Sbjct: 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 81/341 (23%), Positives = 140/341 (41%), Gaps = 60/341 (17%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D      VAVK + R  +   + +R   E++  + + H N
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81

Query: 79  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
           I+    V  TP         + +VME          +C       D  R  +   Q++ G
Sbjct: 82  IISLLNV-FTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCG 135

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--------LSVQYS 241
           +L   Y   + D+WS G  +  ++ G+  F+  +    + K I ++          +Q +
Sbjct: 194 ILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252

Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           + +YV   P                            + R L+S++ V DP KRIS+ E 
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312

Query: 274 RNHEW---FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIM 311
             H +   +     A+       + Q EE +  ++   E++
Sbjct: 313 LRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELI 353

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 24/207 (11%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFKE 84
           +G GN G         T  ++AVK I     I   +Q++I++   + +    P I+ F  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 85  VILTPTHLAIVMEYASGGEL--FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCH 140
                  ++I  E+  GG L  + +I     GR +          ++ G++Y  S+++ H
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           RD+K  N L++     ++K+CDFG S   V +S  K+ VGT AY+APE +  ++Y G  +
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY-GIHS 174

Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKN 227
           DVWS G++   + +G +P+  P+  KN
Sbjct: 175 DVWSLGISFMELALGRFPY--PQIQKN 199

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 1e-17
 Identities = 73/259 (28%), Positives = 114/259 (44%), Gaps = 33/259 (12%)

Query: 29  IGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
           IG G FG   L   R +K    VAVK ++      +    E     +LRHPN+V+   V+
Sbjct: 14  IGKGEFGDVMLGDYRGQK----VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 87  LTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
           L    L IV EY + G L + + + GR   +  +   F   +  G+ Y       HRDL 
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129

Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVW 203
             N L+        K+ DFG +K +   SQ + +   P  + APE L +K++  K +DVW
Sbjct: 130 ARNVLVSEDLVA--KVSDFGLAKEA---SQGQDSGKLPVKWTAPEALREKKFSTK-SDVW 183

Query: 204 SCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI------PDYVHISPECRHLI 256
           S G+ L+ +   G  P+  P  P    K +   +   Y +      P  V+       ++
Sbjct: 184 SFGILLWEIYSFGRVPY--PRIP---LKDVVPHVEKGYRMEAPEGCPPEVY------KVM 232

Query: 257 SRIFVADPAKRISIPEIRN 275
              +  DPAKR +  ++R 
Sbjct: 233 KDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 73/275 (26%), Positives = 126/275 (45%), Gaps = 27/275 (9%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
           D  E++ ++G G +GV   MR   T  ++AVK I       E  Q+ +     I+ RS+ 
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVD 58

Query: 76  HPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE--ARFFFQQLISGVS 131
            P  V F   +     + I ME    S  + ++++ + G    ++   +     ++  + 
Sbjct: 59  CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV-SIVKALE 117

Query: 132 YCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE-- 188
           Y HS + V HRD+K  N L++     ++K+CDFG S   V         G   Y+APE  
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERI 175

Query: 189 --VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
              L +K YD K +DVWS G+T+  +  G +P++  + P    K +     V+   P   
Sbjct: 176 NPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-----VEEPSPQLP 229

Query: 247 H--ISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
               SPE +  +++    +  +R + PE+  H +F
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 62/240 (25%), Positives = 117/240 (48%), Gaps = 20/240 (8%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
           Y +++ +  G+ G   +       + V +K  ++G  + E +  + +NH     P+++R 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNH-----PSVIRM 122

Query: 83  KEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
           K+ +++     +V+ + S  +L+  +   +     D+A    +Q++ G+ Y H+ ++ HR
Sbjct: 123 KDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
           D+K EN  ++     ++ I D G ++  V+        GT    APEVL + +Y+ K AD
Sbjct: 182 DVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK-AD 238

Query: 202 VWSCGVTLYVMLVGAYP---FEDP-----EEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
           +WS G+ L+ ML  AYP   FEDP     E  K+    + +I+S     P+     P  R
Sbjct: 239 IWSAGIVLFEML--AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296

Length = 357

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 80.7 bits (199), Expect = 5e-17
 Identities = 72/293 (24%), Positives = 127/293 (43%), Gaps = 43/293 (14%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPN 78
           RY  ++ +GSG +G      DK+T E VA+K + R    +   +   RE+   + ++H N
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 79  IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           ++   +V  +           +VM Y       ++I      SED+ ++   Q++ G+ Y
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLKY 132

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
            HS  + HRDLK  N  L  +    LKI DFG ++ +   ++    V T  Y APEV+L 
Sbjct: 133 IHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILN 188

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE--------------------------DPEEPK 226
             +  +  D+WS G  +  ML G   F+                          + +  K
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248

Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           ++ K++ +     +S   +   SP+   L+ ++   D  KR++  E   H +F
Sbjct: 249 SYIKSLPKYPRKDFSTL-FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 79.2 bits (195), Expect = 5e-17
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)

Query: 19  DSDRYELVRDIGSGNFGVARL---MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
                 LV++IGSG FG+  L   +  +K    VA+K I  G   +E+   E      L 
Sbjct: 2   HPSELTLVQEIGSGQFGLVWLGYWLEKRK----VAIKTIREGAMSEEDFIEEAQVMMKLS 57

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
           HP +V+   V    + + +V E+   G L + +    G+FS++        +  G++Y  
Sbjct: 58  HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLL 191
           S  V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV  
Sbjct: 118 SSNVIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFS 174

Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
             +Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 175 FSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.4 bits (196), Expect = 7e-17
 Identities = 65/197 (32%), Positives = 95/197 (48%), Gaps = 21/197 (10%)

Query: 29  IGSGNFGVARLMR----DKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFK 83
           +G GNFG   L R       T E+VAVK ++        + +REI   +SL+H NIV++K
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 84  EVILTP--THLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
            V  +    +L +VMEY   G L +    +  R    +   +  Q+  G+ Y  S +  H
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPA-----YIAPEVLLKK 193
           RDL   N L++     R+KI DFG +K   +  Q K    V  P      + APE L + 
Sbjct: 132 RDLATRNILVESE--NRVKIGDFGLTK---VLPQDKEYYKVREPGESPIFWYAPESLTES 186

Query: 194 EYDGKIADVWSCGVTLY 210
           ++    +DVWS GV LY
Sbjct: 187 KFS-VASDVWSFGVVLY 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.7 bits (194), Expect = 8e-17
 Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 10/200 (5%)

Query: 26  VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 85
           ++++GSG FGV  L +  + +  VA+K I  G   +E+   E      L HP +V+   V
Sbjct: 9   MKELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
                 L IV E+   G L   +    G+ S+D      Q +  G+ Y       HRDL 
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127

Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGKIAD 201
             N L+  S    +K+ DFG ++  VL  +  S+ G      +  PEV    +Y  K +D
Sbjct: 128 ARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-SD 183

Query: 202 VWSCGVTLY-VMLVGAYPFE 220
           VWS GV ++ V   G  PFE
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 25/201 (12%)

Query: 28  DIGSGNFGVARLMRDKKTEEL-----VAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
            +G G+FGV R  R + +        VAVK   + DK+ + +    +E     SL H N+
Sbjct: 2   KLGDGSFGVVR--RGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
           +R   V+LT   L +V E A  G L +R+  +A G F       +  Q+ +G+ Y  S +
Sbjct: 59  IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLL 191
             HRDL   N LL  +   ++KI DFG  ++   +      +    V  P A+ APE L 
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173

Query: 192 KKEYDGKIADVWSCGVTLYVM 212
            + +    +DVW  GVTL+ M
Sbjct: 174 TRTFS-HASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 70/271 (25%), Positives = 118/271 (43%), Gaps = 23/271 (8%)

Query: 27  RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
           R +G G FG     + + T ++ A K +E+       G+ +  N +++I+   + +   +
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQF--V 62

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
           V       T   L +V+   +GG+L   I N G   F E+ A F+  +++ G+   H   
Sbjct: 63  VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
             +RDLK EN LLD      ++I D G +         +  VGT  Y+APEVL  + Y  
Sbjct: 123 TVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-T 179

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
              D W  G  +Y M+ G  PF   +E     +   R+L  +         S E + +  
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICK 237

Query: 258 RIFVADPAKRISIP-----EIRNHEWFLKNL 283
            +   DP +R+        E++ H  F +N+
Sbjct: 238 MLLTKDPKQRLGCQEEGAGEVKRHP-FFRNM 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 74/266 (27%), Positives = 109/266 (40%), Gaps = 38/266 (14%)

Query: 47  ELVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
           +LVA+K I    K +E V     RE    + L+H NIV   ++I T   L  V EY    
Sbjct: 31  QLVALKVISM--KTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTD 88

Query: 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
                I + G       R F  QL+ G++Y H   + HRDLK +N L+  S    LK+ D
Sbjct: 89  LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLAD 146

Query: 163 FGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
           FG +++  + SQ  S+ V T  Y  P+VLL   +Y   + D+W  G     ML G   F 
Sbjct: 147 FGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL-DIWGAGCIFIEMLQGQPAFP 205

Query: 221 DPEEPKNFRKTIHRILSV--------------------QYSIPDYVHI-------SPECR 253
              +     + I  +L V                        P  + +        P+  
Sbjct: 206 GVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAE 265

Query: 254 HLISRIFVADPAKRISIPEIRNHEWF 279
            L S++ +  P  RIS  +   H +F
Sbjct: 266 DLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 136 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGA--YPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249

Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 250 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308

Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 309 PDDEPVADPYDQSFESRD 326

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 5e-16
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 10/201 (4%)

Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
            ++++GSG FGV  L + +   + VA+K I  G   +++   E      L HPN+V+   
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 85  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
           V      + IV EY + G L   +    G+   +        +   + Y  S    HRDL
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKKEYDGKIA 200
              N L+       +K+ DFG ++  VL  Q  S+ GT   +    PEV     +  K +
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182

Query: 201 DVWSCGVTLY-VMLVGAYPFE 220
           DVWS GV ++ V   G  P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 71/333 (21%), Positives = 122/333 (36%), Gaps = 62/333 (18%)

Query: 20  SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDE-----N 63
           S+RY      +G G +G      D  T ++VA+K +          +    +        
Sbjct: 7   SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66

Query: 64  VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
             RE+     ++H NI+   +V +    + +VM+  +  +L + +    R +E + +   
Sbjct: 67  TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCIL 125

Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------H 172
            Q+++G++  H     HRDL   N  ++       KI DFG ++                
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDET 183

Query: 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228
            Q +    S V T  Y APE+L+  E      D+WS G     +L G   F    E    
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243

Query: 229 RKTIHRILSV--------QYSIPDYVHISP---------------ECRHLISRIFVADPA 265
            + I  +L             +P Y   +P               +   L+  +   +P 
Sbjct: 244 GR-IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302

Query: 266 KRISIPEIRNHEWF----LKNLPADLVVDNTTN 294
           +RIS  E   HE+F    L   P+ L  +  T 
Sbjct: 303 ERISAKEALKHEYFKSDPLPCDPSQLPFNFLTK 335

Length = 335

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 78.2 bits (192), Expect = 5e-16
 Identities = 77/305 (25%), Positives = 126/305 (41%), Gaps = 57/305 (18%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84

Query: 79  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
           I+    V  TP         + IVME          +C   +   D  R  +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+ G   F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255

Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315

Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 76.6 bits (189), Expect = 5e-16
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 18/207 (8%)

Query: 27  RDIGSGNFGVAR--LMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRS----LRHPNI 79
           +++G GNFG     +   K  +E+ VAVK +++ + I    ++E +   S    L HP I
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAG-KKEFLREASVMAQLDHPCI 58

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           VR   V      L +VME A  G L + +         + +    Q+  G++Y  S    
Sbjct: 59  VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLLKKEY 195
           HRDL   N LL      + KI DFG S++        ++T     P  + APE +   ++
Sbjct: 118 HRDLAARNVLLVNR--HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 196 DGKIADVWSCGVTLYVML-VGAYPFED 221
             K +DVWS GVTL+     GA P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 76.9 bits (189), Expect = 6e-16
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 17/205 (8%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLR--- 75
           +YE V +IG G +G     RD  +   VA+K +      D +  +  RE+   + L    
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 76  HPNIVRFKEVILT-----PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLIS 128
           HPNIVR  +V  T      T + +V E+         +++   G    +  +   +Q + 
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLR 119

Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
           G+ + H+  + HRDLK EN L+  +   ++K+ DFG ++           V T  Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177

Query: 189 VLLKKEYDGKIADVWSCGVTLYVML 213
           VLL+  Y   + D+WS G     M 
Sbjct: 178 VLLQSTYATPV-DMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 79/314 (25%), Positives = 130/314 (41%), Gaps = 68/314 (21%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
           RY+ ++ IGSG  G+     D  T + VA+K + R     +NV       RE++  + + 
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73

Query: 76  HPNIVRFKEVILTP-------THLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQL 126
           H NI+    V  TP         + +VME   A+  ++ +   +  R S     +   Q+
Sbjct: 74  HKNIIGLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQM 127

Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
           + G+ + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y A
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRA 185

Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI--------HRILSV 238
           PEV+L   Y   + D+WS G  +  M+ G   F   +    + K I          +  +
Sbjct: 186 PEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244

Query: 239 QYSIPDYVHISPEC-----------------------------RHLISRIFVADPAKRIS 269
           Q ++ +YV   P+                              R L+S++ V DP KRIS
Sbjct: 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304

Query: 270 IPEIRNHE----WF 279
           + +   H     W+
Sbjct: 305 VDDALQHPYINVWY 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 30/210 (14%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
           IG G FG    M  K +  ++AVK I R    ++  +R +++     RS   P IV+F  
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 85  VILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 133
            +       I ME    S  + ++ +    +          ++++  ++           
Sbjct: 71  ALFREGDCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
             +++ HRD+K  N LLD +    +K+CDFG S   V  S  K+   G   Y+APE +  
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDP 181

Query: 192 --KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
             +  YD + +DVWS G+TLY +  G +P+
Sbjct: 182 SARDGYDVR-SDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + HS
Sbjct: 78  IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
              + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ +YV 
Sbjct: 196 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254

Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 278
             P                            + R L+S++ V DPAKRIS+ E   H +
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 21/253 (8%)

Query: 27  RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 77
           R +G G FG     + + T ++ A K +E+       G+ +  N +R  E +N R     
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF---- 61

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
            +V       T   L +V+   +GG+L   I N G   F E  A F+  +L  G+     
Sbjct: 62  -VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ +RDLK EN LLD      ++I D G +         +  VGT  Y+APEV+  ++Y
Sbjct: 121 ERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
                D W  G  +Y M+ G  PF   +E     +   R+   Q    +    S + + +
Sbjct: 179 TFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSI 235

Query: 256 ISRIFVADPAKRI 268
              +   +P +R+
Sbjct: 236 CRMLLTKNPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 73.4 bits (180), Expect = 7e-15
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 24/219 (10%)

Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+   ++ + IG+G FG     RL    K E  VA+K ++ G    E  +R+ ++  S+ 
Sbjct: 2   DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIM 59

Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+  + V+     + IV EY   G L  F R  + G+F+  +     + + SG
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASG 118

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 174

Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           + APE +  +++    +DVWS G+ ++ VM  G  P+ +
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 74.3 bits (182), Expect = 8e-15
 Identities = 74/299 (24%), Positives = 124/299 (41%), Gaps = 48/299 (16%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D +  + VAVK + R  +         RE+   + ++H 
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 78  NIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V    T +    E        G +L   I    + S++  +F   QL+ G+ Y
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKY 133

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
            HS  + HRDLK  N  ++      L+I DFG ++ +    +    V T  Y APE++L 
Sbjct: 134 IHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLN 189

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSV------------- 238
             +  +  D+WS G  +  +L G   F     P N +   + RI+ V             
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALF-----PGNDYIDQLKRIMEVVGTPSPEVLKKIS 244

Query: 239 -----QY--SIPDYVH---------ISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
                +Y  S+P              +P    L+ ++ V D  KRIS  E   H +F +
Sbjct: 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 75.3 bits (185), Expect = 9e-15
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 6/149 (4%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
           + +V+ I  G FG   L R K   +L AVK +++ D I++N+  ++   R      + P 
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           IV     + +  ++ +VMEY  GG++   +   G F E+ A  +  ++   + Y H   +
Sbjct: 66  IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK 167
            HRDLK +N L+  S    +K+ DFG SK
Sbjct: 126 IHRDLKPDNMLI--SNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 76/253 (30%), Positives = 109/253 (43%), Gaps = 25/253 (9%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IG G FG   +++ + T + VAVK I    K D   Q    E      L H N+VR   V
Sbjct: 14  IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 86  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQVCHRDL 143
           IL    L IVME  S G L   +   GR      +   F   +  G+ Y  S ++ HRDL
Sbjct: 68  ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADV 202
              N L+  S     K+ DFG ++   + S        P  + APE L  K++  K +DV
Sbjct: 127 AARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDV 180

Query: 203 WSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261
           WS GV L+ V   G  P+     PK   K +   +   Y +        +   L++  + 
Sbjct: 181 WSYGVLLWEVFSYGRAPY-----PKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE 235

Query: 262 ADPAKRISIPEIR 274
            +P KR S  ++R
Sbjct: 236 TEPKKRPSFHKLR 248

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 35/218 (16%)

Query: 25  LVRDIGSGNFG---VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 79
           + + IG G FG     RL    K E  VA+K ++ G  DK   +   E        HPNI
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 80  VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGV 130
           +R + V+     + I+ EY   G L  F R        E++ +F   QL+       SG+
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGM 119

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-----PA-Y 184
            Y   M   HRDL   N L++ +     K+ DFG S+   L    ++T  T     P  +
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSR--RLED-SEATYTTKGGKIPIRW 174

Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
            APE +  +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 175 TAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 26/215 (12%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           +  Y+L   IG+G+FGV        T E VA+K + +  +      RE++  ++L H NI
Sbjct: 65  NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINI 121

Query: 80  VRFKEVILTPT--------HLAIVMEYASGG-----ELFERICNAGRFSEDEARFFFQQL 126
           +  K+   T           L +VME+         + + R  N         + +  QL
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQL 179

Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPA 183
              ++Y HS  +CHRDLK +N L+D    P    LK+CDFG +K+ +   +  S + +  
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235

Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218
           Y APE++L         D+WS G  +  M++G YP
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YP 269

Length = 440

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 18/206 (8%)

Query: 22  RYELVRDIGSGNFGVARLMRD-KKTEELVAVKYI-----ERGDKIDENVQREIINH-RSL 74
           +YE V +IG G +G     RD K     VA+K +     E G  +    +  ++ H  + 
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61

Query: 75  RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 127
            HPN+VR  +V         T L +V E+         +++   G  +E      FQ L+
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 120

Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
            G+ + HS +V HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178

Query: 188 EVLLKKEYDGKIADVWSCGVTLYVML 213
           EVLL+  Y   + D+WS G     M 
Sbjct: 179 EVLLQSSYATPV-DLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 81/313 (25%), Positives = 130/313 (41%), Gaps = 66/313 (21%)

Query: 29  IGSGNFGVARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
           +G G +G     +  D K E+  A+K IE G  I  +  REI   R L+HPN++  ++V 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 87  LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
           L+ +   + ++ +YA         F R   A +          +    Q++ G+ Y H+ 
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
            V HRDLK  N L+  +G    R+KI D G+++   L + P          V T  Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184

Query: 188 EVLLKKEYDGKIADVWSCGVTLYVML-----------------------------VGAYP 218
           E+LL   +  K  D+W+ G     +L                             V  +P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244

Query: 219 ----FED----PEEP---KNFRKTIHRILS-VQYSIPDYVHISPECRHLISRIFVADPAK 266
               +ED    PE P   K+FR+T +   S ++Y     V    +   L+ ++   DP K
Sbjct: 245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTK 304

Query: 267 RISIPEIRNHEWF 279
           RI+  +     +F
Sbjct: 305 RITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 65/257 (25%), Positives = 106/257 (41%), Gaps = 32/257 (12%)

Query: 25  LVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           L R +G+G FG V     +  T+  VAVK ++ G    E   +E    + LRH  +V+  
Sbjct: 10  LERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67

Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHS 135
            V      + IV EY S G L + +         E +     QL+        G++Y  S
Sbjct: 68  AVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLES 121

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP-AYIAPEVLL 191
               HRDL   N L+  +     KI DFG ++  ++       +     P  + APE   
Sbjct: 122 RNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAAN 177

Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
              +  K +DVWS G+ L  ++  G  P+         R+ + ++    Y +P   +   
Sbjct: 178 YGRFTIK-SDVWSFGILLTEIVTYGRVPYPG----MTNREVLEQV-ERGYRMPRPPNCPE 231

Query: 251 ECRHLISRIFVADPAKR 267
           E   L+ + +  DP +R
Sbjct: 232 ELYDLMLQCWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 18/194 (9%)

Query: 27  RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
           R + S N G  +       E L+A K ++ G +    ++ EI+    L H NI++ +E++
Sbjct: 180 RGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232

Query: 87  LTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLISGVSYCHSMQVCHR 141
            +  +  ++ +     +L+  + +     +D     + R   +QL+  V Y H  ++ HR
Sbjct: 233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKI 199
           D+KLEN  L+      L   DFG +       +      VGT A  +PE+L    Y  +I
Sbjct: 292 DIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEI 348

Query: 200 ADVWSCGVTLYVML 213
            D+WSCG+ L  ML
Sbjct: 349 TDIWSCGLILLDML 362

Length = 501

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 70.2 bits (172), Expect = 8e-14
 Identities = 64/258 (24%), Positives = 103/258 (39%), Gaps = 30/258 (11%)

Query: 23  YELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIV 80
           + L R +GSG FG   +     K    VA+K ++  D +  ++ Q+E+   + LRH +++
Sbjct: 8   FTLERKLGSGYFG--EVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
               V      + I+ E    G L   + +        A       Q+  G++Y      
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQPKSTVGTPAYIAPEVLLKKE 194
            HRDL   N L+        K+ DFG +   K  V L S  K       + APE      
Sbjct: 126 IHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHGT 180

Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
           +  K +DVWS G+ LY +   G  P+       N  +   +I +  Y +P       +C 
Sbjct: 181 FSTK-SDVWSFGILLYEMFTYGQVPYPG----MNNHEVYDQITA-GYRMPC----PAKCP 230

Query: 254 HLISRIFV----ADPAKR 267
             I +I +    A+P  R
Sbjct: 231 QEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 26/211 (12%)

Query: 29  IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 81
           IG+G FG     RL    K E  VA+K ++ G    E  +R+ ++  S+     HPNI+ 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 82  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
            + V+     + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128

Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 191
           HRDL   N L++ +     K+ DFG S+   L         T +        + APE + 
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
            +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 81/313 (25%), Positives = 129/313 (41%), Gaps = 66/313 (21%)

Query: 29  IGSGNFG-VARLMR-DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
           +G G +G V +  R D K +   A+K IE G  I  +  REI   R L+HPN++  ++V 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 87  LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
           L+     + ++ +YA         F R   A +          +    Q++ G+ Y H+ 
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
            V HRDLK  N L+  +G    R+KI D G+++   L + P          V T  Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184

Query: 188 EVLLKKEYDGKIADVWSCGVTLYVML-----------------------------VGAYP 218
           E+LL   +  K  D+W+ G     +L                             V  +P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244

Query: 219 ----FED----PEEP---KNFRKTIHRILS-VQYSIPDYVHISPECRHLISRIFVADPAK 266
               +ED    PE     K+FR+  +   S ++Y     V    +  HL+ ++   DP K
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 304

Query: 267 RISIPEIRNHEWF 279
           RI+  +     +F
Sbjct: 305 RITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)

Query: 29  IGSGNFG-VAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 81
           IG+G FG V R  L    + E  VA+K ++ G    E  +++ ++  S+     H NI+R
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 82  FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
            + V+       I+ EY   G L + +  + G FS  +     + + +G+ Y   M   H
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLKKE 194
           RDL   N L++ +     K+ DFG S+  VL   P+ T  T        + APE +  ++
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
           +    +DVWS G+ ++ VM  G  P+ D
Sbjct: 187 FTSA-SDVWSFGIVMWEVMSFGERPYWD 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 68.3 bits (167), Expect = 4e-13
 Identities = 78/273 (28%), Positives = 109/273 (39%), Gaps = 50/273 (18%)

Query: 27  RDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL---RHPNIV 80
             IG GNFG      L    K    VAVK   R     +  ++ +     L    HPNIV
Sbjct: 1   EKIGKGNFGDVYKGVL----KGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIV 55

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYC 133
           +   V +    + IVME   GG L   +       + + R   ++L+       +G+ Y 
Sbjct: 56  KLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYL 109

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG---------YSKSSVLHSQP-KSTVGTPA 183
            S    HRDL   N L+  +    LKI DFG         Y+ S  L   P K T     
Sbjct: 110 ESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT----- 162

Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242
             APE L    Y  + +DVWS G+ L+    +G  P+       + ++T  RI S  Y +
Sbjct: 163 --APEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPG----MSNQQTRERIES-GYRM 214

Query: 243 PDYVHISPECRHLISRIFVADPAKRISIPEIRN 275
           P       E   L+ + +  DP  R S  EI N
Sbjct: 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 18/262 (6%)

Query: 21  DRYELVRDIGSGNFGVAR--LMRDKKTEEL-VAVKY--IERGDKIDENVQREIINHRSLR 75
           +   L R IG G FG     +    + E++ VAVK         + E   +E    R   
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
           HP+IV+   VI T   + IVME A  GEL   +  N           +  QL + ++Y  
Sbjct: 66  HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-P-AYIAPEVLLK 192
           S +  HRD+   N L+  SP   +K+ DFG S+     S  K++ G  P  ++APE +  
Sbjct: 125 SKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182

Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
           + +    +DVW  GV ++ ++++G  PF+  +        I RI + +  +P   +  P 
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKN----NDVIGRIENGE-RLPMPPNCPPT 236

Query: 252 CRHLISRIFVADPAKRISIPEI 273
              L+++ +  DP+KR    E+
Sbjct: 237 LYSLMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 34/225 (15%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-- 73
           ++  L+R++G G+FG     +A+ +   + E  VA+K +     + E    E +N  S  
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63

Query: 74  --LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-------- 121
                 ++VR   V+ T     +VME  + G+L  + R     R   +            
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQK 120

Query: 122 FFQ---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
           F Q   ++  G++Y  + +  HRDL   N ++       +KI DFG ++        +  
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKG 178

Query: 179 VGT--PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPF 219
                P  ++APE L    +  K +DVWS GV L+ M  +   P+
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 68/250 (27%), Positives = 104/250 (41%), Gaps = 19/250 (7%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
           IG GNFG     R +     VAVK     + +  +++ + +      +   HPNIVR   
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 85  VILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
           V      + IVME   GG+    +   G R    E     +   +G+ Y  S    HRDL
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLKKEYDGKIA 200
              N L+       LKI DFG S+     +++        P  + APE L    Y  + +
Sbjct: 121 AARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-S 177

Query: 201 DVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
           DVWS G+ L+    +GA P+ +    +  R+ I +   V+   P+          L+ R 
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQT-REAIEQ--GVRLPCPE--LCPDAVYRLMERC 232

Query: 260 FVADPAKRIS 269
           +  DP +R S
Sbjct: 233 WEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 15/193 (7%)

Query: 28  DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
           ++GSGNFG  +  + + KK+E+ VAVK I + D  D  ++ E++      + L +P IVR
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
               I       +VME A  G L + +      +E        Q+  G+ Y       HR
Sbjct: 61  MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLLKKEYDG 197
           DL   N LL        KI DFG SK   +   + + K+    P  + APE +   ++  
Sbjct: 120 DLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177

Query: 198 KIADVWSCGVTLY 210
           K +DVWS GV ++
Sbjct: 178 K-SDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 66/233 (28%), Positives = 94/233 (40%), Gaps = 41/233 (17%)

Query: 24  ELVRDIGSGNFGVARLMR----------------DKKTEELVAVKYIERG--DKIDENVQ 65
             V  +G G FG   L                  +     LVAVK +     D   E+  
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 66  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER---------ICNAGRF 114
           +E+     L  PNI R   V      L ++MEY   G+L  F +          CN+   
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
           S     +   Q+ SG+ Y  S+   HRDL   N L+       +KI DFG S++  L+S 
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN--LYSS 183

Query: 175 PKSTVG--TPAYI---APEVLLKKEYDGKIADVWSCGVTLY--VMLVGAYPFE 220
               V    P  I   A E +L  ++  K +DVW+ GVTL+  + L    P+E
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYE 235

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 28/219 (12%)

Query: 24  ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
           EL+  IG G  +     L R K T E V V+ I      +E V   Q E+   +   HPN
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSM 136
           IV ++   +    L +V  + + G   + IC       SE    +  Q ++  + Y H M
Sbjct: 61  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120

Query: 137 QVCHRDLKLENTL--LDGSPAPRLKICDFGY----------SKSSVLHSQPKSTVGTPAY 184
              HR +K  + L  +DG      K+   G            +  V+H  PK +V    +
Sbjct: 121 GYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174

Query: 185 IAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
           ++PEVL +  + YD K +D++S G+T   +  G  PF+D
Sbjct: 175 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 33/218 (15%)

Query: 29  IGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
           +GSG FG         ++        VAVK + +G    E  ++E +    L     HPN
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVS 131
           IV+   V L      I+ME   GG+L   + +A            ++L+        G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSVLHSQPKSTVGTPAYI 185
           Y   M   HRDL   N L+   G  A R +KI DFG ++    S  + +    +    ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 186 APEVLLKKEYDGKI---ADVWSCGVTLY-VMLVGAYPF 219
           APE LL    DGK    +DVWS GV ++ ++ +G  P+
Sbjct: 181 APESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 19/213 (8%)

Query: 22  RYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RS 73
             E ++ +GSG FG       + + +  ++ VA+K +   ++      +EI++      S
Sbjct: 8   ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMAS 65

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 132
           + HP++VR   + L+     ++ +    G L + +  +           +  Q+  G+SY
Sbjct: 66  VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP-AYIAPEV 189
               ++ HRDL   N L+  +P   +KI DFG +K   V   +  +  G  P  ++A E 
Sbjct: 125 LEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           +L + Y  K +DVWS GVT++ +M  GA P+E 
Sbjct: 183 ILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 47/161 (29%), Positives = 65/161 (40%), Gaps = 16/161 (9%)

Query: 45  TEELVAVKYIERGDKIDE-----NVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY 98
           T   VA+K + R D  +E       +RE      L HPNIV         P  L  V EY
Sbjct: 2   TGHEVAIKLL-RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 99  ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APR 157
             G  L E +   G     E      Q++  ++  H+  + HRDLK +N ++  +   P 
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 158 LKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVL 190
            K+ DFG             +    T   +GTP Y APE L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 62.1 bits (151), Expect = 6e-11
 Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 39/278 (14%)

Query: 25  LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
           L R++G G FG   L     +  +  +ELVAVK ++    +   ++ +RE     + +H 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERI--------------CNAGRFSEDEARFFF 123
           NIV+F  V        +V EY   G+L + +                 G  +  +     
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
            Q+ SG+ Y  S    HRDL   N L+       +KI DFG S+   +++     VG   
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGHT 184

Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP-FEDPEEPKNFRKTIHRIL 236
                ++ PE ++ +++  + +DVWS GV L+ +   G  P +    E     + I  I 
Sbjct: 185 MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNE-----EVIECIT 238

Query: 237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 274
             +           E   ++   +  DP +RI+I +I 
Sbjct: 239 QGRLLQRPRT-CPSEVYDIMLGCWKRDPQQRINIKDIH 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 53/285 (18%)

Query: 29  IGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVR 81
           +G G FG      A  ++ +     VAVK ++      E  ++  E    + + HP++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 82  FKEVILTPTHLAIVMEYASGGEL--FERIC---------------NAGRFSEDEARFFFQ 124
                     L +++EYA  G L  F R                 ++   + DE      
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 125 QLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 171
            LIS       G+ Y   M++ HRDL   N L+  +   ++KI DFG S+      S V 
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVK 185

Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNF 228
            S+ +  V    ++A E L    Y  + +DVWS GV L+ ++ +G   YP   PE   N 
Sbjct: 186 RSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL 241

Query: 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
            KT +R+       P+  + S E  +L+   +  +P KR +  +I
Sbjct: 242 LKTGYRM-----ERPE--NCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)

Query: 28  DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 81
           ++GSGNFG  +  + + +K +  VA+K ++  +  +++V+ E++    + H    P IVR
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 82  FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
              V      L +VME ASGG L + +       +         Q+  G+ Y       H
Sbjct: 60  MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLKKEYD 196
           RDL   N LL        KI DFG SK+      + + +S    P  + APE +  +++ 
Sbjct: 119 RDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 197 GKIADVWSCGVTLYVML-VGAYPFEDPEEPK 226
            + +DVWS G+T++     G  P++  + P+
Sbjct: 177 SR-SDVWSYGITMWEAFSYGQKPYKKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 59.5 bits (144), Expect = 3e-10
 Identities = 56/246 (22%), Positives = 107/246 (43%), Gaps = 24/246 (9%)

Query: 39  LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
           L+ D +T++   +K + +  +     +  II H     PN+V   + I++   + +V+++
Sbjct: 11  LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66

Query: 99  ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
           A GG+L+  I       E+  + +  +++  +   H   +  RDL   N LLD     +L
Sbjct: 67  AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126

Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218
                 +S+ S +            Y APEV    E + +  D WS G  L+ +L G   
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTL 181

Query: 219 FEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEI 273
            E      N   T+        +IP+   +S E R L+ ++   +P +R+      + +I
Sbjct: 182 VECHPSGINTHTTL--------NIPE--WVSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231

Query: 274 RNHEWF 279
           ++H +F
Sbjct: 232 KSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 20/216 (9%)

Query: 19  DSDRYELVRDIGSGNFG-VAR--LMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
           D+   ++ R +G+G FG + R  L    K E  VA+  +  G  DK       E +    
Sbjct: 3   DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
             H NIVR + VI     + IV EY S G L  F R  + G+    +       L SG+ 
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMK 121

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHS--QPKSTVGTPAYIA 186
           Y   M   H+ L     L++       KI  F      KS  +++    KS V    + A
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWAA 176

Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           PE +    +    +DVWS G+ ++ VM  G  P+ D
Sbjct: 177 PEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 13/189 (6%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
           +G G +G       KK    VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 89  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLE 146
                I+ E+ + G L + +    R   +     +   Q+ S + Y       HRDL   
Sbjct: 74  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 133

Query: 147 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
           N L+       +K+ DFG S+     +   H+  K  +    + APE L   ++  K +D
Sbjct: 134 NCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 187

Query: 202 VWSCGVTLY 210
           VW+ GV L+
Sbjct: 188 VWAFGVLLW 196

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 23/213 (10%)

Query: 19  DSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP 77
           D    +L+R +G+G FG V   + +  T   VAVK ++ G    ++   E    + LRHP
Sbjct: 4   DRTSIQLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 130
            +++   V      + IV E    G L E +                QLI       SG+
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGM 116

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---AP 187
           +Y  +    HRDL   N L+  +     K+ DFG ++  +     ++  G    I   AP
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFPIKWTAP 173

Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           E  L   +  K +DVWS G+ L  ++  G  P+
Sbjct: 174 EAALYNRFSIK-SDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 50/186 (26%), Positives = 76/186 (40%), Gaps = 32/186 (17%)

Query: 72  RSLRHPNIVRFKEVILTPTHLAI--------VMEYASGGEL--FERIC------NAGRFS 115
             L H NI       L   H+ I        +  Y + G L  F + C      N    S
Sbjct: 63  YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115

Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLH 172
             +      Q+  G+SY H   V H+D+   N ++D     ++KI D   S+       H
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYH 173

Query: 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE--DPEEPKNFR 229
               +      ++A E L+ KEY    +DVWS GV L+ +M +G  P+   DP E   + 
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL 232

Query: 230 KTIHRI 235
           K  +R+
Sbjct: 233 KDGYRL 238

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 74/290 (25%), Positives = 120/290 (41%), Gaps = 54/290 (18%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDENVQREI 68
           DR  L + +G G FG      A  + +      VAVK +       +  D + E    ++
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 69  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF------- 121
           I     +H NI+    V      L +V+EYA+ G L + +  A R   + A         
Sbjct: 72  IG----KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126

Query: 122 ----------FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
                     F  Q+  G+ +  S +  HRDL   N L+  +    +KI DFG ++   +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--I 182

Query: 172 HSQP---KSTVG-TPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPE 223
           H      K+T G  P  ++APE L  + Y  + +DVWS GV L+ +  +G   YP    E
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVE 241

Query: 224 EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           E     K  +R+   Q    +  H+  +C H         P++R +  ++
Sbjct: 242 ELFKLLKEGYRMEKPQNCTQELYHLMRDCWH-------EVPSQRPTFKQL 284

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 59.5 bits (144), Expect = 5e-10
 Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 35/225 (15%)

Query: 18  HDSDRYELVRDIGSGNFGV---ARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIIN 70
           +  +  E VRDIG G FG    AR       E   +VAVK ++      +  + QRE   
Sbjct: 2   YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61

Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------------------RICN 110
                HPNIV+   V      + ++ EY + G+L E                    R C 
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 111 AGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK- 167
                 S  E     +Q+ +G++Y    +  HRDL   N L+  +    +KI DFG S+ 
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRN 179

Query: 168 --SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
             S+  +   ++      ++ PE +    Y  + +DVW+ GV L+
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 26/218 (11%)

Query: 25  LVRDIGSGNFGVARLMR-----DKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 78
           L R++G G FG   L        ++ + LVAVK + +  D   ++  RE     +L+H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQ 125
           IV+F  V +    L +V EY   G+L + +   G               ++ +     QQ
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 182
           + +G+ Y  S    HRDL   N L+  +    +KI DFG S+   S+  +     T+   
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
            ++ PE ++ +++  + +DVWS GV L+ +   G  P+
Sbjct: 187 RWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 11/205 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
           +  +LV+ +G+G FG    M        VAVK ++ G    +    E    ++L+H  +V
Sbjct: 6   ESIKLVKKLGAGQFGEV-WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 64

Query: 81  RFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           R   V+     + I+ EY + G L  F +    G+    +   F  Q+  G++Y      
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEY 195
            HRDL+  N L+  S +   KI DFG ++  +  ++  +  G      + APE +    +
Sbjct: 125 IHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSF 181

Query: 196 DGKIADVWSCGVTLY-VMLVGAYPF 219
             K +DVWS G+ LY ++  G  P+
Sbjct: 182 TIK-SDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 38/227 (16%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEE--------------LVAVKYIERGDKIDENVQ- 65
            +  L   +G G FG   L   +   E              LVAVK + R D + +  + 
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RAD-VTKTARN 62

Query: 66  ---REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL------------FERICN 110
              +EI     L++PNI+R   V ++   L ++ EY   G+L            F    N
Sbjct: 63  DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122

Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--- 167
               S     +   Q+ SG+ Y  S+   HRDL   N L+       +KI DFG S+   
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLY 180

Query: 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
           S   +      V    ++A E +L  ++    +DVW+ GVTL+ M  
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 24/220 (10%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINH 71
           D   L+R +G G FG     + R       E  VAVK +       D+ D  ++  I++ 
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS- 64

Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC--NAGRFSE---DEARFFFQ 124
               H NIVR   V        I++E  +GG+L  F R       R S     +  F  +
Sbjct: 65  -KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SVLHSQPKSTVG 180
            +  G  Y       HRD+   N LL      R+ KI DFG ++    +  + +    + 
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
              ++ PE  L   +  K  DVWS GV L+ +  +G  P+
Sbjct: 184 PIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 39/202 (19%)

Query: 29  IGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFK 83
           +G GNFG      ++DK     VAVK  +  D   E   + +   R L+   HPNIV+  
Sbjct: 3   LGKGNFGEVFKGTLKDKTP---VAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLI 58

Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 136
            V      + IVME   GG+    +    R  +DE +   +QL+       +G++Y  S 
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESK 112

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
              HRDL   N L+  +    LKI DFG S+        SS L   P        + APE
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPE 164

Query: 189 VLLKKEYDGKIADVWSCGVTLY 210
            L    Y  + +DVWS G+ L+
Sbjct: 165 ALNYGRYSSE-SDVWSYGILLW 185

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 66/283 (23%), Positives = 114/283 (40%), Gaps = 48/283 (16%)

Query: 25  LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREI-------INHRSL 74
           L + +G G FG     +L +D  ++  VAVK +    K+D +   EI          +  
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDF 58

Query: 75  RHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI- 127
            HPN+++   V    + L       +++ +   G+L   +    R      +   Q L+ 
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLK 117

Query: 128 ------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPK 176
                  G+ Y  +    HRDL   N +L       + +C  DFG SK   S   + Q +
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGR 173

Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPE--EPKNFRKTIH 233
                  +IA E L  + Y  K +DVW+ GVT++ +   G  P+   E  E  ++ +  +
Sbjct: 174 IAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232

Query: 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 276
           R L       D ++       L+   + ADP  R +  ++R  
Sbjct: 233 R-LKQPEDCLDELY------DLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 16/213 (7%)

Query: 24  ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
           EL  +IG G  N     L R   T  LV V+  +  +  +E++   Q E++     RHPN
Sbjct: 1   ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60

Query: 79  IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           I+    V  T + L ++   M Y S   L +     G  SE          + G++Y H 
Sbjct: 61  IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ 119

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEV 189
               HR++K  + L+ G     L      YS      K+ V++  P+ +     +++PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179

Query: 190 LLKKEYDGKI-ADVWSCGVTLYVMLVGAYPFED 221
           L +  Y   + +D++S G+T   +  G  PF+D
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 45/230 (19%)

Query: 21  DRYELVRDIGSGNFGVARL-----MRDKKTEE-----------LVAVKYIERGDKIDENV 64
            R      +G G FG   L     M     ++           LVAVK + R D  ++N 
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDA-NKNA 62

Query: 65  Q----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----------- 109
           +    +EI     L+ PNI+R   V +T   L ++ EY   G+L + +            
Sbjct: 63  RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122

Query: 110 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
           +    S     F   Q+ SG+ Y  S+   HRDL   N L+  +    +KI DFG S++ 
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN- 179

Query: 170 VLHS------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
            L+S      Q ++ +         +LL K      +DVW+ GVTL+ +L
Sbjct: 180 -LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA--SDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 67/284 (23%), Positives = 116/284 (40%), Gaps = 43/284 (15%)

Query: 24  ELVRDIGSGNFG-VAR----LMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
             + ++G G FG V +       ++ +   VA+K ++     K+ +  ++E      L+H
Sbjct: 8   RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFE------RICNAGRFSED-------EARFFF 123
           PNIV    V        ++ EY + G+L E         + G  S D       +   F 
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 124 Q---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKS 177
               Q+ +G+ Y  S    HRDL   N L+       +KI DFG S+   S+  +     
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP---FEDPEEPKNFRKTIH 233
           ++    ++ PE +L  ++  + +D+WS GV L+ +   G  P   F + E  +  R    
Sbjct: 186 SLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ- 243

Query: 234 RILSVQYSIPDYVH-ISPECRHLISRIFVADPAKRISIPEIRNH 276
            +L      P  V+ +  EC + I       PA+R    +I   
Sbjct: 244 -LLPCPEDCPARVYALMIECWNEI-------PARRPRFKDIHTR 279

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 15/155 (9%)

Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
           Q+  G+ +  S +  HRDL   N LL  S    +KICDFG ++   ++  P    K +  
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237

Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSV 238
            P  ++APE +  K Y  + +DVWS GV L+ +  +GA P+   +  + F + +      
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD--GT 294

Query: 239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           +   P+    +PE   ++   +  DP +R +   +
Sbjct: 295 RMRAPENA--TPEIYRIMLACWQGDPKERPTFSAL 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 77/263 (29%), Positives = 115/263 (43%), Gaps = 37/263 (14%)

Query: 27  RDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
           R IG G+FG      L+     +   AVK + R   ++E  Q  +E I  +   HPN++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 82  FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVC 139
              + L       +V+ Y   G+L   I +     +  +   F  Q+  G+ Y  S +  
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120

Query: 140 HRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
           HRDL   N +LD S    +K+ DFG     Y K   S   H+  K  V    ++A E L 
Sbjct: 121 HRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQ 175

Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRILSVQYSIPDYV-- 246
            +++  K +DVWS GV L+ +M  GA  YP  D  +   +     R+L  +Y  PD +  
Sbjct: 176 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYC-PDPLYE 233

Query: 247 ------HISPECR----HLISRI 259
                 H  PE R     L+SRI
Sbjct: 234 VMLSCWHPKPEMRPTFSELVSRI 256

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 29/221 (13%)

Query: 25  LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
           L R++G G FG   L     +   K + LVAVK ++       ++ QRE     +L+H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 79  IVRFKEVILTPTHLAIVMEYASGGEL--FER--------------ICNAGRFSEDEARFF 122
           IV+F  V      L +V EY   G+L  F R                  G     +    
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTV 179
             Q+ SG+ Y  S    HRDL   N L+  +    +KI DFG S+   S+  +     T+
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               ++ PE ++ +++  + +DVWS GV L+ +   G  P+
Sbjct: 187 LPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 33/217 (15%)

Query: 29  IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
           IG GNFG V R M  K   ++  A+K ++  +   EN  R+      +      HPNI+ 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA---------RFFFQQLI----- 127
                    +L I +EYA  G L + +  +     D A             QQL+     
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 128 --SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
             +G+ Y    Q  HRDL   N L+  + A   KI DFG S+   ++   K T+G  P  
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183

Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           ++A E L    Y  K +DVWS GV L+ ++ +G  P+
Sbjct: 184 WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.1 bits (132), Expect = 1e-08
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 33/217 (15%)

Query: 29  IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
           IG GNFG V +    K    +  A+K ++  +   ++  R+      +      HPNI+ 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 82  FKEVILTPTHLAIVMEYASGGELFE-----RIC-----------NAGRFSEDEARFFFQQ 125
                    +L + +EYA  G L +     R+             A   S  +   F   
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
           +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176

Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           ++A E L    Y    +DVWS GV L+ ++ +G  P+
Sbjct: 177 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 41/272 (15%)

Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK ++  D   E    ++++   
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 72

Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEAR--- 120
           +     +H NI+           L +++EYAS G L E +  A R     +S D AR   
Sbjct: 73  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPD 131

Query: 121 --FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SS 169
               F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  ++
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNN 189

Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEEP 225
           + + +  +    P  ++APE L  + Y  + +DVWS GV ++ +       YP    EE 
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248

Query: 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
               K  HR+        +   +  +C H I 
Sbjct: 249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIP 280

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 32/217 (14%)

Query: 29  IGSGNFGVARLMRDKKTEE-----LVAVKYIERGDKIDENVQ----REIINHRSLRHPNI 79
           +G G FG   L + K  EE     LV VK +++    DEN+Q    RE+   R L H N+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNV 70

Query: 80  VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 130
           VR   +        +++EY   G+L  F R   +            +Q ++       G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 131 SYCHSMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 185
            +  + +  HRDL   N L+            L      Y+            +    ++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL---RWL 185

Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           APE + + ++  K +DVWS GV ++ V   G  PF  
Sbjct: 186 APEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYG 221

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)

Query: 28  DIGSGNFGVARL-----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
           ++G G FG   L     +  ++ + LVAVK + E  +   ++ QRE      L+H +IVR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 82  FKEVILTPTHLAIVMEYASGGEL--FER-------------ICNAGRFSEDEARFFFQQL 126
           F  V      L +V EY   G+L  F R                 G+ +  +      Q+
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
            SG+ Y  S+   HRDL   N L+       +KI DFG S+   ++S     VG      
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTMLP 187

Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLY 210
             ++ PE +L +++  + +D+WS GV L+
Sbjct: 188 IRWMPPESILYRKFTTE-SDIWSFGVVLW 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 66/268 (24%), Positives = 110/268 (41%), Gaps = 23/268 (8%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINH 71
           +     + +G+G FG      A  +        VAVK ++      E      + +I++H
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               H NIV           + ++ EY   G+L  F R       + ++   F  Q+  G
Sbjct: 95  LG-NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA-YIA 186
           +++  S    HRDL   N LL  +    +KICDFG ++  +  S    K     P  ++A
Sbjct: 154 MAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211

Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
           PE +    Y  + +DVWS G+ L+ +  +G+ P+        F K I       Y +   
Sbjct: 212 PESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMAQP 266

Query: 246 VHISPECRHLISRIFVADPAKRISIPEI 273
            H   E   ++   + ADP KR +  +I
Sbjct: 267 EHAPAEIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 31/247 (12%)

Query: 41  RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
                E  V +K +    +              L H ++V+   V +   ++ +V EY  
Sbjct: 25  VGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVK 83

Query: 101 GGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----- 150
            G L      E+   +  +  D A    +QL S + Y    ++ H ++  +N L+     
Sbjct: 84  FGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGL 139

Query: 151 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA-DVWSCGVTL 209
           +    P +K+ D G   + +   +    +    +IAPE +   +    IA D WS G TL
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPECIRNGQASLTIAADKWSFGTTL 196

Query: 210 Y-VMLVGAYPFE--DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
             +   G  P       E + F +  HR+      +PD      E  +LI++ +  DP K
Sbjct: 197 LEICSNGEEPLSTLSSSEKERFYQDQHRL-----PMPD----CAELANLINQCWTYDPTK 247

Query: 267 RISIPEI 273
           R S   I
Sbjct: 248 RPSFRAI 254

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 21/161 (13%)

Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
           Q+  G+ +  S +  HRDL   N LL  S    +KICDFG ++   ++  P    K    
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242

Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH---RI 235
            P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + F + +    R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301

Query: 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 276
            +  Y+ P+      +C H        +P++R +  E+  H
Sbjct: 302 RAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 29/218 (13%)

Query: 27  RDIGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPN 78
            +IG+G FG        R M   +    V VK +      DE +   +E+  +R L HPN
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKAR----VVVKELRASATPDEQLLFLQEVQPYRELNHPN 56

Query: 79  IVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYC 133
           +++     +      +V+E+   G+L       R   A    +D  +    ++ SG+ + 
Sbjct: 57  VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTP-AYIAPEVL 190
           H     H DL L N  L    +  +KI D+G    +    +   K     P  ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174

Query: 191 LKKEYDGKIAD------VWSCGVTLYVML-VGAYPFED 221
             +  D    D      +WS GVT++ +      P+ D
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 15/216 (6%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV+ +G+G FG    M        VA+K +++G    E    E    + L+HP +VR  
Sbjct: 9   KLVKKLGAGQFGEV-WMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY 67

Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +     + + ++      Q+  G+++       HR
Sbjct: 68  AVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
           DL+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 127 DLRAANILV--SETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 199 IADVWSCGVTLY-VMLVGAYPF---EDPEEPKNFRK 230
            +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 184 -SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 6/102 (5%)

Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
           +GTP Y+APE+LL K + G   D W+ GV L+  L G  PF D E P+   +    IL+ 
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFND-ETPQ---QVFQNILNR 595

Query: 239 QYSIPDYVH-ISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
               P+    +S   ++ I  +   DP KR  + E++ H  F
Sbjct: 596 DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 73/270 (27%), Positives = 117/270 (43%), Gaps = 41/270 (15%)

Query: 22  RYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL 74
           R  L + +G G FG   +       +DK  + + VAVK + + D  D+++  ++++   +
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLS-DLVSEMEM 70

Query: 75  -----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EA 119
                +H NI+           L +++EYAS G L E +  A R     +S D     E 
Sbjct: 71  MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEE 129

Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           +  F+ L+S       G+ Y  S +  HRDL   N L+       +KI DFG ++    +
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNI 187

Query: 172 HSQPKSTVG--TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEEPK 226
               K+T G     ++APE L  + Y  + +DVWS GV L+ +       YP    EE  
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246

Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLI 256
              K  HR+        +   I  EC H +
Sbjct: 247 KLLKEGHRMDKPANCTHELYMIMRECWHAV 276

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 26/212 (12%)

Query: 21  DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           +  +L++ +G+G FG V     +  T+  VAVK ++ G    E+   E    + LRH  +
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSE-----DEARFFFQQLISGVSYC 133
           V+   V+ +   + IV EY S G L + + +  GR  +     D A     Q+ +G++Y 
Sbjct: 64  VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 188
             M   HRDL+  N L+        KI DFG ++   L    + T    A     + APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 173

Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPF 219
             L   +  K +DVWS G+ L  ++  G  P+
Sbjct: 174 AALYGRFTIK-SDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 23/204 (11%)

Query: 16  IMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
           I  +S R E+   +G G FG V     +  T   VA+K ++ G    E   +E    + L
Sbjct: 3   IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL 58

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE----DEARFFFQQLISGV 130
           RH  +V+   V+ +   + IV EY S G L + +   G   +     +      Q+ SG+
Sbjct: 59  RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGM 115

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YI 185
           +Y   M   HRDL+  N L+  +     K+ DFG ++   L    + T    A     + 
Sbjct: 116 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWT 170

Query: 186 APEVLLKKEYDGKIADVWSCGVTL 209
           APE  L   +  K +DVWS G+ L
Sbjct: 171 APEAALYGRFTIK-SDVWSFGILL 193

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 19/182 (10%)

Query: 49  VAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
           VA+K I+  D+      +EI +H     SL H  IVR   +    + L +V + +  G L
Sbjct: 39  VAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSL 95

Query: 105 FERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163
            + +  +           +  Q+  G+ Y    ++ HR+L   N LL  S +  ++I DF
Sbjct: 96  LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK-SDS-IVQIADF 153

Query: 164 GYSKSSVLHSQPK----STVGTP-AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAY 217
           G +   +L+   K    S   TP  ++A E +L   Y  + +DVWS GVT++ M+  GA 
Sbjct: 154 GVA--DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAE 210

Query: 218 PF 219
           P+
Sbjct: 211 PY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
           Q+  G+ +  S +  HRDL   N LL  S    +KICDFG ++   ++  P    K    
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236

Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNF-RKTIH--RI 235
            P  ++APE +  K Y  + +DVWS GV L+ +  +GA P+   +  + F R+     R+
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295

Query: 236 LSVQYSIPDYVHISPECRH 254
            + +Y+ P+   I  +C H
Sbjct: 296 RAPEYATPEIYSIMLDCWH 314

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 18/219 (8%)

Query: 24  ELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
           +L + +G+G FG V     +K T+  VAVK ++ G    E    E    ++L+H  +V+ 
Sbjct: 9   KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66

Query: 83  KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
             V+ T   + I+ E+ + G L  F +     +    +   F  Q+  G+++       H
Sbjct: 67  HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           RDL+  N L+  S +   KI DFG ++             K  +    + APE +    +
Sbjct: 126 RDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAINFGSF 180

Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH 233
             K +DVWS G+ L  ++  G  P+     P+  R    
Sbjct: 181 TIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 44/146 (30%), Positives = 62/146 (42%), Gaps = 20/146 (13%)

Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 175
           +QL+S + Y H   + HRD+K EN L++G       IC  DFG       S S+  H   
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322

Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN--FRKTI 232
             TV T    APEVL    Y   + D+WS G+ ++   V  A  F      +   +   I
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378

Query: 233 HRILSVQYSIPDYVHISPECRHLISR 258
            RI+       D        R L+S+
Sbjct: 379 LRIIRQAQVHVDEFPQHAGSR-LVSQ 403

Length = 461

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 30/220 (13%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           + R++++  +G G FG      D+K +E  AVK +    K   + + EI     +R  + 
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187

Query: 80  V-RFKEVILT------PTHLAIVM-EYASGGELFERICNAGRFSEDE-ARFFFQQLISGV 130
             RF  + +         H+ IVM +Y  G  L + I   G FS    A+  FQ  ++ +
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVA-L 244

Query: 131 SYCHS-MQVCHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSVLHSQP 175
            Y H+ + + H DLK EN L++ S             P P R++ICD G       HS+ 
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR- 302

Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
            + V T  Y +PEV+L   +     D+WS G  +Y +  G
Sbjct: 303 TAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 35/218 (16%)

Query: 29  IGSGNFGV---ARLMRDKKTEELVAVK----YIERGDKIDENVQREIINHRSLRHPNIVR 81
           IG GNFG    AR+ +D    +  A+K    Y  + D  D   + E++  +   HPNI+ 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLC-KLGHHPNIIN 72

Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF----------QQLIS--- 128
                    +L + +EYA  G L + +    R  E +  F            QQL+    
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 129 ----GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA 183
               G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P 
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPV 187

Query: 184 -YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
            ++A E L    Y    +DVWS GV L+ ++ +G  P+
Sbjct: 188 RWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 17/179 (9%)

Query: 42  DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM-EYAS 100
           D KT E V +K  +RG    E     I+  R++ HP+I++ K          +++  Y +
Sbjct: 113 DNKTCEHVVIKAGQRGGTATE---AHIL--RAINHPSIIQLKGTFTYNKFTCLILPRYKT 167

Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
             +L+  +      +  +     + ++  + Y H  ++ HRD+K EN  ++  P     +
Sbjct: 168 --DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPG---DV 221

Query: 161 C--DFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
           C  DFG +   V  +  K     GT A  APE+L +  Y G   D+WS G+ L+ M   
Sbjct: 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 19/211 (9%)

Query: 23  YELVRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG V + +   + E++   VA+K +      K ++ +  E     S+ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHS 135
           P++ R   + LT T + ++ +    G L + +  +           +  Q+  G++Y   
Sbjct: 69  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVL 190
            ++ HRDL   N L+       +KI DFG +K  +L +  K            ++A E +
Sbjct: 128 RRLVHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMALESI 183

Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
           L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 184 LHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 31/210 (14%)

Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-------ENVQREIINHRSLRHP 77
           L + +G G FG   +M  +  ++   +K   +  KI        E+   E +  +   HP
Sbjct: 3   LGKTLGEGEFG--SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 78  NIVRFKEVILTPTHL------AIVMEYASGGEL-----FERICNAGRFSEDEARF-FFQQ 125
           N++R   V L            +++ +   G+L     + R+ +  ++   +    F   
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVG 180
           + SG+ Y  S    HRDL   N +L+ +    + +C  DFG SK   +   + Q +    
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
              +IA E L  + Y  K +DVWS GVT++
Sbjct: 177 PVKWIAIESLADRVYTTK-SDVWSFGVTMW 205

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 15/143 (10%)

Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 178
           F  Q+ +G+ +  S    HRDL   N L+       +KICDFG ++  +  S      ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301

Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKN--FRKTIHRI 235
                ++APE +    Y   ++DVWS G+ L+ +  +G  P+  PE P N  F   I R 
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY--PELPMNEQFYNAIKR- 357

Query: 236 LSVQYSIPDYVHISPECRHLISR 258
               Y +    H S E   ++ +
Sbjct: 358 ---GYRMAKPAHASDEIYEIMQK 377

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 15/206 (7%)

Query: 26  VRDIGSGNFGVAR---LMRDKKTEEL-VAVKYIER--GDKIDENVQREIINHRSLRHPNI 79
           V+ +GSG FG       + + +T ++ VA+K +    G K +     E +   S+ HP++
Sbjct: 12  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           VR   V L+PT + +V +    G L + +  +           +  Q+  G+ Y    ++
Sbjct: 72  VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEY 195
            HRDL   N L+  SP   +KI DFG ++      +  +  G      ++A E +  +++
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFE 220
             + +DVWS GVT++ +M  G  P++
Sbjct: 189 THQ-SDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 26  VRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRHPNI 79
           V+ +GSG FG V + +     E +   VA+K +      K ++ +  E      +  P +
Sbjct: 12  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            R   + LT T + +V +    G L + +  N  R    +   +  Q+  G+SY   +++
Sbjct: 72  CRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLKKEY 195
            HRDL   N L+  SP   +KI DFG ++   +        G      ++A E +L + +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188

Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFE 220
             + +DVWS GVT++ +M  GA P++
Sbjct: 189 THQ-SDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 39/232 (16%)

Query: 21  DRYELVRDIGSGNFG-VARLMR---DKKTEE---LVAVKYIERGDKIDENVQREIINHRS 73
           DR  L + +G G FG V R      DK   +    VAVK + + +  D+++  ++I+   
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLA-DLISEME 69

Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----E 118
           L     +H NI+    V      L +++EYA+ G L E +  A R     ++ D     E
Sbjct: 70  LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPE 128

Query: 119 ARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--S 169
            +  F+ L+S       G+ Y  S +  HRDL   N L+       +KI DFG ++    
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHD 186

Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + + +  S    P  ++APE L  + Y  + +DVWS G+ ++ +  +G  P+
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 13/153 (8%)

Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
           F  Q+  G+ +  S    HRDL   N LL  +    +KICDFG ++  ++H     + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298

Query: 182 P----AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRIL 236
                 ++APE +    Y   ++DVWS G+ L+ +  +G  P+        F   I    
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS-- 355

Query: 237 SVQYSIPDYVHISPECRHLISRIFVADPAKRIS 269
             + + PD  H + E   ++ + + ++P KR S
Sbjct: 356 GYRMAKPD--HATQEVYDIMVKCWNSEPEKRPS 386

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 17/159 (10%)

Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 179
           F  Q+  G+S+  S    HRDL   N LL  +     KICDFG ++     S    K   
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 180 GTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTI---HR 234
             P  ++APE +    Y  + +DVWS G+ L+ +  +G+ P+        F K I   +R
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335

Query: 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           +LS + +  +   I   C       + ADP KR +  +I
Sbjct: 336 MLSPECAPSEMYDIMKSC-------WDADPLKRPTFKQI 367

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 11/182 (6%)

Query: 41  RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
              +  + V VK +  G    +   REI   +++ H  I+         + + +VM    
Sbjct: 114 HGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169

Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
             +LF  +  +G    ++A    ++L+  ++Y H   + HRD+K EN  LD      L  
Sbjct: 170 C-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG- 227

Query: 161 CDFGYSKSSVLHS-QPKST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217
            DFG +     H   P+     GT    +PE+L    Y  K  D+WS G+ L+ M V   
Sbjct: 228 -DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNV 285

Query: 218 PF 219
             
Sbjct: 286 TL 287

Length = 392

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 31/222 (13%)

Query: 23  YELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
           + L R +G G FG  R   L  +  + + VAVK ++       +++   RE    +   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 77  PNIVRFKEVIL---TPTHLAIVM---EYASGGELFERICNAGRFSEDEARFFFQQLI--- 127
           PN+++   V L       L I M    +   G+L   +    R  E+      Q L+   
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFM 119

Query: 128 ----SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKST 178
               SG+ Y  S    HRDL   N +L+ +    + +C  DFG SK   S   + Q  ++
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
                ++A E L    Y    +DVW+ GVT++ +M  G  P+
Sbjct: 176 KLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 68/251 (27%), Positives = 104/251 (41%), Gaps = 43/251 (17%)

Query: 21  DRYELVRDIGSGNFGVARL-----MRDKKTEEL--VAVKYIER-------GDKIDENVQR 66
           DR  L + +G G FG   +     +  +K   +  VAVK ++         D I E    
Sbjct: 18  DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77

Query: 67  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED----- 117
           ++I     +H NI+           L +++EYAS G L E    R      +  +     
Sbjct: 78  KMIG----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133

Query: 118 EARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-S 169
           E +  F+ L+S       G+ Y  S +  HRDL   N L+       +KI DFG ++   
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIH 191

Query: 170 VLHSQPKSTVG--TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEE 224
            +    K+T G     ++APE L  + Y  + +DVWS GV L+ +       YP    EE
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE 250

Query: 225 PKNFRKTIHRI 235
                K  HR+
Sbjct: 251 LFKLLKEGHRM 261

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 35/219 (15%)

Query: 27  RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 82
           ++IG+G FG   L  +    T   V VK +     + E ++   E   +RSL+H N+++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 83  KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ---QLISGVSYCHSMQ 137
                  T   +VME+   G+L  + R C        +     +   ++  G+ + H   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEV 189
             H DL L N LL       +KI D+G S     H++ K               +IAPE+
Sbjct: 121 FIHSDLALRNCLLTADLT--VKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAPEL 173

Query: 190 LLKKEYDG--------KIADVWSCGVTLYVML-VGAYPF 219
           +   E  G        K ++VWS GVT++ +  +G+ P+
Sbjct: 174 V--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 39/203 (19%)

Query: 48  LVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103
           LVAVK I R D  ++N + + +        L+ PNI+R   V +    L ++ EY   G+
Sbjct: 48  LVAVK-ILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105

Query: 104 LFERICNAGRFSEDEAR--------------------FFFQQLISGVSYCHSMQVCHRDL 143
           L  +  ++    + E                          Q+ SG+ Y  S+   HRDL
Sbjct: 106 L-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164

Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGK 198
              N L+  +    +KI DFG S++  L++     +   A     ++A E +L  ++   
Sbjct: 165 ATRNCLVGENLT--IKIADFGMSRN--LYAGDYYRIQGRAVLPIRWMAWECILMGKFT-T 219

Query: 199 IADVWSCGVTLY--VMLVGAYPF 219
            +DVW+ GVTL+  +ML    P+
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPY 242

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 25/202 (12%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
           I  G  G +   +  K      VK I   + I  +   EI +   L+HPNIV+   +  +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS---EIADMGKLQHPNIVKLIGLCRS 754

Query: 89  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS------YCH-SMQVCHR 141
                ++ EY  G  L E + N       E R   +++  G++      +C  S  V   
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRNLSW----ERR---RKIAIGIAKALRFLHCRCSPAVVVG 807

Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
           +L  E  ++DG   P L++     S   +L +  K  + + AY+APE    K+   K +D
Sbjct: 808 NLSPEKIIIDGKDEPHLRL-----SLPGLLCTDTKCFISS-AYVAPETRETKDITEK-SD 860

Query: 202 VWSCGVTLYVMLVGAYPFEDPE 223
           ++  G+ L  +L G  P  D E
Sbjct: 861 IYGFGLILIELLTGKSP-ADAE 881

Length = 968

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 14/163 (8%)

Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQ 174
           +D  RF  Q +  G+ +  S    HRD+   N LL DG  A   KICDFG ++  +  S 
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267

Query: 175 --PKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
              K     P  ++APE +    Y  + +DVWS G+ L+ +  +G  P+        F K
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326

Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
            + R    Q S PD+    PE   ++   +  +P +R +  +I
Sbjct: 327 MVKR--GYQMSRPDFA--PPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 47/197 (23%), Positives = 89/197 (45%), Gaps = 29/197 (14%)

Query: 47  ELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
           + VA+K ++  DK +    E  + E +    L+HPNIV    V+     L+++  Y S  
Sbjct: 36  QAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93

Query: 103 ELFERIC------NAGRFSEDE--------ARFF--FQQLISGVSYCHSMQVCHRDLKLE 146
           +L E +       + G   +D+        A F     Q+ +G+ +  S  V H+DL   
Sbjct: 94  DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153

Query: 147 NTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
           N L+       +KI D G  +   ++  +    +++    +++PE ++  ++    +D+W
Sbjct: 154 NVLV--FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIW 210

Query: 204 SCGVTLY-VMLVGAYPF 219
           S GV L+ V   G  P+
Sbjct: 211 SYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 61/254 (24%), Positives = 107/254 (42%), Gaps = 39/254 (15%)

Query: 47  ELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
           +LVA+K ++  +   +    Q+E      L HPNIV    V+     + ++ EY + G+L
Sbjct: 35  QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94

Query: 105 FERI----------CNAG-----RFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLEN 147
            E +          C++      + S D   F     Q+ +G+ Y  S    H+DL   N
Sbjct: 95  HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154

Query: 148 TLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
            L+       +KI D G S+    +     QPKS +    ++ PE ++  ++    +D+W
Sbjct: 155 ILI--GEQLHVKISDLGLSREIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIW 210

Query: 204 SCGVTLYVM----LVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
           S GV L+ +    L   Y F + E  +  RK   ++L      P      P    L++  
Sbjct: 211 SFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--RQLLPCSEDCP------PRMYSLMTEC 262

Query: 260 FVADPAKRISIPEI 273
           +   P++R    +I
Sbjct: 263 WQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 16/199 (8%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
           +G G FG   +     T + VA+K ++ G  + E   +E    + LRH  +V    V+ +
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71

Query: 89  PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
              + IV E+   G L  F +  +       +      Q+  G++Y   M   HRDL+  
Sbjct: 72  EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131

Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGKIAD 201
           N L+  +     KI DFG ++   L    + T    A     + APE  L   +  K +D
Sbjct: 132 NILVGDNLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SD 185

Query: 202 VWSCGVTLYVMLV-GAYPF 219
           VWS G+ L  ++  G  P+
Sbjct: 186 VWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 25/170 (14%)

Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ----QL 126
           +R L+HPNI++     +      +V EY   G+L   +        +      Q    ++
Sbjct: 49  YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI 108

Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS----KSSVLHSQPKSTVGTP 182
            +GV++ H     H DL L N  L       +K+ D+G      K   + ++    V   
Sbjct: 109 AAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL- 165

Query: 183 AYIAPEVLLKKEYDG-------KIADVWSCGVTLYVMLVGAYPFEDPEEP 225
            ++APE L+ + + G       K ++VW+ GVTL+ +      FE+  +P
Sbjct: 166 RWLAPE-LVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQP 208

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 38.4 bits (89), Expect = 0.003
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 33/215 (15%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           ++  L+R++G G+FG      AR +   + E  VAVK +     + E +  E +N  S+ 
Sbjct: 6   EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63

Query: 76  HP----NIVRFKEVILTPTHLAIVMEYASGGEL--FERIC------NAGRFSE--DEARF 121
                 ++VR   V+       +VME  + G+L  + R        N GR      E   
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123

Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
              ++  G++Y ++ +  HRDL   N ++       +KI DFG ++    +  + +    
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYYRKGGKG 181

Query: 179 VGTPAYIAPEVLLKKEYDGKI---ADVWSCGVTLY 210
           +    ++APE L     DG     +D+WS GV L+
Sbjct: 182 LLPVRWMAPESL----KDGVFTTSSDMWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 37.4 bits (87), Expect = 0.004
 Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 13/83 (15%)

Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
             +++  HR  K  N LL  DG           G    SV    P+ +   P ++APEV+
Sbjct: 27  LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76

Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
             + Y  K AD++S G+TLY  L
Sbjct: 77  QGQSYTEK-ADIYSLGITLYEAL 98

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	363
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
PRK12274	218	serine/threonine protein kinase; Provisional	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
PRK10345	210	hypothetical protein; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
smart00090	237	RIO RIO-like kinase.	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
KOG1243	690	consensus Protein kinase [General function predict	99.61
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.58
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.57
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.55
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.38
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.38
KOG3087	229	consensus Serine/threonine protein kinase [General	99.34
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.33
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.22
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.21
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.12
COG4248	637	Uncharacterized protein with protein kinase and he	99.1
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.0
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.95
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.93
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.91
PRK09902	216	hypothetical protein; Provisional	98.88
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.71
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.69
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.63
PLN02876	822	acyl-CoA dehydrogenase	98.54
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.52
PF01636	239	APH: Phosphotransferase enzyme family This family	98.51
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.49
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.45
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.45
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.44
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.34
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.32
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.27
PRK10593	297	hypothetical protein; Provisional	98.23
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.08
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.04
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.04
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.95
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.94
PRK05231	319	homoserine kinase; Provisional	97.8
KOG2270	520	consensus Serine/threonine protein kinase involved	97.79
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.78
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.59
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.54
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.46
PLN02236	344	choline kinase	97.39
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.32
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.25
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.24
PRK12396	409	5-methylribose kinase; Reviewed	97.13
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.05
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.96
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.85
PRK11768	325	serine/threonine protein kinase; Provisional	96.82
PTZ00384	383	choline kinase; Provisional	96.76
PLN02756	418	S-methyl-5-thioribose kinase	96.68
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.56
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.51
PTZ00296	442	choline kinase; Provisional	96.35
COG2334	331	Putative homoserine kinase type II (protein kinase	96.24
PRK06148	1013	hypothetical protein; Provisional	96.1
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.86
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.77
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.37

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-63  Score=439.02  Aligned_cols=259  Identities=39%  Similarity=0.634  Sum_probs=228.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--------IDENVQREIINHRSLRHPNIVRFKEVILTPTH   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~   91 (363)
                      .+.|.+.+.||+|+||.|.+|..+.+|+.||||++.+...        ....+.+|+++|++|+|||||+++++|..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            5779999999999999999999999999999999976422        12346799999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC-CCCcEEEeecCCcccCc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSV  170 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~-~~~~vkL~DFgla~~~~  170 (363)
                      .|+||||++||+|.+.+..++.+.+..-+.+++|++.|+.|||++||+||||||+|||+..+ ....+||+|||+|+...
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g  330 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG  330 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence            99999999999999999999999999999999999999999999999999999999999766 23469999999999888


Q ss_pred             cCCCCCccccCCCcCChhhhhcCC--CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--CCCCCC
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYV  246 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~  246 (363)
                      ......+.||||.|.|||++.+..  +++.++|+|||||++|-+++|.+||........+.++   +..+.+  -.+.|.
T Consensus       331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ---I~~G~y~f~p~~w~  407 (475)
T KOG0615|consen  331 EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ---ILKGRYAFGPLQWD  407 (475)
T ss_pred             cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH---HhcCcccccChhhh
Confidence            788889999999999999997655  3344589999999999999999999876654433333   334444  345678


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .+|++..+||.+||..||++|||++|+|+||||+.
T Consensus       408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~  442 (475)
T KOG0615|consen  408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKD  442 (475)
T ss_pred             hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence            89999999999999999999999999999999974

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-61  Score=444.98  Aligned_cols=254  Identities=39%  Similarity=0.647  Sum_probs=234.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeec----CCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..+|...+.||+|||+.+|.+++..+|+.||+|++.+    .....+.+.+||+++++|+|||||+++++|++.+++|+|
T Consensus        17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence            3679999999999999999999999999999999987    566778899999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~  174 (363)
                      .|+|..++|..++++.++++|.+++.+++||+.||.|||++||||||||..|+|++++-+  |||+|||||...... ..
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGER  174 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCcccc
Confidence            999999999999999999999999999999999999999999999999999999987655  999999999876644 66


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ..+.||||.|+|||++.....+-. +||||+||+||.|++|++||..    +.+.+...++....+..|.  .+|.++++
T Consensus       175 k~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y~~P~--~ls~~A~d  247 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEYSMPS--HLSAEAKD  247 (592)
T ss_pred             cceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCccccc--ccCHHHHH
Confidence            778899999999999997777655 9999999999999999999986    5566777788888888887  68999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ||.+||+++|.+|||++++|.|+||+..
T Consensus       248 LI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence            9999999999999999999999999654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-60  Score=416.66  Aligned_cols=259  Identities=30%  Similarity=0.486  Sum_probs=228.1

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeec--CCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-eEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~   98 (363)
                      +.+.+..||+|+.|+||+|+|+.+++.+|+|++..  +....+++.+|+.+++.++||+||++|++|..+. .++++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            67889999999999999999999999999999943  4455678899999999999999999999999998 59999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      |+||+|...+...++++|..+..++.+|++||.|||+ .+||||||||+|||++..+.  |||||||.|+..... ...+
T Consensus       160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~t  236 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IANT  236 (364)
T ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hccc
Confidence            9999999999999999999999999999999999995 99999999999999976655  999999999876555 6678


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHHhccc-cCCCCCCCCCHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILSVQ-YSIPDYVHISPECRHL  255 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~l  255 (363)
                      .+||..|||||.+.+..|+.+ +||||||++++|+++|++||... .........+..+.... ...|.. .+|+++++|
T Consensus       237 fvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~F  314 (364)
T KOG0581|consen  237 FVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSF  314 (364)
T ss_pred             ccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHH
Confidence            899999999999999999888 99999999999999999999875 22234445555565533 344432 589999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccccCCC
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKNLPA  285 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~~~~  285 (363)
                      +..||++||.+|||+.|+++|||+++....
T Consensus       315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  315 VSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             HHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence            999999999999999999999999876443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-59  Score=412.71  Aligned_cols=256  Identities=35%  Similarity=0.603  Sum_probs=224.7

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ...++|++++.||+|+||+|++|+.+.+++.||+|++++..    ...+....|..+|..++||+||+++..|++..++|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            34688999999999999999999999999999999998753    23456789999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-  172 (363)
                      +|+||+.||.|+..+++.+.|++..++.|+..|+.||.|||++|||||||||+|||++..++  ++|+|||+|+..... 
T Consensus       102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccCC
Confidence            99999999999999999999999999999999999999999999999999999999987665  999999999965444 


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ....+.+||+.|||||++.+..|+.. +|+||||+++|+|++|.+||...+....    ..++....... ....+|.++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~----~~~I~~~k~~~-~p~~ls~~a  253 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKM----YDKILKGKLPL-PPGYLSEEA  253 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHH----HHHHhcCcCCC-CCccCCHHH
Confidence            44456699999999999999988765 9999999999999999999998665443    34444444222 222379999


Q ss_pred             HHHHHHhcccCCCCCC----CHHHHhcCccccc
Q 017936          253 RHLISRIFVADPAKRI----SIPEIRNHEWFLK  281 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~----t~~ell~h~~~~~  281 (363)
                      +++|+++|+.+|++|.    ++.++.+||||..
T Consensus       254 rdll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  254 RDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             HHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence            9999999999999996    7899999999964

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-57  Score=419.97  Aligned_cols=257  Identities=52%  Similarity=0.864  Sum_probs=233.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----C--cccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----D--KIDENVQREIINHRSLR-HPNIVRFKEVILTPTH   91 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~--~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~   91 (363)
                      ..++|.+.+.||+|+||+|+++.+..++..||+|++.+.    .  ...+.+.+|+.+++.++ ||||+++++++.+...
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            457899999999999999999999999999999987664    1  24567789999999999 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC-c
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-V  170 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~-~  170 (363)
                      +|+|||||.||+|++++.+.++++|.+++.+++||+.|++|||++||+||||||+|||++.+. +.+||+|||++... .
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPG  173 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999998773 45999999999977 4


Q ss_pred             cCCCCCccccCCCcCChhhhhcCC-CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      ......+.+|||.|+|||++.+.. |.++++||||+|+++|.|++|..||.......    ...++....+.+|.+.. |
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~----l~~ki~~~~~~~p~~~~-S  248 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN----LYRKIRKGEFKIPSYLL-S  248 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----HHHHHhcCCccCCCCcC-C
Confidence            566778899999999999999988 99999999999999999999999999855443    34446777888887655 9


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ++++.||++||..+|.+|+|+.++++||||+.
T Consensus       249 ~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  249 PEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            99999999999999999999999999999987

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-57  Score=404.38  Aligned_cols=259  Identities=37%  Similarity=0.595  Sum_probs=229.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .++|.+.+.||+|+||+||+++++.++..||||.+.+..   +..+.+..|+.+|+.++|||||+++++++..+.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357999999999999999999999999999999997753   34566789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC-CC---CcEEEeecCCcccCccC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSVLH  172 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~-~~---~~vkL~DFgla~~~~~~  172 (363)
                      |||+||+|..++.+.+.+++..++.++.||+.||++||+++||||||||+|||++.. ..   ..+||+|||+|+...+.
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            999999999999999999999999999999999999999999999999999999865 22   46999999999998888


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC-CCCCCCHH
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-DYVHISPE  251 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~  251 (363)
                      ....+.+|+|.|||||++....|+.+ +|+||+|+|+|+|++|+.||...+..+.+.    .+.......| ....++..
T Consensus       169 ~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~----~~~k~~~~~~~~~~~~s~~  243 (429)
T KOG0595|consen  169 SMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL----YIKKGNEIVPVLPAELSNP  243 (429)
T ss_pred             hHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhccccccCchhhhccCc
Confidence            88889999999999999999999998 899999999999999999999877655444    2222222222 22346778


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          252 CRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      +.+++...|+.+|.+|.+..+-+.|+++....
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            88999999999999999999999999987643

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-57  Score=422.80  Aligned_cols=255  Identities=38%  Similarity=0.733  Sum_probs=238.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .-|++.+.||.|+.|.|.+|++..||+..|||++.+.    ......+.+||.+|+.+.|||++++++++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3499999999999999999999999999999999764    233466889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      ||++||.|++++.+.+++++.+++++++||+.|+.|||..+|+||||||+|+|++..++  +||+|||+|..-.+.....
T Consensus        92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLe  169 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLE  169 (786)
T ss_pred             EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCcccc
Confidence            99999999999999999999999999999999999999999999999999999987766  9999999999888888889


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      +.||+|.|.|||++.|.+|++.++||||.|||||.|+||++||++    ++.+..+.++..+.+..|.  .+|+++++||
T Consensus       170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQdLL  243 (786)
T KOG0588|consen  170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQDLL  243 (786)
T ss_pred             ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHHHH
Confidence            999999999999999999999999999999999999999999986    6667788888888888884  6899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCccccccC
Q 017936          257 SRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      ++||..||.+|+|.+||++|||+....
T Consensus       244 r~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  244 RRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HHHhccCccccccHHHHhhCchhhcCC
Confidence            999999999999999999999998753

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.6e-56  Score=409.23  Aligned_cols=257  Identities=34%  Similarity=0.580  Sum_probs=227.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|+++++||+|+||.||+|+.+.||+.||+|+++++.    ...+.++.|-.+|...++|.||+++..|++..++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            5678999999999999999999999999999999998864    345678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc---
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---  171 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~---  171 (363)
                      ||||++||++..++.+.+.|++..++.|+.+++.|++.||+.|+|||||||+|+|||..|+  +||+|||||.....   
T Consensus       219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhh
Confidence            9999999999999999999999999999999999999999999999999999999987665  99999999853111   


Q ss_pred             -------------------C-CC-----C--------------------CccccCCCcCChhhhhcCCCCCcchhhhhHH
Q 017936          172 -------------------H-SQ-----P--------------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCG  206 (363)
Q Consensus       172 -------------------~-~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG  206 (363)
                                         . ..     .                    .+.+|||.|+|||++.+..|.-. +|+||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG  375 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLG  375 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHH
Confidence                               0 00     0                    12469999999999999998655 9999999


Q ss_pred             HHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccc
Q 017936          207 VTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK  281 (363)
Q Consensus       207 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~---t~~ell~h~~~~~  281 (363)
                      ||+||||.|.+||.+.+..+.+++++..  ...+.+|....+++++++||.+||. ||.+|.   .++||.+||||+.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~  450 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG  450 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence            9999999999999998887777766543  3446777777889999999999998 999998   5999999999974

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-56  Score=410.47  Aligned_cols=254  Identities=32%  Similarity=0.563  Sum_probs=223.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc----HHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~   93 (363)
                      ...+|...+.||+|+|++|++|+++.+++.||||++.+.....    .-+.+|-..|..| .||.|++|+-.|+++..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            4678999999999999999999999999999999998754333    3356778888888 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      +|+||+++|+|.+++++.+.|++..++.|+.+|+.||+|||++|||||||||+|||++.++.  +||+|||.|+......
T Consensus       151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQ  228 (604)
T ss_pred             EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhh
Confidence            99999999999999999999999999999999999999999999999999999999987665  9999999998543221


Q ss_pred             C--------------CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc
Q 017936          174 Q--------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ  239 (363)
Q Consensus       174 ~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (363)
                      .              ..+.+||..|++||++..+..... +|+|+||||+|+|+.|.+||.+......    .+++....
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~Neyli----FqkI~~l~  303 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEYLI----FQKIQALD  303 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHHHH----HHHHHHhc
Confidence            1              145689999999999988777555 9999999999999999999998766544    44556666


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       240 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +.+|.  .+++.+++|++++|..||.+|+|+++|.+||||..
T Consensus       304 y~fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  304 YEFPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             ccCCC--CCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            76665  57899999999999999999999999999999954

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-56  Score=381.27  Aligned_cols=253  Identities=34%  Similarity=0.646  Sum_probs=228.7

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..-++|++++.||.|+||.|.+++++.+|..||+|++.+..    +..+...+|..+|+.+.||+++++++.|.+.+.+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            34578999999999999999999999999999999998754    33466788999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      +||||++||.|+.++++.++|++..++.++.||+.||+|||+++|++|||||+|||+|.++.  +||+|||+|+....  
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~--  196 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSG--  196 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecC--
Confidence            99999999999999999999999999999999999999999999999999999999987765  99999999986533  


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      ..-+.||||.|+|||++....+. +++|+||||+++|||+.|.+||...+.    ..+..+++.....+|..  ++++++
T Consensus       197 rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~~--fs~~~k  269 (355)
T KOG0616|consen  197 RTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPSY--FSSDAK  269 (355)
T ss_pred             cEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCcc--cCHHHH
Confidence            35678999999999999988885 559999999999999999999988655    46667788888888875  799999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          254 HLISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       254 ~li~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      +||+++|+.|-.+|.     ...+|.+||||..
T Consensus       270 dLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  270 DLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             HHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence            999999999999994     5789999999963

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.3e-56  Score=382.97  Aligned_cols=258  Identities=26%  Similarity=0.471  Sum_probs=218.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|+.+.++|+|+||+||+|+++.||+.||||.+..++   ...+-..|||++|++++|||+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            57999999999999999999999999999999986543   234567899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc-cCCCC
Q 017936           98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~-~~~~~  175 (363)
                      ||+. ++.+.+.+.+ .+++..++.+++|++.|+.|+|++++|||||||+||||+.++.  +||||||+|+... +...-
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchh
Confidence            9966 5555565544 5999999999999999999999999999999999999987766  9999999999765 33333


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc----------cc-----c
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----------VQ-----Y  240 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~~-----~  240 (363)
                      ...+.|.||+|||.+.+...+++++||||+||++.||++|.+.|.+.++-+++..+...+-.          .+     .
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            45679999999999999665567799999999999999999999998887776655433211          00     1


Q ss_pred             CCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          241 SIPD----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       241 ~~~~----------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ++|.          +..++.-+.+|++.||..||.+|++.++++.||||..
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            2222          2346778999999999999999999999999999943

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-57  Score=376.36  Aligned_cols=257  Identities=36%  Similarity=0.637  Sum_probs=227.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .++|.+.+.||+|.|++|+.+.+..+|+.||+|+++..   ...-+.+.+|+.+-+.|+||||+++++.+......|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            47899999999999999999999999999999998653   234577899999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC-CcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~-~~vkL~DFgla~~~~~~~~~  175 (363)
                      |+++|++|..-+...-.++|..+..+++||++||.|+|.+||||||+||+|+++-.... .-|||+|||+|.........
T Consensus        90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~  169 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW  169 (355)
T ss_pred             ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence            99999999888776667899999999999999999999999999999999999964333 25999999999987755666


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--CCCCCCCCCHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECR  253 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~  253 (363)
                      ....|||.|||||++...+|..+ +|||+.|+++|-|+.|.+||++.+....+.    ++....+  ..|.|..++++++
T Consensus       170 ~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rlye----~I~~g~yd~~~~~w~~is~~Ak  244 (355)
T KOG0033|consen  170 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYE----QIKAGAYDYPSPEWDTVTPEAK  244 (355)
T ss_pred             ccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHHH----HHhccccCCCCcccCcCCHHHH
Confidence            77889999999999998888655 999999999999999999999866544443    3444444  5567899999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +|+++||..||.+|+|+.|+|+|||+.+
T Consensus       245 ~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  245 SLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             HHHHHHhccChhhhccHHHHhCCchhcc
Confidence            9999999999999999999999999976

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-55  Score=398.80  Aligned_cols=261  Identities=31%  Similarity=0.488  Sum_probs=225.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHH--HHHHHHHHHcCC-CCCeeeeeEEEEcCC-eEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREIINHRSLR-HPNIVRFKEVILTPT-HLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~e~~~l~~l~-hpnIv~~~~~~~~~~-~~~lv   95 (363)
                      -+||.++++||.|.||.||+|+.+.+|..||||.+++.-..-++  -.||+..|++++ |||||++.+++.+++ ++|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            47899999999999999999999999999999999875433333  368999999999 999999999999888 99999


Q ss_pred             EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      |||| ..+|+++++.++ .|++..++.|+.||++||+|+|.+|+.|||+||+|||+..+..  |||+|||+|+.......
T Consensus        89 fE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRSKPP  165 (538)
T ss_pred             HHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccccCCC
Confidence            9999 569999998654 5999999999999999999999999999999999999975444  99999999998877777


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh---------------ccc
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL---------------SVQ  239 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------~~~  239 (363)
                      -...+.|.||+|||++....+++.+.||||+|||++|+.+-++.|.+.++.+++.++..-+-               ...
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence            77889999999999998887777779999999999999999999999887776665543221               122


Q ss_pred             cCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          240 YSIPDY---------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       240 ~~~~~~---------~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      +.+|..         ...+.++.++|.+||+.||.+|||++++|+||||+...
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            233322         24689999999999999999999999999999997643

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-55  Score=392.97  Aligned_cols=258  Identities=36%  Similarity=0.624  Sum_probs=223.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---------------cccHHHHHHHHHHHcCCCCCeeeeeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------------KIDENVQREIINHRSLRHPNIVRFKE   84 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------------~~~~~~~~e~~~l~~l~hpnIv~~~~   84 (363)
                      .++|++.+.||+|.||+|.+|++..+++.||||++.+..               ...+.+.+||.+|+++.|||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            578999999999999999999999999999999996531               12357899999999999999999999


Q ss_pred             EEEcC--CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEee
Q 017936           85 VILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD  162 (363)
Q Consensus        85 ~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~D  162 (363)
                      +.-+.  +.+|+|+|||..|.+...-.....+++.+++.|++.++.||+|||.+|||||||||+|+|++.++  +|||+|
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g--~VKIsD  253 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG--TVKISD  253 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC--cEEeec
Confidence            98765  67999999999998865444333499999999999999999999999999999999999998765  499999


Q ss_pred             cCCcccCccC------CCCCccccCCCcCChhhhhc---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 017936          163 FGYSKSSVLH------SQPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH  233 (363)
Q Consensus       163 Fgla~~~~~~------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  233 (363)
                      ||.+..+...      .......|||.|+|||.+.+   ..+.+++.|||||||+||.|+.|+.||.+...    .....
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----~~l~~  329 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----LELFD  329 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----HHHHH
Confidence            9998755222      22344789999999999987   45778889999999999999999999988544    44556


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       234 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      ++....+.+|....+.+.+++||.+||++||++|+++.++..|||.....
T Consensus       330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            67778888898888999999999999999999999999999999998753

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.7e-54  Score=396.75  Aligned_cols=252  Identities=33%  Similarity=0.612  Sum_probs=224.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc---HHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|.+.+.||+|+||.||+++.+.+.+.||+|++.+..+..   +.+.+|+++++.++|||||.++++|++..++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57999999999999999999999999999999998765444   567899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-CC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~~  176 (363)
                      ||.| +|..++...+.++|+.++.++.+++.||.|||+.+|+|||+||.|||+...+.  +|++|||+|+....... ..
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeee
Confidence            9977 99999999999999999999999999999999999999999999999976655  99999999996544332 34


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ...|||.|||||+..+..|+.. +|+||||||+||+++|++||...+    +...+..+...+...|.  ..|.++.+||
T Consensus       159 sikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~s----i~~Lv~~I~~d~v~~p~--~~S~~f~nfl  231 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYARS----ITQLVKSILKDPVKPPS--TASSSFVNFL  231 (808)
T ss_pred             eccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHHH----HHHHHHHHhcCCCCCcc--cccHHHHHHH
Confidence            4569999999999999999877 999999999999999999998743    34455556555555554  6799999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccc
Q 017936          257 SRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ..+|.+||.+|.|+.+++.|||.+..
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhhh
Confidence            99999999999999999999998753

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-53  Score=382.89  Aligned_cols=259  Identities=33%  Similarity=0.493  Sum_probs=214.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC--eEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~   96 (363)
                      ..+|...+.||+|+||.||++.+..+|..+|||.+..... ..+.+.+|+.+|+.++|||||++++......  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            4579999999999999999999999999999998876421 1456899999999999999999999754444  699999


Q ss_pred             eccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC-CCCCcEEEeecCCcccCcc---
Q 017936           97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL---  171 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~-~~~~~vkL~DFgla~~~~~---  171 (363)
                      ||+++|+|.+.+.+.+ ++++..++.+.+||++||+|||++|||||||||+|||++. ++.  +||+|||+++....   
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGT  173 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccc
Confidence            9999999999999887 7999999999999999999999999999999999999987 344  99999999986543   


Q ss_pred             -CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       172 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                       ........|||.|||||++..+....+++|||||||++.||+||..||... .....    +..+.......+.+..+|
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~----~~~ig~~~~~P~ip~~ls  249 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA----LLLIGREDSLPEIPDSLS  249 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH----HHHHhccCCCCCCCcccC
Confidence             222345789999999999986444444699999999999999999999763 22111    112222221113334589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP  284 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~~  284 (363)
                      +++++||.+||..+|++|||++++|.|||.....+
T Consensus       250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999999977543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.8e-53  Score=357.28  Aligned_cols=259  Identities=29%  Similarity=0.466  Sum_probs=221.5

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|...+.||+|.||+||+|++..+|+.||||.+....   .......|||+.|+.++||||+.+.++|.+.+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            58999999999999999999999999999999997653   335678999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      |++ .+|...++... .+++.+++.|+.+++.||+|||++.|+||||||+|+|++.++.  +||+|||+|+.........
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence            995 58988887644 5999999999999999999999999999999999999987765  9999999999765544433


Q ss_pred             -ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-CCC-----------
Q 017936          177 -STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIP-----------  243 (363)
Q Consensus       177 -~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-----------  243 (363)
                       ..+-|.+|+|||.+.|...++..+||||.|||+.||+-|.+-|.+.++-+++..+....-.... ..|           
T Consensus       159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence             3478999999999999877777799999999999999999999998887776655543211100 111           


Q ss_pred             ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          244 ----------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       244 ----------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                .+...+.++.+|+.+||..||.+|+|+.|+++|+||+..
T Consensus       239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence                      122357889999999999999999999999999999863

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-53  Score=353.87  Aligned_cols=253  Identities=36%  Similarity=0.640  Sum_probs=229.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|.+.+.||+|.||.||+++.+.++-.+|+|++.++.    .....+.+|+++.+.|+||||++++++|.+...+|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4678999999999999999999999999999999998764    334678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           95 VMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        95 v~e~~~~~~L~~~~~--~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ++||..+|+|+..+.  ...++++...+.|++|++.||.|+|.+++|||||||+|+|++..+.  +||+|||.+.... .
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~  176 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-S  176 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-C
Confidence            999999999999999  6678999999999999999999999999999999999999987665  9999999997665 6


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ....+.+||..|.+||...+...+.+ +|+|++|++.|+++.|.+||.....    .+..+++......+|  ..+|.++
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~----~etYkrI~k~~~~~p--~~is~~a  249 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSH----SETYKRIRKVDLKFP--STISGGA  249 (281)
T ss_pred             CCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhh----HHHHHHHHHccccCC--cccChhH
Confidence            67788899999999999999988877 9999999999999999999987654    345556666777777  4689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +++|.+||.++|.+|.+..|++.|||+..
T Consensus       250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  250 ADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            99999999999999999999999999865

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-54  Score=366.42  Aligned_cols=243  Identities=32%  Similarity=0.489  Sum_probs=207.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeE-EEEcCC-eEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKE-VILTPT-HLAIV   95 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~-~~~~~~-~~~lv   95 (363)
                      ..|+|.++||+|+||.||+|.+..+|+.+|.|.+.-.   ....+....|+.+|++|+|||||++++ .|..++ .+++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4699999999999999999999999999999988643   344567889999999999999999998 444444 49999


Q ss_pred             EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--cC--ceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936           96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS--MQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~--~g--iiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      ||||.+|+|.+.++.    .+.++|..+|.++.|++.||.++|+  .+  |+||||||.||+++.++.  |||+|||+++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r  176 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGR  176 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHh
Confidence            999999999998864    3459999999999999999999999  45  999999999999987776  9999999998


Q ss_pred             cCccCCC-CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          168 SSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       168 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                      ....... ..+.+|||+||+||.+....|+.+ ||||||||++|||+.-++||.+.    ++.....++....+..-...
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p~~  251 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLPDE  251 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCcHH
Confidence            7654433 345689999999999999999877 99999999999999999999985    45556666666655321224


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCH
Q 017936          247 HISPECRHLISRIFVADPAKRISI  270 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~  270 (363)
                      .+|.++..+|..|+..||+.||+.
T Consensus       252 ~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  252 HYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HhhhHHHHHHHHHccCCcccCCCc
Confidence            579999999999999999999985

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-52  Score=385.64  Aligned_cols=260  Identities=37%  Similarity=0.626  Sum_probs=231.6

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~   93 (363)
                      ....|.+.+.||+|.||.||.|+++.+|+.+|+|++.+...    ..+.+.+|+.+|+.+. |||||.++++|++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            35689999999999999999999999999999999977533    3368999999999998 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC--CcEEEeecCCcccCcc
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVL  171 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~--~~vkL~DFgla~~~~~  171 (363)
                      +|||+|.||.|++.+... .+++..+..+++||+.+++|||+.||+||||||+|+|+.....  +.+|++|||+|.....
T Consensus       113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            999999999999999877 4999999999999999999999999999999999999976543  4799999999998776


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      .......+|||.|+|||++....|... +||||+|+++|.|++|.+||.+.+....+..+...  ...+..+.|..+|..
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--DFDFTSEPWDDISES  268 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--CCCCCCCCccccCHH
Confidence            666778899999999999988888766 99999999999999999999998876655543322  224466778899999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +++||++||..||.+|+|+.++|+|||+...
T Consensus       269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            9999999999999999999999999998764

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-52  Score=393.50  Aligned_cols=254  Identities=34%  Similarity=0.584  Sum_probs=221.7

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~   92 (363)
                      ..-++|.++++||+|+||+|+++..+.+++.||||++++...    ..+....|.+++... +||.++.++..|++++++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            346789999999999999999999999999999999998643    345667788887766 599999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc-c
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-L  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~-~  171 (363)
                      |+||||+.||++ -.++..+.|++..++.|+..|+.||+|||++|||+||||.+|||+|.+|.  +||+|||+++... .
T Consensus       445 ~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  445 FFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCCC
Confidence            999999999994 34455578999999999999999999999999999999999999987665  9999999999765 4


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      .....+.+|||.|||||++.+..|+.. +|+|||||+||+|+.|..||.+.+..+.+..    +.......|.+  +|.+
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~Fds----I~~d~~~yP~~--ls~e  594 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFDS----IVNDEVRYPRF--LSKE  594 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HhcCCCCCCCc--ccHH
Confidence            455677899999999999999999655 9999999999999999999998777655544    44555566654  7999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          252 CRHLISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      +.++++++|.++|++|..     +++|..||||..
T Consensus       595 a~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  595 AIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             HHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence            999999999999999984     688999999964

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-52  Score=387.63  Aligned_cols=257  Identities=29%  Similarity=0.500  Sum_probs=223.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc-cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ...|....+||+|+.|.||.++...+++.||||.+...... .+-+.+|+.+|+..+|+|||.+++.|.-.+.+++||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            45799999999999999999999999999999999875443 46678999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~  177 (363)
                      ++||+|.+.+... .++|.+++.+++.++.||+|||.+||+|||||.+|||++.++.  +||+|||++....... ...+
T Consensus       352 m~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             cCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCcccc
Confidence            9999988877654 4999999999999999999999999999999999999987776  9999999998665544 5667


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      .+|||+|||||+.....|..+ +||||||++++||+-|.+||........+. .+  ...+...+..+..+|+.+++||.
T Consensus       429 mVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAly-LI--a~ng~P~lk~~~klS~~~kdFL~  504 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALY-LI--ATNGTPKLKNPEKLSPELKDFLD  504 (550)
T ss_pred             ccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHHH-HH--hhcCCCCcCCccccCHHHHHHHH
Confidence            789999999999999999877 899999999999999999998644332222 22  22344555566679999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCccccccC
Q 017936          258 RIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      +||+.|+++|+++.|||.||||+...
T Consensus       505 ~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  505 RCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             HHhhcchhcCCCHHHHhcChhhhhcC
Confidence            99999999999999999999996543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-52  Score=377.19  Aligned_cols=259  Identities=29%  Similarity=0.490  Sum_probs=220.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~   93 (363)
                      ..+.|+.+++||+|.||.||+|++..+|+.||+|.+..+.   .......+||.+|++|+||||+++.+.....  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            4578999999999999999999999999999999987543   3345578999999999999999999998876  6899


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +|+|||+ -+|..++... -.|++.+++.+++||+.||+|||++||+|||||.+||||+.++.  +||+|||||+.....
T Consensus       195 lVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  195 LVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPS  271 (560)
T ss_pred             EEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCC
Confidence            9999995 4888877764 36999999999999999999999999999999999999987766  999999999955443


Q ss_pred             C--CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-------ccCCC
Q 017936          173 S--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------QYSIP  243 (363)
Q Consensus       173 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------~~~~~  243 (363)
                      .  .....+-|.||+|||.+.|..-++.++|+||+||||.||++|++.|.+.++.+++..+.+- +..       ...+|
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl-cGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL-CGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH-hCCCChhccccccCC
Confidence            3  3466778999999999999876677799999999999999999999999988777766532 110       11122


Q ss_pred             C-----------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          244 D-----------------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       244 ~-----------------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .                 +..+++.+.+|+..||..||.+|.|+.++|.|+||..
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            1                 2346889999999999999999999999999999954

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-52  Score=364.61  Aligned_cols=262  Identities=31%  Similarity=0.459  Sum_probs=218.6

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeec---CCcccHHHHHHHHHHHcCCCCCeeeeeEEEEc-----CC
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILT-----PT   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-----~~   90 (363)
                      ...+|..++.||+|+||.|+.+.++.+|+.||||.+..   .....++..+|+++|+.++|+||+.+.+++..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            35567778999999999999999999999999998874   33445678899999999999999999999876     25


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+|+|+|++ +.+|.+.++....+++..+..+++||+.||+|+|+.||+||||||.|+|++.+..  +||+|||+|+...
T Consensus       100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLD  176 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeecc
Confidence            699999999 6799998888888999999999999999999999999999999999999987766  9999999999765


Q ss_pred             c---CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHH-------------
Q 017936          171 L---HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------  234 (363)
Q Consensus       171 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------  234 (363)
                      .   .......+.|.+|+|||++....-.+++.||||+|||+.||++|++.|.+.+...++..++.-             
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            4   333456678999999999877665567699999999999999999999887654444333211             


Q ss_pred             ------HhccccCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          235 ------ILSVQYSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       235 ------~~~~~~~~~------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                            ........|      .+...++.+.+|+.+||..||.+|+|++|+|.|||+....
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence                  111111111      1346789999999999999999999999999999998753

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-53  Score=359.74  Aligned_cols=255  Identities=34%  Similarity=0.574  Sum_probs=223.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC------C---cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCC
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------D---KIDENVQREIINHRSL-RHPNIVRFKEVILTPT   90 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~---~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~   90 (363)
                      .+|.-.+.||+|..++|..+.++.+|+.+|+|++...      .   ...+.-.+|+.+|+++ .||+|+++.++|+++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4688899999999999999999999999999998542      1   1124456899999988 5999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+++|+|.|+.|.|++++...-.+++.+.+.+++|+++|++|||.++||||||||+|||++++.+  +||+|||+|+...
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~  174 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence            99999999999999999999989999999999999999999999999999999999999987766  9999999999888


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCC-----CCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc--ccCCC
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIP  243 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~  243 (363)
                      ........||||+|+|||.+..+-+     .++.+|+||+|+|+|.|+.|.+||+.....-    .+..+..+  ++..|
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml----MLR~ImeGkyqF~sp  250 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML----MLRMIMEGKYQFRSP  250 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH----HHHHHHhcccccCCc
Confidence            8888888999999999999865432     2455899999999999999999998643222    22334444  45778


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          244 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .|.++|.+.++||++||+.||.+|.|++|+|.||||.+
T Consensus       251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            89999999999999999999999999999999999965

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-52  Score=371.63  Aligned_cols=252  Identities=38%  Similarity=0.689  Sum_probs=230.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc----HHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      -.+|++.+.||+|.||+|-+|.....|+.||||.++++...+    -.+.+||++|..|+||||+.++++|+..+.+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            357999999999999999999999999999999998764333    3478999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |||..+|.|++++.+.+.+++.+++.+++||+.|+.|+|.++++|||||.+|||+|.+++  +||+|||++..+......
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfL  209 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFL  209 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHH
Confidence            999999999999999999999999999999999999999999999999999999998877  999999999877777777


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      .+.||+|.|.+||+.+|..|.++.+|.||||+++|.|+.|..||++.+-    ...+..+..+.+.-|.   -+.++.-|
T Consensus       210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQIs~GaYrEP~---~PSdA~gL  282 (668)
T KOG0611|consen  210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQISRGAYREPE---TPSDASGL  282 (668)
T ss_pred             HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHHhhcccccCCC---CCchHHHH
Confidence            8999999999999999999999999999999999999999999998554    3455566667776555   37789999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                      |+.||-.+|++|.|++++.+|=|..
T Consensus       283 IRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  283 IRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHHHhcCcccchhHHHHhhhheee
Confidence            9999999999999999999998874

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-51  Score=367.43  Aligned_cols=256  Identities=29%  Similarity=0.498  Sum_probs=223.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..+.|++++.||.|.-|+||+|+...++..+|+|++.+....    ..+++.|-.+|..++||.++.+|..|++++..|+
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            346799999999999999999999999999999999875432    3456779999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-
Q 017936           95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-  171 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-  171 (363)
                      +||||.||+|..++++++  .|++..++.|+..++-||+|||..|||+|||||+||||.++++  |.|+||.|+..... 
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCCC
Confidence            999999999999988754  5999999999999999999999999999999999999987765  99999999742100 


Q ss_pred             --------------------------------C-C-----------------------CCCccccCCCcCChhhhhcCCC
Q 017936          172 --------------------------------H-S-----------------------QPKSTVGTPAYIAPEVLLKKEY  195 (363)
Q Consensus       172 --------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~~~  195 (363)
                                                      . .                       ...+.+||-.|+|||++.|...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                       0012358999999999998887


Q ss_pred             CCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HH
Q 017936          196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS----IP  271 (363)
Q Consensus       196 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t----~~  271 (363)
                      ... +|+|+||+.+|||+.|..||.+.+..+.    +..++.....+|....++..+++||+++|.+||.+|..    ++
T Consensus       313 gsA-VDWWtfGIflYEmLyG~TPFKG~~~~~T----l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~  387 (459)
T KOG0610|consen  313 GSA-VDWWTFGIFLYEMLYGTTPFKGSNNKET----LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA  387 (459)
T ss_pred             Cch-hhHHHHHHHHHHHHhCCCCcCCCCchhh----HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence            655 9999999999999999999999776544    45566777888888889999999999999999999998    99


Q ss_pred             HHhcCccccc
Q 017936          272 EIRNHEWFLK  281 (363)
Q Consensus       272 ell~h~~~~~  281 (363)
                      ||..||||..
T Consensus       388 eIK~HpFF~g  397 (459)
T KOG0610|consen  388 EIKRHPFFEG  397 (459)
T ss_pred             HhhcCccccC
Confidence            9999999964

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.6e-51  Score=354.10  Aligned_cols=262  Identities=30%  Similarity=0.445  Sum_probs=221.9

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--Ce
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--TH   91 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~   91 (363)
                      +-..+.|+.+..|++|+||+||+++++.+++.||+|.++.+..   ..-...+||.+|.+++|||||.+-++....  +.
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            4467889999999999999999999999999999999875431   223457999999999999999999988754  57


Q ss_pred             EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      +|+|||||+ .+|..++...+ +|+..+++.++.|++.||+|||.+.|+||||||+|+|+...+.  +||+|||+|+...
T Consensus       152 iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  152 IYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYG  228 (419)
T ss_pred             eeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhc
Confidence            999999995 58999998766 7999999999999999999999999999999999999976665  9999999999765


Q ss_pred             cCCCC-CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-------cccCC
Q 017936          171 LHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------VQYSI  242 (363)
Q Consensus       171 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~~  242 (363)
                      ..... ...+-|.+|+|||.+.+...++.+.|+||+|||+.||+++.+.|.+.+..+++.++....-.       .-...
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            55433 44568999999999999887777799999999999999999999999888887777643211       10011


Q ss_pred             C--------C---------C--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          243 P--------D---------Y--VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       243 ~--------~---------~--~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      |        .         +  ..+|+...+|+..+|..||.+|.|+++.|+|+||.+
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence            1        1         0  115688999999999999999999999999999987

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.4e-51  Score=376.72  Aligned_cols=251  Identities=32%  Similarity=0.571  Sum_probs=217.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.+..    ...+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            468999999999999999999999999999999987542    2335678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....  ..
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~--~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD--RT  172 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--Cc
Confidence            999999999999998889999999999999999999999999999999999999986654  99999999875432  22


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......    ....+.......|.  .++..+++|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~l  245 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFR----IYEKILAGRLKFPN--WFDGRARDL  245 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCcCCCC--CCCHHHHHH
Confidence            34579999999999988877655 999999999999999999998755432    22333344444443  478999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          256 ISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      |++||+.||.+||+     ++++++||||..
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            99999999999997     799999999975

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-51  Score=370.97  Aligned_cols=250  Identities=34%  Similarity=0.616  Sum_probs=215.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999987532    23456788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      ||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++....  ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--~~kl~Dfg~~~~~~~--~~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRD--RTW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEEecCcchhccC--Ccc
Confidence            9999999999999888999999999999999999999999999999999999997655  499999999875432  223


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|..||.........    ..+......+|  ..++..+++||
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~li  229 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFGIY----EKILAGKLEFP--RHLDLYAKDLI  229 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCcCCC--ccCCHHHHHHH
Confidence            4579999999999988777655 99999999999999999999876543332    22333333333  34689999999


Q ss_pred             HHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          257 SRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       257 ~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      ++||+.||.+||+     +++++.||||..
T Consensus       230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            9999999999995     999999999964

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-50  Score=363.31  Aligned_cols=267  Identities=29%  Similarity=0.446  Sum_probs=221.9

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ...+.|++...||.|..++||+|+...+++.||||++....  ..-..+.+|+..++.++||||++++..|..+..+|+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            34678999999999999999999999999999999997543  2246789999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      |.||.+|++.+.++..-  .++|..|..++++++.||.|||++|.||||||+.||||+.++.  |||+|||.+......+
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSG  180 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccC
Confidence            99999999999998754  3999999999999999999999999999999999999987776  9999999987544333


Q ss_pred             CC-----CccccCCCcCChhhhh--cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc----ccCC
Q 017936          174 QP-----KSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----QYSI  242 (363)
Q Consensus       174 ~~-----~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~  242 (363)
                      ..     .+..|||+|||||++.  ...|+.+ +||||||++..||.+|..||......+.+...++.....    ....
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence            22     4557999999999954  3457767 999999999999999999998765544433332221110    0011


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCcc
Q 017936          243 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL  287 (363)
Q Consensus       243 ~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~~~~~  287 (363)
                      .....++..++.++..||++||.+|||++++|+|+||++....+.
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~  304 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY  304 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence            123346778999999999999999999999999999988765544

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.6e-50  Score=366.90  Aligned_cols=261  Identities=26%  Similarity=0.449  Sum_probs=208.3

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .+.++|++.+.||+|+||+||+|++..+++.||+|++....  .......+|+.+++.++||||+++++++.+...+++|
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             CccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            35688999999999999999999999999999999987543  2234567899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CC
Q 017936           96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS  173 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~  173 (363)
                      |||+. ++|.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... ..
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSH  158 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCc
Confidence            99995 5777777654 56999999999999999999999999999999999999986654  99999999874322 22


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc--------------
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------------  239 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  239 (363)
                      ......+|+.|+|||++.+......++|||||||++|+|++|..||.+..........+.......              
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            234456899999999987655434559999999999999999999987544322211111111000              


Q ss_pred             ----cC--CC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          240 ----YS--IP-------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       240 ----~~--~~-------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                          ..  .+       .....+.++.+||.+||+.+|++|||+.|+++||||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~  293 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD  293 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence                00  00       00124578999999999999999999999999999965

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.2e-50  Score=377.31  Aligned_cols=255  Identities=28%  Similarity=0.486  Sum_probs=213.0

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++++.||+|+||+||+|++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999997532    22346778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  173 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---  173 (363)
                      |||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccc
Confidence            99999999999998889999999999999999999999999999999999999986654  9999999987432110   


Q ss_pred             ---------------------------------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCC
Q 017936          174 ---------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE  220 (363)
Q Consensus       174 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  220 (363)
                                                       .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCC
Confidence                                             0123479999999999988887766 999999999999999999998


Q ss_pred             CCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCC---CCCCHHHHhcCccccc
Q 017936          221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA---KRISIPEIRNHEWFLK  281 (363)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~---~R~t~~ell~h~~~~~  281 (363)
                      ..+.......+..  ......+|....++++++++|.+|+. +|.   .||+++|+++||||..
T Consensus       238 ~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~  298 (363)
T cd05628         238 SETPQETYKKVMN--WKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG  298 (363)
T ss_pred             CCCHHHHHHHHHc--CcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence            7655433332221  11233455555689999999999875 444   4689999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.9e-50  Score=364.61  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=213.5

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.+...    ....+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            38899999999999999999999999999999875421    22356789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |+.+++|...+...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.  ++|+|||++.........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV  158 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence            99999998887543  36899999999999999999999999999999999999976654  999999998764433333


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...............+.....  +....+++++.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~l  235 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSEKFSEDAKSI  235 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc--cCCccCCHHHHHH
Confidence            45679999999999988888766 89999999999999999999876543322222222222222  2334579999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          256 ISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      |++||+.+|.+||+     ++++++||||..
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence            99999999999997     899999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-51  Score=352.73  Aligned_cols=259  Identities=34%  Similarity=0.550  Sum_probs=223.9

Q ss_pred             CCCCcee-eceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEc----CCeE
Q 017936           19 DSDRYEL-VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT----PTHL   92 (363)
Q Consensus        19 ~~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~----~~~~   92 (363)
                      ..++|++ .++||-|-.|+|..|.++.+++.+|+|++..+    ...++|+.+.... .|||||+++++|+.    ..++
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4678988 58899999999999999999999999998665    4456788777655 69999999999875    3678


Q ss_pred             EEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecCCcccC
Q 017936           93 AIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS  169 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~~~  169 (363)
                      .+|||.++||.|++.++..+.  |+|.++..|++||..|+.|||+.+|.||||||+|+|+..+. +..+||+|||+|+..
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence            999999999999999998775  99999999999999999999999999999999999996543 346999999999988


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC--CCCCC
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVH  247 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  247 (363)
                      .......+.+-||+|.|||++...+|+-. +|+||+||++|-|++|.+||........-.....++..+++.+  |+|.+
T Consensus       215 ~~~~~L~TPc~TPyYvaPevlg~eKydks-cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~  293 (400)
T KOG0604|consen  215 QEPGDLMTPCFTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC  293 (400)
T ss_pred             CCCccccCCcccccccCHHHhCchhcCCC-CCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence            77788889999999999999988887644 9999999999999999999987554332223334555666655  46889


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +|++++++|+++|..+|.+|.|++++++|||+...
T Consensus       294 VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  294 VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             HHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            99999999999999999999999999999999764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.5e-50  Score=373.00  Aligned_cols=246  Identities=37%  Similarity=0.612  Sum_probs=210.1

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  102 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~  102 (363)
                      +.||+|+||.||+|++..+|+.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+|+||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999987632    22345678999999999999999999999999999999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCccccC
Q 017936          103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT  181 (363)
Q Consensus       103 ~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~gt  181 (363)
                      +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... ........||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence            99999998889999999999999999999999999999999999999986654  99999999875322 2223445799


Q ss_pred             CCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcc
Q 017936          182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV  261 (363)
Q Consensus       182 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  261 (363)
                      +.|+|||++.+..++.+ +|||||||++|+|++|..||...+.....    ..+......+|  ..+++++.+||++||+
T Consensus       159 ~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~~~p--~~~~~~~~~li~~~L~  231 (323)
T cd05571         159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFP--RTLSPEAKSLLAGLLK  231 (323)
T ss_pred             ccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHHHcc
Confidence            99999999988877666 99999999999999999999875543222    22333333333  4579999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCccccc
Q 017936          262 ADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       262 ~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      .||++||     ++.++++||||..
T Consensus       232 ~dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            9999999     8999999999965

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.2e-50  Score=363.35  Aligned_cols=258  Identities=28%  Similarity=0.460  Sum_probs=210.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .-++|++.+.||.|+||+||++++..+++.||+|++....  .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            4578999999999999999999999999999999986532  23456789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-C
Q 017936           97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~  174 (363)
                      ||+.+ +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...... .
T Consensus        83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKT  159 (288)
T ss_pred             eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcc
Confidence            99975 8988887654 4899999999999999999999999999999999999986654  9999999987543222 2


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc---------------c
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------Q  239 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~  239 (363)
                      .....+++.|+|||++.+....+.++|||||||++|+|++|..||...+..+............               .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            2345689999999998765433445999999999999999999998766544433322211000               0


Q ss_pred             cCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          240 YSIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       240 ~~~~~---------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ...|.         ...+++++.+||++||+.+|.+|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            00111         12468899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-50  Score=378.23  Aligned_cols=255  Identities=33%  Similarity=0.593  Sum_probs=215.0

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++++.||+|+||+||+|++..+++.||||++.+..    .....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999997532    23345778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  173 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---  173 (363)
                      |||.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  ++|+|||+++......   
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence            99999999999988888999999999999999999999999999999999999987665  9999999986432110   


Q ss_pred             ------------------------------------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCC
Q 017936          174 ------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY  217 (363)
Q Consensus       174 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  217 (363)
                                                          .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~  237 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCC
Confidence                                                0112469999999999988887666 999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccc
Q 017936          218 PFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS---IPEIRNHEWFLK  281 (363)
Q Consensus       218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t---~~ell~h~~~~~  281 (363)
                      ||...+..........  .......|....+++++.+||++||. +|.+|++   +++++.||||..
T Consensus       238 Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~  301 (364)
T cd05599         238 PFCSDNPQETYRKIIN--WKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG  301 (364)
T ss_pred             CCCCCCHHHHHHHHHc--CCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            9987654333322221  11223344445679999999999996 9999998   999999999965

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-50  Score=371.31  Aligned_cols=254  Identities=31%  Similarity=0.507  Sum_probs=216.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999987542    22355778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      ||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....  ...
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence            99999999999998888999999999999999999999999999999999999976654  99999999875433  334


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCC----CCCCHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY----VHISPEC  252 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~  252 (363)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+...........  ......|..    ..+++++
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW--KETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             CcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc--cccccCCCCCccccccCHHH
Confidence            5679999999999988877666 99999999999999999999876553333222211  111112222    2568999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .+||.+||+.+|.+||+++++++||||..
T Consensus       234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         234 WDLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             HHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence            99999999999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.5e-50  Score=352.10  Aligned_cols=259  Identities=31%  Similarity=0.453  Sum_probs=217.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCC-eeeeeEEEEcCC------
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPN-IVRFKEVILTPT------   90 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpn-Iv~~~~~~~~~~------   90 (363)
                      ..|..+++||+|+||+||+|+++.+|+.||+|.+.....   ......+|+.+++.++|+| ||++++++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            458889999999999999999999999999999976533   5567789999999999999 999999999877      


Q ss_pred             eEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCc
Q 017936           91 HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  166 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla  166 (363)
                      .+++|+||+ ..+|..++...+    .++...++.+++||+.||+|||++||+||||||+||||+.++.  +||+|||+|
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlA  167 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGLA  167 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--EeeeccchH
Confidence            899999999 569999998765    4888999999999999999999999999999999999987554  999999999


Q ss_pred             ccCc-cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc------
Q 017936          167 KSSV-LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------  239 (363)
Q Consensus       167 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  239 (363)
                      +... +.....+.++|.+|+|||++.+....+...||||+|||++||++++..|.+.++.++...+....-...      
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            9665 333356678999999999999985555559999999999999999999999888666655543321110      


Q ss_pred             ------c--CCCCC----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          240 ------Y--SIPDY----------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       240 ------~--~~~~~----------~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                            +  .++.+          ...+++..+++.+||+.+|.+|.|++.++.||||...
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence                  0  11111          1234589999999999999999999999999999764

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.8e-49  Score=360.97  Aligned_cols=256  Identities=28%  Similarity=0.438  Sum_probs=209.5

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++.+.||+|+||+||+++++.+++.||+|++....   ...+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999999999999999987542   234567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--CC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--~~  175 (363)
                      |+.++.+..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.  +||+|||++.......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence            9998877666555567999999999999999999999999999999999999986654  9999999987543222  22


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc----------c-----cc
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----------V-----QY  240 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~-----~~  240 (363)
                      ....|++.|+|||++.+..++.+ +|||||||++|+|++|++||...+..+...........          .     ..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            34568999999999988877655 99999999999999999999876543332221110000          0     00


Q ss_pred             CCCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          241 SIPD-----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       241 ~~~~-----------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ..+.           ...+|.++.+||++||+.+|++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            0111           11368889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-50  Score=376.74  Aligned_cols=255  Identities=31%  Similarity=0.528  Sum_probs=212.7

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|.+++.||+|+||+||++++..+++.||||++.+..    .....+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999986532    22345778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  173 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---  173 (363)
                      ||++|++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+|+......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999976654  9999999986321100   


Q ss_pred             ---------------------------------------------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHH
Q 017936          174 ---------------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT  208 (363)
Q Consensus       174 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  208 (363)
                                                                   .....+||+.|+|||++.+..++.+ +|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvi  237 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAI  237 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchh
Confidence                                                         0012469999999999988887665 999999999


Q ss_pred             HHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCccccc
Q 017936          209 LYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR---ISIPEIRNHEWFLK  281 (363)
Q Consensus       209 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R---~t~~ell~h~~~~~  281 (363)
                      +|+|++|..||........+..+...  ......|....++.++.+||.+||. +|.+|   +|+.+++.||||..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            99999999999876553333322211  1233445555689999999999997 66665   59999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.7e-49  Score=375.50  Aligned_cols=255  Identities=31%  Similarity=0.496  Sum_probs=212.8

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .|++++.||+|+||+||+|++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5999999999999999999999999999999997643    223467889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-----
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----  172 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-----  172 (363)
                      ||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++.....     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~--~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC--CEEEeeCcCCccccccccccc
Confidence            999999999999888899999999999999999999999999999999999997655  4999999997532100     


Q ss_pred             -------------------------------------------CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHH
Q 017936          173 -------------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL  209 (363)
Q Consensus       173 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  209 (363)
                                                                 ....+.+||+.|+|||++.+..++.+ +|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il  238 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVIL  238 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhHH
Confidence                                                       00123469999999999988877665 9999999999


Q ss_pred             HHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHhcCccccc
Q 017936          210 YVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV--ADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       210 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~--~~p~~R~t~~ell~h~~~~~  281 (363)
                      |+|++|..||...+.......+..  .......|....+++++.+||.+|+.  .+|..|++++++++||||..
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE  310 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence            999999999987654333322221  12234455556689999999999664  45556999999999999965

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-50  Score=374.32  Aligned_cols=255  Identities=35%  Similarity=0.588  Sum_probs=218.3

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|.+.+.||+|+||+||+|++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999987532    23456788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  173 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---  173 (363)
                      ||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.......   
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence            99999999999998888999999999999999999999999999999999999987655  9999999987543322   


Q ss_pred             ---------------------------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH
Q 017936          174 ---------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK  226 (363)
Q Consensus       174 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  226 (363)
                                                 ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                       2234569999999999988877666 999999999999999999998766433


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCccccc
Q 017936          227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-IPEIRNHEWFLK  281 (363)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t-~~ell~h~~~~~  281 (363)
                      ....+..  .......|....+++++.+||.+||. +|.+||+ ++++++||||..
T Consensus       238 ~~~~i~~--~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         238 TYNKIIN--WKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHHHHhc--cCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            3322221  11334455555579999999999997 9999999 999999999964

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-49  Score=369.40  Aligned_cols=252  Identities=31%  Similarity=0.533  Sum_probs=215.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCC-cEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|.+.+.||+|+||.||+|.+..++ ..||+|++.+..    ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            4578999999999999999999876554 689999986532    23356778999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      +||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....  
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~~--  183 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVDT--  183 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecCC--
Confidence            99999999999999998889999999999999999999999999999999999999976554  99999999875432  


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+.......|  ..+++.+.
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~  256 (340)
T PTZ00426        184 RTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLI----YQKILEGIIYFP--KFLDNNCK  256 (340)
T ss_pred             CcceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHH
Confidence            2345679999999999988777655 9999999999999999999987654332    233333333333  34789999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          254 HLISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       254 ~li~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      ++|++||+.+|.+|+     |++++++||||..
T Consensus       257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            999999999999995     8999999999964

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-49  Score=376.64  Aligned_cols=254  Identities=33%  Similarity=0.537  Sum_probs=213.9

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      +|++++.||+|+||+||+|++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            6999999999999999999999999999999987642    223567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-----
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----  172 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-----  172 (363)
                      ||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCccccccccccc
Confidence            9999999999988888999999999999999999999999999999999999986654  999999997532100     


Q ss_pred             -------------------------------------------CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHH
Q 017936          173 -------------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL  209 (363)
Q Consensus       173 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  209 (363)
                                                                 ....+.+||+.|+|||++.+..++.+ +|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvil  238 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVIL  238 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHHH
Confidence                                                       00123469999999999988888766 9999999999


Q ss_pred             HHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccc
Q 017936          210 YVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS---IPEIRNHEWFLK  281 (363)
Q Consensus       210 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t---~~ell~h~~~~~  281 (363)
                      |+|++|..||...+.......+..  .......|....+++++.++|.+|+ .+|.+|++   ++++++||||..
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  310 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT  310 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence            999999999987654333322221  1223345555678999999999986 59999997   999999999965

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-49  Score=365.72  Aligned_cols=244  Identities=33%  Similarity=0.587  Sum_probs=208.5

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCch
Q 017936           29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        29 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      ||+|+||.||++++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999999999999999987532    2234567899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCccccCCC
Q 017936          105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA  183 (363)
Q Consensus       105 ~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~~~gt~~  183 (363)
                      .+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... .......||+.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence            999998888999999999999999999999999999999999999976654  999999998753222 22334579999


Q ss_pred             cCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccC
Q 017936          184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD  263 (363)
Q Consensus       184 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~  263 (363)
                      |+|||++.+..++.+ +|||||||++|+|++|..||.........    ..+......+|  ..+++++.+||.+||+.+
T Consensus       159 y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li~~~L~~d  231 (312)
T cd05585         159 YLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNEMY----RKILQEPLRFP--DGFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             cCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHHHH----HHHHcCCCCCC--CcCCHHHHHHHHHHcCCC
Confidence            999999988877666 89999999999999999999875543332    33333333333  457999999999999999


Q ss_pred             CCCCC---CHHHHhcCccccc
Q 017936          264 PAKRI---SIPEIRNHEWFLK  281 (363)
Q Consensus       264 p~~R~---t~~ell~h~~~~~  281 (363)
                      |.+||   ++.++++||||.+
T Consensus       232 p~~R~~~~~~~e~l~hp~~~~  252 (312)
T cd05585         232 PTRRLGYNGAQEIKNHPFFSQ  252 (312)
T ss_pred             HHHcCCCCCHHHHHcCCCcCC
Confidence            99997   5799999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-49  Score=375.65  Aligned_cols=255  Identities=33%  Similarity=0.526  Sum_probs=214.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .+|++++.||+|+||.||+|++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36999999999999999999999999999999986532    23456788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC----
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----  172 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~----  172 (363)
                      |||++++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|......    
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence            99999999999998888999999999999999999999999999999999999986654  999999997522100    


Q ss_pred             ----------------------------------------CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHH
Q 017936          173 ----------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM  212 (363)
Q Consensus       173 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  212 (363)
                                                              ......+||+.|+|||++.+..++.+ +|||||||++|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyel  237 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEM  237 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeeh
Confidence                                                    00113469999999999988887666 9999999999999


Q ss_pred             HhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccc
Q 017936          213 LVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK  281 (363)
Q Consensus       213 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~---t~~ell~h~~~~~  281 (363)
                      ++|..||..............  .......+....+++++.++|.+|+ .+|.+|+   |+.++++||||..
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            999999987665433222211  1123344555568999999999987 5999999   9999999999965

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3e-49  Score=379.63  Aligned_cols=258  Identities=27%  Similarity=0.403  Sum_probs=207.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--------Ce
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--------TH   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--------~~   91 (363)
                      ..+|++.+.||+|+||+||+|.+..+++.||||.+....   ....+|+.+++.++||||++++++|...        ..
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            467999999999999999999999999999999886542   2345799999999999999999987542        24


Q ss_pred             EEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936           92 LAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      +++||||+++ +|..++.    ....+++..++.++.||+.||+|||++||+||||||+|||++.++ +.+||+|||+|+
T Consensus       142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla~  219 (440)
T PTZ00036        142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSAK  219 (440)
T ss_pred             EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-Cceeeeccccch
Confidence            7799999975 6766654    345699999999999999999999999999999999999997543 249999999998


Q ss_pred             cCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc---------
Q 017936          168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------  238 (363)
Q Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------  238 (363)
                      ............||+.|+|||++.+....+.++|||||||++|+|++|.+||.+....+.+..++......         
T Consensus       220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~  299 (440)
T PTZ00036        220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN  299 (440)
T ss_pred             hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence            65544444566789999999998765433444999999999999999999998876655544443321100         


Q ss_pred             ----ccCCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          239 ----QYSIPD----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       239 ----~~~~~~----------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                          ...+|.          +...|+++.+||.+||+.+|.+|||+.|+++||||...
T Consensus       300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence                001111          12367899999999999999999999999999999754

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-50  Score=364.48  Aligned_cols=255  Identities=37%  Similarity=0.689  Sum_probs=231.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ..=|.+-+.||+|.|++|.+|++.-+|..||||++.+..   .....+.+|++.|+.++|||||++|++..+...+|+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            456999999999999999999999999999999998743   34567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |+=++|+|++++.+.. .++|..+++|+.||+.|+.|+|+..+|||||||+|+.+-+ ..|-|||+|||++..+.+....
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE-KlGlVKLTDFGFSNkf~PG~kL  175 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE-KLGLVKLTDFGFSNKFQPGKKL  175 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee-ecCceEeeeccccccCCCcchh
Confidence            9999999999997754 5999999999999999999999999999999999998864 3456999999999999888899


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      .+.+|+..|-|||++.|..|+.+++||||||||+|.|++|++||....+.+.    +..+....+..|.  .+|.+|++|
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----LTmImDCKYtvPs--hvS~eCrdL  249 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----LTMIMDCKYTVPS--HVSKECRDL  249 (864)
T ss_pred             hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----hhhhhcccccCch--hhhHHHHHH
Confidence            9999999999999999999999999999999999999999999988766543    4445566666665  579999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      |.+||..||++|.+.++|.+|+|++.
T Consensus       250 I~sMLvRdPkkRAslEeI~s~~Wlq~  275 (864)
T KOG4717|consen  250 IQSMLVRDPKKRASLEEIVSTSWLQA  275 (864)
T ss_pred             HHHHHhcCchhhccHHHHhccccccC
Confidence            99999999999999999999999975

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.9e-49  Score=363.51  Aligned_cols=258  Identities=26%  Similarity=0.467  Sum_probs=214.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .++|++++.||+|+||.||++++..++..+|+|++....  ...+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            478999999999999999999999999999999987542  234568899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~-giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      |+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.  +||+|||++..... ....
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~  160 (331)
T cd06649          84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMAN  160 (331)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-cccc
Confidence            999999999998888899999999999999999999986 6999999999999986655  99999999875432 2234


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHH-----------------------
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-----------------------  233 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-----------------------  233 (363)
                      ...|++.|+|||++.+..++.+ +|||||||++|+|++|+.||......+ ....+.                       
T Consensus       161 ~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         161 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCcccccccc
Confidence            4579999999999988877665 999999999999999999997544321 111110                       


Q ss_pred             --------------------HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          234 --------------------RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       234 --------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                          .+............+++++.+||.+||+.+|++|||+.++++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                0101100001112468899999999999999999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.7e-49  Score=365.88  Aligned_cols=246  Identities=35%  Similarity=0.595  Sum_probs=209.3

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  102 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~  102 (363)
                      +.||+|+||.||++++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997642    22345678999999999999999999999999999999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCccccC
Q 017936          103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT  181 (363)
Q Consensus       103 ~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~gt  181 (363)
                      +|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... ........||
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence            99999988888999999999999999999999999999999999999986654  99999999875322 2223345799


Q ss_pred             CCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcc
Q 017936          182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV  261 (363)
Q Consensus       182 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  261 (363)
                      +.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+......+|  ..+++++.+||++||+
T Consensus       159 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~~----~~~~~~~~~~~p--~~~~~~~~~li~~~L~  231 (328)
T cd05593         159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEDIKFP--RTLSADAKSLLSGLLI  231 (328)
T ss_pred             cCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHHH----HHHhccCCccCC--CCCCHHHHHHHHHHcC
Confidence            99999999988777655 9999999999999999999987554322    222333333333  4579999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCccccc
Q 017936          262 ADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       262 ~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      .+|.+|+     ++.++++||||..
T Consensus       232 ~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            9999997     8999999999964

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.9e-49  Score=365.22  Aligned_cols=256  Identities=32%  Similarity=0.555  Sum_probs=211.6

Q ss_pred             CceeeceecccCCeEEEEEEEc---CCCcEEEEEEeecCC-----cccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeE
Q 017936           22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHL   92 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~-----~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~   92 (363)
                      +|++++.||+|+||+||++++.   .+++.||+|++.+..     ...+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4899999999999999999874   578999999987532     22345678999999994 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ++||||+.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~  158 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence            999999999999999988888999999999999999999999999999999999999986654  999999998754322


Q ss_pred             C--CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          173 S--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       173 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                      .  ......||+.|+|||++.+....+.++|||||||++|+|++|..||...............+......  ....+++
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  236 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP--FPSFIGP  236 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCH
Confidence            2  22345699999999999876544455999999999999999999997544322222333333333332  2345799


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          251 ECRHLISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      .+.++|.+||+.+|++||     +++++++||||..
T Consensus       237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            999999999999999999     8889999999975

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-51  Score=368.73  Aligned_cols=255  Identities=29%  Similarity=0.446  Sum_probs=220.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ...|+.++.||+|+||.||++.+..+++.||+|++....  ...+.+++|+.++.+++++||.++|+.|.....++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            456999999999999999999999999999999997653  345789999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-CC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~~  176 (363)
                      ||.||++.+.+...+.+.+.++..++++++.||.|||..+.+|||||+.|||+..++.  |||+|||++........ ..
T Consensus        92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~rr~  169 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKRRK  169 (467)
T ss_pred             HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhccc
Confidence            9999999999999888899999999999999999999999999999999999987754  99999999976544333 37


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      +.+|||.|||||++.+..|+.+ +||||||++.|||++|.+|+.......    .+.-+.+..+.. ....+|+.+++|+
T Consensus       170 tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmr----vlflIpk~~PP~-L~~~~S~~~kEFV  243 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMR----VLFLIPKSAPPR-LDGDFSPPFKEFV  243 (467)
T ss_pred             cccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcce----EEEeccCCCCCc-cccccCHHHHHHH
Confidence            7899999999999998899988 899999999999999999997654421    111111111111 1126799999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccc
Q 017936          257 SRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ..||.++|+.||++.+||+|+|++..
T Consensus       244 ~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  244 EACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             HHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            99999999999999999999999764

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.4e-49  Score=365.41  Aligned_cols=246  Identities=35%  Similarity=0.613  Sum_probs=209.3

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  102 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~  102 (363)
                      +.||+|+||.||++++..+|+.||+|++.+..    .....+.+|+.+++.++||||++++++|...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999987632    22345668999999999999999999999999999999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCccccC
Q 017936          103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT  181 (363)
Q Consensus       103 ~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~~~gt  181 (363)
                      +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... .......||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence            99999988888999999999999999999999999999999999999986654  999999998753222 222345699


Q ss_pred             CCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcc
Q 017936          182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV  261 (363)
Q Consensus       182 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  261 (363)
                      +.|+|||++.+..++.+ +|||||||++|+|++|..||...+......    .+......+|  ..+++++.+||.+||+
T Consensus       159 ~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----~~~~~~~~~p--~~~~~~~~~li~~~L~  231 (323)
T cd05595         159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFP--RTLSPEAKSLLAGLLK  231 (323)
T ss_pred             cCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCCCCC--CCCCHHHHHHHHHHcc
Confidence            99999999988877655 999999999999999999998755433222    2222333333  3579999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCccccc
Q 017936          262 ADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       262 ~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      .+|.+|+     ++.++++||||..
T Consensus       232 ~dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHcCCCcCC
Confidence            9999998     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.3e-49  Score=369.69  Aligned_cols=258  Identities=31%  Similarity=0.497  Sum_probs=213.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++.+.||+|+||.||++++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+++.+|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3578999999999999999999999999999999986522    223457789999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      |||||+||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|........
T Consensus       121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCc
Confidence            99999999999988654 6899999999999999999999999999999999999986654  99999999975432221


Q ss_pred             --CCccccCCCcCChhhhhcCC---CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          175 --PKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       175 --~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                        ..+..||+.|+|||++.+..   +.+.++|||||||++|+|++|..||...+.......+...  ......|....++
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s  275 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--KNSLNFPEDVEIS  275 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcccCCCCcccCC
Confidence              23557999999999997643   2334599999999999999999999876654433332221  1234455556789


Q ss_pred             HHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 017936          250 PECRHLISRIFVADPAK--RISIPEIRNHEWFLK  281 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~--R~t~~ell~h~~~~~  281 (363)
                      ..++++|.+||+.++.+  |+|++++++||||+.
T Consensus       276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             HHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence            99999999999865543  899999999999965

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-50  Score=368.22  Aligned_cols=254  Identities=32%  Similarity=0.490  Sum_probs=225.9

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe-EEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~   96 (363)
                      ++|.+++++|+|+||.+++++++..++.|++|.+...   ....+...+|+.++++++|||||.+.+.|..++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            6799999999999999999999999999999998753   3445577899999999999999999999999888 99999


Q ss_pred             eccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           97 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      +||+||+|.+.+.+.+  .|+++.+..|+.|++.|+.|||+++|+|||||+.|||++.++.  |||+|||+|+...... 
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPEDS  161 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCchh
Confidence            9999999999997654  5999999999999999999999999999999999999987765  9999999999877665 


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      ...+.+|||.|+.||++.+.+|..+ +|||||||++|||++-+++|...+......++..    .. ..|.+..+|.+++
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~----~~-~~Plp~~ys~el~  235 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINR----GL-YSPLPSMYSSELR  235 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhh----cc-CCCCCccccHHHH
Confidence            6677889999999999999999888 9999999999999999999998766554444433    32 3455567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .+++.||..+|..||++.++|.+|.+...
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            99999999999999999999999988753

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.7e-50  Score=352.47  Aligned_cols=260  Identities=32%  Similarity=0.499  Sum_probs=219.5

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--C---eEEEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--T---HLAIVM   96 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~---~~~lv~   96 (363)
                      .|.-.+.+|.|+||+||.+...++++.||||.+-.+....   -+|+.+|+.++|||||++.-+|...  +   ++.+||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            4888999999999999999999999999999887665433   3789999999999999999988743  2   467999


Q ss_pred             eccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ||++ .+|.+.+..    +..++...++-+..||++||.|||+.||+||||||.|||+|.+ .+.+||||||.|+.....
T Consensus       102 eymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~-tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  102 EYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD-TGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             Hhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC-CCeEEeccCCcceeeccC
Confidence            9995 589888874    5679999999999999999999999999999999999999854 457999999999988888


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH--------hcccc----
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--------LSVQY----  240 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------~~~~~----  240 (363)
                      ....+...|..|+|||.+.|....+.+.||||.||++.||+.|++.|.+.+..+++..+++-+        .....    
T Consensus       180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~  259 (364)
T KOG0658|consen  180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE  259 (364)
T ss_pred             CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence            777888899999999999987766666999999999999999999999988877777665421        11111    


Q ss_pred             -CCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCc
Q 017936          241 -SIP----------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD  286 (363)
Q Consensus       241 -~~~----------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~~~~  286 (363)
                       ..|          .....++++.+|+.++|+.+|.+|.++.|++.||||.+....+
T Consensus       260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence             111          1234689999999999999999999999999999997754443

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.5e-49  Score=367.38  Aligned_cols=255  Identities=28%  Similarity=0.494  Sum_probs=213.7

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|.+.+.||+|+||+||++++..+++.||+|++.+...    ....+.+|+.+++.++||||+++++++...+.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            479999999999999999999999999999999976432    3455778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-
Q 017936           97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-  174 (363)
                      ||+++++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence            999999999999876 67999999999999999999999999999999999999986654  99999999875433222 


Q ss_pred             -CCccccCCCcCChhhhhc------CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          175 -PKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       175 -~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                       .....||+.|+|||++..      ..++.+ +|||||||++|+|++|..||...........+...  ......|....
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~  235 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVE-CDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPK  235 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCc-ceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCC
Confidence             223468999999999863      334444 99999999999999999999876554433322211  11224455556


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +++++.+||++||+ +|.+|||++++++||||..
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            89999999999997 9999999999999999965

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.5e-49  Score=369.40  Aligned_cols=255  Identities=30%  Similarity=0.532  Sum_probs=213.8

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++++.||+|+||+||+|++..+++.||+|++....    .....+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999987532    23356778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  173 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---  173 (363)
                      |||+|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .++|+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~--~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEeeccCCcccccccccc
Confidence            9999999999999888999999999999999999999999999999999999997655  49999999986432110   


Q ss_pred             ---------------------------------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCC
Q 017936          174 ---------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE  220 (363)
Q Consensus       174 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  220 (363)
                                                       .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCC
Confidence                                             0123469999999999988888766 999999999999999999998


Q ss_pred             CCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccc
Q 017936          221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK  281 (363)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~---t~~ell~h~~~~~  281 (363)
                      ..+.......+..  ......+|....+++++++||.+|+ .+|.+|+   +++++++||||..
T Consensus       238 ~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         238 SETPQETYRKVMN--WKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             CCCHHHHHHHHHc--CCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence            7665433332221  1122334544557999999999987 5999998   5899999999965

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.2e-49  Score=369.19  Aligned_cols=258  Identities=31%  Similarity=0.509  Sum_probs=215.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++.+.||+|+||.||++++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+++.+|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4578999999999999999999999999999999987532    223446789999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      ||||++||+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++....... 
T Consensus       121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCc
Confidence            9999999999988865 46899999999999999999999999999999999999986655  9999999987543322 


Q ss_pred             -CCCccccCCCcCChhhhhcCC---CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          174 -QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       174 -~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                       ......||+.|+|||++.+..   ..+.++|||||||++|+|++|..||...........+...  ......|....+|
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s  275 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEIS  275 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCCCC
Confidence             223457999999999987543   2234599999999999999999999876554333332211  1234455555689


Q ss_pred             HHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 017936          250 PECRHLISRIFVADPAK--RISIPEIRNHEWFLK  281 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~--R~t~~ell~h~~~~~  281 (363)
                      .++.+||++||+.+|.+  |+|++++++||||..
T Consensus       276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            99999999999999987  999999999999965

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-48  Score=362.26  Aligned_cols=250  Identities=29%  Similarity=0.500  Sum_probs=207.5

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||.||++++..+++.||+|++.+..    .....+.+|+.+++.+ +||||+++++++.+.+.+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999999999999999997642    2234467888888888 799999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      ++|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence            999999988889999999999999999999999999999999999999986654  99999999875322 223344579


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH-----HHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----NFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      |+.|+|||++.+..++.+ +|+|||||++|+|++|..||.......     ........+.......|  ..++.++.++
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l  235 (329)
T cd05588         159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKASSV  235 (329)
T ss_pred             CccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC--CCCCHHHHHH
Confidence            999999999988877666 999999999999999999996422111     11112223333344444  3578999999


Q ss_pred             HHHhcccCCCCCCC------HHHHhcCccccc
Q 017936          256 ISRIFVADPAKRIS------IPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t------~~ell~h~~~~~  281 (363)
                      |++||+.+|.+|+|      ++++++||||..
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            99999999999997      789999999954

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-48  Score=361.27  Aligned_cols=246  Identities=33%  Similarity=0.529  Sum_probs=207.5

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||+||+|+++.+++.||+|++.+..    ...+.+..|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999987532    2234556777777765 699999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      ++|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence            999999988889999999999999999999999999999999999999986655  99999999875322 222344569


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+.......|  ..++.++.+||++||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~li~~~L  231 (320)
T cd05590         159 TPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEVVYP--TWLSQDAVDILKAFM  231 (320)
T ss_pred             CccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHHHHHHHHc
Confidence            999999999988777665 8999999999999999999987654332    233333333333  347999999999999


Q ss_pred             ccCCCCCCCH------HHHhcCccccc
Q 017936          261 VADPAKRISI------PEIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~t~------~ell~h~~~~~  281 (363)
                      +.+|.+||++      +++++||||..
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence            9999999998      99999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.1e-48  Score=360.34  Aligned_cols=251  Identities=32%  Similarity=0.561  Sum_probs=212.0

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCC-CeeeeeEEEEcCCeEEEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~   96 (363)
                      +|++++.||+|+||.||+|++..+++.||+|++.+..    ...+.+..|+.+++.++|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4899999999999999999999999999999987532    2334567888889888765 5888999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~  175 (363)
                      ||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence            99999999999988888999999999999999999999999999999999999986654  99999999874322 2223


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.........    ..+.......|  ..+++++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~l  231 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYP--KSLSKEAVSI  231 (324)
T ss_pred             eeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHH
Confidence            34569999999999988877665 89999999999999999999876543333    23333333333  3579999999


Q ss_pred             HHHhcccCCCCCCCH-----HHHhcCccccc
Q 017936          256 ISRIFVADPAKRISI-----PEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t~-----~ell~h~~~~~  281 (363)
                      |++||..+|.+|++.     +++++||||..
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            999999999999986     89999999965

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-48  Score=362.61  Aligned_cols=257  Identities=29%  Similarity=0.449  Sum_probs=205.4

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC-----CeEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA   93 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~~~~   93 (363)
                      +|++.+.||+|+||.||++++..+++.||||.+....   .....+.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            6999999999999999999999999999999886432   2234578899999999999999999988643     3589


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      +|||||. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence            9999994 689999988888999999999999999999999999999999999999976654  9999999987532221


Q ss_pred             C----CCccccCCCcCChhhhhc--CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHH---------------
Q 017936          174 Q----PKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---------------  232 (363)
Q Consensus       174 ~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---------------  232 (363)
                      .    .....||+.|+|||++.+  ..++.+ +|||||||++|+|++|+.||.+...........               
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCch-hHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            1    134569999999999865  445444 999999999999999999997655322211110               


Q ss_pred             --------HHHhcccc-C-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          233 --------HRILSVQY-S-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       233 --------~~~~~~~~-~-~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                              ........ . ......+++++.++|.+||+.+|.+|||++++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence                    00000000 0 01123468889999999999999999999999999999753

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-48  Score=367.76  Aligned_cols=253  Identities=21%  Similarity=0.311  Sum_probs=205.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      ..+|++++.||+|+||.||+|.+..+++.||+|....     ..+.+|+.+++.++||||++++++|......++|+|++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            3679999999999999999999999999999996432     45678999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC--CCCCc
Q 017936          100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKS  177 (363)
Q Consensus       100 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~--~~~~~  177 (363)
                      . ++|..++.....+++.+++.++.||+.||.|||++|||||||||+|||++.++.  +||+|||+|+.....  .....
T Consensus       166 ~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        166 K-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCccccccccccccccc
Confidence            4 689888888888999999999999999999999999999999999999976654  999999998643221  12234


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCc-------hHHHHHHHHH----------------
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHR----------------  234 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~----------------  234 (363)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++|..||.....       ...+..++..                
T Consensus       243 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~  321 (391)
T PHA03212        243 WAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL  321 (391)
T ss_pred             ccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence            579999999999988777655 9999999999999999988754321       0111111110                


Q ss_pred             ------HhccccC----CCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          235 ------ILSVQYS----IPDY---VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       235 ------~~~~~~~----~~~~---~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                            .......    .+.+   ..++.++.+||.+||+.||.+|||++|+|+||||..
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~  381 (391)
T PHA03212        322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD  381 (391)
T ss_pred             HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence                  0000000    1111   135678999999999999999999999999999965

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.6e-49  Score=363.03  Aligned_cols=246  Identities=37%  Similarity=0.606  Sum_probs=208.5

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  102 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~  102 (363)
                      +.||+|+||.||++++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999987632    22345678899999999999999999999999999999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       103 ~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      +|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence            999999888889999999999999999999997 89999999999999986654  99999999875322 222334569


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||.........    ..+......+|  ..+++++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~li~~~L  231 (325)
T cd05594         159 TPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFP--RTLSPEAKSLLSGLL  231 (325)
T ss_pred             CcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHHHH----HHHhcCCCCCC--CCCCHHHHHHHHHHh
Confidence            999999999988877665 99999999999999999999875543222    22223333333  357999999999999


Q ss_pred             ccCCCCCC-----CHHHHhcCccccc
Q 017936          261 VADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      +.+|++|+     ++.++++||||..
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence            99999997     9999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.5e-49  Score=369.01  Aligned_cols=258  Identities=30%  Similarity=0.422  Sum_probs=219.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-C-----CCeeeeeEEEEcCCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-H-----PNIVRFKEVILTPTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-h-----pnIv~~~~~~~~~~~~~   93 (363)
                      ..+|.|.+.||+|+||.|-+|.+..|++.||||++++..........|+.+|..|+ |     -|+|+++++|...+|+|
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            44899999999999999999999999999999999988777778889999999887 3     48999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ||+|.+ +.+|+++++.+.  .|+...++.++.||+.||.+||+.||||+||||+||||...+...||++|||.|+....
T Consensus       265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            999999 679999998765  58999999999999999999999999999999999999887777899999999986543


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH----------------
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI----------------  235 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------------  235 (363)
                      ..  .+.+-+..|+|||++.|.+|+.+ .||||||||++||++|.+.|.+.+..+++..++.-+                
T Consensus       344 ~v--ytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k  420 (586)
T KOG0667|consen  344 RV--YTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK  420 (586)
T ss_pred             cc--eeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence            33  37788999999999999999888 899999999999999999999877766655444210                


Q ss_pred             -h-------------------------------ccccCCC-CCC--------CCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017936          236 -L-------------------------------SVQYSIP-DYV--------HISPECRHLISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       236 -~-------------------------------~~~~~~~-~~~--------~~s~~~~~li~~~L~~~p~~R~t~~ell  274 (363)
                       .                               ......| ...        .-...+.+||++||..||.+|+|+.++|
T Consensus       421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal  500 (586)
T KOG0667|consen  421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL  500 (586)
T ss_pred             ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence             0                               0000111 000        1124589999999999999999999999


Q ss_pred             cCccccc
Q 017936          275 NHEWFLK  281 (363)
Q Consensus       275 ~h~~~~~  281 (363)
                      +||||..
T Consensus       501 ~Hpfl~~  507 (586)
T KOG0667|consen  501 NHPFLTG  507 (586)
T ss_pred             cCccccc
Confidence            9999974

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-47  Score=360.45  Aligned_cols=258  Identities=27%  Similarity=0.424  Sum_probs=207.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC------
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------   90 (363)
                      .++|++.+.||+|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++...+      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            478999999999999999999999999999999986532   23456778999999999999999999986543      


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+|+||||+.+ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~  174 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAC  174 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccc
Confidence            57999999965 5656553  34899999999999999999999999999999999999986654  9999999997654


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHH----------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR----------------  234 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------------  234 (363)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+...........                
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            4444455678999999999988888766 99999999999999999999876543322221111                


Q ss_pred             --HhccccCC--------------C----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          235 --ILSVQYSI--------------P----DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       235 --~~~~~~~~--------------~----~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                        ........              +    .....++++++||.+||+.||++|||+.|+++||||....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence              00000000              0    0112467899999999999999999999999999997643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.3e-48  Score=358.98  Aligned_cols=249  Identities=34%  Similarity=0.584  Sum_probs=208.0

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHH---HcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l---~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      |++++.||+|+||.||++.+..+++.||||++.+..    ...+.+.+|+.++   +.++||||+++++++.+.+.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            789999999999999999999999999999997542    2234556666554   567899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~  174 (363)
                      |||++|++|...+.. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... ...
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence            999999999887754 56999999999999999999999999999999999999987654  99999999875322 222


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      .....|++.|+|||.+.+..++.+ +|||||||++|+|++|..||...+......    .+.......|  ..++.++.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~  230 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFD----SIVNDEVRYP--RFLSREAIS  230 (324)
T ss_pred             ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCC--CCCCHHHHH
Confidence            344579999999999988777655 999999999999999999998765533332    2333333333  357999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          255 LISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       255 li~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      +|++||+.+|.+||     ++.++++||||..
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence            99999999999999     7999999999975

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.3e-48  Score=350.94  Aligned_cols=255  Identities=30%  Similarity=0.431  Sum_probs=204.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcC-CCcEEEEEEeecCC---cccHHHHHHHHHHHcC---CCCCeeeeeEEEE-----c
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVIL-----T   88 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l---~hpnIv~~~~~~~-----~   88 (363)
                      .+|++.+.||+|+||+||+|++.. +++.||+|.+....   .......+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 56889999886532   2233456677776655   6999999999885     2


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCc
Q 017936           89 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  166 (363)
Q Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla  166 (363)
                      ...+++||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence            456899999996 5898888654  35899999999999999999999999999999999999986654  999999999


Q ss_pred             ccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-ccCCC--
Q 017936          167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIP--  243 (363)
Q Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~--  243 (363)
                      +............||+.|+|||.+.+..++.+ +|||||||++|+|++|.+||.+.........+....... ....+  
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            76544444455679999999999988777666 999999999999999999998876655444443221100 00000  


Q ss_pred             ------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          244 ------------------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       244 ------------------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                                        ....+++.+.+||.+||+.+|++|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.9e-48  Score=359.13  Aligned_cols=250  Identities=30%  Similarity=0.513  Sum_probs=206.4

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||+||++++..+++.||+|++.+..    .....+.+|+.++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999997642    2224466788877665 899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence            999999988888999999999999999999999999999999999999987655  99999999875322 222344579


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCc-----hHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----PKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||.....     ..........+......+|  ..++..+.+|
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~l  235 (329)
T cd05618         159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAASV  235 (329)
T ss_pred             CccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC--CCCCHHHHHH
Confidence            999999999988877666 9999999999999999999963211     1111122223333344444  3578999999


Q ss_pred             HHHhcccCCCCCCC------HHHHhcCccccc
Q 017936          256 ISRIFVADPAKRIS------IPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t------~~ell~h~~~~~  281 (363)
                      |++||+.+|.+|||      ++++++||||..
T Consensus       236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            99999999999998      589999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.1e-48  Score=358.67  Aligned_cols=246  Identities=32%  Similarity=0.528  Sum_probs=207.7

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||.||+|++..+++.||+|++.+..    ...+.+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999987632    2224456778888755 799999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~~~g  180 (363)
                      ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++...... .......|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence            999999988889999999999999999999999999999999999999987654  999999998753222 22334569


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.....    ..+.......|.  .++.++.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~ll~~~L  231 (321)
T cd05591         159 TPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDLF----ESILHDDVLYPV--WLSKEAVSILKAFM  231 (321)
T ss_pred             CccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence            999999999988877666 99999999999999999999876554333    233333333333  47899999999999


Q ss_pred             ccCCCCCC-------CHHHHhcCccccc
Q 017936          261 VADPAKRI-------SIPEIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~-------t~~ell~h~~~~~  281 (363)
                      +.+|++||       +++++++||||..
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            99999999       8999999999954

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4e-48  Score=364.49  Aligned_cols=258  Identities=33%  Similarity=0.509  Sum_probs=212.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            4579999999999999999999999999999999986532    223446789999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      |||||+|++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...... 
T Consensus       121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCc
Confidence            99999999999988654 5899999999999999999999999999999999999986654  9999999987543222 


Q ss_pred             -CCCccccCCCcCChhhhhcCC---CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          174 -QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       174 -~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                       ......||+.|+|||++.+..   ..+.++|||||||++|+|++|..||...+....+..+...  .....+|....++
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s  275 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--KNSLTFPDDNDIS  275 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCcccCCCcCCCC
Confidence             223557999999999987543   1234499999999999999999999876554333332211  1223455656789


Q ss_pred             HHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 017936          250 PECRHLISRIFVADPAK--RISIPEIRNHEWFLK  281 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~--R~t~~ell~h~~~~~  281 (363)
                      ..++++|.+||..++.+  |++++++++||||+.
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence            99999999999844433  789999999999965

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.3e-48  Score=358.82  Aligned_cols=247  Identities=31%  Similarity=0.556  Sum_probs=208.8

Q ss_pred             eceecccCCeEEEEEEEc---CCCcEEEEEEeecCC-----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           26 VRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++.||+|+||.||+|++.   .+++.||+|++.+..     .....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            468999999999999874   578899999987532     223456789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~  176 (363)
                      |+.+++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence            9999999999998888999999999999999999999999999999999999976654  999999998743222 2233


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|..||........    ...+.......|  ..+++++.+||
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~li  231 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKT----IDKILKGKLNLP--PYLTPEARDLL  231 (323)
T ss_pred             ccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHHHH
Confidence            4569999999999988777655 9999999999999999999987654332    333333333333  35789999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          257 SRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       257 ~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      ++||+.+|++||     +++++++||||..
T Consensus       232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             HHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence            999999999999     8999999999965

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-48  Score=350.87  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=213.3

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .|++.+.||+|+||+||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48999999999999999999999999999999875321    22446789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |+.+++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCcc
Confidence            99999999887653  45999999999999999999999999999999999999986654  999999998765433333


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....|++.|+|||++.+..++.+ +||||+||++|+|++|..||.+.............+......  ....++..+.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  235 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEE--YSEKFSEAARSI  235 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccc--cCcccCHHHHHH
Confidence            45578999999999988777666 899999999999999999998755433332332323222222  223579999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          256 ISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      |.+||+.||.+||     ++++++.||||..
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            9999999999999     8999999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-48  Score=356.86  Aligned_cols=251  Identities=33%  Similarity=0.471  Sum_probs=210.1

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEEcCCCcE-EEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-e
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEEL-VAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT-H   91 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~-~aiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-~   91 (363)
                      ..+.+...+.+.||+|+||+||.+...  |+. ||+|++......   .+.+.+|+.+|.+++|||||++++++..+. .
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS  114 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            344566778888999999999988854  555 999999765433   458999999999999999999999999887 7


Q ss_pred             EEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcC-ceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           92 LAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~L~~LH~~g-iiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      +++||||+++|+|..++..  .+.++...+..++.||+.|++|||+++ ||||||||+|||++.+. .++||+|||+++.
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSRE  193 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCcccee
Confidence            9999999999999999987  578999999999999999999999999 99999999999998765 2599999999986


Q ss_pred             CccC-CCCCccccCCCcCChhhhh--cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCC
Q 017936          169 SVLH-SQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY  245 (363)
Q Consensus       169 ~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (363)
                      .... .......||+.|||||++.  ...|+.+ +||||||+++|||+||..||........    ...+.....+.+.+
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~~----~~~v~~~~~Rp~~p  268 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQV----ASAVVVGGLRPPIP  268 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhcCCCCCCC
Confidence            6544 3334478999999999999  5578777 9999999999999999999988665222    22222233333334


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          246 VHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..+++.+..++.+||..+|.+||++.+++.
T Consensus       269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  269 KECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            458999999999999999999999999864

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.1e-48  Score=356.41  Aligned_cols=246  Identities=33%  Similarity=0.557  Sum_probs=205.5

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHc-CCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||.||+++++.+++.||+|++.+..    ...+....|..++.. ++||||+++++++.+.+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999999999999999987642    223445667777764 5899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      ++|..++.....+++.++..++.||+.||+|||++||+||||||+|||++.++.  ++|+|||+++.... ........|
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence            999999988888999999999999999999999999999999999999986654  99999999874322 222344579


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+.....    ..+.......|.  .++.++++||++||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~li~~~l  231 (316)
T cd05620         159 TPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELF----ESIRVDTPHYPR--WITKESKDILEKLF  231 (316)
T ss_pred             CcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCC--CCCHHHHHHHHHHc
Confidence            999999999988887666 99999999999999999999876543322    222222333333  47899999999999


Q ss_pred             ccCCCCCCCH-HHHhcCccccc
Q 017936          261 VADPAKRISI-PEIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~t~-~ell~h~~~~~  281 (363)
                      +.+|.+||++ +++++||||..
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~~  253 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFKT  253 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcCC
Confidence            9999999998 58999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.5e-47  Score=355.85  Aligned_cols=258  Identities=27%  Similarity=0.459  Sum_probs=212.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .++|++.+.||+|+||.||++.+..+++.+|+|++....  .....+.+|+.+++.++||||++++++|...+.+++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999999999999999887542  234568899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~-giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      |+.+++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.  +||+|||++..... ....
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~~  160 (333)
T cd06650          84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMAN  160 (333)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hccc
Confidence            999999999998888899999999999999999999985 7999999999999976654  99999999874422 2223


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHH------------------------
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI------------------------  232 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~------------------------  232 (363)
                      ...|++.|+|||++.+..++.+ +|||||||++|+|++|..||....... .....                        
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         161 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKE-LELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhH-HHHHhcCcccCCccccccCcccCCccchh
Confidence            4568999999999988777665 999999999999999999997543311 11100                        


Q ss_pred             -----------------HHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          233 -----------------HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       233 -----------------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                       ..+............++.++++||.+||+.+|++|||++|++.||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                             00000000000112357899999999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.4e-48  Score=355.80  Aligned_cols=251  Identities=32%  Similarity=0.546  Sum_probs=211.2

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      +|.+.+.||+|+||.||++++..+++.||+|++.+...    ..+....|..++..+ .||+|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            48999999999999999999999999999999876421    123455677777666 5899999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~  175 (363)
                      ||+++|+|...+...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence            99999999999988888999999999999999999999999999999999999987654  99999999875332 2223


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.........    ..+.......|  ..++.++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~l  231 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEHNVAYP--KSMSKEAVAI  231 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC--CcCCHHHHHH
Confidence            45579999999999988888766 99999999999999999999876543333    23333333333  3579999999


Q ss_pred             HHHhcccCCCCCCCH-----HHHhcCccccc
Q 017936          256 ISRIFVADPAKRISI-----PEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t~-----~ell~h~~~~~  281 (363)
                      +.+||+.+|.+|++.     .++++||||..
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             HHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            999999999999984     89999999964

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.6e-48  Score=356.03  Aligned_cols=246  Identities=35%  Similarity=0.597  Sum_probs=208.2

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||+||++++..+++.||+|++.+..    .....+.+|+.+++.+ +||||+++++++.+.+.+|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999997642    2234456788888777 699999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~~~g  180 (363)
                      ++|...+.+.+.+++.++..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence            999999988889999999999999999999999999999999999999987655  999999998753222 22334569


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      ++.|+|||++.+..++.+ +|||||||++|+|++|..||.........    ..+.......|  ..++.++.+||++||
T Consensus       159 ~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~li~~~l  231 (318)
T cd05570         159 TPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELF----QSILEDEVRYP--RWLSKEAKSILKSFL  231 (318)
T ss_pred             CccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCCCC--CcCCHHHHHHHHHHc
Confidence            999999999988888766 99999999999999999999875543322    22333333333  357999999999999


Q ss_pred             ccCCCCCCCH-----HHHhcCccccc
Q 017936          261 VADPAKRISI-----PEIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~t~-----~ell~h~~~~~  281 (363)
                      +.+|.+|||+     .+++.||||..
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            9999999999     99999999965

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-47  Score=347.96  Aligned_cols=248  Identities=31%  Similarity=0.434  Sum_probs=205.0

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCch
Q 017936           29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        29 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      ||+|+||+||++.+..+++.||+|.+.+...    ..+.+..|+.+++.++||||+++.+++.....+++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999999999999999999875422    124567899999999999999999999999999999999999999


Q ss_pred             HHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCccc
Q 017936          105 FERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV  179 (363)
Q Consensus       105 ~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~~~  179 (363)
                      ...+..    ...+++..++.++.||+.||+|||++||+||||||+||+++.++.  ++|+|||++....... ......
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence            887743    346999999999999999999999999999999999999976554  9999999987543222 223456


Q ss_pred             cCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017936          180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI  259 (363)
Q Consensus       180 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  259 (363)
                      ||+.|+|||.+.+..++.+ +|||||||++|+|++|+.||...............+......  ....++.++.+++.+|
T Consensus       159 g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~  235 (280)
T cd05608         159 GTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT--YPDKFSPASKSFCEAL  235 (280)
T ss_pred             CCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCC--CcccCCHHHHHHHHHH
Confidence            8999999999998887766 999999999999999999998654432222333333322222  2235799999999999


Q ss_pred             cccCCCCCC-----CHHHHhcCccccc
Q 017936          260 FVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       260 L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      |+.+|++||     |++++++||||+.
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            999999999     8899999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.1e-48  Score=357.03  Aligned_cols=246  Identities=33%  Similarity=0.567  Sum_probs=204.6

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHH-HHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||+||++++..+++.||+|++.+...    ....+.+|.. +++.++||||+++++.+...+.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            479999999999999999999999999875321    1223344443 56789999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      ++|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence            999999998889999999999999999999999999999999999999976654  99999999875322 222334569


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+......    .+.......  ...++..+.++|++||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~----~i~~~~~~~--~~~~~~~~~~li~~~l  231 (323)
T cd05575         159 TPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTAEMYD----NILNKPLRL--KPNISVSARHLLEGLL  231 (323)
T ss_pred             ChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCHHHHHH----HHHcCCCCC--CCCCCHHHHHHHHHHh
Confidence            999999999988877665 999999999999999999998755433322    233333322  2356999999999999


Q ss_pred             ccCCCCCCCH----HHHhcCccccc
Q 017936          261 VADPAKRISI----PEIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~t~----~ell~h~~~~~  281 (363)
                      +.+|.+||++    .++++||||..
T Consensus       232 ~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         232 QKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             hcCHHhCCCCCCCHHHHHcCCCcCC
Confidence            9999999987    69999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-47  Score=354.13  Aligned_cols=246  Identities=33%  Similarity=0.582  Sum_probs=205.5

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHc-CCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||+||++++..+++.||+|++.+..    ...+....|..++.. ++||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999987642    223445567777764 5899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      ++|...+.....+++.++..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence            999999988888999999999999999999999999999999999999987654  99999999875322 222344579


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||.........    ..+.......|.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~----~~i~~~~~~~~~--~~~~~~~~li~~~l  231 (316)
T cd05619         159 TPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEELF----QSIRMDNPCYPR--WLTREAKDILVKLF  231 (316)
T ss_pred             CccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCc--cCCHHHHHHHHHHh
Confidence            999999999988877666 99999999999999999999876543322    222222223332  47899999999999


Q ss_pred             ccCCCCCCCHH-HHhcCccccc
Q 017936          261 VADPAKRISIP-EIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~t~~-ell~h~~~~~  281 (363)
                      +.+|.+||++. +++.||||..
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFRE  253 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccCC
Confidence            99999999996 8999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.8e-47  Score=347.94  Aligned_cols=254  Identities=28%  Similarity=0.413  Sum_probs=204.0

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcC---CCCCeeeeeEEEEc-----CC
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT-----PT   90 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l---~hpnIv~~~~~~~~-----~~   90 (363)
                      +|++.+.||+|+||+||+|+++.+++.||+|.+....   .......+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5999999999999999999999999999999987532   2223455677766655   79999999998864     34


Q ss_pred             eEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           91 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      .+++||||+.+ +|..++...  ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI  157 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence            68999999974 888888664  34899999999999999999999999999999999999986655  99999999986


Q ss_pred             CccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-------cccC
Q 017936          169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------VQYS  241 (363)
Q Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~  241 (363)
                      ...........||+.|+|||++.+..++.+ +|||||||++|+|++|.+||..........+.......       ....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            544444445678999999999988777666 99999999999999999999876554444333321100       0000


Q ss_pred             C--------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          242 I--------------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       242 ~--------------~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      .              .....++..+.++|.+||+.||++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0              0112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-47  Score=353.47  Aligned_cols=246  Identities=37%  Similarity=0.613  Sum_probs=204.1

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHH-cCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHR-SLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||+||+|++..+++.||+|++....    ...+....|..++. ..+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999987532    12233445666665 45899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence            999999988888999999999999999999999999999999999999986654  99999999875322 222344579


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.......    ..+.......|  ..++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~ll~~~l  231 (316)
T cd05592         159 TPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELF----DSILNDRPHFP--RWISKEAKDCLSKLF  231 (316)
T ss_pred             CccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHHHc
Confidence            999999999988877666 99999999999999999999876543322    22333332333  347899999999999


Q ss_pred             ccCCCCCCCH-HHHhcCccccc
Q 017936          261 VADPAKRISI-PEIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~t~-~ell~h~~~~~  281 (363)
                      +.+|.+||++ ++++.||||..
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccCC
Confidence            9999999986 58899999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6e-47  Score=356.12  Aligned_cols=257  Identities=27%  Similarity=0.408  Sum_probs=207.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC------C
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~   90 (363)
                      .++|++.+.||+|+||.||++.+..+++.||||++....   .....+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            578999999999999999999999999999999987532   2335677899999999999999999988653      3


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+|+||||+.+ +|...+..  .+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~  177 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  177 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccC
Confidence            57999999965 67776643  4889999999999999999999999999999999999986654  9999999998654


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------  237 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  237 (363)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+........+.....             
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  256 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence            4444455678999999999988887766 99999999999999999999876654443333221100             


Q ss_pred             -----cccC------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          238 -----VQYS------------------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       238 -----~~~~------------------~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                           ....                  .......+..+++||.+||+.||.+|||+.++|.||||...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                 0000                  00011235678999999999999999999999999999654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.9e-47  Score=350.30  Aligned_cols=262  Identities=27%  Similarity=0.444  Sum_probs=211.1

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ...++|.+.+.||+|+||.||+++++.+++.||+|.+....  .....+.+|+.+++.++||||+++++++..++..++|
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            34578999999999999999999999999999999987532  2334677899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      |||+.+ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...... 
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTK  159 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCcc
Confidence            999975 7888776544 5899999999999999999999999999999999999986654  9999999987532222 


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------------c
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------V  238 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~  238 (363)
                      ......+++.|+|||.+.+....+.++|||||||++|+|++|..||...+..+...........               .
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            2234568999999999876544345599999999999999999999876554433322221100               0


Q ss_pred             ccCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          239 QYSIP---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       239 ~~~~~---------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ....+         ....++.++.+||.+||+.+|.+|||++|++.||||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            00111         123478899999999999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2e-47  Score=370.49  Aligned_cols=261  Identities=25%  Similarity=0.385  Sum_probs=205.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC------CCeeeeeEEEEcC-CeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTP-THL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h------pnIv~~~~~~~~~-~~~   92 (363)
                      .++|++.+.||+|+||+||+|.+..+++.||||++............|+.+++.++|      +++++++++|..+ .++
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~  207 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM  207 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence            578999999999999999999999999999999997654444556677777776654      4589999998765 578


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCC--------------Cc
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA--------------PR  157 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~--------------~~  157 (363)
                      ++||+++ |++|.+++.+.+.+++.+++.++.||+.||.|||+ .|||||||||+|||++.++.              ..
T Consensus       208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~  286 (467)
T PTZ00284        208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR  286 (467)
T ss_pred             EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence            9999998 77899999888889999999999999999999998 59999999999999976542              24


Q ss_pred             EEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh-
Q 017936          158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-  236 (363)
Q Consensus       158 vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-  236 (363)
                      +||+|||.+....  ......+||+.|+|||++.+..++.+ +|||||||++|+|++|++||......+.+..+..... 
T Consensus       287 vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~  363 (467)
T PTZ00284        287 VRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR  363 (467)
T ss_pred             EEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence            9999999876422  22345679999999999998888766 9999999999999999999987654332222111000 


Q ss_pred             ------------------ccccC-CCC----------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          237 ------------------SVQYS-IPD----------------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       237 ------------------~~~~~-~~~----------------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                                        ..... .+.                ....++.+.+||.+||+.||.+|||++|+|+||||.+
T Consensus       364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence                              00000 000                0011456889999999999999999999999999987


Q ss_pred             cCC
Q 017936          282 NLP  284 (363)
Q Consensus       282 ~~~  284 (363)
                      ..+
T Consensus       444 ~~~  446 (467)
T PTZ00284        444 YYP  446 (467)
T ss_pred             cCC
Confidence            544

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.1e-47  Score=356.58  Aligned_cols=256  Identities=29%  Similarity=0.454  Sum_probs=207.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .++|++++.||+|+||.||++++..+++.||||++....  .....+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            467999999999999999999999999999999986542  234568899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~  176 (363)
                      |+.+++|...    ...++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...... ...
T Consensus       153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~  226 (353)
T PLN00034        153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCN  226 (353)
T ss_pred             cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceeccccccccc
Confidence            9999998643    34678889999999999999999999999999999999986654  9999999987543222 223


Q ss_pred             ccccCCCcCChhhhhc----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          177 STVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ...||+.|+|||++..    ..+.+.++|||||||++|+|++|+.||....... .......+.. .........++.++
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~l  304 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAICM-SQPPEAPATASREF  304 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhc-cCCCCCCCccCHHH
Confidence            4579999999998743    2334445999999999999999999997433222 2222222211 11222234578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      .+||.+||+.+|++|||+.|+++||||.+..
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            9999999999999999999999999998753

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-47  Score=353.90  Aligned_cols=257  Identities=28%  Similarity=0.515  Sum_probs=207.7

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++.+.||+|+||+||++++..+++.||+|++.+..    ...+.+.+|+.+++.++||||+++++++.+++++|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999987532    22345778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-
Q 017936           97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-  174 (363)
                      ||+.|++|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV  158 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence            99999999999976 457999999999999999999999999999999999999976654  99999999865433222 


Q ss_pred             -CCccccCCCcCChhhhhc----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC-CCCCC
Q 017936          175 -PKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-DYVHI  248 (363)
Q Consensus       175 -~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  248 (363)
                       .....||+.|+|||++..    ....+.++|||||||++|+|++|..||...........+...  ......+ ....+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~  236 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KEHFQFPPDVTDV  236 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCcccCCCccCCC
Confidence             123469999999999863    222234489999999999999999999875544333322211  1112222 23357


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 017936          249 SPECRHLISRIFVADPAK--RISIPEIRNHEWFLK  281 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~--R~t~~ell~h~~~~~  281 (363)
                      +.++++||++||..++.+  |++++++++||||..
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            999999999998764443  789999999999954

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.4e-47  Score=355.88  Aligned_cols=257  Identities=27%  Similarity=0.404  Sum_probs=207.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC------C
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~   90 (363)
                      .++|++.+.||+|+||.||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            478999999999999999999999999999999987532   2235667899999999999999999998654      3


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+|+||||+++ +|.+.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~  170 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  170 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCC
Confidence            57999999965 66666643  4899999999999999999999999999999999999986654  9999999998654


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh--------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------------  236 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------  236 (363)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+..........+....              
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             CccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            4444455679999999999988887766 9999999999999999999987654333322221110              


Q ss_pred             ----cccc-----C---------C----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          237 ----SVQY-----S---------I----PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       237 ----~~~~-----~---------~----~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                          ....     .         .    ......+.++++||.+||+.+|++|||+.|+++||||...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                0000     0         0    0112245678999999999999999999999999999654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.3e-48  Score=356.71  Aligned_cols=247  Identities=32%  Similarity=0.588  Sum_probs=208.1

Q ss_pred             eceecccCCeEEEEEEE---cCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           26 VRDIGSGNFGVARLMRD---KKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~---~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      ++.||+|+||.||++++   ..+++.||+|++.+..   .....+.+|+.++++++||||+++++++.+++.+|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999987   3578999999997632   12345678999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCcc
Q 017936          100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST  178 (363)
Q Consensus       100 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~~  178 (363)
                      .+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ......
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence            99999999988888999999999999999999999999999999999999986654  999999998754333 223345


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR  258 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  258 (363)
                      .||+.|+|||.+.+..++.+ +|||||||++|+|++|..||...+.....    ..+.......|  ..+++++.+||++
T Consensus       159 ~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~li~~  231 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETM----TMILKAKLGMP--QFLSPEAQSLLRA  231 (318)
T ss_pred             cCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHH
Confidence            78999999999988777655 99999999999999999999875543322    22333333333  3579999999999


Q ss_pred             hcccCCCCCCC-----HHHHhcCccccc
Q 017936          259 IFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       259 ~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      ||+.+|.+|||     +++++.||||..
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence            99999999999     778999999965

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.5e-47  Score=353.54  Aligned_cols=250  Identities=29%  Similarity=0.508  Sum_probs=206.9

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||+||+|++..+++.||+|++.+...    ....+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999976422    234567888888777 699999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence            999999988888999999999999999999999999999999999999987665  99999999875322 223345679


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||......   .........+.......|  ..++..+.++|+
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~  235 (327)
T cd05617         159 TPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP--RFLSVKASHVLK  235 (327)
T ss_pred             CcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC--CCCCHHHHHHHH
Confidence            999999999988887665 99999999999999999999643211   111122222333333333  357899999999


Q ss_pred             HhcccCCCCCCC------HHHHhcCccccc
Q 017936          258 RIFVADPAKRIS------IPEIRNHEWFLK  281 (363)
Q Consensus       258 ~~L~~~p~~R~t------~~ell~h~~~~~  281 (363)
                      +||+.+|.+|++      ++++++||||..
T Consensus       236 ~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            999999999998      569999999965

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.9e-48  Score=355.95  Aligned_cols=246  Identities=30%  Similarity=0.525  Sum_probs=204.8

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHH-HHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~-~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||+||++++..+|+.||+|++.+..    .....+..|. .+++.++||||+++++++...+.+|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999987532    1223344444 356789999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence            999999988889999999999999999999999999999999999999987664  99999999875322 222344579


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+......    .+.......  ....+..+.++|++||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~ll~~ll  231 (325)
T cd05604         159 TPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYD----NILHKPLVL--RPGASLTAWSILEELL  231 (325)
T ss_pred             ChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHHH----HHHcCCccC--CCCCCHHHHHHHHHHh
Confidence            999999999988887766 999999999999999999998765433332    233332222  2357899999999999


Q ss_pred             ccCCCCCCCH----HHHhcCccccc
Q 017936          261 VADPAKRISI----PEIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~t~----~ell~h~~~~~  281 (363)
                      +.+|.+||++    .++++||||..
T Consensus       232 ~~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         232 EKDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             ccCHHhcCCCCCCHHHHhcCCCcCC
Confidence            9999999976    58999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.2e-47  Score=351.36  Aligned_cols=251  Identities=31%  Similarity=0.555  Sum_probs=210.6

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      +|.+.+.||+|+||+||+|+++.+++.||+|++.+..    ...+.+..|+.+++.+. ||+|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788999999999999999999999999999987532    22244667888887775 577888999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~  175 (363)
                      ||++|++|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence            99999999999998889999999999999999999999999999999999999986654  9999999987533222 23


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.........    ..+.......|  ..++.++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~l  231 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYP--KSLSKEAVSI  231 (323)
T ss_pred             cCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC--ccCCHHHHHH
Confidence            34569999999999988777655 99999999999999999999876543332    33333333333  3578999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          256 ISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      +.+||+.+|.+|++     .+++++||||..
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             HHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence            99999999999997     478999999965

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-47  Score=343.85  Aligned_cols=253  Identities=39%  Similarity=0.625  Sum_probs=208.9

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHH---HHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      |++++.||+|+||+||++++..+++.||+|++.........   ..+|+.+++.++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            88999999999999999999999999999999886543332   345999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC-ccCCCCCcc
Q 017936          100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST  178 (363)
Q Consensus       100 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~-~~~~~~~~~  178 (363)
                      .+++|.+++...+.+++.++..++.||+.||.+||++||+||||||+||+++.++.  ++|+|||.+... .........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence            99999999998888999999999999999999999999999999999999985554  999999998752 223334456


Q ss_pred             ccCCCcCChhhhh-cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--CCCCCCCCCHHHHHH
Q 017936          179 VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHL  255 (363)
Q Consensus       179 ~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~l  255 (363)
                      .+++.|+|||++. +.....+ +||||||+++|+|++|..||......+.. ...........  ........+..+.++
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~-~Di~slG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l  236 (260)
T PF00069_consen  159 VGTPEYMAPEVLQQGKKYTRK-SDIWSLGIILYELLTGKLPFEESNSDDQL-EIIEKILKRPLPSSSQQSREKSEELRDL  236 (260)
T ss_dssp             SSSGGGSCHHHHTTTSSBSTH-HHHHHHHHHHHHHHHSSSSSTTSSHHHHH-HHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred             ccccccccccccccccccccc-ccccccccccccccccccccccccchhhh-hhhhhcccccccccccccchhHHHHHHH
Confidence            7899999999988 5555444 99999999999999999999876322222 22222111111  111111224899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      |.+||+.+|++|||+.++++||||
T Consensus       237 i~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-47  Score=353.60  Aligned_cols=246  Identities=34%  Similarity=0.575  Sum_probs=204.1

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHH-HHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~-~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||+||+|++..+++.||+|++.+...    ....+..|. .+++.++||||+++++++...+.+|+||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            479999999999999999999999999875321    122333333 456789999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccC
Confidence            999999998888999999999999999999999999999999999999976654  99999999875322 223345579


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...........    +......  ....++..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~~--~~~~~~~~~~~li~~~l  231 (325)
T cd05602         159 TPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPLQ--LKPNITNSARHLLEGLL  231 (325)
T ss_pred             CccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHHH----HHhCCcC--CCCCCCHHHHHHHHHHc
Confidence            999999999988877666 9999999999999999999987655433322    2222222  22357999999999999


Q ss_pred             ccCCCCCCCHH----HHhcCccccc
Q 017936          261 VADPAKRISIP----EIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~t~~----ell~h~~~~~  281 (363)
                      +.+|.+|+++.    ++++|+||..
T Consensus       232 ~~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         232 QKDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             ccCHHHCCCCCCCHHHHhcCcccCC
Confidence            99999999876    8999999954

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.1e-47  Score=360.22  Aligned_cols=258  Identities=27%  Similarity=0.396  Sum_probs=209.1

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-----eEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA   93 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-----~~~   93 (363)
                      +|++.+.||+|+||+||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++...+     .+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4789999999999999999999999999999886532   22356788999999999999999999998876     799


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      +||||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence            9999996 588888888888999999999999999999999999999999999999986654  9999999987543221


Q ss_pred             --CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHH-----------------
Q 017936          174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-----------------  234 (363)
Q Consensus       174 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----------------  234 (363)
                        ......+++.|+|||.+.+....+.++|||||||++|+|++|+.||...........+...                 
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence              2233468999999999987554344599999999999999999999876544333222110                 


Q ss_pred             --HhccccCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          235 --ILSVQYSI-------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       235 --~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                        +.......       ......++++.+||.+||+.||.+|||+.++++||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence              00111111       1123458899999999999999999999999999999763

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.1e-47  Score=342.85  Aligned_cols=249  Identities=26%  Similarity=0.407  Sum_probs=204.9

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCch
Q 017936           29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        29 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      ||+|+||.||+++++.+|+.||+|.+.....    .......|+.+++.++||||+++++++.+...+++||||+.|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999999865321    123456699999999999999999999999999999999999999


Q ss_pred             HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCC
Q 017936          105 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP  182 (363)
Q Consensus       105 ~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~  182 (363)
                      ..++....  .+++..+..++.||+.||+|||+.||+||||||+||+++.++.  ++|+|||++.............|++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence            88876543  5899999999999999999999999999999999999986654  9999999987654333334457899


Q ss_pred             CcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhccc
Q 017936          183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA  262 (363)
Q Consensus       183 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  262 (363)
                      .|+|||++.+..++.+ +|||||||++|+|++|..||.......................+ ...+++++.+||++||+.
T Consensus       159 ~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         159 GYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhcc
Confidence            9999999988887655 99999999999999999999765432222233333332222222 235799999999999999


Q ss_pred             CCCCCCCH----HHHhcCccccc
Q 017936          263 DPAKRISI----PEIRNHEWFLK  281 (363)
Q Consensus       263 ~p~~R~t~----~ell~h~~~~~  281 (363)
                      +|++||++    ++++.||||+.
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcC
Confidence            99999999    67889999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-47  Score=355.99  Aligned_cols=246  Identities=32%  Similarity=0.523  Sum_probs=202.2

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcC---CCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        29 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      ||+|+||+||++++..+++.||+|++.+...    .......|..++..+   +||||+++++++.+.+.+|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999999999999999865321    112234455555544   699999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      ++|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  ++|+|||+++.... ........|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence            999999988889999999999999999999999999999999999999986654  99999999875322 222345679


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      |+.|+|||++.+....+.++|||||||++|+|++|..||........    ...+......++. ..+++++.+||++||
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~-~~~~~~~~~li~~~L  233 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM----YRNIAFGKVRFPK-NVLSDEGRQFVKGLL  233 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH----HHHHHcCCCCCCC-ccCCHHHHHHHHHHc
Confidence            99999999997655334559999999999999999999987554322    2333333334443 247899999999999


Q ss_pred             ccCCCCCC----CHHHHhcCccccc
Q 017936          261 VADPAKRI----SIPEIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~----t~~ell~h~~~~~  281 (363)
                      +.+|.+||    +++++++||||..
T Consensus       234 ~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhcCccccC
Confidence            99999998    7999999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9e-47  Score=343.17  Aligned_cols=255  Identities=26%  Similarity=0.423  Sum_probs=210.2

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .|++.+.||+|+||.||++.+..+++.||+|.+......    ...+.+|+.+++.++|+||+++++.+.+.+.+++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            488899999999999999999999999999998754221    2346789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |+.|++|...+...+  .+++..+..++.|++.||.|||+.||+||||||+||+++.++.  ++|+|||++.........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence            999999998886433  5899999999999999999999999999999999999986654  999999998754433333


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....|++.|+|||++.+..++.+ +|||||||++|+|++|..||.......... ........ ........+++++.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~l  235 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE-VQEEYSEKFSPDARSL  235 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHH-HHHhhhhh-hhhhcCccCCHHHHHH
Confidence            44579999999999988877665 999999999999999999998654321111 11111110 0111224578999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          256 ISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      +.+||+.+|++|||     ++|+++||||.+
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            99999999999999     899999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=338.90  Aligned_cols=253  Identities=36%  Similarity=0.627  Sum_probs=221.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc----HHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      -++|..++.||+|.||+|-+|+-+.+++.||||++++.....    ..-..|-+.|+..+||.+..+...|++.+++|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            367999999999999999999999999999999998764332    2345688899999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~  174 (363)
                      |||.+||.|+-.+.+.+.|++...+.+-..|+.||.|||+++||.||||.+|+|++.+++  +||+|||+++.... ...
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccce
Confidence            999999999999999999999999999999999999999999999999999999987765  99999999986543 344


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ..+.||||.|+|||++....|... +|+|.+||++|+|++|++||...+....+.-+    .-...++|.  .+|++++.
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI----l~ed~kFPr--~ls~eAkt  397 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI----LMEDLKFPR--TLSPEAKT  397 (516)
T ss_pred             eccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccchhHHHHHH----HhhhccCCc--cCCHHHHH
Confidence            577899999999999999988655 99999999999999999999987665544433    334445554  58999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          255 LISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       255 li~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      ||..+|.+||.+|.     .+.|+..|+||..
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            99999999999998     5899999999953

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-46  Score=336.81  Aligned_cols=252  Identities=32%  Similarity=0.469  Sum_probs=212.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      +.|.+.+.||+|++|.||.+.+..+++.||+|.+.....      ....+.+|+.+++.++||||+++++++..+..+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999999999999999999865321      12457889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      |+||+++++|.+.+...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.  ++|+|||+++.......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence            9999999999999988888999999999999999999999999999999999999986654  99999999874332211


Q ss_pred             C----CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          175 P----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       175 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                      .    ....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+.......    ........+....++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  234 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSP  234 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCH
Confidence            1    23457889999999988776555 9999999999999999999976544332222    2222222233345789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      .+.++|++||..+|.+|||+.++++||||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         235 DARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.2e-47  Score=350.55  Aligned_cols=246  Identities=33%  Similarity=0.545  Sum_probs=204.2

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHH-HHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~-~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||+||+|++..+++.||+|++.+..    .....+.+|. .+++.++||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999987532    1223344444 467889999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCCcccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~~~~g  180 (363)
                      ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence            999999988888999999999999999999999999999999999999987654  99999999875322 222344579


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+.......|  ...+.++.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~li~~~l  231 (321)
T cd05603         159 TPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQM----YDNILHKPLQLP--GGKTVAACDLLVGLL  231 (321)
T ss_pred             CcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHHHHHHHHc
Confidence            999999999988777766 9999999999999999999987654322    223333333333  356899999999999


Q ss_pred             ccCCCCCCCH----HHHhcCccccc
Q 017936          261 VADPAKRISI----PEIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~t~----~ell~h~~~~~  281 (363)
                      +.+|.+||++    .++++|+||..
T Consensus       232 ~~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         232 HKDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             cCCHhhcCCCCCCHHHHhCCCCcCC
Confidence            9999999975    59999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.3e-47  Score=350.26  Aligned_cols=256  Identities=27%  Similarity=0.508  Sum_probs=208.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|.+.+.||+|+||.||++++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999987532    22344678899999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-
Q 017936           97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-  174 (363)
                      ||+.||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....... 
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence            99999999999987 467999999999999999999999999999999999999976654  99999999875433222 


Q ss_pred             -CCccccCCCcCChhhhhc-----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC-CCC
Q 017936          175 -PKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVH  247 (363)
Q Consensus       175 -~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  247 (363)
                       .....||+.|+|||++.+     ..++.+ +|||||||++|+|++|+.||...........+...  ......|. ...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~  235 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHITD  235 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCc-ccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC--CCcccCCCcccc
Confidence             123469999999999875     334444 89999999999999999999875543333322211  11122222 245


Q ss_pred             CCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 017936          248 ISPECRHLISRIFVADPAK--RISIPEIRNHEWFLK  281 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~--R~t~~ell~h~~~~~  281 (363)
                      ++++++++|.+||...+.+  |++++++++||||..
T Consensus       236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            7899999999999876544  468999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-46  Score=349.94  Aligned_cols=256  Identities=25%  Similarity=0.501  Sum_probs=207.5

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+..    .....+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999986522    22334678889999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-
Q 017936           97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-  174 (363)
                      ||+.+|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence            99999999999977 457999999999999999999999999999999999999976554  99999999875432222 


Q ss_pred             -CCccccCCCcCChhhhhc-----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC-CCC
Q 017936          175 -PKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVH  247 (363)
Q Consensus       175 -~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  247 (363)
                       .....||+.|+|||++..     ..++. ++|||||||++|+|++|+.||...+.......+....  .....|. ...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~  235 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPAQVTD  235 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCC-cCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--ccccCCCcccc
Confidence             223569999999999863     23444 4999999999999999999998765443333322111  1112222 245


Q ss_pred             CCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 017936          248 ISPECRHLISRIFVADPAK--RISIPEIRNHEWFLK  281 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~--R~t~~ell~h~~~~~  281 (363)
                      +++++++||++||..++.+  |++++++++||||..
T Consensus       236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            7999999999999765544  689999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-49  Score=364.35  Aligned_cols=255  Identities=28%  Similarity=0.444  Sum_probs=218.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeec-CCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .+.|.|+..||.|+||+||+|.++.++-..|.|++.. +....+++.-||.+|..++||+||++++.|..++.++++.||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            4568999999999999999999999998889999875 344567888999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCCC
Q 017936           99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPK  176 (363)
Q Consensus        99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~~  176 (363)
                      |.||-+...+..- ..+++.+|..+++|++.||.|||+++|||||||..|||++.+|.  ++|+|||.+..... .....
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRD  188 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRD  188 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhc
Confidence            9999998888764 46999999999999999999999999999999999999988776  99999999864432 23345


Q ss_pred             ccccCCCcCChhhhh-----cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh-ccccCCCCCCCCCH
Q 017936          177 STVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-SVQYSIPDYVHISP  250 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~  250 (363)
                      +.+|||+|||||+..     ..+|+.+ +||||||+++.+|..+.+|-+......    .+.++. ..+..+-.+..++.
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMR----VllKiaKSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMR----VLLKIAKSEPPTLLQPSHWSR  263 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchHH----HHHHHhhcCCCcccCcchhhh
Confidence            678999999999864     4678777 899999999999999999987654432    222222 23334445567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .+.+||.+||.++|..||++++|++||||..
T Consensus       264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~  294 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN  294 (1187)
T ss_pred             HHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence            9999999999999999999999999999954

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3e-46  Score=339.70  Aligned_cols=255  Identities=26%  Similarity=0.407  Sum_probs=212.9

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .|++.+.||+|+||+||++.+..+++.+|+|.+.....    ....+.+|+.+++.++|+||+++.+.+...+..++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            48889999999999999999999999999999865422    22346789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |+.+++|...+...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.  ++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESI  158 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcc
Confidence            99999998887653  36999999999999999999999999999999999999976654  999999998754333333


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....|++.|+|||.+.+..++.+ +|+|||||++|+|++|..||......................  ....++.++.+|
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  235 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV--YSAKFSEEAKSI  235 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc--cCccCCHHHHHH
Confidence            45578999999999988777666 899999999999999999998755433333333333222222  224578999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          256 ISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      +.+||+.+|++|||     +.+++.|+||..
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN  266 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence            99999999999999     889999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-48  Score=347.64  Aligned_cols=256  Identities=29%  Similarity=0.451  Sum_probs=225.0

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      +.|+..++||+|+||.||-|+.+.||+.||+|.+.+..    ........|-.+|..++.|.||.+-.+|++.+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            56899999999999999999999999999999987532    23345678999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           97 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ..|+||+|.-.+...+  .|++..++.|+.+|+.||++||+.+||.|||||+|||+|+.++  |+|+|.|+|........
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGKP  342 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCCc
Confidence            9999999998887766  6999999999999999999999999999999999999986665  99999999998777766


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....+||.+|||||++.+..|+.. .|+|||||++|+|+.|+.||..........++-+.+.......+  ..+|+++++
T Consensus       343 ~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~--~kFS~eaks  419 (591)
T KOG0986|consen  343 IRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS--DKFSEEAKS  419 (591)
T ss_pred             cccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--cccCHHHHH
Confidence            677799999999999999998777 89999999999999999999876554444444455555555555  468999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          255 LISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       255 li~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      +.+.+|++||++|.     +++++.+||||+.
T Consensus       420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             HHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            99999999999998     5789999999975

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.9e-46  Score=341.58  Aligned_cols=260  Identities=27%  Similarity=0.447  Sum_probs=210.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ..++|.+.+.||+|+||.||++++..+++.||+|.+....  .....+.+|+.+++.++||||+++++++...+.+++||
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            4578999999999999999999999999999999986532  23456778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-C
Q 017936           97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~  174 (363)
                      ||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.  ++|+|||++....... .
T Consensus        84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT  160 (301)
T ss_pred             eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCc
Confidence            9996 5888887654 46899999999999999999999999999999999999986654  9999999987543222 2


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh-----------c----cc
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-----------S----VQ  239 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------~----~~  239 (363)
                      .....+++.|+|||.+.+....+.++|||||||++|+|++|++||...+..+..........           .    ..
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            23446789999999987655444559999999999999999999987654333322211100           0    00


Q ss_pred             cCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          240 YSIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       240 ~~~~~---------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ...+.         ...+++.+.+||.+||+.+|.+|||++|+++||||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~  291 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            01111         1346889999999999999999999999999999964

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-46  Score=362.69  Aligned_cols=253  Identities=29%  Similarity=0.442  Sum_probs=211.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCC-CcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..|.+.+.||+|++|.||+|.+..+ ++.||+|.+..... ....+.+|+.+++.++|||||++++++...+.+|+||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            4599999999999999999998877 78899997754432 234567899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           99 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        99 ~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      ++||+|.+++..    ..++++.++..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...... 
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCccc
Confidence            999999887653    446999999999999999999999999999999999999986654  9999999998543322 


Q ss_pred             --CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       174 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                        .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........    .+...... +....++.+
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~----~~~~~~~~-~~~~~~s~~  298 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIMQ----QVLYGKYD-PFPCPVSSG  298 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCC-CCCccCCHH
Confidence              2334569999999999988777655 999999999999999999998755433222    22222221 233457899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +.++|.+||+.+|++|||+++++.|+|+..
T Consensus       299 ~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        299 MKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999999999999864

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-49  Score=340.77  Aligned_cols=258  Identities=24%  Similarity=0.404  Sum_probs=218.3

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      -|.++.+||+|+||.||++.++.+|+.+|||.+.... ..+.+..|+.++.++++|++|++++.|.....+++|||||..
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            3899999999999999999999999999999887653 346678899999999999999999999999999999999999


Q ss_pred             CchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC-ccCCCCCccc
Q 017936          102 GELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV  179 (363)
Q Consensus       102 ~~L~~~~~-~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~-~~~~~~~~~~  179 (363)
                      |++.+.+. ++.++++.++..+++..+.||+|||...-||||||..|||++.++.  .||+|||.|... .......+.+
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTVI  190 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTVI  190 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCccc
Confidence            99999886 4567999999999999999999999999999999999999976654  999999998743 2334457788


Q ss_pred             cCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017936          180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI  259 (363)
Q Consensus       180 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  259 (363)
                      |||.|||||++..-.|+.+ +||||||++..+|..|++||..--..   +.+..-.......+..+..+|.++.+|+++|
T Consensus       191 GTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C  266 (502)
T KOG0574|consen  191 GTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC  266 (502)
T ss_pred             cCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence            9999999999999999988 89999999999999999999753221   1111111111223333445799999999999


Q ss_pred             cccCCCCCCCHHHHhcCccccccCCCc
Q 017936          260 FVADPAKRISIPEIRNHEWFLKNLPAD  286 (363)
Q Consensus       260 L~~~p~~R~t~~ell~h~~~~~~~~~~  286 (363)
                      |-++|++|-|+-++++|||++.....+
T Consensus       267 LiK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  267 LIKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             hcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence            999999999999999999998765444

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-47  Score=356.97  Aligned_cols=256  Identities=40%  Similarity=0.672  Sum_probs=232.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ...|.+.+.||+|.|++|.++++..++..||||.+.+....   ...+.+|+.++..++|||||+++.+.+++..+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            45699999999999999999999999999999999875432   345789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      ||+.+|.+++++.+.+++.+..++.++.|++.|++|||+++|||||||++|||++.+.+  +||+|||++..........
T Consensus       135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lq  212 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQ  212 (596)
T ss_pred             EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeeccccccc
Confidence            99999999999999999999999999999999999999999999999999999988776  9999999999888888889


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      +.+|++.|.|||++.+..|+++.+|+||||+++|.|+.|.+||++.......    .+.+...+.+|.+  ++.++.++|
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr----~rvl~gk~rIp~~--ms~dce~lL  286 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR----PRVLRGKYRIPFY--MSCDCEDLL  286 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc----chheeeeecccce--eechhHHHH
Confidence            9999999999999999999999999999999999999999999986654322    2344556666664  689999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCccccccC
Q 017936          257 SRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      +++|-.+|.+|++++++..|.|.....
T Consensus       287 rk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  287 RKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             HHhhccCccccCCHHHhhhhcccchhh
Confidence            999999999999999999999986543

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.6e-46  Score=375.35  Aligned_cols=261  Identities=31%  Similarity=0.493  Sum_probs=212.7

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCe
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT--PTH   91 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~   91 (363)
                      ....++|.+++.||+|+||+||+|++..+++.||+|++....   .....+..|+.+++.++|||||+++++|..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            334578999999999999999999999999999999987532   234567889999999999999999998864  457


Q ss_pred             EEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc-------CceecCCCCCCEEEeCC-------
Q 017936           92 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-------QVCHRDLKLENTLLDGS-------  153 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~-------giiHrDlkp~NIll~~~-------  153 (363)
                      +|+||||+.+++|..++..    ...+++..++.|+.||+.||.|||+.       +||||||||+||||+..       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            9999999999999998865    35699999999999999999999984       49999999999999642       


Q ss_pred             --------CCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcC--CCCCcchhhhhHHHHHHHHHhCCCCCCCCC
Q 017936          154 --------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPE  223 (363)
Q Consensus       154 --------~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~  223 (363)
                              +.+.+||+|||++.............||+.|+|||++.+.  .++.+ +||||||||+|+|++|..||....
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~K-SDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCch-hHHHHHHHHHHHHHHCCCCCCcCC
Confidence                    2335899999999865444444556799999999998653  34444 999999999999999999998655


Q ss_pred             chHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          224 EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      ....+...+   .. ....+ ....+.++.+||.+||+.+|.+|||+.++|.|||+....
T Consensus       248 ~~~qli~~l---k~-~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        248 NFSQLISEL---KR-GPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             cHHHHHHHH---hc-CCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            433332222   11 11222 234689999999999999999999999999999997543

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9e-46  Score=336.16  Aligned_cols=257  Identities=28%  Similarity=0.472  Sum_probs=209.9

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++.+.||+|++|.||++.++.+++.||+|++....   ...+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            57999999999999999999999999999999886532   223557789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~  176 (363)
                      |++++.|..+......+++..++.++.||+.||+|||+.|++||||||+||+++.++.  ++|+|||++....... ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCccccc
Confidence            9999988888777778999999999999999999999999999999999999986654  9999999987543332 222


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc---------------ccC
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYS  241 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  241 (363)
                      ...++..|+|||.+.+....+.++||||||+++|+|++|..||.+....+............               ...
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS  238 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence            34578899999998764433444999999999999999999998765543332222111000               000


Q ss_pred             CCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          242 IPD----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       242 ~~~----------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      .+.          ...++..+.+||.+||+.+|++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            111          13468889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-46  Score=351.37  Aligned_cols=253  Identities=24%  Similarity=0.402  Sum_probs=201.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      ..+|++++.||+|+||.||++++..+++.||+|+....     ....|+.+++.++||||+++++++......++|||++
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            45799999999999999999999999999999975433     2356899999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCcc
Q 017936          100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  178 (363)
Q Consensus       100 ~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~  178 (363)
                      . ++|..++.. ...+++.+++.++.||+.||.|||++|||||||||+|||++.++.  +||+|||+++...........
T Consensus       140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~  216 (357)
T PHA03209        140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGL  216 (357)
T ss_pred             C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcccccc
Confidence            5 578777764 456999999999999999999999999999999999999976654  999999998754333334456


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH----------HHHHHHHHHhccccCCC-----
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK----------NFRKTIHRILSVQYSIP-----  243 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----------~~~~~~~~~~~~~~~~~-----  243 (363)
                      .||+.|+|||++.+..++.+ +|||||||++|+|+++..|+.......          .+...+.........++     
T Consensus       217 ~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  295 (357)
T PHA03209        217 AGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS  295 (357)
T ss_pred             cccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence            79999999999988888766 999999999999998655543221110          11111111100000011     


Q ss_pred             -----------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          244 -----------------------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       244 -----------------------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                                             ....++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                   11245778889999999999999999999999999964

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.8e-46  Score=363.43  Aligned_cols=256  Identities=30%  Similarity=0.446  Sum_probs=212.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-----
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT-----   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-----   90 (363)
                      ..++|.+.+.||+|+||+||++++..+++.||||++.....   ....+.+|+..+..++|+||+++++.+....     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            35799999999999999999999999999999999876432   2345678999999999999999998775432     


Q ss_pred             ---eEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeec
Q 017936           91 ---HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF  163 (363)
Q Consensus        91 ---~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DF  163 (363)
                         .+++||||+++|+|.+++..    ...+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+||
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DF  187 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDF  187 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEec
Confidence               37899999999999998864    246999999999999999999999999999999999999987654  999999


Q ss_pred             CCcccCccC---CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc
Q 017936          164 GYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY  240 (363)
Q Consensus       164 gla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (363)
                      |+++.....   .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||........    +..+.....
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~----~~~~~~~~~  262 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEV----MHKTLAGRY  262 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHhcCCC
Confidence            998754321   22344579999999999988877666 9999999999999999999987554332    222322222


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       241 ~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                       .+....+++++.+++.+||+.+|.+|||+.++++|||++..
T Consensus       263 -~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        263 -DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence             23344679999999999999999999999999999998754

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.4e-46  Score=337.10  Aligned_cols=255  Identities=29%  Similarity=0.452  Sum_probs=205.5

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|++.+.||+|++|.||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++..++.+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4899999999999999999999999999999886532   2235678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-C
Q 017936           99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q  174 (363)
Q Consensus        99 ~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~  174 (363)
                      +. ++|.+++...   ..+++..++.++.||+.||+|||++||+||||||+||+++.++.  ++|+|||++....... .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV  157 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence            97 5888887643   45899999999999999999999999999999999999987655  9999999987543221 1


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc--------------c--
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------V--  238 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~--  238 (363)
                      .....+++.|+|||++.+....+.++|||||||++|+|+||+.||..................              .  
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            233467899999999876554344599999999999999999999875543322222111000              0  


Q ss_pred             -------ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          239 -------QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       239 -------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                             .........+++++.++|++||+.+|.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                   00001123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=330.42  Aligned_cols=262  Identities=31%  Similarity=0.518  Sum_probs=220.9

Q ss_pred             cee-eceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEecc
Q 017936           23 YEL-VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        23 y~i-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      |++ .+.||+|+|+.|--|.+-.+++.||||++.+... ...++.+|++++.+++ |+||++++++|+++..+|+|||-+
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm  158 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM  158 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence            555 5789999999999999999999999999988643 4577899999999885 999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC-CCCCcEEEeecCCcccCcc-------
Q 017936          100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL-------  171 (363)
Q Consensus       100 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~-~~~~~vkL~DFgla~~~~~-------  171 (363)
                      .||+|...+.+...|++.++..+++.|+.||.+||.+||.||||||+|||... +....|||+||.+......       
T Consensus       159 ~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa  238 (463)
T KOG0607|consen  159 RGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA  238 (463)
T ss_pred             cCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence            99999999999999999999999999999999999999999999999999854 3334699999999754221       


Q ss_pred             -CCCCCccccCCCcCChhhhh----cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCc-----------hHHHHHHHHHH
Q 017936          172 -HSQPKSTVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----------PKNFRKTIHRI  235 (363)
Q Consensus       172 -~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~~  235 (363)
                       .....+.+|+..|||||+..    ...++.+.+|.||||+|+|-|+.|++||.+...           ..-.......+
T Consensus       239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI  318 (463)
T KOG0607|consen  239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI  318 (463)
T ss_pred             CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence             22334567999999999863    222334559999999999999999999975321           11223444567


Q ss_pred             hccccCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 017936          236 LSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP  284 (363)
Q Consensus       236 ~~~~~~~~--~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~~  284 (363)
                      ..+.+.+|  .|..+|.+.+++|+.+|..++.+|.++.++++|||+....+
T Consensus       319 QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  319 QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            77777777  47889999999999999999999999999999999986543

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-46  Score=348.86  Aligned_cols=257  Identities=25%  Similarity=0.422  Sum_probs=205.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC------C
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~   90 (363)
                      .++|.+++.||+|+||+||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            478999999999999999999999999999999987542   2234567899999999999999999988643      4


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+|++++++ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        94 ~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~  169 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQAD  169 (343)
T ss_pred             cEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecC
Confidence            579999998 778877665 456999999999999999999999999999999999999986655  9999999987543


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh--------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------------  236 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------  236 (363)
                      .  ......||+.|+|||++.+....+.++|||||||++|+|++|..||.................              
T Consensus       170 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07878         170 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH  247 (343)
T ss_pred             C--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence            2  234457899999999997744344559999999999999999999976554333222211100              


Q ss_pred             -----ccccCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          237 -----SVQYSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       237 -----~~~~~~~------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                           ......+      .....++.+.+||.+||+.+|.+|||+.|+++||||.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence                 0000001      112456789999999999999999999999999999764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=346.88  Aligned_cols=246  Identities=28%  Similarity=0.436  Sum_probs=213.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      ...+++++.||+|.||.||++....+ ..||+|.+.......+.+.+|+.+|++|+|+|||++++++..+..+||||||+
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            34567889999999999999997543 36899999887777788999999999999999999999999988999999999


Q ss_pred             CCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC--
Q 017936          100 SGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--  175 (363)
Q Consensus       100 ~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~--  175 (363)
                      ..|+|.++++.  ...+...+...++.||++|++||+++++|||||...||||+.+..  +||+|||||+........  
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccCCCceeec
Confidence            99999999987  456999999999999999999999999999999999999987765  999999999943322222  


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....-...|.|||.+..+.++.+ |||||||++|+||+| |+.||.+.+..+.+.     .+...++.|.+..+|+++.+
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~-----~le~GyRlp~P~~CP~~vY~  435 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-----LLERGYRLPRPEGCPDEVYE  435 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHH-----HHhccCcCCCCCCCCHHHHH
Confidence            22234567999999999999888 999999999999998 999998876644332     34566788888899999999


Q ss_pred             HHHHhcccCCCCCCCHHHHh
Q 017936          255 LISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell  274 (363)
                      ++..||..+|++|||++.+.
T Consensus       436 lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  436 LMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHHhhCCcccCCCHHHHH
Confidence            99999999999999999764

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.5e-46  Score=337.21  Aligned_cols=250  Identities=36%  Similarity=0.657  Sum_probs=214.5

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999987542    23456788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      ||+++++|.+++.....+++..+..++.||+.||.|||++|++||||+|.||+++.++.  +||+|||++......  ..
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence            99999999999998889999999999999999999999999999999999999986654  999999998764333  34


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ...+++.|+|||.+.+...+.+ +||||||+++|+|++|..||........    ...+.......|  ..++..++++|
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~--~~~~~~l~~li  229 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDNPIQI----YEKILEGKVRFP--SFFSPDAKDLI  229 (290)
T ss_pred             CCCCCccccChhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCccCC--ccCCHHHHHHH
Confidence            4568999999999877766545 8999999999999999999976553222    222333333333  34689999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          257 SRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       257 ~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      ++||+.+|.+|+     +++++++||||..
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  259 (290)
T cd05580         230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAG  259 (290)
T ss_pred             HHHccCCHHHccCcccCCHHHHHcCccccc
Confidence            999999999999     9999999999954

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.7e-46  Score=352.11  Aligned_cols=255  Identities=24%  Similarity=0.346  Sum_probs=206.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEc--CCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ..+|.+++.||+|+||.||++...  .+++.||+|.+...    ....+|+.+++.++||||+++++++.....+++|||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            457999999999999999999754  45678999987653    345689999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC---
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---  174 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~---  174 (363)
                      ++. ++|..++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.  ++|+|||+++.......   
T Consensus       167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccc
Confidence            995 688888877788999999999999999999999999999999999999986654  99999999875433221   


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhccc------------
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQ------------  239 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~------------  239 (363)
                      .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+....   ..+..++.......            
T Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  322 (392)
T PHA03207        244 CYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC  322 (392)
T ss_pred             ccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence            223569999999999988888766 99999999999999999999765421   12222221111000            


Q ss_pred             -------------cCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          240 -------------YSIPD---YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       240 -------------~~~~~---~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                   +..+.   ...++.++.+||++||..+|++|||+.+++.||||.+.
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                         01111   12356789999999999999999999999999999763

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.5e-46  Score=337.45  Aligned_cols=255  Identities=27%  Similarity=0.473  Sum_probs=203.8

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|++.+.||+|+||.||++++..+|+.+|+|.+....   .....+.+|+.+++.++||||+++++++.+.+.+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            5999999999999999999999999999999986532   2235677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCC
Q 017936           99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  176 (363)
Q Consensus        99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~  176 (363)
                      ++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.  ++|+|||+++...... ...
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence            96 478777764 467999999999999999999999999999999999999986654  9999999987543222 123


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHHhc-------------cccCC
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-NFRKTIHRILS-------------VQYSI  242 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~-------------~~~~~  242 (363)
                      ...+++.|+|||.+.+....+.++|||||||++|+|++|..||....... ....+......             .....
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY  237 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence            34678999999998776544455999999999999999998865433322 22221111000             00000


Q ss_pred             ----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          243 ----------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       243 ----------~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                                .....+++++.+||.+||+.+|.+|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                      0112468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2e-45  Score=338.07  Aligned_cols=256  Identities=28%  Similarity=0.494  Sum_probs=210.7

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+.....  ....+.+|+.+++.++||||+++++++..++.+++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            469999999999999999999999999999998865422  235578899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      +++++|.+++.+.+.+++..+..++.|++.||.|||+ .|++||||||+|||++.++.  ++|+|||++..... .....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~~~~  157 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  157 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-ccccc
Confidence            9999999999888889999999999999999999997 59999999999999987654  99999999865422 22344


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHH-----------------------
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-----------------------  234 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----------------------  234 (363)
                      ..|++.|+|||.+.+..++.+ +|+|||||++|+|++|..||...+. .........                       
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             CCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            578999999999887776655 9999999999999999999975432 111111100                       


Q ss_pred             ----------Hhcc-ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          235 ----------ILSV-QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       235 ----------~~~~-~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                .... ....| ...++.++.+|+.+||..+|++|||+.+++.||||.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                      0000 00111 11367889999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1e-45  Score=333.45  Aligned_cols=253  Identities=27%  Similarity=0.426  Sum_probs=208.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC------CeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP------THL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~------~~~   92 (363)
                      .++|++.+.||+|+||.||++.+..+++.||+|++.........+.+|+.+++.+ +||||+++++++...      ..+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            4679999999999999999999999999999999987665567788999999888 699999999998753      468


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           93 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      ++||||+.+++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.  ++|+|||++....
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~  162 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceecc
Confidence            9999999999999998763  36899999999999999999999999999999999999987665  9999999987543


Q ss_pred             cC-CCCCccccCCCcCChhhhhc-----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 017936          171 LH-SQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD  244 (363)
Q Consensus       171 ~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (363)
                      .. .......|++.|+|||++.+     ..++.+ +||||+||++|+|++|..||...........    ..........
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~  237 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLK  237 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCch-hhHHHHHHHHHHHHhCCCCccccCHHHHHHH----HhcCCCCCCC
Confidence            22 22334568999999999863     234444 9999999999999999999976443222211    1122222222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ...++.++.+||.+||..+|.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            34578999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7e-46  Score=342.27  Aligned_cols=252  Identities=27%  Similarity=0.417  Sum_probs=192.5

Q ss_pred             eceecccCCeEEEEEEEc--CCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCeEEEEEeccCC
Q 017936           26 VRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG  101 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~  101 (363)
                      .++||+|+||+||+|+++  .+++.||+|.+.... ......+|+.+++.++||||+++++++..  ...++++|||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            468999999999999965  467899999886543 34567889999999999999999999864  467899999995 


Q ss_pred             CchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC--CCCcEEEeecCCcccCc
Q 017936          102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV  170 (363)
Q Consensus       102 ~~L~~~~~~~---------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~--~~~~vkL~DFgla~~~~  170 (363)
                      ++|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||+..+  ..+.+||+|||+|+...
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence            5787776532         248999999999999999999999999999999999999532  23469999999997543


Q ss_pred             cCC----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch---------HHHHHHHHH---
Q 017936          171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHR---  234 (363)
Q Consensus       171 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~---  234 (363)
                      ...    ......||+.|+|||++.+....+.++|||||||++|+|++|.+||......         .........   
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07868         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF  243 (317)
T ss_pred             CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence            221    2234578999999999987554445599999999999999999999754321         111111100   


Q ss_pred             --------Hhc-------------cccCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          235 --------ILS-------------VQYSI--------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       235 --------~~~-------------~~~~~--------~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                              ...             .....        ......+.++.+||++||+.||.+|||++|+++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                    000             00000        0011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.3e-46  Score=332.96  Aligned_cols=253  Identities=29%  Similarity=0.454  Sum_probs=209.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ..++|.+.+.||+|+||.||++++..+++.||+|++..... ....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            45689999999999999999999999999999999875432 23457789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~  176 (363)
                      |+++++|.+++...+.+++.+++.++.|++.||+|||+.|++||||||+||+++.++.  ++|+|||++...... ....
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccccc
Confidence            9999999999988889999999999999999999999999999999999999976554  999999998644322 2223


Q ss_pred             ccccCCCcCChhhhh---cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccC---CCCCCCCCH
Q 017936          177 STVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS---IPDYVHISP  250 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~  250 (363)
                      ...|++.|+|||.+.   ...++.+ +|+|||||++|+|++|..||...........    .......   ......++.
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~-~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQL-CDIWAVGITAIELAELQPPMFDLHPMRALFL----MTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             cccCcccccChhhhccccCCCCCch-hhhHHHHHHHHHHhcCCCCcccccchhhHHh----hhccCCCCCcccccCCCCH
Confidence            456899999999974   3345444 9999999999999999999975443222111    1111111   112234688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNHEW  278 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h~~  278 (363)
                      .+.++|.+||+.+|++|||+++++.|||
T Consensus       240 ~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         240 SFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            9999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.4e-45  Score=334.29  Aligned_cols=253  Identities=24%  Similarity=0.404  Sum_probs=206.8

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ++|++++.||+|+||.||++.+..+++.||+|++....  .....+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            46899999999999999999999999999999987542  2235678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCcc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  178 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~  178 (363)
                      +++++|..+    ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.  ++|+|||++..... ......
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~-~~~~~~  153 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVN-SIAKTY  153 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceeccc-ccccCC
Confidence            999998654    35789999999999999999999999999999999999987654  99999999875432 223445


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHH---HHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN---FRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      .|++.|+|||.+.+..++.+ +|+|||||++|+|++|..||........   .......+.............++++.++
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF  232 (279)
T ss_pred             CCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence            78999999999988777665 9999999999999999999965322110   1111111111111111223468899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +.+||+.+|.+||++++++.||||..
T Consensus       233 i~~~l~~~P~~Rp~~~eil~~~~~~~  258 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMDHPFIVQ  258 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhcCccccc
Confidence            99999999999999999999999965

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.2e-46  Score=346.28  Aligned_cols=251  Identities=24%  Similarity=0.401  Sum_probs=200.3

Q ss_pred             CCCCCceeeceecccCCeEEEEEEE-----cCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP   89 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~   89 (363)
                      ...++|++.+.||+|+||.||+|.+     ..+++.||+|++.....  ....+.+|+.+++.+ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            3457899999999999999999975     24456899999875432  235678899999999 899999999988764


Q ss_pred             -CeEEEEEeccCCCchHHHHHhC---------------------------------------------------------
Q 017936           90 -THLAIVMEYASGGELFERICNA---------------------------------------------------------  111 (363)
Q Consensus        90 -~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------------------  111 (363)
                       ..+++||||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999888642                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---CCCccccCCC
Q 017936          112 -----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPA  183 (363)
Q Consensus       112 -----~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~  183 (363)
                           .+++..++..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......   ......+++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCcc
Confidence                 23778899999999999999999999999999999999986654  9999999997532211   1223346788


Q ss_pred             cCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhccc
Q 017936          184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA  262 (363)
Q Consensus       184 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  262 (363)
                      |+|||++.+..++.+ +|||||||++|+|++ |..||............+   ... ........+++++.+++.+||+.
T Consensus       242 y~aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~l~~li~~cl~~  316 (338)
T cd05102         242 WMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL---KDG-TRMRAPENATPEIYRIMLACWQG  316 (338)
T ss_pred             ccCcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---hcC-CCCCCCCCCCHHHHHHHHHHccC
Confidence            999999988887766 999999999999997 999998755433222222   111 12222345789999999999999


Q ss_pred             CCCCCCCHHHHhc
Q 017936          263 DPAKRISIPEIRN  275 (363)
Q Consensus       263 ~p~~R~t~~ell~  275 (363)
                      +|.+|||+.++++
T Consensus       317 dp~~RPs~~el~~  329 (338)
T cd05102         317 DPKERPTFSALVE  329 (338)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-47  Score=374.92  Aligned_cols=258  Identities=32%  Similarity=0.513  Sum_probs=218.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|.|++.||+|+||.|.+++++.+++.||+|++++-    .....-|..|-.+|.--+.+=|+.++-+|++++++|+
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            357899999999999999999999999999999999872    2233446677888888889999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      ||||++||+|..++.+..++++..++.|+..|+.||.-||+.|+|||||||+|||++..|  ++||+|||.+-.....+ 
T Consensus       153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G--HikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG--HIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC--cEeeccchhHHhcCCCCc
Confidence            999999999999999998999999999999999999999999999999999999998665  49999999876544333 


Q ss_pred             -CCCccccCCCcCChhhhhcC----CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          174 -QPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       174 -~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                       .....+|||.|++||++...    ..+++.+|+|||||++|||+.|..||+..+..+.+.++..-  ...+.+|.-..+
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--k~~l~FP~~~~V  308 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--KESLSFPDETDV  308 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch--hhhcCCCccccc
Confidence             23456899999999999632    23355599999999999999999999985544444433322  235677766779


Q ss_pred             CHHHHHHHHHhcccCCCCCCC---HHHHhcCccccc
Q 017936          249 SPECRHLISRIFVADPAKRIS---IPEIRNHEWFLK  281 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t---~~ell~h~~~~~  281 (363)
                      |+++++||++++ .+|+.|..   ++++.+||||..
T Consensus       309 SeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  309 SEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             CHHHHHHHHHHh-cChhhhcccccHHHHHhCccccC
Confidence            999999999998 67889998   999999999954

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.7e-45  Score=329.43  Aligned_cols=254  Identities=31%  Similarity=0.468  Sum_probs=211.3

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ++|++.+.||.|+||+||++....++..+|+|++....  .....+.+|+..++.++||||+++++.+...+.+++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47999999999999999999998899999999986543  2346688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      +.+++|.+++...   ..+++..++.++.||+.||.+||+.|++||||+|+||+++.++.  ++|+|||++.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR  158 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence            9999999999764   45899999999999999999999999999999999999987654  999999998754332221


Q ss_pred             -----CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC---CCC
Q 017936          176 -----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD---YVH  247 (363)
Q Consensus       176 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  247 (363)
                           ....|++.|+|||.+......+.++|+|||||++|+|++|..||..........+....   .....+.   +..
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  235 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYKK  235 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCcccccc
Confidence                 33468899999999877633344499999999999999999999876554333333222   1111111   235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +++.+.+++.+||+.+|.+|||+++++.||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            78999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.2e-45  Score=329.37  Aligned_cols=250  Identities=34%  Similarity=0.489  Sum_probs=209.6

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----------cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLRHPNIVRFKEVILTPTH   91 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~   91 (363)
                      +|.+...||+|++|.||++.+..+++.+|+|.+......          .+.+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            588899999999999999999989999999988653221          2457789999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      .+++|||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.  ++|+|||+++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence            9999999999999999988888999999999999999999999999999999999999976554  99999999875432


Q ss_pred             CC-------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 017936          172 HS-------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD  244 (363)
Q Consensus       172 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (363)
                      ..       ......|++.|+|||.+.+..++.+ +|+|||||++|+|++|..||..........    ..... .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~-~~~~~  232 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIF----KIGEN-ASPEI  232 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHH----HHhcc-CCCcC
Confidence            11       1122357889999999988777655 899999999999999999998754432222    11111 11122


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ...++..+.++|++||+.+|.+||++.++++||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            34578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-45  Score=342.34  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=200.7

Q ss_pred             eeceeccc--CCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           25 LVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        25 i~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      ++++||+|  +|++||+++++.+|+.||+|.+....   ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56889999  78899999999999999999987542   23356778999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC---
Q 017936          100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---  174 (363)
Q Consensus       100 ~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~---  174 (363)
                      ++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  ++++||+.+........   
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhcccccccccc
Confidence            999999998653  45899999999999999999999999999999999999986654  99999986543211111   


Q ss_pred             -----CCccccCCCcCChhhhhcC--CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc--------
Q 017936          175 -----PKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------  239 (363)
Q Consensus       175 -----~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  239 (363)
                           .....++..|+|||++.+.  .++.+ +|||||||++|+|++|..||....................        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 1223567789999999763  35444 9999999999999999999976543322222111000000        


Q ss_pred             --------------------------------cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          240 --------------------------------YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       240 --------------------------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                                                      ...+....+++.+.+||++||+.||++|||++++++||||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                                            000112235778999999999999999999999999999965

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-45  Score=337.55  Aligned_cols=254  Identities=33%  Similarity=0.545  Sum_probs=214.5

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+.....    ....+.+|+..++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            479999999999999999999999999999999876532    2345778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||+.|++|.+++...  ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.  ++|+|||++........
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence            999999999998754  46999999999999999999999999999999999999987654  99999999864322111


Q ss_pred             ------------------------------CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCc
Q 017936          175 ------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE  224 (363)
Q Consensus       175 ------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  224 (363)
                                                    .....|+..|+|||++.+..++.+ +||||||+++|+|++|..||...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                          112357889999999988777555 9999999999999999999987665


Q ss_pred             hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCccccc
Q 017936          225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS----IPEIRNHEWFLK  281 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t----~~ell~h~~~~~  281 (363)
                      ...+..    +.......+....++..+.++|.+||+.+|++|||    +++++.||||..
T Consensus       238 ~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         238 DETFSN----ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             HHHHHH----HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            443333    23333344444447999999999999999999999    999999999975

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-45  Score=330.55  Aligned_cols=252  Identities=29%  Similarity=0.500  Sum_probs=214.6

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      +|++.+.||.|+||.||++++..+++.||+|++.+..    ...+.+.+|+..+++++||||+++++.+.....+++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5899999999999999999999999999999987543    234577889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      |+.|++|...+....++++..+..++.||+.||.|||++|++|+||+|+||+++.++.  ++|+|||++...........
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence            9999999999988778999999999999999999999999999999999999986654  99999999876554444455


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      ..|+..|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .............  ...+..++.++.++|.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~  234 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETAD--VLYPATWSTEAIDAIN  234 (258)
T ss_pred             cCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcccc--ccCcccCcHHHHHHHH
Confidence            678899999999987776655 99999999999999999999876542 1111222222122  2233457899999999


Q ss_pred             HhcccCCCCCCCH--HHHhcCccc
Q 017936          258 RIFVADPAKRISI--PEIRNHEWF  279 (363)
Q Consensus       258 ~~L~~~p~~R~t~--~ell~h~~~  279 (363)
                      +||+.+|.+||++  +++++||||
T Consensus       235 ~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=351.12  Aligned_cols=255  Identities=29%  Similarity=0.459  Sum_probs=214.8

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc----HHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .|.=++.||.|+||.||.|++..+.+.||||.+.-+.+..    .++..|+.+|++++|||+|.+-++|..+...++|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4788999999999999999999999999999987654332    467899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      || -|+-.+++.- ..++.+.+|..|+.+.+.||.|||+.+.||||||..|||+.+.+.  |||+|||.|...   ....
T Consensus       107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi~---~PAn  180 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASIM---APAN  180 (948)
T ss_pred             HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhhc---Cchh
Confidence            99 4566666653 356999999999999999999999999999999999999987665  999999987643   3457


Q ss_pred             ccccCCCcCChhhhh---cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          177 STVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      +.+|||+|||||++.   .+.|+++ +||||||+++.+|.-.++|+......+.+.-+.+   .....++ ...+|..++
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ---NesPtLq-s~eWS~~F~  255 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NESPTLQ-SNEWSDYFR  255 (948)
T ss_pred             cccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHHh---cCCCCCC-CchhHHHHH
Confidence            889999999999986   4678888 8999999999999999999877655444332221   1222222 335799999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccccccCCCcc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADL  287 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~~~~~~~~~  287 (363)
                      +|+..||++-|..|||.+++|.|+|.....|...
T Consensus       256 ~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tv  289 (948)
T KOG0577|consen  256 NFVDSCLQKIPQERPTSEELLKHRFVLRERPPTV  289 (948)
T ss_pred             HHHHHHHhhCcccCCcHHHHhhcchhccCCCchH
Confidence            9999999999999999999999999987665543

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-45  Score=329.93  Aligned_cols=256  Identities=29%  Similarity=0.465  Sum_probs=211.8

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      +|+..+.||+|++|.||++++..+++.||+|++.....       ....+.+|+..++.++||||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            48889999999999999999999999999999865321       23567889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||||+.+++|.+++.+.+++++..++.++.||+.||.|||++|++||||+|+||+++.++. .++|+|||++........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence            9999999999999988888999999999999999999999999999999999999975442 499999999875433211


Q ss_pred             -----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          175 -----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       175 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                           .....++..|+|||.+.+..++.+ +|+|||||++|+|++|..||......... ..+..........+....++
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHL-ALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchH-HHHHHHhccCCCCCCchhhC
Confidence                 123457889999999987777655 89999999999999999999754432222 22222222222222333578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                      +++.+++.+||..+|.+|||+.++++||||.
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.5e-45  Score=332.71  Aligned_cols=258  Identities=27%  Similarity=0.430  Sum_probs=214.6

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ....+|++.+.||+|++|.||++.+..+++.+|+|.+.... ...+.+.+|+.+++.++||||+++++.+......++||
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            34578999999999999999999999999999999887643 23456788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~  175 (363)
                      ||+.+++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||+++.++.  ++|+|||++....... ..
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~  173 (296)
T cd06654          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR  173 (296)
T ss_pred             cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhcccccccc
Confidence            99999999998864 46899999999999999999999999999999999999986654  9999999987543222 12


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....+++.|+|||.+.+..++.+ +|||||||++|+|++|..||............   ........+....++..+.++
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~l  249 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDF  249 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCHHHHHH
Confidence            33468899999999987776655 99999999999999999999765543222111   111222223344578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +.+||..+|++|||+.+++.||||...
T Consensus       250 i~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         250 LNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-45  Score=350.75  Aligned_cols=253  Identities=22%  Similarity=0.291  Sum_probs=201.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      ...|.+.+.||+|+||.||++.+..+++.||+|...     .....+|+.+++.++|||||++++++...+..++|||++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            557999999999999999999999999999999532     234578999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---CC
Q 017936          100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QP  175 (363)
Q Consensus       100 ~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---~~  175 (363)
                      . ++|..++... ..+++.+++.++.||+.||.|||++|||||||||+|||++.++.  +||+|||+++......   ..
T Consensus       243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceecccccccccc
Confidence            5 6888887654 46999999999999999999999999999999999999976554  9999999987542221   12


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCc-------hHHHHHHHHHHhccc---------
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQ---------  239 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~---------  239 (363)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|..|+.....       ...+..++.......         
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            23469999999999988887766 9999999999999998876543221       111222221110000         


Q ss_pred             -----------------cCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          240 -----------------YSIP---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       240 -----------------~~~~---~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                                       ...+   ....++.++.+||++||+.||.+|||+.|+|+||||+.
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                             0001   11235678999999999999999999999999999953

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-45  Score=330.50  Aligned_cols=254  Identities=30%  Similarity=0.486  Sum_probs=213.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ++|++.+.||.|++|.||++++..+++.||+|.+....  .....+.+|+.+++.++||||+++++++.....+++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            47999999999999999999999999999999987543  2234678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~  177 (363)
                      +.+++|.+++... ++++..++.++.|++.||.|||+.|++||||+|+||+++.++.  ++|+|||+++..... .....
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence            9999999998765 7999999999999999999999999999999999999987655  999999998765433 22344


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc-cCCCCCCCCCHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRHLI  256 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li  256 (363)
                      ..+++.|+|||.+.+..++.+ +|||||||++|+|++|..||.........    ..+.... ...+. ..++.++.+++
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~l  231 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVL----FLIPKNNPPSLEG-NKFSKPFKDFV  231 (274)
T ss_pred             ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHHH----HHhhhcCCCCCcc-cccCHHHHHHH
Confidence            568899999999988776655 99999999999999999999765432222    1121111 11222 12789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCccccccC
Q 017936          257 SRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      .+||..+|++|||++++++||||.+..
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCC
Confidence            999999999999999999999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-45  Score=331.00  Aligned_cols=252  Identities=28%  Similarity=0.435  Sum_probs=207.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++|++.+.||+|+||.||++++..+++.||+|++..... ....+.+|+.+++.++||||+++++++.....+++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            4679999999999999999999999999999999875432 234577899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~  177 (363)
                      +++++|.+++.....+++..+..++.|++.||+|||+.||+||||+|+||+++.++.  ++|+|||++....... ....
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06646          88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKS  165 (267)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCc
Confidence            999999999988888999999999999999999999999999999999999976654  9999999987543222 2234


Q ss_pred             cccCCCcCChhhhhc---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccC---CCCCCCCCHH
Q 017936          178 TVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS---IPDYVHISPE  251 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~  251 (363)
                      ..|++.|+|||.+..   ..++ .++|+||+||++|+|++|..||..........    .+......   .+....++..
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALF----LMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cccCccccCHhHcccccCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhhhhe----eeecCCCCCCCCccccccCHH
Confidence            568899999998753   3344 44899999999999999999996543221111    11111111   1222356899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRNHEW  278 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~h~~  278 (363)
                      +.+||++||+.+|++|||++++++|+|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.4e-45  Score=326.91  Aligned_cols=253  Identities=27%  Similarity=0.453  Sum_probs=212.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|+||.||++.+..+++.+|+|.+..... .+.+.+|+.+++.++||||+++++.+.....+|+++||+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            3689999999999999999999998899999999876533 577889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCc
Q 017936          100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  177 (363)
Q Consensus       100 ~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~  177 (363)
                      .+++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.  ++|+|||++....... ....
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~  158 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT  158 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence            99999999875 456899999999999999999999999999999999999987654  9999999987544332 2233


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      ..++..|+|||.+.+..++.+ +||||||+++|+|++|..||.............   ............++.++.++|.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         159 VIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---NKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             ccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---cCCCCCCCchhhcCHHHHHHHH
Confidence            458899999999988877666 999999999999999999997654432221110   0111112223346789999999


Q ss_pred             HhcccCCCCCCCHHHHhcCccc
Q 017936          258 RIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +||+.+|.+|||+.+++.||||
T Consensus       235 ~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-44  Score=324.06  Aligned_cols=250  Identities=27%  Similarity=0.477  Sum_probs=207.3

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEc-CCeEEEEEe
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME   97 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e   97 (363)
                      .|++.+.||+|++|.||++.+..+++.||+|.+....   ...+.+.+|+.+++.++|||++++++.+.. ...++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4999999999999999999999999999999986543   223467889999999999999999998864 446899999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-C
Q 017936           98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q  174 (363)
Q Consensus        98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~  174 (363)
                      |+++++|.+++...  ..+++.+++.++.|++.||.+||++|++||||||+||+++.++.  ++|+|||++....... .
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM  158 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence            99999999988763  45899999999999999999999999999999999999986654  9999999987543222 2


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      .....+++.|+|||++.+..++.+ +|+|||||++|+|++|..||...+.......    +..... .+....+++++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~  232 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYR----IIEGKL-PPMPKDYSPELGE  232 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHhcCC-CCCccccCHHHHH
Confidence            234468999999999988877666 8999999999999999999986554322222    222211 1223457899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccc
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ++.+||+.+|.+|||+.+++.||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-45  Score=332.59  Aligned_cols=258  Identities=24%  Similarity=0.398  Sum_probs=210.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ++|++++.||+|+||.||++++..+++.||+|.+....  .....+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            47999999999999999999999999999999886532  2235678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        99 ~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      +++++|..++...   ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++  .++|+|||++..... ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVA-SL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccC-Cc
Confidence            9999998888763   369999999999999999999997 5999999999999998754  499999999875422 22


Q ss_pred             CCccccCCCcCChhhhhcCCC-----CCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          175 PKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      .....+++.|+|||.+.+...     .+.++|+|||||++|+|++|..||......... ..+..+..... ......++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~  235 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIVDGDP-PTLPSGYS  235 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHHHHhhcCC-CCCCcccC
Confidence            334568889999999865432     134489999999999999999999765432222 22222222211 12223479


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      .++.+||.+||+.+|.+||++++++.||||....
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            9999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.8e-45  Score=330.52  Aligned_cols=257  Identities=29%  Similarity=0.512  Sum_probs=213.0

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ++|++.+.||.|++|.||++.++.+++.+|+|.+....  .....+.+|+.+++.++||||+++++++...+.+++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46899999999999999999999999999999987653  2335678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      +.+++|.+++... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.  ++|+|||.+........ .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~-~  157 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLA-K  157 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHHh-h
Confidence            9999999999876 789999999999999999999999 99999999999999987554  99999999865432221 2


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHHhcccc-CCCCCCCCCHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILSVQY-SIPDYVHISPECRH  254 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~  254 (363)
                      ...++..|+|||.+.+..++.+ +||||||+++|+|++|..||..... ................ ..+. ..++.++.+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  235 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-GKFSPDFQD  235 (265)
T ss_pred             cccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-hhcCHHHHH
Confidence            2678899999999988877666 9999999999999999999976421 1122222332222211 1111 127899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +|.+||..+|.+|||+.+++.||||++.
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.1e-45  Score=331.24  Aligned_cols=256  Identities=28%  Similarity=0.464  Sum_probs=210.0

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|++.+.||+|++|.||+|.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++.....+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5999999999999999999999999999999987643   2345788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--CC
Q 017936           99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP  175 (363)
Q Consensus        99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--~~  175 (363)
                      + +++|.+++.. ...+++.+++.++.||+.||+|||+.|++||||||+||+++.++.  ++|+|||++.......  ..
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence            9 9999998865 456999999999999999999999999999999999999987554  9999999987654332  13


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc---------------cc
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QY  240 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~  240 (363)
                      ....++..|+|||.+.+....+.++|||||||++|+|++|.+||...................               ..
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            345689999999998765544555999999999999999988887665544333332211100               00


Q ss_pred             CCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017936          241 SIP---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       241 ~~~---------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                      ..+         .....+..+.++|++||+.+|.+|||+++++.||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            000         1124578999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.5e-45  Score=330.66  Aligned_cols=261  Identities=23%  Similarity=0.420  Sum_probs=215.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      +.++|++++.||+|+||+||++.+..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            3468999999999999999999999999999999886542  33467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      ||+++++|..++.+.+.+++..+..++.+++.||.|||+ .|++||||+|+||+++.++.  ++|+|||++..... ...
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~-~~~  159 (284)
T cd06620          83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELIN-SIA  159 (284)
T ss_pred             ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhh-hcc
Confidence            999999999999888889999999999999999999997 69999999999999976554  99999999864322 222


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch-------HHHHHHHHHHhccccCCCCCCCC
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                      ....|+..|+|||++.+..++.+ +|+|||||++|+|++|..||......       .........+............+
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF  238 (284)
T ss_pred             CccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence            34578999999999987777666 99999999999999999999864432       11112222222221111112236


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      +.++.+||.+||+.+|.+|||+.|+++|+||.+..
T Consensus       239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            78999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-45  Score=330.70  Aligned_cols=256  Identities=28%  Similarity=0.444  Sum_probs=211.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++|++.+.||.|+||.||++.+..+++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.....+++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            578999999999999999999998899999999987543 2335677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCC
Q 017936           99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  176 (363)
Q Consensus        99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~  176 (363)
                      +++++|..++... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.  ++|+|||++....... ...
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccc
Confidence            9999999998764 46999999999999999999999999999999999999976654  9999999886443222 223


Q ss_pred             ccccCCCcCChhhhhcC-----CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc-cCCCCCCCCCH
Q 017936          177 STVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISP  250 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~  250 (363)
                      ...+++.|+|||.+...     .++.+ +|+|||||++|+|++|..||..........    .+.... ........++.
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~-sDi~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  236 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELNPMRVLL----KILKSEPPTLDQPSKWSS  236 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCcc-ccHHHHHHHHHHHHhCCCCcccCCHHHHHH----HHhcCCCCCcCCcccCCH
Confidence            34689999999998532     23334 999999999999999999997654432222    222221 12223345789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ++.++|.+||+.+|.+|||++++++||||...
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            99999999999999999999999999999654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-44  Score=325.37  Aligned_cols=251  Identities=26%  Similarity=0.391  Sum_probs=207.6

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      +|++.+.||+|+||.||++.+ .+++.+|+|.+.....       ....+.+|+.+++.++|+||+++++++...+.+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999986 5788899998865321       12457889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc---
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---  171 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~---  171 (363)
                      ++||+.+++|.+++.+...+++..++.++.|++.||+|||+.||+||||+|+||+++.++.  ++|+|||++.....   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence            9999999999999988888999999999999999999999999999999999999986654  99999999874321   


Q ss_pred             ----CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          172 ----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       172 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                          ........|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||...+......... .  ......+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~--~~~~~~~~~~~  233 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-A--HRGLMPRLPDS  233 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-h--ccCCCCCCCCC
Confidence                111223458899999999988777666 999999999999999999997654433222111 1  10111122345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ++.++.++|++||+.+|.+|||+.+++.||||
T Consensus       234 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            78999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.5e-45  Score=329.16  Aligned_cols=256  Identities=27%  Similarity=0.425  Sum_probs=209.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      +-|++.+.||.|+||.||++.+..++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            34789999999999999999999999999999986543 23456788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCc
Q 017936          100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS  177 (363)
Q Consensus       100 ~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~  177 (363)
                      .+++|...+.+ ..++++..+..++.||+.||.|||+.|++||||||+||+++.++.  ++|+|||++...... .....
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEcccccccccccccccccc
Confidence            99999887764 457999999999999999999999999999999999999976654  999999998654222 12234


Q ss_pred             cccCCCcCChhhhh-----cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          178 TVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       178 ~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ..+++.|+|||++.     +..++. ++|||||||++|+|++|..||...+..........   ......+....++.++
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  238 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDY-KADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSEF  238 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCc-cchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh---cCCCCCCCccccCHHH
Confidence            56899999999984     233433 49999999999999999999986554332222211   1111223334578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .+||.+||+.+|.+|||++++++||||...
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            999999999999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9e-45  Score=327.43  Aligned_cols=253  Identities=32%  Similarity=0.487  Sum_probs=207.2

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-----------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------IDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      +|.+.+.||.|++|.||++.+..+++.+|+|.+.....           ..+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            58999999999999999999999999999998754211           1235678999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.  ++|+|||+++...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999986654  9999999987543


Q ss_pred             cCC---CCCccccCCCcCChhhhhcCC--CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--
Q 017936          171 LHS---QPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--  243 (363)
Q Consensus       171 ~~~---~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  243 (363)
                      ...   ......|+..|+|||.+....  ++ .++|+||||+++|++++|..||..........+....  ......+  
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK--RSAPPIPPD  236 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCC-ccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc--ccCCcCCcc
Confidence            211   122345888999999987654  44 4499999999999999999999754433222221111  1111111  


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          244 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ....++.++.++|.+||..+|.+|||++++++|||+
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            123568999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=324.71  Aligned_cols=255  Identities=33%  Similarity=0.474  Sum_probs=211.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++|++.+.||.|+||.||++.+..+++.+|+|++..... ....+.+|+.+++.++||||+++++++...+.++++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            3689999999999999999999999999999999876432 346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCC
Q 017936           99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  176 (363)
Q Consensus        99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~  176 (363)
                      +.+++|.+++... ..+++.+++.++.|++.||.|||++||+||||+|+||+++.++.  ++|+|||++....... ...
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccc
Confidence            9999999998776 68999999999999999999999999999999999999986654  9999999987543322 223


Q ss_pred             ccccCCCcCChhhhhcC---CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          177 STVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      ...++..|+|||.+.+.   .++.+ +|+|||||++|+|++|..||.................. .........++.++.
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~-~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  237 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP-PPKLKDKEKWSPVFH  237 (262)
T ss_pred             cccCCccccCchhhcccccCCcCch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CccccchhhhhHHHH
Confidence            45688899999998766   56555 99999999999999999999875543322221111000 111112234578899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEW  278 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~  278 (363)
                      +++++||..+|..|||+++++.|+|
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.5e-44  Score=322.70  Aligned_cols=250  Identities=30%  Similarity=0.454  Sum_probs=210.2

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+...   ......+.+|+.+++.++||||+++++++...+.+++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            488999999999999999999999999999998653   23345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-C
Q 017936           99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~  175 (363)
                      +.+++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||+++....... .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence            9999999998764  56899999999999999999999999999999999999986654  99999999875433222 2


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....|++.|+|||++.+..++.+ +|+|||||++++|++|..||..........    .+..... .+....++.++.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~  232 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALIL----KIIRGVF-PPVSQMYSQQLAQL  232 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCC-CCCccccCHHHHHH
Confidence            33468899999999988777666 999999999999999999998765432222    2222221 11222578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +.+||+.+|++||++.+++.|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.6e-45  Score=332.35  Aligned_cols=258  Identities=27%  Similarity=0.433  Sum_probs=209.7

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc------cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      +|.+.+.||+|++|.||++.+..+++.||+|.+......      ...+..|+.+++.++||||+++++++.+.+.+++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            589999999999999999999999999999998764322      34567899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      |||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||+|+||+++.++.  ++|+|||+++...... 
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence            9999 899999998766 7999999999999999999999999999999999999987654  9999999987543322 


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc------------cc-
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------QY-  240 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------~~-  240 (363)
                      ......+++.|+|||.+.+......++|+|||||++|+|++|.+||...................            .. 
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence            22334578889999998665444455999999999999999988887665544333322111000            00 


Q ss_pred             ------CC---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          241 ------SI---PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       241 ------~~---~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                            ..   ......+..+.++|.+||+.+|++|||+.+++.||||.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence                  00   0113457889999999999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.7e-44  Score=330.05  Aligned_cols=257  Identities=28%  Similarity=0.446  Sum_probs=214.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..+|++.+.||.|++|.||++.+..+++.||+|.+.... ...+.+.+|+..++.++||||+++++++...+.+++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            467999999999999999999999999999999886543 2345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-CCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~~~  177 (363)
                      +.+++|..++... .+++.++..++.|++.||.|||+.|++||||||+||+++.++.  ++|+|||++........ ...
T Consensus        98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCCC
Confidence            9999999888654 6899999999999999999999999999999999999976554  99999999875433222 233


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      ..+++.|+|||.+.+..++.+ +|+|||||++|+|++|..||.............   .........+..+++.+.++|.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~  250 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSPIFRDFLN  250 (296)
T ss_pred             cCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCcccCCcccCCHHHHHHHH
Confidence            468899999999987777655 999999999999999999998765433222211   1112222334567899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCccccccC
Q 017936          258 RIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      +||..+|.+|||+.+++.||||....
T Consensus       251 ~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         251 RCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHhhcChhhCCCHHHHhhChHhhhcc
Confidence            99999999999999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9.8e-45  Score=325.40  Aligned_cols=248  Identities=31%  Similarity=0.538  Sum_probs=208.5

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCch
Q 017936           29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        29 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      ||.|++|.||++++..+++.+|+|++.+..    ...+.+.+|+.+++.++||||+++++.+.+.+.++++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999999999999999987643    2335688899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCCCc
Q 017936          105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY  184 (363)
Q Consensus       105 ~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y  184 (363)
                      .+++.+...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.  ++|+|||++.............+++.|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence            999988888999999999999999999999999999999999999986654  999999998865443333445689999


Q ss_pred             CChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCC
Q 017936          185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP  264 (363)
Q Consensus       185 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p  264 (363)
                      +|||.+.+..++.+ +|+||||+++|+|++|..||......  .......+.......+.....++++.++|.+||+.+|
T Consensus       159 ~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         159 VAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             cChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            99999887777666 89999999999999999999876521  1122222332122222233458999999999999999


Q ss_pred             CCCCC-----HHHHhcCccccc
Q 017936          265 AKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       265 ~~R~t-----~~ell~h~~~~~  281 (363)
                      .+||+     ++|+++||||..
T Consensus       236 ~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         236 EERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             hhCcCCcccCHHHHhcChhhhC
Confidence            99999     999999999964

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.7e-45  Score=331.75  Aligned_cols=259  Identities=27%  Similarity=0.421  Sum_probs=214.0

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ....+|++++.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            34578999999999999999999999999999999987543 23456788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-C
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~  175 (363)
                      ||+++++|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+|||++.++.  ++|+|||++........ .
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccCc
Confidence            99999999998865 45899999999999999999999999999999999999986654  99999999875433221 2


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....+++.|+|||.+.+..++.+ +|+|||||++|+|++|..||............   .............++..+.+|
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l  248 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPERLSAVFRDF  248 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCcchheeee---ccCCCCCCCCccccCHHHHHH
Confidence            33468899999999987777555 99999999999999999999765432211111   111111222334578899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      +.+||..+|.+|||+++++.||||....
T Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         249 LNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             HHHHccCChhhCcCHHHHhcCchhcccc
Confidence            9999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.8e-44  Score=323.68  Aligned_cols=253  Identities=32%  Similarity=0.501  Sum_probs=212.8

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|.+.+.||+|+||.||++.+..+++.||+|.+.....   ..+.+.+|+.+++.++||||+++++++...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            69999999999999999999998999999999876543   346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC---
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~---  175 (363)
                      +.+++|.+++.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++.  +||+|||++.........   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence            999999999988878999999999999999999999999999999999999987554  999999998754332221   


Q ss_pred             --CccccCCCcCChhhhhcCC---CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          176 --KSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       176 --~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                        ....+++.|+|||.+.+..   ...+ +||||||+++|++++|..||............  .........|....+++
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~-~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  235 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGAGHKPPIPDSLQLSP  235 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcc-cchHHHHHHHHHHHhCCCCccCCcchHHHHHH--HhcCCCCCCCcccccCH
Confidence              1245788999999987665   4444 99999999999999999999765432211111  11122334555556689


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      .+.++|++||+.+|.+|||+.+++.|||+
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-44  Score=330.59  Aligned_cols=255  Identities=28%  Similarity=0.441  Sum_probs=209.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .+.|++++.||.|+||.||++++..+++.+|+|.+.... ...+.+.+|+.+++.++||||+++++.+..++.+++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            467999999999999999999999999999999987543 2345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCC
Q 017936           99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  176 (363)
Q Consensus        99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~  176 (363)
                      +++++|...+.+ ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.  ++|+|||++...... ....
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceeccccccccc
Confidence            999999887754 456899999999999999999999999999999999999976554  999999988643222 2223


Q ss_pred             ccccCCCcCChhhhhc-----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-ccCCCCCCCCCH
Q 017936          177 STVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISP  250 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~  250 (363)
                      ...+++.|+|||.+.+     ..++.+ +|+|||||++|+|++|..||..........    ..... ....+....++.
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  243 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLL----KIAKSEPPTLSQPSKWSM  243 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCch-hhhHhHHHHHHHHhcCCCCCccccHHHHHH----HHhcCCCccCCCCcccCH
Confidence            4468899999998853     233334 899999999999999999997654322221    12111 112233345788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ++.++|.+||+.+|++||+++++++||||..
T Consensus       244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            9999999999999999999999999999954

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2e-44  Score=328.51  Aligned_cols=257  Identities=27%  Similarity=0.430  Sum_probs=208.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC-----CeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP-----THL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~-----~~~   92 (363)
                      ..++|.+.+.||+|+||.||++.+..+++.+|+|++.........+.+|+.+++.+ +|||++++++++...     ..+
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            46789999999999999999999999999999999876555566778899999988 799999999998754     368


Q ss_pred             EEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           93 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      ++||||+++++|.+++..    ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.  ++|+|||++..
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~  177 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQ  177 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchh
Confidence            999999999999988753    456899999999999999999999999999999999999976654  99999999875


Q ss_pred             CccCC-CCCccccCCCcCChhhhhcCCC----CCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC
Q 017936          169 SVLHS-QPKSTVGTPAYIAPEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP  243 (363)
Q Consensus       169 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (363)
                      ..... ......|+..|+|||.+.....    .+.++|||||||++|+|++|+.||..............   .......
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~  254 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPTLL  254 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCCCC
Confidence            43222 2234568899999999864331    23449999999999999999999976544333222111   1111222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017936          244 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                      ....++..+.+||.+||+.+|++||++.+++.||||+
T Consensus       255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            2334678899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.3e-45  Score=329.85  Aligned_cols=254  Identities=26%  Similarity=0.414  Sum_probs=207.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEc------CCe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------PTH   91 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~------~~~   91 (363)
                      ..+.|++.+.||.|+||.||++++..+++.+|+|++.........+..|+.+++.+ +||||+++++++..      ...
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            45689999999999999999999999999999999877655556788899988888 69999999999853      467


Q ss_pred             EEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           92 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      ++++|||+.+++|.+++...  ..+++..++.++.||+.||.|||+.||+||||+|+||+++.++.  ++|+|||++...
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~  171 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL  171 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhh
Confidence            89999999999999988753  35889999999999999999999999999999999999986654  999999998754


Q ss_pred             ccC-CCCCccccCCCcCChhhhhc-----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC
Q 017936          170 VLH-SQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP  243 (363)
Q Consensus       170 ~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (363)
                      ... .......|++.|+|||.+..     ..++.+ +|+|||||++|+|++|..||...........    .........
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~-~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~  246 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPKL  246 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcc-cchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhCCCCCC
Confidence            322 22344568999999998853     334445 8999999999999999999976543222211    111111112


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          244 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ....++.++.+||.+||+.+|.+|||+.++++||||
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            233578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-44  Score=325.38  Aligned_cols=249  Identities=26%  Similarity=0.469  Sum_probs=201.8

Q ss_pred             CCceeecee--cccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHc-CCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDI--GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~l--g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++.+.+  |+|+||.||++.++.++..+|+|.+........    |+..... .+||||+++++.|...+.+++|||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            567777776  999999999999999999999999876432211    2222222 279999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      |+++++|.+++.....+++.+++.++.||+.||.|||+.|++||||||+||+++.++ +.++|+|||++.....   ...
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~---~~~  165 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK-DRIYLCDYGLCKIIGT---PSC  165 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-CeEEEecCccceecCC---Ccc
Confidence            999999999998888999999999999999999999999999999999999998665 2499999999875432   233


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      ..+++.|+|||++.+..++.+ +||||||+++|+|++|..||............+....  ....+....+|+.+.+||.
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~  242 (267)
T PHA03390        166 YDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFVQ  242 (267)
T ss_pred             CCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHHH
Confidence            468899999999988777665 9999999999999999999985443221111121111  2222334468999999999


Q ss_pred             HhcccCCCCCCC-HHHHhcCcccc
Q 017936          258 RIFVADPAKRIS-IPEIRNHEWFL  280 (363)
Q Consensus       258 ~~L~~~p~~R~t-~~ell~h~~~~  280 (363)
                      +||+.+|.+||+ ++++++||||.
T Consensus       243 ~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        243 SMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHhccChhhCCchHHHHhcCCccc
Confidence            999999999996 69999999995

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.3e-45  Score=328.44  Aligned_cols=248  Identities=32%  Similarity=0.461  Sum_probs=206.0

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCch
Q 017936           29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        29 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      ||+|+||+||+|.+..+++.||+|++....    .....+..|+.+++.++||||+++++++...+.+|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999999999999999986532    2234456899999999999999999999999999999999999999


Q ss_pred             HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCC
Q 017936          105 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP  182 (363)
Q Consensus       105 ~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~  182 (363)
                      .+++.+..  .+++.++..++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||++.............++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence            99987765  6999999999999999999999999999999999999986654  9999999987544333334456888


Q ss_pred             CcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhccc
Q 017936          183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA  262 (363)
Q Consensus       183 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  262 (363)
                      .|+|||.+.+..++.+ +|||||||++|+|++|..||.....................  +....+++.+.++|.+||+.
T Consensus       159 ~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         159 GYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV--EYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccc--cCCccCCHHHHHHHHHHccC
Confidence            9999999987776555 99999999999999999999765542222222222222222  22335699999999999999


Q ss_pred             CCCCCC-----CHHHHhcCccccc
Q 017936          263 DPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       263 ~p~~R~-----t~~ell~h~~~~~  281 (363)
                      +|.+||     ++.++++||||..
T Consensus       236 ~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         236 DPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             ChhHccCCCcccHHHHHhChhhhc
Confidence            999999     8888999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.7e-44  Score=324.67  Aligned_cols=252  Identities=30%  Similarity=0.423  Sum_probs=205.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC------cccHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCeE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHL   92 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~   92 (363)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+....      .....+.+|+.+++.++||||+++++++..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46999999999999999999999999999999886432      122457789999999999999999999875  3678


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ++++||+.+++|.+++.....+++..++.++.|++.||+|||++||+||||+|+||+++.++.  ++|+|||+++.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~  159 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence            999999999999999988888999999999999999999999999999999999999976554  999999998743221


Q ss_pred             ----CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          173 ----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       173 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                          .......++..|+|||.+.+..++.+ +|||||||++|+|++|..||...........    .............+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~  234 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQPTNPQLPSHI  234 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCCCCCCCchhc
Confidence                11123458889999999988777655 9999999999999999999986544332222    11111111112346


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                      ++.+.++| +||..+|++|||++|+++||||.
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            88899999 57778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-44  Score=328.84  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=206.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEE-----cCCeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL-----TPTHL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~-----~~~~~   92 (363)
                      ..++|++.+.||+|+||.||++.+..+++.+|+|++.........+.+|+.+++.+ +||||+++++++.     ..+.+
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            56899999999999999999999999999999998876544456788899999998 6999999999874     34679


Q ss_pred             EEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           93 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      ++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+++||||||+||+++.++.  ++|+|||+++.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~  173 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQ  173 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceee
Confidence            999999999999987652    346899999999999999999999999999999999999987654  99999999875


Q ss_pred             CccCC-CCCccccCCCcCChhhhhc-----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-ccC
Q 017936          169 SVLHS-QPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYS  241 (363)
Q Consensus       169 ~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~  241 (363)
                      ..... ......|++.|+|||++..     ..++.+ +|||||||++|+|++|..||...........    .... ...
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~----~~~~~~~~  248 (286)
T cd06638         174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFK----IPRNPPPT  248 (286)
T ss_pred             cccCCCccccccCCCcccChhhhchhhhccccccch-hhhhhHHHHHHHHhcCCCCCCCCchhHHHhh----ccccCCCc
Confidence            43322 2234568999999999853     224444 9999999999999999999976543222211    1111 111


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          242 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       242 ~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ......++..+.+||.+||+.+|++|||+.++++|+||
T Consensus       249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            22223467899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-45  Score=327.35  Aligned_cols=255  Identities=28%  Similarity=0.467  Sum_probs=208.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCC------e
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT------H   91 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~------~   91 (363)
                      .+++|++.+.||.|++|.||+|.+..+++.+++|++.......+.+.+|+.+++.+ .||||+++++++....      .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            46899999999999999999999998999999999887666667789999999998 6999999999997644      4


Q ss_pred             EEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936           92 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      +++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.  ++|+|||++.
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~  161 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSA  161 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccce
Confidence            8999999999999988765    347999999999999999999999999999999999999987654  9999999986


Q ss_pred             cCccC-CCCCccccCCCcCChhhhhcC-----CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccC
Q 017936          168 SSVLH-SQPKSTVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS  241 (363)
Q Consensus       168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (363)
                      ..... .......|++.|+|||.+...     .++.+ +|||||||++|+|++|..||..............   .....
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~  237 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPT  237 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCcccc-ccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCC
Confidence            43222 222345689999999987543     23334 8999999999999999999976443332222211   11112


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          242 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       242 ~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ......++.++++||.+||..+|++|||+++++.|||+
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            22233468899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-44  Score=328.28  Aligned_cols=258  Identities=30%  Similarity=0.490  Sum_probs=204.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ..++|++.+.||+|++|.||++.++.+++.||+|.+....  .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            3478999999999999999999999899999999986532  22345678999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-C
Q 017936           97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~  174 (363)
                      ||+.+ +|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++...... .
T Consensus        83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKT  159 (291)
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCcc
Confidence            99975 898888764 46899999999999999999999999999999999999987665  9999999987532211 1


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc----------------
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------------  238 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------------  238 (363)
                      .....+++.|+|||.+.+....+.++||||+|+++|+|++|..||............+......                
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence            2233578899999998764433444999999999999999999997655222111111111000                


Q ss_pred             ccCC---------CCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          239 QYSI---------PDYVHIS--PECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       239 ~~~~---------~~~~~~s--~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ....         .....++  .++.++|.+||+.+|++|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000         0011234  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.3e-45  Score=330.75  Aligned_cols=257  Identities=27%  Similarity=0.481  Sum_probs=209.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            479999999999999999999998999999998865322   23567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-CC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~~  176 (363)
                      |+++++|..+......+++.+++.++.||+.||.|||+.|++||||+|+||+++.++.  ++|+|||++........ ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence            9999999887776667999999999999999999999999999999999999987654  99999999875433222 22


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------------cccC
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYS  241 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~  241 (363)
                      ...++..|+|||++.+....+.++||||||+++|+|++|.+||......+...........               ....
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence            3457889999999876554445599999999999999999999765543332222211000               0000


Q ss_pred             CC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          242 IP----------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       242 ~~----------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      .+          ....++..+.+|+++||+.+|.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            11          123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.8e-44  Score=331.23  Aligned_cols=254  Identities=31%  Similarity=0.545  Sum_probs=210.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|.+.+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++||||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            469999999999999999999999999999999876432    2345678999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  173 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---  173 (363)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++.  ++|+|||+++......   
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence            99999999999988888999999999999999999999999999999999999976554  9999999986321100   


Q ss_pred             -------------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc
Q 017936          174 -------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY  240 (363)
Q Consensus       174 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (363)
                                   ......++..|+|||.+.+..++.+ +|+|||||++|+|++|..||.+....+..    ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~----~~~~~~~~  233 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELF----GQVISDDI  233 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhccc
Confidence                         0112357889999999887777655 99999999999999999999865443222    22222222


Q ss_pred             CCCC-CCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccc
Q 017936          241 SIPD-YVHISPECRHLISRIFVADPAKRIS---IPEIRNHEWFLK  281 (363)
Q Consensus       241 ~~~~-~~~~s~~~~~li~~~L~~~p~~R~t---~~ell~h~~~~~  281 (363)
                      ..+. ...++.++.++|++||+.+|++||+   +.++++||||..
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            2222 1257899999999999999999998   799999999954

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-44  Score=328.17  Aligned_cols=253  Identities=29%  Similarity=0.462  Sum_probs=202.9

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCC-CCCeeeeeEEEEcC--CeEEEEEe
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIVME   97 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv~e   97 (363)
                      |++++.||+|+||.||++.+..+++.||+|.+.....  ......+|+..++++. ||||+++++++.+.  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            7889999999999999999999999999998875422  2223456888888885 99999999999987  88999999


Q ss_pred             ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      |+.+ +|.+.+.. ...+++.+++.++.||+.||+|||+.|++||||+|+||+++.   +.+||+|||++..........
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEecccccccccCCCcC
Confidence            9975 77777765 356899999999999999999999999999999999999986   459999999997654443334


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh--------------ccccCC
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------------SVQYSI  242 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------~~~~~~  242 (363)
                      ...+++.|+|||.+......+.++|||||||++|+|++|..||...+..+..........              ...+..
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            456889999999876555445559999999999999999999987654433322221100              001111


Q ss_pred             CC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          243 PD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       243 ~~---------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +.         ...++.++.++|.+||+.+|++|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            11         12468999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-44  Score=332.86  Aligned_cols=260  Identities=30%  Similarity=0.470  Sum_probs=207.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~   93 (363)
                      ..++|++.+.||+|+||.||++.+..+|+.||+|.+.....   ......+|+.+++.++||||+++++++...  +.++
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            45789999999999999999999999999999999865322   223456899999999999999999998765  5689


Q ss_pred             EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +||||+.+ +|.+++.. ...+++.+++.++.||+.||+|||+.|++||||||+||+++.++.  +||+|||++......
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~  161 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLP  161 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCc
Confidence            99999964 78887765 356999999999999999999999999999999999999986654  999999998765432


Q ss_pred             C-CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc--------------
Q 017936          173 S-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------  237 (363)
Q Consensus       173 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------  237 (363)
                      . ......+++.|+|||.+.+....+.++|||||||++|+|++|..||...+....+.........              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence            2 2223346888999999876544445599999999999999999999876654444333321100              


Q ss_pred             -cccCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          238 -VQYSIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       238 -~~~~~~~---------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                       .....+.         ....++++.+||++||+.||++|||+++++.||||.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence             0000000         1225888999999999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.9e-44  Score=322.06  Aligned_cols=251  Identities=36%  Similarity=0.522  Sum_probs=211.7

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|.+.+.||+|++|.||++.+..+++.+|+|.+....   .....+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5999999999999999999999999999999987642   2345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      +++++|.+++...  ..+++..+..++.|++.+|+|||++|++||||+|+||+++.++ ..++|+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK-MVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEccCCCceecCCCcccc
Confidence            9999999999764  3589999999999999999999999999999999999997543 248999999998654444444


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ...+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+.........    ... ..+....++.++.+++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~l~~li  233 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIM----SGT-FAPISDRYSPDLRQLI  233 (256)
T ss_pred             ccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHHH----hcC-CCCCCCCcCHHHHHHH
Confidence            5578999999999987766555 999999999999999999997765433332221    111 1122335789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCccc
Q 017936          257 SRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      .+||+.+|.+|||+.+++.||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-44  Score=321.89  Aligned_cols=251  Identities=31%  Similarity=0.465  Sum_probs=210.6

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC------cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      +|+..+.||+|++|+||++.+..+++.||+|.+....      ...+.+.+|+.+++.++||||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5888999999999999999998899999999986533      1335678899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      +||+++++|.+++.+.+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.  +||+|||++.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence            999999999999988888999999999999999999999999999999999999986654  999999998765444334


Q ss_pred             CccccCCCcCChhhhhcCC-CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....+++.|+|||.+.... ++.+ +|+|||||++|+|++|..||...........    .............+++++.+
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~-~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  233 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLA-ADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPIPDHLSDEAKD  233 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCch-hhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccCCCcCCCcCHHHHH
Confidence            4566899999999987666 5444 9999999999999999999976553222211    11111111122357899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccc
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ++++||+.+|.+|||+.+++.|||+
T Consensus       234 li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         234 FILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHhhcCcccCcCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.2e-44  Score=327.22  Aligned_cols=258  Identities=28%  Similarity=0.429  Sum_probs=202.5

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      +.++|++.+.||+|+||.||++.+..+++.||+|++....  .....+.+|+.+++.++|+||+++++++......++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999999999999999986543  22346678999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-C
Q 017936           97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~  174 (363)
                      ||+. ++|.+.+.. ...+++.++..++.||+.||.|||+.||+||||||+||+++.++.  ++|+|||+++...... .
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~  159 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQT  159 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCC
Confidence            9995 677666654 356889999999999999999999999999999999999986654  9999999987532221 2


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc------------c---
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------Q---  239 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------~---  239 (363)
                      .....+++.|+|||.+.+....+..+|||||||++|+|++|..||...................            .   
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence            2334578999999998764433344999999999999999999997654321111111100000            0   


Q ss_pred             ---cCC--C-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          240 ---YSI--P-------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       240 ---~~~--~-------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                         ...  +       .....+.++.+++.+||+.+|.+|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence               000  0       001136789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.2e-44  Score=320.88  Aligned_cols=250  Identities=31%  Similarity=0.511  Sum_probs=212.1

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|++++.||.|+||.||.+++..+++.+++|.+....   .....+.+|+.+++.++||||+++++++...+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            6999999999999999999999999999999886532   3345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CC
Q 017936           99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~  175 (363)
                      +++++|.+++.+.  ..+++.++..++.|++.||.|||+.|++||||+|+||+++.++.  +||+|||++....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence            9999999999765  46899999999999999999999999999999999999987654  9999999987543332 23


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||......+....    +...... +....++.++.++
T Consensus       159 ~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~  232 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVK----IVQGNYT-PVVSVYSSELISL  232 (256)
T ss_pred             cccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCC-CCccccCHHHHHH
Confidence            44568999999999887776655 8999999999999999999977554333322    2222222 2224578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      |.+||+.+|.+|||+.++++|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.1e-44  Score=327.71  Aligned_cols=258  Identities=31%  Similarity=0.406  Sum_probs=204.8

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCe-----
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTH-----   91 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~-----   91 (363)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.....   ....+.+|+.+++.++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            479999999999999999999999999999998765422   2356788999999995 6999999999987665     


Q ss_pred             EEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCc
Q 017936           92 LAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  166 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla  166 (363)
                      .|+||||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||+|+||+++.+ .+.+||+|||++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~-~~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ-KGLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC-CCeEEEeecccc
Confidence            8999999986 788877542     358999999999999999999999999999999999999862 235999999998


Q ss_pred             ccCccC-CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-----
Q 017936          167 KSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-----  240 (363)
Q Consensus       167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  240 (363)
                      ...... .......+++.|+|||.+.+......++|+||||+++|+|++|..||.+.+...........+.....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            754222 22233467889999999876544344599999999999999999999876655444333322110000     


Q ss_pred             --------CCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017936          241 --------SIP---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       241 --------~~~---------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                              ..+         ....++.++.+||.+||..+|.+|||+.+++.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                    000         0134789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.8e-44  Score=337.89  Aligned_cols=258  Identities=27%  Similarity=0.420  Sum_probs=207.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC------C
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~   90 (363)
                      .++|++.+.||+|+||.||++.+..+++.||+|++.+..   .....+.+|+.+++.++||||++++++|...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            478999999999999999999999999999999986532   2234567899999999999999999998654      3


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      ..|+||||+. ++|.+.+...  +++..+..++.||+.||+|||++||+||||||+||+++.++.  +||+|||+++...
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~  169 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  169 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCC
Confidence            5799999995 5888877654  899999999999999999999999999999999999987654  9999999998654


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh--------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------------  236 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------  236 (363)
                      .........+++.|+|||.+.+..++.+ +|||||||++|+|++|..||...+.......+.....              
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
T cd07850         170 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV  248 (353)
T ss_pred             CCCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence            4333344568899999999988888766 9999999999999999999986554333222221100              


Q ss_pred             ----ccccC--------------CCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          237 ----SVQYS--------------IPD-----YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       237 ----~~~~~--------------~~~-----~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                          .....              .+.     ....++.++++|.+||+.||.+|||+.|+|.||||....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~  318 (353)
T cd07850         249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY  318 (353)
T ss_pred             hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence                00000              000     112466789999999999999999999999999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.8e-44  Score=322.47  Aligned_cols=250  Identities=30%  Similarity=0.543  Sum_probs=210.2

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|++.+.||+|+||.||++++..+++.||+|.+...   ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            699999999999999999999999999999998653   22345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-C
Q 017936           99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~  175 (363)
                      +.+++|.+.+....  .+++.++..++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++........ .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence            99999999887643  5899999999999999999999999999999999999976654  99999999875433221 1


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....|++.|+|||.+.+...+.+ +|+|||||++|+|++|..||...........    +..... .+....++.++.++
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~l  232 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLK----IIRGSY-PPVSSHYSYDLRNL  232 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHHHH----HhcCCC-CCCcccCCHHHHHH
Confidence            23458889999999988776655 8999999999999999999976544333322    222221 12234578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      |.+||+.+|.+||++.++++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-44  Score=328.49  Aligned_cols=255  Identities=31%  Similarity=0.467  Sum_probs=206.4

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|++++.||.|++|.||++++..+++.||||.+.....   ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            48999999999999999999999999999998865322   235678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CC
Q 017936           99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP  175 (363)
Q Consensus        99 ~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~  175 (363)
                      +. ++|..++..  ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.  +||+|||++....... ..
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence            95 588888765  346899999999999999999999999999999999999987665  9999999987543221 12


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc--------------ccC
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QYS  241 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~  241 (363)
                      ....+++.|+|||.+.+....+.++|||||||++|+|+||..||...+......+........              ...
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            234578899999988766554555999999999999999999998765544333322211000              000


Q ss_pred             CC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          242 IP---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       242 ~~---------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ++         ....++++++++|.+||+.+|.+|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            01         012468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.3e-44  Score=321.82  Aligned_cols=256  Identities=31%  Similarity=0.504  Sum_probs=215.5

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.....  ....+.+|+..+..++||||+++++++...+.+++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            469999999999999999999999999999999876542  356788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC-
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-  176 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~-  176 (363)
                      +++++|.+++.....+++..++.++.|++.||+|||+ +|++||||+|+||+++.++.  ++|+|||++.......... 
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence            9999999999888889999999999999999999999 99999999999999976654  9999999987654333322 


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCC-CCHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHL  255 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~l  255 (363)
                      ...++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...... ........+.... ..+.... ++..+.++
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l  235 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGP-PPSLPAEEFSPEFRDF  235 (264)
T ss_pred             ceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCC-CCCCCcccCCHHHHHH
Confidence            4568899999999887766555 99999999999999999999776421 1122222222222 1222233 78999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      |++||..+|.+|||+.++++|||++.
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHh
Confidence            99999999999999999999999954

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.1e-44  Score=327.23  Aligned_cols=238  Identities=21%  Similarity=0.219  Sum_probs=198.0

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc----HHHHHHHHHHHcCCCCCeeeeeEEEEc----CCeEEEEEec
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEY   98 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~   98 (363)
                      ..||+|++|.||++..  +|+.||+|.+.......    +.+.+|+.++++++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999986  68899999987654333    556799999999999999999999876    3578999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      +++|+|.+++.+.+.++......++.|++.||.|||+ .+++||||||+|||++.++.  +||+|||+++....  ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~--~~~~  179 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILSS--PPFK  179 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhcc--cccc
Confidence            9999999999988889999999999999999999998 49999999999999987654  99999999875322  2234


Q ss_pred             cccCCCcCChhhhhc--CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          178 TVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ..|++.|+|||++.+  ..++.+ +|||||||++|+|++|..||...+......    .+.......+....+++++.+|
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k-~Di~SlGvil~el~~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~l~~l  254 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWEIFTGKIPFENLTTKEIYD----LIINKNNSLKLPLDCPLEIKCI  254 (283)
T ss_pred             ccCcccccCHHHhhhccccccch-hhhhHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcCCCCCCCCcCcHHHHHH
Confidence            568999999999976  456555 999999999999999999998765433322    2222222333333579999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 017936          256 ISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~  275 (363)
                      +.+||+.+|++|||+++++.
T Consensus       255 i~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        255 VEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHhcCCcccCcCHHHHHH
Confidence            99999999999999999975

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=313.56  Aligned_cols=255  Identities=29%  Similarity=0.450  Sum_probs=208.5

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC-----C
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP-----T   90 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~   90 (363)
                      ...++||+|.+.||+|||+-||++++..+++.||+|.+.... ...+...+|+...++++|||+++++++...+     .
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            445789999999999999999999999999999999987654 4567789999999999999999998876433     3


Q ss_pred             eEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCCEEEeCCCCCcEEEeecC
Q 017936           91 HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFG  164 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~g--iiHrDlkp~NIll~~~~~~~vkL~DFg  164 (363)
                      ..|++++|...|+|.+.+..    ...+++.++.+|+.+|++||++||+..  +.||||||.|||+..++.  .+|.|||
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~G  174 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLG  174 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEEecc
Confidence            48999999999999998864    235999999999999999999999999  999999999999987554  9999999


Q ss_pred             CcccCccCCCCC----------ccccCCCcCChhhhhcCC---CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 017936          165 YSKSSVLHSQPK----------STVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT  231 (363)
Q Consensus       165 la~~~~~~~~~~----------~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  231 (363)
                      .++.........          ....|..|+|||.+.-..   .+.+ +|||||||++|.|+.|..||...-....  ..
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er-tDIWSLGCtLYa~mf~~sPfe~~~~~Gg--Sl  251 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER-TDIWSLGCTLYAMMFGESPFERIYQQGG--SL  251 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc-cchhhhhHHHHHHHHcCCcchHHhhcCC--eE
Confidence            987544332222          124788999999986443   3455 8999999999999999999963111000  00


Q ss_pred             HHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       232 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .-.+...++.+|....+|+.+.+||+.||+.||.+||++.+++++
T Consensus       252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            011344567778777799999999999999999999999999864

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-44  Score=333.87  Aligned_cols=260  Identities=29%  Similarity=0.464  Sum_probs=203.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcC-----CeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~~~   92 (363)
                      +++|++.+.||+|+||.||++.+..+|+.||+|++...  ......+.+|+.+++.++||||+++++++...     ..+
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            57899999999999999999999999999999998642  22345677899999999999999999987644     358


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ++|+||+. ++|...+. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.  ++|+|||++......
T Consensus        84 ~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~  159 (336)
T cd07849          84 YIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPE  159 (336)
T ss_pred             EEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeecccc
Confidence            99999996 47877664 457999999999999999999999999999999999999976654  999999998754322


Q ss_pred             CC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHH-----------HHh-
Q 017936          173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-----------RIL-  236 (363)
Q Consensus       173 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-----------~~~-  236 (363)
                      ..    .....|++.|+|||.+.+....+.++|||||||++|+|++|+.||..............           .+. 
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            21    12346899999999876544334559999999999999999999976543222111110           000 


Q ss_pred             -------c---cccCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          237 -------S---VQYSIP---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       237 -------~---~~~~~~---~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                             .   .....+   ....+++++.++|.+||+.+|.+|||+.++++||||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                   0   000000   0124578899999999999999999999999999998765

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.3e-44  Score=321.25  Aligned_cols=251  Identities=32%  Similarity=0.478  Sum_probs=206.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC------cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL   92 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~   92 (363)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+....      ...+.+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57999999999999999999999999999999885422      1234677899999999999999999998763  568


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +++|||+++++|.+++.+...+++..+..++.|++.||+|||++|++||||||+||+++.++.  ++|+|||+++.....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~  159 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccc
Confidence            899999999999999988888999999999999999999999999999999999999976554  999999998743221


Q ss_pred             ----CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          173 ----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       173 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                          .......|+..|+|||.+.+..++.+ +|||||||++|+|++|..||..........    ...........+..+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~  234 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQPTNPVLPPHV  234 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccchHHHHH----HHhcCCCCCCCchhh
Confidence                11233458899999999987776555 999999999999999999997654333222    121111112223356


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +..+.++|++|+ .+|++|||+++++.|||+
T Consensus       235 ~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~  264 (265)
T cd06652         235 SDHCRDFLKRIF-VEAKLRPSADELLRHTFV  264 (265)
T ss_pred             CHHHHHHHHHHh-cChhhCCCHHHHhcCccc
Confidence            888999999999 499999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-44  Score=333.83  Aligned_cols=252  Identities=27%  Similarity=0.408  Sum_probs=190.8

Q ss_pred             eceecccCCeEEEEEEEcC--CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCeEEEEEeccCC
Q 017936           26 VRDIGSGNFGVARLMRDKK--TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG  101 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~  101 (363)
                      ...||+|+||+||+|++..  ++..||+|.+.... ....+.+|+.+++.++||||+++++++..  ...+++||||+. 
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            3679999999999999653  56789999886543 34567889999999999999999999854  567899999996 


Q ss_pred             CchHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC--CCCcEEEeecCCcccCc
Q 017936          102 GELFERICN---------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV  170 (363)
Q Consensus       102 ~~L~~~~~~---------~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~--~~~~vkL~DFgla~~~~  170 (363)
                      ++|.+.+..         ...+++..++.++.||+.||.|||++||+||||||+|||+..+  ..+.+||+|||+++...
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence            477777642         1248899999999999999999999999999999999999532  23469999999997543


Q ss_pred             cCC----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch---------HHHHHHHHH---
Q 017936          171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHR---  234 (363)
Q Consensus       171 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~---  234 (363)
                      ...    ......||+.|+|||++.+....+.++|||||||++|+|+||.+||......         .........   
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07867         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF  243 (317)
T ss_pred             CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence            222    1234568999999999977554455599999999999999999999754321         001100000   


Q ss_pred             --------Hh-------------ccccC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          235 --------IL-------------SVQYS--------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       235 --------~~-------------~~~~~--------~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                              ..             .....        .......+..+.+||.+||+.||.+|||++|+++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                    00             00000        00011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.1e-44  Score=328.60  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=198.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcC----------------CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeee
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVR   81 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~   81 (363)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|++.....  ....+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4689999999999999999998532                344799999876432  2356889999999999999999


Q ss_pred             eeEEEEcCCeEEEEEeccCCCchHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecC
Q 017936           82 FKEVILTPTHLAIVMEYASGGELFERICNAG-------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRD  142 (363)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------------~l~~~~~~~~~~qil~~L~~LH~~giiHrD  142 (363)
                      +++++...+..++||||+.+++|.+++....                   .++...++.++.||+.||.|||+.||+|||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d  163 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD  163 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            9999999999999999999999999886432                   367788999999999999999999999999


Q ss_pred             CCCCCEEEeCCCCCcEEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh--CCC
Q 017936          143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAY  217 (363)
Q Consensus       143 lkp~NIll~~~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~  217 (363)
                      |||+|||++.++.  +||+|||+++......   ......+++.|+|||++.+..++.+ +|||||||++|+|++  +..
T Consensus       164 lkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         164 LATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             cchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCC
Confidence            9999999986654  9999999987543221   1223345788999999988877666 999999999999986  667


Q ss_pred             CCCCCCchHHHHHHHHHHhc--cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017936          218 PFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       218 pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell  274 (363)
                      ||..................  ..........++..+.+|+.+||+.+|.+|||+++|.
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            88765443322221111111  1111122335689999999999999999999999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.4e-44  Score=327.30  Aligned_cols=257  Identities=33%  Similarity=0.467  Sum_probs=207.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~l   94 (363)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.+.....   ....+.+|+.+++.++||||+++++++...  +.+|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            3679999999999999999999999999999999875432   223567899999999999999999999877  88999


Q ss_pred             EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-
Q 017936           95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  172 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-  172 (363)
                      ||||+.+ +|.+.+.... .+++.+++.++.||+.||+|||++|++||||||+||+++.++.  ++|+|||++...... 
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~  160 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPL  160 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCc
Confidence            9999974 8988887644 5999999999999999999999999999999999999987654  999999998865433 


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------------
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------  237 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------  237 (363)
                      .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||..........+.......               
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            22234567899999999876554345599999999999999999999876554433332211100               


Q ss_pred             --cccC-------CCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          238 --VQYS-------IPDYVH--ISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       238 --~~~~-------~~~~~~--~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                        ....       ......  +++.+.++|++||+.+|++|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence              0000       000111  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.9e-44  Score=324.82  Aligned_cols=247  Identities=31%  Similarity=0.472  Sum_probs=197.3

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----cHHHHHHHHHH---HcCCCCCeeeeeEEEEcCCeEEEEEeccC
Q 017936           28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        28 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l---~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  100 (363)
                      .||+|+||.||++.+..+++.+|+|++.+....    .....++..++   ....||||+.+++++...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998754221    12233444333   34579999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCcccc
Q 017936          101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  180 (363)
Q Consensus       101 ~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~g  180 (363)
                      +++|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.  ++|+|||++...... ......|
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG  157 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence            9999999988888999999999999999999999999999999999999986654  999999998644322 2234568


Q ss_pred             CCCcCChhhhhcCC-CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017936          181 TPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI  259 (363)
Q Consensus       181 t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  259 (363)
                      ++.|+|||.+.++. ++.+ +|+||+||++|+|++|..||........ ............  ..+..++.++.++|++|
T Consensus       158 ~~~y~aPE~~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~li~~~  233 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNV--ELPDSFSPELKSLLEGL  233 (279)
T ss_pred             CcCccCHHHhcCCCCCCch-hhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCc--CCccccCHHHHHHHHHH
Confidence            99999999986443 4444 9999999999999999999976443221 111111111222  22345789999999999


Q ss_pred             cccCCCCCC-----CHHHHhcCccccc
Q 017936          260 FVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       260 L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      |..+|.+||     |++++++||||+.
T Consensus       234 l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         234 LQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             hcCCHHHhcCCCCCCHHHHHhCccccC
Confidence            999999999     6999999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-44  Score=341.43  Aligned_cols=250  Identities=23%  Similarity=0.372  Sum_probs=200.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCC
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPT   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~   90 (363)
                      ..++|++.+.||+|+||.||++++..     +++.||+|++.....  ..+.+.+|+.+++.+ +||||+++++++...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            35679999999999999999998644     335799999875432  235678899999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhC-----------------------------------------------------------
Q 017936           91 HLAIVMEYASGGELFERICNA-----------------------------------------------------------  111 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~-----------------------------------------------------------  111 (363)
                      .+++|||||.+|+|.+++...                                                           
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            999999999999999987532                                                           


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC---CCc
Q 017936          112 -----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKS  177 (363)
Q Consensus       112 -----------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~---~~~  177 (363)
                                 .++++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.......   ...
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeeccC
Confidence                       24788899999999999999999999999999999999986554  99999999875432211   112


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ..+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.............    ......+....+++++.+++
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li  348 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV----KRGYQMSRPDFAPPEIYSIM  348 (374)
T ss_pred             CCCccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----HcccCccCCCCCCHHHHHHH
Confidence            235667999999988777666 999999999999997 999997654433222222    22222233344689999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 017936          257 SRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~  275 (363)
                      .+||+.+|.+|||+.++++
T Consensus       349 ~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         349 KMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-45  Score=336.23  Aligned_cols=255  Identities=27%  Similarity=0.380  Sum_probs=200.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeec---CCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~l   94 (363)
                      .+..|+++++||+||.+.||+|.... .+.||+|.+..   +......+..|+.+|.+|+ |.+||+++++-..++.+|+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            46789999999999999999999754 45567665532   3344567899999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           95 VMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      ||||= ..+|..++.+... .+...++.|++|+|.|++++|+.||||.||||.|+|+-.   |.+||+|||+|.......
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk---G~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK---GRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe---eeEEeeeechhcccCccc
Confidence            99965 6799999987765 444689999999999999999999999999999999953   359999999998654433


Q ss_pred             ---CCCccccCCCcCChhhhhcCCCC----------CcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc
Q 017936          174 ---QPKSTVGTPAYIAPEVLLKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY  240 (363)
Q Consensus       174 ---~~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (363)
                         ...+.+||+.||+||.+....+.          +++|||||||||+|+|+.|+.||..-.   +...-+..+....-
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKLHAITDPNH  590 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHHHhhcCCCc
Confidence               33567899999999999754433          345999999999999999999995421   11222223333322


Q ss_pred             CCCCCCCC-CHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          241 SIPDYVHI-SPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       241 ~~~~~~~~-s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .++.+..- ..++.++++.||+.||++|||+.+||+|||++-
T Consensus       591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            22221111 233999999999999999999999999999965

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-46  Score=338.35  Aligned_cols=254  Identities=35%  Similarity=0.626  Sum_probs=220.1

Q ss_pred             cee--eceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           23 YEL--VRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        23 y~i--~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      |.|  -+.||+|.||+||-+++..+|+.||||++.+-   .+....+++|+.+|..+.||.||.+.-.|++.+.+++|||
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME  643 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME  643 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence            555  37899999999999999999999999999874   3345678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC-CCCcEEEeecCCcccCccCCC
Q 017936           98 YASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        98 ~~~~~~L~~~~~--~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~-~~~~vkL~DFgla~~~~~~~~  174 (363)
                      -+.| ++.+.+.  +.+++++...+.++.||+.||.|||.+||+|+||||+|||+... .-.++||||||+|+.......
T Consensus       644 Kl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  644 KLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             hhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            9965 5555553  45789999999999999999999999999999999999999653 345799999999998888888


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ..+.+|||.|+|||+++++.|+.. -|+||+|+|+|--+.|.+||....+-   .++++. ....+....|..+|+++.+
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdI---ndQIQN-AaFMyPp~PW~eis~~Aid  797 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDI---NDQIQN-AAFMYPPNPWSEISPEAID  797 (888)
T ss_pred             hhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccch---hHHhhc-cccccCCCchhhcCHHHHH
Confidence            889999999999999999999766 79999999999999999999765432   222221 1234455678899999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ||..+|+..-.+|.|++..+.|||++..
T Consensus       798 lIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  798 LINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            9999999999999999999999999763

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.5e-44  Score=322.09  Aligned_cols=249  Identities=22%  Similarity=0.335  Sum_probs=203.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc---CCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++.+.||+|+||.||++..+   ..+..||+|.+....  .....+.+|+..++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3567999999999999999999765   456789999987643  22356788999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +||||+++++|.+++... ..+++.+++.++.||+.||+|||++|++||||||+|||++.++.  ++++|||.+......
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~~  160 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCccccccccc
Confidence            999999999999998764 57999999999999999999999999999999999999976654  999999987643222


Q ss_pred             CCC--CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          173 SQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       173 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      ...  ....++..|+|||.+.+..++.+ +|||||||++|++++ |..||..........    .+. .....+....++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~  234 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIK----AVE-DGFRLPAPRNCP  234 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH----HHH-CCCCCCCCCCCC
Confidence            111  12235678999999988887666 999999999999775 999998765433222    222 222334455689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..+.+++.+||+.+|.+|||+++|++
T Consensus       235 ~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         235 NLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7e-46  Score=341.42  Aligned_cols=239  Identities=31%  Similarity=0.458  Sum_probs=213.9

Q ss_pred             eeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCc
Q 017936           24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE  103 (363)
Q Consensus        24 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~  103 (363)
                      .-++.||.|+.|.||+++.+  ++.||||.++      +.-..+|+-|++|+||||+.|.++|....++|||||||..|.
T Consensus       127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeecc--CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            34688999999999999854  6789999653      334567899999999999999999999999999999999999


Q ss_pred             hHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCCC
Q 017936          104 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA  183 (363)
Q Consensus       104 L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~  183 (363)
                      |...++..++++......|.++|+.|++|||...|||||||.-||||..+..  |||+|||.++...........+||..
T Consensus       199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVa  276 (904)
T KOG4721|consen  199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVA  276 (904)
T ss_pred             HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHh
Confidence            9999999999999999999999999999999999999999999999987776  99999999987666677778899999


Q ss_pred             cCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccC
Q 017936          184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD  263 (363)
Q Consensus       184 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~  263 (363)
                      |||||++.+.+.+.+ +|||||||+||||+||..||...+..    .+++.+-...+.+|-+..+++.++-|+++||+-.
T Consensus       277 WMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sK  351 (904)
T KOG4721|consen  277 WMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSK  351 (904)
T ss_pred             hhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHHHHHHhcC
Confidence            999999999888777 99999999999999999999765442    3555566667777888889999999999999999


Q ss_pred             CCCCCCHHHHhcCc
Q 017936          264 PAKRISIPEIRNHE  277 (363)
Q Consensus       264 p~~R~t~~ell~h~  277 (363)
                      |..||++.+++.|=
T Consensus       352 pRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  352 PRNRPSFRQILLHL  365 (904)
T ss_pred             CCCCccHHHHHHHH
Confidence            99999999999983

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.2e-44  Score=324.24  Aligned_cols=254  Identities=27%  Similarity=0.446  Sum_probs=201.5

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHH-HHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~-l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++.+.||+|+||.||++.++.+|+.||+|.+.....  ....+..|+.. ++.++||||+++++++...+.++++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            479999999999999999999999999999999876432  22344455554 677899999999999999999999999


Q ss_pred             ccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           98 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        98 ~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~-giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      |++ ++|.+.+..    ...+++..++.++.||+.||+|||++ +++||||||+||+++.++.  +||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence            996 577766643    34689999999999999999999997 9999999999999986654  999999998754333


Q ss_pred             CCCCccccCCCcCChhhhhc----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhccccCCCCCCC
Q 017936          173 SQPKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      .......++..|+|||.+.+    ..++.+ +|+|||||++|+|++|..||...... ......   ........+. ..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-~~  232 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTPFQQLKQV---VEEPSPQLPA-EK  232 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCcc-ccchhhHHHHHHHHhCCCCCCccccCHHHHHHH---HhcCCCCCCc-cc
Confidence            22333568899999998865    233444 89999999999999999999653321 222111   1111222222 24


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +|.++.++|.+||..+|.+|||+++++.||||.+.
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            78999999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-44  Score=326.02  Aligned_cols=256  Identities=30%  Similarity=0.511  Sum_probs=208.8

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+...   ......+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            4799999999999999999999999999999988653   2334678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--CC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--~~  175 (363)
                      |+.++.+..+..+...+++.+++.++.||+.||.|||+.|++||||+|+||+++.++.  +||+|||++.......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL  158 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence            9998777766666677999999999999999999999999999999999999986554  9999999987654433  22


Q ss_pred             CccccCCCcCChhhhhcC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc----------c--cc--
Q 017936          176 KSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----------V--QY--  240 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~--~~--  240 (363)
                      ....++..|+|||++.+. .++ .++|+||||+++|+|++|..||......+...........          .  .+  
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~-~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYG-KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            345678999999999877 444 4499999999999999999999866544332222110000          0  00  


Q ss_pred             -CCC-----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          241 -SIP-----------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       241 -~~~-----------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                       ..+           ....++.++.+||++||..+|++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             000           011248899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.5e-44  Score=323.55  Aligned_cols=258  Identities=28%  Similarity=0.462  Sum_probs=207.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~   96 (363)
                      ++|...+.||.|++|.||++.+..+++.+|+|.+.....  ....+.+|+.+++.++||||+++++++...  +.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            479999999999999999999999999999999876433  345688999999999999999999988654  4789999


Q ss_pred             eccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++.  ++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~  158 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS  158 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence            99999999887643    345899999999999999999999999999999999999986654  999999998654322


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhccc-cCC----CCCC
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQ-YSI----PDYV  246 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~-~~~----~~~~  246 (363)
                      . .....++..|+|||.+.+..++.+ +|||||||++|+|++|..||...... ....+....+.... ...    +...
T Consensus       159 ~-~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd06621         159 L-AGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI  236 (287)
T ss_pred             c-cccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence            2 223457889999999988777766 99999999999999999999865220 00111111111111 111    1112


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .+++.+.+||.+||..+|.+|||+.|++.||||++.
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             chHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            356789999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.9e-44  Score=334.01  Aligned_cols=261  Identities=27%  Similarity=0.452  Sum_probs=208.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEc----CCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----~~~~   92 (363)
                      .++|++.+.||+|++|.||++.++.+++.||+|++....   .....+.+|+.+++.++||||+++++++..    ...+
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999999999999999987542   234567789999999999999999998763    3578


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ++||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++......
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~  160 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeeccc
Confidence            99999995 589998887778999999999999999999999999999999999999986654  999999998754322


Q ss_pred             CC-----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHH-------------
Q 017936          173 SQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------  234 (363)
Q Consensus       173 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------  234 (363)
                      ..     .....|+..|+|||.+.+......++|||||||++|+|++|+.||...........+...             
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            21     123468899999999866443345599999999999999999999765443222111110             


Q ss_pred             ------Hhc-cc--cCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          235 ------ILS-VQ--YSIP---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       235 ------~~~-~~--~~~~---~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                            ... ..  ...+   .....+.++.++|++||+.+|.+|||+++++.||||.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence                  000 00  0000   0134689999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-44  Score=329.49  Aligned_cols=257  Identities=27%  Similarity=0.372  Sum_probs=201.4

Q ss_pred             CceeeceecccCCeEEEEEEEcC--CCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKK--TEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA   93 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~   93 (363)
                      +|.+.+.||+|++|.||++.+..  +++.||+|.+....    ...+...+|+.+++.++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  89999999987632    3346678899999999999999999999988  8899


Q ss_pred             EEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC--CCcEEEeecCCc
Q 017936           94 IVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYS  166 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~--~~~vkL~DFgla  166 (363)
                      +||||+++ +|.+.+...     ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999965 676665422     2689999999999999999999999999999999999997611  345999999998


Q ss_pred             ccCccCCC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH---------HHHHHHH
Q 017936          167 KSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---------NFRKTIH  233 (363)
Q Consensus       167 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---------~~~~~~~  233 (363)
                      ........    .....+++.|+|||++.+......++|||||||++|+|++|++||.......         .......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            75432221    2344678999999998775543455999999999999999999997654321         0111100


Q ss_pred             HHh----------------------ccccCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          234 RIL----------------------SVQYSIP---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       234 ~~~----------------------~~~~~~~---------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ...                      ......+         .....+.++.++|.+||+.+|++|||+.|++.||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            000                      0000000         011467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.5e-44  Score=333.10  Aligned_cols=260  Identities=29%  Similarity=0.459  Sum_probs=207.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcC-----Ce
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~~   91 (363)
                      .++|++.+.||+|+||+||++++..+++.||||.+...   ......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            46899999999999999999999999999999998653   22234567899999999999999999988654     35


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      +|+|+||+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++.....
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~  160 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSE  160 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCC
Confidence            899999995 689999988888999999999999999999999999999999999999986654  99999999875533


Q ss_pred             C-CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHH----------------
Q 017936          172 H-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR----------------  234 (363)
Q Consensus       172 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------------  234 (363)
                      . .......++..|+|||.+.+....+.++|||||||++|+|++|..||...+...........                
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            3 22234468899999999875433344599999999999999999999765432211111100                


Q ss_pred             ---Hhc---cccC---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          235 ---ILS---VQYS---IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       235 ---~~~---~~~~---~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                         ...   ....   ......+++++.++|++||+.+|.+|||++++++||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence               000   0000   00123578999999999999999999999999999999653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-43  Score=323.22  Aligned_cols=259  Identities=30%  Similarity=0.469  Sum_probs=206.9

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++.+.||+|++|+||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++.....+++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57999999999999999999999999999999886542   223567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-C
Q 017936           98 YASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q  174 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~  174 (363)
                      |++ ++|.+.+.....  +++..++.++.||+.||+|||++|++||||+|+||+++..+ +.+||+|||++....... .
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~-~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-CEEEEcccccccccCCCccc
Confidence            995 578887765443  58889999999999999999999999999999999997543 249999999987543221 1


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc--------------cc
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QY  240 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~  240 (363)
                      .....+++.|+|||.+.+......++|||||||++|+|+||..||...+..+............              ..
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS  239 (294)
T ss_pred             cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence            2334678999999998765544445999999999999999999998765544333322111000              00


Q ss_pred             CCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          241 SIP---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       241 ~~~---------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ..+         ....+++++.+++.+||+.+|++||++.+++.||||..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence            000         12346889999999999999999999999999999964

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-45  Score=352.15  Aligned_cols=251  Identities=29%  Similarity=0.475  Sum_probs=211.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC-CcccHHHHHHHHHHHcCC-CCCeeeeeEE-EEc---C---C
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLR-HPNIVRFKEV-ILT---P---T   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~e~~~l~~l~-hpnIv~~~~~-~~~---~---~   90 (363)
                      ..+++|.+.|-+|||+.||+|++...+..||+|.+... ....+.+.+|+.+|+.|+ |||||.+++. ...   +   -
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            55789999999999999999999988899999987654 344577899999999997 9999999993 221   1   2


Q ss_pred             eEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCCEEEeCCCCCcEEEeecCCc
Q 017936           91 HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS  166 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~L~~LH~~g--iiHrDlkp~NIll~~~~~~~vkL~DFgla  166 (363)
                      .++|.||||.||.|.+++..  ...|++.+|++|+.++++|+.+||.++  |||||||-+||||..++.  .||||||.|
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCccccc
Confidence            57899999999999999974  345999999999999999999999998  999999999999987665  999999998


Q ss_pred             ccCccCCCC----------CccccCCCcCChhhhh---cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 017936          167 KSSVLHSQP----------KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH  233 (363)
Q Consensus       167 ~~~~~~~~~----------~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  233 (363)
                      .........          .....|+.|+|||++.   +...+.+ +|||+|||+||-||+...||......        
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~sg~l--------  264 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEESGKL--------  264 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence            754333211          1235899999999874   4556566 99999999999999999999875332        


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       234 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .|+...+.+|.+..++..+.+||+.||+.+|.+||++-+++.+-+-..
T Consensus       265 aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  265 AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence            367889999999999999999999999999999999999987766543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.2e-44  Score=338.57  Aligned_cols=250  Identities=25%  Similarity=0.369  Sum_probs=201.5

Q ss_pred             CCCceeeceecccCCeEEEEEEE-----cCCCcEEEEEEeecCC--cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~   91 (363)
                      .++|++.+.||+|+||+||+|+.     ..++..||+|++....  ...+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45899999999999999999974     3456789999986543  2335678899999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCC-----------------------------------------------------------
Q 017936           92 LAIVMEYASGGELFERICNAG-----------------------------------------------------------  112 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~-----------------------------------------------------------  112 (363)
                      .++|||||++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999886422                                                           


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--
Q 017936          113 ----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--  174 (363)
Q Consensus       113 ----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--  174 (363)
                                      .+++..+..++.||+.||.|||++||+||||||+|||++.+..  +||+|||+++.......  
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCccccc
Confidence                            3678889999999999999999999999999999999986554  99999999875432221  


Q ss_pred             -CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       175 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                       .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||..........+.+.    .......+...+.++
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l  346 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK----EGYRMLSPECAPSEM  346 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH----hCccCCCCCCCCHHH
Confidence             112335667999999988877666 999999999999998 8999976554333333222    122222233468899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcC
Q 017936          253 RHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .+||.+||+.+|++|||+.++++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.1e-44  Score=328.75  Aligned_cols=257  Identities=26%  Similarity=0.466  Sum_probs=212.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ..+.|.....||+|+||.||++.+..+++.||||.+.... ...+.+.+|+..++.++||||+++++.+...+..++|||
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            4566788899999999999999999999999999886533 234567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~  176 (363)
                      |+++++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+||+++.++.  ++|+|||++...... ....
T Consensus       100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~  176 (292)
T cd06658         100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRK  176 (292)
T ss_pred             CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCc
Confidence            9999999887754 46899999999999999999999999999999999999986654  999999998643222 1223


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ...|++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........... +...  .....+....++..+.+++
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~li  252 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDN--LPPRVKDSHKVSSVLRGFL  252 (292)
T ss_pred             eeecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhc--CCCccccccccCHHHHHHH
Confidence            4568999999999987777655 9999999999999999999987554332222 1111  1222233335688999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccc
Q 017936          257 SRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .+||..+|.+|||+++++.||||...
T Consensus       253 ~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         253 DLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             HHHccCChhHCcCHHHHhhChhhhcc
Confidence            99999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=346.08  Aligned_cols=252  Identities=31%  Similarity=0.478  Sum_probs=212.3

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecC-CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCchH
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF  105 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (363)
                      -+||+|.||+||.+++..+....|||-+... ....+-+..||.+.++|+|.|||++++.+..++.+-+.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            4699999999999999999999999988643 344456789999999999999999999999999999999999999999


Q ss_pred             HHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC-ccCCCCCccccC
Q 017936          106 ERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVGT  181 (363)
Q Consensus       106 ~~~~~~-~~l--~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~-~~~~~~~~~~gt  181 (363)
                      .++... +++  +|..+..|.+||++||.|||.+.|||||||-+|+||+.- .|.+||+|||.++.. .......+..||
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy-SGvlKISDFGTsKRLAginP~TETFTGT  739 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY-SGVLKISDFGTSKRLAGINPCTETFTGT  739 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec-cceEEecccccchhhccCCccccccccc
Confidence            999865 456  888999999999999999999999999999999999753 356999999998754 334445667799


Q ss_pred             CCcCChhhhhcCC-CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          182 PAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       182 ~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      ..|||||++..+. -.++++|||||||++.||.||++||.....+....-   ++--.....|.+..+|.++++||.+|+
T Consensus       740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF---kVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF---KVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh---hhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            9999999996543 346779999999999999999999987766543321   211112233444568999999999999


Q ss_pred             ccCCCCCCCHHHHhcCcccccc
Q 017936          261 VADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       261 ~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .++|..||++.++|..||++..
T Consensus       817 epd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCCcccCccHHHhccCcccccC
Confidence            9999999999999999999764

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-45  Score=342.65  Aligned_cols=256  Identities=25%  Similarity=0.434  Sum_probs=215.0

Q ss_pred             CCCCc-eeeceecccCCeEEEEEEEcCCCcEEEEEEee-----cCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC--
Q 017936           19 DSDRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--   90 (363)
Q Consensus        19 ~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~-----~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~--   90 (363)
                      ...|| +....||+|+|-+||+|.|..+|..||--.++     ++....+++..|+.+|+.|+|||||+++..+.+..  
T Consensus        37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~  116 (632)
T KOG0584|consen   37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK  116 (632)
T ss_pred             CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence            35677 55789999999999999999999888854332     33444578999999999999999999999998765  


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~g--iiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      .+.+|+|++..|+|..++++.+.++...++.|++||+.||.|||++.  |||||||++||||+.+ .|.|||+|.|||+.
T Consensus       117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLATL  195 (632)
T ss_pred             eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHHHH
Confidence            48999999999999999999999999999999999999999999885  9999999999999854 56799999999986


Q ss_pred             CccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                      .... ...+.+|||.|||||+.. ..|+.. +||||||++++||+|+..||.....+..   +.+++..+........--
T Consensus       196 ~r~s-~aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQ---IYKKV~SGiKP~sl~kV~  269 (632)
T KOG0584|consen  196 LRKS-HAKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQ---IYKKVTSGIKPAALSKVK  269 (632)
T ss_pred             hhcc-ccceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHH---HHHHHHcCCCHHHhhccC
Confidence            5433 335589999999999886 677766 9999999999999999999988776553   444444443322222333


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .+++++||.+||.. .+.|||+.|||.||||...
T Consensus       270 dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  270 DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            78999999999988 8999999999999999764

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-43  Score=315.72  Aligned_cols=252  Identities=34%  Similarity=0.502  Sum_probs=214.0

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeEEEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM   96 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~   96 (363)
                      +|++.+.||+|++|.||++.+..+++.|++|++....   ...+.+.+|+..+++++||||+++++.+...  ..+++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5889999999999999999999999999999987654   3456788999999999999999999999988  8999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--  174 (363)
                      ||+++++|.+++.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++  .++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEcccccEEecccccccc
Confidence            9999999999998888999999999999999999999999999999999999998755  499999999886554433  


Q ss_pred             -CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                       .....++..|+|||.+.+...+.+ +||||||+++|+|++|..||.......   .....+............++..+.
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPM---AALYKIGSSGEPPEIPEHLSEEAK  234 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHhccccCCCcCCCcccCHHHH
Confidence             345678999999999987776555 999999999999999999998765222   122222211122222335689999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ++|.+||+.+|.+||++.+++.||||
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         235 DFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=311.20  Aligned_cols=259  Identities=26%  Similarity=0.389  Sum_probs=210.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc--cHHHHHHHHHHHc-CCCCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .++.+.+..||.|+.|+||+++.+.+|...|||.+.+....  .++++..+.++.. -++|+||+.+++|..+..+++.|
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            45567789999999999999999999999999999876432  2344445544433 35899999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      |.+ +.-+..++.+ .++++|.-+-++...++.||.||.. .||||||+||+|||+|+.++  +||||||+|........
T Consensus       171 elM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  171 ELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeecccc
Confidence            988 3344444443 4579999999999999999999996 58999999999999988776  99999999987766666


Q ss_pred             CCccccCCCcCChhhhhc---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhccccCCCCCCCCCH
Q 017936          175 PKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                      .....|.+.|||||.+.-   ..|+-+ +||||||++++||.||+.||.+.... +.+-+++.   .....++....+|+
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~ePP~L~~~~gFSp  323 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EEPPLLPGHMGFSP  323 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cCCCCCCcccCcCH
Confidence            677789999999999853   457777 89999999999999999999875432 22222222   33345566666999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccccccCCC
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA  285 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~~~  285 (363)
                      ++++|+..||++|+.+||...++|+|||+....+.
T Consensus       324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a  358 (391)
T KOG0983|consen  324 DFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA  358 (391)
T ss_pred             HHHHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence            99999999999999999999999999999876443

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-43  Score=321.63  Aligned_cols=255  Identities=29%  Similarity=0.494  Sum_probs=206.8

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      +|++.+.||.|++|.||++++..+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            58999999999999999999999999999999876432  2456678999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CC
Q 017936          100 SGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP  175 (363)
Q Consensus       100 ~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~  175 (363)
                      .+ +|.+++...   ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.  ++|+|||++....... ..
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence            75 888877654   35899999999999999999999999999999999999986654  9999999987543221 12


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc--------------cccC
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------VQYS  241 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~  241 (363)
                      ....+++.|+|||.+.+......++|||||||++|+|++|..||...+..+...........              ....
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            33457889999999876554445599999999999999999999877655444333221100              0000


Q ss_pred             CCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          242 IPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       242 ~~~---------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      .+.         ...++..+.++|.+||+.+|.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            010         12357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-44  Score=321.80  Aligned_cols=253  Identities=28%  Similarity=0.481  Sum_probs=207.7

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEEEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .|++.+.||+|+||.||++.+..+++.||+|.+....  .....+.+|+.+++.++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5889999999999999999999999999999986532  23456778999998886   999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-C
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~  175 (363)
                      ||+.+++|.+++.. +.+++..++.++.|++.||.|||+.||+||||+|+||+++.++  .++|+|||++........ .
T Consensus        82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG--NVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC--CEEEccCCceeecCCCcccc
Confidence            99999999988865 4799999999999999999999999999999999999998755  499999999875443322 2


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-CCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~  254 (363)
                      ....|+..|+|||.+.++...+.++|+|||||++|+|++|..||..........    .+..... ..+ ...++.++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~  233 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM----LIPKSKPPRLE-DNGYSKLLRE  233 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh----ccccCCCCCCC-cccCCHHHHH
Confidence            334688999999998765543445999999999999999999997654322211    1111111 111 1136889999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ++.+||+.+|.+|||+.+++.|+||++.
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            9999999999999999999999999664

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9.8e-44  Score=321.74  Aligned_cols=253  Identities=29%  Similarity=0.462  Sum_probs=209.7

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..|+.++.||.|+||.||++.+..+++.+|+|++....  .....+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35889999999999999999999999999999987543  2345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~  177 (363)
                      ++|++|.+++.. +++++.++..++.|++.||.|||+.|++|+||+|+||+++.++.  ++|+|||++....... ....
T Consensus        84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCcccccc
Confidence            999999998865 56899999999999999999999999999999999999986654  9999999987543322 1223


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      ..++..|+|||.+.+..++.+ +|+|||||++|+|++|..||..........    .+.. .........++..+.+++.
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~  234 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLF----LIPK-NNPPTLTGEFSKPFKEFID  234 (277)
T ss_pred             ccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhh----hhhc-CCCCCCchhhhHHHHHHHH
Confidence            457889999999987777655 999999999999999999997654322211    1111 1111122346788999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccc
Q 017936          258 RIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +||+.+|++||++++++.|+||.+.
T Consensus       235 ~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         235 ACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             HHcccCcccCcCHHHHHhChHhhhc
Confidence            9999999999999999999999653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.6e-43  Score=325.05  Aligned_cols=262  Identities=28%  Similarity=0.460  Sum_probs=204.0

Q ss_pred             CCCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      +++....++|++.+.||+|+||.||++.+..+++.||+|.+....   .......+|+.+++.++||||+++++++....
T Consensus         5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865           5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             CcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            445555678999999999999999999999999999999886532   22345578999999999999999999987643


Q ss_pred             --------eEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEe
Q 017936           91 --------HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC  161 (363)
Q Consensus        91 --------~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~  161 (363)
                              ..++||||+. ++|.+.+.... .+++.+++.++.||+.||+|||+.|++||||||+||+++.++.  +||+
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~  161 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKLA  161 (310)
T ss_pred             ccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEEC
Confidence                    4699999996 47877776543 6899999999999999999999999999999999999976654  9999


Q ss_pred             ecCCcccCccCCC-----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh
Q 017936          162 DFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL  236 (363)
Q Consensus       162 DFgla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  236 (363)
                      |||++........     .....++..|+|||.+.+....+.++||||||+++|+|++|..||.......... .+..+.
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~~  240 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQLC  240 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHh
Confidence            9999875432221     1234578899999998765533445999999999999999999997655432221 111111


Q ss_pred             ccc----------------cCCCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          237 SVQ----------------YSIPD-----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       237 ~~~----------------~~~~~-----------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ...                ...+.           ....+..+.+||.+||+.+|.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            000                00000           01135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.7e-43  Score=317.02  Aligned_cols=250  Identities=33%  Similarity=0.507  Sum_probs=207.6

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCeEEEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVM   96 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~   96 (363)
                      +|++.+.||.|+||.||++.+..+++.||+|.+.....   ..+.+..|+.+++.++||||+++++++..  ...++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            58999999999999999999999999999999865432   23457789999999999999999998764  45689999


Q ss_pred             eccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HcCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936           97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus        97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH-----~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      ||+++++|.+++..    ..++++..++.++.||+.||.|||     +.+++||||+|+||+++.++.  +||+|||++.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~  158 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK  158 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccc
Confidence            99999999998865    357999999999999999999999     899999999999999986654  9999999988


Q ss_pred             cCccCCC-CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          168 SSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       168 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                      ....... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .   ....+..... .+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~-~---~~~~~~~~~~-~~~~~  232 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQL-Q---LASKIKEGKF-RRIPY  232 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCHH-H---HHHHHhcCCC-CCCcc
Confidence            6544332 334568999999999987776555 99999999999999999999876532 2   2222222221 12233


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      .++..+.+++.+||+.+|.+|||+.++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            578999999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.2e-43  Score=320.82  Aligned_cols=255  Identities=29%  Similarity=0.500  Sum_probs=211.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .+|...+.||+|++|.||++.+..+++.+|+|.+..... ..+.+.+|+.+++.++||||+++++++...+..++++||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            467778899999999999999999999999998865332 2345788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCcc
Q 017936          100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST  178 (363)
Q Consensus       100 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~~  178 (363)
                      .+++|.+++.. .++++.++..++.|++.||+|||++|++||||+|+||+++.++.  ++|+|||++....... .....
T Consensus        99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCcccccc
Confidence            99999998877 67999999999999999999999999999999999999986654  9999999876432221 22334


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-ccCCCCCCCCCHHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~  257 (363)
                      .|++.|+|||.+.+..++.+ +|||||||++|+|++|..||...+.......    +... .........++..+.+|+.
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~  250 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR----IRDNLPPKLKNLHKVSPRLRSFLD  250 (285)
T ss_pred             cCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH----HHhcCCCCCcccccCCHHHHHHHH
Confidence            68999999999988777666 9999999999999999999976544322222    2211 1122223347899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCccccccC
Q 017936          258 RIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      +||+.+|++|||+.+++.||||.+..
T Consensus       251 ~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         251 RMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             HHcccChhhCcCHHHHccCcccccCC
Confidence            99999999999999999999997754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-43  Score=317.60  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=206.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      ...|.+.+.||+|+||.||++.+..+++.+|+|.+.........+.+|+..++.++||||+++++++...+.++++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45699999999999999999999999999999998766555567889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC--
Q 017936          100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--  175 (363)
Q Consensus       100 ~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~--  175 (363)
                      .+++|.+++...  ..+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||++.........  
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~~  162 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAH  162 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeecc
Confidence            999999998754  35899999999999999999999999999999999999976554  999999998754332211  


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||......+....    + ......+....++.++.+
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~  236 (263)
T cd05052         163 AGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----L-EKGYRMERPEGCPPKVYE  236 (263)
T ss_pred             CCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----H-HCCCCCCCCCCCCHHHHH
Confidence            12234567999999988777666 999999999999998 9999976544322222    1 122233344567899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017936          255 LISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~  275 (363)
                      +|.+||+.+|++|||+.++++
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=318.32  Aligned_cols=245  Identities=33%  Similarity=0.520  Sum_probs=199.9

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----cHHHHHHHH-HHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||.|+||.||+|.+..+++.||+|++.+....    ...+..|.. .....+||||+++++++...+.+|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999999999999999998754321    122334433 34566899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccC
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT  181 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt  181 (363)
                      ++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.  ++|+|||++.....   .....++
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~  156 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGT  156 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCC
Confidence            999999988888999999999999999999999999999999999999986654  99999999875332   3345688


Q ss_pred             CCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC--CCCCCCCHHHHHHHHHh
Q 017936          182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRI  259 (363)
Q Consensus       182 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~  259 (363)
                      +.|+|||.+.+..++.+ +||||||+++|+|++|..||...+.......    +.......  .....+++++.++|.+|
T Consensus       157 ~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~i~~~  231 (260)
T cd05611         157 PDYLAPETILGVGDDKM-SDWWSLGCVIFEFLFGYPPFHAETPDAVFDN----ILSRRINWPEEVKEFCSPEAVDLINRL  231 (260)
T ss_pred             cCccChhhhcCCCCcch-hhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcccCCCCcccccCCHHHHHHHHHH
Confidence            99999999987776555 9999999999999999999976554332222    22222111  22235789999999999


Q ss_pred             cccCCCCCC---CHHHHhcCccccc
Q 017936          260 FVADPAKRI---SIPEIRNHEWFLK  281 (363)
Q Consensus       260 L~~~p~~R~---t~~ell~h~~~~~  281 (363)
                      |+.+|.+||   +++|+++||||.+
T Consensus       232 l~~~p~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         232 LCMDPAKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             ccCCHHHccCCCcHHHHHcChHhhc
Confidence            999999999   5589999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=322.42  Aligned_cols=254  Identities=31%  Similarity=0.467  Sum_probs=206.1

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      |++.+.||.|++|.||++.+..+|+.||+|++....   .....+.+|+..++.++||||+++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            778999999999999999999999999999987543   22356788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCC
Q 017936          100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  176 (363)
Q Consensus       100 ~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~  176 (363)
                      + ++|.+++....  .+++..+..++.|++.||+|||++|++||||+|+||+++.++  .++|+|||++....... ...
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--cEEEeecccccccCCCccccC
Confidence            5 68999987766  699999999999999999999999999999999999998755  49999999987543221 223


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc--------------cccCC
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------VQYSI  242 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~  242 (363)
                      ...+++.|+|||++.+......++|+||||+++|+|++|..||...+..............              .....
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            3457889999998876543344499999999999999999999876554333332221000              00000


Q ss_pred             ---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          243 ---------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       243 ---------~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                               .....++..+.++|.+||+.+|.+|||+++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                     1123567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.8e-43  Score=312.07  Aligned_cols=251  Identities=31%  Similarity=0.503  Sum_probs=212.4

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccC
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  100 (363)
                      .|.+.+.||+|++|.||++.+..+++.+++|++..... ....+.+|+..++.++||||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            48899999999999999999998999999999877543 45678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccc
Q 017936          101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV  179 (363)
Q Consensus       101 ~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~  179 (363)
                      +++|.+++... ..+++..++.++.|++.||.+||++|++||||+|+||+++.++  .++|+|||.+.............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG--EVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC--eEEEeecccccccccccccccee
Confidence            99999998776 5799999999999999999999999999999999999998655  49999999987654433234567


Q ss_pred             cCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017936          180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI  259 (363)
Q Consensus       180 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  259 (363)
                      ++..|+|||.+.+...+.+ +|+||||+++|+|++|..||...+..........   ......+....++..+.++|++|
T Consensus       159 ~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~  234 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFLKKC  234 (253)
T ss_pred             cCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCcccccCHHHHHHHHHH
Confidence            8999999999987776555 9999999999999999999986543322222111   12222333334589999999999


Q ss_pred             cccCCCCCCCHHHHhcCcc
Q 017936          260 FVADPAKRISIPEIRNHEW  278 (363)
Q Consensus       260 L~~~p~~R~t~~ell~h~~  278 (363)
                      |+.+|.+|||+.+++.|||
T Consensus       235 l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         235 LQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ccCChhhCCCHHHHhcCCC
Confidence            9999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.6e-44  Score=325.02  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=202.8

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|...+.||+|+||.||++.+..+++.+|+|.+....  .....+.+|+..+.++. ||||+++++++..++..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            46788899999999999999999999999999987543  23346778998898886 9999999999999999999999


Q ss_pred             ccCCCchHHH---HH--hCCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           98 YASGGELFER---IC--NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        98 ~~~~~~L~~~---~~--~~~~l~~~~~~~~~~qil~~L~~LH~~-giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      |+.+ ++.++   +.  ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.  ++|+|||+++....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhcc
Confidence            9854 54443   22  235699999999999999999999974 9999999999999986654  99999999875544


Q ss_pred             CCCCCccccCCCcCChhhhhcC---CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc-cCC--CCC
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSI--PDY  245 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~--~~~  245 (363)
                      ........|++.|+|||.+.+.   .++.+ +|||||||++|+|++|..||.....   ....+....... ...  ...
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVR-SDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGDPPILSNSEE  236 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcch-hhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcCCCCCcCCCcCC
Confidence            3333455789999999998766   34444 9999999999999999999975432   111222222111 111  122


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          246 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ..++.++.+||.+||+.+|.+|||+++++.||||..
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            357899999999999999999999999999999965

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.1e-44  Score=323.05  Aligned_cols=248  Identities=23%  Similarity=0.374  Sum_probs=204.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCC-----cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTE-----ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ++|++.+.||+|+||.||++.....+     +.+|+|.+....  .....+.+|+..++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            47999999999999999999976555     679999886543  23356789999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCc
Q 017936           94 IVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR  157 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~  157 (363)
                      ++|||+++++|.+++...                ..+++.+++.++.||+.||.|||++|++||||||+||+++.++.  
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~--  162 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT--  162 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc--
Confidence            999999999999998764                45788999999999999999999999999999999999986654  


Q ss_pred             EEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017936          158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH  233 (363)
Q Consensus       158 vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~  233 (363)
                      ++|+|||+++......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+....+..    .
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~~----~  237 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVI----E  237 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----H
Confidence            9999999987542221   2233456888999999988777666 999999999999998 99999876543322    2


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       234 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .+.... ..+....++.++.+|+.+||+.+|.+|||+.+++++
T Consensus       238 ~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            222221 223345679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.5e-43  Score=315.02  Aligned_cols=247  Identities=33%  Similarity=0.519  Sum_probs=206.0

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      +|++.+.||+|+||.||++.+..+++.||+|.+...  ....+.+.+|+.+++.++||||+++++.+.+.+.+++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            589999999999999999999999999999998643  233466788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCC
Q 017936          100 SGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  176 (363)
Q Consensus       100 ~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~  176 (363)
                      ++++|.+++..  ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.  ++|+|||++....... ...
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence            99999998864  345899999999999999999999999999999999999976654  9999999987543322 223


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ...|++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+....    ...+..... .+....++..+.+||
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~li  232 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNL----ILKVCQGSY-KPLPSHYSYELRSLI  232 (255)
T ss_pred             cccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHH----HHHHhcCCC-CCCCcccCHHHHHHH
Confidence            4568899999999987776655 9999999999999999999986543222    222222222 122345789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcC
Q 017936          257 SRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h  276 (363)
                      .+||+.+|.+|||+.++++-
T Consensus       233 ~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         233 KQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.7e-44  Score=330.15  Aligned_cols=258  Identities=31%  Similarity=0.464  Sum_probs=211.0

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-----eEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA   93 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-----~~~   93 (363)
                      +|++.+.||.|++|.||+|++..+++.||+|.+....   ...+.+.+|+..++.++||||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6999999999999999999999999999999887642   23456888999999999999999999998775     789


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      ++|||+. ++|.+.+.+...+++..++.++.||+.||++||+.||+||||||+|||++.++  .++|+|||++.......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~--~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC--DLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccCceEeecccc
Confidence            9999997 58999988878899999999999999999999999999999999999998764  49999999998654432


Q ss_pred             ----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc----------
Q 017936          174 ----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------  239 (363)
Q Consensus       174 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  239 (363)
                          ......+++.|+|||.+.+....+.++|+||||+++|+|++|..||......+....+........          
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence                233456899999999998773334449999999999999999999987665433332222110000          


Q ss_pred             ----------c--C---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          240 ----------Y--S---IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       240 ----------~--~---~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                .  .   ......++.++.++|.+||+.+|.+|||+++++.||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence                      0  0   00112368899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.5e-43  Score=316.45  Aligned_cols=256  Identities=30%  Similarity=0.459  Sum_probs=204.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ..+.......||+|+||.||++++..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            34455566789999999999999999999999998865432 34568899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           98 YASGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        98 ~~~~~~L~~~~~~~-~~l--~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      |+.+++|..++... ..+  ++..+..++.||+.||+|||++||+||||||+||+++... +.++|+|||++....... 
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCC
Confidence            99999999998764 445  8889999999999999999999999999999999997532 359999999986442221 


Q ss_pred             CCCccccCCCcCChhhhhcCC--CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      ......|++.|+|||.+.+..  +. .++|+||||+++|+|++|..||............ ..........  ...++++
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~-~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~  240 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYG-APADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEI--PESLSAE  240 (268)
T ss_pred             ccccCCCCccccChhhhccccccCC-chhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCC--CcccCHH
Confidence            122345889999999986543  44 4499999999999999999999764432211110 1111111122  2357899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +.+|+++||+.+|.+|||+.+++.||||
T Consensus       241 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         241 AKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-43  Score=318.54  Aligned_cols=246  Identities=36%  Similarity=0.592  Sum_probs=207.6

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCch
Q 017936           29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        29 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      ||.|+||.||++++..+++.+|+|++.....    ..+.+.+|+.+++.++||||+++++.+...+.+|+++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999999999999999875432    345678899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---------CC
Q 017936          105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------QP  175 (363)
Q Consensus       105 ~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---------~~  175 (363)
                      .+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.  ++|+|||++.......         ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence            999988788999999999999999999999999999999999999987665  9999999987543321         12


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....+++.|+|||.+.+...+.+ +||||||+++|+|++|..||.........    ..........+....++..+.++
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPEEIF----QNILNGKIEWPEDVEVSDEAIDL  233 (265)
T ss_pred             cCcccCccccCHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCcCCCccccCCHHHHHH
Confidence            23457889999999987776545 99999999999999999999866543322    22333333444443458999999


Q ss_pred             HHHhcccCCCCCCCH---HHHhcCccccc
Q 017936          256 ISRIFVADPAKRISI---PEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t~---~ell~h~~~~~  281 (363)
                      +.+||+.+|.+|||+   .++++||||..
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            999999999999999   99999999963

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-44  Score=332.54  Aligned_cols=260  Identities=25%  Similarity=0.411  Sum_probs=208.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe----
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH----   91 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~----   91 (363)
                      ..++|.+.+.||+|++|.||++++..+++.||+|++....   .....+.+|+.+++.++||||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3578999999999999999999999999999999886532   223456789999999999999999998876554    


Q ss_pred             --EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           92 --LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        92 --~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                        .++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||+|+||+++.++.  ++|+|||++...
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~  168 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHT  168 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEccccccccc
Confidence              89999999 6799888765 46999999999999999999999999999999999999986654  999999998754


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc------------
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------  237 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------  237 (363)
                      ...  .....+++.|+|||.+.+....+.++|||||||++|+|++|+.||...........+......            
T Consensus       169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             ccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            322  344568889999999876444445599999999999999999999866543333222211000            


Q ss_pred             --------ccc-CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 017936          238 --------VQY-SI----PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP  284 (363)
Q Consensus       238 --------~~~-~~----~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~~  284 (363)
                              ... ..    .....+++.+.++|.+||+.+|.+|||+.+|+.||||.+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence                    000 00    011245889999999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-44  Score=349.44  Aligned_cols=258  Identities=22%  Similarity=0.349  Sum_probs=192.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCC-cEEEEE------------------EeecCCcccHHHHHHHHHHHcCCCCCeee
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTE-ELVAVK------------------YIERGDKIDENVQREIINHRSLRHPNIVR   81 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~-~~~aiK------------------~~~~~~~~~~~~~~e~~~l~~l~hpnIv~   81 (363)
                      ++|++++.||+|+||+||+|..+... ...+.|                  .+.........+.+|+.+++.++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            57999999999999999998764322 222222                  11122223455788999999999999999


Q ss_pred             eeEEEEcCCeEEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCC
Q 017936           82 FKEVILTPTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP  156 (363)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~  156 (363)
                      +++++...+..|+|++++. ++|..++...     ......+++.++.||+.||.|||++|||||||||+|||++.++. 
T Consensus       228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~-  305 (501)
T PHA03210        228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK-  305 (501)
T ss_pred             EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-
Confidence            9999999999999999994 5777766432     22456778899999999999999999999999999999976654 


Q ss_pred             cEEEeecCCcccCccCC--CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCc---hHHHHHH
Q 017936          157 RLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---PKNFRKT  231 (363)
Q Consensus       157 ~vkL~DFgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~  231 (363)
                       +||+|||+++......  ......||+.|+|||++.+..++.+ +|||||||++|+|++|..++.....   ...+.+.
T Consensus       306 -vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        306 -IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             -EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence             9999999997543322  2234579999999999988888766 9999999999999998765432221   1222222


Q ss_pred             HHHHhccccCCC--------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          232 IHRILSVQYSIP--------------------------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       232 ~~~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +..+......+|                          ....++.++.++|.+||+.||.+|||+.|+|.||||...
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            211100000000                          012356788899999999999999999999999999653

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.5e-43  Score=325.45  Aligned_cols=262  Identities=25%  Similarity=0.410  Sum_probs=204.2

Q ss_pred             CCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--
Q 017936           15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--   89 (363)
Q Consensus        15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--   89 (363)
                      +.+...++|++.+.||+|+||.||++.+..+++.+|+|.+.....   ......+|+.+++.++||||+++++++...  
T Consensus         2 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (311)
T cd07866           2 YGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD   81 (311)
T ss_pred             CCCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence            344456899999999999999999999999999999998865322   234567899999999999999999987543  


Q ss_pred             ------CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEee
Q 017936           90 ------THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD  162 (363)
Q Consensus        90 ------~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~D  162 (363)
                            ..+++||||+.+ +|...+.. ...+++..++.++.||++||.|||++||+||||||+||+++.++.  ++|+|
T Consensus        82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~d  158 (311)
T cd07866          82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIAD  158 (311)
T ss_pred             cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECc
Confidence                  357999999965 66666654 457999999999999999999999999999999999999987655  99999


Q ss_pred             cCCcccCccCCCC------------CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHH
Q 017936          163 FGYSKSSVLHSQP------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK  230 (363)
Q Consensus       163 Fgla~~~~~~~~~------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  230 (363)
                      ||+++........            ....+++.|+|||.+.+......++|||||||++|+|++|.+||...........
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9998743322111            1235688899999987654334449999999999999999999987665444333


Q ss_pred             HHHHHhccc-------------------cCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          231 TIHRILSVQ-------------------YSIP-----DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       231 ~~~~~~~~~-------------------~~~~-----~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      .........                   ...+     ....+++.+.+||.+||+.+|.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            222110000                   0000     012345789999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-43  Score=324.63  Aligned_cols=255  Identities=27%  Similarity=0.487  Sum_probs=210.3

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .-|.....||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++..++.+++||||+
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            45677789999999999999999999999999986532 33456788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCcc
Q 017936          100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST  178 (363)
Q Consensus       100 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~~  178 (363)
                      ++++|...+.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++....... .....
T Consensus       101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659         101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccce
Confidence            99999886654 56899999999999999999999999999999999999986654  9999999986433222 22345


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR  258 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  258 (363)
                      .|++.|+|||.+.+..++.+ +|||||||++|+|++|..||........... +...  ..........++..+.++|.+
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~l~~~i~~  253 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDS--PPPKLKNAHKISPVLRDFLER  253 (297)
T ss_pred             ecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-Hhcc--CCCCccccCCCCHHHHHHHHH
Confidence            68999999999987777655 9999999999999999999986554332221 1111  111122234578899999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccccc
Q 017936          259 IFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       259 ~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ||+.+|.+||++++++.||||.+.
T Consensus       254 ~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         254 MLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             HhcCCcccCcCHHHHhhChhhccC
Confidence            999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.2e-43  Score=320.80  Aligned_cols=259  Identities=30%  Similarity=0.493  Sum_probs=217.6

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ...+.|++...||+|++|.||++.+..+++.||+|++.......+.+.+|+..++.++||||+++++.+...+..++|+|
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            34678999999999999999999999889999999998765445678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CC
Q 017936           98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~  175 (363)
                      |+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.  ++|+|||++....... ..
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~  173 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKR  173 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhh
Confidence            999999999998876 8999999999999999999999999999999999999986654  9999999876433221 12


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.............   .......+....++.++.+|
T Consensus       174 ~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l  249 (286)
T cd06614         174 NSVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGIPPLKNPEKWSPEFKDF  249 (286)
T ss_pred             ccccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCcchhhCCHHHHHH
Confidence            33457889999999987777655 999999999999999999997654433222211   11122233333478999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      |.+||+.+|.+|||+.+++.|+||.+.
T Consensus       250 i~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         250 LNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HHHHhccChhhCcCHHHHhhChHhhcc
Confidence            999999999999999999999999773

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.8e-44  Score=321.53  Aligned_cols=250  Identities=34%  Similarity=0.604  Sum_probs=211.8

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ++|.+.+.||+|++|.||++.+..+++.||+|++.+..    .....+.+|+.+++.++ ||||+++++++...+.+++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999987632    22356778899999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--  173 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--  173 (363)
                      |||+.+++|.+++.+.+.+++..++.++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++.......  
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence            999999999999998889999999999999999999999999999999999999976554  9999999987543222  


Q ss_pred             -------------------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017936          174 -------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR  234 (363)
Q Consensus       174 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  234 (363)
                                         ......++..|+|||.+.+...+.+ +|+||||++++++++|..||........+..    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----  233 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTFQK----  233 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----
Confidence                               1122357889999999877766555 9999999999999999999987664333222    


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccc
Q 017936          235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI----PEIRNHEWF  279 (363)
Q Consensus       235 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~----~ell~h~~~  279 (363)
                      ........+  ..+++.+.+||.+||+.+|.+|||+    +++++||||
T Consensus       234 ~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         234 ILKLEYSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHhcCCCCC--CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            222233333  3568999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.2e-43  Score=318.63  Aligned_cols=248  Identities=30%  Similarity=0.473  Sum_probs=199.0

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----cHHHHHH---HHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccC
Q 017936           28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQRE---IINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        28 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e---~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  100 (363)
                      .||+|+||.||++++..+++.||+|++.+....    ......|   +..++...||||+++++++...+.+++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998764221    1122333   334455689999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCcccc
Q 017936          101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  180 (363)
Q Consensus       101 ~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~g  180 (363)
                      |++|..++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.  ++|+|||++...... ......|
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG  157 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CCcCcCC
Confidence            9999999988888999999999999999999999999999999999999986654  999999998754322 2334578


Q ss_pred             CCCcCChhhhhcC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017936          181 TPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI  259 (363)
Q Consensus       181 t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  259 (363)
                      ++.|+|||.+.++ .++.+ +||||+||++|+|++|..||........ ..............  ...+|.++.++|.+|
T Consensus       158 ~~~y~aPE~~~~~~~~~~~-~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~--~~~~s~~~~~li~~~  233 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVEL--PDSFSPELRSLLEGL  233 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcc-cchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCC--CCcCCHHHHHHHHHH
Confidence            9999999998755 45544 8999999999999999999986533211 11111122222222  234689999999999


Q ss_pred             cccCCCCCC-----CHHHHhcCcccccc
Q 017936          260 FVADPAKRI-----SIPEIRNHEWFLKN  282 (363)
Q Consensus       260 L~~~p~~R~-----t~~ell~h~~~~~~  282 (363)
                      |..+|.+||     ++.++++||||...
T Consensus       234 l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         234 LQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             hhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            999999999     99999999999663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.7e-44  Score=323.22  Aligned_cols=252  Identities=29%  Similarity=0.429  Sum_probs=208.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +.|++.+.||+|+||.||++.+..+++.||+|.+....  ...+.+.+|+.+++.++||||+++++++..++.+++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45888999999999999999999999999999886432  2345678999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-CCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~~~  177 (363)
                      +++++|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.  ++|+|||++........ ...
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence            999999988764 56899999999999999999999999999999999999987654  99999999875432221 123


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      ..++..|+|||.+.+..++.+ +|+|||||++|+|++|..||..........    .+... ........++.++.++|.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~li~  234 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLF----LIPKN-SPPTLEGQYSKPFKEFVE  234 (277)
T ss_pred             ccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHh----hhhcC-CCCCCCcccCHHHHHHHH
Confidence            457889999999988777655 999999999999999999997544322111    11111 111112246889999999


Q ss_pred             HhcccCCCCCCCHHHHhcCccccc
Q 017936          258 RIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +||+.+|.+|||+.+++.||||..
T Consensus       235 ~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         235 ACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             HHccCCcccCcCHHHHHHhHHHHH
Confidence            999999999999999999999965

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.1e-43  Score=328.37  Aligned_cols=260  Identities=24%  Similarity=0.381  Sum_probs=208.9

Q ss_pred             CCCcee-eceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc---------------HHHHHHHHHHHcCCCCCeeeee
Q 017936           20 SDRYEL-VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---------------ENVQREIINHRSLRHPNIVRFK   83 (363)
Q Consensus        20 ~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---------------~~~~~e~~~l~~l~hpnIv~~~   83 (363)
                      .++|.. .+.||.|+||+||++.+..+++.||+|.+.......               ..+.+|+.+++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            467875 577999999999999999999999999986543221               2467899999999999999999


Q ss_pred             EEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeec
Q 017936           84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF  163 (363)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DF  163 (363)
                      +++...+..++||||+. ++|.+++.....+++..+..++.||+.||+|||+.||+||||+|+||+++.++.  ++|+||
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~df  163 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADF  163 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCc
Confidence            99999999999999996 589999988888999999999999999999999999999999999999986654  999999


Q ss_pred             CCcccCcc---------------CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHH
Q 017936          164 GYSKSSVL---------------HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF  228 (363)
Q Consensus       164 gla~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  228 (363)
                      |++.....               ........+++.|+|||.+.+....+.++|+|||||++|+|++|..||.........
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  243 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL  243 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99875431               111122356889999999876554445599999999999999999999876654433


Q ss_pred             HHHHHHHhcccc-------CCC---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          229 RKTIHRILSVQY-------SIP---------------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       229 ~~~~~~~~~~~~-------~~~---------------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ..+.........       ..+               .....+.++.++|.+||+.+|++|||+++++.||||...
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            333221110000       000               012357889999999999999999999999999999764

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.5e-43  Score=323.33  Aligned_cols=257  Identities=28%  Similarity=0.434  Sum_probs=212.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC-CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++|++.+.||+|+||.||++.+..+++.||+|.+... ....+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            57899999999999999999999889999999998643 23345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~  177 (363)
                      +++++|.+++.+. .+++.++..++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||++....... ....
T Consensus        98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647          98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             CCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccccccc
Confidence            9999999988653 5889999999999999999999999999999999999986654  9999999886543322 2233


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      ..+++.|+|||.+.+..++.+ +|+|||||++|++++|..||...+........   ........+....++..+.++|+
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             ccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hcCCCCCCCCccccCHHHHHHHH
Confidence            468899999999987777655 99999999999999999999765432221111   11112223334456889999999


Q ss_pred             HhcccCCCCCCCHHHHhcCccccccC
Q 017936          258 RIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      +||+.+|.+||++.+++.|+||....
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.1e-43  Score=314.66  Aligned_cols=247  Identities=25%  Similarity=0.383  Sum_probs=203.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|+||.||++..+. +..+|+|.+.........+.+|+.+++.++||||+++++++.....+++||||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            3579999999999999999998754 557999998766555678889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC--C
Q 017936          100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--K  176 (363)
Q Consensus       100 ~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~--~  176 (363)
                      ++++|.+++... +.+++..++.++.|++.||+|||++||+||||||+||+++.++.  +||+|||+++........  .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceeccC
Confidence            999999988753 46899999999999999999999999999999999999986654  999999998754322211  1


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ...++..|+|||.+.+..++.+ +|+||||+++|+|++ |+.||...........    +.... ..+.....+..+.++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~----i~~~~-~~~~~~~~~~~~~~l  233 (256)
T cd05114         160 GAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM----ISRGF-RLYRPKLASMTVYEV  233 (256)
T ss_pred             CCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHCCC-CCCCCCCCCHHHHHH
Confidence            2234567999999987777655 999999999999999 9999977654433322    22221 222233468899999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 017936          256 ISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~  275 (363)
                      +.+||+.+|.+|||+++++.
T Consensus       234 i~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         234 MYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-43  Score=314.67  Aligned_cols=251  Identities=33%  Similarity=0.531  Sum_probs=209.6

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|.+.+.||+|+||.||++.++.+++.+|+|.+....   ...+.+.+|+.+++.++||||+++++.+.....+++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5899999999999999999999999999999986532   2345678999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-C
Q 017936           99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~  175 (363)
                      +.+++|.+++.+..  .+++..+..++.|++.||.|||+.|++||||||+||+++.++. .++|+|||.+........ .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence            99999999987644  4799999999999999999999999999999999999986543 379999999875433222 1


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....|++.|+|||.+.+..++.+ +|+||||+++++|++|..||...........    ..... ..+....++.++.++
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~  233 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLK----ICQGY-FAPISPNFSRDLRSL  233 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hhccc-CCCCCCCCCHHHHHH
Confidence            23458899999999887776655 9999999999999999999976544332222    22211 122234578899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      |.+||+.+|++|||+.+++.||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=287.76  Aligned_cols=258  Identities=28%  Similarity=0.514  Sum_probs=214.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .+|.-.++||+|.||+|+++++..+++.||+|.++.++   .......+||-+++.++|.|||+++++...++.+.+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            35888899999999999999999999999999997643   345678999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-C
Q 017936           98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~  175 (363)
                      || ..+|..+... ++.+..+.++.++.|++.||.++|+.++.||||||.|+||+.++.  +||+|||+|+.+..... -
T Consensus        82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy  158 (292)
T KOG0662|consen   82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence            99 5588887765 467999999999999999999999999999999999999987766  99999999996644332 2


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccc-------cCCCCC--
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ-------YSIPDY--  245 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~--  245 (363)
                      ...+-|.+|.+|.++.+....+...|+||.|||+.|+.. |++.|.+.+-.+++.++.+..-...       ...|.+  
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            344679999999999998866666899999999999986 8888888776666666554321111       011111  


Q ss_pred             --------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          246 --------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       246 --------------~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                                    +.++..-+++++++|.-+|.+|++++++++||||..
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence                          123456789999999999999999999999999954

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-43  Score=311.14  Aligned_cols=250  Identities=32%  Similarity=0.484  Sum_probs=212.1

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|++.+.||+|++|.||++.+..+++.||+|.+.....   ....+.+|+.+++.++|||++++++++.+.+.++++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            58999999999999999999999999999999877543   446688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-CCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~~~  177 (363)
                      +++++|.+++.....+++..++.++.|++.||.+||++||+||||+|+||+++.++  .++|+|||++........ ...
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC--CEEEeccccceecCCCcccccc
Confidence            99999999998888899999999999999999999999999999999999998654  499999999875443322 234


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      ..++..|+|||.+.+...+.+ +||||||+++|+|++|..||...........    .... ...+....++..+.+++.
T Consensus       159 ~~~~~~y~~pe~~~~~~~~~~-~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~i~  232 (254)
T cd06627         159 VVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFR----IVQD-DHPPLPEGISPELKDFLM  232 (254)
T ss_pred             cccchhhcCHhhhcCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hhcc-CCCCCCCCCCHHHHHHHH
Confidence            568899999999877765544 9999999999999999999976553222211    1111 112223457899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCccc
Q 017936          258 RIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +||..+|++|||+.+++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.3e-43  Score=319.51  Aligned_cols=248  Identities=26%  Similarity=0.389  Sum_probs=204.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      .++|.+.+.||+|+||.||++.+..     +++.||+|.+.....  ..+.+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4579999999999999999998753     357899999876433  246788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcE
Q 017936           93 AIVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL  158 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~--------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~v  158 (363)
                      ++||||+++++|.+++...+              .+++.++..++.||+.||.+||++|++||||||+||+++.++.  +
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~  161 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--V  161 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--E
Confidence            99999999999999987542              3789999999999999999999999999999999999986654  9


Q ss_pred             EEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHH
Q 017936          159 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR  234 (363)
Q Consensus       159 kL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  234 (363)
                      +|+|||+++......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||..........    .
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~----~  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE----C  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----H
Confidence            999999987432221   1233446788999999988887666 999999999999998 999997765433222    2


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       235 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +...... +....++..+.+++.+||+.+|.+|||+.|+++
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         237 ITQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2222222 223457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.1e-43  Score=314.67  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=205.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..++|+++++||+|++|.||++... +++.||+|.+.......+.+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            4578999999999999999999864 556799998876655567888999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--
Q 017936           99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--  174 (363)
Q Consensus        99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--  174 (363)
                      +.+++|.+++.+.  ..++...+..++.|++.||+|||+.|++||||||+||+++.++.  ++|+|||++........  
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCceec
Confidence            9999999998653  45899999999999999999999999999999999999986654  99999999975432221  


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||...........    +. .....+....++.++.
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~  234 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA----LQ-RGYRMPRMENCPDELY  234 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH----HH-cCCCCCCCCCCCHHHH
Confidence            122335678999999987777655 999999999999998 9999976544322221    21 2233444456789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017936          254 HLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +++.+||..+|++|||++++.+
T Consensus       235 ~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         235 DIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2e-43  Score=323.96  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=200.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcE--EEEEEeecCC--cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++.+.||+|+||.||+|.+..++..  +|+|.+....  .....+.+|+.++..+ +||||+++++++...+.+|
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            346899999999999999999999877764  4677655322  2335677899999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCc
Q 017936           94 IVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR  157 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~  157 (363)
                      +||||+++++|.+++...+                .+++..++.++.||+.||+|||++|++||||||+|||++.++.  
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~--  162 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--  162 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--
Confidence            9999999999999986542                4789999999999999999999999999999999999986654  


Q ss_pred             EEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHh
Q 017936          158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRIL  236 (363)
Q Consensus       158 vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  236 (363)
                      +||+|||++.............++..|+|||.+.+..++.+ +|||||||++|+|+| |..||......+...    .. 
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~-  236 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KL-  236 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCChHHHHH----HH-
Confidence            99999999864322222222234667999999877776655 999999999999998 999997655433222    11 


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       237 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ......+....+++++.+||.+||+.+|++||++++++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1222233334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.4e-43  Score=318.20  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=204.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      .++|.+.+.||+|++|.||++.+..     ++..||+|.+.....  ....+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4679999999999999999999977     778899998764322  234678899999999999999999999998999


Q ss_pred             EEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC-CcEEEeecC
Q 017936           93 AIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFG  164 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~-~~vkL~DFg  164 (363)
                      ++||||+.|++|.+++...+       .+++..+..++.||+.||+|||++|++||||||+||+++.++. ..+||+|||
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg  164 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG  164 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence            99999999999999987653       4899999999999999999999999999999999999986542 358999999


Q ss_pred             CcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhcccc
Q 017936          165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY  240 (363)
Q Consensus       165 la~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (363)
                      +++.......   ......++.|+|||++.+..++.+ +|||||||++|+|++ |..||...+...... .   +. ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~-~---~~-~~~  238 (277)
T cd05036         165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-F---VT-GGG  238 (277)
T ss_pred             cccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-H---HH-cCC
Confidence            9875422111   112234567999999988887666 999999999999997 999998755433222 1   11 112


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       241 ~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ..+....++..+.+++.+||+.+|++|||+.++++|
T Consensus       239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            223334578999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.3e-43  Score=352.55  Aligned_cols=250  Identities=28%  Similarity=0.394  Sum_probs=201.7

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    ...+++.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            58999999999999999999999999999999987532    22456788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           97 EYASGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        97 e~~~~~~L~~~~~~~-----------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                      ||++|++|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||++.++.  ++|+|||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGL  159 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGA  159 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCc
Confidence            999999999988642           23556778999999999999999999999999999999986655  99999999


Q ss_pred             cccCccC-------------------CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH
Q 017936          166 SKSSVLH-------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK  226 (363)
Q Consensus       166 a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  226 (363)
                      ++.....                   .......||+.|+|||.+.+..++.+ +|||||||++|+|+||..||.......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9754110                   01122469999999999988877655 999999999999999999997644322


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ....   ..............+++.+.+++.+||+.+|++||+..+.+.+
T Consensus       239 i~~~---~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        239 ISYR---DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhh---hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1111   1111112223345688999999999999999999876555433

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.3e-43  Score=313.94  Aligned_cols=248  Identities=23%  Similarity=0.377  Sum_probs=203.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|+||+||+++... +..+|+|.+.......+.+.+|+.+++.++||||+++++++.....+++||||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            3579999999999999999998754 456999998766555677899999999999999999999999888999999999


Q ss_pred             CCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--CC
Q 017936          100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PK  176 (363)
Q Consensus       100 ~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--~~  176 (363)
                      .+++|.+++... ..+++.+++.++.||+.||.|||+.|++||||||+||+++.++.  +||+|||+++.......  ..
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSSV  159 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeecC
Confidence            999999998764 36899999999999999999999999999999999999976554  99999999875432221  11


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ...++..|+|||.+.+..++.+ +|||||||++|+|++ |..||............    ... ...+.....+..+.++
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~l  233 (256)
T cd05113         160 GSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV----SQG-LRLYRPHLASEKVYAI  233 (256)
T ss_pred             CCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----hcC-CCCCCCCCCCHHHHHH
Confidence            2335567999999987777666 999999999999998 99999765543322222    221 1222233468999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcC
Q 017936          256 ISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h  276 (363)
                      +.+||+.+|.+|||+.+++.+
T Consensus       234 i~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         234 MYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHcCCCcccCCCHHHHHHh
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-43  Score=327.91  Aligned_cols=258  Identities=26%  Similarity=0.413  Sum_probs=206.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-----
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-----   90 (363)
                      ..++|++++.||+|+||.||++.+..+++.||+|.+.+..   .....+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            3578999999999999999999999999999999986532   22346778999999999999999999987653     


Q ss_pred             -eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        91 -~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                       .+++||||+ +++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.  ++|+|||++...
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~  168 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQT  168 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeccccccc
Confidence             468999999 7788877754 57999999999999999999999999999999999999986554  999999998754


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-----------
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-----------  238 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  238 (363)
                      ..  ......+++.|+|||.+.+....+.++|+|||||++|+|++|..||...................           
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         169 DS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             cc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            32  22344678999999998764433455999999999999999999998665433332222110000           


Q ss_pred             -----ccCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          239 -----QYSIP---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       239 -----~~~~~---------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                           ....+         ....+++.+.++|.+||+.+|.+|||+.+++.||||...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                 00000         113568889999999999999999999999999999765

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.1e-43  Score=321.83  Aligned_cols=253  Identities=29%  Similarity=0.441  Sum_probs=204.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..+|.+.+.||+|+||+||++.+..+++.||+|.+.....    ....+.+|+.+++.++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            4569999999999999999999999999999999864322    224577899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      |||+. +++.+.+.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.  ++|+|||++.....   
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~---  167 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSP---  167 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCC---
Confidence            99996 466666543 456999999999999999999999999999999999999987654  99999999864322   


Q ss_pred             CCccccCCCcCChhhhh---cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          175 PKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      .....+++.|+|||++.   ...++.+ +||||||+++|+|++|..||...........    +............++..
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  242 (307)
T cd06607         168 ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNDSPTLSSNDWSDY  242 (307)
T ss_pred             CCCccCCccccCceeeeccCCCCCCcc-cchHHHHHHHHHHHcCCCCCCCccHHHHHHH----HhcCCCCCCCchhhCHH
Confidence            23456888999999874   2344444 9999999999999999999976544332221    11111111112246889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          252 CRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      +.++|.+||+.+|.+||++.+++.||||....
T Consensus       243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            99999999999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.6e-43  Score=311.42  Aligned_cols=250  Identities=35%  Similarity=0.556  Sum_probs=211.8

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|.+.+.||.|++|.||++.+..+++.||+|++....   .....+.+|+..++.++|||++++.+.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5899999999999999999999999999999987643   2345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           99 ASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        99 ~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      +++++|.+.+.+.    ..+++.++..++.+++.||.+||++|++||||+|+||+++.++.  ++|+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence            9999999998764    67999999999999999999999999999999999999986554  9999999987543332 


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      ......|++.|+|||.+.+..++.+ +|+||+|+++++|++|..||..........    ...... ..+....++..+.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~  232 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELAL----KILKGQ-YPPIPSQYSSELR  232 (258)
T ss_pred             eecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHHHHH----HHhcCC-CCCCCCCCCHHHH
Confidence            2234568899999999887777666 999999999999999999997655332222    222221 1222336789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +++.+||..+|.+|||+.++++||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-43  Score=312.99  Aligned_cols=251  Identities=31%  Similarity=0.466  Sum_probs=207.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC------cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL   92 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~   92 (363)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+....      .....+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57999999999999999999999999999999875321      1234678899999999999999999998764  568


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ++++||+.+++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.  ++|+|||+++.....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~  159 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccc
Confidence            999999999999999988778999999999999999999999999999999999999976554  999999998754221


Q ss_pred             ----CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          173 ----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       173 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                          .......++..|+|||.+.+..++.+ +|+|||||++|+|++|..||..........    ...........+..+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~p~~~  234 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIF----KIATQPTKPMLPDGV  234 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHHHH----HHHcCCCCCCCCccc
Confidence                11123458899999999987776655 899999999999999999997654433322    222222222233467


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ++.+.++|.+||+ +|..|||+.+++.|||.
T Consensus       235 ~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         235 SDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            8999999999998 57999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.3e-43  Score=314.91  Aligned_cols=250  Identities=28%  Similarity=0.421  Sum_probs=203.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++.+.||+|+||.||++++..+++.||||.+....    .....+.+|+.+++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999999999999999876432    22345778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ||+++++|..++..    ...+++..+..++.||+.||.|||++|++||||||+||+++.++.  ++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~  159 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence            99999999888753    345899999999999999999999999999999999999986654  999999998754322


Q ss_pred             CC-CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       173 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      .. .....|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||......  .......+............++..
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCHH
Confidence            21 223468889999999988777655 99999999999999999999654321  112222222222111112346789


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +.+++.+||+.+|.+|||+.++++
T Consensus       237 ~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         237 LRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHHHHCCCCcccCcCHHHHHH
Confidence            999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-43  Score=313.21  Aligned_cols=246  Identities=23%  Similarity=0.382  Sum_probs=203.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccC
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  100 (363)
                      .+|++.+.||+|+||.||++.++ ++..+|+|++.+.......+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            56999999999999999999876 46679999987665556678889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC--Cc
Q 017936          101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KS  177 (363)
Q Consensus       101 ~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~--~~  177 (363)
                      +++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||+++........  ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccCC
Confidence            99999998764 46899999999999999999999999999999999999986654  999999998754322111  11


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ..++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+......    .+. .....+....++..+.+++
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~li  234 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----SVS-AGYRLYRPKLAPTEVYTIM  234 (256)
T ss_pred             CCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHH----HHH-cCCcCCCCCCCCHHHHHHH
Confidence            223457999999988777666 999999999999999 899997655433222    221 2223333445799999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 017936          257 SRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~  275 (363)
                      .+||..+|++|||+.++++
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~  253 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLS  253 (256)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.1e-43  Score=317.03  Aligned_cols=251  Identities=27%  Similarity=0.402  Sum_probs=197.2

Q ss_pred             CCc-eeeceecccCCeEEEEEE----EcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--Ce
Q 017936           21 DRY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--TH   91 (363)
Q Consensus        21 ~~y-~i~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~   91 (363)
                      +|| ++++.||+|+||+||++.    ...+++.||+|++.....  ....+.+|+.+++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            456 999999999999998865    345778999999876432  345678899999999999999999987653  46


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ++++|||+++++|.+++... .+++.+++.++.|++.||.|||++||+||||||+|||++.++.  ++|+|||+++....
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~  159 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPE  159 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCC
Confidence            89999999999999988764 5999999999999999999999999999999999999976654  99999999875432


Q ss_pred             CCC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHH-H---------HHHHHHHhc
Q 017936          172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-F---------RKTIHRILS  237 (363)
Q Consensus       172 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~---------~~~~~~~~~  237 (363)
                      ...    .....++..|+|||.+.+..++.+ +||||||+++|+|++|..||......-. .         .........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            211    122345667999999987777665 9999999999999999999865432100 0         000011111


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          238 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       238 ~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .....+....++.++.+++.+||+.+|++|||+++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11222334457899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-43  Score=317.54  Aligned_cols=254  Identities=33%  Similarity=0.529  Sum_probs=205.5

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeEEEEEe
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVME   97 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e   97 (363)
                      |++.+.||.|++|.||++.+..+++.+|+|.+....   .....+.+|+.+++.++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            788999999999999999999999999999997653   2345678899999999999999999999988  88999999


Q ss_pred             ccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--C
Q 017936           98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q  174 (363)
Q Consensus        98 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--~  174 (363)
                      |+++ +|...+... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.  ++|+|||++.......  .
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence            9974 888888765 57999999999999999999999999999999999999987655  9999999987554332  1


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc-cCCC----------
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIP----------  243 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~----------  243 (363)
                      .....++..|+|||.+.+....+.++||||||+++|+|++|..||.................... ...+          
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            23345788899999876544334559999999999999999999987665443333222110000 0000          


Q ss_pred             -------------CCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          244 -------------DYVH-ISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       244 -------------~~~~-~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                                   .... ++..+.++|++||+.+|.+|||+++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                         0111 38899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.9e-43  Score=320.37  Aligned_cols=256  Identities=30%  Similarity=0.511  Sum_probs=204.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC------
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------   90 (363)
                      .++|++.+.||+|+||.||++.++.+++.||+|.+....   .....+.+|+.+++.++||||+++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            467999999999999999999999999999999987542   22356778999999999999999999987654      


Q ss_pred             ----eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           91 ----HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        91 ----~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                          .+++|+||+++ ++...+... ..+++.+++.++.||+.||+|||+.||+||||||+||+++.++.  +||+|||+
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~  162 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGL  162 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccc
Confidence                79999999976 666666543 46999999999999999999999999999999999999986654  99999999


Q ss_pred             cccCccCCC--CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--C
Q 017936          166 SKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--S  241 (363)
Q Consensus       166 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~  241 (363)
                      +........  .....+++.|+|||.+.+....+.++|||||||++|+|++|++||.............. ......  .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~  241 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR-LCGSPCPAV  241 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCChhh
Confidence            875433221  12235678899999886554334459999999999999999999987655443333222 111100  0


Q ss_pred             -----------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          242 -----------------------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       242 -----------------------~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                                             ......++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                   01123468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8e-43  Score=315.78  Aligned_cols=252  Identities=27%  Similarity=0.442  Sum_probs=207.8

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      -|++.+.||+|+||.||++.+..+++.||+|++....  .....+.+|+..++.++||||+++++++..++.+++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4788999999999999999999999999999876432  22356788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCcc
Q 017936          100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST  178 (363)
Q Consensus       100 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~~  178 (363)
                      ++++|..++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||++....... .....
T Consensus        85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhccc
Confidence            99999988764 46899999999999999999999999999999999999976654  9999999986543221 12234


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR  258 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  258 (363)
                      .++..|+|||.+.+...+.+ +|+|||||++|+|++|..||..........    .+.... .......++.++.++|.+
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~i~~  235 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLF----LIPKNN-PPTLEGNYSKPLKEFVEA  235 (277)
T ss_pred             cCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHHHH----HHhcCC-CCCCCcccCHHHHHHHHH
Confidence            67889999999987766655 999999999999999999997644322211    111111 111223468999999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccccc
Q 017936          259 IFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       259 ~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ||+.+|.+||++.+++.||||.+.
T Consensus       236 ~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         236 CLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HccCChhhCcCHHHHHhCHHHhhh
Confidence            999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-43  Score=311.73  Aligned_cols=242  Identities=27%  Similarity=0.423  Sum_probs=204.1

Q ss_pred             ceecccCCeEEEEEEEcCC---CcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||.||++.+...   +..||+|.+......  ...+.+|+..++.++||||+++++++.....+++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4799999999999999866   889999998765433  46788999999999999999999999999999999999999


Q ss_pred             CchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936          102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus       102 ~~L~~~~~~~---------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ++|.+++...         ..+++.+++.++.|++.||+|||++|++||||+|+||+++.++.  ++|+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence            9999999875         67999999999999999999999999999999999999987654  999999999865433


Q ss_pred             C---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          173 S---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       173 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                      .   ......+++.|+|||.+....++.+ +|||||||++|+|++ |..||...........    +.. ....+....+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~  232 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY----LRK-GYRLPKPEYC  232 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCCCCCccC
Confidence            2   2334567889999999987766655 999999999999999 6999987654333222    221 2233344567


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      |.++.+++.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         233 PDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            9999999999999999999999999864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.3e-43  Score=318.30  Aligned_cols=248  Identities=26%  Similarity=0.407  Sum_probs=202.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      .++|.+.+.||+|+||+||++.+.     .++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+.++
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            467999999999999999999852     345678999886543 33456889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEE
Q 017936           94 IVMEYASGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI  160 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~-------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL  160 (363)
                      +||||+.+++|.+++...+             .+++..++.++.||+.||+|||++|++||||||+|||++.++.  ++|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~kl  161 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKI  161 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEe
Confidence            9999999999999987543             3899999999999999999999999999999999999986654  999


Q ss_pred             eecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHh
Q 017936          161 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRIL  236 (363)
Q Consensus       161 ~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  236 (363)
                      +|||+++......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.........    ..+.
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~----~~i~  236 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVI----ECIT  236 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHH
Confidence            9999987442221   1223345778999999987777665 999999999999998 99999776543322    2222


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       237 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .... .+....++.++.+|+.+||+.+|.+|||+.++++
T Consensus       237 ~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         237 QGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2221 2223457899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.5e-43  Score=327.74  Aligned_cols=259  Identities=30%  Similarity=0.418  Sum_probs=204.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC---------
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP---------   89 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~---------   89 (363)
                      ..+|.+.+.||.|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            478999999999999999999999999999999986543 3345678899999999999999999876543         


Q ss_pred             -----CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecC
Q 017936           90 -----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG  164 (363)
Q Consensus        90 -----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFg  164 (363)
                           ..+++||||+. ++|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++..+ +.++|+|||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-~~~kl~dfg  160 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-LVLKIGDFG  160 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-ceEEECCcc
Confidence                 35799999996 588877754 4699999999999999999999999999999999999997433 248999999


Q ss_pred             CcccCccCC----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh----
Q 017936          165 YSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL----  236 (363)
Q Consensus       165 la~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----  236 (363)
                      +++......    ......++..|+|||.+.+....+.++|||||||++|+|++|+.||.................    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            987532211    112335788999999876544444559999999999999999999976654333332221100    


Q ss_pred             --------------c---cccCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          237 --------------S---VQYSIP---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       237 --------------~---~~~~~~---~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                                    .   .....+   ....++.++.+||.+||+.+|.+|||+++++.||||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                          0   000000   01246889999999999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.9e-43  Score=312.04  Aligned_cols=241  Identities=28%  Similarity=0.401  Sum_probs=196.0

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCch
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      +.||+|+||.||++++..+++.+|+|.+....  .....+.+|+.+++.++||||+++++++.....+++||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999999999999999876432  2345688999999999999999999999999999999999999999


Q ss_pred             HHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC---Ccccc
Q 017936          105 FERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG  180 (363)
Q Consensus       105 ~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~---~~~~g  180 (363)
                      .+++...+ .+++..++.++.|++.||.|||++|++||||||+|||++.++.  +||+|||++.........   ....+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence            99987644 5899999999999999999999999999999999999976554  999999998753321111   11123


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI  259 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  259 (363)
                      +..|+|||.+.+..+..+ +|||||||++|+|++ |..||....... ....+.    .....+....++..+.+++.+|
T Consensus       159 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~li~~~  232 (252)
T cd05084         159 PVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQ-TREAIE----QGVRLPCPELCPDAVYRLMERC  232 (252)
T ss_pred             ceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHH-HHHHHH----cCCCCCCcccCCHHHHHHHHHH
Confidence            456999999988877666 999999999999998 999997654322 112111    1222233445789999999999


Q ss_pred             cccCCCCCCCHHHHhc
Q 017936          260 FVADPAKRISIPEIRN  275 (363)
Q Consensus       260 L~~~p~~R~t~~ell~  275 (363)
                      |+.+|++|||+.+++.
T Consensus       233 l~~~p~~Rps~~~~~~  248 (252)
T cd05084         233 WEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-42  Score=312.38  Aligned_cols=246  Identities=23%  Similarity=0.348  Sum_probs=201.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|+||.||++++..++ .||+|.+.......+.+.+|+.+++.++||||+++++++. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            467999999999999999999986654 5999998875555667899999999999999999999875 45679999999


Q ss_pred             CCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--C
Q 017936          100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P  175 (363)
Q Consensus       100 ~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--~  175 (363)
                      .+++|.+++.+.  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.  ++|+|||+++.......  .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~~  160 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTAR  160 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeeccccccccc
Confidence            999999999763  35899999999999999999999999999999999999986654  99999999875432221  1


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....++..|+|||...+..++.+ +|||||||++|+|++ |..||..........    .+.. ....+....++..+.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~l~~  234 (262)
T cd05071         161 QGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVER-GYRMPCPPECPESLHD  234 (262)
T ss_pred             cCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHH----HHhc-CCCCCCccccCHHHHH
Confidence            23346678999999987777666 999999999999999 888997655433222    2211 2223334567899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017936          255 LISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.+||+.+|.+|||++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         235 LMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=308.73  Aligned_cols=258  Identities=30%  Similarity=0.538  Sum_probs=216.5

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHH-HcCCCCCeeeeeEEEEcCCeE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINH-RSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l-~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      ..-++|.++++||+|+|++|-+++.+.+.+.||+|++++.    +....-++.|-... ..-+||.+|.++.+|+++..+
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            3457899999999999999999999999999999999764    22233445555544 445799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc-c
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-L  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~-~  171 (363)
                      ++|.||++||+|.-.+++.++++++.++.+...|+.||.|||++|||.||||.+|+|++..+.  +||+|+|+++... +
T Consensus       327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke~l~~  404 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhcCCCC
Confidence            999999999999999999999999999999999999999999999999999999999987665  9999999998654 3


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCC--ch--HHHHHHHHHHhccccCCCCCCC
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--EP--KNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~--~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      .....+.+|||.|+|||++.+..|.-. +|+|+||+++++|+.|+.||+...  .+  ..-.-..+-+++.+.++|.  .
T Consensus       405 gd~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--s  481 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--S  481 (593)
T ss_pred             CcccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--e
Confidence            444567789999999999999988655 999999999999999999997421  11  1112233445566666665  4


Q ss_pred             CCHHHHHHHHHhcccCCCCCC------CHHHHhcCcccc
Q 017936          248 ISPECRHLISRIFVADPAKRI------SIPEIRNHEWFL  280 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~------t~~ell~h~~~~  280 (363)
                      +|-.+..+++..|++||.+|.      .+.++..|+||.
T Consensus       482 lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr  520 (593)
T KOG0695|consen  482 LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR  520 (593)
T ss_pred             eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence            677889999999999999997      478999999996

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-42  Score=312.09  Aligned_cols=247  Identities=23%  Similarity=0.332  Sum_probs=204.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|++|.||++.+.. ++.||+|.+.......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            4679999999999999999998754 567999998776555677889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC--
Q 017936          100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--  175 (363)
Q Consensus       100 ~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~--  175 (363)
                      .+++|.+++....  .++...+..++.|++.||.+||++|++||||||+||+++.++.  ++|+|||+++........  
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEAR  161 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCccccc
Confidence            9999999987654  6899999999999999999999999999999999999987655  999999998755422111  


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      .....+..|+|||.+.+..++.+ +||||||+++|+|++ |+.||.+........    .+. .....+....++..+.+
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~  235 (261)
T cd05068         162 EGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ----QVD-QGYRMPCPPGCPKELYD  235 (261)
T ss_pred             CCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHH-cCCCCCCCCcCCHHHHH
Confidence            11123457999999887777666 899999999999999 999997655432222    121 22233344567899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017936          255 LISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.+||+.+|.+||++.+++.
T Consensus       236 li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         236 IMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.7e-43  Score=317.27  Aligned_cols=257  Identities=30%  Similarity=0.533  Sum_probs=209.5

Q ss_pred             CceeeceecccCCeEEEEEEEc---CCCcEEEEEEeecCC-----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeE
Q 017936           22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~-----~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~   92 (363)
                      .|++.+.||.|+||.||+|++.   .+|+.||+|++....     ...+.+.+|+.+++.+ +||||+++++++..+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999975   478999999987532     2335677899999999 599999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ++||||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++  .++|+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~  158 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC--CEEEeeCccceecccc
Confidence            99999999999999998888899999999999999999999999999999999999998665  4999999998754322


Q ss_pred             C--CCCccccCCCcCChhhhhcCC-CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          173 S--QPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       173 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      .  ......|+..|+|||.+.+.. ....++||||||+++|+|++|..||.....................  +....++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  236 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMS  236 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCccCC
Confidence            1  122356889999999986532 2234489999999999999999999754332223333333322222  2234578


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 017936          250 PECRHLISRIFVADPAKRI-----SIPEIRNHEWFLKN  282 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~-----t~~ell~h~~~~~~  282 (363)
                      +.+.+++++||+.+|.+||     +++++++||||.+.
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            9999999999999999997     89999999999663

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.1e-43  Score=330.97  Aligned_cols=261  Identities=25%  Similarity=0.370  Sum_probs=206.0

Q ss_pred             CCCCCCCCCC----CCCCCceeeceecccCCeEEEEEEEcCC-----CcEEEEEEeecCCc--ccHHHHHHHHHHHcCC-
Q 017936            8 VGPGMDMPIM----HDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLR-   75 (363)
Q Consensus         8 ~~~~~~~~~~----~~~~~y~i~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~-   75 (363)
                      .+..+.+|..    ...++|.+.+.||+|+||.||++.+...     +..||+|++.....  ..+.+.+|+.+++.+. 
T Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~   99 (400)
T cd05105          20 YVDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGP   99 (400)
T ss_pred             eeccccCCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC
Confidence            3344555533    2467899999999999999999987432     34699999865432  2456889999999996 


Q ss_pred             CCCeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhC--------------------------------------------
Q 017936           76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--------------------------------------------  111 (363)
Q Consensus        76 hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------------------------------------------  111 (363)
                      ||||+++++++.....+|+|||||++|+|.+++...                                            
T Consensus       100 HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (400)
T cd05105         100 HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMD  179 (400)
T ss_pred             CCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccc
Confidence            999999999999999999999999999999887542                                            


Q ss_pred             ----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCce
Q 017936          112 ----------------------------------------------------GRFSEDEARFFFQQLISGVSYCHSMQVC  139 (363)
Q Consensus       112 ----------------------------------------------------~~l~~~~~~~~~~qil~~L~~LH~~gii  139 (363)
                                                                          ..+++.++..++.||+.||+|||++||+
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv  259 (400)
T cd05105         180 MKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV  259 (400)
T ss_pred             cccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence                                                                2377888999999999999999999999


Q ss_pred             ecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-C
Q 017936          140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-G  215 (363)
Q Consensus       140 HrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g  215 (363)
                      ||||||+|||++.+..  +||+|||+++......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |
T Consensus       260 H~dikp~Nill~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~ellt~g  336 (400)
T cd05105         260 HRDLAARNVLLAQGKI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWEIFSLG  336 (400)
T ss_pred             CCCCChHhEEEeCCCE--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHHHHHCC
Confidence            9999999999986654  9999999987543221   1223456788999999988777665 999999999999997 9


Q ss_pred             CCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          216 AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..||............+    ......+....++.++.+++.+||+.+|++|||+.++.+
T Consensus       337 ~~P~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         337 GTPYPGMIVDSTFYNKI----KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             CCCCcccchhHHHHHHH----hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            99997654333222221    222233344567899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=9.7e-43  Score=315.15  Aligned_cols=250  Identities=20%  Similarity=0.288  Sum_probs=200.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH   91 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~   91 (363)
                      ..++|++.+.||+|+||+||++.+.     .++..||+|.+.....  ....+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999864     2456799998865322  23457789999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEe
Q 017936           92 LAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC  161 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~  161 (363)
                      .++||||+.+++|.+++.+..          .++...+..++.|++.||.|||+.|++||||||+||+++.++.  ++|+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~  161 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIG  161 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEEC
Confidence            999999999999999986532          2577889999999999999999999999999999999986554  9999


Q ss_pred             ecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhc
Q 017936          162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS  237 (363)
Q Consensus       162 DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  237 (363)
                      |||+++.......   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||..........    .+..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~~----~~~~  236 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLR----FVME  236 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHc
Confidence            9999874322111   122345778999999988777665 999999999999999 789997655432222    1222


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          238 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       238 ~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .. ..+....++..+.+++.+||+.+|++|||+.+++++
T Consensus       237 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         237 GG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            21 122334578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.6e-43  Score=322.87  Aligned_cols=249  Identities=21%  Similarity=0.352  Sum_probs=202.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcE----EEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      ...+|++.+.||+|+||+||++.+..+++.    ||+|++....  ...+.+.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            346799999999999999999998666654    8999886532  2345678899999999999999999998765 46


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      +++++|+.+|+|.+.+... ..++...+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~  161 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA  161 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccC
Confidence            8999999999999998764 35899999999999999999999999999999999999976654  99999999985443


Q ss_pred             CCCC---CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       172 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      ....   ....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+.... ....    +.......+....
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~----~~~~~~~~~~~~~  235 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPAS-EISS----ILEKGERLPQPPI  235 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHH----HHhCCCCCCCCCC
Confidence            2221   12234668999999988877666 999999999999997 99999765432 2222    2223334444556


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ++.++.+++.+||+.+|.+|||+.+++.+
T Consensus       236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         236 CTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            78999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.7e-42  Score=320.52  Aligned_cols=258  Identities=28%  Similarity=0.433  Sum_probs=202.9

Q ss_pred             CceeeceecccCCeEEEEEEEcCC--CcEEEEEEeecCC---cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC----Ce
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTP----TH   91 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~----~~   91 (363)
                      +|++.+.||+|+||.||++++..+  ++.||+|.+....   ...+.+.+|+.+++.+ .||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999888  8999999886532   2235677899999988 599999999875432    45


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ++++++|+. ++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.  ++|+|||+++....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence            789999985 689999988888999999999999999999999999999999999999987654  99999999875432


Q ss_pred             CC-----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh----------
Q 017936          172 HS-----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL----------  236 (363)
Q Consensus       172 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------  236 (363)
                      ..     ......|++.|+|||.+.+....+.++|+|||||++|+|++|..||........+...+....          
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            21     122346899999999887644334459999999999999999999976553332222111100          


Q ss_pred             -------------ccc-cCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          237 -------------SVQ-YSI-PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       237 -------------~~~-~~~-~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                   ... ..+ ......+..+.+|+.+||+.+|.+|||+.+++.||||.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence                         000 000 0123457899999999999999999999999999999765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.6e-43  Score=326.84  Aligned_cols=252  Identities=23%  Similarity=0.385  Sum_probs=200.5

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP   89 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~   89 (363)
                      ...++|++.+.||+|+||.||+|...     .+++.||+|++.....  ..+.+.+|+.+++.+ +||||+++++++...
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            34578999999999999999999743     3457899998875332  224567899999999 799999999988654


Q ss_pred             -CeEEEEEeccCCCchHHHHHhC---------------------------------------------------------
Q 017936           90 -THLAIVMEYASGGELFERICNA---------------------------------------------------------  111 (363)
Q Consensus        90 -~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------------------  111 (363)
                       ..++++|||+.+++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             5789999999999999888542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---CCCccccCCCc
Q 017936          112 ----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAY  184 (363)
Q Consensus       112 ----~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y  184 (363)
                          ..++...+..++.||+.||+|||++||+||||||+|||++.++.  ++|+|||+++......   ......++..|
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCccc
Confidence                25789999999999999999999999999999999999986654  9999999997542211   12233456789


Q ss_pred             CChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccC
Q 017936          185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD  263 (363)
Q Consensus       185 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~  263 (363)
                      +|||++.+..++.+ +|||||||++|+|++ |..||............+.    ...........++++.+++.+||+.+
T Consensus       242 ~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~cl~~~  316 (337)
T cd05054         242 MAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK----EGTRMRAPEYATPEIYSIMLDCWHNN  316 (337)
T ss_pred             cCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh----ccCCCCCCccCCHHHHHHHHHHccCC
Confidence            99999988888777 999999999999998 9999976543333222221    11122223356899999999999999


Q ss_pred             CCCCCCHHHHhcC
Q 017936          264 PAKRISIPEIRNH  276 (363)
Q Consensus       264 p~~R~t~~ell~h  276 (363)
                      |++||++.++++|
T Consensus       317 p~~RPs~~ell~~  329 (337)
T cd05054         317 PEDRPTFSELVEI  329 (337)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-42  Score=315.92  Aligned_cols=248  Identities=21%  Similarity=0.350  Sum_probs=200.8

Q ss_pred             CCceeeceecccCCeEEEEEEE----cCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~----~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      +.|++.+.||+|+||+||++..    ..+++.+|+|.+.....  ....+.+|+.+++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5699999999999999999985    34567899999875322  22467889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCc
Q 017936           95 VMEYASGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR  157 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~-----------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~  157 (363)
                      ||||+.+++|.+++...                 ..+++.++..++.||+.||.|||++|++||||||+|||++.+..  
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~--  162 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH--  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc--
Confidence            99999999999988532                 23788999999999999999999999999999999999986654  


Q ss_pred             EEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017936          158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH  233 (363)
Q Consensus       158 vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~  233 (363)
                      +||+|||+++......   ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+..... ....  
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~~-~~~~--  238 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQE-VIEM--  238 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH--
Confidence            9999999987543221   1233345678999999987777655 999999999999998 999997654322 1121  


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       234 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                       +. .....+....+++.+.+++.+||+.+|.+||++.+++++
T Consensus       239 -~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 -VR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             -HH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence             11 122233445678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.1e-43  Score=318.65  Aligned_cols=256  Identities=27%  Similarity=0.472  Sum_probs=209.5

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccC
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  100 (363)
                      .|.-...||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++.+...+..++||||++
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            3555678999999999999999999999999875432 234567889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCccc
Q 017936          101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV  179 (363)
Q Consensus       101 ~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~~~  179 (363)
                      +++|.+++. .+.+++..++.++.|++.||+|||+.|++||||+|+||+++.++.  ++|+|||++....... ......
T Consensus       101 ~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657         101 GGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccc
Confidence            999988764 456899999999999999999999999999999999999987654  9999999876433221 223346


Q ss_pred             cCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017936          180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI  259 (363)
Q Consensus       180 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  259 (363)
                      |++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||.......... .+...  ..........++..+.+++.+|
T Consensus       178 ~~~~y~~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~l~~li~~~  253 (292)
T cd06657         178 GTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDN--LPPKLKNLHKVSPSLKGFLDRL  253 (292)
T ss_pred             cCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhh--CCcccCCcccCCHHHHHHHHHH
Confidence            8899999999877776555 999999999999999999998654433222 11111  1122223345789999999999


Q ss_pred             cccCCCCCCCHHHHhcCccccccCC
Q 017936          260 FVADPAKRISIPEIRNHEWFLKNLP  284 (363)
Q Consensus       260 L~~~p~~R~t~~ell~h~~~~~~~~  284 (363)
                      |+.+|.+||++.+++.||||.+..+
T Consensus       254 l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         254 LVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HhCCcccCcCHHHHhcChHHhccCC
Confidence            9999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.3e-43  Score=326.13  Aligned_cols=254  Identities=23%  Similarity=0.327  Sum_probs=197.3

Q ss_pred             ceeccc--CCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSG--NFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      ..||+|  +||+||++++..+++.||+|++.....   ..+.+.+|+.+++.++||||++++++|...+..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456776  999999999999999999999875432   235678899999999999999999999999999999999999


Q ss_pred             CchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC----
Q 017936          102 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----  175 (363)
Q Consensus       102 ~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~----  175 (363)
                      ++|.+++.+..  .+++..+..++.||+.||+|||++||+||||||+|||++.++.  ++++||+.+.........    
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCcccccc
Confidence            99999887643  4899999999999999999999999999999999999986654  999999865322111111    


Q ss_pred             ----CccccCCCcCChhhhhcCCC-CCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh--------------
Q 017936          176 ----KSTVGTPAYIAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------------  236 (363)
Q Consensus       176 ----~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------  236 (363)
                          ....++..|+|||++.+... .+.++|||||||++|+|++|..||.................              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence                11234567999999876432 23449999999999999999999976544332221111000              


Q ss_pred             ---------------------------ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          237 ---------------------------SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       237 ---------------------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                                 ......+....++..+.+||++||+.+|++|||+.++++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                       0000111223357789999999999999999999999999999654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8e-43  Score=319.05  Aligned_cols=248  Identities=25%  Similarity=0.345  Sum_probs=199.8

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCc--EEEEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~--~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ++|++.+.||+|+||.||++....++.  .+++|.+...  ....+.+.+|+.+++++ +||||+++++++...+.++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            679999999999999999999877665  4688877642  22335678899999888 799999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEE
Q 017936           96 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK  159 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vk  159 (363)
                      |||+++++|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~k  159 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SK  159 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EE
Confidence            99999999999986542                4889999999999999999999999999999999999986654  99


Q ss_pred             EeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhcc
Q 017936          160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV  238 (363)
Q Consensus       160 L~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  238 (363)
                      |+|||++..............+..|+|||.+.+..++.+ +|||||||++|+|++ |..||...........    +.. 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~----~~~-  233 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK----LPQ-  233 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----Hhc-
Confidence            999999864322211122233557999999987777665 999999999999997 9999987654333222    211 


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       239 ~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ....+....++..+.+||.+||+.+|.+|||+++++..
T Consensus       234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22223334578999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-42  Score=309.73  Aligned_cols=249  Identities=31%  Similarity=0.465  Sum_probs=209.4

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +|++.+.||+|+||.||++++..+++.+|+|.+....   .....+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5899999999999999999999999999999987643   2234567899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           99 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        99 ~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      +++++|..++.+    ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++  .+||+|||++...... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~--~~kl~d~g~~~~~~~~-~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND--LVKIGDLGISKVLKKN-M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC--cEEEeeccchhhhccC-C
Confidence            999999998866    35689999999999999999999999999999999999998755  4999999998765443 3


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+......    .+..... .+....++.++.+
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~  231 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRY----KVQRGKY-PPIPPIYSQDLQN  231 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCC-CCCchhhCHHHHH
Confidence            334568899999999988777655 999999999999999999998765432221    1222221 1222357899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccc
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ++.+||+.+|.+|||+.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.3e-43  Score=313.67  Aligned_cols=250  Identities=28%  Similarity=0.415  Sum_probs=204.3

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++.+.||+|++|.||++.+..+++.+|||.+....    .....+.+|+.+++.++||||+++++++...+.++++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57999999999999999999999999999999886532    22346778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ||+.+++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.  ++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~  159 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccC
Confidence            99999999998763    345899999999999999999999999999999999999986654  999999998754332


Q ss_pred             CC-CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       173 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      .. .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||......  .......+............+++.
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             CcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccHH
Confidence            22 233468899999999987777655 99999999999999999999754321  112222222222221223357889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +.++|.+||+.+|.+|||+.++++
T Consensus       237 ~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHHH
Confidence            999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-43  Score=316.82  Aligned_cols=254  Identities=31%  Similarity=0.493  Sum_probs=206.0

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      |++.+.||.|++|.||++.+..+++.+|+|.+.....   ....+.+|+.+++.++||||+++++++...+.+++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            6788999999999999999999999999999865432   2456788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCc
Q 017936          100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  177 (363)
Q Consensus       100 ~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~  177 (363)
                      .+ +|.+.+.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.  ++|+|||.+....... ....
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence            75 88777766 457999999999999999999999999999999999999986554  9999999987554433 2233


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc---------------ccCC
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYSI  242 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~  242 (363)
                      ..++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+............               ....
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            4688899999998776333445999999999999999999997766544333322211100               0000


Q ss_pred             C---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          243 P---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       243 ~---------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +         ....++.++.+||.+||+.+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            0         112367899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=313.93  Aligned_cols=253  Identities=31%  Similarity=0.454  Sum_probs=203.9

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcC---CCCCeeeeeEEEEcCCe-----
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILTPTH-----   91 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l---~hpnIv~~~~~~~~~~~-----   91 (363)
                      |++.+.||+|+||.||++++..+++.||+|.+.....   ....+.+|+.+++.+   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7889999999999999999998899999999875322   123455677766555   69999999999988776     


Q ss_pred             EEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      ++++|||+.+ +|.+++....  .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++  .++|+|||++...
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCcceec
Confidence            9999999975 7888887643  489999999999999999999999999999999999998775  4999999998765


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-ccCCC-----
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIP-----  243 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~-----  243 (363)
                      ..........+++.|+|||.+.+..++.+ +|+|||||++|+|++|.+||...+..+............ ....+     
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            44433344568889999999988877666 999999999999999999998766655444443321100 00000     


Q ss_pred             ---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          244 ---------------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       244 ---------------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                                     ....++..+.++|.+||+.+|.+||++++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                           011356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.9e-44  Score=308.12  Aligned_cols=260  Identities=29%  Similarity=0.435  Sum_probs=207.4

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCC----cEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEc-CCeE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHL   92 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~~   92 (363)
                      ..|+++..||+|.||.||+|..+.++    +.||||.++..   .......-+|+.++|.++||||+.+..+|.+ +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            36999999999999999999665544    36899988654   2345677899999999999999999999987 7889


Q ss_pred             EEEEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC--CCCcEEEeecCC
Q 017936           93 AIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGY  165 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~--~~~~vkL~DFgl  165 (363)
                      ++++||.+. +|+..+.-     ...++...++.++.||+.|+.|||++-|+||||||.|||+..+  ..|+|||+|||+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999999965 88888752     2459999999999999999999999999999999999999755  346799999999


Q ss_pred             cccCccCC----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch---------HHHHHHH
Q 017936          166 SKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTI  232 (363)
Q Consensus       166 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~~~  232 (363)
                      ++.....-    .....+-|.+|+|||.+.|..-.+++.||||+|||+.||+|-.+.|.+....         +++.++.
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            98654332    2345678999999999999988888899999999999999999988764321         1122221


Q ss_pred             HHHhcc--------ccCCCCC------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017936          233 HRILSV--------QYSIPDY------------------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       233 ~~~~~~--------~~~~~~~------------------------~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                       .++..        -...|.+                        ..-++...+||.+||+.||.+|.|++++++|+||.
T Consensus       263 -~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~  341 (438)
T KOG0666|consen  263 -EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT  341 (438)
T ss_pred             -HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence             11110        0011111                        11355689999999999999999999999999998


Q ss_pred             cc
Q 017936          281 KN  282 (363)
Q Consensus       281 ~~  282 (363)
                      +.
T Consensus       342 ~d  343 (438)
T KOG0666|consen  342 ED  343 (438)
T ss_pred             cC
Confidence            75

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.1e-42  Score=309.66  Aligned_cols=250  Identities=28%  Similarity=0.433  Sum_probs=204.3

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+....    .....+.+|+.+++.++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999899999999886422    23456889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ||+++++|..++..    ...+++.+++.++.|++.||.|||+.|++||||+|+||+++.++.  ++|+|||++......
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~  159 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence            99999999998864    345899999999999999999999999999999999999986654  999999998754322


Q ss_pred             C-CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          173 S-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       173 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      . ......+++.|+|||.+.+..++.+ +|+|||||++|+|++|..||......  .......+............++..
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             CcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhcCCCCCCChhhcCHH
Confidence            2 2233468899999999988777666 89999999999999999999654321  112222222222111112256889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +.++|.+||..+|.+|||+.++++
T Consensus       237 ~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         237 LRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHH
Confidence            999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.6e-43  Score=312.51  Aligned_cols=246  Identities=23%  Similarity=0.364  Sum_probs=205.7

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .+|++.+.||.|+||.||++.+.. ++.+|+|++..... ....+.+|+.+++.++||||+++++++.....+++||||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            469999999999999999999977 88899999876544 4567889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-CC
Q 017936          100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK  176 (363)
Q Consensus       100 ~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~~  176 (363)
                      ++++|.+++.+.  ..++...++.++.||+.||.|||++|++||||+|+||+++.++.  +||+|||++........ ..
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcccccc
Confidence            999999999753  45899999999999999999999999999999999999986654  99999999875432221 12


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ...++..|+|||.+.+..++.+ +||||||+++|+|++ |..||......+.+...    . .....+....+++.+.++
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI----T-AGYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             CCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH----H-hCCcCCCCCCCCHHHHHH
Confidence            2345678999999987777655 999999999999998 89999765543333322    2 223334445679999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 017936          256 ISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~  275 (363)
                      +.+||+.+|.+|||+.++++
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         237 MLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-42  Score=322.96  Aligned_cols=259  Identities=25%  Similarity=0.423  Sum_probs=205.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC------C
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~   90 (363)
                      .++|.+.+.||+|+||.||++.+..+++.||+|++.+..   ...+.+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            578999999999999999999999999999999987532   2235677899999999999999999988643      3


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      ..+++++++ +++|.+.+.. ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.  +||+|||+++...
T Consensus        96 ~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~  171 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD  171 (345)
T ss_pred             cEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEeccccccccc
Confidence            478888887 7788877654 46999999999999999999999999999999999999987654  9999999987542


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh--------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------------  236 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------  236 (363)
                      .  ......+++.|+|||.+.+....+.++|||||||++|+|++|..||.................              
T Consensus       172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (345)
T cd07877         172 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  249 (345)
T ss_pred             c--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence            2  223456889999999987643334449999999999999999999976554333322221100              


Q ss_pred             -----ccccCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 017936          237 -----SVQYSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP  284 (363)
Q Consensus       237 -----~~~~~~~------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~~  284 (363)
                           ......+      .....++++.+||.+||+.+|.+|||+.+++.||||.+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence                 0000001      01235888999999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2e-42  Score=314.94  Aligned_cols=254  Identities=20%  Similarity=0.315  Sum_probs=202.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH   91 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~   91 (363)
                      ..++|++.+.||+|+||.||++..+     ..+..||+|.+.....  ....+.+|+..++.++||||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3578999999999999999998764     2345799998865432  22356789999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEe
Q 017936           92 LAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC  161 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~  161 (363)
                      .++||||+.+++|.+++...          ..++...+..++.||+.||.|||++||+||||||+||+++.++.  ++|+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L~  161 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIG  161 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEEC
Confidence            99999999999999999753          23467789999999999999999999999999999999986554  9999


Q ss_pred             ecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhc
Q 017936          162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS  237 (363)
Q Consensus       162 DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  237 (363)
                      |||+++.......   .....++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||......+..    ..+..
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~  236 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQVL----KFVMD  236 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHc
Confidence            9999874322111   122345678999999988777665 999999999999998 78899765543222    22222


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------Ccccc
Q 017936          238 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN------HEWFL  280 (363)
Q Consensus       238 ~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~------h~~~~  280 (363)
                      .. ..+.....++.+.+++.+||+.+|++|||+.++++      ||||.
T Consensus       237 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  284 (288)
T cd05061         237 GG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP  284 (288)
T ss_pred             CC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence            11 12223356899999999999999999999999986      77774

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-42  Score=323.00  Aligned_cols=259  Identities=30%  Similarity=0.440  Sum_probs=205.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC--CeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~--~~~~   93 (363)
                      .++|++.+.||+|+||.||++.+..+++.+|+|.+...   ......+.+|+.+++.+ +||||+++++++...  ..++
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            46899999999999999999999989999999988542   22234567899999999 999999999998654  4689


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      +||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.......
T Consensus        86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~  161 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELE  161 (337)
T ss_pred             EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhcccccc
Confidence            9999996 5898888765 7899999999999999999999999999999999999987665  9999999987543322


Q ss_pred             ------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH------------
Q 017936          174 ------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI------------  235 (363)
Q Consensus       174 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------  235 (363)
                            ......|++.|+|||.+.+......++|+||||+++|+|++|+.||................            
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence                  12234588999999988665444455999999999999999999997655433322221110            


Q ss_pred             -------hc----ccc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          236 -------LS----VQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       236 -------~~----~~~--~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                             ..    ...  .......++.++.++|.+||+.+|.+|||+.+++.||||.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                   00    000  001122368899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-42  Score=311.43  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=203.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCC---CcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      .++|++.+.||+|+||+||++....+   ...||+|.+....  .....+.+|+..++.++||||+++++++...+.+++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            46799999999999999999998644   4579999886543  233567889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      ||||+.+++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.  ++|+|||+++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~  160 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhcccccc
Confidence            99999999999998764 46899999999999999999999999999999999999986654  9999999998653111


Q ss_pred             C---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          174 Q---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       174 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      .   .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.........    ..+. .....+....++
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~~  234 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVI----KAVE-DGYRLPPPMDCP  234 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHH----HHHH-cCCCCCCCCCCC
Confidence            1   112234678999999988777666 899999999999998 99999765543222    2221 222334445679


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      +.+.+++.+||+.+|++||++.+++++
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.2e-42  Score=315.64  Aligned_cols=253  Identities=26%  Similarity=0.380  Sum_probs=203.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCC----------------cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeee
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTE----------------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVR   81 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~----------------~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~   81 (363)
                      ..+|++++.||+|+||.||++.+...+                ..||+|.+....  ...+.+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            468999999999999999999876544                457999887543  23456788999999999999999


Q ss_pred             eeEEEEcCCeEEEEEeccCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEE
Q 017936           82 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL  150 (363)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll  150 (363)
                      +++++..+...+++|||+.+++|.+++.+..           .+++..++.++.|++.||.|||+.|++||||||+||++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili  163 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence            9999999999999999999999999997765           68999999999999999999999999999999999999


Q ss_pred             eCCCCCcEEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh--CCCCCCCCCch
Q 017936          151 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEP  225 (363)
Q Consensus       151 ~~~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~  225 (363)
                      +.++  .++|+|||+++......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++  |..||......
T Consensus       164 ~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         164 GKNY--TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             cCCC--ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            8664  49999999987543221   1223456788999999987777655 999999999999998  78888765543


Q ss_pred             HHHHHHHHHHh--ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          226 KNFRKTIHRIL--SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       226 ~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ...........  ......+....++.++.+++.+||+.+|.+|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            33222211100  111122333456899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-42  Score=324.19  Aligned_cols=257  Identities=27%  Similarity=0.436  Sum_probs=202.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC------C
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~   90 (363)
                      .++|.+.+.||+|+||.||++.+..+++.||+|.+.+..   .....+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368999999999999999999999999999999986532   2235578899999999999999999998754      3


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+++|+||+. .+|....  ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.  ++|+|||+++...
T Consensus        94 ~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~  168 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHAD  168 (342)
T ss_pred             eEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCC
Confidence            5799999995 4666554  346899999999999999999999999999999999999986654  9999999987542


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH---------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI---------------  235 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------------  235 (363)
                      .  ......+++.|+|||.+.+....+.++|||||||++|+|++|+.||............+...               
T Consensus       169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         169 A--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             C--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence            2  22344678899999998764433445999999999999999999998755433332222100               


Q ss_pred             ----hccccCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          236 ----LSVQYSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       236 ----~~~~~~~~------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                          .......+      .....+.++.+||.+||+.+|.+|||+++++.||||....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                00000000      0124678899999999999999999999999999997653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.7e-42  Score=309.26  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=201.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|+||.||++.+. .+..+|+|.+.......+.+.+|+.+++.++||||+++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            468999999999999999999875 5567999998776555677899999999999999999999875 45689999999


Q ss_pred             CCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--C
Q 017936          100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P  175 (363)
Q Consensus       100 ~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--~  175 (363)
                      .+++|.+++...  ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.  ++|+|||++........  .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCcccccc
Confidence            999999998753  35899999999999999999999999999999999999986554  99999999875432221  1


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||......+....    +. .....+.....+..+.+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~  234 (260)
T cd05070         161 QGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQ----VE-RGYRMPCPQDCPISLHE  234 (260)
T ss_pred             cCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HH-cCCCCCCCCcCCHHHHH
Confidence            12235567999999887777655 999999999999999 8999976554332222    21 12233444567899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017936          255 LISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~  275 (363)
                      |+.+||..+|.+|||++++.+
T Consensus       235 li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         235 LMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5e-42  Score=316.68  Aligned_cols=253  Identities=28%  Similarity=0.449  Sum_probs=206.5

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ..|...+.||+|+||.||++++..+++.+|+|.+.....    ....+.+|+.+++.++|||++++++++...+..++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            458999999999999999999999999999999875422    2245778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      ||+.| +|.+.+.. ..++++.++..++.||+.||.|||++|++||||+|+||+++.++.  ++|+|||++....   ..
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~~  178 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---PA  178 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---Cc
Confidence            99975 77666654 456999999999999999999999999999999999999976554  9999999886432   23


Q ss_pred             CccccCCCcCChhhhh---cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ....|++.|+|||.+.   .+.++.+ +|||||||++|+|++|..||...........    +............+++.+
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l  253 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPTLQSNEWSDYF  253 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhccCCCCCCccccHHH
Confidence            3456889999999974   2345444 9999999999999999999976543332222    222222222234578899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLKNLP  284 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~~~~  284 (363)
                      .+++.+||+.+|.+||++.+++.|+|+....+
T Consensus       254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            99999999999999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-42  Score=308.14  Aligned_cols=245  Identities=27%  Similarity=0.424  Sum_probs=203.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..++|++.+.||.|+||.||++...  ++.||+|.+.......+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            3468999999999999999999864  78899999877655556788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        99 ~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      +++++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||+++......  .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~--~  157 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQ--D  157 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEccccccccccccc--c
Confidence            99999999997665  6999999999999999999999999999999999999986654  9999999987652221  2


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ...++..|+|||.+.+..+..+ +||||||+++|++++ |..||....... ....+.    ..........+++.+.++
T Consensus       158 ~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~l  231 (256)
T cd05039         158 SGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPHVE----KGYRMEAPEGCPPEVYKV  231 (256)
T ss_pred             cCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHh----cCCCCCCccCCCHHHHHH
Confidence            3345667999999987777655 999999999999997 999997654322 222111    122222334578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 017936          256 ISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~  275 (363)
                      |++||..+|++|||+.++++
T Consensus       232 i~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         232 MKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHhccChhhCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-44  Score=318.72  Aligned_cols=253  Identities=33%  Similarity=0.571  Sum_probs=215.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc----HHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..+|..+.+||+|+||+|.++..+.+.+.||||+++++....    +--..|-++|... +-|.+++++.+|++-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            457899999999999999999999999999999998764322    1123455555544 57899999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-C
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~  173 (363)
                      ||||++||+|.-.++..++|.+..+..|+..|+-||-+||++|||.||||.+|||++.++  ++||+|||+++..... .
T Consensus       428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG--HiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIFDGV  505 (683)
T ss_pred             EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC--ceEeeecccccccccCCc
Confidence            999999999999999999999999999999999999999999999999999999997665  4999999999865443 3


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      ...+.+|||.|+|||++..++|. +++|+||+|+++|||+.|++||.+.+..+.++.+...    ....|  ..+|.++.
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh----nvsyP--KslSkEAv  578 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH----NVSYP--KSLSKEAV  578 (683)
T ss_pred             ceeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----cCcCc--ccccHHHH
Confidence            44667899999999999988885 5599999999999999999999998887666554433    33333  46899999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          254 HLISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      ++++..|.+.|.+|..     -.++..||||..
T Consensus       579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             HHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence            9999999999999985     367999999964

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=307.65  Aligned_cols=242  Identities=39%  Similarity=0.636  Sum_probs=205.6

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCch
Q 017936           29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        29 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      ||.|+||.||++.+..+++.+|+|++.+...    ....+..|+.+++.++||||+++++.+..++.+++||||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999998899999999876532    234678899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCccccCCC
Q 017936          105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA  183 (363)
Q Consensus       105 ~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~~~gt~~  183 (363)
                      .+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.  ++|+|||++...... .......++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence            999998888999999999999999999999999999999999999986654  999999998754333 22344568889


Q ss_pred             cCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccC
Q 017936          184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD  263 (363)
Q Consensus       184 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~  263 (363)
                      |+|||.+.+...+.+ +|+||||+++|++++|..||.......    ....+.....  +....++..+.++|++||..+
T Consensus       159 ~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~--~~~~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         159 YLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEKILKDPL--RFPEFLSPEARDLISGLLQKD  231 (250)
T ss_pred             ccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhcCCC--CCCCCCCHHHHHHHHHHhcCC
Confidence            999999887766555 999999999999999999997655422    2222322222  333346899999999999999


Q ss_pred             CCCCCCH---HHHhcCccc
Q 017936          264 PAKRISI---PEIRNHEWF  279 (363)
Q Consensus       264 p~~R~t~---~ell~h~~~  279 (363)
                      |.+|||+   +++++||||
T Consensus       232 p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         232 PTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HhhCCCcccHHHHHhCCCC
Confidence            9999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-42  Score=316.62  Aligned_cols=252  Identities=24%  Similarity=0.377  Sum_probs=204.6

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEE-----cCCCcEEEEEEeecCC--cccHHHHHHHHHHHcC-CCCCeeeeeEEEEc
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT   88 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~   88 (363)
                      ....++|.+.+.||+|+||.||++.+     ..++..+|+|++....  ...+.+.+|+.+++.+ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            34567899999999999999999975     2345689999887543  2235678899999999 79999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCc
Q 017936           89 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  166 (363)
Q Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla  166 (363)
                      .+.+++||||+.+++|.+++....  .+++.++..++.||+.||+|||++||+||||||+|||++.++  .++|+|||++
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~  188 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLA  188 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEECCCccc
Confidence            999999999999999999987643  389999999999999999999999999999999999997655  4999999998


Q ss_pred             ccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCC
Q 017936          167 KSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSI  242 (363)
Q Consensus       167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (363)
                      +.......   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||........+.....    .....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~  263 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGYRM  263 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH----cCCcC
Confidence            75432211   122345778999999988877666 999999999999998 9999987655443333222    12222


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          243 PDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       243 ~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +.....++++.+++.+||..+|++|||+.+++.
T Consensus       264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            333456899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=331.34  Aligned_cols=245  Identities=35%  Similarity=0.538  Sum_probs=208.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHH-HHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .+.|.+...+|.|+||.|..+.+..+++.+++|++.+..   .+..+|+. .+..-+||||+++++++.+..+.|+|||.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~  397 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL  397 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence            567999999999999999999999999999999998762   22334553 34556899999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCcc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  178 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~  178 (363)
                      +.|+.+.+.+...+.+. .++..|+++|+.|+.|||++|+|||||||+|||++ +..++++|+|||.++.....  ..+.
T Consensus       398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~~~~--~~tp  473 (612)
T KOG0603|consen  398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFWSELERS--CDTP  473 (612)
T ss_pred             ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechhhhCchh--hccc
Confidence            99999999988877666 88889999999999999999999999999999996 33445999999998865443  4556


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR  258 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  258 (363)
                      +-|..|.|||++....|+.. +||||||++||+|++|+.||......   .++..++.....+    ..+|..+++||++
T Consensus       474 ~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s----~~vS~~AKdLl~~  545 (612)
T KOG0603|consen  474 ALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS----ECVSDEAKDLLQQ  545 (612)
T ss_pred             chhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----cccCHHHHHHHHH
Confidence            78899999999998888766 99999999999999999999876554   2333333333222    5689999999999


Q ss_pred             hcccCCCCCCCHHHHhcCccc
Q 017936          259 IFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       259 ~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ||+.+|.+||++.+++.||||
T Consensus       546 LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  546 LLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             hccCChhhCcChhhhccCcch
Confidence            999999999999999999999

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-42  Score=307.55  Aligned_cols=248  Identities=24%  Similarity=0.344  Sum_probs=205.5

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..++|.+.+.||+|+||.||++.+. .++.+|+|.+.........+.+|+.+++.++||||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            3578999999999999999999975 457799999887666667889999999999999999999999998999999999


Q ss_pred             cCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--
Q 017936           99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--  174 (363)
Q Consensus        99 ~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--  174 (363)
                      +++++|.+++....  .++...+..++.||+.||.|||++|++||||||+||+++.++.  ++|+|||++........  
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~  160 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTA  160 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhhh
Confidence            99999999997643  6899999999999999999999999999999999999986654  99999999875432111  


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      .....++..|+|||.+.+..+..+ +|+||||+++|+|++ |+.||...+.......    +. .....+.....+.++.
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~  234 (261)
T cd05034         161 REGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ----VE-RGYRMPRPPNCPEELY  234 (261)
T ss_pred             hhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH-cCCCCCCCCCCCHHHH
Confidence            112234568999999987776655 999999999999998 9999976554332222    22 1223344445689999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017936          254 HLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +++.+||+.+|.+||++++++.
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         235 DLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-42  Score=311.31  Aligned_cols=249  Identities=21%  Similarity=0.308  Sum_probs=202.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCC-----CcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH   91 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~   91 (363)
                      ..++|.+.+.||+|+||.||++.+...     +..||+|.+.....  ....+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            357899999999999999999998643     37899999865432  23457789999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEe
Q 017936           92 LAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC  161 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~  161 (363)
                      .++||||+.+++|.+++....          .+++..+..++.||+.||.|||+.|++||||||+|||++.++.  +||+
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~  161 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIG  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEEC
Confidence            999999999999999986432          3678899999999999999999999999999999999987655  9999


Q ss_pred             ecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhc
Q 017936          162 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS  237 (363)
Q Consensus       162 DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  237 (363)
                      |||+++......   ......++..|+|||.+.+..++.+ +|||||||++|++++ |..||...+..... +..   . 
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~-~~~---~-  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVL-KFV---I-  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHH-HHH---h-
Confidence            999987543221   1223456788999999987777665 999999999999998 99999765543322 222   1 


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          238 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       238 ~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .....+....++.++.++|.+||+.+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         236 DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            11122233456899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.1e-42  Score=308.10  Aligned_cols=246  Identities=23%  Similarity=0.383  Sum_probs=202.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|+||.||+|..+ +++.||+|.+.........+.+|+.+++.++||||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467999999999999999999864 5678999998876666678899999999999999999999874 45689999999


Q ss_pred             CCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--C
Q 017936          100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P  175 (363)
Q Consensus       100 ~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--~  175 (363)
                      .+++|.+++...  ..++..++..++.|++.||+|||+.|++||||||+||+++.++.  ++|+|||++........  .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCcccc
Confidence            999999988653  35899999999999999999999999999999999999987655  99999999875432211  1


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....++..|+|||.+.+..++.+ +||||||+++|++++ |..||...+.......    + ......+.....+.++.+
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~  234 (260)
T cd05067         161 EGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN----L-ERGYRMPRPDNCPEELYE  234 (260)
T ss_pred             cCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHH----H-HcCCCCCCCCCCCHHHHH
Confidence            22345678999999987777655 999999999999999 9999987654332222    1 122233444557899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017936          255 LISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.+||+.+|++|||++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         235 LMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=314.90  Aligned_cols=254  Identities=31%  Similarity=0.487  Sum_probs=205.2

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc--cHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEecc
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      |.+.+.||+|++|+||+++...+++.||+|.+......  .....+|+..++.++ ||||+++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            78899999999999999999989999999988654322  223457889999999 999999999999999999999999


Q ss_pred             CCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc
Q 017936          100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus       100 ~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                       +++|.+.+....  .+++.++..++.|++.+|.|||++|++|+||+|+||+++.++.  ++|+|||++...........
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence             789998887754  7899999999999999999999999999999999999987554  99999999886544444445


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh---------------ccccCC
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL---------------SVQYSI  242 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------~~~~~~  242 (363)
                      ..++..|+|||++.+....+.++|+||||+++++|++|..||......+..........               ......
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            56889999999886544334559999999999999999999977655443332221100               000000


Q ss_pred             CC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          243 PD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       243 ~~---------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +.         ....+..+.+||++||+.+|++|||++|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            00         11236889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.4e-42  Score=313.21  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=202.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      ...+|.+.+.||+|+||.||++...     .++..+|+|.+.... .....+.+|+.+++.++||||+++++++......
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            3567999999999999999999743     356689999876533 3345788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCc
Q 017936           93 AIVMEYASGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR  157 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~---------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~  157 (363)
                      +++|||+.+++|.+++...+               .+++..+..++.||+.||+|||++|++||||||+|||++.++  .
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~--~  160 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL--V  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC--C
Confidence            99999999999999987643               488999999999999999999999999999999999998655  4


Q ss_pred             EEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017936          158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH  233 (363)
Q Consensus       158 vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~  233 (363)
                      +||+|||+++......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |.+||............  
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--  237 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI--  237 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH--
Confidence            9999999987432221   1223345788999999988887666 899999999999998 99999765543332222  


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       234 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                        ... ...+....+++.+.++|.+||+.+|.+||++++++.
T Consensus       238 --~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 --TQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             --HcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence              111 122233457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.5e-42  Score=311.16  Aligned_cols=248  Identities=21%  Similarity=0.362  Sum_probs=200.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCc----EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      ..++|++.+.||+|+||+||++++..+++    .||+|++....  .....+.+|+.+++.+.||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV   83 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence            35789999999999999999999877776    48999886532  2345678899999999999999999998754 46


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      +++++|+++|+|.+.+... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~  161 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDI  161 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeeccc
Confidence            8999999999999998764 46999999999999999999999999999999999999976554  99999999875432


Q ss_pred             CCCC---CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       172 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      ....   ....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||....... ....    .......+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~----~~~~~~~~~~~~  235 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPARE-IPDL----LEKGERLPQPPI  235 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH----HHCCCcCCCCcc
Confidence            2221   12235678999999988877666 999999999999998 999997644322 2122    222223344456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.++.+++.+||+.+|++||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.1e-42  Score=314.18  Aligned_cols=260  Identities=28%  Similarity=0.413  Sum_probs=205.4

Q ss_pred             CCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeE
Q 017936           16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~   92 (363)
                      .....++|++.+.||+|++|.||++.+..+++.||+|.+.....  ....+.+|+.++..+ .||||+++++++.....+
T Consensus        10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            34456889999999999999999999999899999999876432  233455666655555 599999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      |++|||+. ++|...+.. ...+++..+..++.||+.||+|||+ .||+||||+|+||+++.++  .+||+|||++....
T Consensus        90 ~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~--~~kL~dfg~~~~~~  166 (296)
T cd06618          90 FICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLV  166 (296)
T ss_pred             EEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC--CEEECccccchhcc
Confidence            99999985 467666654 4578999999999999999999997 5999999999999997655  49999999987543


Q ss_pred             cCCCCCccccCCCcCChhhhhcCC----CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-ccCCCCC
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDY  245 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~  245 (363)
                      .........+++.|+|||.+.+..    ++.+ +||||||+++|+|++|+.||.......   ......... ....+..
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~  242 (296)
T cd06618         167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIR-ADVWSLGISLVELATGQFPYKNCKTEF---EVLTKILQEEPPSLPPN  242 (296)
T ss_pred             CCCcccCCCCCccccCHhhcCCCCCccccccc-hhHHHHHHHHHHHHhCCCCCCcchhHH---HHHHHHhcCCCCCCCCC
Confidence            333334446788999999987553    4444 899999999999999999996532211   112222222 2233333


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          246 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ..++.++.+|+.+||+.+|.+|||+++++.||||...
T Consensus       243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            3578999999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.4e-42  Score=306.87  Aligned_cols=239  Identities=26%  Similarity=0.352  Sum_probs=193.3

Q ss_pred             eecccCCeEEEEEEE--cCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCC
Q 017936           28 DIGSGNFGVARLMRD--KKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  102 (363)
Q Consensus        28 ~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~  102 (363)
                      .||+|+||.||++..  ..+++.+|+|++.....   ..+.+.+|+.+++.++||||+++++++. ....++||||+.++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999864  46778999998865432   2456788999999999999999999875 45678999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC----CCcc
Q 017936          103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKST  178 (363)
Q Consensus       103 ~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~----~~~~  178 (363)
                      +|.+++.....+++..+..++.|++.||+|||++||+||||||.||+++.++  .+||+|||+++.......    ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH--YAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC--eEEECCCccccccCCCCCeeeecCCC
Confidence            9999998888899999999999999999999999999999999999998655  499999999875433221    1222


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      .+++.|+|||.+.+..++.+ +|+|||||++|+|++ |..||........    ...+... ...+.+..+++++.++|.
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~----~~~i~~~-~~~~~~~~~~~~l~~li~  232 (257)
T cd05116         159 KWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNEV----TQMIESG-ERMECPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHCC-CCCCCCCCCCHHHHHHHH
Confidence            34578999999877666655 999999999999998 9999976544322    2222222 223334467999999999


Q ss_pred             HhcccCCCCCCCHHHHhc
Q 017936          258 RIFVADPAKRISIPEIRN  275 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~  275 (363)
                      +||+.+|.+||++++|..
T Consensus       233 ~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         233 LCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHhccCchhCcCHHHHHH
Confidence            999999999999999854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-42  Score=312.79  Aligned_cols=254  Identities=34%  Similarity=0.530  Sum_probs=206.6

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      |++.+.||+|++|.||++++..+++.||+|++...   ....+.+..|+.+++.++||||+++++++.....+++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            67889999999999999999999999999998764   333466778999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCc
Q 017936          100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  177 (363)
Q Consensus       100 ~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~  177 (363)
                      . ++|.+++.+. ..+++..+..++.|++.||++||++||+||||+|+||+++.++.  ++|+|||++....... ....
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence            7 5899999876 57999999999999999999999999999999999999987554  9999999987543322 2233


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHh-----------cc---ccCCC
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-----------SV---QYSIP  243 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------~~---~~~~~  243 (363)
                      ..++..|+|||.+.+....+.++|||||||++|++++|..||...........+.....           ..   ....+
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP  237 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence            45678899999987763334449999999999999999999987654443333221110           00   00011


Q ss_pred             ---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          244 ---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       244 ---------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                               ....++..+.++|.+||+.+|++||++++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                     112347889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.6e-42  Score=313.23  Aligned_cols=248  Identities=21%  Similarity=0.342  Sum_probs=200.9

Q ss_pred             CCceeeceecccCCeEEEEEEEcC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      .+|++.+.||+|+||.||++.+..     .++.||+|++.....  ..+.+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            468999999999999999998754     357899999875432  2356788999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCc
Q 017936           94 IVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR  157 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~  157 (363)
                      +++||+.+++|..++...                ..+++..+..++.|++.||.|||++||+||||||+||+++.+..  
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--
Confidence            999999999999988532                24788899999999999999999999999999999999976554  


Q ss_pred             EEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017936          158 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH  233 (363)
Q Consensus       158 vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~  233 (363)
                      +||+|||+++.......   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+......    ..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDV----IE  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HH
Confidence            99999999875432221   223346789999999987777666 999999999999998 8888876544322    22


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       234 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .+.... ..+....++..+.+|+.+||+.+|.+||++.+++..
T Consensus       238 ~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         238 MIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            222222 222334679999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7e-42  Score=306.70  Aligned_cols=245  Identities=23%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccC
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  100 (363)
                      ++|.+.+.||+|++|.||++.+..++ .+|+|.+.......+.+.+|+.+++.++|||++++++++. .+..+++|||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            67999999999999999999886654 5899988766555677889999999999999999999875 456799999999


Q ss_pred             CCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--CC
Q 017936          101 GGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PK  176 (363)
Q Consensus       101 ~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--~~  176 (363)
                      +++|.+++....  .++...+..++.|++.||.|||+.|++||||||+||+++.++.  ++|+|||++........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCcccccC
Confidence            999999987543  4889999999999999999999999999999999999986654  99999999875432211  12


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ...++..|+|||...+..++.+ +||||||+++|+|++ |..||...........    +. .....+.....+..+.++
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~l  235 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQ----VE-RGYRMPCPQGCPESLHEL  235 (260)
T ss_pred             CCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH-cCCCCCCCcccCHHHHHH
Confidence            2345678999999887777655 999999999999999 9999987554332222    11 122233344678999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 017936          256 ISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~  275 (363)
                      +++||..+|.+||+++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.6e-42  Score=314.93  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=204.5

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      +.|...+.||+|+||+||++++..+++.||+|.+.....    ....+.+|+.+++.++|||++++++++.+....|+||
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            457778899999999999999999999999999865322    2245778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      ||+. +++...+.. ..++++.++..++.||+.||.|||++|++||||+|+||+++.++.  ++|+|||++...   ...
T Consensus       101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~---~~~  174 (313)
T cd06633         101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKS---SPA  174 (313)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCccc---CCC
Confidence            9996 577776654 456999999999999999999999999999999999999976554  999999988643   223


Q ss_pred             CccccCCCcCChhhhhc---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          176 KSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ....|+..|+|||.+..   ..++.+ +|||||||++|+|++|..||.............    ...........++..+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l  249 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNDSPTLQSNEWTDSF  249 (313)
T ss_pred             CCccccccccChhhccccCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCCCccccCHHH
Confidence            45578999999999842   344444 899999999999999999998765433333221    1111111223467889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ++|+.+||+.+|.+||++.+++.||||...
T Consensus       250 ~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         250 RGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.3e-42  Score=314.13  Aligned_cols=251  Identities=24%  Similarity=0.376  Sum_probs=202.3

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCC-----CcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP   89 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~   89 (363)
                      ...++|++.+.||+|+||.||++.....     ...+|+|.+.....  ....+.+|+.+++.+ +||||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            3457899999999999999999997643     36899998875422  224577899999999 799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC
Q 017936           90 THLAIVMEYASGGELFERICN----------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS  153 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~----------------~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~  153 (363)
                      +.++++|||+.+++|..++..                ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED  168 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence            999999999999999999854                2358899999999999999999999999999999999999766


Q ss_pred             CCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017936          154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR  229 (363)
Q Consensus       154 ~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~  229 (363)
                      +  .+||+|||+++.......   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||..........
T Consensus       169 ~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         169 H--VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             C--eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            5  499999999875433221   112234567999999887777666 999999999999997 999997655433222


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      . +    ......+.....+.++.+|+.+||..+|++|||+.+++++
T Consensus       246 ~-~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 L-L----KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             H-H----HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            1 1    1222223334568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.7e-42  Score=313.01  Aligned_cols=248  Identities=26%  Similarity=0.384  Sum_probs=201.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..+|.+.+.||+|+||.||++.+.     .++..+++|.+..... ....+.+|+..++.++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            456999999999999999999853     3456789998765432 2356889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCc
Q 017936           94 IVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR  157 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~  157 (363)
                      +||||+++++|.+++...+                .+++..++.++.||+.||+|||++||+||||||+|||++.++.  
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~--  161 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--  161 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--
Confidence            9999999999999987543                3889999999999999999999999999999999999986654  


Q ss_pred             EEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017936          158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH  233 (363)
Q Consensus       158 vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~  233 (363)
                      ++|+|||++.......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||..........    
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~----  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIE----  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----
Confidence            9999999987543221   1233456788999999988777666 999999999999999 999997655433222    


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       234 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .+..... .......+..+.+++.+||+.+|.+|||+.++++
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         237 CITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            2222211 1223346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-43  Score=328.27  Aligned_cols=254  Identities=31%  Similarity=0.500  Sum_probs=217.6

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      -|..++.||-|+||.|++++...|...||+|.+++.+.    ....++.|-.||...+++-||+|+-.|++.+++|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            48889999999999999999999999999999987543    33457889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc------
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL------  171 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~------  171 (363)
                      |++||++..++.+.+-|.|..++.|+..+..|+++.|..|+|||||||+|||||.+++  +||+||||+..+.=      
T Consensus       710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceecccccc
Confidence            9999999999999999999999999999999999999999999999999999987765  99999999863210      


Q ss_pred             --CCC-----------------------------------CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh
Q 017936          172 --HSQ-----------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV  214 (363)
Q Consensus       172 --~~~-----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~  214 (363)
                        .+.                                   ....+||+.|+|||++....|... +|+||.|||||+|+.
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEMLV  866 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHhh
Confidence              000                                   011259999999999999888766 999999999999999


Q ss_pred             CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccc
Q 017936          215 GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK  281 (363)
Q Consensus       215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~---t~~ell~h~~~~~  281 (363)
                      |++||...+..+...+++.  +...+.++....+|.++.++|.++. .+++.|+   .++++.+||||+.
T Consensus       867 g~~pf~~~tp~~tq~kv~n--w~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVIN--WRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             CCCCccCCCCCcceeeeee--hhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence            9999988776554443321  2344567777889999999999975 6788887   4778999999974

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-42  Score=313.78  Aligned_cols=253  Identities=25%  Similarity=0.365  Sum_probs=199.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCC--------------cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeee
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTE--------------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFK   83 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~--------------~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~   83 (363)
                      .++|++.+.||+|+||.||+|++..++              ..||+|.+....  .....+.+|+.+++.++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            468999999999999999999875432              358999887542  2335688899999999999999999


Q ss_pred             EEEEcCCeEEEEEeccCCCchHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEe
Q 017936           84 EVILTPTHLAIVMEYASGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD  151 (363)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~  151 (363)
                      +++...+..++||||+.+++|.+++....            .+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~  163 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG  163 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence            99999999999999999999999886432            368889999999999999999999999999999999998


Q ss_pred             CCCCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh--CCCCCCCCCchH
Q 017936          152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPK  226 (363)
Q Consensus       152 ~~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~~  226 (363)
                      .++.  +||+|||++........   .....+++.|+|||.+.+..++.+ +|||||||++|+|++  |..||.......
T Consensus       164 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         164 NHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             CCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            6554  99999999875432211   122345678999999988777655 999999999999988  678887655433


Q ss_pred             HHHHHHHHHh--ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          227 NFRKTIHRIL--SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       227 ~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..........  ...........+++.+.+|+.+||+.+|.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            3222211111  111112223346899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.3e-42  Score=316.61  Aligned_cols=259  Identities=29%  Similarity=0.485  Sum_probs=204.8

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEc-CCeEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLA   93 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~~~   93 (363)
                      ..+++|++.+.||.|+||.||++.+..+++.||+|.+.+.   ....+.+.+|+.+++.++||||+++.++|.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            3568899999999999999999999999999999987643   2234667889999999999999999999876 56789


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      +++||+ +++|...+.. .++++..+..++.||+.||+|||++||+||||+|.||+++.++.  ++|+|||++.....  
T Consensus        87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~--  160 (328)
T cd07856          87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQDP--  160 (328)
T ss_pred             EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccCC--
Confidence            999999 5688777654 46899999999999999999999999999999999999986554  99999999874322  


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHH-------------------
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------------  234 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------------  234 (363)
                      ......+++.|+|||.+.+....++++|||||||++|+|++|..||...............                   
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence            2234467889999998766443345599999999999999999999765432211111100                   


Q ss_pred             -Hhcc--ccCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          235 -ILSV--QYSIP---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       235 -~~~~--~~~~~---~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                       ....  ....+   ....++.++.++|++||+.+|++|||+++++.||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence             0000  00011   113468899999999999999999999999999999654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.2e-42  Score=312.13  Aligned_cols=256  Identities=32%  Similarity=0.541  Sum_probs=206.4

Q ss_pred             CceeeceecccCCeEEEEEEEc---CCCcEEEEEEeecCC-----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeE
Q 017936           22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~-----~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~   92 (363)
                      +|++.+.||+|++|.||++++.   .+++.||+|++.+..     .....+.+|+.++..+ +||||+++++.+.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4899999999999999999864   467889999987532     2234567899999999 599999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ++||||+.+++|...+.....+++..++.++.|++.||.|||+.|++||||+|.||+++.++.  ++|+|||+++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~  158 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccc
Confidence            999999999999999988788999999999999999999999999999999999999986654  999999998754332


Q ss_pred             CC--CCccccCCCcCChhhhhcCC-CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          173 SQ--PKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       173 ~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      ..  .....|++.|+|||.+.+.. ....++|+||||+++|+|++|..||.....................  +....++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  236 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMS  236 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccC
Confidence            21  12345889999999987654 1234489999999999999999999643322222222233333222  3334578


Q ss_pred             HHHHHHHHHhcccCCCCCCC---HHHHhcCccccc
Q 017936          250 PECRHLISRIFVADPAKRIS---IPEIRNHEWFLK  281 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t---~~ell~h~~~~~  281 (363)
                      ..+.++|.+||+.+|++|||   +.++++||||+.
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~  271 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG  271 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence            99999999999999999998   567899999965

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-42  Score=305.53  Aligned_cols=240  Identities=26%  Similarity=0.347  Sum_probs=195.8

Q ss_pred             ceecccCCeEEEEEEEcCCC---cEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTE---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||.||++....++   ..+|+|.+.....  ..+.+.+|+.+++.++||||+++++++. .+.+++||||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999876554   7899999876543  3456788999999999999999999876 4568999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC----c
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----S  177 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~----~  177 (363)
                      ++|.+++.....+++..+..++.|++.||+|||+.|++||||||+|||++.++.  +||+|||+++.........    .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence            999999998888999999999999999999999999999999999999986654  9999999987543322211    1


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ..++..|+|||.+.+..++.+ +|||||||++|++++ |..||......... ..   +. .....+....++..+.++|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~~-~~---~~-~~~~~~~~~~~~~~l~~li  231 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AM---LE-SGERLPRPEECPQEIYSIM  231 (257)
T ss_pred             ccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHHH-HH---HH-cCCcCCCCCCCCHHHHHHH
Confidence            123467999999987777666 999999999999998 99999765543222 22   11 1223344456789999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 017936          257 SRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~  275 (363)
                      .+||+.+|++|||+.++++
T Consensus       232 ~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         232 LSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.4e-42  Score=315.63  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=199.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcC-------CCcEEEEEEeecCC--cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP   89 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~   89 (363)
                      .++|.+.+.||+|+||.||++++..       +...+|+|.+....  .....+.+|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4789999999999999999998643       23579999987542  2234577899999999 799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC
Q 017936           90 THLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS  153 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~  153 (363)
                      +.+++||||+.+++|.+++...+                .++..++..++.||+.||+|||++|++||||||+||+++.+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~  176 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED  176 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence            99999999999999999997542                47889999999999999999999999999999999999866


Q ss_pred             CCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017936          154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR  229 (363)
Q Consensus       154 ~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~  229 (363)
                      +  .+||+|||+++.......   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||..... ....
T Consensus       177 ~--~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~~-~~~~  252 (307)
T cd05098         177 N--VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-EELF  252 (307)
T ss_pred             C--cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCCH-HHHH
Confidence            5  499999999875432111   111234568999999988777655 999999999999998 8899876443 2222


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ..+    ......+....++.++.++|.+||..+|.+|||+.+++++
T Consensus       253 ~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         253 KLL----KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHH----HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            222    1222223344678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.4e-42  Score=308.61  Aligned_cols=248  Identities=23%  Similarity=0.384  Sum_probs=202.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCc---EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..+|++.+.||+|+||.||++.+..++.   .+|+|.+....  ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4679999999999999999999865543   79999886543  234567889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      ||||+++++|.+++.+. ..++..++..++.|++.||.+||++|++||||||+|||++.++  .++|+|||++.......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC--eEEeCCCCccccccccc
Confidence            99999999999998765 4689999999999999999999999999999999999997655  49999999987543322


Q ss_pred             CC----CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          174 QP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       174 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                      ..    ....++..|+|||.+.+..++.+ +|+|||||++|++++ |..||..........    .+.. ....+....+
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~  234 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIK----AIEE-GYRLPAPMDC  234 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHH----HHhC-CCcCCCCCCC
Confidence            11    11123567999999988777666 999999999999886 999997655433222    2222 2234445567


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.+.+++.+||+.+|.+|||+.++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6e-42  Score=314.89  Aligned_cols=253  Identities=27%  Similarity=0.426  Sum_probs=204.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .+.|...+.||+|+||.||++++..+++.+|+|.+....    .....+.+|+.+++.++|||++++.+++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            456899999999999999999999999999999886432    1224567899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      |||+. ++|...+.. ...+++.++..++.|++.||.|||+.|++||||+|+||+++.++  .++|+|||++.....   
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~---  167 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---  167 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC--cEEECCcccceeecC---
Confidence            99996 577776643 45689999999999999999999999999999999999997655  499999999875432   


Q ss_pred             CCccccCCCcCChhhhhc---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          175 PKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      .....+++.|+|||.+.+   ..++.+ +|||||||++|+|++|..||...........    .............++..
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  242 (308)
T cd06634         168 ANXFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEY  242 (308)
T ss_pred             cccccCCccccCHHHHhhcccCCCCcc-cchHHHHHHHHHHHcCCCCCccccHHHHHHH----HhhcCCCCcCcccccHH
Confidence            234568899999999853   334444 9999999999999999999976543222221    11111111122357889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          252 CRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      +.+||++||+.+|.+||++++++.|||+....
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            99999999999999999999999999997753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-42  Score=308.28  Aligned_cols=246  Identities=22%  Similarity=0.334  Sum_probs=196.4

Q ss_pred             ceeeceecccCCeEEEEEEEcC---CCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe-----
Q 017936           23 YELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH-----   91 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~-----   91 (363)
                      |.+.+.||+|+||.||.+....   ++..||+|.+......   ...+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6788999999999999998764   3478999998754322   3467889999999999999999998866543     


Q ss_pred             -EEEEEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecC
Q 017936           92 -LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG  164 (363)
Q Consensus        92 -~~lv~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFg  164 (363)
                       .+++|||+.+++|..++...      ..+++..++.++.|++.||.|||++|++||||||+||+++.++  .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC--eEEECCcc
Confidence             79999999999999887432      2589999999999999999999999999999999999997655  49999999


Q ss_pred             CcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhcccc
Q 017936          165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY  240 (363)
Q Consensus       165 la~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (363)
                      +++.......   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||..........    .+... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~----~~~~~-~  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYD----YLRHG-N  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcC-C
Confidence            9875433221   112235678999999877777665 999999999999999 999997655433222    22211 1


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       241 ~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ..+....++.++.+++.+||+.+|.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            223334678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.1e-42  Score=308.85  Aligned_cols=246  Identities=23%  Similarity=0.353  Sum_probs=194.9

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCc--EEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC------Ce
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------TH   91 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~~   91 (363)
                      |.+.+.||+|+||.||++....++.  .+|+|.+....   ...+.+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4577899999999999999877765  58999886542   2345678899999999999999999976432      35


Q ss_pred             EEEEEeccCCCchHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           92 LAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~------~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                      .+++|||+.+++|.+++..      ...+++..+..++.||+.||+|||++||+||||||+|||++.++.  ++|+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence            7899999999999888742      234899999999999999999999999999999999999976554  99999999


Q ss_pred             cccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccC
Q 017936          166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS  241 (363)
Q Consensus       166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (363)
                      ++.......   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.........    ..+... ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~----~~~~~~-~~  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIY----DYLRQG-NR  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHcC-CC
Confidence            886433221   122346778999999987777655 999999999999999 89999765443222    122222 12


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          242 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       242 ~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .+....++..+.++|.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            23344678999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=9.7e-42  Score=311.69  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=199.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcC----------------CCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeee
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVR   81 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~   81 (363)
                      .++|++.+.||+|+||.||++++..                ++..+|+|++....  .....+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            4679999999999999999986432                34579999987542  23456889999999999999999


Q ss_pred             eeEEEEcCCeEEEEEeccCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEE
Q 017936           82 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL  150 (363)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll  150 (363)
                      +++++...+..++||||+.+++|.+++....           .+++..+..++.||+.||+|||++|++||||||+|||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili  163 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence            9999999999999999999999999987543           36778999999999999999999999999999999999


Q ss_pred             eCCCCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh--CCCCCCCCCch
Q 017936          151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEP  225 (363)
Q Consensus       151 ~~~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~  225 (363)
                      +.++  .++|+|||+++.......   .....+++.|+|||...++.++.+ +|+|||||++|+|++  |..||...+..
T Consensus       164 ~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         164 GKNY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             cCCC--CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            7655  499999999875432211   122334678999999888777655 999999999999998  78899765543


Q ss_pred             HHHHHHHHHH--hccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          226 KNFRKTIHRI--LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       226 ~~~~~~~~~~--~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..........  .......+....+++.+.+|+.+||+.+|.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3222111111  0111223444557899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.7e-42  Score=311.33  Aligned_cols=252  Identities=27%  Similarity=0.418  Sum_probs=199.8

Q ss_pred             CCceeeceecccCCeEEEEEEE----cCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeE
Q 017936           21 DRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL   92 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~----~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~   92 (363)
                      .-|++++.||+|+||.||+++.    ..++..||+|.+....  .....+.+|+.+++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4579999999999999999984    4678899999986542  2345688999999999999999999998875  568


Q ss_pred             EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ++||||++|++|.+++.+.. .+++.++..++.||+.||+|||++|++||||||+||+++.++.  ++|+|||+++....
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~  161 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCcccccccc
Confidence            99999999999999987654 5899999999999999999999999999999999999976554  99999999875433


Q ss_pred             CCC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch-----------HHHHHHHHHHh
Q 017936          172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----------KNFRKTIHRIL  236 (363)
Q Consensus       172 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~  236 (363)
                      ...    .....++..|+|||.+.+..++.+ +|||||||++|+|+++..|+......           ....... ...
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  239 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVL  239 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHH
Confidence            221    123446778999999987777655 99999999999999987765432110           0011111 111


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       237 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ......+....++..+.+|+.+||+.+|.+|||+.+++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1222334455689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-41  Score=310.48  Aligned_cols=246  Identities=23%  Similarity=0.379  Sum_probs=198.5

Q ss_pred             CceeeceecccCCeEEEEEEEcC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      +|++.+.||+|+||.||++.+..     ....+|+|.+.....  ....+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            48899999999999999998753     235688998765432  23567889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEE
Q 017936           95 VMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL  150 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~------------------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll  150 (363)
                      ++||+.+++|.+++...                        ..+++..++.++.|++.||.|||+.|++||||||+|||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            99999999999987642                        247889999999999999999999999999999999999


Q ss_pred             eCCCCCcEEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchH
Q 017936          151 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK  226 (363)
Q Consensus       151 ~~~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~  226 (363)
                      +.++  .+||+|||+++......   ......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.+.....
T Consensus       161 ~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         161 AEGR--KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             cCCC--cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            7655  49999999987532221   1122345678999999877777655 999999999999998 999997654322


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                       ...    ........+....++.++.+|+.+||+.+|++||+++++++
T Consensus       238 -~~~----~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 -LFN----LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             -HHH----HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence             222    22222333444567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-42  Score=308.26  Aligned_cols=241  Identities=25%  Similarity=0.352  Sum_probs=193.7

Q ss_pred             ceecccCCeEEEEEEEcCCCc--EEEEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~--~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||.||++++..++.  .+|+|.+...  ....+.+.+|+.++..+ +||||+++++++...+.+++||||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999988776  4688877642  22345678899999999 799999999999999999999999999


Q ss_pred             CchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936          102 GELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus       102 ~~L~~~~~~~~----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                      ++|.+++....                .+++.+++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence            99999987543                4789999999999999999999999999999999999986654  99999999


Q ss_pred             cccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 017936          166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD  244 (363)
Q Consensus       166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (363)
                      +..............+..|+|||++.+..++.+ +|||||||++|+|++ |..||...+......    .+. .....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~----~~~-~~~~~~~  232 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KLP-QGYRLEK  232 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHHHHHH----HHh-CCCCCCC
Confidence            864322222222334567999999977776655 999999999999997 999997654433222    121 2223333


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ...++.++.+++.+||..+|.+|||+++++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            3457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-41  Score=306.39  Aligned_cols=248  Identities=23%  Similarity=0.368  Sum_probs=203.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCc---EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      .++|+..+.||+|+||.||+++++.+++   .+|+|.+....  ...+.+.+|+.+++.++||||+++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            4579999999999999999999876654   79999886542  234567889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      ||||+++++|..++... +.+++.++..++.|++.||+|||+.|++||||||+||+++.+.  .+||+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL--ECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC--cEEECCCccceeccccc
Confidence            99999999999998764 5789999999999999999999999999999999999998655  49999999987543222


Q ss_pred             CCC----ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          174 QPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       174 ~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                      ...    ....++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.........    ..+.. ....|....+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~----~~i~~-~~~~~~~~~~  235 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVM----KAIND-GFRLPAPMDC  235 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHH----HHHhc-CCCCCCCCCC
Confidence            111    1123457999999988777666 999999999999997 99999765543322    22222 2344444567


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +.++.+++.+||+.+|.+||++.++++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.2e-41  Score=304.44  Aligned_cols=244  Identities=26%  Similarity=0.396  Sum_probs=198.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEE-cCCeEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e   97 (363)
                      ..++|++.+.||+|+||.||++...  +..+|+|.+.... ..+.+.+|+.+++.++|||++++++++. ..+.++++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            3467999999999999999999754  7789999886543 3457889999999999999999999754 5567899999


Q ss_pred             ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |+++++|.+++....  .+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||++......  .
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~--~  156 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--Q  156 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceecccc--C
Confidence            999999999987644  4889999999999999999999999999999999999986654  999999998754322  2


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....++..|+|||++.+..++.+ +|||||||++|+|++ |..||.........    ..+.. .........+++.+.+
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~  230 (256)
T cd05082         157 DTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVV----PRVEK-GYKMDAPDGCPPVVYD  230 (256)
T ss_pred             CCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHhc-CCCCCCCCCCCHHHHH
Confidence            23345678999999987777655 999999999999997 99999765432221    11211 2222333467899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017936          255 LISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.+||+.+|++|||+.++++
T Consensus       231 li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         231 VMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8e-42  Score=308.66  Aligned_cols=249  Identities=22%  Similarity=0.394  Sum_probs=204.4

Q ss_pred             CCceeeceecccCCeEEEEEEEcC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ++|++++.||+|+||.||+++.+.     ..+.+|+|.+.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            679999999999999999999754     346799998865432  3467889999999999999999999999989999


Q ss_pred             EEEeccCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecC
Q 017936           94 IVMEYASGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG  164 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFg  164 (363)
                      +||||+++++|.+++....         .+++..+..++.||+.||+|||++||+||||||+||+++.++.  ++|+|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcccc
Confidence            9999999999999997665         6999999999999999999999999999999999999987654  9999999


Q ss_pred             CcccCccC--CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccC
Q 017936          165 YSKSSVLH--SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS  241 (363)
Q Consensus       165 la~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (363)
                      ++......  .......+++.|+|||.+.+..+..+ +||||||+++|+|++ |..||.......    ...........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~~~~~~~~  237 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRLQAGKLE  237 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccchHH----HHHHHHcCCcC
Confidence            98643221  12233456778999999887776555 999999999999998 889997654432    22223323333


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          242 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       242 ~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .+....++..+.+++.+||+.+|.+|||+.+++..
T Consensus       238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            33444678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.2e-42  Score=316.61  Aligned_cols=247  Identities=26%  Similarity=0.428  Sum_probs=193.1

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCchHHHHH
Q 017936           33 NFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC  109 (363)
Q Consensus        33 ~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~  109 (363)
                      ++|.||++++..+++.||+|++...   ......+.+|+.+++.++||||+++++++...+..+++|||+.+++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            5567777778889999999998754   2233568899999999999999999999999999999999999999999987


Q ss_pred             hC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--------CCccc
Q 017936          110 NA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTV  179 (363)
Q Consensus       110 ~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--------~~~~~  179 (363)
                      ..  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.  +||+|||.+........        .....
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~  169 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSV  169 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccccccccccc
Confidence            63  45899999999999999999999999999999999999986654  99999998864322211        12335


Q ss_pred             cCCCcCChhhhhcC--CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-------------------
Q 017936          180 GTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------------  238 (363)
Q Consensus       180 gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------  238 (363)
                      ++..|+|||++.+.  .++.+ +|+||+||++|+|++|..||...................                   
T Consensus       170 ~~~~y~aPE~~~~~~~~~~~~-~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         170 KNLPWLSPEVLQQNLQGYNEK-SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             ccccccCHHHhcCCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence            77889999998763  34444 999999999999999999998654433222111100000                   


Q ss_pred             ---------ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          239 ---------QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       239 ---------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                               ....+....++.++.+|+.+||+.+|.+|||++++++||||...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence                     00001111235678999999999999999999999999999653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-41  Score=313.72  Aligned_cols=249  Identities=23%  Similarity=0.342  Sum_probs=199.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc-------CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEc
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT   88 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~   88 (363)
                      ..++|.+.+.||+|+||.||++++.       .....+|+|++.....  ....+.+|+.+++.+ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3468999999999999999999863       2345799998875322  234577899999999 69999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC
Q 017936           89 PTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG  152 (363)
Q Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~  152 (363)
                      .+.++++|||+.+++|.+++...                ..++..++..++.||+.||.|||++|++||||||+|||++.
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~  169 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE  169 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence            99999999999999999998653                24888999999999999999999999999999999999976


Q ss_pred             CCCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHH
Q 017936          153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF  228 (363)
Q Consensus       153 ~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  228 (363)
                      ++  .+||+|||+++.......   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||........+
T Consensus       170 ~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         170 DN--VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             CC--cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            65  499999999975432211   112234567999999988777665 999999999999999 89999765443222


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      . .+   .. .........++.++.+++.+||..+|++|||+.++++
T Consensus       247 ~-~~---~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         247 K-LL---RE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             H-HH---Hc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2 21   11 1122223457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.8e-41  Score=303.06  Aligned_cols=247  Identities=26%  Similarity=0.402  Sum_probs=202.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      ..+|++.+.||+|+||.||++.+. .+..+|+|.+.........+.+|+.+++.++||||+++++++......++||||+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            457999999999999999999875 4678999998776555677899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--CC
Q 017936          100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PK  176 (363)
Q Consensus       100 ~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--~~  176 (363)
                      .+++|.+++... +.+++..++.++.|++.||++||+.|++||||||+||+++.++.  ++|+|||++........  ..
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCcccccC
Confidence            999999988764 46899999999999999999999999999999999999976554  99999999874422211  12


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ...++..|+|||.+.+..++.+ +||||||+++|+|++ |..||..........    .+... .........+..+.+|
T Consensus       160 ~~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~l  233 (256)
T cd05112         160 GTKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSEVVE----TINAG-FRLYKPRLASQSVYEL  233 (256)
T ss_pred             CCccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH----HHhCC-CCCCCCCCCCHHHHHH
Confidence            2335678999999987777655 999999999999998 999997654432222    22111 1222233468999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 017936          256 ISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~  275 (363)
                      +.+||+.+|++|||+.++++
T Consensus       234 ~~~~l~~~p~~Rp~~~~~l~  253 (256)
T cd05112         234 MQHCWKERPEDRPSFSLLLH  253 (256)
T ss_pred             HHHHcccChhhCCCHHHHHH
Confidence            99999999999999999985

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1e-41  Score=307.13  Aligned_cols=247  Identities=23%  Similarity=0.384  Sum_probs=201.9

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCc---EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..|++.+.||+|+||.||++....+++   .||+|++....  .....+..|+.+++.++||||+++++++.....+++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            469999999999999999999877664   69999987542  2345788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      |||+.+++|.+++... +.++..+++.++.|++.||.|||++|++||||||+||+++.+.  .++|+|||++........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC--cEEECCCccccccccCcc
Confidence            9999999999988754 5689999999999999999999999999999999999997655  499999999864432221


Q ss_pred             CC---ccc---cCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          175 PK---STV---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       175 ~~---~~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      ..   ...   .+..|+|||.+.+..++.+ +|||||||++|++++ |..||......+...    .+ ......+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~----~i-~~~~~~~~~~~  235 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIN----AI-EQDYRLPPPMD  235 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH----HH-HcCCcCCCccc
Confidence            11   111   2357999999988777666 999999999999886 999998755432222    22 12234444556


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++..+.+++.+||+.+|.+||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-41  Score=307.51  Aligned_cols=248  Identities=21%  Similarity=0.321  Sum_probs=197.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCc----EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      ..++|++.+.||+|+||+||++....+++    .+++|.+....  .....+..|+..++.++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            34689999999999999999999877776    46777764322  122456778888899999999999998754 457


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ++++||+.+++|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++  .+||+|||+++....
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~--~~kl~Dfg~~~~~~~  161 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS--IVQIADFGVADLLYP  161 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEEcCCccceeccC
Confidence            8999999999999999764 5689999999999999999999999999999999999997655  499999999975432


Q ss_pred             CCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          172 HSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       172 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      ...   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+..... ....    .......+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~----~~~~~~~~~~~~  235 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDL----LEKGERLAQPQI  235 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH----HHCCCcCCCCCC
Confidence            221   123346778999999988777666 999999999999998 999997654322 1122    122222233344


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .+.++.+++.+||..+|.+|||+.++++
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         236 CTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            6789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.5e-42  Score=342.46  Aligned_cols=146  Identities=31%  Similarity=0.476  Sum_probs=133.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|.+++.||+|+||+||++.+..+++.||||++......    ...+.+|+.+++.++||||++++.++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            36899999999999999999999999999999998764322    35677899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      |||+.|++|..++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++  .+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g--~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG--HIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC--CEEEEeCCCCc
Confidence            99999999999998888899999999999999999999999999999999999997655  49999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.6e-42  Score=307.18  Aligned_cols=249  Identities=31%  Similarity=0.458  Sum_probs=202.8

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC------cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      +|.+.+.||+|+||.||++++..++..+++|++....      .....+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            6999999999999999999998887777777765421      1223456788999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      +||+.+++|..++..    ...+++.+++.++.|++.||.|||+.|++||||+|+||+++. +  .++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~--~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N--LLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C--CEeecccCceeecCC
Confidence            999999999988753    346999999999999999999999999999999999999974 2  499999999875433


Q ss_pred             CC-CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          172 HS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       172 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                      .. ......|++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.........    ........ ......++.
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~  231 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVV----LRIVEGPT-PSLPETYSR  231 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHcCCC-CCCcchhcH
Confidence            22 2234458899999999887777666 99999999999999999999764432222    22222111 111235688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      ++.++|.+||..+|.+||++.+++.||||
T Consensus       232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3e-42  Score=305.03  Aligned_cols=229  Identities=23%  Similarity=0.358  Sum_probs=189.6

Q ss_pred             cCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhC
Q 017936           32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA  111 (363)
Q Consensus        32 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  111 (363)
                      |.+|.||+|++..+++.||+|.+.....    ..+|...+....||||+++++++...+.+++||||++|++|.+++.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            8999999999999999999999876532    233444555567999999999999999999999999999999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhh
Q 017936          112 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL  191 (363)
Q Consensus       112 ~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~  191 (363)
                      ..+++..+..++.|++.||+|||++||+||||||+||+++.++.  ++|+|||.+.....  ......++..|+|||.+.
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~--~~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVED--SCDGEAVENMYCAPEVGG  155 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhcccc--ccccCCcCccccCCcccC
Confidence            88999999999999999999999999999999999999987655  99999998764332  223445678899999987


Q ss_pred             cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-
Q 017936          192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-  270 (363)
Q Consensus       192 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~-  270 (363)
                      +..++.+ +|+||+|+++|+|++|..||......      ..  .......|  ..+++.++++|.+||+.||.+|||+ 
T Consensus       156 ~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~------~~--~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         156 ISEETEA-CDWWSLGAILFELLTGKTLVECHPSG------IN--THTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CCCCCch-hhHHHHHHHHHHHHHCcchhhcCchh------cc--cccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            7777655 89999999999999999988643211      00  01111223  3478999999999999999999985 


Q ss_pred             ----HHHhcCccc
Q 017936          271 ----PEIRNHEWF  279 (363)
Q Consensus       271 ----~ell~h~~~  279 (363)
                          +++++||||
T Consensus       225 ~~~~~~~~~h~~~  237 (237)
T cd05576         225 VAGVEDIKSHPFF  237 (237)
T ss_pred             ccchHHHHcCCCC
Confidence                999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.7e-42  Score=309.35  Aligned_cols=244  Identities=33%  Similarity=0.484  Sum_probs=194.5

Q ss_pred             eeeceecccCCeEEEEEEEc----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           24 ELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        24 ~i~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .+.+.||.|+||.||+|...    ..+..|+||.+.....  ..+.+.+|+..+++++||||+++++++...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            46789999999999999987    4567899999965322  24678899999999999999999999998888999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--
Q 017936           98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--  173 (363)
Q Consensus        98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--  173 (363)
                      ||.+|+|.+++...  ..+++.++..++.||+.||.|||+++++||+|+|+||+++.++.  +||+|||++.......  
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence            99999999999886  67999999999999999999999999999999999999987664  9999999987652211  


Q ss_pred             -CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       174 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                       ..........|+|||.+.+..++.+ +||||||+++|++++ |..||.........    ..+. .....+....++..
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~  233 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEEII----EKLK-QGQRLPIPDNCPKD  233 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHHHH----HHHH-TTEETTSBTTSBHH
T ss_pred             cccccccccccccccccccccccccc-cccccccccccccccccccccccccccccc----cccc-ccccceeccchhHH
Confidence             1233457778999999988877555 999999999999999 78999776443222    2221 22233344567999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +.++|.+||..+|++|||++++++
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.9e-41  Score=302.67  Aligned_cols=245  Identities=29%  Similarity=0.430  Sum_probs=202.3

Q ss_pred             ceeeceecccCCeEEEEEEEcCCC----cEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      +.+.+.||.|+||.||++.+...+    ..+|+|.+.....  ....+.+|+..++.++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            457899999999999999998766    8999999876543  3567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||+.+++|.+++.....  +++..+..++.|++.||.+||+.|++||||||+||+++.++.  ++|+|||++........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY  158 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence            99999999999976554  999999999999999999999999999999999999987654  99999999875443321


Q ss_pred             CC--ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          175 PK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       175 ~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      ..  ...+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||...........    +... ...+....++.+
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~  232 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY----LKKG-YRLPKPENCPPE  232 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcC-CCCCCCCcCCHH
Confidence            11  2236789999999976666555 999999999999998 8889876444332222    2111 122333447999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +.+++.+||..+|++|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-41  Score=307.36  Aligned_cols=253  Identities=27%  Similarity=0.417  Sum_probs=198.3

Q ss_pred             CCCceeeceecccCCeEEEEEE----EcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILT--PTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~   92 (363)
                      ..+|++.+.||+|+||.||.+.    +..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++..  ...+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            3579999999999999999997    456788999999865432 24567899999999999999999998754  3468


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ++||||+++++|.+++.+. ..+++..++.++.||+.||+|||++|++||||||+||+++.++.  ++|+|||+++....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~  160 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccC
Confidence            9999999999999998764 46899999999999999999999999999999999999976654  99999999885432


Q ss_pred             CCCC----CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH-----------HHHHHHHHHh
Q 017936          172 HSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----------NFRKTIHRIL  236 (363)
Q Consensus       172 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----------~~~~~~~~~~  236 (363)
                      ....    ....++..|+|||.+.+..++.+ +|||||||++|+|++|..|+......-           .....+....
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            2211    11123456999999987777655 999999999999999887764332110           0000111122


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       237 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ......+....++.++.+|+.+||+.+|++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            222333444567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.3e-41  Score=302.54  Aligned_cols=241  Identities=27%  Similarity=0.405  Sum_probs=197.5

Q ss_pred             ceecccCCeEEEEEEEcC-CCc--EEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDKK-TEE--LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~-~~~--~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|++|+||++.+.. +++  .+|+|.+.....  ..+.+.+|+..+++++||||+++++++.. ..+++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999865 333  689999876544  34578899999999999999999999988 889999999999


Q ss_pred             CchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC----C
Q 017936          102 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----P  175 (363)
Q Consensus       102 ~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~----~  175 (363)
                      ++|.+++....  .+++..++.++.|++.||.|||++|++||||+|+||+++.++  .+||+|||++........    .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC--EEEeccccccccccccccceecc
Confidence            99999997754  689999999999999999999999999999999999998765  499999999875433211    1


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||...+..+.....    .......+....++..+.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  232 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGERLERPEACPQDIYN  232 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCcCCCCccCCHHHHH
Confidence            22346788999999988777666 999999999999998 99999765544332222    1122223333457899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017936          255 LISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.+||+.+|++|||+.+++.
T Consensus       233 li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         233 VMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHCCCCcccCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-44  Score=325.07  Aligned_cols=253  Identities=29%  Similarity=0.527  Sum_probs=226.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .+++++..||-|+||.|=++..+.....+|+|++++..    ...+.+..|-.+|..+++|.||++|..|.+.+.+|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            46788999999999999999987666669999998743    44567888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      |-|-||.|+..+...+.|.+..++.++..+++|++|||++|||.|||||+|++++.++.  +||.|||+|+........-
T Consensus       500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KTw  577 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKTW  577 (732)
T ss_pred             HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCcee
Confidence            99999999999999999999999999999999999999999999999999999987776  9999999999888888888


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      +.+|||.|.|||++.+...+.. +|.||||+++|||++|.+||.+.+.-.....+++.+-...  +|  ..++..+.+|+
T Consensus       578 TFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~--~P--r~I~k~a~~Li  652 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE--FP--RRITKTATDLI  652 (732)
T ss_pred             eecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh--cc--cccchhHHHHH
Confidence            8999999999999998888766 8999999999999999999999887766666665553332  23  56899999999


Q ss_pred             HHhcccCCCCCCC-----HHHHhcCcccc
Q 017936          257 SRIFVADPAKRIS-----IPEIRNHEWFL  280 (363)
Q Consensus       257 ~~~L~~~p~~R~t-----~~ell~h~~~~  280 (363)
                      +++...+|.+|..     +.+|.+|.||.
T Consensus       653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  653 KKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             HHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence            9999999999985     89999999994

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.3e-42  Score=323.57  Aligned_cols=251  Identities=25%  Similarity=0.378  Sum_probs=202.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcc--cHHHHHHHHHHHcCC-CCCeeeeeEEEEcCC
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKEVILTPT   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~   90 (363)
                      ..++|.+.+.||+|+||.||++++.     .+++.||+|++......  .+.+.+|+.++..+. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3567899999999999999999853     35568999999764322  346788999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC----------------------------------------------------------
Q 017936           91 HLAIVMEYASGGELFERICNAG----------------------------------------------------------  112 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~----------------------------------------------------------  112 (363)
                      .+++|||||.+|+|.+++.+.+                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999886431                                                          


Q ss_pred             ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC
Q 017936          113 ----------------------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG  152 (363)
Q Consensus       113 ----------------------------------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~  152 (363)
                                                              .++...++.++.||+.||+|||++|++||||||+|||++.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~  274 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE  274 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence                                                    2567788999999999999999999999999999999986


Q ss_pred             CCCCcEEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHH
Q 017936          153 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF  228 (363)
Q Consensus       153 ~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  228 (363)
                      ++  .+||+|||+++......   ......+++.|+|||.+.+..+..+ +|||||||++|+|++ |..||......+..
T Consensus       275 ~~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         275 GK--LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             CC--EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            55  49999999987532211   1223457888999999987777655 999999999999998 89999765443322


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ...+    ......+.+..++.++.+|+.+||..+|.+||++.+|+..
T Consensus       352 ~~~~----~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         352 YNAI----KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHH----HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2222    1222233344578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-41  Score=302.86  Aligned_cols=246  Identities=23%  Similarity=0.380  Sum_probs=201.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|+||.||++.+. .+..+|+|.+.........+.+|+.+++.++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            468999999999999999999865 45569999887665555678899999999999999999999887 7789999999


Q ss_pred             CCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--C
Q 017936          100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P  175 (363)
Q Consensus       100 ~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--~  175 (363)
                      ++++|.+++.+.  ..++...+..++.||+.||.|||+.|++||||||+||+++.++  .+||+|||++........  .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~  160 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTAR  160 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCCcceeeccCCCcccc
Confidence            999999998763  3578899999999999999999999999999999999997655  499999999875432211  1


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....++..|+|||.+.+..++.+ +|+|||||++|++++ |..||...+.......    + ......+.....+.++.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~  234 (260)
T cd05073         161 EGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----L-ERGYRMPRPENCPEELYN  234 (260)
T ss_pred             cCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH----H-hCCCCCCCcccCCHHHHH
Confidence            22335677999999987776655 899999999999998 9999987554332221    1 222333444567899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017936          255 LISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.+||+.+|++||++.++++
T Consensus       235 ~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         235 IMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-41  Score=312.10  Aligned_cols=251  Identities=23%  Similarity=0.350  Sum_probs=201.7

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEc-------CCCcEEEEEEeecCC--cccHHHHHHHHHHHcC-CCCCeeeeeEEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL   87 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~   87 (363)
                      ...++|.+.+.||+|+||.||+++..       ..+..+|+|.+....  .....+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34678999999999999999999752       234579999886532  2335688999999999 8999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEe
Q 017936           88 TPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD  151 (363)
Q Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~  151 (363)
                      ....+++||||+.+++|.+++.+.                ..++..++..++.||+.||.|||++|++||||||+||+++
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~  171 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT  171 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence            999999999999999999998753                2377888999999999999999999999999999999997


Q ss_pred             CCCCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHH
Q 017936          152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN  227 (363)
Q Consensus       152 ~~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  227 (363)
                      .++  .+||+|||+++.......   .....+++.|+|||++.+..++.+ +||||||+++|+|++ |..||........
T Consensus       172 ~~~--~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         172 ENN--VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             CCC--cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            665  499999999875432221   122345678999999988777666 999999999999998 8889876544322


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          228 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ..    .+. ..........++.++.+||.+||+.+|.+|||+.++++.
T Consensus       249 ~~----~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         249 FK----LLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HH----HHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            22    121 122223334678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.4e-42  Score=318.94  Aligned_cols=252  Identities=23%  Similarity=0.396  Sum_probs=198.7

Q ss_pred             CCCCCceeeceecccCCeEEEEEEE-----cCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP   89 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~   89 (363)
                      ...++|++.+.||+|+||+||+|.+     ..+++.||||++.....  ....+.+|+.++..+ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            3457899999999999999999984     35678999999875432  234577899999999 689999999987654


Q ss_pred             -CeEEEEEeccCCCchHHHHHhC---------------------------------------------------------
Q 017936           90 -THLAIVMEYASGGELFERICNA---------------------------------------------------------  111 (363)
Q Consensus        90 -~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------------------  111 (363)
                       ..++++||||++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             5689999999999999988642                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---CCCcc
Q 017936          112 ----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKST  178 (363)
Q Consensus       112 ----------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---~~~~~  178 (363)
                                ..++...+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.......   .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCC
Confidence                      13677888999999999999999999999999999999986654  9999999987532211   11223


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      .+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||............+.    .....+.....++++.+++.
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  316 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK----EGTRMRAPDYTTPEMYQTML  316 (343)
T ss_pred             CCCcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh----ccCCCCCCCCCCHHHHHHHH
Confidence            45678999999988777666 999999999999997 9999976543332222221    11122222346889999999


Q ss_pred             HhcccCCCCCCCHHHHhcC
Q 017936          258 RIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~h  276 (363)
                      +||+.+|.+|||+.++++|
T Consensus       317 ~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         317 DCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.2e-41  Score=307.96  Aligned_cols=248  Identities=25%  Similarity=0.388  Sum_probs=200.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      .++|++.+.||+|+||.||++.+.     .++..+|+|++.....  ....+.+|+.+++.++||||+++++++.....+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999874     3678899998875432  235678899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEE
Q 017936           93 AIVMEYASGGELFERICNAG----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL  150 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~----------------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll  150 (363)
                      +++|||+.+++|.+++....                      .+++.+++.++.||+.||.|||++|++||||||+||++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~  163 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV  163 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence            99999999999999986432                      37888999999999999999999999999999999999


Q ss_pred             eCCCCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchH
Q 017936          151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK  226 (363)
Q Consensus       151 ~~~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~  226 (363)
                      +.++.  ++|+|||++........   ......++.|+|||.+.+..++.+ +|||||||++|+|++ |..||......+
T Consensus       164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         164 GENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             cCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            76654  99999999874322211   122345667999999988877666 999999999999997 888997654432


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..    ..+..... .+....++.++.+||.+||+.+|.+|||+.|+++
T Consensus       241 ~~----~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         241 VI----YYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HH----HHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            22    22222221 2223357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.6e-41  Score=301.05  Aligned_cols=239  Identities=26%  Similarity=0.396  Sum_probs=190.2

Q ss_pred             eecccCCeEEEEEEEc--CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCc
Q 017936           28 DIGSGNFGVARLMRDK--KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE  103 (363)
Q Consensus        28 ~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~  103 (363)
                      .||+|+||.||++...  ..+..||+|++.....  ..+.+.+|+.++++++||||+++++++.. ..+++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999998765  4456799998865432  23568899999999999999999998854 56899999999999


Q ss_pred             hHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC----CCcc
Q 017936          104 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKST  178 (363)
Q Consensus       104 L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~----~~~~  178 (363)
                      |.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.  +||+|||++........    ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence            9998875 456999999999999999999999999999999999999976654  99999999874322211    1112


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      .+++.|+|||.+.+..++.+ +|||||||++|++++ |..||......... ..+   .. ....+.....++++.++|.
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~---~~-~~~~~~~~~~~~~l~~li~  232 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFI---EQ-GKRLDCPAECPPEMYALMK  232 (257)
T ss_pred             CCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-HHH---HC-CCCCCCCCCCCHHHHHHHH
Confidence            23578999999987777655 999999999999996 99999876543322 111   11 1222333456899999999


Q ss_pred             HhcccCCCCCCCHHHHhc
Q 017936          258 RIFVADPAKRISIPEIRN  275 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~  275 (363)
                      +||+.+|++||++.++.+
T Consensus       233 ~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         233 DCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-44  Score=354.94  Aligned_cols=253  Identities=30%  Similarity=0.448  Sum_probs=213.5

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      -||.....||.|.||.||.|.+..+|...|+|-+.-.   .+....+.+|..++..++|||+|+++++-.+.+.++|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            3677888999999999999999999999999987643   3344567899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC----
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----  173 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~----  173 (363)
                      ||+||+|.+.+...+..++...+.+..|++.||.|||+.|||||||||+||+++.++.  +|++|||.|.......    
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCC
Confidence            9999999999998888999999999999999999999999999999999999988775  9999999997544432    


Q ss_pred             -CCCccccCCCcCChhhhhcCCC--CCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc-ccCCCCCCCCC
Q 017936          174 -QPKSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHIS  249 (363)
Q Consensus       174 -~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s  249 (363)
                       ......|||.|||||++.+..-  ...+.|||||||++.||+||+.||...+..-   .+.-.+-.+ ...+|.  .+|
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V~~gh~Pq~P~--~ls 1467 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHVAAGHKPQIPE--RLS 1467 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHHhccCCCCCch--hhh
Confidence             2245679999999999987653  2445899999999999999999997654321   222222222 223444  489


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                      ++.++||.+||+.||++|.++.||++|.|=+
T Consensus      1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred             HhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence            9999999999999999999999999999864

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=323.24  Aligned_cols=249  Identities=28%  Similarity=0.404  Sum_probs=209.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCc---E-EEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEE---L-VAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~---~-~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~   91 (363)
                      .++-.+.++||+|+||.||+++-+..+.   . ||+|....+    ......+.+|+++++.++|||||+++|+......
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3445666999999999999999875432   3 899988742    2345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           92 LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      +++|||+|.||+|.+++++.+. ++..+...++.+.+.||+|||++++|||||-..|+|++.+..  +||+|||+|+...
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~  313 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGS  313 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCc
Confidence            9999999999999999999874 999999999999999999999999999999999999987665  8999999998654


Q ss_pred             cCCCCC-ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          171 LHSQPK-STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       171 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                      ...... ...-...|+|||.+....++.+ +||||+||++||+++ |..||.+.....    ...++....++.+.+...
T Consensus       314 ~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~~----v~~kI~~~~~r~~~~~~~  388 (474)
T KOG0194|consen  314 QYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNYE----VKAKIVKNGYRMPIPSKT  388 (474)
T ss_pred             ceeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHHH----HHHHHHhcCccCCCCCCC
Confidence            222222 2235678999999999988777 999999999999998 888999866543    333444556666666677


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +.++..++.+|+..+|++|||+.++.+
T Consensus       389 p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  389 PKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHHHhccCChhhccCHHHHHH
Confidence            899999999999999999999999764

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.5e-41  Score=304.65  Aligned_cols=250  Identities=22%  Similarity=0.292  Sum_probs=201.8

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcC----CCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEc-CC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PT   90 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~   90 (363)
                      ...++|++.+.||+|+||.||++.+..    ++..+|+|.+....  .....+.+|+.+++.++||||+++++++.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            356889999999999999999999876    35789999876532  234567889999999999999999998766 46


Q ss_pred             eEEEEEeccCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEee
Q 017936           91 HLAIVMEYASGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD  162 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~--------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~D  162 (363)
                      ..+++++|+.+++|..++...        ..+++..++.++.||+.||+|||++|++||||||+||+++.+.  .+||+|
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kl~d  160 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITD  160 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC--cEEECC
Confidence            789999999999999998653        4589999999999999999999999999999999999997665  499999


Q ss_pred             cCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhcc
Q 017936          163 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV  238 (363)
Q Consensus       163 Fgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  238 (363)
                      ||+++.......   .....++..|+|||.+.+..++.+ +|||||||++|++++ |..||......+ ...   .+ ..
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~---~~-~~  234 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFE-MAA---YL-KD  234 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHH---HH-Hc
Confidence            999975432211   122345677999999987777666 999999999999999 999997654322 111   11 12


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       239 ~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ....+....+++++.+++.+||+.+|++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         235 GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            2333344457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.4e-41  Score=313.41  Aligned_cols=249  Identities=23%  Similarity=0.348  Sum_probs=199.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCC-------CcEEEEEEeecCC--cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP   89 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~   89 (363)
                      ..+|++.+.||+|+||.||+|.+...       +..+|+|.+....  .....+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            45799999999999999999986432       2368999876532  2235678899999999 799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC
Q 017936           90 THLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS  153 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~  153 (363)
                      +.++++|||+.+++|.+++.+..                .++..++..++.||+.||.|||++|++||||||+|||++.+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~  170 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED  170 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence            99999999999999999987532                37788899999999999999999999999999999999866


Q ss_pred             CCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017936          154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR  229 (363)
Q Consensus       154 ~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~  229 (363)
                      +.  +||+|||+++.......   .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||..........
T Consensus       171 ~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~  247 (334)
T cd05100         171 NV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  247 (334)
T ss_pred             Cc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            54  99999999875432211   112234567999999988877666 999999999999998 889997654433222


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                          .+. .....+....++.++.+++.+||+.+|.+|||+.+++.+
T Consensus       248 ----~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         248 ----LLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             ----HHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                121 122223334568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=315.74  Aligned_cols=253  Identities=24%  Similarity=0.341  Sum_probs=200.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc-cHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-eEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~   96 (363)
                      .+++|.-...||+|+||.||++.-.. ++.||||.+...... ..++.+|+.++.+++|||+|+++++|.+.+ +.+||+
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            47789999999999999999998754 488999988765544 566999999999999999999999999888 599999


Q ss_pred             eccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC---ceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           97 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~g---iiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ||+..|+|.+++....  .+++....+|+.+++.||+|||...   ||||||||+|||+|.+..  .||+|||+|+....
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPE  229 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCc
Confidence            9999999999997655  8999999999999999999999753   999999999999987765  99999999976544


Q ss_pred             -CCCCCcc-ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCC--chHHHHHHHHHHhcc----ccCCC
Q 017936          172 -HSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--EPKNFRKTIHRILSV----QYSIP  243 (363)
Q Consensus       172 -~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~----~~~~~  243 (363)
                       .....+. .||.+|+|||++..+..+.+ +||||||+++.||+||+.|.+...  ....+..........    ..--|
T Consensus       230 ~~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~  308 (361)
T KOG1187|consen  230 GDTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP  308 (361)
T ss_pred             cccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC
Confidence             3333333 89999999999988777777 999999999999999999887543  111122211111111    01111


Q ss_pred             CC--CCCC-----HHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          244 DY--VHIS-----PECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       244 ~~--~~~s-----~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..  ...+     ..+..+..+|++.+|..||++.|+..
T Consensus       309 ~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  309 RLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            11  1222     22667788999999999999999743

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.9e-41  Score=297.54  Aligned_cols=240  Identities=24%  Similarity=0.346  Sum_probs=194.3

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCch
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      +.||+|+||.||++... +++.+|+|.+.....  ....+.+|+.+++.++||||+++++++...+..++||||+.+++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            46899999999999864 678899998865432  234678899999999999999999999999999999999999999


Q ss_pred             HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC--CccccC
Q 017936          105 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGT  181 (363)
Q Consensus       105 ~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~--~~~~gt  181 (363)
                      .+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++.........  ....++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence            9988654 45899999999999999999999999999999999999976654  999999998643222111  122345


Q ss_pred             CCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       182 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      +.|+|||++.+..++.+ +||||||+++|++++ |..||..........    .+. ..........++..+.+++.+||
T Consensus       158 ~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~li~~~l  231 (250)
T cd05085         158 IKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQARE----QVE-KGYRMSCPQKCPDDVYKVMQRCW  231 (250)
T ss_pred             ccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHH-cCCCCCCCCCCCHHHHHHHHHHc
Confidence            67999999987777655 999999999999998 999997654432221    111 12222333457899999999999


Q ss_pred             ccCCCCCCCHHHHhc
Q 017936          261 VADPAKRISIPEIRN  275 (363)
Q Consensus       261 ~~~p~~R~t~~ell~  275 (363)
                      +.+|++|||+.++++
T Consensus       232 ~~~p~~Rp~~~~l~~  246 (250)
T cd05085         232 DYKPENRPKFSELQK  246 (250)
T ss_pred             ccCcccCCCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-41  Score=306.15  Aligned_cols=253  Identities=27%  Similarity=0.419  Sum_probs=203.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEc----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT--PTH   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~   91 (363)
                      ...|++.+.||+|+||.||+++..    .+++.+|+|++.....  ..+.+.+|+..++.++||||+++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            356889999999999999999864    3478999999876554  35678899999999999999999999887  567


Q ss_pred             EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+++|||+++++|.+++.... .++...+..++.||+.||+|||++|++||||||+||+++.++  .++|+|||++....
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~  160 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LVKISDFGLAKVLP  160 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccccccccc
Confidence            999999999999999997655 599999999999999999999999999999999999998664  49999999987554


Q ss_pred             cCCCC----CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH----------HHHHHHHHHh
Q 017936          171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK----------NFRKTIHRIL  236 (363)
Q Consensus       171 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----------~~~~~~~~~~  236 (363)
                      .....    ....++..|+|||.+.+..++.+ +|||||||++|+|++|..||.......          .....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            22111    12234567999999987777655 899999999999999999986543211          0112222222


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       237 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ......+....++.++.+++.+||+.+|.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            333344444567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-41  Score=302.95  Aligned_cols=248  Identities=23%  Similarity=0.358  Sum_probs=201.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCc----EEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      ...+|++.+.||+|+||+||++.++.+++    .+|+|.......  ....+.+|+..++.++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            35789999999999999999999876654    589998765532  23567889999999999999999999987 778


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ++||||+.+++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||+++....
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~  161 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDV  161 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccC
Confidence            9999999999999998764 46999999999999999999999999999999999999976554  99999999875432


Q ss_pred             CCCCC---ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          172 HSQPK---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       172 ~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      .....   ...++..|+|||.+....++.+ +|+|||||++|++++ |..||......+.. .   .+.. ....+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~---~~~~-~~~~~~~~~  235 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEIP-D---LLEK-GERLPQPPI  235 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-H---HHhC-CCCCCCCCC
Confidence            22111   1223567999999987777666 999999999999998 99999875543222 2   2222 223334445


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .+.++.+++.+||..+|..|||+.++++
T Consensus       236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         236 CTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            6889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-41  Score=305.24  Aligned_cols=239  Identities=19%  Similarity=0.214  Sum_probs=189.8

Q ss_pred             ceecccCCeEEEEEEEcCCCc-------EEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           27 RDIGSGNFGVARLMRDKKTEE-------LVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~-------~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +.||+|+||.||++.+...+.       .+|+|.+.... ...+.+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999999865543       38888876543 2335678899999999999999999999998999999999


Q ss_pred             cCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCC------cEEEeecCCcccCcc
Q 017936           99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVL  171 (363)
Q Consensus        99 ~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~------~vkL~DFgla~~~~~  171 (363)
                      +.+++|..++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++..      .++++|||++.....
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~  160 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP  160 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence            99999999997654 58999999999999999999999999999999999999765432      379999999864432


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                         .....+++.|+|||++.+....+.++|||||||++|+|++|. .||....... ...    ........|  ...+.
T Consensus       161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~~~----~~~~~~~~~--~~~~~  230 (258)
T cd05078         161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-KLQ----FYEDRHQLP--APKWT  230 (258)
T ss_pred             ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-HHH----HHHccccCC--CCCcH
Confidence               233567889999999976543344499999999999999985 5655433321 111    111222222  23568


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.++|.+||+.+|++|||++++++
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~  255 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIR  255 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            8999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.1e-41  Score=302.04  Aligned_cols=243  Identities=21%  Similarity=0.353  Sum_probs=186.7

Q ss_pred             ceecccCCeEEEEEEEcC--CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCC
Q 017936           27 RDIGSGNFGVARLMRDKK--TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  102 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~  102 (363)
                      +.||+|+||+||++....  ....+|+|.+.....  ....+.+|+..++.++||||+++++.+.....+++||||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            468999999999996532  445788887654322  2345678999999999999999999999999999999999999


Q ss_pred             chHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---C
Q 017936          103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q  174 (363)
Q Consensus       103 ~L~~~~~~~~-----~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---~  174 (363)
                      +|.+++....     .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.......   .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence            9999987643     2467888999999999999999999999999999999987654  9999999986432221   1


Q ss_pred             CCccccCCCcCChhhhhcC------CCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCC---C
Q 017936          175 PKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIP---D  244 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~  244 (363)
                      .....+++.|+|||++...      ...+.++|||||||++|+|++ |..||...............   .....+   .
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~  235 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE---QDIKLPKPQL  235 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc---cCccCCCCcc
Confidence            1233456789999997542      122445999999999999999 88898766544333332221   221222   1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ...++..+.+++..|+ .+|++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            2357888999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-41  Score=297.99  Aligned_cols=240  Identities=28%  Similarity=0.376  Sum_probs=196.2

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCch
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      ++||.|+||.||++.+.. ++.||+|.+.....  ....+.+|+.+++.++||||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999877 89999998876433  345688899999999999999999999999999999999999999


Q ss_pred             HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC---Ccccc
Q 017936          105 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG  180 (363)
Q Consensus       105 ~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~---~~~~g  180 (363)
                      .+++... ..++...+..++.+++.||.|||++|++||||+|+||+++.++.  ++|+|||++.........   ....+
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence            9998653 46899999999999999999999999999999999999976654  999999998754321111   12233


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI  259 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  259 (363)
                      +..|+|||.+.++.++.+ +|+|||||++|+|++ |..||......... ..+    ......+....++..+.+++.+|
T Consensus       158 ~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~li~~~  231 (251)
T cd05041         158 PIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTR-ERI----ESGYRMPAPQLCPEEIYRLMLQC  231 (251)
T ss_pred             eeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHHH-HHH----hcCCCCCCCccCCHHHHHHHHHH
Confidence            567999999987777655 999999999999999 88999765542222 111    11223333446789999999999


Q ss_pred             cccCCCCCCCHHHHhc
Q 017936          260 FVADPAKRISIPEIRN  275 (363)
Q Consensus       260 L~~~p~~R~t~~ell~  275 (363)
                      |+.+|.+|||++++++
T Consensus       232 l~~~p~~Rp~~~ell~  247 (251)
T cd05041         232 WAYDPENRPSFSEIYN  247 (251)
T ss_pred             hccChhhCcCHHHHHH
Confidence            9999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=312.08  Aligned_cols=264  Identities=27%  Similarity=0.406  Sum_probs=217.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc--------HHHHHHHHHHHcCCCCCeeeeeEEEE-cC
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVIL-TP   89 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~e~~~l~~l~hpnIv~~~~~~~-~~   89 (363)
                      ..++|.++..||+|||+.||+|.+...++.||||+-.....+.        +..-+|..+.+.|+||.||+++++|. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            3679999999999999999999999999999999865433332        34568999999999999999999996 45


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--CceecCCCCCCEEEeC-CCCCcEEEeecCCc
Q 017936           90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--QVCHRDLKLENTLLDG-SPAPRLKICDFGYS  166 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~--giiHrDlkp~NIll~~-~~~~~vkL~DFgla  166 (363)
                      +.+|-|+|||+|.+|.-+++....+++.+++.|+.||+.||.||...  -|||-||||.|||+.. +..|.+||+|||++
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            67999999999999999999999999999999999999999999976  5999999999999853 33457999999999


Q ss_pred             ccCccCCCC--------CccccCCCcCChhhhhcCCCC---CcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH
Q 017936          167 KSSVLHSQP--------KSTVGTPAYIAPEVLLKKEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI  235 (363)
Q Consensus       167 ~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~---~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  235 (363)
                      +........        ....||-||++||.+.-+...   +.++||||+|||+|+++.|+.||..............-+
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            865443322        234699999999998654222   334899999999999999999997654433322222223


Q ss_pred             hccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          236 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       236 ~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ......+|.-+.++++++.||++||++--+.|..+.++..||+|...
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            33455778778899999999999999999999999999999999754

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.2e-41  Score=300.95  Aligned_cols=243  Identities=24%  Similarity=0.324  Sum_probs=187.5

Q ss_pred             ceecccCCeEEEEEEEc--CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCC
Q 017936           27 RDIGSGNFGVARLMRDK--KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  102 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~  102 (363)
                      +.||+|+||.||++...  .++..+|+|.+.....  ....+.+|+.+++.++||||+++++++.+...+++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46899999999999754  4556799998865432  2246778999999999999999999999989999999999999


Q ss_pred             chHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC---
Q 017936          103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---  174 (363)
Q Consensus       103 ~L~~~~~~~~-----~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~---  174 (363)
                      +|.+++....     ..++..+..++.|++.||.|||+.|++||||||+||+++.++  .+||+|||+++.......   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL--TVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEECCccccccccCcceeec
Confidence            9999986432     356778889999999999999999999999999999998655  499999999864322211   


Q ss_pred             CCccccCCCcCChhhhhcCCC------CCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCC---
Q 017936          175 PKSTVGTPAYIAPEVLLKKEY------DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD---  244 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  244 (363)
                      .....+++.|+|||++.+...      .+.++|+||||+++|+|++ |..||.............   .......+.   
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~  235 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV---REQQLKLPKPRL  235 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh---hcccCCCCCCcc
Confidence            123456788999999864321      1344999999999999996 999997655433222211   111122221   


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ....++.+.+++.+|+ .+|.+|||+++|+.
T Consensus       236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            1246788999999998 68999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.9e-41  Score=301.20  Aligned_cols=248  Identities=30%  Similarity=0.471  Sum_probs=200.1

Q ss_pred             CceeeceecccCCeEEEEEEEcC-CCcEEEEEEeecCC-----------cccHHHHHHHHHHH-cCCCCCeeeeeEEEEc
Q 017936           22 RYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD-----------KIDENVQREIINHR-SLRHPNIVRFKEVILT   88 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~-----------~~~~~~~~e~~~l~-~l~hpnIv~~~~~~~~   88 (363)
                      .|++.+.||+|+||.||++.+.. +++.+|+|.+....           .....+.+|+.+++ .++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 78899999875321           11234566777776 4799999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeec
Q 017936           89 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDF  163 (363)
Q Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DF  163 (363)
                      .+..+++|||+++++|.+++..    ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.  ++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence            9999999999999999888743    3469999999999999999999996 78999999999999976654  999999


Q ss_pred             CCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC
Q 017936          164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP  243 (363)
Q Consensus       164 gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (363)
                      |++.............|+..|+|||.+.+..++.+ +|+||||+++|+|++|..||..........    .+........
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~  233 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLAT----KIVEAVYEPL  233 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHHHHH----HHhhccCCcC
Confidence            99876544433345568999999999987777555 999999999999999999997654433222    2222222222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          244 DYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ....+++++.++|.+||+.+|++||++.|+.++
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            223568999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=307.38  Aligned_cols=259  Identities=31%  Similarity=0.466  Sum_probs=211.6

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC--CCC----eeeeeEEEEcCCeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--HPN----IVRFKEVILTPTHL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~--hpn----Iv~~~~~~~~~~~~   92 (363)
                      ..++|.++..+|+|.||.|-.+.+..++..||+|+++.-....+..+-|+..+.++.  .|+    +|.+.++|...++.
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            378999999999999999999999999999999999887777788889999999884  333    88888999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC----------------
Q 017936           93 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP----------------  154 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~----------------  154 (363)
                      |+|+|.+ |.++++.+..+.  +|+-..++.+.+|+++++++||+.+++|.||||+|||+.++.                
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~  245 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP  245 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence            9999999 779999998755  699999999999999999999999999999999999984221                


Q ss_pred             --CCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 017936          155 --APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI  232 (363)
Q Consensus       155 --~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  232 (363)
                        ...|+|+|||.|+....  ...+.+.|..|+|||++.+-.++.+ +||||+||||+||.||...|...+..+.+ ...
T Consensus       246 ~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMM  321 (415)
T KOG0671|consen  246 LKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMM  321 (415)
T ss_pred             CCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHH
Confidence              22489999999875432  3366788999999999999999888 99999999999999999999877654422 111


Q ss_pred             HHHhc------------------cccCCCCC--------------------CCCC---HHHHHHHHHhcccCCCCCCCHH
Q 017936          233 HRILS------------------VQYSIPDY--------------------VHIS---PECRHLISRIFVADPAKRISIP  271 (363)
Q Consensus       233 ~~~~~------------------~~~~~~~~--------------------~~~s---~~~~~li~~~L~~~p~~R~t~~  271 (363)
                      ..++.                  .....+..                    ...+   .++-+||++||..||.+|+|+.
T Consensus       322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~  401 (415)
T KOG0671|consen  322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR  401 (415)
T ss_pred             HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence            11111                  00110100                    0011   2488999999999999999999


Q ss_pred             HHhcCcccccc
Q 017936          272 EIRNHEWFLKN  282 (363)
Q Consensus       272 ell~h~~~~~~  282 (363)
                      |+|.||||...
T Consensus       402 EAL~HpFF~~~  412 (415)
T KOG0671|consen  402 EALSHPFFARL  412 (415)
T ss_pred             HHhcCHHhhcC
Confidence            99999999753

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=320.91  Aligned_cols=248  Identities=25%  Similarity=0.364  Sum_probs=199.4

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ...++..+.+.||+|+||+||++++..   .||||+++....   ..+.++.|+..+++-+|-||+-+++++..+.. .|
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            345667889999999999999999764   499999986543   45678999999999999999999999988777 99


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc--
Q 017936           95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  171 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~--  171 (363)
                      |..+|+|.+|+.++.-. .+|.....+.|++||++|+.|||.++|||||||..|||+.++.  +|||+|||++.....  
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~--kVkIgDFGLatvk~~w~  542 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL--KVKIGDFGLATVKTRWS  542 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC--cEEEecccceeeeeeec
Confidence            99999999999998643 4699999999999999999999999999999999999998664  499999999864322  


Q ss_pred             -CCCCCccccCCCcCChhhhhcCC--CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc---CCCCC
Q 017936          172 -HSQPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---SIPDY  245 (363)
Q Consensus       172 -~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~  245 (363)
                       ........|...|||||++....  ..++.+|||||||++|||+||..||.....    ..++..+-.+..   .....
T Consensus       543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~----dqIifmVGrG~l~pd~s~~~  618 (678)
T KOG0193|consen  543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR----DQIIFMVGRGYLMPDLSKIR  618 (678)
T ss_pred             cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh----hheEEEecccccCccchhhh
Confidence             22334456888999999997433  224559999999999999999999984222    233322222211   11123


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          246 VHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ...+.++++|+..||..++++||++.+||.
T Consensus       619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  619 SNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            456779999999999999999999999886

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1e-40  Score=305.98  Aligned_cols=249  Identities=21%  Similarity=0.346  Sum_probs=200.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCc----EEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      ..++|++.+.||+|+||.||++.+..++.    .+|+|.+.....  ....+.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            45789999999999999999999887776    468888765432  223577899999999999999999998764 46


Q ss_pred             EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ++++||+++|+|.+.+.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.  +||+|||+++....
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~  161 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEG  161 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccC
Confidence            79999999999999987654 5899999999999999999999999999999999999976554  99999999975432


Q ss_pred             CCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          172 HSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       172 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      ...   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+.... .....    .......+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~~-~~~~~----~~~~~~~~~~~~  235 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPTR-EIPDL----LEKGERLPQPPI  235 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH----HHCCCCCCCCCC
Confidence            221   122345678999999987777656 999999999999997 99999764432 22222    222333444455


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .+..+.+++.+||..+|++||++++++..
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         236 CTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.5e-40  Score=303.69  Aligned_cols=250  Identities=16%  Similarity=0.159  Sum_probs=188.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCC---CcEEEEEEeecCCcc--cH----------HHHHHHHHHHcCCCCCeeeee
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKI--DE----------NVQREIINHRSLRHPNIVRFK   83 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~--~~----------~~~~e~~~l~~l~hpnIv~~~   83 (363)
                      ..++|++.+.||+|+||+||++.+..+   +..+|+|+.......  .+          ....++..+..+.|+||++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            357899999999999999999998777   667788864332211  11          112233445667899999999


Q ss_pred             EEEEcCC----eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEE
Q 017936           84 EVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK  159 (363)
Q Consensus        84 ~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vk  159 (363)
                      +++....    ..+++++++. .++...+.....+++..++.++.|++.||+|||++||+||||||+|||++.++  .++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--~~~  166 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--RGY  166 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--cEE
Confidence            8766543    3478888873 46666666666678999999999999999999999999999999999997655  499


Q ss_pred             EeecCCcccCccCC--------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHH-
Q 017936          160 ICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK-  230 (363)
Q Consensus       160 L~DFgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-  230 (363)
                      |+|||+|+......        ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||........... 
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999997543211        1123469999999999988887655 9999999999999999999987643222111 


Q ss_pred             ----HHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          231 ----TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       231 ----~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                          .+..+......   ....+..+.++++.|++.+|++||+++++++
T Consensus       246 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        246 AKCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             hHHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                12222222222   2345889999999999999999999999874

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.5e-41  Score=299.36  Aligned_cols=237  Identities=21%  Similarity=0.219  Sum_probs=191.2

Q ss_pred             ceecccCCeEEEEEEEcCCC----------cEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           27 RDIGSGNFGVARLMRDKKTE----------ELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~----------~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      +.||+|+||.||++.+..++          ..+++|.+.........+.+|+.+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46899999999999998776          357888776554436778899999999999999999999988 7789999


Q ss_pred             eccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCC-----cEEEeecCCcccCc
Q 017936           97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSV  170 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~-----~vkL~DFgla~~~~  170 (363)
                      ||+.+++|.+++...+ .++...+..++.||+.||+|||++||+||||||+|||++.++..     .+||+|||++....
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence            9999999999998766 79999999999999999999999999999999999999866521     59999999987543


Q ss_pred             cCCCCCccccCCCcCChhhhhcC--CCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      .   .....++..|+|||.+.+.  .++ .++|||||||++|+|++ |..||...+... ......    .....+.  .
T Consensus       160 ~---~~~~~~~~~y~aPE~~~~~~~~~~-~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~~~~----~~~~~~~--~  228 (259)
T cd05037         160 S---REERVERIPWIAPECIRNGQASLT-IAADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFYQ----DQHRLPM--P  228 (259)
T ss_pred             c---ccccccCCCccChhhhcCCCCCcc-hhhHHHHHHHHHHHHHhCCCCCcccCCchh-HHHHHh----cCCCCCC--C
Confidence            2   2344577889999998776  444 44999999999999999 688887654322 111111    1111121  1


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ....+.++|.+||..+|.+|||+.++++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         229 DCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2478999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-40  Score=300.65  Aligned_cols=248  Identities=26%  Similarity=0.363  Sum_probs=199.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCC---CcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      .++|.+.+.||+|+||.||++.+...   ...+|+|......  ...+.+.+|+.+++.++||||+++++++.. ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            46799999999999999999987544   3468999876543  234568889999999999999999998876 45689


Q ss_pred             EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      ||||+++++|.+++.+.. .+++..++.++.|++.||+|||+.|++||||||+||+++.++.  ++|+|||+++......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~  161 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeeccccc
Confidence            999999999999997644 5899999999999999999999999999999999999986654  9999999987543322


Q ss_pred             CC--CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          174 QP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       174 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                      ..  ....+++.|+|||.+....++.+ +||||||+++|++++ |..||...........    +. .....+.+..++.
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~-~~~~~~~~~~~~~  235 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----IE-NGERLPMPPNCPP  235 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HH-cCCcCCCCCCCCH
Confidence            11  12234567999999877777655 999999999999986 9999987654332222    21 1223334456789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .+.+++.+||..+|.+|||+.+++..
T Consensus       236 ~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         236 TLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-42  Score=324.98  Aligned_cols=247  Identities=32%  Similarity=0.438  Sum_probs=201.4

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC------eE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HL   92 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------~~   92 (363)
                      .-|...+.||+|+||.||+++++.+|+.||||.+++.  ....+..-+|++++++++|||||++.++-++..      ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            3467789999999999999999999999999999763  344567789999999999999999999866543      46


Q ss_pred             EEEEeccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC--CCCcEEEeecCCcc
Q 017936           93 AIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSK  167 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~--~~~~vkL~DFgla~  167 (363)
                      .+|||||.||+|...+.+-   ..+++.+++.++..+..||.|||++||+||||||.||++-..  +....||+|||.|+
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            8999999999999999753   359999999999999999999999999999999999998533  33358999999999


Q ss_pred             cCccCCCCCccccCCCcCChhhhhc-CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------
Q 017936          168 SSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------  237 (363)
Q Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  237 (363)
                      .........+.+||+.|.+||.... +.|+.. +|.||+||++|+++||..||.....+.+.......+..         
T Consensus       173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~t-VDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTAT-VDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             cCCCCCeeeeecCchhhcChHHHhhccCcCce-eehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence            9888888888999999999999985 455444 99999999999999999999766555443333322221         


Q ss_pred             ----------cccCCCCCCCCCHH----HHHHHHHhcccCCCCCC
Q 017936          238 ----------VQYSIPDYVHISPE----CRHLISRIFVADPAKRI  268 (363)
Q Consensus       238 ----------~~~~~~~~~~~s~~----~~~li~~~L~~~p~~R~  268 (363)
                                ....+|.+..+++.    +..+|..+|..+|++|-
T Consensus       252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                      11233333344443    56788889999999998

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-40  Score=299.64  Aligned_cols=240  Identities=21%  Similarity=0.228  Sum_probs=187.5

Q ss_pred             ceecccCCeEEEEEEEcC------------CCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           27 RDIGSGNFGVARLMRDKK------------TEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~------------~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      +.||+|+||.||++....            ....+|+|++..... ....+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532            223588898765432 2346778899999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC-----CcEEEeecCCcc
Q 017936           94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-----PRLKICDFGYSK  167 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~-----~~vkL~DFgla~  167 (363)
                      +||||+++++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.     ..++++|||++.
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~  160 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI  160 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence            99999999999888865 356999999999999999999999999999999999999975442     138999999886


Q ss_pred             cCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                      ...   ......++..|+|||.+.+....+.++|||||||++|+|+ +|..||........ .    ........  ...
T Consensus       161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~----~~~~~~~~--~~~  230 (262)
T cd05077         161 TVL---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-E----RFYEGQCM--LVT  230 (262)
T ss_pred             ccc---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-H----HHHhcCcc--CCC
Confidence            432   2234467889999999874443344499999999999997 58888865432211 1    11111111  122


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ..+.++.+||.+||+.+|.+||++.+|+.+
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-40  Score=298.10  Aligned_cols=242  Identities=28%  Similarity=0.382  Sum_probs=197.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|+||.||++.  .+++.||+|.+.... ....+.+|+.+++.++||||+++++++..+ ..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            3579999999999999999886  467889999886542 346788999999999999999999998765 479999999


Q ss_pred             CCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc
Q 017936          100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus       100 ~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      .+++|.+++....  .+++..++.++.|++.||.|||+.|++||||||+||+++.++.  ++|+|||++......  ...
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~--~~~  156 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG--VDN  156 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--CCC
Confidence            9999999987643  4899999999999999999999999999999999999976654  999999998753221  223


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ...+..|+|||.+.+..++.+ +|+|||||++|+|++ |..||......... ..+   . .....+....++..+.+++
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~---~-~~~~~~~~~~~~~~~~~li  230 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-ECV---E-KGYRMEPPEGCPADVYVLM  230 (254)
T ss_pred             CCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHHH-HHH---h-CCCCCCCCCcCCHHHHHHH
Confidence            345678999999987777665 999999999999997 99999765543222 221   1 1222333446789999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 017936          257 SRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~  275 (363)
                      ++||+.+|.+||++++++.
T Consensus       231 ~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         231 TSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.5e-41  Score=300.91  Aligned_cols=243  Identities=24%  Similarity=0.384  Sum_probs=195.2

Q ss_pred             ceecccCCeEEEEEEEcCCC------cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           27 RDIGSGNFGVARLMRDKKTE------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +.||+|+||.||+++++...      +.+|+|.+....  .....+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            46899999999999986544      689999886543  3345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC---CCcEEEeecCCccc
Q 017936           99 ASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS  168 (363)
Q Consensus        99 ~~~~~L~~~~~~~-------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~---~~~vkL~DFgla~~  168 (363)
                      +++++|.+++...       ..++..++..++.||+.||+|||++|++||||||+||+++.+.   ...++|+|||+++.
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9999999998642       3478899999999999999999999999999999999998655   12599999999874


Q ss_pred             CccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 017936          169 SVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD  244 (363)
Q Consensus       169 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (363)
                      .....   ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||..........    .+. .......
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~~~----~~~-~~~~~~~  234 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEVLQ----HVT-AGGRLQK  234 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHHHH----HHh-cCCccCC
Confidence            42221   1123345788999999988877655 999999999999998 999997655433221    111 1222233


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ...+|..+.++|.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4457899999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-41  Score=328.51  Aligned_cols=247  Identities=28%  Similarity=0.418  Sum_probs=210.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      ..+-+..+.||+|+||+||+++-.     ...+.||||.++....  ...+|++|+.+++.++|||||++++++...+.+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            345678899999999999999864     2346899999976543  467899999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcE
Q 017936           93 AIVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL  158 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~--------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~v  158 (363)
                      ++|+|||..|+|.+++....              +++..+...++.||+.|+.||-++.+|||||-..|+||.++-.  |
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--V  642 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--V  642 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--E
Confidence            99999999999999986321              2889999999999999999999999999999999999976655  9


Q ss_pred             EEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHH
Q 017936          159 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR  234 (363)
Q Consensus       159 kL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  234 (363)
                      ||+|||+++.......   .....-...|||||.+..++++++ |||||+||++||+++ |..||.+.+..+    .+..
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~E----VIe~  717 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQE----VIEC  717 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHH----HHHH
Confidence            9999999986443322   223445678999999999999988 999999999999998 999999877643    3444


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017936          235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       235 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell  274 (363)
                      +..... ++.+..+|.++.+|+..||+.+|++||++.||-
T Consensus       718 i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  718 IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            445554 677778999999999999999999999999974

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-40  Score=301.15  Aligned_cols=239  Identities=22%  Similarity=0.262  Sum_probs=187.6

Q ss_pred             eecccCCeEEEEEEEcCC------------------------CcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeee
Q 017936           28 DIGSGNFGVARLMRDKKT------------------------EELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRF   82 (363)
Q Consensus        28 ~lg~G~~g~V~~~~~~~~------------------------~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~   82 (363)
                      .||+|+||.||++....+                        ...+|+|++..... ....+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            689999999999875321                        23588888765432 23467788999999999999999


Q ss_pred             eEEEEcCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-----CC
Q 017936           83 KEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-----AP  156 (363)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-----~~  156 (363)
                      ++++......++||||+++++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++..+     ..
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~  161 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP  161 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence            9999999999999999999999988865 45789999999999999999999999999999999999997543     22


Q ss_pred             cEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHH
Q 017936          157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRI  235 (363)
Q Consensus       157 ~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~  235 (363)
                      .+|++|||++.....   .....+++.|+|||.+.+....+.++|||||||++|+++ +|..||........ ....   
T Consensus       162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~---  234 (274)
T cd05076         162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFY---  234 (274)
T ss_pred             eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHH---
Confidence            489999998764321   223457888999998876443344499999999999985 69999976544322 1111   


Q ss_pred             hccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          236 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       236 ~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                       ......+.  ..++.+.++|.+||+.+|++|||+.+++++
T Consensus       235 -~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 -EKKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -HhccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             11222222  246789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.5e-41  Score=336.33  Aligned_cols=251  Identities=32%  Similarity=0.486  Sum_probs=196.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEc----------
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT----------   88 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----------   88 (363)
                      .+|+.++.||+||||.||+|+++-+|+.||||.+...  ......+.+|+..+++|+|||||+++..+..          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            4578899999999999999999999999999998765  4445678999999999999999998643110          


Q ss_pred             --------------------------------------------------------------------------------
Q 017936           89 --------------------------------------------------------------------------------   88 (363)
Q Consensus        89 --------------------------------------------------------------------------------   88 (363)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ---------------------C--------CeEEEEEeccCCCchHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHcCc
Q 017936           89 ---------------------P--------THLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQV  138 (363)
Q Consensus        89 ---------------------~--------~~~~lv~e~~~~~~L~~~~~~~~~l-~~~~~~~~~~qil~~L~~LH~~gi  138 (363)
                                           +        ..+||-||||+..++...+.++... ....+|.++++|++||.|+|++||
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                                 0        1368889999887777777665544 478899999999999999999999


Q ss_pred             eecCCCCCCEEEeCCCCCcEEEeecCCcccCc-------------------cCCCCCccccCCCcCChhhhhcCC---CC
Q 017936          139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-------------------LHSQPKSTVGTPAYIAPEVLLKKE---YD  196 (363)
Q Consensus       139 iHrDlkp~NIll~~~~~~~vkL~DFgla~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~---~~  196 (363)
                      |||||||.|||++.+..  |||+|||+|+...                   ..+...+.+||-.|+|||++.+..   |+
T Consensus       719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999986655  9999999997511                   111234557999999999997765   76


Q ss_pred             CcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017936          197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       197 ~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~~p~~R~t~~ell  274 (363)
                      .+ +|+||||++|+||+   .||....+..   .++..+.......+.  +..-=+.-..+|++||+.||.+||||.|+|
T Consensus       797 ~K-iDmYSLGIVlFEM~---yPF~TsMERa---~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL  869 (1351)
T KOG1035|consen  797 SK-IDMYSLGIVLFEML---YPFGTSMERA---SILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL  869 (1351)
T ss_pred             ch-hhhHHHHHHHHHHh---ccCCchHHHH---HHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence            66 99999999999998   4676543332   333334333333330  111124567899999999999999999999


Q ss_pred             cCcccc
Q 017936          275 NHEWFL  280 (363)
Q Consensus       275 ~h~~~~  280 (363)
                      ++.||.
T Consensus       870 ~s~llp  875 (1351)
T KOG1035|consen  870 NSELLP  875 (1351)
T ss_pred             hccCCC
Confidence            999996

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-43  Score=292.29  Aligned_cols=268  Identities=27%  Similarity=0.419  Sum_probs=214.6

Q ss_pred             CCCCCCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeec---CCcccHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 017936           11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVIL   87 (363)
Q Consensus        11 ~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~   87 (363)
                      .+..|.+...+.|.-+.++|+|.||.||+|+.+.+|+.||+|.+--   .........+|+.+|..++|+|++.+++++.
T Consensus         7 s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~   86 (376)
T KOG0669|consen    7 SMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   86 (376)
T ss_pred             cccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence            4667788888999999999999999999999999999999986532   2234466789999999999999999988775


Q ss_pred             cC--------CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcE
Q 017936           88 TP--------THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL  158 (363)
Q Consensus        88 ~~--------~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~v  158 (363)
                      +.        ..+|+||.+|+ .+|..++... .+|+..++..+++++++||.|+|+..|+|||+||+|+||+.++.  +
T Consensus        87 tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--l  163 (376)
T KOG0669|consen   87 TKATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--L  163 (376)
T ss_pred             hccCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--E
Confidence            32        34899999995 4888888665 57999999999999999999999999999999999999987665  9


Q ss_pred             EEeecCCcccCccCCC-----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 017936          159 KICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH  233 (363)
Q Consensus       159 kL~DFgla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  233 (363)
                      ||+|||+++.+.....     -...+.|.+|++||.+.|....+++.|||..|||+.+|+|+.+-+.+.+....+..+- 
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is-  242 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS-  242 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH-
Confidence            9999999975433221     1223569999999999998877777999999999999999999998877654433221 


Q ss_pred             HHhcc--------ccCCCCC----------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          234 RILSV--------QYSIPDY----------------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       234 ~~~~~--------~~~~~~~----------------------~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .++..        .-..|.+                      -.-++++.+|+.+||..||.+|+++.++++|.||++.
T Consensus       243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence            11110        0000000                      0124578999999999999999999999999999864

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7e-40  Score=295.13  Aligned_cols=246  Identities=21%  Similarity=0.289  Sum_probs=186.2

Q ss_pred             ceecccCCeEEEEEEEcCC--CcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCC
Q 017936           27 RDIGSGNFGVARLMRDKKT--EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  102 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~  102 (363)
                      +.||+|+||+||+++....  ...+++|.+....  ...+.+.+|+..++.++||||+++++.+.....+++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            4699999999999975433  2356677665432  23457888999999999999999999999999999999999999


Q ss_pred             chHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC---CCC
Q 017936          103 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP  175 (363)
Q Consensus       103 ~L~~~~~~~----~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~---~~~  175 (363)
                      +|.+++.+.    ..+++..++.++.||+.||+|||++|++||||||+|||++.++.  ++|+|||++......   ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence            999998753    24677788999999999999999999999999999999976554  999999997642221   112


Q ss_pred             CccccCCCcCChhhhhcCC------CCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          176 KSTVGTPAYIAPEVLLKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                      ....+++.|+|||++....      ..+.++|||||||++|+|++ |..||......+.....+...............+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            3456788999999875321      11344899999999999997 5778876555444433332211111111122346


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.+.+++..|+ .+|.+|||++++++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            889999999999 67999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=319.82  Aligned_cols=256  Identities=28%  Similarity=0.461  Sum_probs=217.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEc-----CCeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT-----PTHL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~-----~~~~   92 (363)
                      ..+.|++.+.+|.|.+|.||+++++.+++..|+|+.......++.++.|..+++.+ .|||++.++++|.-     .+.+
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            35779999999999999999999999999999999998888889999999999877 59999999999863     4689


Q ss_pred             EEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           93 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      +||||||.||+..++++.  ..++.|..+..|++.++.||.+||++.++|||||-.|||++.++.  |||.|||++....
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQld  174 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLD  174 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeee
Confidence            999999999999999975  446899999999999999999999999999999999999987765  9999999987654


Q ss_pred             c-CCCCCccccCCCcCChhhhhc-----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-cccCCC
Q 017936          171 L-HSQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-VQYSIP  243 (363)
Q Consensus       171 ~-~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~  243 (363)
                      . -....+.+|||.|||||++..     ..|+.+ +|+||||++..||.-|.+|+-..-...    .+..+.. ....+-
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmr----aLF~IpRNPPPkLk  249 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMR----ALFLIPRNPPPKLK  249 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhh----hhccCCCCCCcccc
Confidence            3 344567789999999999854     345666 899999999999999999996644322    2222221 222333


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          244 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .+..++.++.+||..||.+|.++||+..+++.|||+++
T Consensus       250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            35567999999999999999999999999999999963

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.7e-40  Score=293.90  Aligned_cols=241  Identities=24%  Similarity=0.311  Sum_probs=187.5

Q ss_pred             ceecccCCeEEEEEEEcC---CCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEE-cCCeEEEEEeccC
Q 017936           27 RDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYAS  100 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~~  100 (363)
                      +.||+|+||.||++.+..   .+..+|+|.+....  ...+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998643   34579999875432  22356778999999999999999999775 4556899999999


Q ss_pred             CCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-----C
Q 017936          101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----Q  174 (363)
Q Consensus       101 ~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-----~  174 (363)
                      +++|.+++.+. ..++...+..++.||+.||.|||+.|++||||||+|||++.++.  +||+|||+++......     .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence            99999998764 34678888999999999999999999999999999999986654  9999999987432211     1


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      .....+++.|+|||.+.+..++.+ +|||||||++|+|++| .+||........    ....... ...+....+++.+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~  232 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDI----TVYLLQG-RRLLQPEYCPDPLY  232 (262)
T ss_pred             cccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHhcC-CCCCCCCcCCHHHH
Confidence            123345778999999987777666 9999999999999995 566655433222    1122221 12222335689999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017936          254 HLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +++.+||+.+|++||++.+++.
T Consensus       233 ~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         233 EVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-39  Score=294.44  Aligned_cols=245  Identities=23%  Similarity=0.374  Sum_probs=192.7

Q ss_pred             ceeeceecccCCeEEEEEEEc---CCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC------
Q 017936           23 YELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------   90 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------   90 (363)
                      |.+.+.||+|+||.||++...   .+++.+|||++....   ...+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999864   357889999987542   22345778999999999999999999886542      


Q ss_pred             eEEEEEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecC
Q 017936           91 HLAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG  164 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFg  164 (363)
                      ..+++++|+.+++|..++...      ..++...++.++.||+.||+|||++||+||||||+||+++.+.  .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~--~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM--TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC--CEEECccc
Confidence            247899999999998876432      2478999999999999999999999999999999999997655  49999999


Q ss_pred             CcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhcccc
Q 017936          165 YSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY  240 (363)
Q Consensus       165 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (363)
                      +++......   ......+++.|++||.+.+..++.+ +|||||||++|+|++ |..||..........    .+.... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~~----~~~~~~-  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYN----YLIKGN-  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH----HHHcCC-
Confidence            987543221   1223345678999999987777665 999999999999999 889997654422221    111111 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       241 ~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..+.....+..+.+++.+||+.+|.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            12222356899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=8e-41  Score=277.06  Aligned_cols=258  Identities=23%  Similarity=0.445  Sum_probs=209.7

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEcC--CeEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAI   94 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~--~~~~l   94 (363)
                      ..+++|++++++|+|.|+.|+.+.+..+++.++||+++.-.  .+.+.+|+.+|+.|. ||||++++++..++  ....+
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            45789999999999999999999999999999999987642  467899999999997 99999999999876  45789


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      |+||++..+...+.   +.++...++.++.+++.||.|||+.||.|||+||.|++|+.... .++|+|+|+|....+...
T Consensus       113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~e  188 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKE  188 (338)
T ss_pred             HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCce
Confidence            99999887766553   45889999999999999999999999999999999999986543 699999999988777766


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHH---------hccccCC--
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRI---------LSVQYSI--  242 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~---------~~~~~~~--  242 (363)
                      -.-.+.+..|--||.+..-....-.-|+|||||++..|+..+-||... +..+++.++.+-+         .+....+  
T Consensus       189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp  268 (338)
T KOG0668|consen  189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP  268 (338)
T ss_pred             eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence            677789999999999876554333379999999999999999998543 3434433332110         0000000  


Q ss_pred             -------------------CCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          243 -------------------PDY-VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       243 -------------------~~~-~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                                         +.. .-+++++.+||.++|..|-.+|+|+.|++.||||..
T Consensus       269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence                               011 124799999999999999999999999999999964

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=327.33  Aligned_cols=249  Identities=26%  Similarity=0.380  Sum_probs=208.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCc-----EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH   91 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~   91 (363)
                      ...+-...+.||+|+||.||.+.-.....     .||+|.+.+..  .....+.+|..+|+.++|||||++++++.+...
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            34678889999999999999998754333     38999887753  334678999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecC
Q 017936           92 LAIVMEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG  164 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFg  164 (363)
                      .++++|||+||+|..++++.       ..++..+...++.+|++|.+||+++++|||||...|+|++...  .|||+|||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r--~VKIaDFG  847 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR--VVKIADFG  847 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC--cEEEcccc
Confidence            99999999999999999876       2489999999999999999999999999999999999998774  49999999


Q ss_pred             CcccCc-cCCCCCc--cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhcccc
Q 017936          165 YSKSSV-LHSQPKS--TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY  240 (363)
Q Consensus       165 la~~~~-~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (363)
                      +|+... .......  ..-...|||||.+..+.++++ +|||||||++||+++ |..||......+..    ....... 
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~----~~~~~gg-  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVL----LDVLEGG-  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHH----HHHHhCC-
Confidence            999322 1111111  223467999999999999888 999999999999999 99999876554332    2222222 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       241 ~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +++.+..+++.+.+++..||+.+|++||++..|++
T Consensus       922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            66777789999999999999999999999999986

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-42  Score=289.27  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=206.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHH-HHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~-l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..++.+-+..||.|+||+|++..++.+|+..|||.+....  ....+++.|... ++.-+.||||+++++...++..++.
T Consensus        62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            3456677889999999999999999999999999997643  334556666654 4556799999999999999999999


Q ss_pred             EeccCCCchHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           96 MEYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        96 ~e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      ||++ ..+|..+.+     ....++|.-+..+..-.+.||.||.. ..|||||+||+|||++..+.  |||||||++...
T Consensus       142 MELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqL  218 (361)
T KOG1006|consen  142 MELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQL  218 (361)
T ss_pred             HHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhH
Confidence            9999 446644332     34569999999999999999999995 68999999999999987665  999999998765


Q ss_pred             ccCCCCCccccCCCcCChhhhhc--CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC-C---
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-P---  243 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~---  243 (363)
                      ..+.......|...|||||.+..  ..|+-+ |||||||+++||+.||..|+..-..   ..+++..+....... .   
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gdpp~l~~~~  294 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGDPPILLFDK  294 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCCCCeecCcc
Confidence            55555556689999999999854  346777 9999999999999999999975432   334444444333221 1   


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          244 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ....+|..+..||.-||.+|-..||+..+++++||+...
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            224579999999999999999999999999999999764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=297.78  Aligned_cols=267  Identities=26%  Similarity=0.419  Sum_probs=203.9

Q ss_pred             CCCCCCCC----CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-----C---CC
Q 017936           11 GMDMPIMH----DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----H---PN   78 (363)
Q Consensus        11 ~~~~~~~~----~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-----h---pn   78 (363)
                      |.+.|+..    ...||.+.++||+|.|++||+|.|..+.+.||+|+++....-.+....||++|++++     |   .+
T Consensus        64 GGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~  143 (590)
T KOG1290|consen   64 GGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKC  143 (590)
T ss_pred             CCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence            45555553    358999999999999999999999999999999999887777788899999998874     2   46


Q ss_pred             eeeeeEEEEc----CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEe
Q 017936           79 IVRFKEVILT----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLD  151 (363)
Q Consensus        79 Iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~  151 (363)
                      ||++++.|..    ..|+|+|+|++ |.+|..++...  +.++...++.|++|||.||.|||+ +||||.||||+|||+.
T Consensus       144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            9999999975    46899999999 78999998764  469999999999999999999995 7999999999999983


Q ss_pred             CC------------------------------------------------------------------------------
Q 017936          152 GS------------------------------------------------------------------------------  153 (363)
Q Consensus       152 ~~------------------------------------------------------------------------------  153 (363)
                      .+                                                                              
T Consensus       223 ~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s  302 (590)
T KOG1290|consen  223 STEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQES  302 (590)
T ss_pred             ccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccc
Confidence            00                                                                              


Q ss_pred             ---------------------------------------------------------------CC---------------
Q 017936          154 ---------------------------------------------------------------PA---------------  155 (363)
Q Consensus       154 ---------------------------------------------------------------~~---------------  155 (363)
                                                                                     ..               
T Consensus       303 ~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p  382 (590)
T KOG1290|consen  303 YNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNP  382 (590)
T ss_pred             cccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCC
Confidence                                                                           00               


Q ss_pred             --------CcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch--
Q 017936          156 --------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--  225 (363)
Q Consensus       156 --------~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--  225 (363)
                              -+|||+|||-|+.....  ....+.|..|+|||++.+..|... +||||++|+++||+||...|...+..  
T Consensus       383 ~~~~~~~di~vKIaDlGNACW~~kh--FT~DIQTRQYRapEVllGsgY~~~-ADiWS~AC~~FELaTGDyLFePhsG~~Y  459 (590)
T KOG1290|consen  383 DIPLPECDIRVKIADLGNACWVHKH--FTEDIQTRQYRAPEVLLGSGYSTS-ADIWSTACMAFELATGDYLFEPHSGENY  459 (590)
T ss_pred             CCCCCccceeEEEeeccchhhhhhh--hchhhhhhhccCcceeecCCCCCc-hhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence                    02556666655543221  123457888999999999999888 89999999999999999999643211  


Q ss_pred             HHHHHHHHHHhccccCCC---------------------------CC---------CCC----CHHHHHHHHHhcccCCC
Q 017936          226 KNFRKTIHRILSVQYSIP---------------------------DY---------VHI----SPECRHLISRIFVADPA  265 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~---------------------------~~---------~~~----s~~~~~li~~~L~~~p~  265 (363)
                      ..-...+..+.+.-..+|                           .|         ..+    ..++.+||.-||+.+|+
T Consensus       460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe  539 (590)
T KOG1290|consen  460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE  539 (590)
T ss_pred             CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence            000011111111000000                           00         012    24689999999999999


Q ss_pred             CCCCHHHHhcCccccc
Q 017936          266 KRISIPEIRNHEWFLK  281 (363)
Q Consensus       266 ~R~t~~ell~h~~~~~  281 (363)
                      +||||+++|+|||+..
T Consensus       540 KR~tA~~cl~hPwLn~  555 (590)
T KOG1290|consen  540 KRPTAAQCLKHPWLNP  555 (590)
T ss_pred             ccccHHHHhcCccccC
Confidence            9999999999999964

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.6e-39  Score=317.66  Aligned_cols=260  Identities=18%  Similarity=0.210  Sum_probs=177.8

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCC----CcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEE------EE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV------IL   87 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~----~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~------~~   87 (363)
                      ...++|.+.+.||+|+||.||++++..+    +..||+|.+..... .+....+  .++...+.++..+...      ..
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            3567899999999999999999999988    89999998754321 1111111  1122222333332222      23


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCC
Q 017936           88 TPTHLAIVMEYASGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN  147 (363)
Q Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~N  147 (363)
                      ....+++|+||+.+++|.+++.....                    .....+..++.||+.||.|||++||+||||||+|
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N  285 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN  285 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence            45679999999999999998865321                    1234567899999999999999999999999999


Q ss_pred             EEEeCCCCCcEEEeecCCcccCcc--CCCCCccccCCCcCChhhhhcCCCC---------------------Ccchhhhh
Q 017936          148 TLLDGSPAPRLKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEVLLKKEYD---------------------GKIADVWS  204 (363)
Q Consensus       148 Ill~~~~~~~vkL~DFgla~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~Diws  204 (363)
                      ||++.+ .+.+||+|||+|+....  ........+++.|+|||.+......                     ..++||||
T Consensus       286 ILl~~~-~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        286 IIFSEG-SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             EEEeCC-CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999753 23599999999975322  2223456789999999976433221                     11259999


Q ss_pred             HHHHHHHHHhCCCCCCCCCchHHHHHHHHH----------HhccccC------CCCCCCCCHHHHHHHHHhcccCCCCCC
Q 017936          205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHR----------ILSVQYS------IPDYVHISPECRHLISRIFVADPAKRI  268 (363)
Q Consensus       205 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~~~------~~~~~~~s~~~~~li~~~L~~~p~~R~  268 (363)
                      |||++|+|+++..|+...  ...+...+..          .......      +......+....+||.+||+.||++||
T Consensus       365 lGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~  442 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI  442 (566)
T ss_pred             HHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence            999999999987765421  1112111111          0000000      000111234466999999999999999


Q ss_pred             CHHHHhcCccccccC
Q 017936          269 SIPEIRNHEWFLKNL  283 (363)
Q Consensus       269 t~~ell~h~~~~~~~  283 (363)
                      |+.++|+||||....
T Consensus       443 ta~e~L~Hpff~~~~  457 (566)
T PLN03225        443 SAKAALAHPYFDREG  457 (566)
T ss_pred             CHHHHhCCcCcCCCC
Confidence            999999999997653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.6e-40  Score=303.24  Aligned_cols=258  Identities=26%  Similarity=0.412  Sum_probs=212.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC------CCCeeeeeEEEEcCCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR------HPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~------hpnIv~~~~~~~~~~~~~   93 (363)
                      ..+|.+....|+|-||+|..|++...|+.||||++.........=++|+.+|++|+      --|+++++..|...+|+|
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC  510 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC  510 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence            57899999999999999999999999999999999988777777789999999995      358999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           94 IVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      +|+|.+ ..+|.+.+++.+.   |....++.|+.|++.||..|..+||+|.||||+|||+++... .+||||||.|....
T Consensus       511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~  588 (752)
T KOG0670|consen  511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFAS  588 (752)
T ss_pred             EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccc
Confidence            999988 5689999988764   888999999999999999999999999999999999987654 69999999886543


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHH-------HH-hcccc--
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-------RI-LSVQY--  240 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-------~~-~~~~~--  240 (363)
                      .+ .......+..|.|||++.|-.|+.. -|+||+||+||||.||+..|.+.+....++-.+.       ++ ....+  
T Consensus       589 en-eitPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~d  666 (752)
T KOG0670|consen  589 EN-EITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKD  666 (752)
T ss_pred             cc-cccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhh
Confidence            22 2233456778999999999999988 7999999999999999999998776443332211       00 00000  


Q ss_pred             -----C-----------------------CC---------CCCCCC-------HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          241 -----S-----------------------IP---------DYVHIS-------PECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       241 -----~-----------------------~~---------~~~~~s-------~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                           .                       -|         ....++       ..+.+||.+||..||++|.|+.++|.|
T Consensus       667 qHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  667 QHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             hhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence                 0                       00         000012       358999999999999999999999999


Q ss_pred             ccccc
Q 017936          277 EWFLK  281 (363)
Q Consensus       277 ~~~~~  281 (363)
                      |||+.
T Consensus       747 pFi~~  751 (752)
T KOG0670|consen  747 PFITE  751 (752)
T ss_pred             CcccC
Confidence            99964

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.9e-38  Score=278.67  Aligned_cols=241  Identities=43%  Similarity=0.693  Sum_probs=203.2

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCchHHHHHh
Q 017936           33 NFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN  110 (363)
Q Consensus        33 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  110 (363)
                      +||.||++.+..+++.+|+|++......  ...+.+|+..++.++|+||+++++++......++++||+.+++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            5899999999988999999998765432  47788999999999999999999999999999999999999999999987


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCCCcCChhhh
Q 017936          111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL  190 (363)
Q Consensus       111 ~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~  190 (363)
                      ...++...++.++.+++.+|.+||+.|++|+||+|.||+++.++  .++|+|||.+.............++..|+|||.+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG--HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC--cEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            77799999999999999999999999999999999999998764  4999999998866554445566789999999999


Q ss_pred             hcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCC-CCCHHHHHHHHHhcccCCCCCCC
Q 017936          191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-HISPECRHLISRIFVADPAKRIS  269 (363)
Q Consensus       191 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~~p~~R~t  269 (363)
                      .+..++.+ +|+||||++++++++|..||...........   ............. .++.++.+++.+||..+|.+||+
T Consensus       159 ~~~~~~~~-~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      159 LGKGYGKA-VDVWSLGVILYELLTGKPPFPGDDQLLELFK---KIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             ccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            87777665 9999999999999999999976433332222   2222222222211 17899999999999999999999


Q ss_pred             HHHHhcCccc
Q 017936          270 IPEIRNHEWF  279 (363)
Q Consensus       270 ~~ell~h~~~  279 (363)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-38  Score=303.88  Aligned_cols=262  Identities=19%  Similarity=0.246  Sum_probs=189.5

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEc----------------CCCcEEEEEEeecCCcc---------------cHHHHH
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDK----------------KTEELVAVKYIERGDKI---------------DENVQR   66 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~----------------~~~~~~aiK~~~~~~~~---------------~~~~~~   66 (363)
                      ...++|++.++||+|+||+||++...                ..++.||||.+......               .+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            35789999999999999999998642                34567999998643211               122234


Q ss_pred             HHHHHHcCCCCCe-----eeeeEEEEc--------CCeEEEEEeccCCCchHHHHHhCC---------------------
Q 017936           67 EIINHRSLRHPNI-----VRFKEVILT--------PTHLAIVMEYASGGELFERICNAG---------------------  112 (363)
Q Consensus        67 e~~~l~~l~hpnI-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~---------------------  112 (363)
                      |+.++..++|.++     ++++++|..        ....++||||+.+++|.+++....                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6666666766554     666666643        356899999999999998876321                     


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc--cccCCCcCCh
Q 017936          113 ---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPAYIAP  187 (363)
Q Consensus       113 ---~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~--~~gt~~y~aP  187 (363)
                         .++...++.++.|++.+|.|||+.||+||||||+|||++.++.  +||+|||++...........  ..+|+.|+||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeCh
Confidence               2356678899999999999999999999999999999986654  99999999865432222222  2358999999


Q ss_pred             hhhhcCCC--------------------C-CcchhhhhHHHHHHHHHhCCC-CCCCCCchHH-------HHHHHHHHhcc
Q 017936          188 EVLLKKEY--------------------D-GKIADVWSCGVTLYVMLVGAY-PFEDPEEPKN-------FRKTIHRILSV  238 (363)
Q Consensus       188 E~~~~~~~--------------------~-~~~~DiwslG~il~~l~~g~~-pf~~~~~~~~-------~~~~~~~~~~~  238 (363)
                      |.+.....                    . ....||||+||++|+|++|.. ||........       ....+......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98854321                    1 112699999999999999886 7753221111       11112223334


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCccccc
Q 017936          239 QYSIPDYVHISPECRHLISRIFVADP---AKRISIPEIRNHEWFLK  281 (363)
Q Consensus       239 ~~~~~~~~~~s~~~~~li~~~L~~~p---~~R~t~~ell~h~~~~~  281 (363)
                      .+.++.+...++..++|+.+||..+|   .+|+|++|+|+||||..
T Consensus       460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            44556666789999999999999866   68999999999999964

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=278.80  Aligned_cols=256  Identities=27%  Similarity=0.414  Sum_probs=207.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcC------
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------   89 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------   89 (363)
                      ...||.-++.+|.|.- .|..+-|...++.||+|.+...   ....++..+|...+..+.|+||++++.+|.-.      
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3468999999999998 8888999999999999987653   22345677899999999999999999999754      


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      ...|+|||++ ..+|.+.+.  -.+.-..+..++.|++.|++|||+.||+||||||+||++..+..  +||.|||+|+..
T Consensus        94 ~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e  168 (369)
T KOG0665|consen   94 QEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTE  168 (369)
T ss_pred             HhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhccc
Confidence            3589999999 558887776  34788899999999999999999999999999999999976665  999999999876


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc------------
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------  237 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------  237 (363)
                      .........+.|..|.|||++.+..+..+ +||||+||++.+|++|...|.+.+.-+++.+++...-.            
T Consensus       169 ~~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~  247 (369)
T KOG0665|consen  169 DTDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT  247 (369)
T ss_pred             CcccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence            66655566789999999999999888777 89999999999999999999876544433333221100            


Q ss_pred             ---------------cccCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          238 ---------------VQYSIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       238 ---------------~~~~~~~---------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                                     ....+|.         ...-+..+++++.+||-.+|++|.+++++|.|||++-
T Consensus       248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v  315 (369)
T KOG0665|consen  248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV  315 (369)
T ss_pred             HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence                           0001111         0012346899999999999999999999999999973

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-39  Score=301.34  Aligned_cols=262  Identities=25%  Similarity=0.392  Sum_probs=216.9

Q ss_pred             CCCCCCCCCCCceeeceecccCCeEEEEEEEcC-CCc--EEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEE
Q 017936           12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKK-TEE--LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVI   86 (363)
Q Consensus        12 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~--~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~   86 (363)
                      ..+.-.+..++.++.+.||+|+||+|+.+.... +|+  .||||++.....  ...+|.+|+.+|.+|+|||++++|++.
T Consensus       101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvV  180 (1039)
T KOG0199|consen  101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVV  180 (1039)
T ss_pred             CCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeee
Confidence            333333445678889999999999999998764 333  689999987543  457899999999999999999999999


Q ss_pred             EcCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecC
Q 017936           87 LTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG  164 (363)
Q Consensus        87 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFg  164 (363)
                      .+ ..+.+|||++++|+|.+.+.+.  ..|.......|+.||+.|+.||.++++|||||-..|+|+-....  |||+|||
T Consensus       181 l~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~DFG  257 (1039)
T KOG0199|consen  181 LD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKICDFG  257 (1039)
T ss_pred             cc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeeeccc
Confidence            88 6789999999999999999873  35888999999999999999999999999999999999976544  9999999


Q ss_pred             CcccCccCCCCCc----cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccc
Q 017936          165 YSKSSVLHSQPKS----TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ  239 (363)
Q Consensus       165 la~~~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  239 (363)
                      |++..........    ..-...|+|||.++...++.. ||||++||++|||++ |.-||.+....    .+++.+. ..
T Consensus       258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~----qIL~~iD-~~  331 (1039)
T KOG0199|consen  258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGI----QILKNID-AG  331 (1039)
T ss_pred             ceeccCCCCcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHH----HHHHhcc-cc
Confidence            9997655444332    224567999999999999877 999999999999998 89999987653    3333333 44


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       240 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .+++....+|+++.+++.+||..+|.+|||+..|.+.-++.+.
T Consensus       332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence            5677777899999999999999999999999998766555443

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=293.22  Aligned_cols=252  Identities=24%  Similarity=0.369  Sum_probs=206.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ..++..++++||+|-||.|.+|.-. .+..||+|.++...  ....++.+|+++|.+|+|||||+++++|..++.+++|+
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            3466789999999999999999963 46889999997653  33467999999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||++.|+|.+++.++  +.+.......++.||+.|++||.+.++|||||.+.|+|++.+.+  +||+|||+|+.......
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCc
Confidence            999999999999876  34456667789999999999999999999999999999976655  99999999985433322


Q ss_pred             ---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh--CCCCCCCCCchHHHHHHHHHHhccc---cCCCCCC
Q 017936          175 ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPKNFRKTIHRILSVQ---YSIPDYV  246 (363)
Q Consensus       175 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~  246 (363)
                         ....+-...|||||.+..+++++. ||+|++|+++||+++  ...||...++.... +........+   ...+.+.
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vv-en~~~~~~~~~~~~~l~~P~  770 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVV-ENAGEFFRDQGRQVVLSRPP  770 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHH-HhhhhhcCCCCcceeccCCC
Confidence               123345688999999999999877 999999999999864  88999876663332 2222222222   1234455


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      -++..+.+++.+||..+.++|||++++..
T Consensus       771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  771 ACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             cCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            67999999999999999999999999843

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-38  Score=292.24  Aligned_cols=242  Identities=26%  Similarity=0.383  Sum_probs=200.7

Q ss_pred             eeeceecccCCeEEEEEEEcC--CCc--EEEEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           24 ELVRDIGSGNFGVARLMRDKK--TEE--LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        24 ~i~~~lg~G~~g~V~~~~~~~--~~~--~~aiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .+.+.||.|.||.||.+.-..  .|+  .||||..+.+  ....+.+.+|..+++.++|||||++++++.. ...++|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            446789999999999987542  232  5889988764  3346789999999999999999999999965 45799999


Q ss_pred             ccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      +++.|.|..+++.+. .++......++.||+.||.|||++++|||||-..|||+.....  |||+|||+|+.......-.
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccchhh
Confidence            999999999998765 5999999999999999999999999999999999999987665  9999999999665444333


Q ss_pred             ccc--cCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          177 STV--GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       177 ~~~--gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      ...  -...|||||.++-..+++. ||||-|||++||++. |..||.+....+..     ..++..-+.|.+..+|+.+.
T Consensus       549 aS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----~~iEnGeRlP~P~nCPp~LY  622 (974)
T KOG4257|consen  549 ASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----GHIENGERLPCPPNCPPALY  622 (974)
T ss_pred             ccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceE-----EEecCCCCCCCCCCCChHHH
Confidence            223  3567999999988888766 999999999999876 99999886653321     12234447788888999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHh
Q 017936          254 HLISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell  274 (363)
                      .|..+||.++|.+||++.++.
T Consensus       623 slmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHH
Confidence            999999999999999988764

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=275.41  Aligned_cols=256  Identities=27%  Similarity=0.435  Sum_probs=204.0

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeec---CCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-----eEEE
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAI   94 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-----~~~l   94 (363)
                      .+--+.||-|+||+||.+.+..+|+.+|+|.+..   +-...+++.+|+.++.-.+|.|++..+++.+..+     .+|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            3446899999999999999999999999998754   2234577889999999999999999999876553     4678


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      +.|.+ ..+|...+..-..++.+.++-+++||++||+|||+.||.||||||.|+|++.+-.  +||||||+++.......
T Consensus       135 ~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhhh
Confidence            88888 4577777777778999999999999999999999999999999999999976665  99999999986543332


Q ss_pred             --CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHH-------------------
Q 017936          175 --PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-------------------  233 (363)
Q Consensus       175 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-------------------  233 (363)
                        ....+-|.+|+|||++.|..-.+.+.||||+|||+.||+..+..|.....-..+.-+..                   
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence              23446789999999999987666779999999999999999999976554333332221                   


Q ss_pred             HHhccccCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          234 RILSVQYSIPDY---------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       234 ~~~~~~~~~~~~---------~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .++....+.|..         ..-.-+...++.++|..+|.+|.+.++++.|+++.+
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence            112222222221         123356889999999999999999999999999854

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=302.00  Aligned_cols=248  Identities=30%  Similarity=0.381  Sum_probs=193.3

Q ss_pred             ceeeceecccCCe-EEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEeccC
Q 017936           23 YELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        23 y~i~~~lg~G~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~  100 (363)
                      |.-.+.+|.|+.| .||++.  -.++.||||.+-...  -....+|+..|+.. +|||||++++.-.+...+|+..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEe--eCCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            4446789999998 557776  557899999765432  34567999999887 5999999999999999999999999 


Q ss_pred             CCchHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC---CCCCcEEEeecCCcccCccCC
Q 017936          101 GGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus       101 ~~~L~~~~~~~~~----l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~---~~~~~vkL~DFgla~~~~~~~  173 (363)
                      ..+|.+++.....    ......+.++.|++.||++||+.+||||||||.||||..   ++..+++|+|||+++......
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            5699999977421    222556889999999999999999999999999999986   355579999999998654332


Q ss_pred             C----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHhccccCCCCCCC-
Q 017936          174 Q----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-  247 (363)
Q Consensus       174 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  247 (363)
                      .    ..+..||-+|+|||++....... ++|||||||++|+.++| ..||...-..+      ..++...+..-.... 
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~-avDiFslGCvfyYvltgG~HpFGd~~~R~------~NIl~~~~~L~~L~~~  738 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQ-AVDIFSLGCVFYYVLTGGSHPFGDSLERQ------ANILTGNYTLVHLEPL  738 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCc-ccchhhcCceEEEEecCCccCCCchHHhh------hhhhcCccceeeeccC
Confidence            2    34456999999999998777655 49999999999999985 99997543221      123333332221111 


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ...++.+||.+||.++|..||++.++|.||||+..
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            11289999999999999999999999999999863

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=286.64  Aligned_cols=244  Identities=23%  Similarity=0.344  Sum_probs=213.2

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCC
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  102 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~  102 (363)
                      .....+||-|.||.||.+..+...-.||||.++.+....+.++.|+.+|+.++|||+|+++++|..+..+|||.|||..|
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG  348 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG  348 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence            34578999999999999999998889999999888777899999999999999999999999999999999999999999


Q ss_pred             chHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc--c
Q 017936          103 ELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--T  178 (363)
Q Consensus       103 ~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~--~  178 (363)
                      +|.+++.+..  .++.-....++.||..|++||..+++|||||-..|+|+.++..  ||++|||+++..........  .
T Consensus       349 NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAHAGA  426 (1157)
T KOG4278|consen  349 NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAHAGA  426 (1157)
T ss_pred             cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceecccCc
Confidence            9999997654  3778888889999999999999999999999999999987765  99999999997644433322  2


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      .-...|.|||.+..+.++.+ +|||+|||+|||+.| |-.||.+.+. .    ++-.+++..++...+..+++.+.+|++
T Consensus       427 KFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidl-S----qVY~LLEkgyRM~~PeGCPpkVYeLMr  500 (1157)
T KOG4278|consen  427 KFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDL-S----QVYGLLEKGYRMDGPEGCPPKVYELMR  500 (1157)
T ss_pred             cCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccH-H----HHHHHHhccccccCCCCCCHHHHHHHH
Confidence            24567999999998889888 999999999999998 8899987654 2    333456667777777889999999999


Q ss_pred             HhcccCCCCCCCHHHHh
Q 017936          258 RIFVADPAKRISIPEIR  274 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell  274 (363)
                      .||+.+|.+||+++|+.
T Consensus       501 aCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  501 ACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHhcCCcccCccHHHHH
Confidence            99999999999999874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=297.54  Aligned_cols=261  Identities=30%  Similarity=0.418  Sum_probs=216.9

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ...++|.+++.+|.|.||.||+++++.+++..|+|+++.... .-..+++|+.+++..+|||||.+++.+.....+++.|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            346789999999999999999999999999999999986543 2356788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~  175 (363)
                      |||.||+|.+.-.-.+++++.++..+++..+.||+|||++|=+|||||-.|||++..+.  |||+|||.+..... -...
T Consensus        92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Kr  169 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKR  169 (829)
T ss_pred             EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhh
Confidence            99999999988888889999999999999999999999999999999999999987666  99999999864332 2345


Q ss_pred             CccccCCCcCChhhh---hcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          176 KSTVGTPAYIAPEVL---LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ...+|||+|||||+.   ..+.|... +|+|++|++..++-.-++|-...-... ......+.........+...+++.+
T Consensus       170 ksfiGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdlhpmr-~l~LmTkS~~qpp~lkDk~kws~~f  247 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDLHPMR-ALFLMTKSGFQPPTLKDKTKWSEFF  247 (829)
T ss_pred             hcccCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcccccchHH-HHHHhhccCCCCCcccCCccchHHH
Confidence            677899999999986   34556555 999999999999988888854432211 1111111111222334455689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .+|++.+|.++|++|||++.+|.|||....
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            999999999999999999999999998754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-38  Score=296.97  Aligned_cols=249  Identities=24%  Similarity=0.414  Sum_probs=214.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCC---cEEEEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ...-+|.++||.|.||.||.++.+..|   ..||||.++..  .+...+|+.|+.+|-+++||||+++.++....+.+.+
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            345688899999999999999998766   47999999865  4566789999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      |.|||++|+|..++.. .+.|+..++..+++.|+.|++||-+.|+|||||...|||++.+-.  +|++|||+++......
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDP  785 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccCC
Confidence            9999999999999875 467999999999999999999999999999999999999976654  9999999998543332


Q ss_pred             -CCCccc-c--CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          174 -QPKSTV-G--TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       174 -~~~~~~-g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                       ...++. |  ...|.|||.+...++++. |||||+|++|||.+. |..||+..+..+...     .....+++|.+..+
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIk-----aIe~gyRLPpPmDC  859 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIK-----AIEQGYRLPPPMDC  859 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHH-----HHHhccCCCCCCCC
Confidence             122222 2  467999999999999776 999999999999775 999999877644332     34567889999999


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      |..+.+|+..||+++-.+||++.+|.++
T Consensus       860 P~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  860 PAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             cHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            9999999999999999999999998764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.5e-36  Score=314.73  Aligned_cols=242  Identities=22%  Similarity=0.249  Sum_probs=185.5

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      .|.....||+|+||.||++++..+++.||+|.+......   ...|+..+++++|||||++++++.+.+..++||||+++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            456678899999999999999999999999988654322   23568889999999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCcc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  178 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH---~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~  178 (363)
                      |+|.+++..   +++.++..++.||+.||+|||   +.+|+||||||+||+++.+..  .++. ||.+....   .....
T Consensus       768 g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~~  838 (968)
T PLN00113        768 KNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTKC  838 (968)
T ss_pred             CcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCCc
Confidence            999999863   789999999999999999999   679999999999999987665  4443 55443221   12334


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhcc-------ccCCCCCC----
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-------QYSIPDYV----  246 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~-------~~~~~~~~----  246 (363)
                      .+|+.|+|||++.+..++.+ +|||||||++|||+||+.||...... ....+........       ........    
T Consensus       839 ~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (968)
T PLN00113        839 FISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ  917 (968)
T ss_pred             cccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence            68899999999988888766 99999999999999999999643211 1111111110000       00000000    


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ....++.+++.+||+.+|++|||+.|+++.
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            112357789999999999999999999864

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=284.44  Aligned_cols=198  Identities=29%  Similarity=0.467  Sum_probs=177.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc---------cHHHHHHHHHHHcCC---CCCeeeeeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------DENVQREIINHRSLR---HPNIVRFKEVIL   87 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~e~~~l~~l~---hpnIv~~~~~~~   87 (363)
                      ...|..++.||.|+||.|++|.++++...|+||.+.+.+..         .-.+-.||.+|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            45699999999999999999999999999999999875321         123457999999997   999999999999


Q ss_pred             cCCeEEEEEec-cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCc
Q 017936           88 TPTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  166 (363)
Q Consensus        88 ~~~~~~lv~e~-~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla  166 (363)
                      +++.+|++||- =+|.+|++++...+.++|.++..|++|++.|+++||++||||||||-+|+.++.++-  +||+|||.|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsa  717 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSA  717 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccch
Confidence            99999999995 467899999999999999999999999999999999999999999999999987765  999999988


Q ss_pred             ccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCC
Q 017936          167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE  220 (363)
Q Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  220 (363)
                      ... ..+.....+||..|.|||++.|.+|-++..|||+||+++|.++....||.
T Consensus       718 a~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            644 34455677899999999999999999999999999999999999999986

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=7.2e-36  Score=267.63  Aligned_cols=257  Identities=24%  Similarity=0.399  Sum_probs=201.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcC---CCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .+.|.++.+||.|.|++||++.+..   ..+.||+|.+..... ...+..|+++|..+. +.||+++.+++..+++..+|
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv  113 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV  113 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence            4679999999999999999999877   788999999876533 456889999999885 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC------
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS------  169 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~------  169 (363)
                      +||++..+..++...   ++-.+++.+++.++.||.++|.+|||||||||.|+|.+.. .++-.|.|||+|...      
T Consensus       114 lp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~-t~rg~LvDFgLA~~~d~~~~~  189 (418)
T KOG1167|consen  114 LPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRR-TQRGVLVDFGLAQRYDGYQQT  189 (418)
T ss_pred             ecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccc-cCCceEEechhHHHHHhhhhh
Confidence            999988777776544   6789999999999999999999999999999999999743 446899999998610      


Q ss_pred             -----------cc-CC----------------C-----------CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHH
Q 017936          170 -----------VL-HS----------------Q-----------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY  210 (363)
Q Consensus       170 -----------~~-~~----------------~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~  210 (363)
                                 .+ .+                .           .....||++|.|||++..-+..+.++||||.|+|+.
T Consensus       190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L  269 (418)
T KOG1167|consen  190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL  269 (418)
T ss_pred             hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence                       00 00                0           001259999999999988777677799999999999


Q ss_pred             HHHhCCCCCCCCCch-HHHHHHHH------------------------------------HH-hccccC-------C-CC
Q 017936          211 VMLVGAYPFEDPEEP-KNFRKTIH------------------------------------RI-LSVQYS-------I-PD  244 (363)
Q Consensus       211 ~l~~g~~pf~~~~~~-~~~~~~~~------------------------------------~~-~~~~~~-------~-~~  244 (363)
                      .+++++.||....+. ....++..                                    .. ......       . ..
T Consensus       270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~  349 (418)
T KOG1167|consen  270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG  349 (418)
T ss_pred             hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence            999999999643321 11111100                                    00 000000       0 00


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ....+..+.+|+.+||..+|.+|.|++++|+||||..
T Consensus       350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  350 SDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             cccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence            1124558999999999999999999999999999974

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=283.21  Aligned_cols=245  Identities=23%  Similarity=0.351  Sum_probs=205.9

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCc----EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..+..++||+|+||+||++..-..++    +||+|++....  .....+..|+-.|.+++|||++|+++++.... +.||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            35567899999999999998865554    68888886543  44678899999999999999999999998766 8899


Q ss_pred             EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ++|+++|+|.++++..+ .+.......|+.||++|+.|||.+++|||||-..|+||.....  ||+.|||+|+.......
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCcccc
Confidence            99999999999998654 6999999999999999999999999999999999999976554  99999999987655444


Q ss_pred             CCcc---ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          175 PKST---VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       175 ~~~~---~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                      ..+.   .-.+.|||-|.+....|... +||||+||++||++| |..|+.+....+     +..+++...+++.+..++-
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~~e-----I~dlle~geRLsqPpiCti  927 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPAEE-----IPDLLEKGERLSQPPICTI  927 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCHHH-----hhHHHhccccCCCCCCccH
Confidence            3332   23567999999998888766 999999999999998 999998766532     3334444556777778899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.-++.+||..|+..||+++++.+
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHH
Confidence            9999999999999999999999754

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=251.48  Aligned_cols=266  Identities=23%  Similarity=0.382  Sum_probs=205.3

Q ss_pred             CCCCCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeE-EEEcC
Q 017936           12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKE-VILTP   89 (363)
Q Consensus        12 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~-~~~~~   89 (363)
                      ..++-+.-.+.|.|.+.||+|.||.+-+|+|+.+++.+++|.+.+......++.+|...--.|. |.||+.-++ .|++.
T Consensus        15 ~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   15 EELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             ccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            3344445578999999999999999999999999999999999998888889999987766664 899999877 47888


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      +.+++++||++.|+|.+-+... .+.|.....++.|++.||.|||++++||||||.+||||-.....+|||||||+++..
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            9999999999999998877653 488999999999999999999999999999999999996655568999999988743


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCC---C-CCcchhhhhHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHHhccccCCC-
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKE---Y-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-NFRKTIHRILSVQYSIP-  243 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~-  243 (363)
                      ....  ...--+..|.|||++....   + ..+.+|+|.||+++|.++||.+||......+ ...+..+-........| 
T Consensus       174 g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~  251 (378)
T KOG1345|consen  174 GTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK  251 (378)
T ss_pred             Ccee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence            2211  1122456799999875332   1 1344899999999999999999997432211 11111121222222333 


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCcccc
Q 017936          244 DYVHISPECRHLISRIFVADPAKR---ISIPEIRNHEWFL  280 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R---~t~~ell~h~~~~  280 (363)
                      .+..+|+.+..+.++-|..+|++|   -++.......|..
T Consensus       252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            345679999999999999999999   4555555666653

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=238.68  Aligned_cols=201  Identities=28%  Similarity=0.435  Sum_probs=164.3

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHH-HcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINH-RSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l-~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      +....+..||+|+||.|-+.++..+|+..|+|.+...-.  ...++.+|+.+. +...+|++|.+++.+..+..+++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            445567889999999999999999999999999875432  334556666654 45579999999999999999999999


Q ss_pred             ccCCCchHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           98 YASGGELFER----ICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        98 ~~~~~~L~~~----~~~~~~l~~~~~~~~~~qil~~L~~LH~~-giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      .+ ..+|..+    +.+.+.++|..+-+++..++.||.|||++ .+||||+||+|||++..+  +||+||||.|.....+
T Consensus       126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G--qVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG--QVKICDFGISGYLVDS  202 (282)
T ss_pred             Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC--cEEEcccccceeehhh
Confidence            99 4466443    45567899999999999999999999965 899999999999997655  5999999998765444


Q ss_pred             CCCCccccCCCcCChhhhhc----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch
Q 017936          173 SQPKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP  225 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  225 (363)
                      -......|...|||||.+..    ..|+-+ |||||||++++||.+++.||.....+
T Consensus       203 iAkt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  203 IAKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             hHHHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCH
Confidence            43344678999999999853    356666 99999999999999999999765443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-34  Score=280.98  Aligned_cols=249  Identities=27%  Similarity=0.431  Sum_probs=202.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEc---C----CCcEEEEEEeecCC--cccHHHHHHHHHHHcCC-CCCeeeeeEEEEcC
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK---K----TEELVAVKYIERGD--KIDENVQREIINHRSLR-HPNIVRFKEVILTP   89 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~---~----~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~   89 (363)
                      .++..+.+.||+|.||.|+++.-.   .    ....||||.+....  ...+.+..|+.+++.+. ||||+.+++++...
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            344567779999999999998743   1    14579999887543  33567889999999885 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC
Q 017936           90 THLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS  153 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~  153 (363)
                      +.+++|+|||..|+|..++...+                .++..+...++.||+.|++||++.++|||||-..|||+..+
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~  454 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN  454 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence            99999999999999999998766                38899999999999999999999999999999999999877


Q ss_pred             CCCcEEEeecCCcccCccCCCC--Ccccc--CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHH
Q 017936          154 PAPRLKICDFGYSKSSVLHSQP--KSTVG--TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF  228 (363)
Q Consensus       154 ~~~~vkL~DFgla~~~~~~~~~--~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  228 (363)
                      ..  +||+|||+|+.......-  ....|  ...|||||.+....|+.+ |||||+|+++||+++ |..||.+......+
T Consensus       455 ~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~l  531 (609)
T KOG0200|consen  455 KV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEEL  531 (609)
T ss_pred             CE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence            65  999999999854332222  22222  345999999999888877 899999999999998 89999874422322


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                         .. .+....+...+..++.++.++++.||+.+|++||++.++..
T Consensus       532 ---~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  532 ---LE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             ---HH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence               22 23334455555667999999999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=9.7e-33  Score=237.60  Aligned_cols=209  Identities=45%  Similarity=0.710  Sum_probs=183.0

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCchHH
Q 017936           29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE  106 (363)
Q Consensus        29 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~  106 (363)
                      ||+|++|.||++.+..+++.+++|++.....  ..+.+.+|+..++.++|++|+++++++......++++|++.|++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999988899999999877644  24678899999999999999999999999999999999999999999


Q ss_pred             HHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC-CCCCcEEEeecCCcccCccCC-CCCccccCCC
Q 017936          107 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA  183 (363)
Q Consensus       107 ~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~-~~~~~vkL~DFgla~~~~~~~-~~~~~~gt~~  183 (363)
                      ++... ..++...++.++.+++.+|++||+.|++|+||+|.||+++. ++  +++|+|||.+....... ......+...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG--KVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC--cEEEecCCceEEccCCcchhhcccCCCC
Confidence            98876 57899999999999999999999999999999999999986 44  49999999987543322 1234567889


Q ss_pred             cCChhhhhcC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhccc
Q 017936          184 YIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA  262 (363)
Q Consensus       184 y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  262 (363)
                      |++||.+... ..+ ..+|+|++|++++++                                     ..+.+++.+|++.
T Consensus       159 ~~~pe~~~~~~~~~-~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~  200 (215)
T cd00180         159 YMAPEVLLGKGYYS-EKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQK  200 (215)
T ss_pred             ccChhHhcccCCCC-chhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhC
Confidence            9999998776 444 448999999999999                                     6688999999999


Q ss_pred             CCCCCCCHHHHhcCc
Q 017936          263 DPAKRISIPEIRNHE  277 (363)
Q Consensus       263 ~p~~R~t~~ell~h~  277 (363)
                      +|.+||++.++++|+
T Consensus       201 ~p~~R~~~~~l~~~~  215 (215)
T cd00180         201 DPEKRPSAKEILEHL  215 (215)
T ss_pred             CcccCcCHHHHhhCC
Confidence            999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-33  Score=251.01  Aligned_cols=261  Identities=27%  Similarity=0.377  Sum_probs=195.4

Q ss_pred             cCCCCCCCCCCC---CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHH--cCCCCCeee
Q 017936            7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVR   81 (363)
Q Consensus         7 ~~~~~~~~~~~~---~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~--~l~hpnIv~   81 (363)
                      +.|.|+-+|...   ...+-.+.+.||+|.||.||+++..  |+.||||+|...+.  +...+|.++..  .|+|+||+.
T Consensus       194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILg  269 (513)
T KOG2052|consen  194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILG  269 (513)
T ss_pred             cCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch--hhhhhHHHHHHHHHhccchhhh
Confidence            466676666553   4678899999999999999999854  78899999976543  44566666654  569999999


Q ss_pred             eeEEEEcC----CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----c---CceecCCCCCCEE
Q 017936           82 FKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-----M---QVCHRDLKLENTL  149 (363)
Q Consensus        82 ~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-----~---giiHrDlkp~NIl  149 (363)
                      +++.-...    .+++||.+|-+.|+|++++.+ ..++.+...+++..++.||+|||.     +   .|.|||||..|||
T Consensus       270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL  348 (513)
T KOG2052|consen  270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL  348 (513)
T ss_pred             hhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence            99876543    369999999999999999998 679999999999999999999994     2   4999999999999


Q ss_pred             EeCCCCCcEEEeecCCcccCccC-----CCCCccccCCCcCChhhhhcCCC-----CCcchhhhhHHHHHHHHHh-----
Q 017936          150 LDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLV-----  214 (363)
Q Consensus       150 l~~~~~~~vkL~DFgla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~l~~-----  214 (363)
                      |..++.  +.|+|+|||......     ...+..+||..|||||++...-.     +.+.+||||||+++||++.     
T Consensus       349 VKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g  426 (513)
T KOG2052|consen  349 VKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG  426 (513)
T ss_pred             EccCCc--EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence            987765  999999999754332     23456789999999999865321     1344899999999999974     


Q ss_pred             -----CCCCCCCCCchHHHHHHHHHHhcc---ccCCCC-CCCCC--HHHHHHHHHhcccCCCCCCCHHHHh
Q 017936          215 -----GAYPFEDPEEPKNFRKTIHRILSV---QYSIPD-YVHIS--PECRHLISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       215 -----g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~-~~~~s--~~~~~li~~~L~~~p~~R~t~~ell  274 (363)
                           -++||.+....+...+.+.++.-.   ...+|. |...+  ..+..+++.||..+|..|.|+--+.
T Consensus       427 gi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  427 GIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             CEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence                 357887654333222333332222   222222 11111  2366788999999999999986654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-33  Score=250.93  Aligned_cols=245  Identities=24%  Similarity=0.308  Sum_probs=181.8

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHH--cCCCCCeeeeeEEEEcCC----eEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVRFKEVILTPT----HLAI   94 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~--~l~hpnIv~~~~~~~~~~----~~~l   94 (363)
                      ....+.+.+|+|.||.||++..  +++.||||++....  .+.++.|-.+.+  .++|+||++++.+-....    .++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            4578899999999999999985  46899999987654  345555555554  568999999998766544    7999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------cCceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------MQVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~---------~giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                      |++|-+.|+|.+++..+ .++..+..+++..+++||+|||+         ..|+|||||..||||..+..  ..|+|||+
T Consensus       286 Vt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGL  362 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGL  362 (534)
T ss_pred             EeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccce
Confidence            99999999999999865 58999999999999999999995         35999999999999987765  99999999


Q ss_pred             cccCccC---CCCCccccCCCcCChhhhhcCCCC-----CcchhhhhHHHHHHHHHhCCCCCC-CCC-------------
Q 017936          166 SKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFE-DPE-------------  223 (363)
Q Consensus       166 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~l~~g~~pf~-~~~-------------  223 (363)
                      |....+.   +.....+||..|||||++.+...-     -+..||||+|.++||+++.-.-+. +..             
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            9865432   233446899999999999764322     244799999999999997543332 000             


Q ss_pred             --chHHHHHHHHHHhccccCCCC-CC--CCCHHHHHHHHHhcccCCCCCCCHHHH
Q 017936          224 --EPKNFRKTIHRILSVQYSIPD-YV--HISPECRHLISRIFVADPAKRISIPEI  273 (363)
Q Consensus       224 --~~~~~~~~~~~~~~~~~~~~~-~~--~~s~~~~~li~~~L~~~p~~R~t~~el  273 (363)
                        ..+..+..+.. .+....+|. |.  .--.-+++.+..||..||+.|.|+.=+
T Consensus       443 hPt~e~mq~~VV~-kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  443 HPTLEEMQELVVR-KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             CCCHHHHHHHHHh-hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence              01111111111 112222221 11  123458899999999999999997543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-31  Score=233.76  Aligned_cols=196  Identities=44%  Similarity=0.717  Sum_probs=172.4

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccC
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  100 (363)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+.....  ....+.+|+..++.++|+|++++++++......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6788999999999999999998899999999876543  35678889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--CCCc
Q 017936          101 GGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS  177 (363)
Q Consensus       101 ~~~L~~~~~~~~~-l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--~~~~  177 (363)
                      +++|.+++..... +++..++.++.+++.+|.+||+.|++|+||+|.||+++.+.  .++|+|||++.......  ....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~--~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG--LVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeCceeeEecCcccccccc
Confidence            9999999988776 89999999999999999999999999999999999998664  59999999987654432  3344


Q ss_pred             cccCCCcCChhhh-hcCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Q 017936          178 TVGTPAYIAPEVL-LKKEYDGKIADVWSCGVTLYVMLVGAYPFED  221 (363)
Q Consensus       178 ~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  221 (363)
                      ..++..|++||.+ ....++. ++|+||||+++++|++|+.||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence            5688899999998 4455555 49999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=6.5e-33  Score=284.77  Aligned_cols=199  Identities=17%  Similarity=0.212  Sum_probs=147.3

Q ss_pred             CCC-CCeeeeeEEE-------EcCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCC
Q 017936           74 LRH-PNIVRFKEVI-------LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK  144 (363)
Q Consensus        74 l~h-pnIv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlk  144 (363)
                      ++| +||+++++.|       .....+++++|++ +++|.+++.. ...+++.+++.+++||+.||.|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            445 5777777776       2334678888987 6699999975 3469999999999999999999999999999999


Q ss_pred             CCCEEEeCC-----------------CCCcEEEeecCCcccCccCC-----------------CCCccccCCCcCChhhh
Q 017936          145 LENTLLDGS-----------------PAPRLKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPEVL  190 (363)
Q Consensus       145 p~NIll~~~-----------------~~~~vkL~DFgla~~~~~~~-----------------~~~~~~gt~~y~aPE~~  190 (363)
                      |+||||+..                 ..+.+|++|||+++......                 ......||++|+|||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            999999532                 23347788888776321100                 00123589999999999


Q ss_pred             hcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 017936          191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI  270 (363)
Q Consensus       191 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~  270 (363)
                      .+..++.+ +|||||||++|||++|.+|+.....  .........     ..+......+...+++.+||+++|.+|||+
T Consensus       188 ~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~  259 (793)
T PLN00181        188 NGSSSNCA-SDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-----LPPQILLNWPKEASFCLWLLHPEPSCRPSM  259 (793)
T ss_pred             ccCCCCch-hhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-----cChhhhhcCHHHHHHHHHhCCCChhhCcCh
Confidence            98888665 9999999999999999988753211  111111111     111111124567899999999999999999


Q ss_pred             HHHhcCccccc
Q 017936          271 PEIRNHEWFLK  281 (363)
Q Consensus       271 ~ell~h~~~~~  281 (363)
                      .|+++||||.+
T Consensus       260 ~eil~h~~~~~  270 (793)
T PLN00181        260 SELLQSEFINE  270 (793)
T ss_pred             HHHhhchhhhh
Confidence            99999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=5.4e-30  Score=215.98  Aligned_cols=165  Identities=21%  Similarity=0.220  Sum_probs=126.9

Q ss_pred             CchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCcccc
Q 017936          102 GELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  180 (363)
Q Consensus       102 ~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~g  180 (363)
                      |+|.+++... ..+++.+++.++.||+.||.|||+.+      ||+|||++.++.  +|+  ||+++....    ....|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~----~~~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTP----EQSRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeecc----ccCCC
Confidence            6888888764 46999999999999999999999999      999999976654  888  999875432    22368


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHH-HHHHHHHHhccccC-CCCCCCCCH--HHHHHH
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYS-IPDYVHISP--ECRHLI  256 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~s~--~~~~li  256 (363)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||........ .............. .+....++.  ++.+++
T Consensus        67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            999999999998888766 9999999999999999999976543222 22222221111100 011122333  699999


Q ss_pred             HHhcccCCCCCCCHHHHhcCccccc
Q 017936          257 SRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .+||+.+|.+|||+.+++.|+|+..
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHHH
Confidence            9999999999999999999999853

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.6e-31  Score=262.09  Aligned_cols=259  Identities=34%  Similarity=0.548  Sum_probs=204.6

Q ss_pred             CCc-eeeceecccCCeEEEEEEEcCCCcEEEEEEeec----CC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----GD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        21 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~----~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      +.| .....+|.|++|.|+.+......+.++.|.+..    ..   .....+..|+.+-..+.|||++.....+......
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            446 567899999999999888877777777776542    11   1112256677777889999998888877776666


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +-+||||++ +|+..+...+.++..++..+++|++.|++|||+.||.||||||+|+++..++.  +||+|||.+..+...
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYP  473 (601)
T ss_pred             hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccC
Confidence            666999999 99999999889999999999999999999999999999999999999987765  999999998755433


Q ss_pred             CC-----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---cccCCCC
Q 017936          173 SQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---VQYSIPD  244 (363)
Q Consensus       173 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~  244 (363)
                      ..     ....+|+..|+|||++.+..|+++..||||.|++++.|.+|+.||......++..........   .......
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~  553 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL  553 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence            32     245579999999999999999999999999999999999999999765543321100000000   0001112


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +..++...+.+|.+||+.+|.+|.|+++|++.+||+..
T Consensus       554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  554 LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             HHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            34578899999999999999999999999999999753

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=8.6e-28  Score=221.84  Aligned_cols=252  Identities=24%  Similarity=0.204  Sum_probs=194.8

Q ss_pred             CceeeceecccCCeEEEEEEEcCCC-cEEEEEEeecCCcc-cHHHHHHHHHHHcCC----CCCeeeeeEEE-EcCCeEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKI-DENVQREIINHRSLR----HPNIVRFKEVI-LTPTHLAI   94 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~-~~~~~~e~~~l~~l~----hpnIv~~~~~~-~~~~~~~l   94 (363)
                      +|++.+.||+|+||.||+|.+..++ ..+|+|+....... ...+..|..++..+.    .+++..+++.+ ..+..-|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            8999999999999999999998764 67899987664322 226788888888886    36999999999 57788899


Q ss_pred             EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-C--CcEEEeecCCcc--
Q 017936           95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK--  167 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~--~~vkL~DFgla~--  167 (363)
                      ||+.+ |.+|.++....  +.|+...+..++.|++.+|++||+.|++||||||+|+++.... .  ..+.|.|||+|+  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99999 88999988554  4799999999999999999999999999999999999997653 1  359999999998  


Q ss_pred             cCccCC--------C-CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc
Q 017936          168 SSVLHS--------Q-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV  238 (363)
Q Consensus       168 ~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (363)
                      ......        . .....||..|.++.+..+.....+ .|+||++.++.+++.|..||..........+.... ...
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~-~~~  255 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD-PRK  255 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH-hhh
Confidence            321111        1 123459999999999988887666 89999999999999999999766543322222111 111


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       239 ~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ..........+.++..+...+-..+...+|....+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            11111223346788888888888899999988876543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=5.8e-29  Score=220.97  Aligned_cols=247  Identities=18%  Similarity=0.222  Sum_probs=198.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcC-----CCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEc-CCe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTH   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~   91 (363)
                      .+|++..-.+-+|.||.||.+....     +.+.+-+|.++...  ..-..+..|..++..+.|||+.++.++... ...
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            4678888899999999999996542     22345566665432  233567889999999999999999998765 456


Q ss_pred             EEEEEeccCCCchHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeec
Q 017936           92 LAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF  163 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~--------~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DF  163 (363)
                      .++++.+.+-|+|..++..        .+.++..++..++.|++.|++|||+.|+||.||-..|.+|++.  -+|||+|-
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~--LqVkltDs  440 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ--LQVKLTDS  440 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh--eeEEeccc
Confidence            7889999999999998862        2247888999999999999999999999999999999999765  45999999


Q ss_pred             CCcccCccCCCC---CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccc
Q 017936          164 GYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ  239 (363)
Q Consensus       164 gla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  239 (363)
                      .+|+...+....   ...-....||+||.+.+..|++. +|+||||+++|||+| |+.|+..-+..+..     ..++..
T Consensus       441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm~-----~ylkdG  514 (563)
T KOG1024|consen  441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEME-----HYLKDG  514 (563)
T ss_pred             hhccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHHH-----HHHhcc
Confidence            999976554432   22235667999999999999776 999999999999998 99999776553322     233445


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017936          240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       240 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell  274 (363)
                      +++..+-++|+++-.++..||...|++||+++|+.
T Consensus       515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  515 YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLV  549 (563)
T ss_pred             ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence            56666678999999999999999999999999975

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=6.6e-27  Score=214.54  Aligned_cols=255  Identities=36%  Similarity=0.578  Sum_probs=202.1

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCC-CeeeeeEEEEcCCeEEEEEe
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~e   97 (363)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+.....    ....+.+|+..++.+.|+ +|+++.+++......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999987   7789999876433    356788999999999988 79999999988888999999


Q ss_pred             ccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      ++.++++...+....   .++...+..++.|++.++.++|+.|++|||+||+||+++.... .++++|||.++...... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence            999999997776664   7999999999999999999999999999999999999986552 49999999987443332 


Q ss_pred             ------CCCccccCCCcCChhhhhcC--CCCCcchhhhhHHHHHHHHHhCCCCCCCCCc---hHHHHHHHHHHhccccCC
Q 017936          174 ------QPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---PKNFRKTIHRILSVQYSI  242 (363)
Q Consensus       174 ------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~  242 (363)
                            ......|++.|+|||.+.+.  .......|+||+|++++++++|..||.....   .......+..........
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence                  23566899999999999874  3444459999999999999999999876653   222222222211110111


Q ss_pred             CCCCCC----CHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          243 PDYVHI----SPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       243 ~~~~~~----s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +.....    ...+.+++.+++..+|..|.+..+...+++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            111111    257999999999999999999999988876654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=6.6e-28  Score=222.73  Aligned_cols=169  Identities=17%  Similarity=0.161  Sum_probs=129.9

Q ss_pred             CCCCCCCCCCCCCCceeeceecccCCeEEEEEEEcC-CCcEEEEEEeecC------CcccHHHHHHHHHHHcCCCCCeee
Q 017936            9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVR   81 (363)
Q Consensus         9 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~------~~~~~~~~~e~~~l~~l~hpnIv~   81 (363)
                      .|+..++..  .++|.+.+.||+|+||+||+|.+.. +++.+|||.+...      ....+.+.+|+.+++.++|+|+++
T Consensus         8 ~~~~~~~~~--~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~   85 (365)
T PRK09188          8 LPGDQIPAL--SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVP   85 (365)
T ss_pred             Ccccccccc--cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCc
Confidence            344444444  4679999999999999999999876 6788899986532      112456889999999999999985


Q ss_pred             -eeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCC-CCCCEEEeCCCCCcEE
Q 017936           82 -FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLK  159 (363)
Q Consensus        82 -~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDl-kp~NIll~~~~~~~vk  159 (363)
                       +++.    +..|+|||||+|++|.. +..   ..   ...++.|++.+|.|||++||+|||| ||+|||++.++  ++|
T Consensus        86 ~l~~~----~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ik  152 (365)
T PRK09188         86 QLLAT----GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAA  152 (365)
T ss_pred             EEEEc----CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEE
Confidence             4432    45799999999999963 211   11   2568899999999999999999999 99999997554  499


Q ss_pred             EeecCCcccCccCCCC---------CccccCCCcCChhhhhc
Q 017936          160 ICDFGYSKSSVLHSQP---------KSTVGTPAYIAPEVLLK  192 (363)
Q Consensus       160 L~DFgla~~~~~~~~~---------~~~~gt~~y~aPE~~~~  192 (363)
                      |+|||+|+........         ....+++.|+|||.+.-
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999999854333211         23457888999998753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-29  Score=235.52  Aligned_cols=236  Identities=30%  Similarity=0.530  Sum_probs=196.5

Q ss_pred             eecccCCeEEEEEEE---cCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEeccC
Q 017936           28 DIGSGNFGVARLMRD---KKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        28 ~lg~G~~g~V~~~~~---~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~  100 (363)
                      .+|.|+||.|++++.   ...++.||+|+..+..   ........|..++..++ ||.+|+++..|+++..+++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            479999999998764   3567889999987632   11224456777777776 9999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCcccc
Q 017936          101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  180 (363)
Q Consensus       101 ~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~g  180 (363)
                      ||.|...+.....+.+...+.+...++-+++++|+.||+|||+|++||+++.+|+  +++.|||+++......   ..+|
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~---~~cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEK---IACG  155 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhh---hccc
Confidence            9999999999999999999999999999999999999999999999999987765  9999999998654332   2289


Q ss_pred             CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017936          181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF  260 (363)
Q Consensus       181 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  260 (363)
                      |..|||||++++.  ... +|+||+|+++++|+||..||..        .....+......  .+..++..+++++..++
T Consensus       156 t~eymApEI~~gh--~~a-~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~--~p~~l~~~a~~~~~~l~  222 (612)
T KOG0603|consen  156 TYEYRAPEIINGH--LSA-ADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELE--MPRELSAEARSLFRQLF  222 (612)
T ss_pred             chhhhhhHhhhcc--CCc-ccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccC--CchhhhHHHHHHHHHHH
Confidence            9999999999832  233 7999999999999999999986        333444444433  33467999999999999


Q ss_pred             ccCCCCCCC-----HHHHhcCccccc
Q 017936          261 VADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       261 ~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      ..+|.+|.-     +.++++|+||..
T Consensus       223 ~r~p~nrLg~~~~~~~eik~h~f~~~  248 (612)
T KOG0603|consen  223 KRNPENRLGAGPDGVDEIKQHEFFQS  248 (612)
T ss_pred             hhCHHHHhccCcchhHHHhccchhee
Confidence            999999974     589999999964

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-27  Score=196.99  Aligned_cols=249  Identities=22%  Similarity=0.254  Sum_probs=195.3

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC-CCeeeeeEEEEcCCeEEEE
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~~~~~~~~~~~~~lv   95 (363)
                      +..+.+|+++++||.|+||.+|++.+-.+|..||||+-... .-...+..|..+.+.|++ ..|+.+..++.+..+-.+|
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            34567899999999999999999999999999999975443 334567788888888874 6788888888888888999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC-CcEEEeecCCcccCccCC
Q 017936           96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~-~~vkL~DFgla~~~~~~~  173 (363)
                      |+.+ |.+|.++..- .+.|+...+.-++-|++.-++|+|.+++|||||||+|+|..-... .++.|+|||+|+......
T Consensus        90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            9999 8888887753 346999999999999999999999999999999999999864332 269999999998543322


Q ss_pred             --------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--
Q 017936          174 --------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--  243 (363)
Q Consensus       174 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  243 (363)
                              ......||..|.+--...+...+.+ -|+-|+|.++.++.-|.+||.+....... +-..++.+...+.|  
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~-QKyEkI~EkK~s~~ie  246 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKK-QKYEKISEKKMSTPIE  246 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHH-HHHHHHHHhhcCCCHH
Confidence                    2234469999999988877766655 89999999999999999999886653322 22333444443333  


Q ss_pred             -CCCCCCHHHHHHHHHhcccCCCCCCC
Q 017936          244 -DYVHISPECRHLISRIFVADPAKRIS  269 (363)
Q Consensus       244 -~~~~~s~~~~~li~~~L~~~p~~R~t  269 (363)
                       .+..+|.++.-.|.-|-..--++-|.
T Consensus       247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pd  273 (341)
T KOG1163|consen  247 VLCKGFPAEFAMYLNYCRGLGFEEKPD  273 (341)
T ss_pred             HHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence             24567899999999887776666665

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-26  Score=202.04  Aligned_cols=246  Identities=22%  Similarity=0.285  Sum_probs=191.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +-.|++.++||+|+||+++++++.-+++.||||.-.. ......+..|.+..+.|. .++|+..+-+.....+-.+|||+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            3469999999999999999999999999999996443 344567888888888774 79999999999988888999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC---CcEEEeecCCcccCccC--
Q 017936           99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLH--  172 (363)
Q Consensus        99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~---~~vkL~DFgla~~~~~~--  172 (363)
                      + |-+|.++..= .++|+...+..++.|++.-++++|++.+|.|||||+|+||...+.   ..|-++|||+|+.....  
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            9 7888887754 346999999999999999999999999999999999999964332   24899999999854332  


Q ss_pred             ------CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC---
Q 017936          173 ------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP---  243 (363)
Q Consensus       173 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---  243 (363)
                            ...++..||..||+-....+...+.+ -|+-|||-++++++-|.+||.+.....+ .....++-......|   
T Consensus       185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA~tn-K~kYeKIGe~Kr~T~i~~  262 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKADTN-KEKYEKIGETKRSTPIEV  262 (449)
T ss_pred             cccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccCcch-HHHHHHhccccccCCHHH
Confidence                  23345579999999999998888766 8999999999999999999988765332 233333322221111   


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCC
Q 017936          244 DYVHISPECRHLISRIFVADPAKRIS  269 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t  269 (363)
                      .+..+|.++..-++-.-..+-.+-|.
T Consensus       263 Lc~g~P~efa~Yl~yvR~L~F~E~PD  288 (449)
T KOG1165|consen  263 LCEGFPEEFATYLRYVRRLDFFETPD  288 (449)
T ss_pred             HHhcCHHHHHHHHHHHHhcCcccCCC
Confidence            12345666666665555555555554

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=4.5e-26  Score=224.52  Aligned_cols=220  Identities=31%  Similarity=0.533  Sum_probs=167.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      -+.|..++.+..|+||.||+++|+.+.+.+|+|+ ++.....+.      ++.....|.+|                   
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilRn------ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILRN------ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhhc------cccccCCccee-------------------
Confidence            4679999999999999999999999999999964 333221111      34444455555                   


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-------
Q 017936          100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-------  172 (363)
Q Consensus       100 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-------  172 (363)
                        |+-...++..++++...        +.+++|||+.||+|||+||+|.+|+.-  |++|++|||+++.....       
T Consensus       136 --gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~m--GhiKlTDfgLsk~GLms~atnl~e  203 (1205)
T KOG0606|consen  136 --GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSM--GHIKLTDFGLSKKGLMSLATNLKE  203 (1205)
T ss_pred             --chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeec--ccccccchhhhhhhhhhccchhhh
Confidence              44455555556665554        789999999999999999999999754  45999999998742211       


Q ss_pred             ---------CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC
Q 017936          173 ---------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP  243 (363)
Q Consensus       173 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (363)
                               ...+..+|||.|+|||++....|. +.+|+|++|+|+|+++-|..||.+.+..+.+...+.........  
T Consensus       204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~--  280 (1205)
T KOG0606|consen  204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE--  280 (1205)
T ss_pred             cchHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc--
Confidence                     112345899999999999988885 55999999999999999999999987766665555443222211  


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccc
Q 017936          244 DYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK  281 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~---t~~ell~h~~~~~  281 (363)
                       ...++++++++|.++|+.+|..|.   .+-++.+|+||+.
T Consensus       281 -dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  281 -DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             -CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence             234689999999999999999996   5778999999964

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.93  E-value=1.8e-25  Score=192.69  Aligned_cols=170  Identities=16%  Similarity=0.181  Sum_probs=130.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHH----------HHHHHHHHHcCCCCCeeeeeEEEEc
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----------VQREIINHRSLRHPNIVRFKEVILT   88 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----------~~~e~~~l~~l~hpnIv~~~~~~~~   88 (363)
                      ..++|++++.||.|+||.||++.+  ++..+|+|++.......+.          +.+|+..+.++.||+|..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            368999999999999999999765  4667999999754332222          5789999999999999999988764


Q ss_pred             C--------CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEE
Q 017936           89 P--------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI  160 (363)
Q Consensus        89 ~--------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL  160 (363)
                      .        +..++||||++|.+|.+..    .+++    ..+.+++.+|..||+.|++|||+||+||+++.++   ++|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~l  175 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRI  175 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEE
Confidence            3        3578999999999997763    2333    3466999999999999999999999999997544   999


Q ss_pred             eecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHH
Q 017936          161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML  213 (363)
Q Consensus       161 ~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  213 (363)
                      +|||.+........ .          ........+..+ +|+||||+++..+.
T Consensus       176 iDfg~~~~~~e~~a-~----------d~~vler~y~~~-~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRKA-K----------DRIDLERHYGIK-NEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchhh-H----------HHHHHHhHhccc-ccccceeEeehHHH
Confidence            99998764321110 0          113344556644 89999999987764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=5.4e-25  Score=187.22  Aligned_cols=137  Identities=21%  Similarity=0.210  Sum_probs=109.3

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc--c-------------------------HHHHHHHHHHHcCCCCC
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--D-------------------------ENVQREIINHRSLRHPN   78 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~-------------------------~~~~~e~~~l~~l~hpn   78 (363)
                      ...||+|++|.||+|.+. +|+.||+|+++.+...  .                         ....+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999986 8999999999754211  0                         12235899999998877


Q ss_pred             eeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHcCceecCCCCCCEEEeCCCCCc
Q 017936           79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAPR  157 (363)
Q Consensus        79 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~L-H~~giiHrDlkp~NIll~~~~~~~  157 (363)
                      +.....+... . .++||||++|+++.........++...+..++.|++.+|.+| |+.||+||||||+|||++.   +.
T Consensus        81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---~~  155 (190)
T cd05147          81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---GK  155 (190)
T ss_pred             CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC---Cc
Confidence            6443333222 2 289999999987766555567899999999999999999999 7999999999999999973   34


Q ss_pred             EEEeecCCccc
Q 017936          158 LKICDFGYSKS  168 (363)
Q Consensus       158 vkL~DFgla~~  168 (363)
                      ++|+|||+|..
T Consensus       156 v~LiDFG~a~~  166 (190)
T cd05147         156 LYIIDVSQSVE  166 (190)
T ss_pred             EEEEEcccccc
Confidence            99999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-25  Score=222.13  Aligned_cols=237  Identities=24%  Similarity=0.375  Sum_probs=180.9

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHH---HHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQ---REIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~---~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      +|...+.||++.|=+|.+|++.+ |. |+||++-+...  ..+.++   .+++ .+..++||++++..+-.+.+..|+|.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            68899999999999999999865 44 89999866432  223333   3444 55678999999999988888899999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC-
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~-  175 (363)
                      +|. ..+|++++..++.+...+.++|+.||+.||.-+|..||+|||||.+||||+.-+-  +.|+||..-+........ 
T Consensus       101 qyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  101 QYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCc
Confidence            999 5699999998888999999999999999999999999999999999999986544  899999866533222111 


Q ss_pred             -------CccccCCCcCChhhhhcCC----------CCCcchhhhhHHHHHHHHHh-CCCCCCCCCch-------HHHHH
Q 017936          176 -------KSTVGTPAYIAPEVLLKKE----------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP-------KNFRK  230 (363)
Q Consensus       176 -------~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~-------~~~~~  230 (363)
                             .+...-.+|.|||.+....          .-.++.||||+||++.||++ |++||.-....       .....
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~  257 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ  257 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence                   1223456799999986421          02345799999999999998 78888532110       01111


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .+.++            -+..++++|..|++.+|.+|.++++.|+.
T Consensus       258 ~Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  258 LLEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHhC------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            11111            14578999999999999999999999875

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.92  E-value=4.3e-24  Score=182.22  Aligned_cols=139  Identities=18%  Similarity=0.153  Sum_probs=111.3

Q ss_pred             eeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc---------------------------cHHHHHHHHHHHcCCCC
Q 017936           25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------------------------DENVQREIINHRSLRHP   77 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------------------------~~~~~~e~~~l~~l~hp   77 (363)
                      +.+.||+|++|+||+|.+. +|+.||||++......                           ......|+..+..+.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 8999999998764211                           11235788999999999


Q ss_pred             CeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCC
Q 017936           78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP  156 (363)
Q Consensus        78 nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~  156 (363)
                      ++.....+....  .++||||++|+++.........++..++..++.|++.+|.+||+ .||+||||||+|||++ +  +
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~--~  154 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D--G  154 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C--C
Confidence            875544443332  38999999988665443445678899999999999999999999 9999999999999997 3  3


Q ss_pred             cEEEeecCCcccC
Q 017936          157 RLKICDFGYSKSS  169 (363)
Q Consensus       157 ~vkL~DFgla~~~  169 (363)
                      .++|+|||+|+..
T Consensus       155 ~~~liDFG~a~~~  167 (190)
T cd05145         155 KPYIIDVSQAVEL  167 (190)
T ss_pred             CEEEEEcccceec
Confidence            5999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=3.4e-24  Score=190.16  Aligned_cols=230  Identities=22%  Similarity=0.255  Sum_probs=144.5

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCC----------CCeeeeeEEE-
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRH----------PNIVRFKEVI-   86 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h----------pnIv~~~~~~-   86 (363)
                      .+...+.||.|+++.||.+++..+++.+|+|++.....    ..+.+++|......+.+          -.++.-++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            46778999999999999999999999999999864322    22445555544433322          1111112211 


Q ss_pred             --------Ec---CC-----eEEEEEeccCCCchHHHHH---hCCCC--CH-HHH-HHHHHHHHHHHHHHHHcCceecCC
Q 017936           87 --------LT---PT-----HLAIVMEYASGGELFERIC---NAGRF--SE-DEA-RFFFQQLISGVSYCHSMQVCHRDL  143 (363)
Q Consensus        87 --------~~---~~-----~~~lv~e~~~~~~L~~~~~---~~~~l--~~-~~~-~~~~~qil~~L~~LH~~giiHrDl  143 (363)
                              ..   ..     ..+++|+-+ .++|...+.   .....  .. ..+ ..+..|++..+++||+.|+||+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                    11   11     236778777 457766643   22222  11 222 345589999999999999999999


Q ss_pred             CCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcC--------CCCCcchhhhhHHHHHHHHHhC
Q 017936          144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK--------EYDGKIADVWSCGVTLYVMLVG  215 (363)
Q Consensus       144 kp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~l~~g  215 (363)
                      +|+|++++.++.  ++|+||+...........  ...+..|.+||.....        .+ +.+.|.|+||+++|.|++|
T Consensus       172 ~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~-t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPY-TFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE--HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCccccee-eeccCHHHHHHHHHHHHHc
Confidence            999999987765  999999976643322211  3456789999987542        23 3448999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 017936          216 AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR  267 (363)
Q Consensus       216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R  267 (363)
                      ..||........          ....+..+..+|+.++.||+++|+.+|.+|
T Consensus       247 ~lPf~~~~~~~~----------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEAD----------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGST----------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCcccc----------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999986543211          111334444789999999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.1e-23  Score=177.83  Aligned_cols=186  Identities=17%  Similarity=0.148  Sum_probs=140.6

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccH-----HHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEE
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-----NVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      +.+...|++|+||+|+++..  .+..++.+.+.......+     .+.+|+.+|++|. |+++++++++    +..+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            34678899999999998775  567788777765544333     5789999999995 5889999886    3469999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCC-CCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDl-kp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      +|+.|.+|......       ....++.|++.+|.+||++||+|||| ||+|||++.++  .++|+|||+|.........
T Consensus        78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g--~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG--SPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC--CEEEEECCCceecCCcchH
Confidence            99999998654321       12457889999999999999999999 79999997654  4999999999854433321


Q ss_pred             ----C----------ccccCCCcCChhhhhcC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCC
Q 017936          176 ----K----------STVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPE  223 (363)
Q Consensus       176 ----~----------~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~  223 (363)
                          .          -...++.|++|+...-- ..+-...++++.|+-+|.++|+..|+.+..
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                0          11368899999865432 222122588899999999999999987643

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=6.3e-23  Score=183.33  Aligned_cols=190  Identities=29%  Similarity=0.407  Sum_probs=140.9

Q ss_pred             CCCCeeeeeEEEEcC---------------------------CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHH
Q 017936           75 RHPNIVRFKEVILTP---------------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI  127 (363)
Q Consensus        75 ~hpnIv~~~~~~~~~---------------------------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil  127 (363)
                      +|||||++..+|.+.                           ..+|+||... ..+|.+++... ..+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence            599999998887542                           2588999876 45898888764 367788888999999


Q ss_pred             HHHHHHHHcCceecCCCCCCEEEe--CCCCCcEEEeecCCcccCccC-------CCCCccccCCCcCChhhhhcCC----
Q 017936          128 SGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLH-------SQPKSTVGTPAYIAPEVLLKKE----  194 (363)
Q Consensus       128 ~~L~~LH~~giiHrDlkp~NIll~--~~~~~~vkL~DFgla~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~----  194 (363)
                      +|+.|||+.||.|||+|.+|||+.  .+....++++|||++-.....       +......|.-.-||||+....+    
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999984  445567999999987533221       1123345888899999986433    


Q ss_pred             -CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 017936          195 -YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI  270 (363)
Q Consensus       195 -~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~  270 (363)
                       .+..++|.|+.|.+.||+++...||......-.-...   ....+ ..+.+..+++.+++++..+|+.+|.+|++.
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---Yqe~q-LPalp~~vpp~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---YQESQ-LPALPSRVPPVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhh---hhhhh-CCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence             1223389999999999999999999873321100001   11111 122334679999999999999999999984

>PRK10345 hypothetical protein; Provisional

Probab=99.89  E-value=1.6e-22  Score=173.77  Aligned_cols=137  Identities=18%  Similarity=0.229  Sum_probs=109.3

Q ss_pred             eeeceecccCCeEEEEEEEcCCCcEEEEEEeecC-CcccHHHHHHHHHHHcC-----CCCCeeeeeEEEEcCC---eEE-
Q 017936           24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSL-----RHPNIVRFKEVILTPT---HLA-   93 (363)
Q Consensus        24 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~e~~~l~~l-----~hpnIv~~~~~~~~~~---~~~-   93 (363)
                      .-.+.||+|++|.||.  ++.++.. +||++... ....+.+.+|+.+++.+     .||||++++++++++.   .++ 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            3457899999999995  6666665 79988754 22346789999999999     5799999999999874   434 


Q ss_pred             EEEec--cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHcCceecCCCCCCEEEeCCC--CCcEEEeecCCc
Q 017936           94 IVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYS  166 (363)
Q Consensus        94 lv~e~--~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L-~~LH~~giiHrDlkp~NIll~~~~--~~~vkL~DFgla  166 (363)
                      +|+||  +.+++|.+++.+. .+++.  ..++.|++.++ +|||+++|+||||||+|||++..+  ..+++|+||+-+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            78999  5579999999764 46666  46688888888 999999999999999999997532  336999995533

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=5.5e-23  Score=175.27  Aligned_cols=241  Identities=22%  Similarity=0.312  Sum_probs=190.4

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeec---CCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +..++.+|.+...|..|+++..  |..+++|++..   .....+++..|.-.|+.+.||||+.+++.+..+.++.++..|
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            4556778889999999999865  34467777654   334557788899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           99 ASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~L~~LH~~g--iiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ++.|+|+..+.....  ....++.+++.+|+.|++|||+..  |.---|....++++++-..++-.+|--++.      +
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------q  342 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------Q  342 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------e
Confidence            999999999987654  678899999999999999999875  444578899999998877666666654432      2


Q ss_pred             CCccccCCCcCChhhhhcCCCC--CcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      .....-+|.||+||.+...+.+  -+++|+|||+++++||.|...||...+..+--.++    .-..++...++.+|..+
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----aleglrv~ippgis~hm  418 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----ALEGLRVHIPPGISRHM  418 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----hhccccccCCCCccHHH
Confidence            2445568999999999876654  34589999999999999999999876654322222    12223344455789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHh
Q 017936          253 RHLISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell  274 (363)
                      ..|++-|+..||.+||.+..+.
T Consensus       419 ~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHhcCCCCcCCCcceeh
Confidence            9999999999999999987754

>smart00090 RIO RIO-like kinase

Probab=99.87  E-value=7.8e-22  Score=173.44  Aligned_cols=142  Identities=17%  Similarity=0.096  Sum_probs=113.0

Q ss_pred             CCCceeeceecccCCeEEEEEE-EcCCCcEEEEEEeecCCcc-------------------------cHHHHHHHHHHHc
Q 017936           20 SDRYELVRDIGSGNFGVARLMR-DKKTEELVAVKYIERGDKI-------------------------DENVQREIINHRS   73 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~-~~~~~~~~aiK~~~~~~~~-------------------------~~~~~~e~~~l~~   73 (363)
                      +.-|.+.+.||+|++|.||+|. +..+|+.||+|++......                         ...+.+|+.++..
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458999999999999999999 6788999999998754210                         1234679999998


Q ss_pred             CCCC--CeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC-ceecCCCCCCEEE
Q 017936           74 LRHP--NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLL  150 (363)
Q Consensus        74 l~hp--nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~g-iiHrDlkp~NIll  150 (363)
                      +.+.  .++++++.   . ..++||||++|.+|.........+...++..++.||+.+|.+||+.| ++||||||+||++
T Consensus       107 L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli  182 (237)
T smart00090      107 LYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV  182 (237)
T ss_pred             HHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence            8753  23444432   2 34899999999888776545556777788899999999999999999 9999999999999


Q ss_pred             eCCCCCcEEEeecCCccc
Q 017936          151 DGSPAPRLKICDFGYSKS  168 (363)
Q Consensus       151 ~~~~~~~vkL~DFgla~~  168 (363)
                      + ++  .++|+|||.|..
T Consensus       183 ~-~~--~i~LiDFg~a~~  197 (237)
T smart00090      183 H-DG--KVVIIDVSQSVE  197 (237)
T ss_pred             E-CC--CEEEEEChhhhc
Confidence            8 33  499999998763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.4e-23  Score=206.16  Aligned_cols=260  Identities=32%  Similarity=0.523  Sum_probs=209.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcC-CCcEEEEEEeecCC---cccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~l   94 (363)
                      ...|.+.+.||+|+|+.|-++.+.. +...+|+|.+....   ...+....|..+...+. |+|++++++........++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4679999999999999999888754 33456677665432   33445556777777777 9999999999999999999


Q ss_pred             EEeccCCCchHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           95 VMEYASGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        95 v~e~~~~~~L~~~~-~~~~-~l~~~~~~~~~~qil~~L~~LH-~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      +++|..|+++...+ .... ..+...+..++.|+..+|.|+| ..++.|||+||+|.+++.++. .++++|||+|.....
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRN  177 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhccccc
Confidence            99999999999988 5554 6888999999999999999999 999999999999999987773 499999999986544


Q ss_pred             -CCC---CCcccc-CCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          172 -HSQ---PKSTVG-TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       172 -~~~---~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                       .+.   ....+| ++.|+|||...+..+..+..|+||.|+++..+++|..||............+... ........+.
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  256 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN-KGRFTQLPWN  256 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc-ccccccCccc
Confidence             222   233468 9999999999887777777999999999999999999998765433221111111 1122355667


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .++....+++.+++..+|..|.+.+++..+||+..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccccccccc
Confidence            78999999999999999999999999999999977

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.7e-21  Score=195.58  Aligned_cols=194  Identities=24%  Similarity=0.326  Sum_probs=156.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++.|.|-+.||+|+||+||.|.+.. |+.||+|+-.....+.=-  --.+++.+|+   -+.|..+..++...+.-++|+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY--I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY--ICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee--ehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            6789999999999999999999877 999999986654332211  1112233333   345666666666777789999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC-----CCCcEEEeecCCcccCcc
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~-----~~~~vkL~DFgla~~~~~  171 (363)
                      ||.+.|+|.+++...+.+++.-+..+..|++..+++||..|||||||||+|+||...     +...++|+|||.|.....
T Consensus       774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l  853 (974)
T KOG1166|consen  774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL  853 (974)
T ss_pred             eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence            999999999999988889999999999999999999999999999999999999532     223499999999875433


Q ss_pred             CC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCC
Q 017936          172 HS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY  217 (363)
Q Consensus       172 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  217 (363)
                      ..   .....++|-.+-.+|...|..++.. .|.|.|+.+++.|++|+.
T Consensus       854 fp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  854 FPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence            32   3345578999999999999998777 899999999999999863

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=7.2e-22  Score=182.95  Aligned_cols=175  Identities=27%  Similarity=0.348  Sum_probs=133.5

Q ss_pred             eEEEEEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936           91 HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      ++|+.|++|...+|.+|+.+...   -+......++.|+..|++|   +|.+|||+||.||+...+..  +||+|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhee
Confidence            58999999999999999975543   6777899999999999999   99999999999999976664  9999999987


Q ss_pred             cCccCC-------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccc
Q 017936          168 SSVLHS-------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ  239 (363)
Q Consensus       168 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  239 (363)
                      ......       ......||.+||+||.+.+..|..+ +||||||++++||+. =..+|..    .   .....+....
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er----~---~t~~d~r~g~  476 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFER----I---ATLTDIRDGI  476 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHH----H---HhhhhhhcCC
Confidence            554433       3345579999999999999999877 999999999999997 2222221    1   1111222222


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       240 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +....... -++-..|+.+||...|.+||++.+.-.|+|.
T Consensus       477 ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  477 IPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             CChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            21111222 3456689999999999999988887777764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=7e-20  Score=158.90  Aligned_cols=134  Identities=22%  Similarity=0.220  Sum_probs=111.6

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++.||+|++|.||++..  .+..+++|+......         ....+.+|+.++..+.|++|+....++......+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999986  567799997653221         1234678999999999999887777777777889999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      ||++|++|.+.+.....    +...++.+++.+|.+||+.|++|||++|.|||++ ++  .++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~--~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG--KIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC--CEEEEECCcccC
Confidence            99999999998865432    8889999999999999999999999999999998 33  499999998764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=2.9e-20  Score=175.25  Aligned_cols=203  Identities=25%  Similarity=0.355  Sum_probs=156.6

Q ss_pred             HHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCc-eecCCCCCCE
Q 017936           71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQV-CHRDLKLENT  148 (363)
Q Consensus        71 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~gi-iHrDlkp~NI  148 (363)
                      |+.+.|.|+.++++.+.+....++|.+||..|+|.+.+.. ...++......+++.|+.||.|||+..| +|+.|+..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4578999999999999999999999999999999999987 4468889999999999999999998765 9999999999


Q ss_pred             EEeCCCCCcEEEeecCCcccCcc---CCCCCccccCCCcCChhhhhcCCC------CCcchhhhhHHHHHHHHHhCCCCC
Q 017936          149 LLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLKKEY------DGKIADVWSCGVTLYVMLVGAYPF  219 (363)
Q Consensus       149 ll~~~~~~~vkL~DFgla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~~l~~g~~pf  219 (363)
                      +++....  +||+|||+......   ........-...|.|||.+.+...      .++..|+||+|++++|+++...||
T Consensus        81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9987765  99999999764421   011112234556999999876422      234489999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhc-cc-cCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          220 EDPEEPKNFRKTIHRILS-VQ-YSIPD---YVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~-~~-~~~~~---~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..........+++..+.. .. ...|.   .....+++..+++.||..+|..||+++++-.
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            874433332344444333 11 11121   1145668999999999999999999998753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=2.3e-19  Score=154.24  Aligned_cols=129  Identities=21%  Similarity=0.189  Sum_probs=103.8

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeecCCc---------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        28 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .||+|++|.||++.  ..+..+++|+......         ..+.+.+|+.+++.+.|+++....-++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            48999999999998  4567899998643211         124567899999999988765555555566677999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      ++|++|.+.+.....       .++.+++.+|.+||+.|++|||++|.||+++ +  +.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~--~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D--DKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C--CcEEEEECCCCcC
Confidence            999999887755321       8899999999999999999999999999998 3  3599999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=2.1e-19  Score=154.44  Aligned_cols=134  Identities=22%  Similarity=0.264  Sum_probs=105.4

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-----------------------ccHHHHHHHHHHHcCCCCC
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------------------IDENVQREIINHRSLRHPN   78 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----------------------~~~~~~~e~~~l~~l~hpn   78 (363)
                      .|.+.+.||+|+||.||++... +|+.+|||++..+..                       ......+|+.++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4888999999999999999874 799999998764320                       0123567888888887774


Q ss_pred             --eeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCC
Q 017936           79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP  156 (363)
Q Consensus        79 --Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~  156 (363)
                        +++.++    ....++||||++|++|.....      ......++.+++.++.++|+.||+||||||+||+++.++  
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~--  162 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE--  162 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--
Confidence              444443    234589999999999876432      145678889999999999999999999999999998654  


Q ss_pred             cEEEeecCCccc
Q 017936          157 RLKICDFGYSKS  168 (363)
Q Consensus       157 ~vkL~DFgla~~  168 (363)
                      .++|+|||++..
T Consensus       163 ~~~liDfg~~~~  174 (198)
T cd05144         163 KIYIIDWPQMVS  174 (198)
T ss_pred             cEEEEECCcccc
Confidence            499999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=9.8e-19  Score=172.16  Aligned_cols=134  Identities=22%  Similarity=0.194  Sum_probs=108.0

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEee-cCC--------cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGD--------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~-~~~--------~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      .|...+.||+|+||+||++......  +++|... +..        ...+.+.+|+.+++.++|++++....++......
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            4566889999999999998865433  4444322 111        1124578899999999999999887777777778


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      ++||||++|++|.+.+.        ....++.+++.+|.+||+.|++||||||+|||++ ++  .++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCccccc
Confidence            99999999999998775        4577899999999999999999999999999994 33  499999999874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=1.8e-18  Score=147.16  Aligned_cols=134  Identities=21%  Similarity=0.264  Sum_probs=94.9

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHH-------------------------HHHHHHHHHcCCCCC--
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-------------------------VQREIINHRSLRHPN--   78 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-------------------------~~~e~~~l~~l~hpn--   78 (363)
                      .+.||+|+||+||++.+. +++.||||++.........                         ...|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999986 7899999998754221111                         123444454444332  


Q ss_pred             eeeeeEEEEcCCeEEEEEeccCCCchHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCC
Q 017936           79 IVRFKEVILTPTHLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP  156 (363)
Q Consensus        79 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-~~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~  156 (363)
                      +++.+.+    ...++||||++++.+... +... .. ..+++.++.+++.++.++|+ .||+||||||+||+++ ++  
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~--  151 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG--  151 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC--
Confidence            4444432    235899999998543221 1111 11 16788999999999999999 9999999999999998 43  


Q ss_pred             cEEEeecCCcccC
Q 017936          157 RLKICDFGYSKSS  169 (363)
Q Consensus       157 ~vkL~DFgla~~~  169 (363)
                      .++|+|||.+...
T Consensus       152 ~~~liDfg~a~~~  164 (187)
T cd05119         152 KVYIIDVPQAVEI  164 (187)
T ss_pred             cEEEEECcccccc
Confidence            4999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.75  E-value=2.4e-17  Score=145.22  Aligned_cols=134  Identities=19%  Similarity=0.239  Sum_probs=102.8

Q ss_pred             eceec-ccCCeEEEEEEEcCCCcEEEEEEeecCC--------------cccHHHHHHHHHHHcCCCCCe--eeeeEEEEc
Q 017936           26 VRDIG-SGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNI--VRFKEVILT   88 (363)
Q Consensus        26 ~~~lg-~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~e~~~l~~l~hpnI--v~~~~~~~~   88 (363)
                      ...|| .||.|+||.+...  +..+++|.+.+..              .....+.+|+.++..+.|++|  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35687 7899999998864  6779999885421              123457889999999998875  666666443


Q ss_pred             CC----eEEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeec
Q 017936           89 PT----HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF  163 (363)
Q Consensus        89 ~~----~~~lv~e~~~~-~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DF  163 (363)
                      ..    ..++|||+++| .+|.+++.. ..+++..    +.+|+.+|.+||++||+||||||.|||++.++  .++|+||
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDf  186 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDF  186 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEEC
Confidence            22    23599999997 688877754 3566543    57899999999999999999999999997655  4999999


Q ss_pred             CCccc
Q 017936          164 GYSKS  168 (363)
Q Consensus       164 gla~~  168 (363)
                      |.+..
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            98763

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=3.2e-17  Score=133.74  Aligned_cols=131  Identities=24%  Similarity=0.272  Sum_probs=111.2

Q ss_pred             eeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC--CCeeeeeEEEEcCCeEEEEEeccCCC
Q 017936           25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG  102 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~~  102 (363)
                      +++.||.|.++.||++....  +.+++|....... ...+.+|+..++.+++  +++++++.++...+..+++|||+.|+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            56789999999999999754  6799998866543 5678889999999976  58999999888888899999999988


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc---CceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       103 ~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~---giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      ++...       +......++.+++.+|++||..   +++|||++|+||+++..+  .++++|||.++
T Consensus        79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~--~~~l~Df~~~~  137 (155)
T cd05120          79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAG  137 (155)
T ss_pred             ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc--EEEEEeccccc
Confidence            77653       5667788899999999999984   799999999999998643  59999999876

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=5.6e-17  Score=153.24  Aligned_cols=250  Identities=20%  Similarity=0.182  Sum_probs=191.5

Q ss_pred             CCceeeceecc--cCCeEEEEEEE--cCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeE
Q 017936           21 DRYELVRDIGS--GNFGVARLMRD--KKTEELVAVKYIERG---DKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHL   92 (363)
Q Consensus        21 ~~y~i~~~lg~--G~~g~V~~~~~--~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~   92 (363)
                      ..+-+.+.+|.  |.+|.||.++.  ..++..+|+|.-...   ......-.+|+...+.++ |+|.++.+..++..+.+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45778899999  99999999998  889999999974321   222333455666666664 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936           93 AIVMEYASGGELFERICNAGR-FSEDEARFFFQQLIS----GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~qil~----~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      ++-+|+| +.+|..+...... ++...++..+.+...    ||.++|+.+++|-|+||.||+...+. ...+++|||+..
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~  271 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVS  271 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCcceeE
Confidence            9999999 4677777665444 899999999999999    99999999999999999999998773 348999999987


Q ss_pred             cCccCCCC------CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCC--CchHHHHHHHHHHhccc
Q 017936          168 SSVLHSQP------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP--EEPKNFRKTIHRILSVQ  239 (363)
Q Consensus       168 ~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~  239 (363)
                      ........      ....|...|++||.+++. + +..+|+++||.++.+-.++..++...  .....++.       ..
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~-~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-------~~  342 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-A-TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-------GY  342 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhhccc-c-chHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-------cc
Confidence            54333211      222577889999987543 3 34489999999999999888776544  22211111       11


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       240 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .........+.++...+..|++.+|..|++++.+++|+++..
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            112223345777888999999999999999999999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=1.8e-17  Score=164.32  Aligned_cols=256  Identities=27%  Similarity=0.411  Sum_probs=197.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc----HHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..+.+.+.+.+-+|+++.++.+.-..+|..+++|+........    +...++-.++-...+|.+++..--+......+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            5678899999999999999999988888888888765543322    222223333333455666665554555677899


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC-cc--
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VL--  171 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~-~~--  171 (363)
                      +++|.++++|...+...+..+++-.+.++..+..++++||+..++|||++|.|++...++.  .+++|||..... ..  
T Consensus       882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccC
Confidence            9999999999999999998999999999999999999999999999999999999976665  899999843210 00  


Q ss_pred             ---C--------------------------CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Q 017936          172 ---H--------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP  222 (363)
Q Consensus       172 ---~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  222 (363)
                         .                          .......||+.|.+||.+.+...... +|+|++|+++++.++|.+||...
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCc
Confidence               0                          00112358999999999988777555 89999999999999999999987


Q ss_pred             CchHHHHHHHHHHhccccCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCccccc
Q 017936          223 EEPKNFRKTIHRILSVQYSIPD-YVHISPECRHLISRIFVADPAKRISIP---EIRNHEWFLK  281 (363)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~~R~t~~---ell~h~~~~~  281 (363)
                      +....++    .+.......|. ....+.++++++.++|..+|.+|..+.   ++..|+||+.
T Consensus      1039 tpq~~f~----ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~ 1097 (1205)
T KOG0606|consen 1039 TPQQIFE----NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQD 1097 (1205)
T ss_pred             chhhhhh----ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCC
Confidence            7655443    34444444333 234688999999999999999999877   8999999964

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.61  E-value=2.1e-14  Score=137.34  Aligned_cols=182  Identities=18%  Similarity=0.263  Sum_probs=136.6

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      |.+ ....-++.+..-.+..+.++..+.|.+...+.. ..+..++-++.++.++||||+++++.++.++++|+|+|-+  
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--   91 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--   91 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--
Confidence            455 444444444333455677888888888766543 2345678889999999999999999999999999999988  


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-CCccc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV  179 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH-~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-~~~~~  179 (363)
                      ..|..++.+.   +...+..-+.||+.||.||| .++++|++|....|+|+..+.  .||++|.++........ .....
T Consensus        92 ~Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~  166 (690)
T KOG1243|consen   92 RPLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLY  166 (690)
T ss_pred             ccHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccch
Confidence            4676677664   47889999999999999998 678999999999999987765  99999998864433222 11122


Q ss_pred             cCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhC
Q 017936          180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG  215 (363)
Q Consensus       180 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g  215 (363)
                      ---.|..|+.+.....  . .|.|-|||++++++.|
T Consensus       167 ~~~s~~~P~~~~~s~~--s-~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  167 LIESFDDPEEIDPSEW--S-IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhcccChhhcCcccc--c-hhhhhHHHHHHHHhCc
Confidence            2234677776543332  2 5999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.58  E-value=1.4e-14  Score=120.96  Aligned_cols=127  Identities=20%  Similarity=0.239  Sum_probs=96.2

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEcCCeEEEEEeccCCCch
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      ++.|+.|.++.||+++..  ++.|++|+............+|+..++.+.+.++ ++++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            467889999999999864  7789999876554333456788989888865554 44555433  234799999999888


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCc-----eecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       105 ~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~gi-----iHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      ...        ......++.+++.+|..||+.++     +|||++|.||+++ ++  .++++|||.+.
T Consensus        79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~  135 (170)
T cd05151          79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG  135 (170)
T ss_pred             ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence            643        11224567899999999999985     9999999999998 33  49999999765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=2.4e-15  Score=132.14  Aligned_cols=201  Identities=18%  Similarity=0.282  Sum_probs=140.6

Q ss_pred             HHHHcCCCCCeeeeeEEEEcCC-----eEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHcC--
Q 017936           69 INHRSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQ--  137 (363)
Q Consensus        69 ~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~L~~LH~~g--  137 (363)
                      ..+-.+.|.|||+++.++.+.+     ...++.||++.|++.+.+++..    .+......+|+-||+.||.|||+..  
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            3345667999999999986643     4789999999999999997643    4889999999999999999999874  


Q ss_pred             ceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC------CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHH
Q 017936          138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYV  211 (363)
Q Consensus       138 iiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~  211 (363)
                      |+|+++..+-|++..++-  +|+.--.-.. ....      .......+-++|.|||.=......+. +|||++|.+..+
T Consensus       199 iihgnlTc~tifiq~ngL--Ikig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAle  274 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGL--IKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALE  274 (458)
T ss_pred             cccCCcchhheeecCCce--EEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHH
Confidence            999999999999985543  5553211111 0010      11112246789999997554455455 899999999999


Q ss_pred             HHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          212 MLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       212 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      |..+..--............+....-   ...     ..--++++.+||+..|..||++.+++-||.+.+
T Consensus       275 mailEiq~tnseS~~~~ee~ia~~i~---~le-----n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEENIANVII---GLE-----NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             HHHheeccCCCcceeehhhhhhhhee---ecc-----CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            98876553322222222222221111   101     122356899999999999999999999998754

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.57  E-value=2.7e-15  Score=145.20  Aligned_cols=141  Identities=23%  Similarity=0.345  Sum_probs=96.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-----------------------------------ccHHH-
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------------------------------IDENV-   64 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----------------------------------~~~~~-   64 (363)
                      ..|+. +.||+|++|+||.|+.+.+|+.||||+.++.-.                                   ..+.+ 
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34666 899999999999999988899999999865310                                   01112 


Q ss_pred             -----HHHHHHHHcC----CCCCeeeeeEEEEc-CCeEEEEEeccCCCchHHH--HHhCC----CCCHHHHHHHHHHHHH
Q 017936           65 -----QREIINHRSL----RHPNIVRFKEVILT-PTHLAIVMEYASGGELFER--ICNAG----RFSEDEARFFFQQLIS  128 (363)
Q Consensus        65 -----~~e~~~l~~l----~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~L~~~--~~~~~----~l~~~~~~~~~~qil~  128 (363)
                           .+|+..+.++    .+.+.+.+-.++.+ ....++||||++|+++.+.  +...+    .+.+..+..++.|++ 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-  277 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-  277 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence                 2333333332    24444444444433 3446899999999999764  33333    255555666666665 


Q ss_pred             HHHHHHHcCceecCCCCCCEEEeCCC--CCcEEEeecCCcccC
Q 017936          129 GVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS  169 (363)
Q Consensus       129 ~L~~LH~~giiHrDlkp~NIll~~~~--~~~vkL~DFgla~~~  169 (363)
                            ..|++|+|+||.||+++.++  .++++++|||++...
T Consensus       278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence                  59999999999999998654  236999999998644

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.55  E-value=7.7e-14  Score=117.95  Aligned_cols=137  Identities=14%  Similarity=0.163  Sum_probs=99.4

Q ss_pred             eceecccCCeEEEEEEEcC------CCcEEEEEEeecC--------------Cc---------ccHHH----HHHHHHHH
Q 017936           26 VRDIGSGNFGVARLMRDKK------TEELVAVKYIERG--------------DK---------IDENV----QREIINHR   72 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~--------------~~---------~~~~~----~~e~~~l~   72 (363)
                      ...||.|.-+.||.+....      .+..+|||+.+.+              ..         ....+    ++|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998653      3578999987421              00         11122    37888888


Q ss_pred             cCCC--CCeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHcCceecCCCCCCEE
Q 017936           73 SLRH--PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTL  149 (363)
Q Consensus        73 ~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~L-H~~giiHrDlkp~NIl  149 (363)
                      ++..  -++++.+.+    ..-++||||+.+..+.....+...+++.++..++.+++.+|..| |+.|+|||||+|.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8753  456666654    23489999997754433222333466777888899999999998 8999999999999999


Q ss_pred             EeCCCCCcEEEeecCCcccC
Q 017936          150 LDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus       150 l~~~~~~~vkL~DFgla~~~  169 (363)
                      +..   +.+.|+|||.|...
T Consensus       158 ~~~---~~v~iIDF~qav~~  174 (197)
T cd05146         158 WHD---GKVWFIDVSQSVEP  174 (197)
T ss_pred             EEC---CcEEEEECCCceeC
Confidence            973   24999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=4.4e-15  Score=140.51  Aligned_cols=249  Identities=21%  Similarity=0.200  Sum_probs=182.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDK---IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..+|-.+..||.|.|+.|+.+.-. .++..|++|-..+...   .+..-..|+.+...+ .|.+++++...+....+.|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            457889999999999999887755 6788999997765422   122234566666655 49999999888888888889


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      --|||+++++.....-...+.+...+....|++.++.++|++.++|+|+||+||++..++ +-.+++|||+.....  ..
T Consensus       344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~--~~  420 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLA--FS  420 (524)
T ss_pred             chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccccc--ee
Confidence            999999999887775556689999999999999999999999999999999999997654 458999999876421  11


Q ss_pred             CCccccCCCcC-ChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 PKSTVGTPAYI-APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 ~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      .....+.-++. .+|++........+.|++|||..+++..++...-......       ..+..  ...|.....+.++.
T Consensus       421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-------~~i~~--~~~p~~~~~~~~~q  491 (524)
T KOG0601|consen  421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-------LTIRS--GDTPNLPGLKLQLQ  491 (524)
T ss_pred             cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-------eeeec--ccccCCCchHHhhh
Confidence            11222333344 3555544444445589999999999999986543221111       11111  12333344568899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcccc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                      .+.+.++..++..||.+.++..|+-|.
T Consensus       492 ~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  492 VLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhhhcCCccccchhhhhhcccchhh
Confidence            999999999999999999998887664

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=8.1e-14  Score=133.24  Aligned_cols=137  Identities=18%  Similarity=0.193  Sum_probs=92.2

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc--c---------------------------------H------HHH
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--D---------------------------------E------NVQ   65 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~---------------------------------~------~~~   65 (363)
                      +.||.|++|.||+|+. .+|+.||||+.+..-..  .                                 .      ++.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            6799999999999987 47899999997543100  0                                 0      123


Q ss_pred             HHHHHHHcC----CCCCeeeeeEEEE-cCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHHcCc
Q 017936           66 REIINHRSL----RHPNIVRFKEVIL-TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHSMQV  138 (363)
Q Consensus        66 ~e~~~l~~l----~hpnIv~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~-~L~~LH~~gi  138 (363)
                      +|+..+..+    ++.+-+.+-.++. .....++||||++|++|.+..... ..+.   ...++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            344444333    2333333333332 233468999999999998765432 1222   2345555555 4678999999


Q ss_pred             eecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936          139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus       139 iHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      +|+|++|.||+++.++  +++|+|||++...
T Consensus       279 ~H~D~hPgNilv~~~g--~i~liDfG~~~~l  307 (437)
T TIGR01982       279 FHADLHPGNIFVLKDG--KIIALDFGIVGRL  307 (437)
T ss_pred             eeCCCCcccEEECCCC--cEEEEeCCCeeEC
Confidence            9999999999997654  4999999998643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=8.2e-12  Score=102.33  Aligned_cols=129  Identities=22%  Similarity=0.218  Sum_probs=95.8

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEe-ecC---Ccc-----cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYI-ERG---DKI-----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~-~~~---~~~-----~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ..+++|+-+.++.+..  -|..+++|.= .+.   +..     .++..+|+.+++.++--.|..-.=++.+.+...++||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            3578899999998854  2334667643 221   111     2345678999988875555554445566777789999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      |++|..|.+.+...       ...+++.+-.-+.-||..|||||||+++||++....   +.++||||+.
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~  139 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE  139 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence            99999988887665       256777777888889999999999999999997543   8999999986

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.38  E-value=4.8e-12  Score=110.31  Aligned_cols=140  Identities=21%  Similarity=0.273  Sum_probs=106.6

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCC--CeeeeeEEEEcC---CeEEEEEec
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP--NIVRFKEVILTP---THLAIVMEY   98 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hp--nIv~~~~~~~~~---~~~~lv~e~   98 (363)
                      ++.|+.|..+.||++.... |+.+++|+......  ....+.+|+.+++.+.+.  .+++++.+....   +..++||||
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            3678999999999998743 57899998765433  356788999999988763  457777766553   267899999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------  135 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-------------------------------------------  135 (363)
                      ++|.++...+.. ..+++.+...++.+++.+|..||+                                           
T Consensus        82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            999988765432 356777778888888888888873                                           


Q ss_pred             -------------cCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          136 -------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       136 -------------~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                                   ..++|||++|.||+++.+..+.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                         23699999999999986323347899999776

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.34  E-value=1.8e-11  Score=99.94  Aligned_cols=142  Identities=16%  Similarity=0.108  Sum_probs=104.8

Q ss_pred             eeceecccCCeEEEEEEEcCCCcEEEEEEee-cC--------CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RG--------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~-~~--------~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .+..+.+|+-+.|+.+..  .|+.++||.-. +.        .....+.++|++.+.++.--.|.--.-+|.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            567788999999998874  57777888532 21        12235667899999888655555444456666666899


Q ss_pred             EeccCC-CchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCC-cEEEeecCCccc
Q 017936           96 MEYASG-GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKS  168 (363)
Q Consensus        96 ~e~~~~-~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~-~vkL~DFgla~~  168 (363)
                      |||++| .++.+++....  .....-...++++|-+.+.-||..+||||||..+||++...+.. .+.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999987 46777765432  23333447899999999999999999999999999999866553 358999999864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.33  E-value=1e-10  Score=109.26  Aligned_cols=213  Identities=18%  Similarity=0.223  Sum_probs=151.6

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEeecCCcccH-HHHHHHHHHHcCCCCCeeeeeEEEEc----CCeEEEEEeccCC-CchHH
Q 017936           33 NFGVARLMRDKKTEELVAVKYIERGDKIDE-NVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEYASG-GELFE  106 (363)
Q Consensus        33 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~e~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~~~~-~~L~~  106 (363)
                      .-.+.|++....+|..|++|.+.-...... ....-++.++++.|+|+|++.++|.+    ...+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            345789999999999999999843322221 22345678899999999999999984    3578999998864 67776


Q ss_pred             HHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936          107 RICN---------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus       107 ~~~~---------------~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      +.-.               ....+|..+|.|+.|+..||.++|+.|+..+-|.|.+||++++.  +++|...|..-....
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecC
Confidence            6421               22378999999999999999999999999999999999997554  488887776543222


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      ..           .  +-+...    .+-|.=.||.+++.|.||..--...+.....  .+..+         ...+|.+
T Consensus       446 d~-----------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~~~~I---------~~~yS~D  497 (655)
T KOG3741|consen  446 DP-----------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSS--HLTRI---------TTTYSTD  497 (655)
T ss_pred             CC-----------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHH--HHHHh---------hhhhhHH
Confidence            11           0  112211    1258889999999999996543322221111  01111         1235899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          252 CRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      +++++.-+...+++. -++.+++.+
T Consensus       498 ~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  498 LRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHhcCccc-ccHHHHHHH
Confidence            999999999988886 677887754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.22  E-value=9.4e-11  Score=98.82  Aligned_cols=123  Identities=26%  Similarity=0.306  Sum_probs=81.6

Q ss_pred             EEEEEEEcCCCcEEEEEEeecC--------------Cc-------------ccHHHHHHHHHHHcCCCC--CeeeeeEEE
Q 017936           36 VARLMRDKKTEELVAVKYIERG--------------DK-------------IDENVQREIINHRSLRHP--NIVRFKEVI   86 (363)
Q Consensus        36 ~V~~~~~~~~~~~~aiK~~~~~--------------~~-------------~~~~~~~e~~~l~~l~hp--nIv~~~~~~   86 (363)
                      .||.|.. ..|..+|+|+....              ..             .....++|...|..+..-  ++++.+.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3888886 45678999987421              00             113467899999999765  566766553


Q ss_pred             EcCCeEEEEEeccC--CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHcCceecCCCCCCEEEeCCCCCcEEEeec
Q 017936           87 LTPTHLAIVMEYAS--GGELFERICNAGRFSEDEARFFFQQLISGVSY-CHSMQVCHRDLKLENTLLDGSPAPRLKICDF  163 (363)
Q Consensus        87 ~~~~~~~lv~e~~~--~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~-LH~~giiHrDlkp~NIll~~~~~~~vkL~DF  163 (363)
                        .+  ++||||++  |..+..+....  ++..+...++.+++..+.. +|+.|||||||.+.|||++.+   .+.++||
T Consensus        80 --~~--~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf  150 (188)
T PF01163_consen   80 --RN--VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDF  150 (188)
T ss_dssp             --TT--EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--G
T ss_pred             --CC--EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEec
Confidence              22  79999998  66665433322  2256677888888885555 679999999999999999865   3999999


Q ss_pred             CCccc
Q 017936          164 GYSKS  168 (363)
Q Consensus       164 gla~~  168 (363)
                      |.+..
T Consensus       151 ~qav~  155 (188)
T PF01163_consen  151 GQAVD  155 (188)
T ss_dssp             TTEEE
T ss_pred             Cccee
Confidence            98764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.21  E-value=4.1e-10  Score=100.50  Aligned_cols=129  Identities=13%  Similarity=0.064  Sum_probs=91.6

Q ss_pred             EEEEEEcCCCcEEEEEEeecCC------------cccHHHHHHHHHHHcCCCCCe--eeeeEEEEc-----CCeEEEEEe
Q 017936           37 ARLMRDKKTEELVAVKYIERGD------------KIDENVQREIINHRSLRHPNI--VRFKEVILT-----PTHLAIVME   97 (363)
Q Consensus        37 V~~~~~~~~~~~~aiK~~~~~~------------~~~~~~~~e~~~l~~l~hpnI--v~~~~~~~~-----~~~~~lv~e   97 (363)
                      |..+.  -.|+.|.||......            .......+|+..+..+...+|  ++.+.+++.     ...-++|||
T Consensus        38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            44443  356788899653321            111246788888877743333  233444432     234689999


Q ss_pred             ccCCC-chHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC-----CCCCcEEEeecCCcc
Q 017936           98 YASGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK  167 (363)
Q Consensus        98 ~~~~~-~L~~~~~~--~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~-----~~~~~vkL~DFgla~  167 (363)
                      ++++. +|.+++..  ....++.....++.+++..+..||..||+|||+++.|||++.     ++...+.|+||+.+.
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99886 78888753  345677788899999999999999999999999999999985     234569999999775

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.12  E-value=3.1e-11  Score=116.36  Aligned_cols=153  Identities=19%  Similarity=0.286  Sum_probs=107.5

Q ss_pred             HHHHHHHHHHH-HcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CC---------CccccCCCcCChhhhhc
Q 017936          124 QQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP---------KSTVGTPAYIAPEVLLK  192 (363)
Q Consensus       124 ~qil~~L~~LH-~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~---------~~~~gt~~y~aPE~~~~  192 (363)
                      .+++.||.++| +.++||++|.|++|.++.++.  +||+.|+.+....... ..         ........|.|||++.+
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34459999999 569999999999999987766  9999999876433211 10         11135567999999987


Q ss_pred             CCCCCcchhhhhHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 017936          193 KEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP  271 (363)
Q Consensus       193 ~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~  271 (363)
                      .... .++|++|+||++|.+. .|+.-+.......... .. ..............+++++++=|.++|..++..||++.
T Consensus       184 ~~~~-~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~-~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~  260 (700)
T KOG2137|consen  184 TTNT-PASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FS-RNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD  260 (700)
T ss_pred             cccc-ccccceeeeeEEEEEecCCcchhhccCCcchhh-hh-hcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence            5544 4499999999999998 4554454332211111 10 01111111222356899999999999999999999999


Q ss_pred             HHhcCccccc
Q 017936          272 EIRNHEWFLK  281 (363)
Q Consensus       272 ell~h~~~~~  281 (363)
                      +++.-|||..
T Consensus       261 ~l~~~~ff~D  270 (700)
T KOG2137|consen  261 LLLSIPFFSD  270 (700)
T ss_pred             hhhcccccCC
Confidence            9999999965

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.10  E-value=3.5e-09  Score=96.93  Aligned_cols=241  Identities=14%  Similarity=0.129  Sum_probs=151.7

Q ss_pred             eeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHH-HcCCCCCeeeeeEEE------EcC-CeEEEE
Q 017936           24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVI------LTP-THLAIV   95 (363)
Q Consensus        24 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l-~~l~hpnIv~~~~~~------~~~-~~~~lv   95 (363)
                      ...+.||+|+-+.+|-+-...+   .+.|+........+.-  ....| ..-.||-+-.-+.+=      -.. ..+.+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq--k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ--KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchhhc---hhheeecCCCchHHHH--HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            4468899999999997653322   3567776554333221  12223 333566543311110      112 237888


Q ss_pred             EeccCCCchHHHH-------HhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           96 MEYASGGELFERI-------CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        96 ~e~~~~~~L~~~~-------~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      |..+.|..=...+       +..+.+....+.++.+.|+.+.+.||..|.+-||+.++|+|+..++.  |.|.|-..-..
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi  166 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQI  166 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceee
Confidence            9888775322222       12233677889999999999999999999999999999999976655  88888654333


Q ss_pred             CccCCCCCccccCCCcCChhhhhcCC-----CCCcchhhhhHHHHHHHHHhC-CCCCCCCCc----hHHHH-HHHHHH--
Q 017936          169 SVLHSQPKSTVGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVG-AYPFEDPEE----PKNFR-KTIHRI--  235 (363)
Q Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g-~~pf~~~~~----~~~~~-~~~~~~--  235 (363)
                      ..........+|.+.|.+||..+-..     -+.. +|.|.||+++++++.| +.||.+-..    +.... .+....  
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            33333344567999999999865332     2334 7999999999999886 999975321    11111 010000  


Q ss_pred             --------hccccCCCCCCCCCHHHHHHHHHhcccC--CCCCCCHHH
Q 017936          236 --------LSVQYSIPDYVHISPECRHLISRIFVAD--PAKRISIPE  272 (363)
Q Consensus       236 --------~~~~~~~~~~~~~s~~~~~li~~~L~~~--p~~R~t~~e  272 (363)
                              .......+.+.-++++++.+..+|+...  +.-|||++.
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence                    0001111234457899999999999753  568998654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.00  E-value=4.9e-11  Score=113.86  Aligned_cols=242  Identities=20%  Similarity=0.196  Sum_probs=171.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..-|....-+++|+++++++.+...+.... .+++...    ....-++++|.+++||| .++.++-+..+....+++++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            445778899999999999999977665544 6655443    44456788999999999 77777777788899999999


Q ss_pred             cCCC-chHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           99 ASGG-ELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        99 ~~~~-~L~~~~-~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      +.++ +....+ ...-.+.+.+....++.=+.+|++||+.-=+|||    ||+..++.   .++.||+............
T Consensus       316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~  388 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPR  388 (829)
T ss_pred             hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccc
Confidence            9877 221111 1112355666777888888999999998778999    88876533   7999999887665555567


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC---CCCCCCHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP---DYVHISPECR  253 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~  253 (363)
                      +..+++.++|||+...+.+... .|+|++|.--.++.-|.+|-..+....      ..+ ......+   .....+....
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~~~~------~~~-g~~p~s~~L~~~~aw~~~~~  460 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSPPAVL------PMI-GNGPNSPMLTDKSAWSPVFH  460 (829)
T ss_pred             cCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCCcccc------CCC-CCCCCccccchhhhcCcccc
Confidence            7789999999999999998887 799999988778877777754321100      000 0000000   0000111122


Q ss_pred             -HHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          254 -HLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       254 -~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                       ++-..|+..-|..|++...++.|.+|..
T Consensus       461 ~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  461 RDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             cCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence             3677789999999999999999999864

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.95  E-value=6.6e-09  Score=90.44  Aligned_cols=133  Identities=20%  Similarity=0.222  Sum_probs=100.6

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC-----------------------CcccHHHHHHHHHHHcCCCC--
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----------------------DKIDENVQREIINHRSLRHP--   77 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----------------------~~~~~~~~~e~~~l~~l~hp--   77 (363)
                      +.+..+||-|.-|.||.+.+. .|..+|||.=+..                       .......++|...|..|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            467789999999999999975 5778999964211                       01123467899999988755  


Q ss_pred             CeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCc
Q 017936           78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR  157 (363)
Q Consensus        78 nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~  157 (363)
                      .+++-+++    +.=.+|||+++|..|...-     ++.+....++..|++-+..+-..||||||+.+-||++++++.  
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--  240 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--  240 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence            56666553    2237999999998886532     245667777777887777777999999999999999987765  


Q ss_pred             EEEeecCCcc
Q 017936          158 LKICDFGYSK  167 (363)
Q Consensus       158 vkL~DFgla~  167 (363)
                      +.++||-.+.
T Consensus       241 ~~vIDwPQ~v  250 (304)
T COG0478         241 IVVIDWPQAV  250 (304)
T ss_pred             EEEEeCcccc
Confidence            9999997654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.93  E-value=1.8e-08  Score=85.92  Aligned_cols=135  Identities=16%  Similarity=0.193  Sum_probs=89.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHH----------HHHHHHHHHcCCC---CCeeeeeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----------VQREIINHRSLRH---PNIVRFKEVI   86 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----------~~~e~~~l~~l~h---pnIv~~~~~~   86 (363)
                      .++|++++.+-......|.+..  ..|+.+++|.......-.++          ..+.+.....++.   -....++-+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            5678999999888888887776  55788999987643221111          2233333333322   2222222222


Q ss_pred             -----EcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEe
Q 017936           87 -----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC  161 (363)
Q Consensus        87 -----~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~  161 (363)
                           .-....+++|||++|..|.+...    +++    .+...|.+++.-||+.|++|||.+|.|++++.++   ++++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iI  176 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRII  176 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEE
Confidence                 12244578999999988865421    232    2445677889999999999999999999998543   9999


Q ss_pred             ecCCcc
Q 017936          162 DFGYSK  167 (363)
Q Consensus       162 DFgla~  167 (363)
                      ||+..+
T Consensus       177 D~~~k~  182 (229)
T PF06176_consen  177 DTQGKR  182 (229)
T ss_pred             ECcccc
Confidence            998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=8e-09  Score=89.11  Aligned_cols=107  Identities=18%  Similarity=0.188  Sum_probs=83.2

Q ss_pred             cHHHHHHHHHHHcCCCCC--eeeeeEEEEcC----CeEEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 017936           61 DENVQREIINHRSLRHPN--IVRFKEVILTP----THLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYC  133 (363)
Q Consensus        61 ~~~~~~e~~~l~~l~hpn--Iv~~~~~~~~~----~~~~lv~e~~~~-~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~L  133 (363)
                      .....+|...+..|..-+  .++.+.+.+..    ...++|+|++++ .+|.+.+......+......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            456778888777664332  34444444432    245899999987 47888888755578888999999999999999


Q ss_pred             HHcCceecCCCCCCEEEeCCC-CCcEEEeecCCcc
Q 017936          134 HSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK  167 (363)
Q Consensus       134 H~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~  167 (363)
                      |.+||+|+|++|.|||++.++ ...+.|+||+-++
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            999999999999999998765 3369999999765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.88  E-value=4.7e-08  Score=83.10  Aligned_cols=135  Identities=10%  Similarity=0.097  Sum_probs=98.8

Q ss_pred             cccCCeEEEEEEEcCCCcEEEEEEeec----C---CcccHHHHHHHHHHHcCCCCC--eeeeeEEEE---cC--CeEEEE
Q 017936           30 GSGNFGVARLMRDKKTEELVAVKYIER----G---DKIDENVQREIINHRSLRHPN--IVRFKEVIL---TP--THLAIV   95 (363)
Q Consensus        30 g~G~~g~V~~~~~~~~~~~~aiK~~~~----~---~~~~~~~~~e~~~l~~l~hpn--Iv~~~~~~~---~~--~~~~lv   95 (363)
                      |+||.|-|+.....  |+.|-+|.-..    +   +.....+.+|+..+..+...+  +++.. ++.   ..  ..-+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            56888889887643  44688887642    1   334578899999888775322  44444 222   11  246899


Q ss_pred             EeccCC-CchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936           96 MEYASG-GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus        96 ~e~~~~-~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      +|-++| .+|.+++...  .+.++.+...++.+|+..+.-||+.|+.|+|+.+.|||++..+...++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997654 6887777653  34678888899999999999999999999999999999985554459999998665

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.71  E-value=1e-07  Score=97.24  Aligned_cols=202  Identities=21%  Similarity=0.261  Sum_probs=144.3

Q ss_pred             HHHHHHHHHcCCCCCeeeeeEEEEcCCeE----EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCce
Q 017936           64 VQREIINHRSLRHPNIVRFKEVILTPTHL----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC  139 (363)
Q Consensus        64 ~~~e~~~l~~l~hpnIv~~~~~~~~~~~~----~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~gii  139 (363)
                      ...|+..+....|+|+++++.+.......    .+..++|++.++...++.-+.++...++.+..+++.||.++|+....
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~  308 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE  308 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence            34566667788999999999887665433    35567999999999999999999999999999999999999999655


Q ss_pred             ecCCCCC---CEEEeCCCCCcEEEe--ecCCcccCccCCCCCccccCCCcCChhhhhcCCCCC-cchhhhhHHHHHHHHH
Q 017936          140 HRDLKLE---NTLLDGSPAPRLKIC--DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG-KIADVWSCGVTLYVML  213 (363)
Q Consensus       140 HrDlkp~---NIll~~~~~~~vkL~--DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~il~~l~  213 (363)
                      |.-|...   +--.+  +.+.+.++  ||+.++............-+..+.|||......+.. ...|+|++|.....+.
T Consensus       309 ~v~L~~s~~~~~~~~--~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  309 HVVLSASSSKESTVD--GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             eeEEecccccccccC--ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence            5555444   22222  23335555  888887665555555555677788898876555432 2269999999999998


Q ss_pred             hCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          214 VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .|..+-.......       ....       .. ......+.+.+|+..++++|+++.+++.|+|....
T Consensus       387 ~~~~i~~~~~~~~-------~~l~-------~~-~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  387 QGEDISEKSAVPV-------SLLD-------VL-STSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             hcCcccccccchh-------hhhc-------cc-cchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence            8765532211111       0100       00 11267888999999999999999999999998643

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.69  E-value=2.6e-07  Score=79.84  Aligned_cols=134  Identities=18%  Similarity=0.140  Sum_probs=89.8

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCC--------------------ccc-----HHHHHHHHHHHcCC--CCC
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------------------KID-----ENVQREIINHRSLR--HPN   78 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------------~~~-----~~~~~e~~~l~~l~--hpn   78 (363)
                      ...|++|.-++||+|.. ..+..+|+|++....                    ...     ....+|+..|+++.  +=.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34677888889999986 557889999985321                    000     11345666676664  223


Q ss_pred             eeeeeEEEEcCCeEEEEEeccCCCchH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCC
Q 017936           79 IVRFKEVILTPTHLAIVMEYASGGELF-ERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP  156 (363)
Q Consensus        79 Iv~~~~~~~~~~~~~lv~e~~~~~~L~-~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~  156 (363)
                      +++-+.+..    -.|||||+...-.- -.+.. -++...++..+..++++.+.-|-. .|+||+||..-|||+. ++. 
T Consensus       132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~-  204 (268)
T COG1718         132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE-  204 (268)
T ss_pred             CCCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe-
Confidence            344444332    27999999543111 11111 123444788889999999999887 9999999999999998 333 


Q ss_pred             cEEEeecCCccc
Q 017936          157 RLKICDFGYSKS  168 (363)
Q Consensus       157 ~vkL~DFgla~~  168 (363)
                       +.++|||.|..
T Consensus       205 -p~iID~~QaV~  215 (268)
T COG1718         205 -PYIIDVSQAVT  215 (268)
T ss_pred             -EEEEECccccc
Confidence             89999998763

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.63  E-value=6e-07  Score=78.47  Aligned_cols=72  Identities=17%  Similarity=0.168  Sum_probs=54.5

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eeeeeEEEEcCCeEEEEEeccCCCc
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGE  103 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~e~~~~~~  103 (363)
                      ..||.|..+.||+.    .+..+++|...... ....+.+|...++.+..-.  +++.+.+....+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999974    24457899876533 3456789999998886433  4677777777788899999999964

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.54  E-value=1.3e-06  Score=90.55  Aligned_cols=145  Identities=15%  Similarity=0.258  Sum_probs=92.5

Q ss_pred             eeceecccCCeEEEEEEEcCCC--cEEEEEEeecCC--cccHHHHHHHHHHHcCC-CCCe--eeeeEEEEcC---CeEEE
Q 017936           25 LVRDIGSGNFGVARLMRDKKTE--ELVAVKYIERGD--KIDENVQREIINHRSLR-HPNI--VRFKEVILTP---THLAI   94 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~~--~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~-hpnI--v~~~~~~~~~---~~~~l   94 (363)
                      -++.++.|.++.+|++.....+  ..+++|+.....  .....+.+|+.+++.+. |+++  ++++.++.+.   +..|+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            3677899999999998765432  467888764432  12356889999999985 6665  7777777654   46789


Q ss_pred             EEeccCCCchHH--------------------HHHhCCC----------------CCHHHHHHHHHH-------------
Q 017936           95 VMEYASGGELFE--------------------RICNAGR----------------FSEDEARFFFQQ-------------  125 (363)
Q Consensus        95 v~e~~~~~~L~~--------------------~~~~~~~----------------l~~~~~~~~~~q-------------  125 (363)
                      ||||++|..+.+                    .+..-..                +...++..|..+             
T Consensus       122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~  201 (822)
T PLN02876        122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN  201 (822)
T ss_pred             EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence            999998865321                    1110000                112234333222             


Q ss_pred             --HHHHHHHHHH-----------cCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936          126 --LISGVSYCHS-----------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus       126 --il~~L~~LH~-----------~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                        +...+.+|..           ..+||+|++|.|||++.++...+-|.||.++...
T Consensus       202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence              2233455532           2599999999999997543323579999998643

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.52  E-value=9.7e-07  Score=85.54  Aligned_cols=137  Identities=20%  Similarity=0.192  Sum_probs=87.2

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCC-----------------------c---c---------cHH------HH
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------------K---I---------DEN------VQ   65 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------------------~---~---------~~~------~~   65 (363)
                      ..|+.++-|.||.|+-+. |+.||||+.+++-                       .   .         .+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            678899999999999755 9999999975320                       0   0         011      23


Q ss_pred             HHHHHHHcC----CCCCeeeeeEEEE-cCCeEEEEEeccCCCchHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 017936           66 REIINHRSL----RHPNIVRFKEVIL-TPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSMQV  138 (363)
Q Consensus        66 ~e~~~l~~l----~hpnIv~~~~~~~-~~~~~~lv~e~~~~~~L~~~~--~~~~~l~~~~~~~~~~qil~~L~~LH~~gi  138 (363)
                      +|...+.++    +..-=+++=.+|. -.+.-.++|||++|..+.+..  .. ..++...+...+.++.  +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            444444333    2222233333332 234458999999999988774  33 3455444433322221  222335899


Q ss_pred             eecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936          139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus       139 iHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      .|.|.+|.||+++.++  ++.+.|||+....
T Consensus       287 fHaDpHpGNi~v~~~g--~i~~lDfGi~g~l  315 (517)
T COG0661         287 FHADPHPGNILVRSDG--RIVLLDFGIVGRL  315 (517)
T ss_pred             cccCCCccceEEecCC--cEEEEcCcceecC
Confidence            9999999999998765  4999999987643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.51  E-value=9.1e-07  Score=77.43  Aligned_cols=78  Identities=18%  Similarity=0.210  Sum_probs=56.2

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCC--CeeeeeEEEEc---CCeEEEEEeccC
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--NIVRFKEVILT---PTHLAIVMEYAS  100 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~~~~~~~~---~~~~~lv~e~~~  100 (363)
                      ++.|+.|..+.||.+....  ..+++|+.... .....+.+|..+++.+...  -+++++.....   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            5789999999999999765  47999986554 4456777888888777533  35566654432   345799999999


Q ss_pred             CCchHH
Q 017936          101 GGELFE  106 (363)
Q Consensus       101 ~~~L~~  106 (363)
                      |.++..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            988877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.49  E-value=2.1e-06  Score=76.00  Aligned_cols=75  Identities=12%  Similarity=0.050  Sum_probs=52.5

Q ss_pred             eecccCC-eEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEeccCCCchH
Q 017936           28 DIGSGNF-GVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF  105 (363)
Q Consensus        28 ~lg~G~~-g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (363)
                      .|-.|.. +.||.+...  +..+++|......  ...+.+|+.+++.+. +--+++++.+....+..++||++++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3444555 788998753  3578899765543  345678888887774 344667777777666789999999998776


Q ss_pred             H
Q 017936          106 E  106 (363)
Q Consensus       106 ~  106 (363)
                      .
T Consensus        81 ~   81 (244)
T cd05150          81 A   81 (244)
T ss_pred             H
Confidence            4

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.45  E-value=8.1e-06  Score=69.49  Aligned_cols=129  Identities=20%  Similarity=0.201  Sum_probs=91.9

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCC-----------------cccHHHHHHHHHHHcCC------CCCeeee
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------KIDENVQREIINHRSLR------HPNIVRF   82 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------------~~~~~~~~e~~~l~~l~------hpnIv~~   82 (363)
                      ...||+|+.=.||.-   .......||+.....                 .......+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            357899999999863   233446899886654                 12344556665555544      8899999


Q ss_pred             eEEEEcCCeEEEEEeccC------CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCC
Q 017936           83 KEVILTPTHLAIVMEYAS------GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP  156 (363)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~------~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~  156 (363)
                      +++.+++.-+.+|+|.+.      ..+|.+++... .+++ .+..   .+-+-.++|-+.+|+.+|++|.||++.....+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            999999999999999763      24677777443 4555 3333   34445567789999999999999999766544


Q ss_pred             --cEEEee
Q 017936          157 --RLKICD  162 (363)
Q Consensus       157 --~vkL~D  162 (363)
                        .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.45  E-value=1.6e-06  Score=70.96  Aligned_cols=129  Identities=19%  Similarity=0.189  Sum_probs=91.9

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeee-eeEEEEcCCeEEEEEeccC
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~-~~~~~~~~~~~~lv~e~~~  100 (363)
                      .-.+.+.|++|.+|.||++..  .|..+|+|+ .+.+.....++.|++++..+..-++-+ ++.+..+    ++.|||+.
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kv-rr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~   95 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKV-RRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID   95 (201)
T ss_pred             hhhhhhhhhcccccEEEEeec--cCceEEEEE-ecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence            346688999999999999984  456889995 444566788999999999887666544 3333222    56699999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCC--CCEEEeCCCCCcEEEeecCCcc
Q 017936          101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL--ENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       101 ~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp--~NIll~~~~~~~vkL~DFgla~  167 (363)
                      |.+|...-...   .    +.-+..+++.---|-..||-|+.|.-  .||++.. .  .+.|+||.-|+
T Consensus        96 G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~--~~~iIDFd~At  154 (201)
T COG2112          96 GRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-R--DVYIIDFDSAT  154 (201)
T ss_pred             Ccchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecC-C--cEEEEEccchh
Confidence            98887654321   2    33344555655557789999999874  5666643 2  39999999776

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.44  E-value=1.1e-05  Score=68.18  Aligned_cols=125  Identities=18%  Similarity=0.252  Sum_probs=85.9

Q ss_pred             CCCceeeceecccCC-eEEEEEEEcCCCcEEEEEEeec----CC------c------------ccHHHHHHHHH---HHc
Q 017936           20 SDRYELVRDIGSGNF-GVARLMRDKKTEELVAVKYIER----GD------K------------IDENVQREIIN---HRS   73 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~-g~V~~~~~~~~~~~~aiK~~~~----~~------~------------~~~~~~~e~~~---l~~   73 (363)
                      +..++.++.||.|.- |.||+++-  .|+.||+|++..    ..      .            ...-+..|.+.   |+.
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            478999999999999 99999984  577999999421    00      0            01123344444   445


Q ss_pred             CCCCCe--eeeeEEEEcC------------------CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 017936           74 LRHPNI--VRFKEVILTP------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC  133 (363)
Q Consensus        74 l~hpnI--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~L  133 (363)
                      +.+.++  |+++++..-.                  ....||.||.....         .++...    +.+|++-|..+
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~  180 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKIL  180 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHH
Confidence            556677  9999987321                  12467888776543         223333    45667777789


Q ss_pred             HHcCceecCCCCCCEEEeCCCCCcEEEeecCCc
Q 017936          134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  166 (363)
Q Consensus       134 H~~giiHrDlkp~NIll~~~~~~~vkL~DFgla  166 (363)
                      |..||+-+|+++.|..   +    -+|+|||.+
T Consensus       181 ~k~gI~~~Dv~~~ny~---~----G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLGIVPRDVKPRNYR---G----GKLVDFSSS  206 (207)
T ss_pred             HHCCeeeccCcccccc---C----CEEEecccC
Confidence            9999999999999975   2    389999864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.34  E-value=3.7e-06  Score=81.36  Aligned_cols=138  Identities=17%  Similarity=0.157  Sum_probs=88.4

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--------------------------------ccHH------HHHH
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--------------------------------IDEN------VQRE   67 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------------------------------~~~~------~~~e   67 (363)
                      -+.||.-+.|.|+.|+-+. |+.||||+-+++-.                                ..+.      +.+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3789999999999999866 99999998653210                                0011      2333


Q ss_pred             HHHHH----cCCCCC------eeeeeEEEEcCCeEEEEEeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 017936           68 IINHR----SLRHPN------IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM  136 (363)
Q Consensus        68 ~~~l~----~l~hpn------Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~qil~~L~~LH~~  136 (363)
                      ++...    .+.|-+      |++++.-+  .....|+||||+|..+.+.-. +...++...+...+.+...-  -|=..
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qIf~~  320 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QIFKT  320 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HHHhc
Confidence            33322    233444      44443333  234589999999988866532 22346666554443333221  13367


Q ss_pred             CceecCCCCCCEEEeCC--CCCcEEEeecCCccc
Q 017936          137 QVCHRDLKLENTLLDGS--PAPRLKICDFGYSKS  168 (363)
Q Consensus       137 giiHrDlkp~NIll~~~--~~~~vkL~DFgla~~  168 (363)
                      |++|+|=+|.||+++.+  +...+.+.|||+...
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            89999999999999854  345799999999764

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.32  E-value=4e-06  Score=73.89  Aligned_cols=74  Identities=11%  Similarity=-0.007  Sum_probs=46.8

Q ss_pred             eceecccCCe-EEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCC---CeeeeeEEEEcC---CeEEEEEec
Q 017936           26 VRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVILTP---THLAIVMEY   98 (363)
Q Consensus        26 ~~~lg~G~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hp---nIv~~~~~~~~~---~~~~lv~e~   98 (363)
                      ++.++.|+.. .||.+.     ..+++|+... ......+.+|...++.+...   -++++++.....   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567777666 588762     2478887554 23345788999999877532   344444433322   234889999


Q ss_pred             cCCCchH
Q 017936           99 ASGGELF  105 (363)
Q Consensus        99 ~~~~~L~  105 (363)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9997763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.27  E-value=1.2e-05  Score=70.67  Aligned_cols=75  Identities=15%  Similarity=0.241  Sum_probs=49.5

Q ss_pred             eceecccCCeEEEEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEcCCeEEEEEeccCCCc
Q 017936           26 VRDIGSGNFGVARLMRDKK-TEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYASGGE  103 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e~~~~~~  103 (363)
                      ++.|..|-...+|++.... .++.|++|+........-...+|+.+++.+...+ .++++..+.  +  .++|||++|.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~   78 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT   78 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence            4677788888999997543 3567899977654332233457888888775333 444444332  2  47999999977


Q ss_pred             h
Q 017936          104 L  104 (363)
Q Consensus       104 L  104 (363)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            6

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=98.23  E-value=2.9e-05  Score=70.88  Aligned_cols=78  Identities=14%  Similarity=0.076  Sum_probs=56.9

Q ss_pred             eeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC---CCeeeeeEEEEc---CCeEEEEEe
Q 017936           24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---PNIVRFKEVILT---PTHLAIVME   97 (363)
Q Consensus        24 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h---pnIv~~~~~~~~---~~~~~lv~e   97 (363)
                      .-.+.||.|..+.||...... + .+++|.. +.......+..|...++.+.-   -.++++++++..   .+..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            446789999999999986432 3 4677874 332244688899999988753   357778877654   366899999


Q ss_pred             ccCCCch
Q 017936           98 YASGGEL  104 (363)
Q Consensus        98 ~~~~~~L  104 (363)
                      +++|.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.08  E-value=2.5e-05  Score=69.73  Aligned_cols=132  Identities=14%  Similarity=0.104  Sum_probs=77.3

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeecCCccc-HHHHHHHHHHHcCCCCCe-eeeeEEEEcCCeEEEEEeccCCCchH
Q 017936           28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGELF  105 (363)
Q Consensus        28 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~e~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~~~L~  105 (363)
                      .+..|-.+.+|++.  .+++.+++|......... -...+|..+++.+....+ ++++...  .  -++||||++|.++.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence            45568888999887  446678899765432221 235778888888764333 3444433  2  26899999987653


Q ss_pred             HH--------------HHh---CC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------cCceecCCCCC
Q 017936          106 ER--------------ICN---AG----RFSE-DEARFFFQQL---------ISGVSYCHS--------MQVCHRDLKLE  146 (363)
Q Consensus       106 ~~--------------~~~---~~----~l~~-~~~~~~~~qi---------l~~L~~LH~--------~giiHrDlkp~  146 (363)
                      ..              +.+   ..    +++. ..+..+..++         ...+..+-.        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21              111   11    1121 2222332222         111222222        25899999999


Q ss_pred             CEEEeCCCCCcEEEeecCCccc
Q 017936          147 NTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus       147 NIll~~~~~~~vkL~DFgla~~  168 (363)
                      ||+++.++   +.|+||..|..
T Consensus       157 Nil~~~~~---~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG---LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC---CEEEeccccCc
Confidence            99998654   78999998763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.04  E-value=0.00015  Score=68.43  Aligned_cols=76  Identities=18%  Similarity=0.110  Sum_probs=53.9

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecC--------CcccHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEEE
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--------~~~~~~~~~e~~~l~~l~---hpnIv~~~~~~~~~~~~~l   94 (363)
                      .+.||.|.+..||.+.+...++.++||.-...        ....++...|...|+.+.   ..++++++.+  ++...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            57899999999999998654468999974311        123456677777777653   3467777766  4455689


Q ss_pred             EEeccCCCc
Q 017936           95 VMEYASGGE  103 (363)
Q Consensus        95 v~e~~~~~~  103 (363)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998644

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.04  E-value=1.1e-06  Score=91.95  Aligned_cols=209  Identities=13%  Similarity=0.064  Sum_probs=142.5

Q ss_pred             HHHHHHHHHcCCCCCeeeeeEEEEc--CCeEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHcC
Q 017936           64 VQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQ  137 (363)
Q Consensus        64 ~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~L~~LH~~g  137 (363)
                      ...|...++...|+++.....-...  ....+..++||.+|.++..+.+..    .+.+.-+.....+.+.+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3445555667789998887665543  235689999999999999886543    3444444444455577777777542


Q ss_pred             -----ceecCCCCCCEEEeCCCCCcEEEeecCCcc-cCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHH
Q 017936          138 -----VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYV  211 (363)
Q Consensus       138 -----iiHrDlkp~NIll~~~~~~~vkL~DFgla~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~  211 (363)
                           .+|+++|+-|.+|..+-.  ++++++|+.+ ............+++.|++|++.+.-.++.+ +|+|+.|+.+|.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYL 1432 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHH
Confidence                 789999999999976654  9999999998 4333444456678899999999988888777 999999999999


Q ss_pred             HHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017936          212 MLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       212 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                      +..|..+|.     ...+...+.+...........-.|.+.......+|-..-..||.-...+..+.|.
T Consensus      1433 rs~~n~~fi-----~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1433 RSDGNAYFI-----FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HhcccHHHH-----HHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            998887773     2222223332222221111122344455555555556667889888888777763

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.95  E-value=9e-05  Score=67.82  Aligned_cols=76  Identities=13%  Similarity=0.127  Sum_probs=49.8

Q ss_pred             eceecccCCeEEEEEEEcC------CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEcCCeEEEEEec
Q 017936           26 VRDIGSGNFGVARLMRDKK------TEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e~   98 (363)
                      ++.|..|-...+|++....      .++.+++|+............+|..+++.+...+ .++++.++..    ..|++|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            4556667777999887543      2578999987665444445678888887775333 3445555432    358999


Q ss_pred             cCCCchH
Q 017936           99 ASGGELF  105 (363)
Q Consensus        99 ~~~~~L~  105 (363)
                      ++|.++.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.94  E-value=8.2e-05  Score=67.84  Aligned_cols=137  Identities=18%  Similarity=0.149  Sum_probs=81.2

Q ss_pred             eeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eeeeeE------EEEcCCeEEEEE
Q 017936           25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVM   96 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~~~~------~~~~~~~~~lv~   96 (363)
                      -++.|..|....+|++...  +..+++|+...  .....+..|+.++..+.+.+  +++++.      +....+..++|+
T Consensus        18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             heecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            3667888888899998743  34689998764  23455667777777664322  344433      123345678999


Q ss_pred             eccCCCchHH----H-------HH---hC-CCCCH--------HHHH------------HHHHHHHHHHHHHHH------
Q 017936           97 EYASGGELFE----R-------IC---NA-GRFSE--------DEAR------------FFFQQLISGVSYCHS------  135 (363)
Q Consensus        97 e~~~~~~L~~----~-------~~---~~-~~l~~--------~~~~------------~~~~qil~~L~~LH~------  135 (363)
                      ++++|.++..    .       +.   .. ..+..        .-..            .....+..++.++.+      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999876521    0       00   00 00000        0000            011122334444443      


Q ss_pred             -cCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       136 -~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                       .+++|+|+.|.||+++.++.  +.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDEL--SGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence             47999999999999986432  5799998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.80  E-value=0.00042  Score=63.93  Aligned_cols=75  Identities=11%  Similarity=0.030  Sum_probs=44.7

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eeeeeE------EEEcCCeEEEEEe
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVME   97 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~~~~------~~~~~~~~~lv~e   97 (363)
                      ++.|+.|....+|.+... +| .+++|++..  ...+.+..++..++.|...+  +++.+.      +....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeC-CC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            466777888899998753 33 689998762  22344445555555442111  233322      1223456789999


Q ss_pred             ccCCCch
Q 017936           98 YASGGEL  104 (363)
Q Consensus        98 ~~~~~~L  104 (363)
                      |++|..+
T Consensus       103 ~l~G~~~  109 (319)
T PRK05231        103 FLEGKWP  109 (319)
T ss_pred             ecCCCCC
Confidence            9998754

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.79  E-value=0.00019  Score=65.65  Aligned_cols=139  Identities=22%  Similarity=0.215  Sum_probs=94.3

Q ss_pred             eeeceecccCCeEEEEEEEcCCCcEEEEEEeecC-----------------------Ccc----cHHHHHHHHHHHcCCC
Q 017936           24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----------------------DKI----DENVQREIINHRSLRH   76 (363)
Q Consensus        24 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----------------------~~~----~~~~~~e~~~l~~l~h   76 (363)
                      .|-..|..|.-+.||.|.. .+|..+|||+++.+                       ...    ......|++.|.++..
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            4456788899999999885 66788999987431                       001    1124567777777765


Q ss_pred             CCeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCCCEEEeCCCC
Q 017936           77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPA  155 (363)
Q Consensus        77 pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH-~~giiHrDlkp~NIll~~~~~  155 (363)
                      -.|+.- +-..-.++ .|||+++....--.-..+.-.++...+..+-.|++.-+.-|- .+++||.||.--|+|+..   
T Consensus       226 aGIP~P-ePIlLk~h-VLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd---  300 (520)
T KOG2270|consen  226 AGIPCP-EPILLKNH-VLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD---  300 (520)
T ss_pred             cCCCCC-Cceeeecc-eEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC---
Confidence            553322 11111222 699999954322221223345788889999999998888876 579999999999999964   


Q ss_pred             CcEEEeecCCccc
Q 017936          156 PRLKICDFGYSKS  168 (363)
Q Consensus       156 ~~vkL~DFgla~~  168 (363)
                      |++.++|-+.|..
T Consensus       301 G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 GKLYIIDVSQSVE  313 (520)
T ss_pred             CEEEEEEcccccc
Confidence            3499999987653

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.78  E-value=0.0004  Score=63.74  Aligned_cols=140  Identities=19%  Similarity=0.170  Sum_probs=80.5

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eeeeeEE------EEcCCeEEE
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAI   94 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~~~~~------~~~~~~~~l   94 (363)
                      ...++.++.|....+|++.. .++ .+++|+..... ....+..|+.+++.|....  +++++..      ....+..++
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~  100 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC  100 (307)
T ss_pred             ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence            44467788888889999874 333 58899765532 2345556667666664222  3333331      122456789


Q ss_pred             EEeccCCCchH-----------HHH---Hh-CCCCCH-------HHHH----------------HHHHHHHHHHHHHHH-
Q 017936           95 VMEYASGGELF-----------ERI---CN-AGRFSE-------DEAR----------------FFFQQLISGVSYCHS-  135 (363)
Q Consensus        95 v~e~~~~~~L~-----------~~~---~~-~~~l~~-------~~~~----------------~~~~qil~~L~~LH~-  135 (363)
                      +++|++|.++.           ..+   .. ...++.       ...+                .....+...++++.. 
T Consensus       101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~  180 (307)
T TIGR00938       101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF  180 (307)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence            99999885532           111   00 000100       0000                001123334555542 


Q ss_pred             ------cCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          136 ------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       136 ------~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                            .+++|+|+++.||+++.++.  +.|+||+.+.
T Consensus       181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~  216 (307)
T TIGR00938       181 WPRDLPRGVIHADLFPDNVLFDGDSV--KGVIDFYFAC  216 (307)
T ss_pred             hhhcCCCccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence                  68999999999999986542  6899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.59  E-value=0.00033  Score=59.30  Aligned_cols=97  Identities=14%  Similarity=0.071  Sum_probs=76.0

Q ss_pred             HHHHHHHHcCCC-CCeeeeeEEEEcCCeEEEEEeccCCCchHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 017936           65 QREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHS---MQ  137 (363)
Q Consensus        65 ~~e~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~---~~~~~~l~~~~~~~~~~qil~~L~~LH~---~g  137 (363)
                      ..|..+++.+.+ +++++++|++=.    +++.||...+++...   +.....-++.....++.++++.+.+|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357788888876 699999999832    678899987665421   1122235889999999999999999997   45


Q ss_pred             ceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       138 iiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      +.-.|++|+|+-++.++.  +|++|...+.
T Consensus        83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~  110 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVF  110 (188)
T ss_pred             EEEeecchHHeEEeCCCc--EEEEechhcc
Confidence            888999999999986554  9999998764

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.54  E-value=7.5e-05  Score=67.17  Aligned_cols=133  Identities=14%  Similarity=0.161  Sum_probs=91.8

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-------------------cc----cHHHHHHHHHHHcCCCC-
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-------------------KI----DENVQREIINHRSLRHP-   77 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------------------~~----~~~~~~e~~~l~~l~hp-   77 (363)
                      =|.+..+||-|.-+-||++-+ ..|+..++|+-....                   .+    .-...+|...|+.|... 
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            367888999999999999987 457778999532110                   00    11235677777777432 


Q ss_pred             -CeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCC
Q 017936           78 -NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP  156 (363)
Q Consensus        78 -nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~  156 (363)
                       -+++.+++    +.-++|||++.|.+|.+...      ...+..+...+...+--|-..|+||+|..--||+++.++. 
T Consensus       172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~-  240 (465)
T KOG2268|consen  172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK-  240 (465)
T ss_pred             CCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC-
Confidence             23333332    33489999999988865431      2234455566666777789999999999999999986554 


Q ss_pred             cEEEeecCCcc
Q 017936          157 RLKICDFGYSK  167 (363)
Q Consensus       157 ~vkL~DFgla~  167 (363)
                       ++++||-...
T Consensus       241 -i~vIDFPQmv  250 (465)
T KOG2268|consen  241 -IVVIDFPQMV  250 (465)
T ss_pred             -EEEeechHhh
Confidence             9999997543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.46  E-value=0.0027  Score=58.80  Aligned_cols=74  Identities=19%  Similarity=0.174  Sum_probs=48.1

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeec-----C---CcccHHHHHHHHHHHcCC--CC-CeeeeeEEEEcCCeEEEE
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----G---DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~---~~~~~~~~~e~~~l~~l~--hp-nIv~~~~~~~~~~~~~lv   95 (363)
                      +.||.|....||++.+...++.++||.-..     +   +...++..-|...|+...  .| .+++++.  .++....+|
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~v   78 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTV   78 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccceeh
Confidence            357999999999999864446899997431     1   223355566777776553  34 4555544  345555799


Q ss_pred             EeccCCC
Q 017936           96 MEYASGG  102 (363)
Q Consensus        96 ~e~~~~~  102 (363)
                      ||+++..
T Consensus        79 MEdL~~~   85 (370)
T TIGR01767        79 MEDLSHH   85 (370)
T ss_pred             HhhCccc
Confidence            9998553

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=97.39  E-value=0.0021  Score=60.02  Aligned_cols=138  Identities=15%  Similarity=0.185  Sum_probs=79.8

Q ss_pred             eeceecccCCeEEEEEEEcC----CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEcCCeEEEEEecc
Q 017936           25 LVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~   99 (363)
                      -++.|..|-...+|++....    .++.|++|+........-+-.+|..+++.+..-++ +++++.+.. .   .|.+|+
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi  115 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI  115 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence            34556558888999987432    34689999876543222223678888877754333 345555533 2   578898


Q ss_pred             CCCchHHH--------------HH---hCC------CCCHHHHHHHHHHHH-----------------HHHHHH----H-
Q 017936          100 SGGELFER--------------IC---NAG------RFSEDEARFFFQQLI-----------------SGVSYC----H-  134 (363)
Q Consensus       100 ~~~~L~~~--------------~~---~~~------~l~~~~~~~~~~qil-----------------~~L~~L----H-  134 (363)
                      ++.++...              +.   ...      .....++..++.++.                 ..+..|    . 
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            88776421              11   000      011233334432221                 111112    1 


Q ss_pred             ---HcCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          135 ---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       135 ---~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                         ...++|+|+++.|||++... +.+.|+||..|.
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~  230 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS  230 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence               23589999999999997532 359999998765

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.32  E-value=0.0024  Score=59.27  Aligned_cols=75  Identities=16%  Similarity=0.181  Sum_probs=46.3

Q ss_pred             eceecccCCeEEEEEEEcCC---CcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEcCCeEEEEEeccCC
Q 017936           26 VRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      ++.|..|-...+|++.....   +..|++|+........-+-.+|..+++.+..-++ ++++.++. ++   +|.+|++|
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            44555587788998875432   3478999876543322223567788877764444 45555553 22   58889887


Q ss_pred             Cch
Q 017936          102 GEL  104 (363)
Q Consensus       102 ~~L  104 (363)
                      .+|
T Consensus        95 ~~l   97 (330)
T PLN02421         95 RTL   97 (330)
T ss_pred             CCC
Confidence            765

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.25  E-value=0.00088  Score=63.91  Aligned_cols=166  Identities=16%  Similarity=0.198  Sum_probs=101.2

Q ss_pred             HHHHHHHHHHHcCCCCCeeeeeEEEEcC-CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcee
Q 017936           62 ENVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH  140 (363)
Q Consensus        62 ~~~~~e~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiH  140 (363)
                      ..+.-...+++.+.|+|...++++.... ....+|||++ +.+|.+.+.... +-.....                  .|
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~~   86 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------AH   86 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------cc
Confidence            3455567888999999999999987654 4578999999 668888766543 1111100                  22


Q ss_pred             cCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCC
Q 017936          141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE  220 (363)
Q Consensus       141 rDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  220 (363)
                      |=+ +-||         ++.+| .++..    .  .+..|                 +++||||+|.++.++.-|...+.
T Consensus        87 ~~~-~~~~---------~~~td-~~~t~----~--~~~~~-----------------pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   87 GVL-HLNI---------IYITD-HFLTK----Y--PSPIG-----------------PKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             ccc-eehh---------hhccc-ccccc----C--CCCCC-----------------cchhhhhHHHHHHHHHHhhHHHH
Confidence            211 1111         33444 11110    0  11111                 24999999999999999988776


Q ss_pred             CCCchHHHHHHHHHHhccccCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          221 DPEEPKNFRKTIHRILSVQYSIP-------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .....+.... +.+....+....       ....++.....++.+|+...|..||...++.+++-|.+-
T Consensus       133 ~~~~s~~l~~-i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  133 ELTESEYLEI-LLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHH-HHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            5444332222 221111111000       011246668889999999999999999999999999653

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.24  E-value=0.0024  Score=57.55  Aligned_cols=30  Identities=23%  Similarity=0.325  Sum_probs=23.9

Q ss_pred             CceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       137 giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      .++|+|++|.|||++.++. ..-|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence            4899999999999985322 25699999776

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.13  E-value=0.0061  Score=57.24  Aligned_cols=74  Identities=19%  Similarity=0.144  Sum_probs=50.3

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeec----C---CcccHHHHHHHHHHHcCC--CC-CeeeeeEEEEcCCeEEEE
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIER----G---DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~----~---~~~~~~~~~e~~~l~~l~--hp-nIv~~~~~~~~~~~~~lv   95 (363)
                      ++.||.|.-.-||++.+...++.++||.-..    .   +...++..-|...|+...  .| ++++++.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            7889999999999999854456799997431    1   223456666777777553  34 45556443  45556789


Q ss_pred             EeccCC
Q 017936           96 MEYASG  101 (363)
Q Consensus        96 ~e~~~~  101 (363)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.05  E-value=0.0066  Score=55.47  Aligned_cols=144  Identities=12%  Similarity=0.099  Sum_probs=81.7

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeec---CCcccHHHHHHHHHHHcCCCC--CeeeeeEEEEcCC--eEEEE
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP--NIVRFKEVILTPT--HLAIV   95 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~e~~~l~~l~hp--nIv~~~~~~~~~~--~~~lv   95 (363)
                      ..+++....|....+|.....  ++.+++. ...   .........+|+..++.+.--  -+.+.++.+..+.  ..|.|
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            455555655555566666544  7778888 331   122345567888888876532  2333444444444  56999


Q ss_pred             EeccCCCchHHH------------------HHhC--------------CCCCHHHHHHHHHHH--------------HHH
Q 017936           96 MEYASGGELFER------------------ICNA--------------GRFSEDEARFFFQQL--------------ISG  129 (363)
Q Consensus        96 ~e~~~~~~L~~~------------------~~~~--------------~~l~~~~~~~~~~qi--------------l~~  129 (363)
                      |+|+.|..+.+.                  +..-              ..+...++..+..+.              ..-
T Consensus       104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            999988322111                  1100              001112222222222              222


Q ss_pred             HHHHHHc--------CceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936          130 VSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus       130 L~~LH~~--------giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ..+|+.+        .++|||+++.||+++..+.  +-+.||+++....+
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lGDP  231 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATLGDP  231 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEeccccccCCc
Confidence            3444432        4899999999999986655  89999999875443

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.96  E-value=0.024  Score=51.99  Aligned_cols=29  Identities=31%  Similarity=0.620  Sum_probs=24.4

Q ss_pred             cCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       136 ~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      .+++|||+.+.||+++. +  .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~--~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N--EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C--cEEEEECcccc
Confidence            57999999999999975 3  38999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.85  E-value=0.017  Score=52.98  Aligned_cols=29  Identities=21%  Similarity=0.266  Sum_probs=25.1

Q ss_pred             CceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       137 giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      +++|+|+.+.|+|++.++.  +.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence            7999999999999976654  8999998765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.82  E-value=0.036  Score=51.33  Aligned_cols=72  Identities=13%  Similarity=0.059  Sum_probs=43.9

Q ss_pred             cCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eee---eeE--EEEcCCeEEEEEeccCCCch
Q 017936           32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVR---FKE--VILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        32 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~---~~~--~~~~~~~~~lv~e~~~~~~L  104 (363)
                      +.-..||.+.. .++..+++|+..........+..|+..+..|....  ++.   .-+  +...++..+.++++++|...
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            34457888875 44567999987655445566777877776653211  121   111  22334567889999987643

>PTZ00384 choline kinase; Provisional

Probab=96.76  E-value=0.023  Score=53.64  Aligned_cols=78  Identities=9%  Similarity=0.005  Sum_probs=45.7

Q ss_pred             eeeceecccCCeEEEEEEEcCCC-cE-----EEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEcCCeEEEEE
Q 017936           24 ELVRDIGSGNFGVARLMRDKKTE-EL-----VAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        24 ~i~~~lg~G~~g~V~~~~~~~~~-~~-----~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~   96 (363)
                      ..++.|..|-...+|++...... ..     |.++.........-+-.+|+.+++.+...+ -+++++.+..    +++.
T Consensus        53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~  128 (383)
T PTZ00384         53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ  128 (383)
T ss_pred             EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence            34455655888899999754321 22     344432222111112356888888886544 4555666543    6999


Q ss_pred             eccCCCchH
Q 017936           97 EYASGGELF  105 (363)
Q Consensus        97 e~~~~~~L~  105 (363)
                      ||++|.+|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999987764

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.68  E-value=0.041  Score=52.08  Aligned_cols=73  Identities=16%  Similarity=0.186  Sum_probs=50.0

Q ss_pred             eeceecccCCeEEEEEEEcCCCcEEEEEEeec-----CC---cccHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEE
Q 017936           25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GD---KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~---~~~~~~~~e~~~l~~l~---hpnIv~~~~~~~~~~~~~   93 (363)
                      ..+.||.|....||++.+.  ++.++||.-..     +.   ....+...|...|+.+.   ..++++++.+..+  .-+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence            4788899999999999873  45689997642     21   12344455566665543   3578888887763  347


Q ss_pred             EEEeccCC
Q 017936           94 IVMEYASG  101 (363)
Q Consensus        94 lv~e~~~~  101 (363)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.56  E-value=0.0053  Score=52.97  Aligned_cols=55  Identities=16%  Similarity=0.113  Sum_probs=32.5

Q ss_pred             CcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEcCCeEEEEEeccCCCch
Q 017936           46 EELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        46 ~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      ++.|++++........-.-..|..+++.+...++ +++++.+..    ..|.+|++|.+|
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE-
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEeccccc
Confidence            4578899887764444455678888877754333 555555533    256688877665

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.51  E-value=0.036  Score=50.22  Aligned_cols=75  Identities=11%  Similarity=0.073  Sum_probs=49.0

Q ss_pred             eeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEEEEEeccC
Q 017936           24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        24 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~  100 (363)
                      +-.+.++.|..+.+|.+.  .+++.+.+|+-.  ......+..|..-|+.|.   .-.+++.+.+....+.-++||||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            446788999999999987  677889999766  333456778888777773   4567888888887777799999997


Q ss_pred             CC
Q 017936          101 GG  102 (363)
Q Consensus       101 ~~  102 (363)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            66

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00296 choline kinase; Provisional

Probab=96.35  E-value=0.042  Score=52.92  Aligned_cols=76  Identities=16%  Similarity=0.051  Sum_probs=46.6

Q ss_pred             eeceecccCCeEEEEEEEcCC--------CcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCee-eeeEEEEcCCeEEEE
Q 017936           25 LVRDIGSGNFGVARLMRDKKT--------EELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIV   95 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~--------~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv-~~~~~~~~~~~~~lv   95 (363)
                      -++.|..|-...+|++.....        ++.|.+++........-.-.+|..+++.+...+|- ++++.+. +   +.|
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~I  184 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---GRI  184 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---CEE
Confidence            566777688888999875421        46789998765432222335677776666533332 4455543 2   457


Q ss_pred             EeccCCCch
Q 017936           96 MEYASGGEL  104 (363)
Q Consensus        96 ~e~~~~~~L  104 (363)
                      .+|++|.+|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            889888754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.24  E-value=0.068  Score=49.34  Aligned_cols=136  Identities=16%  Similarity=0.187  Sum_probs=80.3

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC------eeeeeE----EEEcCCeEEEEE
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKE----VILTPTHLAIVM   96 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn------Iv~~~~----~~~~~~~~~lv~   96 (363)
                      ..|.+ .-..||.+... .|+ +++|+.... .....+..|+..+..|.-..      +..+-+    ........+-++
T Consensus        32 ~~l~s-~eN~~f~~~~~-~g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          32 RGLNS-EENSNFRVQTE-DGR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             ccccc-ccCceEEEEec-CCC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            33444 45578888754 333 499988877 66677778888887663211      222222    111223778999


Q ss_pred             eccCCCchHH-H--------------HH----hCC----C-C---CHH----HH---------HHHHHHHHHHHHHHHH-
Q 017936           97 EYASGGELFE-R--------------IC----NAG----R-F---SED----EA---------RFFFQQLISGVSYCHS-  135 (363)
Q Consensus        97 e~~~~~~L~~-~--------------~~----~~~----~-l---~~~----~~---------~~~~~qil~~L~~LH~-  135 (363)
                      +|++|..+.. .              +.    ...    . +   ...    ..         .....++...+..+.+ 
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999987762 1              00    000    0 0   010    00         0123344555555553 


Q ss_pred             -------cC--ceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          136 -------MQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       136 -------~g--iiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                             .+  +||+|+.|.||+++.+.. .+.++||+-+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence                   34  999999999999986653 37899999765

>PRK06148 hypothetical protein; Provisional

Probab=96.10  E-value=0.16  Score=54.40  Aligned_cols=140  Identities=15%  Similarity=0.198  Sum_probs=77.4

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-------CCCCeeeee-----EEEEc-CC--
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-------RHPNIVRFK-----EVILT-PT--   90 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-------~hpnIv~~~-----~~~~~-~~--   90 (363)
                      .+.|+ |..-.+|++.. .+++.|++|+.+... ....+..|...+..|       .-|.+++-.     ..... .+  
T Consensus        30 ~~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~  106 (1013)
T PRK06148         30 ATPLD-GERDLNFRLTT-DDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP  106 (1013)
T ss_pred             EeecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence            35675 45678888875 456689999987643 223333444444333       334444422     11111 22  


Q ss_pred             eEEEEEeccCCCchHHH-----------------HH----hC------CCCC-----------------HHHHHHHHHHH
Q 017936           91 HLAIVMEYASGGELFER-----------------IC----NA------GRFS-----------------EDEARFFFQQL  126 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~-----------------~~----~~------~~l~-----------------~~~~~~~~~qi  126 (363)
                      +.+.+++|++|..+.+.                 +.    ..      ..+.                 ....+.++.++
T Consensus       107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~  186 (1013)
T PRK06148        107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF  186 (1013)
T ss_pred             EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence            56788999999877541                 00    00      0000                 01122233333


Q ss_pred             HHHHHH-----HH--HcCceecCCCCCCEEEeCCCCCcEE-EeecCCccc
Q 017936          127 ISGVSY-----CH--SMQVCHRDLKLENTLLDGSPAPRLK-ICDFGYSKS  168 (363)
Q Consensus       127 l~~L~~-----LH--~~giiHrDlkp~NIll~~~~~~~vk-L~DFgla~~  168 (363)
                      +..+..     +.  ..++||+|+.+.|||++.+...++. |+|||-+..
T Consensus       187 ~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        187 LARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            333322     22  2579999999999999866432455 999998763

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.86  E-value=0.034  Score=51.28  Aligned_cols=86  Identities=23%  Similarity=0.226  Sum_probs=59.6

Q ss_pred             CCCCeeeeeEEEEcC-CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCCEEEeC
Q 017936           75 RHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDG  152 (363)
Q Consensus        75 ~hpnIv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~-giiHrDlkp~NIll~~  152 (363)
                      ..++..+.+-+-.++ ...|++|++- |+++...    ..-..+++..++.+.+..|.-+..+ ..-|||+...||||+ 
T Consensus       283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-  356 (488)
T COG5072         283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-  356 (488)
T ss_pred             cchhhhcceEEecCCceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-
Confidence            344444443333233 3567888875 5555321    1235678888999988888777754 689999999999998 


Q ss_pred             CCCCcEEEeecCCccc
Q 017936          153 SPAPRLKICDFGYSKS  168 (363)
Q Consensus       153 ~~~~~vkL~DFgla~~  168 (363)
                      +|+  |-|+||-+|+.
T Consensus       357 ~Gn--vtLIDfklsRl  370 (488)
T COG5072         357 EGN--VTLIDFKLSRL  370 (488)
T ss_pred             cCc--eEEEEeeeeec
Confidence            454  99999999984

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.77  E-value=0.051  Score=46.73  Aligned_cols=97  Identities=19%  Similarity=0.106  Sum_probs=60.3

Q ss_pred             EEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHH
Q 017936           50 AVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI  127 (363)
Q Consensus        50 aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil  127 (363)
                      .+|.+...+-  ....+..+..+++++  ..|+++..=  ....+.++.|+|......         +.    .++.-=+
T Consensus        89 ~lKKi~slp~~~~~~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i~---------~~----N~i~agi  151 (308)
T PF07387_consen   89 FLKKIRSLPCCINDALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKIN---------FS----NFITAGI  151 (308)
T ss_pred             hhhhccCCCcccchhhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCcccc---------hh----HHHHHhH
Confidence            4444443322  344566677777654  367777632  334578999999542221         11    1111114


Q ss_pred             HHHHHHHH--cCceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936          128 SGVSYCHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus       128 ~~L~~LH~--~giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                      .+|.-.|+  .+.+|||..|+|||-+..+.  +||.|=+.
T Consensus       152 ~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~  189 (308)
T PF07387_consen  152 KDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPVC  189 (308)
T ss_pred             HHHHHhhccCCCeecCCCChhheeecCCCC--EEecChhh
Confidence            56777883  57999999999999987776  99998663

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.37  E-value=0.091  Score=49.31  Aligned_cols=63  Identities=16%  Similarity=0.108  Sum_probs=44.6

Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCCCEEEeCCCC
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPA  155 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH-~~giiHrDlkp~NIll~~~~~  155 (363)
                      ..++-+|..|.++...+... ..++.-...++.--.+||--|- -.+++|.|+.|.||++..+..
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~t  383 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNKT  383 (565)
T ss_pred             ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecCC
Confidence            35666688898888777643 2455566666666666665544 568999999999999975443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	363
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		0.0
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		0.0
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		0.0
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-180
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-172
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-170
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-56
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-51
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-51
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-51
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-50
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-50
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-49
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-49
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-49
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-49
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-49
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-49
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-48
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-48
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-48
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-48
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-48
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-47
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-42
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-42
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-41
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-40
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-40
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-40
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-40
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-40
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-40
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-40
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-40
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-40
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-40
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-40
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-40
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-40
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-40
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-40
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-40
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-40
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-39
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-39
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-39
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-39
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-39
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-39
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-39
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-39
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-39
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-38
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-38
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-38
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-38
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-38
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-38
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-38
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-38
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-38
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-38
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-38
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-38
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-38
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-38
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-38
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-38
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-38
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-38
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-38
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-38
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-38
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-38
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-38
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-38
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-38
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-38
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-38
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-38
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-38
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-38
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-38
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-37
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-37
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-37
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-37
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-37
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-37
3soa_A	444	Full-Length Human Camkii Length = 444		5e-37
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-37
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-37
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-37
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-37
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-37
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-37
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-37
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-37
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-37
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-37
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-37
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-37
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-37
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-36
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-36
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-36
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-36
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-36
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-36
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-36
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-36
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-36
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-36
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-36
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-36
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-36
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-36
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-36
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-36
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-36
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-36
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-36
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-36
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-36
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-35
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-35
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-35
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-35
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-35
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-35
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-34
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-34
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-34
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-34
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-34
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-34
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-34
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-34
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-34
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-34
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-34
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-34
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-34
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-33
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-33
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-33
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-33
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-33
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-33
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-33
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-33
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-33
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-33
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-33
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-33
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-33
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-33
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-33
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-33
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-33
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-33
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-33
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-33
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-33
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-32
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-32
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-32
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-32
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-32
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-32
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-32
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-32
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-32
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-32
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-32
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-32
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-32
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-32
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-32
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-32
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-32
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-32
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-32
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-32
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-32
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-32
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-32
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-32
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-32
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-32
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-32
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-32
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-32
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-32
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-32
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-32
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-32
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-32
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-32
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-32
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-32
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-32
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-32
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-32
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-32
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-32
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-32
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-32
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-32
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-31
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-31
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-31
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-31
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-31
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-31
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-31
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-31
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-31
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-31
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-31
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-31
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-31
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-31
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-31
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-31
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-31
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-31
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-31
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-31
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-31
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-31
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-31
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-31
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-31
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-31
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-31
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-31
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-31
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-31
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-31
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-31
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-31
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-30
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-30
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-30
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-30
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-30
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-30
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-30
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-29
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-29
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-29
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-29
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-29
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-28
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-28
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-28
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-27
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-27
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-27
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-27
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-26
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-26
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-26
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-26
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-26
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-26
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-26
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-26
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-26
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-26
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-26
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-26
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-26
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-26
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-26
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-26
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-26
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-26
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-26
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-26
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-26
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-26
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-26
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-26
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-26
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-26
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-26
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-26
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-26
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-26
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-25
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-25
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-25
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-25
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-25
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-25
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-24
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-24
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-24
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-24
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-23
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-23
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-23
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-23
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-23
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-23
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-23
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-23
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-23
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-23
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-23
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-23
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-23
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-23
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-23
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-23
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-23
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-23
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-23
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-23
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-23
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-23
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-23
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-23
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-23
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-23
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-22
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-22
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-22
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-22
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-22
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-22
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-22
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-22
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-22
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-22
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-22
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-22
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-22
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-22
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-22
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-22
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-22
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-22
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-22
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-22
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-22
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-22
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-22
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-22
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-22
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-22
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-22
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-22
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-22
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-22
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-22
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-22
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-22
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-22
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-22
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-22
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-22
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-22
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-22
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-22
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-22
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-22
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-22
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-21
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-21
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-21
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-21
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-21
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-21
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-21
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-21
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-21
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-21
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-21
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-21
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-21
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-21
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-21
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-21
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-21
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-21
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-21
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-21
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-21
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-21
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-21
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-21
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-21
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-21
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-21
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-21
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-21
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-21
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-21
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-21
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-21
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-20
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-20
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-20
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-20
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-20
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-20
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-20
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-20
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-20
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-20
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-20
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-20
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-19
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-19
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-19
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-19
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-19
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-19
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-19
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-19
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-19
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-19
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-19
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-19
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-19
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-19
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-19
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-19
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-19
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-18
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-18
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-18
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-18
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-18
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-18
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-18
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-18
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-17
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-17
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-17
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-17
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-17
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-17
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-17
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-17
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-17
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-17
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-17
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-17
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-17
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-17
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-17
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-17
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-17
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-17
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-17
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-17
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-17
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-17
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-17
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-17
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-17
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-17
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-17
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-17
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-17
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-17
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-17
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-17
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-17
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-17
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-17
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-17
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-17
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-17
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-17
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-17
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-17
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-17
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-17
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-17
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-17
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-17
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-17
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-17
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-17
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-17
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-17
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-17
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-17
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-17
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-17
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-17
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-17
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-17
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-17
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-17
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-17
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-17
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-17
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-16
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-16
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-16
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-16
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-16
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-16
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-16
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-16
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-16
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-16
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-16
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-16
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-16
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-16
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-16
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-16
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-15
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-15
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-15
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-15
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-15
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-15
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-15
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-15
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-15
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-15
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-15
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-15
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-15
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-15
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-15
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-15
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-15
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-15
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-15
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-15
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-15
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-14
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-14
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-14
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-14
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-14
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-14
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-14
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		9e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-13
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-13
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-13
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		8e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-13
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		9e-13
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		9e-13
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-12
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-12
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-12
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-12
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-12
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-12
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-12
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-12
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-12
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-11
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-11
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		8e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-10
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-10
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-10
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-10
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-10
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-10
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-10
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-10
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-10
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-10
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-10
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-10
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-09
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-09
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		8e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-09
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-08
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		7e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		7e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		7e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-08
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		8e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		8e-08
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		8e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		8e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		8e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		9e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-07
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		2e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-07
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		7e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-06
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		1e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-06
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		3e-06
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		3e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-06
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		4e-06
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-06
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		4e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-05

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  633 bits (1632), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 312/364 (85%), Positives = 329/364 (90%), Gaps = 3/364 (0%)
Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1   MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKIC FGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           +IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL+ DNT   QF+E 
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298
Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSL-XXXXXXXXXXXXXXXXXXXSSGEI 359
           DQP QSI+EIMQIIAEAT+P AGTQ+LN  L GSL                    SSGEI
Sbjct: 299 DQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSGEI 358
Query: 360 VYAM 363
           VYAM
Sbjct: 359 VYAM 362

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  631 bits (1628), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/364 (85%), Positives = 328/364 (90%), Gaps = 3/364 (0%)
Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1   MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKIC FGYSKSSVLHSQPK TVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           +IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL+ DNT   QF+E 
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298
Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSL-XXXXXXXXXXXXXXXXXXXSSGEI 359
           DQP QSI+EIMQIIAEAT+P AGTQ+LN  L GSL                    SSGEI
Sbjct: 299 DQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSGEI 358
Query: 360 VYAM 363
           VYAM
Sbjct: 359 VYAM 362

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  630 bits (1626), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/364 (85%), Positives = 328/364 (90%), Gaps = 3/364 (0%)
Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1   MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
             NV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59  AANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           +IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL+ DNT   QF+E 
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298
Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSL-XXXXXXXXXXXXXXXXXXXSSGEI 359
           DQP QSI+EIMQIIAEAT+P AGTQ+LN  L GSL                    SSGEI
Sbjct: 299 DQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSGEI 358
Query: 360 VYAM 363
           VYAM
Sbjct: 359 VYAM 362

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  627 bits (1618), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 305/352 (86%), Positives = 319/352 (90%), Gaps = 1/352 (0%)
Query: 13  DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
           D+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KIDENV+REIINHR
Sbjct: 10  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHR 69
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 129
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           CH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK
Sbjct: 130 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 189
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
           KEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY+IPDYVHISPEC
Sbjct: 190 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC 249
Query: 253 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 312
           RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL+ DNT   QF   DQP QSI+EIMQ
Sbjct: 250 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFAASDQPGQSIEEIMQ 309
Query: 313 IIAEATIPAAGTQSLNQCLNGSL-XXXXXXXXXXXXXXXXXXXSSGEIVYAM 363
           IIAEAT+P AGTQ+LN  L GSL                    SSGEIVYAM
Sbjct: 310 IIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSGEIVYAM 361

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  601 bits (1549), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 287/319 (89%), Positives = 303/319 (94%), Gaps = 2/319 (0%)
Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDR A+  GP MD+PIMHDSDRYELV+DIG+GNFGVARLMRDK+  ELVAVKYIERG+KI
Sbjct: 1   MDRPAVA-GP-MDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKI 58
Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQLISGVSY H+MQV HRDLKLENTLLDGSPAPRLKI DFGYSK+SVLHSQPKS VG
Sbjct: 119 FFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           +IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL+ DNT   QF+E 
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298
Query: 301 DQPMQSIDEIMQIIAEATI 319
           DQP QSI+EIMQIIAEAT+
Sbjct: 299 DQPGQSIEEIMQIIAEATV 317

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  595 bits (1534), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 288/366 (78%), Positives = 318/366 (86%), Gaps = 8/366 (2%)
Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERG  I
Sbjct: 1   MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59
Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           SIPD + ISPEC HLISRIFVADPA RISIPEI+ H WFLKNLPADL+ ++ T +QF+EP
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299
Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLXXXXXXXXXXXXXXXXXXX---SSG 357
           +QPMQS+D IMQII+EATIPA      N+CL+  +                      SSG
Sbjct: 300 EQPMQSLDTIMQIISEATIPAVR----NRCLDDFMTDNLDLDDDMDDFDSESEIDIDSSG 355
Query: 358 EIVYAM 363
           EIVYA+
Sbjct: 356 EIVYAL 361

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  215 bits (547), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 120/266 (45%), Positives = 162/266 (60%), Gaps = 13/266 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----GDKIDENVQREIINHRSLRHPN 78
           Y +   +G G+FG  +L    KT++ VA+K+I R       +   V+REI   + LRHP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I++  +VI TPT + +V+EYA GGELF+ I    R +EDE R FFQQ+I  + YCH  ++
Sbjct: 71  IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRDLK EN LLD +    +KI DFG S      +  K++ G+P Y APEV+  K Y G 
Sbjct: 130 VHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
             DVWSCG+ LYVMLVG  PF+D   P  F+K    + S  Y +PD+  +SP  + LI R
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPDF--LSPGAQSLIRR 241
Query: 259 IFVADPAKRISIPEIRNHEWFLKNLP 284
           + VADP +RI+I EIR   WF  NLP
Sbjct: 242 MIVADPMQRITIQEIRRDPWFNVNLP 267

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 113/269 (42%), Positives = 151/269 (56%), Gaps = 12/269 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           Y L   +G G FG  ++   + T   VAVK + R       +   ++REI N +  RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I++  +VI TPT   +VMEY SGGELF+ IC  GR  E EAR  FQQ++S V YCH   V
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRDLK EN LLD       KI DFG S         +++ G+P Y APEV+  + Y G 
Sbjct: 133 VHRDLKPENVLLDAHMNA--KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
             D+WSCGV LY +L G  PF+D   P  F+K    I    + IP+Y++ S     L+  
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEYLNRSVAT--LLMH 244
Query: 259 IFVADPAKRISIPEIRNHEWFLKNLPADL 287
           +   DP KR +I +IR HEWF ++LP+ L
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  199 bits (507), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 113/269 (42%), Positives = 150/269 (55%), Gaps = 12/269 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           Y L   +G G FG  ++   + T   VAVK + R       +   ++REI N +  RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I++  +VI TPT   +VMEY SGGELF+ IC  GR  E EAR  FQQ++S V YCH   V
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRDLK EN LLD       KI DFG S         + + G+P Y APEV+  + Y G 
Sbjct: 133 VHRDLKPENVLLDAHMNA--KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
             D+WSCGV LY +L G  PF+D   P  F+K    I    + IP+Y++ S     L+  
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEYLNRSVAT--LLMH 244
Query: 259 IFVADPAKRISIPEIRNHEWFLKNLPADL 287
           +   DP KR +I +IR HEWF ++LP+ L
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  197 bits (502), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 113/301 (37%), Positives = 162/301 (53%), Gaps = 12/301 (3%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           Y L   +G G FG  ++ + + T   VAVK + R       +   ++REI N +  RHP+
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I++  +VI TP+ + +VMEY SGGELF+ IC  GR  E E+R  FQQ++SGV YCH   V
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRDLK EN LLD       KI DFG S         + + G+P Y APEV+  + Y G 
Sbjct: 138 VHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
             D+WS GV LY +L G  PF+D   P  F+K    I    +  P Y  ++P    L+  
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----FYTPQY--LNPSVISLLKH 249
Query: 259 IFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 318
           +   DP KR +I +IR HEWF ++LP  L  ++ + +     D+ ++ + E  +   E  
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEV 309
Query: 319 I 319
           +
Sbjct: 310 L 310

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  194 bits (493), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 104/259 (40%), Positives = 151/259 (58%), Gaps = 11/259 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
           Y L++ IG GNF   +L R   T + VAVK I++      ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           V+  EVI T   L +VMEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            DVWS GV LY ++ G+ PF+     +N ++   R+L  +Y IP Y  +S +C +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDG----QNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 260 FVADPAKRISIPEIRNHEW 278
            + +P+KR ++ +I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  194 bits (492), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 104/259 (40%), Positives = 151/259 (58%), Gaps = 11/259 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
           Y L++ IG GNF   +L R   T + VAVK I++      ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           V+  EVI T   L +VMEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            DVWS GV LY ++ G+ PF+     +N ++   R+L  +Y IP Y  +S +C +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDG----QNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 260 FVADPAKRISIPEIRNHEW 278
            + +P+KR ++ +I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 104/259 (40%), Positives = 150/259 (57%), Gaps = 11/259 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
           Y L++ IG GNF   +L R   T + VAVK I++      ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           V+  EVI T   L +VMEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK EN LLD      +KI DFG+S      ++  +  G P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            DVWS GV LY ++ G+ PF+     +N ++   R+L  +Y IP Y  +S +C +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDG----QNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 260 FVADPAKRISIPEIRNHEW 278
            + +P+KR ++ +I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 104/259 (40%), Positives = 150/259 (57%), Gaps = 11/259 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
           Y L++ IG GNF   +L R   T   VA+K I++      ++Q   RE+   + L HPNI
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           V+  EVI T   L ++MEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH  ++ 
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK EN LLD      +KI DFG+S    +  +  +  G+P Y APE+   K+YDG  
Sbjct: 134 HRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            DVWS GV LY ++ G+ PF+     +N ++   R+L  +Y IP Y  +S +C +L+ R 
Sbjct: 192 VDVWSLGVILYTLVSGSLPFDG----QNLKELRERVLRGKYRIPFY--MSTDCENLLKRF 245
Query: 260 FVADPAKRISIPEIRNHEW 278
            V +P KR ++ +I    W
Sbjct: 246 LVLNPIKRGTLEQIMKDRW 264

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  193 bits (490), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 151/259 (58%), Gaps = 11/259 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
           Y L++ IG GNF   +L R   T + VAV+ I++      ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           V+  EVI T   L +VMEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            DVWS GV LY ++ G+ PF+     +N ++   R+L  +Y IP Y  +S +C +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDG----QNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 260 FVADPAKRISIPEIRNHEW 278
            + +P+KR ++ +I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 104/259 (40%), Positives = 149/259 (57%), Gaps = 11/259 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
           Y L++ IG GNF   +L R   T   VA+K I++      ++Q   RE+   + L HPNI
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           V+  EVI T   L ++MEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH  ++ 
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+   K+YDG  
Sbjct: 137 HRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            DVWS GV LY ++ G+ PF+     +N ++   R+L  +Y IP Y  +S +C +L+ R 
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDG----QNLKELRERVLRGKYRIPFY--MSTDCENLLKRF 248
Query: 260 FVADPAKRISIPEIRNHEW 278
            V +P KR ++ +I    W
Sbjct: 249 LVLNPIKRGTLEQIMKDRW 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  192 bits (488), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 150/259 (57%), Gaps = 11/259 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
           Y L++ IG GNF   +L R   T + VAV+ I++      ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           V+  EVI T   L +VMEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK EN LLD      +KI DFG+S      ++     G+P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            DVWS GV LY ++ G+ PF+     +N ++   R+L  +Y IP Y  +S +C +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDG----QNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 260 FVADPAKRISIPEIRNHEW 278
            + +P+KR ++ +I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  191 bits (484), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 150/259 (57%), Gaps = 11/259 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
           Y L++ IG GNF   +L R   T + VAVK I++      ++Q   RE+   + L HPNI
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           V+  EVI T   L +VMEYASGGE+F+ +   G   E EAR  F+Q++S V YCH   + 
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   K+YDG  
Sbjct: 129 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            DVWS GV LY ++ G+ PF+     +N ++   R+L  +Y IP Y  +S +C +L+ + 
Sbjct: 187 VDVWSLGVILYTLVSGSLPFDG----QNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 240
Query: 260 FVADPAKRISIPEIRNHEW 278
            + +P+KR ++ +I    W
Sbjct: 241 LILNPSKRGTLEQIMKDRW 259

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 110/270 (40%), Positives = 155/270 (57%), Gaps = 13/270 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPN 78
           Y++V+ +G G+FG  +L     T + VA+K I +       +   ++REI   R LRHP+
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I++  +VI +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  ++
Sbjct: 76  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 134
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+  K Y G 
Sbjct: 135 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
             DVWSCGV LYVML    PF+D   P  F+   + +    Y++P +  +SP    LI R
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 246
Query: 259 IFVADPAKRISIPEIRNHEWFLKNLPADLV 288
           + + +P  RISI EI   +WF  +LP  L+
Sbjct: 247 MLIVNPLNRISIHEIMQDDWFKVDLPEYLL 276

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 110/270 (40%), Positives = 155/270 (57%), Gaps = 13/270 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPN 78
           Y++V+ +G G+FG  +L     T + VA+K I +       +   ++REI   R LRHP+
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I++  +VI +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  ++
Sbjct: 70  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 128
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+  K Y G 
Sbjct: 129 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
             DVWSCGV LYVML    PF+D   P  F+   + +    Y++P +  +SP    LI R
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 240
Query: 259 IFVADPAKRISIPEIRNHEWFLKNLPADLV 288
           + + +P  RISI EI   +WF  +LP  L+
Sbjct: 241 MLIVNPLNRISIHEIMQDDWFKVDLPEYLL 270

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 110/270 (40%), Positives = 155/270 (57%), Gaps = 13/270 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPN 78
           Y++V+ +G G+FG  +L     T + VA+K I +       +   ++REI   R LRHP+
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I++  +VI +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  ++
Sbjct: 75  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+  K Y G 
Sbjct: 134 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
             DVWSCGV LYVML    PF+D   P  F+   + +    Y++P +  +SP    LI R
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 245
Query: 259 IFVADPAKRISIPEIRNHEWFLKNLPADLV 288
           + + +P  RISI EI   +WF  +LP  L+
Sbjct: 246 MLIVNPLNRISIHEIMQDDWFKVDLPEYLL 275

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 110/270 (40%), Positives = 155/270 (57%), Gaps = 13/270 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPN 78
           Y++V+ +G G+FG  +L     T + VA+K I +       +   ++REI   R LRHP+
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I++  +VI +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  ++
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+  K Y G 
Sbjct: 125 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
             DVWSCGV LYVML    PF+D   P  F+   + +    Y++P +  +SP    LI R
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 236
Query: 259 IFVADPAKRISIPEIRNHEWFLKNLPADLV 288
           + + +P  RISI EI   +WF  +LP  L+
Sbjct: 237 MLIVNPLNRISIHEIMQDDWFKVDLPEYLL 266

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 148/259 (57%), Gaps = 11/259 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
           Y L++ IG GNF   +L R   T + VAVK I++      ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           V+  EVI T   L +V EYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK EN LLD      +KI DFG+S      ++  +  G P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDAD--XNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            DVWS GV LY ++ G+ PF+     +N ++   R+L  +Y IP Y   S +C +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDG----QNLKELRERVLRGKYRIPFYX--STDCENLLKKF 247
Query: 260 FVADPAKRISIPEIRNHEW 278
            + +P+KR ++ +I    W
Sbjct: 248 LILNPSKRGTLEQIXKDRW 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 107/259 (41%), Positives = 151/259 (58%), Gaps = 11/259 (4%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
           Y L + IG GNF   +L R   T   VAVK I++      ++Q   RE+   + L HPNI
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           V+  EVI T   L +VMEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIV 136
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK EN LLDG     +KI DFG+S    + ++  +  G+P Y APE+   K+YDG  
Sbjct: 137 HRDLKAENLLLDGD--MNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE 194
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
            DVWS GV LY ++ G+ PF+     +N ++   R+L  +Y IP Y  +S +C +L+ ++
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDG----QNLKELRERVLRGKYRIPFY--MSTDCENLLKKL 248
Query: 260 FVADPAKRISIPEIRNHEW 278
            V +P KR S+ +I    W
Sbjct: 249 LVLNPIKRGSLEQIMKDRW 267

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/269 (37%), Positives = 148/269 (55%), Gaps = 13/269 (4%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLR 75
           SDRY+ V+ +GSG +G   L +DK T    A+K I++      +    +++     + L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           HPNI++  E      +  +VME   GGELF+ I    +FSE +A    +Q++SG +Y H 
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK 122
Query: 136 MQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
             + HRDLK EN LL+      L KI DFG S    +  + K  +GT  YIAPEV L+K+
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEV-LRKK 181
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPEC 252
           YD K  DVWSCGV LY++L G  PF    +    ++ + R+   ++S   PD+  +S E 
Sbjct: 182 YDEK-CDVWSCGVILYILLCGYPPFGGQTD----QEILKRVEKGKFSFDPPDWTQVSDEA 236
Query: 253 RHLISRIFVADPAKRISIPEIRNHEWFLK 281
           + L+  +   +P+KRIS  E  NH W +K
Sbjct: 237 KQLVKLMLTYEPSKRISAEEALNHPWIVK 265

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 100/269 (37%), Positives = 148/269 (55%), Gaps = 13/269 (4%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLR 75
           SDRY+ V+ +GSG +G   L +DK T    A+K I++      +    +++     + L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           HPNI++  E      +  +VME   GGELF+ I    +FSE +A    +Q++SG +Y H 
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK 139
Query: 136 MQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
             + HRDLK EN LL+      L KI DFG S    +  + K  +GT  YIAPEV L+K+
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEV-LRKK 198
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPEC 252
           YD K  DVWSCGV LY++L G  PF    +    ++ + R+   ++S   PD+  +S E 
Sbjct: 199 YDEK-CDVWSCGVILYILLCGYPPFGGQTD----QEILKRVEKGKFSFDPPDWTQVSDEA 253
Query: 253 RHLISRIFVADPAKRISIPEIRNHEWFLK 281
           + L+  +   +P+KRIS  E  NH W +K
Sbjct: 254 KQLVKLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 149/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTPA++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEI-V 189
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 146/269 (54%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D YE+  ++GSG F + R  R K T +  A K+I+       R     E ++RE+   R 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           +RHPNI+   ++    T + +++E  SGGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS ++ H DLK EN +L     P PR+K+ DFG +      ++ K+  GTP ++APE+ +
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI-V 183
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  I +V Y   +  + + S
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSNTS 239
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP +R++I +   H W
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 145/269 (53%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D YE+  ++GSG F + R  R K T +  A K+I+       R     E ++RE+   R 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           +RHPNI+   ++    T + +++E  SGGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 131
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS ++ H DLK EN +L     P PR+K+ DFG +      ++ K+  GTP ++APE+ +
Sbjct: 132 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI-V 190
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  I +V Y   +  + + S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSNTS 246
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP +R+ I +   H W
Sbjct: 247 ELAKDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 145/269 (53%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D YE+  ++GSG F + R  R K T +  A K+I+       R     E ++RE+   R 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           +RHPNI+   ++    T + +++E  SGGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 145
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS ++ H DLK EN +L     P PR+K+ DFG +      ++ K+  GTP ++APE+ +
Sbjct: 146 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI-V 204
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  I +V Y   +  + + S
Sbjct: 205 NYEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSNTS 260
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP +R+ I +   H W
Sbjct: 261 ELAKDFIRRLLVKDPKRRMXIAQSLEHSW 289

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 188
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 244
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 188
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 244
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  160 bits (405), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 101/285 (35%), Positives = 155/285 (54%), Gaps = 13/285 (4%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR-EIINHRSLRHPN 78
           SD +E+  ++G G   +    + K T++  A+K +++   +D+ + R EI     L HPN
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPN 109
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I++ KE+  TPT +++V+E  +GGELF+RI   G +SE +A    +Q++  V+Y H   +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 139 CHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            HRDLK EN LL  +PAP   LKI DFG SK        K+  GTP Y APE+L    Y 
Sbjct: 170 VHRDLKPEN-LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY- 227
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRH 254
           G   D+WS G+  Y++L G  PF D E    F     RIL+ +Y    P +  +S   + 
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFYD-ERGDQF--MFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 255 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 299
           L+ ++ V DP KR++  +   H W +    A+ V  +T   + +E
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPW-VTGKAANFVHMDTAQKKLQE 328

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 147/269 (54%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y+   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           ++HPN++   EV    T + ++ E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 134 HSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  + +V Y   D  + + S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I R+ V DP KR++I +   H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 152/300 (50%), Gaps = 22/300 (7%)
Query: 9   GPGMDMPIMHD-------------SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE 55
           GPG  M  +H              SDRY+  R +G G+FG   L +DK T +  AVK I 
Sbjct: 1   GPGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
Query: 56  R---GDKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 111
           +     K D E++ RE+   + L HPNI++  E      +  +V E  +GGELF+ I + 
Sbjct: 61  KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 120
Query: 112 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSV 170
            RFSE +A    +Q++SG++Y H  ++ HRDLK EN LL+  S    ++I DFG S    
Sbjct: 121 KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
              + K  +GT  YIAPEV L   YD K  DVWS GV LY++L G  PF    E    +K
Sbjct: 181 ASKKMKDKIGTAYYIAPEV-LHGTYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKK 238
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
                 +  + +P +  +S   + LI ++    P+ RIS  +  +HEW        + VD
Sbjct: 239 VEKGKYT--FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVD 296

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 146/276 (52%), Gaps = 9/276 (3%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKID-ENVQREIINHRSLR 75
           SDRY+  R +G G+FG   L +DK T +  AVK I +     K D E++ RE+   + L 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           HPNI++  E      +  +V E  +GGELF+ I +  RFSE +A    +Q++SG++Y H 
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 167
Query: 136 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
            ++ HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEV L   
Sbjct: 168 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV-LHGT 226
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           YD K  DVWS GV LY++L G  PF    E    +K      +  + +P +  +S   + 
Sbjct: 227 YDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT--FELPQWKKVSESAKD 283
Query: 255 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
           LI ++    P+ RIS  +  +HEW        + VD
Sbjct: 284 LIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVD 319

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 146/276 (52%), Gaps = 9/276 (3%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKID-ENVQREIINHRSLR 75
           SDRY+  R +G G+FG   L +DK T +  AVK I +     K D E++ RE+   + L 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           HPNI++  E      +  +V E  +GGELF+ I +  RFSE +A    +Q++SG++Y H 
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 168
Query: 136 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
            ++ HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEV L   
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV-LHGT 227
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           YD K  DVWS GV LY++L G  PF    E    +K      +  + +P +  +S   + 
Sbjct: 228 YDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT--FELPQWKKVSESAKD 284
Query: 255 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
           LI ++    P+ RIS  +  +HEW        + VD
Sbjct: 285 LIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVD 320

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 104/279 (37%), Positives = 148/279 (53%), Gaps = 15/279 (5%)
Query: 9   GPGMDMPIMHD----SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKID 61
           GPGM   + H     SDRY+  R +G G+FG   L +DK T +  AVK I +     K D
Sbjct: 18  GPGM--FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 75
Query: 62  -ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
            E++ RE+   + L HPNI++  E      +  +V E  +GGELF+ I +  RFSE +A 
Sbjct: 76  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 135
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTV 179
              +Q++SG++Y H  ++ HRDLK EN LL+  S    ++I DFG S       + K  +
Sbjct: 136 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 195
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
           GT  YIAPEV L   YD K  DVWS GV LY++L G  PF    E    +K         
Sbjct: 196 GTAYYIAPEV-LHGTYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG--KYT 251
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
           + +P +  +S   + LI ++    P+ RIS  +  +HEW
Sbjct: 252 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 143/267 (53%), Gaps = 10/267 (3%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVR 81
           Y L   IG G++G  ++   K T    A K I +    D +  ++EI   +SL HPNI+R
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
             E     T + +VME  +GGELFER+ +   F E +A    + ++S V+YCH + V HR
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 147
Query: 142 DLKLENTL-LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           DLK EN L L  SP   LK+ DFG +         ++ VGTP Y++P+VL  +   G   
Sbjct: 148 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPEC 205
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISR 258
           D WS GV +YV+L G  PF  P +     + + +I    ++ P  D++++SP+   LI R
Sbjct: 206 DEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 261
Query: 259 IFVADPAKRISIPEIRNHEWFLKNLPA 285
           +    P +RI+  +   HEWF K L +
Sbjct: 262 LLTKSPKQRITSLQALEHEWFEKQLSS 288

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 96/265 (36%), Positives = 142/265 (53%), Gaps = 10/265 (3%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVR 81
           Y L   IG G++G  ++   K T    A K I +    D +  ++EI   +SL HPNI+R
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 82  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
             E     T + +VME  +GGELFER+ +   F E +A    + ++S V+YCH + V HR
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 130
Query: 142 DLKLENTL-LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           DLK EN L L  SP   LK+ DFG +         ++ VGTP Y++P+VL  +   G   
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPEC 188
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISR 258
           D WS GV +YV+L G  PF  P +     + + +I    ++ P  D++++SP+   LI R
Sbjct: 189 DEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244
Query: 259 IFVADPAKRISIPEIRNHEWFLKNL 283
           +    P +RI+  +   HEWF K L
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEKQL 269

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 96/268 (35%), Positives = 146/268 (54%), Gaps = 12/268 (4%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRH 76
           ++RY +V  +G G+FG     +D+ T++  AVK I +    +K    + RE+   + L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI++  E++   +   IV E  +GGELF+ I    RFSE +A    +Q+ SG++Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            + HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEV L+  Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
           D K  DVWS GV LY++L G  PF      KN    + R+ + +Y+  +P +  IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPF----YGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLK 281
            LI ++    P+ RI+  +   H W  K
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 144/276 (52%), Gaps = 9/276 (3%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKID-ENVQREIINHRSLR 75
           SDRY+  R +G G+FG   L +DK T +  AVK I +     K D E++ RE+   + L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           HPNI +  E      +  +V E  +GGELF+ I +  RFSE +A    +Q++SG++Y H 
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHK 144
Query: 136 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
            ++ HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEV L   
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEV-LHGT 203
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           YD K  DVWS GV LY++L G  PF    E    +K      +  + +P +  +S   + 
Sbjct: 204 YDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT--FELPQWKKVSESAKD 260
Query: 255 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
           LI +     P+ RIS  +  +HEW        + VD
Sbjct: 261 LIRKXLTYVPSXRISARDALDHEWIQTYTKEQISVD 296

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 96/286 (33%), Positives = 146/286 (51%), Gaps = 14/286 (4%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPN 78
           D Y+    +G+G F    L  DK+T++LVA+K I +   +  + +++ EI     ++HPN
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 77
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           IV   ++  +  HL ++M+  SGGELF+RI   G ++E +A     Q++  V Y H + +
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 139 CHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            HRDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL +K Y
Sbjct: 138 VHRDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECR 253
             K  D WS GV  Y++L G  PF D  + K F     +IL  +Y    P +  IS   +
Sbjct: 196 -SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAK 250
Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 299
             I  +   DP KR +  +   H W   +   D  +  + + Q ++
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKK 296

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 97/283 (34%), Positives = 144/283 (50%), Gaps = 14/283 (4%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
           D Y+    +G+G F    L  DK+T++LVA+K I  E  +  + +++ EI     ++HPN
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           IV   ++  +  HL ++M+  SGGELF+RI   G ++E +A     Q++  V Y H + +
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 139 CHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            HRDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL +K Y
Sbjct: 138 VHRDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECR 253
             K  D WS GV  Y++L G  PF D  + K F     +IL  +Y    P +  IS   +
Sbjct: 196 -SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAK 250
Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 296
             I  +   DP KR +  +   H W   +   D  +  + + Q
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQ 293

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 153/287 (53%), Gaps = 33/287 (11%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
           M +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 186
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRIL 236
           PE+L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I 
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           S   +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 236 SAPLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 153/287 (53%), Gaps = 33/287 (11%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
           M +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 186
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRIL 236
           PE+L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I 
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           S   +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 236 SAPLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 153/287 (53%), Gaps = 33/287 (11%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
           M +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 186
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRIL 236
           PE+L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I 
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           S   +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 236 SAPLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 153/287 (53%), Gaps = 33/287 (11%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
           M +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 186
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRIL 236
           PE+L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I 
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           S   +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 236 SAPLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/281 (33%), Positives = 155/281 (55%), Gaps = 21/281 (7%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
           M +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIX 57
Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 186
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----EEPKNFRKTIHRILSVQYSI 242
           PE+L ++E+  +  DVWSCG+ L  ML G  P++ P    +E  ++++        +  +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-------KTYL 228
Query: 243 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
             +  I      L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 153/287 (53%), Gaps = 33/287 (11%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
           M +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 186
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRIL 236
           PE+L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I 
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           S   +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 236 SAPLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/286 (33%), Positives = 146/286 (51%), Gaps = 14/286 (4%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
           D Y+    +G+G F    L  DK+T++LVA+K I  E  +  + +++ EI     ++HPN
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           IV   ++  +  HL ++M+  SGGELF+RI   G ++E +A     Q++  V Y H + +
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 139 CHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            HRDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL +K Y
Sbjct: 138 VHRDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECR 253
             K  D WS GV  Y++L G  PF D  + K F     +IL  +Y    P +  IS   +
Sbjct: 196 -SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAK 250
Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 299
             I  +   DP KR +  +   H W   +   D  +  + + Q ++
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKK 296

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/286 (33%), Positives = 146/286 (51%), Gaps = 14/286 (4%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
           D Y+    +G+G F    L  DK+T++LVA+K I  E  +  + +++ EI     ++HPN
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           IV   ++  +  HL ++M+  SGGELF+RI   G ++E +A     Q++  V Y H + +
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 139 CHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            HRDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL +K Y
Sbjct: 138 VHRDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECR 253
             K  D WS GV  Y++L G  PF D  + K F     +IL  +Y    P +  IS   +
Sbjct: 196 -SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAK 250
Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 299
             I  +   DP KR +  +   H W   +   D  +  + + Q ++
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKK 296

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 153/287 (53%), Gaps = 33/287 (11%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
           M +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 186
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRIL 236
           PE+L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I 
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           S   +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 236 SAPLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 95/264 (35%), Positives = 141/264 (53%), Gaps = 8/264 (3%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRH 76
           +D Y+L  DIG G F V R      T    A K I   +   +  + ++RE    R L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
            NIVR  + I       +V +  +GGELFE I     +SE +A    QQ++  V +CH M
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 137 QVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLKKE 194
            V HRDLK EN LL        +K+ DFG +       Q      GTP Y++PEVL K+ 
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y GK  D+W+CGV LY++LVG  PF D ++ K +++   +  +  +  P++  ++PE ++
Sbjct: 183 Y-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI--KAGAYDFPSPEWDTVTPEAKN 239
Query: 255 LISRIFVADPAKRISIPEIRNHEW 278
           LI+++   +PAKRI+  E   H W
Sbjct: 240 LINQMLTINPAKRITAHEALKHPW 263

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 96/268 (35%), Positives = 146/268 (54%), Gaps = 12/268 (4%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRH 76
           ++RY +V  +G G+FG     +D+ T++  AVK I +    +K    + RE+   + L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI++  E++   +   IV E  +GGELF+ I    RFSE +A    +Q+ SG++Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            + HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEV L+  Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
           D K  DVWS GV LY++L G  PF      KN    + R+ + +Y+  +P +  IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPF----YGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLK 281
            LI ++    P+ RI+  +   H W  K
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 92/261 (35%), Positives = 133/261 (50%), Gaps = 10/261 (3%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIV 80
           +E    +G+G F    L  +K T +L AVK I +      + +++ EI   R ++H NIV
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
             +++  +P HL +VM+  SGGELF+RI   G ++E +A    +Q++  V Y H M + H
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 141 RDLKLENTL-LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           RDLK EN L        ++ I DFG SK         +  GTP Y+APEVL +K Y  K 
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPY-SKA 202
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLIS 257
            D WS GV  Y++L G  PF D  + K F     +IL  +Y    P +  IS   +  I 
Sbjct: 203 VDCWSIGVIAYILLCGYPPFYDENDSKLF----EQILKAEYEFDSPYWDDISDSAKDFIR 258
Query: 258 RIFVADPAKRISIPEIRNHEW 278
            +   DP KR +  +   H W
Sbjct: 259 NLMEKDPNKRYTCEQAARHPW 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 96/268 (35%), Positives = 146/268 (54%), Gaps = 12/268 (4%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRH 76
           ++RY +V  +G G+FG     +D+ T++  AVK I +    +K    + RE+   + L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI++  E++   +   IV E  +GGELF+ I    RFSE +A    +Q+ SG++Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            + HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEV L+  Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
           D K  DVWS GV LY++L G  PF      KN    + R+ + +Y+  +P +  IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPF----YGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLK 281
            LI ++    P+ RI+  +   H W  K
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 151/275 (54%), Gaps = 13/275 (4%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
           +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 188
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
           +L ++E+  +  DVWSCG+ L  ML G  P+   ++P +  +        +  +  +  I
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSXQEYSDWKEKKTYLNPWKKI 233
Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
                 L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 234 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 96/285 (33%), Positives = 152/285 (53%), Gaps = 33/285 (11%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
           +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 188
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRILSV 238
           +L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I S 
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 236
Query: 239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
             +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 237 PLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 94/279 (33%), Positives = 154/279 (55%), Gaps = 21/279 (7%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
           +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXIN 58
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 188
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----EEPKNFRKTIHRILSVQYSIPD 244
           +L ++E+  +  DVWSCG+ L  ML G  P++ P    +E  ++++        +  +  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-------KTYLNP 229
Query: 245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           +  I      L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 230 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 94/279 (33%), Positives = 154/279 (55%), Gaps = 21/279 (7%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
           +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXIN 58
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 188
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----EEPKNFRKTIHRILSVQYSIPD 244
           +L ++E+  +  DVWSCG+ L  ML G  P++ P    +E  ++++        +  +  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-------KTYLNP 229
Query: 245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           +  I      L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 230 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 95/281 (33%), Positives = 154/281 (54%), Gaps = 21/281 (7%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
           M +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            +  L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 186
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----EEPKNFRKTIHRILSVQYSI 242
           PE+L ++E+  +  DVWSCG+ L  ML G  P++ P    +E  ++++        +  +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-------KTYL 228
Query: 243 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
             +  I      L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 94/279 (33%), Positives = 154/279 (55%), Gaps = 21/279 (7%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
           +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 188
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----EEPKNFRKTIHRILSVQYSIPD 244
           +L ++E+  +  DVWSCG+ L  ML G  P++ P    +E  ++++        +  +  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-------KTYLNP 229
Query: 245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           +  I      L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 230 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 96/285 (33%), Positives = 152/285 (53%), Gaps = 33/285 (11%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
           +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 188
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRILSV 238
           +L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I S 
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 236
Query: 239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
             +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 237 PLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 96/285 (33%), Positives = 152/285 (53%), Gaps = 33/285 (11%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
           +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 188
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRILSV 238
           +L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I S 
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 236
Query: 239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
             +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 237 PLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 96/285 (33%), Positives = 152/285 (53%), Gaps = 33/285 (11%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
           +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 188
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRILSV 238
           +L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I S 
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 236
Query: 239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
             +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 237 PLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 96/285 (33%), Positives = 152/285 (53%), Gaps = 33/285 (11%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
           +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 188
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRILSV 238
           +L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I S 
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 236
Query: 239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
             +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 237 PLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 94/279 (33%), Positives = 154/279 (55%), Gaps = 21/279 (7%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
           +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 188
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----EEPKNFRKTIHRILSVQYSIPD 244
           +L ++E+  +  DVWSCG+ L  ML G  P++ P    +E  ++++        +  +  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-------KTYLNP 229
Query: 245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           +  I      L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 230 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 30/276 (10%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIV 80
           ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI  ++ L H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
           +F           + +EY SGGELF+RI       E +A+ FF QL++GV Y H + + H
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 126
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLKKEYDG 197
           RD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE+L ++E+  
Sbjct: 127 RDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRILSVQYSIPDYVH 247
           +  DVWSCG+ L  ML G  P++ P          +E K +     +I S   +      
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------ 238
Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
                  L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 239 -------LLHKILVENPSARITIPDIKKDRWYNKPL 267

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 96/285 (33%), Positives = 152/285 (53%), Gaps = 33/285 (11%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
           +P + D   ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 188
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRILSV 238
           +L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I S 
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 236
Query: 239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
             +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 237 PLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 91/264 (34%), Positives = 149/264 (56%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  GE+++ +    +F E     +  +L + +SYCHS +V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 135 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 191
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 192 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 244
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITAN 268

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 142/264 (53%), Gaps = 8/264 (3%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRH 76
           +D Y+L  ++G G F V R      T +  A K I   +   +  + ++RE    R L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNIVR  + I       +V +  +GGELFE I     +SE +A    QQ++  V++CH  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLKKE 194
            + HRDLK EN LL   S    +K+ DFG +       Q      GTP Y++PEVL K  
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y GK  D+W+CGV LY++LVG  PF D ++ + +++   +  +  +  P++  ++PE + 
Sbjct: 183 Y-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEAKD 239
Query: 255 LISRIFVADPAKRISIPEIRNHEW 278
           LI+++   +PAKRI+  E   H W
Sbjct: 240 LINKMLTINPAKRITASEALKHPW 263

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  154 bits (388), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 142/264 (53%), Gaps = 8/264 (3%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRH 76
           +D Y+L  ++G G F V R      T +  A K I   +   +  + ++RE    R L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNIVR  + I       +V +  +GGELFE I     +SE +A    QQ++  V++CH  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLKKE 194
            + HRDLK EN LL   S    +K+ DFG +       Q      GTP Y++PEVL K  
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y GK  D+W+CGV LY++LVG  PF D ++ + +++   +  +  +  P++  ++PE + 
Sbjct: 183 Y-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEAKD 239
Query: 255 LISRIFVADPAKRISIPEIRNHEW 278
           LI+++   +PAKRI+  E   H W
Sbjct: 240 LINKMLTINPAKRITASEALKHPW 263

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 141/263 (53%), Gaps = 12/263 (4%)
Query: 23  YELVRDIGSGNFGVAR-----LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP 77
           Y+L  ++G G F V R     L   +   +++  K +   D   + ++RE    R L+HP
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDH--QKLEREARICRLLKHP 81
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           NIVR  + I    H  ++ +  +GGELFE I     +SE +A    QQ++  V +CH M 
Sbjct: 82  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 141
Query: 138 VCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLKKEY 195
           V HRDLK EN LL        +K+ DFG +       Q      GTP Y++PEVL K  Y
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 201
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
            GK  D+W+CGV LY++LVG  PF D ++ + +++   +  +  +  P++  ++PE + L
Sbjct: 202 -GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEAKDL 258
Query: 256 ISRIFVADPAKRISIPEIRNHEW 278
           I+++   +P+KRI+  E   H W
Sbjct: 259 INKMLTINPSKRITAAEALKHPW 281

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/264 (34%), Positives = 148/264 (56%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  GE+++ +    +F E     +  +L + +SYCHS +V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++  + +D K
Sbjct: 135 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRXXLXGTLDYLPPEMIEGRMHDEK 191
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 192 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 244
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITAN 268

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/285 (33%), Positives = 151/285 (52%), Gaps = 33/285 (11%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
           +P + D   ++LV+ +G G  G  +L  ++ TEE VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 188
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------EEPKNFRKTIHRILSV 238
           +L ++E+  +  DVWSCG+ L  ML G  P++ P          +E K +     +I S 
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 236
Query: 239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
             +             L+ +I V +P+ RI+IP+I+   W+ K L
Sbjct: 237 PLA-------------LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 150/296 (50%), Gaps = 25/296 (8%)
Query: 5   AMTVGPGMDMPIMHD--SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----- 57
            + + PGM +        + Y  VR +GSG +G   L ++K      A+K I++      
Sbjct: 18  GIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKG 77
Query: 58  ---------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 108
                    +K  E +  EI   +SL HPNI++  +V     +  +V E+  GGELFE+I
Sbjct: 78  RYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI 137
Query: 109 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSK 167
            N  +F E +A    +Q++SG+ Y H   + HRD+K EN LL+   +   +KI DFG S 
Sbjct: 138 INRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
                 + +  +GT  YIAPEV LKK+Y+ K  DVWSCGV +Y++L G YP   P   +N
Sbjct: 198 FFSKDYKLRDRLGTAYYIAPEV-LKKKYNEK-CDVWSCGVIMYILLCG-YP---PFGGQN 251
Query: 228 FRKTIHRILSVQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
            +  I ++   +Y     D+ +IS E + LI  +   D  KR +  E  N  W  K
Sbjct: 252 DQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 92/261 (35%), Positives = 140/261 (53%), Gaps = 11/261 (4%)
Query: 27  RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEV 85
           + +G G+F + R    KK+ +  AVK I +  +++ N Q+EI   +    HPNIV+  EV
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 86  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
                H  +VME  +GGELFERI     FSE EA +  ++L+S VS+ H + V HRDLK 
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 146 ENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVW 203
           EN L  D +    +KI DFG+++     +QP K+   T  Y APE+L +  YD +  D+W
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLW 193
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-----YSIPDYVHISPECRHLISR 258
           S GV LY ML G  PF+  +        +  +  ++     +    + ++S E + LI  
Sbjct: 194 SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQG 253
Query: 259 IFVADPAKRISIPEIRNHEWF 279
           +   DP KR+ +  +R +EW 
Sbjct: 254 LLTVDPNKRLKMSGLRYNEWL 274

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 155
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 156 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 212
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 213 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 265
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 266 LLKHNPSQRPMLREVLEHPWITAN 289

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 142/266 (53%), Gaps = 12/266 (4%)
Query: 20  SDRYELVRDIGSGNFGVAR-----LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
           ++ Y+L  ++G G F V R     L   +    ++  K +   D   + ++RE    R L
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH--QKLEREARICRLL 67
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +HPNIVR  + I    H  ++ +  +GGELFE I     +SE +A    QQ++  V +CH
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 135 SMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLK 192
            M V HR+LK EN LL        +K+ DFG +       Q      GTP Y++PEVL K
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
             Y GK  D+W+CGV LY++LVG  PF D ++ + +++   +  +  +  P++  ++PE 
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEA 244
Query: 253 RHLISRIFVADPAKRISIPEIRNHEW 278
           + LI+++   +P+KRI+  E   H W
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPW 270

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  151 bits (381), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE +  + +D K
Sbjct: 135 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEXIEGRXHDEK 191
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 192 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 244
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 245 LLKHNPSQRPXLREVLEHPWITAN 268

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 87  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 146
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 147 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 203
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 204 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 256
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 257 LLKHNPSQRPMLREVLEHPWITAN 280

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 133 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMHDEK 189
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 190 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 242
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 135 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 191
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 192 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 244
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITAN 268

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 133 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 190 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 242
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN 266

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 133
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 134 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 191 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 243
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 244 LLKHNPSQRPMLREVLEHPWITAN 267

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 239
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S      S+  +  GT  Y+ PE++  + +D K
Sbjct: 131 IHRDIKPENLLL-GS-AGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEK 187
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 188 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 240
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITAN 264

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 128
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 129 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 185
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 186 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 238
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 239 LLKHNPSQRPMLREVLEHPWITAN 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 133 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 190 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 242
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 239
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 131 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRDTLCGTLDYLPPEMIEGRMHDEK 187
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 188 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 240
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITAN 264

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 155
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++  + +D K
Sbjct: 156 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMHDEK 212
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 213 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 265
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 266 LLKHNPSQRPMLREVLEHPWITAN 289

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++  + +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMHDEK 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 239
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++  + +D K
Sbjct: 135 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMHDEK 191
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 192 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 244
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITAN 268

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++  + +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTELCGTLDYLPPEMIEGRMHDEK 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 239
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++  + +D K
Sbjct: 133 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMHDEK 189
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 190 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 242
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++  + +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMHDEK 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 239
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++  + +D K
Sbjct: 133 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMHDEK 189
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 190 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 242
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+ + ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 126
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 127 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 183
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 184 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 236
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 237 LLKHNPSQRPMLREVLEHPWITAN 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++  + +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMHDEK 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 239
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 131
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++  + +D K
Sbjct: 132 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMHDEK 188
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 189 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 241
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 242 LLKHNPSQRPMLREVLEHPWITAN 265

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++  + +D K
Sbjct: 131 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMHDEK 187
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 188 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 240
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITAN 264

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++  + +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTXLCGTLDYLPPEMIEGRMHDEK 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 239
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 145/264 (54%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K ++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKV 129
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   ++ T  RI  V+++ PD+V  +   R LISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQDTYKRISRVEFTFPDFV--TEGARDLISR 239
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 131
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI +FG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 132 IHRDIKPENLLL-GS-AGELKIANFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 188
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 189 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 241
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 242 LLKHNPSQRPMLREVLEHPWITAN 265

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS +V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS A  LKI +FG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 133 IHRDIKPENLLL-GS-AGELKIANFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 190 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV--TEGARDLISR 242
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   +P++R  + E+  H W   N
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 144/279 (51%), Gaps = 10/279 (3%)
Query: 6   MTVGPGMDMPIM--HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKI 60
           +   PGM +     H S+ Y+ V+ +GSG +G   L RDK T    A+K I +       
Sbjct: 20  LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS 79
Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           +  +  E+   + L HPNI++  +      +  +VME   GGELF+ I +  +F+E +A 
Sbjct: 80  NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA 139
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTV 179
              +Q++SGV+Y H   + HRDLK EN LL+      L KI DFG S       + K  +
Sbjct: 140 VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
           GT  YIAPEVL KK YD K  DVWS GV L+++L G  PF    + +  RK      +  
Sbjct: 200 GTAYYIAPEVLRKK-YDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT-- 255
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
           +  P++ ++S   + LI ++   D  +RIS  +   H W
Sbjct: 256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 140/264 (53%), Gaps = 8/264 (3%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRH 76
           +D Y+L  ++G G F V R    K   +  A K I   +   +  + ++RE    R L+H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNIVR  + I       +V +  +GGELFE I     +SE +A     Q++  V++ H  
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 137 QVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLKKE 194
            + HRDLK EN LL        +K+ DFG +       Q      GTP Y++PEVL K  
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDP 209
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y GK  D+W+CGV LY++LVG  PF D ++ K +++   +  +  +  P++  ++PE ++
Sbjct: 210 Y-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI--KAGAYDFPSPEWDTVTPEAKN 266
Query: 255 LISRIFVADPAKRISIPEIRNHEW 278
           LI+++   +PAKRI+  +   H W
Sbjct: 267 LINQMLTINPAKRITADQALKHPW 290

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  147 bits (372), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 87/264 (32%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +++ R +G G FG   L R+++++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    RF E     +  +L + +SYCHS +V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS    LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 134 IHRDIKPENLLL-GSNG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 191 V-DLWSLGVLCYEFLVGMPPF----EAHTYQETYRRISRVEFTFPDFV--TEGARDLISR 243
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   + ++R+++ E+  H W   N
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 139/268 (51%), Gaps = 13/268 (4%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
           SD Y++  ++G G F V R    K T    A K I       +  + ++RE    R L+H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNIVR  + I   +   +V +  +GGELFE I     +SE +A    QQ++  ++YCHS 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            + HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL K  Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
             K  D+W+CGV LY++LVG  PF D ++ + + +   +  +  Y  P++  ++PE + L
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 264
Query: 256 ISRIFVADPAKRIS------IPEIRNHE 277
           I  +   +P KRI+      +P I N E
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRE 292

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  147 bits (371), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 87/264 (32%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           +++ R +G G FG   L R+++++ ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R        T + +++EYA  G ++  +    RF E     +  +L + +SYCHS +V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            HRD+K EN LL GS    LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D K
Sbjct: 134 IHRDIKPENLLL-GSNG-ELKIADFGWSVHAP-SSRRDTLCGTLDYLPPEMIEGRMHDEK 190
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           + D+WS GV  Y  LVG  PF    E   +++T  RI  V+++ PD+V  +   R LISR
Sbjct: 191 V-DLWSLGVLCYEFLVGMPPF----EAHTYQETYRRISRVEFTFPDFV--TEGARDLISR 243
Query: 259 IFVADPAKRISIPEIRNHEWFLKN 282
           +   + ++R+++ E+  H W   N
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 140/268 (52%), Gaps = 13/268 (4%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRH 76
           SD Y++  ++G G F V R    K T    A K I   +   +  + ++RE    R L+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNIVR  + I   +   +V +  +GGELFE I     +SE +A    QQ++  ++YCHS 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            + HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL K  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
             K  D+W+CGV LY++LVG  PF D ++ + + +   +  +  Y  P++  ++PE + L
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 241
Query: 256 ISRIFVADPAKRIS------IPEIRNHE 277
           I  +   +P KRI+      +P I N E
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRE 269

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 88/252 (34%), Positives = 134/252 (53%), Gaps = 6/252 (2%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVIL 87
           +GSG F    L++ + T +L A+K I++     D +++ EI   + ++H NIV  +++  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
           + TH  +VM+  SGGELF+RI   G ++E +A    QQ++S V Y H   + HRDLK EN
Sbjct: 77  STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPEN 136
Query: 148 TL-LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
            L L      ++ I DFG SK    +    +  GTP Y+APEVL +K Y  K  D WS G
Sbjct: 137 LLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIG 194
Query: 207 VTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
           V  Y++L G  PF +  E K F K   +    ++  P +  IS   +  I  +   DP +
Sbjct: 195 VITYILLCGYPPFYEETESKLFEKI--KEGYYEFESPFWDDISESAKDFICHLLEKDPNE 252
Query: 267 RISIPEIRNHEW 278
           R +  +  +H W
Sbjct: 253 RYTCEKALSHPW 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 140/268 (52%), Gaps = 13/268 (4%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRH 76
           SD Y++  ++G G F V R    K T    A K I   +   +  + ++RE    R L+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNIVR  + I   +   +V +  +GGELFE I     +SE +A    QQ++  ++YCHS 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            + HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL K  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
             K  D+W+CGV LY++LVG  PF D ++ + + +   +  +  Y  P++  ++PE + L
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 241
Query: 256 ISRIFVADPAKRIS------IPEIRNHE 277
           I  +   +P KRI+      +P I N E
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRE 269

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 140/268 (52%), Gaps = 13/268 (4%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRH 76
           SD Y++  ++G G F V R    K T    A K I   +   +  + ++RE    R L+H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNIVR  + I   +   +V +  +GGELFE I     +SE +A    QQ++  ++YCHS 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 123
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            + HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL K  Y
Sbjct: 124 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 183
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
             K  D+W+CGV LY++LVG  PF D ++ + + +   +  +  Y  P++  ++PE + L
Sbjct: 184 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 240
Query: 256 ISRIFVADPAKRIS------IPEIRNHE 277
           I  +   +P KRI+      +P I N E
Sbjct: 241 IDSMLTVNPKKRITADQALKVPWICNRE 268

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 144/269 (53%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y++  ++GSG F + +  R+K T    A K+I+       R     E ++RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           + H N++   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 134 HSMQVCHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           H+ ++ H DLK EN  LLD + P P +K+ DFG +       + K+  GTP ++APE+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-V 190
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  I SV Y   +  + H S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSHTS 246
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I ++ V +  KR++I E   H W
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 144/269 (53%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y++  ++GSG F + +  R+K T    A K+I+       R     E ++RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           + H N++   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 134 HSMQVCHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           H+ ++ H DLK EN  LLD + P P +K+ DFG +       + K+  GTP ++APE+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-V 190
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  I SV Y   +  + H S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSHTS 246
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I ++ V +  KR++I E   H W
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 144/269 (53%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y++  ++GSG F + +  R+K T    A K+I+       R     E ++RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           + HPNI+   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 134 HSMQVCHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           H+ ++ H DLK EN  LLD + P P +K+ DFG +       + K+  GTP ++APE+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-V 190
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  I +V Y   +  +   S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQTS 246
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I ++ V +  KR++I E   H W
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 144/269 (53%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y++  ++GSG F + +  R+K T    A K+I+       R     E ++RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           + H N++   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 134 HSMQVCHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           H+ ++ H DLK EN  LLD + P P +K+ DFG +       + K+  GTP ++APE+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-V 190
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  I SV Y   +  + H S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSHTS 246
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I ++ V +  KR++I E   H W
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 100/295 (33%), Positives = 145/295 (49%), Gaps = 49/295 (16%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID------------------- 61
           ++Y L  +IG G++GV +L  ++      A+K + +   I                    
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 62  --------ENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNA 111
                   E V +EI   + L HPN+V+  EV+  P   HL +V E  + G + E +   
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTL 131
Query: 112 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSK-- 167
              SED+ARF+FQ LI G+ Y H  ++ HRD+K  N L+  DG     +KI DFG S   
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFGVSNEF 187
Query: 168 --SSVLHSQPKSTVGTPAYIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223
             S  L S   +TVGTPA++APE L   +K + GK  DVW+ GVTLY  + G  PF D  
Sbjct: 188 KGSDALLS---NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-- 242
Query: 224 EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
             +       +I S     PD   I+ + + LI+R+   +P  RI +PEI+ H W
Sbjct: 243 --ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y++  ++GSG F + +  R+K T    A K+I+       R     E ++RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           + H N++   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 134 HSMQVCHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           H+ ++ H DLK EN  LLD + P P +K+ DFG +       + K+  GTP ++APE+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-V 190
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  I +V Y   +  +   S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQTS 246
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I ++ V +  KR++I E   H W
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 16/269 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRS 73
           D Y++  ++GSG F + +  R+K T    A K+I+       R     E ++RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           + H N++   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 134 HSMQVCHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           H+ ++ H DLK EN  LLD + P P +K+ DFG +       + K+  GTP ++APE+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-V 190
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
             E  G  AD+WS GV  Y++L GA PF    +    ++T+  I +V Y   +  +   S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQTS 246
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
              +  I ++ V +  KR++I E   H W
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/282 (34%), Positives = 142/282 (50%), Gaps = 22/282 (7%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL- 74
           M+D D  +L   +G G FG   L+R+K T    A+K + +   I ++ V   +   R L 
Sbjct: 4   MNDFDYLKL---LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 75  --RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
             RHP +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
            HS  V +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
             +Y G+  D W  GV +Y M+ G  PF + +  + F      IL  +   P    +SPE
Sbjct: 179 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPE 231
Query: 252 CRHLISRIFVADPAKRIS-----IPEIRNHEWFLKNLPADLV 288
            + L++ +   DP +R+        E+  H +FL     D+V
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 96/282 (34%), Positives = 142/282 (50%), Gaps = 22/282 (7%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL- 74
           M+D D  +L   +G G FG   L+R+K T    A+K + +   I ++ V   +   R L 
Sbjct: 7   MNDFDYLKL---LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 75  --RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
             RHP +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
            HS  V +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL 
Sbjct: 124 LHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 181
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
             +Y G+  D W  GV +Y M+ G  PF + +  + F      IL  +   P    +SPE
Sbjct: 182 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPE 234
Query: 252 CRHLISRIFVADPAKRIS-----IPEIRNHEWFLKNLPADLV 288
            + L++ +   DP +R+        E+  H +FL     D+V
Sbjct: 235 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 276

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 96/282 (34%), Positives = 142/282 (50%), Gaps = 22/282 (7%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL- 74
           M+D D  +L   +G G FG   L+R+K T    A+K + +   I ++ V   +   R L 
Sbjct: 4   MNDFDYLKL---LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 75  --RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
             RHP +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
            HS  V +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
             +Y G+  D W  GV +Y M+ G  PF + +  + F      IL  +   P    +SPE
Sbjct: 179 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPE 231
Query: 252 CRHLISRIFVADPAKRIS-----IPEIRNHEWFLKNLPADLV 288
            + L++ +   DP +R+        E+  H +FL     D+V
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
           D +++VR +G G FG   L R+K+ + ++A+K + +     + ++  ++REI     LRH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L   + YCH  
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKK 193
           +V HRD+K EN L+       LKI DFG+S    +H+   + +   GT  Y+ PE++  K
Sbjct: 134 KVIHRDIKPENLLMGYKGE--LKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
            +D K+ D+W  GV  Y  LVG  PF+ P   +  R    RI++V    P +  +S   +
Sbjct: 188 THDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHR----RIVNVDLKFPPF--LSDGSK 240
Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKN 282
            LIS++    P +R+ +  +  H W   N
Sbjct: 241 DLISKLLRYHPPQRLPLKGVMEHPWVKAN 269

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 152/275 (55%), Gaps = 25/275 (9%)
Query: 19  DSDRYELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERG-----DKIDENVQREIIN 70
           D  ++EL++ +G G+FG   L++        +L A+K +++      D++   ++R+I+ 
Sbjct: 23  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 82
Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
              + HP IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   +
Sbjct: 83  --EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEV 189
            + HS+ + +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV
Sbjct: 141 DHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 198
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           + ++ +  + AD WS GV ++ ML G  PF+     K+ ++T+  IL  +  +P +  +S
Sbjct: 199 VNRRGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LS 251
Query: 250 PECRHLISRIFVADPAKRI-----SIPEIRNHEWF 279
           PE + L+  +F  +PA R+      + EI+ H +F
Sbjct: 252 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 96/282 (34%), Positives = 140/282 (49%), Gaps = 22/282 (7%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL- 74
           M+D D  +L   +G G FG   L+R+K T    A+K + +   I  + V   +   R L 
Sbjct: 4   MNDFDYLKL---LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 75  --RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
             RHP +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
            HS  V +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
             +Y G+  D W  GV +Y M+ G  PF + +  + F      IL  +   P    +SPE
Sbjct: 179 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPE 231
Query: 252 CRHLISRIFVADPAKRIS-----IPEIRNHEWFLKNLPADLV 288
            + L++ +   DP +R+        E+  H +FL     D+V
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D++E +R +G+G+FG   L++ K+T    A+K +++   +        +N + ++     
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +V+EYA GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +K+ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 270
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 152/275 (55%), Gaps = 25/275 (9%)
Query: 19  DSDRYELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERG-----DKIDENVQREIIN 70
           D  ++EL++ +G G+FG   L++        +L A+K +++      D++   ++R+I+ 
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
              + HP IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   +
Sbjct: 82  --EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEV 189
            + HS+ + +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV
Sbjct: 140 DHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           + ++ +  + AD WS GV ++ ML G  PF+     K+ ++T+  IL  +  +P +  +S
Sbjct: 198 VNRRGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LS 250
Query: 250 PECRHLISRIFVADPAKRI-----SIPEIRNHEWF 279
           PE + L+  +F  +PA R+      + EI+ H +F
Sbjct: 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 96/282 (34%), Positives = 140/282 (49%), Gaps = 22/282 (7%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL- 74
           M+D D  +L   +G G FG   L+R+K T    A+K + +   I  + V   +   R L 
Sbjct: 9   MNDFDYLKL---LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 75  --RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
             RHP +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 125
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
            HS  V +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL 
Sbjct: 126 LHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 183
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
             +Y G+  D W  GV +Y M+ G  PF + +  + F      IL  +   P    +SPE
Sbjct: 184 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPE 236
Query: 252 CRHLISRIFVADPAKRIS-----IPEIRNHEWFLKNLPADLV 288
            + L++ +   DP +R+        E+  H +FL     D+V
Sbjct: 237 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 278

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 152/275 (55%), Gaps = 25/275 (9%)
Query: 19  DSDRYELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERG-----DKIDENVQREIIN 70
           D  ++EL++ +G G+FG   L++        +L A+K +++      D++   ++R+I+ 
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
              + HP IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   +
Sbjct: 82  --EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEV 189
            + HS+ + +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV
Sbjct: 140 DHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           + ++ +  + AD WS GV ++ ML G  PF+     K+ ++T+  IL  +  +P +  +S
Sbjct: 198 VNRRGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LS 250
Query: 250 PECRHLISRIFVADPAKRI-----SIPEIRNHEWF 279
           PE + L+  +F  +PA R+      + EI+ H +F
Sbjct: 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 97/294 (32%), Positives = 146/294 (49%), Gaps = 25/294 (8%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RH 76
           + +E ++ +G G FG   L+++K T    A+K +++   +  + V   +  +R L   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +   K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y HS 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 137 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKE 194
           + V +RDLKLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL   +
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y G+  D W  GV +Y M+ G  PF + +  K F      IL  +   P    + PE + 
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLGPEAKS 378
Query: 255 LISRIFVADPAKRIS-----IPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 303
           L+S +   DP +R+        EI  H +F     A +V  +    +   P +P
Sbjct: 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF-----AGIVWQHVYEKKLSPPFKP 427

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 96/282 (34%), Positives = 140/282 (49%), Gaps = 22/282 (7%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL- 74
           M+D D  +L   +G G FG   L+R+K T    A+K + +   I  + V   +   R L 
Sbjct: 4   MNDFDYLKL---LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 75  --RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
             RHP +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
            HS  V +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
             +Y G+  D W  GV +Y M+ G  PF + +  + F      IL  +   P    +SPE
Sbjct: 179 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPE 231
Query: 252 CRHLISRIFVADPAKRIS-----IPEIRNHEWFLKNLPADLV 288
            + L++ +   DP +R+        E+  H +FL     D+V
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 96/282 (34%), Positives = 140/282 (49%), Gaps = 22/282 (7%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL- 74
           M+D D  +L   +G G FG   L+R+K T    A+K + +   I  + V   +   R L 
Sbjct: 4   MNDFDYLKL---LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 75  --RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
             RHP +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
            HS  V +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
             +Y G+  D W  GV +Y M+ G  PF + +  + F      IL  +   P    +SPE
Sbjct: 179 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPE 231
Query: 252 CRHLISRIFVADPAKRIS-----IPEIRNHEWFLKNLPADLV 288
            + L++ +   DP +R+        E+  H +FL     D+V
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 97/294 (32%), Positives = 146/294 (49%), Gaps = 25/294 (8%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RH 76
           + +E ++ +G G FG   L+++K T    A+K +++   +  + V   +  +R L   RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +   K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y HS 
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 270
Query: 137 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKE 194
           + V +RDLKLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL   +
Sbjct: 271 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 328
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y G+  D W  GV +Y M+ G  PF + +  K F      IL  +   P    + PE + 
Sbjct: 329 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLGPEAKS 381
Query: 255 LISRIFVADPAKRIS-----IPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 303
           L+S +   DP +R+        EI  H +F     A +V  +    +   P +P
Sbjct: 382 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF-----AGIVWQHVYEKKLSPPFKP 430

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 97/294 (32%), Positives = 145/294 (49%), Gaps = 25/294 (8%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RH 76
           + +E ++ +G G FG   L+++K T    A+K +++   +  + V   +  +R L   RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +   K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y HS 
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 128
Query: 137 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKE 194
           + V +RDLKLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL   +
Sbjct: 129 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND 186
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y G+  D W  GV +Y M+ G  PF + +  K F      IL  +   P    + PE + 
Sbjct: 187 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLGPEAKS 239
Query: 255 LISRIFVADPAKRIS-----IPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 303
           L+S +   DP +R+        EI  H +F     A +V  +    +   P +P
Sbjct: 240 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF-----AGIVWQHVYEKKLSPPFKP 288

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 97/294 (32%), Positives = 145/294 (49%), Gaps = 25/294 (8%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RH 76
           + +E ++ +G G FG   L+++K T    A+K +++   +  + V   +  +R L   RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +   K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y HS 
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 129
Query: 137 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKE 194
           + V +RDLKLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL   +
Sbjct: 130 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND 187
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y G+  D W  GV +Y M+ G  PF + +  K F      IL  +   P    + PE + 
Sbjct: 188 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLGPEAKS 240
Query: 255 LISRIFVADPAKRIS-----IPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 303
           L+S +   DP +R+        EI  H +F     A +V  +    +   P +P
Sbjct: 241 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF-----AGIVWQHVYEKKLSPPFKP 289

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 97/294 (32%), Positives = 145/294 (49%), Gaps = 25/294 (8%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RH 76
           + +E ++ +G G FG   L+++K T    A+K +++   +  + V   +  +R L   RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +   K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y HS 
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 127
Query: 137 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKE 194
           + V +RDLKLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL   +
Sbjct: 128 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND 185
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y G+  D W  GV +Y M+ G  PF + +  K F      IL  +   P    + PE + 
Sbjct: 186 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLGPEAKS 238
Query: 255 LISRIFVADPAKRIS-----IPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 303
           L+S +   DP +R+        EI  H +F     A +V  +    +   P +P
Sbjct: 239 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF-----AGIVWQHVYEKKLSPPFKP 287

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 83/268 (30%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++ K+T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 162 DLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 270
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 90/265 (33%), Positives = 143/265 (53%), Gaps = 18/265 (6%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHP 77
           +EL + +G G+FG   L   KKT +  A+K +++   + D++V+  ++  R L     HP
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
            +        T  +L  VMEY +GG+L   I +  +F    A F+  ++I G+ + HS  
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 139
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYD 196
           + +RDLKL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+LL ++Y+
Sbjct: 140 IVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYN 197
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHL 255
             + D WS GV LY ML+G  PF   +E + F        S++   P Y   +  E + L
Sbjct: 198 HSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFH-------SIRMDNPFYPRWLEKEAKDL 249
Query: 256 ISRIFVADPAKRISI-PEIRNHEWF 279
           + ++FV +P KR+ +  +IR H  F
Sbjct: 250 LVKLFVREPEKRLGVRGDIRQHPLF 274

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
           D +++ R +G G FG   L R+K+ + ++A+K + +     + ++  ++REI     LRH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L   + YCH  
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKK 193
           +V HRD+K EN L+       LKI DFG+S    +H+   + +   GT  Y+ PE++  K
Sbjct: 135 KVIHRDIKPENLLMGYKGE--LKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
            +D K+ D+W  GV  Y  LVG  PF+ P   +  R    RI++V    P +  +S   +
Sbjct: 189 THDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHR----RIVNVDLKFPPF--LSDGSK 241
Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKN 282
            LIS++    P +R+ +  +  H W   N
Sbjct: 242 DLISKLLRYHPPQRLPLKGVMEHPWVKAN 270

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++ K+T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++ K+T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++ K+T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 134/263 (50%), Gaps = 14/263 (5%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
           RY   R +G G F     + D  T+E+ A K + +   +     E +  EI  H+SL +P
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           ++V F         + +V+E      L E        +E EAR+F +Q I GV Y H+ +
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEYD 196
           V HRDLKL N  L+      +KI DFG +       + K T+ GTP YIAPEVL KK + 
Sbjct: 163 VIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHS 220
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            ++ D+WS G  LY +LVG  PFE        ++T  RI   +YS+P   HI+P    LI
Sbjct: 221 FEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPR--HINPVASALI 273
Query: 257 SRIFVADPAKRISIPEIRNHEWF 279
            R+  ADP  R S+ E+   E+F
Sbjct: 274 RRMLHADPTLRPSVAELLTDEFF 296

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++ K+T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 270
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++ K+T    A+K +++   +        +N +    ++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 181
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 182 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 237
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 238 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 290
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 291 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 83/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ IG+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +K+ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++ K+T    A+K +++   +        +N +    ++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 153
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 154 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 209
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 210 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 262
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 263 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++ K+T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 270
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   E  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADEPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLAGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 181
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +     +  GTP Y+APE++L K Y+
Sbjct: 182 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGATWTLCGTPEYLAPEIILSKGYN 237
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 238 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 290
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 291 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYQMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 139/259 (53%), Gaps = 18/259 (6%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
           +G G+FG   L   KKT +  A+K +++   + D++V+  ++  R L     HP +    
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T  +L  VMEY +GG+L   I +  +F    A F+  ++I G+ + HS  + +RDL
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
           KL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+LL ++Y+  + D 
Sbjct: 145 KLDNILLDKD--GHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSV-DW 201
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFV 261
           WS GV LY ML+G  PF   +E + F        S++   P Y   +  E + L+ ++FV
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFH-------SIRMDNPFYPRWLEKEAKDLLVKLFV 254
Query: 262 ADPAKRISI-PEIRNHEWF 279
            +P KR+ +  +IR H  F
Sbjct: 255 REPEKRLGVRGDIRQHPLF 273

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 162 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 270
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 90/284 (31%), Positives = 144/284 (50%), Gaps = 21/284 (7%)
Query: 6   MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ 65
           + +GP  + P    SD +  ++ IG G+FG   L R K  E   AVK +++   + +  +
Sbjct: 25  INLGPSSN-PHAKPSD-FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEE 82
Query: 66  REIINHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           + I++ R++     +HP +V       T   L  V++Y +GGELF  +     F E  AR
Sbjct: 83  KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR 142
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV- 179
           F+  ++ S + Y HS+ + +RDLK EN LLD      + + DFG  K ++ H+   ST  
Sbjct: 143 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTFC 200
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
           GTP Y+APEVL K+ YD +  D W  G  LY ML G  PF      + +   +++ L ++
Sbjct: 201 GTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 259
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIP----EIRNHEWF 279
            +I +        RHL+  +   D  KR+       EI++H +F
Sbjct: 260 PNITN------SARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLXGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++ K+T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 270
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I NH+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIXNHKWF 298

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +  +  GTP Y+APE++L K Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGYN 217
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 270
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 136/270 (50%), Gaps = 11/270 (4%)
Query: 16  IMHDS--DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHR 72
           I HD   D Y++  ++G+G FGV   + ++ T    A K++    + D E V++EI    
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 209
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVS 131
            LRHP +V   +       + ++ E+ SGGELFE++ +   + SEDEA  + +Q+  G+ 
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           + H     H DLK EN +     +  LK+ DFG +         K T GT  + APEV  
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
            K   G   D+WS GV  Y++L G  PF      +N  +T+  + S  +++ D  +  IS
Sbjct: 330 GKPV-GYYTDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSGIS 384
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEWF 279
            + +  I ++ +ADP  R++I +   H W 
Sbjct: 385 EDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ IG+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GG++F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +K+ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P + + +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 162 DLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 270
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN ++D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLMIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P + + +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 162 DLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 270
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ IG+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GG++F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +K+ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLPNGVNDIKNHKWF 297

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 133/263 (50%), Gaps = 14/263 (5%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
           RY   R +G G F     + D  T+E+ A K + +   +     E +  EI  H+SL +P
Sbjct: 27  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 86
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           ++V F         + +V+E      L E        +E EAR+F +Q I GV Y H+ +
Sbjct: 87  HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 146
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
           V HRDLKL N  L+      +KI DFG  +K      + K   GTP YIAPEVL KK + 
Sbjct: 147 VIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHS 204
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            ++ D+WS G  LY +LVG  PFE        ++T  RI   +YS+P   HI+P    LI
Sbjct: 205 FEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPR--HINPVASALI 257
Query: 257 SRIFVADPAKRISIPEIRNHEWF 279
            R+  ADP  R S+ E+   E+F
Sbjct: 258 RRMLHADPTLRPSVAELLTDEFF 280

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 136/270 (50%), Gaps = 11/270 (4%)
Query: 16  IMHDS--DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHR 72
           I HD   D Y++  ++G+G FGV   + ++ T    A K++    + D E V++EI    
Sbjct: 44  IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 103
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVS 131
            LRHP +V   +       + ++ E+ SGGELFE++ +   + SEDEA  + +Q+  G+ 
Sbjct: 104 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 163
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           + H     H DLK EN +     +  LK+ DFG +         K T GT  + APEV  
Sbjct: 164 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 223
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
            K   G   D+WS GV  Y++L G  PF      +N  +T+  + S  +++ D  +  IS
Sbjct: 224 GKPV-GYYTDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSGIS 278
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEWF 279
            + +  I ++ +ADP  R++I +   H W 
Sbjct: 279 EDGKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++ K+T    A+K +++   +        +N +    ++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRF E  ARF+  Q++    Y HS+
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 153
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 154 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 209
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 210 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 262
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 263 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 133/263 (50%), Gaps = 14/263 (5%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
           RY   R +G G F     + D  T+E+ A K + +   +     E +  EI  H+SL +P
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           ++V F         + +V+E      L E        +E EAR+F +Q I GV Y H+ +
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
           V HRDLKL N  L+      +KI DFG  +K      + K   GTP YIAPEVL KK + 
Sbjct: 163 VIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHS 220
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            ++ D+WS G  LY +LVG  PFE        ++T  RI   +YS+P   HI+P    LI
Sbjct: 221 FEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPR--HINPVASALI 273
Query: 257 SRIFVADPAKRISIPEIRNHEWF 279
            R+  ADP  R S+ E+   E+F
Sbjct: 274 RRMLHADPTLRPSVAELLTDEFF 296

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 133/263 (50%), Gaps = 14/263 (5%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
           RY   R +G G F     + D  T+E+ A K + +   +     E +  EI  H+SL +P
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           ++V F         + +V+E      L E        +E EAR+F +Q I GV Y H+ +
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
           V HRDLKL N  L+      +KI DFG  +K      + K   GTP YIAPEVL KK + 
Sbjct: 163 VIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHS 220
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            ++ D+WS G  LY +LVG  PFE        ++T  RI   +YS+P   HI+P    LI
Sbjct: 221 FEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPR--HINPVASALI 273
Query: 257 SRIFVADPAKRISIPEIRNHEWF 279
            R+  ADP  R S+ E+   E+F
Sbjct: 274 RRMLHADPTLRPSVAELLTDEFF 296

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEYA GGE+F  +   GRF E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 147
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 148 DLIYRDLKPENLLID--EQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 203
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 204 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 256
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 257 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 284

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 146
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +  +  GTP Y+APE++L K Y+
Sbjct: 147 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGYN 202
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 203 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 255
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 256 RNLLQVDLTKRFGNLKDGVNDIKNHKWF 283

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN ++D      +K+ DFG +K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLMIDQQGY--IKVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/255 (32%), Positives = 130/255 (50%), Gaps = 9/255 (3%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           +G G FG      +  T   +A K I+ RG K  E V+ EI     L H N+++  +   
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 88  TPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
           +   + +VMEY  GGELF+RI +     +E +   F +Q+  G+ + H M + H DLK E
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE 216
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
           N L     A ++KI DFG ++      + K   GTP ++APEV +  ++     D+WS G
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDFVSFPTDMWSVG 275
Query: 207 VTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLISRIFVADP 264
           V  Y++L G  PF       N  +T++ IL+ ++ + D  +  IS E +  IS++ + + 
Sbjct: 276 VIAYMLLSGLSPF----LGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 265 AKRISIPEIRNHEWF 279
           + RIS  E   H W 
Sbjct: 332 SWRISASEALKHPWL 346

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRF+E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 270
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRF E  ARF+  Q++    Y HS+
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 181
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 182 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 237
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 238 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 290
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 291 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  134 bits (337), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 89/270 (32%), Positives = 137/270 (50%), Gaps = 20/270 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           D +   R +GSG FG   L+ ++ +  E ++     +R     E ++ EI   +SL HPN
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNA---GR-FSEDEARFFFQQLISGVSYCH 134
           I++  EV     ++ IVME   GGEL ERI +A   G+  SE       +Q+++ ++Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 135 SMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
           S  V H+DLK EN L  D SP   +KI DFG ++         +  GT  Y+APEV  K+
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FKR 200
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV----HIS 249
           +   K  D+WS GV +Y +L G  PF      +  +K         Y  P+Y      ++
Sbjct: 201 DVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT-------YKEPNYAVECRPLT 252
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEWF 279
           P+   L+ ++   DP +R S  ++ +HEWF
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 146/277 (52%), Gaps = 28/277 (10%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID------ENVQREIINHRSL 74
           D YEL   IG G F V R   +++T +  AVK ++            E+++RE      L
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGEL-FERI--CNAGR-FSEDEARFFFQQLISGV 130
           +HP+IV   E   +   L +V E+  G +L FE +   +AG  +SE  A  + +Q++  +
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 131 SYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFGYS----KSSVLHSQPKSTVGTPAY 184
            YCH   + HRD+K EN LL    + AP +K+ DFG +    +S ++       VGTP +
Sbjct: 144 RYCHDNNIIHRDVKPENVLLASKENSAP-VKLGDFGVAIQLGESGLVAG---GRVGTPHF 199
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP- 243
           +APEV+ ++ Y GK  DVW CGV L+++L G  PF   +E     +    I+  +Y +  
Sbjct: 200 MAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNP 253
Query: 244 -DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
             + HIS   + L+ R+ + DPA+RI++ E  NH W 
Sbjct: 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRF E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P + + +      ++L +VMEYA GGE+F  +   GRF E  ARF+  Q++    Y HS+
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 161
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 162 DLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 270
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRF E  ARF+  Q++    Y HS+
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 155
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 156 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 211
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 212 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 264
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 265 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 292

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN ++D      +++ DFG +K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLMIDQQGY--IQVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  134 bits (336), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 90/273 (32%), Positives = 136/273 (49%), Gaps = 18/273 (6%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDE----NVQREIINH 71
           D Y + + +GSG  G  +L  ++KT + VA+K I +     G   +     NV+ EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 191 LKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPD-YV 246
           +     G  +  D WS GV L++ L G  PF +     + +    +I S +Y+ IP+ + 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            +S +   L+ ++ V DP  R +  E   H W 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  134 bits (336), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 141/272 (51%), Gaps = 14/272 (5%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 31  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHI 87
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 88  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 147
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL  
Sbjct: 148 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 207
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISP 250
           ++YD K  D+WS GV +Y++L G  PF              RI   QY    P++  +S 
Sbjct: 208 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 266
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           E + LI  +   +P +R++I E  NH W +++
Sbjct: 267 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 298

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  134 bits (336), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 90/273 (32%), Positives = 136/273 (49%), Gaps = 18/273 (6%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDE----NVQREIINH 71
           D Y + + +GSG  G  +L  ++KT + VA+K I +     G   +     NV+ EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 191 LKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPD-YV 246
           +     G  +  D WS GV L++ L G  PF +     + +    +I S +Y+ IP+ + 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            +S +   L+ ++ V DP  R +  E   H W 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRF E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRF E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 90/273 (32%), Positives = 136/273 (49%), Gaps = 18/273 (6%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDE----NVQREIINH 71
           D Y + + +GSG  G  +L  ++KT + VA+K I +     G   +     NV+ EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 191 LKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPD-YV 246
           +     G  +  D WS GV L++ L G  PF +     + +    +I S +Y+ IP+ + 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            +S +   L+ ++ V DP  R +  E   H W 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 90/273 (32%), Positives = 136/273 (49%), Gaps = 18/273 (6%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDE----NVQREIINH 71
           D Y + + +GSG  G  +L  ++KT + VA+K I +     G   +     NV+ EI   
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 76  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 135 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 194
Query: 191 LKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPD-YV 246
           +     G  +  D WS GV L++ L G  PF +     + +    +I S +Y+ IP+ + 
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 251
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            +S +   L+ ++ V DP  R +  E   H W 
Sbjct: 252 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 90/273 (32%), Positives = 136/273 (49%), Gaps = 18/273 (6%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDE----NVQREIINH 71
           D Y + + +GSG  G  +L  ++KT + VA+K I +     G   +     NV+ EI   
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 69  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 128 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 187
Query: 191 LKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPD-YV 246
           +     G  +  D WS GV L++ L G  PF +     + +    +I S +Y+ IP+ + 
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 244
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            +S +   L+ ++ V DP  R +  E   H W 
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN ++D      +++ DFG++K   +  +     GTP Y+APE+++ K Y+
Sbjct: 161 DLIYRDLKPENLIID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIIISKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+AP ++L K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPAIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 143/272 (52%), Gaps = 25/272 (9%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           SD Y +   IG G++   +    K T    AVK I++  K D + + EI+  R  +HPNI
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDK-SKRDPSEEIEIL-LRYGQHPNI 83
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           +  K+V     H+ +V E   GGEL ++I     FSE EA F    +   V Y HS  V 
Sbjct: 84  ITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 140 HRDLKLENTL-LDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAY----IAPEVLLKK 193
           HRDLK  N L +D S  P  L+ICDFG++K   L ++    + TP Y    +APEVL ++
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQ 200
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFED-----PEEPKNFRKTIHRILSVQYSIP--DYV 246
            YD +  D+WS G+ LY ML G  PF +     PEE       + RI S ++++   ++ 
Sbjct: 201 GYD-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEE------ILTRIGSGKFTLSGGNWN 253
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEW 278
            +S   + L+S++   DP +R++  ++  H W
Sbjct: 254 TVSETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 141/272 (51%), Gaps = 14/272 (5%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 67  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHI 123
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 124 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 183
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL  
Sbjct: 184 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 243
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISP 250
           ++YD K  D+WS GV +Y++L G  PF              RI   QY    P++  +S 
Sbjct: 244 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 302
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           E + LI  +   +P +R++I E  NH W +++
Sbjct: 303 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 334

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/274 (32%), Positives = 144/274 (52%), Gaps = 18/274 (6%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 23  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHI 79
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 80  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 139
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL  
Sbjct: 140 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 199
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE----EPKNFRKTIHRILSVQYSIPDYVHI 248
           ++YD K  D+WS GV +Y++L G  PF         P    KT  R+   ++  P++  +
Sbjct: 200 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQYEFPNPEWSEV 256
Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           S E + LI  +   +P +R++I E  NH W +++
Sbjct: 257 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 290

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 141/272 (51%), Gaps = 14/272 (5%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 22  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHI 78
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 79  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 138
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL  
Sbjct: 139 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 198
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISP 250
           ++YD K  D+WS GV +Y++L G  PF              RI   QY    P++  +S 
Sbjct: 199 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 257
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           E + LI  +   +P +R++I E  NH W +++
Sbjct: 258 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 289

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 143/272 (52%), Gaps = 25/272 (9%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           SD Y +   IG G++   +    K T    AVK I++  K D + + EI+  R  +HPNI
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDK-SKRDPSEEIEIL-LRYGQHPNI 83
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           +  K+V     H+ +V E   GGEL ++I     FSE EA F    +   V Y HS  V 
Sbjct: 84  ITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 140 HRDLKLENTL-LDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAY----IAPEVLLKK 193
           HRDLK  N L +D S  P  L+ICDFG++K   L ++    + TP Y    +APEVL ++
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQ 200
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFED-----PEEPKNFRKTIHRILSVQYSIP--DYV 246
            YD +  D+WS G+ LY ML G  PF +     PEE       + RI S ++++   ++ 
Sbjct: 201 GYD-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEE------ILTRIGSGKFTLSGGNWN 253
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEW 278
            +S   + L+S++   DP +R++  ++  H W
Sbjct: 254 TVSETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 141/272 (51%), Gaps = 14/272 (5%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHI 117
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL  
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 237
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISP 250
           ++YD K  D+WS GV +Y++L G  PF              RI   QY    P++  +S 
Sbjct: 238 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 296
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           E + LI  +   +P +R++I E  NH W +++
Sbjct: 297 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 146/290 (50%), Gaps = 25/290 (8%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
           ++++R +G+G+FG   L+R +      A+K +++      K  E+   E +    + HP 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+R          + ++M+Y  GGELF  +  + RF    A+F+  ++   + Y HS  +
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            +RDLK EN LLD +    +KI DFG++K   +        GTP YIAPEV+  K Y+  
Sbjct: 128 IYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYXLCGTPDYIAPEVVSTKPYNKS 183
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
           I D WS G+ +Y ML G  PF D     N  KT  +IL+ +   P +   + + + L+SR
Sbjct: 184 I-DWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPPF--FNEDVKDLLSR 236
Query: 259 IFVADPAKRI-----SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 303
           +   D ++R+        +++NH WF      ++V +   +   E P +P
Sbjct: 237 LITRDLSQRLGNLQNGTEDVKNHPWF-----KEVVWEKLLSRNIETPYEP 281

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/274 (32%), Positives = 144/274 (52%), Gaps = 18/274 (6%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 21  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHI 77
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 78  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 137
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL  
Sbjct: 138 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 197
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE----EPKNFRKTIHRILSVQYSIPDYVHI 248
           ++YD K  D+WS GV +Y++L G  PF         P    KT  R+   ++  P++  +
Sbjct: 198 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQYEFPNPEWSEV 254
Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           S E + LI  +   +P +R++I E  NH W +++
Sbjct: 255 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 288

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 141/272 (51%), Gaps = 14/272 (5%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHI 73
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL  
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 193
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISP 250
           ++YD K  D+WS GV +Y++L G  PF              RI   QY    P++  +S 
Sbjct: 194 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 252
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           E + LI  +   +P +R++I E  NH W +++
Sbjct: 253 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 284

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 150/275 (54%), Gaps = 25/275 (9%)
Query: 19  DSDRYELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERG-----DKIDENVQREIIN 70
           D   +EL++ +G G+FG   L+R      +  L A+K +++      D++   ++R+I+ 
Sbjct: 26  DPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILA 85
Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
              + HP +V+      T   L +++++  GG+LF R+     F+E++ +F+  +L  G+
Sbjct: 86  --DVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEV 189
            + HS+ + +RDLK EN LLD      +K+ DFG SK ++ H +   S  GT  Y+APEV
Sbjct: 144 DHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV 201
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           + ++ +    AD WS GV ++ ML G+ PF+     K+ ++T+  IL  +  +P +  +S
Sbjct: 202 VNRQGHSHS-ADWWSYGVLMFEMLTGSLPFQG----KDRKETMTLILKAKLGMPQF--LS 254
Query: 250 PECRHLISRIFVADPAKRI-----SIPEIRNHEWF 279
            E + L+  +F  +PA R+        EI+ H ++
Sbjct: 255 TEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVFY 289

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 141/272 (51%), Gaps = 14/272 (5%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 15  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHI 71
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 72  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL  
Sbjct: 132 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 191
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISP 250
           ++YD K  D+WS GV +Y++L G  PF              RI   QY    P++  +S 
Sbjct: 192 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 250
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           E + LI  +   +P +R++I E  NH W +++
Sbjct: 251 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 282

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/274 (32%), Positives = 144/274 (52%), Gaps = 18/274 (6%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 16  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHI 72
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 73  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 132
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL  
Sbjct: 133 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 192
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE----EPKNFRKTIHRILSVQYSIPDYVHI 248
           ++YD K  D+WS GV +Y++L G  PF         P    KT  R+   ++  P++  +
Sbjct: 193 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQYEFPNPEWSEV 249
Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           S E + LI  +   +P +R++I E  NH W +++
Sbjct: 250 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 283

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRF E  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 161
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 270
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAK-----RISIPEIRNHEWF 279
             +   D  K     +  + +I+NH+WF
Sbjct: 270 RNLLQVDLTKAFGNLKNGVNDIKNHKWF 297

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRF E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D++E ++ +G+G+FG   L++  +T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY  GGE+F  +   GRF E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 141/272 (51%), Gaps = 14/272 (5%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHI 73
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL  
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 193
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISP 250
           ++YD K  D+WS GV +Y++L G  PF              RI   QY    P++  +S 
Sbjct: 194 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 252
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           E + LI  +   +P +R++I E  NH W +++
Sbjct: 253 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 284

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/256 (34%), Positives = 131/256 (51%), Gaps = 17/256 (6%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL---- 74
           D +E +R +G G+FG   L R K+T +L AVK +++ D I  D++V+  +   R L    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK-DVILQDDDVECTMTEKRILSLAR 81
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
            HP + +      TP  L  VME+ +GG+L   I  + RF E  ARF+  ++IS + + H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 193
              + +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+L + 
Sbjct: 142 DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
            Y G   D W+ GV LY ML G  PFE   E   F      IL+ +   P ++H   +  
Sbjct: 200 LY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPTWLH--EDAT 252
Query: 254 HLISRIFVADPAKRIS 269
            ++      +P  R+ 
Sbjct: 253 GILKSFMTKNPTMRLG 268

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/274 (34%), Positives = 142/274 (51%), Gaps = 25/274 (9%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           +D YE+  DIG G++ V +    K T    AVK I++  K D   + EI+  R  +HPNI
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDPTEEIEIL-LRYGQHPNI 78
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           +  K+V     ++ +V E   GGEL ++I     FSE EA      +   V Y H+  V 
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 140 HRDLKLENTL-LDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAY----IAPEVLLKK 193
           HRDLK  N L +D S  P  ++ICDFG++K   L ++    + TP Y    +APEVL ++
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLERQ 195
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFED-----PEEPKNFRKTIHRILSVQYSIPD--YV 246
            YD    D+WS GV LY ML G  PF +     PEE       + RI S ++S+    + 
Sbjct: 196 GYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEE------ILARIGSGKFSLSGGYWN 248
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFL 280
            +S   + L+S++   DP +R++   +  H W +
Sbjct: 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 140/272 (51%), Gaps = 14/272 (5%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 15  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHI 71
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 72  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K +  H+       TP Y+APEVL  
Sbjct: 132 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGP 191
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISP 250
           ++YD K  D+WS GV +Y++L G  PF              RI   QY    P++  +S 
Sbjct: 192 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 250
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           E + LI  +   +P +R++I E  NH W +++
Sbjct: 251 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 282

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 135/271 (49%), Gaps = 15/271 (5%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 84
           +G G F     + D  T+E+ A K + +   +     E +  EI  HRSL H ++V F  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
                  + +V+E      L E        +E EAR++ +Q++ G  Y H  +V HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKIADVW 203
           L N  L+      +KI DFG +       + K T+ GTP YIAPEVL KK +  ++ DVW
Sbjct: 149 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 205
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
           S G  +Y +LVG  PFE        ++T  RI   +YSIP   HI+P    LI ++   D
Sbjct: 206 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 259
Query: 264 PAKRISIPEIRNHEWFLKN-LPADLVVDNTT 293
           P  R +I E+ N E+F    +PA L +   T
Sbjct: 260 PTARPTINELLNDEFFTSGYIPARLPITCLT 290

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 142/268 (52%), Gaps = 20/268 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP  +APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEALAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + L+
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  KR       + +I+NH+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 135/271 (49%), Gaps = 15/271 (5%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 84
           +G G F     + D  T+E+ A K + +   +     E +  EI  HRSL H ++V F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
                  + +V+E      L E        +E EAR++ +Q++ G  Y H  +V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKIADVW 203
           L N  L+      +KI DFG +       + K T+ GTP YIAPEVL KK +  ++ DVW
Sbjct: 145 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
           S G  +Y +LVG  PFE        ++T  RI   +YSIP   HI+P    LI ++   D
Sbjct: 202 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 255
Query: 264 PAKRISIPEIRNHEWFLKN-LPADLVVDNTT 293
           P  R +I E+ N E+F    +PA L +   T
Sbjct: 256 PTARPTINELLNDEFFTSGYIPARLPITCLT 286

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 135/271 (49%), Gaps = 15/271 (5%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 84
           +G G F     + D  T+E+ A K + +   +     E +  EI  HRSL H ++V F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
                  + +V+E      L E        +E EAR++ +Q++ G  Y H  +V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKIADVW 203
           L N  L+      +KI DFG +       + K T+ GTP YIAPEVL KK +  ++ DVW
Sbjct: 145 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
           S G  +Y +LVG  PFE        ++T  RI   +YSIP   HI+P    LI ++   D
Sbjct: 202 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 255
Query: 264 PAKRISIPEIRNHEWFLKN-LPADLVVDNTT 293
           P  R +I E+ N E+F    +PA L +   T
Sbjct: 256 PTARPTINELLNDEFFTSGYIPARLPITCLT 286

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 136/273 (49%), Gaps = 18/273 (6%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDE----NVQREIINH 71
           D Y + + +GSG  G  +L  ++KT + VA++ I +     G   +     NV+ EI   
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 209 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 327
Query: 191 LKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPD-YV 246
           +     G  +  D WS GV L++ L G  PF +     + +    +I S +Y+ IP+ + 
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 384
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            +S +   L+ ++ V DP  R +  E   H W 
Sbjct: 385 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 136/273 (49%), Gaps = 18/273 (6%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDE----NVQREIINH 71
           D Y + + +GSG  G  +L  ++KT + VA++ I +     G   +     NV+ EI   
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313
Query: 191 LKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPD-YV 246
           +     G  +  D WS GV L++ L G  PF +     + +    +I S +Y+ IP+ + 
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 370
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            +S +   L+ ++ V DP  R +  E   H W 
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 134/271 (49%), Gaps = 15/271 (5%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 84
           +G G F     + D  T+E+ A K + +   +     E +  EI  HRSL H ++V F  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
                  + +V+E      L E        +E EAR++ +Q++ G  Y H  +V HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKIADVW 203
           L N  L+      +KI DFG +       + K  + GTP YIAPEVL KK +  ++ DVW
Sbjct: 169 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 225
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
           S G  +Y +LVG  PFE        ++T  RI   +YSIP   HI+P    LI ++   D
Sbjct: 226 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 279
Query: 264 PAKRISIPEIRNHEWFLKN-LPADLVVDNTT 293
           P  R +I E+ N E+F    +PA L +   T
Sbjct: 280 PTARPTINELLNDEFFTSGYIPARLPITCLT 310

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 134/271 (49%), Gaps = 15/271 (5%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 84
           +G G F     + D  T+E+ A K + +   +     E +  EI  HRSL H ++V F  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
                  + +V+E      L E        +E EAR++ +Q++ G  Y H  +V HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKIADVW 203
           L N  L+      +KI DFG +       + K  + GTP YIAPEVL KK +  ++ DVW
Sbjct: 167 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 223
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
           S G  +Y +LVG  PFE        ++T  RI   +YSIP   HI+P    LI ++   D
Sbjct: 224 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 277
Query: 264 PAKRISIPEIRNHEWFLKN-LPADLVVDNTT 293
           P  R +I E+ N E+F    +PA L +   T
Sbjct: 278 PTARPTINELLNDEFFTSGYIPARLPITCLT 308

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 134/271 (49%), Gaps = 15/271 (5%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 84
           +G G F     + D  T+E+ A K + +   +     E +  EI  HRSL H ++V F  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
                  + +V+E      L E        +E EAR++ +Q++ G  Y H  +V HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKIADVW 203
           L N  L+      +KI DFG +       + K  + GTP YIAPEVL KK +  ++ DVW
Sbjct: 143 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 199
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
           S G  +Y +LVG  PFE        ++T  RI   +YSIP   HI+P    LI ++   D
Sbjct: 200 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 253
Query: 264 PAKRISIPEIRNHEWFLKN-LPADLVVDNTT 293
           P  R +I E+ N E+F    +PA L +   T
Sbjct: 254 PTARPTINELLNDEFFTSGYIPARLPITCLT 284

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 94/274 (34%), Positives = 140/274 (51%), Gaps = 25/274 (9%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           +D YE+  DIG G++ V +    K T    AVK I++  K D   + EI+  R  +HPNI
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDK-SKRDPTEEIEIL-LRYGQHPNI 78
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           +  K+V     ++ +V E   GGEL ++I     FSE EA      +   V Y H+  V 
Sbjct: 79  ITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 140 HRDLKLENTL-LDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAY----IAPEVLLKK 193
           HRDLK  N L +D S  P  ++ICDFG++K   L ++    + TP Y    +APEVL ++
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAE-NGLLXTPCYTANFVAPEVLERQ 195
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFED-----PEEPKNFRKTIHRILSVQYSIPD--YV 246
            YD    D+WS GV LY  L G  PF +     PEE       + RI S ++S+    + 
Sbjct: 196 GYDAA-CDIWSLGVLLYTXLTGYTPFANGPDDTPEE------ILARIGSGKFSLSGGYWN 248
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFL 280
            +S   + L+S+    DP +R++   +  H W +
Sbjct: 249 SVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 136/260 (52%), Gaps = 15/260 (5%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 84
           +G G+F          T   VA+K I++         + VQ E+  H  L+HP+I+    
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
                 ++ +V+E    GE+   + N  + FSE+EAR F  Q+I+G+ Y HS  + HRDL
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDL 138
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
            L N LL  +    +KI DFG +    + H +  +  GTP YI+PE+  +  + G  +DV
Sbjct: 139 TLSNLLL--TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH-GLESDV 195
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           WS G   Y +L+G  PF D +  KN   T+++++   Y +P ++ I  E + LI ++   
Sbjct: 196 WSLGCMFYTLLIGRPPF-DTDTVKN---TLNKVVLADYEMPSFLSI--EAKDLIHQLLRR 249
Query: 263 DPAKRISIPEIRNHEWFLKN 282
           +PA R+S+  + +H +  +N
Sbjct: 250 NPADRLSLSSVLDHPFMSRN 269

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 139/269 (51%), Gaps = 20/269 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
           D +E+ R +G G FG   L R+KK+  +VA+K + +     + ++  ++REI     L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI+R          + +++EYA  GEL++ +  +  F E       ++L   + YCH  
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGK 142
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKK 193
           +V HRD+K EN LL       LKI DFG+S    +H+   + K+  GT  Y+ PE++  +
Sbjct: 143 KVIHRDIKPENLLLGLKGE--LKIADFGWS----VHAPSLRRKTMCGTLDYLPPEMIEGR 196
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
            ++ K+ D+W  GV  Y +LVG  PFE     + +R+ +   L    S+P         +
Sbjct: 197 MHNEKV-DLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPT------GAQ 249
Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKN 282
            LIS++   +P++R+ + ++  H W   N
Sbjct: 250 DLISKLLRHNPSERLPLAQVSAHPWVRAN 278

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 133/262 (50%), Gaps = 20/262 (7%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
           +G G+FG   L   K TEEL A+K +++   I D++V+  ++  R L    + P + +  
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T   L  VMEY +GG+L   I   G+F E +A F+  ++  G+ + H   + +RDL
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDL 146
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
           KL+N +LD      +KI DFG  K  ++     +   GTP YIAPE++  + Y GK  D 
Sbjct: 147 KLDNVMLDSE--GHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPY-GKSVDW 203
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           W+ GV LY ML G  PF+  +E + F+  +   +S   S      +S E   +   +   
Sbjct: 204 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS------LSKEAVSICKGLMTK 257
Query: 263 DPAKRISI-PE----IRNHEWF 279
            PAKR+   PE    +R H +F
Sbjct: 258 HPAKRLGCGPEGERDVREHAFF 279

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 136/272 (50%), Gaps = 14/272 (5%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVE---LHWRASQCPHI 117
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IV E   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 118 VRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYL 177
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL  
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 237
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISP 250
           ++YD K  D WS GV  Y++L G  PF              RI   QY    P++  +S 
Sbjct: 238 EKYD-KSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSE 296
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           E + LI  +   +P +R +I E  NH W  ++
Sbjct: 297 EVKXLIRNLLKTEPTQRXTITEFXNHPWIXQS 328

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/262 (33%), Positives = 131/262 (50%), Gaps = 20/262 (7%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
           +G G+FG   L   K T+EL AVK +++   I D++V+  ++  R L    + P + +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T   L  VMEY +GG+L   I   GRF E  A F+  ++  G+ +  S  + +RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
           KL+N +LD      +KI DFG  K ++      K   GTP YIAPE++  + Y GK  D 
Sbjct: 148 KLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY-GKSVDW 204
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           W+ GV LY ML G  PFE  +E + F+  +   ++   S      +S E   +   +   
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS------MSKEAVAICKGLMTK 258
Query: 263 DPAKRISI-PE----IRNHEWF 279
            P KR+   PE    I+ H +F
Sbjct: 259 HPGKRLGCGPEGERDIKEHAFF 280

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 143/277 (51%), Gaps = 28/277 (10%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID------ENVQREIINHRSL 74
           D YEL   IG G F V R   +++T +  AVK ++            E+++RE      L
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGEL-FERI--CNAGR-FSEDEARFFFQQLISGV 130
           +HP+IV   E   +   L +V E+  G +L FE +   +AG  +SE  A  + +Q++  +
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 145
Query: 131 SYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFGYS----KSSVLHSQPKSTVGTPAY 184
            YCH   + HRD+K    LL    + AP +K+  FG +    +S ++       VGTP +
Sbjct: 146 RYCHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHF 201
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP- 243
           +APEV+ ++ Y GK  DVW CGV L+++L G  PF   +E     +    I+  +Y +  
Sbjct: 202 MAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNP 255
Query: 244 -DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
             + HIS   + L+ R+ + DPA+RI++ E  NH W 
Sbjct: 256 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 143/277 (51%), Gaps = 28/277 (10%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID------ENVQREIINHRSL 74
           D YEL   IG G F V R   +++T +  AVK ++            E+++RE      L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGEL-FERI--CNAGR-FSEDEARFFFQQLISGV 130
           +HP+IV   E   +   L +V E+  G +L FE +   +AG  +SE  A  + +Q++  +
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 131 SYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFGYS----KSSVLHSQPKSTVGTPAY 184
            YCH   + HRD+K    LL    + AP +K+  FG +    +S ++       VGTP +
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHF 199
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP- 243
           +APEV+ ++ Y GK  DVW CGV L+++L G  PF   +E     +    I+  +Y +  
Sbjct: 200 MAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNP 253
Query: 244 -DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
             + HIS   + L+ R+ + DPA+RI++ E  NH W 
Sbjct: 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 87/262 (33%), Positives = 131/262 (50%), Gaps = 20/262 (7%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
           +G G+FG   L   K T+EL AVK +++   I D++V+  ++  R L    + P + +  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
               T   L  VMEY +GG+L   I   GRF E  A F+  ++  G+ +  S  + +RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
           KL+N +LD      +KI DFG  K ++      K   GTP YIAPE++  + Y GK  D 
Sbjct: 469 KLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY-GKSVDW 525
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
           W+ GV LY ML G  PFE  +E + F+  +   ++   S      +S E   +   +   
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS------MSKEAVAICKGLMTK 579
Query: 263 DPAKRISI-PE----IRNHEWF 279
            P KR+   PE    I+ H +F
Sbjct: 580 HPGKRLGCGPEGERDIKEHAFF 601

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 138/273 (50%), Gaps = 27/273 (9%)
Query: 23  YELVRDIGSGNFGVA---RLMRDKKTEELVAVKYIERG-------DKIDENVQREIINHR 72
           +EL+R +G G +G     R +    T ++ A+K +++        D      +R I+   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE-- 76
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
            ++HP IV       T   L +++EY SGGELF ++   G F ED A F+  ++   + +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLL 191
            H   + +RDLK EN +L+      +K+ DFG  K S+       T  GT  Y+APE+L+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
           +  ++ +  D WS G  +Y ML GA PF      +N +KTI +IL  + ++P Y  ++ E
Sbjct: 195 RSGHN-RAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LTQE 247
Query: 252 CRHLISRIFVADPAKRIS-----IPEIRNHEWF 279
            R L+ ++   + A R+        E++ H +F
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 128/264 (48%), Gaps = 11/264 (4%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-NVQREIINHRSLRHPNI 79
           D Y+++ ++GSG FGV     +K T  +   K+I     +D+  V+ EI     L HP +
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
           +   +       + +++E+ SGGELF+RI     + SE E   + +Q   G+ + H   +
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            H D+K EN + +   A  +KI DFG +         K T  T  + APE+ + +E  G 
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI-VDREPVGF 229
Query: 199 IADVWSCGVTLYVMLVGAYPF---EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
             D+W+ GV  YV+L G  PF   +D E  +N ++        ++    +  +SPE +  
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-----DWEFDEDAFSSVSPEAKDF 284
Query: 256 ISRIFVADPAKRISIPEIRNHEWF 279
           I  +   +P KR+++ +   H W 
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWL 308

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 149/284 (52%), Gaps = 24/284 (8%)
Query: 11  GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQRE 67
           G +       ++Y  ++ IG G+FG A L++  +      +K I       K  E  +RE
Sbjct: 14  GTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRRE 73
Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQ 124
           +    +++HPNIV+++E       L IVM+Y  GG+LF+RI NA +   F ED+   +F 
Sbjct: 74  VAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFV 132
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTV 179
           Q+   + + H  ++ HRD+K +N  L  DG+    +++ DFG ++  VL+S     ++ +
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGT----VQLGDFGIAR--VLNSTVELARACI 186
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
           GTP Y++PE+   K Y+ K +D+W+ G  LY +    + F    E  + +  + +I+S  
Sbjct: 187 GTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAF----EAGSMKNLVLKIISGS 241
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           +  P  +H S + R L+S++F  +P  R S+  I    +  K +
Sbjct: 242 FP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 137/273 (50%), Gaps = 27/273 (9%)
Query: 23  YELVRDIGSGNFGVA---RLMRDKKTEELVAVKYIERG-------DKIDENVQREIINHR 72
           +EL+R +G G +G     R +    T ++ A+K +++        D      +R I+   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE-- 76
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
            ++HP IV       T   L +++EY SGGELF ++   G F ED A F+  ++   + +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLL 191
            H   + +RDLK EN +L+      +K+ DFG  K S+          GT  Y+APE+L+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
           +  ++ +  D WS G  +Y ML GA PF      +N +KTI +IL  + ++P Y  ++ E
Sbjct: 195 RSGHN-RAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LTQE 247
Query: 252 CRHLISRIFVADPAKRIS-----IPEIRNHEWF 279
            R L+ ++   + A R+        E++ H +F
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 137/274 (50%), Gaps = 22/274 (8%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
           ++ YE+V+ IG G FG  +L+R K T ++ A+K + + + I  +        R +     
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            P +V+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   HS
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 186
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           M   HRD+K +N LLD S    LK+ DFG     +K  ++     + VGTP YI+PEVL 
Sbjct: 187 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 242
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
            +    Y G+  D WS GV LY MLVG  PF        + K ++   S+ +  PD   I
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDI 300
Query: 249 SPECRHLISRIFVADPAKRI---SIPEIRNHEWF 279
           S E ++LI   F+ D   R+    + EI+ H +F
Sbjct: 301 SKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 333

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 137/274 (50%), Gaps = 22/274 (8%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
           ++ YE+V+ IG G FG  +L+R K T ++ A+K + + + I  +        R +     
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            P +V+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   HS
Sbjct: 133 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 191
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           M   HRD+K +N LLD S    LK+ DFG     +K  ++     + VGTP YI+PEVL 
Sbjct: 192 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 247
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
            +    Y G+  D WS GV LY MLVG  PF        + K ++   S+ +  PD   I
Sbjct: 248 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDI 305
Query: 249 SPECRHLISRIFVADPAKRI---SIPEIRNHEWF 279
           S E ++LI   F+ D   R+    + EI+ H +F
Sbjct: 306 SKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 338

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 137/274 (50%), Gaps = 22/274 (8%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
           ++ YE+V+ IG G FG  +L+R K T ++ A+K + + + I  +        R +     
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            P +V+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   HS
Sbjct: 133 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 191
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           M   HRD+K +N LLD S    LK+ DFG     +K  ++     + VGTP YI+PEVL 
Sbjct: 192 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 247
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
            +    Y G+  D WS GV LY MLVG  PF        + K ++   S+ +  PD   I
Sbjct: 248 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDI 305
Query: 249 SPECRHLISRIFVADPAKRI---SIPEIRNHEWF 279
           S E ++LI   F+ D   R+    + EI+ H +F
Sbjct: 306 SKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 338

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/329 (26%), Positives = 151/329 (45%), Gaps = 39/329 (11%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHP 77
           ++L+R IG G++    L+R KKT+ + A++ +++      + ID     + +  ++  HP
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
            +V       T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++Y H   
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEYD 196
           + +RDLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L  ++Y 
Sbjct: 174 IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 230
Query: 197 GKIADVWSCGVTLYVMLVGAYPFE-----DPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
           G   D W+ GV ++ M+ G  PF+     D  +          IL  Q  IP    +S +
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVK 288
Query: 252 CRHLISRIFVADPAKRISI------------PEIRNHEW-----------FLKNLPADLV 288
              ++      DP +R+              P  RN +W           F  N+  +  
Sbjct: 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFG 348
Query: 289 VDNTTNNQFEEPDQPMQSIDEIMQIIAEA 317
           +DN  +    EP Q     D+I++ I ++
Sbjct: 349 LDNFDSQFTNEPVQLXPDDDDIVRKIDQS 377

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-----STVGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K     S VGT  Y++PE+L +K
Sbjct: 151 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 207 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 259
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 260 DLVEKLLVLDATKRLGCEEMEGY 282

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 140/279 (50%), Gaps = 23/279 (8%)
Query: 21  DRYELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGDKIDE-------NVQREIIN 70
           + +EL++ +G+G +G   L+R      T +L A+K +++   + +         +R+++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
           H   + P +V       T T L ++++Y +GGELF  +    RF+E E + +  +++  +
Sbjct: 114 HIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
            + H + + +RD+KLEN LLD +    + + DFG SK  V     ++    GT  Y+AP+
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 189 VLLKKEYD-GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
           ++   +    K  D WS GV +Y +L GA PF    E  +  +   RIL  +   P    
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--E 288
Query: 248 ISPECRHLISRIFVADPAKRIS-----IPEIRNHEWFLK 281
           +S   + LI R+ + DP KR+        EI+ H +F K
Sbjct: 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-----STVGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K     S VGT  Y++PE+L +K
Sbjct: 155 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 211 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 263
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 264 DLVEKLLVLDATKRLGCEEMEGY 286

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 152 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGY 283

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 152 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGY 283

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 154 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 262
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGY 285

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 152 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGY 283

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 152 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGY 283

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 154 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 262
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 151 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 207 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 259
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 260 DLVEKLLVLDATKRLGCEEMEGY 282

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 154 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 262
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 155 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 211 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 263
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 264 DLVEKLLVLDATKRLGCEEMEGY 286

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 154 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F K    I+ ++Y  P+     P+ R
Sbjct: 210 S-AXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK----IIKLEYDFPE--KFFPKAR 262
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/343 (26%), Positives = 155/343 (45%), Gaps = 41/343 (11%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHP 77
           ++L+R IG G++    L+R KKT+ + A+K +++      + ID     + +  ++  HP
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
            +V       T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++Y H   
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 126
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEYD 196
           + +RDLKL+N LLD      +K+ D+G  K  +      S   GTP YIAPE+L  ++Y 
Sbjct: 127 IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY- 183
Query: 197 GKIADVWSCGVTLYVMLVGAYPFE-----DPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
           G   D W+ GV ++ M+ G  PF+     D  +          IL  Q  IP    +S +
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVK 241
Query: 252 CRHLISRIFVADPAKRISI------------PEIRNHEW-----------FLKNLPADLV 288
              ++      DP +R+              P  RN +W           F  N+  +  
Sbjct: 242 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFG 301
Query: 289 VDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCL 331
           +DN  +    EP Q     D+I++ I ++     G + +N  L
Sbjct: 302 LDNFDSQFTNEPVQLXPDDDDIVRKIDQSEF--EGFEYINPLL 342

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 158
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 159 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 215 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 267
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 268 DLVEKLLVLDATKRLGCEEMEGY 290

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 136 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 192 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 244
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 245 DLVEKLLVLDATKRLGCEEMEGY 267

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/329 (26%), Positives = 150/329 (45%), Gaps = 39/329 (11%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHP 77
           ++L+R IG G++    L+R KKT+ + A+K +++      + ID     + +  ++  HP
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
            +V       T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++Y H   
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEYD 196
           + +RDLKL+N LLD      +K+ D+G  K  +      S   GTP YIAPE+L  ++Y 
Sbjct: 131 IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY- 187
Query: 197 GKIADVWSCGVTLYVMLVGAYPFE-----DPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
           G   D W+ GV ++ M+ G  PF+     D  +          IL  Q  IP    +S +
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVK 245
Query: 252 CRHLISRIFVADPAKRISI------------PEIRNHEW-----------FLKNLPADLV 288
              ++      DP +R+              P  RN +W           F  N+  +  
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFG 305
Query: 289 VDNTTNNQFEEPDQPMQSIDEIMQIIAEA 317
           +DN  +    EP Q     D+I++ I ++
Sbjct: 306 LDNFDSQFTNEPVQLXPDDDDIVRKIDQS 334

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 128/275 (46%), Gaps = 20/275 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREI-I 69
           + YE    +G G   V R    K T +  AVK I          E   ++ E   +E+ I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
             +   HPNI++ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           +   H + + HRDLK EN LLD      +K+ DFG+S       + +S  GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEI 194
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
           +     D     GK  D+WS GV +Y +L G+ PF   ++    R  +    + Q+  P+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 252
Query: 245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           +   S   + L+SR  V  P KR +  E   H +F
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 128
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 129 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 185 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 237
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 238 DLVEKLLVLDATKRLGCEEMEGY 260

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 154 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F K    I+ ++Y  P+     P+ R
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK----IIKLEYDFPE--KFFPKAR 262
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 130 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 186 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 238
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGY 261

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 131 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 187 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 239
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 240 DLVEKLLVLDATKRLGCEEMEGY 262

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 131
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 132 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 188 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 240
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 241 DLVEKLLVLDATKRLGCEEMEGY 263

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 156
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+L +K
Sbjct: 157 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P      P+ R
Sbjct: 213 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFP--AAFFPKAR 265
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 266 DLVEKLLVLDATKRLGCEEMEGY 288

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 78
           ++  + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            V+          L   + YA  G L + I   G F E   RF+  +++S + Y H   +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-----STVGTPAYIAPEVLLKK 193
            HRDLK EN LL+      ++I DFG +K  VL  + K     S VGT  Y++PE+L +K
Sbjct: 154 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 210 S-ASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 262
Query: 254 HLISRIFVADPAKRISIPEIRNH 276
            L+ ++ V D  KR+   E+  +
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 137/309 (44%), Gaps = 54/309 (17%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLR 75
           +Y L   IG G++GV R+  + +T  + A+K + +        K  E ++ E+   + L 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFER--------------------ICNAGRFS 115
           HPNI R  EV     ++ +VME   GG L ++                    IC     +
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 116 ED----------EARFFFQ----------QLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155
           E+          E+  F Q          Q+ S + Y H+  +CHRD+K EN L   + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 156 PRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL-LKKEYDGKIADVWSCGVTL 209
             +K+ DFG SK     ++  +    +  GTP ++APEVL    E  G   D WS GV L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 210 YVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 269
           +++L+GA PF    +     + +++ L   +  P+Y  +SP  R L+S +   +  +R  
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNKKLC--FENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 270 IPEIRNHEW 278
                 H W
Sbjct: 325 AMRALQHPW 333

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 20/275 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREI-I 69
           + YE    +G G   V R    K T +  AVK I          E   ++ E   +E+ I
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
             +   HPNI++ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           +   H + + HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
           +     D     GK  D+WS GV +Y +L G+ PF   ++    R  +    + Q+  P+
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 239
Query: 245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           +   S   + L+SR  V  P KR +  E   H +F
Sbjct: 240 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 129/267 (48%), Gaps = 21/267 (7%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE---------RGDKIDENVQREI-INHRSLRHPN 78
           IG G   V R    + T    AVK +E         + +++ E  +RE  I  +   HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+   +   + + + +V +    GELF+ +      SE E R   + L+  VS+ H+  +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD-- 196
            HRDLK EN LLD +   ++++ DFG+S       + +   GTP Y+APE+ LK   D  
Sbjct: 222 VHRDLKPENILLDDN--MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI-LKCSMDET 278
Query: 197 ----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
               GK  D+W+CGV L+ +L G+ PF    +    R  +      Q+S P++   S   
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG--QYQFSSPEWDDRSSTV 336
Query: 253 RHLISRIFVADPAKRISIPEIRNHEWF 279
           + LISR+   DP  R++  +   H +F
Sbjct: 337 KDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 20/275 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREI-I 69
           + YE    +G G   V R    K T +  AVK I          E   ++ E   +E+ I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
             +   HPNI++ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           +   H + + HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
           +     D     GK  D+WS GV +Y +L G+ PF   ++    R  +    + Q+  P+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 252
Query: 245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           +   S   + L+SR  V  P KR +  E   H +F
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/278 (31%), Positives = 137/278 (49%), Gaps = 26/278 (9%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-----DENVQREIINHRSLRH 76
           +Y +   +G G++G  + + D +T    AVK +++         + NV++EI   R LRH
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 77  PNIVRFKEVILT--PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSY 132
            N+++  +V+       + +VMEY   G  E+ + +    RF   +A  +F QLI G+ Y
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEY 124
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTPAYIAP 187
            HS  + H+D+K  N LL  +    LKI   G +++  LH        +++ G+PA+  P
Sbjct: 125 LHSQGIVHKDIKPGNLLL--TTGGTLKISALGVAEA--LHPFAADDTCRTSQGSPAFQPP 180
Query: 188 EVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
           E+    + + G   D+WS GVTLY +  G YPFE      N  K    I    Y+IP   
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG----DNIYKLFENIGKGSYAIPG-- 234
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
              P    L+  +   +PAKR SI +IR H WF K  P
Sbjct: 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 137/276 (49%), Gaps = 19/276 (6%)
Query: 20  SDRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--RSLRH 76
           +D Y+L + + G G  G       ++T +  A+K +      D    R+ ++H  ++   
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGG 81
Query: 77  PNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGV 130
           P+IV   +V     H    L I+ME   GGELF RI   G   F+E EA    + + + +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
            + HS  + HRD+K EN L         LK+ DFG++K +  ++  ++   TP Y+APEV
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEV 200
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVH 247
           L  ++YD K  D+WS GV +Y++L G  PF              RI   QY  P  ++  
Sbjct: 201 LGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           +S + + LI  +   DP +R++I +  NH W  +++
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 137/276 (49%), Gaps = 19/276 (6%)
Query: 20  SDRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--RSLRH 76
           +D Y+L + + G G  G       ++T +  A+K +      D    R+ ++H  ++   
Sbjct: 8   TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGG 62
Query: 77  PNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGV 130
           P+IV   +V     H    L I+ME   GGELF RI   G   F+E EA    + + + +
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
            + HS  + HRD+K EN L         LK+ DFG++K +  ++  ++   TP Y+APEV
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEV 181
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVH 247
           L  ++YD K  D+WS GV +Y++L G  PF              RI   QY  P  ++  
Sbjct: 182 LGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 240
Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
           +S + + LI  +   DP +R++I +  NH W  +++
Sbjct: 241 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 276

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 138/283 (48%), Gaps = 23/283 (8%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHP 77
           ++L+R IG G++    L+R KKT+ + A+K +++      + ID     + +  ++  HP
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
            +V       T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++Y H   
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 141
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEYD 196
           + +RDLKL+N LLD      +K+ D+G  K  +      S   GTP YIAPE+L  ++Y 
Sbjct: 142 IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY- 198
Query: 197 GKIADVWSCGVTLYVMLVGAYPFE-----DPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
           G   D W+ GV ++ M+ G  PF+     D  +          IL  Q  IP    +S +
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SMSVK 256
Query: 252 CRHLISRIFVADPAKRI------SIPEIRNHEWFLKNLPADLV 288
              ++      DP +R+         +I+ H +F +N+  D++
Sbjct: 257 AASVLKSFLNKDPKERLGCLPQTGFADIQGHPFF-RNVDWDMM 298

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 133/260 (51%), Gaps = 13/260 (5%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           +G G +G+    RD   +  +A+K I ER  +  + +  EI  H+ L+H NIV++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 88  TPTHLAIVMEYASGGELFERI-CNAGRFSEDEAR--FFFQQLISGVSYCHSMQVCHRDLK 144
               + I ME   GG L   +    G   ++E    F+ +Q++ G+ Y H  Q+ HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 145 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIAD 201
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ K  + Y GK AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAAD 207
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261
           +WS G T+  M  G  PF +  EP+     +  +  V   IP+   +S E +  I + F 
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MFKVHPEIPE--SMSAEAKAFILKCFE 264
Query: 262 ADPAKRISIPEIRNHEWFLK 281
            DP KR    ++   E FLK
Sbjct: 265 PDPDKRACANDLLVDE-FLK 283

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/246 (32%), Positives = 127/246 (51%), Gaps = 12/246 (4%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           +G G +G+    RD   +  +A+K I ER  +  + +  EI  H+ L+H NIV++     
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 88  TPTHLAIVMEYASGGELFERI-CNAGRFSEDEAR--FFFQQLISGVSYCHSMQVCHRDLK 144
               + I ME   GG L   +    G   ++E    F+ +Q++ G+ Y H  Q+ HRD+K
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 145 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIAD 201
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ K  + Y GK AD
Sbjct: 136 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAAD 193
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261
           +WS G T+  M  G  PF +  EP+     +  +  V   IP+   +S E +  I + F 
Sbjct: 194 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MFKVHPEIPE--SMSAEAKAFILKCFE 250
Query: 262 ADPAKR 267
            DP KR
Sbjct: 251 PDPDKR 256

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 137/274 (50%), Gaps = 22/274 (8%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
           ++ Y++V+ IG G FG  +L+R K ++++ A+K + + + I  +        R +     
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            P +V+         +L +VMEY  GG+L   + N     E  A+F+  +++  +   HS
Sbjct: 134 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 192
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           M + HRD+K +N LLD      LK+ DFG      ++ ++H    + VGTP YI+PEVL 
Sbjct: 193 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVHCD--TAVGTPDYISPEVLK 248
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
            +    Y G+  D WS GV L+ MLVG  PF        + K +    S+ +  P+   I
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCF--PEDAEI 306
Query: 249 SPECRHLISRIFVADPAKRI---SIPEIRNHEWF 279
           S   ++LI   F+ D   R+    + EI+ H +F
Sbjct: 307 SKHAKNLIC-AFLTDREVRLGRNGVEEIKQHPFF 339

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 129/287 (44%), Gaps = 32/287 (11%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEEL-VAVKYIER---------GDKIDENVQREIINHR 72
           Y L   +G G FG       + T+ L VA+K I R          D +   ++  ++   
Sbjct: 33  YRLGPLLGKGGFGTV-FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 73  SLR--HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLISG 129
                HP ++R  +   T     +V+E      +LF+ I   G   E  +R FF Q+++ 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
           + +CHS  V HRD+K EN L+D       K+ DFG    ++LH +P +   GT  Y  PE
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFG--SGALLHDEPYTDFDGTRVYSPPE 208
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
            + + +Y    A VWS G+ LY M+ G  PFE  +E          IL  +   P   H+
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------ILEAELHFP--AHV 256
Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNN 295
           SP+C  LI R     P+ R S+ EI    W     PA+ V  N +  
Sbjct: 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWM--QTPAEDVPLNPSKG 301

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 16/263 (6%)
Query: 27  RDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREI-INHRSLRHPNIVRF 82
           +++G G F V R    K T +  A K+++   RG      +  EI +   +   P ++  
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 83  KEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQVC 139
            EV    + + +++EYA+GGE+F  +C    A   SE++     +Q++ GV Y H   + 
Sbjct: 95  HEVYENTSEIILILEYAAGGEIF-SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 140 HRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD-- 196
           H DLK +N LL    P   +KI DFG S+      + +  +GTP Y+APE+L    YD  
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL---NYDPI 210
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
               D+W+ G+  Y++L    PF   +  + +       ++V YS   +  +S      I
Sbjct: 211 TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ--VNVDYSEETFSSVSQLATDFI 268
Query: 257 SRIFVADPAKRISIPEIRNHEWF 279
             + V +P KR +     +H W 
Sbjct: 269 QSLLVKNPEKRPTAEICLSHSWL 291

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 140/265 (52%), Gaps = 14/265 (5%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           IG G+ G+  L R+K +   VAVK ++ R  +  E +  E++  R  +H N+V   +  L
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
               L ++ME+  GG L + I +  R +E++     + ++  ++Y H+  V HRD+K ++
Sbjct: 113 VGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDS 171
Query: 148 TL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            L  LDG    R+K+ DFG+ ++ S    + K  VGTP ++APEV+ +  Y  ++ D+WS
Sbjct: 172 ILLTLDG----RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV-DIWS 226
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            G+ +  M+ G  P+   + P    K +    S    + +   +SP  R  + R+ V DP
Sbjct: 227 LGIMVIEMVDGEPPYFS-DSPVQAMKRLRD--SPPPKLKNSHKVSPVLRDFLERMLVRDP 283
Query: 265 AKRISIPEIRNHEWFLKN-LPADLV 288
            +R +  E+ +H + L+  LP  LV
Sbjct: 284 QERATAQELLDHPFLLQTGLPECLV 308

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 137/272 (50%), Gaps = 13/272 (4%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           IG G+ G+  +   + + +LVAVK ++ R  +  E +  E++  R  +H N+V      L
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
               L +VME+  GG L + I    R +E++       ++  +S  H+  V HRD+K ++
Sbjct: 142 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 200
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APE++ +  Y G   D+WS
Sbjct: 201 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 255
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            G+ +  M+ G  P+ + E P    K I   L  +  + +   +SP  +  + R+ V DP
Sbjct: 256 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPR--LKNLHKVSPSLKGFLDRLLVRDP 312
Query: 265 AKRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 296
           A+R +  E+  H +  K  P   +V     N+
Sbjct: 313 AQRATAAELLKHPFLAKAGPPASIVPLMRQNR 344

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 103/206 (50%), Gaps = 9/206 (4%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLR 75
           ++RY++V  +G G      L  D      VA+K I       ++  +  +RE+ N   L 
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           H NIV   +V        +VMEY  G  L E I + G  S D A  F  Q++ G+ + H 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKK 193
           M++ HRD+K +N L+D +    LKI DFG +K  S    +Q    +GT  Y +PE   K 
Sbjct: 130 MRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAKG 186
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPF 219
           E   +  D++S G+ LY MLVG  PF
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 137/272 (50%), Gaps = 13/272 (4%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           IG G+ G+  +   + + +LVAVK ++ R  +  E +  E++  R  +H N+V      L
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
               L +VME+  GG L + I    R +E++       ++  +S  H+  V HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 146
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APE++ +  Y G   D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            G+ +  M+ G  P+ + E P    K I   L  +  + +   +SP  +  + R+ V DP
Sbjct: 202 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPR--LKNLHKVSPSLKGFLDRLLVRDP 258
Query: 265 AKRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 296
           A+R +  E+  H +  K  P   +V     N+
Sbjct: 259 AQRATAAELLKHPFLAKAGPPASIVPLMRQNR 290

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 137/272 (50%), Gaps = 13/272 (4%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           IG G+ G+  +   + + +LVAVK ++ R  +  E +  E++  R  +H N+V      L
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
               L +VME+  GG L + I    R +E++       ++  +S  H+  V HRD+K ++
Sbjct: 97  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 155
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APE++ +  Y G   D+WS
Sbjct: 156 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 210
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            G+ +  M+ G  P+ + E P    K I   L  +  + +   +SP  +  + R+ V DP
Sbjct: 211 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPR--LKNLHKVSPSLKGFLDRLLVRDP 267
Query: 265 AKRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 296
           A+R +  E+  H +  K  P   +V     N+
Sbjct: 268 AQRATAAELLKHPFLAKAGPPASIVPLMRQNR 299

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 137/272 (50%), Gaps = 13/272 (4%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           IG G+ G+  +   + + +LVAVK ++ R  +  E +  E++  R  +H N+V      L
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
               L +VME+  GG L + I    R +E++       ++  +S  H+  V HRD+K ++
Sbjct: 99  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 157
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APE++ +  Y G   D+WS
Sbjct: 158 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 212
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            G+ +  M+ G  P+ + E P    K I   L  +  + +   +SP  +  + R+ V DP
Sbjct: 213 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPR--LKNLHKVSPSLKGFLDRLLVRDP 269
Query: 265 AKRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 296
           A+R +  E+  H +  K  P   +V     N+
Sbjct: 270 AQRATAAELLKHPFLAKAGPPASIVPLMRQNR 301

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 137/272 (50%), Gaps = 13/272 (4%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           IG G+ G+  +   + + +LVAVK ++ R  +  E +  E++  R  +H N+V      L
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
               L +VME+  GG L + I    R +E++       ++  +S  H+  V HRD+K ++
Sbjct: 219 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 277
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APE++ +  Y G   D+WS
Sbjct: 278 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 332
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            G+ +  M+ G  P+ + E P    K I   L  +  + +   +SP  +  + R+ V DP
Sbjct: 333 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPR--LKNLHKVSPSLKGFLDRLLVRDP 389
Query: 265 AKRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 296
           A+R +  E+  H +  K  P   +V     N+
Sbjct: 390 AQRATAAELLKHPFLAKAGPPASIVPLMRQNR 421

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 137/272 (50%), Gaps = 13/272 (4%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           IG G+ G+  +   + + +LVAVK ++ R  +  E +  E++  R  +H N+V      L
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
               L +VME+  GG L + I    R +E++       ++  +S  H+  V HRD+K ++
Sbjct: 92  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 150
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APE++ +  Y G   D+WS
Sbjct: 151 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 205
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            G+ +  M+ G  P+ + E P    K I   L  +  + +   +SP  +  + R+ V DP
Sbjct: 206 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPR--LKNLHKVSPSLKGFLDRLLVRDP 262
Query: 265 AKRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 296
           A+R +  E+  H +  K  P   +V     N+
Sbjct: 263 AQRATAAELLKHPFLAKAGPPASIVPLMRQNR 294

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 130/272 (47%), Gaps = 35/272 (12%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           D Y++   + G G  G    + +K+T+E  A+K ++   K    V+   ++ R+ + P+I
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHI 73
Query: 80  VR----FKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
           VR    ++ +      L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 134 HSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS+ + HRD+K EN L     P   LK+ DFG++K          T G            
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---------TTG------------ 172
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISP 250
           ++YD K  D+WS GV +Y++L G  PF              RI   QY  P  ++  +S 
Sbjct: 173 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           E + LI  +   +P +R++I E  NH W +++
Sbjct: 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 19  DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 75
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 76  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 135
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 136 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 193
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 194 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 247
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 248 ----IIGGQVFFRQRV--SSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 20  DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 76
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 77  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 136
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 137 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 194
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 195 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 248
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 249 ----IIGGQVFFRQRV--SSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 19  DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 75
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 76  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 135
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 136 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 193
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 194 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 247
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 248 ----IIGGQVFFRQRV--SSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 20  DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 76
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 77  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 136
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 137 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 194
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 195 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 248
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 249 ----IIGGQVFFRQRV--SXECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 20  DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 76
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 77  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 136
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 137 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 194
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 195 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 248
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 249 ----IIGGQVFFRQRV--SSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 20  DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 76
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 77  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 136
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 137 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 194
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 195 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 248
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 249 ----IIGGQVFFRQRV--SXECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 19  DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 75
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 76  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 135
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 136 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 193
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 194 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 247
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 248 ----IIGGQVFFRQRV--SXECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 34  DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 90
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 91  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 150
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 151 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 208
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 209 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 262
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 263 ----IIRGQVFFRQRV--SSECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 6   DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 62
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 63  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 122
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 123 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 180
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 181 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 234
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 235 ----IIRGQVFFRQRV--SSECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 19  DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 75
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 76  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 135
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 136 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 193
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 194 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 247
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 248 ----IIRGQVFFRQRV--SSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 34  DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 90
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 91  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 150
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 151 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 208
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 209 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 262
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 263 ----IIRGQVFFRQRV--SXECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 6   DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 62
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 63  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 122
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 123 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 180
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 181 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 234
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 235 ----IIRGQVFFRQRV--SXECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 26  DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 82
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 83  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 142
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 143 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 200
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 254
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 255 ----IIRGQVFFRQRV--SSECQHLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 7   DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 63
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 64  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 123
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 124 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 181
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 182 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 235
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 236 ----IIRGQVFFRQRV--SSECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 7   DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 63
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 64  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 123
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 124 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 181
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 182 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 235
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 236 ----IIRGQVFFRQRV--SXECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 39  DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 95
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 96  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 155
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 156 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 213
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 214 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 267
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P+ R +  EI+NH W
Sbjct: 268 ----IIRGQVFFRQRV--SXECQHLIRWCLALRPSDRPTFEEIQNHPW 309

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 131/288 (45%), Gaps = 28/288 (9%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           D  A  + PG +   +    +Y++   +GSG FG             VA+K++E+ D+I 
Sbjct: 7   DLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRIS 63
Query: 62  E--------NVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICN 110
           +         V  E++  + +      ++R  +    P    +++E      +LF+ I  
Sbjct: 64  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 123
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
            G   E+ AR FF Q++  V +CH+  V HRD+K EN L+D +    LK+ DFG S + +
Sbjct: 124 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALL 181
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  PFE  EE      
Sbjct: 182 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 235
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
               I+  Q      V  S EC+HLI       P  R +  EI+NH W
Sbjct: 236 ----IIRGQVFFRQRV--SXECQHLIRWCLALRPXDRPTFEEIQNHPW 277

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHRS 73
           +Y++   +GSG FG             VA+K++E+ D+I +         V  E++  + 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 63
Query: 74  LR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGV 130
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            +CH+  V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
               Y G+ A VWS G+ LY M+ G  PFE  EE          I+  Q      V  S 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SS 229
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEW 278
           EC+HLI       P+ R +  EI+NH W
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHRS 73
           +Y++   +GSG FG             VA+K++E+ D+I +         V  E++  + 
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 67
Query: 74  LR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGV 130
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            +CH+  V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI 185
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
               Y G+ A VWS G+ LY M+ G  PFE  EE          I+  Q      V  S 
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQRV--SS 233
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEW 278
           EC+HLI       P+ R +  EI+NH W
Sbjct: 234 ECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 94/292 (32%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 64
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+ S     ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 123 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 238
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHRS 73
           +Y++   +GSG FG             VA+K++E+ D+I +         V  E++  + 
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 68
Query: 74  LR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGV 130
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            +CH+  V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI 186
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
               Y G+ A VWS G+ LY M+ G  PFE  EE          I+  Q      V  S 
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQRV--SS 234
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEW 278
           EC+HLI       P+ R +  EI+NH W
Sbjct: 235 ECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 94/292 (32%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+ S     ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 121 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 236
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHRS 73
           +Y++   +GSG FG             VA+K++E+ D+I +         V  E++  + 
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 68
Query: 74  LR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGV 130
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            +CH+  V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI 186
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
               Y G+ A VWS G+ LY M+ G  PFE  EE          I+  Q        +S 
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSS 234
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEW 278
           EC+HLI       P+ R +  EI+NH W
Sbjct: 235 ECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHRS 73
           +Y++   +GSG FG             VA+K++E+ D+I +         V  E++  + 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 63
Query: 74  LR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGV 130
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            +CH+  V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +
Sbjct: 124 RHCHNXGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
               Y G+ A VWS G+ LY M+ G  PFE  EE          I+  Q      V  S 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQRV--SX 229
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEW 278
           EC+HLI       P+ R +  EI+NH W
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 124/269 (46%), Gaps = 24/269 (8%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE---------NVQREIIN 70
           S +Y  +  +GSG FG      DK+  + V VK+I++   +++          V  EI  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISG 129
              + H NI++  ++        +VME + SG +LF  I    R  E  A + F+QL+S 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           V Y     + HRD+K EN ++  +    +K+ DFG +          +  GT  Y APEV
Sbjct: 143 VGYLRLKDIIHRDIKDENIVI--AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           L+   Y G   ++WS GVTLY ++    PF + EE       IH         P Y+ +S
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--TVEAAIH---------PPYL-VS 248
Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEW 278
            E   L+S +    P +R ++ ++    W
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLVTDPW 277

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHRS 73
           +Y++   +GSG FG             VA+K++E+ D+I +         V  E++  + 
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 68
Query: 74  LR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGV 130
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            +CH+  V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI 186
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
               Y G+ A VWS G+ LY M+ G  PFE  EE          I+  Q      V  S 
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQRV--SS 234
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEW 278
           EC+HLI       P+ R +  EI+NH W
Sbjct: 235 ECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHRS 73
           +Y++   +GSG FG             VA+K++E+ D+I +         V  E++  + 
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 67
Query: 74  LR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGV 130
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            +CH+  V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI 185
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
               Y G+ A VWS G+ LY M+ G  PFE  EE          I+  Q      V  S 
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQRV--SS 233
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEW 278
           EC+HLI       P+ R +  EI+NH W
Sbjct: 234 ECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHRS 73
           +Y++   +GSG FG             VA+K++E+ D+I +         V  E++  + 
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 66
Query: 74  LR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGV 130
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 126
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            +CH+  V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +
Sbjct: 127 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI 184
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
               Y G+ A VWS G+ LY M+ G  PFE  EE          I+  Q      V  S 
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQRV--SS 232
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEW 278
           EC+HLI       P+ R +  EI+NH W
Sbjct: 233 ECQHLIRWCLALRPSDRPTFEEIQNHPW 260

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHRS 73
           +Y++   +GSG FG             VA+K++E+ D+I +         V  E++  + 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 63
Query: 74  LR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGV 130
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            +CH+  V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
               Y G+ A VWS G+ LY M+ G  PFE  EE          I+  Q      V  S 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQRV--SS 229
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEW 278
           EC+HLI       P+ R +  EI+NH W
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHRS 73
           +Y++   +GSG FG             VA+K++E+ D+I +         V  E++  + 
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 90
Query: 74  LR--HPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGV 130
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 91  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 150
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            +CH+  V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +
Sbjct: 151 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI 208
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
               Y G+ A VWS G+ LY M+ G  PFE  EE          I+  Q      V  S 
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQRV--SX 256
Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEW 278
           EC+HLI       P+ R +  EI+NH W
Sbjct: 257 ECQHLIRWCLALRPSDRPTFEEIQNHPW 284

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 96/304 (31%), Positives = 140/304 (46%), Gaps = 46/304 (15%)
Query: 9   GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--- 65
           GP +DM      + ++ V  IG G +GV    R+K T E+VA+K I R D   E V    
Sbjct: 1   GPLVDM------ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTA 53
Query: 66  -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARF 121
            REI   + L HPNIV+  +VI T   L +V E+    +  ++  +A   +       + 
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKS 111
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 180
           +  QL+ G+++CHS +V HRDLK +N L++   A  +K+ DFG +++  V        V 
Sbjct: 112 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVV 169
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ 239
           T  Y APE+LL  +Y     D+WS G     M+     F  D E  + FR  I R L   
Sbjct: 170 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTP 227
Query: 240 --------YSIPDYVHISPEC----------------RHLISRIFVADPAKRISIPEIRN 275
                    S+PDY    P+                 R L+S++   DP KRIS      
Sbjct: 228 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 287
Query: 276 HEWF 279
           H +F
Sbjct: 288 HPFF 291

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 133/288 (46%), Gaps = 34/288 (11%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHP 77
           +YE +  IG G +G     ++++T E+VA+K + R D  DE V     REI   + L+H 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 61
Query: 78  NIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           NIVR  +V+ +   L +V E+     + +   CN G    +  + F  QL+ G+ +CHS 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
            V HRDLK +N L++ +    LK+ DFG +++  +  +  S  V T  Y  P+VL   + 
Sbjct: 121 NVLHRDLKPQNLLINRN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------QYSIPDY-- 245
                D+WS G     +   A P     +  +  K I R+L             +PDY  
Sbjct: 179 YSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 246 ----------VHISPEC----RHLISRIFVADPAKRISIPEIRNHEWF 279
                     V++ P+     R L+  +   +P +RIS  E   H +F
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 136/280 (48%), Gaps = 20/280 (7%)
Query: 10  PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQRE 67
           PGM   I    + +  +  IG G+FG      D +T+++VA+K I+    +   E++Q+E
Sbjct: 12  PGMQNNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQE 71
Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
           I          + ++    L  + L I+MEY  GG   + +  AG F E +     ++++
Sbjct: 72  ITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEIL 130
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYI 185
            G+ Y HS +  HRD+K  N LL  S    +K+ DFG +   +  +Q K  + VGTP ++
Sbjct: 131 KGLDYLHSEKKIHRDIKAANVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWM 187
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIP 243
           APEV+ +  YD K AD+WS G+T   +  G        EP N      R+L +  + + P
Sbjct: 188 APEVIQQSAYDSK-ADIWSLGITAIELAKG--------EPPNSDMHPMRVLFLIPKNNPP 238
Query: 244 DYV-HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
             V   +   +  I      DP+ R +  E+  H++ +KN
Sbjct: 239 TLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 278

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 68
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 242
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 243 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 235
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 127/264 (48%), Gaps = 14/264 (5%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
           +Y     IG G  G      D  T + VA++ +  +     E +  EI+  R  ++PNIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + HS QV H
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
           RD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ +K Y  
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           K+ D+WS G+    M+ G  P+ + E P      I    + +   P+   +S   R  ++
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 251
Query: 258 RIFVADPAKRISIPEIRNHEWFLK 281
           R    D  KR S  E+  H+ FLK
Sbjct: 252 RCLDMDVEKRGSAKELLQHQ-FLK 274

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 93/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 63
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 122 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 237
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 93/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+S+C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 235
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 93/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 121 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 236
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 138/304 (45%), Gaps = 47/304 (15%)
Query: 9   GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--- 65
           GPG         + ++ V  IG G +GV    R+K T E+VA+K I R D   E V    
Sbjct: 1   GPG-------SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTA 52
Query: 66  -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARF 121
            REI   + L HPNIV+  +VI T   L +V E+    +  ++  +A   +       + 
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVD--QDLKKFMDASALTGIPLPLIKS 110
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 180
           +  QL+ G+++CHS +V HRDLK +N L++   A  +K+ DFG +++  V        V 
Sbjct: 111 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVV 168
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ 239
           T  Y APE+LL  +Y     D+WS G     M+     F  D E  + FR  I R L   
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTP 226
Query: 240 --------YSIPDYVHISPEC----------------RHLISRIFVADPAKRISIPEIRN 275
                    S+PDY    P+                 R L+S++   DP KRIS      
Sbjct: 227 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 286
Query: 276 HEWF 279
           H +F
Sbjct: 287 HPFF 290

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 235
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 68
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 242
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 243 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 236
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 64
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 238
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 63
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 237
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 138/304 (45%), Gaps = 47/304 (15%)
Query: 9   GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--- 65
           GPG         + ++ V  IG G +GV    R+K T E+VA+K I R D   E V    
Sbjct: 1   GPG-------SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTA 52
Query: 66  -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARF 121
            REI   + L HPNIV+  +VI T   L +V E+    +  ++  +A   +       + 
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKS 110
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 180
           +  QL+ G+++CHS +V HRDLK +N L++   A  +K+ DFG +++  V        V 
Sbjct: 111 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVV 168
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ 239
           T  Y APE+LL  +Y     D+WS G     M+     F  D E  + FR  I R L   
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTP 226
Query: 240 --------YSIPDYVHISPEC----------------RHLISRIFVADPAKRISIPEIRN 275
                    S+PDY    P+                 R L+S++   DP KRIS      
Sbjct: 227 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 286
Query: 276 HEWF 279
           H +F
Sbjct: 287 HPFF 290

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 178
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 236
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 235
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 234
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 93/292 (31%), Positives = 134/292 (45%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 63
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+ S     +   +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMD--LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 237
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 93/292 (31%), Positives = 134/292 (45%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 64
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+ S     +   +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMD--LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 238
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 234
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 63
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 237
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 234
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 235
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 235
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 65
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 181
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 239
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 240 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 236
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 234
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 235
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 235
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
           +Y     IG G  G      D  T + VA++ +  +     E +  EI+  R  ++PNIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + HS QV H
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV+ +K Y  
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           K+ D+WS G+    M+ G  P+ + E P      I    + +   P+   +S   R  ++
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 251
Query: 258 RIFVADPAKRISIPEIRNHEWFLK 281
           R    D  KR S  E+  H+ FLK
Sbjct: 252 RCLEMDVEKRGSAKELLQHQ-FLK 274

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 78  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH+ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +    Y 
Sbjct: 177 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           G+ A VWS G+ LY M+ G  PFE  EE          I+  Q      V  S EC+HLI
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQRV--SSECQHLI 282
Query: 257 SRIFVADPAKRISIPEIRNHEW 278
                  P+ R +  EI+NH W
Sbjct: 283 RWCLALRPSDRPTFEEIQNHPW 304

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 93/292 (31%), Positives = 134/292 (45%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  +   +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 235
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
           +Y     IG G  G      D  T + VA++ +  +     E +  EI+  R  ++PNIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + HS QV H
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV+ +K Y  
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           K+ D+WS G+    M+ G  P+ + E P      I    + +   P+   +S   R  ++
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 251
Query: 258 RIFVADPAKRISIPEIRNHEWFLK 281
           R    D  KR S  E+  H+ FLK
Sbjct: 252 RCLDMDVEKRGSAKELLQHQ-FLK 274

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 131/257 (50%), Gaps = 14/257 (5%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           IG G+ G+  +  +K T + VAVK ++ R  +  E +  E++  R   H N+V      L
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 88  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
               L +VME+  GG L + I    R +E++       ++  +SY H+  V HRD+K ++
Sbjct: 113 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 171
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
            LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APEV+ +  Y G   D+WS
Sbjct: 172 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPY-GTEVDIWS 226
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
            G+ +  M+ G  P+ + E P    + I    S+   + D   +S   R  +  + V +P
Sbjct: 227 LGIMVIEMIDGEPPYFN-EPPLQAMRRIRD--SLPPRVKDLHKVSSVLRGFLDLMLVREP 283
Query: 265 AKRISIPEIRNHEWFLK 281
           ++R +  E+  H  FLK
Sbjct: 284 SQRATAQELLGHP-FLK 299

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 95/302 (31%), Positives = 134/302 (44%), Gaps = 43/302 (14%)
Query: 9   GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--- 65
           GPG         + ++ V  IG G +GV    R+K T E+VA+K I R D   E V    
Sbjct: 1   GPG-------SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTA 52
Query: 66  -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFF 123
            REI   + L HPNIV+  +VI T   L +V E+     + F              + + 
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL 112
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTP 182
            QL+ G+++CHS +V HRDLK +N L++   A  +K+ DFG +++  V        V T 
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ-- 239
            Y APE+LL  +Y     D+WS G     M+     F  D E  + FR  I R L     
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDE 228
Query: 240 ------YSIPDYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHE 277
                  S+PDY    P+                 R L+S++   DP KRIS      H 
Sbjct: 229 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 288
Query: 278 WF 279
           +F
Sbjct: 289 FF 290

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
           +Y     IG G  G      D  T + VA++ +  +     E +  EI+  R  ++PNIV
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + HS QV H
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 140
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV+ +K Y  
Sbjct: 141 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 196
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           K+ D+WS G+    M+ G  P+ + E P      I    + +   P+   +S   R  ++
Sbjct: 197 KV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 252
Query: 258 RIFVADPAKRISIPEIRNHEWFLK 281
           R    D  KR S  E+  H+ FLK
Sbjct: 253 RCLEMDVEKRGSAKELIQHQ-FLK 275

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 127/274 (46%), Gaps = 21/274 (7%)
Query: 26  VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
           +R+IG G+FG     RD +  E+VA+K +    K      ++II      + LRHPN ++
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 82  FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           ++   L      +VMEY   S  +L E   +     E E        + G++Y HS  + 
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
           HRD+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV+L   + +YD
Sbjct: 177 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 231
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           GK+ DVWS G+T  + L    P   P    N    ++ I   +       H S   R+ +
Sbjct: 232 GKV-DVWSLGITC-IELAERKP---PLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286
Query: 257 SRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
                  P  R +   +  H + L+  P  +++D
Sbjct: 287 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 127/264 (48%), Gaps = 14/264 (5%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
           +Y     IG G  G      D  T + VA++ +  +     E +  EI+  R  ++PNIV
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + HS QV H
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 140
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
           R++K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ +K Y  
Sbjct: 141 RNIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 196
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           K+ D+WS G+    M+ G  P+ + E P      I    + +   P+   +S   R  ++
Sbjct: 197 KV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 252
Query: 258 RIFVADPAKRISIPEIRNHEWFLK 281
           R    D  KR S  E+  H+ FLK
Sbjct: 253 RCLEMDVEKRGSAKELIQHQ-FLK 275

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+K I R D   E V     REI   + L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           PNIV+  +VI T   L +V E+     + F              + +  QL+ G+++CHS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
            +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL  +
Sbjct: 121 HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIPDY 245
           Y     D+WS G     M+     F  D E  + FR  I R L            S+PDY
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMPDY 236
Query: 246 VHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
               P+                 R L+S++   DP KRIS      H +F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 34/288 (11%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHP 77
           +YE +  IG G +G     ++++T E+VA+K + R D  DE V     REI   + L+H 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 61
Query: 78  NIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           NIVR  +V+ +   L +V E+     + +   CN G    +  + F  QL+ G+ +CHS 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
            V HRDLK +N L++ +    LK+ +FG +++  +  +  S  V T  Y  P+VL   + 
Sbjct: 121 NVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------QYSIPDY-- 245
                D+WS G     +     P     +  +  K I R+L             +PDY  
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 246 ----------VHISPEC----RHLISRIFVADPAKRISIPEIRNHEWF 279
                     V++ P+     R L+  +   +P +RIS  E   H +F
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 127/274 (46%), Gaps = 21/274 (7%)
Query: 26  VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
           +R+IG G+FG     RD +  E+VA+K +    K      ++II      + LRHPN ++
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 82  FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           ++   L      +VMEY   S  +L E   +     E E        + G++Y HS  + 
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
           HRD+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV+L   + +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           GK+ DVWS G+T  + L    P   P    N    ++ I   +       H S   R+ +
Sbjct: 193 GKV-DVWSLGITC-IELAERKP---PLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 257 SRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
                  P  R +   +  H + L+  P  +++D
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 95/315 (30%), Positives = 134/315 (42%), Gaps = 40/315 (12%)
Query: 5   AMTVGPGM----DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           A T GPG       P     DRY  +  +G G +G      D  T E VA+K I R +  
Sbjct: 14  AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHE 72
Query: 61  DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 116
           +E V     RE+   + L+H NI+  K VI     L ++ EYA   +L + +      S 
Sbjct: 73  EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM 131
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKS-SVLH 172
              + F  QLI+GV++CHS +  HRDLK +N LL   D S  P LKI DFG +++  +  
Sbjct: 132 RVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191
Query: 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
            Q    + T  Y  PE+LL   +     D+WS       ML+    F    E     K I
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK-I 250
Query: 233 HRILSVQ--------YSIPDYVHISPECR-HLISRIFVA----------------DPAKR 267
             +L +          ++PD+    P+ R   + R+  A                DP KR
Sbjct: 251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKR 310
Query: 268 ISIPEIRNHEWFLKN 282
           IS      H +F  N
Sbjct: 311 ISAKNALEHPYFSHN 325

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 130/274 (47%), Gaps = 33/274 (12%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
           ++ YE++  IG+G++G  + +R K   +++  K ++ G   +   Q    E+   R L+H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 77  PNIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGV 130
           PNIVR+ + I+  T T L IVMEY  GG+L   I    +      E+       QL   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 131 SYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTP 182
             CH        V HRDLK  N  LDG     +K+ DFG ++  +L+   S  K+ VGTP
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLAR--ILNHDTSFAKTFVGTP 180
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP---FEDPEEPKNFRKTIHRILSVQ 239
            Y++PE + +  Y+ K +D+WS G  LY +     P   F   E     R+   R +  +
Sbjct: 181 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           Y        S E   +I+R+       R S+ EI
Sbjct: 240 Y--------SDELNEIITRMLNLKDYHRPSVEEI 265

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 130/274 (47%), Gaps = 33/274 (12%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
           ++ YE++  IG+G++G  + +R K   +++  K ++ G   +   Q    E+   R L+H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 77  PNIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGV 130
           PNIVR+ + I+  T T L IVMEY  GG+L   I    +      E+       QL   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 131 SYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTP 182
             CH        V HRDLK  N  LDG     +K+ DFG ++  +L+   S  K+ VGTP
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLAR--ILNHDTSFAKAFVGTP 180
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP---FEDPEEPKNFRKTIHRILSVQ 239
            Y++PE + +  Y+ K +D+WS G  LY +     P   F   E     R+   R +  +
Sbjct: 181 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           Y        S E   +I+R+       R S+ EI
Sbjct: 240 Y--------SDELNEIITRMLNLKDYHRPSVEEI 265

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 91/292 (31%), Positives = 134/292 (45%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+  I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 235
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 91/292 (31%), Positives = 134/292 (45%), Gaps = 40/292 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           + ++ V  IG G +GV    R+K T E+VA+  I R D   E V     REI   + L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 133
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK 192
           HS +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIP 243
            +Y     D+WS G     M+     F  D E  + FR  I R L            S+P
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSMP 234
Query: 244 DYVHISPEC----------------RHLISRIFVADPAKRISIPEIRNHEWF 279
           DY    P+                 R L+S++   DP KRIS      H +F
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 28/284 (9%)
Query: 10  PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQRE 67
           PGM        + +  +  IG G+FG      D +T+++VA+K I+    +   E++Q+E
Sbjct: 11  PGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE 70
Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
           I        P + ++    L  T L I+MEY  GG   + +   G   E +     ++++
Sbjct: 71  ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREIL 129
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYI 185
            G+ Y HS +  HRD+K  N LL  S    +K+ DFG +   +  +Q K    VGTP ++
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNXFVGTPFWM 186
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED--PEE-----PKNFRKTIHRILSV 238
           APEV+ +  YD K AD+WS G+T   +  G  P  +  P +     PKN   T    L  
Sbjct: 187 APEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT----LEG 241
Query: 239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
            YS P         +  +      +P+ R +  E+  H++ L+N
Sbjct: 242 NYSKP--------LKEFVEACLNKEPSFRPTAKELLKHKFILRN 277

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 124/268 (46%), Gaps = 12/268 (4%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
           ++Y +  D+G G FG+     +  +++    K+++        V++EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 81  RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
              E   +   L ++ E+ SG ++FERI  +A   +E E   +  Q+   + + HS  + 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD--G 197
           H D++ EN +     +  +KI +FG ++        +     P Y APEV    ++D   
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV---HQHDVVS 181
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHL 255
              D+WS G  +YV+L G  PF      +  ++ I  I++ +Y+  +  +  IS E    
Sbjct: 182 TATDMWSLGTLVYVLLSGINPF----LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 256 ISRIFVADPAKRISIPEIRNHEWFLKNL 283
           + R+ V +   R++  E   H W  + +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKI 265

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 130/291 (44%), Gaps = 35/291 (12%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------ 76
           + + R IG G FG     R   T ++ A+K +++     +  +   +N R +        
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 77  -PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            P IV       TP  L+ +++  +GG+L   +   G FSE + RF+  ++I G+ + H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 136 MQVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
             V +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL 
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQ 363
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
           K       AD +S G  L+ +L G  PF    + K+  +     L++   +PD    SPE
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPD--SFSPE 420
Query: 252 CRHLISRIFVADPAKRISI-----------PEIRNHEW---FLKNLPADLV 288
            R L+  +   D  +R+             P  R+ +W   FL+  P  L+
Sbjct: 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 471

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 130/291 (44%), Gaps = 35/291 (12%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------ 76
           + + R IG G FG     R   T ++ A+K +++     +  +   +N R +        
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 77  -PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            P IV       TP  L+ +++  +GG+L   +   G FSE + RF+  ++I G+ + H+
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 309
Query: 136 MQVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
             V +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL 
Sbjct: 310 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQ 362
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
           K       AD +S G  L+ +L G  PF    + K+  +     L++   +PD    SPE
Sbjct: 363 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPD--SFSPE 419
Query: 252 CRHLISRIFVADPAKRISI-----------PEIRNHEW---FLKNLPADLV 288
            R L+  +   D  +R+             P  R+ +W   FL+  P  L+
Sbjct: 420 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 470

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 130/291 (44%), Gaps = 35/291 (12%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------ 76
           + + R IG G FG     R   T ++ A+K +++     +  +   +N R +        
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 77  -PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            P IV       TP  L+ +++  +GG+L   +   G FSE + RF+  ++I G+ + H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 136 MQVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
             V +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL 
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQ 363
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
           K       AD +S G  L+ +L G  PF    + K+  +     L++   +PD    SPE
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPD--SFSPE 420
Query: 252 CRHLISRIFVADPAKRISI-----------PEIRNHEW---FLKNLPADLV 288
            R L+  +   D  +R+             P  R+ +W   FL+  P  L+
Sbjct: 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 471

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 130/291 (44%), Gaps = 35/291 (12%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------ 76
           + + R IG G FG     R   T ++ A+K +++     +  +   +N R +        
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 77  -PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            P IV       TP  L+ +++  +GG+L   +   G FSE + RF+  ++I G+ + H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 136 MQVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
             V +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL 
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQ 363
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
           K       AD +S G  L+ +L G  PF    + K+  +     L++   +PD    SPE
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPD--SFSPE 420
Query: 252 CRHLISRIFVADPAKRISI-----------PEIRNHEW---FLKNLPADLV 288
            R L+  +   D  +R+             P  R+ +W   FL+  P  L+
Sbjct: 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 471

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 137/280 (48%), Gaps = 20/280 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------SIPDYVHI 248
             + +D+WS G++L  M VG YP   P+  ++ R  +     + Y        +P  V  
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGV-F 238
Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 288
           S E +  +++  + +PA+R  + ++  H  F+K   A+ V
Sbjct: 239 SLEFQDFVNKCLIKNPAERADLKQLMVHA-FIKRSDAEEV 277

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLR 75
           ++  D +E++ ++G G FG     ++K+T  L A K I+ + ++  E+   EI    S  
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 92
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 134
           HPNIV+  +      +L I++E+ +GG +   +    R  +E + +   +Q +  ++Y H
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 135 SMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL 191
             ++ HRDLK  N L  LDG     +K+ DFG S  +    Q + S +GTP ++APEV++
Sbjct: 153 DNKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 192 -----KKEYDGKIADVWSCGVTLYVM 212
                 + YD K ADVWS G+TL  M
Sbjct: 209 CETSKDRPYDYK-ADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLR 75
           ++  D +E++ ++G G FG     ++K+T  L A K I+ + ++  E+   EI    S  
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 92
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 134
           HPNIV+  +      +L I++E+ +GG +   +    R  +E + +   +Q +  ++Y H
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 135 SMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL 191
             ++ HRDLK  N L  LDG     +K+ DFG S  +    Q + S +GTP ++APEV++
Sbjct: 153 DNKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 208
Query: 192 -----KKEYDGKIADVWSCGVTLYVM 212
                 + YD K ADVWS G+TL  M
Sbjct: 209 CETSKDRPYDYK-ADVWSLGITLIEM 233

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 142/303 (46%), Gaps = 42/303 (13%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIIN 70
           +H  D +E+++ IG G FG   +++ K TE + A+K + + + +          +R+++ 
Sbjct: 87  LHRED-FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLV 145
Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISG 129
           +   +    + +        HL +VM+Y  GG+L   +     +  ED ARF+  +++  
Sbjct: 146 NGDCQWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 203
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTP 182
           +   H +   HRD+K +N LLD +   R       LK+ D G  +SSV        VGTP
Sbjct: 204 IDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-------AVGTP 256
Query: 183 AYIAPEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
            YI+PE+L   E      G   D WS GV +Y ML G  PF      + + K ++     
Sbjct: 257 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EE 314
Query: 239 QYSIPDYV-HISPECRHLISRIFVADPAKRI---SIPEIRNHEWF-------LKNLPADL 287
           ++  P +V  +S E + LI R+ +    +R+    I + + H +F       ++NL A  
Sbjct: 315 RFQFPSHVTDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPY 373
Query: 288 VVD 290
           + D
Sbjct: 374 IPD 376

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 134/291 (46%), Gaps = 28/291 (9%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINH 71
           +P   + D YEL   IGSG   V +       +E VA+K I  E+     + + +EI   
Sbjct: 8   LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAM 67
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--------AGRFSEDEARFFF 123
               HPNIV +    +    L +VM+  SGG + + I +        +G   E       
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSK-----SSVLHSQPK 176
           ++++ G+ Y H     HRD+K  N LL  DGS    ++I DFG S        +  ++ +
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVR 183
Query: 177 ST-VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234
            T VGTP ++APEV+ + + YD K AD+WS G+T   +  GA P+      K    T+  
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 235 I-LSVQYSIPDYVHI---SPECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
              S++  + D   +       R +IS     DP KR +  E+  H++F K
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 132/277 (47%), Gaps = 28/277 (10%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSL 74
           M   + +  +  IG G+FG      D +T+++VA+K I+    +   E++Q+EI      
Sbjct: 23  MDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 82
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
             P + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y H
Sbjct: 83  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH 141
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLK 192
           S +  HRD+K  N LL  S    +K+ DFG +   +  +Q K  + VGTP ++APEV+ +
Sbjct: 142 SEKKIHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFED--PEE-----PKNFRKTIHRILSVQYSIPDY 245
             YD K AD+WS G+T   +  G  P  +  P +     PKN   T    L   YS P  
Sbjct: 199 SAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKP-- 251
Query: 246 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
                  +  +      +P+ R +  E+  H++ L+N
Sbjct: 252 ------LKEFVEACLNKEPSFRPTAKELLKHKFILRN 282

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 142/303 (46%), Gaps = 42/303 (13%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIIN 70
           +H  D +E+++ IG G FG   +++ K TE + A+K + + + +          +R+++ 
Sbjct: 71  LHRED-FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLV 129
Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISG 129
           +   +    + +        HL +VM+Y  GG+L   +     +  ED ARF+  +++  
Sbjct: 130 NGDCQWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 187
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTP 182
           +   H +   HRD+K +N LLD +   R       LK+ D G  +SSV        VGTP
Sbjct: 188 IDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-------AVGTP 240
Query: 183 AYIAPEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
            YI+PE+L   E      G   D WS GV +Y ML G  PF      + + K ++     
Sbjct: 241 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EE 298
Query: 239 QYSIPDYV-HISPECRHLISRIFVADPAKRI---SIPEIRNHEWF-------LKNLPADL 287
           ++  P +V  +S E + LI R+ +    +R+    I + + H +F       ++NL A  
Sbjct: 299 RFQFPSHVTDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPY 357
Query: 288 VVD 290
           + D
Sbjct: 358 IPD 360

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 128/273 (46%), Gaps = 31/273 (11%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
           ++ YE++  IG+G++G  + +R K   +++  K ++ G   +   Q    E+   R L+H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 77  PNIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGV 130
           PNIVR+ + I+  T T L IVMEY  GG+L   I    +      E+       QL   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 131 SYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA 183
             CH        V HRDLK  N  LDG     +K+ DFG ++  + H +   K  VGTP 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLAR-ILNHDEDFAKEFVGTPY 181
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP---FEDPEEPKNFRKTIHRILSVQY 240
           Y++PE + +  Y+ K +D+WS G  LY +     P   F   E     R+   R +  +Y
Sbjct: 182 YMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
                   S E   +I+R+       R S+ EI
Sbjct: 241 --------SDELNEIITRMLNLKDYHRPSVEEI 265

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 134/291 (46%), Gaps = 28/291 (9%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINH 71
           +P   + D YEL   IGSG   V +       +E VA+K I  E+     + + +EI   
Sbjct: 3   LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAM 62
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--------AGRFSEDEARFFF 123
               HPNIV +    +    L +VM+  SGG + + I +        +G   E       
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSK-----SSVLHSQPK 176
           ++++ G+ Y H     HRD+K  N LL  DGS    ++I DFG S        +  ++ +
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVR 178
Query: 177 ST-VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234
            T VGTP ++APEV+ + + YD K AD+WS G+T   +  GA P+      K    T+  
Sbjct: 179 KTFVGTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 237
Query: 235 I-LSVQYSIPDYVHI---SPECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
              S++  + D   +       R +IS     DP KR +  E+  H++F K
Sbjct: 238 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 124/275 (45%), Gaps = 23/275 (8%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
           D +   R +G G FG     + K T +L A K + +             V+++I+     
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGV 130
           R   IV       T T L +VM   +GG++   I N       F E  A F+  Q++SG+
Sbjct: 245 RF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEV 189
            + H   + +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           LL +EYD  + D ++ GVTLY M+    PF    E    ++   R+L    + PD    S
Sbjct: 361 LLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFS 417
Query: 250 PECRHLISRIFVADPAKRISIPE-----IRNHEWF 279
           P  +     +   DP KR+   +     +R H  F
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 124/275 (45%), Gaps = 23/275 (8%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
           D +   R +G G FG     + K T +L A K + +             V+++I+     
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGV 130
           R   IV       T T L +VM   +GG++   I N       F E  A F+  Q++SG+
Sbjct: 245 RF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEV 189
            + H   + +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           LL +EYD  + D ++ GVTLY M+    PF    E    ++   R+L    + PD    S
Sbjct: 361 LLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFS 417
Query: 250 PECRHLISRIFVADPAKRISIPE-----IRNHEWF 279
           P  +     +   DP KR+   +     +R H  F
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 124/275 (45%), Gaps = 23/275 (8%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
           D +   R +G G FG     + K T +L A K + +             V+++I+     
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGV 130
           R   IV       T T L +VM   +GG++   I N       F E  A F+  Q++SG+
Sbjct: 245 RF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEV 189
            + H   + +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           LL +EYD  + D ++ GVTLY M+    PF    E    ++   R+L    + PD    S
Sbjct: 361 LLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFS 417
Query: 250 PECRHLISRIFVADPAKRISIPE-----IRNHEWF 279
           P  +     +   DP KR+   +     +R H  F
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLR 75
           ++  D +E++ ++G G FG     ++K+T  L A K I+ + ++  E+   EI    S  
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 92
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 134
           HPNIV+  +      +L I++E+ +GG +   +    R  +E + +   +Q +  ++Y H
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 135 SMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 191
             ++ HRDLK  N L  LDG     +K+ DFG S  +    Q +   +GTP ++APEV++
Sbjct: 153 DNKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 192 -----KKEYDGKIADVWSCGVTLYVM 212
                 + YD K ADVWS G+TL  M
Sbjct: 209 CETSKDRPYDYK-ADVWSLGITLIEM 233

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 124/275 (45%), Gaps = 23/275 (8%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
           D +   R +G G FG     + K T +L A K + +             V+++I+     
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGV 130
           R   IV       T T L +VM   +GG++   I N       F E  A F+  Q++SG+
Sbjct: 245 RF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEV 189
            + H   + +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           LL +EYD  + D ++ GVTLY M+    PF    E    ++   R+L    + PD    S
Sbjct: 361 LLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFS 417
Query: 250 PECRHLISRIFVADPAKRISIPE-----IRNHEWF 279
           P  +     +   DP KR+   +     +R H  F
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 90/298 (30%), Positives = 132/298 (44%), Gaps = 31/298 (10%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREI-INHRSLRHP 77
           D Y+L  D+ G G     +   +  T +  AVK IE+    I   V RE+ + ++   H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           N++   E         +V E   GG +   I     F+E EA    Q + S + + H+  
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 138 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS--QPKST------VGTPAYIAPE 188
           + HRDLK EN L +  +    +KICDFG      L+    P ST       G+  Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 189 VL--LKKE---YDGKIADVWSCGVTLYVMLVGAYPF---------EDPEE--PKNFRKTI 232
           V+    +E   YD K  D+WS GV LY++L G  PF          D  E  P       
Sbjct: 192 VVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 233 HRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 288
             I   +Y  P  D+ HIS   + LIS++ V D  +R+S  ++  H W     P + +
Sbjct: 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTL 308

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 129/268 (48%), Gaps = 28/268 (10%)
Query: 26  VRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNIVRFK 83
           +  IG G+FG      D +T+++VA+K I+    +   E++Q+EI        P + ++ 
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
              L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS +  HRD+
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIAD 201
           K  N LL  S    +K+ DFG +   +  +Q K  + VGTP ++APEV+ +  YD K AD
Sbjct: 131 KAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-AD 186
Query: 202 VWSCGVTLYVMLVGAYPFED--PEE-----PKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           +WS G+T   +  G  P  +  P +     PKN   T    L   YS P         + 
Sbjct: 187 IWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKP--------LKE 234
Query: 255 LISRIFVADPAKRISIPEIRNHEWFLKN 282
            +      +P+ R +  E+  H++ L+N
Sbjct: 235 FVEACLNKEPSFRPTAKELLKHKFILRN 262

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 117/257 (45%), Gaps = 27/257 (10%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
           +G G+FG    M DK+T    AVK +    +++     E++    L  P IV     +  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 156
Query: 89  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148
              + I ME   GG L + +   G   ED A ++  Q + G+ Y HS ++ H D+K +N 
Sbjct: 157 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 216
Query: 149 LL--DGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLKKEYDGKIA 200
           LL  DGS A    +CDFG++         KS +      GT  ++APEV+L +  D K+ 
Sbjct: 217 LLSSDGSHA---ALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKV- 272
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI- 259
           DVWS    +  ML G +P+      + FR  +   L +    P    I P C  L ++  
Sbjct: 273 DVWSSCCMMLHMLNGCHPWT-----QFFRGPL--CLKIASEPPPVREIPPSCAPLTAQAI 325
Query: 260 ---FVADPAKRISIPEI 273
                 +P  R+S  E+
Sbjct: 326 QEGLRKEPIHRVSAAEL 342

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 129/294 (43%), Gaps = 31/294 (10%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIER-GDKIDENVQREIIN-HRSLRHP 77
           D Y+L  ++ G G +   +     +  +  AVK IE+        V RE+   ++   + 
Sbjct: 12  DMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNK 71
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           NI+   E     T   +V E   GG +   I     F+E EA    + + + + + H+  
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG 131
Query: 138 VCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLH------SQPKSTV--GTPAYIAP 187
           + HRDLK EN L + SP     +KICDF       L+      + P+ T   G+  Y+AP
Sbjct: 132 IAHRDLKPENILCE-SPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 188 EVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPF---------EDPEEPKNF--RKTI 232
           EV+     +  +  K  D+WS GV LY+ML G  PF          D  E       K  
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 250
Query: 233 HRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
             I   +Y  P  D+ HIS E + LIS++ V D  +R+S  ++  H W     P
Sbjct: 251 ESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAP 304

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 128/268 (47%), Gaps = 28/268 (10%)
Query: 26  VRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNIVRFK 83
           +  IG G+FG      D +T+++VA+K I+    +   E++Q+EI        P + ++ 
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
              L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS +  HRD+
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKIAD 201
           K  N LL  S    +K+ DFG +   +  +Q K    VGTP ++APEV+ +  YD K AD
Sbjct: 131 KAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSK-AD 186
Query: 202 VWSCGVTLYVMLVGAYPFED--PEE-----PKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           +WS G+T   +  G  P  +  P +     PKN   T    L   YS P         + 
Sbjct: 187 IWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKP--------LKE 234
Query: 255 LISRIFVADPAKRISIPEIRNHEWFLKN 282
            +      +P+ R +  E+  H++ L+N
Sbjct: 235 FVEACLNKEPSFRPTAKELLKHKFILRN 262

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 9   GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--- 65
           G  MD+P         +   IG+G+FG     R +     VAVK +   D   E V    
Sbjct: 29  GDDMDIPWCD----LNIKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFL 82
Query: 66  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQ 124
           RE+   + LRHPNIV F   +  P +L+IV EY S G L+  +  +G R   DE R    
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 125 --QLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKS 177
              +  G++Y H+    + HR+LK  N L+D      +K+CDFG S+   S+ L S  KS
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKASTFLSS--KS 198
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
             GTP ++APEV L+ E   + +DV+S GV L+ +     P+ +    +       +   
Sbjct: 199 AAGTPEWMAPEV-LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR 257
Query: 238 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           ++  IP   +++P+   +I   +  +P KR S   I
Sbjct: 258 LE--IPR--NLNPQVAAIIEGCWTNEPWKRPSFATI 289

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 119/255 (46%), Gaps = 11/255 (4%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
           D +E++R IG G+FG   +++   T+++ A+KY+ +   ++ N  R +       + L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V           + +V++   GG+L   +     F E+  + F  +L+  + Y  + 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
           ++ HRD+K +N LLD      + I DF  +      +Q  +  GT  Y+APE+   ++  
Sbjct: 135 RIIHRDMKPDNILLDEH--GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGA 192
Query: 197 GK--IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           G     D WS GVT Y +L G  P+       + ++ +H   +   + P     S E   
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPS--AWSQEMVS 249
Query: 255 LISRIFVADPAKRIS 269
           L+ ++   +P +R S
Sbjct: 250 LLKKLLEPNPDQRFS 264

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 131/276 (47%), Gaps = 26/276 (9%)
Query: 9   GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--- 65
           G  MD+P         +   IG+G+FG     R +     VAVK +   D   E V    
Sbjct: 29  GDDMDIPWCD----LNIKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFL 82
Query: 66  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQ 124
           RE+   + LRHPNIV F   +  P +L+IV EY S G L+  +  +G R   DE R    
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 125 --QLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKS 177
              +  G++Y H+    + HRDLK  N L+D      +K+CDFG S+   S  L S  K 
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKASXFLXS--KX 198
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
             GTP ++APEV L+ E   + +DV+S GV L+ +     P+ +    +       +   
Sbjct: 199 AAGTPEWMAPEV-LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR 257
Query: 238 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           ++  IP   +++P+   +I   +  +P KR S   I
Sbjct: 258 LE--IPR--NLNPQVAAIIEGCWTNEPWKRPSFATI 289

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 136/293 (46%), Gaps = 43/293 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           ++Y+ +  +G G +GV    +D +   +VA+K I R D  DE +     REI   + L H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRI-RLDAEDEGIPSTAIREISLLKELHH 78
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 134
           PNIV   +VI +   L +V E+       +++ +  +    + + + +  QL+ GV++CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLKK 193
             ++ HRDLK +N L++   A  LK+ DFG +++  +  +  +  V T  Y AP+VL+  
Sbjct: 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPKNF--------------------- 228
           +      D+WS G     M+ G   F    +D + PK F                     
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 229 RKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           ++T        +S  IP +     E   L+S +   DP KRIS  +  NH +F
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQ---EGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 136/293 (46%), Gaps = 43/293 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           ++Y+ +  +G G +GV    +D +   +VA+K I R D  DE +     REI   + L H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRI-RLDAEDEGIPSTAIREISLLKELHH 78
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 134
           PNIV   +VI +   L +V E+       +++ +  +    + + + +  QL+ GV++CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLKK 193
             ++ HRDLK +N L++   A  LK+ DFG +++  +  +  +  V T  Y AP+VL+  
Sbjct: 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPKNF--------------------- 228
           +      D+WS G     M+ G   F    +D + PK F                     
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 229 RKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           ++T        +S  IP +     E   L+S +   DP KRIS  +  NH +F
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQ---EGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 116/257 (45%), Gaps = 27/257 (10%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
           +G G+FG    M DK+T    AVK +    +++     E++    L  P IV     +  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 137
Query: 89  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148
              + I ME   GG L + +   G   ED A ++  Q + G+ Y HS ++ H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 197
Query: 149 LL--DGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLKKEYDGKIA 200
           LL  DGS A    +CDFG++         K  +      GT  ++APEV+L +  D K+ 
Sbjct: 198 LLSSDGSHA---ALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKV- 253
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI- 259
           DVWS    +  ML G +P+      + FR  +   L +    P    I P C  L ++  
Sbjct: 254 DVWSSCCMMLHMLNGCHPWT-----QFFRGPL--CLKIASEPPPVREIPPSCAPLTAQAI 306
Query: 260 ---FVADPAKRISIPEI 273
                 +P  R+S  E+
Sbjct: 307 QEGLRKEPIHRVSAAEL 323

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 139/291 (47%), Gaps = 27/291 (9%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDK--IDENVQREIINHRSLRHP 77
           ++YE +  +G G++G+    R+K T  +VA+K ++E  D   + +   REI   + LRH 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           N+V   EV        +V E+     L   E   N   +   +   F  Q+I+G+ +CHS
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF--QIINGIGFCHS 142
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKE 194
             + HRD+K EN L+  S +  +K+CDFG++++     +     V T  Y APE+L+   
Sbjct: 143 HNIIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
             GK  DVW+ G  +  M +G   F  P +  +  +  H ++ +   IP         RH
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLF--PGDS-DIDQLYHIMMCLGNLIP---------RH 248
Query: 255 LISRIFVADPA-KRISIPEIRNHEWFLKNLP--ADLVVDNTTNNQFEEPDQ 302
               +F  +P    + +PEI+  E   +  P  +++V+D        +PD+
Sbjct: 249 --QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK 297

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 131/292 (44%), Gaps = 36/292 (12%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           ++Y  +  IG G +GV    ++   E   A+K I R +K DE +     REI   + L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETF-ALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            NIV+  +VI T   L +V E+     +    +C  G      A+ F  QL++G++YCH 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
            +V HRDLK +N L++      LKI DFG +++  +   +    V T  Y AP+VL+  +
Sbjct: 119 RRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI------------ 242
                 D+WS G     M+ GA  F    E     + I RIL    S             
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMR-IFRILGTPNSKNWPNVTELPKYD 235
Query: 243 PDYVHISP------------ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           P++    P                L+S++   DP +RI+  +   H +F +N
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/298 (29%), Positives = 131/298 (43%), Gaps = 31/298 (10%)
Query: 21  DRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREI-INHRSLRHP 77
           D Y+L  D+ G G     +   +  T +  AVK IE+    I   V RE+ + ++   H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           N++   E         +V E   GG +   I     F+E EA    Q + S + + H+  
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 138 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS--QPKST------VGTPAYIAPE 188
           + HRDLK EN L +  +    +KICDF       L+    P ST       G+  Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 189 VL--LKKE---YDGKIADVWSCGVTLYVMLVGAYPF---------EDPEE--PKNFRKTI 232
           V+    +E   YD K  D+WS GV LY++L G  PF          D  E  P       
Sbjct: 192 VVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 233 HRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 288
             I   +Y  P  D+ HIS   + LIS++ V D  +R+S  ++  H W     P + +
Sbjct: 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTL 308

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
           IG G+FG      D  T+E+VA+K I+    +   E++Q+EI        P I R+    
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 87  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
           L  T L I+MEY  GG   + +   G   E       ++++ G+ Y HS +  HRD+K  
Sbjct: 87  LKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 145
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKIADVWS 204
           N LL  S    +K+ DFG +   +  +Q K    VGTP ++APEV+ +  YD K AD+WS
Sbjct: 146 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFK-ADIWS 201
Query: 205 CGVTLYVMLVGAYPFED 221
            G+T   +  G  P  D
Sbjct: 202 LGITAIELAKGEPPNSD 218

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
           +G G+FG    M+DK+T    AVK +    +++     E++    L  P IV     +  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 89  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148
              + I ME   GG L + I   G   ED A ++  Q + G+ Y H+ ++ H D+K +N 
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 149 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLKKEYDGKIADV 202
           LL  S   R  +CDFG++         KS +      GT  ++APEV++ K  D K+ D+
Sbjct: 182 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 239
Query: 203 WSCGVTLYVMLVGAYPF 219
           WS    +  ML G +P+
Sbjct: 240 WSSCCMMLHMLNGCHPW 256

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 127/266 (47%), Gaps = 24/266 (9%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-- 74
           M D    E+   +G G FGV  + + K   + VA+K IE     +   +  I+  R L  
Sbjct: 5   MIDYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQIES----ESERKAFIVELRQLSR 58
Query: 75  -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISGV 130
             HPNIV+     L P  + +VMEYA GG L+  +  A     ++   A  +  Q   GV
Sbjct: 59  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 116
Query: 131 SYCHSMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
           +Y HSMQ   + HRDLK  N LL       LKICDFG   +  + +   +  G+ A++AP
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAG-GTVLKICDFG--TACDIQTHMTNNKGSAAWMAP 173
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
           EV     Y  K  DV+S G+ L+ ++    PF++   P  FR  I   +      P   +
Sbjct: 174 EVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPA-FR--IMWAVHNGTRPPLIKN 229
Query: 248 ISPECRHLISRIFVADPAKRISIPEI 273
           +      L++R +  DP++R S+ EI
Sbjct: 230 LPKPIESLMTRCWSKDPSQRPSMEEI 255

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
           +G G+FG    M+DK+T    AVK +    +++     E++    L  P IV     +  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 137
Query: 89  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148
              + I ME   GG L + I   G   ED A ++  Q + G+ Y H+ ++ H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 197
Query: 149 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLKKEYDGKIADV 202
           LL  S   R  +CDFG++         KS +      GT  ++APEV++ K  D K+ D+
Sbjct: 198 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 255
Query: 203 WSCGVTLYVMLVGAYPF 219
           WS    +  ML G +P+
Sbjct: 256 WSSCCMMLHMLNGCHPW 272

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 127/266 (47%), Gaps = 24/266 (9%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-- 74
           M D    E+   +G G FGV  + + K   + VA+K IE     +   +  I+  R L  
Sbjct: 4   MIDYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQIES----ESERKAFIVELRQLSR 57
Query: 75  -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISGV 130
             HPNIV+     L P  + +VMEYA GG L+  +  A     ++   A  +  Q   GV
Sbjct: 58  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 131 SYCHSMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
           +Y HSMQ   + HRDLK  N LL       LKICDFG   +  + +   +  G+ A++AP
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAG-GTVLKICDFG--TACDIQTHMTNNKGSAAWMAP 172
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
           EV     Y  K  DV+S G+ L+ ++    PF++   P  FR  I   +      P   +
Sbjct: 173 EVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPA-FR--IMWAVHNGTRPPLIKN 228
Query: 248 ISPECRHLISRIFVADPAKRISIPEI 273
           +      L++R +  DP++R S+ EI
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEI 254

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
           +G G+FG    M+DK+T    AVK +    +++     E++    L  P IV     +  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 135
Query: 89  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148
              + I ME   GG L + I   G   ED A ++  Q + G+ Y H+ ++ H D+K +N 
Sbjct: 136 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 195
Query: 149 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLKKEYDGKIADV 202
           LL  S   R  +CDFG++         KS +      GT  ++APEV++ K  D K+ D+
Sbjct: 196 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 253
Query: 203 WSCGVTLYVMLVGAYPF 219
           WS    +  ML G +P+
Sbjct: 254 WSSCCMMLHMLNGCHPW 270

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 134/274 (48%), Gaps = 14/274 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 82
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 142
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 143 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRH 254
             + +D+WS G++L  M VG YP           + +  I++     +P  V  S E + 
Sbjct: 200 SVQ-SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGV-FSLEFQD 257
Query: 255 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 288
            +++  + +PA+R  + ++  H  F+K   A+ V
Sbjct: 258 FVNKCLIKNPAERADLKQLMVHA-FIKRSDAEEV 290

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 89/333 (26%), Positives = 143/333 (42%), Gaps = 49/333 (14%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQ 65
           M + +   + RYE +  +G G F      RDK T ++VA+K I+ G      D I+    
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60
Query: 66  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFF 123
           REI   + L HPNI+   +     +++++V ++       E I   N+   +    + + 
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYM 118
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----V 179
              + G+ Y H   + HRDLK  N LLD +    LK+ DFG +KS      P       V
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKS---FGSPNRAYXHQV 173
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRI 235
            T  Y APE+L      G   D+W+ G  L  +L+   PF     D ++     +T+   
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTP 232
Query: 236 LSVQY----SIPDYV-----------HI----SPECRHLISRIFVADPAKRISIPEIRNH 276
              Q+    S+PDYV           HI      +   LI  +F+ +P  RI+  +    
Sbjct: 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292
Query: 277 EWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDE 309
           ++F  N P       T   Q   P+ P++++ E
Sbjct: 293 KYF-SNRPGP-----TPGCQLPRPNCPVETLKE 319

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 130/292 (44%), Gaps = 36/292 (12%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           ++Y  +  IG G +GV    ++   E   A+K I R +K DE +     REI   + L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETF-ALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            NIV+  +VI T   L +V E+     +    +C  G      A+ F  QL++G++YCH 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
            +V HRDLK +N L++      LKI DFG +++  +   +    V T  Y AP+VL+  +
Sbjct: 119 RRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI------------ 242
                 D+WS G     M+ G   F    E     + I RIL    S             
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR-IFRILGTPNSKNWPNVTELPKYD 235
Query: 243 PDYVHISP------------ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           P++    P                L+S++   DP +RI+  +   H +F +N
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/213 (34%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
           +E+   +G+G FG       + T E VA+K    E   K  E    EI   + L HPN+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 81  RFKEV-----ILTPTHLAIV-MEYASGGEL------FERICNAGRFSEDEARFFFQQLIS 128
             +EV      L P  L ++ MEY  GG+L      FE  C      E   R     + S
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISS 132
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRL--KICDFGYSKSSVLHSQPKSTVGTPAYIA 186
            + Y H  ++ HRDLK EN +L   P  RL  KI D GY+K           VGT  Y+A
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQ-RLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           PE+L +K+Y   + D WS G   +  + G  PF
Sbjct: 192 PELLEQKKYTVTV-DYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/213 (34%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
           +E+   +G+G FG       + T E VA+K    E   K  E    EI   + L HPN+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 81  RFKEV-----ILTPTHLAIV-MEYASGGEL------FERICNAGRFSEDEARFFFQQLIS 128
             +EV      L P  L ++ MEY  GG+L      FE  C      E   R     + S
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISS 133
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRL--KICDFGYSKSSVLHSQPKSTVGTPAYIA 186
            + Y H  ++ HRDLK EN +L   P  RL  KI D GY+K           VGT  Y+A
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQ-RLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           PE+L +K+Y   + D WS G   +  + G  PF
Sbjct: 193 PELLEQKKYTVTV-DYWSFGTLAFECITGFRPF 224

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 6/201 (2%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
           ++++  +G G++G       K+T ++VA+K +     + E + +EI   +    P++V++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII-KEISIMQQCDSPHVVKY 89
Query: 83  KEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
                  T L IVMEY   G + + I       +EDE     Q  + G+ Y H M+  HR
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149
Query: 142 DLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           D+K  N LL+       K+ DFG + + +   ++    +GTP ++APEV+ +  Y+  +A
Sbjct: 150 DIKAGNILLNTE--GHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNC-VA 206
Query: 201 DVWSCGVTLYVMLVGAYPFED 221
           D+WS G+T   M  G  P+ D
Sbjct: 207 DIWSLGITAIEMAEGKPPYAD 227

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 125
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 186 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 242
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
             + +D+WS G++L  M VG YP   P+
Sbjct: 243 SVQ-SDIWSMGLSLVEMAVGRYPIPPPD 269

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 133/291 (45%), Gaps = 37/291 (12%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAV-KYIERGDK--IDENVQREIINHRSLRHP 77
           ++YE +  IG G++GV    R++ T ++VA+ K++E  D   I +   REI   + L+HP
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           N+V   EV      L +V EY     L E         E   +    Q +  V++CH   
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEVLLKK 193
             HRD+K EN L+       +K+CDFG+++   L + P       V T  Y +PE+L+  
Sbjct: 123 CIHRDVKPENILITKHSV--IKLCDFGFAR---LLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 194 EYDGKIADVWSCGVTLYVMLVGA--YPFE-DPEEPKNFRKTIHRIL--------SVQY-- 240
              G   DVW+ G     +L G   +P + D ++    RKT+  ++        + QY  
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 241 --SIPD----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
              IPD          + +IS     L+      DP +R++  ++ +H +F
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
             + +D+WS G++L  M VG YP   P+
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 130/292 (44%), Gaps = 36/292 (12%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           ++Y  +  IG G +GV    ++   E   A+K I R +K DE +     REI   + L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETF-ALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            NIV+  +VI T   L +V E+     +    +C  G      A+ F  QL++G++YCH 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
            +V HRDLK +N L++      LKI DFG +++  +   +    + T  Y AP+VL+  +
Sbjct: 119 RRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI------------ 242
                 D+WS G     M+ G   F    E     + I RIL    S             
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR-IFRILGTPNSKNWPNVTELPKYD 235
Query: 243 PDYVHISP------------ECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           P++    P                L+S++   DP +RI+  +   H +F +N
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
             + +D+WS G++L  M VG YP   P+
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
             + +D+WS G++L  M VG YP   P+
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
             + +D+WS G++L  M VG YP   P+
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRHPNIVRFK 83
           IG G FG  ++ R     + VAVK        D     ENV++E      L+HPNI+  +
Sbjct: 15  IGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---MQVCH 140
            V L   +L +VME+A GG L  R+ +  R   D    +  Q+  G++Y H    + + H
Sbjct: 73  GVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 141 RDLKLENTLL-----DGSPAPR-LKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLKK 193
           RDLK  N L+     +G  + + LKI DFG ++    H   K S  G  A++APEV+   
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAAGAYAWMAPEVIRAS 189
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPF 219
            +  K +DVWS GV L+ +L G  PF
Sbjct: 190 MFS-KGSDVWSYGVLLWELLTGEVPF 214

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 90
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 151 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 207
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
             + +D+WS G++L  M VG YP   P+
Sbjct: 208 SVQ-SDIWSMGLSLVEMAVGRYPIPPPD 234

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   ++ + +  ++A K I    +I   ++ +II    + H    
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 73
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV F     +   ++I ME+  GG L + +  A R  E+        ++ G++Y    
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 133
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            Q+ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y+APE L    Y
Sbjct: 134 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMAPERLQGTHY 190
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
             + +D+WS G++L  + VG YP   P+
Sbjct: 191 SVQ-SDIWSMGLSLVELAVGRYPIPPPD 217

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 133/274 (48%), Gaps = 18/274 (6%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
           D +E + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 66
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            ++ HRD+K  N L++      +K+CDFG S   ++       VGT +Y++PE L    Y
Sbjct: 127 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDEMANEFVGTRSYMSPERLQGTHY 183
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRH 254
             + +D+WS G++L  M VG Y    P  P    + +  I++     +P  V  S E + 
Sbjct: 184 SVQ-SDIWSMGLSLVEMAVGRY----PRPPMAIFELLDYIVNEPPPKLPSAV-FSLEFQD 237
Query: 255 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 288
            +++  + +PA+R  + ++  H  F+K   A+ V
Sbjct: 238 FVNKCLIKNPAERADLKQLMVHA-FIKRSDAEEV 270

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 106/223 (47%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + +G        R
Sbjct: 9   TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NR 62
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 118
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 177
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 106/223 (47%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + +G        R
Sbjct: 9   TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NR 62
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 118
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 177
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 19/202 (9%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNI 79
           +E+V ++G G FG     ++K+T  L A K IE   K +E ++  I+    L    HP I
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYIVEIEILATCDHPYI 70
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
           V+          L I++E+  GG +   +    R  +E + +   +Q++  +++ HS ++
Sbjct: 71  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 130
Query: 139 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL---- 191
            HRDLK  N L  L+G     +++ DFG S  ++   Q + S +GTP ++APEV++    
Sbjct: 131 IHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 192 -KKEYDGKIADVWSCGVTLYVM 212
               YD K AD+WS G+TL  M
Sbjct: 187 KDTPYDYK-ADIWSLGITLIEM 207

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + +G        R
Sbjct: 9   TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NR 62
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSED--- 117
           E+   R L H NIVR +    +        +L +V++Y     ++    +  R  +    
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPV 121
Query: 118 -EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176
              + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V      
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNV 180
Query: 177 STVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
           S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 87/304 (28%), Positives = 128/304 (42%), Gaps = 48/304 (15%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP 77
           S  ++L   +G G +GV      K T E+VA+K IE  DK        REI   +  +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 133
           NI+     I  P       E     EL +    R+ +    S+D  ++F  Q +  V   
Sbjct: 70  NIITIFN-IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKS-------TVGTP 182
           H   V HRDLK  N L++ +    LK+CDFG ++    S+  +S+P          V T 
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFED--------------PEEPK 226
            Y APEV+L      +  DVWSCG  L  + +    +P  D              P    
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 227 NFRKTIHRILSVQY--SIPDY---------VHISPECRHLISRIFVADPAKRISIPEIRN 275
           + R  I    + +Y  S+P Y           ++P+   L+ R+ V DPAKRI+  E   
Sbjct: 247 DLR-CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 276 HEWF 279
           H + 
Sbjct: 306 HPYL 309

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 87/304 (28%), Positives = 128/304 (42%), Gaps = 48/304 (15%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP 77
           S  ++L   +G G +GV      K T E+VA+K IE  DK        REI   +  +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 133
           NI+     I  P       E     EL +    R+ +    S+D  ++F  Q +  V   
Sbjct: 70  NIITIFN-IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKST-------VGTP 182
           H   V HRDLK  N L++ +    LK+CDFG ++    S+  +S+P          V T 
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFED--------------PEEPK 226
            Y APEV+L      +  DVWSCG  L  + +    +P  D              P    
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 227 NFRKTIHRILSVQY--SIPDY---------VHISPECRHLISRIFVADPAKRISIPEIRN 275
           + R  I    + +Y  S+P Y           ++P+   L+ R+ V DPAKRI+  E   
Sbjct: 247 DLR-CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 276 HEWF 279
           H + 
Sbjct: 306 HPYL 309

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 87/304 (28%), Positives = 128/304 (42%), Gaps = 48/304 (15%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP 77
           S  ++L   +G G +GV      K T E+VA+K IE  DK        REI   +  +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 133
           NI+     I  P       E     EL +    R+ +    S+D  ++F  Q +  V   
Sbjct: 70  NIITIFN-IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKST-------VGTP 182
           H   V HRDLK  N L++ +    LK+CDFG ++    S+  +S+P          V T 
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFED--------------PEEPK 226
            Y APEV+L      +  DVWSCG  L  + +    +P  D              P    
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 227 NFRKTIHRILSVQY--SIPDY---------VHISPECRHLISRIFVADPAKRISIPEIRN 275
           + R  I    + +Y  S+P Y           ++P+   L+ R+ V DPAKRI+  E   
Sbjct: 247 DLR-CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 276 HEWF 279
           H + 
Sbjct: 306 HPYL 309

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 14/219 (6%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
           M  S +++ +  +G+G +       +K T   VA+K +  +  +       REI   + L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE-----RICNAGRFSE-DEARFFFQQLIS 128
           +H NIVR  +VI T   L +V E+    +L +      + N  R  E +  ++F  QL+ 
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAP 187
           G+++CH  ++ HRDLK +N L++     +LK+ DFG +++  +  +   S V T  Y AP
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEE 224
           +VL+         D+WSCG  L  M+ G   +P  + EE
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 19/202 (9%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNI 79
           +E+V ++G G FG     ++K+T  L A K IE   K +E ++  I+    L    HP I
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYIVEIEILATCDHPYI 78
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
           V+          L I++E+  GG +   +    R  +E + +   +Q++  +++ HS ++
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138
Query: 139 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL---- 191
            HRDLK  N L  L+G     +++ DFG S  ++   Q + S +GTP ++APEV++    
Sbjct: 139 IHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 192 -KKEYDGKIADVWSCGVTLYVM 212
               YD K AD+WS G+TL  M
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEM 215

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 22/232 (9%)
Query: 49  VAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
           VA+K ++  D +D   + + I      + L HPN++++    +    L IV+E A  G+L
Sbjct: 60  VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 119
Query: 105 FERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
              I +  +      E     +F QL S + + HS +V HRD+K  N  +  +    +K+
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKL 177
Query: 161 CDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
            D G      SK++  H    S VGTP Y++PE + +  Y+ K +D+WS G  LY M   
Sbjct: 178 GDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAAL 232
Query: 216 AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 267
             PF    +  N      +I    Y      H S E R L++     DP KR
Sbjct: 233 QSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 43  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 96
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 152
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 211
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 212 PNVSXICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 253

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 9   TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 62
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 118
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 177
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 178 PNVSXICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 13  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 66
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 122
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 123 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 181
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 182 PNVSXICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 223

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 21  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 74
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 130
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 131 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 189
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 190 PNVSXICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 231

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 17  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 70
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 126
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 127 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 185
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 186 PNVSXICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 227

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 9   TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 62
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 118
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 177
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 178 PNVSXICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 9   TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 62
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 118
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 177
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 178 PNVSXICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 10  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 63
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 119
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 120 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 178
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 179 PNVSXICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 28  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 81
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 137
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 138 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 196
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 197 PNVSXICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 238

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 21  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 74
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 130
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 131 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 189
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 190 PNVSXICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 231

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/318 (24%), Positives = 141/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V + T+  FE  D
Sbjct: 314 PDDEPVADPTDQSFESRD 331

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 14  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 67
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 123
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 124 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 182
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 183 PNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 224

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 37  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 90
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 146
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 147 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 205
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 206 PNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 247

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 43  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 96
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 152
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 211
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 212 PNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 253

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 9   TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 62
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 118
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 177
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 22  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 75
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 131
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 132 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 190
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 191 PNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 232

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 88  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 141
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 197
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 198 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 256
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 257 PNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 298

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 45  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 98
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 154
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 155 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 213
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 214 PNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 255

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  R
Sbjct: 47  TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--R 100
Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-- 118
           E+   R L H NIVR +    +        +L +V++Y    E   R+  A  +S  +  
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQT 156
Query: 119 -----ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
                 + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K  V   
Sbjct: 157 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE 215
Query: 174 QPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
              S + +  Y APE++    +Y   I DVWS G  L  +L+G
Sbjct: 216 PNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG 257

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCAKLTDDHVQFLIYQILRGLKY 136
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 251 ARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 310 PDDEPVADPYDQSFESRD 327

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 81
           +ELV  +G+G +G     R  KT +L A+K ++     +E +++EI +  +   H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 82  FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 133
           +    +          L +VME+   G + + I N       E+   +  ++++ G+S+ 
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 192
           H  +V HRD+K +N LL  +    +K+ DFG S         ++T +GTP ++APEV+  
Sbjct: 146 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 193 KE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
            E     YD K +D+WS G+T   M  GA P  D
Sbjct: 204 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 236

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 128/278 (46%), Gaps = 21/278 (7%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIIN 70
           +H  D +E+++ IG G FG   +++ K  +++ A+K + + + +          +R+++ 
Sbjct: 71  LHRED-FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129
Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISG 129
           +   +   I           +L +VM+Y  GG+L   +     R  E+ ARF+  +++  
Sbjct: 130 NGDSKW--ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAP 187
           +   H +   HRD+K +N L+D +   RL   DFG     +     +S+  VGTP YI+P
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 188 EVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
           E+L   E      G   D WS GV +Y ML G  PF      + + K ++     Q+   
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT- 304
Query: 244 DYVHISPECRHLISRIFVADPAK--RISIPEIRNHEWF 279
               +S   + LI R+  +   +  +  I + + H +F
Sbjct: 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR-----EIINHRSL 74
            D YE++  IG+G +GV    R + T + VA+K I     +  N +R     +I+ H   
Sbjct: 53  GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH--F 110
Query: 75  RHPNIVRFKEVILTPT-------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
           +H NI+  K+ IL PT        + +V++     +L + I ++   + +  R+F  QL+
Sbjct: 111 KHDNIIAIKD-ILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLL 168
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-------STVG 180
            G+ Y HS QV HRDLK  N L++ +    LKI DFG ++   L + P          V 
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVNEN--CELKIGDFGMARG--LCTSPAEHQYFMTEYVA 224
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
           T  Y APE++L      +  D+WS G     ML 
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR-----EIINHRSL 74
            D YE++  IG+G +GV    R + T + VA+K I     +  N +R     +I+ H   
Sbjct: 54  GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH--F 111
Query: 75  RHPNIVRFKEVILTPT-------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
           +H NI+  K+ IL PT        + +V++     +L + I ++   + +  R+F  QL+
Sbjct: 112 KHDNIIAIKD-ILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLL 169
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-------STVG 180
            G+ Y HS QV HRDLK  N L++ +    LKI DFG ++   L + P          V 
Sbjct: 170 RGLKYMHSAQVIHRDLKPSNLLVNEN--CELKIGDFGMARG--LCTSPAEHQYFMTEYVA 225
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
           T  Y APE++L      +  D+WS G     ML 
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 128/274 (46%), Gaps = 24/274 (8%)
Query: 10  PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------ 63
           P   +P + D++  E  + IG G FG+    R  K + +VA+K +  GD   E       
Sbjct: 9   PKSRLPTLADNE-IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 64  --VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
              QRE+    +L HPNIV+   ++  P  +  VME+   G+L+ R+ +     +   + 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKL 125
Query: 122 FFQQLIS-GVSYCHSMQ--VCHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLHSQP 175
                I+ G+ Y  +    + HRDL+  N     LD +     K+ DFG S+ SV HS  
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-HSV- 183
Query: 176 KSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
              +G   ++APE +  +E  Y  K AD +S  + LY +L G  PF++    K     + 
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKR 267
           R   ++ +IP+     P  R++I   +  DP KR
Sbjct: 243 REEGLRPTIPE--DCPPRLRNVIELCWSGDPKKR 274

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/316 (23%), Positives = 138/316 (43%), Gaps = 41/316 (12%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
            HS  + HRDLK  N  ++      LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 161 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHT--DDEMXGXVATRWYRAPEIMLN 216
Query: 193 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEEPK 226
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 276
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPA 285
           N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + P 
Sbjct: 277 NYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335
Query: 286 DLVVDNTTNNQFEEPD 301
           D  V +  +  FE  D
Sbjct: 336 DEPVADPYDQSFESRD 351

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 119/277 (42%), Gaps = 22/277 (7%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSL 74
           D +E+++ IG G F    +++ K+T ++ A+K + + D +          +R+++ +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 133
           R   I +         +L +VMEY  GG+L   +   G R   + ARF+  +++  +   
Sbjct: 121 RW--ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPAYIAPEVLL 191
           H +   HRD+K +N LLD      +++ DFG           +S   VGTP Y++PE+L 
Sbjct: 179 HRLGYVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 192 KKEYDGKI------ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
                          D W+ GV  Y M  G  PF      + + K +H    +   + D 
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296
Query: 246 VHISPECRHLISRIFVADPAK--RISIPEIRNHEWFL 280
             +  E R  I R+      +  R    + R H +F 
Sbjct: 297 -GVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFF 332

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 128/274 (46%), Gaps = 24/274 (8%)
Query: 10  PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------ 63
           P   +P + D++  E  + IG G FG+    R  K + +VA+K +  GD   E       
Sbjct: 9   PKSRLPTLADNE-IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 64  --VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
              QRE+    +L HPNIV+   ++  P  +  VME+   G+L+ R+ +     +   + 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKL 125
Query: 122 FFQQLIS-GVSYCHSMQ--VCHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLHSQP 175
                I+ G+ Y  +    + HRDL+  N     LD +     K+ DFG S+ SV HS  
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV-HSV- 183
Query: 176 KSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
              +G   ++APE +  +E  Y  K AD +S  + LY +L G  PF++    K     + 
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKR 267
           R   ++ +IP+     P  R++I   +  DP KR
Sbjct: 243 REEGLRPTIPE--DCPPRLRNVIELCWSGDPKKR 274

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 275 ARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 334 PDDEPVADPYDQSFESRD 351

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSN--LAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 261 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 320 PDDEPVADPYDQSFESRD 337

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 251 ARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 310 PDDEPVADPYDQSFESRD 327

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSN--LAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 257 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 316 PDDEPVADPYDQSFESRD 333

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 274 ARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 332
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 333 PDDEPVADPYDQSFESRD 350

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  IGSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSN--LAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 260 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 319 PDDEPVADPYDQSFESRD 336

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 261 ARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 320 PDDEPVADPYDQSFESRD 337

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/316 (23%), Positives = 138/316 (43%), Gaps = 41/316 (12%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
            HS  + HRDLK  N  ++      LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 192
Query: 193 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEEPK 226
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPA 285
           N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + P 
Sbjct: 253 NYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 286 DLVVDNTTNNQFEEPD 301
           D  V +  +  FE  D
Sbjct: 312 DEPVADPYDQSFESRD 327

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/316 (23%), Positives = 138/316 (43%), Gaps = 41/316 (12%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
            HS  + HRDLK  N  ++      LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 196
Query: 193 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEEPK 226
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPA 285
           N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + P 
Sbjct: 257 NYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315
Query: 286 DLVVDNTTNNQFEEPD 301
           D  V +  +  FE  D
Sbjct: 316 DEPVADPYDQSFESRD 331

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSN--LAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 266 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 324
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 325 PDDEPVADPYDQSFESRD 342

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 127/284 (44%), Gaps = 39/284 (13%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
           +G G +      + K T+ LVA+K I  E  +       RE+   + L+H NIV   ++I
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 87  LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
            T   L +V EY    +L + + + G   +    + F  QL+ G++YCH  +V HRDLK 
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKP 128
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL-KKEYDGKIADVW 203
           +N L++      LK+ DFG +++  + ++   + V T  Y  P++LL   +Y  +I D+W
Sbjct: 129 QNLLIN--ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI-DMW 185
Query: 204 SCGVTLYVMLVG--AYPFEDPEEPKNFRKTIHRILSV----------------QYSIPDY 245
             G   Y M  G   +P    EE  +F   I RIL                   Y+ P Y
Sbjct: 186 GVGCIFYEMATGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEEFKTYNYPKY 242
Query: 246 V---------HISPECRHLISRIFVADPAKRISIPEIRNHEWFL 280
                      +  +   L++++   +   RIS  +   H +FL
Sbjct: 243 RAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/316 (23%), Positives = 138/316 (43%), Gaps = 41/316 (12%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
            HS  + HRDLK  N  ++      LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 196
Query: 193 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEEPK 226
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPA 285
           N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + P 
Sbjct: 257 NYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315
Query: 286 DLVVDNTTNNQFEEPD 301
           D  V +  +  FE  D
Sbjct: 316 DEPVADPYDQSFESRD 331

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 150
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 151 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 204
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 264
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 265 ARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 323
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 324 PDDEPVADPYDQSFESRD 341

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 138/316 (43%), Gaps = 41/316 (12%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
            HS  + HRDLK  N  L  +    LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLARHT--DDEMTGXVATRWYRAPEIMLN 196
Query: 193 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEEPK 226
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPA 285
           N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + P 
Sbjct: 257 NYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315
Query: 286 DLVVDNTTNNQFEEPD 301
           D  V +  +  FE  D
Sbjct: 316 DEPVADPYDQSFESRD 331

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
           L++++GSG FGV +L + K   + VAVK I+ G   ++   +E      L HP +V+F  
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF-FFQQLISGVSYCHSMQVCHRDL 143
           V      + IV EY S G L   + + G+  E          +  G+++  S Q  HRDL
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDL 130
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGKIA 200
              N L+D      +K+ DFG ++  VL  Q  S+VGT     + APEV    +Y  K +
Sbjct: 131 AARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK-S 186
Query: 201 DVWSCGVTLY-VMLVGAYPFE 220
           DVW+ G+ ++ V  +G  P++
Sbjct: 187 DVWAFGILMWEVFSLGKMPYD 207

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/316 (23%), Positives = 138/316 (43%), Gaps = 41/316 (12%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
            HS  + HRDLK  N  ++      LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 148 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLN 203
Query: 193 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEEPK 226
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPA 285
           N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + P 
Sbjct: 264 NYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322
Query: 286 DLVVDNTTNNQFEEPD 301
           D  V +  +  FE  D
Sbjct: 323 DEPVADPYDQSFESRD 338

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 267 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 326 PDDEPVADPYDQSFESRD 343

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 267 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 326 PDDEPVADPYDQSFESRD 343

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSN--LAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 260 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 319 PDDEPVADPYDQSFESRD 336

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 275 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 334 PDDEPVADPYDQSFESRD 351

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 266 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 324
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 325 PDDEPVADPYDQSFESRD 342

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPQDQSFESRD 331

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 164 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 217
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 277
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 278 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 336
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 337 PDDEPVADPYDQSFESRD 354

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 261 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 320 PDDEPVADPYDQSFESRD 337

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 257 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 316 PDDEPVADPYDQSFESRD 333

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 257 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 316 PDDEPVADPYDQSFESRD 333

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 257 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 316 PDDEPVADPYDQSFESRD 333

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 138
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 139 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 192
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 252
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 253 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 311
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 312 PDDEPVADPYDQSFESRD 329

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 251 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 310 PDDEPVADPYDQSFESRD 327

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 260 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 319 PDDEPVADPYDQSFESRD 336

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 201
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 262 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 321 PDDEPVADPYDQSFESRD 338

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPFDQSFESRD 331

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPRDQSFESRD 331

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 274 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 332
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 333 PDDEPVADPYDQSFESRD 350

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 252 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 310
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 311 PDDEPVADPYDQSFESRD 328

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 252 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 310
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 311 PDDEPVADPYDQSFESRD 328

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 261 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 320 PDDEPVADPYDQSFESRD 337

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 260 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 319 PDDEPVADPYDQSFESRD 336

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 139
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 140 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 193
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 253
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 254 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 312
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 313 PDDEPVADPYDQSFESRD 330

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 124/287 (43%), Gaps = 37/287 (12%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
           +E +  +G G FG     R+       A+K I   ++    +  E++   SL H  +VR+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 83  KEVIL-------------TPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLIS 128
               L               + L I MEY   G L++ I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-------VLHSQP------ 175
            +SY HS  + HRDLK  N  +D S    +KI DFG +K+         L SQ       
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
              S +GT  Y+A EVL    +  +  D++S G+  + M+   YPF    E  N  K + 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKL- 241
Query: 234 RILSVQYSIPDYVHISPECRHLISRIFV-ADPAKRISIPEIRNHEWF 279
           R +S+++  PD+     +    I R+ +  DP KR     + N  W 
Sbjct: 242 RSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 138/316 (43%), Gaps = 41/316 (12%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
            HS  + HRDLK  N  L  +    LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 164 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLARHT--DDEMXGYVATRWYRAPEIMLN 219
Query: 193 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEEPK 226
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 279
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPA 285
           N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + P 
Sbjct: 280 NYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338
Query: 286 DLVVDNTTNNQFEEPD 301
           D  V +  +  FE  D
Sbjct: 339 DEPVADPYDQSFESRD 354

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 20/268 (7%)
Query: 27  RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
           R +G G FG     + + T ++ A K +E+        +   +N + +      RF   +
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 87  L----TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCH 140
                T   L +V+   +GG+L   I + G+  F E  A F+  ++  G+   H  ++ +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+  + Y     
Sbjct: 310 RDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-P 366
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HISPECRHLISR 258
           D W+ G  LY M+ G  PF+   + K  R+ + R++     +P+      SP+ R L S+
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVK---EVPEEYSERFSPQARSLCSQ 422
Query: 259 IFVADPAKRI-----SIPEIRNHEWFLK 281
           +   DPA+R+     S  E++ H  F K
Sbjct: 423 LLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 20/268 (7%)
Query: 27  RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
           R +G G FG     + + T ++ A K +E+        +   +N + +      RF   +
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 87  L----TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCH 140
                T   L +V+   +GG+L   I + G+  F E  A F+  ++  G+   H  ++ +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
           RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+  + Y     
Sbjct: 310 RDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-P 366
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HISPECRHLISR 258
           D W+ G  LY M+ G  PF+   + K  R+ + R++     +P+      SP+ R L S+
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVK---EVPEEYSERFSPQARSLCSQ 422
Query: 259 IFVADPAKRI-----SIPEIRNHEWFLK 281
           +   DPA+R+     S  E++ H  F K
Sbjct: 423 LLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + +  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 267 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 326 PDDEPVADPYDQSFESRD 343

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 24/274 (8%)
Query: 10  PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------ 63
           P   +P + D++  E  + IG G FG+    R  K + +VA+K +  GD   E       
Sbjct: 9   PKSRLPTLADNE-IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 64  --VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
              QRE+    +L HPNIV+   ++  P  +  VME+   G+L+ R+ +     +   + 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKL 125
Query: 122 FFQQLIS-GVSYCHSMQ--VCHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLHSQP 175
                I+ G+ Y  +    + HRDL+  N     LD +     K+ DF  S+ SV HS  
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV-HSV- 183
Query: 176 KSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
              +G   ++APE +  +E  Y  K AD +S  + LY +L G  PF++    K     + 
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKR 267
           R   ++ +IP+     P  R++I   +  DP KR
Sbjct: 243 REEGLRPTIPE--DCPPRLRNVIELCWSGDPKKR 274

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I  + + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKSQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI DFG  +    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDSELKILDFGLCR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 128/293 (43%), Gaps = 40/293 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
            HS  + HRDLK  N  L  +    LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 148 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLN 203
Query: 193 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEEPK 226
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F
Sbjct: 264 NYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI D+G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDYGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 128/293 (43%), Gaps = 40/293 (13%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
            HS  + HRDLK  N  L  +    LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 148 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLN 203
Query: 193 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEEPK 226
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F
Sbjct: 264 NYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 124/297 (41%), Gaps = 45/297 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D      VAVK + R  +   + +R   E++  + + H N
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 84
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C       D  R  +   Q++ G+ + HS
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS 144
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+L   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY 202
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--------LSVQYSIPDYVH 247
              + D+WS G  +  ++ G   F+  +    + K I ++         ++Q ++ +YV 
Sbjct: 203 AANV-DIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 261
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNH 276
             P                            + R L+S++ V DP KRIS+ E   H
Sbjct: 262 NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRH 318

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 80  VRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           +   ++I  PT        ++ +  G +L+ ++      S D   +F  Q++ G+ Y HS
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 191
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 163 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 192 KKEYDGKIADVWSCGVTLYVML 213
             +   K  D+WS G  L  ML
Sbjct: 221 NSKGYTKSIDIWSVGCILAEML 242

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D      VAVK + R  +   + +R   E++  + + H N
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 82
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C       D  R  +   Q++ G+ + HS
Sbjct: 83  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS 142
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+L   Y
Sbjct: 143 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGY 200
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--------LSVQYSIPDYVH 247
              + D+WS G  +  ++ G+  F+  +    + K I ++         ++Q ++ +YV 
Sbjct: 201 KENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 259
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNH 276
             P                            + R L+S++ V DP KRIS+ E   H
Sbjct: 260 NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRH 316

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 18  HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-----NVQREIINHR 72
           H SDRYEL   +G G      L RD +    VAVK + R D   +       +RE  N  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAA 67
Query: 73  SLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
           +L HP IV   +     T       IVMEY  G  L + +   G  +   A         
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAY 184
            +++ H   + HRD+K  N L+  + A  +K+ DFG ++    S     Q  + +GT  Y
Sbjct: 128 ALNFSHQNGIIHRDVKPANILISATNA--VKVVDFGIARAIADSGNSVXQTAAVIGTAQY 185
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           ++PE       D + +DV+S G  LY +L G  PF
Sbjct: 186 LSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
           DR+++ R  G G FG  +L ++K T   VA+K + +  +      + + +   L HPNIV
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIV 82
Query: 81  RFKEVILT-------PTHLAIVMEYASGGELFERICNAGRFSEDEA------RFFFQQLI 127
           + +    T         +L +VMEY    +   R C    +    A      + F  QLI
Sbjct: 83  QLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCR-NYYRRQVAPPPILIKVFLFQLI 139
Query: 128 SGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 185
             +   H  S+ VCHRD+K  N L++ +    LK+CDFG +K         + + +  Y 
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLSPSEPNVAYICSRYYR 198
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
           APE++   ++     D+WS G     M++G
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 18  HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-----NVQREIINHR 72
           H SDRYEL   +G G      L RD +    VAVK + R D   +       +RE  N  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAA 67
Query: 73  SLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
           +L HP IV   +     T       IVMEY  G  L + +   G  +   A         
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAY 184
            +++ H   + HRD+K  N ++  + A  +K+ DFG ++    S    +Q  + +GT  Y
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           ++PE       D + +DV+S G  LY +L G  PF
Sbjct: 186 LSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 18  HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-----NVQREIINHR 72
           H SDRYEL   +G G      L RD +    VAVK + R D   +       +RE  N  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAA 67
Query: 73  SLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
           +L HP IV   +     T       IVMEY  G  L + +   G  +   A         
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAY 184
            +++ H   + HRD+K  N ++  + A  +K+ DFG ++    S    +Q  + +GT  Y
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           ++PE       D + +DV+S G  LY +L G  PF
Sbjct: 186 LSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 116/276 (42%), Gaps = 30/276 (10%)
Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHP 77
           D+  Y  ++ +G G F    L+         A+K I   ++ D E  QRE   HR   HP
Sbjct: 27  DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 78  NIVRFKEVIL---TPTHLA-IVMEYASGGELF---ERICNAGRF-SEDEARFFFQQLISG 129
           NI+R     L      H A +++ +   G L+   ER+ + G F +ED+  +    +  G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---------- 179
           +   H+    HRDLK  N LL     P L   D G    + +H +               
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLM--DLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 180 GTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
            T +Y APE+   + +    +  DVWS G  LY M+ G  P++       F+K     L+
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQKGDSVALA 259
Query: 238 V--QYSIPDYVHISPECRHLISRIFVADPAKRISIP 271
           V  Q SIP     S     L++ +   DP +R  IP
Sbjct: 260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP 295

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 18  HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-----NVQREIINHR 72
           H SDRYEL   +G G      L RD +    VAVK + R D   +       +RE  N  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL-RADLARDPSFYLRFRREAQNAA 67
Query: 73  SLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
           +L HP IV   +     T       IVMEY  G  L + +   G  +   A         
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAY 184
            +++ H   + HRD+K  N ++  + A  +K+ DFG ++    S    +Q  + +GT  Y
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           ++PE       D + +DV+S G  LY +L G  PF
Sbjct: 186 LSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 139/318 (43%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  ++      LKI DF  ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFYLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 130/305 (42%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 129
           I+    V  TP         + IVME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQMLVG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS GV +  M+ G   F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 126/305 (41%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
           I+    V  TP         + IVME          +C   +   D  R  +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPEVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+ G   F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 139/318 (43%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI  FG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILGFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 126/305 (41%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 79  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
           I+    V  TP         + IVME          +C   +   D  R  +   Q++ G
Sbjct: 86  IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 139
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+ G   F   +    + K I ++ +        +Q +
Sbjct: 198 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 274 RNHEW 278
             H +
Sbjct: 317 LQHPY 321

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 126/305 (41%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
           I+    V  TP         + IVME          +C   +   D  R  +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+ G   F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 126/305 (41%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
           I+    V  TP         + IVME          +C   +   D  R  +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+ G   F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 15/214 (7%)
Query: 18  HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE----RGDKIDENVQREIINHRS 73
           H SDRYEL   +G G      L RD +    VAVK +     R        +RE  N  +
Sbjct: 26  HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 85
Query: 74  LRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
           L HP IV   +     T       IVMEY  G  L + +   G  +   A          
Sbjct: 86  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 145
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYI 185
           +++ H   + HRD+K  N ++  + A  +K+ DFG ++    S    +Q  + +GT  Y+
Sbjct: 146 LNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 203
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           +PE       D + +DV+S G  LY +L G  PF
Sbjct: 204 SPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 236

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 125/294 (42%), Gaps = 42/294 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D K+   +AVK + R  +     +   RE+   + ++H 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V    T L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 169
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 170 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 223
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI----------------HR 234
           L   +     D+WS G  +  +L G   F   +     ++ +                H 
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHE 283
Query: 235 ILSVQYSIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
             +   S+P          ++  +P    L+ ++ V D  KRI+  E   H +F
Sbjct: 284 ARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYF 337

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 130/305 (42%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 129
           I+    V  TP         + IVME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQMLVG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS GV +  M+ G   F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 139/318 (43%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDAGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 18  HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-----NVQREIINHR 72
           H SDRYEL   +G G      L RD +    VAVK + R D   +       +RE  N  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL-RADLARDPSFYLRFRREAQNAA 67
Query: 73  SLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
           +L HP IV         T       IVMEY  G  L + +   G  +   A         
Sbjct: 68  ALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAY 184
            +++ H   + HRD+K  N ++  + A  +K+ DFG ++    S    +Q  + +GT  Y
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           ++PE       D + +DV+S G  LY +L G  PF
Sbjct: 186 LSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 126/306 (41%), Gaps = 57/306 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 27  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 86
Query: 79  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
           I+    V  TP         + IVME          +C   +   D  R  +   Q++ G
Sbjct: 87  IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 140
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 141 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMVPFVVTRYYRAPEV 198
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+ G   F   +    + K I ++ +        +Q +
Sbjct: 199 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 257
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 258 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 317
Query: 274 RNHEWF 279
             H + 
Sbjct: 318 LQHPYI 323

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 139/318 (43%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDGGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
           +G G FG A  +  ++T E++ +K + R    DE  QR  +      R L HPN+++F  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 85  VILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
           V+     L  + EY  GG L   I +   ++   +   F + + SG++Y HSM + HRDL
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPK--------------STVGTPAYIAPE 188
              N L+  +    + + DFG ++  V   +QP+              + VG P ++APE
Sbjct: 135 NSHNCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 189 VLLKKEYDGKIADVWSCGVTL 209
           ++  + YD K+ DV+S G+ L
Sbjct: 193 MINGRSYDEKV-DVFSFGIVL 212

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 129/289 (44%), Gaps = 49/289 (16%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEV 85
           +GSG +G      DK++ E VA+K + R    +   +   RE++  + ++H N++   +V
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 86  ILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
               + L       +VM +       ++I    +FSE++ ++   Q++ G+ Y HS  V 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK  N  ++      LKI DFG ++ +   ++    V T  Y APEV+L   +  + 
Sbjct: 149 HRDLKPGNLAVNED--CELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILSWMHYNQT 204
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-------------------- 239
            D+WS G  +  ML G   F+     K++   + +IL V                     
Sbjct: 205 VDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 260
Query: 240 YSIP-----DYVHI----SPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            S+P     D+  +    SP+   L+ ++   D  KR++  +   H +F
Sbjct: 261 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 123/287 (42%), Gaps = 37/287 (12%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
           +E +  +G G FG     R+       A+K I   ++    +  E++   SL H  +VR+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 83  KEVIL-------------TPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLIS 128
               L               + L I MEY     L++ I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-------VLHSQP------ 175
            +SY HS  + HRDLK  N  +D S    +KI DFG +K+         L SQ       
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
              S +GT  Y+A EVL    +  +  D++S G+  + M+   YPF    E  N  K + 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKL- 241
Query: 234 RILSVQYSIPDYVHISPECRHLISRIFV-ADPAKRISIPEIRNHEWF 279
           R +S+++  PD+     +    I R+ +  DP KR     + N  W 
Sbjct: 242 RSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 124/293 (42%), Gaps = 44/293 (15%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNI 79
           Y  ++ +GSG +G      D +T   VA+K + R    +   +   RE+   + +RH N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 80  VRFKEVILTP-------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           +   +V  TP       T   +VM +   G    ++    +  ED  +F   Q++ G+ Y
Sbjct: 87  IGLLDV-FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
            H+  + HRDLK  N  ++      LKI DFG ++ +   S+    V T  Y APEV+L 
Sbjct: 144 IHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQA--DSEMXGXVVTRWYRAPEVILN 199
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE--------------------------DPEEPK 226
                +  D+WS G  +  M+ G   F+                            +E K
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           N+ K +  +    ++     + SP   +L+ ++ V D  +R++  E   H +F
Sbjct: 260 NYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 139/318 (43%), Gaps = 45/318 (14%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
           +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 78  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
            HS  + HRDLK  N  L  +    LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDRGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEE 224
           L   +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NL 283
            +N+ +++ ++  + ++   ++  +P    L+ ++ V D  KRI+  +   H +F + + 
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 284 PADLVVDNTTNNQFEEPD 301
           P D  V +  +  FE  D
Sbjct: 314 PDDEPVADPYDQSFESRD 331

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 128/289 (44%), Gaps = 49/289 (16%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEV 85
           +GSG +G      DK++ E VA+K + R    +   +   RE++  + ++H N++   +V
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 86  ILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
               + L       +VM +       ++I     FSE++ ++   Q++ G+ Y HS  V 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK  N  ++      LKI DFG ++ +   ++    V T  Y APEV+L   +  + 
Sbjct: 167 HRDLKPGNLAVNED--CELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILSWMHYNQT 222
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-------------------- 239
            D+WS G  +  ML G   F+     K++   + +IL V                     
Sbjct: 223 VDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 278
Query: 240 YSIP-----DYVHI----SPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            S+P     D+  +    SP+   L+ ++   D  KR++  +   H +F
Sbjct: 279 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 129/305 (42%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 129
           I+    V  TP         + IVME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+ G   F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + HS
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
              + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ +YV 
Sbjct: 203 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 278
             P                            + R L+S++ V DPAKRIS+ +   H +
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + HS
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 182
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 183 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
              + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ +YV 
Sbjct: 241 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 278
             P                            + R L+S++ V DPAKRIS+ +   H +
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI    + RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 144 SANVLHRDLKPSNLLLNTTSD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEML 224

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 115/249 (46%), Gaps = 20/249 (8%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK ++  D   E  Q    E+   R  RH NI+ F   
Sbjct: 44  IGSGSFGT---VYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
            +T  +LAIV ++  G  L++ +     +F   +     +Q   G+ Y H+  + HRD+K
Sbjct: 101 -MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMK 159
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD--GKI 199
             N  L       +KI DFG +      S   Q +   G+  ++APEV+  ++ +     
Sbjct: 160 SNNIFLH--EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
           +DV+S G+ LY ++ G  P+       N R  I  ++   Y+ PD   +   C   + R+
Sbjct: 218 SDVYSYGIVLYELMTGELPYSHI----NNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRL 273
Query: 260 FVADPAKRI 268
            VAD  K++
Sbjct: 274 -VADCVKKV 281

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + HS
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
              + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ +YV 
Sbjct: 196 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 278
             P                            + R L+S++ V DPAKRIS+ +   H +
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + HS
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 145
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 146 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
              + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ +YV 
Sbjct: 204 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 278
             P                            + R L+S++ V DPAKRIS+ +   H +
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 321

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + HS
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 138
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 139 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
              + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ +YV 
Sbjct: 197 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 278
             P                            + R L+S++ V DPAKRIS+ +   H +
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 314

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 129/305 (42%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 129
           I+    V  TP         + IVME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+ G   F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 146 SANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEML 226

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + HS
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 145
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 146 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
              + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ +YV 
Sbjct: 204 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 278
             P                            + R L+S++ V DPAKRIS+ +   H +
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 321

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + HS
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
              + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ +YV 
Sbjct: 203 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 278
             P                            + R L+S++ V DPAKRIS+ +   H +
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + HS
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 138
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 139 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
              + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ +YV 
Sbjct: 197 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 278
             P                            + R L+S++ V DPAKRIS+ +   H +
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 314

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + HS
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 182
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 183 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
              + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ +YV 
Sbjct: 241 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 278
             P                            + R L+S++ V DPAKRIS+ +   H +
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + HS
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
              + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ +YV 
Sbjct: 203 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 278
             P                            + R L+S++ V DPAKRIS+ +   H +
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 24  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 83
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + HS
Sbjct: 84  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 143
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 144 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 201
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
              + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ +YV 
Sbjct: 202 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 260
Query: 248 ISP----------------------------ECRHLISRIFVADPAKRISIPEIRNHEW 278
             P                            + R L+S++ V DPAKRIS+ +   H +
Sbjct: 261 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 319

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 129/305 (42%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 129
           I+    V  TP         + IVME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQMLVG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+ G   F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/240 (33%), Positives = 116/240 (48%), Gaps = 28/240 (11%)
Query: 9   GPGMDMPIMHDSDRY-ELVRDIGSGNFGVARLM----RDKKTEELVAVKYI--ERGDKID 61
           GPG D  + H   RY + +RD+G G+FG   L      +  T E+VAVK +  + G +  
Sbjct: 21  GPG-DPTVFHK--RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR 77
Query: 62  ENVQREIINHRSLRHPNIVRFKEVI--LTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
              ++EI   R+L H +I+++K          L +VMEY   G L + +    R S   A
Sbjct: 78  SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLA 134
Query: 120 RF--FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175
           +   F QQ+  G++Y H+    HRDL   N LLD      +KI DFG +K+     +   
Sbjct: 135 QLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEXYR 192
Query: 176 -KSTVGTPA-YIAPEVLLKKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
            +    +P  + APE L  KEY    A DVWS GVTLY +L      + P  P  F + I
Sbjct: 193 VREDGDSPVFWYAPECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELI 248

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 92/365 (25%), Positives = 156/365 (42%), Gaps = 56/365 (15%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREI 68
           ++ P   +  +YE +  IG G FG     R +KT + VA+K +      +       REI
Sbjct: 9   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 68
Query: 69  INHRSLRHPNIVRFKEVILTPTH--------LAIVMEYASGGELFERICNA-GRFSEDEA 119
              + L+H N+V   E+  T           + +V ++    +L   + N   +F+  E 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEI 127
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL--HSQP 175
           +   Q L++G+ Y H  ++ HRD+K  N L+  DG     LK+ DFG +++  L  +SQP
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQP 183
Query: 176 K---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM-------------------- 212
               + V T  Y  PE+LL +   G   D+W  G  +  M                    
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243
Query: 213 -LVGAYPFEDPEEPKNFR--KTIHRILSVQYSIPD----YVHISPECRHLISRIFVADPA 265
            L G+   E      N+   + +  +   +  + D    YV   P    LI ++ V DPA
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR-DPYALDLIDKLLVLDPA 302
Query: 266 KRISIPEIRNHEWFLKN-LPADL--VVDNTTNNQFEEPDQPMQSIDEI-MQIIAEATIPA 321
           +RI   +  NH++F  + +P+DL  ++     + FE    P +   +I  Q   ++  PA
Sbjct: 303 QRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNPA 362
Query: 322 AGTQS 326
              Q+
Sbjct: 363 TTNQT 367

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI    + RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 144 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEML 224

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 121/308 (39%), Gaps = 45/308 (14%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIV 80
           RY  ++ +G G  G+     D   ++ VA+K I   D +  ++  REI   R L H NIV
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 81  RFKEVILTPTHLAIVMEYASGGEL-------------FERICNAGRFSEDEARFFFQQLI 127
           +  E IL P+   +  +  S  EL                +   G   E+ AR F  QL+
Sbjct: 72  KVFE-ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG----TPA 183
            G+ Y HS  V HRDLK  N  ++      LKI DFG ++    H   K  +     T  
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFINTEDL-VLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-- 241
           Y +P +LL      K  D+W+ G     ML G   F    E +  +  +  I  V     
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249
Query: 242 ------IPDYVH----------------ISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
                 IP Y+                 IS E    + +I    P  R++  E  +H + 
Sbjct: 250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309
Query: 280 -LKNLPAD 286
            + + P D
Sbjct: 310 SIYSFPMD 317

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 127/305 (41%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
           I+    V  TP         + IVME          +C   +   D  R  +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++      +  V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+     F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           + +YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 256 VRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 142 SANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEML 222

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 129/305 (42%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 129
           I+    V  TP         + IVME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+ G   F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 142 SANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEML 222

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 146 SANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEML 226

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 146 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 203
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEML 226

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 204
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEML 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 142 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEML 222

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  ++ IG G +G+     D   +  VA+K I         +   REI      RH N+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 80  VRFKEVILTPTHLAI----VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           +  ++++   T  A+    +++     +L+ ++  + + S D   +F  Q++ G+ Y HS
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLY-KLLKSQQLSNDHICYFLYQILRGLKYIHS 162
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 191
             V HRDLK  N L++ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 163 ANVLHRDLKPSNLLINTTCD--LKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 192 KKEYDGKIADVWSCGVTLYVML 213
             +   K  D+WS G  L  ML
Sbjct: 221 NSKGYTKSIDIWSVGCILAEML 242

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 140 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEML 220

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 144 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEML 224

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 140 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEML 220

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 109/219 (49%), Gaps = 17/219 (7%)
Query: 10  PGMDMPIMHDSDRY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYI--ERGDKIDE 62
           P  ++   H   R+ + +RD+G G+FG   L R       T E VAVK +  E G     
Sbjct: 9   PATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA 68
Query: 63  NVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEA 119
           ++++EI   R+L H NIV++K +        + ++ME+   G L E +  N  + +  + 
Sbjct: 69  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---K 176
             +  Q+  G+ Y  S Q  HRDL   N L++     ++KI DFG +K+     +    K
Sbjct: 129 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEXXTVK 186
Query: 177 STVGTPAY-IAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
               +P +  APE L++ ++    +DVWS GVTL+ +L 
Sbjct: 187 DDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLT 224

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 204
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEML 227

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 147
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 148 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 205
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 206 LNSKGYTKSIDIWSVGCILAEML 228

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 138
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 139 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 196
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 197 LNSKGYTKSIDIWSVGCILAEML 219

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 146 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEML 226

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 92  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 149
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 150 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 207
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 208 LNSKGYTKSIDIWSVGCILAEML 230

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 142 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEML 222

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKCQHLSNDHICYFLYQILRGLKYIH 145
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 146 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEML 226

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 7   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 66
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +A R    +   +  Q+
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQI 126
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 183
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 184 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 231

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 140/323 (43%), Gaps = 53/323 (16%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREI 68
           ++ P   +  +YE +  IG G FG     R +KT + VA+K +      +       REI
Sbjct: 9   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 68
Query: 69  INHRSLRHPNIVRFKEVILTPTH--------LAIVMEYASGGELFERICNA-GRFSEDEA 119
              + L+H N+V   E+  T           + +V ++    +L   + N   +F+  E 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEI 127
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL--HSQP 175
           +   Q L++G+ Y H  ++ HRD+K  N L+  DG     LK+ DFG +++  L  +SQP
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQP 183
Query: 176 K---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM-------------------- 212
               + V T  Y  PE+LL +   G   D+W  G  +  M                    
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243
Query: 213 -LVGAYPFEDPEEPKNFR--KTIHRILSVQYSIPD----YVHISPECRHLISRIFVADPA 265
            L G+   E      N+   + +  +   +  + D    YV   P    LI ++ V DPA
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR-DPYALDLIDKLLVLDPA 302
Query: 266 KRISIPEIRNHEWFLKN-LPADL 287
           +RI   +  NH++F  + +P+DL
Sbjct: 303 QRIDSDDALNHDFFWSDPMPSDL 325

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 135
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 104 IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 191
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 163 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 192 KKEYDGKIADVWSCGVTLYVML 213
             +   K  D+WS G  L  ML
Sbjct: 221 NSKGYTKSIDIWSVGCILAEML 242

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 140/323 (43%), Gaps = 53/323 (16%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREI 68
           ++ P   +  +YE +  IG G FG     R +KT + VA+K +      +       REI
Sbjct: 9   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 68
Query: 69  INHRSLRHPNIVRFKEVILTPTH--------LAIVMEYASGGELFERICNA-GRFSEDEA 119
              + L+H N+V   E+  T           + +V ++    +L   + N   +F+  E 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEI 127
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL--HSQP 175
           +   Q L++G+ Y H  ++ HRD+K  N L+  DG     LK+ DFG +++  L  +SQP
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQP 183
Query: 176 K---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM-------------------- 212
               + V T  Y  PE+LL +   G   D+W  G  +  M                    
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243
Query: 213 -LVGAYPFEDPEEPKNFR--KTIHRILSVQYSIPD----YVHISPECRHLISRIFVADPA 265
            L G+   E      N+   + +  +   +  + D    YV   P    LI ++ V DPA
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR-DPYALDLIDKLLVLDPA 302
Query: 266 KRISIPEIRNHEWFLKN-LPADL 287
           +RI   +  NH++F  + +P+DL
Sbjct: 303 QRIDSDDALNHDFFWSDPMPSDL 325

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 140/323 (43%), Gaps = 53/323 (16%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREI 68
           ++ P   +  +YE +  IG G FG     R +KT + VA+K +      +       REI
Sbjct: 8   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 67
Query: 69  INHRSLRHPNIVRFKEVILTPTH--------LAIVMEYASGGELFERICNA-GRFSEDEA 119
              + L+H N+V   E+  T           + +V ++    +L   + N   +F+  E 
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEI 126
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL--HSQP 175
           +   Q L++G+ Y H  ++ HRD+K  N L+  DG     LK+ DFG +++  L  +SQP
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQP 182
Query: 176 K---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM-------------------- 212
               + V T  Y  PE+LL +   G   D+W  G  +  M                    
Sbjct: 183 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 213 -LVGAYPFEDPEEPKNFR--KTIHRILSVQYSIPD----YVHISPECRHLISRIFVADPA 265
            L G+   E      N+   + +  +   +  + D    YV   P    LI ++ V DPA
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR-DPYALDLIDKLLVLDPA 301
Query: 266 KRISIPEIRNHEWFLKN-LPADL 287
           +RI   +  NH++F  + +P+DL
Sbjct: 302 QRIDSDDALNHDFFWSDPMPSDL 324

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/239 (33%), Positives = 115/239 (48%), Gaps = 27/239 (11%)
Query: 10  PGMDMPIMHDSDRY-ELVRDIGSGNFGVARLM----RDKKTEELVAVKYIER--GDKIDE 62
           P  D  + H   RY + +RD+G G+FG   L      +  T E+VAVK ++   G +   
Sbjct: 4   PASDPTVFHK--RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRS 61
Query: 63  NVQREIINHRSLRHPNIVRFKEVI--LTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
             ++EI   R+L H +I+++K          L +VMEY   G L + +    R S   A+
Sbjct: 62  GWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQ 118
Query: 121 F--FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQP 175
              F QQ+  G++Y HS    HR+L   N LLD      +KI DFG +K+      + + 
Sbjct: 119 LLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRV 176
Query: 176 KSTVGTPA-YIAPEVLLKKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
           +    +P  + APE L  KEY    A DVWS GVTLY +L      + P  P  F + I
Sbjct: 177 REDGDSPVFWYAPECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELI 231

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 121/293 (41%), Gaps = 39/293 (13%)
Query: 22  RYELVRDIGSGNFGVARLMRD-KKTEELVAVKYI-----ERGDKIDENVQREIINH-RSL 74
           +YE V +IG G +G     RD K     VA+K +     E G  +    +  ++ H  + 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 75  RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 127
            HPN+VR  +V         T L +V E+         +++   G  +E      FQ L+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 130
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
            G+ + HS +V HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LSVQYSIPDYV 246
           EVLL+  Y   + D+WS G     M      F    +     K +  I L  +   P  V
Sbjct: 189 EVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 247 HISPECRH--------------------LISRIFVADPAKRISIPEIRNHEWF 279
            +  +  H                    L+ +    +PAKRIS     +H +F
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 121/293 (41%), Gaps = 39/293 (13%)
Query: 22  RYELVRDIGSGNFGVARLMRD-KKTEELVAVKYI-----ERGDKIDENVQREIINH-RSL 74
           +YE V +IG G +G     RD K     VA+K +     E G  +    +  ++ H  + 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 75  RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 127
            HPN+VR  +V         T L +V E+         +++   G  +E      FQ L+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 130
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
            G+ + HS +V HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LSVQYSIPDYV 246
           EVLL+  Y   + D+WS G     M      F    +     K +  I L  +   P  V
Sbjct: 189 EVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 247 HISPECRH--------------------LISRIFVADPAKRISIPEIRNHEWF 279
            +  +  H                    L+ +    +PAKRIS     +H +F
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 26  VRDIGSGNFGVARLMR----DKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNI 79
           +RD+G G+FG   L R       T E VAVK +  E G     ++++EI   R+L H NI
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 80  VRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSM 136
           V++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G+ Y  S 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLLK 192
           Q  HRDL   N L++     ++KI DFG +K+     +    K    +P +  APE L++
Sbjct: 134 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 193 KEYDGKIADVWSCGVTLYVMLV 214
            ++    +DVWS GVTL+ +L 
Sbjct: 192 SKF-YIASDVWSFGVTLHELLT 212

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA++ I         +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 146 SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEML 226

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 126/305 (41%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
           I+    V  TP         + IVME          +C   +   D  R  +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++      +  V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+     F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 121/293 (41%), Gaps = 39/293 (13%)
Query: 22  RYELVRDIGSGNFGVARLMRD-KKTEELVAVKYI-----ERGDKIDENVQREIINH-RSL 74
           +YE V +IG G +G     RD K     VA+K +     E G  +    +  ++ H  + 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 75  RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 127
            HPN+VR  +V         T L +V E+         +++   G  +E      FQ L+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 130
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
            G+ + HS +V HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LSVQYSIPDYV 246
           EVLL+  Y   + D+WS G     M      F    +     K +  I L  +   P  V
Sbjct: 189 EVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 247 HISPECRH--------------------LISRIFVADPAKRISIPEIRNHEWF 279
            +  +  H                    L+ +    +PAKRIS     +H +F
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + +R +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 7   PTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 66
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++ME+   G L E +  +  R    +   +  Q+
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQI 126
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 183
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 184 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 231

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 120/291 (41%), Gaps = 38/291 (13%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPN 78
           R + +R +GSG +G      D +  + VAVK + R  +         RE+   + L+H N
Sbjct: 29  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHEN 88
Query: 79  IVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           ++   +V    T +     + +     G     I  +   S++  +F   QL+ G+ Y H
Sbjct: 89  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           S  + HRDLK  N  ++      L+I DFG ++ +    +    V T  Y APE++L   
Sbjct: 149 SAGIIHRDLKPSNVAVNED--SELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNWM 204
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-----------------HRILS 237
           +  +  D+WS G  +  +L G   F   +     ++ +                 H    
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 238 VQYSIP-----DYVHI----SPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           +Q S+P     D   I    +P    L+ R+ V D  +R+S  E   H +F
Sbjct: 265 IQ-SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
           Y   + IG+G+FGV    +  +++E+   K ++  DK  +N  RE+   R ++HPN+V  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ--DKRFKN--RELQIMRIVKHPNVVDL 97
Query: 83  KEVILT------PTHLAIVMEYASGGELFERICNAGRFSEDEA--------RFFFQQLIS 128
           K    +         L +V+EY       E +  A R              + +  QL+ 
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
            ++Y HS+ +CHRD+K +N LLD  P+  LK+ DFG +K  +      S + +  Y APE
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLD-PPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPE 211
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------VQYSI 242
           ++          D+WS G  +  ++ G  P    E   +    I ++L       ++   
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270
Query: 243 PDYV-HISPECR-----------------HLISRIFVADPAKRISIPEIRNHEWF 279
           P+Y+ H  P+ R                  LISR+    P+ R++  E   H +F
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/239 (32%), Positives = 115/239 (48%), Gaps = 27/239 (11%)
Query: 10  PGMDMPIMHDSDRY-ELVRDIGSGNFGVARLM----RDKKTEELVAVKYIER--GDKIDE 62
           P  D  + H   RY + +RD+G G+FG   L      +  T E+VAVK ++   G +   
Sbjct: 4   PASDPTVFHK--RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRS 61
Query: 63  NVQREIINHRSLRHPNIVRFKEVI--LTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
             ++EI   R+L H +I+++K          L +VMEY   G L + +    R S   A+
Sbjct: 62  GWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQ 118
Query: 121 F--FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQP 175
              F QQ+  G++Y H+    HR+L   N LLD      +KI DFG +K+      + + 
Sbjct: 119 LLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRV 176
Query: 176 KSTVGTPA-YIAPEVLLKKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
           +    +P  + APE L  KEY    A DVWS GVTLY +L      + P  P  F + I
Sbjct: 177 REDGDSPVFWYAPECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELI 231

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 79  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
           I+    V  TP         + IVME          +C   +   D  R  +   Q++ G
Sbjct: 79  IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 132
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+     F   +    + K I ++ +        +Q +
Sbjct: 191 ILGMGYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 249
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 250 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 309
Query: 274 RNHEW 278
             H +
Sbjct: 310 LQHPY 314

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   E  VA+K + R  +   + +R   E++  + + H N
Sbjct: 30  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 89
Query: 79  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
           I+    V  TP         + IVME          +C   +   D  R  +   Q++ G
Sbjct: 90  IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 143
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 144 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 201
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+     F   +    + K I ++ +        +Q +
Sbjct: 202 ILGMGYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 260
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           +  YV   P                            + R L+S++ V D +KRIS+ E 
Sbjct: 261 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 320
Query: 274 RNHEW 278
             H +
Sbjct: 321 LQHPY 325

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
           D+   ++ + IG G FG     RL    K E  VA+K ++ G  DK   +   E      
Sbjct: 27  DASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ 86
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
             HPNI+  + V+     + I+ EY   G L  F R  N GRF+  +     + + SG+ 
Sbjct: 87  FDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMK 145
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YI 185
           Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + 
Sbjct: 146 YLSDMSAVHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWT 201
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           APE +  +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 202 APEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 237

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 130/305 (42%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 129
           I+    V  TP         + +VME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IISLLNV-FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLYQMLXG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+     F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           + +YV   P                            + R L+S++ V DPAKRIS+ + 
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 21  DRYELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLR 75
           +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYC 133
           HP+IV+   VI T   + I+ME  + GEL        +FS D A    +  QL + ++Y 
Sbjct: 70  HPHIVKLIGVI-TENPVWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYL 127
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP--AYIAPEVLL 191
            S +  HRD+   N L+  +    +K+ DFG S+     +  K++ G     ++APE + 
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESIN 185
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            + +    +DVW  GV ++ +++ G  PF+  +        I RI + +  +P   +  P
Sbjct: 186 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGE-RLPMPPNCPP 239
Query: 251 ECRHLISRIFVADPAKRISIPEIR 274
               L+++ +  DP++R    E++
Sbjct: 240 TLYSLMTKCWAYDPSRRPRFTELK 263

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 130/305 (42%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 129
           I+    V  TP         + +VME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IISLLNV-FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLYQMLXG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+     F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           + +YV   P                            + R L+S++ V DPAKRIS+ + 
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 118/291 (40%), Gaps = 38/291 (13%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPN 78
           R + +R +GSG +G      D +  + VAVK + R  +         RE+   + L+H N
Sbjct: 29  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHEN 88
Query: 79  IVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           ++   +V    T +     + +     G     I      S++  +F   QL+ G+ Y H
Sbjct: 89  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           S  + HRDLK  N  ++      L+I DFG ++ +    +    V T  Y APE++L   
Sbjct: 149 SAGIIHRDLKPSNVAVNED--SELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNWM 204
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-----------------HRILS 237
           +  +  D+WS G  +  +L G   F   +     ++ +                 H    
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 238 VQYSIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           +Q S+P          +   +P    L+ R+ V D  +R+S  E   H +F
Sbjct: 265 IQ-SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 19  DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
           D      V++IGSG FG+  L     +DK     VA+K I  G   +E+   E      L
Sbjct: 5   DPSELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIEEAEVMMKL 59
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 133
            HP +V+   V L    + +V E+   G L + +    G F+ +        +  G++Y 
Sbjct: 60  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVL 190
               V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV 
Sbjct: 120 EEASVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVF 176
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
               Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 177 SFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 130/305 (42%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 79  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 129
           I+    V  TP         + +VME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 78  IISLLNV-FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLYQMLXG 131
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+     F   +    + K I ++ +        +Q +
Sbjct: 190 ILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           + +YV   P                            + R L+S++ V DPAKRIS+ + 
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 274 RNHEW 278
             H +
Sbjct: 309 LQHPY 313

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 34/228 (14%)
Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRS 73
           +H  D Y +   IG G++G   L  DK TE+ VA+K + R   D ID + + REI     
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 74  LRHPNIVRFKEVI-----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
           L+   I+R  ++I     L    L IV+E A   +L +        +E+  +     L+ 
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLL 140
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------------------- 168
           G ++ H   + HRDLK  N LL+   +  +K+CDFG +++                    
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 169 ---SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
                L  Q  S V T  Y APE++L +E   K  D+WS G     +L
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 130/305 (42%), Gaps = 57/305 (18%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
           RY+ ++ IGSG  G+     D   +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 79  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 129
           I+    V  TP         + +VME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IISLLNV-FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
           +L   Y   + D+WS G  +  M+     F   +    + K I ++ +        +Q +
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 242 IPDYVHISP----------------------------ECRHLISRIFVADPAKRISIPEI 273
           + +YV   P                            + R L+S++ V DPAKRIS+ + 
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 274 RNHEW 278
             H +
Sbjct: 316 LQHPY 320

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 21  DRYELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLR 75
           +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYC 133
           HP+IV+   VI T   + I+ME  + GEL        +FS D A    +  QL + ++Y 
Sbjct: 70  HPHIVKLIGVI-TENPVWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYL 127
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP--AYIAPEVLL 191
            S +  HRD+   N L+  +    +K+ DFG S+     +  K++ G     ++APE + 
Sbjct: 128 ESKRFVHRDIAARNVLVSATDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            + +    +DVW  GV ++ +++ G  PF+  +        I RI + +  +P   +  P
Sbjct: 186 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGE-RLPMPPNCPP 239
Query: 251 ECRHLISRIFVADPAKRISIPEIR 274
               L+++ +  DP++R    E++
Sbjct: 240 TLYSLMTKCWAYDPSRRPRFTELK 263

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
           D+   ++ + IG G FG     RL    K E  VA+K ++ G  DK   +   E      
Sbjct: 6   DASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ 65
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
             HPNI+  + V+     + I+ EY   G L  F R  N GRF+  +     + + SG+ 
Sbjct: 66  FDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMK 124
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YI 185
           Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + 
Sbjct: 125 YLSDMSYVHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWT 180
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           APE +  +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 181 APEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 216

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
           D+   ++ + IG G FG     RL    K E  VA+K ++ G  DK   +   E      
Sbjct: 12  DASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ 71
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
             HPNI+  + V+     + I+ EY   G L  F R  N GRF+  +     + + SG+ 
Sbjct: 72  FDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMK 130
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YI 185
           Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + 
Sbjct: 131 YLSDMSYVHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWT 186
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           APE +  +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 187 APEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 222

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 26  VRDIGSGNFGVARLM----RDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 79
           +RD+G G+FG   L      +  T E+VAVK ++ G   ++    QREI   R+L H +I
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 80  VRFKEVI--LTPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCH 134
           V++K          + +VMEY   G L     R C        +   F QQ+  G++Y H
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 129
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA-YIAPEVL 190
           +    HR L   N LLD      +KI DFG +K+      + + +    +P  + APE L
Sbjct: 130 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 191 LKKEYDGKIADVWSCGVTLYVMLV 214
            + ++    +DVWS GVTLY +L 
Sbjct: 188 KECKFY-YASDVWSFGVTLYELLT 210

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 29  IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 81
           IG+G FG     RL    K E  VA+K ++ G    E  +RE ++  S+     HPNI+R
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG--YTERQRREFLSEASIMGQFEHPNIIR 81
Query: 82  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
            + V+     + I+ E+   G L  F R+ N G+F+  +     + + SG+ Y   M   
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 140
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA---YIAPEVLLKK 193
           HRDL   N L++ +     K+ DFG S+    +S      S++G      + APE +  +
Sbjct: 141 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           ++    +D WS G+ ++ VM  G  P+ D
Sbjct: 199 KFTSA-SDAWSYGIVMWEVMSFGERPYWD 226

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 120/264 (45%), Gaps = 22/264 (8%)
Query: 28  DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-----RSLRHPNIVRF 82
           +IG G+F       D  TE  V V + E  D+     +R+         + L+HPNIVRF
Sbjct: 33  EIGRGSFKTVYKGLD--TETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 83  ----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ- 137
               +  +     + +V E  + G L   +           R + +Q++ G+ + H+   
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 138 -VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + HRDLK +N  + G P   +KI D G + +    S  K+ +GTP + APE   +K YD
Sbjct: 151 PIIHRDLKCDNIFITG-PTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEEK-YD 207
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-VQYSIPDYVHISPECRHL 255
             + DV++ G          YP+    E +N  +   R+ S V+ +  D V I PE + +
Sbjct: 208 ESV-DVYAFGXCXLEXATSEYPY---SECQNAAQIYRRVTSGVKPASFDKVAI-PEVKEI 262
Query: 256 ISRIFVADPAKRISIPEIRNHEWF 279
           I      +  +R SI ++ NH +F
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFF 286

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 26  VRDIGSGNFGVARLM----RDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 79
           +RD+G G+FG   L      +  T E+VAVK ++ G   ++    QREI   R+L H +I
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 80  VRFKEVI--LTPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCH 134
           V++K          + +VMEY   G L     R C        +   F QQ+  G++Y H
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 128
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA-YIAPEVL 190
           +    HR L   N LLD      +KI DFG +K+      + + +    +P  + APE L
Sbjct: 129 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 191 LKKEYDGKIADVWSCGVTLYVMLV 214
            + ++    +DVWS GVTLY +L 
Sbjct: 187 KECKFY-YASDVWSFGVTLYELLT 209

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 19  DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
           D      V++IGSG FG+  L     +DK     VA+K I  G   +E+   E      L
Sbjct: 5   DPSELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIEEAEVMMKL 59
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 133
            HP +V+   V L    + +V E+   G L + +    G F+ +        +  G++Y 
Sbjct: 60  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVL 190
               V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV 
Sbjct: 120 EEACVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVF 176
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
               Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 177 SFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 35  PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 211
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 212 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 259

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 29  IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 81
           IG+G FG     RL    K E  VA+K ++ G    E  +RE ++  S+     HPNI+R
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG--YTERQRREFLSEASIMGQFEHPNIIR 79
Query: 82  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
            + V+     + I+ E+   G L  F R+ N G+F+  +     + + SG+ Y   M   
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 138
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPA---YIAPEVLLKK 193
           HRDL   N L++ +     K+ DFG S+    +S      S++G      + APE +  +
Sbjct: 139 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           ++    +D WS G+ ++ VM  G  P+ D
Sbjct: 197 KFTSA-SDAWSYGIVMWEVMSFGERPYWD 224

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 19  DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
           D      V++IGSG FG+  L     +DK     VA+K I  G   +E+   E      L
Sbjct: 3   DPSELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIEEAEVMMKL 57
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 133
            HP +V+   V L    + +V E+   G L + +    G F+ +        +  G++Y 
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVL 190
               V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV 
Sbjct: 118 EEACVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
               Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 175 SFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 205

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 19/234 (8%)
Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQR 66
           M  P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +R
Sbjct: 1   MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 67  EIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFF 123
           EI   +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   + 
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
            Q+  G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P 
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPG 177
Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
                + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 178 ESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 228

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 4   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 180
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 181 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 228

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 7   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 66
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 126
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 183
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 184 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 231

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 8   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 67
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 68  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 127
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 128 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 184
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 185 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 232

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 2   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 61
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 62  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 121
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 122 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 178
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 179 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 226

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 3   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 62
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 63  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 122
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 123 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 179
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 180 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 227

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 10  PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 69
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 70  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 129
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 130 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 186
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 187 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 234

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 21  DRYELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLR 75
           +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R   
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYC 133
           HP+IV+   VI T   + I+ME  + GEL        +FS D A    +  QL + ++Y 
Sbjct: 450 HPHIVKLIGVI-TENPVWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYL 507
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP--AYIAPEVLL 191
            S +  HRD+   N L+  +    +K+ DFG S+     +  K++ G     ++APE + 
Sbjct: 508 ESKRFVHRDIAARNVLVSATDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            + +    +DVW  GV ++ +++ G  PF+  +        I RI + +  +P   +  P
Sbjct: 566 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGE-RLPMPPNCPP 619
Query: 251 ECRHLISRIFVADPAKRISIPEIR 274
               L+++ +  DP++R    E++
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTELK 643

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 10/217 (4%)
Query: 10  PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREII 69
           P   + ++ D      V++IGSG FG+  L      ++ VA+K I+ G   +++   E  
Sbjct: 16  PRGSLHMVIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIKEGSMSEDDFIEEAE 74
Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLIS 128
               L HP +V+   V L    + +V E+   G L + +    G F+ +        +  
Sbjct: 75  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 134
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYI 185
           G++Y     V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + 
Sbjct: 135 GMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWA 191
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           +PEV     Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 192 SPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 227

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 19  DSDRYELVRDIGSGNFGVARLM----RDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
           D      V++IGSG FG+  L     +DK     VA+K I  G   +E+   E      L
Sbjct: 8   DPSELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIEEAEVMMKL 62
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 133
            HP +V+   V L    + +V E+   G L + +    G F+ +        +  G++Y 
Sbjct: 63  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 122
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVL 190
               V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV 
Sbjct: 123 EEACVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVF 179
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
               Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 180 SFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 9   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 68
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 69  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 128
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 129 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 185
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 186 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 233

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 11  PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 70
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 71  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 130
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 131 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 187
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 188 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 235

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 137/306 (44%), Gaps = 33/306 (10%)
Query: 25  LVRDIGSGNFGVARLMR-DKKTEELVAVKY-------IERGDKIDENVQREIINHRSLRH 76
           L+  +G G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 74
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
            N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKSTVGTPAYIAPE 188
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 134 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 188
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
            L  + +    +D W  GVTL+ M       ++P    N  + +H+I      +P     
Sbjct: 189 SLKTRTF-SHASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKIDKEGERLPRPEDC 244
Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSID 308
             +  +++ + +   P  R +   +R+  + L+  P D+         FEEPD+    ++
Sbjct: 245 PQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQPTDM----RALQDFEEPDKLHIQMN 298
Query: 309 EIMQII 314
           +++ +I
Sbjct: 299 DVITVI 304

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 119/291 (40%), Gaps = 38/291 (13%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPN 78
           R + +R +GSG +G      D +  + VAVK + R  +         RE+   + L+H N
Sbjct: 21  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHEN 80
Query: 79  IVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           ++   +V    T +     + +     G     I      S++  +F   QL+ G+ Y H
Sbjct: 81  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           S  + HRDLK  N  ++      L+I DFG ++ +    +    V T  Y APE++L   
Sbjct: 141 SAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNWM 196
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-----------------HRILS 237
           +  +  D+WS G  +  +L G   F   +     ++ +                 H    
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 256
Query: 238 VQYSIP-----DYVHI----SPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           +Q S+P     D   I    +P    L+ R+ V D  +R+S  E   H +F
Sbjct: 257 IQ-SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 306

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 100
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 159
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 160 MKYLSDMGFVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 215
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 216 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 19  DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
           D      V++IGSG FG+  L     +DK     VA+K I  G   +E+   E      L
Sbjct: 6   DPSELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIEEAEVMMKL 60
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 133
            HP +V+   V L    + +V E+   G L + +    G F+ +        +  G++Y 
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVL 190
               V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV 
Sbjct: 121 EEACVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVF 177
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
               Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 178 SFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 31  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 88
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 147
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 148 MKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 203
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 204 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 239

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-P 77
           + D Y+LVR +G G +       +    E V VK ++   K    ++REI    +LR  P
Sbjct: 35  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--NKIKREIKILENLRGGP 92
Query: 78  NIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           NI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHS 149
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  + 
Sbjct: 150 MGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 196 DGKIADVWSCGVTLYVMLVGAYPF 219
                D+WS G  L  M+    PF
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 14  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 71
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 130
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 186
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 187 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 222

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 41  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 98
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 157
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 158 MKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 213
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 214 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 249

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 100/236 (42%), Gaps = 24/236 (10%)
Query: 3   RSAMTVGP---GMD--------MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAV 51
           R  MT GP   G D        +P  H + RYE+++ IG G+FG      D K  + VA+
Sbjct: 68  RQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVAL 127
Query: 52  KYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILTPTHLAIVMEYASGG--E 103
           K +    +       EI     LR        N++   E      H+ +  E  S    E
Sbjct: 128 KMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYE 187
Query: 104 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163
           L ++    G FS    R F   ++  +   H  ++ H DLK EN LL       +K+ DF
Sbjct: 188 LIKKNKFQG-FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
Query: 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           G   S   H +  + + +  Y APEV+L   Y G   D+WS G  L  +L G YP 
Sbjct: 247 G--SSCYEHQRVYTXIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTG-YPL 298

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 100
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 159
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 215
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 216 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 100
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 159
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 215
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 216 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 100
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 159
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 215
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 216 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 100
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 159
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 215
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 216 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 21  DRYELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLR 75
           +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R   
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYC 133
           HP+IV+   VI T   + I+ME  + GEL        +FS D A    +  QL + ++Y 
Sbjct: 450 HPHIVKLIGVI-TENPVWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYL 507
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP--AYIAPEVLL 191
            S +  HRD+   N L+  +    +K+ DFG S+     +  K++ G     ++APE + 
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            + +    +DVW  GV ++ +++ G  PF+  +        I RI + +  +P   +  P
Sbjct: 566 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGE-RLPMPPNCPP 619
Query: 251 ECRHLISRIFVADPAKRISIPEIR 274
               L+++ +  DP++R    E++
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTELK 643

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 100/236 (42%), Gaps = 24/236 (10%)
Query: 3   RSAMTVGP---GMD--------MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAV 51
           R  MT GP   G D        +P  H + RYE+++ IG G+FG      D K  + VA+
Sbjct: 68  RQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVAL 127
Query: 52  KYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILTPTHLAIVMEYASGG--E 103
           K +    +       EI     LR        N++   E      H+ +  E  S    E
Sbjct: 128 KMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYE 187
Query: 104 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163
           L ++    G FS    R F   ++  +   H  ++ H DLK EN LL       +K+ DF
Sbjct: 188 LIKKNKFQG-FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
Query: 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           G   S   H +  + + +  Y APEV+L   Y G   D+WS G  L  +L G YP 
Sbjct: 247 G--SSCYEHQRVYTXIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTG-YPL 298

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
           RY  +  IG G +G+     D   +  VA+K I         +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 80  VRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           +   ++I  PT      + IV +         ++      S D   +F  Q++ G+ Y H
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKI DFG ++ +   H         V T  Y APE++
Sbjct: 142 SANVLHRDLKPSNLLLNTTXD--LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
           L  +   K  D+WS G  L  ML
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEML 222

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 19/222 (8%)
Query: 24  ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPN 78
           + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI   +SL+H N
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 79  IVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
           IV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y  +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVL 190
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 151 KRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
            + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 208 TESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 246

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 19/222 (8%)
Query: 24  ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPN 78
           + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI   +SL+H N
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 79  IVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
           IV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y  +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVL 190
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 151 KRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
            + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 208 TESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 246

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 109/237 (45%), Gaps = 21/237 (8%)
Query: 20  SDRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-NVQ-REIINHRSLRH 76
           S+   L+ DI G G        R KKT +L A+K       +   +VQ RE    + L H
Sbjct: 7   SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 77  PNIVRFK--EVILTPTHLAIVMEYASGGELF---ERICNAGRFSEDEARFFFQQLISGVS 131
            NIV+    E   T  H  ++ME+   G L+   E   NA    E E     + ++ G++
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 132 YCHSMQVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
           +     + HR++K  N +     DG      K+ DFG ++      Q  S  GT  Y+ P
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSV--YKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 188 EV----LLKKEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
           ++    +L+K++    G   D+WS GVT Y    G+ PF   E P+  ++ +++I++
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 21  DRYELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLR 75
           +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYC 133
           HP+IV+   VI T   + I+ME  + GEL        ++S D A    +  QL + ++Y 
Sbjct: 70  HPHIVKLIGVI-TENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYL 127
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP--AYIAPEVLL 191
            S +  HRD+   N L+  +    +K+ DFG S+     +  K++ G     ++APE + 
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            + +    +DVW  GV ++ +++ G  PF+  +        I RI + +  +P   +  P
Sbjct: 186 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGE-RLPMPPNCPP 239
Query: 251 ECRHLISRIFVADPAKRISIPEIR 274
               L+++ +  DP++R    E++
Sbjct: 240 TLYSLMTKCWAYDPSRRPRFTELK 263

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 53/277 (19%)
Query: 26  VRDIGSGN-FGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF-- 82
            +D+GSG  + + RL+ +++ +    ++ +    K+               HPNIV+F  
Sbjct: 47  AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG-------------HPNIVQFCS 93
Query: 83  ------KEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
                 +E         ++ E   G   E  +++ + G  S D     F Q    V + H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 135 SMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-------SQPKSTV------ 179
             +  + HRDLK+EN LL  S    +K+CDFG S +++ H       +Q ++ V      
Sbjct: 154 RQKPPIIHRDLKVENLLL--SNQGTIKLCDFG-SATTISHYPDYSWSAQRRALVEEEITR 210
Query: 180 -GTPAYIAPEVL-LKKEYD-GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 236
             TP Y  PE++ L   +  G+  D+W+ G  LY++    +PFED  +         RI+
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--------LRIV 262
Query: 237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           + +YSIP +         LI  +   +P +R+SI E+
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 20/216 (9%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 79
           ++ E+   IG G FG     R    E  + +  IER ++   +  +RE++ +R  RH N+
Sbjct: 33  EQLEIGELIGKGRFGQVYHGR-WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVSYCHSMQV 138
           V F    ++P HLAI+     G  L+  + +A    + ++ R   Q+++ G+ Y H+  +
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFG-YSKSSVLHSQPKSTV-----GTPAYIAPEVLLK 192
            H+DLK +N   D     ++ I DFG +S S VL +  +        G   ++APE++ +
Sbjct: 152 LHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 193 KEYD--------GKIADVWSCGVTLYVMLVGAYPFE 220
              D         K +DV++ G   Y +    +PF+
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 125/275 (45%), Gaps = 36/275 (13%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIIN----HRSLRHPNI 79
           E + ++GSG  G    MR +KT  ++AVK + R    +EN +R +++     +S   P I
Sbjct: 28  ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN-KRILMDLDVVLKSHDCPYI 86
Query: 80  VRFKEVILTPTHLAIVMEYASG----------GELFERICNAGRFSEDEARFFFQQLISG 129
           V+     +T T + I ME              G + ERI      +  +A ++ ++    
Sbjct: 87  VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---- 142
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
                   V HRD+K  N LLD     ++K+CDFG S   V       + G  AY+APE 
Sbjct: 143 -----KHGVIHRDVKPSNILLD--ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPER 195
Query: 190 L-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IP 243
           +      K +YD + ADVWS G++L  +  G +P+++    K   + + ++L  +   +P
Sbjct: 196 IDPPDPTKPDYDIR-ADVWSLGISLVELATGQFPYKN---CKTDFEVLTKVLQEEPPLLP 251
Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
            ++  S + +  +      D  KR    ++  H +
Sbjct: 252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 21  DRYELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLR 75
           +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R   
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYC 133
           HP+IV+   VI T   + I+ME  + GEL        ++S D A    +  QL + ++Y 
Sbjct: 98  HPHIVKLIGVI-TENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYL 155
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP--AYIAPEVLL 191
            S +  HRD+   N L+  +    +K+ DFG S+     +  K++ G     ++APE + 
Sbjct: 156 ESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 213
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            + +    +DVW  GV ++ +++ G  PF+  +        I RI + +  +P   +  P
Sbjct: 214 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGE-RLPMPPNCPP 267
Query: 251 ECRHLISRIFVADPAKRISIPEIR 274
               L+++ +  DP++R    E++
Sbjct: 268 TLYSLMTKCWAYDPSRRPRFTELK 291

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 4   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEFFKVKEPGESP 180
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 181 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 228

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 21  DRYELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLR 75
           +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R   
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYC 133
           HP+IV+   VI T   + I+ME  + GEL        ++S D A    +  QL + ++Y 
Sbjct: 75  HPHIVKLIGVI-TENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP--AYIAPEVLL 191
            S +  HRD+   N L+  +    +K+ DFG S+     +  K++ G     ++APE + 
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            + +    +DVW  GV ++ +++ G  PF+  +        I RI + +  +P   +  P
Sbjct: 191 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGE-RLPMPPNCPP 244
Query: 251 ECRHLISRIFVADPAKRISIPEIR 274
               L+++ +  DP++R    E++
Sbjct: 245 TLYSLMTKCWAYDPSRRPRFTELK 268

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 21  DRYELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLR 75
           +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYC 133
           HP+IV+   VI T   + I+ME  + GEL        ++S D A    +  QL + ++Y 
Sbjct: 70  HPHIVKLIGVI-TENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYL 127
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP--AYIAPEVLL 191
            S +  HRD+   N L+  +    +K+ DFG S+     +  K++ G     ++APE + 
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            + +    +DVW  GV ++ +++ G  PF+  +        I RI + +  +P   +  P
Sbjct: 186 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGE-RLPMPPNCPP 239
Query: 251 ECRHLISRIFVADPAKRISIPEIR 274
               L+++ +  DP++R    E++
Sbjct: 240 TLYSLMTKCWAYDPSRRPRFTELK 263

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 100
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 159
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG ++  VL   P++   T        
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLAR--VLEDDPEAAYTTRGGKIPIR 215
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 216 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 21  DRYELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLR 75
           +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYC 133
           HP+IV+   VI T   + I+ME  + GEL        ++S D A    +  QL + ++Y 
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP--AYIAPEVLL 191
            S +  HRD+   N L+  +    +K+ DFG S+     +  K++ G     ++APE + 
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            + +    +DVW  GV ++ +++ G  PF+  +        I RI + +  +P   +  P
Sbjct: 183 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGE-RLPMPPNCPP 236
Query: 251 ECRHLISRIFVADPAKRISIPEIR 274
               L+++ +  DP++R    E++
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELK 260

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 21  DRYELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLR 75
           +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R   
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYC 133
           HP+IV+   VI T   + I+ME  + GEL        ++S D A    +  QL + ++Y 
Sbjct: 73  HPHIVKLIGVI-TENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYL 130
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP--AYIAPEVLL 191
            S +  HRD+   N L+  +    +K+ DFG S+     +  K++ G     ++APE + 
Sbjct: 131 ESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 188
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            + +    +DVW  GV ++ +++ G  PF+  +        I RI + +  +P   +  P
Sbjct: 189 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGE-RLPMPPNCPP 242
Query: 251 ECRHLISRIFVADPAKRISIPEIR 274
               L+++ +  DP++R    E++
Sbjct: 243 TLYSLMTKCWAYDPSRRPRFTELK 266

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 21  DRYELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLR 75
           +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R   
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYC 133
           HP+IV+   VI T   + I+ME  + GEL        ++S D A    +  QL + ++Y 
Sbjct: 72  HPHIVKLIGVI-TENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYL 129
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP--AYIAPEVLL 191
            S +  HRD+   N L+  +    +K+ DFG S+     +  K++ G     ++APE + 
Sbjct: 130 ESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 187
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            + +    +DVW  GV ++ +++ G  PF+  +        I RI + +  +P   +  P
Sbjct: 188 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGE-RLPMPPNCPP 241
Query: 251 ECRHLISRIFVADPAKRISIPEIR 274
               L+++ +  DP++R    E++
Sbjct: 242 TLYSLMTKCWAYDPSRRPRFTELK 265

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 119/287 (41%), Gaps = 37/287 (12%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
           +E +  +G G FG     R+       A+K I   ++    +  E+    SL H  +VR+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRY 67
Query: 83  KEVIL-------------TPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLIS 128
               L               + L I  EY     L++ I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-------VLHSQP------ 175
            +SY HS  + HR+LK  N  +D S    +KI DFG +K+         L SQ       
Sbjct: 128 ALSYIHSQGIIHRNLKPXNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
              S +GT  Y+A EVL    +  +  D +S G+  +  +   YPF    E  N  K + 
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVNILKKL- 241
Query: 234 RILSVQYSIPDYVHISPECRHLISRIFV-ADPAKRISIPEIRNHEWF 279
           R +S+++  PD+     +    I R+ +  DP KR     + N  W 
Sbjct: 242 RSVSIEFP-PDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 98/236 (41%), Gaps = 24/236 (10%)
Query: 3   RSAMTVGP---GMD--------MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAV 51
           R  MT GP   G D        +P  H + RYE+++ IG G FG      D K  + VA+
Sbjct: 68  RQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVAL 127
Query: 52  KYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILTPTHLAIVMEYASGG--E 103
           K +    +       EI     LR        N++   E      H+ +  E  S    E
Sbjct: 128 KMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYE 187
Query: 104 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163
           L ++    G FS    R F   ++  +   H  ++ H DLK EN LL       +K+ DF
Sbjct: 188 LIKKNKFQG-FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
Query: 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           G   S   H +    + +  Y APEV+L   Y G   D+WS G  L  +L G YP 
Sbjct: 247 G--SSCYEHQRVYXXIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTG-YPL 298

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 100
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 159
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG  +  VL   P++   T        
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIR 215
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 216 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
            ++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
           V      + I+ EY + G      C      E   RF  QQL+         + Y  S Q
Sbjct: 87  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
             HRDL   N L++      +K+ DFG S+  VL  +  S+VG+     +  PEVL+  +
Sbjct: 141 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSK 197
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 198 FSSK-SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 94/224 (41%), Gaps = 28/224 (12%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLR-HP 77
           +YELV+ +G G +G+     D++T E+VAVK I    +   + Q   REI+    L  H 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           NIV    V+       + + +         +  A        ++   QLI  + Y HS  
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--------------------HSQPKS 177
           + HRD+K  N LL+      +K+ DFG S+S V                       QP  
Sbjct: 130 LLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 178 T--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           T  V T  Y APE+LL      K  D+WS G  L  +L G   F
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERG-DKIDENVQREII 69
           P   +    + ++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 5   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 64
Query: 70  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 65  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 124
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  + +  HR+L   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 125 CKGMEYLGTKRYIHRNLATRNILVENE--NRVKIGDFGLTK-VLPQDKEYYKVKEPGESP 181
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
             + APE L + ++    +DVWS GV LY +       + P  P  F + I
Sbjct: 182 IFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 229

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 123/273 (45%), Gaps = 21/273 (7%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSL 74
           +D  E + ++G G +GV   MR   + +++AVK I     ++   Q+ +     I+ R++
Sbjct: 50  ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTV 107
Query: 75  RHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGR-FSEDEARFFFQQLISGVS 131
             P  V F   +     + I ME    S  + ++++ + G+   ED        ++  + 
Sbjct: 108 DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 167
Query: 132 YCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV- 189
           + HS + V HRD+K  N L++     ++K+CDFG S   V         G   Y+APE  
Sbjct: 168 HLHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERI 225
Query: 190 ---LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
              L +K Y  K +D+WS G+T+  + +  +P++    P    K +    S Q     + 
Sbjct: 226 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF- 283
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
             S E     S+    +  +R + PE+  H +F
Sbjct: 284 --SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 10  PGMDMPIMHDS----DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-E 62
           P   MP  H      DRYE+   IG+G++G      DK  + +VA+K I R   D ID +
Sbjct: 38  PTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK 97
Query: 63  NVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRF-SE 116
            + REI     L H ++V+  ++++         L +V+E A     F+++     + +E
Sbjct: 98  RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTE 155
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------- 167
              +     L+ GV Y HS  + HRDLK  N L++   +  +K+CDFG ++         
Sbjct: 156 LHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGN 213
Query: 168 -------------------SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208
                              +  L  Q    V T  Y APE++L +E   +  DVWS G  
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 209 LYVML 213
              +L
Sbjct: 274 FAELL 278

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
            ++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
           V      + I+ EY + G      C      E   RF  QQL+         + Y  S Q
Sbjct: 71  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 124
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
             HRDL   N L++      +K+ DFG S+  VL  +  S+VG+     +  PEVL+  +
Sbjct: 125 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 181
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 182 FSSK-SDIWAFGVLMWEIYSLGKMPYE 207

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
            ++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
           V      + I+ EY + G      C      E   RF  QQL+         + Y  S Q
Sbjct: 67  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
             HRDL   N L++      +K+ DFG S+  VL  +  S+VG+     +  PEVL+  +
Sbjct: 121 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 178 FSSK-SDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
            ++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
           V      + I+ EY + G      C      E   RF  QQL+         + Y  S Q
Sbjct: 72  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
             HRDL   N L++      +K+ DFG S+  VL  +  S+VG+     +  PEVL+  +
Sbjct: 126 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 182
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 183 FSSK-SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 123/273 (45%), Gaps = 21/273 (7%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSL 74
           +D  E + ++G G +GV   MR   + +++AVK I     ++   Q+ +     I+ R++
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTV 63
Query: 75  RHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGR-FSEDEARFFFQQLISGVS 131
             P  V F   +     + I ME    S  + ++++ + G+   ED        ++  + 
Sbjct: 64  DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 132 YCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE-- 188
           + HS + V HRD+K  N L++     ++K+CDFG S   V         G   Y+APE  
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181
Query: 189 --VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
              L +K Y  K +D+WS G+T+  + +  +P++    P    K +    S Q     + 
Sbjct: 182 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF- 239
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
             S E     S+    +  +R + PE+  H +F
Sbjct: 240 --SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
            ++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
           V      + I+ EY + G      C      E   RF  QQL+         + Y  S Q
Sbjct: 87  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
             HRDL   N L++      +K+ DFG S+  VL  +  S+VG+     +  PEVL+  +
Sbjct: 141 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 197
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 198 FSSK-SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 21/237 (8%)
Query: 20  SDRYELVRDI-GSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-NVQ-REIINHRSLRH 76
           S+   L+ DI G G        R KKT +L A+K       +   +VQ RE    + L H
Sbjct: 7   SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 77  PNIVRFK--EVILTPTHLAIVMEYASGGELF---ERICNAGRFSEDEARFFFQQLISGVS 131
            NIV+    E   T  H  ++ME+   G L+   E   NA    E E     + ++ G++
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 132 YCHSMQVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
           +     + HR++K  N +     DG      K+ DFG ++      Q     GT  Y+ P
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSV--YKLTDFGAARELEDDEQFVXLYGTEEYLHP 184
Query: 188 EV----LLKKEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
           ++    +L+K++    G   D+WS GVT Y    G+ PF   E P+  ++ +++I++
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 100
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV E    G L  F R  +A +F+  +     + + SG
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 159
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 160 MKYLSDMGAVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 215
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 216 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
            ++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
           V      + I+ EY + G      C      E   RF  QQL+         + Y  S Q
Sbjct: 78  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 131
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
             HRDL   N L++      +K+ DFG S+  VL  +  S+VG+     +  PEVL+  +
Sbjct: 132 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 188
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 189 FSSK-SDIWAFGVLMWEIYSLGKMPYE 214

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 14  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 71
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV E    G L  F R  +A +F+  +     + + SG
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 130
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 186
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 187 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 222

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 95/222 (42%), Gaps = 14/222 (6%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREII------NHRSL 74
           DRYE+   IG G+FG      D+  +E VA+K I+         Q E+        H + 
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 132
               IV  K   +   HL +V E  S   L++  R  N    S +  R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 133 CHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
             +  + + H DLK EN LL       +KI DFG   S  L  +    + +  Y +PEVL
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPEVL 230
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
           L   YD  I D+WS G  L  M  G   F    E     K +
Sbjct: 231 LGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+    + + +G+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIM 100
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+     + IV E    G L  F R  +A +F+  +     + + SG
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 159
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 215
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + +PE +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 216 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRHP 77
           D YE+   IG G++G   L  DK   + VA+K + R   D ID + + REI     L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 78  NIVRFKEVI-----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
            I+R  ++I     L    L IV+E A   +L +        +E   +     L+ G  +
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------------------------ 168
            H   + HRDLK  N LL+   +  +KICDFG +++                        
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCS--VKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 169 --SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
               L  Q  S V T  Y APE++L +E      D+WS G     +L
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 27  RDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----HPNI 79
           R IG+G FG     RL    K E  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNI 85
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           +  + V+     + IV EY   G L   +  N G+F+  +     + + +G+ Y   M  
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY 145
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLK 192
            HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE +  
Sbjct: 146 VHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           +++    +DVWS G+ ++ V+  G  P+
Sbjct: 202 RKFTSA-SDVWSYGIVMWEVVSYGERPY 228

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 95/222 (42%), Gaps = 14/222 (6%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREII------NHRSL 74
           DRYE+   IG G+FG      D+  +E VA+K I+         Q E+        H + 
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 132
               IV  K   +   HL +V E  S   L++  R  N    S +  R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 133 CHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
             +  + + H DLK EN LL       +KI DFG   S  L  +    + +  Y +PEVL
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRXAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPEVL 230
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
           L   YD  I D+WS G  L  M  G   F    E     K +
Sbjct: 231 LGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 95/222 (42%), Gaps = 14/222 (6%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREII------NHRSL 74
           DRYE+   IG G+FG      D+  +E VA+K I+         Q E+        H + 
Sbjct: 35  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 94
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 132
               IV  K   +   HL +V E  S   L++  R  N    S +  R F QQ+ + + +
Sbjct: 95  MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 153
Query: 133 CHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
             +  + + H DLK EN LL       +KI DFG   S  L  +    + +  Y +PEVL
Sbjct: 154 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPEVL 211
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
           L   YD  I D+WS G  L  M  G   F    E     K +
Sbjct: 212 LGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 252

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 132/298 (44%), Gaps = 43/298 (14%)
Query: 23  YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI---ERGDKIDENVQREI--INHRSLRH 76
           Y +++ IGSG    V +++ +KK  ++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 188
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 189 VL----------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
            +            K      +DVWS G  LY M  G  PF   ++  N    +H I+  
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDP 283
Query: 239 QYSI--PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF-LKNLPADLVVDNTT 293
            + I  PD      + + ++      DP +RISIPE+  H +  ++  P + +   TT
Sbjct: 284 NHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 339

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 23  YELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHP 77
           YEL+  IG G  +     L R K T E V V+ I      +E V   Q E+   +   HP
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 70
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHS 135
           NIV ++   +    L +V  + + G   + IC       +E    +  Q ++  + Y H 
Sbjct: 71  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 130
Query: 136 MQVCHRDLKLENTLL--DGSP-----APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
           M   HR +K  + L+  DG          L +   G  +  V+H  PK +V    +++PE
Sbjct: 131 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 189
Query: 189 VLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
           VL +  + YD K +D++S G+T   +  G  PF+D
Sbjct: 190 VLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 223

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 47/238 (19%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           S +Y L + +G+G+FG+   + D ++ +  A+K + +  +      RE+   + L H NI
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NRELDIMKVLDHVNI 62
Query: 80  VRF-----------------------------------KEVILTPT---HLAIVMEYASG 101
           ++                                    K VI+ P+   +L ++MEY   
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 102 G--ELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
              ++ +    +GR    +    +  QL   V + HS+ +CHRD+K +N L++ S    L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN-SKDNTL 181
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
           K+CDFG +K  +      + + +  Y APE++L   EY   I D+WS G     +++G
Sbjct: 182 KLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILG 238

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 23  YELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHP 77
           YEL+  IG G  +     L R K T E V V+ I      +E V   Q E+   +   HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHS 135
           NIV ++   +    L +V  + + G   + IC       +E    +  Q ++  + Y H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 136 MQVCHRDLKLENTLL--DGSP-----APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
           M   HR +K  + L+  DG          L +   G  +  V+H  PK +V    +++PE
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 205
Query: 189 VLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
           VL +  + YD K +D++S G+T   +  G  PF+D
Sbjct: 206 VLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 133/300 (44%), Gaps = 47/300 (15%)
Query: 23  YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI---ERGDKIDENVQREI--INHRSLRH 76
           Y +++ IGSG    V +++ +KK  ++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 188
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 189 VL----------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
            +            K      +DVWS G  LY M  G  PF   ++  N    +H I+  
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDP 255
Query: 239 QYSI--PDYVHISPE--CRHLISRIFVADPAKRISIPEIRNHEWF-LKNLPADLVVDNTT 293
            + I  PD     PE   + ++      DP +RISIPE+  H +  ++  P + +   TT
Sbjct: 256 NHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 311

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 133/300 (44%), Gaps = 47/300 (15%)
Query: 23  YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI---ERGDKIDENVQREI--INHRSLRH 76
           Y +++ IGSG    V +++ +KK  ++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 71
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 72  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 130
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 188
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE
Sbjct: 131 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 182
Query: 189 VL----------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
            +            K      +DVWS G  LY M  G  PF   ++  N    +H I+  
Sbjct: 183 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDP 239
Query: 239 QYSI--PDYVHISPE--CRHLISRIFVADPAKRISIPEIRNHEWF-LKNLPADLVVDNTT 293
            + I  PD     PE   + ++      DP +RISIPE+  H +  ++  P + +   TT
Sbjct: 240 NHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 295

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 133/300 (44%), Gaps = 47/300 (15%)
Query: 23  YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI---ERGDKIDENVQREI--INHRSLRH 76
           Y +++ IGSG    V +++ +KK  ++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 67
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 68  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 188
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE
Sbjct: 127 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 178
Query: 189 VL----------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
            +            K      +DVWS G  LY M  G  PF   ++  N    +H I+  
Sbjct: 179 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDP 235
Query: 239 QYSI--PDYVHISPE--CRHLISRIFVADPAKRISIPEIRNHEWF-LKNLPADLVVDNTT 293
            + I  PD     PE   + ++      DP +RISIPE+  H +  ++  P + +   TT
Sbjct: 236 NHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 291

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 133/300 (44%), Gaps = 47/300 (15%)
Query: 23  YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI---ERGDKIDENVQREI--INHRSLRH 76
           Y +++ IGSG    V +++ +KK  ++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 188
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 189 VL----------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
            +            K      +DVWS G  LY M  G  PF   ++  N    +H I+  
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDP 283
Query: 239 QYSI--PDYVHISPE--CRHLISRIFVADPAKRISIPEIRNHEWF-LKNLPADLVVDNTT 293
            + I  PD     PE   + ++      DP +RISIPE+  H +  ++  P + +   TT
Sbjct: 284 NHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 339

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIER-GDKIDENVQREII 69
           P + +    + +  +G GNFG   L R       T  LVAVK ++  G     + QREI 
Sbjct: 1   PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 60
Query: 70  NHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGG---ELFERICNAGRFSEDEARFFFQ 124
             ++L    IV+++ V   P    L +VMEY   G   +  +R  +  R        +  
Sbjct: 61  ILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSS 118
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 183
           Q+  G+ Y  S +  HRDL   N L++      +KI DFG +K   L  +    V  P  
Sbjct: 119 QICKGMEYLGSRRCVHRDLAARNILVESE--AHVKIADFGLAKLLPL-DKDXXVVREPGQ 175
Query: 184 ----YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
               + APE L    +  + +DVWS GV LY +  
Sbjct: 176 SPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFT 209

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSL 74
           + RYE V +IG G +G     RD  +   VA+K +     E G  I  +  RE+   R L
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRL 60
Query: 75  R---HPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQ 124
               HPN+VR  +V  T        + +V E+         ++    G    +  +   +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMR 119
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
           Q + G+ + H+  + HRDLK EN L+       +K+ DFG ++           V T  Y
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALAPVVVTLWY 177
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVML 213
            APEVLL+  Y   + D+WS G     M 
Sbjct: 178 RAPEVLLQSTYATPV-DMWSVGCIFAEMF 205

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSL 74
           + RYE V +IG G +G     RD  +   VA+K +     E G  I  +  RE+   R L
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRL 60
Query: 75  R---HPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQ 124
               HPN+VR  +V  T        + +V E+         ++    G    +  +   +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMR 119
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
           Q + G+ + H+  + HRDLK EN L+       +K+ DFG ++           V T  Y
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALDPVVVTLWY 177
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVML 213
            APEVLL+  Y   + D+WS G     M 
Sbjct: 178 RAPEVLLQSTYATPV-DMWSVGCIFAEMF 205

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 133/300 (44%), Gaps = 47/300 (15%)
Query: 23  YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI---ERGDKIDENVQREI--INHRSLRH 76
           Y +++ IGSG    V +++ +KK  ++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 69  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 188
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE
Sbjct: 128 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 189 VL----------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
            +            K      +DVWS G  LY M  G  PF   ++  N    +H I+  
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDP 236
Query: 239 QYSI--PDYVHISPE--CRHLISRIFVADPAKRISIPEIRNHEWF-LKNLPADLVVDNTT 293
            + I  PD     PE   + ++      DP +RISIPE+  H +  ++  P + +   TT
Sbjct: 237 NHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 292

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 28  DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-----RSLRHPNIVRF 82
           +IG G +G    M  K + +++AVK I     +DE  Q++++       RS   P IV+F
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 83  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 133
              +       I ME  S    F++         D+     ++++  ++           
Sbjct: 87  YGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDV--IPEEILGKITLATVKALNHLK 142
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL--- 190
            ++++ HRD+K  N LLD S    +K+CDFG S   V         G   Y+APE +   
Sbjct: 143 ENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVH 247
             ++ YD + +DVWS G+TLY +  G +P+  P+    F +    +     Q S  +   
Sbjct: 201 ASRQGYDVR-SDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQLSNSEERE 257
Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFL 280
            SP   + ++     D +KR    E+  H + L
Sbjct: 258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 121/290 (41%), Gaps = 58/290 (20%)
Query: 50  AVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGEL--- 104
           A+K IE G  I  +  REI   R L+HPN++  ++V L+     + ++ +YA        
Sbjct: 52  ALKQIE-GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII 110
Query: 105 -FERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPR 157
            F R   A +          +    Q++ G+ Y H+  V HRDLK  N L+  +G    R
Sbjct: 111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170
Query: 158 LKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
           +KI D G+++      +P +     V T  Y APE+LL   +  K  D+W+ G     +L
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230
Query: 214 -----------------------------VGAYP----FED----PEEP---KNFRKTIH 233
                                        V  +P    +ED    PE     K+FR+  +
Sbjct: 231 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY 290
Query: 234 RILS-VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
              S ++Y     V    +  HL+ ++   DP KRI+  +     +FL++
Sbjct: 291 TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 29  IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 81
           IG+G FG      L    K E  VA+K ++ G    E  +R+ ++  S+     HPN++ 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 82  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
            + V+   T + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 191
           HRDL   N L++ +     K+ DFG S+   L         T A        + APE + 
Sbjct: 158 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
            +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 214 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 243

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 93/325 (28%), Positives = 131/325 (40%), Gaps = 70/325 (21%)
Query: 20  SDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI--INHRSLRH 76
           S RYE+V  +G G FG V   +  K     VAVK ++  D+  E  + EI  + H +   
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTD 72
Query: 77  PN----IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 130
           PN     V+  E      H+ IV E   G   ++ I   G   F  D  R    Q+   V
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 131 SYCHSMQVCHRDLKLENTLL---DGSPA--------------PRLKICDFGYSKSSVLHS 173
           ++ HS ++ H DLK EN L    D + A              P +K+ DFG   S+    
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 174 QPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTL--YVMLVGAYPFEDPEE------ 224
           +  ST V T  Y APEV+L   +  +  DVWS G  L  Y +    +P  D +E      
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 225 ------PKNF------RKTIH-------------RILSVQYSIPDYVHISPECRH----- 254
                 PK+       RK  H             R +S          +S +  H     
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 255 LISRIFVADPAKRISIPEIRNHEWF 279
           LI ++   DPAKRI++ E   H +F
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
            ++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
           V      + I+ EY + G      C      E   RF  QQL+         + Y  S Q
Sbjct: 72  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
             HRDL   N L++      +K+ DFG S+  VL  +  S+ G+     +  PEVL+  +
Sbjct: 126 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSK 182
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 183 FSSK-SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 17/213 (7%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIER-GDKIDENVQREII 69
           P + +    + +  +G GNFG   L R       T  LVAVK ++  G     + QREI 
Sbjct: 4   PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 63
Query: 70  NHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQL 126
             ++L    IV+++ V   P    L +VMEY   G L + +  +  R        +  Q+
Sbjct: 64  ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 123
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
             G+ Y  S +  HRDL   N L++      +KI DFG +K   L  +    V  P    
Sbjct: 124 CKGMEYLGSRRCVHRDLAARNILVESE--AHVKIADFGLAKLLPL-DKDYYVVREPGQSP 180
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
             + APE L    +  + +DVWS GV LY +  
Sbjct: 181 IFWYAPESLSDNIFS-RQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 11  GMDMPIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIER-GDKIDENVQ 65
           G   P + +    + +  +G GNFG   L R       T  LVAVK ++  G     + Q
Sbjct: 1   GPQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ 60
Query: 66  REIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERIC-NAGRFSEDEARFF 122
           REI   ++L    IV+++ V   P    L +VMEY   G L + +  +  R        +
Sbjct: 61  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 120
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
             Q+  G+ Y  S +  HRDL   N L++      +KI DFG +K   L  +    V  P
Sbjct: 121 SSQICKGMEYLGSRRCVHRDLAARNILVESE--AHVKIADFGLAKLLPL-DKDYYVVREP 177
Query: 183 A-----YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
                 + APE L    +  + +DVWS GV LY +  
Sbjct: 178 GQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 15  PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIER-GDKIDENVQREII 69
           P + +    + +  +G GNFG   L R       T  LVAVK ++  G     + QREI 
Sbjct: 17  PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 70  NHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGG---ELFERICNAGRFSEDEARFFFQ 124
             ++L    IV+++ V   P    L +VMEY   G   +  +R  +  R        +  
Sbjct: 77  ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSS 134
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 183
           Q+  G+ Y  S +  HRDL   N L++      +KI DFG +K   L  +    V  P  
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVESE--AHVKIADFGLAKLLPL-DKDYYVVREPGQ 191
Query: 184 ----YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
               + APE L    +  + +DVWS GV LY +  
Sbjct: 192 SPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFT 225

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 29/295 (9%)
Query: 9   GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMR-DKKTEELVAVKY-------IERGDKI 60
           GP   +  +       L+  +G G+FGV R    D  + + V+V         + + + +
Sbjct: 6   GPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM 65
Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEA 119
           D+ + RE+    SL H N++R   V+LTP  + +V E A  G L +R+  + G F     
Sbjct: 66  DDFI-REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLH 172
             +  Q+  G+ Y  S +  HRDL   N LL  +    +KI DFG  ++        V+ 
Sbjct: 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQ 181
Query: 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
              K      A+ APE L  + +    +D W  GVTL+ M       ++P    N  + +
Sbjct: 182 EHRKVPF---AWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYG---QEPWIGLNGSQIL 234
Query: 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 287
           H+I      +P       +  +++ + +   P  R +   +R+  + L+  P D+
Sbjct: 235 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQPTDM 287

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 47/300 (15%)
Query: 23  YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI---ERGDKIDENVQREI--INHRSLRH 76
           Y +++ IGSG    V +++ +KK  ++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPK-------STVGTPAYIAPE 188
            + H DLK  N L+ DG     LK+ DFG +       QP        S VGT  Y+ PE
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDXXXVVKDSQVGTVNYMPPE 198
Query: 189 VL----------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
            +            K      +DVWS G  LY M  G  PF   ++  N    +H I+  
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDP 255
Query: 239 QYSI--PDYVHISPE--CRHLISRIFVADPAKRISIPEIRNHEWF-LKNLPADLVVDNTT 293
            + I  PD     PE   + ++      DP +RISIPE+  H +  ++  P + +   TT
Sbjct: 256 NHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 311

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSL 74
           + RYE V +IG G +G     RD  +   VA+K +     E G  I  +  RE+   R L
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRL 60
Query: 75  R---HPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQ 124
               HPN+VR  +V  T        + +V E+         ++    G    +  +   +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMR 119
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
           Q + G+ + H+  + HRDLK EN L+       +K+ DFG ++           V T  Y
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALFPVVVTLWY 177
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVML 213
            APEVLL+  Y   + D+WS G     M 
Sbjct: 178 RAPEVLLQSTYATPV-DMWSVGCIFAEMF 205

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 111/258 (43%), Gaps = 23/258 (8%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 32  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 89  STAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD--GKI 199
             N  L       +KI DFG +      S   Q +   G+  ++APEV+  ++ +     
Sbjct: 148 SNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC----RHL 255
           +DV++ G+ LY ++ G  P+ +     N R  I  ++      PD   +   C    + L
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNI----NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 256 ISRIFVADPAKRISIPEI 273
           ++        +R S P I
Sbjct: 262 MAECLKKKRDERPSFPRI 279

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D+   ++ R IG+G FG     RL    K +  VA+K ++ G    E  +R+ +   S+ 
Sbjct: 41  DASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVG--YTEKQRRDFLCEASIM 98
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPN+V  + V+     + IV+E+   G L  F R  + G+F+  +     + + +G
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRK-HDGQFTVIQLVGMLRGIAAG 157
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   M   HRDL   N L++ +     K+ DFG S+  V+   P++   T        
Sbjct: 158 MRYLADMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VIEDDPEAVYTTTGGKIPVR 213
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           + APE +  +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 214 WTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 251

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 29/295 (9%)
Query: 9   GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMR-DKKTEELVAVKY-------IERGDKI 60
           GP   +  +       L+  +G G+FGV R    D  + + V+V         + + + +
Sbjct: 6   GPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM 65
Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEA 119
           D+ + RE+    SL H N++R   V+LTP  + +V E A  G L +R+  + G F     
Sbjct: 66  DDFI-REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLH 172
             +  Q+  G+ Y  S +  HRDL   N LL  +    +KI DFG  ++        V+ 
Sbjct: 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQ 181
Query: 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
              K      A+ APE L  + +    +D W  GVTL+ M       ++P    N  + +
Sbjct: 182 EHRKVPF---AWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYG---QEPWIGLNGSQIL 234
Query: 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 287
           H+I      +P       +  +++ + +   P  R +   +R+  + L+  P D+
Sbjct: 235 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQPTDM 287

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 111/258 (43%), Gaps = 23/258 (8%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 32  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 89  STKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD--GKI 199
             N  L       +KI DFG +      S   Q +   G+  ++APEV+  ++ +     
Sbjct: 148 SNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC----RHL 255
           +DV++ G+ LY ++ G  P+ +     N R  I  ++      PD   +   C    + L
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNI----NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 256 ISRIFVADPAKRISIPEI 273
           ++        +R S P I
Sbjct: 262 MAECLKKKRDERPSFPRI 279

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 113/259 (43%), Gaps = 25/259 (9%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 20  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 77  STKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 135
Query: 145 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD--GK 198
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+  ++ +    
Sbjct: 136 SNNIFLHEDNT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC----RH 254
            +DV++ G+ LY ++ G  P+ +     N R  I  ++      PD   +   C    + 
Sbjct: 193 QSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 248
Query: 255 LISRIFVADPAKRISIPEI 273
           L++        +R S P I
Sbjct: 249 LMAECLKKKRDERPSFPRI 267

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           ++ R  + + IGSG+ G     RL    + +  VA+K ++ G    E  +R+ ++  S+ 
Sbjct: 47  EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIM 104
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+       IV EY   G L  F R  + G+F+  +     + + +G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAG 163
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   +   HRDL   N L+D +     K+ DFG S+  VL   P +   T        
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAXTTTGGKIPIR 219
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + APE +  + +    +DVWS GV ++ V+  G  P+
Sbjct: 220 WTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPY 255

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 132/300 (44%), Gaps = 47/300 (15%)
Query: 23  YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI---ERGDKIDENVQREI--INHRSLRH 76
           Y +++ IGSG    V +++ +KK  ++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 188
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VG   Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 189 VL----------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
            +            K      +DVWS G  LY M  G  PF   ++  N    +H I+  
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDP 283
Query: 239 QYSI--PDYVHISPE--CRHLISRIFVADPAKRISIPEIRNHEWF-LKNLPADLVVDNTT 293
            + I  PD     PE   + ++      DP +RISIPE+  H +  ++  P + +   TT
Sbjct: 284 NHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 339

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 105/241 (43%), Gaps = 21/241 (8%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 16  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 73  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLL---KKEYDGK 198
             N  L       +KI DFG +      S   Q +   G+  ++APEV+    K  Y  +
Sbjct: 132 SNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
            +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD   +   C   + R
Sbjct: 190 -SDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 259 I 259
           +
Sbjct: 245 L 245

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 107/242 (44%), Gaps = 23/242 (9%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 16  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 73  STAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131
Query: 145 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYDG 197
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+    K  Y  
Sbjct: 132 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           + +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD   +   C   + 
Sbjct: 189 Q-SDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 258 RI 259
           R+
Sbjct: 244 RL 245

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 19  DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           ++ R  + + IGSG+ G     RL    + +  VA+K ++ G    E  +R+ ++  S+ 
Sbjct: 47  EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIM 104
Query: 76  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
               HPNI+R + V+       IV EY   G L  F R  + G+F+  +     + + +G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAG 163
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           + Y   +   HRDL   N L+D +     K+ DFG S+  VL   P +   T        
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAYTTTGGKIPIR 219
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           + APE +  + +    +DVWS GV ++ V+  G  P+
Sbjct: 220 WTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPY 255

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 21/243 (8%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 36  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 93  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 151
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLL---KKEYDGK 198
             N  L       +KI DFG +      S   Q +   G+  ++APEV+    K  Y  +
Sbjct: 152 SNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
            +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD   +   C   + R
Sbjct: 210 -SDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 264
Query: 259 IFV 261
           +  
Sbjct: 265 LMA 267

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRS 73
           + RYE V +IG G +G     RD  +   VA+K +   +       +  +  RE+   R 
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 74  LR---HPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFF 123
           L    HPN+VR  +V  T        + +V E+         ++    G    +  +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 126
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
           +Q + G+ + H+  + HRDLK EN L+       +K+ DFG ++           V T  
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALTPVVVTLW 184
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
           Y APEVLL+  Y   + D+WS G     M 
Sbjct: 185 YRAPEVLLQSTYATPV-DMWSVGCIFAEMF 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 23/243 (9%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 21  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 78  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 136
Query: 145 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYDG 197
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+    K  Y  
Sbjct: 137 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           + +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD   +   C   + 
Sbjct: 194 Q-SDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 248
Query: 258 RIF 260
           R+ 
Sbjct: 249 RLM 251

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 21/243 (8%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 44  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 101 STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 159
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLL---KKEYDGK 198
             N  L       +KI DFG +      S   Q +   G+  ++APEV+    K  Y  +
Sbjct: 160 SNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
            +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD   +   C   + R
Sbjct: 218 -SDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 272
Query: 259 IFV 261
           +  
Sbjct: 273 LMA 275

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 107/244 (43%), Gaps = 23/244 (9%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 44  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 101 STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 159
Query: 145 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYDG 197
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+    K  Y  
Sbjct: 160 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           + +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD   +   C   + 
Sbjct: 217 Q-SDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 271
Query: 258 RIFV 261
           R+  
Sbjct: 272 RLMA 275

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 107/242 (44%), Gaps = 23/242 (9%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 16  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 73  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131
Query: 145 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYDG 197
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+    K  Y  
Sbjct: 132 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           + +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD   +   C   + 
Sbjct: 189 Q-SDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 258 RI 259
           R+
Sbjct: 244 RL 245

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 23/243 (9%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 21  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 78  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 136
Query: 145 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYDG 197
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+    K  Y  
Sbjct: 137 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           + +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD   +   C   + 
Sbjct: 194 Q-SDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 248
Query: 258 RIF 260
           R+ 
Sbjct: 249 RLM 251

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 107/244 (43%), Gaps = 23/244 (9%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 43  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 100 STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 158
Query: 145 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYDG 197
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+    K  Y  
Sbjct: 159 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           + +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD   +   C   + 
Sbjct: 216 Q-SDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 270
Query: 258 RIFV 261
           R+  
Sbjct: 271 RLMA 274

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 29  IGSGNFG-VARLM---RDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIV 80
           IG+G FG V + M      K E  VA+K ++ G     ++D   +  I+   S  H NI+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNII 109
Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVC 139
           R + VI     + I+ EY   G L + +    G FS  +     + + +G+ Y  +M   
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLKK 193
           HRDL   N L++ +     K+ DFG S+  VL   P++T  T        + APE +  +
Sbjct: 170 HRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPF 219
           ++    +DVWS G+ ++ VM  G  P+
Sbjct: 226 KFTSA-SDVWSFGIVMWEVMTYGERPY 251

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 23/243 (9%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
           IGSG+FG    +   K    VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 18  IGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 86  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  + HRDLK
Sbjct: 75  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 133
Query: 145 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYDG 197
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+    K  Y  
Sbjct: 134 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           + +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD   +   C   + 
Sbjct: 191 Q-SDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 245
Query: 258 RIF 260
           R+ 
Sbjct: 246 RLM 248

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 30/270 (11%)
Query: 21  DRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           D++E+ R        +G G FG       KK    VAVK ++      E   +E    + 
Sbjct: 4   DKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 63
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVS 131
           ++HPN+V+   V        I+ E+ + G L +  R CN    S     +   Q+ S + 
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 123
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
           Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    + A
Sbjct: 124 YLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTA 178
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVML---VGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
           PE L   ++  K +DVW+ GV L+ +    +  YP  DP +       ++ +L   Y + 
Sbjct: 179 PESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDPSQ-------VYELLEKDYRME 230
Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEI 273
                  +   L+   +  +P+ R S  EI
Sbjct: 231 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 108/267 (40%), Gaps = 26/267 (9%)
Query: 21  DRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           D++E+ R        +G G +G   +   KK    VAVK ++      E   +E    + 
Sbjct: 25  DKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 84
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVS 131
           ++HPN+V+   V        IV EY   G L +  R CN    +     +   Q+ S + 
Sbjct: 85  IKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAME 144
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
           Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    + A
Sbjct: 145 YLEKKNFIHRDLAARNCLVGENHV--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTA 199
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
           PE L    +  K +DVW+ GV L+ +   G  P+     P      ++ +L   Y +   
Sbjct: 200 PESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYDLLEKGYRMEQP 253
Query: 246 VHISPECRHLISRIFVADPAKRISIPE 272
               P+   L+   +   PA R S  E
Sbjct: 254 EGCPPKVYELMRACWKWSPADRPSFAE 280

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 123/278 (44%), Gaps = 29/278 (10%)
Query: 25  LVRDIGSGNFGVARLMR-DKKTEELVAVKY-------IERGDKIDENVQREIINHRSLRH 76
           L+  +G G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 70
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
            N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKSTVGTPAYIAPE 188
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 184
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
            L  + +    +D W  GVTL+ M       ++P    N  + +H+I      +P     
Sbjct: 185 SLKTRTF-SHASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 286
             +  +++ + +   P  R +   +R+  + L+  P D
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQPTD 276

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 92/325 (28%), Positives = 130/325 (40%), Gaps = 70/325 (21%)
Query: 20  SDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI--INHRSLRH 76
           S RYE+V  +G G FG V   +  K     VAVK ++  D+  E  + EI  + H +   
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTD 72
Query: 77  PN----IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 130
           PN     V+  E      H+ IV E   G   ++ I   G   F  D  R    Q+   V
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 131 SYCHSMQVCHRDLKLENTLL---DGSPA--------------PRLKICDFGYSKSSVLHS 173
           ++ HS ++ H DLK EN L    D + A              P +K+ DFG   S+    
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 174 QPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTL--YVMLVGAYPFEDPEE------ 224
           +  ST V    Y APEV+L   +  +  DVWS G  L  Y +    +P  D +E      
Sbjct: 189 EHHSTLVXXRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 225 ------PKNF------RKTIH-------------RILSVQYSIPDYVHISPECRH----- 254
                 PK+       RK  H             R +S          +S +  H     
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 255 LISRIFVADPAKRISIPEIRNHEWF 279
           LI ++   DPAKRI++ E   H +F
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 27/227 (11%)
Query: 25  LVRDIGSGNFGVARLMR-DKKTEELVAVKY-------IERGDKIDENVQREIINHRSLRH 76
           L+  +G G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 70
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
            N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKSTVGTPAYIAPE 188
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF---AWCAPE 184
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
            L  + +    +D W  GVTL+ M       ++P    N  + +H+I
Sbjct: 185 SLKTRTF-SHASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKI 227

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 30/270 (11%)
Query: 21  DRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           D++E+ R        +G G +G       KK    VAVK ++      E   +E    + 
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 63
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVS 131
           ++HPN+V+   V        I++E+ + G L +  R CN    S     +   Q+ S + 
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 123
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
           Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    + A
Sbjct: 124 YLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTA 178
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVML---VGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
           PE L   ++  K +DVW+ GV L+ +    +  YP  DP +       ++ +L   Y + 
Sbjct: 179 PESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDPSQ-------VYELLEKDYRME 230
Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEI 273
                  +   L+   +  +P+ R S  EI
Sbjct: 231 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 29  IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 81
           IG+G FG      L    K E  VA+K ++ G    E  +R+ ++  S+     HPN++ 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 82  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
            + V+   T + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 131
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 191
           HR L   N L++ +     K+ DFG S+   L         T A        + APE + 
Sbjct: 132 HRALAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
            +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 188 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 217

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 27/227 (11%)
Query: 25  LVRDIGSGNFGVARLMR-DKKTEELVAVKY-------IERGDKIDENVQREIINHRSLRH 76
           L+  +G G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 74
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
            N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKSTVGTPAYIAPE 188
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 134 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 188
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
            L  + +    +D W  GVTL+ M       ++P    N  + +H+I
Sbjct: 189 SLKTRTFS-HASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKI 231

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 31/259 (11%)
Query: 27  RDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVR 81
           R IG G+FGV      +   +     A+K + R  ++   E   RE +  R L HPN++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 82  FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVC 139
              ++L P  L  +++ Y   G+L + I +  R  +  +   F  Q+  G+ Y    +  
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEVLL 191
           HRDL   N +LD S    +K+ DFG ++        S   H   +  V    + A E L 
Sbjct: 147 HRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPV---KWTALESLQ 201
Query: 192 KKEYDGKIADVWSCGVTLYVMLV-GAYPFE--DPEEPKNFRKTIHRILSVQYSIPDYVHI 248
              +  K +DVWS GV L+ +L  GA P+   DP +  +F     R+   +Y  PD ++ 
Sbjct: 202 TYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYC-PDSLY- 258
Query: 249 SPECRHLISRIFVADPAKR 267
                 ++ + + ADPA R
Sbjct: 259 -----QVMQQCWEADPAVR 272

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 27/227 (11%)
Query: 25  LVRDIGSGNFGVARLMR-DKKTEELVAVKY-------IERGDKIDENVQREIINHRSLRH 76
           L+  +G G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 70
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
            N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKSTVGTPAYIAPE 188
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 184
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
            L  + +    +D W  GVTL+ M       ++P    N  + +H+I
Sbjct: 185 SLKTRTF-SHASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKI 227

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 19/171 (11%)
Query: 124 QQLISGVSYCHSMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
           + +++  SY H+ + +CHRD+K  N L+D +   R+K+ DFG S+  V   + K + GT 
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGESEYMV-DKKIKGSRGTY 214
Query: 183 AYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFE---------DPEEPKNFRKTI 232
            ++ PE    +  Y+G   D+WS G+ LYVM     PF          +    KN    +
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274
Query: 233 HRI-----LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
            R      L+ + S      +S E    +      +PA+RI+  +   HEW
Sbjct: 275 DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 28  DIGSGNFGVAR--LMRDKKTEELVAVKYIERG-DKID-ENVQREIINHRSLRHPNIVRFK 83
           ++G GNFG  R  + R +K +  VA+K +++G +K D E + RE      L +P IVR  
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYCHSMQVCH 140
            V      L +VME A GG L + +   G+  E           Q+  G+ Y       H
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLKKEYD 196
           RDL   N LL        KI DFG SK+      +   +S    P  + APE +  +++ 
Sbjct: 134 RDLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 197 GKIADVWSCGVTLYVML-VGAYPFEDPEEPK 226
            + +DVWS GVT++  L  G  P++  + P+
Sbjct: 192 SR-SDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 112/270 (41%), Gaps = 30/270 (11%)
Query: 21  DRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           D++E+ R        +G G +G       KK    VAVK ++      E   +E    + 
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 63
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVS 131
           ++HPN+V+   V        I+ E+ + G L +  R CN    S     +   Q+ S + 
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 123
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
           Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    + A
Sbjct: 124 YLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTFTAHAGAKFPI---KWTA 178
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVML---VGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
           PE L   ++  K +DVW+ GV L+ +    +  YP  DP +       ++ +L   Y + 
Sbjct: 179 PESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDPSQ-------VYELLEKDYRME 230
Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEI 273
                  +   L+   +  +P+ R S  EI
Sbjct: 231 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 19  DSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP 77
           + D Y+LVR +G G +  V   +     E++          K  +   + + N R    P
Sbjct: 35  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLRG--GP 92
Query: 78  NIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           NI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHS 149
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           M + HRD+K  N L+D     +L++ D+G ++      +    V +  +  PE+L+  + 
Sbjct: 150 MGIMHRDVKPHNVLIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 196 DGKIADVWSCGVTLYVMLVGAYPF 219
                D+WS G  L  M+    PF
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 110/267 (41%), Gaps = 20/267 (7%)
Query: 19  DSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
           + D++E+ R        +G G +G       KK    VAVK ++      E   +E    
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 64
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISG 129
           + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q+ S 
Sbjct: 65  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 124
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 187
           + Y       HRDL   N L+  +    +K+ DFG S+  +   ++ P        + AP
Sbjct: 125 MEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP 182
Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
           E L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   Y +    
Sbjct: 183 ESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPE 236
Query: 247 HISPECRHLISRIFVADPAKRISIPEI 273
               +   L+   +  +P+ R S  EI
Sbjct: 237 GCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 112/270 (41%), Gaps = 26/270 (9%)
Query: 19  DSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
           + D++E+ R        +G G +G       KK    VAVK ++      E   +E    
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISG 129
           + ++HPN+V+   V        I++E+ + G L +  R CN    S     +   Q+ S 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAY 184
           + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    +
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KW 178
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
            APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   Y + 
Sbjct: 179 TAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRME 232
Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEI 273
                  +   L+   +  +P+ R S  EI
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 110/267 (41%), Gaps = 20/267 (7%)
Query: 19  DSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
           + D++E+ R        +G G +G       KK    VAVK ++      E   +E    
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 65
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISG 129
           + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q+ S 
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 187
           + Y       HRDL   N L+  +    +K+ DFG S+  +   ++ P        + AP
Sbjct: 126 MEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP 183
Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
           E L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   Y +    
Sbjct: 184 ESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPE 237
Query: 247 HISPECRHLISRIFVADPAKRISIPEI 273
               +   L+   +  +P+ R S  EI
Sbjct: 238 GCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 144/318 (45%), Gaps = 50/318 (15%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK ++  D   E    ++++   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 92
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-----EA 119
           +     +H NI+           L +++EYAS G L E    R      +S D     E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           +  F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNI 210
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNF 228
               K+T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+     P   
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIP 264
Query: 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 288
            + + ++L   + +    + + E   ++   + A P++R +  ++      +++L  D +
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDL--DRI 316
Query: 289 VDNTTNNQFEEPDQPMQS 306
           +  TTN ++ +  QP++ 
Sbjct: 317 LTLTTNEEYLDLSQPLEQ 334

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 114/278 (41%), Gaps = 27/278 (9%)
Query: 11  GMDMPIMHDSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
            MD P   + D++E+ R        +G G +G       KK    VAVK ++      E 
Sbjct: 2   AMD-PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 60
Query: 64  VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF 121
             +E    + ++HPN+V+   V        I+ E+ + G L +  R CN    S     +
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 120
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPK 176
              Q+ S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAK 178
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRI 235
             +    + APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +
Sbjct: 179 FPI---KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYEL 229
Query: 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           L   Y +        +   L+   +  +P+ R S  EI
Sbjct: 230 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 122/296 (41%), Gaps = 39/296 (13%)
Query: 11  GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQRE 67
            M M   + ++ +EL + IGSG FG       +    + A+K  ++   G   ++N  RE
Sbjct: 2   AMGMKSRYTTEFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 68  IINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFF 122
           +  H  L +H ++VR+        H+ I  EY +GG L + I    R    F E E +  
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR-----------------LKICDFGY 165
             Q+  G+ Y HSM + H D+K  N  +  +  P                   KI D G+
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
                  S P+   G   ++A EVL +       AD+++  +T+ V   GA P      P
Sbjct: 181 VTRI---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-----P 231
Query: 226 KNFRKTIHRILSVQY-SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 280
           +N  +  H I   +   IP    +S E   L+  +   DP +R S   +  H   L
Sbjct: 232 RNGDQW-HEIRQGRLPRIPQV--LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 142/318 (44%), Gaps = 50/318 (15%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK ++  D   E    ++++   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 92
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-----------CNAGRFSED 117
           +     +H NI+           L +++EYAS G L E +            +  R  E+
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEE 152
Query: 118 EARF-----FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           +  F        QL  G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNI 210
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNF 228
               K+T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+     P   
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIP 264
Query: 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 288
            + + ++L   + +    + + E   ++   + A P++R +  ++      +++L  D +
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDL--DRI 316
Query: 289 VDNTTNNQFEEPDQPMQS 306
           +  TTN ++ +  QP++ 
Sbjct: 317 LTLTTNEEYLDLSQPLEQ 334

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 112/270 (41%), Gaps = 26/270 (9%)
Query: 19  DSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
           + D++E+ R        +G G +G       KK    VAVK ++      E   +E    
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISG 129
           + ++HPN+V+   V        I++E+ + G L +  R CN    S     +   Q+ S 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAY 184
           + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    +
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KW 178
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
            APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   Y + 
Sbjct: 179 TAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRME 232
Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEI 273
                  +   L+   +  +P+ R S  EI
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 82
           L   IG GNFG     R +    LVAVK        D   +  +E    +   HPNIVR 
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 83  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHS 135
             V      + IVME   GG+    +   G      AR   + L+       +G+ Y  S
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLES 231
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLK 192
               HRDL   N L+       LKI DFG S+     +++        P  + APE L  
Sbjct: 232 KCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPF 219
             Y  + +DVWS G+ L+    +GA P+
Sbjct: 290 GRYSSE-SDVWSFGILLWETFSLGASPY 316

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 111/270 (41%), Gaps = 26/270 (9%)
Query: 19  DSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
           + D++E+ R        +G G +G       KK    VAVK ++      E   +E    
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISG 129
           + ++HPN+V+   V        I+ E+ + G L +  R CN    S     +   Q+ S 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAY 184
           + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    +
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KW 178
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
            APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   Y + 
Sbjct: 179 TAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRME 232
Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEI 273
                  +   L+   +  +P+ R S  EI
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 115/261 (44%), Gaps = 52/261 (19%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------------DENVQ 65
           RY LVR +G G+F    L +D      VA+K I RGDK+                D +  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 66  RE----------IINHRSLRHPNIVRFKEV--ILTPTHLAIVMEYASGGELFERICNAGR 113
           +E          +++H + + PN V    V  +L    LA++ +Y   G     +    +
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 114 FSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAP----RLKICDFGYSKS 168
                      QL+ G+ Y H    + H D+K EN L++   +P    ++KI D G   +
Sbjct: 139 -----------QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NA 185
Query: 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228
                   +++ T  Y +PEVLL   + G  AD+WS    ++ ++ G + FE P+E  ++
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE-PDEGHSY 243
Query: 229 RKT---IHRILSVQYSIPDYV 246
            K    I +I+ +   +P Y+
Sbjct: 244 TKDDDHIAQIIELLGELPSYL 264

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 112/270 (41%), Gaps = 26/270 (9%)
Query: 19  DSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
           + D++E+ R        +G G +G       KK    VAVK ++      E   +E    
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 64
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISG 129
           + ++HPN+V+   V        I++E+ + G L +  R CN    +     +   Q+ S 
Sbjct: 65  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 124
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAY 184
           + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    +
Sbjct: 125 MEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KW 179
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
            APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   Y + 
Sbjct: 180 TAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRME 233
Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEI 273
                  +   L+   +  +P+ R S  EI
Sbjct: 234 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 26/268 (9%)
Query: 21  DRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           D++E+ R        +G G +G       KK    VAVK ++      E   +E    + 
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 65
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVS 131
           ++HPN+V+   V        I+ E+ + G L +  R CN    S     +   Q+ S + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
           Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    + A
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTA 180
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
           PE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   Y +   
Sbjct: 181 PESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERP 234
Query: 246 VHISPECRHLISRIFVADPAKRISIPEI 273
                +   L+   +  +P+ R S  EI
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 115/261 (44%), Gaps = 52/261 (19%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------------DENVQ 65
           RY LVR +G G+F    L +D      VA+K I RGDK+                D +  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 66  RE----------IINHRSLRHPNIVRFKEV--ILTPTHLAIVMEYASGGELFERICNAGR 113
           +E          +++H + + PN V    V  +L    LA++ +Y   G     +    +
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 114 FSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAP----RLKICDFGYSKS 168
                      QL+ G+ Y H    + H D+K EN L++   +P    ++KI D G   +
Sbjct: 139 -----------QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NA 185
Query: 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228
                   +++ T  Y +PEVLL   + G  AD+WS    ++ ++ G + FE P+E  ++
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE-PDEGHSY 243
Query: 229 RKT---IHRILSVQYSIPDYV 246
            K    I +I+ +   +P Y+
Sbjct: 244 TKDDDHIAQIIELLGELPSYL 264

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 112/278 (40%), Gaps = 20/278 (7%)
Query: 4   SAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
            AM   P  D   M  +D   +   +G G +G       KK    VAVK ++      E 
Sbjct: 1   GAMDPSPNYDKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 59
Query: 64  VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF 121
             +E    + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +
Sbjct: 60  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 119
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPK 176
              Q+ S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K
Sbjct: 120 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAK 177
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRI 235
             +    + APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +
Sbjct: 178 FPI---KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYEL 228
Query: 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           L   Y +        +   L+   +  +P+ R S  EI
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 113/274 (41%), Gaps = 26/274 (9%)
Query: 15  PIMHDSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
           P   + D++E+ R        +G G +G       KK    VAVK ++      E   +E
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 64
Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQ 125
               + ++HPN+V+   V        I++E+ + G L +  R CN    +     +   Q
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 124
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
           + S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  + 
Sbjct: 125 ISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI- 181
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
              + APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   
Sbjct: 182 --KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKD 233
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           Y +        +   L+   +  +P+ R S  EI
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 27/278 (9%)
Query: 11  GMDMPIMHDSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
            MD P   + D++E+ R        +G G +G       KK    VAVK ++      E 
Sbjct: 2   AMD-PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 60
Query: 64  VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF 121
             +E    + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 120
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPK 176
              Q+ S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAK 178
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRI 235
             +    + APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +
Sbjct: 179 FPI---KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYEL 229
Query: 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           L   Y +        +   L+   +  +P+ R S  EI
Sbjct: 230 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 119/275 (43%), Gaps = 43/275 (15%)
Query: 29  IGSGNFG--VARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRF-- 82
           +G G  G  V R M D +    VAVK I  E     D  VQ   +   S  HPN++R+  
Sbjct: 32  LGHGAEGTIVYRGMFDNRD---VAVKRILPECFSFADREVQ---LLRESDEHPNVIRYFC 85
Query: 83  KEVILTPTHLAIVMEYASGGELFER--ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
            E      ++AI +  A+  E  E+    + G     E     QQ  SG+++ HS+ + H
Sbjct: 86  TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL----EPITLLQQTTSGLAHLHSLNIVH 141
Query: 141 RDLKLENTLLDGSPAP---RLKICDFGYSKSSVL----HSQPKSTVGTPAYIAPEVLLK- 192
           RDLK  N L+    A    +  I DFG  K   +     S+     GT  +IAPE+L + 
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 193 -KEYDGKIADVWSCG-VTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            KE      D++S G V  YV+  G++PF          K++ R  ++         + P
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPFG---------KSLQRQANILLGACSLDCLHP 252
Query: 251 E------CRHLISRIFVADPAKRISIPEIRNHEWF 279
           E       R LI ++   DP KR S   +  H +F
Sbjct: 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 112/274 (40%), Gaps = 26/274 (9%)
Query: 15  PIMHDSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
           P   + D++E+ R        +G G +G       KK    VAVK ++      E   +E
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 64
Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQ 125
               + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 124
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
           + S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  + 
Sbjct: 125 ISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI- 181
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
              + APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   
Sbjct: 182 --KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKD 233
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           Y +        +   L+   +  +P+ R S  EI
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 113/278 (40%), Gaps = 38/278 (13%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSL-RHPNIVRFKE 84
           IGSG FG       +    + A+K  ++   G   ++N  RE+  H  L +H ++VR+  
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 74
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCH 140
                 H+ I  EY +GG L + I    R    F E E +    Q+  G+ Y HSM + H
Sbjct: 75  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVH 134
Query: 141 RDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSVLHSQPKSTVGTPA 183
            D+K  N  +  +  P                   KI D G+       S P+   G   
Sbjct: 135 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSPQVEEGDSR 191
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI 242
           ++A EVL +       AD+++  +T+ V   GA P      P+N  +  H I   +   I
Sbjct: 192 FLANEVLQENYTHLPKADIFALALTV-VXAAGAEPL-----PRNGDQW-HEIRQGRLPRI 244
Query: 243 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 280
           P    +S E   L+  +   DP +R S   +  H   L
Sbjct: 245 PQV--LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 280

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 112/274 (40%), Gaps = 26/274 (9%)
Query: 15  PIMHDSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
           P   + D++E+ R        +G G +G       KK    VAVK ++      E   +E
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 64
Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQ 125
               + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 124
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
           + S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  + 
Sbjct: 125 ISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI- 181
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
              + APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   
Sbjct: 182 --KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKD 233
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           Y +        +   L+   +  +P+ R S  EI
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 85/208 (40%), Gaps = 22/208 (10%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 82
           L   IG GNFG     R +    LVAVK        D   +  +E    +   HPNIVR 
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 83  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHS 135
             V      + IVME   GG+    +   G      AR   + L+       +G+ Y  S
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLES 231
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLK 192
               HRDL   N L+       LKI DFG S+     + +        P  + APE L  
Sbjct: 232 KCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNY 289
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPF 219
             Y  + +DVWS G+ L+    +GA P+
Sbjct: 290 GRYSSE-SDVWSFGILLWETFSLGASPY 316

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 122/294 (41%), Gaps = 39/294 (13%)
Query: 13  DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREII 69
           +M   + ++ +EL + IGSG FG       +    + A+K  ++   G   ++N  RE+ 
Sbjct: 2   EMKSRYTTEFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 60
Query: 70  NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQ 124
            H  L +H ++VR+        H+ I  EY +GG L + I    R    F E E +    
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 120
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR-----------------LKICDFGYSK 167
           Q+  G+ Y HSM + H D+K  N  +  +  P                   KI D G+  
Sbjct: 121 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 180
Query: 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
                S P+   G   ++A EVL +       AD+++  +T+ V   GA P      P+N
Sbjct: 181 RI---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-----PRN 231
Query: 228 FRKTIHRILSVQY-SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 280
             +  H I   +   IP    +S E   L+  +   DP +R S   +  H   L
Sbjct: 232 GDQW-HEIRQGRLPRIPQV--LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 20/274 (7%)
Query: 8   VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
           V P  D   M  +D   +   +G G +G       KK    VAVK ++      E   +E
Sbjct: 1   VSPNYDKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 59
Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQ 125
               + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 119
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
           + S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  + 
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI- 176
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
              + APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   
Sbjct: 177 --KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKD 228
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           Y +        +   L+   +  +P+ R S  EI
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 28  DIGSGNFGVAR--LMRDKKTEELVAVKYIERG-DKID-ENVQREIINHRSLRHPNIVRFK 83
           ++G GNFG  R  + R +K +  VA+K +++G +K D E + RE      L +P IVR  
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 84  EVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYCHSMQVCH 140
            V      L +VME A GG L + +   G+  E           Q+  G+ Y       H
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLKKEYD 196
           R+L   N LL        KI DFG SK+      +   +S    P  + APE +  +++ 
Sbjct: 460 RNLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 197 GKIADVWSCGVTLYVML-VGAYPFEDPEEPK 226
            + +DVWS GVT++  L  G  P++  + P+
Sbjct: 518 SR-SDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 77  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           SM + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 77  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           SM + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 77  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           SM + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 20/274 (7%)
Query: 8   VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
           V P  D   M  +D   +   +G G +G       KK    VAVK ++      E   +E
Sbjct: 1   VSPNYDKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 59
Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQ 125
               + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 119
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
           + S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  + 
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI- 176
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
              + APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   
Sbjct: 177 --KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKD 228
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           Y +        +   L+   +  +P+ R S  EI
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 77  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           SM + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 96/204 (47%), Gaps = 9/204 (4%)
Query: 19  DSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP 77
           + D Y+LVR +G G +  V   +     E++V         K  +   + + N R    P
Sbjct: 35  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG--GP 92
Query: 78  NIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           NI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHS 149
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  + 
Sbjct: 150 MGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 196 DGKIADVWSCGVTLYVMLVGAYPF 219
                D+WS G  L  M+    PF
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 77  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           SM + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 77  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           SM + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
                 D+WS G  L  M+    PF
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 77  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           SM + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 111/270 (41%), Gaps = 26/270 (9%)
Query: 19  DSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
           + D++E+ R        +G G +G       KK    VAVK ++      E   +E    
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 76
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISG 129
           + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q+ S 
Sbjct: 77  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAY 184
           + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    +
Sbjct: 137 MEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KW 191
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
            APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   Y + 
Sbjct: 192 TAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRME 245
Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEI 273
                  +   L+   +  +P+ R S  EI
Sbjct: 246 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 77  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 146
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           SM + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
                 D+WS G  L  M+    PF
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 77  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           SM + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
                 D+WS G  L  M+    PF
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/301 (21%), Positives = 126/301 (41%), Gaps = 41/301 (13%)
Query: 14  MPIMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
           +P   + D Y+LVR +G G +  V   +     E +V         K  +   + + N R
Sbjct: 31  VPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLR 90
Query: 73  SLRHPNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
                NI++  + +  P     A+V EY +  + F+++      ++ + RF+  +L+  +
Sbjct: 91  G--GTNIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKAL 145
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            YCHS  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L
Sbjct: 146 DYCHSKGIMHRDVKPHNVMIDHQ-QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL 204
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF---ED-------------PEEPKNFRKTIHR 234
           +  +      D+WS G  L  M+    PF   +D              EE   + K  H 
Sbjct: 205 VDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI 264
Query: 235 ILSVQYS----------IPDYVH------ISPECRHLISRIFVADPAKRISIPEIRNHEW 278
            L   ++            +++H      +SPE   L+ ++   D  +R++  E   H +
Sbjct: 265 DLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 324
Query: 279 F 279
           F
Sbjct: 325 F 325

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 110/268 (41%), Gaps = 26/268 (9%)
Query: 21  DRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           D++E+ R        +G G +G       KK    VAVK ++      E   +E    + 
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 67
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVS 131
           ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q+ S + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
           Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    + A
Sbjct: 128 YLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTA 182
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
           PE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   Y +   
Sbjct: 183 PESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERP 236
Query: 246 VHISPECRHLISRIFVADPAKRISIPEI 273
                +   L+   +  +P+ R S  EI
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 77  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 153
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           SM + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +
Sbjct: 154 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
                 D+WS G  L  M+    PF
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 77  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           SM + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 20/274 (7%)
Query: 8   VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
           V P  D   M  +D   +   +G G +G       KK    VAVK ++      E   +E
Sbjct: 208 VSPNYDKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 266
Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQ 125
               + ++HPN+V+   V        I+ E+ + G L +  R CN    S     +   Q
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 326
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
           + S + Y       HR+L   N L+  +    +K+ DFG S+     +   H+  K  + 
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI- 383
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
              + APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   
Sbjct: 384 --KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKD 435
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           Y +        +   L+   +  +P+ R S  EI
Sbjct: 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 113/278 (40%), Gaps = 38/278 (13%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSL-RHPNIVRFKE 84
           IGSG FG       +    + A+K  ++   G   ++N  RE+  H  L +H ++VR+  
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 76
Query: 85  VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCH 140
                 H+ I  EY +GG L + I    R    F E E +    Q+  G+ Y HSM + H
Sbjct: 77  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVH 136
Query: 141 RDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSVLHSQPKSTVGTPA 183
            D+K  N  +  +  P                   KI D G+       S P+   G   
Sbjct: 137 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSPQVEEGDSR 193
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI 242
           ++A EVL +       AD+++  +T+ V   GA P      P+N  +  H I   +   I
Sbjct: 194 FLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-----PRNGDQW-HEIRQGRLPRI 246
Query: 243 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 280
           P    +S E   L+  +   DP +R S   +  H   L
Sbjct: 247 PQV--LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFK 83
           +G G FGV  + +       VAVK +        +++ +   +EI      +H N+V   
Sbjct: 39  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 84  EVILTPTHLAIVMEYASGGELFERI-CNAGR--FSEDEARFFFQQLISGVSYCHSMQVCH 140
                   L +V  Y   G L +R+ C  G    S        Q   +G+++ H     H
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDG 197
           RD+K  N LLD   A   KI DFG +++S   +Q       VGT AY+APE  L+ E   
Sbjct: 157 RDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEA-LRGEITP 213
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
           K +D++S GV L  ++ G    ++  EP+
Sbjct: 214 K-SDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 111/270 (41%), Gaps = 26/270 (9%)
Query: 19  DSDRYELVR-------DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
           + D++E+ R        +G G +G       KK    VAVK ++      E   +E    
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 65
Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISG 129
           + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q+ S 
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAY 184
           + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    +
Sbjct: 126 MEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KW 180
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
            APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   Y + 
Sbjct: 181 TAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRME 234
Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEI 273
                  +   L+   +  +P+ R S  EI
Sbjct: 235 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 77  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLRQT--LTDYDIRFYMYEILKALDYCH 148
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           SM + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/301 (21%), Positives = 126/301 (41%), Gaps = 41/301 (13%)
Query: 14  MPIMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
           +P   + D Y+LVR +G G +  V   +     E +V         K  +   + + N R
Sbjct: 36  VPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLR 95
Query: 73  SLRHPNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
                NI++  + +  P     A+V EY +  + F+++      ++ + RF+  +L+  +
Sbjct: 96  G--GTNIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKAL 150
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            YCHS  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L
Sbjct: 151 DYCHSKGIMHRDVKPHNVMIDHQ-QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL 209
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF---ED-------------PEEPKNFRKTIHR 234
           +  +      D+WS G  L  M+    PF   +D              EE   + K  H 
Sbjct: 210 VDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI 269
Query: 235 ILSVQYS----------IPDYVH------ISPECRHLISRIFVADPAKRISIPEIRNHEW 278
            L   ++            +++H      +SPE   L+ ++   D  +R++  E   H +
Sbjct: 270 DLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 329
Query: 279 F 279
           F
Sbjct: 330 F 330

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 117/273 (42%), Gaps = 21/273 (7%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSL 74
           +D  E + ++G G +GV    R   + ++ AVK I     ++   Q+ +     I+ R++
Sbjct: 33  ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRA--TVNSQEQKRLLXDLDISXRTV 90
Query: 75  RHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGR-FSEDEARFFFQQLISGVS 131
             P  V F   +     + I  E    S  + ++++ + G+   ED        ++  + 
Sbjct: 91  DCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 150
Query: 132 YCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE-- 188
           + HS + V HRD+K  N L++     ++K CDFG S   V         G   Y APE  
Sbjct: 151 HLHSKLSVIHRDVKPSNVLINA--LGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERI 208
Query: 189 --VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
              L +K Y  K +D+WS G+T   + +  +P++    P    K +    S Q     + 
Sbjct: 209 NPELNQKGYSVK-SDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF- 266
Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
             S E     S+    +  +R + PE+  H +F
Sbjct: 267 --SAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFK 83
           +G G FGV  + +       VAVK +        +++ +   +EI      +H N+V   
Sbjct: 39  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 84  EVILTPTHLAIVMEYASGGELFERI-CNAGR--FSEDEARFFFQQLISGVSYCHSMQVCH 140
                   L +V  Y   G L +R+ C  G    S        Q   +G+++ H     H
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDG 197
           RD+K  N LLD   A   KI DFG +++S   +Q       VGT AY+APE  L+ E   
Sbjct: 157 RDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEA-LRGEITP 213
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
           K +D++S GV L  ++ G    ++  EP+
Sbjct: 214 K-SDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFK 83
           +G G FGV  + +       VAVK +        +++ +   +EI      +H N+V   
Sbjct: 33  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 84  EVILTPTHLAIVMEYASGGELFERI-CNAGR--FSEDEARFFFQQLISGVSYCHSMQVCH 140
                   L +V  Y   G L +R+ C  G    S        Q   +G+++ H     H
Sbjct: 91  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 150
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 197
           RD+K  N LLD   A   KI DFG +++S   +Q       VGT AY+APE  L+ E   
Sbjct: 151 RDIKSANILLD--EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEA-LRGEITP 207
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
           K +D++S GV L  ++ G    ++  EP+
Sbjct: 208 K-SDIYSFGVVLLEIITGLPAVDEHREPQ 235

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 92/206 (44%), Gaps = 30/206 (14%)
Query: 29  IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF--- 82
           IGSG FG    A+   D KT  +  VKY       +E  +RE+     L H NIV +   
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKALAKLDHVNIVHYNGC 72
Query: 83  ------------KEVILTPTH-LAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLI 127
                       K    + T  L I ME+   G L + I      +  +  A   F+Q+ 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
            GV Y HS ++ +RDLK  N  L      ++KI DFG   S     +   + GT  Y++P
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSP 190
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVML 213
           E +  ++Y GK  D+++ G+ L  +L
Sbjct: 191 EQISSQDY-GKEVDLYALGLILAELL 215

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 25  LVRDIGSGNFGVARL-----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 78
           L R++G G FG   L     +  ++ + LVAVK + +  D   ++  RE     +L+H +
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQ 125
           IV+F  V +    L +V EY   G+L + +   G               ++ +     QQ
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 182
           + +G+ Y  S    HRDL   N L+  +    +KI DFG S+   S+  +     T+   
Sbjct: 137 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
            ++ PE ++ +++  + +DVWS GV L+ +   G  P+
Sbjct: 195 RWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 231

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 17/208 (8%)
Query: 30  GSGNFGVARLMRDKKTEELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFKE 84
           G G FGV  + +       VAVK +        +++ +   +EI      +H N+V    
Sbjct: 31  GEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 85  VILTPTHLAIVMEYASGGELFERI-CNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHR 141
                  L +V  Y   G L +R+ C  G    S        Q   +G+++ H     HR
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGK 198
           D+K  N LLD   A   KI DFG +++S   +Q       VGT AY APE  L+ E   K
Sbjct: 149 DIKSANILLD--EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEA-LRGEITPK 205
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPK 226
            +D++S GV L  ++ G    ++  EP+
Sbjct: 206 -SDIYSFGVVLLEIITGLPAVDEHREPQ 232

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK + + D  +E++   +     
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEEDLSDLVSEMEM 93
Query: 74  LR----HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-----EAR 120
           ++    H NI+           L +++EYAS G L E    R      +S D     E +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 121 FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLH 172
             F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + + 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNID 211
Query: 173 SQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
              K+T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 20/274 (7%)
Query: 8   VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
           V P  D   M  +D   +   +G G +G       KK    VAVK ++      E   +E
Sbjct: 247 VSPNYDKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 305
Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQ 125
               + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 365
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
           + S + Y       HR+L   N L+  +    +K+ DFG S+     +   H+  K  + 
Sbjct: 366 ISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI- 422
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
              + APE L   ++  K +DVW+ GV L+ +   G  P+     P      ++ +L   
Sbjct: 423 --KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKD 474
Query: 240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
           Y +        +   L+   +  +P+ R S  EI
Sbjct: 475 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK ++  D   E    ++++   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 92
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-----EA 119
           +     +H NI+           L +++EYAS G L E    R      +S D     E 
Sbjct: 93  MMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           +  F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNI 210
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               K+T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 110/256 (42%), Gaps = 52/256 (20%)
Query: 11  GMDMPIMHDSDRYELVRD---------------IGSGNFGVARLM------RDKKTEEL- 48
            MD P++     YEL  D               +G G FG   +       +DK  E + 
Sbjct: 2   AMDTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVT 61
Query: 49  VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGE 103
           VAVK ++  D   E    ++++   +     +H NI+           L +++EYAS G 
Sbjct: 62  VAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 119
Query: 104 LFE----RICNAGRFSED-----EARFFFQQLIS-------GVSYCHSMQVCHRDLKLEN 147
           L E    R      +S D     E +  F+ L+S       G+ Y  S +  HRDL   N
Sbjct: 120 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 179
Query: 148 TLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWS 204
            L+  +    +KI DFG ++  + +    K+T G     ++APE L  + Y  + +DVWS
Sbjct: 180 VLVTENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWS 236
Query: 205 CGVTLY-VMLVGAYPF 219
            GV ++ +  +G  P+
Sbjct: 237 FGVLMWEIFTLGGSPY 252

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 16/226 (7%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV+ +G+G FG    M        VAVK ++ G    +    E    ++L+H  +VR  
Sbjct: 16  KLVKRLGAGQFGEV-WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 74
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+     + I+ EY + G L  F +    G+    +   F  Q+  G++Y       HR
Sbjct: 75  AVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 134
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
           DL+  N L+  S +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 135 DLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 199 IADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
            +DVWS G+ LY ++  G  P+     P      +   LS  Y +P
Sbjct: 192 -SDVWSFGILLYEIVTYGKIPY-----PGRTNADVMTALSQGYRMP 231

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK ++  D   E    ++++   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 92
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-----EA 119
           +     +H NI+           L +++EYAS G L E    R      +S D     E 
Sbjct: 93  MMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           +  F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNI 210
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               K+T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK ++  D   E    ++++   
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 138
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-----EA 119
           +     +H NI+           L +++EYAS G L E    R      +S D     E 
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           +  F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNI 256
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               K+T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK ++  D   E    ++++   
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 79
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-----EA 119
           +     +H NI+           L +++EYAS G L E    R      +S D     E 
Sbjct: 80  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 139
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           +  F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +
Sbjct: 140 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNV--MKIADFGLARDINNI 197
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               K+T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 198 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 247

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK ++  D   E    ++++   
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 81
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-----EA 119
           +     +H NI+           L +++EYAS G L E    R      +S D     E 
Sbjct: 82  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 141
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           +  F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +
Sbjct: 142 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNI 199
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               K+T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 200 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 249

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 38/237 (16%)
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--------FFQQLI 127
           HPN++R+     T   L I +E  +     + +  +   S++  +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 128 SGVSYCHSMQVCHRDLKLENTLLD-----------GSPAPRLKICDFGYSKS-----SVL 171
           SGV++ HS+++ HRDLK +N L+            G+   R+ I DFG  K      S  
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 172 HSQPKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE 224
            +   +  GT  + APE+L +      K    +  D++S G   Y +L  G +PF D   
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 225 PKNFRKTIHRILSVQ--YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            ++    I  I S+     + D   I+ E   LIS++   DP KR +  ++  H  F
Sbjct: 246 RES--NIIRGIFSLDEMKCLHDRSLIA-EATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 37/231 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK ++  D   E    ++++   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 92
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-----EA 119
           +     +H NI+           L +++EYAS G L E    R      +S D     E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSV 170
           +  F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  +++
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNI 210
Query: 171 LHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
            + +  +    P  ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 211 DYYKNTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 36/227 (15%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIV 80
           +E ++ +G G FGV    ++K  +   A+K I   ++    E V RE+     L HP IV
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 81  RFKEVILTPT------------HLAIVMEYASGGELFERICNAGRFSEDEARF---FFQQ 125
           R+    L               +L I M+      L + +       E E       F Q
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY--------SKSSVLHSQP-- 175
           +   V + HS  + HRDLK  N          +K+ DFG          + +VL   P  
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 176 ---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
                 VGT  Y++PE +    Y  K+ D++S G+ L+ +L   YPF
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKV-DIFSLGLILFELL---YPF 227

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK ++  D   E    ++++   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 92
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-----EA 119
           +     +H NI+           L +++EYAS G L E    R      +S D     E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           +  F+ L+S       G+ Y  S +  HRDL   N L+  +    ++I DFG ++  + +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MRIADFGLARDINNI 210
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               K+T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 92/219 (42%), Gaps = 43/219 (19%)
Query: 29  IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF--- 82
           IGSG FG    A+   D KT  +  VKY       +E  +RE+     L H NIV +   
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYN------NEKAEREVKALAKLDHVNIVHYNGC 73
Query: 83  -------------------------KEVILTPTH-LAIVMEYASGGELFERICN--AGRF 114
                                    K    + T  L I ME+   G L + I      + 
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
            +  A   F+Q+  GV Y HS ++ HRDLK  N  L      ++KI DFG   S     +
Sbjct: 134 DKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDGK 191
Query: 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
              + GT  Y++PE +  ++Y GK  D+++ G+ L  +L
Sbjct: 192 RTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELL 229

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 34/233 (14%)
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--------FFQQLI 127
           HPN++R+     T   L I +E  +     + +  +   S++  +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 128 SGVSYCHSMQVCHRDLKLENTLLD-----------GSPAPRLKICDFGYSKS-----SVL 171
           SGV++ HS+++ HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 172 HSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228
                +  GT  + APE+L +  K    +  D++S G   Y +L  G +PF D    ++ 
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 262
Query: 229 RKTIHRILSVQ--YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
              I  I S+     + D   I+ E   LIS++   DP KR +  ++  H  F
Sbjct: 263 -NIIRGIFSLDEMKCLHDRSLIA-EATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 27/280 (9%)
Query: 10  PGMD--MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENV 64
           PG D   P       ++ +  +G G++G    +R K+   L AVK      RG K     
Sbjct: 44  PGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARK 103
Query: 65  QREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF-- 121
             E+ +H  + +HP  VR ++       L +  E    G   ++ C A   S  EA+   
Sbjct: 104 LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC--GPSLQQHCEAWGASLPEAQVWG 161
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
           + +  +  +++ HS  + H D+K  N  L   P  R K+ DFG           +   G 
Sbjct: 162 YLRDTLLALAHLHSQGLVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTAGAGEVQEGD 219
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
           P Y+APE LL+  Y G  ADV+S G+T+  +   A   E P   + +++     L  +++
Sbjct: 220 PRYMAPE-LLQGSY-GTAADVFSLGLTILEV---ACNMELPHGGEGWQQLRQGYLPPEFT 274
Query: 242 IPDYVHISPECRHLISRIFVADPAKR------ISIPEIRN 275
                 +S E R ++  +   DP  R      +++P +R 
Sbjct: 275 ----AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 34/233 (14%)
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--------FFQQLI 127
           HPN++R+     T   L I +E  +     + +  +   S++  +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 128 SGVSYCHSMQVCHRDLKLENTLLD-----------GSPAPRLKICDFGYSKS-----SVL 171
           SGV++ HS+++ HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 172 HSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228
                +  GT  + APE+L +  K    +  D++S G   Y +L  G +PF D    ++ 
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 262
Query: 229 RKTIHRILSVQ--YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
              I  I S+     + D   I+ E   LIS++   DP KR +  ++  H  F
Sbjct: 263 -NIIRGIFSLDEMKCLHDRSLIA-EATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 20  SDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRS 73
            +RYE+V  +G G FG V + +  ++    VA+K I+  +K  E  + EI     IN + 
Sbjct: 32  QERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKD 91
Query: 74  LRHPNI-VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS 131
             + N+ V+  +      H+ I  E        F +  N   +   + R    QL   V 
Sbjct: 92  PDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVK 151
Query: 132 YCHSMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQ 174
           + H  ++ H DLK EN L   S                  +  +++ DFG   ++  H  
Sbjct: 152 FLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG--SATFDHEH 209
Query: 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
             + V T  Y APEV+L+  +  +  DVWS G  ++   VG   F+
Sbjct: 210 HSTIVSTRHYRAPEVILELGW-SQPCDVWSIGCIIFEYYVGFTLFQ 254

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 38/236 (16%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRS 73
           ++ + ++R +G G FG   L +    ++  AVK +       R  KI+ ++ ++I  +  
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKI-QNDD 92
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVS 131
           + + NIV++    +   H+ ++ E   G  L+E I   N   F  ++ + +  +++  ++
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 132 YCHSMQVCHRDLKLENTLLDG-----------------------SPAPRLKICDFGYSK- 167
           Y   M + H DLK EN LLD                        + +  +K+ DFG +  
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223
            S  H    S + T  Y APEV+L   +D   +D+WS G  L  +  G+  F   E
Sbjct: 212 KSDYHG---SIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHE 263

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 37/231 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK ++  D   E    ++++   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 92
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-----EA 119
           +     +H NI+           L +++ YAS G L E    R      +S D     E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           +  F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNI 210
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               K+T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 16/226 (7%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV+ +G+G FG   +     + + VAVK ++ G    +    E    ++L+H  +VR  
Sbjct: 15  KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 73
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+     + I+ E+ + G L  F +    G+    +   F  Q+  G++Y       HR
Sbjct: 74  AVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 133
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
           DL+  N L+  S +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 134 DLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 199 IADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
            ++VWS G+ LY ++  G  P+     P      +   LS  Y +P
Sbjct: 191 -SNVWSFGILLYEIVTYGKIPY-----PGRTNADVMSALSQGYRMP 230

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 26  VRDIGSGNFGVAR---LMRDKKTEEL-VAVKYIERGD--KIDENVQREIINHRSLRHPNI 79
           V+ +GSG FG       + D +  ++ VA+K +      K ++ +  E      +  P +
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
            R   + LT T + +V +    G L + +  N GR    +   +  Q+  G+SY   +++
Sbjct: 82  SRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRL 140
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLKKEY 195
            HRDL   N L+  SP   +KI DFG ++   +        G      ++A E +L++ +
Sbjct: 141 VHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFE 220
             + +DVWS GVT++ +M  GA P++
Sbjct: 199 THQ-SDVWSYGVTVWELMTFGAKPYD 223

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 37/231 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
           D+  L + +G G FG   +       +DK  E + VAVK ++  D   E    ++++   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 92
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-----EA 119
           +     +H NI+           L +++ YAS G L E    R      +S D     E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           +  F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNI 210
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               K+T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 78/339 (23%), Positives = 127/339 (37%), Gaps = 68/339 (20%)
Query: 20  SDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
            +RYE+V ++G G FG V   +   + +  VA+K I    K  E  + EI   + ++  +
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKD 77
Query: 79  IV-RFKEVILTPT-----HLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGV 130
              +F  V+++       H+ I  E   G   FE +   N   +     R    QL   +
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRL-----------------KICDFGYSKSSVLHS 173
            + H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H 
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHE 194
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF----- 228
              + V T  Y  PEV+L+  +  +  DVWS G  L+    G   F+  E  ++      
Sbjct: 195 HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253
Query: 229 ------RKTIHRILSVQY----------SIPDYVHISPECR-----------------HL 255
                    IHR    +Y          +  D  ++   C+                  L
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313
Query: 256 ISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTN 294
           + R+   DPA+RI++ E   H +F    P +     + N
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 101/237 (42%), Gaps = 38/237 (16%)
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--------FFQQLI 127
           HPN++R+     T   L I +E  +     + +  +   S++  +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 128 SGVSYCHSMQVCHRDLKLENTLLD-----------GSPAPRLKICDFGYSKS-----SVL 171
           SGV++ HS+++ HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 172 HSQPKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE 224
                +  GT  + APE+L +      K    +  D++S G   Y +L  G +PF D   
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 225 PKNFRKTIHRILSVQ--YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
            ++    I  I S+     + D   I+ E   LIS++   DP KR +  ++  H  F
Sbjct: 246 RES--NIIRGIFSLDEMKCLHDRSLIA-EATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/330 (23%), Positives = 125/330 (37%), Gaps = 68/330 (20%)
Query: 21  DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           +RYE+V ++G G FG V   +   + +  VA+K I    K  E  + EI   + ++  + 
Sbjct: 51  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 110
Query: 80  V-RFKEVILTPT-----HLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVS 131
             +F  V+++       H+ I  E   G   FE +   N   +     R    QL   + 
Sbjct: 111 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 169
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRL-----------------KICDFGYSKSSVLHSQ 174
           + H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H  
Sbjct: 170 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEH 227
Query: 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF------ 228
             + V T  Y  PEV+L+  +  +  DVWS G  L+    G   F+  E  ++       
Sbjct: 228 HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 286
Query: 229 -----RKTIHRILSVQY----------SIPDYVHISPECR-----------------HLI 256
                   IHR    +Y          +  D  ++   C+                  L+
Sbjct: 287 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 346
Query: 257 SRIFVADPAKRISIPEIRNHEWFLKNLPAD 286
            R+   DPA+RI++ E   H +F    P +
Sbjct: 347 RRMLEFDPAQRITLAEALLHPFFAGLTPEE 376

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/331 (23%), Positives = 125/331 (37%), Gaps = 68/331 (20%)
Query: 20  SDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
            +RYE+V ++G G FG V   +   + +  VA+K I    K  E  + EI   + ++  +
Sbjct: 27  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKD 86
Query: 79  IV-RFKEVILTPT-----HLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGV 130
              +F  V+++       H+ I  E   G   FE +   N   +     R    QL   +
Sbjct: 87  KENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 145
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRL-----------------KICDFGYSKSSVLHS 173
            + H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H 
Sbjct: 146 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHE 203
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF----- 228
              + V T  Y  PEV+L+  +  +  DVWS G  L+    G   F+  E  ++      
Sbjct: 204 HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 262
Query: 229 ------RKTIHRILSVQY----------SIPDYVHISPECR-----------------HL 255
                    IHR    +Y          +  D  ++   C+                  L
Sbjct: 263 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 322
Query: 256 ISRIFVADPAKRISIPEIRNHEWFLKNLPAD 286
           + R+   DPA+RI++ E   H +F    P +
Sbjct: 323 MRRMLEFDPAQRITLAEALLHPFFAGLTPEE 353

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 25  LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
           L R++G G FG   L     +   K + LVAVK ++       ++ QRE     +L+H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 79  IVRFKEVILTPTHLAIVMEYASGGEL--FERICN--------------AGRFSEDEARFF 122
           IV+F  V      L +V EY   G+L  F R                  G     +    
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTV 179
             Q+ SG+ Y  S    HRDL   N L+  +    +KI DFG S+   S+  +     T+
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               ++ PE ++ +++  + +DVWS GV L+ +   G  P+
Sbjct: 197 LPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 236

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 37/221 (16%)
Query: 24  ELVRDIGSGNFGVARLMRDK-----KTEELVAVKYI--ERGDKIDENVQREIINHRSLRH 76
           E VRDIG G FG     R       +   +VAVK +  E    +  + QRE        +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFE----------------------RICNAG-- 112
           PNIV+   V      + ++ EY + G+L E                      R+ + G  
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--SV 170
             S  E     +Q+ +G++Y    +  HRDL   N L+  +    +KI DFG S++  S 
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSA 227
Query: 171 LHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY 210
            + +       P  ++ PE +    Y  + +DVW+ GV L+
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 267

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 114/259 (44%), Gaps = 29/259 (11%)
Query: 24  ELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
           +L + +G+G FG V     +K T+  VAVK ++ G    E    E    ++L+H  +V+ 
Sbjct: 185 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 242
Query: 83  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQVCH 140
             V+ T   + I+ E+ + G L + + +     +   +   F  Q+  G+++       H
Sbjct: 243 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 301
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDG 197
           RDL+  N L+  S     KI DFG ++           VG      + APE +    +  
Sbjct: 302 RDLRAANILVSASLV--CKIADFGLAR-----------VGAKFPIKWTAPEAINFGSFTI 348
Query: 198 KIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           K +DVWS G+ L  ++  G  P+     P+     + R L   Y +P   +   E  +++
Sbjct: 349 K-SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELYNIM 402
Query: 257 SRIFVADPAKRISIPEIRN 275
            R +   P +R +   I++
Sbjct: 403 MRCWKNRPEERPTFEYIQS 421

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 24/244 (9%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLKKEYD 196
           DL   N +LD      +K+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 157 DLAARNCMLDEKFT--VKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFT 214
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHISP 250
            K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       +  
Sbjct: 215 TK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVML 270
Query: 251 ECRH 254
           +C H
Sbjct: 271 KCWH 274

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKI 60
           D  A+TV  G       + D YE+VR +G G +  V   +     E+ +         K 
Sbjct: 19  DYEALTVQWG-------EQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK 71
Query: 61  DENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFS 115
            +   + + N   +  PNIV+  +++      TP+   ++ EY +  + F+ +      +
Sbjct: 72  IKREIKILQN--LMGGPNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LT 123
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175
           + + R++  +L+  + YCHS  + HRD+K  N ++D     +L++ D+G ++      + 
Sbjct: 124 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEY 182
Query: 176 KSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPF 219
              V +  +  PE+L+  ++YD  + D+WS G     M+    PF
Sbjct: 183 NVRVASRYFKGPELLVDLQDYDYSL-DMWSLGCMFAGMIFRKEPF 226

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 36/234 (15%)
Query: 5   AMTVGPGMDMPIMHD---SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
           + T G G  +P +     + +  L+  +G G +G   + R     E VAVK     D+  
Sbjct: 18  SCTSGSGSGLPFLVQRTVARQITLLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKS 75
Query: 62  ENVQREIINHRSLRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSED 117
              + E+ N   LRH NI+ F    +T  H    L ++  Y   G L++ +      +  
Sbjct: 76  WFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS 135
Query: 118 EARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
             R     + SG+++ H           + HRDLK +N L+  +   +  I D G    +
Sbjct: 136 CLRIVL-SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN--GQCCIADLGL---A 189
Query: 170 VLHSQPKST--------VGTPAYIAPEVLLKK----EYDG-KIADVWSCGVTLY 210
           V+HSQ  +         VGT  Y+APEVL +      +D  K  D+W+ G+ L+
Sbjct: 190 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 243

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 24/244 (9%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 175
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLKKEYD 196
           DL   N +LD      +K+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 176 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 233
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHISP 250
            K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       +  
Sbjct: 234 TK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVML 289
Query: 251 ECRH 254
           +C H
Sbjct: 290 KCWH 293

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 24/244 (9%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLKKEYD 196
           DL   N +LD      +K+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 215
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHISP 250
            K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       +  
Sbjct: 216 TK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVML 271
Query: 251 ECRH 254
           +C H
Sbjct: 272 KCWH 275

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 24/244 (9%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 176
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLKKEYD 196
           DL   N +LD      +K+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 177 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 234
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHISP 250
            K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       +  
Sbjct: 235 TK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVML 290
Query: 251 ECRH 254
           +C H
Sbjct: 291 KCWH 294

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 117/259 (45%), Gaps = 19/259 (7%)
Query: 24  ELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
           +L + +G+G FG V     +K T+  VAVK ++ G    E    E    ++L+H  +V+ 
Sbjct: 18  KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 75
Query: 83  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQVCH 140
             V+ T   + I+ E+ + G L + + +     +   +   F  Q+  G+++       H
Sbjct: 76  HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 134
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDG 197
           RDL+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  
Sbjct: 135 RDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 191
Query: 198 KIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           K +DVWS G+ L  ++  G  P+     P+     + R L   Y +P   +   E  +++
Sbjct: 192 K-SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELYNIM 245
Query: 257 SRIFVADPAKRISIPEIRN 275
            R +   P +R +   I++
Sbjct: 246 MRCWKNRPEERPTFEYIQS 264

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 24/244 (9%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 149
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLKKEYD 196
           DL   N +LD      +K+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 150 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 207
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHISP 250
            K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       +  
Sbjct: 208 TK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVML 263
Query: 251 ECRH 254
           +C H
Sbjct: 264 KCWH 267

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 24/244 (9%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 154
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLKKEYD 196
           DL   N +LD      +K+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 155 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHISP 250
            K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       +  
Sbjct: 213 TK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVML 268
Query: 251 ECRH 254
           +C H
Sbjct: 269 KCWH 272

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 24/244 (9%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLKKEYD 196
           DL   N +LD      +K+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 215
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHISP 250
            K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       +  
Sbjct: 216 TK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVML 271
Query: 251 ECRH 254
           +C H
Sbjct: 272 KCWH 275

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 24/244 (9%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLKKEYD 196
           DL   N +LD      +K+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 157 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 214
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHISP 250
            K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       +  
Sbjct: 215 TK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVML 270
Query: 251 ECRH 254
           +C H
Sbjct: 271 KCWH 274

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 24/244 (9%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 152
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLKKEYD 196
           DL   N +LD      +K+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 153 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 210
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHISP 250
            K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       +  
Sbjct: 211 TK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVML 266
Query: 251 ECRH 254
           +C H
Sbjct: 267 KCWH 270

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 24/244 (9%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 155
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLKKEYD 196
           DL   N +LD      +K+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 156 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 213
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHISP 250
            K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       +  
Sbjct: 214 TK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVML 269
Query: 251 ECRH 254
           +C H
Sbjct: 270 KCWH 273

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 103/225 (45%), Gaps = 24/225 (10%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKI 60
           D  A+TV  G       + D YE+VR +G G +  V   +     E+ +         K 
Sbjct: 19  DYEALTVQWG-------EQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK 71
Query: 61  DENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFS 115
            +   + + N      PNIV+  +++      TP+   ++ EY +  + F+ +      +
Sbjct: 72  IKREIKILQNLXG--GPNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LT 123
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175
           + + R++  +L+  + YCHS  + HRD+K  N ++D     +L++ D+G ++      + 
Sbjct: 124 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEY 182
Query: 176 KSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPF 219
              V +  +  PE+L+  ++YD  + D+WS G     M+    PF
Sbjct: 183 NVRVASRYFKGPELLVDLQDYDYSL-DMWSLGCMFAGMIFRKEPF 226

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 117/259 (45%), Gaps = 19/259 (7%)
Query: 24  ELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
           +L + +G+G FG V     +K T+  VAVK ++ G    E    E    ++L+H  +V+ 
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 248
Query: 83  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQVCH 140
             V+ T   + I+ E+ + G L + + +     +   +   F  Q+  G+++       H
Sbjct: 249 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 307
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDG 197
           RDL+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  
Sbjct: 308 RDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 198 KIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           K +DVWS G+ L  ++  G  P+     P+     + R L   Y +P   +   E  +++
Sbjct: 365 K-SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELYNIM 418
Query: 257 SRIFVADPAKRISIPEIRN 275
            R +   P +R +   I++
Sbjct: 419 MRCWKNRPEERPTFEYIQS 437

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 103/225 (45%), Gaps = 24/225 (10%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKI 60
           D  A+TV  G       + D YE+VR +G G +  V   +     E+ +         K 
Sbjct: 19  DYEALTVQWG-------EQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK 71
Query: 61  DENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFS 115
            +   + + N      PNIV+  +++      TP+   ++ EY +  + F+ +      +
Sbjct: 72  IKREIKILQNLXG--GPNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LT 123
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175
           + + R++  +L+  + YCHS  + HRD+K  N ++D     +L++ D+G ++      + 
Sbjct: 124 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEY 182
Query: 176 KSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPF 219
              V +  +  PE+L+  ++YD  + D+WS G     M+    PF
Sbjct: 183 NVRVASRYFKGPELLVDLQDYDYSL-DMWSLGCMFAGMIFRKEPF 226

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 72  RSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLI 127
           R   HPN++       +P   H  ++  +   G L+  +     F  D+++   F   + 
Sbjct: 62  RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 128 SGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 185
            G+++ H+++  +    L   + ++D     R+ + D  +S       Q    +  PA++
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS------FQSPGRMYAPAWV 175
Query: 186 APEVLLKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
           APE L KK  D   + AD+WS  V L+ ++    PF D    +   K    +  ++ +IP
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA--LEGLRPTIP 233
Query: 244 DYVHISPECRHLISRIFVADPAKR 267
               ISP    L+      DPAKR
Sbjct: 234 P--GISPHVSKLMKICMNEDPAKR 255

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 29/235 (12%)
Query: 11  GMDMPIMHDSDRYELVR-DIGSGNFGVARL-----MRDKKTEELVAVKYI-ERGDKIDEN 63
           G D  + H   R  +++ ++G G FG   L     +  ++ + LVAVK + E  +   ++
Sbjct: 1   GSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD 60
Query: 64  VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------RFSED 117
            QRE      L+H +IVRF  V      L +V EY   G+L   + + G         ED
Sbjct: 61  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 120
Query: 118 EA---------RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK- 167
            A              Q+ +G+ Y   +   HRDL   N L+       +KI DFG S+ 
Sbjct: 121 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD 178
Query: 168 --SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
             S+  +     T+    ++ PE +L +++  + +DVWS GV L+ +   G  P+
Sbjct: 179 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 232

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 25  LVRDIGSGNFGVARL-----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 78
           L  ++G G FG   L     +  ++ + LVAVK + E  +   ++ QRE      L+H +
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAG------RFSEDEA---------RFFF 123
           IVRF  V      L +V EY   G+L   + + G         ED A             
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 180
            Q+ +G+ Y   +   HRDL   N L+       +KI DFG S+   S+  +     T+ 
Sbjct: 142 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
              ++ PE +L +++  + +DVWS GV L+ +   G  P+
Sbjct: 200 PIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 238

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 77  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           YCHS  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 192 K-KEYDGKIADVWSCGVTLYVMLVGAYPF 219
             ++YD  + D+WS G     M+    PF
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 226

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 103/225 (45%), Gaps = 24/225 (10%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKI 60
           D  A+TV  G       + D YE+VR +G G +  V   +     E+ +         K 
Sbjct: 40  DYEALTVQWG-------EQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK 92
Query: 61  DENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFS 115
            +   + + N      PNIV+  +++      TP+   ++ EY +  + F+ +      +
Sbjct: 93  IKREIKILQNLXG--GPNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LT 144
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175
           + + R++  +L+  + YCHS  + HRD+K  N ++D     +L++ D+G ++      + 
Sbjct: 145 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEY 203
Query: 176 KSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPF 219
              V +  +  PE+L+  ++YD  + D+WS G     M+    PF
Sbjct: 204 NVRVASRYFKGPELLVDLQDYDYSL-DMWSLGCMFAGMIFRKEPF 247

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 103/225 (45%), Gaps = 24/225 (10%)
Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKI 60
           D  A+TV  G       + D YE+VR +G G +  V   +     E+ +         K 
Sbjct: 20  DYEALTVQWG-------EQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK 72
Query: 61  DENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFS 115
            +   + + N      PNIV+  +++      TP+   ++ EY +  + F+ +      +
Sbjct: 73  IKREIKILQNLXG--GPNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LT 124
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175
           + + R++  +L+  + YCHS  + HRD+K  N ++D     +L++ D+G ++      + 
Sbjct: 125 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEY 183
Query: 176 KSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPF 219
              V +  +  PE+L+  ++YD  + D+WS G     M+    PF
Sbjct: 184 NVRVASRYFKGPELLVDLQDYDYSL-DMWSLGCMFAGMIFRKEPF 227

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 25  LVRDIGSGNFGVARL-----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 78
           L  ++G G FG   L     +  ++ + LVAVK + E  +   ++ QRE      L+H +
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAG------RFSEDEA---------RFFF 123
           IVRF  V      L +V EY   G+L   + + G         ED A             
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 180
            Q+ +G+ Y   +   HRDL   N L+       +KI DFG S+   S+  +     T+ 
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
              ++ PE +L +++  + +DVWS GV L+ +   G  P+
Sbjct: 223 PIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 26/245 (10%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSV------LHSQPKSTVGTPAYIAPEVLLKKEY 195
           DL   N +LD      +K+ DFG ++  +      +H++  + +    ++A E L  +++
Sbjct: 159 DLAARNCMLDEKFT--VKVADFGLARDMLDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 215
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHIS 249
             K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       + 
Sbjct: 216 TTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVM 271
Query: 250 PECRH 254
            +C H
Sbjct: 272 LKCWH 276

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 112/264 (42%), Gaps = 30/264 (11%)
Query: 20  SDRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
            D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK 68
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGV 130
            LRH  +V+   V+ +   + IVMEY S G L + +    G++    +      Q+ SG+
Sbjct: 69  KLRHEKLVQLYAVV-SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPE 188
           +Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +       + APE
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
             L   +  K +DVWS G+ L  +   G  P+     P    + +   +   Y +P    
Sbjct: 186 AALYGRFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMP---- 235
Query: 248 ISPEC----RHLISRIFVADPAKR 267
             PEC      L+ + +  DP +R
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEER 259

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 103/261 (39%), Gaps = 66/261 (25%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PN- 78
           RY ++R +G G+F    L  D + ++ VA+K ++  +   E    EI   +S+R+  PN 
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 79  -----IVR----FKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLI 127
                +V+    FK   +  TH+ +V E   G  L + I   N         +   QQ++
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 128 SGVSYCHS-MQVCHRDLKLENTLL-------------------DGSPAP----------- 156
            G+ Y H+  ++ H D+K EN LL                    G+P P           
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 157 -----------------RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
                            ++KI D G   +  +H      + T  Y + EVL+   Y+   
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP- 273
Query: 200 ADVWSCGVTLYVMLVGAYPFE 220
           AD+WS     + +  G Y FE
Sbjct: 274 ADIWSTACMAFELATGDYLFE 294

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 77  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 140
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           YCHS  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 141 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 192 K-KEYDGKIADVWSCGVTLYVMLVGAYPF 219
             ++YD  + D+WS G     M+    PF
Sbjct: 200 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 227

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 103/261 (39%), Gaps = 66/261 (25%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PN- 78
           RY ++R +G G+F    L  D + ++ VA+K ++  +   E    EI   +S+R+  PN 
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 81
Query: 79  -----IVR----FKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLI 127
                +V+    FK   +  TH+ +V E   G  L + I   N         +   QQ++
Sbjct: 82  PNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 140
Query: 128 SGVSYCHS-MQVCHRDLKLENTLL-------------------DGSPAP----------- 156
            G+ Y H+  ++ H D+K EN LL                    G+P P           
Sbjct: 141 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 200
Query: 157 -----------------RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
                            ++KI D G   +  +H      + T  Y + EVL+   Y+   
Sbjct: 201 AGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP- 257
Query: 200 ADVWSCGVTLYVMLVGAYPFE 220
           AD+WS     + +  G Y FE
Sbjct: 258 ADIWSTACMAFELATGDYLFE 278

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 77  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           YCHS  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 192 K-KEYDGKIADVWSCGVTLYVMLVGAYPF 219
             ++YD  + D+WS G     M+    PF
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 226

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 77  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           YCHS  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 192 K-KEYDGKIADVWSCGVTLYVMLVGAYPF 219
             ++YD  + D+WS G     M+    PF
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 226

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 114/265 (43%), Gaps = 32/265 (12%)
Query: 20  SDRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
            D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK 68
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGV 130
            LRH  +V+   V+ +   + IV+EY S G L + +    G++    +      Q+ SG+
Sbjct: 69  KLRHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAP 187
           +Y   M   HRDL+  N L+  +     K+ DFG ++  +  ++  +  G      + AP
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR-LIEDNEXTARQGAKFPIKWTAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
           E  L   +  K +DVWS G+ L  +   G  P+     P    + +   +   Y +P   
Sbjct: 185 EAALYGRFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMP--- 235
Query: 247 HISPEC----RHLISRIFVADPAKR 267
              PEC      L+ + +  DP +R
Sbjct: 236 -CPPECPESLHDLMCQCWRKDPEER 259

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 77  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 88  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 141
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           YCHS  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 142 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 200
Query: 192 K-KEYDGKIADVWSCGVTLYVMLVGAYPF 219
             ++YD  + D+WS G     M+    PF
Sbjct: 201 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 228

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 113/270 (41%), Gaps = 39/270 (14%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTE-ELVAVKYIERGDKIDENVQREIINHRS 73
           DR  L + +G G FG   L       +DK      VAVK + + D  ++++   I     
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEM 86
Query: 74  LR----HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEARFFFQ 124
           ++    H NI+           L +++EYAS G L E +  A R     FS + +    +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEFSFNPSHNPEE 145
Query: 125 QLIS------------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           QL S            G+ Y  S +  HRDL   N L+       +KI DFG ++    +
Sbjct: 146 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHI 203
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPK 226
               K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G   YP    EE  
Sbjct: 204 DXXKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLI 256
              K  HR+        +   +  +C H +
Sbjct: 263 KLLKEGHRMDKPSNCTNELYMMMRDCWHAV 292

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 112/264 (42%), Gaps = 30/264 (11%)
Query: 20  SDRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
            D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK 68
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGV 130
            LRH  +V+   V+ +   + IV+EY S G L + +    G++    +      Q+ SG+
Sbjct: 69  KLRHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPE 188
           +Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +       + APE
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
             L   +  K +DVWS G+ L  +   G  P+     P    + +   +   Y +P    
Sbjct: 186 AALYGRFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMP---- 235
Query: 248 ISPEC----RHLISRIFVADPAKR 267
             PEC      L+ + +  DP +R
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEER 259

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
           L+  +G G +G   + R     E VAVK     D+     + E+ N   LRH NI+ F  
Sbjct: 12  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 85  VILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH------ 134
             +T  H    L ++  Y   G L++ +      +    R     + SG+++ H      
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVL-SIASGLAHLHIEIFGT 128
Query: 135 --SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------VGTPAY 184
                + HRDLK +N L+  +   +  I D G    +V+HSQ  +         VGT  Y
Sbjct: 129 QGKPAIAHRDLKSKNILVKKN--GQCCIADLGL---AVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 185 IAPEVLLKKE----YDG-KIADVWSCGVTLY 210
           +APEVL +      +D  K  D+W+ G+ L+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 94/229 (41%), Gaps = 30/229 (13%)
Query: 7   TVGPGMDMPIMHD---SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
           T G G  +P++     +    L   IG G FG   + R K   E VAVK     ++    
Sbjct: 25  TSGSGSGLPLLVQRTIARTIVLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWF 82
Query: 64  VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
            + EI     LRH NI+ F     +   T T L +V +Y   G LF+ +       E   
Sbjct: 83  REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI 142
Query: 120 RFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----S 166
           +       SG+++ H           + HRDLK +N L+  +      I D G      S
Sbjct: 143 KLALST-ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDS 199
Query: 167 KSSVLHSQPKSTVGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLY 210
            +  +   P   VGT  Y+APEVL     +K     K AD+++ G+  +
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 26/245 (10%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 216
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 217 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 273
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHIS 249
             K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       + 
Sbjct: 274 TTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVM 329
Query: 250 PECRH 254
            +C H
Sbjct: 330 LKCWH 334

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 94/229 (41%), Gaps = 30/229 (13%)
Query: 7   TVGPGMDMPIMHD---SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
           T G G  +P++     +    L   IG G FG   + R K   E VAVK     ++    
Sbjct: 12  TSGSGSGLPLLVQRTIARTIVLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWF 69
Query: 64  VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
            + EI     LRH NI+ F     +   T T L +V +Y   G LF+ +       E   
Sbjct: 70  REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI 129
Query: 120 RFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----S 166
           +       SG+++ H           + HRDLK +N L+  +      I D G      S
Sbjct: 130 KLALST-ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDS 186
Query: 167 KSSVLHSQPKSTVGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLY 210
            +  +   P   VGT  Y+APEVL     +K     K AD+++ G+  +
Sbjct: 187 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 235

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 26  VRDIGSGNFGVAR---LMRDKKTEEL-VAVKYIER--GDKIDENVQREIINHRSLRHPNI 79
           V+ +GSG FG       + + +T ++ VA+K +    G K +     E +   S+ HP++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           VR   V L+PT + +V +    G L E +  +           +  Q+  G+ Y    ++
Sbjct: 80  VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 138
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEY 195
            HRDL   N L+  SP   +KI DFG ++      +  +  G      ++A E +  +++
Sbjct: 139 VHRDLAARNVLVK-SPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFE 220
             + +DVWS GVT++ +M  G  P++
Sbjct: 197 THQ-SDVWSYGVTIWELMTFGGKPYD 221

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
           L+  +G G +G   + R     E VAVK     D+     + E+ N   LRH NI+ F  
Sbjct: 12  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 85  VILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH------ 134
             +T  H    L ++  Y   G L++ +      +    R     + SG+++ H      
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVL-SIASGLAHLHIEIFGT 128
Query: 135 --SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------VGTPAY 184
                + HRDLK +N L+  +   +  I D G    +V+HSQ  +         VGT  Y
Sbjct: 129 QGKPAIAHRDLKSKNILVKKN--GQCCIADLGL---AVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 185 IAPEVLLKKE----YDG-KIADVWSCGVTLY 210
           +APEVL +      +D  K  D+W+ G+ L+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 26/245 (10%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHIS 249
             K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       + 
Sbjct: 215 TTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVM 270
Query: 250 PECRH 254
            +C H
Sbjct: 271 LKCWH 275

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 26/245 (10%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHIS 249
             K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       + 
Sbjct: 215 TTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVM 270
Query: 250 PECRH 254
            +C H
Sbjct: 271 LKCWH 275

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 26  VRDIGSGNFGVAR---LMRDKKTEEL-VAVKYIER--GDKIDENVQREIINHRSLRHPNI 79
           V+ +GSG FG       + + +T ++ VA+K +    G K +     E +   S+ HP++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           VR   V L+PT + +V +    G L E +  +           +  Q+  G+ Y    ++
Sbjct: 103 VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 161
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEY 195
            HRDL   N L+  SP   +KI DFG ++      +  +  G      ++A E +  +++
Sbjct: 162 VHRDLAARNVLVK-SPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFE 220
             + +DVWS GVT++ +M  G  P++
Sbjct: 220 THQ-SDVWSYGVTIWELMTFGGKPYD 244

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 26/245 (10%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 155
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 156 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 212
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHIS 249
             K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       + 
Sbjct: 213 TTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVM 268
Query: 250 PECRH 254
            +C H
Sbjct: 269 LKCWH 273

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 21  DRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    + 
Sbjct: 1   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKK 59
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGVS 131
           LRH  +V+   V+ +   + IV EY S G L + +    G++    +      Q+ SG++
Sbjct: 60  LRHEKLVQLYAVV-SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 118
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPE 188
           Y   M   HRDL+  N L+  +     K+ DFG ++  +  ++  +  G      + APE
Sbjct: 119 YVERMNYVHRDLRAANILVGENLV--CKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPE 175
Query: 189 VLLKKEYDGKIADVWSCGVTL 209
             L   +  K +DVWS G+ L
Sbjct: 176 AALYGRFTIK-SDVWSFGILL 195

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 162
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 163 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 219
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFED 221
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 220 TTK-SDVWSFGVLLWELMTRGAPPYPD 245

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +L++ +G+G FG    M        VA+K ++ G    E+   E    + L+H  +V+  
Sbjct: 12  QLIKRLGNGQFGEV-WMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLY 70
Query: 84  EVILTPTHLAIVMEYASGGELFERICNA-GR-FSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ +   + IV EY + G L + + +  GR            Q+ +G++Y   M   HR
Sbjct: 71  AVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
           DL+  N L+        KI DFG ++  +  ++  +  G      + APE  L   +  K
Sbjct: 130 DLRSANILVGNGLI--CKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 199 IADVWSCGVTLYVMLV-GAYPF 219
            +DVWS G+ L  ++  G  P+
Sbjct: 187 -SDVWSFGILLTELVTKGRVPY 207

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 111/264 (42%), Gaps = 30/264 (11%)
Query: 20  SDRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
            D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK 68
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGV 130
            LRH  +V+   V+ +   + IV EY S G L + +    G++    +      Q+ SG+
Sbjct: 69  KLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPE 188
           +Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +       + APE
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
             L   +  K +DVWS G+ L  +   G  P+     P    + +   +   Y +P    
Sbjct: 186 AALYGRFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMP---- 235
Query: 248 ISPEC----RHLISRIFVADPAKR 267
             PEC      L+ + +  DP +R
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEER 259

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 26/245 (10%)
Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
           IG G+FG      L+ +   +   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 84  EVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHR 141
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 159 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 215
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH-----RILSVQYSIPDYVHIS 249
             K +DVWS GV L+ +M  GA P+ D      F  T++     R+L  +Y       + 
Sbjct: 216 TTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEVM 271
Query: 250 PECRH 254
            +C H
Sbjct: 272 LKCWH 276

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 110/291 (37%), Gaps = 68/291 (23%)
Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----- 76
           RY ++R +G G+F    L  D + +  VA+K ++      E    EI   + +R      
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSD 91
Query: 77  PN-------IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLI 127
           PN       I  FK   +   H+ +V E   G  L + I   N         +   +Q++
Sbjct: 92  PNKDMVVQLIDDFKISGMNGIHVCMVFE-VLGHHLLKWIIKSNYQGLPVRCVKSIIRQVL 150
Query: 128 SGVSYCHS-MQVCHRDLKLENTLL-------------------DGSPAP----------- 156
            G+ Y HS  ++ H D+K EN L+                    G+P P           
Sbjct: 151 QGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAA 210
Query: 157 ---------------RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
                          R+KI D G   +  +H      + T  Y + EVL+   Y    AD
Sbjct: 211 DLLVNPLDPRNADKIRVKIADLG--NACWVHKHFTEDIQTRQYRSIEVLIGAGYSTP-AD 267
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKT---IHRILSVQYSIPDYVHIS 249
           +WS     + +  G Y FE P   +++ +    I  I+ +  SIP +  +S
Sbjct: 268 IWSTACMAFELATGDYLFE-PHSGEDYSRDEDHIAHIIELLGSIPRHFALS 317

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 111/264 (42%), Gaps = 30/264 (11%)
Query: 20  SDRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
            D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    +
Sbjct: 1   KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK 59
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGV 130
            LRH  +V+   V+ +   + IV EY S G L + +    G++    +      Q+ SG+
Sbjct: 60  KLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 118
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPE 188
           +Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +       + APE
Sbjct: 119 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 176
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
             L   +  K +DVWS G+ L  +   G  P+     P    + +   +   Y +P    
Sbjct: 177 AALYGRFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMP---- 226
Query: 248 ISPEC----RHLISRIFVADPAKR 267
             PEC      L+ + +  DP +R
Sbjct: 227 CPPECPESLHDLMCQCWRKDPEER 250

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 111/261 (42%), Gaps = 25/261 (9%)
Query: 16  IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           I  +S R E+   +G G FG   +     T   VA+K ++ G    E   +E    + LR
Sbjct: 4   IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLR 60
Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGVSYC 133
           H  +V+   V+ +   + IV EY S G L + +    G++    +      Q+ SG++Y 
Sbjct: 61  HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 119
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL 191
             M   HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L
Sbjct: 120 ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 177
Query: 192 KKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
              +  K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      P
Sbjct: 178 YGRFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMP----CPP 227
Query: 251 EC----RHLISRIFVADPAKR 267
           EC      L+ + +  DP +R
Sbjct: 228 ECPESLHDLMCQCWRKDPEER 248

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 111/264 (42%), Gaps = 30/264 (11%)
Query: 20  SDRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
            D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK 68
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGV 130
            LRH  +V+   V+ +   + IV EY S G L + +    G++    +      Q+ SG+
Sbjct: 69  KLRHEKLVQLYAVV-SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPE 188
           +Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +       + APE
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
             L   +  K +DVWS G+ L  +   G  P+     P    + +   +   Y +P    
Sbjct: 186 AALYGRFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMP---- 235
Query: 248 ISPEC----RHLISRIFVADPAKR 267
             PEC      L+ + +  DP +R
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEER 259

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 125/304 (41%), Gaps = 49/304 (16%)
Query: 22  RYELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSL 74
           ++ L R +G G FG  R   L ++  +   VAVK + + D I     E   RE    +  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF 82
Query: 75  RHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI- 127
            HP++ +   V L            +++ +   G+L   +  A R  E+      Q L+ 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFNLPLQTLVR 141
Query: 128 ------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPK 176
                  G+ Y  S    HRDL   N +L    A  + +C  DFG S+   S   + Q  
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCML----AEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRI 235
           ++     ++A E L    Y    +DVW+ GVT++ +M  G  P+   E  + +   I   
Sbjct: 198 ASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG-- 254
Query: 236 LSVQYSIPDYVHISPECRH----LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDN 291
                   + +   PEC      L+ + + ADP +R S   +R     L+N+   L V +
Sbjct: 255 -------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME---LENILGHLSVLS 304
Query: 292 TTNN 295
           T+ +
Sbjct: 305 TSQD 308

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 44/270 (16%)
Query: 21  DRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           D +E+ R+       +G G FG   +     T   VA+K ++ G+   E   +E    + 
Sbjct: 178 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGNMSPEAFLQEAQVMKK 236
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--------- 124
           LRH  +V+   V+ +   + IV EY S G L +       F + E   + +         
Sbjct: 237 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAA 288
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTP 182
           Q+ SG++Y   M   HRDL+  N L+  +     K+ DFG  +      ++  +      
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLGRLIEDNEYTARQGAKFPI 346
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS 241
            + APE  L   +  K +DVWS G+ L  +   G  P+     P    + +   +   Y 
Sbjct: 347 KWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYR 400
Query: 242 IPDYVHISPEC----RHLISRIFVADPAKR 267
           +P      PEC      L+ + +  DP +R
Sbjct: 401 MP----CPPECPESLHDLMCQCWRKDPEER 426

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF-- 82
           L   IG G FG   + R K   E VAVK     ++     + EI     LRH NI+ F  
Sbjct: 7   LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 83  --KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH------ 134
              +   T T L +V +Y   G LF+ +       E   +       SG+++ H      
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGT 123
Query: 135 --SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 187
                + HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 188 EVL-----LKKEYDGKIADVWSCGVTLY 210
           EVL     +K     K AD+++ G+  +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFW 209

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF-- 82
           L   IG G FG   + R K   E VAVK     ++     + EI     LRH NI+ F  
Sbjct: 13  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 70
Query: 83  --KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH------ 134
              +   T T L +V +Y   G LF+ +       E   +       SG+++ H      
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGT 129
Query: 135 --SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 187
                + HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 188 EVL-----LKKEYDGKIADVWSCGVTLY 210
           EVL     +K     K AD+++ G+  +
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFW 215

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF-- 82
           L   IG G FG   + R K   E VAVK     ++     + EI     LRH NI+ F  
Sbjct: 8   LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 65
Query: 83  --KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH------ 134
              +   T T L +V +Y   G LF+ +       E   +       SG+++ H      
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGT 124
Query: 135 --SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 187
                + HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 188 EVL-----LKKEYDGKIADVWSCGVTLY 210
           EVL     +K     K AD+++ G+  +
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFW 210

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 106/276 (38%), Gaps = 46/276 (16%)
Query: 62  ENVQREI--INHRSLRHPNI-------VRFKEVILTPTHLAIVMEYASGGELF--ERICN 110
           + V REI  +NH    HPNI       V F+E  +   +L   +      ++   +RI  
Sbjct: 74  KRVLREIRLLNH--FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV- 130
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
               S    ++F   ++ G+   H   V HRDL   N LL  +    + ICDF  ++   
Sbjct: 131 ---ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITICDFNLAREDT 185
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +     V    Y APE++++ +   K+ D+WS G  +  M      F          K
Sbjct: 186 ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245
Query: 231 TIHRILS------VQYSIP---DYVHIS-----------------PECRHLISRIFVADP 264
            +  + +      V +S P   DY+  S                 P    LI+++   +P
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305
Query: 265 AKRISIPEIRNHEWFLKNL-PADLVVDNTTNNQFEE 299
            +RIS  +   H +F     P DL    +    F+E
Sbjct: 306 QRRISTEQALRHPYFESLFDPLDLTEGLSERFHFDE 341

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF-- 82
           L   IG G FG   + R K   E VAVK     ++     + EI     LRH NI+ F  
Sbjct: 10  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 67
Query: 83  --KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH------ 134
              +   T T L +V +Y   G LF+ +       E   +       SG+++ H      
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGT 126
Query: 135 --SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 187
                + HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 188 EVL-----LKKEYDGKIADVWSCGVTLY 210
           EVL     +K     K AD+++ G+  +
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFW 212

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 20  SDRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
            D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    +
Sbjct: 3   KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK 61
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGV 130
            LRH  +V+   V+ +   + IV EY S G L + +    G++    +      Q+ SG+
Sbjct: 62  KLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 120
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPE 188
           +Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +       + APE
Sbjct: 121 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 178
Query: 189 VLLKKEYDGKIADVWSCGVTL 209
             L   +  K +DVWS G+ L
Sbjct: 179 AALYGRFTIK-SDVWSFGILL 198

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++
Sbjct: 78  PHVCRLLGICLTST-VQLIMQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 132
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 133 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 191 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 222

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 29  IGSGNFG---VARLMRDKKTEELVAVK----YIERGDKIDENVQREIINHRSLRHPNIVR 81
           IG GNFG    AR+ +D    +  A+K    Y  + D  D   + E++      HPNI+ 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIIN 80
Query: 82  FKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSEDEARFFFQQ 125
                    +L + +EYA  G L + +                  A   S  +   F   
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG-TPA- 183
           +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  
Sbjct: 141 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 196
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           ++A E L    Y    +DVWS GV L+ ++ +G  P+
Sbjct: 197 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 232

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 78/318 (24%), Positives = 131/318 (41%), Gaps = 54/318 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTE-ELVAVKYIERGDKIDENVQREIINHRS 73
           DR  L + +G G FG   L       +DK      VAVK + + D  ++++   I     
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEM 86
Query: 74  LR----HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---------------- 113
           ++    H NI+           L +++EYAS G L E +  A R                
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYCYNPSHNPEE 145
Query: 114 -FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
             S  +      Q+  G+ Y  S +  HRDL   N L+       +KI DFG ++    +
Sbjct: 146 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHI 203
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPK 226
               K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G   YP    EE  
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 286
              K  HR+        +   +  +C H +       P++R +  ++      +++L  D
Sbjct: 263 KLLKEGHRMDKPSNCTNELYMMMRDCWHAV-------PSQRPTFKQL------VEDL--D 307
Query: 287 LVVDNTTNNQFEEPDQPM 304
            +V  T+N ++ +   P+
Sbjct: 308 RIVALTSNQEYLDLSMPL 325

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 110/264 (41%), Gaps = 30/264 (11%)
Query: 20  SDRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
            D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK 68
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGV 130
            LRH  +V+   V+ +   + IV EY S G L + +    G++    +      Q+ SG+
Sbjct: 69  KLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPE 188
           +Y   M   HRDL   N L+  +     K+ DFG ++      ++  +       + APE
Sbjct: 128 AYVERMNYVHRDLAAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
             L   +  K +DVWS G+ L  +   G  P+     P    + +   +   Y +P    
Sbjct: 186 AALYGRFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMP---- 235
Query: 248 ISPEC----RHLISRIFVADPAKR 267
             PEC      L+ + +  DP +R
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEER 259

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 111/264 (42%), Gaps = 30/264 (11%)
Query: 20  SDRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
            D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK 68
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGV 130
            +RH  +V+   V+ +   + IV EY S G L + +    G++    +      Q+ SG+
Sbjct: 69  KIRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPE 188
           +Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +       + APE
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
             L   +  K +DVWS G+ L  +   G  P+     P    + +   +   Y +P    
Sbjct: 186 AALYGRFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMP---- 235
Query: 248 ISPEC----RHLISRIFVADPAKR 267
             PEC      L+ + +  DP +R
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEER 259

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 29  IGSGNFG---VARLMRDKKTEELVAVK----YIERGDKIDENVQREIINHRSLRHPNIVR 81
           IG GNFG    AR+ +D    +  A+K    Y  + D  D   + E++      HPNI+ 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIIN 90
Query: 82  FKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSEDEARFFFQQ 125
                    +L + +EYA  G L + +                  A   S  +   F   
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA 183
           +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G     
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 206
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           ++A E L    Y    +DVWS GV L+ ++ +G  P+
Sbjct: 207 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 242

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 111/251 (44%), Gaps = 46/251 (18%)
Query: 9   GPGMDMPIMHDSDRYELVRD-------IGSGNFGVARLM------RDKKTE-ELVAVKYI 54
           G G+    + +  R+EL RD       +G G FG   L       +DK      VAVK +
Sbjct: 1   GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML 60
Query: 55  ERGDKIDENVQREIINHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 109
            + D  ++++  ++I+   +     +H NI+           L +++EYAS G L E + 
Sbjct: 61  -KSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL- 117
Query: 110 NAGR-----FSEDEARFFFQQLIS------------GVSYCHSMQVCHRDLKLENTLLDG 152
            A R     +S + +    +QL S            G+ Y  S +  HRDL   N L+  
Sbjct: 118 QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 177
Query: 153 SPAPRLKICDFGYSKS-SVLHSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTL 209
                +KI DFG ++    +    K+T G     ++APE L  + Y  + +DVWS GV L
Sbjct: 178 DNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLL 234
Query: 210 Y-VMLVGAYPF 219
           + +  +G  P+
Sbjct: 235 WEIFTLGGSPY 245

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 106/276 (38%), Gaps = 46/276 (16%)
Query: 62  ENVQREI--INHRSLRHPNI-------VRFKEVILTPTHLAIVMEYASGGELF--ERICN 110
           + V REI  +NH    HPNI       V F+E  +   +L   +      ++   +RI  
Sbjct: 74  KRVLREIRLLNH--FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV- 130
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170
               S    ++F   ++ G+   H   V HRDL   N LL  +    + ICDF  ++   
Sbjct: 131 ---ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITICDFNLAREDT 185
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
             +     V    Y APE++++ +   K+ D+WS G  +  M      F          K
Sbjct: 186 ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245
Query: 231 TIHRILS------VQYSIP---DYVHIS-----------------PECRHLISRIFVADP 264
            +  + +      V +S P   DY+  S                 P    LI+++   +P
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305
Query: 265 AKRISIPEIRNHEWFLKNL-PADLVVDNTTNNQFEE 299
            +RIS  +   H +F     P DL    +    F+E
Sbjct: 306 QRRISTEQALRHPYFESLFDPLDLTEGLSERFHFDE 341

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 111/264 (42%), Gaps = 30/264 (11%)
Query: 20  SDRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
            D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK 68
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGV 130
            LRH  +V+   V+ +   + IV EY S G L + +    G++    +      Q+ SG+
Sbjct: 69  KLRHEKLVQLYAVV-SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPE 188
           +Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +       + APE
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
             L   +  K +DVWS G+ L  +   G  P+     P    + +   +   Y +P    
Sbjct: 186 AALYGRFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMP---- 235
Query: 248 ISPEC----RHLISRIFVADPAKR 267
             PEC      L+ + +  DP +R
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEER 259

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTE-ELVAVKYIERGDKIDENVQREIINHRS 73
           DR  L + +G G FG   L       +DK      VAVK + + D  ++++   I     
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEM 79
Query: 74  LR----HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---------------- 113
           ++    H NI+           L +++EYAS G L E +  A R                
Sbjct: 80  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEE 138
Query: 114 -FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
             S  +      Q+  G+ Y  S +  HRDL   N L+       +KI DFG ++    +
Sbjct: 139 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHI 196
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 197 DYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 246

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 113/270 (41%), Gaps = 39/270 (14%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTE-ELVAVKYIERGDKIDENVQREIINHRS 73
           DR  L + +G G FG   L       +DK      VAVK + + D  ++++   I     
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEM 127
Query: 74  LR----HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEARFFFQ 124
           ++    H NI+           L +++EYAS G L E +  A R     +S + +    +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEE 186
Query: 125 QLIS------------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           QL S            G+ Y  S +  HRDL   N L+       +KI DFG ++    +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHI 244
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPK 226
               K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G   YP    EE  
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLI 256
              K  HR+        +   +  +C H +
Sbjct: 304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAV 333

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 39/232 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTE-ELVAVKYIERGDKIDENVQREIINHRS 73
           DR  L + +G G FG   L       +DK      VAVK + + D  ++++  ++I+   
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLS-DLISEME 74
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEARFFF 123
           +     +H NI+           L +++EYAS G L E +  A R     +S + +    
Sbjct: 75  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPE 133
Query: 124 QQLIS------------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SV 170
           +QL S            G+ Y  S +  HRDL   N L+       +KI DFG ++    
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHH 191
Query: 171 LHSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           +    K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 192 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 242

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 112/271 (41%), Gaps = 41/271 (15%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTE-ELVAVKYIERGDKIDENVQREIINHRS 73
           DR  L + +G G FG   L       +DK      VAVK + + D  ++++  ++I+   
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLS-DLISEME 85
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--------------- 113
           +     +H NI+           L +++EYAS G L E +  A R               
Sbjct: 86  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPE 144
Query: 114 --FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SV 170
              S  +      Q+  G+ Y  S +  HRDL   N L+       +KI DFG ++    
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHH 202
Query: 171 LHSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEP 225
           +    K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G   YP    EE 
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
               K  HR+        +   +  +C H +
Sbjct: 262 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAV 292

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTE-ELVAVKYIERGDKIDENVQREIINHRS 73
           DR  L + +G G FG   L       +DK      VAVK + + D  ++++   I     
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEM 71
Query: 74  LR----HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---------------- 113
           ++    H NI+           L +++EYAS G L E +  A R                
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYCYNPSHNPEE 130
Query: 114 -FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
             S  +      Q+  G+ Y  S +  HRDL   N L+       +KI DFG ++    +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHI 188
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 238

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 69/174 (39%), Gaps = 39/174 (22%)
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           N++  K       H+ I M Y    E F  I N+  F   E R +   L   +   H   
Sbjct: 81  NVMGVKYCFRKNDHVVIAMPYLEH-ESFLDILNSLSF--QEVREYMLNLFKALKRIHQFG 137
Query: 138 VCHRDLKLENTLLDGSPAPRLK---ICDFGYSKSS------VLH-----------SQPKS 177
           + HRD+K  N L +     RLK   + DFG ++ +      +L            SQ K 
Sbjct: 138 IVHRDVKPSNFLYNR----RLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKC 193
Query: 178 TV------------GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
           ++            GTP + APEVL K        D+WS GV    +L G YPF
Sbjct: 194 SICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 21  DRYELVRDIGSGNFGVARLM------RDKKTE-ELVAVKYIERGDKIDENVQREIINHRS 73
           DR  L + +G G FG   L       +DK      VAVK + + D  ++++  ++I+   
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLS-DLISEME 85
Query: 74  L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQ 124
           +     +H NI+           L +++EYAS G L E    R      +S + +    +
Sbjct: 86  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEE 145
Query: 125 QLIS------------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
           QL S            G+ Y  S +  HRDL   N L+       +KI DFG ++    +
Sbjct: 146 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHI 203
Query: 172 HSQPKSTVGT--PAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
               K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 253

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 21  DRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    + 
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKK 235
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--------- 124
           LRH  +V+   V+ +   + IV EY S G L +       F + E   + +         
Sbjct: 236 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAA 287
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTP 182
           Q+ SG++Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +      
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPI 345
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTL 209
            + APE  L   +  K +DVWS G+ L
Sbjct: 346 KWTAPEAALYGRFTIK-SDVWSFGILL 371

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 21  DRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    + 
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKK 235
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--------- 124
           LRH  +V+   V+ +   + IV EY S G L +       F + E   + +         
Sbjct: 236 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAA 287
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTP 182
           Q+ SG++Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +      
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPI 345
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTL 209
            + APE  L   +  K +DVWS G+ L
Sbjct: 346 KWTAPEAALYGRFTIK-SDVWSFGILL 371

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G FG    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 18  KLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 76
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 77  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 135
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
           DL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 136 DLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 199 IADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
            +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 193 -SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 227

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 15/216 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G FG    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 16  KLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
           DL+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 134 DLRAANILV--SDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 199 IADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
            +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 191 -SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G FG    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 22  KLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 80
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 81  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
           DL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 140 DLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 199 IADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
            +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 197 -SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 231

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYI 185
           G+ Y H+  + HRD+K  N LLD +  P  KI DFG SK      Q        GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVML 213
            PE  +K     K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK-SDVYSFGVVLFEVL 235

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 15/216 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G FG    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 17  KLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 75
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 76  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 134
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
           DL+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 135 DLRAANILV--SDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 199 IADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
            +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 192 -SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 226

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G FG    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 16  KLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
           DL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 134 DLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 199 IADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
            +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 191 -SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G FG    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 25  KLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 83
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 84  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 142
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
           DL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 143 DLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 199 IADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
            +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 200 -SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 234

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++
Sbjct: 81  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 136 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 194 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 225

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G FG    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 24  KLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 82
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 83  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 141
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
           DL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 142 DLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 199 IADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
            +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 199 -SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 233

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++
Sbjct: 77  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 132 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++
Sbjct: 80  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 134
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 135 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 193 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++
Sbjct: 78  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 132
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 133 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 191 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++
Sbjct: 79  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 133
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 134 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 192 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYI 185
           G+ Y H+  + HRD+K  N LLD +  P  KI DFG SK      Q        GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVML 213
            PE  +K     K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK-SDVYSFGVVLFEVL 235

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 21  DRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    + 
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKK 318
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--------- 124
           LRH  +V+   V+ +   + IV EY S G L +       F + E   + +         
Sbjct: 319 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAA 370
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTP 182
           Q+ SG++Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +      
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPI 428
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTL 209
            + APE  L   +  K +DVWS G+ L
Sbjct: 429 KWTAPEAALYGRFTIK-SDVWSFGILL 454

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 13/215 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G FG    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 11  KLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 69
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 70  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           DL+  N L+  S     KI DFG ++      ++  +       + APE +    +  K 
Sbjct: 129 DLRAANILV--SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK- 185
Query: 200 ADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
           +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 186 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 220

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PN 78
           + + + IG GNFG  RL ++  T E VA+K +E        +  E   ++ L      P 
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 79  IVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           +  F        + A+V+E    S  +LF+ +C+   FS         QLIS + Y HS 
Sbjct: 70  VYYFGPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSK 124
Query: 137 QVCHRDLKLENTLLDGSPAPR----LKICDFGY--------SKSSVLHSQPKSTVGTPAY 184
            + +RD+K EN L+ G P  +    + I DFG         +K  + + + KS  GT  Y
Sbjct: 125 NLIYRDVKPENFLI-GRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
           ++    L KE   +  D+ + G      L G+ P++
Sbjct: 184 MSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 218

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 32/209 (15%)
Query: 20  SDRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
            D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    +
Sbjct: 7   KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK 65
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-------- 124
            LRH  +V+   V+ +   + IV EY + G L +       F + E   + +        
Sbjct: 66  KLRHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLD-------FLKGETGKYLRLPQLVDMS 117
Query: 125 -QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP- 182
            Q+ SG++Y   M   HRDL+  N L+  +     K+ DFG ++  +  ++  +  G   
Sbjct: 118 AQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR-LIEDNEWTARQGAKF 174
Query: 183 --AYIAPEVLLKKEYDGKIADVWSCGVTL 209
              + APE  L   +  K +DVWS G+ L
Sbjct: 175 PIKWTAPEAALYGRFTIK-SDVWSFGILL 202

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 13/215 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G FG    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 16  KLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           DL+  N L+  S     KI DFG ++      ++  +       + APE +    +  K 
Sbjct: 134 DLRAANILV--SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK- 190
Query: 200 ADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
           +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 13/215 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G FG    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 22  KLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 80
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 81  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           DL+  N L+  + +   KI DFG ++      ++  +       + APE +    +  K 
Sbjct: 140 DLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK- 196
Query: 200 ADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
           +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 197 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 231

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++
Sbjct: 79  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 133
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 134 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 192 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 17/230 (7%)
Query: 9   GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI 68
           GP  ++P     +  +LV  +G+G FG    M        VAVK +++G    +    E 
Sbjct: 1   GPEWEVP----RETLKLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEA 55
Query: 69  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQL 126
              + L+H  +VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+
Sbjct: 56  NLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 114
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAY 184
             G+++       HR+L+  N L+  S     KI DFG ++      ++  +       +
Sbjct: 115 AEGMAFIEERNYIHRNLRAANILV--SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 172
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
            APE +    +  K +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 173 TAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 221

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 30/208 (14%)
Query: 20  SDRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR 72
            D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    +
Sbjct: 7   KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK 65
Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-------- 124
            LRH  +V+   V+ +   + IV EY + G L +       F + E   + +        
Sbjct: 66  KLRHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLD-------FLKGETGKYLRLPQLVDMS 117
Query: 125 -QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGT 181
            Q+ SG++Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +     
Sbjct: 118 AQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFP 175
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTL 209
             + APE  L   +  K +DVWS G+ L
Sbjct: 176 IKWTAPEAALYGRFTIK-SDVWSFGILL 202

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 21  DRYELVRD-------IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           D +E+ R+       +G G FG   +     T   VA+K ++ G    E   +E    + 
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKK 235
Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--------- 124
           LRH  +V+   V+ +   + IV EY S G L +       F + E   + +         
Sbjct: 236 LRHEKLVQLYAVV-SEEPIYIVGEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAA 287
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTP 182
           Q+ SG++Y   M   HRDL+  N L+  +     K+ DFG ++      ++  +      
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPI 345
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTL 209
            + APE  L   +  K +DVWS G+ L
Sbjct: 346 KWTAPEAALYGRFTIK-SDVWSFGILL 371

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 13/215 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G FG    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 26  KLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 84
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 85  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 143
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           DL+  N L+  + +   KI DFG ++      ++  +       + APE +    +  K 
Sbjct: 144 DLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK- 200
Query: 200 ADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
           +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 201 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 235

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++
Sbjct: 81  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 136 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 194 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++
Sbjct: 79  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 133
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 134 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 192 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 13/215 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G FG    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 21  KLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 79
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 80  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 138
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           DL+  N L+  + +   KI DFG ++      ++  +       + APE +    +  K 
Sbjct: 139 DLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK- 195
Query: 200 ADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
           +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 196 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 230

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 26  VRDIGSGNFGVAR----LMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHP 77
           ++ +GSG FG       +   +  +  V +K IE  DK      + + +H     SL H 
Sbjct: 36  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQAVTDHMLAIGSLDHA 93
Query: 78  NIVRFKEVILTP-THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
           +IVR   + L P + L +V +Y   G L + +  + G         +  Q+  G+ Y   
Sbjct: 94  HIVRL--LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 151
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEV 189
             + HR+L   N LL  SP+ ++++ DFG +         +L+S+ K+ +    ++A E 
Sbjct: 152 HGMVHRNLAARNVLLK-SPS-QVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALES 206
Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           +   +Y  + +DVWS GVT++ +M  GA P+
Sbjct: 207 IHFGKYTHQ-SDVWSYGVTVWELMTFGAEPY 236

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 26  VRDIGSGNFGVAR----LMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHP 77
           ++ +GSG FG       +   +  +  V +K IE  DK      + + +H     SL H 
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 78  NIVRFKEVILTP-THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
           +IVR   + L P + L +V +Y   G L + +  + G         +  Q+  G+ Y   
Sbjct: 76  HIVRL--LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEV 189
             + HR+L   N LL  SP+ ++++ DFG +         +L+S+ K+ +    ++A E 
Sbjct: 134 HGMVHRNLAARNVLLK-SPS-QVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALES 188
Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           +   +Y  + +DVWS GVT++ +M  GA P+
Sbjct: 189 IHFGKYTHQ-SDVWSYGVTVWELMTFGAEPY 218

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 29  IGSGNFG---VARLMRDKKTEELVAVK----YIERGDKIDENVQREIINHRSLRHPNIVR 81
           IG GNFG    AR+ +D    +  A+K    Y  + D  D   + E++      HPNI+ 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIIN 87
Query: 82  FKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSEDEARFFFQQ 125
                    +L + +EYA  G L + +                  A   S  +   F   
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA 183
           +  G+ Y    Q  HR+L   N L+  +     KI DFG S+   ++   K T+G     
Sbjct: 148 VARGMDYLSQKQFIHRNLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 203
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           ++A E L    Y    +DVWS GV L+ ++ +G  P+
Sbjct: 204 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 239

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 23/232 (9%)
Query: 4   SAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD- 58
            AM   P   +  +     ++ ++ +GSG FG       +   +K +  VA+K +     
Sbjct: 1   GAMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 60
Query: 59  -KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 117
            K ++ +  E     S+ +P++ R   + LT T + ++ +    G L + +    R  +D
Sbjct: 61  PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKD 115
Query: 118 E--ARFFFQ---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172
              +++      Q+  G++Y    ++ HRDL   N L+  +P   +KI DFG +K     
Sbjct: 116 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAE 173
Query: 173 SQPKSTVGTPA---YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +     G      ++A E +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 174 EKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 131/292 (44%), Gaps = 47/292 (16%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           ++V+ IG G +G   +   K   E VAVK     ++     + EI     +RH NI+ F 
Sbjct: 40  QMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 84  EVIL----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--- 136
              +    + T L ++ +Y   G L++ + +    ++   +  +   +SG+ + H+    
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTEIFS 156
Query: 137 -----QVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIA 186
                 + HRDLK +N L+  +      I D G      S ++ +   P + VGT  Y+ 
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 187 PEVL---LKKEYDGK--IADVWSCGVTLYVM--------LVGAY--PFED--PEEP--KN 227
           PEVL   L + +     +AD++S G+ L+ +        +V  Y  P+ D  P +P  ++
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 228 FRKTIHRILSVQYSIPDYVHISPECRH----LISRIFVADPAKRISIPEIRN 275
            R+ +  I  ++ S P+    S EC      L++  +  +PA R++   ++ 
Sbjct: 275 MREIVC-IKKLRPSFPNRWS-SDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 23/232 (9%)
Query: 4   SAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD- 58
            AM   P   +  +     ++ ++ +GSG FG       +   +K +  VA+K +     
Sbjct: 1   GAMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 60
Query: 59  -KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 117
            K ++ +  E     S+ +P++ R   + LT T + ++ +    G L + +    R  +D
Sbjct: 61  PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKD 115
Query: 118 E--ARFFFQ---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172
              +++      Q+  G++Y    ++ HRDL   N L+  +P   +KI DFG +K     
Sbjct: 116 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAE 173
Query: 173 SQPKSTVGTPA---YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +     G      ++A E +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 174 EKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 42/225 (18%)
Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
           +++ L R IGSG+FG   L  + +T E VA+K         ENV+         +HP ++
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVK--------TKHPQLL 50
Query: 81  ---RFKEVILTPTHLAIVMEYASGGEL-----------FERICN--AGRFSEDEARFFFQ 124
              +   ++   T +  V  +   G+             E + N  + + S         
Sbjct: 51  YESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKS--------SVLHSQP 175
           Q+I+ V + HS    HRD+K +N L+  G  A ++ I DFG +K          + + + 
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
           K+  GT  Y +    L  E   +  D+ S G  L   L G+ P++
Sbjct: 171 KNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ 214

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 132 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 43/216 (19%)
Query: 25  LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
           LV  +G G +G   + R     E VAVK     D+     + EI N   LRH NI+ F  
Sbjct: 12  LVECVGKGRYG--EVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 85  VILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS---GVSYCH--- 134
             +T     T L ++  Y   G L++ +    +    E     +  +S   G+++ H   
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEI 125
Query: 135 -----SMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSKSSVLHSQPKS--------TV 179
                   + HRD K  N L+  +    L+ C  D G    +V+HSQ            V
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSN----LQCCIADLGL---AVMHSQGSDYLDIGNNPRV 178
Query: 180 GTPAYIAPEVLLKKEYDG-----KIADVWSCGVTLY 210
           GT  Y+APEVL ++         K  D+W+ G+ L+
Sbjct: 179 GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLW 214

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 26/225 (11%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           M ++     + + + IG GNFG  RL ++  T E VA+K +E        +  E   ++ 
Sbjct: 2   MGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQ 60
Query: 74  LRH----PNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLI 127
           L      P +  F        + A+V+E    S  +LF+ +C+   FS         QLI
Sbjct: 61  LGSGDGIPQVYYFGPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLI 115
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPR----LKICDFGY--------SKSSVLHSQP 175
           S + Y HS  + +RD+K EN L+ G P  +    + I DF          +K  + + + 
Sbjct: 116 SRMEYVHSKNLIYRDVKPENFLI-GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
           KS  GT  Y++    L KE   +  D+ + G      L G+ P++
Sbjct: 175 KSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 218

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 26/225 (11%)
Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           M ++     + + + IG GNFG  RL ++  T E VA+K +E        +  E   ++ 
Sbjct: 23  MGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQ 81
Query: 74  LRH----PNIVRFKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQLI 127
           L      P +  F        + A+V+E    S  +LF+ +C+   FS         QLI
Sbjct: 82  LGSGDGIPQVYYFGPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLI 136
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPR----LKICDFGY--------SKSSVLHSQP 175
           S + Y HS  + +RD+K EN L+ G P  +    + I DF          +K  + + + 
Sbjct: 137 SRMEYVHSKNLIYRDVKPENFLI-GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 195
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
           KS  GT  Y++    L KE   +  D+ + G      L G+ P++
Sbjct: 196 KSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 239

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 83  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 137
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 138 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 195
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 196 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 227

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 84  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 138
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 139 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 197 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 132 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 80  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 134
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 135 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 193 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 79  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 133
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 134 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 192 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 87  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 141
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 142 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 199
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 200 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 231

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 102 PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 156
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 157 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 214
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 215 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 246

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ + SG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++
Sbjct: 84  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 138
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 139 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 197 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------ 76
           + + + IG GNFG  RL ++  T E VA+K     + I     +  + +R  +       
Sbjct: 6   FRVGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPIKSRAPQLHLEYRFYKQLSATEG 61
Query: 77  -PNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
            P +  F        + A+V+E    S  +LF+ +C+   F+         QLI+ + Y 
Sbjct: 62  VPQVYYFGP---XGKYNAMVLELLGPSLEDLFD-LCDR-TFTLKTVLMIAIQLITRMEYV 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPR----LKICDFGY--------SKSSVLHSQPKSTVGT 181
           H+  + +RD+K EN L+ G P  +    + I DFG         +K  + + + KS  GT
Sbjct: 117 HTKSLIYRDVKPENFLV-GRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGT 175
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
             Y++    L KE   +  D+ + G      L G+ P++
Sbjct: 176 ARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 213

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVK-----------YIERGDKIDENVQREI 68
            +RY L R IGSG+FG   L  D    E VA+K           +IE   KI + +Q  +
Sbjct: 8   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE--SKIYKMMQGGV 65
Query: 69  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQL 126
                     I   +       +  +VME    G   E + N  + +FS         Q+
Sbjct: 66  ---------GIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQM 114
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKS--------SVLHSQPKS 177
           IS + Y HS    HRD+K +N L+  G     + I DFG +K          + + + K+
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
             GT  Y +    L  E   +  D+ S G  L    +G+ P++  +     R+   RI  
Sbjct: 175 LTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISE 232
Query: 238 VQYSIP 243
            + S P
Sbjct: 233 KKMSTP 238

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 79  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 133
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 134 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 192 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVK-----------YIERGDKIDENVQREI 68
            +RY L R IGSG+FG   L  D    E VA+K           +IE   KI + +Q  +
Sbjct: 6   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE--SKIYKMMQGGV 63
Query: 69  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQL 126
                     I   +       +  +VME    G   E + N  + +FS         Q+
Sbjct: 64  ---------GIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQM 112
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKS--------SVLHSQPKS 177
           IS + Y HS    HRD+K +N L+  G     + I DFG +K          + + + K+
Sbjct: 113 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
             GT  Y +    L  E   +  D+ S G  L    +G+ P++  +     R+   RI  
Sbjct: 173 LTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISE 230
Query: 238 VQYSIP 243
            + S P
Sbjct: 231 KKMSTP 236

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 84  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 138
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 139 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 197 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 132 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 71  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 125
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 126 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 184 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 215

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 74  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAEGMN 128
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 129 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 186
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 187 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 218

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFGVA----RLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
           ++ ++ +GSG FG       +   +K +  VA+K +      K ++ +  E     S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 132 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 101/246 (41%), Gaps = 42/246 (17%)
Query: 12  MDMPIMHDSDRYEL----------VRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGD 58
           M+MP+++   + +L          + ++G   FG      L      E+  AV      D
Sbjct: 7   MEMPLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD 66
Query: 59  K----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICN 110
           K    + E  + E +    L+HPN+V    V+     L+++  Y S G+L E    R  +
Sbjct: 67  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 126
Query: 111 AGRFSEDEAR------------FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
           +   S D+ R                Q+ +G+ Y  S  V H+DL   N L+       +
Sbjct: 127 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNV 184
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPA----YIAPEVLLKKEYDGKIADVWSCGVTLY-VML 213
           KI D G  +  V  +     +G       ++APE ++  ++    +D+WS GV L+ V  
Sbjct: 185 KISDLGLFR-EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFS 242
Query: 214 VGAYPF 219
            G  P+
Sbjct: 243 YGLQPY 248

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 18/204 (8%)
Query: 72  RSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLI 127
           R   HPN++       +P   H  ++  +   G L+  +     F  D+++   F     
Sbjct: 62  RIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXA 121
Query: 128 SGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 185
            G ++ H+++  +    L   +  +D     R+   D  +S       Q       PA++
Sbjct: 122 RGXAFLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFS------FQSPGRXYAPAWV 175
Query: 186 APEVLLKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
           APE L KK  D   + AD WS  V L+ ++    PF D    +   K    +  ++ +IP
Sbjct: 176 APEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVA--LEGLRPTIP 233
Query: 244 DYVHISPECRHLISRIFVADPAKR 267
               ISP    L       DPAKR
Sbjct: 234 P--GISPHVSKLXKICXNEDPAKR 255

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 15/216 (6%)
Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
           +LV  +G+G  G    M        VAVK +++G    +    E    + L+H  +VR  
Sbjct: 16  KLVERLGAGQAGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 84  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
           DL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 134 DLRAANILVSDTLS--CKIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 199 IADVWSCGVTLYVMLV-GAYPF---EDPEEPKNFRK 230
            +DVWS G+ L  ++  G  P+    +PE  +N  +
Sbjct: 191 -SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 23  YELVRDIGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHR----SLRH 76
           ++ ++ +GSG FG V + +   + E++ + V  +E  +       +EI++      S+ +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 131
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 111 PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 165
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 188
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 166 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
            +L + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 224 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 255

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 21  DRYELVRDIGSGNFGV-----ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           ++  L+R++G G+FG+     AR +   + E  VAVK +     + E +  E +N  S+ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 74
Query: 76  HP----NIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGR--FSEDEARF 121
                 ++VR   V+       +VME  + G+L         E   N GR   +  E   
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
              ++  G++Y ++ +  HRDL   N ++       +KI DFG ++    +  + +    
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETAYYRKGGKG 192
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
           +    ++APE L    +    +D+WS GV L+
Sbjct: 193 LLPVRWMAPESLKDGVFTTS-SDMWSFGVVLW 223

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 32/223 (14%)
Query: 25  LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHP 77
            + ++G   FG      L      E+  AV      DK    + E  + E +    L+HP
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEAR------------F 121
           N+V    V+     L+++  Y S G+L E    R  ++   S D+ R             
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
              Q+ +G+ Y  S  V H+DL   N L+       +KI D G  +  V  +     +G 
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR-EVYAADYYKLLGN 189
Query: 182 PA----YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
                 ++APE ++  ++    +D+WS GV L+ V   G  P+
Sbjct: 190 SLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 17/236 (7%)
Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP-N 78
            ++Y L R IGSG+FG   L  +  + E VA+K +E        +  E   ++ ++    
Sbjct: 8   GNKYRLGRKIGSGSFGDIYLGANIASGEEVAIK-LECVKTKHPQLHIESKFYKMMQGGVG 66
Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSM 136
           I   K       +  +VME    G   E + N  + +FS         Q+IS + Y HS 
Sbjct: 67  IPSIKWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 137 QVCHRDLKLENTLLD-GSPAPRLKICDFGYSKS--------SVLHSQPKSTVGTPAYIAP 187
              HRD+K +N L+  G     + I DFG +K          + + + K+  GT  Y + 
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
              L  E   +  D+ S G  L    +G+ P++  +     R+   RI   + S P
Sbjct: 185 NTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMSTP 238

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 99/250 (39%), Gaps = 41/250 (16%)
Query: 25  LVRDIGSGNFG------VARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSL 74
           L+R +G G FG      V+ +  D    + VAVK +       D++D  ++  II+    
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPEVCSEQDELDFLMEALIIS--KF 90
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEARFFFQQLI 127
            H NIVR   V L      I+ME  +GG+L         R       +  +     + + 
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA 183
            G  Y       HRD+   N LL    P    KI DFG ++    +  + +    +    
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDP---------------EEPKN 227
           ++ PE  ++  +  K  D WS GV L+ +  +G  P+                  + PKN
Sbjct: 211 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN 269
Query: 228 FRKTIHRILS 237
               ++RI++
Sbjct: 270 CPGPVYRIMT 279

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 41/250 (16%)
Query: 25  LVRDIGSGNFG------VARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSL 74
           L+R +G G FG      V+ +  D    + VAVK +       D++D  ++  II+   L
Sbjct: 49  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPEVCSEQDELDFLMEALIIS--KL 105
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEARFFFQQLI 127
            H NIVR   V L      I++E  +GG+L         R       +  +     + + 
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA 183
            G  Y       HRD+   N LL    P    KI DFG ++    +  + +    +    
Sbjct: 166 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDP---------------EEPKN 227
           ++ PE  ++  +  K  D WS GV L+ +  +G  P+                  + PKN
Sbjct: 226 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN 284
Query: 228 FRKTIHRILS 237
               ++RI++
Sbjct: 285 CPGPVYRIMT 294

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 41/250 (16%)
Query: 25  LVRDIGSGNFG------VARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSL 74
           L+R +G G FG      V+ +  D    + VAVK +       D++D  ++  II+   L
Sbjct: 35  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPEVCSEQDELDFLMEALIIS--KL 91
Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEARFFFQQLI 127
            H NIVR   V L      I++E  +GG+L         R       +  +     + + 
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA 183
            G  Y       HRD+   N LL    P    KI DFG ++    +  + +    +    
Sbjct: 152 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDP---------------EEPKN 227
           ++ PE  ++  +  K  D WS GV L+ +  +G  P+                  + PKN
Sbjct: 212 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN 270
Query: 228 FRKTIHRILS 237
               ++RI++
Sbjct: 271 CPGPVYRIMT 280
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	363
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	0.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-155
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-150
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-118
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-116
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-116
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-116
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-114
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-114
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-113
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-113
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-111
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-110
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-110
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-108
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-106
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-105
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-105
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-100
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-96
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-94
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-93
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-93
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-92
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-92
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-91
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-91
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-90
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-90
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-90
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-90
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-90
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-89
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-89
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-89
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-89
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-89
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-88
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-88
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-87
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-87
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-87
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-87
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-87
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-86
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-86
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-86
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-86
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-86
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-86
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-84
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-84
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-84
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-83
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-83
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-83
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-82
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-82
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-81
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-81
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-79
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-76
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-75
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-75
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-73
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-73
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-71
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-70
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-68
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-66
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-65
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-64
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-64
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-64
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-64
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-63
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-62
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-62
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-62
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-61
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-61
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-61
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-60
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-60
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-59
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-59
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-59
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-59
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-58
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-58
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-57
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-57
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-56
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-56
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-56
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-55
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-55
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-48
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-48
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-48
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-47
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-09
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-47
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-47
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-47
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-46
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-46
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-46
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-45
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-45
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-45
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-44
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-44
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-44
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-44
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-44
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-43
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-43
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-42
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-42
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-42
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-42
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-42
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-42
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-41
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-41
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-41
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-41
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-40
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-40
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-40
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-39
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-39
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-39
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-37
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-37
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-36
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-35
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-35
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-35
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-34
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-34
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-34
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-34
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-33
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-33
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-33
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-33
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-33
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-32
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-32
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-32
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-30
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-30
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-30
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-29
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-29
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-29
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-29
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-27
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-26
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-25
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-24
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-23
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-21
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-21
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-21
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-21
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-20
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-20
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-20
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-19
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-18
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-18
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-15
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-15
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-15
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-12
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-08
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-04

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  588 bits (1519), Expect = 0.0
 Identities = 296/363 (81%), Positives = 334/363 (92%), Gaps = 2/363 (0%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERG  I
Sbjct: 1   MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59

Query: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
           FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
           TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 300
           SIPD + ISPEC HLISRIFVADPA RISIPEI+ H WFLKNLPADL+ ++ T +QF+EP
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299

Query: 301 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 360
           +QPMQS+D IMQII+EATIPA   + L+  +  +LD+DD+M +D D++ ++DIDSSGEIV
Sbjct: 300 EQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDM-DDFDSESEIDIDSSGEIV 358

Query: 361 YAM 363
           YA+
Sbjct: 359 YAL 361

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  439 bits (1130), Expect = e-155
 Identities = 99/325 (30%), Positives = 165/325 (50%), Gaps = 19/325 (5%)

Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
           M +P +   + ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57

Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
           V Y H + + HRD+K EN LLD      LKI DFG +     +++        GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDY 245
           PE+L ++E+  +  DVWSCG+ L  ML G  P++ P +  + +          +  +  +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKTYLNPW 231

Query: 246 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP----D 301
             I      L+ +I V +P+ RI+IP+I+   W+ K L         T+    E      
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFS 291

Query: 302 QPMQSIDEIMQIIAEATIPAAGTQS 326
           + +QS  +   + + +  P +G   
Sbjct: 292 KHIQSNLDFSPVNSASRTPGSGWSK 316

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  424 bits (1092), Expect = e-150
 Identities = 93/282 (32%), Positives = 151/282 (53%), Gaps = 15/282 (5%)

Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
           M +P +   + ++LV+ +G G +G  +L  ++ TEE VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57

Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
           V Y H + + HRD+K EN LLD      LKI DFG +     +++        GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDY 245
           PE+L ++E+  +  DVWSCG+ L  ML G  P++ P +  + +          +  +  +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKTYLNPW 231

Query: 246 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 287
             I      L+ +I V +P+ RI+IP+I+   W+ K L    
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  343 bits (881), Expect = e-118
 Identities = 113/271 (41%), Positives = 151/271 (55%), Gaps = 14/271 (5%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
            Y L   +G G FG  ++   + T   VAVK + R  KI        ++REI N +  RH
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P+I++  +VI TPT   +VMEY SGGELF+ IC  GR  E EAR  FQQ++S V YCH  
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            V HRDLK EN LLD       KI DFG S         +++ G+P Y APEV+  + Y 
Sbjct: 131 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           G   D+WSCGV LY +L G  PF+D   P  F+K    I    + IP+  +++     L+
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPE--YLNRSVATLL 242

Query: 257 SRIFVADPAKRISIPEIRNHEWFLKNLPADL 287
             +   DP KR +I +IR HEWF ++LP+ L
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  339 bits (871), Expect = e-116
 Identities = 107/295 (36%), Positives = 156/295 (52%), Gaps = 17/295 (5%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
            Y L++ IG GNF   +L R   T   VA+K I++  +++    + + RE+   + L HP
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           NIV+  EVI T   L ++MEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH  +
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
           + HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+   K+YDG
Sbjct: 135 IVHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
              DVWS GV LY ++ G+ PF+     +   +    +L  +Y IP Y+  S +C +L+ 
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFYM--STDCENLLK 246

Query: 258 RIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 312
           R  V +P KR ++ +I    W       D +          E D   Q   +IM 
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDEL----KPFVEPELDISDQKRIDIMV 297

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  344 bits (884), Expect = e-116
 Identities = 114/303 (37%), Positives = 164/303 (54%), Gaps = 14/303 (4%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
            Y L   +G G FG  ++ + + T   VAVK + R  KI        ++REI N +  RH
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRH 75

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P+I++  +VI TP+ + +VMEY SGGELF+ IC  GR  E E+R  FQQ++SGV YCH  
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            V HRDLK EN LLD       KI DFG S         +++ G+P Y APEV+  + Y 
Sbjct: 136 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           G   D+WS GV LY +L G  PF+D   P  F+K    I    +  P   +++P    L+
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQ--YLNPSVISLL 247

Query: 257 SRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 316
             +   DP KR +I +IR HEWF ++LP  L  ++ + +     D+ ++ + E  +   E
Sbjct: 248 KHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEE 307

Query: 317 ATI 319
             +
Sbjct: 308 EVL 310

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  333 bits (856), Expect = e-114
 Identities = 95/273 (34%), Positives = 133/273 (48%), Gaps = 15/273 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
            RY   R +G G F     + D  T+E+ A K + +         E +  EI  HRSL H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
            ++V F         + +V+E      L E        +E EAR++ +Q++ G  Y H  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
           +V HRDLKL N  L+      +KI DFG +       + K  + GTP YIAPEVL KK +
Sbjct: 135 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
             +  DVWS G  +Y +LVG  PFE        ++T  RI   +YSIP   HI+P    L
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASL 245

Query: 256 ISRIFVADPAKRISIPEIRNHEWFLKN-LPADL 287
           I ++   DP  R +I E+ N E+F    +PA L
Sbjct: 246 IQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  335 bits (860), Expect = e-114
 Identities = 123/303 (40%), Positives = 170/303 (56%), Gaps = 16/303 (5%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
            Y +   +G G+FG  +L    KT++ VA+K+I R   +        V+REI   + LRH
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRH 68

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P+I++  +VI TPT + +V+EYA GGELF+ I    R +EDE R FFQQ+I  + YCH  
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
           ++ HRDLK EN LLD +    +KI DFG S      +  K++ G+P Y APEV+  K Y 
Sbjct: 128 KIVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
           G   DVWSCG+ LYVMLVG  PF+D   P  F+K    + S  Y +PD   +SP  + LI
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPD--FLSPGAQSLI 239

Query: 257 SRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 316
            R+ VADP +RI+I EIR   WF  NLP  L         + +    +  + E M    +
Sbjct: 240 RRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRI-VSKLGEAMGFSED 298

Query: 317 ATI 319
             +
Sbjct: 299 YIV 301

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  331 bits (852), Expect = e-113
 Identities = 89/307 (28%), Positives = 145/307 (47%), Gaps = 25/307 (8%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLR 75
           +Y +   +G G++G  + + D +T    AVK +++  K+      + NV++EI   R LR
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLR 64

Query: 76  HPNIVRFKEVIL--TPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVS 131
           H N+++  +V+       + +VMEY   G  E+ + +    RF   +A  +F QLI G+ 
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPE 188
           Y HS  + H+D+K  N LL       LKI   G +++    +     +++ G+PA+  PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 189 VLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
           +      + G   D+WS GVTLY +  G YPFE      N  K    I    Y+IP    
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGKGSYAIPGD-- 235

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV-VDNTTNNQFEEPDQPMQS 306
             P    L+  +   +PAKR SI +IR H WF K  P     V    +   ++  + M  
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTV 295

Query: 307 IDEIMQI 313
           +  +  +
Sbjct: 296 VPYLEDL 302

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  331 bits (850), Expect = e-113
 Identities = 95/273 (34%), Positives = 133/273 (48%), Gaps = 15/273 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
            RY   R +G G F     + D  T+E+ A K + +         E +  EI  HRSL H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
            ++V F         + +V+E      L E        +E EAR++ +Q++ G  Y H  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
           +V HRDLKL N  L+      +KI DFG +       + K  + GTP YIAPEVL KK +
Sbjct: 161 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
             +  DVWS G  +Y +LVG  PFE        ++T  RI   +YSIP   HI+P    L
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASL 271

Query: 256 ISRIFVADPAKRISIPEIRNHEWFLKN-LPADL 287
           I ++   DP  R +I E+ N E+F    +PA L
Sbjct: 272 IQKMLQTDPTARPTINELLNDEFFTSGYIPARL 304

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  325 bits (836), Expect = e-111
 Identities = 78/270 (28%), Positives = 137/270 (50%), Gaps = 15/270 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
           + +++   +G G+F          T   VA+K I++       + + VQ E+  H  L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
           P+I+          ++ +V+E    GE+   + N    FSE+EAR F  Q+I+G+ Y HS
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
             + HRDL L N LL  +    +KI DFG +    +  +   T+ GTP YI+PE+  +  
Sbjct: 131 HGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           +  + +DVWS G   Y +L+G  PF+        + T+++++   Y +P    +S E + 
Sbjct: 189 HGLE-SDVWSLGCMFYTLLIGRPPFDT----DTVKNTLNKVVLADYEMPS--FLSIEAKD 241

Query: 255 LISRIFVADPAKRISIPEIRNHEWFLKNLP 284
           LI ++   +PA R+S+  + +H +  +N  
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  321 bits (826), Expect = e-110
 Identities = 96/296 (32%), Positives = 141/296 (47%), Gaps = 47/296 (15%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------------- 56
           +Y L  +IG G++GV +L  ++      A+K + +                         
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 57  --GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAG 112
                  E V +EI   + L HPN+V+  EV+  P   HL +V E  + G + E +    
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132

Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----K 167
             SED+ARF+FQ LI G+ Y H  ++ HRD+K  N L+       +KI DFG S      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGS 190

Query: 168 SSVLHSQPKSTVGTPAYIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
            ++L     +TVGTPA++APE L   +K + GK  DVW+ GVTLY  + G  PF D    
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246

Query: 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
               K    I S     PD   I+ + + LI+R+   +P  RI +PEI+ H W  +
Sbjct: 247 CLHSK----IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  321 bits (825), Expect = e-110
 Identities = 82/268 (30%), Positives = 138/268 (51%), Gaps = 14/268 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
           D +++ R +G G FG   L R+K+ + ++A+K + +       ++  ++REI     LRH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L   + YCH  
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
           +V HRD+K EN L+       LKI DFG+S  +    + ++  GT  Y+ PE++  K +D
Sbjct: 134 KVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHD 190

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D+W  GV  Y  LVG  PF+ P   +  R+    I++V    P ++  S   + LI
Sbjct: 191 EK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVNVDLKFPPFL--SDGSKDLI 243

Query: 257 SRIFVADPAKRISIPEIRNHEWFLKNLP 284
           S++    P +R+ +  +  H W   N  
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVKANSR 271

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  318 bits (816), Expect = e-108
 Identities = 86/268 (32%), Positives = 142/268 (52%), Gaps = 14/268 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
           + +E+ R +G G FG   L R+K+++ ++A+K + +       ++  ++RE+     LRH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
           +V HRD+K EN LL  +    LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 129 RVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D+WS GV  Y  LVG  PFE       +++T  RI  V+++ PD   ++   R LI
Sbjct: 186 EK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARDLI 238

Query: 257 SRIFVADPAKRISIPEIRNHEWFLKNLP 284
           SR+   +P++R  + E+  H W   N  
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSS 266

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  313 bits (804), Expect = e-106
 Identities = 83/282 (29%), Positives = 126/282 (44%), Gaps = 33/282 (11%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--------VQREIINHR 72
            +Y++   +GSG FG             VA+K++E+ D+I +         V  E++  +
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLK 101

Query: 73  SLRH--PNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISG 129
            +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIA 186
           V +CH+  V HRD+K EN L+D +    LK+ DFG     K +V         GT  Y  
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSP 216

Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
           PE +    Y G+ A VWS G+ LY M+ G  PFE  E           I+  Q       
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ-- 264

Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADL 287
            +S EC+HLI       P+ R +  EI+NH W     LP + 
Sbjct: 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 306

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  311 bits (800), Expect = e-105
 Identities = 77/284 (27%), Positives = 111/284 (39%), Gaps = 34/284 (11%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHR 72
             Y L   +G G FG             VA+K I R +++              E+    
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLW 89

Query: 73  SLR----HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLI 127
            +     HP ++R  +   T     +V+E      +LF+ I   G   E  +R FF Q++
Sbjct: 90  KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149

Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAY 184
           + + +CHS  V HRD+K EN L+D       K+ DFG                  GT  Y
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVY 204

Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
             PE + + +Y    A VWS G+ LY M+ G  PFE              IL  +   P 
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER----------DQEILEAELHFPA 254

Query: 245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 288
             H+SP+C  LI R     P+ R S+ EI    W         +
Sbjct: 255 --HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPL 296

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  310 bits (797), Expect = e-105
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 24/273 (8%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIINHR 72
           +Y  +  +GSG FG      DK+  + V VK+I++          D     V  EI    
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 73  SLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
            + H NI++  ++        +VME + SG +LF  I    R  E  A + F+QL+S V 
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           Y     + HRD+K EN ++       +K+ DFG +          +  GT  Y APEVL+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
              Y G   ++WS GVTLY ++    PF + EE           +      P  V  S E
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPPYLV--SKE 250

Query: 252 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
              L+S +    P +R ++ ++    W  + + 
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  298 bits (765), Expect = e-100
 Identities = 60/315 (19%), Positives = 112/315 (35%), Gaps = 59/315 (18%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------GDKIDE 62
           + Y ++R +  G F    L    K  +  A+K  E+                       +
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 63  NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------RF 114
           + + E+     +++   +  + +I     + I+ EY     + +                
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 115 SEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
                +   + +++  SY H+   +CHRD+K  N L+D +   R+K+ DFG S+      
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDKK 206

Query: 171 LHSQPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
           +      + GT  ++ PE    +  Y+G   D+WS G+ LYVM     PF       +  
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SLV 259

Query: 230 KTIHRILSVQYSIPDYV-----------------HISPECRHLISRIFVADPAKRISIPE 272
           +  + I +     P                     +S E    +      +PA+RI+  +
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319

Query: 273 IRNHEWFLKNLPADL 287
              HEW       DL
Sbjct: 320 ALKHEWLADTNIEDL 334

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  287 bits (738), Expect = 1e-96
 Identities = 95/271 (35%), Positives = 143/271 (52%), Gaps = 12/271 (4%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHP 77
           +  Y L   IG G++G  ++   K T    A K I +   ++  +  ++EI   +SL HP
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHP 66

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           NI+R  E     T + +VME  +GGELFER+ +   F E +A    + ++S V+YCH + 
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126

Query: 138 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
           V HRDLK EN L    SP   LK+ DFG +         ++ VGTP Y++P+V L+  Y 
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV-LEGLY- 184

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRH 254
           G   D WS GV +YV+L G  PF  P + +   K    I    ++    D++++SP+   
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAES 240

Query: 255 LISRIFVADPAKRISIPEIRNHEWFLKNLPA 285
           LI R+    P +RI+  +   HEWF K L +
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  281 bits (721), Expect = 4e-94
 Identities = 89/276 (32%), Positives = 137/276 (49%), Gaps = 11/276 (3%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
           SD Y++  ++G G F V R    K T    A K I       +  + ++RE    R L+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNIVR  + I   +   +V +  +GGELFE I     +SE +A    QQ++  ++YCHS 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            + HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL K  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
             K  D+W+CGV LY++LVG  PF D ++ + + +    I +  Y    P++  ++PE +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 239

Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVV 289
            LI  +   +P KRI+  +     W          +
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 275

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  282 bits (723), Expect = 8e-94
 Identities = 87/286 (30%), Positives = 130/286 (45%), Gaps = 20/286 (6%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
            D Y + + +GSG  G  +L  ++KT + VA+K I +               NV+ EI  
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
            + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127

Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
            Y H   + HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187

Query: 190 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYSIPDYV 246
           L+        +  D WS GV L++ L G  PF +     +   +    I S +Y+    V
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSGKYNFIPEV 243

Query: 247 --HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
              +S +   L+ ++ V DP  R +  E   H W           D
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  280 bits (718), Expect = 3e-93
 Identities = 64/304 (21%), Positives = 118/304 (38%), Gaps = 41/304 (13%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
           +  + L   +G G        R KKT +L A+K        +  +   RE    + L H 
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67

Query: 78  NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
           NIV+   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G+++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
                + HR++K  N +       +   K+ DFG ++      Q  S  GT  Y+ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 191 --------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS- 241
                    +K+Y     D+WS GVT Y    G+ PF   E P+  ++ +++I++ + S 
Sbjct: 188 ERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 242 ------------------IPDYVHISPECR----HLISRIFVADPAKRISIPEIRNHEWF 279
                             +P    +S   +     +++ I  AD  K     +       
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 280 LKNL 283
           + + 
Sbjct: 307 ILHR 310

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  278 bits (713), Expect = 6e-93
 Identities = 83/268 (30%), Positives = 131/268 (48%), Gaps = 14/268 (5%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKID-ENVQREIINHRSLRHP 77
            D +   R +GSG FG   L+ ++ +     +K I     ++  E ++ EI   +SL HP
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYC 133
           NI++  EV     ++ IVME   GGEL ERI          SE       +Q+++ ++Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 134 HSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           HS  V H+DLK EN L    SP   +KI DFG ++         +  GT  Y+APEV  K
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FK 199

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPE 251
           ++   K  D+WS GV +Y +L G  PF      +  +K        + +   +   ++P+
Sbjct: 200 RDVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQ 254

Query: 252 CRHLISRIFVADPAKRISIPEIRNHEWF 279
              L+ ++   DP +R S  ++ +HEWF
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  280 bits (717), Expect = 4e-92
 Identities = 68/348 (19%), Positives = 128/348 (36%), Gaps = 41/348 (11%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
           +  + L   +G G        R KKT +L A+K        +  +   RE    + L H 
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67

Query: 78  NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
           NIV+   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G+++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
                + HR++K  N +       +   K+ DFG ++      Q  S  GT  Y+ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 191 --------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS- 241
                    +K+Y     D+WS GVT Y    G+ PF   E P+  ++ +++I++ + S 
Sbjct: 188 ERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 242 ------------------IPDYVHISP----ECRHLISRIFVADPAKRISIPEIRNHEWF 279
                             +P    +S         +++ I  AD  K     +       
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 280 LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSL 327
           + +     V         +       +     +++ + T   +  Q L
Sbjct: 307 ILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQEL 354

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  280 bits (718), Expect = 7e-92
 Identities = 84/274 (30%), Positives = 130/274 (47%), Gaps = 18/274 (6%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
            D Y + + +GSG  G  +L  ++KT + VA++ I +               NV+ EI  
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
            + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252

Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
            Y H   + HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312

Query: 190 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDY 245
           L+        +  D WS GV L++ L G  PF +     + +    +I S +Y+     +
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD---QITSGKYNFIPEVW 369

Query: 246 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
             +S +   L+ ++ V DP  R +  E   H W 
Sbjct: 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  274 bits (703), Expect = 5e-91
 Identities = 90/285 (31%), Positives = 142/285 (49%), Gaps = 12/285 (4%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-NVQREIINHRSLRHPN 78
              +  +  +GSG F    L++ + T +L A+K I++     + +++ EI   + ++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           IV  +++  + TH  +VM+  SGGELF+RI   G ++E +A    QQ++S V Y H   +
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127

Query: 139 CHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYD 196
            HRDLK EN L        ++ I DFG SK  +  +    +  GTP Y+APEVL +K Y 
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY- 184

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRH 254
            K  D WS GV  Y++L G  PF +  E K F K    I    Y    P +  IS   + 
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKD 240

Query: 255 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 299
            I  +   DP +R +  +  +H W   N      +  + + Q ++
Sbjct: 241 FICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQIQK 285

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  273 bits (701), Expect = 6e-91
 Identities = 85/286 (29%), Positives = 131/286 (45%), Gaps = 24/286 (8%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREI- 68
            + YE    +G G   V R    K T +  AVK I          E   ++ E   +E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 69  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
           I  +   HPNI++ K+   T T   +V +    GELF+ +      SE E R   + L+ 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135

Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
            +   H + + HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193

Query: 189 VLLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI- 242
           ++     D     GK  D+WS GV +Y +L G+ PF   ++    R     I+S  Y   
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFG 249

Query: 243 -PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 287
            P++   S   + L+SR  V  P KR +  E   H +F + +  ++
Sbjct: 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  273 bits (701), Expect = 1e-90
 Identities = 64/279 (22%), Positives = 113/279 (40%), Gaps = 26/279 (9%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
            Y +++ IGSG       + ++K + + A+KY+   +  +   ++ + EI     L+  +
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 79  --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
            + H DLK  N L+       LK+ DFG +             S VGT  Y+ PE +   
Sbjct: 147 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
                           +DVWS G  LY M  G  PF+      N    +H I+   + I 
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---IINQISKLHAIIDPNHEIE 260

Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
                  + + ++      DP +RISIPE+  H +    
Sbjct: 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  271 bits (696), Expect = 3e-90
 Identities = 94/269 (34%), Positives = 145/269 (53%), Gaps = 12/269 (4%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
           ++RY +V  +G G+FG     +D+ T++  AVK I +    +K    + RE+   + L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI++  E++   +   IV E  +GGELF+ I    RFSE +A    +Q+ SG++Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            + HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEV L+  Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
           D K  DVWS GV LY++L G  PF    E    ++    + + +Y+  +P +  IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAK 254

Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKN 282
            LI ++    P+ RI+  +   H W  K 
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  283 bits (726), Expect = 3e-90
 Identities = 85/371 (22%), Positives = 139/371 (37%), Gaps = 36/371 (9%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
             +E+   +G+G FG       + T E VA+K   +    K  E    EI   + L HPN
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73

Query: 79  IVRFKEVILTPTHLA------IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISG 129
           +V  +EV      LA      + MEY  GG+L + +    N     E   R     + S 
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 130 VSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
           + Y H  ++ HRDLK EN +L  G      KI D GY+K           VGT  Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193

Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------- 234
           +L +K+Y     D WS G   +  + G  PF    +P  +   +                
Sbjct: 194 LLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252

Query: 235 ILSVQYSIPDYVHISPECRHLISRIF----VADPAKRISIPEIRNHEWF-----LKNLPA 285
            +     +P   H+S      + R      +    +R + P+  N   F     + +L  
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312

Query: 286 DLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDI 345
             V++  +      P    +++  +   + + T      Q L Q    +L+    + + +
Sbjct: 313 LSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLALNSAQPLTQYV 372

Query: 346 DTDPDLDIDSS 356
                +D    
Sbjct: 373 IDCTVIDGRQG 383

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  274 bits (702), Expect = 4e-90
 Identities = 90/273 (32%), Positives = 137/273 (50%), Gaps = 11/273 (4%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKID-ENVQREIINHRSLRH 76
           SD Y++  ++G G F V R    K T    A K I   +    D + ++RE    R L+H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNIVR  + I   +   +V +  +GGELFE I     +SE +A    QQ++  ++YCHS 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147

Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            + HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL K  Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
             K  D+W+CGV LY++LVG  PF D ++ + + +    I +  Y    P++  ++PE +
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 262

Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 286
            LI  +   +P KRI+  +     W        
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWICNRERVA 295

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  273 bits (699), Expect = 5e-90
 Identities = 67/331 (20%), Positives = 127/331 (38%), Gaps = 32/331 (9%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
            Y +++ IGSG       + ++K + + A+KY+   +  +   ++ + EI     L+  +
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 79  --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
            + H DLK  N L+       LK+ DFG +             S VGT  Y+ PE +   
Sbjct: 128 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
                           +DVWS G  LY M  G  PF+      +    +H I+   + I 
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIE 241

Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 303
                  + + ++      DP +RISIPE+  H +          +   T  + +     
Sbjct: 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMK----- 296

Query: 304 MQSIDEIMQIIAEATIPAAGTQSLNQCLNGS 334
              + +++ + +  +I  A          G 
Sbjct: 297 -YVLGQLVGLNSPNSILKAAKTLYEHYSGGE 326

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  272 bits (697), Expect = 1e-89
 Identities = 88/266 (33%), Positives = 128/266 (48%), Gaps = 11/266 (4%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
           +D YE+  DIG G++ V +    K T    AVK I   DK   +   EI I  R  +HPN
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPN 77

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           I+  K+V     ++ +V E   GGEL ++I     FSE EA      +   V Y H+  V
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137

Query: 139 CHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
            HRDLK  N L          ++ICDFG++K     +    T   T  ++APEVL ++ Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HISPECR 253
           D    D+WS GV LY ML G  PF          + + RI S ++S+       +S   +
Sbjct: 198 D-AACDIWSLGVLLYTMLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255

Query: 254 HLISRIFVADPAKRISIPEIRNHEWF 279
            L+S++   DP +R++   +  H W 
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWI 281

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  273 bits (699), Expect = 1e-89
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 23/279 (8%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREI-I 69
             +Y+    IG G   V R    + T    AVK +E           +++ E  +RE  I
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 70  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
             +   HP+I+   +   + + + +V +    GELF+ +      SE E R   + L+  
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           VS+ H+  + HRDLK EN LLD +    +++ DFG+S       + +   GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDN-MQ-IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270

Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
           L     +     GK  D+W+CGV L+ +L G+ PF    +    R     I+  QY    
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSS 326

Query: 245 YV--HISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
                 S   + LISR+   DP  R++  +   H +F +
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  272 bits (697), Expect = 4e-89
 Identities = 62/306 (20%), Positives = 120/306 (39%), Gaps = 26/306 (8%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
            Y +++ IGSG       + ++  +++ A+KY+   +  +   ++ + EI     L+  +
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 79  --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKK 193
            + H DLK  N L+       LK+ DFG +      +      S VG   Y+ PE +   
Sbjct: 175 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
                           +DVWS G  LY M  G  PF+      +    +H I+   + I 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIE 288

Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 303
                  + + ++      DP +RISIPE+  H +          +   T  + +     
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQ 348

Query: 304 MQSIDE 309
           +  ++ 
Sbjct: 349 LVGLNS 354

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  270 bits (692), Expect = 6e-89
 Identities = 78/317 (24%), Positives = 129/317 (40%), Gaps = 58/317 (18%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKID-ENVQREIINHRS 73
             +Y L   IG G++GV R+  + +T  + A+K + +      +  D E ++ E+   + 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
           L HPNI R  EV     ++ +VME   GG L +++                         
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 114 --------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
                                 E       +Q+ S + Y H+  +CHRD+K EN L   +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204

Query: 154 PAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYD-GKIADVWSCGV 207
            +  +K+ DFG SK     +        +  GTP ++APEVL       G   D WS GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264

Query: 208 TLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVADPA 265
            L+++L+GA PF    +     +    +L+ +     P+Y  +SP  R L+S +   +  
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320

Query: 266 KRISIPEIRNHEWFLKN 282
           +R        H W  + 
Sbjct: 321 ERFDAMRALQHPWISQF 337

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  268 bits (688), Expect = 6e-89
 Identities = 74/291 (25%), Positives = 116/291 (39%), Gaps = 39/291 (13%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           +  +E +  +G G FG     R+       A+K I   ++    +  E++   SL H  +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64

Query: 80  VRFKEVIL-------------TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQ 125
           VR+    L               + L I MEY   G L++ I +       DE    F+Q
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124

Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SV 170
           ++  +SY HS  + HRDLK  N  +D S    +KI DFG +K+                 
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
                 S +GT  Y+A EVL    +  +  D++S G+  + M+   YPF    E  N  K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILK 239

Query: 231 TIHRILSVQYSIPDYV--HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
              ++ SV    P     +     + +I  +   DP KR     + N  W 
Sbjct: 240 ---KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  267 bits (685), Expect = 1e-88
 Identities = 90/271 (33%), Positives = 142/271 (52%), Gaps = 16/271 (5%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
            D YE+  ++GSG F + R  R K T +  A K+I        R     E ++RE+   R
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
            +RHPNI+   ++    T + +++E  SGGELF+ +      +EDEA  F +Q++ GV Y
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123

Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            HS ++ H DLK EN +L     P PR+K+ DFG +      ++ K+  GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
             +   G  AD+WS GV  Y++L GA PF    + +        I +V Y   +  + + 
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSNT 238

Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           S   +  I R+ V DP +R++I +   H W 
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  271 bits (696), Expect = 9e-88
 Identities = 105/339 (30%), Positives = 166/339 (48%), Gaps = 22/339 (6%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
           ++RY +V  +G G+FG     +D+ T++  AVK I +    +K    + RE+   + L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI++  E++   +   IV E  +GGELF+ I    RFSE +A    +Q+ SG++Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            + HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEV L+  Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECR 253
           D K  DVWS GV LY++L G  PF      KN    + R+ +    + +P +  IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYG----KNEYDILKRVETGKYAFDLPQWRTISDDAK 254

Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQI 313
            LI ++    P+ RI+  +   H W  K       + +  + +         ++  I Q 
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE--------SAMTNIRQF 306

Query: 314 IAEATIPAAGTQSLNQCLNGSLDIDD--EMDEDIDTDPD 350
            AE  +  A    +   L    +     E+   +DT+ D
Sbjct: 307 QAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNND 345

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  266 bits (683), Expect = 1e-87
 Identities = 90/283 (31%), Positives = 147/283 (51%), Gaps = 17/283 (6%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
            D Y+   ++GSG F V +  R+K T    A K+I        R     E+++RE+   +
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
            ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129

Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
             +   G  AD+WS GV  Y++L GA PF    + +        + +V Y   D  + + 
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNT 244

Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDN 291
           S   +  I R+ V DP KR++I +   H W +K       +  
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPW-IKPKDTQQALSR 286

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  266 bits (682), Expect = 1e-87
 Identities = 96/277 (34%), Positives = 142/277 (51%), Gaps = 14/277 (5%)

Query: 20  SDRYEL---VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLR 75
              Y+L    + +G G+F + R    KK+ +  AVK I +  +++ N Q+EI        
Sbjct: 7   YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEG 64

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           HPNIV+  EV     H  +VME  +GGELFERI     FSE EA +  ++L+S VS+ H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124

Query: 136 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKK 193
           + V HRDLK EN L  D +    +KI DFG+++     +QP K+   T  Y APE+L + 
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---HRILSVQYS--IPDYVHI 248
            YD +  D+WS GV LY ML G  PF+  +        +    +I    +S     + ++
Sbjct: 185 GYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243

Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 285
           S E + LI  +   DP KR+ +  +R +EW       
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  266 bits (681), Expect = 1e-87
 Identities = 86/284 (30%), Positives = 140/284 (49%), Gaps = 16/284 (5%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
            D Y++  ++GSG F + +  R+K T    A K+I        R     E ++RE+   R
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
            + H N++   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            H+ ++ H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
             +   G  AD+WS GV  Y++L GA PF    + +        I SV Y   +  + H 
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITSVSYDFDEEFFSHT 245

Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNT 292
           S   +  I ++ V +  KR++I E   H W         +V   
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRE 289

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  266 bits (683), Expect = 3e-87
 Identities = 86/284 (30%), Positives = 140/284 (49%), Gaps = 16/284 (5%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
            D Y++  ++GSG F + +  R+K T    A K+I        R     E ++RE+   R
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
            + HPNI+   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            H+ ++ H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
             +   G  AD+WS GV  Y++L GA PF    + +        I +V Y   +  +   
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITAVSYDFDEEFFSQT 245

Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNT 292
           S   +  I ++ V +  KR++I E   H W         +V   
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRE 289

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  266 bits (681), Expect = 3e-87
 Identities = 95/283 (33%), Positives = 150/283 (53%), Gaps = 9/283 (3%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           SD +E+  ++G G   +    + K T++  A+K +++     + V+ EI     L HPNI
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNI 110

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           ++ KE+  TPT +++V+E  +GGELF+RI   G +SE +A    +Q++  V+Y H   + 
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170

Query: 140 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
           HRDLK EN L    +P   LKI DFG SK        K+  GTP Y APE+L    Y G 
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GP 229

Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLI 256
             D+WS G+  Y++L G  PF D    +  +    RIL+ +Y    P +  +S   + L+
Sbjct: 230 EVDMWSVGIITYILLCGFEPFYD---ERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286

Query: 257 SRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 299
            ++ V DP KR++  +   H W +    A+ V  +T   + +E
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPW-VTGKAANFVHMDTAQKKLQE 328

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  268 bits (688), Expect = 1e-86
 Identities = 103/303 (33%), Positives = 152/303 (50%), Gaps = 15/303 (4%)

Query: 3   RSAMTVGPGM--DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---G 57
              +   PGM         SDRY+  R +G G+FG   L +DK T +  AVK I +    
Sbjct: 6   MDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK 65

Query: 58  DKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 116
            K D E++ RE+   + L HPNI++  E      +  +V E  +GGELF+ I +  RFSE
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125

Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP 175
            +A    +Q++SG++Y H  ++ HRDLK EN LL+  S    ++I DFG S       + 
Sbjct: 126 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185

Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
           K  +GT  YIAPEV L   YD K  DVWS GV LY++L G  PF       N    + ++
Sbjct: 186 KDKIGTAYYIAPEV-LHGTYDEK-CDVWSTGVILYILLSGCPPFNG----ANEYDILKKV 239

Query: 236 LS--VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTT 293
                 + +P +  +S   + LI ++    P+ RIS  +  +HEW        + VD  +
Sbjct: 240 EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPS 299

Query: 294 NNQ 296
            + 
Sbjct: 300 LDN 302

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  268 bits (687), Expect = 3e-86
 Identities = 90/272 (33%), Positives = 142/272 (52%), Gaps = 12/272 (4%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
           S+ Y+ V+ +GSG +G   L RDK T    A+K I +       +  +  E+   + L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI++  +      +  +VME   GGELF+ I +  +F+E +A    +Q++SGV+Y H  
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            + HRDLK EN LL        +KI DFG S       + K  +GT  YIAPEV L+K+Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRKKY 214

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
           D K  DVWS GV L+++L G  PF      +  ++ + ++   +Y+   P++ ++S   +
Sbjct: 215 DEK-CDVWSIGVILFILLAGYPPFGG----QTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269

Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKNLPA 285
            LI ++   D  +RIS  +   H W  +    
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  262 bits (672), Expect = 3e-86
 Identities = 64/281 (22%), Positives = 118/281 (41%), Gaps = 8/281 (2%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
            ++Y +  D+G G FG+     +  +++    K+++        V++EI      RH NI
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
           +   E   +   L ++ E+ SG ++FERI  +    +E E   +  Q+   + + HS  +
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            H D++ EN +     +  +KI +FG ++        +     P Y APEV         
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-ST 182

Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLI 256
             D+WS G  +YV+L G  PF      +        I++ +Y+  +  +  IS E    +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDFV 238

Query: 257 SRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQF 297
            R+ V +   R++  E   H W  + +         T    
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHR 279

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  264 bits (676), Expect = 6e-86
 Identities = 80/325 (24%), Positives = 138/325 (42%), Gaps = 11/325 (3%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
            D Y+++ ++GSG FGV     +K T  +   K+I     +D   V+ EI     L HP 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQ 137
           ++   +       + +++E+ SGGELF+RI     + SE E   + +Q   G+ + H   
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
           + H D+K EN + +   A  +KI DFG +         K T  T  + APE++ ++   G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHL 255
              D+W+ GV  YV+L G  PF      ++  +T+  +    +      +  +SPE +  
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAG----EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284

Query: 256 ISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 315
           I  +   +P KR+++ +   H W   +         ++           +  D      A
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPA 344

Query: 316 EATIPAAGTQSLNQCLNGSLDIDDE 340
              I  A   SL +       I D 
Sbjct: 345 IGRI--ANFSSLRKHRPQEYQIYDS 367

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  267 bits (684), Expect = 9e-86
 Identities = 102/352 (28%), Positives = 162/352 (46%), Gaps = 38/352 (10%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--------------GDKIDENVQ 65
            + Y  VR +GSG +G   L ++K      A+K I++               +K  E + 
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 66  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
            EI   +SL HPNI++  +V     +  +V E+  GGELFE+I N  +F E +A    +Q
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154

Query: 126 LISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
           ++SG+ Y H   + HRD+K EN LL + +    +KI DFG S       + +  +GT  Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214

Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSI 242
           IAPEV LKK+Y+ K  DVWSCGV +Y++L G  PF      +N +  I ++      +  
Sbjct: 215 IAPEV-LKKKYNEK-CDVWSCGVIMYILLCGYPPFGG----QNDQDIIKKVEKGKYYFDF 268

Query: 243 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQ 302
            D+ +IS E + LI  +   D  KR +  E  N  W  K             N   + DQ
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY-----------ANNINKSDQ 317

Query: 303 PMQS--IDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDD--EMDEDIDTDPD 350
                 +  + +      +  A    +   L    +  +  ++ + +D + D
Sbjct: 318 KTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGD 369

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  265 bits (680), Expect = 9e-86
 Identities = 101/356 (28%), Positives = 165/356 (46%), Gaps = 37/356 (10%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
           ++ Y+L  ++G G F V R        +  A   I        D + ++RE    R L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNIVR  + I    H  ++ +  +GGELFE I     +SE +A    QQ++  V +CH M
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129

Query: 137 QVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
            V HR+LK EN LL     G+    +K+ DFG +       Q      GTP Y++PEVL 
Sbjct: 130 GVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHIS 249
           K  Y GK  D+W+CGV LY++LVG  PF D ++ + +++    I +  Y    P++  ++
Sbjct: 187 KDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVT 241

Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQS--I 307
           PE + LI+++   +P+KRI+  E   H W                          +   +
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTV--------------ASCMHRQETV 287

Query: 308 DEIMQIIAEATIPAAGTQSLNQCLNGSL---DIDDEMDEDIDTDPDLDIDSSGEIV 360
           D + +  A   +  A    +    N S+   +I    ++ I+   + D +S  ++ 
Sbjct: 288 DCLKKFNARRKLKGAILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDFESYTKMC 343

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  258 bits (662), Expect = 1e-84
 Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 15/279 (5%)

Query: 20  SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREI-INHRSL 74
           ++ Y L  +++G G F V R    K T +  A K+++   RG      +  EI +   + 
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSY 132
             P ++   EV    + + +++EYA+GGE+F       A   SE++     +Q++ GV Y
Sbjct: 87  SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146

Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
            H   + H DLK +N LL    P   +KI DFG S+      + +  +GTP Y+APE+L 
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
                    D+W+ G+  Y++L    PF   +  + +      I  V     +  +  +S
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVS 261

Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 288
                 I  + V +P KR +     +H W  +    +L 
Sbjct: 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  260 bits (665), Expect = 4e-84
 Identities = 92/294 (31%), Positives = 145/294 (49%), Gaps = 16/294 (5%)

Query: 3   RSAMTVGPGMDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
                V  G+ +      D Y++  + +G G  G    + +K+T+E  A+K ++      
Sbjct: 43  FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----C 98

Query: 62  ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 114
              +RE+ ++ R+ + P+IVR  +V          L IVME   GGELF RI + G   F
Sbjct: 99  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158

Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 173
           +E EA    + +   + Y HS+ + HRD+K EN L     P   LK+ DFG++K +  H+
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218

Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
              +   TP Y+APEVL  ++YD K  D+WS GV +Y++L G  PF              
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277

Query: 234 RILSVQYSIPDYV--HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 285
           RI   QY  P+     +S E + LI  +   +P +R++I E  NH W +++   
Sbjct: 278 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  257 bits (660), Expect = 5e-84
 Identities = 84/277 (30%), Positives = 132/277 (47%), Gaps = 20/277 (7%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRS 73
            D YEL   IG G F V R   +++T +  AVK ++            E+++RE      
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISG 129
           L+HP+IV   E   +   L +V E+  G +L   I         +SE  A  + +Q++  
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142

Query: 130 VSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAP 187
           + YCH   + HRD+K    LL     +  +K+  FG +             VGTP ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202

Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDY 245
           EV+ ++ Y GK  DVW CGV L+++L G  PF   +E     +    I+  +Y      +
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQW 256

Query: 246 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
            HIS   + L+ R+ + DPA+RI++ E  NH W  + 
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  257 bits (659), Expect = 1e-83
 Identities = 81/286 (28%), Positives = 135/286 (47%), Gaps = 11/286 (3%)

Query: 20  SDRYELVR--DIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRH 76
           +  Y + +   +G G FG      +  T   +A K I+ RG K  E V+ EI     L H
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
            N+++  +   +   + +VMEY  GGELF+RI +     +E +   F +Q+  G+ + H 
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           M + H DLK EN L     A ++KI DFG ++      + K   GTP ++APEV +  ++
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDF 264

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
                D+WS GV  Y++L G  PF    + +        IL+ ++     ++  IS E +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN----ILACRWDLEDEEFQDISEEAK 320

Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 299
             IS++ + + + RIS  E   H W   +     +      N+  +
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSD 366

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  255 bits (654), Expect = 3e-83
 Identities = 81/278 (29%), Positives = 131/278 (47%), Gaps = 19/278 (6%)

Query: 20  SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHP 77
           +D Y+L +  +G G  G       ++T +  A+K +          ++E+  + ++   P
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGP 82

Query: 78  NIVRFKEVILTPTHLA----IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVS 131
           +IV   +V     H      I+ME   GGELF RI   G   F+E EA    + + + + 
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 132 YCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV 189
           + HS  + HRD+K EN L         LK+ DFG++K         ++   TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--H 247
           L  ++YD K  D+WS GV +Y++L G  PF              RI   QY  P+     
Sbjct: 201 LGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 285
           +S + + LI  +   DP +R++I +  NH W  +++  
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  261 bits (669), Expect = 9e-83
 Identities = 81/267 (30%), Positives = 133/267 (49%), Gaps = 9/267 (3%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
            D Y++  ++G+G FGV   + ++ T    A K++    + D E V++EI     LRHP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
           +V   +       + ++ E+ SGGELFE++ +   + SEDEA  + +Q+  G+ + H   
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
             H DLK EN +     +  LK+ DFG +         K T GT  + APEV   K   G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHL 255
              D+WS GV  Y++L G  PF      +N  +T+  + S  +++ D  +  IS + +  
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390

Query: 256 ISRIFVADPAKRISIPEIRNHEWFLKN 282
           I ++ +ADP  R++I +   H W    
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPG 417

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  252 bits (647), Expect = 1e-82
 Identities = 81/295 (27%), Positives = 123/295 (41%), Gaps = 31/295 (10%)

Query: 20  SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREI-INHRSLRH 76
            D Y+L  D +G G     +   +  T +  AVK IE +   I   V RE+ + ++   H
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
            N++   E         +V E   GG +   I     F+E EA    Q + S + + H+ 
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130

Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 186
            + HRDLK EN L +     +P +KICDF            S +   +  +  G+  Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 187 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPF-----------EDPEEPKNFRKT 231
           PEV+     +     K  D+WS GV LY++L G  PF                P      
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249

Query: 232 IHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
              I   +Y     D+ HIS   + LIS++ V D  +R+S  ++  H W     P
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  251 bits (644), Expect = 4e-82
 Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 26/285 (9%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHP 77
           D+  Y  ++ +G G F    L+         A+K I   ++ D E  QRE   HR   HP
Sbjct: 27  DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86

Query: 78  NIVRFKEVILTPT----HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISG 129
           NI+R     L          +++ +   G L+  I          +ED+  +    +  G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----------V 179
           +   H+    HRDLK  N LL      +  + D G    + +H +               
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 180 GTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
            T +Y APE+   + +    +  DVWS G  LY M+ G  P++   +  +   ++   + 
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQ 261

Query: 238 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
            Q SIP     S     L++ +   DP +R  IP + +    L+ 
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  250 bits (640), Expect = 5e-81
 Identities = 80/314 (25%), Positives = 151/314 (48%), Gaps = 22/314 (7%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
           ++Y  ++ IG G+FG A L++  +      +K I          E  +RE+    +++HP
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHS 135
           NIV+++E       L IVM+Y  GG+LF+RI       F ED+   +F Q+   + + H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
            ++ HRD+K +N  L       +++ DFG ++  +      ++ +GTP Y++PE+   K 
Sbjct: 144 RKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECR 253
           Y+ K +D+W+ G  LY +    + FE      + +  + +I+S  +  +    H S + R
Sbjct: 202 YNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFPPVSL--HYSYDLR 254

Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQI 313
            L+S++F  +P  R S+  I    +  K +      +   + Q    +  +++  +    
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRI------EKFLSPQLIAEEFCLKTFSKFGSQ 308

Query: 314 IAEATIPAAGTQSL 327
              A  PA+G  S+
Sbjct: 309 PIPAKRPASGQNSI 322

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  247 bits (633), Expect = 6e-81
 Identities = 81/279 (29%), Positives = 133/279 (47%), Gaps = 25/279 (8%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
           + YE++  IG+G++G  + +R K   +++  K ++ G   +   + +  E+   R L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 78  NIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
           NIVR+ + I+  T   L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 132 YCHSM-----QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYI 185
            CH        V HRDLK  N  LDG     +K+ DFG ++  +   S  K+ VGTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPD 244
           +PE + +  Y+ K +D+WS G  LY +     PF       + ++   +I   ++  IP 
Sbjct: 184 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY 238

Query: 245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 283
               S E   +I+R+       R S+ EI  +   L++ 
Sbjct: 239 --RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  243 bits (622), Expect = 4e-79
 Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 34/282 (12%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
             ++ +  IGSG FG     + +   +   +K +      +E  +RE+     L H NIV
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIV 67

Query: 81  RFKEVILTPTH----------------LAIVMEYASGGELFERI--CNAGRFSEDEARFF 122
            +        +                L I ME+   G L + I      +  +  A   
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127

Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
           F+Q+  GV Y HS ++ +RDLK  N  L  +   ++KI DFG   S     +   + GT 
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKNDGKRTRSKGTL 185

Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242
            Y++PE +  ++Y  +  D+++ G+ L  +L          E   F   +         I
Sbjct: 186 RYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDT---AFETSKFFTDLRDG-----II 236

Query: 243 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
            D      + + L+ ++    P  R +  EI       K  P
Sbjct: 237 SD--IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  238 bits (608), Expect = 2e-76
 Identities = 71/292 (24%), Positives = 117/292 (40%), Gaps = 39/292 (13%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSLR-HPNI 79
           R  + R +  G F      +D  +    A+K +   ++     + +E+   + L  HPNI
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 80  VRF-------KEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISG 129
           V+F       KE   T     +++     G+L E +      G  S D     F Q    
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 130 VSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------- 178
           V + H  +  + HRDLK+EN LL       +K+CDFG + +   +     +         
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 179 ----VGTPAYIAPEV--LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
                 TP Y  PE+  L      G+  D+W+ G  LY++    +PFED           
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--------AK 258

Query: 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
            RI++ +YSIP +         LI  +   +P +R+SI E+ +    +    
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  234 bits (598), Expect = 2e-75
 Identities = 85/306 (27%), Positives = 136/306 (44%), Gaps = 36/306 (11%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
            D     + +G G  G    + +K+T+E  A+K ++         +RE+ ++ R+ + P+
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72

Query: 79  IVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 132
           IVR  +V          L IVME   GGELF RI + G   F+E EA    + +   + Y
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
            HS+ + HRD+K EN L     P   LK+ DFG                     A E   
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET-T 171

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HIS 249
            ++YD K  D+WS GV +Y++L G  PF              RI   QY  P+     +S
Sbjct: 172 GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230

Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDE 309
            E + LI  +   +P +R++I E  NH W +++        +T+    E+ ++     +E
Sbjct: 231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 290

Query: 310 IMQIIA 315
           +   +A
Sbjct: 291 MTSALA 296

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  232 bits (595), Expect = 9e-75
 Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 16/278 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
             + + + IG G F              VA+K ++  D +D     +  +EI   + L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
           PN++++    +    L IV+E A  G+L   I +  +      E     +F QL S + +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL 191
            HS +V HRD+K  N  +  +    +K+ D G  +  S   +   S VGTP Y++PE + 
Sbjct: 152 MHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISP 250
           +  Y+ K +D+WS G  LY M     PF    +  N      +I    Y  +P   H S 
Sbjct: 210 ENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPS-DHYSE 265

Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 288
           E R L++     DP KR  +  + +    +    A  +
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  230 bits (588), Expect = 1e-73
 Identities = 59/264 (22%), Positives = 104/264 (39%), Gaps = 17/264 (6%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSL-RH 76
             ++ +  +G G++G    +R K+   L AVK      RG K       E+ +H  + +H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
           P  VR ++       L +  E   G  L +     G    E +   + +  +  +++ HS
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             + H D+K  N  L   P  R K+ DFG           +   G P Y+APE+ L+  Y
Sbjct: 176 QGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-LQGSY 232

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
               ADV+S G+T+  +         P   + +++     L  +        +S E R +
Sbjct: 233 GTA-ADVFSLGLTILEVACNMEL---PHGGEGWQQLRQGYLPPE--FTA--GLSSELRSV 284

Query: 256 ISRIFVADPAKRISIPEIRNHEWF 279
           +  +   DP  R +   +      
Sbjct: 285 LVMMLEPDPKLRATAEALLALPVL 308

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  231 bits (592), Expect = 7e-73
 Identities = 71/336 (21%), Positives = 123/336 (36%), Gaps = 46/336 (13%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNI 79
           +     + +G G+ G     +       VAVK +       +    EI +   S  HPN+
Sbjct: 15  NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-------EARFFFQQLISGVSY 132
           +R+     T   L I +E      L + + +     E+             +Q+ SGV++
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 133 CHSMQVCHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPK 176
            HS+++ HRDLK +N L+  S              R+ I DFG  K      S   +   
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 177 STVGTPAYIAPEVLLKKEYD------GKIADVWSCGVTLYVMLVGAY-PFEDPEEPKNFR 229
           +  GT  + APE+L +           +  D++S G   Y +L     PF D        
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----- 245

Query: 230 KTIHRILSVQYSIPDYV-----HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
                I+   +S+ +        +  E   LIS++   DP KR +  ++  H  F     
Sbjct: 246 -RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304

Query: 285 ADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 320
               +   ++    E   P  ++       ++  IP
Sbjct: 305 KLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIP 340

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  222 bits (568), Expect = 6e-71
 Identities = 67/300 (22%), Positives = 113/300 (37%), Gaps = 41/300 (13%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
             +E ++ +G G FGV    ++K  +   A+K I     +   E V RE+     L HP 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 79  IVRFKEVILT------------PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFF 123
           IVR+    L               +L I M+      L + +   C             F
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSV 170
            Q+   V + HS  + HRDLK  N          +K+ DFG                   
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
            +++    VGT  Y++PE +    Y  K  D++S G+ L+ +L   YPF    E     +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERV---R 235

Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADLVV 289
           T+  + ++++  P +    P    ++  +    P +R     I  +  F   + P   V+
Sbjct: 236 TLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVL 294

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  222 bits (568), Expect = 1e-70
 Identities = 76/272 (27%), Positives = 129/272 (47%), Gaps = 26/272 (9%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
           ++  + +G G+F    L R+  T    A+K     +I + +K+     +R++++   L H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
            + HRDLK EN LL+      ++I DFG +K     S+       VGT  Y++PE+L +K
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
               K +D+W+ G  +Y ++ G  PF    E   F+K    I+ ++Y  P+     P+ R
Sbjct: 208 SA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260

Query: 254 HLISRIFVADPAKRISIP------EIRNHEWF 279
            L+ ++ V D  KR+          ++ H +F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  220 bits (561), Expect = 3e-68
 Identities = 69/291 (23%), Positives = 107/291 (36%), Gaps = 24/291 (8%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIV 80
            +     +G G  G     R       VAVK I    +      RE+ +   S  HPN++
Sbjct: 25  SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVC 139
           R+           I +E      L E +          E     QQ  SG+++ HS+ + 
Sbjct: 82  RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 140 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL-- 190
           HRDLK  N L+   +     +  I DFG  K         S+     GT  +IAPE+L  
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAY-PFEDPEEPKNFRKTIHRILSVQYSIPDY-VH 247
             K+       D++S G   Y ++     PF    +    R+    + +          H
Sbjct: 201 DCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQ----RQANILLGACSLDCLHPEKH 255

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 298
                R LI ++   DP KR S   +  H +F  +L   L      +++ E
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFF-WSLEKQLQFFQDVSDRIE 305

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  212 bits (540), Expect = 7e-66
 Identities = 36/305 (11%), Positives = 75/305 (24%), Gaps = 62/305 (20%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
                  +G  +        D++T E   V      ++      + ++ E++  R LR  
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 76  -----------------------HPNIVRFKEVILTPTHLAIVMEY--------ASGGEL 104
                                     ++R +        L+    Y          G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
                               Q+I  ++  H   + H  L+  + +LD      + +  F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE 251

Query: 165 YSKSSVLHSQPKSTVGTPAYIAPEVL----------LKKEYDGKIADVWSCGVTLYVMLV 214
                V       +  +  +  PE+            ++       D W+ G+ +Y +  
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 215 GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 274
              P             I R            +I    R L+          R+   +  
Sbjct: 309 ADLPITKDAALGGSEW-IFR---------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358

Query: 275 NHEWF 279
               +
Sbjct: 359 ETPEY 363

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  209 bits (535), Expect = 6e-65
 Identities = 64/265 (24%), Positives = 122/265 (46%), Gaps = 16/265 (6%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNI 79
           E++R IG G+FG   +++   T+++ A+KY+ +   ++ N  R +         L HP +
Sbjct: 18  EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
           V           + +V++   GG+L   +     F E+  + F  +L+  + Y  + ++ 
Sbjct: 78  VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137

Query: 140 HRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
           HRD+K +N LLD  G     + I DF  +      +Q  +  GT  Y+APE+   ++  G
Sbjct: 138 HRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193

Query: 198 --KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
                D WS GVT Y +L G  P+       + ++ +H   +   + P     S E   L
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTVVTYPSA--WSQEMVSL 250

Query: 256 ISRIFVADPAKRI-SIPEIRNHEWF 279
           + ++   +P +R   + +++N  + 
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYM 275

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  206 bits (526), Expect = 3e-64
 Identities = 81/274 (29%), Positives = 146/274 (53%), Gaps = 27/274 (9%)

Query: 21  DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----S 73
            ++EL++ +G G+FG   + + +      +L A+K + +   +    +      R     
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVE 82

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           + HP IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142

Query: 134 HSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 190
           HS+ + +RDLK EN LLD  G     +K+ DFG SK S+ H +   +  GT  Y+APEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            ++ +  + AD WS GV ++ ML G  PF+     K+ ++T+  IL  +  +P +  +SP
Sbjct: 199 NRRGH-TQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSP 251

Query: 251 ECRHLISRIFVADPAKRI-SIP----EIRNHEWF 279
           E + L+  +F  +PA R+ + P    EI+ H +F
Sbjct: 252 EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  205 bits (525), Expect = 4e-64
 Identities = 83/272 (30%), Positives = 137/272 (50%), Gaps = 32/272 (11%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
           ++++R +G+G+FG   L+R +      A+K +    K +  V+ + + H          +
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
            HP I+R          + ++M+Y  GGELF  +  + RF    A+F+  ++   + Y H
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123

Query: 135 SMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           S  + +RDLK EN LLD  G     +KI DFG++K   +     +  GTP YIAPEV+  
Sbjct: 124 SKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
           K Y  K  D WS G+ +Y ML G  PF D    K + K    IL+ +   P     + + 
Sbjct: 178 KPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILNAELRFPP--FFNEDV 230

Query: 253 RHLISRIFVADPAKRI-SIP----EIRNHEWF 279
           + L+SR+   D ++R+ ++     +++NH WF
Sbjct: 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  204 bits (521), Expect = 6e-64
 Identities = 68/289 (23%), Positives = 110/289 (38%), Gaps = 40/289 (13%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSL-R 75
           +  +  +  IGSG FG       +    + A+K  +    G   ++N  RE+  H  L +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
           H ++VR+        H+ I  EY +GG L + I    R    F E E +    Q+  G+ 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 132 YCHSMQVCHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSVLHSQ 174
           Y HSM + H D+K  N  +                   S     KI D G+       S 
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISS 186

Query: 175 PKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
           P+   G   ++A EVL     +  K AD+++  +T+           + ++        H
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQ-------WH 238

Query: 234 RILSVQYS-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
            I   +   IP    +S E   L+  +   DP +R S   +  H   L 
Sbjct: 239 EIRQGRLPRIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  206 bits (526), Expect = 6e-64
 Identities = 80/270 (29%), Positives = 143/270 (52%), Gaps = 24/270 (8%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
            + +RDLK EN L+D  G     +++ DFG++K   +  +  +  GTP  +APE++L K 
Sbjct: 161 DLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKG 214

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y  K  D W+ GV +Y M  G  PF   +  + + K    I+S +   P   H S + + 
Sbjct: 215 Y-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKD 267

Query: 255 LISRIFVADPAKRI-----SIPEIRNHEWF 279
           L+  +   D  KR       + +I+NH+WF
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  205 bits (522), Expect = 3e-63
 Identities = 45/301 (14%), Positives = 80/301 (26%), Gaps = 46/301 (15%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
           + +LV  +  G+  V  L+RD +  E  A+K    G +      E +         L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 78  NIVRFKEVI--------------------------LTPTHLAIVMEYASG------GELF 105
           +    ++                                +  ++M  AS         L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 106 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165
                 G            QLI   +   S  + H     +N  +      RL + D   
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--GRLMLGDVS- 239

Query: 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPE 223
             +             P   AP   L           + W  G+++Y +     PF    
Sbjct: 240 --ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 224 EPKNF---RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 280
                   R ++    +   +      +    + LI R    D  +R+   E      FL
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357

Query: 281 K 281
           +
Sbjct: 358 Q 358

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  202 bits (517), Expect = 1e-62
 Identities = 88/272 (32%), Positives = 133/272 (48%), Gaps = 28/272 (10%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
           + + L + +G G+FG   L   KKT +  A+K +    K D  +  + +           
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLS 72

Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
            +  HP +        T  +L  VMEY +GG+L   I +  +F    A F+  ++I G+ 
Sbjct: 73  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132

Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
           + HS  + +RDLKL+N LLD  G     +KI DFG  K ++L     +T  GTP YIAPE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188

Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
           +LL ++Y     D WS GV LY ML+G  PF   +E + F      I       P +  +
Sbjct: 189 ILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRW--L 241

Query: 249 SPECRHLISRIFVADPAKRI-SIPEIRNHEWF 279
             E + L+ ++FV +P KR+    +IR H  F
Sbjct: 242 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  200 bits (511), Expect = 5e-62
 Identities = 82/275 (29%), Positives = 138/275 (50%), Gaps = 27/275 (9%)

Query: 21  DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR---- 72
           + +EL+R +G G +G     R +    T ++ A+K +++   +            R    
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
            ++HP IV       T   L +++EY SGGELF ++   G F ED A F+  ++   + +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136

Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 189
            H   + +RDLK EN +L+  G     +K+ DFG  K S+       T  GT  Y+APE+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           L++  +  +  D WS G  +Y ML GA PF      +N +KTI +IL  + ++P Y  ++
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LT 245

Query: 250 PECRHLISRIFVADPAKRI-SIP----EIRNHEWF 279
            E R L+ ++   + A R+ + P    E++ H +F
Sbjct: 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  201 bits (514), Expect = 7e-62
 Identities = 87/275 (31%), Positives = 133/275 (48%), Gaps = 31/275 (11%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
             +  ++ IG G+FG   L R K  E   AVK + +   I   ++++   H         
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL-QKKAI---LKKKEEKHIMSERNVLL 93

Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           ++++HP +V       T   L  V++Y +GGELF  +     F E  ARF+  ++ S + 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153

Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
           Y HS+ + +RDLK EN LLD  G     + + DFG  K ++ H+   ST  GTP Y+APE
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209

Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
           VL K+ Y  +  D W  G  LY ML G  PF      +N  +    IL+    +    +I
Sbjct: 210 VLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYS----RNTAEMYDNILNKPLQLKP--NI 262

Query: 249 SPECRHLISRIFVADPAKRISIP----EIRNHEWF 279
           +   RHL+  +   D  KR+       EI++H +F
Sbjct: 263 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  199 bits (508), Expect = 2e-61
 Identities = 89/275 (32%), Positives = 139/275 (50%), Gaps = 31/275 (11%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
           + ++ ++ +G G FG   L+R+K T    A+K + R + I   + ++ + H        +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL-RKEVI---IAKDEVAHTVTESRVLQ 60

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
           + RHP +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 189
            HS  V +RD+KLEN +LD  G     +KI DFG  K  +       T  GTP Y+APEV
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           L   +Y G+  D W  GV +Y M+ G  PF + +  + F      IL  +   P    +S
Sbjct: 177 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPRT--LS 229

Query: 250 PECRHLISRIFVADPAKRI-----SIPEIRNHEWF 279
           PE + L++ +   DP +R+        E+  H +F
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  199 bits (509), Expect = 3e-61
 Identities = 82/279 (29%), Positives = 134/279 (48%), Gaps = 33/279 (11%)

Query: 24  ELVRDIGSGNFG---VARLMRDKKTEELVAVK-----YIERGDKIDENVQRE-----IIN 70
           EL++ +G+G +G   + R +    T +L A+K      I +  K  E+ + E      I 
Sbjct: 57  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116

Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
                 P +V       T T L ++++Y +GGELF  +    RF+E E + +  +++  +
Sbjct: 117 Q----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172

Query: 131 SYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 186
            + H + + +RD+KLEN LLD  G     + + DFG SK  V     ++    GT  Y+A
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228

Query: 187 PEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
           P+++   +    K  D WS GV +Y +L GA PF    E  +  +   RIL  +   P  
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288

Query: 246 VHISPECRHLISRIFVADPAKRI-SIP----EIRNHEWF 279
             +S   + LI R+ + DP KR+   P    EI+ H +F
Sbjct: 289 --MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  198 bits (507), Expect = 5e-61
 Identities = 87/275 (31%), Positives = 129/275 (46%), Gaps = 29/275 (10%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
           D +E +R +G G+FG   L R K+T +L AVK + + D I   +Q + +           
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-KKDVI---LQDDDVECTMTEKRILS 78

Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
            +  HP + +      TP  L  VME+ +GG+L   I  + RF E  ARF+  ++IS + 
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
           + H   + +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
            +  Y G   D W+ GV LY ML G  PFE   E   F      IL+ +   P    +  
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPT--WLHE 249

Query: 251 ECRHLISRIFVADPAKRI------SIPEIRNHEWF 279
           +   ++      +P  R+          I  H +F
Sbjct: 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  197 bits (503), Expect = 2e-60
 Identities = 84/276 (30%), Positives = 128/276 (46%), Gaps = 32/276 (11%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
             +  +  +G G+FG   L   K T+EL AVK + + D +   +Q + +           
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL-KKDVV---IQDDDVECTMVEKRVLA 75

Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
              + P + +      T   L  VMEY +GG+L   I   GRF E  A F+  ++  G+ 
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135

Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
           +  S  + +RDLKL+N +LD  G     +KI DFG  K ++       T  GTP YIAPE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191

Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
           ++  + Y GK  D W+ GV LY ML G  PFE  +E + F+     I+    + P    +
Sbjct: 192 IIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--M 244

Query: 249 SPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 279
           S E   +   +    P KR+        +I+ H +F
Sbjct: 245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  196 bits (501), Expect = 2e-60
 Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 34/282 (12%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
             ++L+R IG G++    L+R KKT+ + A+K + + + +      E I+          
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-KKELV---NDDEDIDWVQTEKHVFE 64

Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           ++  HP +V       T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++
Sbjct: 65  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124

Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
           Y H   + +RDLKL+N LLD  G     +K+ D+G  K  +      ST  GTP YIAPE
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180

Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIP 243
           +L  ++Y G   D W+ GV ++ M+ G  PF+                   IL  Q  IP
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239

Query: 244 DYVHISPECRHLISRIFVADPAKRI------SIPEIRNHEWF 279
               +S +   ++      DP +R+         +I+ H +F
Sbjct: 240 RS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  195 bits (497), Expect = 1e-59
 Identities = 53/315 (16%), Positives = 105/315 (33%), Gaps = 49/315 (15%)

Query: 19  DSDRYELVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGDKIDENVQREIIN-HR 72
            S    +   +G G F          + D K ++   +K  +  +  +  +  +++   +
Sbjct: 63  GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLI 127
                  ++F    L      +V E  S G L   I            +     F  +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSVLHSQPKST 178
             +   H  ++ H D+K +N +L      +         L + D G S    +   PK T
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGT 240

Query: 179 V-----GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTI 232
           +      T  +   E+L  K ++ +I D +    T+Y ML G Y   ++           
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299

Query: 233 HR---------ILSVQYSIPDYVHIS--PECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
            R            V  +IPD  H+      R  + ++F      +I           L+
Sbjct: 300 RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRA---------LR 350

Query: 282 NLPADLVVDNTTNNQ 296
           N    L+++   + +
Sbjct: 351 NRLIVLLLECKRSRK 365

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  195 bits (498), Expect = 4e-59
 Identities = 88/275 (32%), Positives = 129/275 (46%), Gaps = 30/275 (10%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
           YE+V+ IG G FG  +L+R K T ++ A+K +       E ++R                
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
             P +V+         +L +VMEY  GG+L   + +     E  ARF+  +++  +   H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
           SM   HRD+K +N LLD S    LK+ DFG           +    VGTP YI+PEVL  
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243

Query: 193 KEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVH 247
           +  D   G+  D WS GV LY MLVG  PF       +   T  +I++     + PD   
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDND 299

Query: 248 ISPECRHLISRIFVADPAKRI---SIPEIRNHEWF 279
           IS E ++LI   F+ D   R+    + EI+ H +F
Sbjct: 300 ISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 333

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  196 bits (500), Expect = 4e-59
 Identities = 90/270 (33%), Positives = 135/270 (50%), Gaps = 20/270 (7%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           + +E ++ +G G FG   L+++K T    A+K +++   + ++     +       + RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +   K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y HS 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267

Query: 137 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
           + V +RDLKLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL   +
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y G+  D W  GV +Y M+ G  PF + +  K F      IL  +   P    + PE + 
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LGPEAKS 378

Query: 255 LISRIFVADPAKRI-SIP----EIRNHEWF 279
           L+S +   DP +R+        EI  H +F
Sbjct: 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  194 bits (496), Expect = 6e-59
 Identities = 78/282 (27%), Positives = 132/282 (46%), Gaps = 34/282 (12%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
             ++L+R IG G++    L+R KKT+ + A++ + + + +      E I+          
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV-KKELV---NDDEDIDWVQTEKHVFE 107

Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           ++  HP +V       T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167

Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
           Y H   + +RDLKL+N LLD  G     +K+ D+G  K  +      ST  GTP YIAPE
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223

Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR-----KTIHRILSVQYSIP 243
           +L  ++Y G   D W+ GV ++ M+ G  PF+      N            IL  Q  IP
Sbjct: 224 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282

Query: 244 DYVHISPECRHLISRIFVADPAKRI------SIPEIRNHEWF 279
               +S +   ++      DP +R+         +I+ H +F
Sbjct: 283 R--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  200 bits (510), Expect = 1e-58
 Identities = 75/268 (27%), Positives = 124/268 (46%), Gaps = 18/268 (6%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------SLRH 76
            + R IG G FG     R   T ++ A+K +++     +  +   +N R       +   
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P IV       TP  L+ +++  +GG+L   +   G FSE + RF+  ++I G+ + H+ 
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            V +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL K    
Sbjct: 312 FVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAY 368

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
              AD +S G  L+ +L G  PF    + K+  +     L++   +PD    SPE R L+
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSLL 425

Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
             +   D  +R+        E++   +F
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  191 bits (486), Expect = 3e-58
 Identities = 70/275 (25%), Positives = 106/275 (38%), Gaps = 15/275 (5%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           +         +G G+FG    M+DK+T    AVK +     ++     E++    L  P 
Sbjct: 56  EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPR 111

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           IV     +     + I ME   GG L + I   G   ED A ++  Q + G+ Y H+ ++
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLK 192
            H D+K +N LL      R  +CDFG++                   GT  ++APEV++ 
Sbjct: 172 LHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
           K  D K  D+WS    +  ML G +P+          K I         IP     +P  
Sbjct: 231 KPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK-IASEPPPIREIPP--SCAPLT 286

Query: 253 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 287
              I      +P  R S  E+R            L
Sbjct: 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  197 bits (502), Expect = 1e-57
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 22/271 (8%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
             +  +  +G G+FG   L   K T+EL AVK +++   I ++      V++ ++     
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPG 399

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           + P + +      T   L  VMEY +GG+L   I   GRF E  A F+  ++  G+ +  
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 193
           S  + +RDLKL+N +LD      +KI DFG  K ++       T  GTP YIAPE++  +
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
            Y GK  D W+ GV LY ML G  PFE  +E + F+     I+    + P    +S E  
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--MSKEAV 570

Query: 254 HLISRIFVADPAKRI-----SIPEIRNHEWF 279
            +   +    P KR+        +I+ H +F
Sbjct: 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  189 bits (482), Expect = 8e-57
 Identities = 69/282 (24%), Positives = 119/282 (42%), Gaps = 34/282 (12%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
           D +E+++ IG G F    +++ K+T ++ A+K +       + ++R  ++          
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSCFREERDVLV 116

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVS 131
           +     I +         +L +VMEY  GG+L   +   G R   + ARF+  +++  + 
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 189
             H +   HRD+K +N LLD      +++ DFG           +S   VGTP Y++PE+
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234

Query: 190 LLKKEYD------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYS 241
           L            G   D W+ GV  Y M  G  PF       +  +T  +I+      S
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA----DSTAETYGKIVHYKEHLS 290

Query: 242 IPDY-VHISPECRHLISRIFVADPAKRI---SIPEIRNHEWF 279
           +P     +  E R  I R  +  P  R+      + R H +F
Sbjct: 291 LPLVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFF 331

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  189 bits (482), Expect = 1e-56
 Identities = 72/291 (24%), Positives = 129/291 (44%), Gaps = 39/291 (13%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
           +E+++ IG G FG   +++ K  +++ A+K +       E ++R              + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNG 131

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYC 133
               I           +L +VM+Y  GG+L   +     R  E+ ARF+  +++  +   
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
           H +   HRD+K +N L+D +    +++ DFG     +     +S+  VGTP YI+PE+L 
Sbjct: 192 HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249

Query: 192 KKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDY 245
             E      G   D WS GV +Y ML G  PF      ++  +T  +I++   ++  P  
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA----ESLVETYGKIMNHKERFQFPTQ 305

Query: 246 V-HISPECRHLISRIFVADPAKRI---SIPEIRNHEWF-------LKNLPA 285
           V  +S   + LI R  +     R+    I + + H +F       ++N  A
Sbjct: 306 VTDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEA 355

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  192 bits (490), Expect = 2e-56
 Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 16/270 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRH 76
           + +   R +G G FG     + + T ++ A K +E+        +   +N +     +  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 134
             +V       T   L +V+   +GG+L   I + G+  F E  A F+  ++  G+   H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
             ++ +RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+  + 
Sbjct: 304 RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y     D W+ G  LY M+ G  PF+  ++     +    +  V     +    SP+ R 
Sbjct: 362 Y-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARS 418

Query: 255 LISRIFVADPAKRI-----SIPEIRNHEWF 279
           L S++   DPA+R+     S  E++ H  F
Sbjct: 419 LCSQLLCKDPAERLGCRGGSAREVKEHPLF 448

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  191 bits (486), Expect = 3e-56
 Identities = 77/275 (28%), Positives = 116/275 (42%), Gaps = 23/275 (8%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
           D +   R +G G FG     + K T +L A K + +         +  +  +     +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSY 132
             IV       T T L +VM   +GG++   I N       F E  A F+  Q++SG+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304

Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
            H   + +RDLK EN LLD  G     ++I D G +              GTP ++APE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
           LL +EY     D ++ GVTLY M+    PF    E    ++   R+L    + PD    S
Sbjct: 361 LLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FS 417

Query: 250 PECRHLISRIFVADPAKRI-----SIPEIRNHEWF 279
           P  +     +   DP KR+     S   +R H  F
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  183 bits (466), Expect = 1e-55
 Identities = 75/259 (28%), Positives = 125/259 (48%), Gaps = 16/259 (6%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVIL 87
           +G G +G+    RD   +  +A+K I   D    + +  EI  H+ L+H NIV++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 88  TPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
               + I ME   GG    L        + +E    F+ +Q++ G+ Y H  Q+ HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149

Query: 145 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKE--YDGKIAD 201
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ K    Y    AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-AD 207

Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRI 259
           +WS G T+  M  G  PF +  EP+     + ++   +    IP+   +S E +  I + 
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGMFKVHPEIPE--SMSAEAKAFILKC 262

Query: 260 FVADPAKRISIPEIRNHEW 278
           F  DP KR    ++   E+
Sbjct: 263 FEPDPDKRACANDLLVDEF 281

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  184 bits (468), Expect = 7e-55
 Identities = 38/309 (12%), Positives = 80/309 (25%), Gaps = 56/309 (18%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
                  +G  +        D++T E   V      ++      + ++ E++  R LR  
Sbjct: 79  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 76  --------------------HPNIVRFKEVILTPTHLAIVMEYAS-----------GGEL 104
                                P   +   V L    + ++  +             G  L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
                               Q+I  ++  H   + H  L+  + +LD      + +  F 
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFE 256

Query: 165 YSKS--SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI----ADVWSCGVTLYVMLVGAYP 218
           +     +   S        P   A  +L   ++   +     D W+ G+ +Y +     P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 219 FEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
             D                         +I    R L+          R+   +      
Sbjct: 317 NTDDAALGGSEWIFRSC----------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366

Query: 279 FLKNLPADL 287
           + + L  +L
Sbjct: 367 Y-EQLRTEL 374

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  165 bits (419), Expect = 1e-48
 Identities = 79/309 (25%), Positives = 124/309 (40%), Gaps = 37/309 (11%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           D    E+   +G G FGV  + + K   + VA+K I   +   +    E+     + HPN
Sbjct: 6   DYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPN 62

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHS 135
           IV+     L P  + +VMEYA GG L+  +  A       A       +    GV+Y HS
Sbjct: 63  IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120

Query: 136 MQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
           MQ   + HRDLK  N LL       LKICDFG +    + +   +  G+ A++APEV   
Sbjct: 121 MQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHRILSVQYSIP 243
             Y  K  DV+S G+ L+ ++    PF++   P            R            + 
Sbjct: 178 SNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP----------LI 226

Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLVVDNTTNNQFEEPDQ 302
             +        L++R +  DP++R S+ EI       ++  P               P +
Sbjct: 227 KNLP--KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGE 284

Query: 303 PMQSIDEIM 311
             +    + 
Sbjct: 285 DGRVEPYVD 293

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  164 bits (416), Expect = 3e-48
 Identities = 77/290 (26%), Positives = 130/290 (44%), Gaps = 24/290 (8%)

Query: 2   DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDK 59
                +  PGM        + +  +  IG G+FG      D +T+++VA+K I  E  + 
Sbjct: 3   HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED 62

Query: 60  IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
             E++Q+EI        P + ++    L  T L I+MEY  GG   + +   G   E + 
Sbjct: 63  EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQI 121

Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 178
               ++++ G+ Y HS +  HRD+K  N LL       +K+ DFG +         ++T 
Sbjct: 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTF 179

Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
           VGTP ++APEV+ +  YD K AD+WS G+T   +  G  P  +   P          + V
Sbjct: 180 VGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSE-LHP----------MKV 227

Query: 239 QYSIPDYV------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
            + IP         + S   +  +      +P+ R +  E+  H++ L+N
Sbjct: 228 LFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  163 bits (415), Expect = 7e-48
 Identities = 68/298 (22%), Positives = 129/298 (43%), Gaps = 16/298 (5%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREI-INHRSLR 75
           + +  E + ++GSG  G    MR +KT  ++AVK +      + ++ +  ++ +  +S  
Sbjct: 23  EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            P IV+     +T T + I ME         +    G   E         ++  + Y   
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---- 190
              V HRD+K  N LLD     ++K+CDFG S   V       + G  AY+APE +    
Sbjct: 143 KHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200

Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHI 248
             K +YD + ADVWS G++L  +  G +P+++    K   + + ++L  +   +P ++  
Sbjct: 201 PTKPDYDIR-ADVWSLGISLVELATGQFPYKN---CKTDFEVLTKVLQEEPPLLPGHMGF 256

Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQS 306
           S + +  +      D  KR    ++  H +  +    ++ V +   +   + + P   
Sbjct: 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRSG 314

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  163 bits (414), Expect = 1e-47
 Identities = 45/238 (18%), Positives = 84/238 (35%), Gaps = 26/238 (10%)

Query: 58  DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---CNAGRF 114
               +    +I         N V   +      +L I M+      L + +   C+    
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
                   F Q+   V + HS  + HRDLK  N          +K+ DFG   +     +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEE 219

Query: 175 PKST-------------VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
            ++              VGT  Y++PE +    Y  K  D++S G+ L+ +L   Y F  
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275

Query: 222 PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
             E     + I  + ++++    +    P+   ++  +    P +R    +I  +  F
Sbjct: 276 QMERV---RIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 2/66 (3%)

Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPN 78
            +E ++ +G G FGV    ++K  +   A+K I   ++    E V RE+     L HP 
Sbjct: 6  TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 79 IVRFKE 84
          IVR+  
Sbjct: 66 IVRYFN 71

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  161 bits (410), Expect = 2e-47
 Identities = 66/261 (25%), Positives = 115/261 (44%), Gaps = 18/261 (6%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPNIVRF--- 82
           IG G+F       D +T   VA   ++         QR   E    + L+HPNIVRF   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 83  -KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VC 139
            +  +     + +V E  + G L   +           R + +Q++ G+ + H+    + 
Sbjct: 94  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153

Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           HRDLK +N  + G P   +KI D G +      S  K+ +GTP ++APE+  +++YD   
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEM-YEEKYDES- 209

Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYSIPDYVHISPECRHLISR 258
            DV++ G+ +  M    YP+ + +     +R+    +     S        PE + +I  
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDK--VAIPEVKEIIEG 265

Query: 259 IFVADPAKRISIPEIRNHEWF 279
               +  +R SI ++ NH +F
Sbjct: 266 CIRQNKDERYSIKDLLNHAFF 286

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  162 bits (412), Expect = 2e-47
 Identities = 69/283 (24%), Positives = 125/283 (44%), Gaps = 29/283 (10%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
            + ++++  +G G++G       K+T ++VA+K +     + E + +EI   +    P++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           V++       T L IVMEY   G + + I       +EDE     Q  + G+ Y H M+ 
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146

Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            HRD+K  N LL  +G      K+ DFG + + +   ++  + +GTP ++APEV+ +  Y
Sbjct: 147 IHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--------DYVH 247
           +   AD+WS G+T   M  G  P+ D   P          +   + IP            
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYAD-IHP----------MRAIFMIPTNPPPTFRKPEL 250

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
            S      + +  V  P +R +  ++  H +        ++ D
Sbjct: 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRD 293

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  160 bits (407), Expect = 6e-47
 Identities = 80/276 (28%), Positives = 128/276 (46%), Gaps = 32/276 (11%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
             +Y     IG G  G      D  T + VA++ +  ++  K +  +  EI+  R  ++P
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           NIV + +  L    L +VMEY +GG L + +       E +     ++ +  + + HS Q
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           V HRD+K +N LL  DG     +K+ DFG+  + +   S+  + VGTP ++APEV+ +K 
Sbjct: 137 VIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--------DYV 246
           Y  K  D+WS G+    M+ G  P+ + E P          L   Y I         +  
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLN-ENP----------LRALYLIATNGTPELQNPE 240

Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
            +S   R  ++R    D  KR S  E+  H+ FLK 
Sbjct: 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ-FLKI 275

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  161 bits (409), Expect = 1e-46
 Identities = 72/305 (23%), Positives = 125/305 (40%), Gaps = 47/305 (15%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
             D +E + ++G+GN GV   +  K +  ++A K I    K      + RE+ + H    
Sbjct: 31  KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-N 89

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
            P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y   
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
             ++ HRD+K  N L++      +K+CDFG S   +  S   S VGT +Y++PE L    
Sbjct: 150 KHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI------ 248
           Y  + +D+WS G++L  M VG YP   P+  +       ++       P           
Sbjct: 207 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265

Query: 249 --------------------------------SPECRHLISRIFVADPAKRISIPEIRNH 276
                                           S E +  +++  + +PA+R  + ++  H
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325

Query: 277 EWFLK 281
            +  +
Sbjct: 326 AFIKR 330

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  160 bits (406), Expect = 1e-46
 Identities = 76/275 (27%), Positives = 133/275 (48%), Gaps = 30/275 (10%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPN 78
               +    IG G+ G+  L R+K +   VAVK ++ R  +  E +  E++  R  +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           +V   +  L    L ++ME+  GG L + I +  R +E++     + ++  ++Y H+  V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162

Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
            HRD+K ++ LL  DG    R+K+ DFG+  + S    + KS VGTP ++APEV+ +  Y
Sbjct: 163 IHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--------DYVH 247
             +  D+WS G+ +  M+ G  P+   + P          +     +         +   
Sbjct: 219 ATE-VDIWSLGIMVIEMVDGEPPYFS-DSP----------VQAMKRLRDSPPPKLKNSHK 266

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 282
           +SP  R  + R+ V DP +R +  E+ +H  FL  
Sbjct: 267 VSPVLRDFLERMLVRDPQERATAQELLDHP-FLLQ 300

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  158 bits (401), Expect = 4e-46
 Identities = 64/275 (23%), Positives = 121/275 (44%), Gaps = 19/275 (6%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
            +D  E + ++G G +GV   MR   + +++AVK I       E   +  ++ I+ R++ 
Sbjct: 5   KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICN-AGRFSEDEARFFFQQLISGVSY 132
            P  V F   +     + I ME       + ++++ +      ED        ++  + +
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 133 CHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
            HS + V HRD+K  N L++     ++K+CDFG S   V     K    G   Y+APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181

Query: 191 L----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
                +K Y  K +D+WS G+T+  + +  +P++    P  F+  + +++          
Sbjct: 182 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP--FQ-QLKQVVEEPSPQLPAD 237

Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
             S E     S+    +  +R + PE+  H +F  
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  156 bits (396), Expect = 6e-45
 Identities = 66/288 (22%), Positives = 122/288 (42%), Gaps = 17/288 (5%)

Query: 6   MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN 63
           + + P         ++  + + +IG G +G    M  K + +++AVK I     +K  + 
Sbjct: 9   LKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66

Query: 64  VQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNA--GRFSEDE 118
           +  ++ +  RS   P IV+F   +       I ME  S    + ++ + +       E+ 
Sbjct: 67  LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126

Query: 119 ARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
                   +  +++    +++ HRD+K  N LLD S    +K+CDFG S   V       
Sbjct: 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQLVDSIAKTR 184

Query: 178 TVGTPAYIAPEVL----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
             G   Y+APE +     ++ YD + +DVWS G+TLY +  G +P+       +    + 
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243

Query: 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
           +    Q S  +    SP   + ++     D +KR    E+  H + L 
Sbjct: 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  155 bits (393), Expect = 8e-45
 Identities = 79/296 (26%), Positives = 128/296 (43%), Gaps = 30/296 (10%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRH 76
           + D YEL   IGSG   V +       +E VA+K I  E+     + + +EI       H
Sbjct: 13  NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGRFSEDEARFFFQQLIS 128
           PNIV +    +    L +VM+  SGG +         +    +G   E       ++++ 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTP 182
           G+ Y H     HRD+K  N LL    +  ++I DFG S           +   K+ VGTP
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHR 234
            ++APEV+ + + YD K AD+WS G+T   +  GA P+             +N   ++  
Sbjct: 191 CWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249

Query: 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
            +  +  +  Y       R +IS     DP KR +  E+  H++F K    + + +
Sbjct: 250 GVQDKEMLKKY---GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQE 302

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  154 bits (392), Expect = 1e-44
 Identities = 70/290 (24%), Positives = 126/290 (43%), Gaps = 36/290 (12%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
           ++ +E+V ++G G FG     ++K+T  L A K I  +  +++++    EI    +  HP
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSM 136
            IV+          L I++E+  GG +   +       +E + +   +Q++  +++ HS 
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLL-- 191
           ++ HRDLK  N L+  +G     +++ DFG S K+     +  S +GTP ++APEV++  
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192

Query: 192 ---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP----- 243
                 YD K AD+WS G+TL  M     P  +   P          + V   I      
Sbjct: 193 TMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE-LNP----------MRVLLKIAKSDPP 240

Query: 244 ---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
                   S E R  +      +P  R S  ++  H +         + +
Sbjct: 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  154 bits (391), Expect = 3e-44
 Identities = 72/305 (23%), Positives = 124/305 (40%), Gaps = 41/305 (13%)

Query: 17  MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
           M  S +++ +  +G+G +       +K T   VA+K +  +  +       REI   + L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60

Query: 75  RHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISG 129
           +H NIVR  +VI T   L +V E+         +             +  ++F  QL+ G
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 188
           +++CH  ++ HRDLK +N L++     +LK+ DFG +++  +     S+ V T  Y AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178

Query: 189 VLL-KKEYDGKIADVWSCGVTLYVMLVGA--------------------YPFED------ 221
           VL+  + Y   I D+WSCG  L  M+ G                      P E       
Sbjct: 179 VLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237

Query: 222 --PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
             P+   N ++   R L           +       +  +   +P  R+S  +  +H WF
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 280 LKNLP 284
                
Sbjct: 298 -AEYY 301

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  154 bits (390), Expect = 3e-44
 Identities = 79/263 (30%), Positives = 123/263 (46%), Gaps = 26/263 (9%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIV 80
            +   IG+G+FG   + R +     VAVK +   D   E V    RE+   + LRHPNIV
Sbjct: 40  NIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSM- 136
            F   +  P +L+IV EY S G L+  +  +G      E         +  G++Y H+  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLK 192
             + HR+LK  N L+D      +K+CDFG S+  +  S     KS  GTP ++APEVL  
Sbjct: 158 PPIVHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRD 213

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISP 250
           +  + K +DV+S GV L+ +     P+ +     N  + +  +        IP  ++  P
Sbjct: 214 EPSNEK-SDVYSFGVILWELATLQQPWGN----LNPAQVVAAVGFKCKRLEIPRNLN--P 266

Query: 251 ECRHLISRIFVADPAKRISIPEI 273
           +   +I   +  +P KR S   I
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATI 289

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  154 bits (391), Expect = 3e-44
 Identities = 87/305 (28%), Positives = 127/305 (41%), Gaps = 53/305 (17%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           DRY  +  +G G +G      D  T E VA+K I R +  +E V     RE+   + L+H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
            NI+  K VI     L ++ EYA   +L + +      S    + F  QLI+GV++CHS 
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151

Query: 137 QVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
           +  HRDLK +N LL  S A     LKI DFG +++  +  +  +  + T  Y  PE+LL 
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211

Query: 192 KKEYDGKIADVWSCGVTLYVML--------------------------------VGAYPF 219
            + Y   + D+WS       ML                                V A P 
Sbjct: 212 SRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270

Query: 220 EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
                PK   KT+ R+L           +  E   L++ +   DP KRIS      H +F
Sbjct: 271 WKQSFPKFRGKTLKRVLG--------ALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

Query: 280 LKNLP 284
             +  
Sbjct: 323 -SHND 326

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  150 bits (382), Expect = 2e-43
 Identities = 76/266 (28%), Positives = 110/266 (41%), Gaps = 27/266 (10%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRHPN 78
            L   IG G FG  ++ R     + VAVK        D     ENV++E      L+HPN
Sbjct: 10  TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-- 136
           I+  + V L   +L +VME+A GG L   +    R   D    +  Q+  G++Y H    
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 137 -QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
             + HRDLK  N L+             LKI DFG ++     +   S  G  A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVH 247
           +    +    +DVWS GV L+ +L G  PF       +     + +   +    IP    
Sbjct: 186 IRASMFSKG-SDVWSYGVLLWELLTGEVPFRG----IDGLAVAYGVAMNKLALPIPSTCP 240

Query: 248 ISPECRHLISRIFVADPAKRISIPEI 273
                  L+   +  DP  R S   I
Sbjct: 241 --EPFAKLMEDCWNPDPHSRPSFTNI 264

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  149 bits (379), Expect = 6e-43
 Identities = 71/271 (26%), Positives = 114/271 (42%), Gaps = 33/271 (12%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV--------QREIINHRSLR 75
           E  + IG G FG+    R  K + +VA+K +  GD   E          QRE+    +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 134
           HPNIV+   ++  P    +VME+   G+L+ R+ +                +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 135 SM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           +    + HRDL+  N  L     +     K+ DFG S+           +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197

Query: 190 LL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-----SI 242
           +   ++ Y  K AD +S  + LY +L G  PF++    K     I  I  ++      +I
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGLRPTI 251

Query: 243 PDYVHISPECRHLISRIFVADPAKRISIPEI 273
           P+     P  R++I   +  DP KR     I
Sbjct: 252 PEDCP--PRLRNVIELCWSGDPKKRPHFSYI 280

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  149 bits (380), Expect = 6e-43
 Identities = 79/304 (25%), Positives = 131/304 (43%), Gaps = 53/304 (17%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
            +YE +  IG G +G     ++++T E+VA+K + R D  DE V     REI   + L+H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60

Query: 77  PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
            NIVR  +V+ +   L +V E+      + F+     G    +  + F  QL+ G+ +CH
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
           S  V HRDLK +N L++ +    LK+ +FG +++  +  +  S  V T  Y  P+VL   
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILSV---------- 238
           K Y   I D+WS G     +     P     +  ++       + RI  +          
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQ-------LKRIFRLLGTPTEEQWP 228

Query: 239 -QYSIPDYV----------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
               +PDY                  ++   R L+  +   +P +RIS  E   H +F  
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-S 287

Query: 282 NLPA 285
           +   
Sbjct: 288 DFCP 291

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  152 bits (385), Expect = 2e-42
 Identities = 96/370 (25%), Positives = 146/370 (39%), Gaps = 59/370 (15%)

Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K +   DK  +N  R
Sbjct: 43  TPGQGPDRPQ---EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--R 96

Query: 67  EIINHRSLRHPNIVRFKEVILTPT------HLAIVMEYASG---GELFERICNAGRFSED 117
           E+   R L H NIVR +    +        +L +V++Y                      
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156

Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
             + +  QL   ++Y HS  +CHRD+K +N LLD   A  LK+CDFG +K   L     +
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPN 213

Query: 178 T--VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEE-------- 224
              + +  Y APE++    +Y   I DVWS G  L  +L+G   +P +   +        
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272

Query: 225 ---PKNFRKTIHRILS--VQYSIPDYV----------HISPECRHLISRIFVADPAKRIS 269
              P   R+ I  +     ++  P                PE   L SR+    P  R++
Sbjct: 273 LGTPT--REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330

Query: 270 IPEIRNHEWF--LKN----LPADLVVDNTTNNQFEE----PDQPMQSIDEIMQIIAEATI 319
             E   H +F  L++    LP         N   +E    P      I    +I A A+ 
Sbjct: 331 PLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAAST 390

Query: 320 PAAGTQSLNQ 329
           P   T + + 
Sbjct: 391 PTNATAASDA 400

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  150 bits (380), Expect = 2e-42
 Identities = 76/288 (26%), Positives = 124/288 (43%), Gaps = 37/288 (12%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSL 74
              +  +R+IG G+FG     RD +  E+VA+K +     +  +K  + + +E+   + L
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 111

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           RHPN ++++   L      +VMEY  G        +     E E        + G++Y H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 191
           S  + HRD+K  N LL   G     +K+ DFG +      +   S VGTP ++APEV+L 
Sbjct: 172 SHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILA 224

Query: 192 --KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP------ 243
             + +YDGK  DVWS G+T   +     P  +              +S  Y I       
Sbjct: 225 MDEGQYDGK-VDVWSLGITCIELAERKPPLFN-MNA----------MSALYHIAQNESPA 272

Query: 244 -DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 290
               H S   R+ +       P  R +   +  H + L+  P  +++D
Sbjct: 273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  147 bits (374), Expect = 3e-42
 Identities = 54/263 (20%), Positives = 100/263 (38%), Gaps = 27/263 (10%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIV 80
             +  +   + G     R +  +  + VK ++  D   +   +   E    R   HPN++
Sbjct: 13  NFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 81  RFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
                  +P   H  ++  +   G L+  +     F  D+++   F   +  G+++ H++
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 137 Q--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           +  +    L   + ++D       +I       S     Q    +  PA++APE L KK 
Sbjct: 131 EPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKKP 184

Query: 195 YDGKI--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISP 250
            D     AD+WS  V L+ ++    PF D     +  +   ++       +IP    ISP
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFAD----LSNMEIGMKVALEGLRPTIPP--GISP 238

Query: 251 ECRHLISRIFVADPAKRISIPEI 273
               L+      DPAKR     I
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMI 261

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  148 bits (375), Expect = 5e-42
 Identities = 73/289 (25%), Positives = 129/289 (44%), Gaps = 41/289 (14%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
           +  +ELV  +G+G +G     R  KT +L A+K ++     +E +++EI   +    H N
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82

Query: 79  IVRF------KEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGV 130
           I  +      K        L +VME+   G + +  +        E+   +  ++++ G+
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142

Query: 131 SYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAP 187
           S+ H  +V HRD+K +N LL  +      +K+ DFG S         ++T +GTP ++AP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198

Query: 188 EVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242
           EV+   E     YD K +D+WS G+T   M  GA P  D   P          +   + I
Sbjct: 199 EVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD-MHP----------MRALFLI 246

Query: 243 P-------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
           P            S + +  I    V + ++R +  ++  H  F+++ P
Sbjct: 247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQP 294

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  147 bits (374), Expect = 6e-42
 Identities = 74/337 (21%), Positives = 129/337 (38%), Gaps = 77/337 (22%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           ++YE +  IG G++GV    R++ T ++VA+K      + D  ++    REI   + L+H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61

Query: 77  PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           PN+V   EV      L +V EY         +R        E   +    Q +  V++CH
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVLL 191
                HRD+K EN L+       +K+CDFG+++   L          V T  Y +PE+L+
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLV 175

Query: 192 K-KEYDGKIADVWSCGVTLYVMLVG----------------------------------- 215
              +Y   + DVW+ G     +L G                                   
Sbjct: 176 GDTQYGPPV-DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234

Query: 216 ---AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 272
                   DPE+ +                    +IS     L+      DP +R++  +
Sbjct: 235 YFSGVKIPDPEDMEPLELKFP-------------NISYPALGLLKGCLHMDPTERLTCEQ 281

Query: 273 IRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDE 309
           + +H +F +N+           +  +E D+P +++  
Sbjct: 282 LLHHPYF-ENIRE-------IEDLAKEHDKPAENLYF 310

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  148 bits (375), Expect = 9e-42
 Identities = 78/316 (24%), Positives = 130/316 (41%), Gaps = 60/316 (18%)

Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------ 65
           M + +   + RYE +  +G G F      RDK T ++VA+K I +     E         
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTA 59

Query: 66  -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFF 122
            REI   + L HPNI+   +     +++++V ++       + +   N+   +    + +
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAY 117

Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-V 179
               + G+ Y H   + HRDLK  N LLD  G     LK+ DFG +KS    ++  +  V
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQV 173

Query: 180 GTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHR 234
            T  Y APE+L   + Y   + D+W+ G  L  +L+   PF     D ++       + R
Sbjct: 174 VTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLRV-PFLPGDSDLDQ-------LTR 224

Query: 235 ILSV-----------QYSIPDYV---------------HISPECRHLISRIFVADPAKRI 268
           I                S+PDYV                   +   LI  +F+ +P  RI
Sbjct: 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284

Query: 269 SIPEIRNHEWFLKNLP 284
           +  +    ++F  N P
Sbjct: 285 TATQALKMKYF-SNRP 299

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  147 bits (374), Expect = 9e-42
 Identities = 71/302 (23%), Positives = 122/302 (40%), Gaps = 46/302 (15%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
           + Y  +  +G G +      + K T+ LVA+K I  E  +       RE+   + L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 79  IVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           IV   ++I T   L +V EY      +  +        +    + F  QL+ G++YCH  
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ 119

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 194
           +V HRDLK +N L++      LK+ DFG +++  + ++     V T  Y  P++LL   +
Sbjct: 120 KVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177

Query: 195 YDGKIADVWSCGVTLYVMLVGA--------------------YPFED--------PE-EP 225
           Y  +I D+W  G   Y M  G                      P E+         E + 
Sbjct: 178 YSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236

Query: 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 285
            N+ K     L           +  +   L++++   +   RIS  +   H +F  +L  
Sbjct: 237 YNYPKYRAEALLSHAP-----RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF-LSLGE 290

Query: 286 DL 287
            +
Sbjct: 291 RI 292

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  148 bits (375), Expect = 2e-41
 Identities = 67/318 (21%), Positives = 114/318 (35%), Gaps = 60/318 (18%)

Query: 19  DSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRS 73
           +   YEL+  IG G  +     L R K T E V V+ I      +++   +Q E+   + 
Sbjct: 23  EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVS 131
             HPNIV ++   +    L +V  + + G   + IC       +E    +  Q ++  + 
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPA 183
           Y H M   HR +K  + L+       + +     +        +  V+H  PK +V    
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200

Query: 184 YIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFED-------------------- 221
           +++PEVL    + YD K +D++S G+T   +  G  PF+D                    
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259

Query: 222 --------------------PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261
                                        T         S P +   SP   H + +   
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319

Query: 262 ADPAKRISIPEIRNHEWF 279
            +P  R S   + NH +F
Sbjct: 320 RNPDARPSASTLLNHSFF 337

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  146 bits (371), Expect = 2e-41
 Identities = 78/319 (24%), Positives = 131/319 (41%), Gaps = 43/319 (13%)

Query: 3   RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
             +  V  G +       ++YE +  +G G++G+    R+K T  +VA+K        D+
Sbjct: 7   HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK 65

Query: 63  NV----QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSE 116
            V     REI   + LRH N+V   EV        +V E+      +  E   N      
Sbjct: 66  MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDY 123

Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176
              + +  Q+I+G+ +CHS  + HRD+K EN L+  S    +K+CDFG++++     +  
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVY 181

Query: 177 ST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIH 233
              V T  Y APE+L+   +Y   + DVW+ G  +  M +G   F  D +  + +   I 
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDSDIDQLYH--IM 238

Query: 234 RIL-----SVQ---YSIPDYV------------------HISPECRHLISRIFVADPAKR 267
             L       Q      P +                    +S     L  +    DP KR
Sbjct: 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKR 298

Query: 268 ISIPEIRNHEWFLKNLPAD 286
               E+ +H++F  +  A+
Sbjct: 299 PFCAELLHHDFFQMDGFAE 317

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  145 bits (368), Expect = 3e-41
 Identities = 79/299 (26%), Positives = 125/299 (41%), Gaps = 56/299 (18%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
           ++Y  +  IG G +GV    ++    E  A+K I R +K DE +     REI   + L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59

Query: 77  PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
            NIV+  +VI T   L +V E+      +L +     G      A+ F  QL++G++YCH
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
             +V HRDLK +N L++      LKI DFG +++  +  +  +  + T  Y AP+VL+  
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 193 KEYDGKIADVWSCGVTLYVML--------------------------------VGAYPFE 220
           K+Y   I D+WS G     M+                                V   P  
Sbjct: 176 KKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           DP             L           +      L+S++   DP +RI+  +   H +F
Sbjct: 235 DPNFTVYEPLPWESFLK---------GLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  145 bits (369), Expect = 4e-41
 Identities = 81/321 (25%), Positives = 136/321 (42%), Gaps = 50/321 (15%)

Query: 1   MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
           M           ++      ++Y+ +  +G G +GV    +D     +VA+K I R D  
Sbjct: 1   MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAE 58

Query: 61  DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRF 114
           DE +     REI   + L HPNIV   +VI +   L +V E+      ++ +   N    
Sbjct: 59  DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGL 116

Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
            + + + +  QL+ GV++CH  ++ HRDLK +N L++      LK+ DFG +++  +  +
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVR 174

Query: 175 PKST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGA---------------- 216
             +  V T  Y AP+VL+  K+Y   + D+WS G     M+ G                 
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF 233

Query: 217 ----YPFED--PE-------EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
                P     P+       + + F+    +  S             E   L+S +   D
Sbjct: 234 SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIP-----GFCQEGIDLLSNMLCFD 288

Query: 264 PAKRISIPEIRNHEWFLKNLP 284
           P KRIS  +  NH +F K+L 
Sbjct: 289 PNKRISARDAMNHPYF-KDLD 308

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  147 bits (372), Expect = 6e-41
 Identities = 85/353 (24%), Positives = 144/353 (40%), Gaps = 53/353 (15%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
              Y   + IG+G+FGV    +  +++E VA+K +   DK  +N  RE+   R ++HPN+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94

Query: 80  VRFKEVILTPTH------LAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLISGV 130
           V  K    +         L +V+EY                        + +  QL+  +
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
           +Y HS+ +CHRD+K +N LLD      LK+ DFG +K  +L +   +   + +  Y APE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPE 211

Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEE-----------PKNFRKTIHR 234
           ++     Y   I D+WS G  +  ++ G   +P E   +           P   R+ I  
Sbjct: 212 LIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS--REQIKT 268

Query: 235 ILS--VQYSIPDYV----------HISPECRHLISRIFVADPAKRISIPEIRNHEWF--L 280
           +    +++  P                P+   LISR+    P+ R++  E   H +F  L
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

Query: 281 KN----LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQ 329
           +     +P    +    N   EE       I  ++   AEA + + G    N 
Sbjct: 329 RTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSRGIDVHNF 381

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  144 bits (365), Expect = 1e-40
 Identities = 58/290 (20%), Positives = 116/290 (40%), Gaps = 53/290 (18%)

Query: 24  ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
           E+   IG G FG     R   +      VA++ I+     ++ ++   RE++ +R  RH 
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
           N+V F    ++P HLAI+     G  L+  + +A      ++ R   Q+++ G+ Y H+ 
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL 190
            + H+DLK +N   D     ++ I DFG         +     + +   G   ++APE++
Sbjct: 150 GILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 191 ---------LKKEYDGKIADVWSCGVTLYVMLVGAYPFED--PEE-----PKNFRKTIHR 234
                     K  +    +DV++ G   Y +    +PF+    E          +  +  
Sbjct: 207 RQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL-- 263

Query: 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
                        +  E   ++   +  +  +R +  ++ +    L+ LP
Sbjct: 264 -------SQI--GMGKEISDILLFCWAFEQEERPTFTKLMDM---LEKLP 301

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  143 bits (363), Expect = 1e-40
 Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 32/279 (11%)

Query: 24  ELVRDIGSGNFG-VAR-LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPN 78
            + + IGSG+FG V +           VAVK +       + +Q    E+   R  RH N
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           I+ F     T   LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y H+  
Sbjct: 82  ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
           + HRDLK  N  L       +KI DFG +          Q +   G+  ++APEV+  ++
Sbjct: 141 IIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 195 ---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
              Y  + +DV++ G+ LY ++ G  P+ +     N R  I  ++      PD   +   
Sbjct: 199 SNPYSFQ-SDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPDLSKVRSN 253

Query: 252 C----RHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 286
           C    + L++        +R S P I      ++ L  +
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILAE---IEELARE 289

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  144 bits (366), Expect = 2e-40
 Identities = 79/328 (24%), Positives = 130/328 (39%), Gaps = 59/328 (17%)

Query: 10  PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----Q 65
             ++ P   +  +YE +  IG G FG     R +KT + VA+K +   +   E       
Sbjct: 6   DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL 64

Query: 66  REIINHRSLRHPNIVRFKEVILTPTHLA--------IVMEYASG--GELFERICNAGRFS 115
           REI   + L+H N+V   E+  T             +V ++       L   +    +F+
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFT 122

Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVL 171
             E +   Q L++G+ Y H  ++ HRD+K  N L+       LK+ DFG    +S +   
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNS 180

Query: 172 HSQP-KSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGA------------- 216
                 + V T  Y  PE+LL +++Y   I D+W  G  +  M   +             
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239

Query: 217 -------YPFED--PE-------EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
                      +  P        E     K   R +  +     YV   P    LI ++ 
Sbjct: 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL--KAYV-RDPYALDLIDKLL 296

Query: 261 VADPAKRISIPEIRNHEWFLKN-LPADL 287
           V DPA+RI   +  NH++F  + +P+DL
Sbjct: 297 VLDPAQRIDSDDALNHDFFWSDPMPSDL 324

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  143 bits (363), Expect = 2e-39
 Identities = 71/326 (21%), Positives = 116/326 (35%), Gaps = 66/326 (20%)

Query: 21  DRYELVRD-IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
           D +E     +G G +G    A+  +D K ++  A+K IE    I  +  REI   R L+H
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77

Query: 77  PNIVRFKEVILTPTHLAI--VMEYAS--------GGELFERICNAGRFSEDEARFFFQQL 126
           PN++  ++V L+     +  + +YA              +      +      +    Q+
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQPKSTVG 180
           + G+ Y H+  V HRDLK  N L+ G    R  +KI D G    ++      +     V 
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 181 TPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVML-------------------------- 213
           T  Y APE+LL  + Y   I D+W+ G     +L                          
Sbjct: 198 TFWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256

Query: 214 ---------------VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
                          +   P          R T      ++Y     V    +  HL+ +
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316

Query: 259 IFVADPAKRISIPEIRNHEWFLKNLP 284
           +   DP KRI+  +     +F    P
Sbjct: 317 LLTMDPIKRITSEQAMQDPYF-LEDP 341

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  139 bits (352), Expect = 8e-39
 Identities = 72/310 (23%), Positives = 110/310 (35%), Gaps = 59/310 (19%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
            RYE V +IG G +G     RD  +   VA+K + R                RE+   R 
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRR 67

Query: 74  LR---HPNIVRFKEVILTPTH-----LAIVMEYASG--GELFERICNAGRFSEDEARFFF 123
           L    HPN+VR  +V  T        + +V E+         ++         +  +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126

Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 180
           +Q + G+ + H+  + HRDLK EN L+       +K+ DFG ++    +S        V 
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPVVV 181

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA--------------------YPFE 220
           T  Y APEVLL+  Y   + D+WS G     M                         P E
Sbjct: 182 TLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240

Query: 221 D--PEEPK----NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 274
           D  P +       F     R +           +      L+  +   +P KRIS     
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVP-----EMEESGAQLLLEMLTFNPHKRISAFRAL 295

Query: 275 NHEWFLKNLP 284
            H +  K+  
Sbjct: 296 QHSYLHKDEG 305

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  138 bits (351), Expect = 2e-38
 Identities = 65/298 (21%), Positives = 121/298 (40%), Gaps = 47/298 (15%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
            D Y+LVR +G G +       +    E V VK ++   K  + ++REI    +LR  PN
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 92

Query: 79  IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           I+   +++  P     A+V E+ +  +  +        ++ + RF+  +++  + YCHSM
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-K 193
            + HRD+K  N ++D     +L++ D+G ++    H   +    V +  +  PE+L+  +
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPF--------------------------------ED 221
            YD  + D+WS G  L  M+    PF                                 D
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265

Query: 222 PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           P       +   +         +   +SPE    + ++   D   R++  E   H +F
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  134 bits (340), Expect = 5e-37
 Identities = 73/297 (24%), Positives = 124/297 (41%), Gaps = 30/297 (10%)

Query: 29  IGSGNFGVARLMRDKKTEELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
           +G G FG A  +  ++T E++ +K + R  ++      +E+   R L HPN+++F  V+ 
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 88  TPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
               L  + EY  GG L   I +    +   +   F + + SG++Y HSM + HRDL   
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137

Query: 147 NTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLL 191
           N L+  +    + + DFG ++                     +  + VG P ++APE++ 
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN--FRKTIHRILSVQYSIPDYVHIS 249
            + YD K  DV+S G+ L  ++       D   P+   F   +   L      P      
Sbjct: 196 GRSYDEK-VDVFSFGIVLCEIIGRVNADPDY-LPRTMDFGLNVRGFL--DRYCPPNCP-- 249

Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQS 306
           P    +  R    DP KR S  ++   E +L+ L   L        Q E+ D+    
Sbjct: 250 PSFFPITVRCCDLDPEKRPSFVKL---EHWLETLRMHLAGHLPLGPQLEQLDRGFWE 303

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  135 bits (343), Expect = 6e-37
 Identities = 75/318 (23%), Positives = 126/318 (39%), Gaps = 45/318 (14%)

Query: 3   RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
             ++      D     + DR+++ R  G G FG  +L ++K T   VA+K +   D    
Sbjct: 5   MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFR 63

Query: 63  N-VQREIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGR- 113
           N   + + +   L HPNIV+ +    T          L +VMEY     L     N  R 
Sbjct: 64  NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRR 122

Query: 114 ---FSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
                    + F  QLI  +   H  S+ VCHRD+K  N L++ +    LK+CDFG +K 
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKK 181

Query: 169 SVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGA--YPFED---- 221
                   + + +  Y APE++   + Y   + D+WS G     M++G   +  ++    
Sbjct: 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQ 240

Query: 222 -----------PEE------PKNFRKTIHRILSVQYS--IPDYV-HISPECRHLISRIFV 261
                        E      P +    ++    + +S    D+    + E   L+S +  
Sbjct: 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300

Query: 262 ADPAKRISIPEIRNHEWF 279
             P +R+   E   H +F
Sbjct: 301 YLPEERMKPYEALCHPYF 318

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  132 bits (335), Expect = 4e-36
 Identities = 76/306 (24%), Positives = 113/306 (36%), Gaps = 52/306 (16%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
             RY  ++ +G G  G+     D   ++ VA+K I   D    ++  REI   R L H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 79  IVRFKEVILTPTHLAIVMEYASGG--------ELFE----RICNAGRFSEDEARFFFQQL 126
           IV+  E++            +           E  E     +   G   E+ AR F  QL
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129

Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
           + G+ Y HS  V HRDLK  N  ++ +    LKI DFG ++    H   K      + T 
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--- 238
            Y +P +LL    Y   I D+W+ G     ML G   F       +  + +  IL     
Sbjct: 189 WYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAG----AHELEQMQLILESIPV 243

Query: 239 ---------QYSIPDYV----------------HISPECRHLISRIFVADPAKRISIPEI 273
                       IP Y+                 IS E    + +I    P  R++  E 
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303

Query: 274 RNHEWF 279
            +H + 
Sbjct: 304 LSHPYM 309

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  130 bits (330), Expect = 1e-35
 Identities = 63/296 (21%), Positives = 106/296 (35%), Gaps = 59/296 (19%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF- 82
            L+  +G G +G   + R     E VAVK     D+     + E+ N   LRH NI+ F 
Sbjct: 11  TLLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 83  ---KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-- 137
                   + T L ++  Y   G L++ +                 + SG+++ H     
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 138 ------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
                 + HRDLK +N L+  +   +  I D G +      ++ L       VGT  Y+A
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 187 PEVL------LKKEYDGKIADVWSCGVTLYVMLVGAY----------PFED--PEEP--- 225
           PEVL         +   +  D+W+ G+ L+ +               PF D  P +P   
Sbjct: 186 PEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 226 --------KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
                      R  I        ++     +  EC +        +P+ R++   I
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWY-------QNPSARLTALRI 293

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  130 bits (330), Expect = 2e-35
 Identities = 78/307 (25%), Positives = 124/307 (40%), Gaps = 56/307 (18%)

Query: 21  DRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQ----REI---INHR 72
            +YE V +IG G +G     RD K     VA+K + R    +E +     RE+    +  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69

Query: 73  SLRHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQ 125
           +  HPN+VR  +V         T L +V E+         ++         +  +    Q
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQ 128

Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
           L+ G+ + HS +V HRDLK +N L+  S   ++K+ DFG ++      Q   T  V T  
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVVVTLW 184

Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA--------------------YPFED-- 221
           Y APEVLL+  Y   + D+WS G     M                         P E+  
Sbjct: 185 YRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243

Query: 222 PEE---PK-NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 277
           P +   P+  F     + +    +      I    + L+ +    +PAKRIS     +H 
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVT-----DIDELGKDLLLKCLTFNPAKRISAYSALSHP 298

Query: 278 WFLKNLP 284
           +F ++L 
Sbjct: 299 YF-QDLE 304

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  129 bits (327), Expect = 7e-35
 Identities = 62/310 (20%), Positives = 121/310 (39%), Gaps = 48/310 (15%)

Query: 7   TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
           + G G  +P++     + + ++V+ IG G +G   +   K   E VAVK     ++    
Sbjct: 20  SSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWF 77

Query: 64  VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
            + EI     +RH NI+ F     +   + T L ++ +Y   G L++ + +         
Sbjct: 78  RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSM 136

Query: 120 RFFFQQLISGVSYCHSMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
                  +SG+ + H+          + HRDLK +N L+  +      I D G +     
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKFIS 194

Query: 168 -SSVLHSQPKSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
            ++ +   P + VGT  Y+ PEVL         +     AD++S G+ L+ +        
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGG 253

Query: 221 DPEEPKN-FRKTIHRILSVQY------------SIPDYVH---ISPECRHLISRIFVADP 264
             EE +  +   +    S +             S P+         +   L++  +  +P
Sbjct: 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313

Query: 265 AKRISIPEIR 274
           A R++   ++
Sbjct: 314 ASRLTALRVK 323

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  128 bits (323), Expect = 4e-34
 Identities = 74/335 (22%), Positives = 137/335 (40%), Gaps = 57/335 (17%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
              Y  ++ +GSG +G      D +T   VA+K + R    ++  +   RE+   + +RH
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 77  PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
            N++   +V      L       +VM +  G +L  ++    +  ED  +F   Q++ G+
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
            Y H+  + HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APE
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPE 195

Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------- 238
           V+L    Y   + D+WS G  +  M+ G   F+      +    +  I+ V         
Sbjct: 196 VILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKG----SDHLDQLKEIMKVTGTPPAEFV 250

Query: 239 ---------QY--SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
                     Y   +P+           + SP   +L+ ++ V D  +R++  E   H  
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP- 309

Query: 279 FLKNL--PADLVVDNTTNNQFEEPDQPMQSIDEIM 311
           + ++L    D       ++ F++ D+ +     + 
Sbjct: 310 YFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVT 344

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  127 bits (322), Expect = 6e-34
 Identities = 78/336 (23%), Positives = 132/336 (39%), Gaps = 59/336 (17%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
            +RY+ +  +GSG +G      D KT   VAVK + R     I  +   RE+   + ++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 77  PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
            N++   +V      L       +V     G +L   I    + ++D  +F   Q++ G+
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
            Y HS  + HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPE 199

Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-------- 238
           ++L    Y+  + D+WS G  +  +L G   F     P  +    +  IL +        
Sbjct: 200 IMLNWMHYNQTV-DIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRLVGTPGAEL 253

Query: 239 ----------QY--SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHE 277
                      Y  S+           ++  +P    L+ ++ V D  KRI+  +   H 
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313

Query: 278 WFLKNL--PADLVVDNTTNNQFEEPDQPMQSIDEIM 311
            +      P D  V +  +   E  D  +     + 
Sbjct: 314 -YFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSLT 348

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  127 bits (320), Expect = 7e-34
 Identities = 71/311 (22%), Positives = 119/311 (38%), Gaps = 48/311 (15%)

Query: 7   TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
           T G G  +P++     +    L   IG G FG   + R K   E VAVK     ++    
Sbjct: 25  TSGSGSGLPLLVQRTIARTIVLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWF 82

Query: 64  VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
            + EI     LRH NI+ F     +   T T L +V +Y   G LF+ + N    + +  
Sbjct: 83  REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM 141

Query: 120 RFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
                   SG+++ H           + HRDLK +N L+  +      I D G +     
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDS 199

Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFE 220
            +  +   P   VGT  Y+APEVL         E   + AD+++ G+  + +        
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGG 258

Query: 221 DPEEPKN-FRKTIHRILSVQY------------SIPDYVHISPECR---HLISRIFVADP 264
             E+ +  +   +    SV+             +IP+        R    ++   + A+ 
Sbjct: 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318

Query: 265 AKRISIPEIRN 275
           A R++   I+ 
Sbjct: 319 AARLTALRIKK 329

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  126 bits (319), Expect = 1e-33
 Identities = 76/301 (25%), Positives = 132/301 (43%), Gaps = 55/301 (18%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
              Y     +GSG +G      DK++ E VA+K + R    +I  +   RE++  + ++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 77  PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
            N++   +V    + L       +VM +    +L + +    +FSE++ ++   Q++ G+
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
            Y HS  V HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APE
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPE 193

Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------- 238
           V+L    Y+  + D+WS G  +  ML G   F+     K++   + +IL V         
Sbjct: 194 VILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGTEFV 248

Query: 239 ---------QY--SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
                     Y  S+P          +   SP+   L+ ++   D  KR++  +   H +
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308

Query: 279 F 279
           F
Sbjct: 309 F 309

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  126 bits (319), Expect = 2e-33
 Identities = 72/347 (20%), Positives = 123/347 (35%), Gaps = 58/347 (16%)

Query: 18  HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------------ 65
                Y + R I SG++G      D +    VA+K +         V             
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 66  REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-CNAGRFSEDEA 119
           REI       HPNI+  +++ +         L +V E     +L + I       S    
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136

Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
           ++F   ++ G+   H   V HRDL   N LL  +    + ICDF  ++     +     V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194

Query: 180 GTPAYIAPEVLLK-KEYDGKIADVWSCG---------------------VTLYVMLVGAY 217
               Y APE++++ K +   + D+WS G                     +   V +VG  
Sbjct: 195 THRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 218 PFEDPEEPKNF--RKTIHRILSVQYSIP---DYVHISPECRHLISRIFVADPAKRISIPE 272
             ED     +   R  +   LS   +           P    LI+++   +P +RIS  +
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313

Query: 273 IRNHEWFLKNL--PADLVVDNTTNNQFEEPDQPMQSI-----DEIMQ 312
              H  + ++L  P DL    +    F+E    +  +      E+ +
Sbjct: 314 ALRHP-YFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIFTAEVER 359

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  124 bits (314), Expect = 2e-33
 Identities = 71/207 (34%), Positives = 100/207 (48%), Gaps = 9/207 (4%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLR 75
           ++RY++V  +G G      L  D      VA+K I    +  E      +RE+ N   L 
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           H NIV   +V        +VMEY  G  L E I + G  S D A  F  Q++ G+ + H 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKK 193
           M++ HRD+K +N L+D      LKI DFG +K  S    +Q    +GT  Y +PE    +
Sbjct: 130 MRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE 220
             D    D++S G+ LY MLVG  PF 
Sbjct: 188 ATDEC-TDIYSIGIVLYEMLVGEPPFN 213

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  125 bits (316), Expect = 4e-33
 Identities = 85/362 (23%), Positives = 143/362 (39%), Gaps = 85/362 (23%)

Query: 18  HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REII 69
           + S  ++L   +G G +GV      K T E+VA+K      KI+  +         REI 
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIK 61

Query: 70  NHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
             +  +H NI+    +    +        I+ E     +L  R+ +    S+D  ++F  
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIY 119

Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKST-- 178
           Q +  V   H   V HRDLK  N L++ +    LK+CDFG      +S+  +S+P     
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 179 -----VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKT 231
                V T  Y APEV+L   +Y   + DVWSCG  L  + +    F     P +++R  
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIF-----PGRDYRHQ 231

Query: 232 IHRILSV-------------------QY--SIPD---------YVHISPECRHLISRIFV 261
           +  I  +                   +Y  S+P          +  ++P+   L+ R+ V
Sbjct: 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291

Query: 262 ADPAKRISIPEIRNHEWFLKNL-------PADLVVDNTTNNQFEEPDQPMQSI-----DE 309
            DPAKRI+  E   H  +L+           + +  +       +     + +     +E
Sbjct: 292 FDPAKRITAKEALEHP-YLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

Query: 310 IM 311
           I 
Sbjct: 351 IF 352

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  125 bits (315), Expect = 6e-33
 Identities = 81/308 (26%), Positives = 123/308 (39%), Gaps = 64/308 (20%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REIINH 71
             RY  +  IG G +G+     D   +  VA+K      KI   E+        REI   
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKIL 79

Query: 72  RSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 126
              RH NI+   ++I  PT      + IV +     +L  ++      S D   +F  Q+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQI 137

Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
           + G+ Y HS  V HRDLK  N LL+ +    LKICDFG ++ +             V T 
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-- 238
            Y APE++L  K Y   I D+WS G  L  ML     F     P K++   ++ IL +  
Sbjct: 196 WYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIF-----PGKHYLDQLNHILGILG 249

Query: 239 ----------------QY--SIPD---------YVHISPECRHLISRIFVADPAKRISIP 271
                            Y  S+P          + +   +   L+ ++   +P KRI + 
Sbjct: 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309

Query: 272 EIRNHEWF 279
           +   H + 
Sbjct: 310 QALAHPYL 317

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  125 bits (315), Expect = 7e-33
 Identities = 70/353 (19%), Positives = 126/353 (35%), Gaps = 76/353 (21%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           S +Y L + +G+G+FG+   + D ++ +  A+K + + D   +N  RE+   + L H NI
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAG--------------------------- 112
           ++  +   T                     N G                           
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 113 --------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
                             +    +  QL   V + HS+ +CHRD+K +N L++      L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181

Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGA- 216
           K+CDFG +K  +      + + +  Y APE++L   EY   I D+WS G     +++G  
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILGKP 240

Query: 217 -YPFEDPEE-----------PKNFRKTIHRILS--VQYSIPDYVHIS----------PEC 252
            +  E   +           P   ++ + R+     +   P                   
Sbjct: 241 LFSGETSIDQLVRIIQIMGTPT--KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298

Query: 253 RHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLVVDNTTNNQFEEPDQP 303
             L+ +I   +P  RI+  E   H +F  L+N     V +N+        + P
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIP 351

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  124 bits (314), Expect = 8e-33
 Identities = 74/305 (24%), Positives = 119/305 (39%), Gaps = 51/305 (16%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
             RY+ ++ IGSG  G+     D   E  VA+K + R   ++   +   RE++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 77  PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
            NI+    V      L       IVME      L  ++        +   +   Q++ G+
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFE------------------DPEE-------- 224
           L   Y   + D+WS G  +  M+ G   F                    PE         
Sbjct: 199 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257

Query: 225 -------PKNFRKTIHRILSVQYSIPDYVH---ISPECRHLISRIFVADPAKRISIPEIR 274
                  PK    +  ++        D  H    + + R L+S++ V D +KRIS+ E  
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317

Query: 275 NHEWF 279
            H + 
Sbjct: 318 QHPYI 322

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  126 bits (318), Expect = 3e-32
 Identities = 56/264 (21%), Positives = 91/264 (34%), Gaps = 46/264 (17%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEE-LVAVKYIERGDKIDENVQ----REIINHRSL 74
           + +YE+   I  G  G   L  D+      V +K +      D   Q     E      +
Sbjct: 79  AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV 136

Query: 75  RHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            HP+IV+    +            IVMEY  G  L        +    EA  +  +++  
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           +SY HS+ + + DLK EN +L      +LK+ D G        +      GTP + APE+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED------PEEPKNFRKTIHRILSVQYSIP 243
           +          D+++ G TL  + +             PE+    +              
Sbjct: 249 VRTGPTVA--TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK-------------- 292

Query: 244 DYVHISPECRHLISRIFVADPAKR 267
                      L+ R    DP +R
Sbjct: 293 ----TYDSYGRLLRRAIDPDPRQR 312

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  122 bits (309), Expect = 4e-32
 Identities = 66/335 (19%), Positives = 112/335 (33%), Gaps = 72/335 (21%)

Query: 18  HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR 72
           +   RY LVR +G G+F    L +D      VA+K +       E  + EI     +N  
Sbjct: 16  YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75

Query: 73  SLRHP------NIVRFKEV----ILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEAR 120
                      +I++  +          H+ +V E   G  L    +            +
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134

Query: 121 FFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQP 175
              +QL+ G+ Y H    + H D+K EN L++   +P     +KI D G   +       
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY 192

Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----------- 224
            +++ T  Y +PEVLL   +     D+WS    ++ ++ G + FE  E            
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251

Query: 225 ---------PKNF------------------------RKTIHRILSVQYSIPDYVHISPE 251
                    P                              +  +L+ +Y        + E
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK--DEAKE 309

Query: 252 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 286
               +S +   DP KR     + NH W    L  +
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  124 bits (313), Expect = 4e-32
 Identities = 73/308 (23%), Positives = 117/308 (37%), Gaps = 57/308 (18%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
             RY+ ++ IGSG  G+     D   +  VA+K + R   ++   +   RE++  + + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 77  PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
            NI+    V      L       +VME      L + I        +   +   Q++ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 177

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
            + HS  + HRDLK  N ++       LKI DFG +++    +    T  V T  Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 233

Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPF---------------------ED------ 221
           V+L   Y   + D+WS G  +  M+     F                     E       
Sbjct: 234 VILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292

Query: 222 ----------PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 271
                           F K     L    S  +    + + R L+S++ V DPAKRIS+ 
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK-LKASQARDLLSKMLVIDPAKRISVD 351

Query: 272 EIRNHEWF 279
           +   H + 
Sbjct: 352 DALQHPYI 359

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  121 bits (305), Expect = 5e-32
 Identities = 62/265 (23%), Positives = 98/265 (36%), Gaps = 38/265 (14%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRHP 77
            Y L R +G G  G      D   E +VA+K +      D       QRE      L+ P
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           ++V   +       L + M   +G +L   +   G  +   A    +Q+ S +   H+  
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
             HRD+K EN L+  S      + DFG   + +    +Q  +TVGT  Y+APE   +   
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 196 DGKIADVWSCGVTLYVMLVGAYPF-------------EDPEEPKNFRKTIHRILSVQYSI 242
             + AD+++    LY  L G+ P+             +    P   R             
Sbjct: 213 TYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR------------- 258

Query: 243 PDYVHISPECRHLISRIFVADPAKR 267
           P    I      +I+R    +P  R
Sbjct: 259 PG---IPVAFDAVIARGMAKNPEDR 280

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  120 bits (304), Expect = 7e-32
 Identities = 71/285 (24%), Positives = 106/285 (37%), Gaps = 46/285 (16%)

Query: 9   GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---- 64
           G  M  P     DRYEL   +G G      L RD +    VAVK +      D +     
Sbjct: 1   GSHMTTPSHLS-DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF 59

Query: 65  QREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
           +RE  N  +L HP IV      +          IVMEY  G  L + +   G  +   A 
Sbjct: 60  RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 176
                    +++ H   + HRD+K  N ++  S    +K+ DFG     + S    +Q  
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTA 177

Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--------------EDP 222
           + +GT  Y++PE       D + +DV+S G  LY +L G  PF              EDP
Sbjct: 178 AVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236

Query: 223 EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 267
             P                      +S +   ++ +    +P  R
Sbjct: 237 IPPSARH-------------EG---LSADLDAVVLKALAKNPENR 265

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  119 bits (301), Expect = 1e-30
 Identities = 79/333 (23%), Positives = 117/333 (35%), Gaps = 75/333 (22%)

Query: 18  HDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
           H + RYE+++ IG G+FG V +   D K  + VA+K +    +       EI   R L H
Sbjct: 94  HVAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEH 149

Query: 77  ---------PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQ 125
                     N++   E      H+ +  E  S   L+E I       FS    R F   
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 184
           ++  +   H  ++ H DLK EN LL       +K+ DFG   SS    Q   T + +  Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFY 265

Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY---------------------VMLVGAYP----- 218
            APEV+L   Y   I D+WS G  L                      + L+G        
Sbjct: 266 RAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324

Query: 219 --------FEDPEEPKNFRKT----IHRILSVQYSIPDYVHISPECR------------- 253
                         P+    T       +L+   S    +   PE R             
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384

Query: 254 --HLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
               + +    DPA R++  +   H W  + LP
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP 417

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  118 bits (297), Expect = 5e-30
 Identities = 75/345 (21%), Positives = 124/345 (35%), Gaps = 89/345 (25%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
            D Y +   IG G++G   L  DK TE+ VA+K + R   D ID + + REI     L+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 77  PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
             I+R  ++I+    L      IV+E A   +L +        +E+  +     L+ G +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-------- 183
           + H   + HRDLK  N LL+      +K+CDFG +++                       
Sbjct: 144 FIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201

Query: 184 ---------------YIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG------------ 215
                          Y APE++L  + Y   I D+WS G     +L              
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNRF 260

Query: 216 ------------AYPFEDPEEPKNFRKTIHRILSV------------------QY--SIP 243
                                 K+ R  ++ I ++                  +Y    P
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP 320

Query: 244 D---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
                     Y  IS +  +L+  +   +P KRI+I +  +H + 
Sbjct: 321 HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  117 bits (294), Expect = 8e-30
 Identities = 77/330 (23%), Positives = 121/330 (36%), Gaps = 75/330 (22%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLR- 75
             +YELV+ +G G +G+     D++T E+VAVK I     +  D +   REI+    L  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67

Query: 76  HPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           H NIV    V+       + +V +Y    +L   +  A        ++   QLI  + Y 
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYL 125

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------------- 178
           HS  + HRD+K  N LL+      +K+ DFG S+S V   +  +                
Sbjct: 126 HSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183

Query: 179 -------VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG--------------- 215
                  V T  Y APE+LL   +Y   I D+WS G  L  +L G               
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIFPGSSTMNQLER 242

Query: 216 --------------------------AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
                                     +   +      N R    +  ++   I      +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302

Query: 250 PECRHLISRIFVADPAKRISIPEIRNHEWF 279
            E   L+ ++   +P KRIS  +   H + 
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFV 332

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  115 bits (290), Expect = 1e-29
 Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 29/240 (12%)

Query: 9   GPGMDMP-IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
           G  +    +   S   +L+     G FG   + + +   E VAVK     DK     + E
Sbjct: 11  GVDLGTENLYFQSMPLQLLEVKARGRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYE 68

Query: 68  IINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
           + +   ++H NI++F    K        L ++  +   G L + +  A   S +E     
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIA 127

Query: 124 QQLISGVSYCHSMQ----------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
           + +  G++Y H             + HRD+K +N LL  +      I DFG +       
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGK 185

Query: 174 QPKST---VGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
               T   VGT  Y+APEVL      +++   +  D+++ G+ L+ +       + P + 
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  117 bits (295), Expect = 1e-29
 Identities = 78/355 (21%), Positives = 128/355 (36%), Gaps = 97/355 (27%)

Query: 18  HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSL 74
              DRYE+   IG+G++G      DK  + +VA+K I R   D ID + + REI     L
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109

Query: 75  RHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            H ++V+  ++++         L +V+E A   +  +        +E   +     L+ G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
           V Y HS  + HRDLK  N L++      +K+CDFG +++        S +          
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226

Query: 184 ----------------------YIAPEVLL-KKEYDGKIADVWSCGVTLYVML------- 213
                                 Y APE++L ++ Y   I DVWS G     +L       
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIFAELLNMIKENV 285

Query: 214 -----------------VGAYPFEDPEEPKNFRKTIH---RILSV--------------- 238
                            +        +   + R        I ++               
Sbjct: 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE 345

Query: 239 ---QY--SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
              +Y    P          +   S +  HL+ R+ V +P KRI+I E   H +F
Sbjct: 346 DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  114 bits (287), Expect = 3e-29
 Identities = 59/304 (19%), Positives = 100/304 (32%), Gaps = 54/304 (17%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           D D  +L+  IG G +G   + +    E  VAVK     ++ +   ++ I     + H N
Sbjct: 11  DLDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68

Query: 79  IVRF-----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
           I RF     +          +VMEY   G L + + +        +      +  G++Y 
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYL 127

Query: 134 HSM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHSQP 175
           H+           + HRDL   N L+         I DFG S               +  
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTGNRLVRPGEEDNAA 185

Query: 176 KSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVML---VGAYPFEDPEE-- 224
            S VGT  Y+APEVL         E   K  D+++ G+  + +       +P E   E  
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245

Query: 225 -------PKNFRKTIHRILSVQY----SIPDYVHISPECRHLISRIFV----ADPAKRIS 269
                    +      ++L  +       P+    +      +          D   R++
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305

Query: 270 IPEI 273
               
Sbjct: 306 AQXA 309

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  114 bits (287), Expect = 7e-29
 Identities = 80/333 (24%), Positives = 115/333 (34%), Gaps = 74/333 (22%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--- 77
           DRYE+   IG G+FG      D+  +E VA+K I+         Q E+     +      
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 78  ---NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
               IV  K   +   HL +V E  S   L++ + N      S +  R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 133 CHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
             +  + + H DLK EN LL       +KI DFG   SS    Q     + +  Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVG---------------------------------- 215
           LL   YD  I D+WS G  L  M  G                                  
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

Query: 216 ----------AYPFEDPEEPKN-----FRKTIHRILSVQYSIP---DYVHISPECR---- 253
                      +  +  ++ K        + +H IL V+   P                 
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348

Query: 254 --HLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
              LI R+   DP  RI       H +F K   
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  108 bits (273), Expect = 4e-27
 Identities = 70/339 (20%), Positives = 114/339 (33%), Gaps = 70/339 (20%)

Query: 21  DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP-- 77
           +RYE+V ++G G FG V   +   + +  VA+K I    K  E  + EI   + ++    
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78

Query: 78  ----NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 131
                 V   +      H+ I  E   G   FE +       +     R    QL   + 
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137

Query: 132 YCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQ 174
           + H  Q+ H DLK EN L   S                     +++ DFG   S+    +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194

Query: 175 PKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA--YPFED---------- 221
             +T V T  Y  PEV+L+  +     DVWS G  L+    G   +   +          
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253

Query: 222 --------------------------PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
                                      E   + R        ++  +        +   L
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313

Query: 256 ISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTN 294
           + R+   DPA+RI++ E   H +F    P +     + N
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  107 bits (268), Expect = 2e-26
 Identities = 63/336 (18%), Positives = 112/336 (33%), Gaps = 88/336 (26%)

Query: 21  DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSL 74
           + + ++R +G G FG V    +    ++  AVK +    K   + + E      I +  +
Sbjct: 35  NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
            + NIV++    +   H+ ++ E   G  L+E I       F  ++ + +  +++  ++Y
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 133 CHSMQVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSS 169
              M + H DLK EN LLD                             +K+ DFG    +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209

Query: 170 VLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG------------- 215
              S    + + T  Y APEV+L   +D    D+WS G  L  +  G             
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTGSLLFRTHEHMEHL 268

Query: 216 --------------------------------AYPFEDPEEPKNFRKTIHRILSVQYSIP 243
                                              + +     N  K + + L +   I 
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328

Query: 244 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
                       +  I   DP  R S  E+  H++ 
Sbjct: 329 H-----ELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  104 bits (260), Expect = 7e-26
 Identities = 40/253 (15%), Positives = 71/253 (28%), Gaps = 38/253 (15%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
            RY L+   G           D   +  VA+ +++    + ++         +    +  
Sbjct: 31  GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P + R  +V+ T     +V E+  GG L E        S   A    Q L +     H  
Sbjct: 91  PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            V           +  S    +                    +  PA +           
Sbjct: 149 GVALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA-------- 179

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH--ISPECRH 254
               D+   G +LY +LV  +P  +            R  + Q   P  +   I  +   
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDTAGQPIEPADIDRDIPFQISA 238

Query: 255 LISRIFVADPAKR 267
           + +R    D   R
Sbjct: 239 VAARSVQGDGGIR 251

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  103 bits (259), Expect = 1e-25
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)

Query: 19  DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
           +    + ++ +G GNFG   +         T E+VAVK +    ++   + +REI   +S
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67

Query: 74  LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
           L+H NIV++K V  +     L ++MEY   G L + +  +  R    +   +  Q+  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
            Y  + +  HRDL   N L+  +   R+KI DFG +K  +   +    V  P        
Sbjct: 128 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWY 184

Query: 186 APEVLLKKEYDGKIADVWSCGVTLY 210
           APE L + ++    +DVWS GV LY
Sbjct: 185 APESLTESKFSVA-SDVWSFGVVLY 208

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (260), Expect = 2e-25
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)

Query: 19  DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
           +    + ++ +G GNFG   +         T E+VAVK +    ++   + +REI   +S
Sbjct: 39  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 98

Query: 74  LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
           L+H NIV++K V  +     L ++MEY   G L + +  +  R    +   +  Q+  G+
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
            Y  + +  HRDL   N L+  +   R+KI DFG +K  +   +    V  P        
Sbjct: 159 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWY 215

Query: 186 APEVLLKKEYDGKIADVWSCGVTLY 210
           APE L + ++    +DVWS GV LY
Sbjct: 216 APESLTESKFSVA-SDVWSFGVVLY 239

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  104 bits (262), Expect = 2e-25
 Identities = 60/207 (28%), Positives = 80/207 (38%), Gaps = 14/207 (6%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
            L   IG GNFG     R +    LVAVK        D   +  +E    +   HPNIVR
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 82  FKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
              V      + IVME   GG+    +     R              +G+ Y  S    H
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236

Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEY 195
           RDL   N L+       LKI DFG S+         +  G    +     APE L    Y
Sbjct: 237 RDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRY 292

Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFED 221
             + +DVWS G+ L+    +GA P+ +
Sbjct: 293 SSE-SDVWSFGILLWETFSLGASPYPN 318

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  103 bits (260), Expect = 2e-25
 Identities = 81/325 (24%), Positives = 115/325 (35%), Gaps = 72/325 (22%)

Query: 21  DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR-- 72
            RYE+V  +G G FG V   +  K     VAVK ++  D+  E  + EI     +N    
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 130
           +      V+  E      H+ IV E   G   ++ I   G   F  D  R    Q+   V
Sbjct: 74  NSTF-RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS 173
           ++ HS ++ H DLK EN L   S                   P +K+ DFG   S+    
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188

Query: 174 QPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY---------------------V 211
           +  ST V T  Y APEV+L   +     DVWS G  L                       
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247

Query: 212 MLVGAYP------------FED-----PEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
            ++G  P            F        E     R        ++  +            
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307

Query: 255 LISRIFVADPAKRISIPEIRNHEWF 279
           LI ++   DPAKRI++ E   H +F
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  102 bits (256), Expect = 5e-25
 Identities = 63/235 (26%), Positives = 94/235 (40%), Gaps = 18/235 (7%)

Query: 19  DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
           +    + +  +G GNFG   L         T  LVAVK +   G     + QREI   ++
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80

Query: 74  LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
           L    IV+++ V   P    L +VMEY   G L + +  +  R        +  Q+  G+
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
            Y  S +  HRDL   N L+  S A  +KI DFG +K  +   +    V  P        
Sbjct: 141 EYLGSRRCVHRDLAARNILV-ESEA-HVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWY 197

Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
           APE L    +  + +DVWS GV LY +            E          + ++ 
Sbjct: 198 APESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  100 bits (252), Expect = 1e-24
 Identities = 57/213 (26%), Positives = 84/213 (39%), Gaps = 21/213 (9%)

Query: 24  ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
            L+  +G G+FGV               VAVK ++           + I       SL H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
            N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEV 189
            +  HRDL   N LL  +    +KI DFG  +   L                    APE 
Sbjct: 140 KRFIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           L  + +    +D W  GVTL+ +   G  P+  
Sbjct: 196 LKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 99.3 bits (248), Expect = 5e-24
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)

Query: 19  DSDRYELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYI--ERGDKIDENVQREIINHR 72
           +    + +RD+G G+FG     R       T E VAVK +  E G     ++++EI   R
Sbjct: 19  EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78

Query: 73  SLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISG 129
           +L H NIV++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI--- 185
           + Y  S Q  HRDL   N L+  S   ++KI DFG +K   + +  +  TV         
Sbjct: 139 MDYLGSRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVF 194

Query: 186 --APEVLLKKEYDGKIADVWSCGVTLY 210
             APE L++ ++    +DVWS GVTL+
Sbjct: 195 WYAPECLMQSKFYIA-SDVWSFGVTLH 220

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  100 bits (251), Expect = 1e-23
 Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 8/208 (3%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           +     +   +G G +G       KK    VAVK ++      E   +E    + ++HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277

Query: 79  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           +V+   V        I+ E+ + G L  + R CN    S     +   Q+ S + Y    
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
              HR+L   N L+  +    +K+ DFG S+     +              APE L   +
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395

Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
           +  K +DVW+ GV L+ +   G  P+  
Sbjct: 396 FSIK-SDVWAFGVLLWEIATYGMSPYPG 422

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 97.0 bits (242), Expect = 4e-23
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)

Query: 21  DRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
              + +RD+G G+FG   L      +  T E+VAVK +  + G +     ++EI   R+L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 75  RHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
            H +I+++K          L +VMEY   G L + +         +   F QQ+  G++Y
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAY 149

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----AP 187
            H+    HRDL   N LL  +    +KI DFG +K +V        V           AP
Sbjct: 150 LHAQHYIHRDLAARNVLL-DNDR-LVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAP 206

Query: 188 EVLLKKEYDGKIADVWSCGVTLY 210
           E L + ++    +DVWS GVTLY
Sbjct: 207 ECLKEYKFYYA-SDVWSFGVTLY 228

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 96.9 bits (242), Expect = 5e-23
 Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 19/211 (9%)

Query: 24  ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RSLR 75
           + ++ +GSG FG       + + +  ++ VA+K +           +EI++      S+ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD 75

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
           +P++ R   + LT T + ++ +    G L + +  +           +  Q+  G++Y  
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLL 191
             ++ HRDL   N L+  +P   +KI DFG +K      +     G   P  ++A E +L
Sbjct: 135 DRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
            + Y  + +DVWS GVT++ +M  G+ P++ 
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 96.2 bits (240), Expect = 5e-23
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 10/209 (4%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           +     +   +G G +G       KK    VAVK ++      E   +E    + ++HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70

Query: 79  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           +V+   V        I+ E+ + G L  + R CN    S     +   Q+ S + Y    
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLKK 193
              HRDL   N L+  +    +K+ DFG S+  +      +  G   P  + APE L   
Sbjct: 131 NFIHRDLAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 187

Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           ++  K +DVW+ GV L+ +   G  P+  
Sbjct: 188 KFSIK-SDVWAFGVLLWEIATYGMSPYPG 215

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 97.7 bits (243), Expect = 6e-23
 Identities = 68/363 (18%), Positives = 117/363 (32%), Gaps = 108/363 (29%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
            RY ++R +G G+F    L  D + ++ VA+K ++  +   E    EI     + +    
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96

Query: 76  HPN---IVR----FKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQL 126
            PN   +V+    FK   +  TH+ +V E       +   +  N         +   QQ+
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK-SNYQGLPLPCVKKIIQQV 155

Query: 127 ISGVSYCHS-MQVCHRDLKLENTLLD---------------------------------- 151
           + G+ Y H+  ++ H D+K EN LL                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 152 -------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
                         +   ++KI D G   +  +H      + T  Y + EVL+   Y+  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273

Query: 199 IADVWSCGVTLYVMLVGAYPFE--DPEE------------------PKNF---------- 228
            AD+WS     + +  G Y FE    EE                  P+            
Sbjct: 274 -ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 229 ------RKTIHRI--LSVQYSIPDYVHISPE----CRHLISRIFVADPAKRISIPEIRNH 276
                  K I ++    +   + +    S E        +  +    P KR +  E   H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 277 EWF 279
            W 
Sbjct: 393 PWL 395

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 95.2 bits (237), Expect = 7e-22
 Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 10/208 (4%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
             +   L   +G G FG   +     T   VA+K ++ G    E   +E    + LRH  
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 240

Query: 79  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           +V+   V+ +   + IV EY S G L  F +          +      Q+ SG++Y   M
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
              HRDL+  N L+  +     K+ DFG ++    +               APE  L   
Sbjct: 300 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
           +  K +DVWS G+ L  +   G  P+  
Sbjct: 358 FTIK-SDVWSFGILLTELTTKGRVPYPG 384

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 16/215 (7%)

Query: 19  DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
           ++ R  + + IGSG+ G     RL    + +  VA+K ++ G  ++   +   E      
Sbjct: 47  EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
             HPNI+R + V+       IV EY   G L  F R  + G+F+  +     + + +G+ 
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMR 165

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---AP 187
           Y   +   HRDL   N L+D +     K+ DFG S+          +T G    I   AP
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223

Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           E +  + +    +DVWS GV ++ V+  G  P+ +
Sbjct: 224 EAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 12/209 (5%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           D      V++IGSG FG+  L      ++ VA+K I  G   +E+   E      L HP 
Sbjct: 6   DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 64

Query: 79  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           +V+   V L    + +V E+   G L  + R    G F+ +        +  G++Y    
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEA 123

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
            V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT   +   +PEV    
Sbjct: 124 CVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 180

Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
            Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 181 RYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 10/208 (4%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
             +   L   +G G FG   +     T   VA+K ++ G    E   +E    + LRH  
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 323

Query: 79  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           +V+   V+ +   + IV EY S G L  F +          +      Q+ SG++Y   M
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
              HRDL+  N L+  +     K+ DFG ++    +               APE  L   
Sbjct: 383 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440

Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
           +  K +DVWS G+ L  +   G  P+  
Sbjct: 441 FTIK-SDVWSFGILLTELTTKGRVPYPG 467

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 61/222 (27%), Positives = 91/222 (40%), Gaps = 28/222 (12%)

Query: 21  DRYELVRD--------IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
            +  L RD        +G GNFG          KK  + VA+K +++G      E + RE
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMRE 60

Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
                 L +P IVR   V      + +VME A GG L + +                 Q+
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119

Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT-- 181
             G+ Y       HRDL   N LL  +     KI DFG SK   L +      +      
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKW 175

Query: 182 P-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           P  + APE +  +++  + +DVWS GVT++  +  G  P++ 
Sbjct: 176 PLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 20/217 (9%)

Query: 19  DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
           D+    + + +G+G FG     RL    K E  VA+K ++ G  +K   +   E      
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
             HPNI+R + V+     + IV EY   G L  F R  +  +F+  +     + + SG+ 
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMK 161

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI--- 185
           Y   M   HRDL   N L++ +     K+ DFG  +  VL   P    +T G    I   
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWT 217

Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           +PE +  +++    +DVWS G+ L+ VM  G  P+ +
Sbjct: 218 SPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 91.2 bits (227), Expect = 4e-21
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 23/217 (10%)

Query: 21  DRYELV---RDIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH---- 71
           DR  L    +++GSGNFG  +    + KK  + VAVK + + +  D  ++ E++      
Sbjct: 14  DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVM 72

Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           + L +P IVR   +    + + +VME A  G L + +       +        Q+  G+ 
Sbjct: 73  QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYI 185
           Y       HRDL   N LL  +     KI DFG SK   L +     K+      P  + 
Sbjct: 132 YLEESNFVHRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWY 187

Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           APE +   ++  K +DVWS GV ++     G  P+  
Sbjct: 188 APECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 50/209 (23%), Positives = 99/209 (47%), Gaps = 15/209 (7%)

Query: 24  ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHRSLRHP 77
           + ++ +GSG FG       + + +  ++ VA+K +      K ++ +  E     S+ +P
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSM 136
           ++ R   + LT T + ++ +    G L + +  +           +  Q+  G++Y    
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLKK 193
           ++ HRDL   N L+  +P   +KI DFG +K      +     G   P  ++A E +L +
Sbjct: 137 RLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
            Y  + +DVWS GVT++ +M  G+ P++ 
Sbjct: 195 IYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 91.2 bits (227), Expect = 5e-21
 Identities = 64/314 (20%), Positives = 126/314 (40%), Gaps = 37/314 (11%)

Query: 19  DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYI--ERGDKIDENVQREIINHR 72
                  ++ +GSG FG       + + ++ ++ V +K I  + G +  + V   ++   
Sbjct: 11  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 131
           SL H +IVR   +    + L +V +Y   G L + +  + G         +  Q+  G+ 
Sbjct: 71  SLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----A 186
           Y     + HR+L   N LL  SP+ ++++ DFG +   +L    K  + + A       A
Sbjct: 130 YLEEHGMVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMA 185

Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRI-----LSVQY 240
            E +   +Y  + +DVWS GVT++ +M  GA P+          +    +     L+   
Sbjct: 186 LESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG----LRLAEVPDLLEKGERLAQPQ 240

Query: 241 SIPDYVH-ISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLVVDNTTNNQFE 298
                V+ +  +C          D   R +  E+ N      ++ P  LV+   +     
Sbjct: 241 ICTIDVYMVMVKCWM-------IDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIA 293

Query: 299 EPDQPMQSIDEIMQ 312
              +P    ++ ++
Sbjct: 294 PGPEPHGLTNKKLE 307

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 12/209 (5%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
             +  +L + +G+G FG   +    K  + VAVK ++ G    E    E    ++L+H  
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDK 244

Query: 79  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           +V+   V+ T   + I+ E+ + G L  F +     +    +   F  Q+  G+++    
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
              HRDL+  N L+  S     KI DFG ++  +  ++  +  G    I   APE +   
Sbjct: 304 NYIHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFG 360

Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
            +  K +DVWS G+ L  ++  G  P+  
Sbjct: 361 SFTIK-SDVWSFGILLMEIVTYGRIPYPG 388

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 88.8 bits (221), Expect = 1e-20
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)

Query: 19  DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
             +   L++++GSG FGV    +     K +  VAVK I+ G   ++   +E      L 
Sbjct: 6   KREEITLLKELGSGQFGVVKLGKW----KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS 61

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
           HP +V+F  V      + IV EY S G L  + R  +       +       +  G+++ 
Sbjct: 62  HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL 120

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
            S Q  HRDL   N L+D      +K+ DFG ++  VL  Q  S+VGT   +   APEV 
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVF 177

Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
              +Y  K +DVW+ G+ ++ V  +G  P++ 
Sbjct: 178 HYFKYSSK-SDVWAFGILMWEVFSLGKMPYDL 208

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 20/206 (9%)

Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 83
           +G GNFG          KK  + VA+K +++G      E + RE      L +P IVR  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 84  EVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
            V      + +VME A GG L + +                 Q+  G+ Y       HR+
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461

Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLKKEYD 196
           L   N LL  +     KI DFG SK   L +      +       +   APE +  +++ 
Sbjct: 462 LAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517

Query: 197 GKIADVWSCGVTLY-VMLVGAYPFED 221
            + +DVWS GVT++  +  G  P++ 
Sbjct: 518 SR-SDVWSYGVTMWEALSYGQKPYKK 542

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 67/305 (21%), Positives = 115/305 (37%), Gaps = 45/305 (14%)

Query: 19  DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHR 72
              ++ L R +G G FG    A+L ++  +   VAVK ++       +++   RE    +
Sbjct: 21  PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80

Query: 73  SLRHPNIVRF------KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
              HP++ +                  +++ +   G+L  F     A R  E+      Q
Sbjct: 81  EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQ 137

Query: 125 QLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
            L+        G+ Y  S    HRDL   N +L       + + DFG S+   ++S    
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYY 193

Query: 178 TVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFR 229
             G  + +     A E L    Y    +DVW+ GVT++ +M  G   Y   +  E  N+ 
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252

Query: 230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLV 288
              +R+       P       E   L+ + + ADP +R S   +R   E  L +L     
Sbjct: 253 IGGNRL-----KQPPEC--MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305

Query: 289 VDNTT 293
             +  
Sbjct: 306 SQDPL 310

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 88.1 bits (219), Expect = 4e-20
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 18/212 (8%)

Query: 19  DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
           D      ++++G+G FGV    +     + +  VA+K I+ G   ++    E     +L 
Sbjct: 22  DPKDLTFLKELGTGQFGVVKYGKW----RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 77

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
           H  +V+   V      + I+ EY + G L  + R     RF   +     + +   + Y 
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL 136

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
            S Q  HRDL   N L++      +K+ DFG S+  VL  +  S+VG+   +    PEVL
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVL 193

Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           +  ++  K +D+W+ GV ++ +  +G  P+E 
Sbjct: 194 MYSKFSSK-SDIWAFGVLMWEIYSLGKMPYER 224

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 88.0 bits (219), Expect = 4e-20
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 12/209 (5%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
             +  +LV  +G+G FG   +       + VAVK +++G    +    E    + L+H  
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69

Query: 79  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           +VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++    
Sbjct: 70  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
              HRDL+  N L+  + +   KI DFG ++  +  ++  +  G    I   APE +   
Sbjct: 129 NYIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
            +  K +DVWS G+ L  ++  G  P+  
Sbjct: 186 TFTIK-SDVWSFGILLTEIVTHGRIPYPG 213

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 87.6 bits (218), Expect = 5e-20
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 18/210 (8%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           +    +L++ IG G FG   L   +  +  VAVK I + D   +    E      LRH N
Sbjct: 19  NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 75

Query: 79  IVRFKEVILTPT-HLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           +V+   VI+     L IV EY + G L  + R         D    F   +   + Y   
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLK 192
               HRDL   N L+  S     K+ DFG +K +       +       +   APE L +
Sbjct: 136 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 188

Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           K++  K +DVWS G+ L+ +   G  P+  
Sbjct: 189 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 18/210 (8%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           +    +L++ IG G FG   L   +  +  VAVK I + D   +    E      LRH N
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 247

Query: 79  IVRFKEVILT-PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           +V+   VI+     L IV EY + G L  + R         D    F   +   + Y   
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLK 192
               HRDL   N L+        K+ DFG +K +       +       +   APE L +
Sbjct: 308 NNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 360

Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           K++  K +DVWS G+ L+ +   G  P+  
Sbjct: 361 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 389

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 87.7 bits (218), Expect = 7e-20
 Identities = 65/311 (20%), Positives = 113/311 (36%), Gaps = 51/311 (16%)

Query: 10  PGMDMPIMHDSDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDK 59
           P     + +  +          L + +G G FG      L ++  T   VAVK ++  + 
Sbjct: 16  PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75

Query: 60  IDENVQ---REIINHRSLRHPNIVR-----FKEVILTPTHLAIVMEYASGGEL--FERIC 109
               ++    E    +   HPN++R      +          +++ +   G+L  +    
Sbjct: 76  SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135

Query: 110 NAGRFSEDEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
              R          Q L+        G+ Y  +    HRDL   N +L       + + D
Sbjct: 136 ---RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVAD 190

Query: 163 FGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA 216
           FG SK   ++S      G  A +     A E L  + Y  K +DVW+ GVT++ +   G 
Sbjct: 191 FGLSK--KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGM 247

Query: 217 --YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 274
             YP     E  ++    HR+       P+      E   ++   +  DP  R +   +R
Sbjct: 248 TPYPGVQNHEMYDYLLHGHRL-----KQPE--DCLDELYEIMYSCWRTDPLDRPTFSVLR 300

Query: 275 NH-EWFLKNLP 284
              E  L++LP
Sbjct: 301 LQLEKLLESLP 311

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 51/219 (23%), Positives = 85/219 (38%), Gaps = 22/219 (10%)

Query: 20  SDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
             +Y        L R +G G FG          K  +  VAVK  ++       E    E
Sbjct: 4   GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63

Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
            +  ++L HP+IV+   +I       I+ME    GEL   +  N           +  Q+
Sbjct: 64  AVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122

Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI- 185
              ++Y  S+   HRD+ + N L+       +K+ DFG S+  +          T   I 
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYYKASVTRLPIK 179

Query: 186 --APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
             +PE +  + +    +DVW   V ++ ++  G  PF  
Sbjct: 180 WMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 86.5 bits (215), Expect = 1e-19
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 17/214 (7%)

Query: 19  DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
             +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R 
Sbjct: 13  QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 72

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
             HP+IV+   VI       I+ME  + GEL  F +              +  QL + ++
Sbjct: 73  FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALA 130

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPE 188
           Y  S +  HRD+   N L+  +    +K+ DFG S+  +  S          P  ++APE
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE 187

Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
            +  + +    +DVW  GV ++ +++ G  PF+ 
Sbjct: 188 SINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 17/216 (7%)

Query: 19  DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHR 72
                   + IG+G FG      L      +E+ VA+K ++ G  +K   +   E     
Sbjct: 42  HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGV 130
              H NI+R + VI     + I+ EY   G L  F R    G FS  +     + + +G+
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGM 160

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---A 186
            Y  +M   HRDL   N L++ +     K+ DFG S+      +   +T G    I   A
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218

Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
           PE +  +++    +DVWS G+ ++ VM  G  P+ +
Sbjct: 219 PEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 53/220 (24%), Positives = 81/220 (36%), Gaps = 24/220 (10%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
               L+R +G G FG         M +  +   VAVK +       + +    E +    
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
             H NIVR   V L      I+ME  +GG+L   +          +      L+      
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 185
             G  Y       HRD+   N LL      R+ KI DFG ++   ++       G  A +
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAML 207

Query: 186 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
                 PE  ++  +  K  D WS GV L+ +  +G  P+
Sbjct: 208 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 86.8 bits (215), Expect = 7e-19
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 17/209 (8%)

Query: 24  ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPN 78
           EL R IG G FG       M  +     VA+K  +    D + E   +E +  R   HP+
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           IV+   VI       I+ME  + GEL   +              +  QL + ++Y  S +
Sbjct: 453 IVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAPEVLLKK 193
             HRD+   N L+  +    +K+ DFG S+   +      K++ G  P  ++APE +  +
Sbjct: 512 FVHRDIAARNVLVSSNDC--VKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFR 567

Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
            +    +DVW  GV ++ +++ G  PF+ 
Sbjct: 568 RFTSA-SDVWMFGVCMWEILMHGVKPFQG 595

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 52/220 (23%), Positives = 81/220 (36%), Gaps = 24/220 (10%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
               L+R +G G FG         M +  +   VAVK +       + +    E +    
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
             H NIVR   V L      I++E  +GG+L   +          +      L+      
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 185
             G  Y       HRD+   N LL      R+ KI DFG ++   ++       G  A +
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAML 248

Query: 186 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
                 PE  ++  +  K  D WS GV L+ +  +G  P+
Sbjct: 249 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 58/309 (18%), Positives = 119/309 (38%), Gaps = 38/309 (12%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
           ++  + R++G G+FG     VA+ +   + E  VA+K +     + E +    E    + 
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEAR--------FFF 123
               ++VR   V+       ++ME  + G+L  + R       +                
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
            ++  G++Y ++ +  HRDL   N ++  +    +KI DFG ++   ++       G   
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKG 200

Query: 184 YI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRI 235
            +     +PE L    +    +DVWS GV L+ +  +    Y     E+   F      +
Sbjct: 201 LLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259

Query: 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLVVDNTTN 294
                  PD  +       L+   +  +P  R S  EI +  +  ++    ++    +  
Sbjct: 260 -----DKPD--NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 312

Query: 295 NQFEEPDQP 303
           N+  EP++ 
Sbjct: 313 NKLPEPEEL 321

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 20/222 (9%)

Query: 13  DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
            + I   S        IG G+FG      L+ +   +   AVK + R   I E  Q   E
Sbjct: 17  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76

Query: 68  IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
            I  +   HPN++    + L       +V+ Y   G+L  F R       +  +   F  
Sbjct: 77  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135

Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 183
           Q+  G+ Y  S +  HRDL   N +LD      +K+ DFG ++  +   +  S       
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR-DMYDKEYYSVHNKTGA 192

Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
                ++A E L  +++  K +DVWS GV L+ +M  GA P+
Sbjct: 193 KLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 32/217 (14%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
               L R++G G FG         +   K + LVAVK ++          QRE     +L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQ 125
           +H +IV+F  V      L +V EY   G+L +          I   G+  + +      Q
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 126 LI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
           ++       SG+ Y  S    HRDL   N L+       +KI DFG S+   ++S     
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYR 190

Query: 179 VGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
           VG    +      PE ++ +++  + +DVWS GV L+
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILW 226

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 82.5 bits (204), Expect = 9e-18
 Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 18/221 (8%)

Query: 13  DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
            + I   S        IG G+FG      L+ +   +   AVK + R   I E  Q   E
Sbjct: 81  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140

Query: 68  IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
            I  +   HPN++    + L       +V+ Y   G+L  F R       +  +   F  
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199

Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
           Q+  G+ +  S +  HRDL   N +LD      +K+ DFG ++             T A 
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAK 257

Query: 185 I-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           +     A E L  +++  K +DVWS GV L+ +M  GA P+
Sbjct: 258 LPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 81.6 bits (202), Expect = 9e-18
 Identities = 37/219 (16%), Positives = 72/219 (32%), Gaps = 29/219 (13%)

Query: 24  ELVRDIGSGNFGV-------ARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR 75
                +G G F               +  E  V +K +++      E+          L 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
           H ++V    V +      +V E+   G L  + +  N    +        +QL + + + 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL 129

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
               + H ++  +N LL      +       K+ D G S + +     +  +    ++ P
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVPP 186

Query: 188 EVLLKKEYDGKI----ADVWSCGVTLY-VMLVGAYPFED 221
           E +     + K      D WS G TL+ +   G  P   
Sbjct: 187 ECIE----NPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 32/226 (14%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
               L  ++G G FG         +  ++ + LVAVK ++   +      QRE      L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 75  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------RICNAGRFSEDEARFFFQQL 126
           +H +IVRF  V      L +V EY   G+L              AG            QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 127 I-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
           +       +G+ Y   +   HRDL   N L+       +KI DFG S+   ++S     V
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSR--DIYSTDYYRV 216

Query: 180 GTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
           G    +      PE +L +++  + +DVWS GV L+ +   G  P+
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 22/229 (9%)

Query: 13  DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
           D+ I H+       R IG G+FGV      +   +     A+K + R  ++ +     RE
Sbjct: 13  DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72

Query: 68  IINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 123
            +  R L HPN++    ++L        +++ Y   G+L  F R       +  +   F 
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFG 130

Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 180
            Q+  G+ Y    +  HRDL   N +LD S    +K+ DFG ++       +S  +    
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHA 188

Query: 181 T-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEE 224
             P  + A E L    +  K +DVWS GV L+ ++  GA  Y   DP +
Sbjct: 189 RLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 79.2 bits (196), Expect = 6e-17
 Identities = 44/230 (19%), Positives = 87/230 (37%), Gaps = 34/230 (14%)

Query: 19  DSDRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINH 71
                  + ++G   FG             +  + VA+K ++      + E  + E +  
Sbjct: 7   SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66

Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFF 122
             L+HPN+V    V+     L+++  Y S G+L            + +       ++   
Sbjct: 67  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 123 FQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175
               +       +G+ Y  S  V H+DL   N L+       +KI D G  +   +++  
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAAD 182

Query: 176 KSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
              +   + +     APE ++  ++    +D+WS GV L+ V   G  P+
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 55/235 (23%), Positives = 86/235 (36%), Gaps = 47/235 (20%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
           +R    + +G+G FG      A  +        VAVK +       ER   + E  V   
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------FERICNAGRFSE 116
           +       H NIV             ++ EY   G+L                +     +
Sbjct: 83  L-----GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
           DE     + L+S       G+++  S    HRDL   N LL        KICDFG ++  
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR-- 193

Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
            + +     V   A +     APE +    Y  + +DVWS G+ L+ +  +G+ P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 22/213 (10%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
           +++ L R IGSG+FG   L  + +T E VA+K  E        +  E   +R L+    I
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65

Query: 80  VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
              +   +   +  +VM+    S  +LF   C+  + S         Q+I+ V + HS  
Sbjct: 66  PNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123

Query: 138 VCHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 188
             HRD+K +N L+  G  A ++ I DFG +K     S+  H    + K+  GT  Y +  
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183

Query: 189 VLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
             L  E    D    D+ S G  L   L G+ P
Sbjct: 184 THLGIEQSRRD----DLESLGYVLMYFLRGSLP 212

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 24/215 (11%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
             Y++ R IG G+FGV     +    + VA+K+ E        ++ E   ++ L     I
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68

Query: 80  VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
                      H  +V++    S  +L   +C   +FS        +Q+++ V   H   
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126

Query: 138 VCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIA 186
           + +RD+K +N L+   +   A  + + DFG  K      +  H    + K+  GT  Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186

Query: 187 PEVLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
               L +E    D    D+ + G      L G+ P
Sbjct: 187 INTHLGREQSRRD----DLEALGHVFMYFLRGSLP 217

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 55/236 (23%), Positives = 90/236 (38%), Gaps = 42/236 (17%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
           +  E VRDIG G FG      A  +   +   +VAVK ++      +  + QRE      
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
             +PNIV+   V      + ++ EY + G+L                  +    A   S 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 117 DEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
                   + +       +G++Y    +  HRDL   N L+       +KI DFG S++ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN- 223

Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
            ++S           I      PE +    Y  + +DVW+ GV L+ +   G  P+
Sbjct: 224 -IYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 68/295 (23%), Positives = 118/295 (40%), Gaps = 47/295 (15%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYIERGDKIDENV--QREIINH 71
           D+  L + +G G FG      A  +   K +E   VAVK ++      +      E+   
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 72  RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
           + + +H NI+           L +++EYAS G L              +       E + 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +++ 
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNI 256

Query: 175 PKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPK 226
                 T   +     APE L  + Y  + +DVWS GV ++ +  +G   YP    EE  
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315

Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH-EWFL 280
              K  HR+       P   + + E   ++   + A P++R +  ++    +  L
Sbjct: 316 KLLKEGHRM-----DKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 58/233 (24%), Positives = 87/233 (37%), Gaps = 47/233 (20%)

Query: 19  DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
           D +  +    IG GNFG    AR+ +D    +  A+K +       +  D   E  V  +
Sbjct: 23  DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCK 81

Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDE 118
           +       HPNI+          +L + +EYA  G L          E        +   
Sbjct: 82  L-----GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136

Query: 119 ARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
           +    QQL+        G+ Y    Q  HRDL   N L+  +     KI DFG S+   +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEV 194

Query: 172 HSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
           +        T   +     A E L    Y    +DVWS GV L+ ++ +G  P
Sbjct: 195 Y-----VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 42/236 (17%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
               L + +G G FG      A  ++ +     VAVK ++         ++  E    + 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
           + HP++++          L +++EYA  G L                      ++     
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
           DE       LIS       G+ Y   M++ HRDL   N L+       +KI DFG S+  
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD- 199

Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
            ++ +      +   I     A E L    Y  + +DVWS GV L+ ++ +G  P+
Sbjct: 200 -VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 46/222 (20%), Positives = 82/222 (36%), Gaps = 42/222 (18%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVK-------YIERGDKIDE-NVQRE 67
           +  +  + +G+G FG      A  +  +     VAVK         E+   + E  +   
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEAR 120
           +      +H NIV           + ++ EY   G+L          +     F+   + 
Sbjct: 106 L-----GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160

Query: 121 FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
              + L+        G+++  S    HRD+   N LL  +     KI DFG ++   + +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARD--IMN 216

Query: 174 QPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
                V   A +     APE +    Y  + +DVWS G+ L+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLW 257

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 24/214 (11%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIV 80
            + + + IG GNFG  RL ++  T E VA+K +E        +  E   ++ L     I 
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 81  RFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           +         + A+V+E    S  +LF  +C+   FS         QLIS + Y HS  +
Sbjct: 69  QVYYFGPCGKYNAMVLELLGPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL 126

Query: 139 CHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---SQPKSTVGTPAYIAP 187
            +RD+K EN L+        ++    DF  +K      +  H    + KS  GT  Y++ 
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186

Query: 188 EVLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
              L KE    D    D+ + G      L G+ P
Sbjct: 187 NTHLGKEQSRRD----DLEALGHMFMYFLRGSLP 216

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 73.6 bits (181), Expect = 6e-15
 Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 22/213 (10%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
           +RY L R IGSG+FG   L  D    E VA+K  E        +  E   ++ ++    I
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67

Query: 80  VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
              +       +  +VME    S  +LF   C+  +FS         Q+IS + Y HS  
Sbjct: 68  PTIRWCGAEGDYNVMVMELLGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125

Query: 138 VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 188
             HRD+K +N L+  G     + I DFG +K      +  H    + K+  GT  Y +  
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185

Query: 189 VLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
             L  E    D    D+ S G  L    +G+ P
Sbjct: 186 THLGIEQSRRD----DLESLGYVLMYFNLGSLP 214

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 57/249 (22%), Positives = 92/249 (36%), Gaps = 53/249 (21%)

Query: 14  MPIMHDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYI------- 54
             + +D+ ++E       L + +G G FG      A  +    T   VAVK +       
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72

Query: 55  ERGDKIDE-NVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGEL-------- 104
           E    + E  +   I       H N+V        P   L +++E+   G L        
Sbjct: 73  EHRALMSELKILIHI-----GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127

Query: 105 -FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAP 156
                         +     + LI        G+ +  S +  HRDL   N LL      
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV- 186

Query: 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY- 210
            +KICDFG ++   ++  P       A +     APE +  + Y  + +DVWS GV L+ 
Sbjct: 187 -VKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWE 242

Query: 211 VMLVGAYPF 219
           +  +GA P+
Sbjct: 243 IFSLGASPY 251

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 37/230 (16%)

Query: 21  DRYELVRDIGSGNFG------VARLMRDKKTEEL-VAVKYIERGDKIDENV--QREIINH 71
           D+  L + +G G FG         + +DK  E + VAVK ++      +      E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 72  RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
           + + +H NI+           L +++EYAS G L              +       E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +++ 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNI 210

Query: 175 PKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
                 T   +     APE L  + Y  + +DVWS GV ++ +  +G  P
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 56/240 (23%), Positives = 85/240 (35%), Gaps = 52/240 (21%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
           +  E  + +GSG FG      A  +        VAVK +       ER   + E  +  +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----------------FERICNA 111
           +       H NIV           + ++ EY   G+L                       
Sbjct: 105 L-----GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159

Query: 112 GRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
               ED     F+ L+        G+ +       HRDL   N L+       +KICDFG
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFG 217

Query: 165 YSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
            ++   + S     V   A +     APE L +  Y  K +DVWS G+ L+ +  +G  P
Sbjct: 218 LARD--IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 58/226 (25%), Positives = 87/226 (38%), Gaps = 46/226 (20%)

Query: 21  DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYI-------ERGDKIDE-NVQ 65
           DR  L + +G G FG      A  +   K      VAVK +       +  D I E  + 
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 66  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSE 116
           + I      +H NI+           L +++EYAS G L              +      
Sbjct: 129 KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
            E +   + L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR-- 239

Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
            +H        T   +     APE L  + Y  + +DVWS GV L+
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLW 284

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.9 bits (157), Expect = 6e-12
 Identities = 39/196 (19%), Positives = 59/196 (30%), Gaps = 52/196 (26%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---------VQREIIN 70
           +++ +    IG G FG         T   VA+K I        N         +  EII 
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 71  HRSL---------RHPNIVRFKEVIL------------------------------TPTH 91
            + L         R    +    V                                    
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 92  LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLL 150
           L IV+E+  GG   E++      S   A+    QL + ++    S++  HRDL   N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 151 DGSPAPRLKICDFGYS 166
             +   +L     G S
Sbjct: 196 KKTSLKKLHYTLNGKS 211

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 63/215 (29%), Positives = 88/215 (40%), Gaps = 52/215 (24%)

Query: 29  IGSGNFG-VAR-LMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRF-- 82
           IG G FG V + ++RD      VA+K         I+E  + EI      RHP++V    
Sbjct: 47  IGHGVFGKVYKGVLRDGAK---VALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSLIG 102

Query: 83  --KEVILTPTHLAIVMEYASGGELFERICNAGRFSE------------DEARFFFQQLIS 128
              E       + ++ +Y   G L   +  +   +               AR        
Sbjct: 103 FCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR-------- 150

Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GTPAYI 185
           G+ Y H+  + HRD+K  N LLD +  P  KI DFG SK      Q   STV  GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208

Query: 186 APE-----VLLKKEYDGKIADVWSCGVTLYVMLVG 215
            PE      L +K      +DV+S GV L+ +L  
Sbjct: 209 DPEYFIKGRLTEK------SDVYSFGVVLFEVLCA 237

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 15/106 (14%)

Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYI 185
           G+++ H     HRD+K  N LLD +     KI DFG ++ S        ++  VGT AY+
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYM 202

Query: 186 APEVLLKKEY-DGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
           AP      E   G+I   +D++S GV L  ++ G    ++  EP+ 
Sbjct: 203 AP------EALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 30/167 (17%), Positives = 60/167 (35%), Gaps = 24/167 (14%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
           ++ L + IGSG FG+  L       E  A   ++   + +  +  E+  ++ +   + ++
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 82  FKEVILTPTHLAI-------------------VMEY--ASGGELFERICNAGRFSEDEAR 120
                    +L I                   VME       ++     N G F +    
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG--QN-GTFKKSTVL 154

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
               +++  + Y H  +  H D+K  N LL      ++ + D+G S 
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 26/197 (13%), Positives = 62/197 (31%), Gaps = 37/197 (18%)

Query: 22  RYELVRDIGSGNFGV--------ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
           +++L       N G+                 ++  ++K ++  D    N Q      R+
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQRA 99

Query: 74  LRHPNIVRFKEVILTPT---------------HLAIVMEY--ASGGELFERICNAGRFSE 116
            +   + ++K++  TP                +  +V+     S     +        SE
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-SPKHVLSE 158

Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH- 172
                   +L+  + + H  +  H ++  EN  +D     ++ +  +G++     S  H 
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

Query: 173 ----SQPKSTVGTPAYI 185
                      G   +I
Sbjct: 219 AYVEGSRSPHEGDLEFI 235

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.0 bits (134), Expect = 1e-08
 Identities = 55/403 (13%), Positives = 131/403 (32%), Gaps = 109/403 (27%)

Query: 23  YELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
            + V ++   N+   ++ +  +++   ++   YIE+ D++  + Q     + S R    +
Sbjct: 80  QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYL 138

Query: 81  RFKEVI--LTPTHLAIV--MEYASGGE----LFERICNAGRFSEDEARFFFQQL-ISGVS 131
           + ++ +  L P    ++  +     G     +   +C + +    + +  F+   ++ + 
Sbjct: 139 KLRQALLELRPAKNVLIDGV----LGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190

Query: 132 YCHS-------MQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
            C+S       +Q + ++      +  D S   +L+I         +L S+P        
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-------- 242

Query: 184 YIAPEVLLKKEYDGKI-ADVWS----------C---------GVTLYVMLVGAY------ 217
           Y     LL       +  +V +          C          VT ++            
Sbjct: 243 Y--ENCLL-------VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDH 293

Query: 218 ---PFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISP--------ECRHLISRIFVADPA 265
                   E      K +      Q  +P  V   +P          R  ++     D  
Sbjct: 294 HSMTLTPDEVKSLLLKYLD--CRPQ-DLPREVLTTNPRRLSIIAESIRDGLATW---DNW 347

Query: 266 KRISIPEIRNH-EWFLKNL-PADLVVDNTTNNQFEE----PDQ---PMQSIDEIMQIIAE 316
           K ++  ++    E  L  L PA+          F+     P     P      ++ +I  
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEY------RKMFDRLSVFPPSAHIPTI----LLSLIWF 397

Query: 317 ATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEI 359
             I +     +N+    SL ++ +  E   + P + ++   ++
Sbjct: 398 DVIKSDVMVVVNKLHKYSL-VEKQPKESTISIPSIYLELKVKL 439

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 27/169 (15%), Positives = 54/169 (31%), Gaps = 25/169 (14%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEEL-----VAVK---------------YIERGDKID 61
            +++   IG G FG   L     +E +       VK               Y        
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 62  ENVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE 118
                     + L  P             ++  ++M+   +   +++E      RFS   
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NA-KRFSRKT 153

Query: 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
                 +++  + Y H  +  H D+K  N LL+     ++ + D+G + 
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 52.6 bits (127), Expect = 6e-08
 Identities = 56/215 (26%), Positives = 82/215 (38%), Gaps = 61/215 (28%)

Query: 29  IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQRE------IINHRSLRHPNI 79
           +G G FG     RL  D     LVAVK ++      +  + +      +I+     H N+
Sbjct: 38  LGRGGFGKVYKGRL-ADGT---LVAVKRLKEERT--QGGELQFQTEVEMISM--AVHRNL 89

Query: 80  VRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFS--------EDEARFFFQQLI 127
           +R +   +TPT   +V  Y + G     L ER  +                AR       
Sbjct: 90  LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR------- 142

Query: 128 SGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----- 179
            G++Y H     ++ HRD+K  N LLD        + DFG +K   L     + V     
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVR 196

Query: 180 GTPAYIAPE-----VLLKKEYDGKIADVWSCGVTL 209
           GT  +IAPE        +K       DV+  GV L
Sbjct: 197 GTIGHIAPEYLSTGKSSEK------TDVFGYGVML 225

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 11/119 (9%)

Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
           +  Q+  G+ +  S +  HRDL   N LL       +KICDFG ++   ++  P      
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253

Query: 182 PAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHR 234
            A +     APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + F + +  
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 40.3 bits (94), Expect = 7e-04
 Identities = 31/153 (20%), Positives = 55/153 (35%), Gaps = 22/153 (14%)

Query: 18  HDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG----DKID 61
           +D+ ++E       L + +G G FG      A  +    T   VAVK ++ G    +   
Sbjct: 12  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71

Query: 62  ENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEAR 120
              + +I+ H    H N+V        P   L +++E+   G L   + +  R      +
Sbjct: 72  LMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYK 129

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
               +   G  Y  +      DLK     +  S
Sbjct: 130 TKGARFRQGKDYVGA---IPVDLKRRLDSITSS 159

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	363
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.89
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.81
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.53
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.35
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.22
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.99
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.86
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.68
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.66
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.61
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.5
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.42
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.35
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.09
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.08
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.04
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.85
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.84
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.82
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.75
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.74
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.69
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.57
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.56
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.54
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.34
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.16
3mes_A	424	Choline kinase; malaria, structural genomics, stru	97.07
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.03
2lv7_A	100	Calcium-binding protein 7; metal binding protein;	93.25
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.0
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.48
1iq3_A	110	Ralbp1-interacting protein (partner of ralbp1); EF	81.96

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.1e-68  Score=501.78  Aligned_cols=361  Identities=82%  Similarity=1.340  Sum_probs=254.9

Q ss_pred             CCCCcccCCCCCCCCCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCee
Q 017936            1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV   80 (363)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv   80 (363)
                      |+|.....+| ..+|+....++|++++.||+|+||+||++++..+++.||+|++.......+.+.+|+.+++.++||||+
T Consensus         1 m~~~~~~~~p-~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv   79 (361)
T 3uc3_A            1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV   79 (361)
T ss_dssp             -----------CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCCCCCCC-CCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCC
Confidence            7888887777 778888889999999999999999999999999999999999988777778899999999999999999


Q ss_pred             eeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEE
Q 017936           81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI  160 (363)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL  160 (363)
                      ++++++.+.+.+++||||+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+++||
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl  159 (361)
T 3uc3_A           80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI  159 (361)
T ss_dssp             CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred             cEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence            99999999999999999999999999998888999999999999999999999999999999999999998777667999


Q ss_pred             eecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc
Q 017936          161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY  240 (363)
Q Consensus       161 ~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (363)
                      +|||+|+............||+.|+|||++.+..+.++++|||||||++|+|++|..||............+..+.....
T Consensus       160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~  239 (361)
T 3uc3_A          160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY  239 (361)
T ss_dssp             CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred             eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence            99999986555555566789999999999998888777689999999999999999999887766666677777777777


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCcccccCccCCCCCCCCCCCCCHHHHHHHHHHhCCC
Q 017936          241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP  320 (363)
Q Consensus       241 ~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      ..|....+++++.+||++||+.+|.+|||++|+++||||.+..+.+..........+..+.++.++++.+.+.+.+...+
T Consensus       240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (361)
T 3uc3_A          240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP  319 (361)
T ss_dssp             CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCCC------------------CCHHHHHHHHHHHTCC
T ss_pred             CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCchhhhccccccccccCCcccccCHHHHHHHHhhccCc
Confidence            77877789999999999999999999999999999999999887776665666667778888999999999999999998


Q ss_pred             CCCCCChhhhhcCCCCcccccccCCCCCCCCCCCCCCeeeecC
Q 017936          321 AAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIVYAM  363 (363)
Q Consensus       321 ~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~~  363 (363)
                      ........+...+..+.|++++ +++++++.|.|+||+|.|+|
T Consensus       320 ~~~~~~~~~~~~~~~d~d~~~~-~~d~~~~~d~d~~g~~~~~~  361 (361)
T 3uc3_A          320 AVRNRCLDDFMTDNLDLDDDMD-DFDSESEIDIDSSGEIVYAL  361 (361)
T ss_dssp             -------------------------------------------
T ss_pred             ccccccchhccccccccccccc-cccchhhhccCCCCcEEecC
Confidence            8777777777766656555443 34567788999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.8e-68  Score=473.95  Aligned_cols=257  Identities=42%  Similarity=0.738  Sum_probs=211.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..    .....+.+|+.+++.++|||||+++++|.+++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            368999999999999999999999999999999997643    2345688999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |||| +|+|.+++.+.+++++.+++.+++||+.||+|||++||+||||||+|||++.++.  +||+|||+|+........
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC---------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCcc
Confidence            9999 6799999999999999999999999999999999999999999999999986654  999999999876555556


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      .+.+||+.|||||++.+..+.+.++|||||||++|+|+||+.||.+.+....    ...+......+|  ..+|+++++|
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~~l  242 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL----FKNISNGVYTLP--KFLSPGAAGL  242 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCC--TTSCHHHHHH
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHHH
Confidence            6788999999999999988876669999999999999999999987654333    333444444444  4589999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccccCCC
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKNLPA  285 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~~~~  285 (363)
                      |++||+.||++|||++|+++||||+..+|.
T Consensus       243 i~~~L~~dP~~R~s~~eil~hpw~k~~~p~  272 (275)
T 3hyh_A          243 IKRMLIVNPLNRISIHEIMQDDWFKVDLPE  272 (275)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHCHHHHTTCCG
T ss_pred             HHHHccCChhHCcCHHHHHcCcccccCCCh
Confidence            999999999999999999999999876654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.8e-67  Score=475.26  Aligned_cols=254  Identities=30%  Similarity=0.533  Sum_probs=223.5

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++.+.||+|+||+||+|+++.+++.||||++.+.    ....+.+.+|+.+++.++|||||+++++|++++.+|+
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            456799999999999999999999999999999999753    2345678999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC--
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--  172 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~--  172 (363)
                      |||||+||+|.+++.+.+.+++.+++.|+.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.....  
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTT
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCC
Confidence            9999999999999999999999999999999999999999999999999999999986654  999999999865332  


Q ss_pred             -CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       173 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                       ....+.+||+.|||||++.+..|+.+ +|||||||++|+|+||.+||.+.+....    ...+....+.+|.  .+|++
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~----~~~i~~~~~~~p~--~~s~~  260 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEGLI----FAKIIKLEYDFPE--KFFPK  260 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCT--TCCHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCc--ccCHH
Confidence             23346689999999999998888655 9999999999999999999987665433    3344455555554  58999


Q ss_pred             HHHHHHHhcccCCCCCCCHHH------HhcCccccc
Q 017936          252 CRHLISRIFVADPAKRISIPE------IRNHEWFLK  281 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~e------ll~h~~~~~  281 (363)
                      +++||++||++||++|||++|      +++||||+.
T Consensus       261 ~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             HHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence            999999999999999999988      589999954

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.1e-66  Score=476.71  Aligned_cols=258  Identities=26%  Similarity=0.467  Sum_probs=223.9

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      ..|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.++|||||+++++|.+++.+|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999999999999999997543 33466889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCcc
Q 017936          100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST  178 (363)
Q Consensus       100 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~~  178 (363)
                      +||+|.+++.+ +.+++.+++.|+.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+..... ....+.
T Consensus       154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~  230 (346)
T 4fih_A          154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL  230 (346)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCccccc
Confidence            99999998876 56999999999999999999999999999999999999987665  999999999865433 334567


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR  258 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  258 (363)
                      +||+.|||||++.+..|+.+ +|||||||++|+|++|.+||.+.+..+.+..+..   ......+.+..+|+++++||.+
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~  306 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR  306 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SSCCCCSCGGGSCHHHHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCCccccCCHHHHHHHHH
Confidence            89999999999998888666 9999999999999999999987665444333221   1223444556789999999999


Q ss_pred             hcccCCCCCCCHHHHhcCccccccCCC
Q 017936          259 IFVADPAKRISIPEIRNHEWFLKNLPA  285 (363)
Q Consensus       259 ~L~~~p~~R~t~~ell~h~~~~~~~~~  285 (363)
                      ||+.||++|||++|+|+||||++..+.
T Consensus       307 ~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          307 LLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            999999999999999999999876543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.5e-66  Score=478.07  Aligned_cols=257  Identities=30%  Similarity=0.515  Sum_probs=216.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .-++|++++.||+|+||+||+|+++.+|+.||||++.+...   ..+.+.+|+.+++.++|||||+++++|++++.+|+|
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            44799999999999999999999999999999999976532   345688999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           96 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      ||||+||+|.+++...  ..+++.+++.|+.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+......
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTV  179 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCc
Confidence            9999999999999754  35799999999999999999999999999999999999987655  9999999998653322


Q ss_pred             -CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       174 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                       ...+.+||+.|||||++.+..|+.+ +|||||||++|+|+||+.||.+.+..+.+..    +....+ .+.+..+|+++
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~~~~-~~~~~~~s~~~  253 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLK----IISGSF-PPVSLHYSYDL  253 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHTCC-CCCCTTSCHHH
T ss_pred             ccccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HHcCCC-CCCCccCCHHH
Confidence             1234579999999999998888766 9999999999999999999988665444333    333332 23445689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      ++||.+||++||.+|||++|+|+||||++..
T Consensus       254 ~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            9999999999999999999999999998754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-64  Score=477.10  Aligned_cols=258  Identities=26%  Similarity=0.467  Sum_probs=224.4

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+++.+|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999999999999999997643 33567889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCcc
Q 017936          100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST  178 (363)
Q Consensus       100 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~~  178 (363)
                      +||+|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.++.  |||+|||+|+..... ....+.
T Consensus       231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCC
T ss_pred             CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCcccccc
Confidence            99999998865 56999999999999999999999999999999999999987665  999999999865433 334567


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR  258 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  258 (363)
                      +||+.|||||++.+..|+.+ +|||||||++|+|++|.+||.+.+....+..+..   ......+.+..+|+++++||.+
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~  383 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR  383 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSCTTSSCHHHHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCcccccCCHHHHHHHHH
Confidence            89999999999998888766 9999999999999999999987665444333221   1223445556789999999999


Q ss_pred             hcccCCCCCCCHHHHhcCccccccCCC
Q 017936          259 IFVADPAKRISIPEIRNHEWFLKNLPA  285 (363)
Q Consensus       259 ~L~~~p~~R~t~~ell~h~~~~~~~~~  285 (363)
                      ||+.||.+|||++|+|+||||++..+.
T Consensus       384 ~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          384 LLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence            999999999999999999999876543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.8e-65  Score=464.73  Aligned_cols=253  Identities=31%  Similarity=0.581  Sum_probs=214.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEc---CCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      .++|++++.||+|+||+||+|++.   .+++.||||++.+..   .....+.+|+.+++.++|||||+++++|++++.+|
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            468999999999999999999984   467899999997642   23346788999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-C
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~  172 (363)
                      +|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.... .
T Consensus       103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC-----
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCC
Confidence            99999999999999999999999999999999999999999999999999999999987665  99999999985433 3


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ....+.+||+.|||||++.+..|+.+ +|||||||++|+|+||+.||.+.+..+..    ..+......+|  ..+|+++
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~----~~i~~~~~~~p--~~~s~~~  253 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETM----TMILKAKLGMP--QFLSPEA  253 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHHH
T ss_pred             ccccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHHHHH----HHHHcCCCCCC--CcCCHHH
Confidence            34456789999999999999888766 99999999999999999999886654433    33444444444  4589999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          253 RHLISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      ++||++||++||++|||     ++|+++||||+.
T Consensus       254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            99999999999999998     579999999964

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-64  Score=455.20  Aligned_cols=254  Identities=25%  Similarity=0.412  Sum_probs=213.1

Q ss_pred             CCc-eeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEc----CCeE
Q 017936           21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL   92 (363)
Q Consensus        21 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----~~~~   92 (363)
                      .+| ++.+.||+|+||+||+|++..+++.||+|++....   ...+.+.+|+.+++.++|||||+++++|.+    ++.+
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            455 77889999999999999999999999999997543   234568899999999999999999999875    3568


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~g--iiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      |+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|  ||||||||+|||++.. .+.+||+|||+|+...
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~-~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST-TSCEEECCTTGGGGCC
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC-CCCEEEEeCcCCEeCC
Confidence            999999999999999999899999999999999999999999999  9999999999999742 2359999999997533


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                       .....+.+|||.|||||++.+ .|+.+ +|||||||++|+|+||+.||..........   ..+............+++
T Consensus       184 -~~~~~~~~GTp~YmAPE~~~~-~y~~~-~DiwSlGvilyelltg~~Pf~~~~~~~~~~---~~i~~~~~~~~~~~~~~~  257 (290)
T 3fpq_A          184 -ASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             -TTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTTCCCGGGGGCCCH
T ss_pred             -CCccCCcccCccccCHHHcCC-CCCcH-HHHHHHHHHHHHHHHCCCCCCCCCcHHHHH---HHHHcCCCCCCCCccCCH
Confidence             233456689999999998865 57655 999999999999999999998765543332   223332222223345789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ++++||.+||+.||++|||++|+|+||||++
T Consensus       258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2e-63  Score=456.62  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=216.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..+.|++.+.||+|+||+||+|+++.+|+.||||++......    .+|+.+++.++|||||+++++|.+++.+|+||||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            345689999999999999999999999999999999765332    4699999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC----
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----  174 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~----  174 (363)
                      |+||+|.+++.+.+.+++.+++.|+.||+.||+|||++|||||||||+|||++.++. ++||+|||+|+.......    
T Consensus       132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~  210 (336)
T 4g3f_A          132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSL  210 (336)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC---------
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccce
Confidence            999999999999899999999999999999999999999999999999999986542 499999999986543221    


Q ss_pred             --CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC-CCCCCCCHH
Q 017936          175 --PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-PDYVHISPE  251 (363)
Q Consensus       175 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~  251 (363)
                        ....+||+.|||||++.+..|+.+ +|||||||++|+|+||++||.+.........+..    ..... ..+..+|++
T Consensus       211 ~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~s~~  285 (336)
T 4g3f_A          211 LTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----EPPPIREIPPSCAPL  285 (336)
T ss_dssp             ---CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----SCCGGGGSCTTSCHH
T ss_pred             ecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----CCCCchhcCccCCHH
Confidence              233579999999999999888766 9999999999999999999987665544444332    22211 223468999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHH-------------hcCcccccc
Q 017936          252 CRHLISRIFVADPAKRISIPEI-------------RNHEWFLKN  282 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~el-------------l~h~~~~~~  282 (363)
                      +.+||.+||++||.+|||+.|+             ++|||+.+.
T Consensus       286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            9999999999999999999997             578998653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-61  Score=455.19  Aligned_cols=261  Identities=27%  Similarity=0.425  Sum_probs=219.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEc------CC
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT------PT   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~------~~   90 (363)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+...   ..+.+.+|+.+|+.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            4689999999999999999999999999999999976432   23567789999999999999999999864      36


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      ++|+|||||+ |+|.+++.+.+.+++.+++.+++||+.||+|||++|||||||||+|||++.++.  +||+|||+|+...
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~  209 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLC  209 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecc
Confidence            7999999995 689999999899999999999999999999999999999999999999986655  9999999998543


Q ss_pred             c-----CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-----
Q 017936          171 L-----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-----  240 (363)
Q Consensus       171 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  240 (363)
                      .     .....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+....+..+.........     
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            2     223456689999999999988776666699999999999999999999987776665554433211110     


Q ss_pred             -----------CCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          241 -----------SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       241 -----------~~~~---------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                                 ..+.         +..+|+++.+||++||+.||.+|||++|+|+||||++..
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence                       0111         235789999999999999999999999999999998753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3e-60  Score=442.67  Aligned_cols=257  Identities=24%  Similarity=0.407  Sum_probs=207.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEc---CCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|++.+.||+|+||+||+|+++   .+++.||+|.+.+.. ....+.+|+.+++.+ +|||||+++++|.+.+++|+|
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv   98 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA   98 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence            478999999999999999999975   467899999886653 345678999999988 699999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--  173 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--  173 (363)
                      ||||+|++|.+++.   .+++.+++.+++||+.||+|||++|||||||||+|||++.+ .+++||+|||+|+......  
T Consensus        99 mE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~-~~~~kl~DFGla~~~~~~~~~  174 (361)
T 4f9c_A           99 MPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRR-LKKYALVDFGLAQGTHDTKIE  174 (361)
T ss_dssp             EECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT-TTEEEECCCTTCEECTTCSCG
T ss_pred             EeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCC-CCeEEECcCCCCcccCCcccc
Confidence            99999999999883   59999999999999999999999999999999999999854 2469999999997432211  


Q ss_pred             ---------------------------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH
Q 017936          174 ---------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK  226 (363)
Q Consensus       174 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  226 (363)
                                                 ...+.+||+.|+|||++.+....+.++||||+||++|+|++|+.||.......
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~  254 (361)
T 4f9c_A          175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL  254 (361)
T ss_dssp             GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence                                       12345799999999999887655566999999999999999999997654422


Q ss_pred             -HHHHHHH----------------------------------HHhcc--------------ccCCCCCCCCCHHHHHHHH
Q 017936          227 -NFRKTIH----------------------------------RILSV--------------QYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       227 -~~~~~~~----------------------------------~~~~~--------------~~~~~~~~~~s~~~~~li~  257 (363)
                       .+..+..                                  .+...              ....+.+..+|+++.+||+
T Consensus       255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~  334 (361)
T 4f9c_A          255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD  334 (361)
T ss_dssp             HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred             HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence             2211111                                  00000              0111234568999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCccccc
Q 017936          258 RIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +||+.||++|||++|+|+||||++
T Consensus       335 ~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          335 KLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHCcCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999964

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.9e-60  Score=432.97  Aligned_cols=250  Identities=25%  Similarity=0.397  Sum_probs=197.3

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC---------
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT---------   90 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~---------   90 (363)
                      +|++++.||+|+||+||+|+++.+|+.||||++.....  ..+.+.+|+.+++.++|||||+++++|.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            59999999999999999999999999999999976432  3456889999999999999999999987544         


Q ss_pred             ---eEEEEEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecC
Q 017936           91 ---HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG  164 (363)
Q Consensus        91 ---~~~lv~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFg  164 (363)
                         .+|+|||||+||+|.+++.....   .++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DFG  163 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFG  163 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccCc
Confidence               47999999999999999987665   445678999999999999999999999999999999987665  9999999


Q ss_pred             CcccCccCCC-------------CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 017936          165 YSKSSVLHSQ-------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT  231 (363)
Q Consensus       165 la~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  231 (363)
                      +|+.......             ..+.+||+.|||||++.+..|+.+ +|||||||++|+|++   ||.....   ....
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~~~---~~~~  236 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQME---RVRT  236 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSHHH---HHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCccH---HHHH
Confidence            9985433221             233579999999999999888766 999999999999996   8854221   1122


Q ss_pred             HHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       232 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +..+..... .+.+...++.+.+||++||+.||.+|||+.|+++||||+.
T Consensus       237 ~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          237 LTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             HHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             HHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            222222221 1122334677899999999999999999999999999964

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.1e-60  Score=464.07  Aligned_cols=255  Identities=29%  Similarity=0.465  Sum_probs=216.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHH---HHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQ---REIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~---~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+..    .....+.   .++.+++.++|||||+++++|++.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999999999999999997532    1122233   346677788999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      |+|||||+||+|..++.+.+.|++..++.|+.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.... 
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~-  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS-
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecCC-
Confidence            999999999999999999999999999999999999999999999999999999999987665  99999999986533 


Q ss_pred             CCCCccccCCCcCChhhhhcC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          173 SQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      ....+.+|||.|||||++.++ .|+. ++|||||||++|+|++|.+||.+..... ...+...+......+|  ..+|++
T Consensus       345 ~~~~t~~GTp~YmAPEvl~~~~~y~~-~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p--~~~S~~  420 (689)
T 3v5w_A          345 KKPHASVGTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELP--DSFSPE  420 (689)
T ss_dssp             CCCCSCCSCGGGCCHHHHSTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCC--TTSCHH
T ss_pred             CCCCCccCCcCccCHHHHhCCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCC--ccCCHH
Confidence            344567899999999999754 4554 4999999999999999999997643322 2234444444554444  458999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          252 CRHLISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      +++||.+||++||.+|++     ++||++||||+.
T Consensus       421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            999999999999999998     799999999964

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.9e-60  Score=464.17  Aligned_cols=258  Identities=29%  Similarity=0.559  Sum_probs=226.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++..... ..+.+.+|+.+|+.++|||||+++++|.+.+.+|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            3689999999999999999999999999999999976543 346688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc
Q 017936           99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      |+||+|.+++.. .+.+++.+++.+++||+.||+|||++||+||||||+|||++.+..+.+||+|||+|+.........+
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~  315 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  315 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence            999999999864 4579999999999999999999999999999999999999876556799999999987665555566


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC--CCCCCCCHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHL  255 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~l  255 (363)
                      .+||+.|||||++.+..|+.+ +|||||||++|+|++|.+||.+.+..+.+    ..+....+.+  +.+..+|+++++|
T Consensus       316 ~~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~dl  390 (573)
T 3uto_A          316 TTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETL----RNVKSCDWNMDDSAFSGISEDGKDF  390 (573)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred             eEECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHH----HHHHhCCCCCCcccccCCCHHHHHH
Confidence            789999999999999888655 99999999999999999999886654433    3344444433  3456789999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      |++||+.||.+|||++|+|+||||+..
T Consensus       391 i~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          391 IRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHccCChhHCcCHHHHhcCcCcCCC
Confidence            999999999999999999999999753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.3e-59  Score=424.23  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=210.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      ..++|.+.+.||+|+||+||++++.     .+++.||||++.... ...+.+.+|+.++++++|||||++++++.+++.+
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            3467999999999999999999864     467889999997643 3346789999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEE
Q 017936           93 AIVMEYASGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK  159 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~-------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vk  159 (363)
                      |+|||||++|+|.+++...             ..+++.++..++.||+.||+|||+++||||||||+|||++.+..  +|
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~K  168 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VK  168 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--EE
Confidence            9999999999999999764             35999999999999999999999999999999999999987665  99


Q ss_pred             EeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHH
Q 017936          160 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI  235 (363)
Q Consensus       160 L~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~  235 (363)
                      |+|||+|+......   ......||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+.+..+...    .+
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~----~i  243 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE----CI  243 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----HH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HH
Confidence            99999997543322   2234569999999999999998766 999999999999998 999998866543332    22


Q ss_pred             hccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          236 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       236 ~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .... ..+.+..+|+++.+|+.+||+.+|++|||++++  |+|+.+
T Consensus       244 ~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          244 TQGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             HHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             HcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence            2222 233445689999999999999999999999998  456643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-58  Score=420.04  Aligned_cols=252  Identities=24%  Similarity=0.357  Sum_probs=201.6

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..+++++.+.||+|+||+||+++...   .||||+++....   ..+.+.+|+.++++++|||||++++++.. +.+++|
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            45688999999999999999998643   589999875432   34568899999999999999999998754 568999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC--
Q 017936           96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--  172 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~--  172 (363)
                      ||||+||+|.+++... .++++.++..|+.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.....  
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC------
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCCc
Confidence            9999999999999764 57999999999999999999999999999999999999987654  999999999854322  


Q ss_pred             -CCCCccccCCCcCChhhhhcC---CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          173 -SQPKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       173 -~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                       ......+||+.|||||++.+.   .|+.+ +|||||||++|||+||+.||.+.+........+..-.........+..+
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k-sDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  266 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ-SDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC  266 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcH-HHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence             223456899999999999754   35545 9999999999999999999987665444433332211111111234568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHE  277 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~  277 (363)
                      |+++.+|+.+||+.+|++|||+.|++++-
T Consensus       267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~L  295 (307)
T 3omv_A          267 PKAMKRLVADCVKKVKEERPLFPQILSSI  295 (307)
T ss_dssp             CHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            99999999999999999999999987653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.1e-58  Score=423.39  Aligned_cols=249  Identities=25%  Similarity=0.387  Sum_probs=203.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      .++|.+.++||+|+||+||+++..     .+++.||||++.... ...+.+.+|+.++++++|||||++++++.+.+.+|
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            356888999999999999999864     468899999997643 33467899999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcE
Q 017936           94 IVMEYASGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL  158 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~---------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~v  158 (363)
                      +|||||++|+|.+++...               +++++.++..|+.||+.||+|||+++||||||||+|||++.+..  +
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~--~  197 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--V  197 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--E
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--E
Confidence            999999999999998753               35899999999999999999999999999999999999987655  9


Q ss_pred             EEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHH
Q 017936          159 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR  234 (363)
Q Consensus       159 kL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  234 (363)
                      ||+|||+|+......   ......||+.|||||++.+..++.+ +|||||||++|||+| |+.||...+..+....    
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~----  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC----  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH----
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence            999999998543322   2234579999999999999888766 999999999999999 9999988665443332    


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       235 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      +... ...+.+..+|+++.+|+.+||+.||++|||++||+++
T Consensus       273 i~~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            2222 2334445789999999999999999999999999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.1e-58  Score=417.63  Aligned_cols=249  Identities=20%  Similarity=0.347  Sum_probs=209.1

Q ss_pred             CCCceeeceecccCCeEEEEEEE-----cCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      ..++++.+.||+|+||+||+++.     ..+++.||||++....  ...+.+.+|+.++++++|||||++++++.+++.+
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            35688999999999999999985     3567899999986532  3356799999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCC
Q 017936           93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP  156 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~  156 (363)
                      ++|||||++|+|.+++...                ..+++.++..++.||+.||+|||+++||||||||+|||++.++. 
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~-  183 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN-  183 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC-
Confidence            9999999999999999643                35899999999999999999999999999999999999987665 


Q ss_pred             cEEEeecCCcccCccC---CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q 017936          157 RLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI  232 (363)
Q Consensus       157 ~vkL~DFgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~  232 (363)
                       +||+|||+|+.....   .......||+.|||||++.+..++.+ +|||||||++|||+| |..||.+.+..+..    
T Consensus       184 -~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~----  257 (308)
T 4gt4_A          184 -VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVV----  257 (308)
T ss_dssp             -EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHHHH----
T ss_pred             -EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHHHH----
Confidence             999999999854332   22345679999999999999988766 999999999999998 89999886654322    


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       233 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ..+.. ....|.+..+|+++.+|+.+||+.+|.+|||+.||+++
T Consensus       258 ~~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          258 EMIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            22222 23345556789999999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.3e-56  Score=409.75  Aligned_cols=256  Identities=39%  Similarity=0.686  Sum_probs=225.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+...   ..+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            4689999999999999999999999999999999976432   3356789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      ||++|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.........
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGG
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccc
Confidence            99999999999998889999999999999999999999999999999999999976655  9999999998665555556


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ..+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+......    ...+....+..|.  .+|+++.+||
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~li  245 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL----RERVLRGKYRIPF--YMSTDCENLL  245 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHHHHH
Confidence            678999999999999888877779999999999999999999987654333    3334444444444  4799999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCccccccC
Q 017936          257 SRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      ++||+.||.+|||++|+++||||....
T Consensus       246 ~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          246 KRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999999997643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-56  Score=416.25  Aligned_cols=251  Identities=23%  Similarity=0.383  Sum_probs=209.6

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCC-----CcEEEEEEeecCCc--ccHHHHHHHHHHHcCCC-CCeeeeeEEEEcC-
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRH-PNIVRFKEVILTP-   89 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h-pnIv~~~~~~~~~-   89 (363)
                      ..++|++.+.||+|+||+||+|++..+     ++.||||.+.....  ..+.+.+|+.++++++| ||||+++++|... 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            357899999999999999999997654     36899999876432  24568899999999976 8999999998764 


Q ss_pred             CeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC
Q 017936           90 THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS  153 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~  153 (363)
                      +.+++|||||++|+|.+++...                ..+++.++..++.||+.||+|||+++||||||||+|||++.+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  221 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence            5789999999999999999753                348999999999999999999999999999999999999876


Q ss_pred             CCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017936          154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR  229 (363)
Q Consensus       154 ~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~  229 (363)
                      +.  +||+|||+|+.......   ....+||+.|||||++.+..|+.+ +|||||||++|||+| |..||.+......+.
T Consensus       222 ~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~  298 (353)
T 4ase_A          222 NV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  298 (353)
T ss_dssp             GC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred             CC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            65  99999999986533322   234578999999999999988766 999999999999998 999998866544444


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ..+..    ....+.+..+|+++.+|+.+||+.||.+|||+.||++|
T Consensus       299 ~~i~~----g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          299 RRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHc----CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            33322    22334445689999999999999999999999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.7e-56  Score=434.63  Aligned_cols=355  Identities=30%  Similarity=0.500  Sum_probs=269.4

Q ss_pred             CcccCCCCCCCCCCCC--CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCC
Q 017936            4 SAMTVGPGMDMPIMHD--SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPN   78 (363)
Q Consensus         4 ~~~~~~~~~~~~~~~~--~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpn   78 (363)
                      +.+.+.|+..+.....  .++|++++.||+|+||+||+|+++.+++.||+|++.+..   .....+.+|+.+++.++|||
T Consensus        18 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn   97 (494)
T 3lij_A           18 GDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN   97 (494)
T ss_dssp             GGCCCCGGGGCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTT
T ss_pred             ceeccchhheeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCC
Confidence            3455556555444322  347999999999999999999999999999999997642   33567889999999999999


Q ss_pred             eeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCc
Q 017936           79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APR  157 (363)
Q Consensus        79 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~  157 (363)
                      |+++++++.+.+.+|+|||||.+++|.+.+.....+++.+++.++.||+.||.|||++||+||||||+|||++..+ .+.
T Consensus        98 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  177 (494)
T 3lij_A           98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDAL  177 (494)
T ss_dssp             BCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCC
T ss_pred             CCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCc
Confidence            9999999999999999999999999999998888999999999999999999999999999999999999997543 346


Q ss_pred             EEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc
Q 017936          158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS  237 (363)
Q Consensus       158 vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (363)
                      +||+|||+|+...........+||+.|+|||++. ..++.+ +|||||||++|+|++|..||.+.........+...  .
T Consensus       178 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~  253 (494)
T 3lij_A          178 IKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG--K  253 (494)
T ss_dssp             EEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--C
T ss_pred             EEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C
Confidence            9999999998766555556678999999999986 456555 99999999999999999999886664433332221  1


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccCCC-----ccc-ccCc--cCCCCCCCC--------
Q 017936          238 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA-----DLV-VDNT--TNNQFEEPD--------  301 (363)
Q Consensus       238 ~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~~~-----~~~-~~~~--~~~~~~~~~--------  301 (363)
                      .....+.+..+|+++.+||++||+.+|.+|||++++++||||++....     ... ..+.  .-..+....        
T Consensus       254 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~  333 (494)
T 3lij_A          254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALL  333 (494)
T ss_dssp             CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHH
T ss_pred             CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHH
Confidence            223344556789999999999999999999999999999999763110     000 0000  000111111        


Q ss_pred             ------CCCCCHHHHHHHHHHhCCCCCCCCChhhhhcCCCCccc----------ccccCCCCCCCCCCCCCCeeeec
Q 017936          302 ------QPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDD----------EMDEDIDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       302 ------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~----------~~~~~~~~~~~~d~d~~g~i~~~  362 (363)
                            .+...+.++.+.+...+.+..|..+.+|+.........          ...+-...+...|.|++|.|+|.
T Consensus       334 ~ia~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~  410 (494)
T 3lij_A          334 YMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYS  410 (494)
T ss_dssp             HHHHHSCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHH
T ss_pred             HHHHhcccHHHHHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHH
Confidence                  12345567778889999999999999998655432211          01111134566788999999874

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.3e-56  Score=437.90  Aligned_cols=352  Identities=31%  Similarity=0.519  Sum_probs=268.8

Q ss_pred             cccCCCCCCCCCCC--CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--------------cccHHHHHHH
Q 017936            5 AMTVGPGMDMPIMH--DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREI   68 (363)
Q Consensus         5 ~~~~~~~~~~~~~~--~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~e~   68 (363)
                      .+...|++.+....  ..++|++++.||+|+||+||+|+++.+++.||+|++.+..              ...+.+.+|+
T Consensus        18 ~~~~~~~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   97 (504)
T 3q5i_A           18 GIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI   97 (504)
T ss_dssp             CCCCCGGGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHH
T ss_pred             ceeechhheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHH
Confidence            34455555544332  3578999999999999999999999999999999987643              2345688999


Q ss_pred             HHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCE
Q 017936           69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT  148 (363)
Q Consensus        69 ~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NI  148 (363)
                      .+++.++||||+++++++.+...+++|||||+|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        98 ~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni  177 (504)
T 3q5i_A           98 SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI  177 (504)
T ss_dssp             HHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             HHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHE
Confidence            99999999999999999999999999999999999999998888999999999999999999999999999999999999


Q ss_pred             EEeCCCC-CcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHH
Q 017936          149 LLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN  227 (363)
Q Consensus       149 ll~~~~~-~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  227 (363)
                      |++.++. ..+||+|||+|+............||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.+......
T Consensus       178 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~  255 (504)
T 3q5i_A          178 LLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDI  255 (504)
T ss_dssp             EESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9986543 2599999999987655555566789999999999864 46555 9999999999999999999988665443


Q ss_pred             HHHHHHHHhcccc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCcccccC------c-cCCCCC
Q 017936          228 FRKTIHRILSVQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDN------T-TNNQFE  298 (363)
Q Consensus       228 ~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~~~~~~~~~------~-~~~~~~  298 (363)
                      ...    +.....  ..+.+..+|+++++||++||+.+|.+|||++|+++||||++........+.      . .-.++.
T Consensus       256 ~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (504)
T 3q5i_A          256 IKK----VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFE  331 (504)
T ss_dssp             HHH----HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCC
T ss_pred             HHH----HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHH
Confidence            332    333333  223346789999999999999999999999999999999875432110000      0 000111


Q ss_pred             CCC--------------CCCCCHHHHHHHHHHhCCCCCCCCChhhhhcCCCCc----------ccccccCCCCCCCCCCC
Q 017936          299 EPD--------------QPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDI----------DDEMDEDIDTDPDLDID  354 (363)
Q Consensus       299 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~----------~~~~~~~~~~~~~~d~d  354 (363)
                      ...              .+...+.++.+.+...+.+..|..+.+++.......          ....++-...+...|.|
T Consensus       332 ~~~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d  411 (504)
T 3q5i_A          332 GSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFD  411 (504)
T ss_dssp             CCSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCC
Confidence            111              123456677888999999999999999975432111          11111111356667888


Q ss_pred             CCCeeeec
Q 017936          355 SSGEIVYA  362 (363)
Q Consensus       355 ~~g~i~~~  362 (363)
                      ++|.|+|.
T Consensus       412 ~dG~I~~~  419 (504)
T 3q5i_A          412 KNGYIEYS  419 (504)
T ss_dssp             CSSSEEHH
T ss_pred             CCCcEeHH
Confidence            89998874

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.3e-55  Score=407.50  Aligned_cols=257  Identities=32%  Similarity=0.587  Sum_probs=224.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.+...       ..+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            5689999999999999999999999999999999976432       236788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC--CcEEEeecCCcccCc
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV  170 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~--~~vkL~DFgla~~~~  170 (363)
                      ++||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  ..+||+|||+++...
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            999999999999999998889999999999999999999999999999999999999976552  259999999998765


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--CCCCC
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHI  248 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  248 (363)
                      ........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+.....    ..+....+.++  .+..+
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETL----ANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCHHHHTTS
T ss_pred             CCCccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcCCCCCchhccCC
Confidence            5555566789999999999988777655 99999999999999999999886554333    33333333333  23568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      |+++++||++||..||.+|||++|+++||||..
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            999999999999999999999999999999974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.1e-56  Score=434.51  Aligned_cols=308  Identities=31%  Similarity=0.541  Sum_probs=247.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .++|++.+.||+|+||+||+|++..+++.||||++.+.   ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999999999999999998653   234567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |||.+++|.+.+...+.+++.+++.++.||+.||.|||++||+||||||+|||++..+ .+.+||+|||+|+........
T Consensus       101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~  180 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM  180 (486)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence            9999999999998888999999999999999999999999999999999999996532 346999999999866555555


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ...+||+.|+|||++.+ .++. ++|||||||++|+|++|..||.+.........+...  ......+.+..+|+++++|
T Consensus       181 ~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~l  256 (486)
T 3mwu_A          181 KDRIGTAYYIAPEVLRG-TYDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG--KYAFDLPQWRTISDDAKDL  256 (486)
T ss_dssp             -CCTTGGGGCCGGGGGS-CCCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCSCSGGGGGSCHHHHHH
T ss_pred             CCCcCCCCCCCHHHhCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCcccCCCCHHHHHH
Confidence            66789999999999875 4554 499999999999999999999886654433332221  2233445566789999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccccCCCcccccCcc--------CCCCCCC--------------CCCCCCHHHHHHH
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTT--------NNQFEEP--------------DQPMQSIDEIMQI  313 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~~~~~~~~~~~~--------~~~~~~~--------------~~~~~~~~~~~~~  313 (363)
                      |++||+.+|.+|||+.++++||||++............        ..++...              ..+...+.++.+.
T Consensus       257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~  336 (486)
T 3mwu_A          257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEI  336 (486)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHHH
Confidence            99999999999999999999999987533221110000        0000000              0123445677788


Q ss_pred             HHHhCCCCCCCCChhhhh
Q 017936          314 IAEATIPAAGTQSLNQCL  331 (363)
Q Consensus       314 ~~~~~~~~~~~~s~~~~~  331 (363)
                      +...+.+..|..+.+|+.
T Consensus       337 F~~~D~d~dG~I~~~El~  354 (486)
T 3mwu_A          337 FRKLDTNNDGMLDRDELV  354 (486)
T ss_dssp             HHHHCTTCSSSBCHHHHH
T ss_pred             HHHhCCCCCceeeHHHHH
Confidence            899999999999999884

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.2e-54  Score=399.60  Aligned_cols=253  Identities=34%  Similarity=0.611  Sum_probs=220.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.+.    ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            36899999999999999999999999999999999763    23346678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~  174 (363)
                      |||++|++|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.... ...
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCCc
Confidence            999999999999998889999999999999999999999999999999999999986654  99999999985432 233


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+.....    ..+......+|  ..+|+++.+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~  234 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFP--RTLSPEAKS  234 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHH
T ss_pred             ccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHH
Confidence            455689999999999988877655 99999999999999999999876543333    23333344444  357999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          255 LISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       255 li~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      ||.+||+.+|.+||     +++++++||||..
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            99999999999999     9999999999964

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3e-56  Score=433.31  Aligned_cols=339  Identities=33%  Similarity=0.518  Sum_probs=260.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|++.+.||+|+||+||+|++..+++.||||++.+..    ...+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999987542    3456788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC-CCCcEEEeecCCcccCccCCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~-~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||||.+++|.+.+...+.+++.+++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+|+.......
T Consensus       105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  184 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK  184 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence            9999999999999998899999999999999999999999999999999999999542 334699999999986655444


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      .....||+.|+|||++.+ .++.+ +|||||||++|+|++|.+||.+.........+...  ......+.+..+|+++++
T Consensus       185 ~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          185 MKDKIGTAYYIAPEVLHG-TYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG--KYTFELPQWKKVSESAKD  260 (484)
T ss_dssp             HHHHTTGGGTCCHHHHHT-CCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCSGGGGGSCHHHHH
T ss_pred             cccCCCCccccCceeecC-CCCCc-ceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCcccccCCHHHHH
Confidence            456679999999999876 56555 99999999999999999999886654433332221  122344556678999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccccccCCCcccccCccCC-------CCCCC--------------CCCCCCHHHHHHH
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNN-------QFEEP--------------DQPMQSIDEIMQI  313 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~-------~~~~~--------------~~~~~~~~~~~~~  313 (363)
                      ||++||+.+|.+|||+.++++||||+.........+.....       ++...              ..+...+.++.+.
T Consensus       261 li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~~~  340 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAI  340 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHHHH
Confidence            99999999999999999999999998653322111000000       00000              0012234456667


Q ss_pred             HHHhCCCCCCCCChhhhhcCCC------Ccccc-------cccCCCCCCCCCCCCCCeeeec
Q 017936          314 IAEATIPAAGTQSLNQCLNGSL------DIDDE-------MDEDIDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       314 ~~~~~~~~~~~~s~~~~~~~~~------~~~~~-------~~~~~~~~~~~d~d~~g~i~~~  362 (363)
                      +...+.+..|..+.+|+..+..      ..+..       .++-.+.+...|.|++|.|+|.
T Consensus       341 F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~  402 (484)
T 3nyv_A          341 FHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYS  402 (484)
T ss_dssp             HHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHH
T ss_pred             HHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHH
Confidence            8888999999999988832210      11111       1111145666788999999874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-55  Score=403.87  Aligned_cols=258  Identities=24%  Similarity=0.471  Sum_probs=224.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+|+.+++.++||||+++++++.+.+.+++|||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            47899999999999999999999999999999999876655677889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCcc
Q 017936          100 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  178 (363)
Q Consensus       100 ~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~  178 (363)
                      +|++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+++...........
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  163 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence            9999999997654 699999999999999999999999999999999999998754567999999999866544444556


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--CCCCCCHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLI  256 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li  256 (363)
                      .||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........    +.......+  .+..+|+++.+||
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T 1tki_A          164 FTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             ESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             cCChhhcCcHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH----HHcCCCCCChhhhccCCHHHHHHH
Confidence            79999999999987766554 9999999999999999999988665443333    333333322  2356899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccc
Q 017936          257 SRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .+||+.+|.+|||+.|+++||||++.
T Consensus       239 ~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHcCCChhHCcCHHHHhcChhhccC
Confidence            99999999999999999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.4e-54  Score=402.91  Aligned_cols=254  Identities=33%  Similarity=0.551  Sum_probs=216.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++++.||+|+||+||+|+++.+++.||||++.+.    ....+.+.+|..+++.+ +||||+++++++.+.+.+|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            457899999999999999999999999999999999763    22345677899999887 7999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-C
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~  172 (363)
                      +|||||+|++|..++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.... .
T Consensus       101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC--
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccCC
Confidence            99999999999999998889999999999999999999999999999999999999986654  99999999985332 2


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+.....    ..+.......|.  .+++++
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~  251 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAILNDEVVYPT--WLHEDA  251 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHH
Confidence            33445679999999999988888665 99999999999999999999876654433    334444444443  479999


Q ss_pred             HHHHHHhcccCCCCCCCH------HHHhcCccccc
Q 017936          253 RHLISRIFVADPAKRISI------PEIRNHEWFLK  281 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~------~ell~h~~~~~  281 (363)
                      .+||++||+.+|.+||++      +++++||||..
T Consensus       252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          252 TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             HHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             HHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            999999999999999998      89999999964

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.3e-54  Score=405.58  Aligned_cols=258  Identities=29%  Similarity=0.505  Sum_probs=218.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+..    ...+.+.+|..+++.+ +||||++++++|.+.+.+|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3568999999999999999999999999999999997642    2234577888888776 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC-ccC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLH  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~-~~~  172 (363)
                      +|||||+||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.. ...
T Consensus       130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTT
T ss_pred             EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecccCC
Confidence            99999999999999998889999999999999999999999999999999999999986654  999999999853 233


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH-----HHHHHHHHHhccccCCCCCCC
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----NFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      ....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......     ........+......+|.  .
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~  284 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--S  284 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--T
T ss_pred             CccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--c
Confidence            34456689999999999998888655 999999999999999999997533211     112233334444444443  5


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH------HHHhcCccccc
Q 017936          248 ISPECRHLISRIFVADPAKRISI------PEIRNHEWFLK  281 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~------~ell~h~~~~~  281 (363)
                      +|+++.+||++||+.||.+||++      +|+++||||..
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            89999999999999999999985      79999999964

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-54  Score=400.21  Aligned_cols=257  Identities=46%  Similarity=0.786  Sum_probs=222.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.+.    ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999999999999999998753    23346788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |||+ +|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.........
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTT
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCccc
Confidence            9999 7899999988889999999999999999999999999999999999999986654  999999999876666666


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ...+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.........    ..+.......  +..+|+++.+|
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~--p~~~s~~~~~l  238 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKVNSCVYVM--PDFLSPGAQSL  238 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CCCCSSCCCC--CTTSCHHHHHH
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----HHHHcCCCCC--cccCCHHHHHH
Confidence            67789999999999988877666699999999999999999999865433211    1111122222  34579999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccccCCC
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKNLPA  285 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~~~~  285 (363)
                      |++||+.||.+|||++|+++||||+...+.
T Consensus       239 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  268 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRRDPWFNVNLPD  268 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred             HHHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence            999999999999999999999999876543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-53  Score=388.36  Aligned_cols=258  Identities=27%  Similarity=0.431  Sum_probs=220.5

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            3578999999999999999999999999999999987543 334668899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~  176 (363)
                      |++|++|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++....... ...
T Consensus        98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBC
T ss_pred             CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccC
Confidence            99999999998765 6999999999999999999999999999999999999986655  9999999987544332 234


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|..||..............   ...........+++.+.+||
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li  250 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFL  250 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSCGGGSCHHHHHHH
T ss_pred             CccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCccccCHHHHHHH
Confidence            4579999999999998888665 9999999999999999999987655443332221   12223333456799999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCccccccC
Q 017936          257 SRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      .+||+.||.+|||++|+++||||+...
T Consensus       251 ~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHccCChhHCcCHHHHhhChhhcccC
Confidence            999999999999999999999997643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8.9e-54  Score=400.71  Aligned_cols=257  Identities=34%  Similarity=0.613  Sum_probs=223.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            3579999999999999999999999999999999976532   2356789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC-CcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~-~~vkL~DFgla~~~~~~~~~  175 (363)
                      |||.|++|.+.+.....+++.+++.++.||+.||.|||++||+||||||+|||++.++. +.+||+|||++.........
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~  187 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW  187 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence            99999999999988888999999999999999999999999999999999999976532 46999999999876554445


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--CCCCCCCCCHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECR  253 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~  253 (363)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+......    .+.....  ..+.+..+++++.
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          188 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYA----QIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             CCSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCCTTGGGGSCHHHH
T ss_pred             ccCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCcccccCCCHHHH
Confidence            56789999999999988877665 999999999999999999998765543332    2333333  3334456899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +||.+||+.+|.+|||+.++++||||..
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            9999999999999999999999999965

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1e-53  Score=409.87  Aligned_cols=257  Identities=33%  Similarity=0.611  Sum_probs=221.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++.....   ..+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            4679999999999999999999999999999999976542   2356789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC-CCCcEEEeecCCcccCccCC-C
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS-Q  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~-~~~~vkL~DFgla~~~~~~~-~  174 (363)
                      |||.|++|.+.+...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+|+...... .
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~  169 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA  169 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence            999999999999998999999999999999999999999999999999999999854 23469999999997554332 2


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc--cCCCCCCCCCHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--YSIPDYVHISPEC  252 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~  252 (363)
                      .....||+.|+|||++.+..++.+ +|||||||++|+|++|.+||...........    +....  ...+.+..+|+++
T Consensus       170 ~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          170 WFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHTCCCCCTTTTTTSCHHH
T ss_pred             eecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhCCCCCCccccccCCHHH
Confidence            345679999999999988877665 9999999999999999999987665443333    33333  3344556789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .+||.+||+.||.+|||++|+++||||..
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            99999999999999999999999999965

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.7e-54  Score=396.09  Aligned_cols=257  Identities=33%  Similarity=0.621  Sum_probs=222.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.....       ..+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4679999999999999999999999999999999976432       246788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC--CCcEEEeecCCcccCc
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSV  170 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~--~~~vkL~DFgla~~~~  170 (363)
                      ++||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++  ...+||+|||+++...
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999998888899999999999999999999999999999999999997655  2259999999998665


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--CCCCC
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHI  248 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  248 (363)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.........    +.......+  .+..+
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~  244 (326)
T 2y0a_A          170 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNT  244 (326)
T ss_dssp             TTSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHTCCCCCHHHHTTS
T ss_pred             CCCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH----HHhcCCCcCccccccC
Confidence            5555566789999999999988877665 9999999999999999999987655433332    222222222  23467


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      |+.+.+||++||+.+|.+|||++++++||||+.
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence            999999999999999999999999999999965

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.8e-54  Score=394.79  Aligned_cols=259  Identities=35%  Similarity=0.619  Sum_probs=220.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ++|++.+.||+|+||+||+|++..+++.||+|++.....  ..+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            679999999999999999999999999999999865432  346688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC---CCC
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~---~~~  175 (363)
                      |++++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....   ...
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCccccc
Confidence            999999999988888999999999999999999999999999999999999986654  999999999754222   223


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....||+.|+|||++.+..+.+.++|||||||++|+|++|..||...........   .........+.+..+++++.+|
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTSTTGGGSCHHHHHH
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCCccccCCHHHHHH
Confidence            4567999999999998887766669999999999999999999987655332222   2222333344456689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccccCC
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKNLP  284 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~~~  284 (363)
                      |.+||+.+|.+|||++|+++||||.+...
T Consensus       242 i~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHccCChhhCcCHHHHhhChhhccccc
Confidence            99999999999999999999999987543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-53  Score=390.93  Aligned_cols=251  Identities=32%  Similarity=0.607  Sum_probs=220.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.+..    ...+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            468999999999999999999999999999999997632    3346678899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....  ..
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~--~~  160 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VT  160 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CB
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--cc
Confidence            999999999999999889999999999999999999999999999999999999976654  99999999975432  23


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      .+.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+......    .+......+|  ..+++++.+|
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~l  233 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYE----KILNAELRFP--PFFNEDVKDL  233 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHCCCCCC--TTSCHHHHHH
T ss_pred             ccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCC--CCCCHHHHHH
Confidence            45689999999999988887666 999999999999999999998765544333    3334444444  3579999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          256 ISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      |++||+.+|.+||     +++++++||||..
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            9999999999999     9999999999964

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.1e-53  Score=383.44  Aligned_cols=259  Identities=27%  Similarity=0.475  Sum_probs=211.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++++.||+|+||+||+|++..+++.||+|++.....   ....+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            689999999999999999999999999999999976432   23667899999999999999999999999999999999


Q ss_pred             ccCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCC
Q 017936           98 YASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP  175 (363)
Q Consensus        98 ~~~~~~L~~~~-~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~  175 (363)
                      |+++ +|...+ ...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... ...
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCC
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCccccc
Confidence            9976 555544 44678999999999999999999999999999999999999986654  999999999754322 233


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc---------------
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---------------  240 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------  240 (363)
                      ....||+.|+|||++.+....+.++|||||||++|+|++|..||............+........               
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence            45678999999999987774455599999999999999988886554443332222222111100               


Q ss_pred             ---------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          241 ---------SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       241 ---------~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                               .......+++++++||++||+.||.+|||++|+++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                     001123478999999999999999999999999999999764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-53  Score=396.65  Aligned_cols=255  Identities=35%  Similarity=0.579  Sum_probs=219.2

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~   92 (363)
                      ...++|++.+.||+|+||+||+|+++.+++.||||++.+.    ....+.+..|..+++.+ +||||+++++++.+.+.+
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            3568899999999999999999999999999999999764    23345677888888766 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-  171 (363)
                      |+||||++||+|..++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.... 
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcccC
Confidence            999999999999999998889999999999999999999999999999999999999986654  99999999985432 


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      .......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+.....    ..+.......|  ..+|++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~  244 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELF----HSIRMDNPFYP--RWLEKE  244 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHH
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHhCCCCCC--cccCHH
Confidence            223455689999999999988877655 99999999999999999999876554333    33333344444  347999


Q ss_pred             HHHHHHHhcccCCCCCCCHH-HHhcCccccc
Q 017936          252 CRHLISRIFVADPAKRISIP-EIRNHEWFLK  281 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~-ell~h~~~~~  281 (363)
                      +.+||.+||+.+|.+||++. ++++||||..
T Consensus       245 ~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence            99999999999999999998 9999999964

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.8e-53  Score=399.29  Aligned_cols=257  Identities=26%  Similarity=0.484  Sum_probs=220.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++++.||+|+||.||+|++..+++.||+|++.+..    ...+.+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3578999999999999999999999999999999987532    334678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||||+.|++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+.......
T Consensus        93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTCC
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCCCc
Confidence            9999999999999999889999999999999999999999999999999999999986654  99999999987655555


Q ss_pred             CCccccCCCcCChhhhhcC---CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          175 PKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      ....+||+.|+|||++.+.   .++.+ +|||||||++|+|++|..||....... .......+.......|  ..+|++
T Consensus       171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~p--~~~s~~  246 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFETTVVTYP--SAWSQE  246 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCCCSSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHHCCCCCC--TTSCHH
T ss_pred             eeccCCCccccCCeeeccCCCCCCCcc-ceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhhcccCCC--CcCCHH
Confidence            5677899999999998643   35444 999999999999999999997644322 2233333333333333  457999


Q ss_pred             HHHHHHHhcccCCCCCCC-HHHHhcCccccc
Q 017936          252 CRHLISRIFVADPAKRIS-IPEIRNHEWFLK  281 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t-~~ell~h~~~~~  281 (363)
                      +.+||.+||+.+|.+||+ ++++++||||..
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            999999999999999998 999999999964

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.5e-53  Score=392.72  Aligned_cols=257  Identities=29%  Similarity=0.507  Sum_probs=217.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~l   94 (363)
                      .++|++++.||+|+||.||+|+++.+++.||+|++.+...    ..+.+.+|+.+++.+ +||||+++++++.+.+.+|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            4679999999999999999999999999999999986532    234577899999887 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc-cCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHS  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~-~~~  173 (363)
                      ||||++|++|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+... ...
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCCC
Confidence            9999999999999998889999999999999999999999999999999999999976654  9999999998533 223


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch-----HHHHHHHHHHhccccCCCCCCCC
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||......     .........+......+|  ..+
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~  242 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSL  242 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC--TTS
T ss_pred             cccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC--CCC
Confidence            3455689999999999988877655 99999999999999999999753221     111222333444444444  357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCH------HHHhcCccccc
Q 017936          249 SPECRHLISRIFVADPAKRISI------PEIRNHEWFLK  281 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~------~ell~h~~~~~  281 (363)
                      |.++.+||++||+.+|.+||++      +++++||||..
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            9999999999999999999995      89999999964

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.9e-54  Score=394.95  Aligned_cols=250  Identities=24%  Similarity=0.288  Sum_probs=190.0

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC----eEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~   96 (363)
                      .+|.+.+.||+|+||+||+++.  +|+.||||++..........+.|+..+..++|||||++++++..++    .+|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4689999999999999999986  5889999999765433333445666667899999999999998653    689999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~--------giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      |||++|+|.+++... ++++..+..++.|++.||+|||++        |||||||||+|||++.++.  +||+|||+|+.
T Consensus        81 Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence            999999999999764 689999999999999999999987        9999999999999987665  99999999975


Q ss_pred             CccCC-----CCCccccCCCcCChhhhhcCCC-----CCcchhhhhHHHHHHHHHhCCCCCCCCCc----------hH-H
Q 017936          169 SVLHS-----QPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEE----------PK-N  227 (363)
Q Consensus       169 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~l~~g~~pf~~~~~----------~~-~  227 (363)
                      .....     .....+||+.|||||++.+...     .+.++|||||||++|||+||..||.....          .. .
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            43322     2234579999999999976531     12349999999999999999877643211          11 1


Q ss_pred             HHHHHHHHhcccc--CCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          228 FRKTIHRILSVQY--SIPDY---VHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       228 ~~~~~~~~~~~~~--~~~~~---~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .......+.....  .+|..   ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            1122222222222  12211   112356899999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.1e-53  Score=394.47  Aligned_cols=254  Identities=32%  Similarity=0.542  Sum_probs=219.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++++.||+|+||+||+|+++.+++.||||++.+.    ....+.+.+|..++..+ +||||+++++++.+.+.+|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            457899999999999999999999999999999999763    23345678899999887 7999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-C
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~  172 (363)
                      +||||++||+|..++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.... .
T Consensus        98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccCC
Confidence            99999999999999998889999999999999999999999999999999999999986654  99999999985332 2


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+.....    ..+......+|  ..+|+++
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~  248 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEHNVAYP--KSMSKEA  248 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHHH
T ss_pred             cccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCHHHHH----HHHHhCCCCCC--CCCCHHH
Confidence            33455679999999999988887655 99999999999999999999876554333    33444444444  3589999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          253 RHLISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      .+||++||+.+|.+||+     ++++++||||..
T Consensus       249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            99999999999999995     699999999964

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2e-53  Score=403.59  Aligned_cols=257  Identities=33%  Similarity=0.497  Sum_probs=220.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+.    ....+.+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l  146 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  146 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            457899999999999999999999999999999998752    2334567899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      |||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+...... 
T Consensus       147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSE
T ss_pred             EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCc
Confidence            9999999999998876 46999999999999999999999999999999999999986654  9999999997543332 


Q ss_pred             -CCCccccCCCcCChhhhhcCC----CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          174 -QPKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       174 -~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                       ...+.+||+.|+|||++.+..    ++ .++|||||||++|+|++|..||...+.......+....  .....|....+
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~  300 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYG-RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NSLTFPDDNDI  300 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEE-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCTTCCC
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCC-CcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc--ccccCCCcccc
Confidence             234668999999999998665    43 44999999999999999999998876655444443321  22355666678


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 017936          249 SPECRHLISRIFVADPAK--RISIPEIRNHEWFLK  281 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~--R~t~~ell~h~~~~~  281 (363)
                      |+++++||++||+.+|.+  ||+++|+++||||+.
T Consensus       301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            999999999999999988  999999999999965

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.6e-53  Score=408.13  Aligned_cols=258  Identities=41%  Similarity=0.754  Sum_probs=226.5

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|.+.+.||+|+||+||+|++..+|+.||||++.+..    .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3578999999999999999999999999999999997532    234578899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      |||||+|++|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus        94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhcccccc
Confidence            9999999999999998889999999999999999999999999999999999999986654  99999999987655555


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ..+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..........    .+.......|  ..+++++.+
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~~  245 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK----KICDGIFYTP--QYLNPSVIS  245 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH----HHHTTCCCCC--TTCCHHHHH
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH----HHhcCCcCCC--ccCCHHHHH
Confidence            5667899999999999888776667999999999999999999998766544333    3333333333  357999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccccccCC
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWFLKNLP  284 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~~~~~~  284 (363)
                      ||++||+.||.+|||++++++||||++..+
T Consensus       246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          246 LLKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             HHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence            999999999999999999999999987654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-53  Score=398.45  Aligned_cols=258  Identities=27%  Similarity=0.519  Sum_probs=222.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++.+...+++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            4689999999999999999999999999999999876532 335688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc
Q 017936           99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      +.|++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.+..+.+||+|||+|+..........
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  209 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  209 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence            99999999887654 69999999999999999999999999999999999999865556799999999986654444455


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--CCCCCCCCCHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHL  255 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~l  255 (363)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........    +....+  ..+.+..+++++.+|
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~l  284 (387)
T 1kob_A          210 TTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDF  284 (387)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             eccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCccccccCCHHHHHH
Confidence            679999999999988777655 9999999999999999999987665433332    222222  223345689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      |++||+.+|.+|||+.++++||||...
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          285 IKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHcCCChhHCcCHHHHhhCccccCC
Confidence            999999999999999999999999754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7e-53  Score=392.69  Aligned_cols=252  Identities=31%  Similarity=0.593  Sum_probs=220.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++++.||+|+||.||+|++..+++.||+|++.+..    ...+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3478999999999999999999999999999999987532    334678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||||++|++|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....  .
T Consensus       119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~--~  194 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--R  194 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--C
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC--C
Confidence            9999999999999998889999999999999999999999999999999999999976654  99999999985432  2


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+.....    ..+......+|  ..+++++.+
T Consensus       195 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~  267 (350)
T 1rdq_E          195 TWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVSGKVRFP--SHFSSDLKD  267 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTCCHHHHH
T ss_pred             cccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHH
Confidence            345689999999999988877655 99999999999999999999876554333    33334444444  357999999


Q ss_pred             HHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          255 LISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       255 li~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      ||.+||+.+|.+||+     ++++++||||..
T Consensus       268 li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            999999999999998     999999999964

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.2e-52  Score=376.04  Aligned_cols=261  Identities=33%  Similarity=0.596  Sum_probs=224.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            5789999999999999999999999999999999876432   2356788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC-CcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~-~~vkL~DFgla~~~~~~~~~  175 (363)
                      ||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++. +.+||+|||++.........
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW  164 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence            99999999999988888999999999999999999999999999999999999975543 35999999999766555555


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....||+.|+|||++.+..++.+ +||||||+++|+|++|..||...............  ......+.+..+++++.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l  241 (284)
T 3kk8_A          165 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG--AYDYPSPEWDTVTPEAKSL  241 (284)
T ss_dssp             CCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHHHHHH
T ss_pred             cCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc--cccCCchhhcccCHHHHHH
Confidence            56789999999999988877655 99999999999999999999876654333322211  2223344456789999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      |.+||+.+|.+|||++|+++||||....
T Consensus       242 i~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          242 IDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             HHHHcccChhhCCCHHHHhcCccccCCh
Confidence            9999999999999999999999997643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.2e-52  Score=383.41  Aligned_cols=259  Identities=28%  Similarity=0.458  Sum_probs=210.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..++|++++.||+|+||+||+|++. +++.||+|++.....   ....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            4689999999999999999999985 589999999875432   235678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-C
Q 017936           96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S  173 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~  173 (363)
                      |||+++ +|.+.+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..... .
T Consensus        98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVR  174 (311)
T ss_dssp             EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCCC
T ss_pred             EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCcc
Confidence            999975 787777654 45999999999999999999999999999999999999986654  999999999864322 2


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-CCC---------
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIP---------  243 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~---------  243 (363)
                      ......||+.|+|||++.+....+.++|||||||++|+|++|..||.+................... ..+         
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  254 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK  254 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence            3344578999999999987554445599999999999999999999887766555544432211110 000         


Q ss_pred             --------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          244 --------------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       244 --------------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                                    ....+++++.+||++||+.||.+|||++|+++||||+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  306 (311)
T 3niz_A          255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD  306 (311)
T ss_dssp             SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence                          01246889999999999999999999999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-53  Score=384.68  Aligned_cols=255  Identities=36%  Similarity=0.607  Sum_probs=211.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---------------------------ccHHHHHHHHHHH
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------------------------IDENVQREIINHR   72 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------------------------~~~~~~~e~~~l~   72 (363)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....                           ..+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4789999999999999999999999999999999875421                           1245789999999


Q ss_pred             cCCCCCeeeeeEEEEc--CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEE
Q 017936           73 SLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL  150 (363)
Q Consensus        73 ~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll  150 (363)
                      .++||||+++++++.+  ...+++||||+++++|.+.+ ....+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            9999999999999987  56899999999999998754 34579999999999999999999999999999999999999


Q ss_pred             eCCCCCcEEEeecCCcccCccCC-CCCccccCCCcCChhhhhcCCC--CCcchhhhhHHHHHHHHHhCCCCCCCCCchHH
Q 017936          151 DGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN  227 (363)
Q Consensus       151 ~~~~~~~vkL~DFgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  227 (363)
                      +.++.  +||+|||+++...... ......||+.|+|||++.+...  .+.++|||||||++|+|++|..||....... 
T Consensus       171 ~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-  247 (298)
T 2zv2_A          171 GEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC-  247 (298)
T ss_dssp             CTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred             CCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH-
Confidence            76654  9999999997543322 2234579999999999876543  3455899999999999999999998754432 


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          228 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                         ....+.......+....+++++.+||.+||+.+|.+|||+.|+++||||.+
T Consensus       248 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          248 ---LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             ---HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             ---HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence               222333344455666678999999999999999999999999999999953

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.6e-52  Score=378.67  Aligned_cols=257  Identities=28%  Similarity=0.443  Sum_probs=209.8

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++++.||+|+||+||+|++ .+++.||+|++....   .....+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            6899999999999999999998 678999999986543   234678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCC
Q 017936           98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~  175 (363)
                      |+++ +|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ...
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCcccccc
Confidence            9975 898888764 67999999999999999999999999999999999999986654  999999998754322 223


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--------------C
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------------S  241 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~  241 (363)
                      ....||+.|+|||++.+....+.++|||||||++|+|++|..||.....................              .
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            44578999999999977553345599999999999999999999887665554444332211100              0


Q ss_pred             C---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          242 I---------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       242 ~---------~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .         .....+++++.+||++||+.||.+|||++|+++||||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            0         011347899999999999999999999999999999965

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-52  Score=380.15  Aligned_cols=259  Identities=27%  Similarity=0.417  Sum_probs=213.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC------cccHHHHHHHHHHHcCC---CCCeeeeeEEEEcCC
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLR---HPNIVRFKEVILTPT   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~e~~~l~~l~---hpnIv~~~~~~~~~~   90 (363)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....      .......+|+.+++.++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            578999999999999999999999999999999986432      22356777888777664   999999999998765


Q ss_pred             -----eEEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeec
Q 017936           91 -----HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF  163 (363)
Q Consensus        91 -----~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DF  163 (363)
                           .+++||||+. ++|.+++.....  +++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Df  164 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADF  164 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSC
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeC
Confidence                 5899999996 599999987654  999999999999999999999999999999999999976654  999999


Q ss_pred             CCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-CC
Q 017936          164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI  242 (363)
Q Consensus       164 gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~  242 (363)
                      |+|+............||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........+......... ..
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            99987655555566789999999999988888766 99999999999999999999887765555544433211100 00


Q ss_pred             C--------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          243 P--------------------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       243 ~--------------------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +                    ....+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            0                    013578999999999999999999999999999999764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.6e-52  Score=390.38  Aligned_cols=258  Identities=35%  Similarity=0.589  Sum_probs=205.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++...+.+++||||+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            467999999999999999999999999999999987653 3456788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC-CCCCcEEEeecCCcccCccCCCCCcc
Q 017936          100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKST  178 (363)
Q Consensus       100 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~-~~~~~vkL~DFgla~~~~~~~~~~~~  178 (363)
                      ++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++...........
T Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  210 (349)
T 2w4o_A          131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV  210 (349)
T ss_dssp             CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence            99999999998888999999999999999999999999999999999999975 22456999999999865544444566


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--CCCCCCCCCHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLI  256 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li  256 (363)
                      .||+.|+|||++.+..++.+ +|||||||++|+|++|..||.........   ...+.....  ..+.+..++.++.+||
T Consensus       211 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~li  286 (349)
T 2w4o_A          211 CGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFM---FRRILNCEYYFISPWWDEVSLNAKDLV  286 (349)
T ss_dssp             --CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHHHH---HHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred             cCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccHHH---HHHHHhCCCccCCchhhhCCHHHHHHH
Confidence            79999999999988877665 99999999999999999999876554322   222333332  2233467899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccc
Q 017936          257 SRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ++||+.||.+|||+.++++||||...
T Consensus       287 ~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          287 RKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             HHHccCChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999999999753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.3e-53  Score=392.32  Aligned_cols=256  Identities=32%  Similarity=0.590  Sum_probs=215.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC------CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      .++|++.+.||+|+||+||+|+++.+++.||||++...      ....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            35799999999999999999999999999999998642      123567899999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecCCccc
Q 017936           94 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS  168 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~~  168 (363)
                      +|||||+|++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999998877542    3589999999999999999999999999999999999997643 24599999999976


Q ss_pred             CccCCC-CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--CC
Q 017936          169 SVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DY  245 (363)
Q Consensus       169 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  245 (363)
                      ...... .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||..... .    ....+.......+  .+
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~-~----~~~~i~~~~~~~~~~~~  256 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTKE-R----LFEGIIKGKYKMNPRQW  256 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSHH-H----HHHHHHHTCCCCCHHHH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcHH-H----HHHHHHcCCCCCCcccc
Confidence            543322 345679999999999988877655 9999999999999999999986422 2    2222333332222  23


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          246 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ..+|+++.+||.+||+.||.+|||+.++++||||+.
T Consensus       257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            568999999999999999999999999999999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.1e-52  Score=382.00  Aligned_cols=262  Identities=25%  Similarity=0.428  Sum_probs=202.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ..++|++++.||+|+||+||+|++..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+++.+++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3468999999999999999999999999999999987543  33467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           97 EYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        97 e~~~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      ||++ ++|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFG  159 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETT
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecC
Confidence            9997 5998888653      35999999999999999999999999999999999999986654  9999999997643


Q ss_pred             cC-CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-------CC
Q 017936          171 LH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------SI  242 (363)
Q Consensus       171 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~  242 (363)
                      .. .......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+.........       ..
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence            22 23345678999999999987543345599999999999999999999887765544444332111000       00


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          243 ---------------------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       243 ---------------------~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                                           .....+++++.+||.+||+.||.+|||++|+++||||.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence                                 01124788999999999999999999999999999998754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.5e-52  Score=392.29  Aligned_cols=259  Identities=29%  Similarity=0.391  Sum_probs=202.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCC--eEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~--~~~   93 (363)
                      .++|++++.||+|+||+||+|.+..+++.||||++.+..   .......+|+.+++.+. ||||+++++++...+  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            368999999999999999999999999999999986532   23355778999999997 999999999998654  799


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc--
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  171 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~--  171 (363)
                      +|||||+ ++|...+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+....  
T Consensus        88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCC
T ss_pred             EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccc
Confidence            9999997 589888876 57999999999999999999999999999999999999986654  99999999975422  


Q ss_pred             --------------------CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 017936          172 --------------------HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT  231 (363)
Q Consensus       172 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  231 (363)
                                          .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+..+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                111233579999999999987444455599999999999999999999987765555444


Q ss_pred             HHHHhccc-----------------------------------------cCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 017936          232 IHRILSVQ-----------------------------------------YSIPDYVHISPECRHLISRIFVADPAKRISI  270 (363)
Q Consensus       232 ~~~~~~~~-----------------------------------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~  270 (363)
                      +..+....                                         ........+++++.+||.+||+.||.+|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            32211000                                         0001122578999999999999999999999


Q ss_pred             HHHhcCcccccc
Q 017936          271 PEIRNHEWFLKN  282 (363)
Q Consensus       271 ~ell~h~~~~~~  282 (363)
                      +|+++||||...
T Consensus       324 ~e~l~Hp~~~~~  335 (388)
T 3oz6_A          324 NDALKHPFVSIF  335 (388)
T ss_dssp             HHHTTSTTTTTT
T ss_pred             HHHhCCHHHHHh
Confidence            999999999764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.7e-53  Score=391.31  Aligned_cols=257  Identities=32%  Similarity=0.552  Sum_probs=216.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++|++.+.||+|+||+||+|.++.+++.||+|++.+...   ...+|+.++..+ +||||+++++++.+.+.+|+||||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            4679999999999999999999999999999999977543   234677777776 799999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC--CcEEEeecCCcccCccC-CCC
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLH-SQP  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~--~~vkL~DFgla~~~~~~-~~~  175 (363)
                      |+|++|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||+.....  +.+||+|||+++..... ...
T Consensus        98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  177 (342)
T 2qr7_A           98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL  177 (342)
T ss_dssp             CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence            999999999999889999999999999999999999999999999999999854322  35999999999854332 233


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--CCCCCCHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECR  253 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~  253 (363)
                      .+.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||..... .........+.......+  .+..+|+++.
T Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  255 (342)
T 2qr7_A          178 MTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAK  255 (342)
T ss_dssp             CCSSCCSSCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHHH
T ss_pred             eccCCCccccCHHHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHHH
Confidence            45679999999999987777655 9999999999999999999986432 122233344444444333  3467899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +||++||+.||.+|||++++++||||..
T Consensus       256 ~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          256 DLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            9999999999999999999999999965

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.9e-52  Score=384.46  Aligned_cols=254  Identities=30%  Similarity=0.531  Sum_probs=210.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc---CCCcEEEEEEeecCC-----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      ..++|++.+.||+|+||.||+|++.   .+++.||+|++.+..     .....+.+|+.+++.++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            4578999999999999999999985   689999999987642     23345778999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~  172 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKESI  172 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC----
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcccccc
Confidence            99999999999999999998888999999999999999999999999999999999999986654  9999999987533


Q ss_pred             cC-CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          171 LH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       171 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      .. .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........    .+.......|  ..++
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~----~i~~~~~~~p--~~~~  245 (327)
T 3a62_A          173 HDGTVTHTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTID----KILKCKLNLP--PYLT  245 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHTCCCCC--TTSC
T ss_pred             cCCccccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCC--CCCC
Confidence            22 22345679999999999988777655 999999999999999999998766544333    3333333333  3579


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          250 PECRHLISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      +++.+||.+||+.+|.+||     +++++++||||..
T Consensus       246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            9999999999999999999     8899999999964

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-52  Score=378.38  Aligned_cols=258  Identities=31%  Similarity=0.538  Sum_probs=210.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ..++|.+.+.||+|+||+||+|++..+++.+|+|++....  ...+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            3578999999999999999999999999999999987643  23477889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC-CCCcEEEeecCCcccCcc
Q 017936           97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~-~~~~vkL~DFgla~~~~~  171 (363)
                      ||+++++|.+.+..    ...+++..++.++.||+.||+|||++||+||||||+|||++.+ ..+.+||+|||++.....
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            99999999998854    3679999999999999999999999999999999999999643 234699999999986555


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      ........||+.|+|||++. ..++ .++|||||||++|+|++|..||..............   ...........++++
T Consensus       180 ~~~~~~~~~t~~y~aPE~~~-~~~~-~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  254 (285)
T 3is5_A          180 DEHSTNAAGTALYMAPEVFK-RDVT-FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY---KEPNYAVECRPLTPQ  254 (285)
T ss_dssp             -------CTTGGGCCHHHHT-TCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCCCCCC--CCCCHH
T ss_pred             cccCcCcccccCcCChHHhc-cCCC-cccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc---CCcccccccCcCCHH
Confidence            55556677999999999985 3454 449999999999999999999987654332222111   111112223347999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +.+||.+||+.+|.+|||++|+++||||++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999975

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.9e-52  Score=391.39  Aligned_cols=254  Identities=33%  Similarity=0.567  Sum_probs=211.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHH-HHcCCCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~-l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++++.||+|+||+||+|+++.+++.||||++.+...    ....+.+|..+ ++.++||||++++++|.+.+.+|
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            45789999999999999999999999999999999976532    22344556655 46789999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc-cC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~-~~  172 (363)
                      +||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++... ..
T Consensus       116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccCC
Confidence            99999999999999998889999999999999999999999999999999999999986654  9999999998532 23


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+......    .+.......+  ..++.++
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~~--~~~~~~~  266 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQLK--PNITNSA  266 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBHHHHHH----HHHHSCCCCC--SSSCHHH
T ss_pred             CccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHhcccCCC--CCCCHHH
Confidence            34456789999999999988887655 999999999999999999998765544333    3333333333  3579999


Q ss_pred             HHHHHHhcccCCCCCCCH----HHHhcCccccc
Q 017936          253 RHLISRIFVADPAKRISI----PEIRNHEWFLK  281 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~----~ell~h~~~~~  281 (363)
                      .+||++||+.+|.+||++    +++++||||..
T Consensus       267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            999999999999999986    69999999964

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-52  Score=400.15  Aligned_cols=258  Identities=25%  Similarity=0.496  Sum_probs=217.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++.+.||+|+||+||+++++.+++.||+|++.+..    .....+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  151 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL  151 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence            3578999999999999999999999999999999997532    223447889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      |||||.||+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.  +||+|||+|+......
T Consensus       152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred             EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCC
Confidence            9999999999999987 567999999999999999999999999999999999999986664  9999999997543332


Q ss_pred             C--CCccccCCCcCChhhhh-----cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCC-
Q 017936          174 Q--PKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-  245 (363)
Q Consensus       174 ~--~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-  245 (363)
                      .  ....+||+.|+|||++.     ...++.+ +|||||||++|+|++|..||...+..+....++....  ...+|.. 
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~-~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~  306 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RFQFPTQV  306 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCSSC
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCc-CeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc--cccCCccc
Confidence            2  23457999999999997     3445444 9999999999999999999998766555544433221  2233332 


Q ss_pred             CCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 017936          246 VHISPECRHLISRIFVADPAK--RISIPEIRNHEWFLK  281 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~--R~t~~ell~h~~~~~  281 (363)
                      ..+|+++++||++||+.+|++  |++++|+++||||..
T Consensus       307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            458999999999999988888  999999999999964

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.2e-52  Score=392.54  Aligned_cols=265  Identities=25%  Similarity=0.419  Sum_probs=215.1

Q ss_pred             CCCCCCCCceeeceeccc--CCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 017936           15 PIMHDSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP   89 (363)
Q Consensus        15 ~~~~~~~~y~i~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~   89 (363)
                      ......++|++.+.||+|  +||+||+|++..+++.||||++.....   ..+.+.+|+.+++.++|||||++++++.+.
T Consensus        19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   98 (389)
T 3gni_B           19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   98 (389)
T ss_dssp             CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence            344456789999999999  999999999999999999999976432   235677899999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936           90 THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      +.+++|||||++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~dfg~~~  176 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNL  176 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCGGGCE
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccccce
Confidence            9999999999999999999875  67999999999999999999999999999999999999976654  9999999875


Q ss_pred             cCccC--------CCCCccccCCCcCChhhhhc--CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc
Q 017936          168 SSVLH--------SQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS  237 (363)
Q Consensus       168 ~~~~~--------~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (363)
                      .....        .......||+.|+|||++.+  ..++.+ +|||||||++|+|++|..||.+................
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  255 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP  255 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            33211        12234578999999999987  455554 99999999999999999999876554433322211100


Q ss_pred             ----------------------------------------cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 017936          238 ----------------------------------------VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE  277 (363)
Q Consensus       238 ----------------------------------------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~  277 (363)
                                                              .....+....+++++.+||++||+.||.+|||++|+++||
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp  335 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  335 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence                                                    0001122345789999999999999999999999999999


Q ss_pred             ccccc
Q 017936          278 WFLKN  282 (363)
Q Consensus       278 ~~~~~  282 (363)
                      ||+..
T Consensus       336 ~f~~~  340 (389)
T 3gni_B          336 FFKQI  340 (389)
T ss_dssp             GGGGC
T ss_pred             HHHHH
Confidence            99764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.1e-52  Score=383.15  Aligned_cols=259  Identities=25%  Similarity=0.434  Sum_probs=206.8

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ++|++++.||+|+||+||+|++..+++.||+|++.....  ....+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            689999999999999999999999999999999865432  122445799999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCC
Q 017936           99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  176 (363)
Q Consensus        99 ~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~  176 (363)
                      ++ ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC--------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccc
Confidence            97 58888887654 5999999999999999999999999999999999999986654  999999998754322 2233


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc---------------C
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---------------S  241 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------~  241 (363)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.................               .
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN  238 (324)
T ss_dssp             ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred             cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence            4578999999999987544445599999999999999999999887665544443332111100               0


Q ss_pred             C---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          242 I---------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       242 ~---------~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .         +....+++++.+||.+||+.||.+|||++|+++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence            0         0123468999999999999999999999999999999764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.9e-52  Score=374.42  Aligned_cols=258  Identities=36%  Similarity=0.630  Sum_probs=221.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++|++.+.||+|+||.||++.+..++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            357999999999999999999999999999999987643 3356788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC-CCCCcEEEeecCCcccCccCCCCCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~-~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      +++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||++...........
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~  167 (277)
T 3f3z_A           88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT  167 (277)
T ss_dssp             CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCC
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhc
Confidence            999999999988888999999999999999999999999999999999999932 1234599999999986655555566


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC--CCCCCHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHL  255 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~l  255 (363)
                      ..||+.|+|||++.+. ++.+ +||||||+++|+|++|..||...........    +.......+.  +..+++++.+|
T Consensus       168 ~~~t~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l  241 (277)
T 3f3z_A          168 KVGTPYYVSPQVLEGL-YGPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAESL  241 (277)
T ss_dssp             CCSCTTTCCHHHHTTC-BCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCHHHHTTSCHHHHHH
T ss_pred             cCCCCCccChHHhccc-CCch-hhehhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCchhhhcCCHHHHHH
Confidence            7899999999998654 5445 9999999999999999999987665433332    2233333332  23679999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      |.+||+.+|.+|||+.++++||||++..
T Consensus       242 i~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          242 IRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            9999999999999999999999998754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.7e-52  Score=381.78  Aligned_cols=257  Identities=32%  Similarity=0.591  Sum_probs=221.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.....       ..+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            4679999999999999999999999999999999976432       246788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCC--cEEEeecCCcccCc
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP--RLKICDFGYSKSSV  170 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~--~vkL~DFgla~~~~  170 (363)
                      ++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++..  .+||+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            9999999999999999988889999999999999999999999999999999999999866521  59999999998665


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC--CCCC
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI  248 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  248 (363)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........    .+.......+.  +..+
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHTTCCCCCHHHHTTC
T ss_pred             ccccccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcccccChhhhccc
Confidence            5545556679999999999988777655 999999999999999999998765543332    23333332221  2457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ++.+.+||.+||+.+|.+|||++++++||||..
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            999999999999999999999999999999964

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-51  Score=376.45  Aligned_cols=260  Identities=27%  Similarity=0.432  Sum_probs=211.9

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++++.||+|+||+||+|++..+++.||+|++......   .+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            6899999999999999999999999999999988664332   3557789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~  176 (363)
                      |+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++...... ....
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC-------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCcccccC
Confidence            9999999999888888999999999999999999999999999999999999976654  999999999754322 2234


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------------cccC
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYS  241 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~  241 (363)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|..||.+................               ....
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            5579999999999987544445599999999999999999999887665444333221110               0001


Q ss_pred             CCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          242 IPD----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       242 ~~~----------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .+.          ...+++++.+||++||+.+|.+|||++|+++||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  291 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI  291 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence            111          13578999999999999999999999999999999763

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-52  Score=408.53  Aligned_cols=258  Identities=28%  Similarity=0.436  Sum_probs=221.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++.+.    ......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            356799999999999999999999999999999999753    2334567899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           95 VMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ||||++||+|..++...+.  +++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.....
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~~  339 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEG  339 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceecccC
Confidence            9999999999999987554  999999999999999999999999999999999999986654  999999999866544


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...............+.......+  ..+|+++
T Consensus       340 ~~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~  416 (576)
T 2acx_A          340 QTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQA  416 (576)
T ss_dssp             CCEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHH
T ss_pred             ccccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHH
Confidence            44455689999999999988777655 99999999999999999999876543222333333333333333  4689999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          253 RHLISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      .+||++||+.||.+||     +++|+++||||+.
T Consensus       417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            9999999999999999     7999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-51  Score=397.42  Aligned_cols=260  Identities=29%  Similarity=0.413  Sum_probs=195.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEc-----CC
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-----PT   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-----~~   90 (363)
                      ..++|++.+.||+|+||+||+|++..+++.||||++.+..   ...+.+.+|+.+++.++||||+++++++..     ..
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            3578999999999999999999999999999999986532   223567899999999999999999999944     35


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+|+||||+ +++|..++.....+++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+...
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~  207 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVD  207 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTT
T ss_pred             eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--Eeecccccchhcc
Confidence            799999998 5799999998888999999999999999999999999999999999999987654  9999999998543


Q ss_pred             cCC----------------------------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh--------
Q 017936          171 LHS----------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--------  214 (363)
Q Consensus       171 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--------  214 (363)
                      ...                            .....+||++|+|||++......+.++|||||||++|+|++        
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            211                            12345789999999987544433455999999999999999        


Q ss_pred             ---CCCCCCCCCc--------------------hHHHHHHHHHHhccc--------------------c------CCCCC
Q 017936          215 ---GAYPFEDPEE--------------------PKNFRKTIHRILSVQ--------------------Y------SIPDY  245 (363)
Q Consensus       215 ---g~~pf~~~~~--------------------~~~~~~~~~~~~~~~--------------------~------~~~~~  245 (363)
                         |.++|.+...                    ...+..+. .+....                    .      ....+
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF-NILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHH-HHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHH-HHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence               6777765431                    01111111 110000                    0      01113


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          246 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ..+++++.+||++||+.||.+|||++|+|+||||...
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            4569999999999999999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.7e-52  Score=400.43  Aligned_cols=258  Identities=27%  Similarity=0.419  Sum_probs=206.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC------C
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~   90 (363)
                      .++|++++.||+|+||+||+|.+..+++.||||++.+..   ...+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999999999999999997642   2345678999999999999999999999654      4


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+|+||||+++ +|.+.+..  .+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+...
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~  215 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  215 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC----
T ss_pred             eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecC
Confidence            68999999976 46666543  4999999999999999999999999999999999999987654  9999999998765


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc-----------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-----------  239 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  239 (363)
                      ........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......++.......           
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~  294 (464)
T 3ttj_A          216 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  294 (464)
T ss_dssp             -CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred             CCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence            5555566789999999999999888766 9999999999999999999998776555544443221100           


Q ss_pred             ----cCCCCCCC---------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          240 ----YSIPDYVH---------------------ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       240 ----~~~~~~~~---------------------~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                          ...+....                     .++++.+||.+||+.||.+|||++|+|+||||....
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                00010000                     156799999999999999999999999999998643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-52  Score=395.09  Aligned_cols=257  Identities=27%  Similarity=0.469  Sum_probs=215.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++++.||+|+||+||+|+++.+++.||||++.+..    ...+.+.+|..++..++||||++++++|.+.+.+|+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            3578999999999999999999999999999999997632    223457889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      ||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+......
T Consensus       139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADG  216 (412)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred             EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCC
Confidence            999999999999998754 7999999999999999999999999999999999999986654  9999999997654332


Q ss_pred             C--CCccccCCCcCChhhhhc-------CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 017936          174 Q--PKSTVGTPAYIAPEVLLK-------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD  244 (363)
Q Consensus       174 ~--~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (363)
                      .  ....+||+.|+|||++..       ..++. ++|||||||++|+|++|+.||...+.......+....  .....|.
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~  293 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP-ECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK--EHLSLPL  293 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCC-
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCCh-HHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCcCCCc
Confidence            2  234579999999999973       34544 4999999999999999999998876655444443221  1122332


Q ss_pred             -CCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCccccc
Q 017936          245 -YVHISPECRHLISRIFVADPAKR---ISIPEIRNHEWFLK  281 (363)
Q Consensus       245 -~~~~s~~~~~li~~~L~~~p~~R---~t~~ell~h~~~~~  281 (363)
                       ...+|+++++||++||+ +|.+|   |+++|+++||||..
T Consensus       294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence             24689999999999998 99998   59999999999964

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.7e-52  Score=400.43  Aligned_cols=253  Identities=36%  Similarity=0.606  Sum_probs=210.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|++.+.||+|+||.||+|++..+++.||||++.+.    ......+.+|+.+++.++||||+++++++...+.+++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46899999999999999999999999999999998753    22335567899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS  173 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~  173 (363)
                      |||+++++|..++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  +||+|||+|+.... ..
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC---
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCCc
Confidence            9999999999999988899999999999999999999998 99999999999999987654  99999999975332 23


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........    .+......+|  ..+++++.
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~  377 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFP--RTLGPEAK  377 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCC--TTSCHHHH
T ss_pred             ccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHH----HHHhCCCCCC--ccCCHHHH
Confidence            3455689999999999988888665 999999999999999999998765543333    2333333433  35799999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          254 HLISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       254 ~li~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      +||.+||+.||.+||     |++|+++||||..
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            999999999999999     9999999999964

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.9e-52  Score=391.00  Aligned_cols=255  Identities=30%  Similarity=0.531  Sum_probs=213.9

Q ss_pred             Ccee--eceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           22 RYEL--VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        22 ~y~i--~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .|.+  .+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+.+++||||
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            4555  678999999999999999999999999997654 3446788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc
Q 017936           99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      +++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+..+..+.+||+|||+++..........
T Consensus       168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~  247 (373)
T 2x4f_A          168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV  247 (373)
T ss_dssp             CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence            9999999988654 469999999999999999999999999999999999999655556799999999987655555556


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC--CCCCCCCHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHL  255 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~l  255 (363)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........+.    ...+..  +.+..+++++.+|
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~~~~~l  322 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL----ACRWDLEDEEFQDISEEAKEF  322 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----HTCCCSCSGGGTTSCHHHHHH
T ss_pred             ccCCCcEeChhhccCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hccCCCChhhhccCCHHHHHH
Confidence            679999999999987777555 999999999999999999998876654443333    222222  2345689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      |.+||+.+|.+|||++|+++||||..
T Consensus       323 i~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          323 ISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             HHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            99999999999999999999999975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.2e-52  Score=384.51  Aligned_cols=262  Identities=31%  Similarity=0.444  Sum_probs=210.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..++|++.+.||+|+||+||+|++..+++.||||++.....   ....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            46789999999999999999999999999999999975432   234567899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC---CCcEEEeecCCcccCcc-
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKSSVL-  171 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~---~~~vkL~DFgla~~~~~-  171 (363)
                      |||+++ +|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++   .+.+||+|||+++.... 
T Consensus       112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            999975 9999999988999999999999999999999999999999999999996432   23599999999975432 


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-C------CCC
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S------IPD  244 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~------~~~  244 (363)
                      ........||+.|+|||++.+....+.++|||||||++|+|++|..||..................... .      .+.
T Consensus       191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (329)
T 3gbz_A          191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD  270 (329)
T ss_dssp             ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence            223345578999999999987654445599999999999999999999887765555444433211100 0      000


Q ss_pred             C-----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          245 Y-----------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       245 ~-----------------~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +                 ..+++++.+||.+||+.||.+|||++|+++||||..
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  324 (329)
T 3gbz_A          271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH  324 (329)
T ss_dssp             CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence            0                 116899999999999999999999999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.5e-52  Score=385.94  Aligned_cols=249  Identities=30%  Similarity=0.476  Sum_probs=216.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      .++|++.+.||+|+||+||+|++..+++.||||++.....         ....+.+|+.+++.++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            3689999999999999999999999999999999976532         2235678999999999999999999999999


Q ss_pred             eEEEEEeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           91 HLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        91 ~~~lv~e~~~~~-~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      .+++||||+.+| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~  180 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYL  180 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceEC
Confidence            999999998766 99999999889999999999999999999999999999999999999986654  999999999866


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      ..........||+.|+|||++.+..+.+.++|||||||++|+|++|..||.....          ....  .......++
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~--~~~~~~~~~  248 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEA--AIHPPYLVS  248 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTT--CCCCSSCCC
T ss_pred             CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhh--ccCCCcccC
Confidence            5555555677999999999998888766669999999999999999999975221          1111  222334579


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +++.+||.+||+.+|.+|||++++++||||++.
T Consensus       249 ~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            999999999999999999999999999999764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5e-51  Score=390.93  Aligned_cols=263  Identities=29%  Similarity=0.405  Sum_probs=206.7

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC----
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP----   89 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~----   89 (363)
                      ....++|++.+.||+|+||+||+|++..+++.||||++....   ...+.+.+|+.+++.++||||+++++++...    
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            345789999999999999999999999999999999997642   2235678999999999999999999999776    


Q ss_pred             -CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           90 -THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        90 -~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                       +.+|+||||++ ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.
T Consensus       102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla~~  178 (432)
T 3n9x_A          102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLART  178 (432)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCccc
Confidence             57999999996 599999998888999999999999999999999999999999999999976654  99999999985


Q ss_pred             CccCC-----------------------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCC-------
Q 017936          169 SVLHS-----------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP-------  218 (363)
Q Consensus       169 ~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p-------  218 (363)
                      .....                       .....+||++|+|||++......+.++|||||||++|+|++|..|       
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            43321                       124567999999999975555445559999999999999985443       


Q ss_pred             ----CCCCCc-----------------hHHHHHHHHH--------------------HhccccCCC-----CCCCCCHHH
Q 017936          219 ----FEDPEE-----------------PKNFRKTIHR--------------------ILSVQYSIP-----DYVHISPEC  252 (363)
Q Consensus       219 ----f~~~~~-----------------~~~~~~~~~~--------------------~~~~~~~~~-----~~~~~s~~~  252 (363)
                          |.+...                 ...+..+...                    +.......+     .+..+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence                433221                 0111111100                    000011111     124579999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .+||++||+.||.+|||++|+|+||||...
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  368 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDV  368 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence            999999999999999999999999999764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.5e-52  Score=395.94  Aligned_cols=258  Identities=34%  Similarity=0.582  Sum_probs=206.6

Q ss_pred             CCCceee-ceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHH-HcCCCCCeeeeeEEEEc----CCeEE
Q 017936           20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT----PTHLA   93 (363)
Q Consensus        20 ~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l-~~l~hpnIv~~~~~~~~----~~~~~   93 (363)
                      .++|.+. +.||+|+||+||++.+..+++.||||++...    ..+.+|+.++ +..+||||++++++|..    ..++|
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            4578887 7899999999999999999999999998643    4567788876 56689999999999875    56799


Q ss_pred             EEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecCCcccCc
Q 017936           94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV  170 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~~~~  170 (363)
                      +|||||+||+|.+++...+  .+++.+++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||+++...
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~  215 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  215 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence            9999999999999998754  599999999999999999999999999999999999998632 3569999999998665


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--CCCCCCCC
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHI  248 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  248 (363)
                      ........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...............+....+  ..+.+..+
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  294 (400)
T 1nxk_A          216 SHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  294 (400)
T ss_dssp             -----------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTS
T ss_pred             CCCccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccC
Confidence            5455566789999999999988877665 99999999999999999999765432211011112222333  33445678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ++++.+||++||+.||.+|||++++++||||.+.
T Consensus       295 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999999764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.6e-51  Score=376.60  Aligned_cols=262  Identities=30%  Similarity=0.490  Sum_probs=212.0

Q ss_pred             CCCceee-ceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHc-CCCCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .++|++. +.||+|+||+||+|++..+++.||||++.... .....+.+|+.++++ ++||||+++++++.+.+.+++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4689996 78999999999999999999999999997653 335678899999988 47999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC-CcEEEeecCCcccCccCC--
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS--  173 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~-~~vkL~DFgla~~~~~~~--  173 (363)
                      ||+++++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||++.......  
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  170 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC  170 (316)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred             EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence            99999999999998888999999999999999999999999999999999999976543 359999999987543211  


Q ss_pred             ------CCCccccCCCcCChhhhhc-----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH-----------HHHHH
Q 017936          174 ------QPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----------NFRKT  231 (363)
Q Consensus       174 ------~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----------~~~~~  231 (363)
                            ......||+.|+|||++.+     ..++.+ +|||||||++|+|++|..||.......           .....
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  249 (316)
T 2ac3_A          171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML  249 (316)
T ss_dssp             -----------CCSGGGCCHHHHHHTSHHHHHHTTT-HHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred             ccccccccccccCCcCccChHHhhcccccccCCCcc-cccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence                  1223469999999999875     345545 999999999999999999997654211           11122


Q ss_pred             HHHHhccccCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          232 IHRILSVQYSIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       232 ~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ...+.......+.  +..+++++.+||++||+.||.+|||++|+++||||+..
T Consensus       250 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             HHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            2333333333332  24579999999999999999999999999999999764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.2e-52  Score=383.28  Aligned_cols=259  Identities=36%  Similarity=0.623  Sum_probs=199.3

Q ss_pred             CCceee---ceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELV---RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~---~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|.+.   +.||+|+||+||+|.+..+++.||||++.+.  ......+|+.+++.+. ||||+++++++.+....|+||
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            357775   7899999999999999999999999998754  3466788999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecCCcccCccC-CC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH-SQ  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~~~~~~-~~  174 (363)
                      ||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++..... ..
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9999999999999988999999999999999999999999999999999999997654 225999999999754332 22


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhccccCCCC--CCCCC
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPD--YVHIS  249 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~s  249 (363)
                      .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||......   .........+.......+.  +..+|
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS  244 (325)
T ss_dssp             ------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred             ccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence            345678999999999988887655 99999999999999999999764321   1122334444444433332  24579


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +++.+||.+||+.||.+|||++++++||||+..
T Consensus       245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            999999999999999999999999999999764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.7e-51  Score=370.59  Aligned_cols=258  Identities=42%  Similarity=0.745  Sum_probs=213.5

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++.+.||+|+||.||++++..+++.||+|++....    ...+.+.+|+.+++.++||||+++++++...+.+++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3578999999999999999999999999999999986532    234578899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++........
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC---
T ss_pred             EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCcc
Confidence            9999999999999998888999999999999999999999999999999999999986654  99999999986654444


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      .....||+.|+|||.+.+..+.+.++||||||+++|+|++|..||.........    ..+.......|  ..++..+.+
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~--~~~~~~l~~  240 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF----KKIRGGVFYIP--EYLNRSVAT  240 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHH
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH----HHhhcCcccCc--hhcCHHHHH
Confidence            456679999999999987776556699999999999999999999875543322    22222332333  357899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccccccCC
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWFLKNLP  284 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~~~~~~  284 (363)
                      +|.+||+.+|.+|||++++++||||++..+
T Consensus       241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          241 LLMHMLQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHHHccCChhhCCCHHHHHhChhhccCch
Confidence            999999999999999999999999987654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=9.3e-52  Score=386.64  Aligned_cols=261  Identities=24%  Similarity=0.408  Sum_probs=215.5

Q ss_pred             CCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-----CCCeeeeeEEEEcCC
Q 017936           16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFKEVILTPT   90 (363)
Q Consensus        16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-----hpnIv~~~~~~~~~~   90 (363)
                      .....++|++++.||+|+||+||+|++..+++.||||++............|+.+++.+.     ||||+++++++...+
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            334478999999999999999999999999999999999876555677788999999886     999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC---------------
Q 017936           91 HLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---------------  153 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~---------------  153 (363)
                      .+++||||+ +++|.+++....  .+++.+++.++.||+.||+|||++||+||||||+|||++..               
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~  188 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG  188 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred             eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence            999999999 999999998754  59999999999999999999999999999999999999751               


Q ss_pred             --------CCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch
Q 017936          154 --------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP  225 (363)
Q Consensus       154 --------~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  225 (363)
                              ..+.+||+|||+|+...  .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||......
T Consensus       189 ~~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~  265 (360)
T 3llt_A          189 KKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHM  265 (360)
T ss_dssp             CEEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHH
Confidence                    24469999999997533  23345679999999999998888766 99999999999999999999876654


Q ss_pred             HHHHHHHHHHhccc----------------------cCCCCC------------------CCCCHHHHHHHHHhcccCCC
Q 017936          226 KNFRKTIHRILSVQ----------------------YSIPDY------------------VHISPECRHLISRIFVADPA  265 (363)
Q Consensus       226 ~~~~~~~~~~~~~~----------------------~~~~~~------------------~~~s~~~~~li~~~L~~~p~  265 (363)
                      ..............                      ...|..                  ...++.+.+||.+||+.||.
T Consensus       266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  345 (360)
T 3llt_A          266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT  345 (360)
T ss_dssp             HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence            43332221110000                      000100                  01247788999999999999


Q ss_pred             CCCCHHHHhcCcccc
Q 017936          266 KRISIPEIRNHEWFL  280 (363)
Q Consensus       266 ~R~t~~ell~h~~~~  280 (363)
                      +|||++|+|+||||+
T Consensus       346 ~Rpta~elL~hp~f~  360 (360)
T 3llt_A          346 LRPSPAELLKHKFLE  360 (360)
T ss_dssp             GSCCHHHHTTSGGGC
T ss_pred             hCCCHHHHhcCcccC
Confidence            999999999999994

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-51  Score=402.01  Aligned_cols=258  Identities=30%  Similarity=0.439  Sum_probs=220.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|.+.+.||+|+||+||+|+++.+|+.||||++.+..    .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            3478999999999999999999999999999999997532    234567899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           95 VMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      ||||++||+|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~  340 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELK  340 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeecc
Confidence            99999999999998764    36999999999999999999999999999999999999986654  9999999998654


Q ss_pred             cCCCC-CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          171 LHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       171 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      ..... ...+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...............+.......|  ..+|
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~s  417 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFS  417 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTSC
T ss_pred             CCCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cccC
Confidence            43332 34589999999999998877665 99999999999999999999876433233334444444444444  4689


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          250 PECRHLISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      +++.+||++||+.+|.+||+     ++++++||||..
T Consensus       418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            99999999999999999996     589999999975

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.2e-51  Score=369.60  Aligned_cols=254  Identities=33%  Similarity=0.623  Sum_probs=216.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++.+.||+|+||.||++++..+++.||+|++....    .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3478999999999999999999999999999999986532    234568899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  ++|+|||++..... ..
T Consensus        87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~-~~  163 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SR  163 (279)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC-----
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCc-cc
Confidence            9999999999999998889999999999999999999999999999999999999976654  99999999864332 22


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      .....||+.|+|||.+.+..++.+ +||||||+++|+|++|..||.........    ..+.......|  ..+++++.+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~  236 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETY----KRISRVEFTFP--DFVTEGARD  236 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCCCC--TTSCHHHHH
T ss_pred             ccccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcHHHHH----HHHHhCCCCCC--CcCCHHHHH
Confidence            345679999999999988777655 99999999999999999999876543332    22333333333  357999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ||.+||+.+|.+|||+.|+++||||...
T Consensus       237 li~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          237 LISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHhccChhhCCCHHHHhhCccccCC
Confidence            9999999999999999999999999764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.4e-51  Score=391.62  Aligned_cols=268  Identities=26%  Similarity=0.369  Sum_probs=217.7

Q ss_pred             CCCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC------CCCCeeeeeEEEE
Q 017936           14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL------RHPNIVRFKEVIL   87 (363)
Q Consensus        14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l------~hpnIv~~~~~~~   87 (363)
                      ++.....++|++.+.||+|+||+||+|.+..+++.||||++.........+.+|+.+++.+      +|+||+++++++.
T Consensus        90 ~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           90 VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             CTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             cCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            3334456789999999999999999999999999999999987655566777888888766      5789999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           88 TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                      ..+.+++||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++...+||+|||+
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999999995 68999887654  49999999999999999999999999999999999999877655599999999


Q ss_pred             cccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc------
Q 017936          166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------  239 (363)
Q Consensus       166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  239 (363)
                      |+...  ....+..||+.|+|||++.+..++.+ +|||||||++|+|++|.+||.+......+..+........      
T Consensus       249 a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~  325 (429)
T 3kvw_A          249 SCYEH--QRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA  325 (429)
T ss_dssp             CEETT--CCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ceecC--CcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence            87533  23345689999999999998888666 9999999999999999999988776554444332210000      


Q ss_pred             ----------cCC-----------------------------CC--------CCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 017936          240 ----------YSI-----------------------------PD--------YVHISPECRHLISRIFVADPAKRISIPE  272 (363)
Q Consensus       240 ----------~~~-----------------------------~~--------~~~~s~~~~~li~~~L~~~p~~R~t~~e  272 (363)
                                ...                             +.        ....++++.+||++||+.||.+|||++|
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e  405 (429)
T 3kvw_A          326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ  405 (429)
T ss_dssp             BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence                      000                             00        0123788999999999999999999999


Q ss_pred             HhcCccccccCCC
Q 017936          273 IRNHEWFLKNLPA  285 (363)
Q Consensus       273 ll~h~~~~~~~~~  285 (363)
                      +|+||||++..+.
T Consensus       406 ~L~Hpw~~~~~~~  418 (429)
T 3kvw_A          406 ALRHPWLRRRLPK  418 (429)
T ss_dssp             HHTSTTTC-----
T ss_pred             HhCChhhccCCCC
Confidence            9999999876543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.9e-51  Score=383.29  Aligned_cols=254  Identities=31%  Similarity=0.544  Sum_probs=216.7

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---------ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCC
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSL-RHPNIVRFKEVILTPT   90 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~   90 (363)
                      ++|++.+.||+|+||.||+|++..+|+.||||++.....         ..+.+.+|+.+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            579999999999999999999999999999999876431         134577899999998 7999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      ..++||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.  +||+|||++....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence            99999999999999999998888999999999999999999999999999999999999986654  9999999998665


Q ss_pred             cCCCCCccccCCCcCChhhhhcC------CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--CC
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SI  242 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~  242 (363)
                      .........||+.|+|||++.+.      .++. ++|||||||++|+|++|..||...........    +.....  ..
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~Di~slG~il~ell~g~~pf~~~~~~~~~~~----i~~~~~~~~~  326 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGK-EVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSS  326 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCCH
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCCCc-hhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCC
Confidence            55555567899999999998743      3444 49999999999999999999987654333322    222222  22


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          243 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       243 ~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +.+..++..+.+||.+||+.+|.+|||++++++||||++
T Consensus       327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            334567999999999999999999999999999999963

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.4e-50  Score=373.02  Aligned_cols=254  Identities=27%  Similarity=0.481  Sum_probs=215.0

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccC
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  100 (363)
                      .|...+.||+|+||.||+|++..+|+.||||++..... ..+.+.+|+.+++.++||||+++++++...+.+++||||++
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            37888999999999999999999999999999876433 34668899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCCccc
Q 017936          101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV  179 (363)
Q Consensus       101 ~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~~~~  179 (363)
                      +++|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...... ......
T Consensus       126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~  202 (321)
T 2c30_A          126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV  202 (321)
T ss_dssp             SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence            9999998764 56999999999999999999999999999999999999986654  9999999987543322 234557


Q ss_pred             cCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017936          180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI  259 (363)
Q Consensus       180 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  259 (363)
                      ||+.|+|||++.+..++.+ +|||||||++|+|++|..||............. .  ...........+++.+.+||.+|
T Consensus       203 gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-D--SPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-H--SSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             CCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-c--CCCCCcCccccCCHHHHHHHHHH
Confidence            9999999999988777665 999999999999999999998765533322221 1  11112233345789999999999


Q ss_pred             cccCCCCCCCHHHHhcCcccccc
Q 017936          260 FVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       260 L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      |+.+|.+|||++++++||||.+.
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             ccCChhhCcCHHHHhcChhhccC
Confidence            99999999999999999999764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.7e-51  Score=378.52  Aligned_cols=267  Identities=27%  Similarity=0.421  Sum_probs=213.9

Q ss_pred             CCCCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEc-
Q 017936           13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-   88 (363)
Q Consensus        13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-   88 (363)
                      ..|.+...++|++++.||+|+||+||+|++..+++.||+|++....   .....+.+|+.+++.++||||+++++++.. 
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   88 (351)
T 3mi9_A            9 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   88 (351)
T ss_dssp             CCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred             cccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence            3455556789999999999999999999999999999999986543   234577899999999999999999999987 


Q ss_pred             -------CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEE
Q 017936           89 -------PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI  160 (363)
Q Consensus        89 -------~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL  160 (363)
                             .+.+++||||+++ +|...+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl  165 (351)
T 3mi9_A           89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKL  165 (351)
T ss_dssp             --------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEE
T ss_pred             ccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEE
Confidence                   4568999999975 776666553 57999999999999999999999999999999999999986654  999


Q ss_pred             eecCCcccCcc-----CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH
Q 017936          161 CDFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI  235 (363)
Q Consensus       161 ~DFgla~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  235 (363)
                      +|||+|+....     ........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+....
T Consensus       166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  245 (351)
T 3mi9_A          166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  245 (351)
T ss_dssp             CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99999975432     1222445789999999999875544455999999999999999999998876654444333222


Q ss_pred             hccccC-CCCCC-------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          236 LSVQYS-IPDYV-------------------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       236 ~~~~~~-~~~~~-------------------------~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ...... .+...                         ..++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence            111110 01000                         026789999999999999999999999999999753

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.4e-51  Score=368.49  Aligned_cols=258  Identities=35%  Similarity=0.624  Sum_probs=219.3

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            57999999999999999999999999999999987543  3346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC---CCC
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~---~~~  175 (363)
                      +++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++......   ...
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhcc
Confidence            999999999988778999999999999999999999999999999999999986654  999999998754322   223


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....||+.|+|||++.+..+.+.++|||||||++|+|++|..||............   ........+.+..+++.+.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH---HHTTCTTSTTGGGSCHHHHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---hhhcccccCchhhcCHHHHHH
Confidence            44578999999999987776555699999999999999999999876543222221   222222334445689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      |.+||+.+|.+|||++++++||||.+..
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccChh
Confidence            9999999999999999999999997643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-51  Score=378.82  Aligned_cols=266  Identities=26%  Similarity=0.420  Sum_probs=211.1

Q ss_pred             CCCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc------ccHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 017936           14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVIL   87 (363)
Q Consensus        14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~~~~~~~   87 (363)
                      +.+....++|++.+.||+|+||.||++++..+|+.||+|++.....      ..+.+.+|+.+++.++||||+++++++.
T Consensus         3 l~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (346)
T 1ua2_A            3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG   82 (346)
T ss_dssp             ----------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe
Confidence            3444556899999999999999999999999999999999875321      2346789999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCc
Q 017936           88 TPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  166 (363)
Q Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla  166 (363)
                      +.+.+++||||+++ +|...+.... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++
T Consensus        83 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a  159 (346)
T 1ua2_A           83 HKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLA  159 (346)
T ss_dssp             CTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGG
T ss_pred             eCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccc
Confidence            99999999999976 8888887643 6999999999999999999999999999999999999986654  999999999


Q ss_pred             ccCccC-CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-CCCC
Q 017936          167 KSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPD  244 (363)
Q Consensus       167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~  244 (363)
                      +..... .......||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.........+......... ..+.
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            865332 23345679999999999977654455599999999999999999999887766555554443211100 0000


Q ss_pred             ---------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          245 ---------------------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       245 ---------------------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                           ...+++++.+||++||+.+|.+|||++|+++||||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence                                 13467899999999999999999999999999999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-51  Score=383.47  Aligned_cols=260  Identities=30%  Similarity=0.535  Sum_probs=213.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC------CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...      ....+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            46899999999999999999999999999999998653      233467889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 017936           94 IVMEYASGGELFERICN----------------------------------------AGRFSEDEARFFFQQLISGVSYC  133 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~----------------------------------------~~~l~~~~~~~~~~qil~~L~~L  133 (363)
                      +|||||+|++|.+++..                                        ...+++..++.++.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999988742                                        11246788999999999999999


Q ss_pred             HHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-----CCCccccCCCcCChhhhhc--CCCCCcchhhhhHH
Q 017936          134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCG  206 (363)
Q Consensus       134 H~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG  206 (363)
                      |++||+||||||+|||++.++...+||+|||+++......     ......||+.|+|||++.+  ..++. ++||||||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwslG  263 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP-KCDAWSAG  263 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT-HHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc-HHHHHHHH
Confidence            9999999999999999987665569999999997542211     2345579999999999975  44544 49999999


Q ss_pred             HHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          207 VTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       207 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      |++|+|++|..||...............  ......+.+..+++++.+||.+||+.+|.+|||+.++++||||.+.
T Consensus       264 ~il~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDADTISQVLNK--KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHCCCCCCCCChHHHHHHHHhc--ccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            9999999999999887665444433322  1122333444579999999999999999999999999999999763

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-51  Score=386.23  Aligned_cols=258  Identities=24%  Similarity=0.407  Sum_probs=210.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEc----------
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------   88 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----------   88 (363)
                      ..++|++.+.||+|+||+||+|++..+++.||||++......   ..+|+.+++.++||||++++++|..          
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            357899999999999999999999999999999998765332   2479999999999999999999844          


Q ss_pred             ----------------------------CCeEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 017936           89 ----------------------------PTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM  136 (363)
Q Consensus        89 ----------------------------~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~L~~LH~~  136 (363)
                                                  ...+++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||++
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  160 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL  160 (383)
T ss_dssp             ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence                                        3458999999975 7666554    456799999999999999999999999


Q ss_pred             CceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCC
Q 017936          137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA  216 (363)
Q Consensus       137 giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~  216 (363)
                      ||+||||||+|||++.. .+.+||+|||+|+............||+.|+|||++.+....+.++|||||||++|+|++|.
T Consensus       161 gi~H~Dikp~Nil~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  239 (383)
T 3eb0_A          161 GICHRDIKPQNLLVNSK-DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK  239 (383)
T ss_dssp             TEECSCCCGGGEEEETT-TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCccCccCHHHEEEcCC-CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence            99999999999999732 23599999999987665666667789999999999987653345599999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHHhcc-------------ccCCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 017936          217 YPFEDPEEPKNFRKTIHRILSV-------------QYSIP----------DYVHISPECRHLISRIFVADPAKRISIPEI  273 (363)
Q Consensus       217 ~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~----------~~~~~s~~~~~li~~~L~~~p~~R~t~~el  273 (363)
                      .||.+....+....++......             ...+|          ....+++++.+||.+||+.+|.+|||+.|+
T Consensus       240 ~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  319 (383)
T 3eb0_A          240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA  319 (383)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            9999877666555544321110             00111          123478999999999999999999999999


Q ss_pred             hcCccccc
Q 017936          274 RNHEWFLK  281 (363)
Q Consensus       274 l~h~~~~~  281 (363)
                      ++||||..
T Consensus       320 l~hp~f~~  327 (383)
T 3eb0_A          320 MAHPFFDH  327 (383)
T ss_dssp             HTSGGGHH
T ss_pred             hcCHHHHH
Confidence            99999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1e-51  Score=394.14  Aligned_cols=257  Identities=33%  Similarity=0.578  Sum_probs=206.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++.+...         ....+.+|+.+++.++||||+++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            4789999999999999999999999999999999875321         12347899999999999999999999865 5


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecCCcccC
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS  169 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~~~  169 (363)
                      .+++||||+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ ...+||+|||+|+..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            5799999999999999998888999999999999999999999999999999999999997543 235999999999876


Q ss_pred             ccCCCCCccccCCCcCChhhhhc---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC--CC
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PD  244 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~  244 (363)
                      .........+||+.|+|||++.+   ..++ .++|||||||++|+|++|..||............+.   ......  +.
T Consensus       293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~---~~~~~~~~~~  368 (419)
T 3i6u_A          293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEV  368 (419)
T ss_dssp             C-----------CTTCCTTTTC----CTTH-HHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH---TTCCCCCHHH
T ss_pred             CCCccccccCCCCCccCceeeecCCCCCCC-chhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh---cCCCCCCchh
Confidence            55555566789999999999854   3343 459999999999999999999987554433333222   222221  12


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +..+++.+.+||++||+.+|.+|||++|+++||||+.
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            3467999999999999999999999999999999964

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.5e-50  Score=377.76  Aligned_cols=261  Identities=28%  Similarity=0.429  Sum_probs=214.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC-----Ce
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH   91 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~~   91 (363)
                      .+++|++++.||+|+||.||+|++..+++.||||++.....  ....+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            45789999999999999999999999999999999875432  236678999999999999999999999765     46


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      +|+||||+. ++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADP  180 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCG
T ss_pred             EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCC
Confidence            899999996 589888865 46999999999999999999999999999999999999976654  99999999975433


Q ss_pred             CCC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc--------
Q 017936          172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------  239 (363)
Q Consensus       172 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  239 (363)
                      ...    .....||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+........        
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            221    24457999999999987665444559999999999999999999988776555544432111100        


Q ss_pred             --------cCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          240 --------YSIP---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       240 --------~~~~---------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                              ...+         ....+++++.+||.+||+.||.+|||++|+++||||.+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence                    0000         1135689999999999999999999999999999998764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.9e-51  Score=370.43  Aligned_cols=257  Identities=34%  Similarity=0.628  Sum_probs=216.4

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ++|++.+.||+|+||.||++++..+++.||+|++.....       ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            579999999999999999999999999999999875421       3467889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC--CCcEEEeecCCcccCcc
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVL  171 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~--~~~vkL~DFgla~~~~~  171 (363)
                      +||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+||+++.++  ...+||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999998888899999999999999999999999999999999999997654  22599999999986554


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--CCCCCC
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHIS  249 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s  249 (363)
                      ........||+.|+|||++.+..++.+ +||||||+++|+|++|..||..........    .+.......+  .+..++
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  239 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLT----NISAVNYDFDEEYFSNTS  239 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHTTCCCCCHHHHTTCC
T ss_pred             CCcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHHHH----HhHhcccCCcchhcccCC
Confidence            444455679999999999988777655 999999999999999999998765533322    2222222222  224578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +.+.+||.+||+.+|.+|||+.++++||||+..
T Consensus       240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            999999999999999999999999999999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.3e-50  Score=368.72  Aligned_cols=258  Identities=31%  Similarity=0.508  Sum_probs=218.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----------cccHHHHHHHHHHHcCC-CCCeeeeeEEEEc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----------KIDENVQREIINHRSLR-HPNIVRFKEVILT   88 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~   88 (363)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....          ...+.+.+|+.+++.+. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            578999999999999999999999999999999987543          12345678999999995 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      .+..++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++..
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~  173 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ  173 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhh
Confidence            9999999999999999999998888999999999999999999999999999999999999976654  99999999986


Q ss_pred             CccCCCCCccccCCCcCChhhhhc------CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC
Q 017936          169 SVLHSQPKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI  242 (363)
Q Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (363)
                      ...........|++.|+|||++.+      ..++ .++||||||+++|+|++|..||...............  ......
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~  250 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYG-KEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGS  250 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCT
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccCC-cccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC--CcccCc
Confidence            655545556679999999999862      2343 4499999999999999999999876553333222211  112223


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          243 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       243 ~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +.+..++..+.+||.+||+.+|.+|||++++++||||++.
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence            3445689999999999999999999999999999999764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.5e-51  Score=372.69  Aligned_cols=257  Identities=35%  Similarity=0.589  Sum_probs=217.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            4689999999999999999999999999999999976532 345688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC-CCCCcEEEeecCCcccCccCCCCCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~-~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      +++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||++.. +..+.+||+|||++..... .....
T Consensus        88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~  166 (304)
T 2jam_A           88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMST  166 (304)
T ss_dssp             CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTTHH
T ss_pred             CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Ccccc
Confidence            999999999988888999999999999999999999999999999999999932 2334599999999875332 22344


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--CCCCCCCCCHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHL  255 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~l  255 (363)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........    +.....  ..+.+..+++++.+|
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~~~~~~l  241 (304)
T 2jam_A          167 ACGTPGYVAPEVLAQKPYSKA-VDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKDF  241 (304)
T ss_dssp             HHSCCCBCCTTTBSSCSCCHH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHCCCCCCTTTTTTSCHHHHHH
T ss_pred             ccCCCCccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCCCCccccccCCHHHHHH
Confidence            569999999999987777655 9999999999999999999987665433332    222222  233445789999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      |.+||+.+|.+|||++++++||||...
T Consensus       242 i~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          242 ICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHHcCCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-50  Score=380.63  Aligned_cols=258  Identities=28%  Similarity=0.426  Sum_probs=201.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC------
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------   90 (363)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....   .....+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999999999999999997643   22356788999999999999999999998765      


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+|+||||+++ +|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+...
T Consensus       104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  178 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC-----
T ss_pred             ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccc
Confidence            78999999965 7888775  35999999999999999999999999999999999999986654  9999999998655


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc-----------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-----------  239 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  239 (363)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+.......++.......           
T Consensus       179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          179 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             cccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            4444456689999999999998887766 9999999999999999999988765444333321100000           


Q ss_pred             ----cCCCCCC---------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          240 ----YSIPDYV---------------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       240 ----~~~~~~~---------------------~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                          ...+...                     ..++++.+||++||+.||.+|||++|+++||||....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                0001100                     0156799999999999999999999999999997643

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.2e-50  Score=407.41  Aligned_cols=254  Identities=32%  Similarity=0.542  Sum_probs=221.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++++.||+|+||+||+++++.+++.||||++.+.    ....+.+..|..++..+ +||||++++++|.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            356899999999999999999999999999999999753    23446678899999887 7999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-C
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~  172 (363)
                      +||||++||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.... .
T Consensus       419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTT
T ss_pred             EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCC
Confidence            99999999999999998889999999999999999999999999999999999999987664  99999999985332 2


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+...    ....+......+|.  .+|+++
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~  569 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHNVAYPK--SMSKEA  569 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHSSCCCCCT--TSCHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCHHH----HHHHHHhCCCCCCc--cCCHHH
Confidence            33455689999999999988888655 999999999999999999998865543    33444455555543  589999


Q ss_pred             HHHHHHhcccCCCCCCCH-----HHHhcCccccc
Q 017936          253 RHLISRIFVADPAKRISI-----PEIRNHEWFLK  281 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~-----~ell~h~~~~~  281 (363)
                      .+||++||+.+|.+||++     ++|++||||..
T Consensus       570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          570 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             HHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             HHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            999999999999999997     99999999964

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-51  Score=381.92  Aligned_cols=256  Identities=25%  Similarity=0.424  Sum_probs=207.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC------
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT------   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------   90 (363)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++.....   ..+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            5789999999999999999999999999999999865322   2356789999999999999999999998763      


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD  179 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeecccccc
Confidence            469999999 8899988876 57999999999999999999999999999999999999986654  9999999998643


Q ss_pred             cCCCCCccccCCCcCChhhhhc-CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc----------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------  239 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  239 (363)
                      .  ......+|+.|+|||++.+ ..++ .++|||||||++|+|++|+.||.+.+.......+........          
T Consensus       180 ~--~~~~~~~t~~y~aPE~~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  256 (367)
T 1cm8_A          180 S--EMTGYVVTRWYRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  256 (367)
T ss_dssp             S--SCCSSCSCGGGCCTHHHHTTTCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             c--ccCcCcCCCCcCCHHHHhCCCCCC-hhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence            2  2345678999999999987 4454 449999999999999999999988766555444432211000          


Q ss_pred             ---------c-----C-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          240 ---------Y-----S-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       240 ---------~-----~-~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                               .     . ......+++++.+||.+||+.||.+|||++++++||||...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                     0     0 01123568999999999999999999999999999999764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-50  Score=366.84  Aligned_cols=254  Identities=32%  Similarity=0.637  Sum_probs=219.6

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++.+.||+|+||.||++++..+++.||+|++...    ......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence            347899999999999999999999999999999998653    2234678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++..... ..
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~  168 (284)
T 2vgo_A           92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LR  168 (284)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SC
T ss_pred             EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-cc
Confidence            9999999999999998888999999999999999999999999999999999999976654  99999999865432 22


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      .....|++.|+|||++.+..++.+ +||||||+++|+|++|..||.........    ..+.......|  ..++.++.+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~  241 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETH----RRIVNVDLKFP--PFLSDGSKD  241 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCC--TTSCHHHHH
T ss_pred             cccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHHH----HHHhccccCCC--CcCCHHHHH
Confidence            345679999999999988777665 99999999999999999999876554332    22333333333  457999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ||.+||+.+|.+|||++++++||||+..
T Consensus       242 li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          242 LISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            9999999999999999999999999764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-50  Score=374.75  Aligned_cols=260  Identities=27%  Similarity=0.496  Sum_probs=215.5

Q ss_pred             CCCceee-ceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~l   94 (363)
                      .++|.+. +.||+|+||+||+|++..+++.||+|++....   .....+.+|+.+++.+. ||||+++++++...+.+++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            4578887 89999999999999999999999999987532   23467889999999885 6999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecCCcccCcc
Q 017936           95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVL  171 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~~~~~  171 (363)
                      ||||+.+++|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+|||++... .+.+||+|||+++....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999988653  5699999999999999999999999999999999999997621 34699999999986655


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||..............  .......+.+..+++.
T Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~  263 (327)
T 3lm5_A          187 ACELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ--VNVDYSEETFSSVSQL  263 (327)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTTTTTSCHH
T ss_pred             ccccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh--cccccCchhhcccCHH
Confidence            545556689999999999988877665 9999999999999999999987665444333222  1223334445678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +.+||.+||+.+|.+|||++++++||||+..
T Consensus       264 ~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            9999999999999999999999999999753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-50  Score=367.05  Aligned_cols=257  Identities=37%  Similarity=0.632  Sum_probs=220.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ...+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            468999999999999999999999999999999986532   34567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~~~~~~~~~  175 (363)
                      ||+.+++|.+.+.....+++.+++.++.||+.||.|||++||+||||||+||+++.++ ...+||+|||++.........
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~  180 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM  180 (287)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence            9999999999998888899999999999999999999999999999999999997643 346999999999866554445


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc--cCCCCCCCCCHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--YSIPDYVHISPECR  253 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~  253 (363)
                      ....||+.|+|||.+.+. ++.+ +||||||+++|+|++|..||..........    .+....  ...+.+..+++++.
T Consensus       181 ~~~~~~~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          181 KDRIGTAYYIAPEVLRGT-YDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILK----RVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             SCHHHHHTTCCHHHHTTC-CCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCSGGGTTSCHHHH
T ss_pred             ccccCcccccChHHhcCC-CCCc-hhhHhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCCchhhhhcCHHHH
Confidence            556799999999998754 5444 999999999999999999998765533222    222222  23344567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +||.+||+.+|.+|||+.++++||||.+.
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            99999999999999999999999999764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.5e-51  Score=372.52  Aligned_cols=249  Identities=21%  Similarity=0.255  Sum_probs=200.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc---cHHHHHHHHHH-HcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINH-RSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l-~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++.+.||+|+||+||+|++..+++.||||++......   ......|+..+ +..+||||+++++++...+.+++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            6799999999999999999999999999999988654322   22334444444 4458999999999999999999999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      ||+ +++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++........
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence            999 66888887654 46999999999999999999999999999999999999976665  999999999866555555


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.....   .    ..+............+++++.+|
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~el~~g~~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~l~~l  284 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYGTA-ADVFSLGLTILEVACNMELPHGGEG---W----QQLRQGYLPPEFTAGLSSELRSV  284 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCSTH-HHHHHHHHHHHHHHHTCCCCSSHHH---H----HHHTTTCCCHHHHTTSCHHHHHH
T ss_pred             cccCCCccccCHhHhcC-CCCch-hhHHHHHHHHHHHHhCCCCCCCccH---H----HHHhccCCCcccccCCCHHHHHH
Confidence            56679999999999876 56555 9999999999999999777754221   1    11222211111234579999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      |.+||+.+|.+|||++|+++||||++
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          285 LVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999965

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.2e-50  Score=373.22  Aligned_cols=261  Identities=27%  Similarity=0.444  Sum_probs=213.6

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++......   .+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            457899999999999999999999999999999998654322   34567899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~  174 (363)
                      |||+++++|..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ..
T Consensus       103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC---------
T ss_pred             EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCccc
Confidence            999999999888887788999999999999999999999999999999999999976654  999999999754332 22


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc---------------cc
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQ  239 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~  239 (363)
                      .....||+.|+|||++.+....+.++|||||||++|+|++|..||..................               ..
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            345679999999999987644455599999999999999999999887765544433321110               00


Q ss_pred             cCCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          240 YSIPD----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       240 ~~~~~----------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ...+.          ...+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            11111          2357899999999999999999999999999999965

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.9e-51  Score=380.43  Aligned_cols=260  Identities=27%  Similarity=0.445  Sum_probs=215.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ..++|++.+.||+|+||+||++++..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            3578999999999999999999999999999999987653  23466889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~-giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      ||+++++|.+++...+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.  +||+|||++..... ...
T Consensus       111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~  187 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA  187 (360)
T ss_dssp             CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC-
T ss_pred             ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-ccc
Confidence            9999999999999888899999999999999999999996 9999999999999987654  99999999864322 223


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHH--------------------------
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR--------------------------  229 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--------------------------  229 (363)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........                          
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ---CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             cCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            45579999999999988877655 999999999999999999998655322111                          


Q ss_pred             ------------HHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          230 ------------KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       230 ------------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                  .....+............++.++.+||.+||+.+|.+|||++|+++||||+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                        11111111222222223478999999999999999999999999999999764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.5e-50  Score=372.37  Aligned_cols=258  Identities=23%  Similarity=0.414  Sum_probs=212.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEc--CCeEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLAIV   95 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv   95 (363)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++...  ..+.+.+|+.+++.++ ||||+++++++..  ....++|
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            357899999999999999999999999999999998754  3467889999999997 9999999999988  6779999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |||+.+++|.+++..   +++.+++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+|+........
T Consensus       112 ~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~  187 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY  187 (330)
T ss_dssp             EECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCC
T ss_pred             EeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCcc
Confidence            999999999888753   899999999999999999999999999999999999985542 5999999999866555555


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH-HHHHHHHH---------Hhcccc-----
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-NFRKTIHR---------ILSVQY-----  240 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~---------~~~~~~-----  240 (363)
                      ....||+.|+|||++.+....+.++|||||||++|+|++|..||....... ........         +.....     
T Consensus       188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (330)
T 3nsz_A          188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR  267 (330)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTH
T ss_pred             ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccc
Confidence            667899999999999874444455999999999999999999996544322 11111110         000000     


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          241 -----------------SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       241 -----------------~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                       .......+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence                             011112379999999999999999999999999999999753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.1e-50  Score=371.44  Aligned_cols=255  Identities=36%  Similarity=0.556  Sum_probs=219.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|.+.+.||+|+||.||++++..+++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            3568999999999999999999999999999999987643    234567889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      ||||+.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...... 
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTC
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCcc
Confidence            9999999999999988888999999999999999999999999999999999999986654  9999999997553222 


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........    .+.......+  ..+++.+.
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~  269 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYL----RIKKNEYSIP--KHINPVAA  269 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHTCCCCC--TTSCHHHH
T ss_pred             cccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHHHHHH----HHhcCCCCCC--ccCCHHHH
Confidence            2344579999999999988777655 999999999999999999998765433322    2333333333  35799999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +||.+||+.+|.+|||++++++||||...
T Consensus       270 ~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          270 SLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            99999999999999999999999999765

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-50  Score=374.25  Aligned_cols=255  Identities=24%  Similarity=0.386  Sum_probs=207.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCC--CCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRH--PNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~h--pnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++.+.||+|+||.||++.+ .+++.||||++......   .+.+.+|+.+++.++|  |||+++++++...+.++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            467899999999999999999998 56889999998764322   3567889999999987  99999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      +||| +.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.   +.+||+|||+|+......
T Consensus        86 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~---~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCCC----
T ss_pred             EEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC---CcEEEeecccccccCccc
Confidence            9999 458899999999999999999999999999999999999999999999999973   349999999998653322


Q ss_pred             C---CCccccCCCcCChhhhhc-----------CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc
Q 017936          174 Q---PKSTVGTPAYIAPEVLLK-----------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ  239 (363)
Q Consensus       174 ~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (363)
                      .   .....||+.|+|||++.+           ..++ .++|||||||++|+|++|..||.......   ..........
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~  237 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPN  237 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHCTT
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCC-chhhHHHHHHHHHHHHhCCCcchhhhhHH---HHHHHHhcCC
Confidence            2   235579999999999875           3444 44999999999999999999997654322   1222233333


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       240 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .........+.++.+||.+||+.+|.+|||+.++++||||+..
T Consensus       238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            3333344568899999999999999999999999999999754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.4e-50  Score=365.60  Aligned_cols=255  Identities=36%  Similarity=0.556  Sum_probs=219.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|.+.+.||+|+||.||++++..+++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            4578999999999999999999999999999999987643    234567889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      ||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++....... 
T Consensus        93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTC
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCcc
Confidence            9999999999999988888999999999999999999999999999999999999986654  9999999997643222 


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      ......||+.|+|||++.+..++.+ +||||||+++|+|++|..||.........    ..+.......|  ..+++.+.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~  243 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEYSIP--KHINPVAA  243 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCC--TTSCHHHH
T ss_pred             ccccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhhccCCCc--cccCHHHH
Confidence            2344569999999999987777655 99999999999999999999876543332    22333333333  45799999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ++|.+||+.+|.+|||++++++||||...
T Consensus       244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          244 SLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHHHHcccChhhCcCHHHHhhChheecC
Confidence            99999999999999999999999999764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.8e-51  Score=374.77  Aligned_cols=251  Identities=24%  Similarity=0.364  Sum_probs=203.9

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC--------
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--------   90 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~--------   90 (363)
                      ++|++.+.||+|+||+||+|++..+++.||||++....  ...+.+.+|+.+++.++||||+++++++....        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            47999999999999999999999999999999987533  34567899999999999999999999986543        


Q ss_pred             -------------------------------------------------eEEEEEeccCCCchHHHHHhCCC---CCHHH
Q 017936           91 -------------------------------------------------HLAIVMEYASGGELFERICNAGR---FSEDE  118 (363)
Q Consensus        91 -------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~---l~~~~  118 (363)
                                                                       .+++|||||++++|.+++.....   .++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             38999999999999999987654   56667


Q ss_pred             HHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-------------CCCccccCCCcC
Q 017936          119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAYI  185 (363)
Q Consensus       119 ~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-------------~~~~~~gt~~y~  185 (363)
                      ++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......             ......||+.|+
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            9999999999999999999999999999999986654  9999999998554331             223457999999


Q ss_pred             ChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCC
Q 017936          186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA  265 (363)
Q Consensus       186 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~  265 (363)
                      |||++.+..++.+ +|||||||++|+|++|..|+.      ............... ......++++.+||.+||+.+|.
T Consensus       244 aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          244 SPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQM------ERVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             CHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHH------HHHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGG
T ss_pred             ChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChh------HHHHHHHHhhccCCC-cccccCChhHHHHHHHHccCCCC
Confidence            9999998887665 999999999999999877752      112222222222111 11123578899999999999999


Q ss_pred             CCCCHHHHhcCccccc
Q 017936          266 KRISIPEIRNHEWFLK  281 (363)
Q Consensus       266 ~R~t~~ell~h~~~~~  281 (363)
                      +|||++|+++||||++
T Consensus       316 ~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          316 ERPEATDIIENAIFEN  331 (332)
T ss_dssp             GSCCHHHHHHSTTCCC
T ss_pred             cCCCHHHHhhchhhhc
Confidence            9999999999999964

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=364.86  Aligned_cols=254  Identities=30%  Similarity=0.525  Sum_probs=194.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|++.+.||+|+||.||++++..+++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            467999999999999999999999999999999986532    2236788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-C
Q 017936           96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S  173 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~  173 (363)
                      |||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++...... .
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC----
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCC
Confidence            9999999999999875 57999999999999999999999999999999999999976654  999999998754322 2


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      ......||+.|+|||.+.+..++.+ +|||||||++|+|++|..||.........    ..+......  ....++.++.
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~  240 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTL----NKVVLADYE--MPSFLSIEAK  240 (278)
T ss_dssp             ------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCC--CCTTSCHHHH
T ss_pred             cceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHH----HHHhhcccC--CccccCHHHH
Confidence            2334578999999999987777655 99999999999999999999875543222    122222222  2345799999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +||.+||+.+|.+|||++++++||||...
T Consensus       241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          241 DLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            99999999999999999999999999754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.9e-50  Score=367.56  Aligned_cols=262  Identities=30%  Similarity=0.387  Sum_probs=211.0

Q ss_pred             CCCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 017936           14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTP   89 (363)
Q Consensus        14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~~~~~~~~~   89 (363)
                      +......++|++.+.||+|+||.||++++..+++.||+|++......    .+.+.+|+.+++.++||||+++++++...
T Consensus         4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~   83 (294)
T 4eqm_A            4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED   83 (294)
T ss_dssp             CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred             chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence            33444468999999999999999999999999999999998654322    35678999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      +.+|+||||++|++|.+++...+++++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~  161 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKAL  161 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC
T ss_pred             CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCcccc
Confidence            999999999999999999998889999999999999999999999999999999999999976654  999999999754


Q ss_pred             ccCC--CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          170 VLHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      ....  ......||+.|+|||.+.+..++.+ +|||||||++|+|++|..||............+.... ..........
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~  239 (294)
T 4eqm_A          162 SETSLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PNVTTDVRKD  239 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-CCHHHHSCTT
T ss_pred             ccccccccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-CCcchhcccC
Confidence            3322  2234569999999999988887665 9999999999999999999987665443322221100 0001112346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +++.+.++|.+||+.+|.+||+..+.+.+.|.
T Consensus       240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             CCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence            79999999999999999999965555656654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.2e-51  Score=373.78  Aligned_cols=259  Identities=23%  Similarity=0.346  Sum_probs=211.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC--eEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~--~~~l   94 (363)
                      ..++|++.+.||+|+||+||+|++..+++.||||++....  ...+.+.+|+.+++.++||||+++++++....  .+++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            3578999999999999999999999999999999987643  23466789999999999999999999998765  7899


Q ss_pred             EEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC--CCCCcEEEeecCCcccC
Q 017936           95 VMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFGYSKSS  169 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~--~~~~~vkL~DFgla~~~  169 (363)
                      ||||+++++|.+++.....   +++.+++.++.||+.||.|||++||+||||||+|||+..  ++.+.+||+|||+|+..
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~  166 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence            9999999999999976543   999999999999999999999999999999999999821  22335999999999876


Q ss_pred             ccCCCCCccccCCCcCChhhhh--------cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLL--------KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-  240 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  240 (363)
                      ..........||+.|+|||++.        +..++.+ +|||||||++|+|++|..||............+..+..... 
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~  245 (319)
T 4euu_A          167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (319)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTT-HHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred             CCCCceeecccCCCccCHHHhhhccccccccCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence            5555555677999999999986        3445444 99999999999999999999765544433334433332221 


Q ss_pred             ------------------CCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017936          241 ------------------SIPDY----VHISPECRHLISRIFVADPAKRISIPEIRNHEW  278 (363)
Q Consensus       241 ------------------~~~~~----~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~  278 (363)
                                        ..+..    ..++..+.+||++||+.||++|||++|+++||-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence                              11111    123457899999999999999999999999974

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.7e-50  Score=374.22  Aligned_cols=252  Identities=28%  Similarity=0.433  Sum_probs=211.5

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++++.||+|+||+||+|++..+++.||||++......    .+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4599999999999999999999999999999998764322    246789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~-~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      ||+. |+|.+.+. ....+++.+++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....   .
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~---~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---A  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSS---B
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEeeccCceecCC---C
Confidence            9997 57777775 456799999999999999999999999999999999999998665  499999999875432   2


Q ss_pred             CccccCCCcCChhhhh---cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ....||+.|+|||++.   +..++.+ +|||||||++|+|++|..||............    ............+++.+
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~-~DiwslG~il~ell~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l  282 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQSGHWSEYF  282 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHSCCCCCCCTTSCHHH
T ss_pred             CcccCCcceeCHhhhccccCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCCCCCCCCCCCHHH
Confidence            4567999999999985   3445544 99999999999999999999876654433322    22222222334679999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      .+||.+||+.+|.+|||++++++||||....
T Consensus       283 ~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            9999999999999999999999999997643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.8e-50  Score=363.36  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=212.6

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEc----CC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PT   90 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----~~   90 (363)
                      .....|++.+.||+|+||.||+|.+..++..||+|++....   ...+.+.+|+.+++.++||||+++++++..    ..
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            34567999999999999999999999999999999987543   234567899999999999999999999875    45


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCCEEEe-CCCCCcEEEeecCCcc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLD-GSPAPRLKICDFGYSK  167 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~g--iiHrDlkp~NIll~-~~~~~~vkL~DFgla~  167 (363)
                      .+++||||+++++|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++  .+||+|||++.
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~kl~Dfg~~~  180 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGG
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC--CEEEeeCCCcc
Confidence            68999999999999999998888999999999999999999999999  99999999999997 333  59999999986


Q ss_pred             cCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      .... .......||+.|+|||++.+ .++.+ +|||||||++|+|++|..||...........   ..............
T Consensus       181 ~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~  254 (290)
T 1t4h_A          181 LKRA-SFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKV  254 (290)
T ss_dssp             GCCT-TSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGC
T ss_pred             cccc-cccccccCCcCcCCHHHHhc-cCCCc-chHHHHHHHHHHHHhCCCCCCCcCcHHHHHH---HHhccCCccccCCC
Confidence            4322 22344579999999998864 45544 9999999999999999999987655443322   22222222222345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .++++.+||.+||+.+|.+|||++++++||||++
T Consensus       255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            6889999999999999999999999999999965

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.6e-50  Score=376.61  Aligned_cols=262  Identities=25%  Similarity=0.387  Sum_probs=203.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe-------E
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH-------L   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~-------~   92 (363)
                      .++|++.+.||+|+||+||++++..+++.||||++...........+++..++.++||||+++++++.....       +
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            578999999999999999999999999999999998776666777888888999999999999999975432       8


Q ss_pred             EEEEeccCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--HcCceecCCCCCCEEEeCCCCCcEEEeecCCc
Q 017936           93 AIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  166 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~----~~~~~l~~~~~~~~~~qil~~L~~LH--~~giiHrDlkp~NIll~~~~~~~vkL~DFgla  166 (363)
                      ++||||++++ |...+    .....+++..++.++.||+.||.|||  ++||+||||||+|||++.. .+.+||+|||++
T Consensus       102 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~~kl~Dfg~a  179 (360)
T 3e3p_A          102 NVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA-DGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT-TTEEEECCCTTC
T ss_pred             EEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC-CCcEEEeeCCCc
Confidence            9999999764 44333    35567999999999999999999999  9999999999999999852 235999999999


Q ss_pred             ccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc-------
Q 017936          167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-------  239 (363)
Q Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------  239 (363)
                      +............||+.|+|||++.+....+.++|||||||++|+|++|..||....................       
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            8766555556678999999999997766444559999999999999999999988776555544433211000       


Q ss_pred             ------cC-------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          240 ------YS-------------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       240 ------~~-------------~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                            ..             .......++++.+||.+||+.||.+|||+.|+++||||....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence                  00             001122568899999999999999999999999999998753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.3e-50  Score=364.56  Aligned_cols=257  Identities=24%  Similarity=0.360  Sum_probs=196.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc---HHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++.......   +.+.++...++.++||||+++++++...+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3578999999999999999999999999999999987643222   2344455567889999999999999999999999


Q ss_pred             EeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           96 MEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        96 ~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~L~~LH~~-giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      |||+++ +|.+.+.    ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++  .+||+|||+++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLV  161 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC--CEEBCCC-------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecCCccccc
Confidence            999975 7766654    356799999999999999999999998 999999999999997655  49999999998665


Q ss_pred             cCCCCCccccCCCcCChhhh----hcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          171 LHSQPKSTVGTPAYIAPEVL----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                      .........||+.|+|||++    .+..+ +.++|||||||++|+|++|..||..........   ..............
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~  237 (290)
T 3fme_A          162 DDVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQL---KQVVEEPSPQLPAD  237 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH---HHHHHSCCCCCCTT
T ss_pred             ccccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHH---HHHhccCCCCcccc
Confidence            55555556799999999997    33344 445999999999999999999998644332211   11222222222234


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .+++++.+||.+||+.+|.+|||++++++||||+..
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            679999999999999999999999999999999753

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.1e-51  Score=375.03  Aligned_cols=257  Identities=33%  Similarity=0.580  Sum_probs=210.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---------cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      .++|++.+.||+|+||.||+|++..+++.||||++....         .....+.+|+.+++.++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            468999999999999999999999999999999986532         12245789999999999999999999997765


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecCCcccC
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS  169 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~~~  169 (363)
                       +++||||+.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++..
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence             899999999999999998888999999999999999999999999999999999999997644 235999999999765


Q ss_pred             ccCCCCCccccCCCcCChhhhh---cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC--CC
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PD  244 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~  244 (363)
                      ..........||+.|+|||++.   ...++ .++|||||||++|+|++|..||............+..   .....  ..
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~  243 (322)
T 2ycf_A          168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYNFIPEV  243 (322)
T ss_dssp             CCCHHHHHHHSCCTTCCHHHHHHTTTTTCT-THHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---TCCCCCHHH
T ss_pred             ccccccccccCCcCccCchhhccCCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---CccccCchh
Confidence            3332223456999999999985   33444 4499999999999999999999865543333322221   11111  11


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +..+++++.+||.+||+.+|.+|||++++++||||..
T Consensus       244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            2457999999999999999999999999999999965

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.2e-50  Score=381.09  Aligned_cols=257  Identities=28%  Similarity=0.443  Sum_probs=209.0

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcC------CeEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAI   94 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~~~~l   94 (363)
                      .+|++.+.||+|+||+||+|++..+++.||||++.....   ...+|+.+++.++||||++++++|...      ..+++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            469999999999999999999999999999999876432   234799999999999999999998542      24789


Q ss_pred             EEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           95 VMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        95 v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      ||||+.+ +|...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++ +.+||+|||+++...
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECC
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC-CeEEeccchhhhhcc
Confidence            9999976 5655543    356799999999999999999999999999999999999998543 248999999998665


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------  237 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  237 (363)
                      .........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+....+.+..++.....             
T Consensus       209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~  288 (420)
T 1j1b_A          209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  288 (420)
T ss_dssp             TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred             cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            5555566789999999999977643344599999999999999999999987765555554432110             


Q ss_pred             cccCCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          238 VQYSIPD----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       238 ~~~~~~~----------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ..+.+|.          ...+++++.+||++||+.||.+|||+.|+++||||...
T Consensus       289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            0111111          12468999999999999999999999999999999764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.7e-50  Score=363.36  Aligned_cols=252  Identities=24%  Similarity=0.335  Sum_probs=207.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....   .....+.+|+..+..+ +||||+++++++.+.+.+++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            367999999999999999999999999999999987642   2345677889889888 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-----------------
Q 017936           96 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-----------------  154 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-----------------  154 (363)
                      |||+++++|.+++...    ..+++.+++.++.||+.||.|||++||+||||||+|||++.++                 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            9999999999999764    6799999999999999999999999999999999999997442                 


Q ss_pred             CCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017936          155 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR  234 (363)
Q Consensus       155 ~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  234 (363)
                      ...+||+|||++.....   .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+.....   ..    .
T Consensus       170 ~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~----~  239 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WH----E  239 (289)
T ss_dssp             CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HH----H
T ss_pred             ceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HH----H
Confidence            23599999999875433   23456999999999998764444559999999999999999988754321   11    1


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       235 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +..... ......+++++.+||.+||+.+|.+|||+.++++||||...
T Consensus       240 ~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          240 IRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            222211 12234679999999999999999999999999999999753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-50  Score=377.95  Aligned_cols=258  Identities=31%  Similarity=0.535  Sum_probs=214.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEc---CCCcEEEEEEeecCC-----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCC
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~-----~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~   90 (363)
                      .++|++.+.||+|+||+||++++.   .+++.||||++.+..     ...+.+.+|+.+++.+ .||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            368999999999999999999984   588999999986532     2345667899999999 6999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~  210 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecc
Confidence            99999999999999999998888999999999999999999999999999999999999986654  9999999997543


Q ss_pred             cC--CCCCccccCCCcCChhhhhcCC-CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          171 LH--SQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       171 ~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      ..  .......||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...............+......  ....
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~  288 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQE  288 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC--CCTT
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC--CCcc
Confidence            22  1223457999999999998633 22445999999999999999999997654433333333344333333  3346


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          248 ISPECRHLISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      ++..+.+||.+||+.+|.+||     |++++++||||..
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            799999999999999999999     9999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.5e-50  Score=377.94  Aligned_cols=258  Identities=25%  Similarity=0.430  Sum_probs=195.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC------C
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~   90 (363)
                      .++|++++.||+|+||.||+|.+..+|+.||||++....   .....+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            578999999999999999999999999999999986542   2345677999999999999999999999764      5


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .+|+|||++ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~  183 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTA  183 (367)
T ss_dssp             CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC--------
T ss_pred             eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccccccc
Confidence            689999999 7899888765 57999999999999999999999999999999999999986654  9999999997543


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------  238 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  238 (363)
                      .  ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+.......            
T Consensus       184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~  261 (367)
T 2fst_X          184 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  261 (367)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred             c--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            2  23456799999999999874333445999999999999999999998877655444433221100            


Q ss_pred             -------ccCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          239 -------QYSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       239 -------~~~~~------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                             ....+      .....++++.+||.+||+.||.+|||++++++||||....
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence                   00001      0134689999999999999999999999999999998653

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.4e-50  Score=380.64  Aligned_cols=257  Identities=26%  Similarity=0.410  Sum_probs=206.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC------eEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------~~~   93 (363)
                      ..+|++.+.||+|+||+||+|++..+++ +|+|.+......   ..+|+.+++.++||||+++++++....      .++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            4579999999999999999999987776 788877654322   237999999999999999999996543      388


Q ss_pred             EEEeccCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEe-CCCCCcEEEeecCCcccC
Q 017936           94 IVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        94 lv~e~~~~~~L~~~~---~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~-~~~~~~vkL~DFgla~~~  169 (363)
                      +||||++++.+....   .....+++..++.++.||+.||+|||++||+||||||+|||++ .++  .+||+|||+|+..
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~  192 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKIL  192 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEEC
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCcccc
Confidence            999999775433322   2356799999999999999999999999999999999999998 344  5999999999876


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc------------
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------  237 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------  237 (363)
                      ..........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......++.....            
T Consensus       193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  272 (394)
T 4e7w_A          193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN  272 (394)
T ss_dssp             CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred             cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence            55555667789999999999977653445599999999999999999999987766555554432110            


Q ss_pred             -cccCCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          238 -VQYSIPD----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       238 -~~~~~~~----------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                       .....+.          ...+++++.+||.+||+.+|.+|||+.|+++||||...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence             0011111          12478999999999999999999999999999999764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.2e-50  Score=377.47  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=208.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCC--CCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~--hpnIv~~~~~~~~~~~~~l   94 (363)
                      .++|++.+.||+|+||+||++.+.. ++.||||++.....   ..+.+.+|+.+++.++  ||||+++++++...+.+|+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            4569999999999999999999865 89999999976432   2356789999999997  5999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      ||| +.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.   +.+||+|||+|+...... 
T Consensus       134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~---~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS---SCEEECCCSSSCCC-----
T ss_pred             EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC---CeEEEEecCccccccCCCc
Confidence            999 568899999999889999999999999999999999999999999999999953   359999999998653322 


Q ss_pred             --CCCccccCCCcCChhhhhcC-----------CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc
Q 017936          174 --QPKSTVGTPAYIAPEVLLKK-----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY  240 (363)
Q Consensus       174 --~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (363)
                        .....+||+.|+|||++.+.           .++ .++|||||||++|+|++|..||.......   ..+..+.....
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~  285 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNH  285 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTS
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCC-ChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCccc
Confidence              22456799999999998752           343 44999999999999999999997654322   12233333333


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       241 ~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ..+.....+.++.+||.+||+.+|.+|||+.|+++||||...
T Consensus       286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            333344468899999999999999999999999999999754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.3e-51  Score=373.21  Aligned_cols=258  Identities=25%  Similarity=0.342  Sum_probs=209.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEcCC----
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPT----   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~----   90 (363)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++......    ...+.+|+.+++.++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            358899999999999999999999999999999999764322    246788999999999999999999987653    


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      ..|+||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~  167 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC----
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCccccc
Confidence            35999999999999999998889999999999999999999999999999999999999987665  9999999997543


Q ss_pred             cCC----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       171 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                      ...    ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||................  .........
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~  244 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED--PIPPSARHE  244 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCHHHHST
T ss_pred             ccccccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--CCCcccccC
Confidence            322    2233568999999999988877655 999999999999999999998766544333222110  011111234


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .+++++.+||.+||+.+|.+||+..+++.|+|+..
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            57999999999999999999999999999999964

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=367.44  Aligned_cols=257  Identities=26%  Similarity=0.421  Sum_probs=210.9

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEc------CC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------PT   90 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~------~~   90 (363)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++.......+.+.+|+.+++.+ +||||+++++++..      .+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            346899999999999999999999999999999999987766778899999999998 79999999999987      46


Q ss_pred             eEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           91 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      .+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~  178 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQ  178 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC-
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCcee
Confidence            899999999999999999864  46999999999999999999999999999999999999976654  99999999875


Q ss_pred             CccC-CCCCccccCCCcCChhhhh-----cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC
Q 017936          169 SVLH-SQPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI  242 (363)
Q Consensus       169 ~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (363)
                      .... .......||+.|+|||++.     +..++.+ +|||||||++|+|++|..||..........    .+.......
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~  253 (326)
T 2x7f_A          179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALF----LIPRNPAPR  253 (326)
T ss_dssp             ------------CCGGGCCHHHHC--------CCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCC
T ss_pred             cCcCccccccccCCccccChhhhccccccCcCCCcc-chHHHHHHHHHHHHhCCCCCCCCcHHHHHH----HhhcCcccc
Confidence            4322 2234457999999999986     3445544 999999999999999999998765433322    222222222


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          243 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       243 ~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .....++..+.+||.+||+.+|.+|||++++++||||..
T Consensus       254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~  292 (326)
T 2x7f_A          254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD  292 (326)
T ss_dssp             CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred             CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence            233467999999999999999999999999999999965

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.6e-50  Score=368.78  Aligned_cols=268  Identities=29%  Similarity=0.433  Sum_probs=194.4

Q ss_pred             CCCCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      .+|.....++|++.+.||+|+||.||++.+..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++...+
T Consensus         7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A            7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred             ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence            3455566789999999999999999999999999999999886542  33456788999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEee
Q 017936           91 HLAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD  162 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~--------~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~D  162 (363)
                      ..++||||+++++|.+++..        ...+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~d  164 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIAD  164 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEe
Confidence            99999999999999999864        456999999999999999999999999999999999999976654  99999


Q ss_pred             cCCcccCccCC------CCCccccCCCcCChhhhhc-CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH
Q 017936          163 FGYSKSSVLHS------QPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI  235 (363)
Q Consensus       163 Fgla~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  235 (363)
                      ||++.......      ......||+.|+|||++.+ ..++ .++|||||||++|+|++|..||................
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  243 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND  243 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCC-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCC-chhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence            99986443221      1234569999999999876 3454 44999999999999999999998766544333222111


Q ss_pred             hccc----cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          236 LSVQ----YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       236 ~~~~----~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      ....    ........+++++.+||.+||+.+|.+|||+.++++||||....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            0000    01112345789999999999999999999999999999997643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2e-49  Score=371.12  Aligned_cols=260  Identities=24%  Similarity=0.361  Sum_probs=202.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc------------cHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRFKEVIL   87 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~e~~~l~~l~hpnIv~~~~~~~   87 (363)
                      .++|++.+.||+|+||.||++.+.. ++.||||++......            .+.+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            5789999999999999999999865 899999998643211            267889999999999999999999985


Q ss_pred             c-----CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEe
Q 017936           88 T-----PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC  161 (363)
Q Consensus        88 ~-----~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~  161 (363)
                      .     ...+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~  176 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITIC  176 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEEC
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEE
Confidence            3     347899999997 5787777654 36999999999999999999999999999999999999976654  9999


Q ss_pred             ecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc---
Q 017936          162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---  238 (363)
Q Consensus       162 DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---  238 (363)
                      |||+++............||+.|+|||++.+....+.++|||||||++|+|++|..||.+.................   
T Consensus       177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (362)
T 3pg1_A          177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE  256 (362)
T ss_dssp             CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence            99999865555555667899999999999874434455999999999999999999998876555444433221100   


Q ss_pred             -----------------ccCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          239 -----------------QYSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       239 -----------------~~~~~------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                                       ....+      ....+++.+.+||.+||+.+|.+|||++|+++||||....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence                             00000      1234688999999999999999999999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-49  Score=361.33  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=212.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|+||.||++.+..+|+.||+|++.... ..+.+.+|+.+++.++||||+++++++...+.+++||||+
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            578999999999999999999999999999999987653 3567889999999999999999999999999999999999


Q ss_pred             CCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCc
Q 017936          100 SGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS  177 (363)
Q Consensus       100 ~~~~L~~~~~-~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~  177 (363)
                      ++++|.+++. ....+++.+++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++...... .....
T Consensus       107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~  184 (314)
T 3com_A          107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNT  184 (314)
T ss_dssp             TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBCC
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccCc
Confidence            9999999987 4567999999999999999999999999999999999999976654  999999999754332 22344


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++|..||............   .............++..+.+||.
T Consensus       185 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~  260 (314)
T 3com_A          185 VIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTNPPPTFRKPELWSDNFTDFVK  260 (314)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCSSGGGSCHHHHHHHH
T ss_pred             cCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcCCCcccCCcccCCHHHHHHHH
Confidence            578999999999988877666 99999999999999999999876543322211   11112222333457899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccc
Q 017936          258 RIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +||+.+|.+|||+.++++||||...
T Consensus       261 ~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          261 QCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HHccCChhhCcCHHHHHhCHHHhcC
Confidence            9999999999999999999999764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1e-49  Score=368.76  Aligned_cols=257  Identities=31%  Similarity=0.408  Sum_probs=211.9

Q ss_pred             CCCceeeceecccCCeEEEEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCC------CeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hp------nIv~~~~~~~~~~~~   92 (363)
                      .++|++.+.||+|+||+||+|.+ ..+++.||+|++.......+.+.+|+.+++.++|+      +|+++++++...+.+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            57899999999999999999998 56889999999987655567788899999888655      599999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC----------------
Q 017936           93 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP----------------  154 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~----------------  154 (363)
                      ++||||+ +++|.+++...+  ++++.+++.++.||+.||+|||++||+||||||+|||++..+                
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~  171 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL  171 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence            9999999 889999998765  689999999999999999999999999999999999997643                


Q ss_pred             -CCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 017936          155 -APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH  233 (363)
Q Consensus       155 -~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  233 (363)
                       .+.+||+|||+++...  .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+........ .
T Consensus       172 ~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~-~  247 (339)
T 1z57_A          172 INPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM-E  247 (339)
T ss_dssp             SCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH-H
T ss_pred             cCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH-H
Confidence             4469999999987533  23345679999999999988887666 99999999999999999999876654433222 1


Q ss_pred             HHhcccc---------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017936          234 RILSVQY---------------------------------------SIPDYVHISPECRHLISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       234 ~~~~~~~---------------------------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell  274 (363)
                      .......                                       ........++++.+||.+||+.||.+|||++|++
T Consensus       248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell  327 (339)
T 1z57_A          248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL  327 (339)
T ss_dssp             HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence            1111000                                       0000112356789999999999999999999999


Q ss_pred             cCccccc
Q 017936          275 NHEWFLK  281 (363)
Q Consensus       275 ~h~~~~~  281 (363)
                      +||||+.
T Consensus       328 ~hp~f~~  334 (339)
T 1z57_A          328 KHPFFDL  334 (339)
T ss_dssp             TSGGGGG
T ss_pred             cCHHHHH
Confidence            9999975

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.6e-49  Score=361.26  Aligned_cols=257  Identities=27%  Similarity=0.447  Sum_probs=217.8

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ....++|++.+.||+|+||.||++++..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.....+++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   97 (303)
T 3a7i_A           18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   97 (303)
T ss_dssp             ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            344678999999999999999999999999999999987643  334678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      ||||+++++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++....... 
T Consensus        98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECBTTBC
T ss_pred             EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccceecCcccc
Confidence            9999999999998865 57999999999999999999999999999999999999976654  9999999997543322 


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........    +.... .......++..+.
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~  248 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFL----IPKNN-PPTLEGNYSKPLK  248 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSC-CCCCCSSCCHHHH
T ss_pred             ccCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHHH----hhcCC-CCCCccccCHHHH
Confidence            2344578999999999988877665 9999999999999999999987554332221    11111 1122346799999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          254 HLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +||.+||+.+|.+|||+.++++||||...
T Consensus       249 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          249 EFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence            99999999999999999999999999764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-49  Score=364.00  Aligned_cols=255  Identities=28%  Similarity=0.422  Sum_probs=204.0

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ...++|++.+.||+|+||+||++++  +++.||+|++......   .+.+.+|+.+++.++||||+++++++...+.+++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            3467899999999999999999986  5788999998765432   3467889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           95 VMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qil~~L~~LH~~g--iiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      ||||+++++|.+++...+.   +++..++.++.||+.||+|||++|  |+||||||+|||++.++.  +||+|||+++..
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~  189 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLK  189 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC-----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCccc
Confidence            9999999999999987654   999999999999999999999999  999999999999976654  999999999754


Q ss_pred             ccCC-CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          170 VLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                      .... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........    .+.......+....+
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~  264 (309)
T 3p86_A          190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVA----AVGFKCKRLEIPRNL  264 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----HHHHSCCCCCCCTTS
T ss_pred             cccccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcCCCCCCCccC
Confidence            3222 2345679999999999988887666 999999999999999999998765533222    222222233444568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc--Cccccc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRN--HEWFLK  281 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~--h~~~~~  281 (363)
                      ++++.+||.+||+.+|.+|||++++++  ++++..
T Consensus       265 ~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            999999999999999999999999987  444433

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.4e-49  Score=369.12  Aligned_cols=256  Identities=26%  Similarity=0.413  Sum_probs=206.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE----
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL----   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~----   92 (363)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++.....   ....+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4789999999999999999999999999999999876432   245678999999999999999999999887654    


Q ss_pred             --EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           93 --AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        93 --~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                        ++||||+. ++|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~  195 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD  195 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC----
T ss_pred             eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccc
Confidence              99999997 58877663  34999999999999999999999999999999999999986654  9999999997543


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------  238 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  238 (363)
                      .  ......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.................            
T Consensus       196 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  273 (371)
T 4exu_A          196 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  273 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred             c--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence            2  23456789999999999873333444999999999999999999998876555444433211000            


Q ss_pred             -------ccCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          239 -------QYSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       239 -------~~~~~------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                             ....+      .+..+++++.+||.+||+.+|.+|||++|+++||||...
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence                   00000      123568999999999999999999999999999999764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.8e-51  Score=383.36  Aligned_cols=245  Identities=13%  Similarity=0.110  Sum_probs=198.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHH---HHHHcCCCCCeeeee-------EE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREI---INHRSLRHPNIVRFK-------EV   85 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~---~~l~~l~hpnIv~~~-------~~   85 (363)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...    ....+.+.+|+   ..++.++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            57899999999999999999999999999999999753    22346788999   555666899999998       77


Q ss_pred             EEcCCe-----------------EEEEEeccCCCchHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHcCceec
Q 017936           86 ILTPTH-----------------LAIVMEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHSMQVCHR  141 (363)
Q Consensus        86 ~~~~~~-----------------~~lv~e~~~~~~L~~~~~~~~~l~~-------~~~~~~~~qil~~L~~LH~~giiHr  141 (363)
                      +...+.                 .|+||||+ +|+|.+++...+.+++       ..++.++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            776543                 89999999 6799999987655655       7888899999999999999999999


Q ss_pred             CCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcC-----------CCCCcchhhhhHHHHHH
Q 017936          142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-----------EYDGKIADVWSCGVTLY  210 (363)
Q Consensus       142 Dlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwslG~il~  210 (363)
                      ||||+|||++.++  .+||+|||+|+....  ......| +.|+|||++.+.           .++.+ +|||||||++|
T Consensus       231 Dikp~NIll~~~~--~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DvwSlG~il~  304 (377)
T 3byv_A          231 YLRPVDIVLDQRG--GVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS-FDAWALGLVIY  304 (377)
T ss_dssp             CCCGGGEEECTTC--CEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH-HHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC--CEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChh-hhHHHHHHHHH
Confidence            9999999998665  499999999985322  2234567 999999999887           66544 99999999999


Q ss_pred             HHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          211 VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       211 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      +|++|..||........          ..........+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       305 elltg~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          305 WIWCADLPITKDAALGG----------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHSSCCC------CC----------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHCCCCCcccccccc----------hhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            99999999976433211          11112233568999999999999999999999999999999965

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2e-49  Score=361.65  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=209.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ..++|++++.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3578999999999999999999999999999999987543 344678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCC
Q 017936           98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~  175 (363)
                      |+++++|..++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||++..... ....
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC-
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCcccccccccc
Confidence            9999999998875 467999999999999999999999999999999999999976654  99999998753211 1122


Q ss_pred             CccccCCCcCChhhhh-----cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          176 KSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                      ....||+.|+|||++.     +..++. ++|||||||++|+|++|..||..............   ...........++.
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  250 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SDPPTLLTPSKWSV  250 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSSGGGSCH
T ss_pred             ccccCChhhcCCeeeccccCCCCCCch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc---cCCcccCCccccCH
Confidence            3457899999999984     344544 49999999999999999999987665433322221   11112223345789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .+.+||.+||+.+|.+|||++++++||||..
T Consensus       251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  281 (302)
T 2j7t_A          251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSS  281 (302)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence            9999999999999999999999999999965

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.2e-49  Score=373.74  Aligned_cols=259  Identities=29%  Similarity=0.379  Sum_probs=211.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CC-----CeeeeeEEEEcCCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HP-----NIVRFKEVILTPTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hp-----nIv~~~~~~~~~~~~~   93 (363)
                      .++|++.+.||+|+||+||+|++..+++.||||++.........+.+|+.+++.++ |+     +|+++++++...+.++
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            57899999999999999999999999999999999876555566778888888775 44     4999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           94 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH--~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      +||||++ ++|.+++...  ..+++..++.++.||+.||.|||  +.||+||||||+|||++.+..+.+||+|||+|+..
T Consensus       133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            9999996 5999998765  45999999999999999999999  57999999999999997655566999999999764


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc----------
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------  239 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  239 (363)
                      .  .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.........+........          
T Consensus       212 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  288 (382)
T 2vx3_A          212 G--QRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA  288 (382)
T ss_dssp             T--CCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred             c--cccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence            3  23345689999999999998887665 9999999999999999999998776555544443211000          


Q ss_pred             -----------c------------CCCCCCC-------------------------CCHHHHHHHHHhcccCCCCCCCHH
Q 017936          240 -----------Y------------SIPDYVH-------------------------ISPECRHLISRIFVADPAKRISIP  271 (363)
Q Consensus       240 -----------~------------~~~~~~~-------------------------~s~~~~~li~~~L~~~p~~R~t~~  271 (363)
                                 +            ..+....                         .++++.+||++||+.||.+|||++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~  368 (382)
T 2vx3_A          289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY  368 (382)
T ss_dssp             HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence                       0            0000000                         013789999999999999999999


Q ss_pred             HHhcCcccccc
Q 017936          272 EIRNHEWFLKN  282 (363)
Q Consensus       272 ell~h~~~~~~  282 (363)
                      |+|+||||++.
T Consensus       369 e~L~hp~f~~~  379 (382)
T 2vx3_A          369 YALQHSFFKKT  379 (382)
T ss_dssp             HHTTSGGGCC-
T ss_pred             HHhcCcccccC
Confidence            99999999764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=9.8e-49  Score=360.92  Aligned_cols=260  Identities=28%  Similarity=0.401  Sum_probs=212.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHcC---CCCCeeeeeEEEE----
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVIL----   87 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l---~hpnIv~~~~~~~----   87 (363)
                      ..++|++.+.||+|+||.||+|++. .+++.||+|++....   .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3478999999999999999999995 678899999986532   2234566777776655   8999999999987    


Q ss_pred             -cCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecC
Q 017936           88 -TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG  164 (363)
Q Consensus        88 -~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFg  164 (363)
                       ....+++||||+. ++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg  165 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFG  165 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCc
Confidence             5577999999997 59999988754  4999999999999999999999999999999999999976654  9999999


Q ss_pred             CcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc-cCC-
Q 017936          165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSI-  242 (363)
Q Consensus       165 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~-  242 (363)
                      +++............||+.|+|||++.+..++.+ +|||||||++|+|++|..||.................... ... 
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          166 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             ccccccCCCCccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            9986544444455679999999999988877665 9999999999999999999988776555544443221100 000 


Q ss_pred             -------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          243 -------------------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       243 -------------------~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                         .....+++.+.+||.+||+.+|.+|||+.++++||||...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence                               0124578999999999999999999999999999999753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.8e-50  Score=378.72  Aligned_cols=256  Identities=25%  Similarity=0.404  Sum_probs=206.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC--------CCCeeeeeEEEE----
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVIL----   87 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~--------hpnIv~~~~~~~----   87 (363)
                      .++|++.+.||+|+||+||+|++..+++.||||++.......+.+.+|+.+++.++        ||||+++++++.    
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            57899999999999999999999999999999999876656677889999998885        788999999998    


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCCEEEeCCC----------
Q 017936           88 TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP----------  154 (363)
Q Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~-giiHrDlkp~NIll~~~~----------  154 (363)
                      ....+++||||+ +++|.+.+...  ..+++.+++.++.||+.||.|||++ ||+||||||+|||++.++          
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence            566899999999 55666666544  4699999999999999999999998 999999999999997553          


Q ss_pred             -------------------------------------CCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCC
Q 017936          155 -------------------------------------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG  197 (363)
Q Consensus       155 -------------------------------------~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  197 (363)
                                                           ...+||+|||+|+....  ......||+.|+|||++.+..++.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  272 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNT  272 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCc
Confidence                                                 12599999999975432  234567999999999999888776


Q ss_pred             cchhhhhHHHHHHHHHhCCCCCCCCCch------HHHHHHHHHHhcc---------ccC---------------------
Q 017936          198 KIADVWSCGVTLYVMLVGAYPFEDPEEP------KNFRKTIHRILSV---------QYS---------------------  241 (363)
Q Consensus       198 ~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~---------~~~---------------------  241 (363)
                      + +|||||||++|+|++|..||...+..      ....... .....         .+.                     
T Consensus       273 ~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (397)
T 1wak_A          273 P-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII-ELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL  350 (397)
T ss_dssp             H-HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHH-HHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred             H-HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHH-HhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence            5 99999999999999999999765421      1111111 11100         000                     


Q ss_pred             -------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017936          242 -------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       242 -------~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                             .......+..+.+||.+||+.||.+|||++|+++||||.
T Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                   000112346789999999999999999999999999995

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1e-49  Score=370.86  Aligned_cols=254  Identities=23%  Similarity=0.414  Sum_probs=214.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----c--------------HHHHHHHHHHHcCCCCCeee
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----D--------------ENVQREIINHRSLRHPNIVR   81 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~--------------~~~~~e~~~l~~l~hpnIv~   81 (363)
                      .++|++.+.||+|+||.||+|++  +++.||+|++......    .              +.+.+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            47899999999999999999998  8999999998753211    1              78899999999999999999


Q ss_pred             eeEEEEcCCeEEEEEeccCCCchHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeC
Q 017936           82 FKEVILTPTHLAIVMEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDG  152 (363)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~--~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~  152 (363)
                      +++++.+.+.+++||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence            99999999999999999999999998      665  5679999999999999999999999 99999999999999976


Q ss_pred             CCCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 017936          153 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT  231 (363)
Q Consensus       153 ~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  231 (363)
                      ++.  +||+|||++...... ......||+.|+|||++.+. .++..++|||||||++|+|++|..||........   .
T Consensus       188 ~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~  261 (348)
T 2pml_X          188 NGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE---L  261 (348)
T ss_dssp             TSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH---H
T ss_pred             CCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---H
Confidence            654  999999999754332 33456799999999999877 4545359999999999999999999987665322   2


Q ss_pred             HHHHhccccCCCCC-----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          232 IHRILSVQYSIPDY-----------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       232 ~~~~~~~~~~~~~~-----------------~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ...+.......|..                 ..+++++.+||.+||+.+|.+|||++++++||||..
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            22333333333321                 467999999999999999999999999999999965

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-48  Score=364.35  Aligned_cols=261  Identities=29%  Similarity=0.424  Sum_probs=210.3

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC-----C
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----T   90 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~   90 (363)
                      ...++|++.+.||+|+||.||++++..+|+.||||++.....  ....+.+|+.+++.++||||+++++++...     .
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            346889999999999999999999999999999999865332  235677999999999999999999988754     6


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      ..++||||+. ++|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIID  163 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEecccccccc
Confidence            7999999996 589888876 57999999999999999999999999999999999999976654  9999999997543


Q ss_pred             cCC-----------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc
Q 017936          171 LHS-----------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ  239 (363)
Q Consensus       171 ~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (363)
                      ...           ......||+.|+|||++.+....+.++|||||||++|+|++|..||.+..................
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            221           112346899999999987644445559999999999999999999987665443332221110000


Q ss_pred             --------------------cCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          240 --------------------YSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       240 --------------------~~~~------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                          ...+      .+..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                                0000      123578999999999999999999999999999999764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-49  Score=362.47  Aligned_cols=265  Identities=28%  Similarity=0.391  Sum_probs=207.2

Q ss_pred             CCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEE------
Q 017936           15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVIL------   87 (363)
Q Consensus        15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~------   87 (363)
                      +.....++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.      
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (320)
T 2i6l_A            5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL   84 (320)
T ss_dssp             -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred             ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence            34445689999999999999999999999999999999987643 23466789999999999999999999874      


Q ss_pred             --------cCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEE
Q 017936           88 --------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK  159 (363)
Q Consensus        88 --------~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vk  159 (363)
                              ..+.+++||||+. ++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++ +.+|
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~k  161 (320)
T 2i6l_A           85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLK  161 (320)
T ss_dssp             CC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEE
T ss_pred             ccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEE
Confidence                    3468899999997 599888864 5799999999999999999999999999999999999997433 3599


Q ss_pred             EeecCCcccCccC----CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH
Q 017936          160 ICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI  235 (363)
Q Consensus       160 L~DFgla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  235 (363)
                      |+|||+++.....    .......+|+.|+|||++.+....+.++|||||||++|+|++|..||................
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999854322    223345679999999998764444555999999999999999999998876544443332211


Q ss_pred             hc------------------cccCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          236 LS------------------VQYSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       236 ~~------------------~~~~~~------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ..                  .....+      ....+++++.+||.+||+.+|.+|||++++++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            00                  000000      123579999999999999999999999999999999753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.9e-49  Score=374.87  Aligned_cols=259  Identities=27%  Similarity=0.431  Sum_probs=191.9

Q ss_pred             CCcee-eceecccCCeEEEEEEEc--CCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCeEEEE
Q 017936           21 DRYEL-VRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIV   95 (363)
Q Consensus        21 ~~y~i-~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~lv   95 (363)
                      +.|.+ .++||+|+||+||+|+++  .+++.||||++.... ....+.+|+.+++.++||||+++++++..  ...+++|
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            45777 458999999999999966  578899999987543 34678899999999999999999999954  6789999


Q ss_pred             EeccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC--CCCCcEEEeecC
Q 017936           96 MEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFG  164 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~---------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~--~~~~~vkL~DFg  164 (363)
                      |||+. ++|.+.+...         ..+++..++.++.||+.||.|||++||+||||||+|||+..  +..+.+||+|||
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            99996 4787777522         24999999999999999999999999999999999999943  223469999999


Q ss_pred             CcccCccC----CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch---------HHHHHH
Q 017936          165 YSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKT  231 (363)
Q Consensus       165 la~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~~  231 (363)
                      +|+.....    ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+....         ..+..+
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i  257 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  257 (405)
T ss_dssp             CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred             CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence            99754322    22344679999999999987654456699999999999999999999765431         222222


Q ss_pred             HHHHhccccC--------C-------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017936          232 IHRILSVQYS--------I-------------------------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW  278 (363)
Q Consensus       232 ~~~~~~~~~~--------~-------------------------~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~  278 (363)
                      .... .....        .                         ......++.+.+||++||+.||.+|||++|+|+|||
T Consensus       258 ~~~~-g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~  336 (405)
T 3rgf_A          258 FNVM-GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  336 (405)
T ss_dssp             HHHH-CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHhh-CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence            2111 10000        0                         001123778999999999999999999999999999


Q ss_pred             cccc
Q 017936          279 FLKN  282 (363)
Q Consensus       279 ~~~~  282 (363)
                      |...
T Consensus       337 f~~~  340 (405)
T 3rgf_A          337 FLED  340 (405)
T ss_dssp             GTSS
T ss_pred             hccC
Confidence            9764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.4e-49  Score=368.77  Aligned_cols=259  Identities=31%  Similarity=0.502  Sum_probs=186.9

Q ss_pred             CCCCceeec-eecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEc----CCeEE
Q 017936           19 DSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----PTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----~~~~~   93 (363)
                      ..++|.+.+ .||+|+||+||+|++..+++.||||++.....   ...+....++.++||||+++++++..    ...++
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            357899965 69999999999999999999999999876432   22233344677899999999999976    45689


Q ss_pred             EEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecCCcccCc
Q 017936           94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV  170 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~~~~  170 (363)
                      +||||++|++|.+++...+  .+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+.+||+|||+++...
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~  182 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT  182 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence            9999999999999998764  699999999999999999999999999999999999997543 3469999999997543


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc--ccCCCCCCCC
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYVHI  248 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  248 (363)
                      . .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||...............+...  ....+.+..+
T Consensus       183 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (336)
T 3fhr_A          183 Q-NALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV  260 (336)
T ss_dssp             ----------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTC
T ss_pred             c-cccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccC
Confidence            2 23345678999999999977776555 999999999999999999997655432221112222222  2233445678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ++++.+||.+||+.+|.+|||++++++||||.+.
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            9999999999999999999999999999999764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.7e-49  Score=358.69  Aligned_cols=256  Identities=33%  Similarity=0.538  Sum_probs=209.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC-----CcccHHHHHHHHHHHcCCCCCeeeeeEEEE--cCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~--~~~~~   92 (363)
                      .++|++.+.||+|+||.||++.+..+++.||+|++...     ....+.+.+|+.+++.++||||+++++++.  ..+.+
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            36899999999999999999999999999999998753     233467889999999999999999999984  44679


Q ss_pred             EEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           93 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      ++||||+.++ |.+.+..  ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~  160 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALH  160 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccC
Confidence            9999999876 7676665  356999999999999999999999999999999999999986654  9999999997543


Q ss_pred             cCC---CCCccccCCCcCChhhhhcCCC-CCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          171 LHS---QPKSTVGTPAYIAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       171 ~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                      ...   ......||+.|+|||++.+... .+.++|||||||++|+|++|..||.........    ..+.......  ..
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~i~~~~~~~--~~  234 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF----ENIGKGSYAI--PG  234 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHCCCCC--CS
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH----HHHhcCCCCC--CC
Confidence            221   1234568999999999876433 244599999999999999999999875543322    2233333333  34


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP  284 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~~  284 (363)
                      .+++.+.+||.+||+.+|.+|||++++++||||.+..+
T Consensus       235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            57999999999999999999999999999999987543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.2e-49  Score=352.74  Aligned_cols=250  Identities=24%  Similarity=0.412  Sum_probs=211.9

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ...++|++.+.||+|+||.||++.+. +++.||+|++.......+.+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            34578999999999999999999986 46779999998877677889999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC--CC
Q 017936           98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQ  174 (363)
Q Consensus        98 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~--~~  174 (363)
                      |+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++.....  ..
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHS
T ss_pred             eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEecccccccccccccccc
Confidence            99999999999654 45999999999999999999999999999999999999976654  999999998743221  12


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      .....+|+.|+|||++.+..++.+ +||||||+++|+|++ |..||...........    +.. .........+++.+.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~  237 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----IST-GFRLYKPRLASTHVY  237 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHT-TCCCCCCTTSCHHHH
T ss_pred             ccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----Hhc-CccCCCCCcCCHHHH
Confidence            234457788999999988887655 999999999999999 9999987655433322    222 223333445799999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 017936          254 HLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ++|.+||+.+|.+|||+.++++|
T Consensus       238 ~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          238 QIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCcccCcCHHHHHHH
Confidence            99999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.7e-49  Score=358.73  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=202.7

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEc------------
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT------------   88 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~------------   88 (363)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.......+.+.+|+.+++.++||||+++++++..            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            57999999999999999999999999999999997665556778899999999999999999998865            


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCc
Q 017936           89 -PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  166 (363)
Q Consensus        89 -~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla  166 (363)
                       .+.+++||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~  163 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLA  163 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcch
Confidence             356899999999999999998654 5889999999999999999999999999999999999976654  999999998


Q ss_pred             ccCccC---------------CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 017936          167 KSSVLH---------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT  231 (363)
Q Consensus       167 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  231 (363)
                      ......               .......||+.|+|||++.+....+.++|||||||++|+|++   ||.....   ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---~~~~  237 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---RVNI  237 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HHHH
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---HHHH
Confidence            754321               122345699999999999865433455999999999999998   6643222   1222


Q ss_pred             HHHHhccccCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          232 IHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       232 ~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ...+.......|  .....++.+.++|.+||+.||.+|||++++++||||..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            333333333222  23456788999999999999999999999999999965

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.9e-48  Score=361.30  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=206.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe-----
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH-----   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~-----   91 (363)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++.....   ....+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            4789999999999999999999999999999999876432   23567889999999999999999999987654     


Q ss_pred             -EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           92 -LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        92 -~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                       +|+||||+. ++|.+.+.  ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~  177 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD  177 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC--
T ss_pred             eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCC
Confidence             599999996 58877764  35999999999999999999999999999999999999986654  9999999987543


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------  237 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  237 (363)
                      .  ......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+......             
T Consensus       178 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  255 (353)
T 3coi_A          178 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  255 (353)
T ss_dssp             --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred             C--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence            2  2344578999999999987433344599999999999999999999887654444333321100             


Q ss_pred             ---------c--ccC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          238 ---------V--QYS-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       238 ---------~--~~~-~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                               .  ... ......+++++.+||.+||+.||.+|||++++++||||....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                     0  000 011235789999999999999999999999999999997643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.5e-49  Score=369.25  Aligned_cols=261  Identities=25%  Similarity=0.370  Sum_probs=208.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-----------CCCeeeeeEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVIL   87 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-----------hpnIv~~~~~~~   87 (363)
                      ..++|++.+.||+|+||+||+|++..+++.||||++.......+.+.+|+.+++.++           ||||+++++++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            467999999999999999999999999999999999876555677888999988776           899999999998


Q ss_pred             cCC----eEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCCEEEeCCC----CC
Q 017936           88 TPT----HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP----AP  156 (363)
Q Consensus        88 ~~~----~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~-giiHrDlkp~NIll~~~~----~~  156 (363)
                      ..+    .+++||||+ +++|.+++...  ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++    .+
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence            654    789999999 89999999764  4599999999999999999999998 999999999999996432    23


Q ss_pred             cEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch------HHHHH
Q 017936          157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP------KNFRK  230 (363)
Q Consensus       157 ~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~  230 (363)
                      .+||+|||+++....  ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||......      .....
T Consensus       176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  252 (373)
T 1q8y_A          176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  252 (373)
T ss_dssp             EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence            699999999975432  2345579999999999998887655 99999999999999999999764421      11111


Q ss_pred             HHHHHhccc------------------------------------cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017936          231 TIHRILSVQ------------------------------------YSIPDYVHISPECRHLISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       231 ~~~~~~~~~------------------------------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell  274 (363)
                      .........                                    ........+++++.+||.+||+.||.+|||++|++
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  332 (373)
T 1q8y_A          253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  332 (373)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence            111100000                                    00001112457899999999999999999999999


Q ss_pred             cCccccccC
Q 017936          275 NHEWFLKNL  283 (363)
Q Consensus       275 ~h~~~~~~~  283 (363)
                      +||||++..
T Consensus       333 ~hp~f~~~~  341 (373)
T 1q8y_A          333 NHPWLKDTL  341 (373)
T ss_dssp             TCGGGTTCT
T ss_pred             hChhhhccc
Confidence            999998754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.3e-49  Score=360.86  Aligned_cols=260  Identities=23%  Similarity=0.357  Sum_probs=194.6

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEEcCCCc---EEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      ....++|++.+.||+|+||+||+|++..++.   .||+|++...   ....+.+.+|+.+++.++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3456789999999999999999999887765   7999998764   233467889999999999999999999998876


Q ss_pred             eE------EEEEeccCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcE
Q 017936           91 HL------AIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL  158 (363)
Q Consensus        91 ~~------~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~v  158 (363)
                      ..      ++||||+.+++|.+++....      .+++.+++.++.||+.||.|||++||+||||||+|||++.++  .+
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~--~~  176 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM--TV  176 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--CE
Confidence            55      99999999999999986432      599999999999999999999999999999999999998665  49


Q ss_pred             EEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHH
Q 017936          159 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR  234 (363)
Q Consensus       159 kL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  234 (363)
                      ||+|||+|+.......   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.............  
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~--  253 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI--  253 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH--
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCCCccccChHHHHHHHh--
Confidence            9999999975433221   223456788999999988877655 999999999999999 999998876654433322  


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCccccccCC
Q 017936          235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-------IPEIRNHEWFLKNLP  284 (363)
Q Consensus       235 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t-------~~ell~h~~~~~~~~  284 (363)
                        . ....+....+++++.+||.+||+.+|.+|||       +++++.|||+....+
T Consensus       254 --~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          254 --G-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             --T-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             --c-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence              1 1223344568999999999999999999999       888999999976533

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.1e-50  Score=378.09  Aligned_cols=255  Identities=16%  Similarity=0.173  Sum_probs=190.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHH---HHHHHcCCCCCeeeee-------EE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQRE---IINHRSLRHPNIVRFK-------EV   85 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e---~~~l~~l~hpnIv~~~-------~~   85 (363)
                      ..+|++.+.||+|+||+||+|++..+++.||||++.....    ..+.+.+|   +..++. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            3459999999999999999999999999999999987542    23456677   455555 799987755       55


Q ss_pred             EEcC-----------------CeEEEEEeccCCCchHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHHcCceec
Q 017936           86 ILTP-----------------THLAIVMEYASGGELFERICNAG-RFSEDEA------RFFFQQLISGVSYCHSMQVCHR  141 (363)
Q Consensus        86 ~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~------~~~~~qil~~L~~LH~~giiHr  141 (363)
                      +...                 ..+|+|||||+ ++|.+++...+ .+++...      ..++.||+.||+|||++||+||
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr  218 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG  218 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence            5433                 34899999998 89999997643 3444444      5677999999999999999999


Q ss_pred             CCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhc--CCCCCcchhhhhHHHHHHHHHhCCCCC
Q 017936          142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPF  219 (363)
Q Consensus       142 Dlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf  219 (363)
                      ||||+|||++.++.  +||+|||+|+....  ......+|+.|+|||++.+  ..++.+ +|||||||++|+|++|..||
T Consensus       219 Dikp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~-~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          219 HFTPDNLFIMPDGR--LMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHA-LNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             TCSGGGEEECTTSC--EEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHH-HHHHHHHHHHHHHHHSSCST
T ss_pred             cCCHHHEEECCCCC--EEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCcc-ccHHHHHHHHHHHHhCCCCC
Confidence            99999999986654  99999999985432  1124567799999999976  556544 99999999999999999999


Q ss_pred             CCCCchHHH--HH-HHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          220 EDPEEPKNF--RK-TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       220 ~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .........  .. ............+.+..+++.+.+||.+||+.+|++|||+.++++||||.+
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            875321100  00 000011123344555678999999999999999999999999999999965

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.2e-49  Score=360.07  Aligned_cols=246  Identities=27%  Similarity=0.413  Sum_probs=207.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC-CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ..++|++.+.||+|+||+||++.+..+++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            467899999999999999999999999999999988653 3345678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC-
Q 017936           98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~-  175 (363)
                      |+++++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++........ 
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC------
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccccc
Confidence            9999999999987 567999999999999999999999999999999999999986655  999999999754322211 


Q ss_pred             --------------CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH-----HHHHHHHHHh
Q 017936          176 --------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----NFRKTIHRIL  236 (363)
Q Consensus       176 --------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~  236 (363)
                                    ....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......     ........  
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--  242 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR--  242 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence                          14579999999999988887666 999999999999999999987533211     11111111  


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       237 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                            .....+++.+.++|.+||+.+|.+|||++++++
T Consensus       243 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          243 ------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             ------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                  112357889999999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.6e-48  Score=352.00  Aligned_cols=259  Identities=29%  Similarity=0.436  Sum_probs=209.2

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ..++|.....||+|+||.||++++..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus        20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            4455666679999999999999999999999999987643 345678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-C
Q 017936           98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S  173 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~  173 (363)
                      |+++++|.+++....   .+++..++.++.||+.||.|||++||+||||||+||+++.. .+.+||+|||++...... .
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-TCCEEECCTTTCEESCC---
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC-CCCEEEeecccccccCCCCC
Confidence            999999999997652   46799999999999999999999999999999999999862 235999999998754332 2


Q ss_pred             CCCccccCCCcCChhhhhcCC--CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      ......||+.|+|||++.+..  ++ .++||||||+++|+|++|..||............ .....  ........++++
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~  254 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYG-KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFK--VHPEIPESMSAE  254 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCS-HHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-HHHHC--CCCCCCTTSCHH
T ss_pred             cccccCCCccccChhhhcCCCCCCC-cHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-hcccc--ccccccccCCHH
Confidence            234557899999999997653  44 4499999999999999999999764433221111 11111  122233467999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +.+||.+||+.+|.+|||++++++||||+..
T Consensus       255 ~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          255 AKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            9999999999999999999999999999653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-48  Score=364.14  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=209.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCC-cEEEEEEeecCCcccHHHHHHHHHHHcCCCCC------eeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn------Iv~~~~~~~~~~~~   92 (363)
                      .++|++.+.||+|+||+||+|.+..++ +.||+|++.......+.+.+|+.+++.++|++      ++.+++++...+.+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            579999999999999999999998777 68999999876556677888999998887665      99999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC-----------------
Q 017936           93 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-----------------  153 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~-----------------  153 (363)
                      ++||||+ +++|.+.+....  .+++.+++.++.||+.||.|||++||+||||||+|||++..                 
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~  176 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV  176 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred             EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence            9999999 667777776543  69999999999999999999999999999999999999432                 


Q ss_pred             CCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 017936          154 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH  233 (363)
Q Consensus       154 ~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  233 (363)
                      ..+.+||+|||+++...  .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||............. 
T Consensus       177 ~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~-  252 (355)
T 2eu9_A          177 KNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMME-  252 (355)
T ss_dssp             SCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-
T ss_pred             CCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-
Confidence            23459999999997532  23345679999999999988887666 999999999999999999998766544332222 


Q ss_pred             HHhcccc---------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017936          234 RILSVQY---------------------------------------SIPDYVHISPECRHLISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       234 ~~~~~~~---------------------------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell  274 (363)
                      .......                                       ........+.++.+||++||+.||.+|||++|++
T Consensus       253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l  332 (355)
T 2eu9_A          253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL  332 (355)
T ss_dssp             HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence            1111000                                       0000111245789999999999999999999999


Q ss_pred             cCcccccc
Q 017936          275 NHEWFLKN  282 (363)
Q Consensus       275 ~h~~~~~~  282 (363)
                      +||||...
T Consensus       333 ~hp~f~~~  340 (355)
T 2eu9_A          333 LHPFFAGL  340 (355)
T ss_dssp             TSGGGGGC
T ss_pred             cChhhcCC
Confidence            99999763

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-48  Score=349.77  Aligned_cols=249  Identities=25%  Similarity=0.384  Sum_probs=210.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..++|++.+.||+|+||.||++++. ++..||+|++.......+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            4578999999999999999999875 566799999988776778899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--CC
Q 017936           99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--~~  175 (363)
                      +++++|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.......  ..
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~  162 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVSS  162 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEEC
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhcc
Confidence            99999999997754 5999999999999999999999999999999999999976654  9999999987543322  12


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....+|+.|+|||.+.+..++.+ +||||||+++|+|++ |..||...........    +... ........+++.+.+
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~l~~  236 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----VSQG-HRLYRPHLASDTIYQ  236 (268)
T ss_dssp             CSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTT-CCCCCCTTSCHHHHH
T ss_pred             cCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHH----HHcC-CCCCCCCcChHHHHH
Confidence            23456778999999988877666 999999999999999 9999987665433322    2222 122333457999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcC
Q 017936          255 LISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h  276 (363)
                      +|.+||+.+|.+|||+.+++++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          237 IMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.2e-49  Score=361.44  Aligned_cols=251  Identities=31%  Similarity=0.482  Sum_probs=213.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCC--CCCeeeeeEEEEcC
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVILTP   89 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~--hpnIv~~~~~~~~~   89 (363)
                      ..++|++.+.||+|+||.||++++..+++.||||++.....       ....+.+|+.+++.++  ||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            36789999999999999999999999999999999976432       2245678999999886  59999999999999


Q ss_pred             CeEEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           90 THLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        90 ~~~~lv~e~~~~-~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      +.+++|||++.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++.
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFGSGAL  199 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-TTEEEECCCTTCEE
T ss_pred             CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC-CCCEEEeeCccccc
Confidence            999999999976 8999999988899999999999999999999999999999999999999732 23599999999875


Q ss_pred             CccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                      ... .......||+.|+|||++.+..+.+.++|||||||++|+|++|..||....      ..    ......  ....+
T Consensus       200 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~----~~~~~~--~~~~~  266 (320)
T 3a99_A          200 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI----IRGQVF--FRQRV  266 (320)
T ss_dssp             CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH----HHCCCC--CSSCC
T ss_pred             ccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hh----hccccc--ccccC
Confidence            532 223445799999999999887776666899999999999999999996521      11    112222  23457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      ++++.+||.+||+.+|.+|||++++++||||....
T Consensus       267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            99999999999999999999999999999997643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=360.49  Aligned_cols=249  Identities=24%  Similarity=0.365  Sum_probs=207.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCc---EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++.+.||+|+||+||++++..+++   .||||++....  ...+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            45789999999999999999999986555   49999997643  23456889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC--
T ss_pred             EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCcccccccC
Confidence            999999999999999754 57999999999999999999999999999999999999976654  999999999854332


Q ss_pred             CC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       173 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      ..    .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||...........    +. .....+....
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~  278 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----VE-EGYRLPAPMG  278 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----HH-TTCCCCCCTT
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----HH-cCCCCCCCCC
Confidence            21    122346778999999988877655 999999999999999 9999987665433322    22 2234455567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +++.+.+||.+||+.+|.+|||+.++++
T Consensus       279 ~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          279 CPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            8999999999999999999999999885

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.9e-48  Score=350.80  Aligned_cols=251  Identities=21%  Similarity=0.360  Sum_probs=209.6

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ....++|++.+.||+|+||+||++.+. ++..||+|++.......+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            345678999999999999999999875 5778999999887766788999999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC--C
Q 017936           97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S  173 (363)
Q Consensus        97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~--~  173 (363)
                      ||+++++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....  .
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A           99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHHHH
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccccccc
Confidence            99999999999976 457999999999999999999999999999999999999986654  999999998744221  1


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ......+|+.|+|||++.+..++.+ +||||||+++|+|++ |..||...........    +.. .........+++.+
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l  250 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQ-GLRLYRPHLASEKV  250 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHT-TCCCCCCTTCCHHH
T ss_pred             cccCCccCcccCCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccChhHHHHH----Hhc-ccCCCCCCcCCHHH
Confidence            2233456788999999988877655 999999999999998 9999987665433322    222 22233334578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcC
Q 017936          253 RHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .++|.+||+.+|.+|||++++++|
T Consensus       251 ~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          251 YTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999876

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-48  Score=352.86  Aligned_cols=253  Identities=22%  Similarity=0.327  Sum_probs=216.1

Q ss_pred             CCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ......++|++.+.||+|+||.||++.+..+++.||+|++.......+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            34445688999999999999999999999999999999998776667889999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      ||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++......
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCC
Confidence            999999999999998643  4999999999999999999999999999999999999976654  999999999754332


Q ss_pred             CC--CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       173 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      ..  .....+|+.|+|||++.+..++.+ +||||||+++|+|++ |..||.......... .+    ......+....++
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-~~----~~~~~~~~~~~~~  238 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LL----EKDYRMERPEGCP  238 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HH----HTTCCCCCCTTCC
T ss_pred             ccccccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HH----hccCCCCCCCCCC
Confidence            21  223457889999999988887655 999999999999999 999998766543322 22    2223334455689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +.+.+||.+||+.+|.+|||++++++
T Consensus       239 ~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          239 EKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            99999999999999999999999975

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.9e-49  Score=354.53  Aligned_cols=255  Identities=31%  Similarity=0.494  Sum_probs=210.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEE--cCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~--~~~~~~l   94 (363)
                      .++|++.+.||+|+||.||++++..+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++.  ....+++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            4689999999999999999999999999999999976432   3456789999999999999999999875  4678999


Q ss_pred             EEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcC-----ceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           95 VMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~L~~LH~~g-----iiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                      ||||+++++|.+++...    ..+++..++.++.||+.||.|||++|     |+||||||+|||++.++.  +||+|||+
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~  162 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL  162 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCCH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCch
Confidence            99999999999998753    34999999999999999999999999     999999999999986654  99999999


Q ss_pred             cccCccCCC-CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 017936          166 SKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD  244 (363)
Q Consensus       166 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (363)
                      ++....... .....||+.|+|||++.+..++.+ +||||||+++|+|++|..||..........    .+..... .+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~i~~~~~-~~~  236 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAG----KIREGKF-RRI  236 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCC-CCC
T ss_pred             heeeccccccccccCCCccccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCcccCHHHHHH----HHhhccc-ccC
Confidence            875432211 123468999999999988777655 999999999999999999998765433222    2222222 122


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ...+++++.++|.+||+.+|.+|||++++++|+|+...
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            34579999999999999999999999999999999764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-49  Score=368.46  Aligned_cols=257  Identities=20%  Similarity=0.289  Sum_probs=211.6

Q ss_pred             CCCceeeceecccCCeEEEEEE-----EcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      .++|++.+.||+|+||+||+|+     +..+++.||||++....  .....+.+|+.+++.++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            4689999999999999999999     55678899999986532  2334678899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecC
Q 017936           93 AIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFG  164 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFg  164 (363)
                      ++|||||.+++|.+++...+       .+++.+++.++.||+.||+|||++||+||||||+|||++.++ ...+||+|||
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG  229 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG  229 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence            99999999999999997643       489999999999999999999999999999999999998543 2359999999


Q ss_pred             CcccCcc---CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhcccc
Q 017936          165 YSKSSVL---HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY  240 (363)
Q Consensus       165 la~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (363)
                      +|+....   ........||+.|+|||++.+..++.+ +|||||||++|+|++ |..||..........    .+... .
T Consensus       230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~~~----~i~~~-~  303 (367)
T 3l9p_A          230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE----FVTSG-G  303 (367)
T ss_dssp             HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHHTT-C
T ss_pred             cccccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcC-C
Confidence            9974321   223344568999999999988887655 999999999999998 999998765533222    22222 2


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       241 ~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ..+....++..+.+||.+||+.+|.+|||+.+++++.++...
T Consensus       304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            233345689999999999999999999999999999887543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.2e-48  Score=365.24  Aligned_cols=250  Identities=23%  Similarity=0.358  Sum_probs=207.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc-------CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEc
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT   88 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~   88 (363)
                      ..++|++.+.||+|+||+||+|++.       .++..||+|++.....  ..+.+.+|+.+++.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3578999999999999999999974       3456799999976532  235688999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC
Q 017936           89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG  152 (363)
Q Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~  152 (363)
                      .+.+|+||||+.+|+|.+++...+                .++..+++.++.||+.||+|||++||+||||||+|||++.
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  238 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  238 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence            999999999999999999997653                4899999999999999999999999999999999999986


Q ss_pred             CCCCcEEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHH
Q 017936          153 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF  228 (363)
Q Consensus       153 ~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  228 (363)
                      ++.  +||+|||+++......   ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.........
T Consensus       239 ~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          239 NNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             TCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             CCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            654  9999999998543322   2233457889999999988877655 999999999999999 99999876654333


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .. +   . .....+....++.++.++|.+||+.+|.+|||+.|++++
T Consensus       316 ~~-~---~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          316 KL-L---K-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HH-H---H-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH-H---h-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22 1   1 122233345689999999999999999999999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.9e-49  Score=362.02  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=188.0

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHH-HHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~-~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ...++|++.+.||+|+||.||++.+..+++.||||++.....  ....+.+|+. +++.++||||+++++++...+..++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            346889999999999999999999999999999999976432  2234455555 7788899999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           95 VMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~L~~LH~~-giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      ||||+.+ +|.+++..     ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.  +||+|||+++.
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~  175 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISGQ  175 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSCC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCcee
Confidence            9999975 77777653     56799999999999999999999999 9999999999999986654  99999999986


Q ss_pred             CccCCCCCccccCCCcCChhhhh----cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc---cC
Q 017936          169 SVLHSQPKSTVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---YS  241 (363)
Q Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~  241 (363)
                      ...........||+.|+|||++.    +..++.+ +|||||||++|+|++|..||.......   ..........   ..
T Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~  251 (327)
T 3aln_A          176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPPQLS  251 (327)
T ss_dssp             ------------------------------CCSH-HHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCC
T ss_pred             cccccccccCCCCccccCceeeccccCcCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCCCCC
Confidence            55444444557999999999983    4445544 999999999999999999997643211   1111111111   11


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          242 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       242 ~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ......+++.+.+||.+||+.+|.+|||+.++++||||...
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            11234579999999999999999999999999999999753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=352.36  Aligned_cols=258  Identities=26%  Similarity=0.377  Sum_probs=193.6

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc---HHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..++|++++.||+|+||.||+|++..+++.||||++.......   +.+.++..+++.++||||+++++++...+.+++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3568999999999999999999999999999999997653322   2334455678888999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~-giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      |||+ ++.+...... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.  +||+|||++.......
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDK  179 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC-------
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCc
Confidence            9999 5555555543 56799999999999999999999996 9999999999999976654  9999999997654444


Q ss_pred             CCCccccCCCcCChhhhh-----cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          174 QPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                      ......||+.|+|||++.     +..++. ++|||||||++|+|++|..||............+  ........+....+
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~  256 (318)
T 2dyl_A          180 AKDRSAGCAAYMAPERIDPPDPTKPDYDI-RADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--LQEEPPLLPGHMGF  256 (318)
T ss_dssp             -------CCTTCCHHHHC--------CCT-HHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH--HHSCCCCCCSSSCC
T ss_pred             cccccCCCccccChhhcccccccccCCcc-ccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH--hccCCCCCCccCCC
Confidence            445567999999999985     334444 4999999999999999999998644332222111  12223344555568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ++++.+||.+||+.+|.+|||++++++||||.+.
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            9999999999999999999999999999999753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.4e-48  Score=352.58  Aligned_cols=256  Identities=25%  Similarity=0.385  Sum_probs=206.0

Q ss_pred             CCCCCCceeeceecccCCeEEEEEE----EcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP--   89 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--   89 (363)
                      ....++|++.+.||+|+||+||+|+    +..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++...  
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            3456889999999999999999999    667899999999876432 335688999999999999999999998653  


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           90 THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      ..+++||||+++++|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~  163 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKV  163 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC-
T ss_pred             CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCccccc
Confidence            56899999999999999998754 4999999999999999999999999999999999999987654  99999999975


Q ss_pred             CccCC----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch-----------HHHHHHHH
Q 017936          169 SVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----------KNFRKTIH  233 (363)
Q Consensus       169 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----------~~~~~~~~  233 (363)
                      .....    ......+++.|+|||++.+..++.+ +|||||||++|+|++|..||......           ........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            43322    1223457778999999998887655 99999999999999999998643210           11111122


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       234 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .........+....+++++.+||.+||+.+|.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            222333345556678999999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.6e-48  Score=364.36  Aligned_cols=252  Identities=23%  Similarity=0.398  Sum_probs=209.3

Q ss_pred             CCCCCceeeceecccCCeEEEEEE-----EcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP   89 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~   89 (363)
                      ...++|++.+.||+|+||.||+|+     +..+++.||||++.....  ..+.+.+|+.+++.+ +||||+++++++...
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            346889999999999999999999     566778999999976432  235688999999999 789999999999876


Q ss_pred             C-eEEEEEeccCCCchHHHHHhCCC-------------------------------------------------------
Q 017936           90 T-HLAIVMEYASGGELFERICNAGR-------------------------------------------------------  113 (363)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~~~~~~~-------------------------------------------------------  113 (363)
                      + .+++|||||.+|+|.+++.....                                                       
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            5 48999999999999999976543                                                       


Q ss_pred             -----------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC---CCCccc
Q 017936          114 -----------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTV  179 (363)
Q Consensus       114 -----------l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~---~~~~~~  179 (363)
                                 +++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......   ......
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~  256 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDAR  256 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CE
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccC
Confidence                       899999999999999999999999999999999999986654  9999999997543222   223456


Q ss_pred             cCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 017936          180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR  258 (363)
Q Consensus       180 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  258 (363)
                      ||+.|+|||++.+..++.+ +|||||||++|+|++ |..||............+..    ....+....+++++.++|.+
T Consensus       257 ~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~  331 (359)
T 3vhe_A          257 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLD  331 (359)
T ss_dssp             ECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHH
T ss_pred             CCceeEChhhhcCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc----CCCCCCCCCCCHHHHHHHHH
Confidence            8899999999988887655 999999999999998 99999877655444333322    22233344579999999999


Q ss_pred             hcccCCCCCCCHHHHhcC
Q 017936          259 IFVADPAKRISIPEIRNH  276 (363)
Q Consensus       259 ~L~~~p~~R~t~~ell~h  276 (363)
                      ||+.+|.+|||++++++|
T Consensus       332 ~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          332 CWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HccCChhhCCCHHHHHHH
Confidence            999999999999999876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.9e-48  Score=356.79  Aligned_cols=255  Identities=24%  Similarity=0.355  Sum_probs=210.2

Q ss_pred             CCCCCCCCCCceeeceecccCCeEEEEEEEcCCCcEE--EEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEE
Q 017936           13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV--AVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVIL   87 (363)
Q Consensus        13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~--aiK~~~~~--~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~   87 (363)
                      .+|.. ..++|++.+.||+|+||.||+|++..++..+  |+|.+...  ....+.+.+|+.+++.+ +||||+++++++.
T Consensus        18 ~~p~~-~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   96 (327)
T 1fvr_A           18 IYPVL-DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE   96 (327)
T ss_dssp             CSSBC-CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred             ccccc-cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence            34444 4578999999999999999999999888865  99988653  23345688999999999 8999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEe
Q 017936           88 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD  151 (363)
Q Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~  151 (363)
                      +.+.+++||||+++++|.+++...+                .+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG  176 (327)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence            9999999999999999999997654                699999999999999999999999999999999999997


Q ss_pred             CCCCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHH
Q 017936          152 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK  230 (363)
Q Consensus       152 ~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  230 (363)
                      .++.  +||+|||+++............+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.........  
T Consensus       177 ~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~--  251 (327)
T 1fvr_A          177 ENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELY--  251 (327)
T ss_dssp             GGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--
T ss_pred             CCCe--EEEcccCcCccccccccccCCCCCccccChhhhccccCCch-hcchHHHHHHHHHHcCCCCCCCCCcHHHHH--
Confidence            6654  99999999975544444445567899999999988777655 999999999999998 99999876543322  


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                        ..+. .....+....+++++.+||.+||+.+|.+|||+++++++
T Consensus       252 --~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          252 --EKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             --HHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --HHhh-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              2222 222334445689999999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.7e-48  Score=358.14  Aligned_cols=251  Identities=23%  Similarity=0.260  Sum_probs=205.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +++|++.+.||+|+||.||++++..+++.||||++.... ..+.+.+|+.+++.+ +||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            578999999999999999999999999999999987653 245688999999999 999999999999999999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC---CcEEEeecCCcccCccCCC
Q 017936           99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~---~~vkL~DFgla~~~~~~~~  174 (363)
                      + +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   ..+||+|||+|+.......
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~  165 (330)
T 2izr_A           87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET  165 (330)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred             C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence            9 9999999986 467999999999999999999999999999999999999975542   1399999999985433221


Q ss_pred             --------CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC--
Q 017936          175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--  244 (363)
Q Consensus       175 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  244 (363)
                              .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||........ ......+.......+.  
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~  243 (330)
T 2izr_A          166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRATPIEV  243 (330)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHSCHHH
T ss_pred             CccccccccCCcCCCccccChHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccCCHHH
Confidence                    245679999999999998877655 9999999999999999999987543221 1222222111111111  


Q ss_pred             -CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          245 -YVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       245 -~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                       ...++ ++.++|.+||+.+|.+||+++++++
T Consensus       244 ~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence             12234 9999999999999999999998875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1e-47  Score=352.49  Aligned_cols=255  Identities=24%  Similarity=0.389  Sum_probs=206.5

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCC--CCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~--hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++.+.||+|+||.||++.+. +++.||+|++.....   ..+.+.+|+.+++.++  ||||+++++++...+.++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            4678999999999999999999985 588999999875432   3356789999999997  599999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      +||| +.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.   +.+||+|||+++......
T Consensus       105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCC-----
T ss_pred             EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC---CeEEEeeccccccccCcc
Confidence            9999 558899999999889999999999999999999999999999999999999964   359999999997543322


Q ss_pred             C---CCccccCCCcCChhhhhc-----------CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc
Q 017936          174 Q---PKSTVGTPAYIAPEVLLK-----------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ  239 (363)
Q Consensus       174 ~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (363)
                      .   .....||+.|+|||++.+           ..+ +.++|||||||++|+|++|..||........   .........
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~  256 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPN  256 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CC-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTT
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccC-CchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhcc
Confidence            1   234568999999999875           234 3459999999999999999999976543221   222233333


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       240 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ...+.....+.++.+||.+||+.+|.+|||++++++||||...
T Consensus       257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            3333344568999999999999999999999999999999754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1e-47  Score=344.99  Aligned_cols=249  Identities=30%  Similarity=0.409  Sum_probs=198.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++.+.||+|+||.||++.+.  ++.||+|++.....     ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            4578999999999999999999974  78899999875422     2367889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC---ceecCCCCCCEEEeCC------CCCcEEEeecC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGS------PAPRLKICDFG  164 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~g---iiHrDlkp~NIll~~~------~~~~vkL~DFg  164 (363)
                      +||||+++++|.+++. .+.+++..++.++.||+.||.|||++|   |+||||||+|||++..      ..+.+||+|||
T Consensus        83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999988875 457999999999999999999999999   9999999999999752      13469999999


Q ss_pred             CcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 017936          165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD  244 (363)
Q Consensus       165 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (363)
                      +++..... ......||+.|+|||.+.+..++.+ +||||||+++|+|++|..||..........    .........+.
T Consensus       162 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~  235 (271)
T 3dtc_A          162 LAREWHRT-TKMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAY----GVAMNKLALPI  235 (271)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----HHHTSCCCCCC
T ss_pred             cccccccc-cccCCCCccceeCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----hhhcCCCCCCC
Confidence            99754332 2235579999999999988877655 999999999999999999998765433222    22333344445


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ...+++.+.++|.+||+.+|.+|||+.+++++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            56789999999999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=356.57  Aligned_cols=248  Identities=31%  Similarity=0.490  Sum_probs=203.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcC----CCCCeeeeeEEEEc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSL----RHPNIVRFKEVILT   88 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l----~hpnIv~~~~~~~~   88 (363)
                      .++|++.+.||+|+||.||++++..+++.||+|++.....       ....+.+|+.+++.+    +||||+++++++..
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            5789999999999999999999999999999999976432       123345788888888    89999999999999


Q ss_pred             CCeEEEEEec-cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEe-CCCCCcEEEeecCCc
Q 017936           89 PTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYS  166 (363)
Q Consensus        89 ~~~~~lv~e~-~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~-~~~~~~vkL~DFgla  166 (363)
                      .+..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++  .+||+|||++
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~  187 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSG  187 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSC
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchh
Confidence            9999999999 78999999999888899999999999999999999999999999999999998 444  5999999998


Q ss_pred             ccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                      +..... ......||+.|+|||++.+..+...++|||||||++|+|++|..||....      .    +.......  ..
T Consensus       188 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~----~~~~~~~~--~~  254 (312)
T 2iwi_A          188 ALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------E----ILEAELHF--PA  254 (312)
T ss_dssp             EECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHTCCCC--CT
T ss_pred             hhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------H----HhhhccCC--cc
Confidence            755332 23455799999999999887776655999999999999999999996421      1    11222222  24


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .++.++.+||.+||+.+|.+|||++++++||||+..
T Consensus       255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            579999999999999999999999999999999753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=360.51  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=208.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcC-------CCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEc
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT   88 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~   88 (363)
                      ..++|.+.+.||+|+||+||+|++..       .+..||+|++.....  ....+.+|+.+++.+ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            45789999999999999999999753       335799999876532  235678999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC
Q 017936           89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG  152 (363)
Q Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~  152 (363)
                      .+.+++||||+++++|.+++....                .+++.+++.++.||+.||.|||++||+||||||+|||++.
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  226 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  226 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence            999999999999999999998754                4999999999999999999999999999999999999986


Q ss_pred             CCCCcEEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHH
Q 017936          153 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF  228 (363)
Q Consensus       153 ~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  228 (363)
                      ++.  +||+|||+|+......   ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.........
T Consensus       227 ~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          227 DNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             TCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             CCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            654  9999999998543322   2233457889999999988777655 999999999999999 99999876543322


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .    .+. .....+....+++++.+||.+||+.+|.+|||+++++++
T Consensus       304 ~----~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          304 K----LLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             H----HHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H----HHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2    222 222333345689999999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6e-48  Score=353.68  Aligned_cols=251  Identities=22%  Similarity=0.350  Sum_probs=209.2

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      ...++|.+.+.||+|+||.||+|.+.     .+++.||+|++.....  ..+.+.+|+.+++.++||||+++++++...+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            34678999999999999999999983     4568899999876432  2356789999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCC
Q 017936           91 HLAIVMEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE  146 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~------------------------l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~  146 (363)
                      .+++||||+.+++|.+++.....                        +++.+++.++.||+.||.|||++||+||||||+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~  179 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR  179 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence            99999999999999999986543                        899999999999999999999999999999999


Q ss_pred             CEEEeCCCCCcEEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCC
Q 017936          147 NTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDP  222 (363)
Q Consensus       147 NIll~~~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~  222 (363)
                      |||++.++.  +||+|||+++......   ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||...
T Consensus       180 NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          180 NILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             GEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             eEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999986654  9999999987543222   2233457888999999988777655 999999999999999 99999876


Q ss_pred             CchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          223 EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ....... .+.    .....+....+++++.++|.+||+.+|.+|||+.+++++
T Consensus       257 ~~~~~~~-~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          257 PPERLFN-LLK----TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CGGGHHH-HHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHH-Hhh----cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6543322 211    122233445689999999999999999999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.2e-47  Score=347.34  Aligned_cols=253  Identities=19%  Similarity=0.212  Sum_probs=207.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++.... ..+.+.+|+..++.+ +|||++++++++......++|||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            3578999999999999999999999999999999986543 345678899999999 79999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC---CcEEEeecCCcccCccCC
Q 017936           98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~---~~vkL~DFgla~~~~~~~  173 (363)
                      |+ +++|.+++...+ ++++.+++.++.||+.||.|||++||+||||||+|||++.++.   ..+||+|||+++......
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99 999999998754 5999999999999999999999999999999999999975432   349999999997543322


Q ss_pred             --------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH---HHHHHHHHHhccccCC
Q 017936          174 --------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---NFRKTIHRILSVQYSI  242 (363)
Q Consensus       174 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~  242 (363)
                              ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......   ............. ..
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~  243 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-LR  243 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-HH
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-HH
Confidence                    2344579999999999988777555 999999999999999999998754322   1111111111111 11


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          243 PDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       243 ~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .....+++++.++|.+||+.+|.+|||++++++
T Consensus       244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            112357999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.3e-48  Score=366.09  Aligned_cols=249  Identities=26%  Similarity=0.363  Sum_probs=208.5

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ..++|++.+.||+|+||.||++++..+++.||||++.....  ..+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            45789999999999999999999999999999999875422  2345778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--
Q 017936           97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--  173 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--  173 (363)
                      ||+++++|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+......  
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYA  269 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSEEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCcee
Confidence            9999999999997654 5999999999999999999999999999999999999976654  9999999997532211  


Q ss_pred             -CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       174 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                       ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||......... ..    .......+.+..++++
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~  343 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTR-EF----VEKGGRLPCPELCPDA  343 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-HH----HHTTCCCCCCTTCCHH
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH----HHcCCCCCCCCCCCHH
Confidence             1122345778999999988877655 999999999999998 99999876543322 11    2223344455568999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +.+||.+||+.+|.+|||++++++
T Consensus       344 l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          344 VFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.9e-48  Score=360.23  Aligned_cols=255  Identities=18%  Similarity=0.222  Sum_probs=199.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcC---CCcEEEEEEeecCCc------------ccHHHHHHHHHHHcCCCCCeeeee
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIVRFK   83 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~------------~~~~~~~e~~~l~~l~hpnIv~~~   83 (363)
                      ..++|++.+.||+|+||+||+|++..   ++..+|+|++.....            ....+.+|+..++.++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            35789999999999999999999987   788999999876432            123456788889999999999999


Q ss_pred             EEEEc----CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEE
Q 017936           84 EVILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK  159 (363)
Q Consensus        84 ~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vk  159 (363)
                      +++..    ...+|+||||+ +++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+.+|
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            99988    77899999999 99999999887789999999999999999999999999999999999999877655699


Q ss_pred             EeecCCcccCccCCC--------CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCc-hHHHHH
Q 017936          160 ICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRK  230 (363)
Q Consensus       160 L~DFgla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~  230 (363)
                      |+|||+|+.......        .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||..... ......
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            999999975432211        134479999999999988777655 9999999999999999999964322 222222


Q ss_pred             HHHHHhcccc----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          231 TIHRILSVQY----SIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       231 ~~~~~~~~~~----~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..........    .......+++++.++|.+||+.+|.+|||++++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            1111111100    00111257999999999999999999999999876

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.8e-47  Score=345.32  Aligned_cols=247  Identities=24%  Similarity=0.329  Sum_probs=209.9

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEc-----------
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-----------   88 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-----------   88 (363)
                      .++|++.+.||+|+||.||++++..+++.||+|++....   +.+.+|+.+++.++||||+++++++..           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            357999999999999999999999999999999987653   467789999999999999999998864           


Q ss_pred             -----CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEe
Q 017936           89 -----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC  161 (363)
Q Consensus        89 -----~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~  161 (363)
                           ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~  164 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIG  164 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEEC
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEEC
Confidence                 44589999999999999999754  57999999999999999999999999999999999999987654  9999


Q ss_pred             ecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccC
Q 017936          162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS  241 (363)
Q Consensus       162 DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (363)
                      |||++.............||+.|+|||++.+..++.+ +|||||||++|+|++|..||...      ......+....  
T Consensus       165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~~--  235 (284)
T 2a19_B          165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFET------SKFFTDLRDGI--  235 (284)
T ss_dssp             CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTTC--
T ss_pred             cchhheeccccccccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhccc--
Confidence            9999987655555566679999999999988877655 99999999999999999987421      11222222211  


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          242 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       242 ~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                        ....++..+.++|.+||+.+|.+|||+.++++|.+..+.
T Consensus       236 --~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          236 --ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             --ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence              123478999999999999999999999999999887653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1e-47  Score=354.47  Aligned_cols=251  Identities=21%  Similarity=0.309  Sum_probs=204.3

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEEcCCCcE----EEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      ....++|++.+.||+|+||+||+|++..+++.    ||+|.+....  .....+.+|+.+++.++||||+++++++. .+
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            34568999999999999999999999888876    6677664432  23356678999999999999999999886 45


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      ..++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~  165 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLL  165 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGS
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCccccc
Confidence            689999999999999999775 57999999999999999999999999999999999999976654  999999999865


Q ss_pred             ccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCC
Q 017936          170 VLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDY  245 (363)
Q Consensus       170 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (363)
                      .....   .....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.......... .+    ......+..
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~----~~~~~~~~~  239 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-LL----EKGERLAQP  239 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-HH----HTTCBCCCC
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCHHHHHH-HH----HcCCCCCCC
Confidence            33222   234457889999999988887655 999999999999999 999998766543222 21    122233334


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          246 VHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ..++.++.++|.+||+.+|.+|||+.++++|
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          240 QICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4578899999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-47  Score=342.64  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=210.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..++|++.+.||+|+||.||++.+. +++.||+|++.......+.+.+|+.+++.++||||+++++++...+.+++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            4578999999999999999999986 577899999988766678899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC--CCC
Q 017936           99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQP  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~--~~~  175 (363)
                      +++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++......  ...
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHST
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEccccccccccccccccc
Confidence            9999999999765 46999999999999999999999999999999999999976654  999999998754221  122


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....+++.|+|||++.+..++.+ +||||||+++|+|++ |..||...........    +... ........+++.+.+
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----i~~~-~~~~~~~~~~~~l~~  236 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTG-FRLYKPRLASTHVYQ  236 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTT-CCCCCCTTSCHHHHH
T ss_pred             ccccccccccChhhhcCCCccch-hchhhhHHHHHHHhccCCCCCCCCCHHHHHHH----HhcC-CcCCCCccCcHHHHH
Confidence            34457788999999988777655 999999999999999 9999987654333222    2222 222333457999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcC
Q 017936          255 LISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h  276 (363)
                      +|.+||+.+|.+|||+.+++++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          237 IMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.9e-47  Score=346.51  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=206.9

Q ss_pred             CCCCCceeeceecccCCeEEEEEE----EcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--   89 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--   89 (363)
                      ...++|++.+.||+|+||.||+|+    +..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++...  
T Consensus        18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            345679999999999999999999    67789999999987543  3346788999999999999999999999877  


Q ss_pred             CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           90 THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      +.+++||||+++++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++..
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~  175 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKA  175 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEE
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECccccccc
Confidence            679999999999999999954 457999999999999999999999999999999999999987654  99999999975


Q ss_pred             CccCC----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCC----------chHHHHHHHHH
Q 017936          169 SVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE----------EPKNFRKTIHR  234 (363)
Q Consensus       169 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----------~~~~~~~~~~~  234 (363)
                      .....    ......||+.|+|||++.+..++.+ +|||||||++|+|++|..|+....          ...........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            44332    2334568888999999988877655 999999999999999999874321          00111111222


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       235 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ........+....+++++.+||.+||+.+|.+|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            22233344555678999999999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-47  Score=356.42  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=210.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCC
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPT   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~   90 (363)
                      ..++|++.+.||+|+||.||+|++.     .+++.||+|++...  ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            4578999999999999999999973     45678999998753  23456789999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCC
Q 017936           91 HLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN  147 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~-----------------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~N  147 (363)
                      .+++||||+++++|.+++....                       .+++..++.++.||+.||.|||++||+||||||+|
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  202 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  202 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence            9999999999999999997653                       37999999999999999999999999999999999


Q ss_pred             EEEeCCCCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCC
Q 017936          148 TLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE  223 (363)
Q Consensus       148 Ill~~~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~  223 (363)
                      ||++.++  .+||+|||++........   .....||+.|+|||++.+..++.+ +|||||||++|+|+| |..||....
T Consensus       203 Ill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          203 VLVTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             EEEETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             EEEcCCC--cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChh-HhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9998665  499999999975433222   233457889999999988877655 999999999999998 999998776


Q ss_pred             chHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017936          224 EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW  278 (363)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~  278 (363)
                      ........+.    .....+....+++++.+||.+||+.+|.+|||+.++++|-.
T Consensus       280 ~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          280 VDANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             CSHHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cHHHHHHHHh----cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            5544443332    22333444567999999999999999999999999998643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-48  Score=356.92  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=208.3

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      ...++|++.+.||+|+||.||++++.     .+++.||+|++.....  ..+.+.+|+.+++.++||||+++++++...+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34678999999999999999999987     4558999999876432  3456889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCC
Q 017936           91 HLAIVMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE  146 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~------------------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~  146 (363)
                      .+++||||+++++|.+++...                        ..+++.+++.++.||+.||.|||++||+||||||+
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  203 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  203 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence            999999999999999999764                        56999999999999999999999999999999999


Q ss_pred             CEEEeCCCCCcEEEeecCCcccCccC---CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCC
Q 017936          147 NTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDP  222 (363)
Q Consensus       147 NIll~~~~~~~vkL~DFgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~  222 (363)
                      |||++.++.  +||+|||+++.....   .......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||...
T Consensus       204 NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          204 NCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             GEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             eEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc-cccHHHHHHHHHHHhcCCCcCCCC
Confidence            999986654  999999998743222   22234568899999999988887655 999999999999999 99999876


Q ss_pred             CchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          223 EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .......    .+.... ..+....+++++.++|.+||+.+|.+|||+.+++++
T Consensus       281 ~~~~~~~----~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          281 AHEEVIY----YVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CHHHHHH----HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ChHHHHH----HHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            5433222    222222 223334679999999999999999999999999863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.7e-48  Score=355.28  Aligned_cols=250  Identities=20%  Similarity=0.337  Sum_probs=201.7

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEE----EEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH   91 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~----aiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~   91 (363)
                      ...++|++.+.||+|+||+||+|++..+++.+    |+|.+...  ....+.+.+|+.+++.++||||+++++++.... 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            45678999999999999999999998887755    77766543  234567889999999999999999999998765 


Q ss_pred             EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      .++|++|+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+...
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~  168 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLG  168 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHT
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeEcc
Confidence            7899999999999999987 456999999999999999999999999999999999999987664  9999999997543


Q ss_pred             cCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          171 LHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       171 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                      ....   .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||......... ..+    ......+...
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~----~~~~~~~~~~  242 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL----EKGERLPQPP  242 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHH----HTTCCCCCCT
T ss_pred             CCcccccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHH----HcCCCCCCCc
Confidence            3222   223356889999999998887655 999999999999999 99999876654322 222    2223344455


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .++.++.+++.+||+.+|.+|||+.+++++
T Consensus       243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          243 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            679999999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=367.98  Aligned_cols=257  Identities=23%  Similarity=0.354  Sum_probs=206.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC--eEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~--~~~l   94 (363)
                      ..++|++.+.||+|+||+||+|++..+++.||||++....  ...+.+.+|+.+++.++||||+++++++...+  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            3578999999999999999999999999999999987643  23466789999999999999999999998765  7899


Q ss_pred             EEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC--CCCCcEEEeecCCcccC
Q 017936           95 VMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFGYSKSS  169 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~--~~~~~vkL~DFgla~~~  169 (363)
                      |||||++++|.+++....   .+++.+++.++.||+.||+|||++||+||||||+|||+..  ++.+.+||+|||+|+..
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            999999999999987643   3999999999999999999999999999999999999821  23335999999999866


Q ss_pred             ccCCCCCccccCCCcCChhhhhc--------CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLK--------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-  240 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  240 (363)
                      ..........||+.|+|||++.+        ..++ .++|||||||++|+|++|..||............+..+..... 
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~  245 (396)
T 4eut_A          167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (396)
T ss_dssp             CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHH-HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred             cCCCccccccCCccccCHHHhhccccccccccCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence            55555556779999999999875        3333 3489999999999999999999754433333333333332211 


Q ss_pred             ------------------CCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          241 ------------------SIPDYV----HISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       241 ------------------~~~~~~----~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                                        ..+...    .++..+.++|++||+.||++|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                              111111    234578999999999999999999998654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.3e-47  Score=342.32  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=205.6

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc--------cHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--------DENVQREIINHRSLRHPNIVRFKEVILTP   89 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~e~~~l~~l~hpnIv~~~~~~~~~   89 (363)
                      ...++|++.+.||+|+||+||++++..+++.||+|++......        .+.+.+|+.+++.++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            3468999999999999999999999999999999998654321        16788999999999999999999999776


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCCEEEeCCCC---CcEEEeec
Q 017936           90 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPA---PRLKICDF  163 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~g--iiHrDlkp~NIll~~~~~---~~vkL~DF  163 (363)
                      .  ++||||+++++|.+.+... ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.   ..+||+||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            6  6999999999998888654 46999999999999999999999999  999999999999975432   23999999


Q ss_pred             CCcccCccCCCCCccccCCCcCChhhhhc--CCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccC
Q 017936          164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS  241 (363)
Q Consensus       164 gla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (363)
                      |+++....  ......||+.|+|||++.+  ..+ +.++|||||||++|+|++|..||.........  ...........
T Consensus       174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~  248 (287)
T 4f0f_A          174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIREEGLR  248 (287)
T ss_dssp             TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHHHHSCCC
T ss_pred             Cccccccc--cccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHHhccCCC
Confidence            99874332  3345679999999999843  333 34599999999999999999999876543321  11222223333


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          242 IPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       242 ~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .+....+++++.++|.+||+.+|.+|||++++++
T Consensus       249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            3444568999999999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.5e-47  Score=350.79  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=211.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEE-----cCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCC
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPT   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~   90 (363)
                      ..++|++.+.||+|+||.||++++     ..+++.||+|++.....  ..+.+.+|+.+++.+ +||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            457899999999999999999985     45778999999976543  346688999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC
Q 017936           91 HLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG  152 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~------------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~  152 (363)
                      ..++||||+++++|.+++....                  .+++.+++.++.||+.||.|||++||+||||||+|||++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH  180 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence            9999999999999999997654                  4899999999999999999999999999999999999986


Q ss_pred             CCCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHH
Q 017936          153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF  228 (363)
Q Consensus       153 ~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  228 (363)
                      ++.  +||+|||+++.......   .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.........
T Consensus       181 ~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          181 GRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             TTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             CCC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            654  99999999975543322   233457889999999988877655 999999999999999 99999877655544


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ...+..    ....+....++.++.++|.+||+.+|.+|||+.+++++
T Consensus       258 ~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          258 YKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            443332    22333345679999999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8e-48  Score=348.85  Aligned_cols=249  Identities=16%  Similarity=0.170  Sum_probs=203.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCC-------cEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      ..++|++.+.||+|+||+||++++..++       ..||+|++.... ...+.+.+|+.+++.++||||+++++++...+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            3578999999999999999999998877       469999986543 34567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCC------cEEEeec
Q 017936           91 HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDF  163 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~------~vkL~DF  163 (363)
                      ..++||||+.+++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++..      .+||+||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df  165 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP  165 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred             CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence            99999999999999999987654 9999999999999999999999999999999999999866531      2999999


Q ss_pred             CCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC
Q 017936          164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP  243 (363)
Q Consensus       164 gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (363)
                      |++....   ......||+.|+|||++.+....+.++|||||||++|+|++|..|+.............    ......+
T Consensus       166 g~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~----~~~~~~~  238 (289)
T 4fvq_A          166 GISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY----EDRHQLP  238 (289)
T ss_dssp             CSCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HTTCCCC
T ss_pred             ccccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh----hccCCCC
Confidence            9986432   22345689999999999874434455999999999999999655554443333222221    1222222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          244 DYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                        ...++++.+||.+||+.+|.+|||+.++++|
T Consensus       239 --~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          239 --APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             --CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             --CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence              3458889999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.1e-47  Score=356.70  Aligned_cols=254  Identities=16%  Similarity=0.205  Sum_probs=198.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCC-----CcEEEEEEeecCCc------------ccHHHHHHHHHHHcCCCCCeeee
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIVRF   82 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~------------~~~~~~~e~~~l~~l~hpnIv~~   82 (363)
                      .++|++.+.||+|+||+||+|.+..+     ++.||+|++.....            .......|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            56899999999999999999998764     57899999876431            11233456667778899999999


Q ss_pred             eEEEEcC----CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCc
Q 017936           83 KEVILTP----THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR  157 (363)
Q Consensus        83 ~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~  157 (363)
                      ++++...    ...++||||+ |++|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.+..+.
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence            9998764    5689999999 99999999876 5799999999999999999999999999999999999998444556


Q ss_pred             EEEeecCCcccCccCCC--------CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHH
Q 017936          158 LKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR  229 (363)
Q Consensus       158 vkL~DFgla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  229 (363)
                      +||+|||+|+.......        .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            99999999975432221        133459999999999988877655 999999999999999999998643322222


Q ss_pred             HHHHHHhcccc-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          230 KTIHRILSVQY-----SIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       230 ~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ...........     .......+++++.+++.+||+.+|.+|||+.++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            11111100000     00011457999999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.9e-47  Score=345.35  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=196.7

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCC---CcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++.+.||+|+||.||++.+..+   +..||+|++....  ...+.+.+|+.+++.++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            457899999999999999999998653   4579999886532  23456889999999999999999999984 56789


Q ss_pred             EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC----------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECccccccccCcc
Confidence            9999999999999998654 6999999999999999999999999999999999999986654  999999999754332


Q ss_pred             CC--CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       173 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      ..  .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||............    ... ...+....++
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----~~~-~~~~~~~~~~  243 (281)
T 1mp8_A          170 TYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENG-ERLPMPPNCP  243 (281)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTT-CCCCCCTTCC
T ss_pred             cccccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH----HcC-CCCCCCCCCC
Confidence            22  223356788999999988877655 999999999999996 99999876654433222    111 2233445689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      +++.++|.+||+.+|.+|||+.+++++
T Consensus       244 ~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          244 PTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.4e-47  Score=345.38  Aligned_cols=252  Identities=23%  Similarity=0.312  Sum_probs=204.8

Q ss_pred             CCCCCCCCceeec-eecccCCeEEEEEE--EcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 017936           15 PIMHDSDRYELVR-DIGSGNFGVARLMR--DKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT   88 (363)
Q Consensus        15 ~~~~~~~~y~i~~-~lg~G~~g~V~~~~--~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~   88 (363)
                      .+....++|.+.+ .||+|+||+||++.  +..+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++ .
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            3444567899998 99999999999994  456788999999876432   246788999999999999999999999 5


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      .+.+++||||+.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~  166 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKA  166 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEE
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCccee
Confidence            5678999999999999999999888999999999999999999999999999999999999987654  99999999875


Q ss_pred             CccCCC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCC
Q 017936          169 SVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIP  243 (363)
Q Consensus       169 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (363)
                      ......    .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......... ..   +.. ....+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~---~~~-~~~~~  240 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AM---LEK-GERMG  240 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HH---HHT-TCCCC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HH---HHc-CCCCC
Confidence            433221    122346788999999988777555 999999999999999 99999876553322 21   211 22233


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          244 DYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ....+++++.++|.+||+.+|.+|||+.++++
T Consensus       241 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            34568999999999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-47  Score=347.89  Aligned_cols=251  Identities=23%  Similarity=0.321  Sum_probs=199.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++.+.||+|+||.||++++..+++.||+|++......    .+.+.+|+.+++.++||||+++++++...+.+++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            457899999999999999999999999999999998764322    3567899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      ||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++....... 
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDEKL  189 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC---------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCcccccccc
Confidence            9999999999999998888999999999999999999999999999999999999986654  9999999987543322 


Q ss_pred             -CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       174 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                       ......|++.|+|||++.+..++.+ +||||||+++|+|++|..||...... .....+...  ..........+|+++
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~l  265 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQA--IPRPSTVRPGIPVAF  265 (309)
T ss_dssp             -------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSC--CCCGGGTSTTCCTHH
T ss_pred             ccccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccC--CCCccccCCCCCHHH
Confidence             2234578999999999988777666 99999999999999999999864432 221111111  111112235679999


Q ss_pred             HHHHHHhcccCCCCCC-CHHHHhc
Q 017936          253 RHLISRIFVADPAKRI-SIPEIRN  275 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~-t~~ell~  275 (363)
                      .++|.+||+.+|.+|| |+++++.
T Consensus       266 ~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          266 DAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHhccCCHHHHHHhHHHHHH
Confidence            9999999999999999 8888764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=351.92  Aligned_cols=251  Identities=20%  Similarity=0.336  Sum_probs=202.6

Q ss_pred             CCCCCCCceeeceecccCCeEEEEEEEcCCCcEE----EEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 017936           16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP   89 (363)
Q Consensus        16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~----aiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~   89 (363)
                      -....++|++.+.||+|+||+||+|++..+++.+    |+|.+...  ....+.+.+|+.+++.++||||+++++++...
T Consensus        10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            3345789999999999999999999998888765    55555432  33456788999999999999999999999876


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           90 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      . .++|++|+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~  166 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKL  166 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC---
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeE
Confidence            5 78999999999999999764 56999999999999999999999999999999999999987654  99999999975


Q ss_pred             CccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 017936          169 SVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD  244 (363)
Q Consensus       169 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (363)
                      ......   .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||......... ..+    ......+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~----~~~~~~~~  240 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL----EKGERLPQ  240 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHH----HTTCCCCC
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHH----HcCCCCCC
Confidence            433222   223346788999999998887655 999999999999999 99999876654332 222    22234444


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ...++.++.++|.+||+.+|.+|||+.++++
T Consensus       241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          241 PPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            5568999999999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.7e-47  Score=341.79  Aligned_cols=245  Identities=22%  Similarity=0.298  Sum_probs=205.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~   93 (363)
                      ..++|++.+.||+|+||+||++++.  ++.||+|++.....   ..+.+.+|+.+++.++||||+++++++.+.  +.++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            4578999999999999999999985  78899999876432   235688999999999999999999999887  7889


Q ss_pred             EEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~g--iiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      +||||+++++|.+++....  .+++.+++.++.||+.||.|||++|  |+||||||+|||++.++.  ++|+|||++...
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~~  163 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFSF  163 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCTT
T ss_pred             eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceeee
Confidence            9999999999999998765  4899999999999999999999999  999999999999986655  888888876542


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCCCCCc--chhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGK--IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                          ......||+.|+|||++.+..+...  ++|||||||++|+|++|..||...........    ........+.+..
T Consensus       164 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~  235 (271)
T 3kmu_A          164 ----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK----VALEGLRPTIPPG  235 (271)
T ss_dssp             ----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH----HHHSCCCCCCCTT
T ss_pred             ----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH----HHhcCCCCCCCCC
Confidence                2244578999999999987655442  48999999999999999999987665433322    2223333344456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +++++.++|.+||+.+|.+|||++++++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8999999999999999999999999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.9e-47  Score=344.10  Aligned_cols=256  Identities=24%  Similarity=0.334  Sum_probs=195.4

Q ss_pred             CCCCCCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 017936           13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP   89 (363)
Q Consensus        13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~   89 (363)
                      +-++-...++|++.+.||+|+||+||++++..   .+|+|++.....   ..+.+.+|+.+++.++||||++++++. ..
T Consensus        16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~   91 (289)
T 3og7_A           16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA   91 (289)
T ss_dssp             --CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred             CCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence            34444567899999999999999999998643   499999875432   235678999999999999999999965 55


Q ss_pred             CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           90 THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      ...++||||+.+++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~  169 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATE  169 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC----
T ss_pred             CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEEccceeccc
Confidence            668999999999999999864 35699999999999999999999999999999999999998765  499999999874


Q ss_pred             Ccc---CCCCCccccCCCcCChhhhh---cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC
Q 017936          169 SVL---HSQPKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI  242 (363)
Q Consensus       169 ~~~---~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (363)
                      ...   ........||+.|+|||++.   +..++ .++|||||||++|+|++|..||............+..........
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS  248 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSC-HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCC-cccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh
Confidence            432   22223456999999999986   34444 349999999999999999999988766554444433321111111


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          243 PDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       243 ~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .....+++.+.+||.+||+.+|.+|||+.++++
T Consensus       249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            123467899999999999999999999999985

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.6e-48  Score=357.06  Aligned_cols=252  Identities=22%  Similarity=0.259  Sum_probs=199.3

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC----eEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLA   93 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~----~~~   93 (363)
                      ...++|++.+.||+|+||+||++++.  ++.||||++...........+|+.+++.++||||+++++++....    .++
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            45678999999999999999999875  789999999776555566677999999999999999999998743    479


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc----------CceecCCCCCCEEEeCCCCCcEEEeec
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM----------QVCHRDLKLENTLLDGSPAPRLKICDF  163 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~----------giiHrDlkp~NIll~~~~~~~vkL~DF  163 (363)
                      +|||||++++|.+++... .+++..++.++.||+.||.|||+.          ||+||||||+|||++.++.  +||+||
T Consensus        99 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~DF  175 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADF  175 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEECCC
T ss_pred             EEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEccC
Confidence            999999999999999764 599999999999999999999999          9999999999999976654  999999


Q ss_pred             CCcccCccCC---CCCccccCCCcCChhhhhcCCCC----CcchhhhhHHHHHHHHHhCCCCCCCCCchH----------
Q 017936          164 GYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPK----------  226 (363)
Q Consensus       164 gla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~----~~~~DiwslG~il~~l~~g~~pf~~~~~~~----------  226 (363)
                      |+|+......   ......||+.|+|||++.+....    +.++|||||||++|+|++|..||.+.....          
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            9997543322   22345799999999999764322    234799999999999999999997643210          


Q ss_pred             --HHHHHHHHHhccccCCCCCC------CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          227 --NFRKTIHRILSVQYSIPDYV------HISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       227 --~~~~~~~~~~~~~~~~~~~~------~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                        ............. ..|...      ..++++.+||.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          256 HPSLEDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             SCCHHHHHHHHTTSC-CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCchhhhhhhhhccc-CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence              1111111111111 111111      12345999999999999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.5e-47  Score=353.64  Aligned_cols=264  Identities=25%  Similarity=0.398  Sum_probs=211.5

Q ss_pred             CCCCCCCCCCCCCCceeeceecccCCeEEEEEE----EcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeee
Q 017936            9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFK   83 (363)
Q Consensus         9 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~   83 (363)
                      ++...+.-+...++|++.+.||+|+||.||+|+    +..+++.||+|++..... ..+.+.+|+.+++.++||||++++
T Consensus        11 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   90 (327)
T 3lxl_A           11 LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR   90 (327)
T ss_dssp             ------CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             HhhcChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEE
Confidence            334444455667899999999999999999999    577899999999876532 345688999999999999999999


Q ss_pred             EEEE--cCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEE
Q 017936           84 EVIL--TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI  160 (363)
Q Consensus        84 ~~~~--~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL  160 (363)
                      +++.  ..+.+++||||+++++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl  168 (327)
T 3lxl_A           91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKI  168 (327)
T ss_dssp             EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEE
T ss_pred             EEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEE
Confidence            9987  45679999999999999999976 456999999999999999999999999999999999999987654  999


Q ss_pred             eecCCcccCccCC----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH----------
Q 017936          161 CDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK----------  226 (363)
Q Consensus       161 ~DFgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----------  226 (363)
                      +|||+++......    ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......          
T Consensus       169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~  247 (327)
T 3lxl_A          169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV  247 (327)
T ss_dssp             CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred             cccccceecccCCccceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence            9999997543222    2233458888999999988777555 999999999999999999996532210          


Q ss_pred             -HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          227 -NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       227 -~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                       .. .............+....+++++.+||.+||+.+|.+|||+.+++++
T Consensus       248 ~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          248 PAL-SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             CHH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccH-HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             11 11122222333445556789999999999999999999999999754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=355.90  Aligned_cols=250  Identities=12%  Similarity=0.159  Sum_probs=203.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcC--------CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeee----------
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKK--------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----------   81 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~----------   81 (363)
                      .++|++.+.||+|+||.||+|++..        .++.||+|++...    +.+.+|+.+++.++||||++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            5789999999999999999999987        4889999998764    46789999999999999887          


Q ss_pred             -----eeEEEEc-CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC
Q 017936           82 -----FKEVILT-PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS  153 (363)
Q Consensus        82 -----~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~  153 (363)
                           +++++.. .+.+++||||+ +++|.+++...  ..+++.+++.++.||+.||.|||++||+||||||+|||++.+
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~  195 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE  195 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence                 6777765 78899999999 99999999876  679999999999999999999999999999999999999876


Q ss_pred             CCCcEEEeecCCcccCccCC--------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCC-c
Q 017936          154 PAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-E  224 (363)
Q Consensus       154 ~~~~vkL~DFgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~  224 (363)
                      +...+||+|||+++......        ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... .
T Consensus       196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCcccCCcC
Confidence            53359999999997543322        1133479999999999988777655 999999999999999999998754 3


Q ss_pred             hHHHHHHHHHHhccccCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          225 PKNFRKTIHRILSVQYSIP----DYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..................+    .+..+++++.+||.+||+.+|.+|||++++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            2333333332222222111    12357999999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.7e-47  Score=370.93  Aligned_cols=249  Identities=22%  Similarity=0.337  Sum_probs=213.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..++|++.+.||+|+||.||++.++.++..||||++.......+.+.+|+.+++.++||||+++++++.....+++||||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            34679999999999999999999999899999999987766678899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--C
Q 017936           99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q  174 (363)
Q Consensus        99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--~  174 (363)
                      +.+++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......  .
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~  375 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTA  375 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEEC
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCceee
Confidence            9999999999864  45999999999999999999999999999999999999976654  9999999998543221  1


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.......... .+    ......+.+..+++++.
T Consensus       376 ~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~l~  449 (495)
T 1opk_A          376 HAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LL----EKDYRMERPEGCPEKVY  449 (495)
T ss_dssp             CTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HH----HTTCCCCCCTTCCHHHH
T ss_pred             cCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-HH----HcCCCCCCCCCCCHHHH
Confidence            223446788999999988887655 999999999999999 999998766543322 22    22334445567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017936          254 HLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +||.+||+.+|.+|||+.++++
T Consensus       450 ~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          450 ELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCcChhHCcCHHHHHH
Confidence            9999999999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.3e-48  Score=354.74  Aligned_cols=256  Identities=21%  Similarity=0.234  Sum_probs=205.5

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ..++|++.+.||+|+||+||++++ .+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  115 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK  115 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence            468999999999999999999996 468899999887643 334678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           98 YASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      |+++++|.+++....    .+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~  193 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTELD  193 (321)
T ss_dssp             CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSSS
T ss_pred             cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeeccccccccccc
Confidence            999999999886543    5899999999999999999999999999999999999976654  9999999997533221


Q ss_pred             ---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHH--HHH-HHHHhcccc-------
Q 017936          174 ---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF--RKT-IHRILSVQY-------  240 (363)
Q Consensus       174 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~-~~~~~~~~~-------  240 (363)
                         ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.........  ... .........       
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
T 2qkw_B          194 QTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN  272 (321)
T ss_dssp             CCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred             ccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence               1233458999999999988888666 99999999999999999999764432111  110 011111110       


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017936          241 -SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW  278 (363)
Q Consensus       241 -~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~  278 (363)
                       ........+..+.+++.+||+.+|++|||+.+++++-.
T Consensus       273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence             00111123567999999999999999999999997644

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-46  Score=362.05  Aligned_cols=244  Identities=26%  Similarity=0.397  Sum_probs=205.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-eEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e   97 (363)
                      ..++|++.+.||+|+||.||++...  ++.||||++.... ..+.+.+|+.+++.++||||+++++++.... .+++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            4578999999999999999999875  6799999987654 5678899999999999999999999987665 7999999


Q ss_pred             ccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           98 YASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |+++|+|.+++...+.  +++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....  .
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~--~  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--Q  343 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc--c
Confidence            9999999999987553  799999999999999999999999999999999999986654  999999999854322  2


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||......+.....    . .....+.+..+++++.+
T Consensus       344 ~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~-~~~~~~~p~~~~~~l~~  417 (450)
T 1k9a_A          344 DTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----E-KGYKMDAPDGCPPAVYD  417 (450)
T ss_dssp             ---CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH----H-TTCCCCCCTTCCHHHHH
T ss_pred             cCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----H-cCCCCCCCCcCCHHHHH
Confidence            33467889999999988887665 999999999999998 99999876654433222    1 22334445678999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017936          255 LISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~  275 (363)
                      ||.+||+.+|.+|||+.+++.
T Consensus       418 li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          418 VMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.7e-47  Score=351.79  Aligned_cols=258  Identities=20%  Similarity=0.291  Sum_probs=208.1

Q ss_pred             CCCCceeeceecccCCeEEEEEE-----EcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH   91 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~   91 (363)
                      ..++|++.+.||+|+||.||+++     +..+++.||+|++....  .....+.+|+.+++.++||||+++++++.....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            35789999999999999999999     56788899999986532  234567889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeec
Q 017936           92 LAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDF  163 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DF  163 (363)
                      .++||||+++++|.+++....       .+++.+++.++.||+.||.|||++||+||||||+|||++.++ ...+||+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df  187 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF  187 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence            999999999999999998653       489999999999999999999999999999999999998443 235999999


Q ss_pred             CCcccCccC---CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccc
Q 017936          164 GYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ  239 (363)
Q Consensus       164 gla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  239 (363)
                      |+++.....   .......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||..........    .+... 
T Consensus       188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~~-  261 (327)
T 2yfx_A          188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE----FVTSG-  261 (327)
T ss_dssp             HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHHTT-
T ss_pred             ccccccccccccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH----HHhcC-
Confidence            998743221   22234568999999999988877655 999999999999998 999998765433222    22222 


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       240 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ...+....+++.+.++|.+||+.+|.+|||+.++++|.|+...
T Consensus       262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            2223345689999999999999999999999999999987543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.5e-47  Score=358.38  Aligned_cols=249  Identities=23%  Similarity=0.387  Sum_probs=198.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc---CCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++.+.||+|+||.||++++.   .++..||||++....  ...+.+.+|+.+++.++||||+++++++...+.++
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            3568999999999999999999986   467789999987643  23456889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +||||+++++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus       123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC---------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccccccccC
Confidence            9999999999999998754 6999999999999999999999999999999999999976654  999999999754332


Q ss_pred             CC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       173 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      ..    .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||..........    .+ ......+....
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~----~i-~~~~~~~~~~~  274 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIK----AV-DEGYRLPPPMD  274 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHHH----HH-HTTEECCCCTT
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HH-HcCCCCCCCcc
Confidence            21    112235778999999988887665 999999999999998 999998765533222    12 22234445557


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++..+.++|.+||+.+|.+|||+.++++
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            8999999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.7e-46  Score=343.74  Aligned_cols=251  Identities=27%  Similarity=0.402  Sum_probs=196.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            468999999999999999999999999999999987532    2345678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      |||+.+++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSS  188 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC--------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeecC
Confidence            999999999998864    456999999999999999999999999999999999999986654  99999999875433


Q ss_pred             CC-CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          172 HS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       172 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                      .. ......|++.|+|||++.+..++.+ +||||||+++|+|++|..||.......  ......+............+++
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CCH--HHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CCccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchhH--HHHHHHhhcccCCCCcccccCH
Confidence            22 2234568999999999988777655 999999999999999999997643221  1222223233322222356799


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.+||.+||+.||.+|||+.++++
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.2e-47  Score=350.05  Aligned_cols=250  Identities=23%  Similarity=0.360  Sum_probs=206.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc-------CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEc
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT   88 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~   88 (363)
                      ..++|++.+.||+|+||+||+|++.       .+++.||+|++.....  ..+.+.+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4578999999999999999999975       4667899999876432  235678999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC
Q 017936           89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG  152 (363)
Q Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~  152 (363)
                      .+.+++||||+++++|.+++....                .+++.+++.++.||+.||.|||++||+||||||+|||++.
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  192 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  192 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence            999999999999999999998654                3899999999999999999999999999999999999976


Q ss_pred             CCCCcEEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHH
Q 017936          153 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF  228 (363)
Q Consensus       153 ~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  228 (363)
                      ++.  +||+|||+++......   ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.........
T Consensus       193 ~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          193 NNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             TCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             CCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            654  9999999997543322   1233457888999999988777655 999999999999999 99999876543322


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .. +   ... ...+....++.++.++|.+||+.+|.+|||+.+++++
T Consensus       270 ~~-~---~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          270 KL-L---KEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HH-H---HHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH-H---hcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            22 1   111 1223345689999999999999999999999999864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.2e-47  Score=364.76  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=209.1

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ...++|++.+.||+|+||+||++.+. ++..||||++.......+.+.+|+.+++.++||||+++++++. .+.+++|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            34578999999999999999999985 4677999999877666788999999999999999999999986 567899999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC--C
Q 017936           98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S  173 (363)
Q Consensus        98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~--~  173 (363)
                      |+.+|+|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.....  .
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~  340 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYT  340 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHHHH
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCcee
Confidence            99999999999754  36899999999999999999999999999999999999986654  999999999854321  1


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+....+......     .....+.+..+++++
T Consensus       341 ~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~l  414 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-----RGYRMPRPENCPEEL  414 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-----HTCCCCCCTTSCHHH
T ss_pred             ccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHH
Confidence            1233456788999999988887655 999999999999999 999998766543332221     223445556789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 017936          253 RHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .+||.+||+.+|.+|||++++++
T Consensus       415 ~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHHH
Confidence            99999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.8e-47  Score=349.56  Aligned_cols=252  Identities=23%  Similarity=0.396  Sum_probs=208.7

Q ss_pred             CCCCCceeeceecccCCeEEEEEEE-----cCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP   89 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~   89 (363)
                      ...++|++.+.||+|+||+||+|++     ..+++.||+|++.....  ..+.+.+|+.+++.+ +||||+++++++...
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            4567899999999999999999985     45778999999876533  235678999999999 699999999998875


Q ss_pred             C-eEEEEEeccCCCchHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC
Q 017936           90 T-HLAIVMEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG  152 (363)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~~~~~~~----------------l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~  152 (363)
                      + .+++||||+++++|.+++.....                +++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~  183 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  183 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence            4 58999999999999999987654                899999999999999999999999999999999999976


Q ss_pred             CCCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHH
Q 017936          153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF  228 (363)
Q Consensus       153 ~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  228 (363)
                      ++.  +||+|||+++.......   .....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.........
T Consensus       184 ~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~  260 (316)
T 2xir_A          184 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF  260 (316)
T ss_dssp             GGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CCC--EEECCCccccccccCccceeccCCCcceeecCchhhccccccch-hHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence            654  99999999975433222   223457889999999988887655 999999999999998 99999876654443


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ...+..    ....+....+++++.++|.+||+.+|.+|||+.++++|
T Consensus       261 ~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          261 CRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcc----CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333322    11223334579999999999999999999999999976

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-47  Score=349.38  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=193.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHc--CCCCCeeeeeEEEEc----CCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILT----PTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~~~~~~~~----~~~~~   93 (363)
                      .++|++.+.||+|+||+||++++  +++.||||++....  .....+|..++..  ++||||+++++++..    ...++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            47899999999999999999987  58899999987643  3444555555554  899999999998654    35689


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HcCceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH--------~~giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                      +||||+++++|.+++.. ..+++..++.++.||+.||+|||        ++||+||||||+|||++.++.  +||+|||+
T Consensus        83 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~  159 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGL  159 (301)
T ss_dssp             EEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTT
T ss_pred             EehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCCC
Confidence            99999999999999854 57999999999999999999999        999999999999999986654  99999999


Q ss_pred             cccCccCCC-----CCccccCCCcCChhhhhcCCCCC-----cchhhhhHHHHHHHHHhC----------CCCCCCCCch
Q 017936          166 SKSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYDG-----KIADVWSCGVTLYVMLVG----------AYPFEDPEEP  225 (363)
Q Consensus       166 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~l~~g----------~~pf~~~~~~  225 (363)
                      |+.......     .....||+.|+|||++.+.....     .++|||||||++|+|++|          ..||......
T Consensus       160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~  239 (301)
T 3q4u_A          160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN  239 (301)
T ss_dssp             CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence            864332221     23347999999999998764321     348999999999999999          8898654332


Q ss_pred             HHHHHHHHHHhccccCCCCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          226 KNFRKTIHRILSVQYSIPDY------VHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~------~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .................+..      ...++++.+||.+||+.+|.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            21112222222222111111      124577999999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-46  Score=341.49  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=207.4

Q ss_pred             CCCCCCCceeec-eecccCCeEEEEEEEc--CCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 017936           16 IMHDSDRYELVR-DIGSGNFGVARLMRDK--KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT   90 (363)
Q Consensus        16 ~~~~~~~y~i~~-~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~   90 (363)
                      +....++|.+.+ .||+|+||.||++.+.  .+++.||+|++....  ...+.+.+|+.+++.++||||+++++++. .+
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   82 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE   82 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence            344567898887 9999999999999864  567889999997643  23466889999999999999999999994 55


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      .+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~  160 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKAL  160 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEEC
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC--CEEECcccceeee
Confidence            689999999999999998654 4699999999999999999999999999999999999998665  4999999999754


Q ss_pred             ccCCC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 017936          170 VLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD  244 (363)
Q Consensus       170 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (363)
                      .....    .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||...........    +.. ....+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----i~~-~~~~~~  234 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQ-GKRMEC  234 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH----HHT-TCCCCC
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----Hhc-CCcCCC
Confidence            32221    223356889999999987777655 999999999999998 9999987665433222    212 112233


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEW  278 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~  278 (363)
                      ...+++++.++|.+||+.+|.+|||+.+++++.+
T Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            4568999999999999999999999999998643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7e-47  Score=349.79  Aligned_cols=251  Identities=22%  Similarity=0.352  Sum_probs=210.1

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCc-----EEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP   89 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~   89 (363)
                      ...++|++.+.||+|+||.||++.+..+++     .||+|.+.....  ..+.+.+|+.+++.+ +||||+++++++...
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            346789999999999999999999977664     799999876532  345688999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC
Q 017936           90 THLAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA  155 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~--------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~  155 (363)
                      +.+++||||+++++|.+++...              ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence            9999999999999999998652              35899999999999999999999999999999999999986654


Q ss_pred             CcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 017936          156 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT  231 (363)
Q Consensus       156 ~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~  231 (363)
                        +||+|||+++.......   .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||............
T Consensus       203 --~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          203 --AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             --EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             --EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence              99999999975433222   233457889999999988877655 999999999999998 99999876655444433


Q ss_pred             HHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       232 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ...    ....+....+++.+.++|.+||+.+|.+|||+.++++
T Consensus       280 ~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          280 VKD----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Hhc----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            322    2233334457999999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-46  Score=339.02  Aligned_cols=247  Identities=22%  Similarity=0.359  Sum_probs=206.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..++|++.+.||+|+||.||++.+. +++.||+|++.......+.+.+|+.+++.++||||+++++++.. +..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            3578999999999999999999975 56789999998776667889999999999999999999999864 558999999


Q ss_pred             cCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--C
Q 017936           99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q  174 (363)
Q Consensus        99 ~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--~  174 (363)
                      +.+++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.......  .
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  166 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTA  166 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEEC
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCccccc
Confidence            99999999987543  6999999999999999999999999999999999999976554  9999999997543322  2


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||...........    +. .....+....+++++.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~l~  240 (279)
T 1qpc_A          167 REGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LE-RGYRMVRPDNCPEELY  240 (279)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HH-TTCCCCCCTTCCHHHH
T ss_pred             ccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH----Hh-cccCCCCcccccHHHH
Confidence            233457889999999987777655 999999999999999 9999987655433222    21 1223334456899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017936          254 HLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++|.+||+.+|.+|||+.++++
T Consensus       241 ~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          241 QLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1e-46  Score=339.93  Aligned_cols=245  Identities=26%  Similarity=0.394  Sum_probs=198.3

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcC-CeEEEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIVM   96 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~   96 (363)
                      ...++|++.+.||+|+||+||++++.  ++.||+|++.... ..+.+.+|+.+++.++||||+++++++... +.+++||
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            34578999999999999999999874  7899999987643 457788999999999999999999997654 4789999


Q ss_pred             eccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||+++++|.+++...+.  +++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++......  
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--  170 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC---------
T ss_pred             ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeecccccccccc--
Confidence            99999999999976543  899999999999999999999999999999999999986654  999999998754322  


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      .....+++.|+|||++.+..++.+ +||||||+++|+|++ |..||...........    +. .....+....+++.+.
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~l~  244 (278)
T 1byg_A          171 QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VE-KGYKMDAPDGCPPAVY  244 (278)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HT-TTCCCCCCTTCCHHHH
T ss_pred             ccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----Hh-cCCCCCCcccCCHHHH
Confidence            234467899999999988777655 999999999999998 9999987655433222    21 2223344456899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017936          254 HLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++|.+||+.+|.+|||+.++++
T Consensus       245 ~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          245 EVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCChhhCCCHHHHHH
Confidence            9999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=9.4e-47  Score=347.19  Aligned_cols=250  Identities=20%  Similarity=0.295  Sum_probs=207.6

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH   91 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~   91 (363)
                      ..++|++.+.||+|+||.||+|++.     .+++.||+|.+.....  ....+.+|+.+++.++||||+++++++.+.+.
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  102 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP  102 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence            4578999999999999999999876     4678899999876433  23457899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEe
Q 017936           92 LAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC  161 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~  161 (363)
                      .++||||+++++|.+++...          ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+
T Consensus       103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~kl~  180 (322)
T 1p4o_A          103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIG  180 (322)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEEC
T ss_pred             cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EEEC
Confidence            99999999999999998653          45799999999999999999999999999999999999986654  9999


Q ss_pred             ecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhc
Q 017936          162 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS  237 (363)
Q Consensus       162 DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  237 (363)
                      |||+++......   ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||..........    .+..
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~~~~  255 (322)
T 1p4o_A          181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLR----FVME  255 (322)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH----HHHT
T ss_pred             cCccccccccccccccccCCCCCCCccChhhhccCCCCch-hhHHHHHHHHHHHHhcCCCccccCCHHHHHH----HHHc
Confidence            999987543222   1223457889999999988877655 999999999999999 899998765433222    2222


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          238 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       238 ~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .. ..+....+++.+.++|.+||+.+|.+|||+.++++|
T Consensus       256 ~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          256 GG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            22 223345689999999999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=350.94  Aligned_cols=251  Identities=26%  Similarity=0.426  Sum_probs=202.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEE----cCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVIL----TPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~----~~~~~~   93 (363)
                      ..++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            4678999999999999999999999999999999886543 33467889999999999999999999987    345789


Q ss_pred             EEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           94 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      +||||+.+++|.+++..    ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++...
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~  184 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQA  184 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEES
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhc
Confidence            99999999999998875    467999999999999999999999999999999999999976654  999999998743


Q ss_pred             ccCCCC----------CccccCCCcCChhhhhcCC---CCCcchhhhhHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHH
Q 017936          170 VLHSQP----------KSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRI  235 (363)
Q Consensus       170 ~~~~~~----------~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~  235 (363)
                      ......          ....||+.|+|||++.+..   ++. ++|||||||++|+|++|..||...... .....    .
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~  259 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE-RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----A  259 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECT-HHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----H
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCc-hhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----H
Confidence            221111          1234799999999987544   344 499999999999999999999531110 01111    1


Q ss_pred             hccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          236 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       236 ~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .......+....+++++.++|.+||+.+|.+|||+.+++++
T Consensus       260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            12233455556789999999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.5e-46  Score=339.05  Aligned_cols=250  Identities=23%  Similarity=0.242  Sum_probs=202.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEE-EcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~e~   98 (363)
                      .++|++.+.||+|+||.||++++..+++.||+|++..... .+.+.+|+.+++.++|++++..+..+ ...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence            5789999999999999999999999999999999876543 45688999999999988866655544 667889999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEe---CCCCCcEEEeecCCcccCccCCC
Q 017936           99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~---~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      + +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++   .++  .+||+|||+++.......
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTT
T ss_pred             c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC--eEEEeeCCCccccccccc
Confidence            9 9999999974 45799999999999999999999999999999999999994   333  599999999975443322


Q ss_pred             --------CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCc---hHHHHHHHHHHhccccCCC
Q 017936          175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---PKNFRKTIHRILSVQYSIP  243 (363)
Q Consensus       175 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~  243 (363)
                              .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.....   ................ ..
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~  241 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EV  241 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HH
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-HH
Confidence                    245579999999999988877655 9999999999999999999986432   1222222222111110 00


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          244 DYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ....+|+++.++|.+||+.+|.+|||++++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            12457999999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.9e-46  Score=359.36  Aligned_cols=251  Identities=26%  Similarity=0.337  Sum_probs=193.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .+.|.+.+.||+|+||+||.+ ...+|+.||||++....  .+.+.+|+.+++.+ +||||+++++++.+.+.+|+||||
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            456778899999999999875 45679999999986642  35678899999875 899999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC-----------CCCcEEE
Q 017936           99 ASGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-----------PAPRLKI  160 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l-------~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~-----------~~~~vkL  160 (363)
                      |+ ++|.+++......       ++..++.++.||+.||+|||++||+||||||+|||++.+           ....+||
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            96 5999999865533       333567899999999999999999999999999999753           2346999


Q ss_pred             eecCCcccCccCCC-----CCccccCCCcCChhhhhc-------CCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHH
Q 017936          161 CDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLK-------KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN  227 (363)
Q Consensus       161 ~DFgla~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  227 (363)
                      +|||+|+.......     .....||+.|+|||++.+       ..+ +.++|||||||++|+|++ |..||....... 
T Consensus       170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCC-CTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCc-chhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            99999986543221     234579999999999976       334 445999999999999999 999997654322 


Q ss_pred             HHHHHHHHhccccCCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          228 FRKTIHRILSVQYSIPDY-----VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~-----~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                       ....    ......+..     ..+++++.+||.+||+.+|.+|||+.++++||||+.
T Consensus       248 -~~i~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          248 -SNII----RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             -HHHH----HTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             -HHHh----cCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence             1122    222222221     124578999999999999999999999999999964

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.3e-46  Score=341.78  Aligned_cols=250  Identities=23%  Similarity=0.247  Sum_probs=198.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEE-EcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~e~   98 (363)
                      .++|++.+.||+|+||+||++++..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            4789999999999999999999999999999998765432 34578899999999988877666554 677889999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEE---eCCCCCcEEEeecCCcccCccCC-
Q 017936           99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHS-  173 (363)
Q Consensus        99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll---~~~~~~~vkL~DFgla~~~~~~~-  173 (363)
                      + +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||+   +.++  .+||+|||+++...... 
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT--CEEECCCTTCEECBCTTT
T ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC--eEEEecCccceeccCccc
Confidence            9 9999999875 4579999999999999999999999999999999999999   4444  49999999997543322 


Q ss_pred             -------CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhccccCCC
Q 017936          174 -------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIP  243 (363)
Q Consensus       174 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~  243 (363)
                             ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||......   ............... ..
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~  241 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EV  241 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HH
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCch-hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-hh
Confidence                   2234579999999999988877555 99999999999999999999864432   222222221111110 01


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          244 DYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ....+|+++.+||.+||+.+|.+|||++++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            12357899999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-46  Score=345.44  Aligned_cols=251  Identities=22%  Similarity=0.335  Sum_probs=202.2

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCC----cEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH   91 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~   91 (363)
                      ...++|++.+.||+|+||+||+|.+..++    ..||+|++.....  ....+.+|+.+++.++||||+++++++...+.
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            34678999999999999999999987553    3599999876432  23467899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      +++||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC-----
T ss_pred             cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC--cEEECCCCcchhhc
Confidence            99999999999999999764 5799999999999999999999999999999999999998665  49999999997543


Q ss_pred             cCCC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCC
Q 017936          171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDY  245 (363)
Q Consensus       171 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (363)
                      ....    .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||..........    .+. .....+..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~~----~~~-~~~~~~~~  272 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMK----AIN-DGFRLPTP  272 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHH-TTCCCCCC
T ss_pred             cccccccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHH-CCCcCCCc
Confidence            3211    122346788999999988777655 999999999999999 999998765533222    222 22234445


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          246 VHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ..+++.+.++|.+||+.+|.+|||+.+++++
T Consensus       273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          273 MDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5789999999999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.3e-47  Score=362.00  Aligned_cols=254  Identities=26%  Similarity=0.332  Sum_probs=196.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ...+|.+.+.||+|+||+|+. ....+++.||||++.....  ....+|+.+++.+ +|||||++++++.+.+.+|+|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            456799999999999999764 4557889999999866432  3456899999998 79999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC---CCCCcEEEeecCCcccCccC-
Q 017936           98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLH-  172 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~---~~~~~vkL~DFgla~~~~~~-  172 (363)
                      ||. ++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.   ++..++||+|||+|+..... 
T Consensus        99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            996 59999987654 4667778899999999999999999999999999999953   33346889999999765432 


Q ss_pred             ---CCCCccccCCCcCChhhhhc---CCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccC-CCC
Q 017936          173 ---SQPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS-IPD  244 (363)
Q Consensus       173 ---~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  244 (363)
                         .......||+.|+|||++.+   ..+ +.++|||||||++|+|++ |..||....... .. ..  ....... ...
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~-~~--~~~~~~~~~~~  252 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-AN-IL--LGACSLDCLHP  252 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HH-HH--TTCCCCTTSCT
T ss_pred             cceeeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HH-HH--hccCCccccCc
Confidence               22344579999999999874   333 334999999999999999 999996543321 11 11  1111111 111


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ....+..+.+||.+||+.+|.+|||++++++||||..
T Consensus       253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            2223566899999999999999999999999999964

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-47  Score=349.44  Aligned_cols=250  Identities=23%  Similarity=0.404  Sum_probs=194.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHc--CCCCCeeeeeEEEEcC----CeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTP----THLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~~~~~~~~~----~~~~   93 (363)
                      .++|++.+.||+|+||.||++++.  ++.||||++.....  ....+|..++..  ++||||+++++++...    ..++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            468999999999999999999875  88999999876533  334445555544  4899999999999877    7899


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~--------giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                      +||||+++++|.+++... .+++..++.++.|++.||.|||++        ||+||||||+|||++.++.  +||+|||+
T Consensus       112 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~  188 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL  188 (337)
T ss_dssp             EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTT
T ss_pred             EEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCC
Confidence            999999999999999664 699999999999999999999999        9999999999999986654  99999999


Q ss_pred             cccCccCCC-----CCccccCCCcCChhhhhcCCCCCc-----chhhhhHHHHHHHHHhC----------CCCCCCCCch
Q 017936          166 SKSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYDGK-----IADVWSCGVTLYVMLVG----------AYPFEDPEEP  225 (363)
Q Consensus       166 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwslG~il~~l~~g----------~~pf~~~~~~  225 (363)
                      ++.......     .....||+.|+|||++.+......     ++|||||||++|+|++|          ..||......
T Consensus       189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~  268 (337)
T 3mdy_A          189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS  268 (337)
T ss_dssp             CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence            975433222     124579999999999987665543     38999999999999999          7777654322


Q ss_pred             HHHHHHHHHHhcccc---CCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          226 KNFRKTIHRILSVQY---SIPD---YVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~---~~~~---~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ...............   ..+.   ...+++++.+||.+||+.+|.+|||+.++++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            211122222221111   1111   12346779999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.7e-46  Score=342.84  Aligned_cols=251  Identities=22%  Similarity=0.328  Sum_probs=197.6

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcC---CCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT-   90 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-   90 (363)
                      ...++|.+.+.||+|+||.||+|.+..   +++.||+|++.....   ..+.+.+|+.+++.++||||+++++++.... 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            456789999999999999999998765   556899999875432   2356789999999999999999999998764 


Q ss_pred             ----eEEEEEeccCCCchHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEE
Q 017936           91 ----HLAIVMEYASGGELFERIC------NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI  160 (363)
Q Consensus        91 ----~~~lv~e~~~~~~L~~~~~------~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL  160 (363)
                          ..++||||+.+++|.+++.      ....+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kl  188 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCV  188 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEE
Confidence                4599999999999999984      3356999999999999999999999999999999999999986654  999


Q ss_pred             eecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHh
Q 017936          161 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRIL  236 (363)
Q Consensus       161 ~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  236 (363)
                      +|||+++......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.............    
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~----  263 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL----  263 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH----
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH----
Confidence            9999987543321   2233457889999999988777655 999999999999999 999998766544333221    


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       237 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      . ....+....+++++.++|.+||+.+|.+|||+.+++++
T Consensus       264 ~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          264 H-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             T-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             c-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1 11233345689999999999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2e-46  Score=338.56  Aligned_cols=249  Identities=23%  Similarity=0.302  Sum_probs=203.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcC---CCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..++|++.+.||+|+||+||++++..   ++..||+|++....  ...+.+.+|+.+++.++||||+++++++..+ ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            45789999999999999999998653   34469999987643  2346788999999999999999999998754 468


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++......
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC---
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCcccccc
Confidence            999999999999999765 45999999999999999999999999999999999999987654  999999998754332


Q ss_pred             C--CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          173 S--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       173 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      .  ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||............ ..    ....+....++
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~-~~----~~~~~~~~~~~  240 (281)
T 3cc6_A          167 DYYKASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-EK----GDRLPKPDLCP  240 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-HH----TCCCCCCTTCC
T ss_pred             cccccccCCCCcceeCchhhccCCCCch-hccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-hc----CCCCCCCCCCC
Confidence            2  1233457889999999988877655 999999999999998 99999876654433222 11    12334445689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      +.+.++|.+||+.+|.+|||+.+++++
T Consensus       241 ~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          241 PVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            999999999999999999999999864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.2e-46  Score=343.21  Aligned_cols=238  Identities=34%  Similarity=0.581  Sum_probs=190.2

Q ss_pred             CCCCceee-ceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHH-HcCCCCCeeeeeEEEEc----CCeE
Q 017936           19 DSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT----PTHL   92 (363)
Q Consensus        19 ~~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l-~~l~hpnIv~~~~~~~~----~~~~   92 (363)
                      ..++|.+. +.||+|+||.||++.+..+++.||+|++..    .....+|+.++ +.++||||+++++++..    ...+
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            35678887 789999999999999999999999999865    35667888887 67799999999999987    6789


Q ss_pred             EEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecCCcccC
Q 017936           93 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS  169 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~~~  169 (363)
                      ++||||+++++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  170 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  170 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence            99999999999999998764  699999999999999999999999999999999999998632 346999999998643


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--CCCC
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVH  247 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  247 (363)
                      .                     +..++ .++|||||||++|+|++|..||...............+.......+  .+..
T Consensus       171 ~---------------------~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (299)
T 3m2w_A          171 T---------------------GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE  228 (299)
T ss_dssp             T---------------------TCGGG-GHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTT
T ss_pred             c---------------------cccCC-chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhccc
Confidence            2                     12333 3499999999999999999999764432111000001111111111  1246


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +++++.+||.+||+.+|.+|||++|+++||||.+.
T Consensus       229 ~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          229 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            79999999999999999999999999999999764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1e-46  Score=341.78  Aligned_cols=254  Identities=26%  Similarity=0.422  Sum_probs=200.7

Q ss_pred             CCCCCCCCCceeeceecccCCeEEEEEEEcC-CCc--EEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEE
Q 017936           14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKK-TEE--LVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVI   86 (363)
Q Consensus        14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~--~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~   86 (363)
                      .......++|++.+.||+|+||+||++++.. +++  .||+|++....    ...+.+.+|+.+++.++||||+++++++
T Consensus        11 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   90 (291)
T 1u46_A           11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV   90 (291)
T ss_dssp             CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            3344567899999999999999999998643 333  68999987542    2346788999999999999999999999


Q ss_pred             EcCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           87 LTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        87 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                      .... .++||||+.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+
T Consensus        91 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~  167 (291)
T 1u46_A           91 LTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGL  167 (291)
T ss_dssp             CSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTT
T ss_pred             ccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEccccc
Confidence            8765 78999999999999998764 56999999999999999999999999999999999999986654  99999999


Q ss_pred             cccCccCCC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhcccc
Q 017936          166 SKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY  240 (363)
Q Consensus       166 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (363)
                      +........    .....+|+.|+|||++.+..++.+ +||||||+++|+|++ |..||........    ...+.....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~~~~~  242 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEGE  242 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTSCC
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcccCCHHHH----HHHHHccCC
Confidence            875433221    223457888999999988777555 999999999999999 9999987655332    233333444


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       241 ~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..+....+++++.++|.+||+.+|.+|||+.++++
T Consensus       243 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            45555678999999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.3e-47  Score=350.16  Aligned_cols=256  Identities=22%  Similarity=0.261  Sum_probs=202.6

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ..++|++.+.||+|+||.||++++ .+++.||+|++....  .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  106 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY  106 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred             HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEE
Confidence            468999999999999999999985 468899999987643  22346889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHc---CceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           97 EYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~L~~LH~~---giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      ||+.+++|.+++....    .+++..++.++.||+.||.|||++   ||+||||||+|||++.++.  +||+|||+++..
T Consensus       107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~  184 (326)
T 3uim_A          107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLM  184 (326)
T ss_dssp             ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEEC
T ss_pred             EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCcccccc
Confidence            9999999999997644    399999999999999999999999   9999999999999986654  999999999754


Q ss_pred             ccCCC--CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCC----CchHHHHHHHHHHhcccc---
Q 017936          170 VLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----EEPKNFRKTIHRILSVQY---  240 (363)
Q Consensus       170 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~---  240 (363)
                      .....  .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...    ..................   
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             CSSSSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             CcccccccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            32222  233459999999999988877655 99999999999999999999521    111111111111111100   


Q ss_pred             ------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017936          241 ------SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW  278 (363)
Q Consensus       241 ------~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~  278 (363)
                            ........+..+.+++.+||+.+|.+|||+.++++|-.
T Consensus       264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                  00001112367999999999999999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.9e-46  Score=343.75  Aligned_cols=251  Identities=28%  Similarity=0.415  Sum_probs=202.9

Q ss_pred             CCc-eeeceecccCCeEEEEEE----EcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCe
Q 017936           21 DRY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT--PTH   91 (363)
Q Consensus        21 ~~y-~i~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~   91 (363)
                      ++| ++++.||+|+||+||++.    +..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+  ...
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            455 999999999999998775    44578999999997653  234568899999999999999999999987  468


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      +++||||+++++|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPE  186 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECCT
T ss_pred             EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCccccccccc
Confidence            99999999999999988765 4999999999999999999999999999999999999976654  99999999976543


Q ss_pred             CC----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch----------HHHHHHHHHHhc
Q 017936          172 HS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----------KNFRKTIHRILS  237 (363)
Q Consensus       172 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----------~~~~~~~~~~~~  237 (363)
                      ..    ......+|+.|+|||++.+..++.+ +|||||||++|+|++|..||......          ......+.....
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            22    2234457888999999988777655 99999999999999999999753211          111111222233


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          238 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       238 ~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .....+....+++++.+||++||+.+|.+|||++++++
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            33345555678999999999999999999999999984

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.7e-46  Score=358.38  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=204.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..++|++.+.||+|+||.||++.+.. +..||||++.......+.+.+|+.+++.++||||+++++++.. +.+++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            45789999999999999999999865 4569999998766666789999999999999999999999876 678999999


Q ss_pred             cCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--C
Q 017936           99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q  174 (363)
Q Consensus        99 ~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--~  174 (363)
                      +.+++|.+++..  ...+++.++..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......  .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~  337 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTA  337 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC---------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCceec
Confidence            999999999974  356999999999999999999999999999999999999976654  9999999997543221  1


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+....+....    + ......+....+++.+.
T Consensus       338 ~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i-~~~~~~~~~~~~~~~l~  411 (452)
T 1fmk_A          338 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----V-ERGYRMPCPPECPESLH  411 (452)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----H-HTTCCCCCCTTSCHHHH
T ss_pred             ccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCHHHH
Confidence            223456788999999988887655 999999999999999 9999987655333222    2 22234455567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017936          254 HLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +||.+||+.+|.+|||++++++
T Consensus       412 ~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          412 DLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-46  Score=342.32  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=206.3

Q ss_pred             CCCCCceeeceecccCCeEEEEEE----EcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC--
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT--   90 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~--   90 (363)
                      ...++|++++.||+|+||.||+++    +..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+  
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            345679999999999999999998    46789999999987643 33467889999999999999999999987654  


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      .+++||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~~~  195 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVL  195 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEEC
T ss_pred             ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchhhc
Confidence            789999999999999999876 45999999999999999999999999999999999999987654  999999999754


Q ss_pred             ccCCC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCc-----------hHHHHHHHHH
Q 017936          170 VLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----------PKNFRKTIHR  234 (363)
Q Consensus       170 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~  234 (363)
                      .....    .....+++.|+|||++.+..++.+ +|||||||++|+|++|..||.....           .......+..
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCch-hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            33221    223457788999999988777555 9999999999999999999864211           0111111222


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       235 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ........+....+++++.++|.+||+.+|.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            22223344555678999999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-45  Score=335.48  Aligned_cols=248  Identities=25%  Similarity=0.344  Sum_probs=201.4

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCc---EEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE-EE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL-AI   94 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~-~l   94 (363)
                      ..|.+.+.||+|+||+||+|++..+++   .+|+|++.....  ..+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            457788999999999999999765554   799999875432  335678999999999999999999999876655 99


Q ss_pred             EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc--
Q 017936           95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  171 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~--  171 (363)
                      ||||+.+++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....  
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDRE  178 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCc
Confidence            9999999999999976 456899999999999999999999999999999999999976654  99999999974322  


Q ss_pred             ---CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          172 ---HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       172 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                         ........+|+.|+|||.+.+..++.+ +|||||||++|+|++|..||............+.    .....+....+
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  253 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA----QGRRLPQPEYC  253 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----TTCCCCCCTTC
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----cCCCCCCCccc
Confidence               122334568899999999988777655 9999999999999996555544443333333222    22233444568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ++.+.++|.+||+.+|.+|||+.++++
T Consensus       254 ~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          254 PDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.3e-46  Score=338.71  Aligned_cols=246  Identities=30%  Similarity=0.467  Sum_probs=197.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..++|++.+.||+|+||+||++++.  ++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+  ..++||||
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            4578999999999999999999874  688999998654 345678899999999999999999998764  47899999


Q ss_pred             cCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           99 ASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHS---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        99 ~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~L~~LH~---~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +++++|.+++....   .++...++.++.||+.||.|||+   +||+||||||+|||++.++. .+||+|||++..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~-  158 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQT-  158 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC-------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccccc-
Confidence            99999999998765   37899999999999999999999   89999999999999986543 379999999875432 


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                       ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||........  ....... .....+....+++.+
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~l  233 (307)
T 2eva_A          159 -HMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH-NGTRPPLIKNLPKPI  233 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHH-TTCCCCCBTTCCHHH
T ss_pred             -ccccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHh-cCCCCCcccccCHHH
Confidence             2234569999999999988877665 9999999999999999999986543221  1111111 122333445689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcC
Q 017936          253 RHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .++|.+||+.+|.+|||+++++++
T Consensus       234 ~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-47  Score=378.76  Aligned_cols=304  Identities=25%  Similarity=0.344  Sum_probs=224.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEc------CCe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT------PTH   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~------~~~   91 (363)
                      .++|++.+.||+|+||.||++.+..+|+.||||++....  ...+.+.+|+.+++.++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            478999999999999999999999999999999987542  234568899999999999999999998765      677


Q ss_pred             EEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC-CcEEEeecCCcc
Q 017936           92 LAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSK  167 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~-~~vkL~DFgla~  167 (363)
                      .++|||||+|++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            899999999999999998754   5999999999999999999999999999999999999986543 248999999998


Q ss_pred             cCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHH-----HHHH-----hc
Q 017936          168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT-----IHRI-----LS  237 (363)
Q Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-----~~~~-----~~  237 (363)
                      ............||+.|+|||++.+..++.+ +|||||||++|+|++|..||............     ....     ..
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~  251 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT  251 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred             ccccccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence            7655555566789999999999988888766 99999999999999999999764322110000     0000     00


Q ss_pred             ccc----CCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc---CCCcc--cccCccCCCCCCCCCCC
Q 017936          238 VQY----SIPD----YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN---LPADL--VVDNTTNNQFEEPDQPM  304 (363)
Q Consensus       238 ~~~----~~~~----~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~---~~~~~--~~~~~~~~~~~~~~~~~  304 (363)
                      ...    ..+.    ...+++.+.+||.+||+.||.+|||++++++||||...   +....  ...-.......-...+.
T Consensus       252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~kil~~f~~~~~~~~~~~i~~~  331 (676)
T 3qa8_A          252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTEN  331 (676)
T ss_dssp             SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCEEECCCSSSSCCCEEECCTT
T ss_pred             cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccccccccccccccceeecCCC
Confidence            000    1111    12256789999999999999999999999999999752   11110  00001111111223355


Q ss_pred             CCHHHHHHHHHHhCCCCCCC
Q 017936          305 QSIDEIMQIIAEATIPAAGT  324 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .++..+...+.+.+.-....
T Consensus       332 ~tl~~l~~~i~~~T~i~~~~  351 (676)
T 3qa8_A          332 ENLQNLKSWLQQDTGIPEEE  351 (676)
T ss_dssp             CCHHHHHHHHHTTSCCCSTT
T ss_pred             ccHHHHHHHHHHHhCCCHHH
Confidence            67788887777655444433

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=345.84  Aligned_cols=248  Identities=27%  Similarity=0.425  Sum_probs=186.5

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCC-CCCeeeeeEEEE--------c
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVIL--------T   88 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~--------~   88 (363)
                      ...+|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.+++.+. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3568999999999999999999999999999999886543 23456788999999996 999999999984        3


Q ss_pred             CCeEEEEEeccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCCEEEeCCCCCcEEEeec
Q 017936           89 PTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDF  163 (363)
Q Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~L~~LH~~g--iiHrDlkp~NIll~~~~~~~vkL~DF  163 (363)
                      ...+++||||+. |+|.+++..   .+.+++.+++.++.||+.||.|||++|  |+||||||+|||++.++.  +||+||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Df  182 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDF  182 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecC
Confidence            456899999995 688888764   557999999999999999999999999  999999999999986654  999999


Q ss_pred             CCcccCccCCC-------------CCccccCCCcCChhhh---hcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHH
Q 017936          164 GYSKSSVLHSQ-------------PKSTVGTPAYIAPEVL---LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN  227 (363)
Q Consensus       164 gla~~~~~~~~-------------~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  227 (363)
                      |+++.......             .....||+.|+|||++   .+..++ .++|||||||++|+|++|..||....... 
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~-  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG-EKQDIWALGCILYLLCFRQHPFEDGAKLR-  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSS-HHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCC-hHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence            99975433221             1144689999999998   344444 45999999999999999999997543321 


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017936          228 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW  278 (363)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~  278 (363)
                             +.......+.....+..+.+||.+||+.+|.+|||+.++++|-+
T Consensus       261 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          261 -------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             -------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                   12223344455567889999999999999999999999998744

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.6e-46  Score=348.27  Aligned_cols=244  Identities=16%  Similarity=0.160  Sum_probs=195.5

Q ss_pred             CCCCceeeceecccCCeEEEEE-----EEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC---CCCeeeeeEEEEcCC
Q 017936           19 DSDRYELVRDIGSGNFGVARLM-----RDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPT   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~-----~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~~~~~~~~~~   90 (363)
                      ..++|.+.+.||+|+||+||+|     .+..+++.||+|++...  ....+.+|+.+++.++   |+||+++++++...+
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            4678999999999999999999     46788999999998764  3456778888888887   999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC---------CCCC
Q 017936           91 HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---------SPAP  156 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~---------~~~~  156 (363)
                      ..++|||||++|+|.+++..     ...+++.+++.++.||+.||+|||++|||||||||+|||++.         ...+
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence            99999999999999999974     456999999999999999999999999999999999999976         1134


Q ss_pred             cEEEeecCCcccCc---cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 017936          157 RLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH  233 (363)
Q Consensus       157 ~vkL~DFgla~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  233 (363)
                      .+||+|||+|+...   ........+||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.......       
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~-------  292 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGE-------  292 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEEETTE-------
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccCCCCc-------
Confidence            59999999996432   2222345679999999999998887665 999999999999999999996432211       


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       234 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                        .......... ..++.+.+++.+||+.+|.+|++..+.+.
T Consensus       293 --~~~~~~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          293 --CKPEGLFRRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             --EEECSCCTTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             --eeechhcccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence              0011111111 24778999999999999999965444443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.9e-45  Score=334.74  Aligned_cols=249  Identities=23%  Similarity=0.282  Sum_probs=198.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCC---cEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEE-cCCeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL-TPTHL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~-~~~~~   92 (363)
                      ...+|++.+.||+|+||+||++++..++   ..+|+|.+.....  ..+.+.+|+.+++.++||||+++++++. .++..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            3457999999999999999999975433   3689998875432  3356789999999999999999999864 55678


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ++||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCCCSC
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC--CEEECcccccccccc
Confidence            9999999999999999764 4589999999999999999999999999999999999997665  499999999975432


Q ss_pred             CC-----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCC
Q 017936          172 HS-----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDY  245 (363)
Q Consensus       172 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (363)
                      ..     ......+|+.|+|||.+.+..++.+ +|||||||++|+|++ |.+||............    .... .....
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~  254 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGR-RLLQP  254 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH----HTTC-CCCCC
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----hcCC-CCCCC
Confidence            21     2234457889999999988887655 999999999999999 66667655543332222    1111 22233


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          246 VHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..+++.+.++|.+||+.+|.+|||+.++++
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            457999999999999999999999999885

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=361.33  Aligned_cols=247  Identities=23%  Similarity=0.349  Sum_probs=207.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..++|++.+.||+|+||.||++.+.. +..||||++.......+.+.+|+.+++.++||||+++++++.. +.+++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            45789999999999999999999865 4569999998766666789999999999999999999999876 678999999


Q ss_pred             cCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC--CC
Q 017936           99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQ  174 (363)
Q Consensus        99 ~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~--~~  174 (363)
                      +.+++|.+++..  ...+++.+++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+++.....  ..
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~  420 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTA  420 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHHHHT
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCceec
Confidence            999999999974  346999999999999999999999999999999999999976654  999999999754321  11


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||......+....    + ......+....+++++.
T Consensus       421 ~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~----i-~~~~~~~~~~~~~~~l~  494 (535)
T 2h8h_A          421 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----V-ERGYRMPCPPECPESLH  494 (535)
T ss_dssp             TCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH----H-HTTCCCCCCTTCCHHHH
T ss_pred             ccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCHHHH
Confidence            233456788999999988887655 999999999999999 9999987655333222    2 22234444567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017936          254 HLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +||.+||+.+|++|||+++|++
T Consensus       495 ~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          495 DLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.6e-45  Score=351.80  Aligned_cols=252  Identities=23%  Similarity=0.254  Sum_probs=201.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC-CCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++|++.+.||+|+||.||++++..+++.||||++..... ...+.+|+.+++.++| ++|+.+..++...+..++||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~   84 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL   84 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence            4789999999999999999999999999999998776433 3457899999999987 5566666677788899999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC-CCCCcEEEeecCCcccCccCCC--
Q 017936           99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ--  174 (363)
Q Consensus        99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~-~~~~~vkL~DFgla~~~~~~~~--  174 (363)
                      + +++|.+++.. ...+++.+++.++.||+.||.|||++|||||||||+|||++. +..+.+||+|||+++.......  
T Consensus        85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (483)
T 3sv0_A           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ  163 (483)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence            9 9999999975 557999999999999999999999999999999999999941 1223599999999975443222  


Q ss_pred             ------CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH---HHHHHHHHHhccccCCCCC
Q 017936          175 ------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---NFRKTIHRILSVQYSIPDY  245 (363)
Q Consensus       175 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~  245 (363)
                            .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......   .+..+........ .....
T Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~l~  241 (483)
T 3sv0_A          164 HIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS-IEALC  241 (483)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC-HHHHH
T ss_pred             ccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc-HHHHh
Confidence                  225679999999999988887655 999999999999999999998755422   1222111111110 00111


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          246 VHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..++.++.+||.+||+.+|.+||++++|++
T Consensus       242 ~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          242 RGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             TTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            357899999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.2e-45  Score=335.82  Aligned_cols=248  Identities=25%  Similarity=0.324  Sum_probs=197.8

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      |...+.||+|+||+||++.+  +++.||+|++....     ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            45559999999999999985  57899999986532     234678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           98 YASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        98 ~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      |+++++|.+++..   ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++.......
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF--TAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSCSS
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC--cEEEeecccccccccccc
Confidence            9999999999864   34699999999999999999999999999999999999997665  499999999875433221


Q ss_pred             ---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--------CC-
Q 017936          175 ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------SI-  242 (363)
Q Consensus       175 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~-  242 (363)
                         .....||+.|+|||++.+. ++.+ +|||||||++|+|++|..||...............+.....        .. 
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~~-~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRGE-ITPK-SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTTE-ECTH-HHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccCCCcCcCChHHhcCC-CCcc-chhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence               2345689999999988654 5444 99999999999999999999875543322222222111110        00 


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          243 PDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       243 ~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      +.....+..+.+++.+||+.+|.+|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1112235679999999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=345.70  Aligned_cols=249  Identities=22%  Similarity=0.272  Sum_probs=193.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCC---cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEc-CCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~~~   93 (363)
                      ..+|.+.+.||+|+||+||++++..++   ..||+|.+....  ...+.+.+|+.+++.++||||+++++++.. ++..+
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            345888999999999999999975433   468999886532  234678899999999999999999998754 56789


Q ss_pred             EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +||||+++++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDK  245 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC---------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeecccccccccc
Confidence            9999999999999997654 5899999999999999999999999999999999999976654  999999999754222


Q ss_pred             C-----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          173 S-----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       173 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                      .     ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |.+||............    ... ...+...
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~~-~~~~~p~  319 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQG-RRLLQPE  319 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HTT-CCCCCCT
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----HcC-CCCCCCC
Confidence            1     1233457789999999988887655 999999999999999 78888765554332221    111 1223344


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .+++.+.++|.+||+.+|.+|||+.+++++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            679999999999999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.1e-45  Score=364.14  Aligned_cols=240  Identities=24%  Similarity=0.314  Sum_probs=197.5

Q ss_pred             ceecccCCeEEEEEEE--cCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRD--KKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      +.||+|+||+||++.+  +.+++.||||++....   ...+.+.+|+.+++.++|||||++++++.. +.+++|||||.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954  5677899999987643   234678999999999999999999999975 457899999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC----CCCc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKS  177 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~----~~~~  177 (363)
                      ++|.+++...+.+++.+++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+......    ....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC----------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccccccccC
Confidence            999999998889999999999999999999999999999999999999987664  9999999997543222    1223


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ..+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+........    .+. .....+....+++++.+||
T Consensus       532 ~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~----~i~-~~~~~~~p~~~~~~l~~li  605 (635)
T 4fl3_A          532 GKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLE-KGERMGCPAGCPREMYDLM  605 (635)
T ss_dssp             ---CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHH-TTCCCCCCTTCCHHHHHHH
T ss_pred             CCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHH-cCCCCCCCCCCCHHHHHHH
Confidence            346788999999988888665 999999999999998 999998766543222    122 2223344456899999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 017936          257 SRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~  275 (363)
                      .+||+.+|++|||++++++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=360.11  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=200.2

Q ss_pred             CCCCceeec-eecccCCeEEEEEEEc--CCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVR-DIGSGNFGVARLMRDK--KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~-~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      ..+++.+.+ .||+|+||.||++.+.  .++..||||++....  ...+.+.+|+.+++.++|||||++++++.. +.++
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            345566666 8999999999999875  355679999997642  345778999999999999999999999976 5689


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +|||||.+|+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.....
T Consensus       412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGAD  489 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC--
T ss_pred             EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccCC
Confidence            999999999999998754 45999999999999999999999999999999999999987654  999999999854322


Q ss_pred             CC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       173 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      ..    .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||......+....    +.. ....+....
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i~~-~~~~~~p~~  563 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQ-GKRMECPPE  563 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH----HHT-TCCCCCCTT
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCc
Confidence            21    122345689999999988888665 999999999999998 9999988766443322    222 223344456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIR  274 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell  274 (363)
                      +++++.+||.+||+.+|.+|||+.+++
T Consensus       564 ~~~~l~~li~~cl~~dP~~RPs~~~l~  590 (613)
T 2ozo_A          564 CPPELYALMSDCWIYKWEDRPDFLTVE  590 (613)
T ss_dssp             CCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            899999999999999999999999985

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=342.22  Aligned_cols=250  Identities=23%  Similarity=0.300  Sum_probs=186.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEc-----CCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-----~~~~~   93 (363)
                      ..++|++.+.||+|+||+||+++.  +++.||||++............++..++.++||||+++++.+..     ...++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            457899999999999999999976  68899999987654322223344444556899999999986542     23689


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc---------CceecCCCCCCEEEeCCCCCcEEEeecC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QVCHRDLKLENTLLDGSPAPRLKICDFG  164 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~---------giiHrDlkp~NIll~~~~~~~vkL~DFg  164 (363)
                      +|||||++++|.+++.... +++..++.++.||+.||.|||++         ||+||||||+|||++.++  .+||+|||
T Consensus        89 lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kL~DFG  165 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFG  165 (336)
T ss_dssp             EEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS--CEEECCCT
T ss_pred             EEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC--cEEEeecc
Confidence            9999999999999997654 58999999999999999999999         999999999999998665  49999999


Q ss_pred             CcccCccC---------CCCCccccCCCcCChhhhhcC-------CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchH--
Q 017936          165 YSKSSVLH---------SQPKSTVGTPAYIAPEVLLKK-------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK--  226 (363)
Q Consensus       165 la~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--  226 (363)
                      +|+.....         .......||+.|+|||++.+.       .+ +.++|||||||++|+|++|..||.......  
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA-LKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH-HHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCccccccccc-ccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            99754322         112244699999999999763       22 234899999999999999977764322110  


Q ss_pred             ------------HHHHHHHHHhccc---cCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          227 ------------NFRKTIHRILSVQ---YSIPD----YVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       227 ------------~~~~~~~~~~~~~---~~~~~----~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                                  .... ........   ..+|.    ...+++++.+||.+||+.+|.+|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFED-MQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             CCTTHHHHCSSCCHHH-HHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhhcccCCCchHHH-HHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                        0001 11111111   11111    1113457999999999999999999999953

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=336.23  Aligned_cols=248  Identities=22%  Similarity=0.349  Sum_probs=199.9

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ...++|++.+.||+|+||.||++++..   .+|+|++....   ...+.+.+|+.+++.++||||+++++++...+.+++
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            346899999999999999999999854   38999987532   233557789999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc--
Q 017936           95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  171 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~--  171 (363)
                      ||||+.+++|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++ ++  .+||+|||+++....  
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~--~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG--KVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC------
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC--CEEEeecCCcccccccc
Confidence            999999999999997755 699999999999999999999999999999999999997 33  599999999764321  


Q ss_pred             ----CCCCCccccCCCcCChhhhhcCC--------CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc
Q 017936          172 ----HSQPKSTVGTPAYIAPEVLLKKE--------YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ  239 (363)
Q Consensus       172 ----~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (363)
                          ........||+.|+|||++.+..        ..+.++|||||||++|+|++|..||..........    .+....
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~  259 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW----QMGTGM  259 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH----HHHTTC
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HhccCC
Confidence                11223345899999999987522        22445999999999999999999998765533222    222222


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          240 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       240 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ........++.++.++|.+||+.+|.+|||+.++++
T Consensus       260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            222223357899999999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.1e-45  Score=337.76  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=198.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHc--CCCCCeeeeeEEEEcCC----eEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~~~~~~~~~~----~~~   93 (363)
                      .++|++.+.||+|+||.||++++  +++.||||++....  ...+.+|+.+++.  ++||||+++++++....    .++
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            46899999999999999999997  48899999986542  4566778888876  79999999999998876    899


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HcCceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH--------~~giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                      +||||+++++|.+++.+ ..+++.+++.++.||+.||.|||        ++||+||||||+|||++.++.  +||+|||+
T Consensus       117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~  193 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL  193 (342)
T ss_dssp             EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTT
T ss_pred             EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCC
Confidence            99999999999999976 46999999999999999999999        899999999999999986654  99999999


Q ss_pred             cccCccCC-----CCCccccCCCcCChhhhhcCCCCC-----cchhhhhHHHHHHHHHhC----------CCCCCCCCch
Q 017936          166 SKSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYDG-----KIADVWSCGVTLYVMLVG----------AYPFEDPEEP  225 (363)
Q Consensus       166 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~l~~g----------~~pf~~~~~~  225 (363)
                      ++......     ......||+.|+|||++.+.....     .++|||||||++|+|++|          ..||......
T Consensus       194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~  273 (342)
T 1b6c_B          194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  273 (342)
T ss_dssp             CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence            97543332     234557999999999997653321     358999999999999999          7898764322


Q ss_pred             H-HHHHHHHHHhccccC--CCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          226 K-NFRKTIHRILSVQYS--IPD---YVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       226 ~-~~~~~~~~~~~~~~~--~~~---~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      . ........+......  .+.   ....+..+.+||.+||+.+|.+|||++++++|
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            1 111222222222211  111   11234579999999999999999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.4e-47  Score=353.53  Aligned_cols=245  Identities=19%  Similarity=0.233  Sum_probs=191.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---------ccHHHHHHHHHHHcCC---------CCCee
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLR---------HPNIV   80 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~e~~~l~~l~---------hpnIv   80 (363)
                      ..++|++.+.||+|+||+||+|++  +++.||||++.....         ..+.+.+|+.+++.++         ||||+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            457899999999999999999998  689999999976431         2267889999988875         77777


Q ss_pred             eeeEEEE------------------------------cCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 017936           81 RFKEVIL------------------------------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV  130 (363)
Q Consensus        81 ~~~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L  130 (363)
                      ++.+++.                              ..+.+|+|||||++|++.+.+.+ +.+++.+++.++.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence            7776643                              26789999999999987777644 5689999999999999999


Q ss_pred             HHHH-HcCceecCCCCCCEEEeCCCC------------------CcEEEeecCCcccCccCCCCCccccCCCcCChhhhh
Q 017936          131 SYCH-SMQVCHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL  191 (363)
Q Consensus       131 ~~LH-~~giiHrDlkp~NIll~~~~~------------------~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~  191 (363)
                      +||| ++||+||||||+|||++.++.                  ..+||+|||+|+....    ...+||+.|+|||++.
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhc
Confidence            9999 999999999999999987651                  1599999999985432    3458999999999998


Q ss_pred             cCCCCCcchhhhhHHHH-HHHHHhCCCCCCCCCchHHHHHHHHHHhc-cccCC----CCCCCCCHHHHHHHHHhcccCCC
Q 017936          192 KKEYDGKIADVWSCGVT-LYVMLVGAYPFEDPEEPKNFRKTIHRILS-VQYSI----PDYVHISPECRHLISRIFVADPA  265 (363)
Q Consensus       192 ~~~~~~~~~DiwslG~i-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~s~~~~~li~~~L~~~p~  265 (363)
                      +..  ..++||||||++ .+++++|..||....   ........+.. .....    +.+..+|+++.+||++||+.+  
T Consensus       251 g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--  323 (336)
T 2vuw_A          251 GDG--DYQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--  323 (336)
T ss_dssp             CCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred             CCC--ccceehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence            665  445999998777 778889999984311   00111112221 11111    112246889999999999876  


Q ss_pred             CCCCHHHHh-cCcccc
Q 017936          266 KRISIPEIR-NHEWFL  280 (363)
Q Consensus       266 ~R~t~~ell-~h~~~~  280 (363)
                         |++|+| +||||+
T Consensus       324 ---sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 ---SATDLLCQHSLFK  336 (336)
T ss_dssp             ---SHHHHHHHCGGGC
T ss_pred             ---CHHHHHhcCCCcC
Confidence               999999 999994

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.9e-45  Score=345.91  Aligned_cols=245  Identities=14%  Similarity=0.113  Sum_probs=189.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCC-CCe---------------
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH-PNI---------------   79 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h-pnI---------------   79 (363)
                      ..+|++.+.||+|+||+||+|++..+|+.||||++....    ...+.+.+|+.+++.++| +|.               
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345889999999999999999999999999999987432    235678899999999977 221               


Q ss_pred             ------eeeeEEEEc-----CCeEEEEEeccCCCchHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHcCceec
Q 017936           80 ------VRFKEVILT-----PTHLAIVMEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHSMQVCHR  141 (363)
Q Consensus        80 ------v~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-------~~~l~~~~~~~~~~qil~~L~~LH~~giiHr  141 (363)
                            ..+..++..     ...++++|+++ +++|.+++..       ...+++..+..++.||+.||+|||++|||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                  111111222     22467888876 6799888741       2347888999999999999999999999999


Q ss_pred             CCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhh----------cCCCCCcchhhhhHHHHHHH
Q 017936          142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL----------KKEYDGKIADVWSCGVTLYV  211 (363)
Q Consensus       142 Dlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~----------~~~~~~~~~DiwslG~il~~  211 (363)
                      ||||+|||++.++.  +||+|||+++.....  ....+| +.|+|||++.          +..++. ++|||||||++|+
T Consensus       236 DiKp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF-AFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH-HHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCc-hhhHHHHHHHHHH
Confidence            99999999987665  999999998754332  344567 9999999993          333443 4999999999999


Q ss_pred             HHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          212 MLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       212 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      |++|+.||........          ....+.....+|+++.+||.+||+.+|.+|||+.++++||||.+
T Consensus       310 lltg~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          310 IWCADLPNTDDAALGG----------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHHSSCCCCTTGGGSC----------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHCCCCCCCcchhhh----------HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            9999999976543221          11122334468999999999999999999999999999999965

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.8e-44  Score=357.26  Aligned_cols=247  Identities=25%  Similarity=0.386  Sum_probs=201.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCC---CcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      .++|++.+.||+|+||+||++.+..+   +..||+|.+....  ...+.+.+|+.+++.++||||+++++++. .+.+++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            46799999999999999999998643   4579999886532  23367889999999999999999999984 466899


Q ss_pred             EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      ||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+......
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~~~  545 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDST  545 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC--
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCCCc
Confidence            999999999999998654 6999999999999999999999999999999999999987654  9999999998643322


Q ss_pred             C--CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          174 Q--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       174 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                      .  .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.........    +... ...+.+..+++
T Consensus       546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~----i~~~-~~~~~~~~~~~  619 (656)
T 2j0j_A          546 YYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENG-ERLPMPPNCPP  619 (656)
T ss_dssp             --------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHHT-CCCCCCTTCCH
T ss_pred             ceeccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHcC-CCCCCCccccH
Confidence            2  123456789999999988877655 999999999999997 9999987665433322    2221 22334456899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .+.+||.+||+.+|.+|||+.++++
T Consensus       620 ~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-43  Score=319.77  Aligned_cols=224  Identities=17%  Similarity=0.140  Sum_probs=182.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCccc----HHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++.+.||+|+||.||+|++..+++.||||++.......    +.+.+|+..++.++||||+++++++...+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            4578999999999999999999999999999999998754433    678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||||++|++|.+++...  ..+.++..++.||+.||+|||++||+||||||+|||++.++.  +||+++|          
T Consensus       109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~----------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA----------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC----------
T ss_pred             EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc----------
Confidence            99999999999998543  467789999999999999999999999999999999987665  8988554          


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC--CCCCCCCHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPEC  252 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~  252 (363)
                               |++|       + +.++|||||||++|+|++|..||.+.+......... .........  .....+++++
T Consensus       175 ---------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l  236 (286)
T 3uqc_A          175 ---------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-RDTAGQPIEPADIDRDIPFQI  236 (286)
T ss_dssp             ---------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-BCTTSCBCCHHHHCTTSCHHH
T ss_pred             ---------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-HHhccCCCChhhcccCCCHHH
Confidence                     3332       3 444999999999999999999998755422110000 000000000  1124579999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 017936          253 RHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .+||.+||+.||.+| |+.++++
T Consensus       237 ~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          237 SAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHHHHcccCCccC-CHHHHHH
Confidence            999999999999999 9999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.6e-44  Score=360.43  Aligned_cols=239  Identities=22%  Similarity=0.276  Sum_probs=196.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe-----
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH-----   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~-----   91 (363)
                      .++|++.+.||+|+||+||++.+.. +++.||||++....  .....+.+|+.+++.++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4799999999999999999999976 78999999886543  233567899999999999999999999987655     


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      .|+||||++|++|.+.+..  .+++.+++.++.||+.||.|||++|||||||||+|||++.+   .+||+|||+++....
T Consensus       159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINS  233 (681)
T ss_dssp             EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTC
T ss_pred             eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhccc
Confidence            7999999999999887755  79999999999999999999999999999999999999864   499999999985433


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                      .   ....||+.|+|||++.+..  +.++|||||||++|+|++|..||.......            ..........++.
T Consensus       234 ~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------~~~~~~~~~~~~~  296 (681)
T 2pzi_A          234 F---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------LPEDDPVLKTYDS  296 (681)
T ss_dssp             C---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------CCTTCHHHHHCHH
T ss_pred             C---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccc------------ccccccccccCHH
Confidence            2   4567999999999987654  445999999999999999999986421100            0000001123678


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017936          252 CRHLISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                      +.+||.+||+.+|.+||+..+.+.|+|+.
T Consensus       297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            99999999999999999999999999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.8e-36  Score=298.43  Aligned_cols=184  Identities=14%  Similarity=0.038  Sum_probs=134.6

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeecCC-----------cccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEE
Q 017936           28 DIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        28 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++.|+.|.+..++....|+.||+|++.+..           ...+.+.+|+.+|+++ .|+||+++++++++++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            4567888888888888899999999997642           1235688999999999 699999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~  174 (363)
                      ||||+|++|.+++.+.+++++.   .|+.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+..... ..
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CC
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCcc
Confidence            9999999999999999889875   47899999999999999999999999999987654  999999999865433 23


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCC
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP  218 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  218 (363)
                      ..+.+||+.|+|||++.+. +... +|+||+|++++.+.++..|
T Consensus       396 ~~t~vGTp~YmAPE~l~g~-~~~~-~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAEN-KSWN-GFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             SHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             ccCceechhhccHHHhCCC-CCCc-ccccccccchhhhccccch
Confidence            4556899999999998765 3334 8999999998887665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=2.5e-30  Score=253.26  Aligned_cols=181  Identities=20%  Similarity=0.124  Sum_probs=140.5

Q ss_pred             eeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..+.||+|+||+||++.  ..++.+|+|.......         ..+.+.+|+.+++.++||||+++..++...+..|+|
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            35789999999999994  5577899998644221         123478999999999999999665555567777999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-  174 (363)
                      ||||+|++|.+++..        +..++.||+.||+|||++||+||||||+|||++.    ++||+|||+|+....... 
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCcccc
Confidence            999999999998865        6789999999999999999999999999999986    499999999986543221 


Q ss_pred             -------CCccccCCCcCChhhhhc--CCCCCcchhhhhHHHHHHHHHhCCCCCC
Q 017936          175 -------PKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFE  220 (363)
Q Consensus       175 -------~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~  220 (363)
                             .....||+.|+|||++..  ..|... +|+||..+-..+-+.++.+|.
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhccccC
Confidence                   124579999999999976  455444 799999988888887777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=4.5e-27  Score=211.87  Aligned_cols=143  Identities=17%  Similarity=0.157  Sum_probs=115.8

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-------------------ccHHHHHHHHHHHcCCCCCeeee
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRF   82 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------------------~~~~~~~e~~~l~~l~hpnIv~~   82 (363)
                      .|.+.+.||+|+||.||+|.+ .+|+.||+|++.....                   ....+.+|+.+++.++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            344559999999999999999 8899999999864321                   2345789999999999  4 666


Q ss_pred             eEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEee
Q 017936           83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD  162 (363)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~D  162 (363)
                      .+++.. +..|+||||++|++|.+ +.      ..+...++.||+.||.|||++||+||||||+|||++ ++  .+||+|
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~D  235 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIID  235 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECC
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEE
Confidence            665544 44599999999999987 31      234567999999999999999999999999999998 44  599999


Q ss_pred             cCCcccCccCCCCCccccCCCcCChhhhh
Q 017936          163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLL  191 (363)
Q Consensus       163 Fgla~~~~~~~~~~~~~gt~~y~aPE~~~  191 (363)
                      ||+|+.            +..++|||.+.
T Consensus       236 FG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          236 FPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             CTTCEE------------TTSTTHHHHHH
T ss_pred             CCCCeE------------CCCCCHHHHHH
Confidence            999863            45589999875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.89  E-value=3e-23  Score=184.53  Aligned_cols=136  Identities=15%  Similarity=0.104  Sum_probs=107.1

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcE--EEEEEeecCCcc-------------------------cHHHHHHHHHHHcC
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKI-------------------------DENVQREIINHRSL   74 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~-------------------------~~~~~~e~~~l~~l   74 (363)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++......                         ...+.+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478999999999999999998778988  999987543111                         12578899999999


Q ss_pred             CCCCe--eeeeEEEEcCCeEEEEEeccCC-C----chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCC
Q 017936           75 RHPNI--VRFKEVILTPTHLAIVMEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLE  146 (363)
Q Consensus        75 ~hpnI--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH-~~giiHrDlkp~  146 (363)
                      .|+++  +.++..    +..++||||+.+ |    +|.+....   .++..+..++.||+.||.||| ++||+||||||+
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            88764  334432    245899999942 3    66554332   345678899999999999999 999999999999


Q ss_pred             CEEEeCCCCCcEEEeecCCccc
Q 017936          147 NTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus       147 NIll~~~~~~~vkL~DFgla~~  168 (363)
                      |||++.    .++|+|||+|..
T Consensus       201 NILl~~----~~~liDFG~a~~  218 (258)
T 1zth_A          201 NIMYID----KVYFIDMGQAVT  218 (258)
T ss_dssp             SEEESS----SEEECCCTTCEE
T ss_pred             HEEEcC----cEEEEECccccc
Confidence            999975    499999999874

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.81  E-value=6.7e-21  Score=176.61  Aligned_cols=137  Identities=16%  Similarity=0.142  Sum_probs=98.3

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---------------ccHH--------HHHHHHHHHcCCCCC
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------------IDEN--------VQREIINHRSLRHPN   78 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------------~~~~--------~~~e~~~l~~l~hpn   78 (363)
                      =|.+...||.|++|.||+|.+. +|+.||||+++....               ....        ..+|...+.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3899999999999999999984 689999998753210               0011        234555666654443


Q ss_pred             eeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCC--
Q 017936           79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP--  156 (363)
Q Consensus        79 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~--  156 (363)
                      +....-+... .+ ++||||++|++|..+.      .......++.||+.+|.+||++|||||||||.|||++.++.+  
T Consensus       175 v~vp~p~~~~-~~-~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          175 FPVPEPIAQS-RH-TIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             CSCCCEEEEE-TT-EEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred             CCCCeeeecc-Cc-eEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence            3221111112 22 7999999999886542      223456788999999999999999999999999999876532  


Q ss_pred             ------cEEEeecCCcc
Q 017936          157 ------RLKICDFGYSK  167 (363)
Q Consensus       157 ------~vkL~DFgla~  167 (363)
                            .+.|+||+.+.
T Consensus       247 ~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             TTSEEEEEEECCCTTCE
T ss_pred             ccccccceEEEEeCCcc
Confidence                  38999999765

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.53  E-value=6.5e-14  Score=124.21  Aligned_cols=138  Identities=17%  Similarity=0.123  Sum_probs=110.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +.|++...++.|+.+.||++...  ++.+++|+..... .....+.+|+.+++.+. +..++++++++...+..|+|||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            45999999999999999999743  6789999886522 22346889999998884 67788999999988999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------  135 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-------------------------------------------  135 (363)
                      ++|.+|.+...     +......++.++..+|..||+                                           
T Consensus        92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            99999876521     223345788999999999998                                           


Q ss_pred             ----------------cCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          136 ----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       136 ----------------~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                                      ..++|||++|.|||++...  .+.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc--EEEEEEchhcc
Confidence                            4589999999999997532  25699999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.39  E-value=2.1e-12  Score=113.95  Aligned_cols=134  Identities=13%  Similarity=0.112  Sum_probs=99.4

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..|.+....+.|..+.||++.. .+|+.+++|+....  ....+.+|+..++.+.+.+  +++++.+....+..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            3566655555677799999964 55677999986554  2356788998888886444  56688888888889999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC-----------------------------------------
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-----------------------------------------  137 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~g-----------------------------------------  137 (363)
                      ++|.+|.  .   ...+   ...++.+++..|..||+..                                         
T Consensus        97 i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           97 VPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             CSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             cCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            9999884  1   1122   2356777888888888643                                         


Q ss_pred             -----------------ceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          138 -----------------VCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       138 -----------------iiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                                       ++|||++|.|||++.+.  .+.|+||+.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGR--FSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc--EEEEEcchhcc
Confidence                             99999999999997543  25699999865

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.35  E-value=3.9e-12  Score=118.08  Aligned_cols=142  Identities=14%  Similarity=0.204  Sum_probs=107.7

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEee--cCC--cccHHHHHHHHHHHcCC--CCCeeeeeEEEEcC---CeEE
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGD--KIDENVQREIINHRSLR--HPNIVRFKEVILTP---THLA   93 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~--~~~--~~~~~~~~e~~~l~~l~--hpnIv~~~~~~~~~---~~~~   93 (363)
                      ...++.|+.|.++.||++...  +..+++|+..  ...  .....+.+|+.+++.+.  +..+++++.++.+.   +..|
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            345788999999999999854  4678999776  332  22456788999998887  45588888888766   4579


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 017936           94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------------------------------------  135 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~--------------------------------------  135 (363)
                      +||||++|.++.+..  ...+++.+...++.+++..|..||+                                      
T Consensus       118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999999998875421  2347888999999999999999997                                      


Q ss_pred             --------------------cCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936          136 --------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus       136 --------------------~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                                          .+++|||++|.|||++.++...+.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                368999999999999865433368999998863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.22  E-value=1.2e-11  Score=112.09  Aligned_cols=184  Identities=17%  Similarity=0.129  Sum_probs=122.5

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCC--eeeeeEEEEcCC---eEEEEEecc
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN--IVRFKEVILTPT---HLAIVMEYA   99 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpn--Iv~~~~~~~~~~---~~~lv~e~~   99 (363)
                      ++.++.|..+.||++.     ..+++|+.... .....+.+|...++.+. +..  +++++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999874     35899975432 33567889999998773 322  444544433333   348899999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 017936          100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------------------------------------------  135 (363)
Q Consensus       100 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~--------------------------------------------  135 (363)
                      +|.+|.....  ..++..+...++.+++..|..||+                                            
T Consensus        99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A           99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            9999875433  347888889999999999999996                                            


Q ss_pred             --------------cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccccCCCc---CChhhhhc--CCCC
Q 017936          136 --------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY---IAPEVLLK--KEYD  196 (363)
Q Consensus       136 --------------~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y---~aPE~~~~--~~~~  196 (363)
                                    ..++|||++|.||+++.+....+.|+||+.+.........   .....+   ..|+....  ..|.
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl---~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF---ISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH---HTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH---HHHHhhccccCHHHHHHHHHHcC
Confidence                          1369999999999998642234789999988643221100   001111   23332211  0011


Q ss_pred             Cc-----------chhhhhHHHHHHHHHhCCCCCC
Q 017936          197 GK-----------IADVWSCGVTLYVMLVGAYPFE  220 (363)
Q Consensus       197 ~~-----------~~DiwslG~il~~l~~g~~pf~  220 (363)
                      ..           -.+.|++|.++|.+.+|..+|.
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            11           1589999999999999987763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.86  E-value=2.8e-08  Score=89.91  Aligned_cols=136  Identities=18%  Similarity=0.144  Sum_probs=96.8

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCC---CeeeeeEEEE-cCCeEEEEEeccCC
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVIL-TPTHLAIVMEYASG  101 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hp---nIv~~~~~~~-~~~~~~lv~e~~~~  101 (363)
                      ++.++.|....||++     +..+++|+. ........+.+|..+++.+.+.   .+++.+.+.. ..+..++||++++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~-~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFP-KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEE-SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEec-CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            556888999999988     456899974 2223346788999999988653   3566666664 44567899999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------------
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------------------------------------------  136 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~---------------------------------------------  136 (363)
                      .++.....  ..++..+...++.++...|..||+.                                             
T Consensus        98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            98876322  2356666667777777777777742                                             


Q ss_pred             ---------------CceecCCCCCCEEEeCC-CCCc-EEEeecCCcccC
Q 017936          137 ---------------QVCHRDLKLENTLLDGS-PAPR-LKICDFGYSKSS  169 (363)
Q Consensus       137 ---------------giiHrDlkp~NIll~~~-~~~~-vkL~DFgla~~~  169 (363)
                                     .++|||++|.|||++.+ ..+. +.|+||+.+...
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           34999999999999751 1123 489999987643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.68  E-value=3e-07  Score=81.26  Aligned_cols=132  Identities=19%  Similarity=0.215  Sum_probs=94.7

Q ss_pred             eecccCCe-EEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEeccCCCchH
Q 017936           28 DIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF  105 (363)
Q Consensus        28 ~lg~G~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (363)
                      .+..|..| .||++.....+..+++|+-...  ....+.+|...++.+. +--+.+++.++.+.+..++|||+++|.++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            34445444 6899888777888999975543  2456788988888774 223778888888889999999999998887


Q ss_pred             HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------------------
Q 017936          106 ERICNAGRFSEDEARFFFQQLISGVSYCHSM-------------------------------------------------  136 (363)
Q Consensus       106 ~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~-------------------------------------------------  136 (363)
                      +.....    ......+..++...|..||+.                                                 
T Consensus       109 ~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  184 (272)
T 4gkh_A          109 QVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH  184 (272)
T ss_dssp             HHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred             ccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence            655432    223344556666666666631                                                 


Q ss_pred             ---------CceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          137 ---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       137 ---------giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                               .++|+|+.|.|||++..+  .+-|+||+.+.
T Consensus       185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~--~~~viDwe~a~  222 (272)
T 4gkh_A          185 KLLPFSPDSVVTHGDFSLDNLIFDEGK--LIGCIDVGRVG  222 (272)
T ss_dssp             TTCCCCCCEEEECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             hcccccCCcEEEcCCCCCCeEEEECCe--EEEEEECcccc
Confidence                     178999999999998543  35699999765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.61  E-value=1.4e-07  Score=88.52  Aligned_cols=77  Identities=17%  Similarity=0.099  Sum_probs=50.4

Q ss_pred             eeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--------cccHHHHHHHHHHHcCCC--C-CeeeeeEEEEcCCeEE
Q 017936           25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------KIDENVQREIINHRSLRH--P-NIVRFKEVILTPTHLA   93 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~e~~~l~~l~h--p-nIv~~~~~~~~~~~~~   93 (363)
                      -++.||.|..+.||++....+++.+++|......        ........|..+++.+..  | .+++++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            4678999999999999766667889999764321        123456778888876632  3 34455543  334458


Q ss_pred             EEEeccCCCc
Q 017936           94 IVMEYASGGE  103 (363)
Q Consensus        94 lv~e~~~~~~  103 (363)
                      +|||+++|..
T Consensus       112 lvmE~l~g~~  121 (397)
T 2olc_A          112 TVMEDLSHLK  121 (397)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEEeCCCcc
Confidence            9999998743

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.42  E-value=2.2e-07  Score=85.67  Aligned_cols=82  Identities=9%  Similarity=0.095  Sum_probs=56.8

Q ss_pred             eeecee-cccCCeEEEEEEEc--C----CCcEEEEEEeecCC---c-ccHHHHHHHHHHHcCCC---CCeeeeeEEEEcC
Q 017936           24 ELVRDI-GSGNFGVARLMRDK--K----TEELVAVKYIERGD---K-IDENVQREIINHRSLRH---PNIVRFKEVILTP   89 (363)
Q Consensus        24 ~i~~~l-g~G~~g~V~~~~~~--~----~~~~~aiK~~~~~~---~-~~~~~~~e~~~l~~l~h---pnIv~~~~~~~~~   89 (363)
                      ..++.| +.|..+.+|++...  .    +++.+++|+.....   . ....+.+|+.+++.+..   -.+++++.+..+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            446778 88889999988753  0    25678999765432   1 23567788888877742   3577788777655


Q ss_pred             ---CeEEEEEeccCCCchH
Q 017936           90 ---THLAIVMEYASGGELF  105 (363)
Q Consensus        90 ---~~~~lv~e~~~~~~L~  105 (363)
                         +..++|||+++|.++.
T Consensus       103 ~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCC
T ss_pred             CccCCceEEEEecCCCChh
Confidence               3568999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.35  E-value=3.6e-06  Score=76.77  Aligned_cols=74  Identities=18%  Similarity=0.247  Sum_probs=42.4

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-----CCCCeeeee-E--EEEcCCeEEEEEe
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK-E--VILTPTHLAIVME   97 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-----~hpnIv~~~-~--~~~~~~~~~lv~e   97 (363)
                      ++.|+.|..+.||++...  +..+++|+....   ...+..|..+++.+     ..|.++... +  +....+..+++|+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            456677788999999863  335899988753   23344455555443     234444311 0  1234667899999


Q ss_pred             ccCCCch
Q 017936           98 YASGGEL  104 (363)
Q Consensus        98 ~~~~~~L  104 (363)
                      |++|.++
T Consensus       112 ~i~G~~~  118 (346)
T 2q83_A          112 WIEGRPF  118 (346)
T ss_dssp             CCCCBCC
T ss_pred             eecCccC
Confidence            9998654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.09  E-value=9.2e-06  Score=72.98  Aligned_cols=72  Identities=13%  Similarity=0.081  Sum_probs=45.0

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEcCCeEEEEEecc-CCCc
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA-SGGE  103 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~-~~~~  103 (363)
                      ++.|+.|....+|++      ..+++|+........-...+|+..++.+...++ ++++.+.  ...-++++||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            788999999999998      458999876542222233567777765542222 4555443  33347899999 7765


Q ss_pred             hH
Q 017936          104 LF  105 (363)
Q Consensus       104 L~  105 (363)
                      +.
T Consensus        95 l~   96 (301)
T 3dxq_A           95 MS   96 (301)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.08  E-value=1.4e-05  Score=75.37  Aligned_cols=73  Identities=14%  Similarity=0.242  Sum_probs=44.9

Q ss_pred             eeceecccCCeEEEEEEEcCCCcEEEEEEeec-----CCc-----ccHHHHHHHHHHH-cCCCCCeeeeeEEEEcCCeEE
Q 017936           25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDK-----IDENVQREIINHR-SLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~-----~~~~~~~e~~~l~-~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      -++.||.|..+.||++..  +++.++||....     ...     ....+..|+..+. ......+++++.+.  ....+
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            467889999999999964  467899994321     111     1122333333222 22334567777665  45568


Q ss_pred             EEEecc-CC
Q 017936           94 IVMEYA-SG  101 (363)
Q Consensus        94 lv~e~~-~~  101 (363)
                      +|||++ +|
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.04  E-value=3.7e-05  Score=69.39  Aligned_cols=77  Identities=18%  Similarity=0.109  Sum_probs=60.5

Q ss_pred             eeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEEEEEeccC
Q 017936           24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYAS  100 (363)
Q Consensus        24 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~  100 (363)
                      .-++.|+.|....+|++..  .+..+++|+....  ....+.+|...++.|.   ...+++++.+....+..++|||+++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3467889999999999985  4677899986643  2456788888887773   3568888888888888999999999


Q ss_pred             CCch
Q 017936          101 GGEL  104 (363)
Q Consensus       101 ~~~L  104 (363)
                      |.++
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8765

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.85  E-value=4.7e-05  Score=70.60  Aligned_cols=138  Identities=16%  Similarity=0.126  Sum_probs=82.5

Q ss_pred             eceecccCCeEEEEEEEcC-------CCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEe
Q 017936           26 VRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++.|..|-...+|++....       .++.+++|+............+|..+++.+. +.-.++++.++.+    .+|||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            4566668888999998642       3578999986443223455678988887774 2223666666543    39999


Q ss_pred             ccCCCchHHH--------------HH---hC----C-CC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 017936           98 YASGGELFER--------------IC---NA----G-RF--SEDEARFFFQQLIS-------------------GVSYCH  134 (363)
Q Consensus        98 ~~~~~~L~~~--------------~~---~~----~-~l--~~~~~~~~~~qil~-------------------~L~~LH  134 (363)
                      |++|.+|...              +.   ..    + ..  -..++..|+.++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665311              11   11    0 11  24566667655432                   233333


Q ss_pred             ----H----cCceecCCCCCCEEEeCC--CCCcEEEeecCCcc
Q 017936          135 ----S----MQVCHRDLKLENTLLDGS--PAPRLKICDFGYSK  167 (363)
Q Consensus       135 ----~----~giiHrDlkp~NIll~~~--~~~~vkL~DFgla~  167 (363)
                          .    ..++|+|+.+.|||++.+  ..+.+.|+||..|.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                2    259999999999999865  12359999999775

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.84  E-value=0.0002  Score=60.22  Aligned_cols=122  Identities=16%  Similarity=0.082  Sum_probs=76.3

Q ss_pred             CchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCccc
Q 017936          102 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV  179 (363)
Q Consensus       102 ~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~~  179 (363)
                      -+|.+.+.. ..+++|+++|.++.|.+.+|..+-. +.-..+=+.|..|++..+|.  |-+.+ +.+.           .
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s~-----------~   98 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AADD-----------A   98 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-cccc-----------c
Confidence            478888864 5689999999999999999887632 22223445568999987765  65543 1110           1


Q ss_pred             cCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017936          180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI  259 (363)
Q Consensus       180 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  259 (363)
                      ....+.|||...  .....+.=|||||+++|.-+--..|=                       .....+|+.+.+||..|
T Consensus        99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------------~eE~eLS~~LE~LL~~M  153 (229)
T 2yle_A           99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------------NEERELSPPLEQLIDHM  153 (229)
T ss_dssp             --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------------TEEECCCHHHHHHHHHH
T ss_pred             cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------------ccchhhCHHHHHHHHHH
Confidence            233466888653  12223368999999999887533221                       11235799999999999


Q ss_pred             ccc
Q 017936          260 FVA  262 (363)
Q Consensus       260 L~~  262 (363)
                      ...
T Consensus       154 t~~  156 (229)
T 2yle_A          154 ANT  156 (229)
T ss_dssp             TTC
T ss_pred             Hhc
Confidence            866

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.82  E-value=3.8e-05  Score=69.46  Aligned_cols=139  Identities=16%  Similarity=0.149  Sum_probs=76.7

Q ss_pred             eeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-----CCCeeeee-E--EEEcCCeEEEE
Q 017936           24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFK-E--VILTPTHLAIV   95 (363)
Q Consensus        24 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-----hpnIv~~~-~--~~~~~~~~~lv   95 (363)
                      .-++.|+.|....+|++... ++ .+++|+.... ...+.+..|+.+++.+.     -|.++... +  +....+..+++
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l  101 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL  101 (322)
T ss_dssp             EEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred             eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence            34677888888999999753 33 5899987653 12345566777766553     23333211 0  11234567899


Q ss_pred             EeccCCCchHH--------------HHHh-CCCC--------CHHHHHHH---------------HHHHHHHHHHHHH--
Q 017936           96 MEYASGGELFE--------------RICN-AGRF--------SEDEARFF---------------FQQLISGVSYCHS--  135 (363)
Q Consensus        96 ~e~~~~~~L~~--------------~~~~-~~~l--------~~~~~~~~---------------~~qil~~L~~LH~--  135 (363)
                      |++++|.++..              .+.. ...+        ........               -..+...+..+++  
T Consensus       102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~  181 (322)
T 2ppq_A          102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW  181 (322)
T ss_dssp             EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred             EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence            99999865411              0111 0011        11100000               0113444555553  


Q ss_pred             -----cCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          136 -----MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       136 -----~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                           .+++|+|++|.|||++.+.  .+.|+||+.+.
T Consensus       182 ~~~~~~~liHgDl~~~Nil~~~~~--~~~lIDf~~a~  216 (322)
T 2ppq_A          182 PKDLPAGVIHADLFQDNVFFLGDE--LSGLIDFYFAC  216 (322)
T ss_dssp             CCSSCEEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             cccCCcccCCCCCCccCEEEeCCc--eEEEecchhcc
Confidence                 4799999999999997543  24799999765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.75  E-value=7.2e-05  Score=69.13  Aligned_cols=76  Identities=14%  Similarity=0.035  Sum_probs=45.6

Q ss_pred             eeceecccCCeEEEEEEEcC--------CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEcCCeEEEE
Q 017936           25 LVRDIGSGNFGVARLMRDKK--------TEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIV   95 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv   95 (363)
                      -++.|+.|....+|++....        .+..+++|+.............|...++.+...+ .++++..+  .+  ++|
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v  112 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI  112 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence            35677888888999998643        1367899987553222222356777777664333 44666554  22  689


Q ss_pred             EeccCCCch
Q 017936           96 MEYASGGEL  104 (363)
Q Consensus        96 ~e~~~~~~L  104 (363)
                      |+|++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.74  E-value=6.5e-05  Score=70.98  Aligned_cols=75  Identities=13%  Similarity=0.103  Sum_probs=50.9

Q ss_pred             eeceecccCCeEEEEEEEcC-------CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEcCCeEEEEE
Q 017936           25 LVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~   96 (363)
                      -++.|+.|....||++....       .++.+++|+.... ...+.+.+|..+++.+...+ .+++++.+.+    .+|+
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            45678888889999998653       2578999987432 12155667888888775333 3667666542    3899


Q ss_pred             eccCCCch
Q 017936           97 EYASGGEL  104 (363)
Q Consensus        97 e~~~~~~L  104 (363)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.69  E-value=0.0001  Score=66.79  Aligned_cols=76  Identities=9%  Similarity=0.056  Sum_probs=48.6

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eeeeeEE-----EEcCCeEEEEEecc
Q 017936           27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV-----ILTPTHLAIVMEYA   99 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~~~~~-----~~~~~~~~lv~e~~   99 (363)
                      ..|+ |....||++.. .+|+.+++|+..........+..|..+++.+....  +++++..     ....+..+++|+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 88889998864 34667999988654334556777877776653212  3333332     22345678999999


Q ss_pred             CCCch
Q 017936          100 SGGEL  104 (363)
Q Consensus       100 ~~~~L  104 (363)
                      +|.++
T Consensus       110 ~G~~~  114 (328)
T 1zyl_A          110 GGRQF  114 (328)
T ss_dssp             CCEEC
T ss_pred             CCCCC
Confidence            88554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.57  E-value=0.00052  Score=62.28  Aligned_cols=138  Identities=14%  Similarity=0.107  Sum_probs=70.6

Q ss_pred             eceecccCCeE-EEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC--CCeeeeeEEEEcCCeEEEEEeccCCC
Q 017936           26 VRDIGSGNFGV-ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG  102 (363)
Q Consensus        26 ~~~lg~G~~g~-V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~~  102 (363)
                      ++.|+.|+... +|++.. .+++.+++|......  ...+..|+.+++.+..  -.+++++.+....+  +++||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            45666565444 667653 235677887654332  1334456666655532  23556666533333  7899999876


Q ss_pred             chHHHHHhC--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH---
Q 017936          103 ELFERICNA--------------------------GRFSEDEAR-------F-FF------------QQLISGVSYC---  133 (363)
Q Consensus       103 ~L~~~~~~~--------------------------~~l~~~~~~-------~-~~------------~qil~~L~~L---  133 (363)
                      ++.+.+...                          +.+......       . +.            ..+...+..+   
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            665433211                          112221111       0 00            0111222233   


Q ss_pred             ---HHcCceecCCCCCCEEEeCCC--CCcEEEeecCCccc
Q 017936          134 ---HSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKS  168 (363)
Q Consensus       134 ---H~~giiHrDlkp~NIll~~~~--~~~vkL~DFgla~~  168 (363)
                         +...++|||+.+.|||++.+.  .+.+.|+||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence               134699999999999997531  13589999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.56  E-value=0.00039  Score=66.07  Aligned_cols=76  Identities=16%  Similarity=0.097  Sum_probs=49.5

Q ss_pred             eeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEcCCeEEEEEeccCCCc
Q 017936           25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGE  103 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~~~  103 (363)
                      -++.|+.|....+|++.....+..+++|+........-...+|..+++.|...++ +++++++.  +  .+||||++|.+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4567888989999999875445788999875432211122578888887764444 56777663  2  35999998855


Q ss_pred             h
Q 017936          104 L  104 (363)
Q Consensus       104 L  104 (363)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.54  E-value=0.00055  Score=60.76  Aligned_cols=79  Identities=11%  Similarity=0.029  Sum_probs=55.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCC---CCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRH---PNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h---pnIv~~~~~~~~~~~~~lv~   96 (363)
                      .+..-++.+|.|..+.||+++. .+|+.|++|+..... .....+.+|+..|+.|..   --+++++.+.  .  -++||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~   89 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAM   89 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEE
Confidence            3466688999999999999985 568899999765433 223457889988887742   1244555442  2  27899


Q ss_pred             eccCCCch
Q 017936           97 EYASGGEL  104 (363)
Q Consensus        97 e~~~~~~L  104 (363)
                      |++.++..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987644

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.34  E-value=0.0024  Score=58.13  Aligned_cols=68  Identities=10%  Similarity=-0.034  Sum_probs=41.4

Q ss_pred             cccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcC---CCCCeeeeeEE------EEcCCeEEEEEeccC
Q 017936           30 GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFKEV------ILTPTHLAIVMEYAS  100 (363)
Q Consensus        30 g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l---~hpnIv~~~~~------~~~~~~~~lv~e~~~  100 (363)
                      |.|....||++... +| .+++|+......     ..|+..++.|   .-|++++.+..      ....+..+++|+|++
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            33446899999753 34 799998766442     2444444433   22334444322      233577899999999


Q ss_pred             CCch
Q 017936          101 GGEL  104 (363)
Q Consensus       101 ~~~L  104 (363)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8766

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=97.07  E-value=0.0023  Score=60.01  Aligned_cols=76  Identities=13%  Similarity=-0.004  Sum_probs=49.1

Q ss_pred             eeceecccCCeEEEEEEEcCC-------CcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEE
Q 017936           25 LVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      -++.|..|-...+|++.....       ++.|++++........-+..+|..+++.+. +.-.+++++.+.  +  ++||
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~  149 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIE  149 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEE
Confidence            356677788889999987521       578999986543222223457887777764 223455655432  2  7899


Q ss_pred             eccCCCch
Q 017936           97 EYASGGEL  104 (363)
Q Consensus        97 e~~~~~~L  104 (363)
                      +|++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.03  E-value=0.019  Score=53.41  Aligned_cols=30  Identities=40%  Similarity=0.606  Sum_probs=24.2

Q ss_pred             ceecCCCCCCEEEeC----CCCCcEEEeecCCcc
Q 017936          138 VCHRDLKLENTLLDG----SPAPRLKICDFGYSK  167 (363)
Q Consensus       138 iiHrDlkp~NIll~~----~~~~~vkL~DFgla~  167 (363)
                      ++|+|+.+.|||+..    +....+.++||.+|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            679999999999953    223459999999876

>2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens}

Probab=93.25  E-value=0.027  Score=41.15  Aligned_cols=60  Identities=17%  Similarity=0.158  Sum_probs=43.7

Q ss_pred             CCCCHHHHHHHHHHhCCCCCCCCChhhhhcCCCCcccccccC--CCCCCCCCCCCCCeeeec
Q 017936          303 PMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDED--IDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~--~~~~~~~d~d~~g~i~~~  362 (363)
                      +...+.++.+.+...+.+..|.++.+++............++  .+.....|.|++|.|+|.
T Consensus        31 ~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~   92 (100)
T 2lv7_A           31 PEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFE   92 (100)
T ss_dssp             CGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHH
T ss_pred             CHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHH
Confidence            456788899999999999999999999765432222222222  145667899999999985

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.00  E-value=3.6  Score=34.30  Aligned_cols=116  Identities=10%  Similarity=0.097  Sum_probs=79.4

Q ss_pred             CCCCCeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC
Q 017936           74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS  153 (363)
Q Consensus        74 l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~  153 (363)
                      ..||+++.. .+-.+++.+.+.++.-+.+.-+..+   ..++..+.++++.+|+....++  ..=+|--|.|+||+++.+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTT
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCC
Confidence            468998876 6777788877777765433223333   3478899999999999887444  344788899999999876


Q ss_pred             CCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhh-HHHHHHHHHhCCCCCC
Q 017936          154 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS-CGVTLYVMLVGAYPFE  220 (363)
Q Consensus       154 ~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws-lG~il~~l~~g~~pf~  220 (363)
                      ..  +++.-.|+-...                +|.     .. .. .|.|. +=|++..+++++..|.
T Consensus       116 ~~--p~i~~RGik~~l----------------~P~-----~~-~e-e~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          116 GL--PIAKTRGLQNVV----------------DPL-----PV-SE-AEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             SC--EEESCCEETTTB----------------SCC-----CC-CH-HHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CC--EEEEEccCccCC----------------CCC-----CC-CH-HHHHHHHHHHHHHHHcCCCCHH
Confidence            65  888877753311                111     11 12 34444 7788889999988883

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.48  E-value=3.9  Score=34.14  Aligned_cols=114  Identities=16%  Similarity=0.153  Sum_probs=78.1

Q ss_pred             CCCCCeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHHcCceecCCCCCCEEEeC
Q 017936           74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS-YCHSMQVCHRDLKLENTLLDG  152 (363)
Q Consensus        74 l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~-~LH~~giiHrDlkp~NIll~~  152 (363)
                      ..||++  -..+-.+++.+.+.++.-+++.-+..+.   .++..+.++++.+|+.... ++  ..-+|--|.|+||+++.
T Consensus        47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~  119 (219)
T 4ano_A           47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNR  119 (219)
T ss_dssp             GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECT
T ss_pred             ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeC
Confidence            368888  3445578888888888765544444443   4788999999999988665 33  44578889999999987


Q ss_pred             CCCCcEEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhh-HHHHHHHHHhCCCCC
Q 017936          153 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS-CGVTLYVMLVGAYPF  219 (363)
Q Consensus       153 ~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws-lG~il~~l~~g~~pf  219 (363)
                      +..  +++.-.|+-..                ++|..+      .. .|.|. +=|++..++.++..|
T Consensus       120 ~~~--p~i~hRGi~~~----------------lpP~e~------~e-e~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          120 ALE--PFFLHVGVKES----------------LPPDEW------DD-ERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             TCC--EEESCCEETTT----------------BSSCSC------CH-HHHHHHHHHHHHHHTTCSSCH
T ss_pred             CCc--EEEEEcCCccc----------------CCCCCC------CH-HHHHHHHHHHHHHHHcCCCCH
Confidence            766  89888875321                222211      12 35443 678888888888777

>1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=81.96  E-value=0.56  Score=34.65  Aligned_cols=60  Identities=10%  Similarity=-0.109  Sum_probs=41.8

Q ss_pred             CCCCHHHHHHHHHHhCCCCCCCCChhhhhcCCCCcccccccCCCCCCCCCCCCCCeeeec
Q 017936          303 PMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~  362 (363)
                      +.....++.+.+...+.+..|.++.+++........-..++-.+.....|.|++|.|+|.
T Consensus        17 s~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~gl~~~el~~i~~~~D~d~dG~I~~~   76 (110)
T 1iq3_A           17 TEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSKLSIPELSYIWELSDADCDGALTLP   76 (110)
T ss_dssp             SSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSSCSSCCHHHHHHHHCSSSCSEEEHH
T ss_pred             CHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCHHHHHHHHHHHcCCCCCcCcHH
Confidence            345688899999999999999999888764432222111111145557799999999984

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	363
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-84
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-82
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-82
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-80
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-80
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-79
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-76
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-76
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-76
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-75
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-75
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-75
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-74
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-73
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-70
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-69
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-68
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-68
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-66
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-65
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-64
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-63
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-63
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-62
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-61
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-61
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-60
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-59
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-59
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-59
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-58
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-57
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-57
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-56
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-56
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-56
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-56
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-54
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-52
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-52
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-50
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-50
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-45
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-44
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-44
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-42
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-15

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  253 bits (648), Expect = 7e-84
 Identities = 91/269 (33%), Positives = 146/269 (54%), Gaps = 10/269 (3%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
           + ++LV+ +G G +G  +L  ++ TEE VAVK +  +R     EN+++EI  ++ L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           +V+F           + +EY SGGELF+RI       E +A+ FF QL++GV Y H + +
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKKEY 195
            HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE+L ++E+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
             +  DVWSCG+ L  ML G  P++ P +     +        +  +  +  I      L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDWKEKKTYLNPWKKIDSAPLAL 239

Query: 256 ISRIFVADPAKRISIPEIRNHEWFLKNLP 284
           + +I V +P+ RI+IP+I+   W+ K L 
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKPLK 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (636), Expect = 4e-82
 Identities = 87/266 (32%), Positives = 142/266 (53%), Gaps = 14/266 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRH 76
           + +E+ R +G G FG   L R+K+++ ++A+K + +       V    +RE+     LRH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
           +V HRD+K EN LL  +    LKI DFG+S  +   S+  +  GT  Y+ PE++  + +D
Sbjct: 126 RVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHD 182

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
            K  D+WS GV  Y  LVG  PFE       +++T  RI  V+++ PD   ++   R LI
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARDLI 235

Query: 257 SRIFVADPAKRISIPEIRNHEWFLKN 282
           SR+   +P++R  + E+  H W   N
Sbjct: 236 SRLLKHNPSQRPMLREVLEHPWITAN 261

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  251 bits (643), Expect = 5e-82
 Identities = 80/327 (24%), Positives = 144/327 (44%), Gaps = 17/327 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 79
           D Y+++ ++GSG FGV     +K T  +   K+I     +D   V+ EI     L HP +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
           +   +       + +++E+ SGGELF+RI     + SE E   + +Q   G+ + H   +
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
            H D+K EN + +   A  +KI DFG +         K T  T  + APE++ ++     
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-F 207

Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLI 256
             D+W+ GV  YV+L G  PF      ++  +T+  +    +   +  +  +SPE +  I
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAG----EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263

Query: 257 SRIFVADPAKRISIPEIRNHEWF---LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQI 313
             +   +P KR+++ +   H W      NL + +      ++++ +  Q ++        
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI-----PSSRYNKIRQKIKEKYADWPA 318

Query: 314 IAEATIPAAGTQSLNQCLNGSLDIDDE 340
              A    A   SL +       I D 
Sbjct: 319 PQPAIGRIANFSSLRKHRPQEYQIYDS 345

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  245 bits (627), Expect = 5e-80
 Identities = 65/267 (24%), Positives = 121/267 (45%), Gaps = 8/267 (2%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
           ++Y +  D+G G FG+     +  +++    K+++        V++EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 81  RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
              E   +   L ++ E+ SG ++FERI  +A   +E E   +  Q+   + + HS  + 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
           H D++ EN +     +  +KI +FG ++        +     P Y APEV          
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183

Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLIS 257
            D+WS G  +YV+L G  PF      +  ++ I  I++ +Y+  +  +  IS E    + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239

Query: 258 RIFVADPAKRISIPEIRNHEWFLKNLP 284
           R+ V +   R++  E   H W  + + 
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIE 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  246 bits (629), Expect = 6e-80
 Identities = 85/313 (27%), Positives = 149/313 (47%), Gaps = 19/313 (6%)

Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIIN 70
           +++   H  D Y++  ++G+G FGV   + ++ T    A K++    + D E V++EI  
Sbjct: 17  VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76

Query: 71  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG 129
              LRHP +V   +       + ++ E+ SGGELFE++ +   + SEDEA  + +Q+  G
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           + + H     H DLK EN +     +  LK+ DFG +         K T GT  + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196

Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVH 247
              K       D+WS GV  Y++L G  PF      +N  +T+  + S  +++ D  +  
Sbjct: 197 AEGKPVGYY-TDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSG 251

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADLV---------VDNTTNNQF 297
           IS + +  I ++ +ADP  R++I +   H W    N P             + ++   ++
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKY 311

Query: 298 EEPDQPMQSIDEI 310
           +   +P+  +  I
Sbjct: 312 DAWPEPLPPLGRI 324

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  243 bits (621), Expect = 3e-79
 Identities = 93/285 (32%), Positives = 143/285 (50%), Gaps = 10/285 (3%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
            D Y+    +G+G F    L  DK+T++LVA+K I +   +  + +++ EI     ++HP
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           NIV   ++  +  HL ++M+  SGGELF+RI   G ++E +A     Q++  V Y H + 
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 138 VCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
           + HRDLK EN L        ++ I DFG SK     S   +  GTP Y+APEVL +K Y 
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRH 254
               D WS GV  Y++L G  PF D    +N  K   +IL  +Y    P +  IS   + 
Sbjct: 188 KA-VDCWSIGVIAYILLCGYPPFYD----ENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242

Query: 255 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 299
            I  +   DP KR +  +   H W   +   D  +  + + Q ++
Sbjct: 243 FIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKK 287

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  235 bits (601), Expect = 3e-76
 Identities = 75/298 (25%), Positives = 130/298 (43%), Gaps = 22/298 (7%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR 75
              +  +R+IG G+FG     RD +  E+VA+K +    K      +++ +E+   + LR
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           HPN ++++   L      +VMEY  G        +     E E        + G++Y HS
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
             + HRD+K  N LL       +K+ DFG +    + +   S VGTP ++APEV+L   +
Sbjct: 134 HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188

Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
            +YDGK  DVWS G+T   +     P  +     N    ++ I   +       H S   
Sbjct: 189 GQYDGK-VDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPALQSGHWSEYF 243

Query: 253 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEI 310
           R+ +       P  R +   +  H + L+  P  +++D       +     ++ +D +
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD-----LIQRTKDAVRELDNL 296

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (599), Expect = 3e-76
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 16/268 (5%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
           + ++  + +G G+F    L R+  T    A+K +E+   I EN    +         L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
            + HRDLK EN LL+      ++I DFG +K     S+       VGT  Y++PE+L +K
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
                 +D+W+ G  +Y ++ G  PF       N      +I+ ++Y  P+     P+ R
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDFPE--KFFPKAR 238

Query: 254 HLISRIFVADPAKRISIPEIRNHEWFLK 281
            L+ ++ V D  KR+   E+  +     
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (598), Expect = 5e-76
 Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 9/267 (3%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
             +Y     IG G  G      D  T + VA++ +    +   E +  EI+  R  ++PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
           IV + +  L    L +VMEY +GG L + +       E +     ++ +  + + HS QV
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
            HRD+K +N LL       +K+ DFG+          +ST VGTP ++APEV+ +K Y  
Sbjct: 138 IHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
           K  D+WS G+    M+ G  P+ +    +          +    + +   +S   R  ++
Sbjct: 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLN 251

Query: 258 RIFVADPAKRISIPEIRNHEWFLKNLP 284
           R    D  KR S  E+  H++     P
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLKIAKP 278

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 1e-75
 Identities = 66/276 (23%), Positives = 126/276 (45%), Gaps = 14/276 (5%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
            D +E++ ++G G FG     ++K+T  L A K I+   + + E+   EI    S  HPN
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
           IV+  +      +L I++E+ +GG +   +    R  +E + +   +Q +  ++Y H  +
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
           + HRDLK  N L        +K+ DFG S  +    Q + + +GTP ++APEV++ +   
Sbjct: 131 IIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 197 GKI----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPE 251
            +     ADVWS G+TL  M     P  +     N  + + +I   +  ++      S  
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHE----LNPMRVLLKIAKSEPPTLAQPSRWSSN 244

Query: 252 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 287
            +  + +    +   R +  ++  H +   +    +
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (596), Expect = 3e-75
 Identities = 95/317 (29%), Positives = 156/317 (49%), Gaps = 16/317 (5%)

Query: 11  GMDMPIMHDSDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
           G+ +      D Y++    +G G  G    + +K+T+E  A+K ++   K     +RE+ 
Sbjct: 1   GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVE 56

Query: 69  INHRSLRHPNIVRFKEVILTP----THLAIVMEYASGGELFERICNAG--RFSEDEARFF 122
           ++ R+ + P+IVR  +V          L IVME   GGELF RI + G   F+E EA   
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
            + +   + Y HS+ + HRD+K EN L     P   LK+ DFG++K +  H+   +   T
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176

Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
           P Y+APEVL  ++YD    D+WS GV +Y++L G  PF              RI   QY 
Sbjct: 177 PYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235

Query: 242 IPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 299
            P+  +  +S E + LI  +   +P +R++I E  NH W +++        +T+    E+
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295

Query: 300 PDQPMQSIDEIMQIIAE 316
            ++     +E+   +A 
Sbjct: 296 KERWEDVKEEMTSALAT 312

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  231 bits (591), Expect = 3e-75
 Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 20/275 (7%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREIIN 70
           + YE    +G G   V R    K T +  AVK I          E   ++ E   +E+  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 71  HRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
            R +  HPNI++ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
           +   H + + HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
           +     D     GK  D+WS GV +Y +L G+ PF   ++    R  +    + Q+  P+
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 238

Query: 245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           +   S   + L+SR  V  P KR +  E   H +F
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (591), Expect = 1e-74
 Identities = 73/303 (24%), Positives = 127/303 (41%), Gaps = 45/303 (14%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
           D +E + ++G+GN GV   +  K +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ- 137
           IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y      
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
           + HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEE--------------------------------- 224
           + +D+WS G++L  M VG YP   P+                                  
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 225 -----PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
                P    + +  I++           S E +  +++  + +PA+R  + ++  H + 
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 280 LKN 282
            ++
Sbjct: 302 KRS 304

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (580), Expect = 3e-73
 Identities = 89/271 (32%), Positives = 145/271 (53%), Gaps = 16/271 (5%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
            D Y+   ++GSG F V +  R+K T    A K+I        R     E+++RE+   +
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
            ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128

Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            HS+Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
             +      AD+WS GV  Y++L GA PF         ++T+  + +V Y   D  + + 
Sbjct: 189 NYEPLG-LEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFEDEYFSNT 243

Query: 249 SPECRHLISRIFVADPAKRISIPEIRNHEWF 279
           S   +  I R+ V DP KR++I +   H W 
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 9e-70
 Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 23/273 (8%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
           + YE++  IG+G++G  + +R K   +++  K ++ G   +   Q    E+   R L+HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 78  NIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
           NIVR+ + I+  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 132 YCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG-TPAYI 185
            CH        V HRDLK  N  LDG     +K+ DFG ++     +        TP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
           +PE + +  Y+ K +D+WS G  LY +     PF       + ++   +I   ++    Y
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY 236

Query: 246 VHISPECRHLISRIFVADPAKRISIPEIRNHEW 278
              S E   +I+R+       R S+ EI  +  
Sbjct: 237 -RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 1e-69
 Identities = 85/266 (31%), Positives = 136/266 (51%), Gaps = 16/266 (6%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLR 75
           + + L + +G G+FG   L   KKT +  A+K +++      D ++  +  + +   +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           HP +        T  +L  VMEY +GG+L   I +  +F    A F+  ++I G+ + HS
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 194
             + +RDLKL+N LLD      +KI DFG  K ++L     +T  GTP YIAPE+LL ++
Sbjct: 122 KGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           Y+    D WS GV LY ML+G  PF      ++  +  H I       P    +  E + 
Sbjct: 180 YNHS-VDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPR--WLEKEAKD 232

Query: 255 LISRIFVADPAKRISIP-EIRNHEWF 279
           L+ ++FV +P KR+ +  +IR H  F
Sbjct: 233 LLVKLFVREPEKRLGVRGDIRQHPLF 258

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 3e-68
 Identities = 79/269 (29%), Positives = 120/269 (44%), Gaps = 24/269 (8%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-------VQREIINHRS 73
            +Y++   +GSG FG             VA+K++E+    D         V  E++  + 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 74  LR--HPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGV 130
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
            +CH+  V HRD+K EN L+D +    LK+ DFG     +  +      GT  Y  PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWI 181

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
               Y G+ A VWS G+ LY M+ G  PFE  EE          I+  Q        +S 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSS 229

Query: 251 ECRHLISRIFVADPAKRISIPEIRNHEWF 279
           EC+HLI       P+ R +  EI+NH W 
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 3e-68
 Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 16/273 (5%)

Query: 16  IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHR 72
           + +D    +   +IG G+F       D +T   VA   ++         +  + E    +
Sbjct: 4   MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63

Query: 73  SLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
            L+HPNIVRF +   +       + +V E  + G L   +           R + +Q++ 
Sbjct: 64  GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123

Query: 129 GVSYCHSM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
           G+ + H+    + HRDLK +N  + G P   +KI D G +      S  K+ +GTP ++A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMA 181

Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
           PE+  +++YD    DV++ G+ +  M    YP+ +    +N  +   R+ S         
Sbjct: 182 PEM-YEEKYDES-VDVYAFGMCMLEMATSEYPYSE---CQNAAQIYRRVTSGVKPASFDK 236

Query: 247 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
              PE + +I      +  +R SI ++ NH +F
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  212 bits (540), Expect = 2e-66
 Identities = 83/321 (25%), Positives = 139/321 (43%), Gaps = 35/321 (10%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------S 73
           + + + R IG G FG     R   T ++ A+K +++     +  +   +N R       +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
              P IV       TP  L+ +++  +GG+L   +   G FSE + RF+  ++I G+ + 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
           H+  V +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL K 
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKG 180

Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
                 AD +S G  L+ +L G  PF    + K+  +     L++   +PD    SPE R
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPD--SFSPELR 237

Query: 254 HLISRIFVADPAKRISIP-----EIRNHEWF---------LKNLPADLV--------VDN 291
            L+  +   D  +R+        E++   +F         L+  P  L+         D 
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADA 297

Query: 292 TTNNQFEEPDQPMQSIDEIMQ 312
                F+E D     + +  Q
Sbjct: 298 FDIGSFDEEDTKGIKLLDSDQ 318

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  206 bits (526), Expect = 5e-65
 Identities = 81/268 (30%), Positives = 136/268 (50%), Gaps = 20/268 (7%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
             ++++R +G+G+FG   L+R +      A+K +++   +     E+   E +    + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P I+R          + ++M+Y  GGELF  +  + RF    A+F+  ++   + Y HS 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN LLD +    +KI DFG++K   +     +  GTP YIAPEV+  K Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
               D WS G+ +Y ML G  PF D     N  KT  +IL+ +   P     + + + L+
Sbjct: 180 KS-IDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPP--FFNEDVKDLL 232

Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF 279
           SR+   D ++R+        +++NH WF
Sbjct: 233 SRLITRDLSQRLGNLQNGTEDVKNHPWF 260

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  204 bits (520), Expect = 1e-64
 Identities = 63/271 (23%), Positives = 103/271 (38%), Gaps = 13/271 (4%)

Query: 18  HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRS 73
           H SDRYEL   +G G      L RD +    VAVK +     R        +RE  N  +
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 74  LRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
           L HP IV   +     T       IVMEY  G  L + +   G  +   A          
Sbjct: 64  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123

Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAP 187
           +++ H   + HRD+K  N ++  + A ++         + S    +Q  + +GT  Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
           E       D + +DV+S G  LY +L G  PF          + +        +  +   
Sbjct: 184 EQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE--G 240

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEW 278
           +S +   ++ +    +P  R         + 
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 1e-63
 Identities = 84/342 (24%), Positives = 127/342 (37%), Gaps = 41/342 (11%)

Query: 7   TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
           T G G D P       Y   + IG+G+FGV    +   + ELVA+K +    +      R
Sbjct: 9   TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR 62

Query: 67  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGG---ELFERICNAGRFSED 117
           E+   R L H NIVR +    +        +L +V++Y                      
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122

Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
             + +  QL   ++Y HS  +CHRD+K +N LLD   A   K+CDFG +K  V      S
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVS 181

Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE------------- 224
            + +  Y APE++          DVWS G  L  +L+G   F                  
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241

Query: 225 ----------PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 274
                     P        +I +  ++        PE   L SR+    P  R++  E  
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301

Query: 275 NHEWF--LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQII 314
            H +F  L++    L     T   F    Q + S   +  I+
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATIL 343

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 2e-63
 Identities = 63/276 (22%), Positives = 110/276 (39%), Gaps = 16/276 (5%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLR 75
              +  + + IGSG+FG     +       VAVK +       + +Q    E+   R  R
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
           H NI+ F     T   LAIV ++  G  L+  +     +F   +     +Q   G+ Y H
Sbjct: 63  HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
           +  + HRDLK  N  L       +KI DFG +          Q +   G+  ++APEV+ 
Sbjct: 122 AKSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 192 KKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
            ++ +     +DV++ G+ LY ++ G  P+ +          + R            +  
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239

Query: 250 PECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLP 284
              + L++        +R   P+I    E   ++LP
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 5e-62
 Identities = 85/269 (31%), Positives = 134/269 (49%), Gaps = 19/269 (7%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
           + ++ ++ +G G FG   L+R+K T    A+K + +   I ++       E    ++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y HS 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
            V +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL   +Y
Sbjct: 125 DVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
                D W  GV +Y M+ G  PF +    ++  +    IL  +   P    +SPE + L
Sbjct: 183 GRA-VDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPR--TLSPEAKSL 235

Query: 256 ISRIFVADPAKRIS-----IPEIRNHEWF 279
           ++ +   DP +R+        E+  H +F
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 3e-61
 Identities = 71/291 (24%), Positives = 117/291 (40%), Gaps = 32/291 (10%)

Query: 24  ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHP 77
           E +  +G G F      RDK T ++VA+K I+ G      D I+    REI   + L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           NI+   +     +++++V ++           N+   +    + +    + G+ Y H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
           + HRDLK  N LLD +    LK+ DFG +KS    +      V T  Y APE+L      
Sbjct: 121 ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------QYSIPDYV--- 246
           G   D+W+ G  L  +L+         +     +    + +          S+PDYV   
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 247 ------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 285
                           +   LI  +F+ +P  RI+  +    ++F  N P 
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRPG 288

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (500), Expect = 4e-61
 Identities = 73/323 (22%), Positives = 126/323 (39%), Gaps = 53/323 (16%)

Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREI 68
           ++ P   +  +YE +  IG G FG     R +KT + VA+K +      +       REI
Sbjct: 1   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60

Query: 69  INHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAGRFSEDEAR 120
              + L+H N+V   E+  T           + +V ++              +F+  E +
Sbjct: 61  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120

Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQP 175
              Q L++G+ Y H  ++ HRD+K  N L+       LK+ DFG ++      +   ++ 
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRY 178

Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
            + V T  Y  PE+LL +   G   D+W  G  +  M   +   +        +  +  I
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG----NTEQHQLALI 234

Query: 236 LSVQYSIPDYVH------------------------------ISPECRHLISRIFVADPA 265
             +  SI   V                                 P    LI ++ V DPA
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294

Query: 266 KRISIPEIRNHEWFLKN-LPADL 287
           +RI   +  NH++F  + +P+DL
Sbjct: 295 QRIDSDDALNHDFFWSDPMPSDL 317

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  195 bits (496), Expect = 4e-60
 Identities = 85/315 (26%), Positives = 155/315 (49%), Gaps = 34/315 (10%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
           D+++ ++ +G+G+FG   L++ K++    A+K +++   +     E+   E    +++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 77  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
            + +RDLK EN L+D      +++ DFG++K      +  +  GTP  +APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
               D W+ GV +Y M  G  PF          +   +I+S +   P   H S + + L+
Sbjct: 217 KA-VDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRFPS--HFSSDLKDLL 269

Query: 257 SRIFVADPAKRI-----SIPEIRNHEWF---------LKNLPADLV-----VDNTTNNQF 297
             +   D  KR       + +I+NH+WF          + + A  +       +T+N   
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

Query: 298 EEPDQPMQSIDEIMQ 312
            E ++   SI+E   
Sbjct: 330 YEEEEIRVSINEKCG 344

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-59
 Identities = 68/326 (20%), Positives = 128/326 (39%), Gaps = 41/326 (12%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
             Y  ++ +GSG +G      D +T   VA+K + R    +   +   RE+   + +RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 78  NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           N++   +V          T   +VM +   G    ++    +  ED  +F   Q++ G+ 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           Y H+  + HRDLK  N  ++      LKI DFG ++     S+    V T  Y APEV+L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV----- 246
                 +  D+WS G  +  M+ G   F+  +     ++ +    +        +     
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251

Query: 247 --------------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPA 285
                               + SP   +L+ ++ V D  +R++  E   H +F   +   
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311

Query: 286 DLVVDNTTNNQFEEPDQPMQSIDEIM 311
           D       ++ F++ D+ +     + 
Sbjct: 312 DEPQVQKYDDSFDDVDRTLDEWKRVT 337

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-59
 Identities = 66/261 (25%), Positives = 104/261 (39%), Gaps = 15/261 (5%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           +    +L++ IG G FG   L   +  +  VAVK I + D   +    E      LRH N
Sbjct: 5   NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 61

Query: 79  IVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
           +V+   VI+     L IV EY + G L + + + GR     D    F   +   + Y   
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
               HRDL   N L+        K+ DFG +K     S   +      + APE L +K++
Sbjct: 122 NNFVHRDLAARNVLVSED--NVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKF 177

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
             K +DVWS G+ L+ +             K+    + +    +   PD     P    +
Sbjct: 178 STK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--GYKMDAPD--GCPPAVYEV 232

Query: 256 ISRIFVADPAKRISIPEIRNH 276
           +   +  D A R S  ++R  
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQ 253

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  192 bits (489), Expect = 2e-59
 Identities = 62/294 (21%), Positives = 120/294 (40%), Gaps = 41/294 (13%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
           D Y+LVR +G G +       +    E V VK ++   K  + ++REI    +LR  PNI
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92

Query: 80  VRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           +   +++  P     A+V E+ +  +  +        ++ + RF+  +++  + YCHSM 
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
           + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  +   
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208

Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY----------------- 240
              D+WS G  L  M+    PF    +  +    I ++L  +                  
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268

Query: 241 ---------------SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
                             +   +SPE    + ++   D   R++  E   H +F
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 5e-59
 Identities = 79/332 (23%), Positives = 129/332 (38%), Gaps = 48/332 (14%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
            RY  +  IG G +G+     D   +  VA+K I         +   REI      RH N
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67

Query: 79  IVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
           I+   ++I  PT        ++ +  G +L++ +      S D   +F  Q++ G+ Y H
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
           S  V HRDLK  N LL+ +    LKICDFG ++               V T  Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD------ 244
           L  +   K  D+WS G  L  ML     F      K++   ++ IL +  S         
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPG----KHYLDQLNHILGILGSPSQEDLNCI 240

Query: 245 -----------------------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 281
                                  + +   +   L+ ++   +P KRI + +   H +  +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300

Query: 282 NL-PADLVVDNTTNN-QFEEPDQPMQSIDEIM 311
              P+D  +         E  D P + + E++
Sbjct: 301 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELI 332

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 4e-58
 Identities = 79/287 (27%), Positives = 125/287 (43%), Gaps = 30/287 (10%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
           + ++ V  IG G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 78  NIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           NIV+  +VI T   L +V E+     + F              + +  QL+ G+++CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
           +V HRDLK +N L++      +K+ DFG +++  +  +  +  V T  Y APE+LL  +Y
Sbjct: 122 RVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-------RILSVQYSIPDYV-- 246
                D+WS G     M+     F    E     +           +     S+PDY   
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 247 --------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
                          +  + R L+S++   DP KRIS      H +F
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 3e-57
 Identities = 73/292 (25%), Positives = 125/292 (42%), Gaps = 30/292 (10%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
            +YE +  IG G +G     ++++T E+VA+K +   +  + +  +  REI   + L+H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           NIVR  +V+ +   L +V E+             G    +  + F  QL+ G+ +CHS  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLKKEYD 196
           V HRDLK +N L++ +    LK+ +FG +++  +  +  S  V T  Y  P+VL   +  
Sbjct: 122 VLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------SVQYSIPDYV-- 246
               D+WS G     +     P     +  +  K I R+L             +PDY   
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 247 --------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 284
                          ++   R L+  +   +P +RIS  E   H +F    P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  184 bits (468), Expect = 8e-57
 Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 30/286 (10%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
           ++Y  +  IG G +GV    ++    E  A+K I   +  + I     REI   + L+H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 78  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           NIV+  +VI T   L +V E+             G      A+ F  QL++G++YCH  +
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
           V HRDLK +N L++      LKI DFG +++  +  +  +  + T  Y AP+VL+  +  
Sbjct: 121 VLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV---------- 246
               D+WS G     M+ G   F    E     +    + +        V          
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 247 -------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
                         +      L+S++   DP +RI+  +   H +F
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 8e-57
 Identities = 52/262 (19%), Positives = 105/262 (40%), Gaps = 13/262 (4%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           D      ++++G+G FGV +  + +  +  VA+K I+ G   ++    E     +L H  
Sbjct: 2   DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
           +V+   V      + I+ EY + G L   +     RF   +     + +   + Y  S Q
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 195
             HRDL   N L++      +K+ DFG S+  +      S        +  PEVL+  ++
Sbjct: 121 FLHRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 196 DGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
             K +D+W+ GV ++ +  +G  P+E     +               +      S +   
Sbjct: 179 SSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPHLASEKVYT 232

Query: 255 LISRIFVADPAKRISIPEIRNH 276
           ++   +     +R +   + ++
Sbjct: 233 IMYSCWHEKADERPTFKILLSN 254

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 2e-56
 Identities = 74/274 (27%), Positives = 128/274 (46%), Gaps = 17/274 (6%)

Query: 21  DRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHR 72
           + +EL++ +G+G +G     R +    T +L A+K +++       K  E+ + E     
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 73  SLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
            +R  P +V       T T L ++++Y +GGELF  +    RF+E E + +  +++  + 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           + H + + +RD+KLEN LLD +    L          +    +     GT  Y+AP+++ 
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 192 -KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
                  K  D WS GV +Y +L GA PF    E  +  +   RIL  +   P    +S 
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSA 261

Query: 251 ECRHLISRIFVADPAKRIS-----IPEIRNHEWF 279
             + LI R+ + DP KR+        EI+ H +F
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 4e-56
 Identities = 65/275 (23%), Positives = 110/275 (40%), Gaps = 19/275 (6%)

Query: 14  MPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKID----ENVQR 66
           +  +       L+  +G G+FGV               VAVK ++          ++  R
Sbjct: 1   LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60

Query: 67  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQ 125
           E+    SL H N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119

Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGT 181
           +  G+ Y  S +  HRDL   N LL       +KI DFG  +    +   +   +     
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
            A+ APE L  + +    +D W  GVTL+ M         P    N  + +H+I      
Sbjct: 178 FAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQE---PWIGLNGSQILHKIDKEGER 233

Query: 242 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 276
           +P       +  +++ + +   P  R +   +R+ 
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 6e-56
 Identities = 59/261 (22%), Positives = 105/261 (40%), Gaps = 11/261 (4%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           D      V++IGSG FG+  L      ++ VA+K I  G   +E+   E      L HP 
Sbjct: 3   DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
           +V+   V L    + +V E+   G L +      G F+ +        +  G++Y     
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
           V HRDL   N L+  +    +K+ DFG ++      ++    T     + +PEV     Y
Sbjct: 122 VIHRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
             K +DVWS GV ++ +         P E ++  + +  I +  + +      S     +
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST-GFRLYKPRLASTHVYQI 234

Query: 256 ISRIFVADPAKRISIPEIRNH 276
           ++  +   P  R +   +   
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQ 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 6e-56
 Identities = 58/272 (21%), Positives = 104/272 (38%), Gaps = 15/272 (5%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
             +   L   +G G FG   +     T   VA+K ++ G    E   +E    + LRH  
Sbjct: 15  PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSM 136
           +V+   V+ +   + IV EY S G L +  +          +      Q+ SG++Y   M
Sbjct: 74  LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
              HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   
Sbjct: 133 NYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           +  K +DVWS G+ L  +             +     + R     Y +P           
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHD 245

Query: 255 LISRIFVADPAKRISIPEIRN--HEWFLKNLP 284
           L+ + +  +P +R +   ++    ++F    P
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 7e-56
 Identities = 70/326 (21%), Positives = 129/326 (39%), Gaps = 39/326 (11%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRH 76
            +RY+ +  +GSG +G      D KT   VAVK + R  +     +   RE+   + ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 77  PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
            N++   +V      L       ++ +  G      I    + ++D  +F   Q++ G+ 
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           Y HS  + HRDLK  N  ++      LKI DFG ++      +    V T  Y APE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML 191

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD------- 244
              +  +  D+WS G  +  +L G   F   +     +  +  + +    +         
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 245 ------------------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPA 285
                             ++  +P    L+ ++ V D  KRI+  +   H +F + + P 
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

Query: 286 DLVVDNTTNNQFEEPDQPMQSIDEIM 311
           D  V +  +  FE  D  +     + 
Sbjct: 312 DEPVADPYDQSFESRDLLIDEWKSLT 337

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (463), Expect = 9e-56
 Identities = 66/295 (22%), Positives = 111/295 (37%), Gaps = 22/295 (7%)

Query: 12  MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
           M++ +    +RY L R IGSG+FG   L  D    E VA+K +E        +  E   +
Sbjct: 1   MELRV---GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIY 56

Query: 72  RSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
           + ++    I   +       +  +VME             + +FS         Q+IS +
Sbjct: 57  KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116

Query: 131 SYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGT 181
            Y HS    HRD+K +N L+  G     + I DFG +K          + + + K+  GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
             Y +    L  E   +  D+ S G  L    +G+ P++  +     +K   RI   + S
Sbjct: 177 ARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMS 234

Query: 242 IPDYV---HISPECRHLISRIFVADPAKRISIPEIRN---HEWFLKNLPADLVVD 290
            P  V       E    ++         +     +R    + +  +    D V D
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-55
 Identities = 76/293 (25%), Positives = 113/293 (38%), Gaps = 37/293 (12%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYI---ERGDKIDENVQREIINHRSL-- 74
            +YE V +IG G +G     RD K     VA+K +      + +  +  RE+   R L  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 75  -RHPNIVRFKEVILTP-----THLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLI 127
             HPN+VR  +V         T L +V E+       +           +  +    QL+
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
            G+ + HS +V HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL----------- 236
           EVLL+  Y     D+WS G     M      F    +     K +  I            
Sbjct: 185 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 237 ----------SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 279
                     S Q        I    + L+ +    +PAKRIS     +H +F
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (460), Expect = 2e-55
 Identities = 55/260 (21%), Positives = 100/260 (38%), Gaps = 11/260 (4%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
           +     +   +G G +G       KK    VAVK ++      E   +E    + ++HPN
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
           +V+   V        I+ E+ + G L + +    R   S     +   Q+ S + Y    
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
              HRDL   N L+  +    +K+ DFG S+  +   ++          + APE L   +
Sbjct: 135 NFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           +  K +DVW+ GV L+ +           +       ++ +L   Y +        +   
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKDYRMERPEGCPEKVYE 247

Query: 255 LISRIFVADPAKRISIPEIR 274
           L+   +  +P+ R S  EI 
Sbjct: 248 LMRACWQWNPSDRPSFAEIH 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 6e-55
 Identities = 54/267 (20%), Positives = 104/267 (38%), Gaps = 15/267 (5%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
             +  +LV  +G+G FG   +       + VAVK +++G    +    E    + L+H  
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69

Query: 79  IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSM 136
           +VR   V+ T   + I+ EY   G L + +   +  + + ++      Q+  G+++    
Sbjct: 70  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
              HRDL+  N L+        KI DFG ++    +             + APE +    
Sbjct: 129 NYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
           +  K +DVWS G+ L  ++                + + R     Y +    +   E   
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQ 241

Query: 255 LISRIFVADPAKRISIPEIRN--HEWF 279
           L+   +   P  R +   +R+   ++F
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 9e-55
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 16/266 (6%)

Query: 19  DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
             +R EL R IG G FG       M  +     VA+K  +    D + E   +E +  R 
Sbjct: 5   QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSY 132
             HP+IV+   VI T   + I+ME  + GEL   +              +  QL + ++Y
Sbjct: 65  FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
             S +  HRD+   N L+  +    +K+ DFG S+     +  K++       ++APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
             + +    +DVW  GV ++ +L+       P +       I RI + +  +P   +  P
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGER-LPMPPNCPP 236

Query: 251 ECRHLISRIFVADPAKRISIPEIRNH 276
               L+++ +  DP++R    E++  
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  178 bits (451), Expect = 5e-54
 Identities = 63/278 (22%), Positives = 115/278 (41%), Gaps = 22/278 (7%)

Query: 19  DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
           D    ++ + IG+G FG      L    K E  VA+K ++ G  +K   +   E      
Sbjct: 24  DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSY 132
             HPN++  + V+   T + I+ E+   G L      N G+F+  +     + + +G+ Y
Sbjct: 84  FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIA 186
              M   HRDL   N L++ +     K+ DFG S+      S   ++          + A
Sbjct: 144 LADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201

Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
           PE +  +++    +DVWS G+ ++ ++  G  P+ D       +  I+ I    Y +P  
Sbjct: 202 PEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD----MTNQDVINAIEQ-DYRLPPP 255

Query: 246 VHISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKN 282
           +        L+   +  D   R    +I N  +  ++N
Sbjct: 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 9e-54
 Identities = 57/293 (19%), Positives = 105/293 (35%), Gaps = 42/293 (14%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEEL-----VAVKYI--ERGDKIDENVQREIINH 71
             +  E  + +GSG FG           +      VAVK +  +      E +  E+   
Sbjct: 35  PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94

Query: 72  RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---------------------- 108
             L  H NIV           + ++ EY   G+L   +                      
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 109 -CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
             +    + ++   F  Q+  G+ +       HRDL   N L+       +KICDFG ++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLAR 212

Query: 168 ---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPE 223
              S   +    +      ++APE L +  Y  K +DVWS G+ L+ +  +G  P+    
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPG-- 269

Query: 224 EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 276
                    ++++   + +    + + E   ++   +  D  KR S P + + 
Sbjct: 270 --IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 8e-53
 Identities = 61/280 (21%), Positives = 103/280 (36%), Gaps = 26/280 (9%)

Query: 21  DRYELV---RDIGSGNFGVARL--MRDKKTEELVAVKYIERG---DKIDENVQREIINHR 72
           DR  L    +++GSGNFG  +    + KK  + VAVK ++       + + +  E    +
Sbjct: 4   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
            L +P IVR   +    + + +VME A  G L + +       +        Q+  G+ Y
Sbjct: 64  QLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 188
                  HRDL   N LL        KI DFG SK+       +           + APE
Sbjct: 123 LEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 189 VLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYV 246
            +   ++  K +DVWS GV ++     G  P+          +    +   +    P   
Sbjct: 181 CINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG----MKGSEVTAMLEKGERMGCPA-- 233

Query: 247 HISPECRHLISRIFVADPAKRISIPEIRN--HEWFLKNLP 284
               E   L++  +  D   R     +      ++   + 
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-52
 Identities = 56/300 (18%), Positives = 109/300 (36%), Gaps = 18/300 (6%)

Query: 14  MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQRE 67
           + I+ +++ ++ ++ +GSG FG           E V +             K ++ +  E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 68  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
                S+ +P++ R   + LT T   I      G  L     +           +  Q+ 
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 184
            G++Y    ++ HRDL   N L+       +KI DFG +K   +       +       +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
           +A E +L + Y  + +DVWS GVT++ ++       D          I  IL     +P 
Sbjct: 180 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQ 234

Query: 245 YVHISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLVVDNTTNNQFEEPDQP 303
               + +   ++ + ++ D   R    E+        ++    LV+          P   
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 3e-52
 Identities = 66/274 (24%), Positives = 107/274 (39%), Gaps = 25/274 (9%)

Query: 21  DRYELV-RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLR 75
           D   +   ++G GNFG  R    R +K +  VA+K +++G +    E + RE      L 
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67

Query: 76  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
           +P IVR   V      L +VME A GG L + +                 Q+  G+ Y  
Sbjct: 68  NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126

Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
                HRDL   N LL      +  I DFG SK        ++   +      + APE +
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 191 LKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHI 248
             +++  + +DVWS GVT++  L  G  P++         + +  I   +    P     
Sbjct: 185 NFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK----MKGPEVMAFIEQGKRMECPP--EC 237

Query: 249 SPECRHLISRIFVADPAKRISIPEIR---NHEWF 279
            PE   L+S  ++     R     +       ++
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-50
 Identities = 62/279 (22%), Positives = 101/279 (36%), Gaps = 28/279 (10%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKID--ENVQREIINHRSL 74
           D +  +    IG GNFG     R KK       A+K ++     D   +   E+     L
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 75  -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSED 117
             HPNI+          +L + +EYA  G L + +                  A   S  
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
           +   F   +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++ +   
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTM 185

Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
                 ++A E L    Y    +DVWS GV L+ ++        P       +   ++  
Sbjct: 186 GRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGT---PYCGMTCAELYEKLPQ 241

Query: 238 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 276
             Y +   ++   E   L+ + +   P +R S  +I   
Sbjct: 242 -GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  168 bits (427), Expect = 2e-50
 Identities = 49/270 (18%), Positives = 95/270 (35%), Gaps = 18/270 (6%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
             Y++ R IG G+FGV     +    + VA+K+  R       ++ E   ++ L     I
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63

Query: 80  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
                      H  +V++               +FS        +Q+++ V   H   + 
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123

Query: 140 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
           +RD+K +N L+    +     + + DFG  K          + + + K+  GT  Y++  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-- 246
             L +E   +  D+ + G      L G+ P++  +   N +K   RI   + S P     
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQSTPLRELC 241

Query: 247 -HISPECRHLISRIFVADPAKRISIPEIRN 275
                E    +                ++ 
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (423), Expect = 6e-50
 Identities = 65/288 (22%), Positives = 110/288 (38%), Gaps = 43/288 (14%)

Query: 21  DRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYI--ERGDKIDENVQREIINHRS 73
           +  E VRDIG G FG     R       +   +VAVK +  E    +  + QRE      
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 74  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
             +PNIV+   V      + ++ EY + G+L E + +                       
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 114 ----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 167
                S  E     +Q+ +G++Y    +  HRDL   N L+  +    +KI DFG S+  
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190

Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
            S+  +    +      ++ PE +    Y  + +DVW+ GV L+ +         P    
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ---PYYGM 246

Query: 227 NFRKTIHRILSVQY-SIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
              + I+ +      + P+  +   E  +L+   +   PA R S   I
Sbjct: 247 AHEEVIYYVRDGNILACPE--NCPLELYNLMRLCWSKLPADRPSFCSI 292

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-48
 Identities = 74/339 (21%), Positives = 131/339 (38%), Gaps = 51/339 (15%)

Query: 21  DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
            RY+ ++ IGSG  G+     D   +  VA+K + R        +   RE++  + + H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 78  NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
           NI+    V            + +VME                   +   +   Q++ G+ 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
           + HS  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIP 243
              Y   + D+WS G  +  M+     F   +    + K I ++ +        +Q ++ 
Sbjct: 192 GMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 244 DYVH----------------------------ISPECRHLISRIFVADPAKRISIPEIRN 275
           +YV                              + + R L+S++ V DPAKRIS+ +   
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

Query: 276 HEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQII 314
           H +         V         ++ D+   +I+E  ++I
Sbjct: 311 HPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELI 349

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-48
 Identities = 57/284 (20%), Positives = 99/284 (34%), Gaps = 35/284 (12%)

Query: 19  DSDRYELVRDIGSGNFGV-----ARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
             +R    + +G+G FG      A  +        VAVK ++    +   E +  E+   
Sbjct: 21  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80

Query: 72  RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC------------------NAG 112
             L  H NIV             ++ EY   G+L   +                   +  
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172
               ++   F  Q+  G+++  S    HRDL   N LL        KICDFG ++     
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKND 198

Query: 173 SQPKST---VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
           S             ++APE +    Y  + +DVWS G+ L+ +                 
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGM---PVD 254

Query: 230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
              ++++   + +    H   E   ++   + ADP KR +  +I
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 8e-48
 Identities = 54/276 (19%), Positives = 99/276 (35%), Gaps = 19/276 (6%)

Query: 13  DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDE--NVQRE 67
            + I   S        IG G+FG      L+ +   +   AVK + R   I E      E
Sbjct: 19  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78

Query: 68  IINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQ 125
            I  +   HPN++    + L +     +V+ Y   G+L           +  +   F  Q
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138

Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
           +  G+ +  S +  HRDL   N +LD      +K+ DFG ++                  
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKL 196

Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
              ++A E L  +++  K +DVWS GV L+ ++    P        +    + +      
Sbjct: 197 PVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----GR 251

Query: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 276
            +    +       ++ + +      R S  E+ + 
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-47
 Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 18/280 (6%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERG--DKIDENVQREIINHR 72
                   + IG+G FG       K +    E  VA+K ++ G  +K   +   E     
Sbjct: 5   HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64

Query: 73  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVS 131
              H NI+R + VI     + I+ EY   G L + +    G FS  +     + + +G+ 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAP 187
           Y  +M   HRDL   N L++ +     K+ DFG S+                    + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
           E +  +++    +DVWS G+ ++ ++                K I+      + +P  + 
Sbjct: 183 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMD 237

Query: 248 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 287
                  L+ + +  + A+R    +I +    L   P  L
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-45
 Identities = 55/283 (19%), Positives = 109/283 (38%), Gaps = 34/283 (12%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEE-------LVAVKYI--ERGDKIDENVQREII 69
             DR  L + +G G FG   L      ++        VAVK +  +  +K   ++  E+ 
Sbjct: 11  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70

Query: 70  NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAG 112
             + + +H NI+           L +++EYAS G L E +                    
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVL 171
           + S  +      Q+  G+ Y  S +  HRDL   N L+      ++              
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
           + +  +      ++APE L  + Y  + +DVWS GV L+ +  +G  P+          +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-----E 244

Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 273
            + ++L   + +    + + E   ++   + A P++R +  ++
Sbjct: 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 6e-45
 Identities = 58/286 (20%), Positives = 105/286 (36%), Gaps = 34/286 (11%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDKKTEEL-----VAVKYIERGDKIDEN---VQREIIN 70
             DR +L + +G G FG          ++      VAVK ++ G    E+   +    I 
Sbjct: 11  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70

Query: 71  HRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR---------------- 113
                H N+V        P   L +++E+   G L   + +                   
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 114 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
            + +    +  Q+  G+ +  S +  HRDL   N LL       +KICDFG ++      
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 188

Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
            + +         ++APE +  + Y  + +DVWS GV L+ +         P       +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDE 244

Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 276
              R L     +    + +PE    +   +  +P++R +  E+  H
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-44
 Identities = 63/293 (21%), Positives = 104/293 (35%), Gaps = 43/293 (14%)

Query: 20  SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
           +    L   IG G FG     + +  E  VAVK     ++     + EI     LRH NI
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVMLRHENI 59

Query: 80  VRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
           + F         T T L +V +Y   G LF+ + N    + +          SG+++ H 
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 118

Query: 136 --------MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTP 182
                     + HRDLK +N L+  +      I D G      S +  +   P   VGT 
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 183 AYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
            Y+APEVL     +K     K AD+++ G+  + +          E+ +     +     
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 238 VQYSIPDYV----------------HISPECRHLISRIFVADPAKRISIPEIR 274
               +   V                        ++   + A+ A R++   I+
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 8e-44
 Identities = 52/279 (18%), Positives = 107/279 (38%), Gaps = 29/279 (10%)

Query: 19  DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKIDE--NVQREIINH 71
             ++  + R++G G+FG+      K     + E  VA+K +     + E      E    
Sbjct: 18  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77

Query: 72  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF----------SEDEARF 121
           +     ++VR   V+       ++ME  + G+L   + +              S  +   
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
              ++  G++Y ++ +  HRDL   N ++       +KI DFG ++    +  + +    
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
           +    +++PE L    +     DVWS GV L+ +   A     P +  +  + +  ++  
Sbjct: 196 LLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVMEG 251

Query: 239 QY-SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 276
                PD  +       L+   +  +P  R S  EI + 
Sbjct: 252 GLLDKPD--NCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (378), Expect = 1e-42
 Identities = 62/326 (19%), Positives = 109/326 (33%), Gaps = 62/326 (19%)

Query: 22  RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
           RY LVR +G G+F    L +D      VA+K +       E  + EI   + +   +  +
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 82  ---------------FKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQ 125
                          F        H+ +V E      L   +            +   +Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 126 LISGVSYCHSMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
           L+ G+ Y H    + H D+K EN L++   SP   ++I       +        +++ T 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQY 240
            Y +PEVLL   +    AD+WS    ++ ++ G + F  ++          I +I+ +  
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 241 SIPDYV----------------------------------------HISPECRHLISRIF 260
            +P Y+                                          + E    +S + 
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 261 VADPAKRISIPEIRNHEWFLKNLPAD 286
             DP KR     + NH W    L  +
Sbjct: 313 QLDPRKRADAGGLVNHPWLKDTLGME 338

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 70.2 bits (171), Expect = 6e-15
 Identities = 29/202 (14%), Positives = 57/202 (28%), Gaps = 39/202 (19%)

Query: 23  YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----------DKIDENVQREIINH 71
             + + +G G          +K  E   VK+ + G           D  D +     I  
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 72  RSLRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
                  + + + + +   +     A++ME               R   +        ++
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMIL 113

Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
             V+  +   + H DL   N L+       + I DF     SV   +          +  
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFP---QSVEVGEEGW----REILER 163

Query: 188 EVL-----LKKEYDGKIADVWS 204
           +V        + Y     D+ S
Sbjct: 164 DVRNIITYFSRTY-RTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	363
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.66
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.29
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.1
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.74
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.65
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.19
d2fcea1	61	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	91.63
d1fw4a_	65	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	88.27
d2opoa1	81	Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta	85.71
d1wlza1	83	DJ-1-binding protein, DJBP {Human (Homo sapiens) [	85.63
d2pq3a1	73	Calmodulin {Rattus norvegicus [TaxId: 10116]}	84.59
d1fi5a_	81	Troponin C {Chicken (Gallus gallus), cardiac isofo	84.54
d1oqpa_	77	Caltractin (centrin 2) {Green algae (Chlamydomonas	82.79
d1jc2a_	75	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	82.74
d1f54a_	77	Calmodulin {Baker's yeast (Saccharomyces cerevisia	82.26
d1tiza_	67	Calmodulin-related protein T21P5.17 {Thale cress (	80.46
d1avsa_	81	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	80.02

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-66  Score=459.69  Aligned_cols=259  Identities=35%  Similarity=0.621  Sum_probs=222.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....  ...+.+.+|+.+++.++|||||++++++.+++.+|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            67999999999999999999999999999999987643  2345688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC---CCC
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~---~~~  175 (363)
                      |+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.....   ...
T Consensus        85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCccccc
Confidence            999999999988888999999999999999999999999999999999999986654  999999999854322   223


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ...+||+.|+|||++.+..++++++|||||||++|+|++|+.||............   ........+.+..+|+++.+|
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLAL  239 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTSTTGGGSCHHHHHH
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCCccccCCHHHHHH
Confidence            45679999999999998888766699999999999999999999876543322222   222333344456789999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccccCC
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKNLP  284 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~~~  284 (363)
                      |++||+.||++|||++|+++||||++.++
T Consensus       240 i~~~L~~dP~~R~t~~eil~hpwf~~~l~  268 (271)
T d1nvra_         240 LHKILVENPSARITIPDIKKDRWYNKPLK  268 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence            99999999999999999999999987554

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-64  Score=449.10  Aligned_cols=252  Identities=33%  Similarity=0.618  Sum_probs=222.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++.+.    ....+.+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            36799999999999999999999999999999998753    23456788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      ||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.... ...
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~~~  161 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRR  161 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-CCC
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-Ccc
Confidence            999999999999999889999999999999999999999999999999999999986654  99999999975432 334


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+...    ....+......+|  ..+|+++++|
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~~l  234 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRISRVEFTFP--DFVTEGARDL  234 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTTCCCCC--TTSCHHHHHH
T ss_pred             cccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCC--ccCCHHHHHH
Confidence            55679999999999998888766 999999999999999999998755433    3334444454444  3579999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      |.+||+.||.+|||++|+++||||..
T Consensus       235 i~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         235 ISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            99999999999999999999999965

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-63  Score=449.80  Aligned_cols=257  Identities=27%  Similarity=0.433  Sum_probs=222.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++|++++.||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.+++.++|||||+++++|.+++.+|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            468999999999999999999999999999999987643 3346789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~  177 (363)
                      |+||+|.+++.+ +.+++.+++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+..... .....
T Consensus        99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred             cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeeccccccccc
Confidence            999999987765 46999999999999999999999999999999999999986654  999999999865433 23455


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS  257 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  257 (363)
                      .+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+............   ......+.+..+|+++++||.
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSSGGGSCHHHHHHHH
T ss_pred             cccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh---CCCCCCCCcccCCHHHHHHHH
Confidence            679999999999998888765 9999999999999999999987665443333222   223334445568999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCccccccC
Q 017936          258 RIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       258 ~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      +||+.||.+|||++|+|+||||+...
T Consensus       252 ~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHccCChhHCcCHHHHhcCHhhCCCC
Confidence            99999999999999999999997543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.5e-64  Score=454.63  Aligned_cols=257  Identities=35%  Similarity=0.629  Sum_probs=208.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .++|++.+.||+|+||+||+|+++.+++.||||++.+..  .....+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            367999999999999999999999999999999997643  233567789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC-CCCCcEEEeecCCcccCccCCCCC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~-~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      ||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+|+.........
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~  167 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS  167 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence            9999999999999889999999999999999999999999999999999999964 234569999999998765555566


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--CCCCCCCCCHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRH  254 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~  254 (363)
                      +.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.......    ..+.....  ..+.+..+|+++.+
T Consensus       168 ~~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~  242 (307)
T d1a06a_         168 TACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLF----EQILKAEYEFDSPYWDDISDSAKD  242 (307)
T ss_dssp             -----CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             eeeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHH----HHHhccCCCCCCccccCCCHHHHH
Confidence            7789999999999998888766 99999999999999999999876554333    33333333  33445678999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ||.+||++||.+|||++|+++||||+.
T Consensus       243 li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         243 FIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            999999999999999999999999965

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-63  Score=453.49  Aligned_cols=260  Identities=27%  Similarity=0.442  Sum_probs=216.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++....  .....+.+|+.+++.++|||||+++++|.+++++|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3578999999999999999999999999999999997643  33467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.  +||+|||+|+.... ...
T Consensus        84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~-~~~  160 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA  160 (322)
T ss_dssp             ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HTC
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCC-Ccc
Confidence            999999999999988899999999999999999999997 59999999999999976654  99999999985432 233


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHH-------------------------
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK-------------------------  230 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-------------------------  230 (363)
                      .+.+||+.|+|||++.+..|+.+ +|||||||++|+|++|+.||...+.......                         
T Consensus       161 ~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             ccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            46689999999999999888776 9999999999999999999976543221100                         


Q ss_pred             -------------HHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          231 -------------TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       231 -------------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                                   .................+|.++++||.+||+.||.+|||++|+|+||||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                         0001111111111112468999999999999999999999999999999763

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7e-63  Score=456.39  Aligned_cols=261  Identities=30%  Similarity=0.557  Sum_probs=226.2

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ...-++|++++.||+|+||+||+|+++.+|+.||||++.+... ..+.+.+|+.+++.++|||||+++++|.+++.+|+|
T Consensus        22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3345689999999999999999999999999999999976543 345678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC
Q 017936           96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~  174 (363)
                      ||||+||+|.+++.+ .+++++.+++.++.||+.||+|||++|||||||||+|||++.+..+.+||+|||+|+.......
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            999999999999854 4579999999999999999999999999999999999999765556799999999987665555


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--CCCCCCHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPEC  252 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~  252 (363)
                      ..+..||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+.+..    +....+..+  .+..+|+++
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~  256 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDG  256 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCSCCGGGGGCCHHH
T ss_pred             cceecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCcccccCCCHHH
Confidence            566789999999999998888655 9999999999999999999987655443333    333333332  335689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ++||++||+.||.+|||++|+|+||||...
T Consensus       257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         257 KDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-62  Score=455.02  Aligned_cols=258  Identities=27%  Similarity=0.523  Sum_probs=225.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+... ....+.+|+.++++++|||||+++++|.+++.+|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4679999999999999999999999999999999976543 345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc
Q 017936           99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      |+||+|.+.+...+ ++++.+++.++.||+.||+|||++|||||||||+|||++....+++||+|||+|+.........+
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~  187 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  187 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence            99999998876544 69999999999999999999999999999999999999865666799999999987766655666


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCC--CCCCCCCHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHL  255 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~l  255 (363)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|+||..||.+.+....+..    +.......  +.+..+|+++.+|
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~l  262 (352)
T d1koba_         188 TTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDF  262 (352)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             ccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCcccccCCCHHHHHH
Confidence            789999999999998888666 9999999999999999999987665444333    33333333  3345789999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          256 ISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      |++||+.||.+|||++|+|+||||+..
T Consensus       263 i~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         263 IKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-62  Score=445.43  Aligned_cols=257  Identities=33%  Similarity=0.618  Sum_probs=225.1

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-------cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..       ...+.+.+|+.++++++|||||+++++|.+.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            468999999999999999999999999999999997532       2346789999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCC--CcEEEeecCCcccCc
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV  170 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~--~~vkL~DFgla~~~~  170 (363)
                      |+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++|||||||||+|||++.++.  ..+||+|||+|+...
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            999999999999999998889999999999999999999999999999999999999976553  259999999998766


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--CCCCC
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHI  248 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  248 (363)
                      ......+..||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+..    ..+.......+  .+..+
T Consensus       169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         169 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETL----ANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             TSCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHTTCCCCCHHHHTTS
T ss_pred             CCccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHHH----HHHHhcCCCCCchhcCCC
Confidence            5556667789999999999988877666 99999999999999999999876554333    33334333332  23568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      |+++++||++||+.||.+|||++|+++||||+.
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999999999999965

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-63  Score=444.32  Aligned_cols=254  Identities=30%  Similarity=0.527  Sum_probs=219.0

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      ..++|++.+.||+|+||+||+|+++.+++.||||++.+.    ....+.+.+|+.++++++|||||+++++|.+++.+|+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            447899999999999999999999999999999999753    2344678999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC--
Q 017936           95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--  172 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~--  172 (363)
                      |||||+||+|.+++...+.+++.+++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.....  
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK  163 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC----
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCc
Confidence            9999999999999999999999999999999999999999999999999999999987655  999999999865332  


Q ss_pred             -CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHH
Q 017936          173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE  251 (363)
Q Consensus       173 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  251 (363)
                       ....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....    ...+....+.+|  ..+|++
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~  236 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLI----FQKIIKLEYDFP--EKFFPK  236 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHTTCCCCC--TTCCHH
T ss_pred             ccccccccCCccccCceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcCHHHH----HHHHHcCCCCCC--ccCCHH
Confidence             22345679999999999998888655 9999999999999999999987654433    334445555544  368999


Q ss_pred             HHHHHHHhcccCCCCCCCHHH------HhcCccccc
Q 017936          252 CRHLISRIFVADPAKRISIPE------IRNHEWFLK  281 (363)
Q Consensus       252 ~~~li~~~L~~~p~~R~t~~e------ll~h~~~~~  281 (363)
                      +++||++||+.||.+|||++|      +++||||..
T Consensus       237 ~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             HHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence            999999999999999999998      578999854

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-62  Score=443.29  Aligned_cols=255  Identities=26%  Similarity=0.427  Sum_probs=217.8

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC-CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      +.|++++.||+|+||+||+|+++.+++.||+|++... ....+.+.+|+.++++++|||||++++++.+++.+|+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            5699999999999999999999999999999999764 344577899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCc
Q 017936          100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS  177 (363)
Q Consensus       100 ~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~  177 (363)
                      +||+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..... ....+
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccc
Confidence            99999998765 457999999999999999999999999999999999999987665  999999999754322 12245


Q ss_pred             cccCCCcCChhhhh-----cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          178 TVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       178 ~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ..||+.|+|||++.     +..|+.+ +|||||||++|+|+||..||.+.+..+.+..+...   .....+.+..+|+++
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k-~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~~  245 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---EPPTLAQPSRWSSNF  245 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTH-HHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS---CCCCCSSGGGSCHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChh-hhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCCCCCccccCCHHH
Confidence            67999999999985     3345444 99999999999999999999887765544433321   122334445689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          253 RHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      ++||++||+.||.+|||++|+++||||+.
T Consensus       246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         246 KDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999999964

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-62  Score=446.34  Aligned_cols=252  Identities=34%  Similarity=0.615  Sum_probs=222.7

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.++|||||+++++|++.+.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999999999999999999763    233467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP  175 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~  175 (363)
                      |||+||+|..++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.... ....
T Consensus        85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCB
T ss_pred             eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCccc
Confidence            99999999999999999999999999999999999999999999999999999987654  99999999986543 3344


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ...+||+.|+|||++.+..|+.+ +|||||||++|+|++|++||.+.+.....    ..+......+|  ..+|+++++|
T Consensus       163 ~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~dl  235 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFP--RTLSPEAKSL  235 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHHH
T ss_pred             ccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCHHHHH----HHHhcCCCCCC--ccCCHHHHHH
Confidence            56789999999999999988766 99999999999999999999886654333    33444444444  4689999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          256 ISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       256 i~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      |++||++||.+|++     ++|+++||||..
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHhhccCCchhhcccccccHHHHHcCccccc
Confidence            99999999999994     899999999964

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.5e-62  Score=443.15  Aligned_cols=252  Identities=28%  Similarity=0.423  Sum_probs=217.6

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      +|++++.||+|+||+||+|++..+++.||||++......    .+.+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            599999999999999999999999999999999765432    2457899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCc
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  177 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~  177 (363)
                      ||.+|+|..++...+++++.+++.++.||+.||.|||++|||||||||+|||++.++.  +||+|||+|+....   ...
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~~  170 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANS  170 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CCc
Confidence            9999999888888889999999999999999999999999999999999999987654  99999999985432   345


Q ss_pred             cccCCCcCChhhhhcC---CCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          178 TVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ..||+.|+|||++.+.   .|+.+ +|||||||++|+|++|..||.+........    .+............+|+++++
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~-~DiwSlGvilyel~~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~s~~~~~  245 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNESPALQSGHWSEYFRN  245 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCSCTTSCHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCch-hhhhhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCCCCCCCHHHHH
Confidence            6899999999998643   35545 999999999999999999998766544333    333333333344568999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          255 LISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      ||.+||+.||.+|||++|+++||||.+..
T Consensus       246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            99999999999999999999999997643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-63  Score=450.87  Aligned_cols=258  Identities=24%  Similarity=0.470  Sum_probs=227.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.+.||+|+||+||+|+++.+++.||||++.........+.+|+.+|+.++|||||+++++|++++.+|+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            47899999999999999999999999999999999877655667889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCCcc
Q 017936          100 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  178 (363)
Q Consensus       100 ~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~~~  178 (363)
                      +|++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++...+||+|||+++...........
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~  163 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence            9999999998765 799999999999999999999999999999999999998766667999999999876555555667


Q ss_pred             ccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--CCCCCCHHHHHHH
Q 017936          179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLI  256 (363)
Q Consensus       179 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li  256 (363)
                      .+|+.|+|||.+.+..++.+ +|||||||++|+|++|..||...+......    .+....+.++  .+..+|+++++||
T Consensus       164 ~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T d1tkia_         164 FTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIE----NIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             ESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             ccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCChhhccCCCHHHHHHH
Confidence            89999999999988887655 999999999999999999998866544333    3334444333  2346899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccc
Q 017936          257 SRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ++||+.||.+|||++|+++||||++.
T Consensus       239 ~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-61  Score=432.34  Aligned_cols=253  Identities=25%  Similarity=0.412  Sum_probs=212.0

Q ss_pred             CCc-eeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEc----CCeE
Q 017936           21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL   92 (363)
Q Consensus        21 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----~~~~   92 (363)
                      .+| ++.+.||+|+||+||+|++..+++.||+|.+....   ...+.+.+|+.++++++|||||++++++.+    ...+
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence            455 77789999999999999999999999999987643   233567899999999999999999999875    4568


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~g--iiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      |+|||||++|+|.+++.+.+.+++.+++.++.||+.||+|||++|  |+||||||+|||++.. .+.+||+|||+|+...
T Consensus        88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~-~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST-TSCEEECCTTGGGGCC
T ss_pred             EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC-CCCEEEeecCcceecc
Confidence            999999999999999999889999999999999999999999999  9999999999999642 2359999999997532


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                      . ....+.+||+.|+|||++.+ .++.+ +|||||||++|+|++|+.||..........   ..+............+++
T Consensus       167 ~-~~~~~~~GT~~Y~aPE~~~~-~~~~~-~DIwSlGvilyel~~g~~Pf~~~~~~~~~~---~~i~~~~~~~~~~~~~~~  240 (270)
T d1t4ha_         167 A-SFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSGVKPASFDKVAIP  240 (270)
T ss_dssp             T-TSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTTCCCGGGGGCCCH
T ss_pred             C-CccCCcccCccccCHHHhCC-CCCCc-CchhhHHHHHHHHHHCCCCCCCcccHHHHH---HHHHcCCCCcccCccCCH
Confidence            2 23345689999999999865 46655 999999999999999999998765544332   233333222223345789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNHEWFL  280 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h~~~~  280 (363)
                      ++++||.+||+.+|++|||++|+++||||+
T Consensus       241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999999995

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-62  Score=433.99  Aligned_cols=252  Identities=31%  Similarity=0.485  Sum_probs=204.0

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~l   94 (363)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.....   ..+.+.+|+.++++++|||||++++++.+  ++.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            4789999999999999999999999999999999876532   23557899999999999999999999865  467899


Q ss_pred             EEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcC-----ceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           95 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~L~~LH~~g-----iiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                      |||||+||+|.+++.+    ...+++.+++.++.||+.||+|||++|     ||||||||+|||++.++.  +||+|||+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~  160 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL  160 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccc
Confidence            9999999999998853    457999999999999999999999987     999999999999987654  99999999


Q ss_pred             cccCccCC-CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 017936          166 SKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD  244 (363)
Q Consensus       166 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (363)
                      |+...... ......||+.|+|||++.+..++.+ +|||||||++|+|+||..||.+.+..+..    ..+...... +.
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~~~~~----~~i~~~~~~-~~  234 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELA----GKIREGKFR-RI  234 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCC-CC
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCC-CC
Confidence            98654332 3345689999999999988888655 99999999999999999999876553322    233333322 23


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF  279 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~  279 (363)
                      +..+|+++.+||++||+.||.+|||++|+++|||+
T Consensus       235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            34689999999999999999999999999999995

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.6e-61  Score=430.05  Aligned_cols=258  Identities=31%  Similarity=0.499  Sum_probs=221.5

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----------ccHHHHHHHHHHHcCC-CCCeeeeeEEEEcC
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----------IDENVQREIINHRSLR-HPNIVRFKEVILTP   89 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~   89 (363)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+...          ..+.+.+|+.+++.++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            689999999999999999999999999999999976432          1235778999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      +.+|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+..
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~  160 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQL  160 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEEC
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeEc
Confidence            999999999999999999999899999999999999999999999999999999999999976655  999999999876


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCCC-----CCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD  244 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (363)
                      ..........||+.|+|||.+.+...     .+.++||||+||++|+|++|+.||.+.+.......+...  ...+..+.
T Consensus       161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~  238 (277)
T d1phka_         161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE  238 (277)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTT
T ss_pred             cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--CCCCCCcc
Confidence            55555566789999999999874322     234599999999999999999999886654433332221  12233444


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          245 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       245 ~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      ...+|+++++||.+||+.+|.+|||++|+++||||++.
T Consensus       239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            55789999999999999999999999999999999763

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.8e-61  Score=437.09  Aligned_cols=250  Identities=32%  Similarity=0.612  Sum_probs=221.0

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999999999999999999753    233467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      |||.||+|..++.....+++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+....  ...
T Consensus        84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~--~~~  159 (316)
T d1fota_          84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VTY  159 (316)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CBC
T ss_pred             eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEecc--ccc
Confidence            99999999999999999999999999999999999999999999999999999987654  99999999986533  334


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      +.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.....    ..+.......|  ..+|+++.++|
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~li  232 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTY----EKILNAELRFP--PFFNEDVKDLL  232 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHHHH
T ss_pred             cccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHHHHH----HHHHcCCCCCC--CCCCHHHHHHH
Confidence            6789999999999998888766 99999999999999999999876554333    33444444444  45799999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          257 SRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       257 ~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      .+||+++|.+|+     |++++++||||+.
T Consensus       233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHHhhhCHHhccccchhhHHHHHcCccccc
Confidence            999999999996     9999999999965

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-61  Score=443.89  Aligned_cols=265  Identities=33%  Similarity=0.543  Sum_probs=219.5

Q ss_pred             CCCCCCCCCCceeec-eecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHH-cCCCCCeeeeeEEEEc--
Q 017936           13 DMPIMHDSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-SLRHPNIVRFKEVILT--   88 (363)
Q Consensus        13 ~~~~~~~~~~y~i~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~-~l~hpnIv~~~~~~~~--   88 (363)
                      .+......++|.++. .||+|+||+||+|++..+++.||||++...    ..+.+|+.++. .++|||||+++++|++  
T Consensus         3 ~~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             CCBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cCCCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            333444457899875 599999999999999999999999998653    56778998864 5689999999999976  


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeec
Q 017936           89 --PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDF  163 (363)
Q Consensus        89 --~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DF  163 (363)
                        ...+|+|||||+||+|.+++.+.  ..+++.+++.|+.||+.||+|||++||+||||||+|||++.+. .+.+||+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              46799999999999999999874  3699999999999999999999999999999999999998643 456999999


Q ss_pred             CCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC
Q 017936          164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP  243 (363)
Q Consensus       164 gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (363)
                      |+|+............||+.|+|||++.+..|+.+ +|||||||++|+|+||++||.+.............+......+|
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            99987766666677889999999999988888765 99999999999999999999876554444333333433444333


Q ss_pred             C--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          244 D--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       244 ~--~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .  +..+|+++.+||++||+.||++|||+.|+++||||.+.
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            2  24579999999999999999999999999999999764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-60  Score=439.30  Aligned_cols=250  Identities=32%  Similarity=0.586  Sum_probs=220.4

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   96 (363)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.++|||||++++++.+...+++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            6899999999999999999999999999999998753    233467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCCC
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  176 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~~  176 (363)
                      ||+.||+|...+.+.+.+++.+++.++.||+.||.|||++|||||||||+|||++.++  ++||+|||+|+....  ...
T Consensus       121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g--~ikL~DFG~a~~~~~--~~~  196 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVKG--RTW  196 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECSS--CBC
T ss_pred             ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC--CEEeeeceeeeeccc--ccc
Confidence            9999999999999989999999999999999999999999999999999999998665  499999999986532  334


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      +..||+.|+|||++.+..++.+ +|||||||++|+|+||..||.+.+....    ...+.......|  ..+|+++.+||
T Consensus       197 ~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~~li  269 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQI----YEKIVSGKVRFP--SHFSSDLKDLL  269 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCC--TTCCHHHHHHH
T ss_pred             cccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCHHHH----HHHHhcCCCCCC--ccCCHHHHHHH
Confidence            5689999999999998888765 9999999999999999999987654333    333444444433  46899999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          257 SRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       257 ~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      ++||+.||.+|+     |++++++||||..
T Consensus       270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHhhhCHHhccccccccHHHHHcCccccC
Confidence            999999999995     9999999999964

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.7e-60  Score=439.93  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=214.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC----cccHHHH---HHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQ---REIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~---~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      -++|++.+.||+|+||+||+|+++.+|+.||||++.+..    .....+.   +++.+++.++|||||+++++|.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            368999999999999999999999999999999986532    1122233   346777888999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      |+|||||+||+|.+++.+...+++.+++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~-  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSS-
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCC-
Confidence            999999999999999999899999999999999999999999999999999999999986655  99999999986543 


Q ss_pred             CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017936          173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC  252 (363)
Q Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  252 (363)
                      ......+||+.|+|||++.++...+.++|||||||++|+|+||+.||........ ............  +.+..+|+++
T Consensus       160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~~--~~~~~~s~~~  236 (364)
T d1omwa3         160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAV--ELPDSFSPEL  236 (364)
T ss_dssp             SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHHHSSSCCC--CCCSSSCHHH
T ss_pred             CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCCC--CCCCCCCHHH
Confidence            3345668999999999997654334459999999999999999999987554322 223333333332  3344689999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017936          253 RHLISRIFVADPAKRIS-----IPEIRNHEWFLK  281 (363)
Q Consensus       253 ~~li~~~L~~~p~~R~t-----~~ell~h~~~~~  281 (363)
                      ++||.+||+.||.+|||     ++|+++||||+.
T Consensus       237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            99999999999999999     799999999964

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-59  Score=428.88  Aligned_cols=252  Identities=35%  Similarity=0.590  Sum_probs=217.1

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHH-HcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINH-RSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l-~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.+.    ....+.+..|+.++ +.++|||||++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            6899999999999999999999999999999999753    22334556666655 579999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  174 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~  174 (363)
                      ||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+..... ..
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhccccccc
Confidence            999999999999999999999999999999999999999999999999999999986654  999999999855433 33


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.....    ..+.......|  ..+|+++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~d  232 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELF----HSIRMDNPFYP--RWLEKEAKD  232 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHH
T ss_pred             ccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCC--ccCCHHHHH
Confidence            344679999999999999888765 99999999999999999999876654333    33333444444  457999999


Q ss_pred             HHHHhcccCCCCCCCHH-HHhcCccccc
Q 017936          255 LISRIFVADPAKRISIP-EIRNHEWFLK  281 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~-ell~h~~~~~  281 (363)
                      ||++||+.||.+|||+. ++++||||..
T Consensus       233 li~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         233 LLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            99999999999999995 8999999964

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-59  Score=425.92  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=212.0

Q ss_pred             eeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc------ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        25 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      .++.||+|+||+||+|+++.+|+.||||++.....      ..+.+.+|+.+++.++|||||++++++.+++++|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            57899999999999999999999999999865422      235688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC-CCCCc
Q 017936           99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS  177 (363)
Q Consensus        99 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~-~~~~~  177 (363)
                      |.++++.........+++.+++.+++||+.||+|||++||+||||||+|||++.++.  +||+|||+|+..... .....
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccc
Confidence            999888777777778999999999999999999999999999999999999986654  999999999765433 23345


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-------C---------
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------S---------  241 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~---------  241 (363)
                      .+||+.|+|||++.+....+.++|||||||++|+|+||.+||.+.+..+....+.........       .         
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS  239 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence            679999999999987665556699999999999999999999887766655554433211100       0         


Q ss_pred             CCC------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          242 IPD------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       242 ~~~------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .+.      ...+|+++.+||++||+.||++|||++|+|+||||+..
T Consensus       240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence            000      12468999999999999999999999999999999753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-58  Score=420.59  Aligned_cols=259  Identities=30%  Similarity=0.439  Sum_probs=214.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++++.||+|+||+||+|++..+|+.||||++....   ...+.+.+|+.++++++|||||++++++.+++++|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999999999999999996542   235678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc-CCCC
Q 017936           98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~-~~~~  175 (363)
                      ||.++.+...... ...+++.+++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.... ....
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCT
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccc
Confidence            9976544433333 456999999999999999999999999999999999999986654  99999999975533 3344


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc--------------C
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------------S  241 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~  241 (363)
                      ....||+.|+|||++....+.+.++|||||||++|+|++|+.||.+.+.................              .
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            55689999999999988887777799999999999999999999887665544444332211100              0


Q ss_pred             CCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          242 IPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       242 ~~~---------~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                      .+.         ...+|+++.+||++||+.||.+|||++|+++||||++
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~  288 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD  288 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence            000         1256889999999999999999999999999999965

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-59  Score=419.72  Aligned_cols=249  Identities=31%  Similarity=0.500  Sum_probs=213.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCC--CCCeeeeeEEEEcCC
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVILTPT   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~--hpnIv~~~~~~~~~~   90 (363)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+...       ....+.+|+.+++.++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            4689999999999999999999999999999999875321       1234678999999886  899999999999999


Q ss_pred             eEEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccC
Q 017936           91 HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  169 (363)
Q Consensus        91 ~~~lv~e~~~~-~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~  169 (363)
                      .+++||||+.+ +++..++.+...+++.+++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+..
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALL  161 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEEC
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceec
Confidence            99999999976 67888888888999999999999999999999999999999999999998543 35999999999754


Q ss_pred             ccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCC
Q 017936          170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS  249 (363)
Q Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  249 (363)
                      .. ....+..||+.|+|||++.+..+.++++|||||||++|+|++|+.||....      .    +.......+  ..+|
T Consensus       162 ~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~----i~~~~~~~~--~~~s  228 (273)
T d1xwsa_         162 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----IIRGQVFFR--QRVS  228 (273)
T ss_dssp             CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHCCCCCS--SCCC
T ss_pred             cc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------H----HhhcccCCC--CCCC
Confidence            32 233456799999999999988877776899999999999999999997521      1    222333333  4589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          250 PECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       250 ~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      +++++||++||+.||++|||++|+++||||++.
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999999999764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.1e-58  Score=412.46  Aligned_cols=258  Identities=27%  Similarity=0.410  Sum_probs=213.7

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++++.||+|+||+||+|+++ +|+.||||++....   ...+.+.+|+.++++++|||||++++++.+++..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            68999999999999999999985 78999999996642   335678999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~  176 (363)
                      |+.++.+.......+.+++.+++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|....... ...
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccc
Confidence            9988888777777888999999999999999999999999999999999999987655  9999999997543322 234


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-------C--------
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------S--------  241 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~--------  241 (363)
                      ...|++.|+|||.+.+..+.+.++|||||||++|+|++|+.||.+.+..+..............       .        
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            4569999999999987776666699999999999999999999887665554444332111000       0        


Q ss_pred             --------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          242 --------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       242 --------~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                              ......+|+++.+||++||+.||++|||++|+++||||++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                    0012346899999999999999999999999999999964

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-58  Score=414.10  Aligned_cols=251  Identities=21%  Similarity=0.290  Sum_probs=215.6

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ...++|++.+.||+|+||+||+|++..+++.||||++..+....+.+.+|+.+++.++|||||++++++.+++.+++|||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            34578999999999999999999999999999999998877777889999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC-
Q 017936           98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  174 (363)
Q Consensus        98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~-  174 (363)
                      ||++|+|..++...  ..+++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+....... 
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSE
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCce
Confidence            99999999998764  46899999999999999999999999999999999999987665  99999999986433222 


Q ss_pred             -CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                       .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........+.+    ......+.+..+|+++.
T Consensus       172 ~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i----~~~~~~~~~~~~~~~l~  246 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRMERPEGCPEKVY  246 (287)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTTCCCCCCTTCCHHHH
T ss_pred             eeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH----hcCCCCCCCccchHHHH
Confidence             233458999999999999888755 999999999999999777765554444333322    23344455567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017936          254 HLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +||.+||+.||++|||++|+++
T Consensus       247 ~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         247 ELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999965

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-58  Score=415.94  Aligned_cols=260  Identities=28%  Similarity=0.385  Sum_probs=212.4

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCC-CcEEEEEEeecC---CcccHHHHHHHHHHHcC---CCCCeeeeeEEEEc---
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERG---DKIDENVQREIINHRSL---RHPNIVRFKEVILT---   88 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l---~hpnIv~~~~~~~~---   88 (363)
                      ..++|++++.||+|+||+||+|++..+ ++.||||++...   ......+.+|+.+++.+   +||||++++++|..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            357899999999999999999999765 667999998653   22334566777776655   79999999999863   


Q ss_pred             --CCeEEEEEeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           89 --PTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        89 --~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                        ...++++||||+++.+..... ....+++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~  162 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGL  162 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCS
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhh
Confidence              357899999999887765444 3456999999999999999999999999999999999999976655  99999999


Q ss_pred             cccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-C---
Q 017936          166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S---  241 (363)
Q Consensus       166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~---  241 (363)
                      ++............||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+.+..+.+..+......... .   
T Consensus       163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhhcccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            987666666667789999999999999888766 99999999999999999999987765555544432211000 0   


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          242 -----------------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       242 -----------------~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                                       ......+|+.+.+||++||+.||++|||++|+|+||||++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~  298 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  298 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence                             0112457899999999999999999999999999999965

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-57  Score=417.47  Aligned_cols=260  Identities=28%  Similarity=0.416  Sum_probs=211.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEc------CCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT------PTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~------~~~~~   93 (363)
                      .-+|+.+++||+|+||+||+|++..+|+.||||++.+....   ..+|+.++++++||||++++++|..      ..+++
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            34699999999999999999999999999999999775432   3479999999999999999999854      34689


Q ss_pred             EEEeccCCCchHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           94 IVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        94 lv~e~~~~~~L~~~---~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      +|||||+++.+...   ......+++.+++.+++||+.||+|||++||+||||||+|||++.++. .+||+|||+|+...
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECC
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhcc
Confidence            99999977643332   234567999999999999999999999999999999999999986542 49999999998766


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc-------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------  237 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  237 (363)
                      ......+..||+.|+|||++.+....+.++|||||||++|+|++|..||...+..+.+..+......             
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  254 (350)
T d1q5ka_         175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  254 (350)
T ss_dssp             TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred             CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence            6666677889999999999877654455599999999999999999999887765554443321100             


Q ss_pred             cccCCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          238 VQYSIP----------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       238 ~~~~~~----------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                      .....+          ....+++++.+||.+||+.||++|||+.|+|+||||.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            000111          1234789999999999999999999999999999997643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.4e-57  Score=406.39  Aligned_cols=252  Identities=26%  Similarity=0.379  Sum_probs=205.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC----e
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPT----H   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~----~   91 (363)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+...    ....+.+|+.+++.++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            5889999999999999999999999999999999976432    2346789999999999999999999998654    4


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      +|+|||||+|++|..++...+++++.+++.++.||+.||+|||++|||||||||+|||++.++.  ++|+|||.++....
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC-
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcc
Confidence            8999999999999999999899999999999999999999999999999999999999987665  99999999864332


Q ss_pred             C----CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccC--CCCC
Q 017936          172 H----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDY  245 (363)
Q Consensus       172 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~  245 (363)
                      .    ......+||+.|+|||++.+..++.+ +|||||||++|+|+||.+||.+.+..+.....+    .....  ....
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~  238 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----REDPIPPSARH  238 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HCCCCCGGGTS
T ss_pred             ccccccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHHH----hcCCCCCchhc
Confidence            2    22345579999999999988888665 999999999999999999998766544433332    22222  2234


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCC-CHHHHhcCccc
Q 017936          246 VHISPECRHLISRIFVADPAKRI-SIPEIRNHEWF  279 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~R~-t~~ell~h~~~  279 (363)
                      ..+|+++.+||++||++||.+|| |+++ +.|+|.
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~-l~~~l~  272 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQTAAE-MRADLV  272 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSSHHH-HHHHHH
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhHHHH-HHHHHH
Confidence            56899999999999999999999 5555 456665

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-57  Score=405.37  Aligned_cols=251  Identities=24%  Similarity=0.334  Sum_probs=202.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   95 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv   95 (363)
                      ..++|++.+.||+|+||+||+|+.+   ..||||++....   ...+.+.+|+.++++++|||||++++++. .+.+++|
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv   81 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV   81 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence            4578999999999999999999753   359999987542   33467889999999999999999999864 4568999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC--
Q 017936           96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--  172 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~--  172 (363)
                      ||||++|+|.+++... .++++.++..++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.....  
T Consensus        82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC------
T ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccCC
Confidence            9999999999999764 56999999999999999999999999999999999999987665  999999999754322  


Q ss_pred             -CCCCccccCCCcCChhhhhcCC---CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          173 -SQPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       173 -~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                       ....+..||+.|+|||++.+..   ++ .++|||||||++|+|+||+.||.+.+........+..-............+
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~-~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  238 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC  238 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCC-chhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence             2234457999999999997543   44 449999999999999999999988766554444433221111111234467


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      |+++.+||.+||+.+|.+|||++|++++
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999999987

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-57  Score=400.60  Aligned_cols=249  Identities=24%  Similarity=0.404  Sum_probs=201.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +.++|++.+.||+|+||+||+|++. +++.||||++.......+.+.+|+.++++++|||||++++++..++.+++||||
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            3578999999999999999999975 567899999988777778899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--C
Q 017936           99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P  175 (363)
Q Consensus        99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--~  175 (363)
                      |++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.......  .
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC-------------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceee
Confidence            9999999988755 56899999999999999999999999999999999999987665  99999999985533322  2


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....||+.|+|||++.+..++.+ +|||||||++|||+|+ .+||....... ....   +.. ....+.+..+++++.+
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~~~-~~~~---i~~-~~~~~~p~~~~~~l~~  233 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSE-VVED---IST-GFRLYKPRLASTHVYQ  233 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCHHH-HHHH---HHH-TCCCCCCTTSCHHHHH
T ss_pred             cceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCHHH-HHHH---HHh-cCCCCCccccCHHHHH
Confidence            34568999999999998888765 9999999999999995 55555444322 2222   222 2233344567999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcC
Q 017936          255 LISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ||.+||+.+|++|||++|+++|
T Consensus       234 li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         234 IMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999876

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-56  Score=402.72  Aligned_cols=261  Identities=26%  Similarity=0.439  Sum_probs=218.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++|++++.||+|+||+||+|++..+++.||||++....   .....+.+|+.+++.++||||+++++++.+...+++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999999999999999986543   234678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC-CCC
Q 017936           98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  176 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~-~~~  176 (363)
                      ++.+++|..++...+.+++.+++.++.|++.||+|||++|||||||||+|||++.++.  +||+|||.|+...... ...
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCC
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccce
Confidence            9999999998888889999999999999999999999999999999999999986654  9999999998654433 333


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc----------------
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY----------------  240 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------  240 (363)
                      ...+++.|+|||++.+..+.+.++|||||||++|+|++|+.||............+........                
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            4467889999999988776566699999999999999999997655443333222222211100                


Q ss_pred             --------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          241 --------SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       241 --------~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                              .......+++.+.+||++||+.||.+|||++|+|+||||++..
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                    0011235688999999999999999999999999999997644

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-56  Score=408.25  Aligned_cols=264  Identities=26%  Similarity=0.385  Sum_probs=211.2

Q ss_pred             CCCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEc-----
Q 017936           17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-----   88 (363)
Q Consensus        17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-----   88 (363)
                      +...++|++++.||+|+||+||+|++..+|+.||||++...   ......+.+|+.+++.++||||+++++++..     
T Consensus         6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            34568999999999999999999999999999999998653   2345678899999999999999999999865     


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCC
Q 017936           89 ---PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY  165 (363)
Q Consensus        89 ---~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgl  165 (363)
                         ++++|+|||||.++.+.........+++.+++.+++||+.||.|||++||+||||||+|||++.++.  +||+|||+
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~  163 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGL  163 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTT
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecce
Confidence               3568999999988877766666778999999999999999999999999999999999999987665  99999999


Q ss_pred             cccCcc-----CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcccc
Q 017936          166 SKSSVL-----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY  240 (363)
Q Consensus       166 a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (363)
                      |+....     .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            974332     122344579999999999987654445599999999999999999999876654444333322211110


Q ss_pred             CC-CCC-------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          241 SI-PDY-------------------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       241 ~~-~~~-------------------------~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                      .. ...                         ...++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            00 000                         0136788999999999999999999999999999753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.7e-56  Score=411.57  Aligned_cols=257  Identities=23%  Similarity=0.434  Sum_probs=213.5

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEc--CCeEEEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLAIV   95 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv   95 (363)
                      ..++|++++.||+|+||+||+|++..+|+.||||++.+..  .+.+.+|+.+++.++ ||||++++++|..  ...+++|
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            4578999999999999999999999999999999987643  467889999999985 9999999999985  4579999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      ||||.+++|....   +.+++.+++.+++||+.||+|||++|||||||||+|||++.++. .+||+|||+|+........
T Consensus       111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~  186 (328)
T d3bqca1         111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY  186 (328)
T ss_dssp             EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCC
T ss_pred             EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcc
Confidence            9999999997653   46999999999999999999999999999999999999985443 4999999999876666666


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc------------c-----
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------V-----  238 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------~-----  238 (363)
                      ...++|+.|+|||.+.+....+.++|||||||++|+|++|..||............+.....            .     
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  266 (328)
T d3bqca1         187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR  266 (328)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred             cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence            77789999999999987765455699999999999999999999876543322222211110            0     


Q ss_pred             ---------------ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017936          239 ---------------QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK  281 (363)
Q Consensus       239 ---------------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~  281 (363)
                                     ....+....+|+++.+||++||+.||.+|||++|+|+||||+.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                           0011112347899999999999999999999999999999965

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=396.85  Aligned_cols=248  Identities=21%  Similarity=0.359  Sum_probs=214.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEecc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA   99 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   99 (363)
                      .++|++.++||+|+||+||+++++ +++.||||++.++....+.+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            478999999999999999999984 7788999999988777889999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC--CC
Q 017936          100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PK  176 (363)
Q Consensus       100 ~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~--~~  176 (363)
                      ++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.......  ..
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCCC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceeec
Confidence            99999998665 456999999999999999999999999999999999999986654  99999999975433322  23


Q ss_pred             ccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017936          177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL  255 (363)
Q Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  255 (363)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|+| |+.||...+..+..    ..+.. ....+.+...++++.+|
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~----~~i~~-~~~~~~p~~~~~~l~~l  233 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETA----EHIAQ-GLRLYRPHLASEKVYTI  233 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----HHHHT-TCCCCCCTTCCHHHHHH
T ss_pred             ccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHHHHH----HHHHh-CCCCCCcccccHHHHHH
Confidence            3568999999999998888765 999999999999998 89999877654332    22322 23444556789999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcC
Q 017936          256 ISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       256 i~~~L~~~p~~R~t~~ell~h  276 (363)
                      |++||+.+|++|||++++++|
T Consensus       234 i~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         234 MYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-56  Score=412.28  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=206.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC------
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT------   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------   90 (363)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+...   ..+.+.+|+.+|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            4789999999999999999999999999999999976432   2356789999999999999999999998664      


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCc
Q 017936           91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  170 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~  170 (363)
                      ++|+||||| +.+|...+. .+.+++..++.+++||+.||+|||++|||||||||+|||++.++.  +||+|||+|+...
T Consensus        97 ~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD  172 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             eEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccC
Confidence            579999999 666766554 567999999999999999999999999999999999999987665  9999999998653


Q ss_pred             cCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhcc------------
Q 017936          171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------  238 (363)
Q Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  238 (363)
                      .  ......||+.|+|||++.+..+.+.++|||||||++|+|++|.+||.+.+...............            
T Consensus       173 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T d1cm8a_         173 S--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  250 (346)
T ss_dssp             S--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             C--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence            3  34567899999999999877665666999999999999999999998876544433322211000            


Q ss_pred             ---------ccC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          239 ---------QYS----IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       239 ---------~~~----~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                               ...    ......+++++.+||++||+.||.+|||++|+|+||||+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                     000    01124578999999999999999999999999999999763

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=410.78  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=210.3

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCc-----EEEEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCe
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~--~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~   91 (363)
                      .++|++.+.||+|+||+||+|++..+++     .||+|.+...  ......+.+|+.+++++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4689999999999999999999876554     6899988653  33456788999999887 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCE
Q 017936           92 LAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT  148 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~-----------------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NI  148 (363)
                      +|+|||||++|+|.+++....                       .+++.+++.++.||+.||+|||++|||||||||+||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni  195 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV  195 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence            999999999999999997542                       489999999999999999999999999999999999


Q ss_pred             EEeCCCCCcEEEeecCCcccCccCCCC---CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCc
Q 017936          149 LLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE  224 (363)
Q Consensus       149 ll~~~~~~~vkL~DFgla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~  224 (363)
                      |++.++.  +||+|||+|+........   .+..||+.|+|||++.+..++.+ +|||||||++|+|+| |..||.+...
T Consensus       196 ll~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         196 LVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             EEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9987654  999999999865443322   34568999999999998888765 999999999999997 8999987665


Q ss_pred             hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ...+.+.+    ......+.+..+|+++.+||.+||+.+|++|||++||++|
T Consensus       273 ~~~~~~~~----~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         273 DANFYKLI----QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             SHHHHHHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHH----hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            54444433    3344455556789999999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-56  Score=399.94  Aligned_cols=253  Identities=21%  Similarity=0.304  Sum_probs=209.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEec
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..++|++.+.||+|+||+||+|+++ +++.||||++.......+.+.+|+.++++++|||||++++++.. +.+++||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            3468999999999999999999975 57789999998877677889999999999999999999998754 567999999


Q ss_pred             cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--C
Q 017936           99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q  174 (363)
Q Consensus        99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--~  174 (363)
                      |++|+|.+.+...  .++++.++..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+......  .
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEEC
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCcccc
Confidence            9999999876543  35999999999999999999999999999999999999986655  9999999998653322  2


Q ss_pred             CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      .....||+.|+|||++.+..++.+ +|||||||++|+|+||..||............   +. .....+.+..+|+++.+
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~---i~-~~~~~~~p~~~~~~l~~  241 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN---LE-RGYRMVRPDNCPEELYQ  241 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HH-TTCCCCCCTTCCHHHHH
T ss_pred             ccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH---HH-hcCCCCCcccChHHHHH
Confidence            344578999999999998888655 99999999999999965554443333322222   22 22334445578999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc--Ccccc
Q 017936          255 LISRIFVADPAKRISIPEIRN--HEWFL  280 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~--h~~~~  280 (363)
                      ||.+||+.+|++|||++++++  |+||.
T Consensus       242 li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         242 LMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            999999999999999999988  78874

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-56  Score=403.10  Aligned_cols=249  Identities=22%  Similarity=0.369  Sum_probs=199.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCc---EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      .++|++.+.||+|+||+||+|+++.+++   .||||.+....  ...+.+.+|+.++++++|||||++++++..++.+++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            4679999999999999999999987665   58889876543  234578899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      |||||++|+|.+++... +.+++.++..++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+......
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC----------
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCC
Confidence            99999999999988764 46999999999999999999999999999999999999987655  9999999998543322


Q ss_pred             CC------CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          174 QP------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       174 ~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                      ..      ....||+.|+|||.+.+..++.+ +|||||||++|||+| |..||...+..+..    ..+. .....+.+.
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~----~~i~-~~~~~~~~~  256 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVI----NAIE-QDYRLPPPM  256 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHH-TTCCCCCCT
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHH----HHHH-cCCCCCCCc
Confidence            21      12357899999999998888665 999999999999998 89999876654322    2222 233455566


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .+++++.+||.+||+.+|.+|||+.|++++
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            789999999999999999999999998764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=407.82  Aligned_cols=261  Identities=28%  Similarity=0.431  Sum_probs=207.9

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-----e
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-----H   91 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-----~   91 (363)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+...  ..+.+.+|+.++++++||||+++++++....     .
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            45789999999999999999999999999999999976432  2356789999999999999999999997653     3


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      +|++ +|+.+++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+....
T Consensus        86 ~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~  161 (345)
T d1pmea_          86 VYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADP  161 (345)
T ss_dssp             EEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCG
T ss_pred             EEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccC
Confidence            4555 556689999998754 6999999999999999999999999999999999999986654  99999999975433


Q ss_pred             C----CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc--------
Q 017936          172 H----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------  239 (363)
Q Consensus       172 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  239 (363)
                      .    ......+||+.|+|||++......+.++||||+||++|+|++|..||...+................        
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            2    2235567999999999986666556669999999999999999999987665443333222110000        


Q ss_pred             --------cCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          240 --------YSIP---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       240 --------~~~~---------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                              ...+         ....+|+++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence                    0000         1235788999999999999999999999999999998654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-56  Score=411.52  Aligned_cols=257  Identities=26%  Similarity=0.392  Sum_probs=199.6

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEc------CCe
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT------PTH   91 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~------~~~   91 (363)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.+...   ....+.+|+.+++.++|||||+++++|..      .++
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            689999999999999999999999999999999976532   23457899999999999999999999964      368


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      +|+|||||.++.+ +.+  ...+++.+++.+++||+.||+|||++||+||||||+|||++.++.  +|++|||+++....
T Consensus        97 ~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~  171 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT  171 (355)
T ss_dssp             EEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred             eEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhcccc
Confidence            9999999976544 444  356999999999999999999999999999999999999986655  99999999987766


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhc--------------
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------  237 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------  237 (363)
                      .......++|+.|+|||++.+..++.+ +||||+||++|+|++|++||.+.+........+.....              
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             ccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence            666677789999999999998888766 99999999999999999999877654444333322111              


Q ss_pred             ----cccCCC------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 017936          238 ----VQYSIP------------------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL  283 (363)
Q Consensus       238 ----~~~~~~------------------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~~  283 (363)
                          ......                  .....|+++.+||++||+.||++|||++|+|+||||++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                000000                  0011367899999999999999999999999999998753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-56  Score=399.08  Aligned_cols=244  Identities=23%  Similarity=0.325  Sum_probs=200.2

Q ss_pred             ceecccCCeEEEEEEEc--CCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeccCC
Q 017936           27 RDIGSGNFGVARLMRDK--KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  101 (363)
Q Consensus        27 ~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  101 (363)
                      ++||+|+||+||+|...  .+++.||||++....   ...+.+.+|+.++++++|||||++++++.++ ..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            47999999999999764  456789999986532   2345788999999999999999999999765 57899999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC----CCc
Q 017936          102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKS  177 (363)
Q Consensus       102 ~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~----~~~  177 (363)
                      |+|.+++.+...+++.++..++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.......    ...
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC---
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccccccccc
Confidence            999999999999999999999999999999999999999999999999987665  99999999985433221    233


Q ss_pred             cccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017936          178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI  256 (363)
Q Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  256 (363)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|+| |..||.+.+..+..    ..+.. ....+.+..+|+++.+||
T Consensus       170 ~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~----~~i~~-~~~~~~p~~~~~~~~~li  243 (277)
T d1xbba_         170 GKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----AMLEK-GERMGCPAGCPREMYDLM  243 (277)
T ss_dssp             -CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHHT-TCCCCCCTTCCHHHHHHH
T ss_pred             cCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHHHH----HHHHc-CCCCCCCcccCHHHHHHH
Confidence            468999999999998888665 999999999999998 89999876553322    22222 223444567899999999


Q ss_pred             HHhcccCCCCCCCHHHHh---cCccc
Q 017936          257 SRIFVADPAKRISIPEIR---NHEWF  279 (363)
Q Consensus       257 ~~~L~~~p~~R~t~~ell---~h~~~  279 (363)
                      .+||+.+|.+|||+++++   +|+|+
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            999999999999999984   55554

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-56  Score=405.25  Aligned_cols=257  Identities=31%  Similarity=0.551  Sum_probs=218.4

Q ss_pred             CCceeeceecccCCeEEEEEEE---cCCCcEEEEEEeecCC-----cccHHHHHHHHHHHcCCC-CCeeeeeEEEEcCCe
Q 017936           21 DRYELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGD-----KIDENVQREIINHRSLRH-PNIVRFKEVILTPTH   91 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~---~~~~~~~aiK~~~~~~-----~~~~~~~~e~~~l~~l~h-pnIv~~~~~~~~~~~   91 (363)
                      ++|++++.||+|+||+||+|++   +.+|+.||||++.+..     ...+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999997   4578999999986532     234567899999999977 899999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ++++|||+.+++|...+...+.+++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+....
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVA  181 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCG
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhcc
Confidence            9999999999999999999999999999999999999999999999999999999999987654  99999999975432


Q ss_pred             --CCCCCccccCCCcCChhhhhcCC-CCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          172 --HSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       172 --~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                        .....+..|++.|+|||.+.+.. +.+.++|||||||++|+|++|..||.......................  +..+
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~--~~~~  259 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQEM  259 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC--CTTS
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCC--cccC
Confidence              22334567999999999997654 234459999999999999999999988766555555555444443333  3468


Q ss_pred             CHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017936          249 SPECRHLISRIFVADPAKRI-----SIPEIRNHEWFLK  281 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~-----t~~ell~h~~~~~  281 (363)
                      |+++.+||.+||+++|.+||     |++|+++||||++
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            99999999999999999999     5899999999964

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=395.75  Aligned_cols=254  Identities=26%  Similarity=0.357  Sum_probs=208.6

Q ss_pred             CCCCCceeece-ecccCCeEEEEEEEcC--CCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           18 HDSDRYELVRD-IGSGNFGVARLMRDKK--TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        18 ~~~~~y~i~~~-lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      ...++|.+.+. ||+|+||+||+|.++.  ++..||||++....  ...+.+.+|+.++++++|||||++++++.++ .+
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~   83 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL   83 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence            34567888885 9999999999998754  44579999987643  2346788999999999999999999999764 57


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      |+|||||++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+....
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~  161 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGA  161 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTT
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhcccc
Confidence            9999999999999987654 57999999999999999999999999999999999999987664  99999999985433


Q ss_pred             CC----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          172 HS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       172 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                      ..    ......||+.|+|||++.+..++.+ +|||||||++|||+| |..||......+...    .+.. ....+.+.
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~----~i~~-~~~~~~p~  235 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQ-GKRMECPP  235 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHHT-TCCCCCCT
T ss_pred             cccccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCC
Confidence            22    2234468999999999998888766 999999999999998 999998766543322    2222 22334445


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHH---hcCcccc
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEI---RNHEWFL  280 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~el---l~h~~~~  280 (363)
                      .+|+++.+||.+||+.+|++|||+.++   |+|+|+.
T Consensus       236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            789999999999999999999999887   6777763

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=406.98  Aligned_cols=258  Identities=25%  Similarity=0.423  Sum_probs=209.7

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEcC-----Ce
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH   91 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~~   91 (363)
                      .+||++++.||+|+||+||+|++..+|+.||||++.+...   ..+.+.+|+.+++.++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            5789999999999999999999999999999999976432   234678999999999999999999999643     23


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      .+++|+|+.|++|.+++.. +++++.+++.+++||+.||+|||++||+||||||+|||++.++.  +|++|||+|.... 
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~-  172 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD-  172 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT-
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC-
Confidence            4566777789999998854 57999999999999999999999999999999999999987655  9999999987543 


Q ss_pred             CCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc------------
Q 017936          172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------------  239 (363)
Q Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------  239 (363)
                       ....+..||+.|+|||++.+..+.+.++|||||||++|+|++|.+||.+.+.......+........            
T Consensus       173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence             2335567999999999988877666669999999999999999999988766554444333211110            


Q ss_pred             -------cCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 017936          240 -------YSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN  282 (363)
Q Consensus       240 -------~~~~------~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h~~~~~~  282 (363)
                             ...+      ....+|+++.+||++||+.||.+|||++|+|+||||++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                   0001      123578999999999999999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-55  Score=393.02  Aligned_cols=255  Identities=22%  Similarity=0.309  Sum_probs=207.5

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      .+.++|++.+.||+|+||+||+|+++.+ +.||||++.......+.+.+|+.++++++|||||++++++.+ +.+++|||
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E   91 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   91 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence            3457899999999999999999998655 569999998776667889999999999999999999999854 55799999


Q ss_pred             ccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC--
Q 017936           98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--  173 (363)
Q Consensus        98 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~--  173 (363)
                      ||.+|+|...+..  .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+......  
T Consensus        92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------
T ss_pred             ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCce
Confidence            9999999988754  356999999999999999999999999999999999999987654  9999999998543222  


Q ss_pred             CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||............+   . .....+....+|+++.
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i---~-~~~~~~~~~~~~~~l~  244 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E-RGYRMPCPPECPESLH  244 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---H-TTCCCCCCTTSCHHHH
T ss_pred             eeccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---H-hcCCCCCCcccCHHHH
Confidence            2234568999999999998888765 999999999999999766655444433322222   2 2234455567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc--Cccccc
Q 017936          254 HLISRIFVADPAKRISIPEIRN--HEWFLK  281 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~--h~~~~~  281 (363)
                      +||.+||+.+|++|||++++++  ++||..
T Consensus       245 ~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            9999999999999999999987  778754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-54  Score=385.48  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=199.8

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCC----cEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~   93 (363)
                      .+.|++.+.||+|+||+||+|..+.++    ..||||++.....  ....+.+|+.++++++|||||++++++.+.+.++
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            467999999999999999999987654    4699999875432  2346789999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccC
Q 017936           94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  172 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~  172 (363)
                      +|||||.++++...+... +.+++.++..++.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+.....
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccCC
Confidence            999999999999887655 57999999999999999999999999999999999999987665  999999999854332


Q ss_pred             C----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCC
Q 017936          173 S----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI  248 (363)
Q Consensus       173 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (363)
                      .    ......||+.|+|||++.+..++.+ +|||||||++|||++|..||............   + ......+.+..+
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~---i-~~~~~~~~~~~~  238 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---I-NDGFRLPTPMDC  238 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---H-HTTCCCCCCTTC
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHHHHH---H-hccCCCCCchhh
Confidence            2    1223458999999999998888766 99999999999999966665444333322222   2 223344555678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          249 SPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       249 s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      +.++.+||.+||+.+|++|||+.|+++
T Consensus       239 ~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         239 PSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            999999999999999999999999976

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=387.30  Aligned_cols=248  Identities=25%  Similarity=0.388  Sum_probs=197.6

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCC---cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~l   94 (363)
                      .++|++.+.||+|+||+||+|++..++   ..||||.+....  ...+.+.+|+.++++++|||||++++++. ++.+|+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            468999999999999999999986543   468899886532  23456889999999999999999999985 567899


Q ss_pred             EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCC
Q 017936           95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  173 (363)
Q Consensus        95 v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~  173 (363)
                      |||||++|+|..++.. ...+++.+++.++.||+.||.|||++|||||||||+||+++.++.  +||+|||+|+......
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCc
Confidence            9999999999998765 456999999999999999999999999999999999999987665  9999999998643322


Q ss_pred             --CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCH
Q 017936          174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP  250 (363)
Q Consensus       174 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  250 (363)
                        ......||+.|+|||++.+..++.+ +|||||||++|+|++ |.+||...+..+....+    .. ....+.+..+|+
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~~-~~~~~~~~~~~~  236 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----EN-GERLPMPPNCPP  236 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HT-TCCCCCCTTCCH
T ss_pred             ceeccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----Hc-CCCCCCCCCCCH
Confidence              2234468999999999998888665 999999999999998 89999877665443322    22 223455567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          251 ECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       251 ~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ++.+||.+||+.+|.+|||++||++|
T Consensus       237 ~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         237 TLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=388.14  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=207.8

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcE--EEEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   93 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~--~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~   93 (363)
                      +.++|++.+.||+|+||+||+|+++.++..  ||||.+...  ....+.+.+|+.+++++ +|||||++++++.+++.++
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            457899999999999999999999888874  667776542  22345789999999998 7999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCc
Q 017936           94 IVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR  157 (363)
Q Consensus        94 lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~  157 (363)
                      +|||||++|+|.+++...                ..+++.++..++.||+.||.|||++|||||||||+|||++.++.  
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--  165 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--  165 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--
Confidence            999999999999998654                56999999999999999999999999999999999999987654  


Q ss_pred             EEEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHHh
Q 017936          158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRIL  236 (363)
Q Consensus       158 vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~  236 (363)
                      +||+|||+|+............||+.|+|||.+.+..++.+ +|||||||++|+|++|. +||...+..+    ....+.
T Consensus       166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~~----~~~~i~  240 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLP  240 (309)
T ss_dssp             EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHGG
T ss_pred             eEEccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHHH----HHHHHH
Confidence            99999999987666555566679999999999998888655 99999999999999965 5676544332    222332


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          237 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       237 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      . ....+.+..+++++.+||.+||+.+|++|||++|+++|
T Consensus       241 ~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         241 Q-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             G-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             h-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2 23445556789999999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=387.33  Aligned_cols=251  Identities=20%  Similarity=0.328  Sum_probs=203.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCc----EEEEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      +.++|++++.||+|+||+||+|++..+|+    .||+|.+...  ....+.+.+|+.++++++|||||++++++.+++ .
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~   85 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   85 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-e
Confidence            34679999999999999999999988876    5788877543  334567899999999999999999999998754 5


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ++++||+.+++|.+.+... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+....
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~  163 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTT
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceeccc
Confidence            7888999899998877654 57999999999999999999999999999999999999987664  99999999986533


Q ss_pred             CCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCC
Q 017936          172 HSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH  247 (363)
Q Consensus       172 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (363)
                      ...   .....||+.|+|||++.++.++.+ +|||||||++|+|+| |.+||.+.+..... ..+.    .....+.+..
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i~----~~~~~~~p~~  237 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE----KGERLPQPPI  237 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHHH----HTCCCCCCTT
T ss_pred             ccccccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHHH----cCCCCCCCcc
Confidence            322   223458999999999999888655 999999999999998 89999876654332 2222    2223444556


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017936          248 ISPECRHLISRIFVADPAKRISIPEIRNHEW  278 (363)
Q Consensus       248 ~s~~~~~li~~~L~~~p~~R~t~~ell~h~~  278 (363)
                      +++++.+||.+||+.+|.+|||+.|++.|..
T Consensus       238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         238 CTIDVYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence            8999999999999999999999999998843

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=381.36  Aligned_cols=248  Identities=26%  Similarity=0.414  Sum_probs=198.2

Q ss_pred             CCCceeeceecccCCeEEEEEEEcC-CC--cEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKK-TE--ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~--~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      .++|++.+.||+|+||+||+|+... ++  ..||||++.+..    ...+.+.+|+.++++++|||||++++++.+ +.+
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            4679999999999999999998653 33  368999987532    234578899999999999999999999976 467


Q ss_pred             EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCcc
Q 017936           93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  171 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~  171 (363)
                      ++|||||+++++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~~~  163 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhccc
Confidence            899999999999987765 456999999999999999999999999999999999999987664  99999999986533


Q ss_pred             CCC----CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCC
Q 017936          172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV  246 (363)
Q Consensus       172 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (363)
                      ...    .....|++.|+|||++.+..++.+ +|||||||++|||+| |..||.+.+..+.    ...+.......+.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~  238 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEGERLPRPE  238 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTSCCCCCCCT
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHH----HHHHHhCCCCCCCcc
Confidence            322    223457889999999998877655 999999999999998 8999987665433    334444555566667


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          247 HISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       247 ~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .+|+++.+||.+||+.+|++|||+++|++
T Consensus       239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         239 DCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            88999999999999999999999999863

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=376.41  Aligned_cols=245  Identities=26%  Similarity=0.389  Sum_probs=198.3

Q ss_pred             CCCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEc-CCeEEEEEe
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME   97 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e   97 (363)
                      +-++|++.+.||+|+||.||+|+.+  |+.||||+++++ ...+.+.+|+.++++++||||+++++++.+ .+.+++|||
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            3467999999999999999999974  778999999664 345788999999999999999999999865 467899999


Q ss_pred             ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCCC
Q 017936           98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  175 (363)
Q Consensus        98 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~~  175 (363)
                      |+++|+|.+++...+  .+++..++.++.||+.||.|||+++|+||||||+|||++.++.  +||+|||+++....  ..
T Consensus        82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~--~~  157 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--TQ  157 (262)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC----------
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCC--CC
Confidence            999999999986543  4999999999999999999999999999999999999987665  99999999985432  33


Q ss_pred             CccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017936          176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH  254 (363)
Q Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  254 (363)
                      ....+|+.|+|||++.+..++.+ +|||||||++|||+| |.+||......+....    +. .....+....+++++.+
T Consensus       158 ~~~~~~~~y~aPE~l~~~~~t~~-sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~----i~-~~~~~~~~~~~~~~~~~  231 (262)
T d1byga_         158 DTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VE-KGYKMDAPDGCPPAVYE  231 (262)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HT-TTCCCCCCTTCCHHHHH
T ss_pred             ccccccccCCChHHHhCCCCChH-HHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH----HH-cCCCCCCCccCCHHHHH
Confidence            44578999999999998888655 999999999999998 7888877655433322    22 22334445568999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcC
Q 017936          255 LISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       255 li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ||++||+.||.+|||+.+++++
T Consensus       232 li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         232 VMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcccCHhHCcCHHHHHHH
Confidence            9999999999999999999864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=383.68  Aligned_cols=250  Identities=23%  Similarity=0.378  Sum_probs=195.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEcC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcC-C
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP-T   90 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~-~   90 (363)
                      .++|++.+.||+|+||+||+|++..     +++.||||++.....  ..+.+.+|...+.++ +||||+.+++++... .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            4789999999999999999999754     446899999875432  234566777766665 689999999988664 5


Q ss_pred             eEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC
Q 017936           91 HLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP  154 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~  154 (363)
                      .+++|||||++|+|.+++...                ..+++.++..++.||+.||+|||++|||||||||+|||++.++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence            689999999999999998643                2489999999999999999999999999999999999998665


Q ss_pred             CCcEEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhC-CCCCCCCCchHHHHH
Q 017936          155 APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRK  230 (363)
Q Consensus       155 ~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~  230 (363)
                      .  +||+|||+|+......   ......||+.|+|||++.+..++.+ +|||||||++|+|+|| .+||........+..
T Consensus       172 ~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~  248 (299)
T d1ywna1         172 V--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  248 (299)
T ss_dssp             C--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             c--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            5  9999999997543322   2234579999999999998888655 9999999999999986 567876665554444


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      .+..    ....+.+..+++++.+||.+||+.||.+|||++|+++|
T Consensus       249 ~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         249 RLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhc----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3332    22333445689999999999999999999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=380.44  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=203.6

Q ss_pred             CCCCCceeeceecccCCeEEEEEEEcCCC-------cEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEE
Q 017936           18 HDSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL   87 (363)
Q Consensus        18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~   87 (363)
                      ...++|.+.+.||+|+||.||+|++..++       ..||||++.+...  ....+.+|...+.++ +|||||++++++.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            44579999999999999999999986554       4799999976543  335677888888777 8999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEe
Q 017936           88 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD  151 (363)
Q Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~  151 (363)
                      +++.+++|||||++|+|.+++....                .+++.+++.++.||+.||+|||++|||||||||+|||++
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence            9999999999999999999997543                489999999999999999999999999999999999998


Q ss_pred             CCCCCcEEEeecCCcccCccCC---CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHH
Q 017936          152 GSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN  227 (363)
Q Consensus       152 ~~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  227 (363)
                      .++.  +||+|||+++......   ......||+.|+|||.+.++.++.+ +|||||||++|+|++ |.+||........
T Consensus       170 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         170 EDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             TTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             CCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            7665  9999999998654332   2344578999999999999888766 999999999999998 7888876554322


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          228 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .    ..+ ......+.+..+|+++.+||.+||+.+|.+|||+.|+++
T Consensus       247 ~----~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 F----KLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             H----HHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H----HHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            2    222 223344555678999999999999999999999999985

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-52  Score=379.63  Aligned_cols=248  Identities=25%  Similarity=0.363  Sum_probs=205.5

Q ss_pred             CCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   92 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~   92 (363)
                      .++|++++.||+|+||+||+|+.+     .+++.||||++.....  ..+.+.+|+.++++++||||+++++++...+..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            468999999999999999999975     3567899999876432  245689999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCE
Q 017936           93 AIVMEYASGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT  148 (363)
Q Consensus        93 ~lv~e~~~~~~L~~~~~~~~------------------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NI  148 (363)
                      ++||||+.+|+|.+++....                        .+++.++..++.||+.||+|||++|||||||||+||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI  171 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC  171 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence            99999999999999986432                        388999999999999999999999999999999999


Q ss_pred             EEeCCCCCcEEEeecCCcccCccC---CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCC-CCCCCCCc
Q 017936          149 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEE  224 (363)
Q Consensus       149 ll~~~~~~~vkL~DFgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~  224 (363)
                      |++.++.  +||+|||+|+.....   ....+..||+.|+|||.+.+..++.+ +|||||||++|+|++|. +||.....
T Consensus       172 Lld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         172 LVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             EECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             EECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChh-hhhccchhhHHHHHccCCCCCCCCCH
Confidence            9987655  999999999743222   22234578999999999999888755 99999999999999985 57776555


Q ss_pred             hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .+..    ..+.... ..+.+..+++++.+||.+||+.+|++|||+.||++
T Consensus       249 ~e~~----~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         249 EEVI----YYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHH----HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHH----HHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4333    2233222 23344578999999999999999999999999964

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.1e-52  Score=376.19  Aligned_cols=261  Identities=22%  Similarity=0.224  Sum_probs=202.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e~   98 (363)
                      +++|++.+.||+|+||+||+|++..+|+.||||++.... ..+.+.+|+.+++.++|+| |+.+..++.+.+..++||||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            368999999999999999999999999999999887643 3456789999999998776 45556667788899999999


Q ss_pred             cCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCC-CCcEEEeecCCcccCccCC---
Q 017936           99 ASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS---  173 (363)
Q Consensus        99 ~~~~~L~~~~-~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~-~~~vkL~DFgla~~~~~~~---  173 (363)
                      +.+ +|...+ ...+.+++..+..++.|++.||+|||++|||||||||+|||++..+ ...+||+|||+|+......   
T Consensus        85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          85 LGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             CCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             cCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            955 555544 4566799999999999999999999999999999999999986432 3459999999998543322   


Q ss_pred             -----CCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC---CC
Q 017936          174 -----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP---DY  245 (363)
Q Consensus       174 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~  245 (363)
                           ......||+.|+|||++.+..++.+ +|||||||++|+|+||..||.............. ........+   ..
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  241 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER-ISEKKMSTPIEVLC  241 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHH-HHHHHHHSCHHHHT
T ss_pred             ceeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHH-hhcccCCCChhHhc
Confidence                 2234579999999999998887655 9999999999999999999987554332222111 111111111   13


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHH---HhcCccccccCC
Q 017936          246 VHISPECRHLISRIFVADPAKRISIPE---IRNHEWFLKNLP  284 (363)
Q Consensus       246 ~~~s~~~~~li~~~L~~~p~~R~t~~e---ll~h~~~~~~~~  284 (363)
                      ..+|+++.+||.+||+.+|.+||++++   +|+|+|.....+
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~  283 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  283 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence            457999999999999999999999874   577877655443

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-52  Score=376.47  Aligned_cols=262  Identities=19%  Similarity=0.268  Sum_probs=212.8

Q ss_pred             CCCcccCCCCCCCCCCCCCCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcc--cHHHHHHHHHHHcC
Q 017936            2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI--DENVQREIINHRSL   74 (363)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l   74 (363)
                      ++++++++..    +-...++|.+.+.||+|+||+||+|.++     .+++.||||++......  ...+.+|+.+++++
T Consensus         5 ~~~~~~~~~~----~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l   80 (308)
T d1p4oa_           5 SAADVYVPDE----WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF   80 (308)
T ss_dssp             BCCSCCCCCT----TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC
T ss_pred             CcccCcCccc----eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc
Confidence            4556666553    2233578999999999999999999875     23578999999764332  24578999999999


Q ss_pred             CCCCeeeeeEEEEcCCeEEEEEeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCC
Q 017936           75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK  144 (363)
Q Consensus        75 ~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlk  144 (363)
                      +|||||++++++..++.+++|||||.+|+|.+++...          ..++...+..++.|++.||.|||+++|+|||||
T Consensus        81 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk  160 (308)
T d1p4oa_          81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLA  160 (308)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCS
T ss_pred             CCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEc
Confidence            9999999999999999999999999999999987532          247899999999999999999999999999999


Q ss_pred             CCCEEEeCCCCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhC-CCCCC
Q 017936          145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFE  220 (363)
Q Consensus       145 p~NIll~~~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~  220 (363)
                      |+|||++.+..  +||+|||+|+.......   .....||+.|+|||.+.+..++.+ +|||||||++|+|+|| .+||.
T Consensus       161 ~~NiLld~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~  237 (308)
T d1p4oa_         161 ARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQ  237 (308)
T ss_dssp             GGGEEECTTCC--EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTT
T ss_pred             CCceeecCCce--EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCC
Confidence            99999986654  99999999975433222   233468999999999998888755 9999999999999998 47776


Q ss_pred             CCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ..+......    .+... ...+.+..+|+.+.++|.+||+.+|.+|||++++++
T Consensus       238 ~~~~~~~~~----~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         238 GLSNEQVLR----FVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             TSCHHHHHH----HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHH----HHHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            655443332    22222 233444578999999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=373.73  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=208.1

Q ss_pred             CCCCceeeceecccCCeEEEEEEEc-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEcCC
Q 017936           19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPT   90 (363)
Q Consensus        19 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~   90 (363)
                      ..++|++.+.||+|+||.||+|+..     .+++.||||++.....  ....+.+|+.+++.+ +|||||++++++.+.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            4578999999999999999999863     5667999999976443  234678899999998 6999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeC
Q 017936           91 HLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG  152 (363)
Q Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~------------------~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~  152 (363)
                      .+++|||||++|+|..++.+..                  .+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~  180 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH  180 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence            9999999999999999987543                  5899999999999999999999999999999999999987


Q ss_pred             CCCCcEEEeecCCcccCccCCC---CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCchHHH
Q 017936          153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF  228 (363)
Q Consensus       153 ~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  228 (363)
                      ++.  +||+|||+++.......   .....||+.|+|||++.+..++.+ +|||||||++|+|+| |.+||........+
T Consensus       181 ~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         181 GRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             TTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             cCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            654  99999999986543222   234578999999999988887665 999999999999998 56666665554444


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .+.+.    .....+....+|+++.+||.+||+.||++|||+++|++
T Consensus       258 ~~~i~----~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         258 YKMIK----EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHH----HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHh----cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            44333    23333444567999999999999999999999999985

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=366.58  Aligned_cols=244  Identities=21%  Similarity=0.258  Sum_probs=196.2

Q ss_pred             eceecccCCeEEEEEEEcCCC---cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEc-CCeEEEEEecc
Q 017936           26 VRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEYA   99 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~   99 (363)
                      .++||+|+||+||+|++..++   ..||||.+.+..  ...+.+.+|+.++++++|||||++++++.. ++.+++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            678999999999999986543   368999987532  234678999999999999999999999765 56899999999


Q ss_pred             CCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeecCCcccCccCCC----
Q 017936          100 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----  174 (363)
Q Consensus       100 ~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~~~~~~~----  174 (363)
                      ++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+..  +||+|||+++.......    
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccccce
Confidence            9999999887544 5788899999999999999999999999999999999986654  99999999985433222    


Q ss_pred             -CCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017936          175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR  253 (363)
Q Consensus       175 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  253 (363)
                       .....||+.|+|||.+.+..++.+ +||||||+++|||+||..||..........   ..+... ...+.+..+++++.
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~~~---~~i~~g-~~~~~p~~~~~~l~  264 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLLQG-RRLLQPEYCPDPLY  264 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC------CH---HHHHTT-CCCCCCTTCCHHHH
T ss_pred             ecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcC-CCCCCcccCcHHHH
Confidence             223468999999999998888656 999999999999999888876543322222   222222 23334456799999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 017936          254 HLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       254 ~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      +||.+||+.+|++|||+.|+++|
T Consensus       265 ~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         265 EVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.1e-50  Score=362.13  Aligned_cols=252  Identities=21%  Similarity=0.240  Sum_probs=204.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC-CCeeeeeEEEEcCCeEEEEEec
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      +++|++.+.||+|+||+||+|++..+|+.||||++.... ....+.+|+..++.++| +|++.+++++......++||||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            478999999999999999999999999999999886543 34567889999999976 8999999999999999999999


Q ss_pred             cCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCC---CCCcEEEeecCCcccCccC--
Q 017936           99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLH--  172 (363)
Q Consensus        99 ~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~---~~~~vkL~DFgla~~~~~~--  172 (363)
                      + +++|.+.+...+ .+++..+..++.|++.||+|||++|||||||||+|||++..   ..+.+||+|||+|+.....  
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  161 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence            9 789988887654 69999999999999999999999999999999999999742   2346999999999854322  


Q ss_pred             ------CCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC---
Q 017936          173 ------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP---  243 (363)
Q Consensus       173 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---  243 (363)
                            ......+||+.|+|||++.+..++.+ +|||||||++|+|+||..||.+.......... ..+.......+   
T Consensus       162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~~~~~~~~~~~  239 (293)
T d1csna_         162 KQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQSTPLRE  239 (293)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHHHSCHHH
T ss_pred             ccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHHhccCCCChHH
Confidence                  12334579999999999998887655 99999999999999999999865443222111 11111100011   


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          244 DYVHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       244 ~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      ....+|+++.+++..|+..+|.+||+++.+.+
T Consensus       240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            12457899999999999999999999877653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=360.65  Aligned_cols=250  Identities=24%  Similarity=0.276  Sum_probs=189.2

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEcCC----eEEEEE
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM   96 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~   96 (363)
                      .+|.+.+.||+|+||.||+|+.  +|+.||||++..........+.|+..++.++|||||++++++.+.+    .+++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            5799999999999999999985  5889999998765433333344555667789999999999998653    689999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------cCceecCCCCCCEEEeCCCCCcEEEeecCCccc
Q 017936           97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  168 (363)
Q Consensus        97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~--------~giiHrDlkp~NIll~~~~~~~vkL~DFgla~~  168 (363)
                      |||++|+|..++.+. ++++.+++.++.|++.||.|||+        +|||||||||+||||+.++.  +||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCcccc
Confidence            999999999999765 69999999999999999999996        69999999999999976654  99999999975


Q ss_pred             CccCC-----CCCccccCCCcCChhhhhcCCCC-----CcchhhhhHHHHHHHHHhCCCCCCCCCch-----------HH
Q 017936          169 SVLHS-----QPKSTVGTPAYIAPEVLLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEP-----------KN  227 (363)
Q Consensus       169 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~l~~g~~pf~~~~~~-----------~~  227 (363)
                      .....     ......||+.|+|||++.+....     +.++|||||||++|+|+||..||......           ..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            43322     22345799999999998765321     23489999999999999999887432210           11


Q ss_pred             HHHHHHHHhccccC--CCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017936          228 FRKTIHRILSVQYS--IPDY---VHISPECRHLISRIFVADPAKRISIPEIRN  275 (363)
Q Consensus       228 ~~~~~~~~~~~~~~--~~~~---~~~s~~~~~li~~~L~~~p~~R~t~~ell~  275 (363)
                      .............+  +|..   ...+..+.+|+.+||+.||++|||+.||++
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            11112222222221  1111   112345899999999999999999999975

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-48  Score=362.57  Aligned_cols=261  Identities=25%  Similarity=0.389  Sum_probs=199.4

Q ss_pred             CCCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-----------CCCeeeeeEEEEc
Q 017936           20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVILT   88 (363)
Q Consensus        20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-----------hpnIv~~~~~~~~   88 (363)
                      .+||++++.||+|+||+||+|++..+|+.||||++++.....+...+|+.+++.++           ||||+++++++..
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35799999999999999999999999999999999876655667788998887764           5889999998864


Q ss_pred             --CCeEEEEEeccCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCCEEEeCCCCC----cE
Q 017936           89 --PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP----RL  158 (363)
Q Consensus        89 --~~~~~lv~e~~~~~~L~~~~---~~~~~l~~~~~~~~~~qil~~L~~LH~-~giiHrDlkp~NIll~~~~~~----~v  158 (363)
                        ....+++++++..+......   .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++..    .+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence              45667777766554433332   234569999999999999999999998 899999999999999755432    49


Q ss_pred             EEeecCCcccCccCCCCCccccCCCcCChhhhhcCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCch------HHHHHHH
Q 017936          159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP------KNFRKTI  232 (363)
Q Consensus       159 kL~DFgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~~~  232 (363)
                      +|+|||.|....  ......+||+.|+|||++.+..++.+ +||||+||++++|++|+.||......      ......+
T Consensus       172 kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~  248 (362)
T d1q8ya_         172 KIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII  248 (362)
T ss_dssp             EECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred             eEeecccccccc--cccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence            999999987543  33456789999999999998888766 99999999999999999999754321      1111111


Q ss_pred             HHHhc--------------------cccC----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017936          233 HRILS--------------------VQYS----------------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNH  276 (363)
Q Consensus       233 ~~~~~--------------------~~~~----------------~~~~~~~s~~~~~li~~~L~~~p~~R~t~~ell~h  276 (363)
                      ..+..                    ....                .......++++.+||.+||+.||.+|||++|+|+|
T Consensus       249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            10000                    0000                00011235789999999999999999999999999


Q ss_pred             ccccccC
Q 017936          277 EWFLKNL  283 (363)
Q Consensus       277 ~~~~~~~  283 (363)
                      |||++..
T Consensus       329 p~f~~~~  335 (362)
T d1q8ya_         329 PWLKDTL  335 (362)
T ss_dssp             GGGTTCT
T ss_pred             cccCCCC
Confidence            9998543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=4.4e-27  Score=197.80  Aligned_cols=164  Identities=15%  Similarity=0.150  Sum_probs=120.3

Q ss_pred             ceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCc-------------------ccHHHHHHHHHHHcCCCCCeeeee
Q 017936           23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFK   83 (363)
Q Consensus        23 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------------------~~~~~~~e~~~l~~l~hpnIv~~~   83 (363)
                      |.+.++||+|+||+||+|++. +|+.||||+++.+..                   ......+|...+..+.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568899999999999999984 688999998753210                   012345678889999999999987


Q ss_pred             EEEEcCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCCEEEeCCCCCcEEEeec
Q 017936           84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF  163 (363)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~L~~LH~~giiHrDlkp~NIll~~~~~~~vkL~DF  163 (363)
                      ++...    +++|||+++..+..       ++...+..++.|++.+|.|||++||+||||||+|||++.++   ++|+||
T Consensus        81 ~~~~~----~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF  146 (191)
T d1zara2          81 AWEGN----AVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF  146 (191)
T ss_dssp             EEETT----EEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred             EecCC----EEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence            66422    79999998876643       56667788999999999999999999999999999998543   899999


Q ss_pred             CCcccCccCCCCCccccCCCcCChh-----hhhcCCCCCcchhhhhHHHHH
Q 017936          164 GYSKSSVLHSQPKSTVGTPAYIAPE-----VLLKKEYDGKIADVWSCGVTL  209 (363)
Q Consensus       164 gla~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~~DiwslG~il  209 (363)
                      |+|+.......       ..|....     .+....|..+ +|+||+.--+
T Consensus       147 G~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~-~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGW-------REILERDVRNIITYFSRTYRTE-KDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCC-CCHHHHHHHH
T ss_pred             CCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCc-ccHHHHHHHH
Confidence            99875321110       0111110     0123456556 8999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.66  E-value=1.1e-07  Score=81.54  Aligned_cols=85  Identities=15%  Similarity=0.057  Sum_probs=61.7

Q ss_pred             CCceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEec
Q 017936           21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY   98 (363)
Q Consensus        21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~   98 (363)
                      ..|++++..+.++.+.||++.  ..++.+++|...... .....+.+|...++.+. +--+++++.+...++..++||++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            467887776666678999886  456678889876532 23445678888877664 33367788888888899999999


Q ss_pred             cCCCchHHH
Q 017936           99 ASGGELFER  107 (363)
Q Consensus        99 ~~~~~L~~~  107 (363)
                      ++|.++...
T Consensus        92 l~G~~~~~~  100 (263)
T d1j7la_          92 ADGVLCSEE  100 (263)
T ss_dssp             CSSEEHHHH
T ss_pred             ccccccccc
Confidence            999887543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.29  E-value=1.4e-06  Score=79.17  Aligned_cols=77  Identities=17%  Similarity=0.117  Sum_probs=49.3

Q ss_pred             eceecccCCeEEEEEEEcCCCcEEEEEEeec-----C---CcccHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEEE
Q 017936           26 VRDIGSGNFGVARLMRDKKTEELVAVKYIER-----G---DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAI   94 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~---~~~~~~~~~e~~~l~~l~---hpnIv~~~~~~~~~~~~~l   94 (363)
                      .+.||.|....||++.+..+++.+++|.-..     .   .....+...|...++.+.   ...+++++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            5678999999999999888888999996432     1   112344566777776552   2346666554  3444578


Q ss_pred             EEeccCCCch
Q 017936           95 VMEYASGGEL  104 (363)
Q Consensus        95 v~e~~~~~~L  104 (363)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.10  E-value=1.1e-05  Score=68.25  Aligned_cols=75  Identities=13%  Similarity=0.065  Sum_probs=52.1

Q ss_pred             eecccC-CeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC--CCeeeeeEEEEcCCeEEEEEeccCCCch
Q 017936           28 DIGSGN-FGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        28 ~lg~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      .+..|. .+.||++.. ..+..+++|......  ...+.+|...++.+..  -.+++++.+..+.+..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            334444 468899875 456668899765442  3456777777766542  3367788888888889999999988766


Q ss_pred             H
Q 017936          105 F  105 (363)
Q Consensus       105 ~  105 (363)
                      .
T Consensus        94 ~   94 (255)
T d1nd4a_          94 L   94 (255)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.74  E-value=5.3e-05  Score=66.63  Aligned_cols=70  Identities=13%  Similarity=0.144  Sum_probs=47.5

Q ss_pred             CeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-----eee--eEEEEcCCeEEEEEeccCCCch
Q 017936           34 FGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-----VRF--KEVILTPTHLAIVMEYASGGEL  104 (363)
Q Consensus        34 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-----v~~--~~~~~~~~~~~lv~e~~~~~~L  104 (363)
                      -..||+++. .+|+.|++|+........+.+..|...+..|....+     +..  -..+......+.+++++.|..+
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            458999986 568889999887766667778888888876642221     111  1123445678899999987443

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.65  E-value=7.8e-05  Score=67.38  Aligned_cols=74  Identities=14%  Similarity=0.095  Sum_probs=51.5

Q ss_pred             eceecccCCeEEEEEEEcC-------CCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEe
Q 017936           26 VRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME   97 (363)
Q Consensus        26 ~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e   97 (363)
                      ++.|+.|-.-.+|++....       ..+.|.+++.... ...-...+|..+++.+. +.-.+++++++..    ++|+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4678888889999998753       3456778876533 23345567888888775 3334577777643    78999


Q ss_pred             ccCCCch
Q 017936           98 YASGGEL  104 (363)
Q Consensus        98 ~~~~~~L  104 (363)
                      |++|.++
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9988655

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.19  E-value=0.00028  Score=61.36  Aligned_cols=141  Identities=16%  Similarity=0.109  Sum_probs=72.6

Q ss_pred             CceeeceecccCCeEEEEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-----CCCeeeeeE---EEEcCCeEE
Q 017936           22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFKE---VILTPTHLA   93 (363)
Q Consensus        22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-----hpnIv~~~~---~~~~~~~~~   93 (363)
                      +..-++.|..|.--+.|++... +| .|++|++... ...+.+..|+.++..|.     .|..+...+   +........
T Consensus        19 ~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~   95 (316)
T d2ppqa1          19 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   95 (316)
T ss_dssp             CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             CceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence            3444566777777889999864 34 4899988654 23445566666666553     222222110   112234556


Q ss_pred             EEEeccCCCchHH--------------HHHhC-C--------CCCHH------------------HHHHHHHHHHHHHHH
Q 017936           94 IVMEYASGGELFE--------------RICNA-G--------RFSED------------------EARFFFQQLISGVSY  132 (363)
Q Consensus        94 lv~e~~~~~~L~~--------------~~~~~-~--------~l~~~------------------~~~~~~~qil~~L~~  132 (363)
                      .++.+..|.....              .+... .        .....                  .....+..+...+..
T Consensus        96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  175 (316)
T d2ppqa1          96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  175 (316)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence            6666665533311              00000 0        00111                  111222223333333


Q ss_pred             HH----HcCceecCCCCCCEEEeCCCCCcEEEeecCCcc
Q 017936          133 CH----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  167 (363)
Q Consensus       133 LH----~~giiHrDlkp~NIll~~~~~~~vkL~DFgla~  167 (363)
                      .+    ..|+||+|+.++||+++.+..  .-++||+.|.
T Consensus       176 ~~~~~L~~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~  212 (316)
T d2ppqa1         176 HWPKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC  212 (316)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred             cCccccccccccCCcchhhhhcccccc--eeEecccccc
Confidence            33    257999999999999986543  5899999765

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=91.63  E-value=0.012  Score=37.09  Aligned_cols=54  Identities=15%  Similarity=0.252  Sum_probs=39.7

Q ss_pred             HHHHHHHHhCCCCCCCCChhhhhcCCCCcccccccCC--CCCCCCCCCCCCeeeec
Q 017936          309 EIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDI--DTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       309 ~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~g~i~~~  362 (363)
                      ++.+.+...+.+..|..+..++...........++++  ......|.|++|.|+|.
T Consensus         2 el~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~   57 (61)
T d2fcea1           2 DFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYK   57 (61)
T ss_dssp             HHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHH
T ss_pred             hHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHH
Confidence            5677888899999999999887655433333333222  56788999999999984

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=88.27  E-value=0.023  Score=36.21  Aligned_cols=55  Identities=16%  Similarity=0.265  Sum_probs=39.7

Q ss_pred             HHHHHHHHHhCCCCCCCCChhhhhcCCCCcccccccC--CCCCCCCCCCCCCeeeec
Q 017936          308 DEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDED--IDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~--~~~~~~~d~d~~g~i~~~  362 (363)
                      +++...+..-+.+..|.++.+++............++  .+.....|.|++|.|+|.
T Consensus         3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~   59 (65)
T d1fw4a_           3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYE   59 (65)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHH
T ss_pred             HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHH
Confidence            5677888899999999999988765433333333222  245677899999999995

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

Probab=85.71  E-value=0.027  Score=37.67  Aligned_cols=58  Identities=19%  Similarity=0.198  Sum_probs=40.9

Q ss_pred             CCHHHHHHHHHHhCCCCCCCCChhhhhcCCCCccc-ccccCCCCCCCCCCCCCCeeeec
Q 017936          305 QSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDD-EMDEDIDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~-~~~~~~~~~~~~d~d~~g~i~~~  362 (363)
                      +.+.++.+.+...+.+..|.++..++......... ..++-.+.+...|.|++|.|+|.
T Consensus         3 ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~ei~~~~~~~D~d~~G~I~~~   61 (81)
T d2opoa1           3 QDIADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEIDTDGDGFISFD   61 (81)
T ss_dssp             HHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTTTCCHHHHHHHHHHHCTTCSSEECHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHH
Confidence            34677888999999999999999887544222221 11111256778899999999985

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.63  E-value=0.061  Score=35.90  Aligned_cols=56  Identities=11%  Similarity=0.071  Sum_probs=41.6

Q ss_pred             HHHHHHHHHHhCCCCCCCCChhhhhcCCCCcccccccCC--CCCCCCCCCCCCeeeec
Q 017936          307 IDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDI--DTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~g~i~~~  362 (363)
                      ...+.+.+...+.+..|..+.+++............+++  ......|.|++|.|+|.
T Consensus        19 ~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~   76 (83)
T d1wlza1          19 YHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYP   76 (83)
T ss_dssp             HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHH
T ss_pred             HHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHH
Confidence            456778889999999999999998765333333333222  57888999999999995

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

Probab=84.59  E-value=0.033  Score=36.35  Aligned_cols=58  Identities=17%  Similarity=0.190  Sum_probs=41.6

Q ss_pred             CCHHHHHHHHHHhCCCCCCCCChhhhhcCCCCcccccccC--CCCCCCCCCCCCCeeeec
Q 017936          305 QSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDED--IDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~--~~~~~~~d~d~~g~i~~~  362 (363)
                      ..+.++...+...+.+..|..+..++............++  .+.....|.|++|.|+|.
T Consensus         5 eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~   64 (73)
T d2pq3a1           5 EQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFP   64 (73)
T ss_dssp             HHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHH
T ss_pred             HHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence            3567788899999999999999888765432322222222  256678899999999985

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

Probab=84.54  E-value=0.063  Score=35.73  Aligned_cols=58  Identities=19%  Similarity=0.192  Sum_probs=41.3

Q ss_pred             CCHHHHHHHHHHhCCCCCCCCChhhhhcCCCCcccccccC--CCCCCCCCCCCCCeeeec
Q 017936          305 QSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDED--IDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~--~~~~~~~d~d~~g~i~~~  362 (363)
                      .+-.++...+...+.+..|..+..++............++  .+.....|.|++|.|+|.
T Consensus        12 ~~ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~   71 (81)
T d1fi5a_          12 KTEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYD   71 (81)
T ss_dssp             CCHHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHH
T ss_pred             CCHHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHH
Confidence            3456788999999999999999998754433333222221  145667899999999985

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=82.79  E-value=0.035  Score=36.59  Aligned_cols=56  Identities=14%  Similarity=0.156  Sum_probs=40.2

Q ss_pred             HHHHHHHHHHhCCCCCCCCChhhhhcCCCCcccccc--cCCCCCCCCCCCCCCeeeec
Q 017936          307 IDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMD--EDIDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~--~~~~~~~~~d~d~~g~i~~~  362 (363)
                      .+++.+.+...+.+..+.++..++............  +-.+.+...|.|++|.|+|.
T Consensus         8 ~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~   65 (77)
T d1oqpa_           8 REEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDED   65 (77)
T ss_dssp             HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHH
T ss_pred             HHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHH
Confidence            457888899999999999999887655333322222  11246678899999999985

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=82.74  E-value=0.061  Score=35.24  Aligned_cols=58  Identities=17%  Similarity=0.099  Sum_probs=40.8

Q ss_pred             CCHHHHHHHHHHhCCCCCCCCChhhhhcCCCCccccccc--CCCCCCCCCCCCCCeeeec
Q 017936          305 QSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDE--DIDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~--~~~~~~~~d~d~~g~i~~~  362 (363)
                      .+-+++...+...+.+..|.++..++............+  -.+...+.|.|++|.|+|.
T Consensus         6 ~~eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~   65 (75)
T d1jc2a_           6 KSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFD   65 (75)
T ss_dssp             CCHHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHH
T ss_pred             CcHHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHH
Confidence            345678889999999999999998876443222222221  1245668899999999995

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=82.26  E-value=0.058  Score=35.47  Aligned_cols=58  Identities=17%  Similarity=0.159  Sum_probs=40.9

Q ss_pred             CCHHHHHHHHHHhCCCCCCCCChhhhhcCCCCcccccc--cCCCCCCCCCCCCCCeeeec
Q 017936          305 QSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMD--EDIDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~--~~~~~~~~~d~d~~g~i~~~  362 (363)
                      ..+.++.+.+...+.+..|..+..++............  +=.+.....|.|++|.|+|.
T Consensus         7 eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~   66 (77)
T d1f54a_           7 EQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFS   66 (77)
T ss_dssp             HHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHH
T ss_pred             HHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence            35667888899999999999998887644322222221  11246678899999999984

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=80.46  E-value=0.046  Score=34.89  Aligned_cols=53  Identities=15%  Similarity=0.261  Sum_probs=35.4

Q ss_pred             HHHHHHHhCCCCCCCCChhhhhcCCCCcccccccC--CCCCCCCCCCCCCeeeec
Q 017936          310 IMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDED--IDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       310 ~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~--~~~~~~~d~d~~g~i~~~  362 (363)
                      +...+...+.+..|..+..++............++  .+.+...|.|++|.|+|.
T Consensus         3 ~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~   57 (67)
T d1tiza_           3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNAD   57 (67)
T ss_dssp             HHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHH
T ss_pred             HHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHH
Confidence            45667778888888888888754432222222221  256778899999999984

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=80.02  E-value=0.062  Score=35.78  Aligned_cols=57  Identities=18%  Similarity=0.067  Sum_probs=39.0

Q ss_pred             CHHHHHHHHHHhCCCCCCCCChhhhhcCCCC--cccccccCCCCCCCCCCCCCCeeeec
Q 017936          306 SIDEIMQIIAEATIPAAGTQSLNQCLNGSLD--IDDEMDEDIDTDPDLDIDSSGEIVYA  362 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~--~~~~~~~~~~~~~~~d~d~~g~i~~~  362 (363)
                      .+.++...+...+.+..|.++..++......  ..-..++-.+.....|.|++|.|+|.
T Consensus        12 ~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~   70 (81)
T d1avsa_          12 MIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFE   70 (81)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHH
T ss_pred             HHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence            4566778888999999999999887543211  11111122246678899999999985